{"meta":{"query_hash":"432dfe733d98","filters":{"venue":"British Journal of Cancer"},"cohort_total":856,"direct_labels_cover":2,"predictions_cover":856,"exported":856,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/432dfe733d98","api":"https://metacan.xera.ac/api/v1/cohort?venue=British+Journal+of+Cancer"},"results":[{"id":"W107843614","doi":"10.1054/bjoc.2001.1944","title":"A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute","keywords":"CDKN2A; Haplotype; Mutation; Founder effect; Genetics; Biology; Cancer; Genotype; Gene","score_opus":0.009766246735765715,"score_gpt":0.27076031012066176,"score_spread":0.26099406338489606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W107843614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794155,0.0001229932,0.00020925619,0.000055218246,0.000006791672,0.000014119938,0.00014375852,0.000013621774,0.0014927301],"genre_scores_gemma":[0.99827874,0.00012353998,0.0004504929,0.000039066275,0.00000540411,0.000010407748,0.00016809146,0.000009500287,0.00091473927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995591,0.000050139857,0.000025696221,0.00014682213,0.0001182556,0.00010001034],"domain_scores_gemma":[0.9994604,0.00013567648,0.00009980895,0.00004410012,0.000096670374,0.00016337204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016015701,0.000629942,0.00040642387,0.0017163769,0.0024842399,0.00040179864,0.00043924147,0.00053902605,0.00345145],"category_scores_gemma":[0.0011221825,0.00038998306,0.00028516236,0.0013131979,0.001078222,0.000115148374,0.000542926,0.0004826456,0.00027376422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008500301,0.0002536352,0.72903025,0.00012486534,0.00019220248,0.11001022,0.009250749,0.0005784749,0.10696821,0.0013355449,0.0019331096,0.039472707],"study_design_scores_gemma":[0.00007555471,0.00023578184,0.87454724,0.00005795168,0.00020447081,0.10996448,0.0022750255,0.0004650422,0.006359578,0.00049295725,0.005235933,0.0000859679],"about_ca_topic_score_codex":0.14917718,"about_ca_topic_score_gemma":0.23948878,"teacher_disagreement_score":0.14917718,"about_ca_system_score_codex":0.001312365,"about_ca_system_score_gemma":0.0013743228,"threshold_uncertainty_score":0.29661775},"labels":[],"label_agreement":null},{"id":"W112815597","doi":"10.1038/bjc.2012.120","title":"Occupational cancer in Britain","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Pathology; Internal medicine","score_opus":0.014418180716164467,"score_gpt":0.31901465409880925,"score_spread":0.3045964733826448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W112815597","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14998099,0.04873188,0.0010436245,0.016896434,0.0066615087,0.00049088284,0.027643323,0.00058338995,0.74796796],"genre_scores_gemma":[0.24725178,0.02058734,0.0009745864,0.00375988,0.0010409924,0.00027195262,0.01276012,0.0001801366,0.7131731],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990214,0.0001865935,0.00007977564,0.00015390081,0.0003126719,0.00024568854],"domain_scores_gemma":[0.9992865,0.00009359927,0.00007789414,0.000087664055,0.00023274419,0.00022163033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005373683,0.00043573583,0.0005050717,0.0027074327,0.0021518185,0.001985597,0.0008878722,0.0009875096,0.12055792],"category_scores_gemma":[0.0017630383,0.0002714508,0.00053856947,0.0042626206,0.0006154672,0.0006586061,0.0020276671,0.0007539647,0.02841699],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032273598,0.00024103693,0.100298345,0.0018344164,0.000048559123,0.0040468946,0.00874065,0.00017799748,0.0014509988,0.014384253,0.4419142,0.42653993],"study_design_scores_gemma":[0.000015997059,0.000095205,0.1313546,0.00033836227,0.000009088177,0.0012199008,0.0030158977,0.000039593597,0.000082715065,0.00047388845,0.863342,0.0000127365265],"about_ca_topic_score_codex":0.035008464,"about_ca_topic_score_gemma":0.044690702,"teacher_disagreement_score":0.12055792,"about_ca_system_score_codex":0.0018498112,"about_ca_system_score_gemma":0.0023844424,"threshold_uncertainty_score":0.40330642},"labels":[],"label_agreement":null},{"id":"W1195715571","doi":"10.1038/bjc.2015.271","title":"TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; Saint John Regional Hospital; McMaster University; Queen's University; University of British Columbia; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Canadian Cancer Society Research Institute; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; Biomarker; Internal medicine; Taxane; Clinical trial; Oncology; Predictive value; Bioinformatics; Breast cancer; Cancer; Biology","score_opus":0.07907511513273946,"score_gpt":0.374545435195704,"score_spread":0.29547032006296453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1195715571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791418,0.011064796,0.0004438855,0.0014632433,0.00009317976,0.00034646905,0.0013434808,0.000046663055,0.006056472],"genre_scores_gemma":[0.99583036,0.0008371839,0.00030263508,0.0004875368,0.00007088901,0.00035588478,0.001180613,0.0000100260495,0.0009249816],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99919826,0.0004843005,0.000056734323,0.00008868636,0.00010054802,0.00007152056],"domain_scores_gemma":[0.9978929,0.00091512373,0.0005721616,0.00016576037,0.00013009836,0.00032390608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025412308,0.00040409976,0.00111935,0.00019372306,0.00021466576,0.00079956383,0.00048608534,0.00080069754,0.0028378195],"category_scores_gemma":[0.004345071,0.00012699568,0.00081576855,0.00035003526,0.00048216974,0.00069412024,0.00026920106,0.0012243802,0.00046212753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63442713,0.0016894845,0.14449929,0.002255852,0.0043839905,0.00044258562,0.00024167962,0.009091132,0.021176841,0.0016688914,0.01325551,0.16686763],"study_design_scores_gemma":[0.16085511,0.19131613,0.5520518,0.0010188777,0.0097059645,0.0026848873,0.00018523424,0.024045678,0.013227916,0.004262517,0.040465914,0.00017995307],"about_ca_topic_score_codex":0.000664152,"about_ca_topic_score_gemma":0.0030173382,"teacher_disagreement_score":0.0028378195,"about_ca_system_score_codex":0.00080777984,"about_ca_system_score_gemma":0.0010342884,"threshold_uncertainty_score":0.0134394765},"labels":[],"label_agreement":null},{"id":"W1275758655","doi":"10.1038/bjc.2015.284","title":"Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pancreatic cancer; Hypoxia (environmental); Stromal cell; Tumour heterogeneity; Pathology; Nitroimidazole; Medicine; Immunohistochemistry; Oncology; Internal medicine; Cancer; Biology; Chemistry; Oxygen","score_opus":0.012143342267712314,"score_gpt":0.26138549190006943,"score_spread":0.2492421496323571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1275758655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939406,0.00018218019,0.00024211375,0.000008084555,6.5391316e-7,0.0000038667786,0.00003849973,0.0000037426782,0.00012691061],"genre_scores_gemma":[0.99943334,0.00008048896,0.00029544835,0.000005880468,0.0000013762744,0.000005610417,0.00007939389,0.0000022324443,0.00009614884],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999137,0.000019749492,0.00000598375,0.000025215219,0.000019938587,0.00001551667],"domain_scores_gemma":[0.9998072,0.000056575736,0.00006658499,0.000012416465,0.000025037043,0.00003222875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001652905,0.00009156103,0.0002162117,0.00031160918,0.00014246716,0.00022758846,0.00008543453,0.00017231374,0.0005657608],"category_scores_gemma":[0.00034888403,0.00010164321,0.00008964232,0.0002670692,0.00018290873,0.00011239657,0.000116737756,0.00022701868,0.00009075392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047607706,0.000097670454,0.37523362,0.000083619285,0.00008456285,0.00094502093,0.00027972183,0.0005491983,0.6022654,0.00005628021,0.00009494628,0.015549127],"study_design_scores_gemma":[0.000018290295,0.0008407828,0.9552443,0.0000028090512,0.000050055005,0.0016217389,0.00014220465,0.0008779814,0.04081199,0.00002957834,0.00035424568,0.0000059765875],"about_ca_topic_score_codex":0.0007988658,"about_ca_topic_score_gemma":0.0007442137,"teacher_disagreement_score":0.0007988658,"about_ca_system_score_codex":0.00026380364,"about_ca_system_score_gemma":0.00009589717,"threshold_uncertainty_score":0.001914084},"labels":[],"label_agreement":null},{"id":"W1480740744","doi":"10.1054/bjoc.2000.1359","title":"Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Biology; Allele; Point mutation; Genotype; Molecular biology; Restriction fragment length polymorphism; Enzyme; Genetics; Mutation; Biochemistry; Gene","score_opus":0.014985762193178783,"score_gpt":0.30051467733111215,"score_spread":0.2855289151379334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480740744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988298,0.00012999568,0.0004456407,0.000011215538,0.0000030089552,0.0000064136825,0.00017684537,0.000008299321,0.00038872918],"genre_scores_gemma":[0.9991053,0.000060463357,0.000292949,0.000005246176,0.0000014362558,0.000006440254,0.00021424759,0.0000034839848,0.00031051043],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99972135,0.00007177917,0.000024686236,0.000066950095,0.00007893767,0.000036357185],"domain_scores_gemma":[0.99910706,0.000318132,0.00022931371,0.00008365312,0.00011512905,0.00014664547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024134251,0.00021681118,0.00014149808,0.00046379043,0.00009033878,0.00022053927,0.0001041148,0.0002487684,0.00096240273],"category_scores_gemma":[0.0011995953,0.00011870803,0.00006945173,0.00023504527,0.00017972648,0.000105289924,0.00013536967,0.00033672416,0.00016216807],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073442026,0.00011332036,0.25296748,0.000025194684,0.000047634025,0.00040040226,0.00007471591,0.0001589716,0.74120694,0.0000946799,0.000046356025,0.004129921],"study_design_scores_gemma":[0.000009470104,0.0011527644,0.8469165,0.0000044151893,0.000056030625,0.004275078,0.00013222144,0.0010121318,0.14561042,0.00010784798,0.000710057,0.000013055911],"about_ca_topic_score_codex":0.00051157916,"about_ca_topic_score_gemma":0.00068641506,"teacher_disagreement_score":0.00096240273,"about_ca_system_score_codex":0.00010276036,"about_ca_system_score_gemma":0.000080434715,"threshold_uncertainty_score":0.003219545},"labels":[],"label_agreement":null},{"id":"W1484628085","doi":"10.1054/bjoc.1999.0964","title":"Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Colorectal cancer; Immunohistochemistry; Medicine; Thymidylate synthase; Chemotherapy; Internal medicine; Hazard ratio; Oncology; Cancer; Immunostaining; Retrospective cohort study; Confidence interval; Gastroenterology; Pathology; Fluorouracil","score_opus":0.007577149139346323,"score_gpt":0.27618548461265835,"score_spread":0.26860833547331203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1484628085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99927,0.00035815596,0.00008475947,0.000019262045,0.000004324058,0.0000036461909,0.000049207247,0.0000027224248,0.00020783179],"genre_scores_gemma":[0.9997663,0.000053739106,0.00003644057,0.000005221377,0.000007852401,0.0000026747039,0.000059172187,6.600039e-7,0.0000679096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982893,0.00005422823,0.000019259956,0.00003278251,0.000033491346,0.000031256688],"domain_scores_gemma":[0.9990675,0.00034685107,0.0002732581,0.0000469801,0.00007357273,0.00019185759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031112117,0.00019638553,0.0002803975,0.0004218499,0.00021113976,0.00032982082,0.000152896,0.00034617225,0.0011655166],"category_scores_gemma":[0.0014457145,0.00013499972,0.00025670644,0.0003033428,0.00020888925,0.00021495558,0.00019450947,0.00033900788,0.00021186375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004042866,0.000016378443,0.99711454,0.0000064324195,0.000020616511,0.00014212863,0.000018692963,0.00007211017,0.0009394944,0.0000055216306,0.000028490535,0.0012312912],"study_design_scores_gemma":[0.0000071247223,0.00015657986,0.9984091,0.0000025024945,0.000031209827,0.000639034,0.000038679467,0.0003703655,0.00020674514,0.000013214747,0.00012329938,0.0000022408844],"about_ca_topic_score_codex":0.0006647653,"about_ca_topic_score_gemma":0.0009874123,"teacher_disagreement_score":0.0011655166,"about_ca_system_score_codex":0.000114001654,"about_ca_system_score_gemma":0.00011545073,"threshold_uncertainty_score":0.0038990378},"labels":[],"label_agreement":null},{"id":"W1485401317","doi":"10.1038/bjc.2015.181","title":"Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Celgene","keywords":"Medicine; Internal medicine; Carboplatin; Lung cancer; Quality of life (healthcare); Toxicity; Surgery; Paclitaxel; Gastroenterology; Oncology; Cancer; Chemotherapy; Cisplatin","score_opus":0.04050747418019523,"score_gpt":0.3860574733065346,"score_spread":0.3455499991263394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1485401317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997621,0.0017391848,0.00009500255,0.00004105848,0.000009407881,0.000023157527,0.00030414766,0.0000020090206,0.00016504743],"genre_scores_gemma":[0.99938,0.0001564924,0.000047551846,0.000030350402,0.000009791657,0.00001765321,0.00031405746,4.890784e-7,0.000043566997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940753,0.00024651096,0.000074261996,0.00009829938,0.00009576566,0.000077711615],"domain_scores_gemma":[0.99842,0.00039259027,0.00077299785,0.000054472373,0.00009526843,0.00026473726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017342286,0.00025219034,0.0007221399,0.00038152662,0.00014702689,0.00043030802,0.00018663604,0.0002748671,0.0008031153],"category_scores_gemma":[0.0019948531,0.00009160339,0.0015368089,0.00067984354,0.00016366495,0.00027562733,0.0002901669,0.00041874836,0.000055488243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04796911,0.0004999053,0.9267914,0.00030443832,0.0042989333,0.00006543017,0.000072599694,0.0013285305,0.0012124778,0.000043680764,0.00023577324,0.017177723],"study_design_scores_gemma":[0.0018903703,0.008241468,0.98599017,0.000031692012,0.0015855477,0.00013434948,0.00004967211,0.0012662433,0.00027222862,0.00007136104,0.00045474857,0.00001219281],"about_ca_topic_score_codex":0.0015526399,"about_ca_topic_score_gemma":0.0017132562,"teacher_disagreement_score":0.0017342286,"about_ca_system_score_codex":0.00058700953,"about_ca_system_score_gemma":0.0002735821,"threshold_uncertainty_score":0.009171605},"labels":[],"label_agreement":null},{"id":"W1490479332","doi":"10.1054/bjoc.2000.1489","title":"Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Comet assay; Hypoxia (environmental); Pathology; Medicine; Chemistry; Cancer research; Biochemistry; Oxygen; DNA damage; DNA","score_opus":0.024850880079954955,"score_gpt":0.2943039160931508,"score_spread":0.26945303601319587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490479332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7811504,0.013899006,0.19682418,0.000342357,0.00033665894,0.00052924646,0.0010610587,0.00061479385,0.005242347],"genre_scores_gemma":[0.8527875,0.00907289,0.12722524,0.0002797078,0.00020999993,0.0012820443,0.0020996009,0.000089531546,0.006953434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970612,0.0011908627,0.00019995122,0.00039715096,0.0009685515,0.00018226106],"domain_scores_gemma":[0.99690765,0.0016946585,0.0005011439,0.000208287,0.00049042323,0.00019781716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023724728,0.0012184533,0.0008094643,0.0026395833,0.00031715512,0.0005882316,0.00061161886,0.0009546167,0.00158636],"category_scores_gemma":[0.0025578155,0.00049052597,0.0006558307,0.0011743137,0.0006017,0.0006336551,0.0005000317,0.0009986579,0.0005998774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023918548,0.00005053274,0.0029677444,0.00024027258,0.00006794595,0.000047845035,0.00012212776,0.00016568795,0.9915236,0.00010779156,0.00006728552,0.0043998947],"study_design_scores_gemma":[0.000073643074,0.0028093052,0.10033649,0.000050192444,0.00020125632,0.0011579547,0.00018403688,0.007168935,0.88500243,0.0002473437,0.0026916217,0.00007682114],"about_ca_topic_score_codex":0.000866248,"about_ca_topic_score_gemma":0.0015689177,"teacher_disagreement_score":0.0026395833,"about_ca_system_score_codex":0.00043234663,"about_ca_system_score_gemma":0.00023887922,"threshold_uncertainty_score":0.012547016},"labels":[],"label_agreement":null},{"id":"W1501445218","doi":"10.1038/bjc.2015.194","title":"SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Wallonie-Bruxelles International; Fondation Medic; Amis de l'Institut Bordet; Institut National Du Cancer; Université Libanaise","keywords":"Messenger RNA; Biology; Untranslated region; Molecular biology; Single-nucleotide polymorphism; microRNA; Cancer research; Genotype; Gene; Genetics","score_opus":0.020855771270648644,"score_gpt":0.27859477050181236,"score_spread":0.2577389992311637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1501445218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815756,0.00073570915,0.00068000844,0.00002371207,0.0000073978345,0.000005584796,0.00012623933,0.0000110363,0.00025277608],"genre_scores_gemma":[0.9990934,0.00011157697,0.0005109894,0.00001418695,0.000004571964,0.000004777488,0.000097127326,0.0000035857843,0.00015979387],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998615,0.000030534204,0.000016106913,0.000050448412,0.00002755504,0.000013952926],"domain_scores_gemma":[0.9996923,0.00010709881,0.00012432273,0.000027268046,0.00002127408,0.000027701419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028105994,0.00020497054,0.00020123927,0.0002515271,0.00010814367,0.00021988983,0.00011882117,0.00026743795,0.0015706111],"category_scores_gemma":[0.00054898,0.00015074453,0.00020007603,0.00014422603,0.00015140184,0.00008742727,0.00010784709,0.0002655752,0.0003286175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022505627,0.00008313258,0.2644378,0.00012068125,0.00012366018,0.00060961663,0.00012216938,0.00046247384,0.7222865,0.00012355208,0.000184787,0.009195009],"study_design_scores_gemma":[0.000039324023,0.00072963274,0.82290155,0.00003190694,0.0002581419,0.0040088953,0.00010957603,0.003116027,0.16630827,0.00024899427,0.002233301,0.000014392808],"about_ca_topic_score_codex":0.00023047089,"about_ca_topic_score_gemma":0.00032630356,"teacher_disagreement_score":0.0015706111,"about_ca_system_score_codex":0.00012327978,"about_ca_system_score_gemma":0.00007041511,"threshold_uncertainty_score":0.005254209},"labels":[],"label_agreement":null},{"id":"W1501785654","doi":"10.1054/bjoc.1999.0941","title":"Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Immunosuppression; Incidence (geometry); Cancer; Breast cancer; House mice; Biology; House mouse; Immunology; Virology; Genetics; Zoology","score_opus":0.011268264321995231,"score_gpt":0.25975462176437686,"score_spread":0.24848635744238162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1501785654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959644,0.0011477923,0.00048188676,0.000059513328,0.000006839944,0.00000569034,0.00046939583,0.00005411618,0.0018103466],"genre_scores_gemma":[0.99769443,0.00029211963,0.00043472994,0.00004590205,0.000007458234,0.000006961897,0.0004890614,0.000013159915,0.0010162267],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997558,0.000040139792,0.000016936325,0.00010252352,0.00004447623,0.000040205497],"domain_scores_gemma":[0.9996984,0.000027691814,0.00012240045,0.000036025158,0.00003291738,0.00008261534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016597578,0.00014686715,0.00025366954,0.0013865406,0.00022592951,0.0003020914,0.00012969488,0.00022099013,0.0020096889],"category_scores_gemma":[0.0002099968,0.00016174602,0.0001826257,0.00037856933,0.00021660888,0.00017816578,0.00026492652,0.00021532296,0.0003056495],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051452185,0.00007741198,0.16568948,0.00006844894,0.0001305206,0.000277488,0.00027454383,0.000052300555,0.82228565,0.00038071186,0.00047186526,0.009776996],"study_design_scores_gemma":[0.000013984924,0.00039166614,0.9541591,0.000016896214,0.00009436471,0.0035914546,0.0003097064,0.00013471436,0.036486086,0.00023324105,0.0045569893,0.000011876222],"about_ca_topic_score_codex":0.0005778359,"about_ca_topic_score_gemma":0.0015903783,"teacher_disagreement_score":0.0020096889,"about_ca_system_score_codex":0.00017603372,"about_ca_system_score_gemma":0.00008299743,"threshold_uncertainty_score":0.006723106},"labels":[],"label_agreement":null},{"id":"W1508317033","doi":"10.1054/bjoc.2000.1332","title":"BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"Cancer Care Ontario","keywords":"Breast cancer; Family history; Ovarian cancer; Turkish population; BRCA2 Protein; Population; Oncology; Medicine; Cancer; Genetic counseling; Germline mutation; BRCA mutation; Mutation; Male breast cancer; Internal medicine; Genetics; Biology; Gene; Genotype","score_opus":0.0040988347143655285,"score_gpt":0.2414855450724439,"score_spread":0.23738671035807837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508317033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993932,0.00031189082,0.000027478642,0.00001595968,0.0000038578028,0.000004049109,0.000059610844,0.000002861724,0.00018111397],"genre_scores_gemma":[0.9993961,0.00021172591,0.00008289425,0.000042582084,0.000007816981,0.000007240269,0.00012218374,0.0000020688974,0.00012739655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963725,0.00007044871,0.000042931493,0.00009291394,0.000060517476,0.00009589113],"domain_scores_gemma":[0.9994222,0.00015483661,0.00020150926,0.000029870125,0.000064363805,0.00012736901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024489363,0.00037240528,0.00037939285,0.0013457823,0.00075438555,0.0003785031,0.00021991668,0.00062208524,0.001439082],"category_scores_gemma":[0.0020588553,0.00038624305,0.000266699,0.0008271387,0.00039107742,0.00022944894,0.00030666555,0.00021397139,0.00024046855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029351524,0.00006599115,0.9842929,0.000030740382,0.000032197826,0.006883172,0.0009514175,0.00006059103,0.002363604,0.000040079212,0.00031978707,0.004666034],"study_design_scores_gemma":[0.000031722142,0.00020675534,0.97055143,0.00001979259,0.000060661856,0.026819056,0.0007422561,0.00014478063,0.00056651747,0.00006713419,0.00077476597,0.0000152008815],"about_ca_topic_score_codex":0.008213251,"about_ca_topic_score_gemma":0.006431115,"teacher_disagreement_score":0.008213251,"about_ca_system_score_codex":0.00047901698,"about_ca_system_score_gemma":0.0002760255,"threshold_uncertainty_score":0.016330898},"labels":[],"label_agreement":null},{"id":"W1509428552","doi":"10.1038/bjc.2015.189","title":"The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Institut National Du Cancer; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale","keywords":"Gene isoform; Tumor suppressor gene; Cancer research; Gene; Suppressor; Biology; Von Hippel–Lindau disease; Gene expression; Pathology; Medicine; Genetics; Carcinogenesis; Disease","score_opus":0.010429803657703665,"score_gpt":0.2533353408332486,"score_spread":0.24290553717554494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1509428552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910452,0.002090686,0.0051363427,0.0003145332,0.000028135413,0.000024308521,0.0003684831,0.000072410214,0.0009199203],"genre_scores_gemma":[0.99039876,0.0016566808,0.004854342,0.00011680012,0.00002296078,0.000017302078,0.00069511303,0.000030249585,0.0022079041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999553,0.0000038312787,0.0000019385557,0.00000983172,0.000019099843,0.000010077012],"domain_scores_gemma":[0.9999422,0.000013447011,0.000017761704,0.0000042037864,0.0000061337755,0.000016287526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009188299,0.00016614742,0.00010050619,0.00022019763,0.00009876931,0.00017271923,0.00015977354,0.00026672494,0.0008097655],"category_scores_gemma":[0.0000802145,0.000092729926,0.000109006935,0.00013758692,0.00022929104,0.00010210727,0.00012749727,0.00040642158,0.00029680142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047755322,0.000011005606,0.0009751361,0.00004209769,0.000004131694,0.00037935012,0.000016990974,0.000052122305,0.9964539,0.00011422611,0.00008853536,0.0018147168],"study_design_scores_gemma":[0.000032298823,0.0002810012,0.037201054,0.000016034246,0.00004720608,0.006394031,0.00010219624,0.0027863118,0.9377582,0.00035581994,0.015014827,0.000011131951],"about_ca_topic_score_codex":0.0004539834,"about_ca_topic_score_gemma":0.000762731,"teacher_disagreement_score":0.0008097655,"about_ca_system_score_codex":0.00023153714,"about_ca_system_score_gemma":0.00020832695,"threshold_uncertainty_score":0.002708912},"labels":[],"label_agreement":null},{"id":"W1512421662","doi":"10.1054/bjoc.2000.1283","title":"Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Wilms' tumor; Wilms tumour; Genetics; Genetic linkage; Biology; Chromosome; Gene; Linkage (software); Cancer research","score_opus":0.0166380690193381,"score_gpt":0.2980254269478705,"score_spread":0.28138735792853237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512421662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960211,0.0016721088,0.00040850678,0.00020514993,0.00001457962,0.000003482603,0.00014241919,0.000020073705,0.0015125561],"genre_scores_gemma":[0.9979857,0.0008036728,0.0003486472,0.000034888784,0.000030933224,0.0000040508476,0.00026603555,0.0000049442956,0.00052110763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985754,0.000024374327,0.000020224532,0.000032328695,0.000039025843,0.00002644983],"domain_scores_gemma":[0.99888617,0.00041731275,0.0002725319,0.00006498443,0.00014661167,0.0002123408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000325501,0.00024760913,0.00021255006,0.0012230928,0.0003180338,0.0002629877,0.00018075868,0.00047514314,0.004925632],"category_scores_gemma":[0.0010903291,0.000121552664,0.0001822995,0.0006197374,0.0005225893,0.00014136377,0.0002720114,0.00023266929,0.0003364535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013615064,0.00010905657,0.7546655,0.0004900444,0.00030238982,0.030833174,0.0010422902,0.0005037557,0.1840397,0.0021929217,0.0017275343,0.02273209],"study_design_scores_gemma":[0.000100194826,0.00026796098,0.8779364,0.000070732916,0.00023508776,0.09170237,0.00038411058,0.00045745843,0.019275097,0.0015794581,0.007961955,0.000029051469],"about_ca_topic_score_codex":0.0010781577,"about_ca_topic_score_gemma":0.0011175601,"teacher_disagreement_score":0.004925632,"about_ca_system_score_codex":0.00014675249,"about_ca_system_score_gemma":0.00020017773,"threshold_uncertainty_score":0.016477883},"labels":[],"label_agreement":null},{"id":"W1513533768","doi":"10.1054/bjoc.2000.1464","title":"Expression of the novel tumour suppressor p33ING1 is independent of p53","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; Vancouver Infectious Diseases Centre; University of British Columbia","funders":"Medical Research Council; Medical Research Council Canada; Canadian Dermatology Foundation","keywords":"HaCaT; Carcinogenesis; Biology; Cancer research; Apoptosis; Keratinocyte; Cell culture; Tumor suppressor gene; Suppressor; Cell growth; Cell biology; Knockout mouse; Molecular biology; Cancer; Gene; Genetics","score_opus":0.011297333942718785,"score_gpt":0.2600544144026229,"score_spread":0.2487570804599041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1513533768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954268,0.0013703423,0.0019411598,0.0000799038,0.000011865092,0.00000997045,0.00016912328,0.000077573975,0.0009132331],"genre_scores_gemma":[0.99695575,0.0006904932,0.0007409391,0.000014164427,0.0000052399637,0.0000070464093,0.00037354167,0.0000106848265,0.0012022047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999393,0.000007838159,0.0000042436436,0.000011361281,0.00001648801,0.00002069427],"domain_scores_gemma":[0.9998628,0.000027649972,0.000042200714,0.0000226842,0.000013363056,0.00003130124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009073618,0.00026018717,0.00014725333,0.00018853859,0.00013038618,0.00029280642,0.00013432124,0.0001720637,0.00070010533],"category_scores_gemma":[0.0001337058,0.00010264949,0.00014335143,0.00012458302,0.00020413929,0.00015263219,0.00014960284,0.00032656093,0.0003529963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041963493,0.0000058651804,0.0003110652,0.000016891921,0.0000010664646,0.0001723441,0.000006791962,0.000027790957,0.9983821,0.00010689471,0.00002105267,0.0009060567],"study_design_scores_gemma":[0.0000075163794,0.00018180917,0.012107031,0.000005503933,0.000013610159,0.0018457419,0.00003352212,0.00083432504,0.98143274,0.00015768506,0.0033767053,0.0000038468597],"about_ca_topic_score_codex":0.00024612065,"about_ca_topic_score_gemma":0.00031964332,"teacher_disagreement_score":0.00070010533,"about_ca_system_score_codex":0.00015875198,"about_ca_system_score_gemma":0.000112197085,"threshold_uncertainty_score":0.002342105},"labels":[],"label_agreement":null},{"id":"W1516737592","doi":"10.1054/bjoc.2000.1203","title":"True","year":2000,"lang":"fr","type":"review","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine","score_opus":0.02665370392028779,"score_gpt":0.34200776626536206,"score_spread":0.31535406234507424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1516737592","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063215184,0.07532491,0.0020487062,0.010498403,0.02157651,0.0014325747,0.14824624,0.0045081144,0.73573244],"genre_scores_gemma":[0.004448629,0.039326984,0.0046757576,0.012920675,0.0056296415,0.00089686393,0.058963995,0.0011472716,0.87199014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994228,0.00010307406,0.00008056836,0.000070644084,0.0002563526,0.00006658999],"domain_scores_gemma":[0.9979367,0.0007708033,0.00027022103,0.00014477607,0.000695236,0.00018237537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059233775,0.0012283822,0.0015025495,0.0043154135,0.00061878655,0.0031721685,0.0016633248,0.0014133643,0.8573107],"category_scores_gemma":[0.0061133895,0.00044488857,0.0010736642,0.0033901457,0.00033238207,0.0016987111,0.0012648429,0.0008022934,0.5350015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003534655,0.0000074059303,0.000040138693,0.002461922,0.000010107698,0.000040365216,0.000013080282,0.00001929109,0.000061677296,0.0006980763,0.91224456,0.084368095],"study_design_scores_gemma":[0.000061236,0.000019642284,0.0002821421,0.0019097119,0.000019991185,0.00019583675,0.000021413138,0.000020122054,0.000070550326,0.00068229705,0.9967114,0.000005757779],"about_ca_topic_score_codex":0.0050258497,"about_ca_topic_score_gemma":0.006536902,"teacher_disagreement_score":0.14268929,"about_ca_system_score_codex":0.0012141123,"about_ca_system_score_gemma":0.0020723832,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W1520347472","doi":"10.1038/bjc.2015.6","title":"MicroRNA in radiotherapy: miRage or miRador?","year":2015,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Prostate Cancer Canada; Movember Foundation","keywords":"Radioresistance; Radiation therapy; microRNA; Prostate cancer; Medicine; Cancer; Radiobiology; Bioinformatics; Cancer research; DNA damage; Oncology; Biology; Internal medicine; DNA; Genetics; Gene","score_opus":0.03150720619588156,"score_gpt":0.3534881633461657,"score_spread":0.32198095715028413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1520347472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015937019,0.99621636,0.0002886911,0.0009470649,0.000618873,0.0000027648744,0.000011396991,0.000011531336,0.0017439392],"genre_scores_gemma":[0.0025575403,0.9934714,0.00039647787,0.00071874255,0.00039365047,0.0000089723835,0.000021021067,0.000006837661,0.0024253374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998215,0.000040679653,0.000025034251,0.000038474966,0.00005436084,0.00002006726],"domain_scores_gemma":[0.9998217,0.000085044136,0.000024346877,0.000008853211,0.000037149664,0.000022862136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005533464,0.0007288998,0.0012764813,0.0009268602,0.00038193108,0.0014013262,0.00059192465,0.0017545836,0.0030183955],"category_scores_gemma":[0.00068231206,0.0002944974,0.00032820168,0.0012010301,0.0013647063,0.001919727,0.00079488795,0.0022083363,0.0033567604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012895215,0.000038183854,0.0002697961,0.00730446,0.000054973272,0.0004316019,0.00027534988,0.00022337632,0.009602836,0.020723905,0.031431705,0.9295148],"study_design_scores_gemma":[0.000006562802,0.000055782693,0.00044176442,0.00090055284,0.000029068411,0.0012030444,0.00010048491,0.00005828597,0.0012460407,0.0040700487,0.9918732,0.000015136688],"about_ca_topic_score_codex":0.0006373467,"about_ca_topic_score_gemma":0.001078134,"teacher_disagreement_score":0.0030183955,"about_ca_system_score_codex":0.0007094192,"about_ca_system_score_gemma":0.0007580576,"threshold_uncertainty_score":0.010097563},"labels":[],"label_agreement":null},{"id":"W1524781181","doi":"10.1038/bjc.2015.171","title":"Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Lung cancer; Medicine; Value (mathematics); Parametric statistics; Lung; Pathology; Internal medicine; Oncology; Statistics; Mathematics","score_opus":0.04659178315381654,"score_gpt":0.36188258368458565,"score_spread":0.3152908005307691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1524781181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972703,0.0009979189,0.00095676543,0.000073764604,0.0000067392907,0.000015075665,0.0001638082,0.000050286493,0.00046535622],"genre_scores_gemma":[0.9992994,0.000058007343,0.0004145181,0.000013800939,0.000009311193,0.000004626153,0.0001248401,0.000003015522,0.00007246887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990934,0.0004893214,0.000039990282,0.00014594352,0.00015921674,0.00007205318],"domain_scores_gemma":[0.99791414,0.0010371781,0.0003717727,0.00018447136,0.0002657606,0.00022674401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025588423,0.0005321441,0.00053080387,0.0009756837,0.0002538977,0.0007850377,0.00030927427,0.00045396094,0.0008501768],"category_scores_gemma":[0.004804271,0.0001526009,0.00043156775,0.0006270174,0.00027370706,0.00033913058,0.0005430968,0.00048078943,0.0002241059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017476063,0.00006749851,0.9699342,0.000033337383,0.00027212227,0.000114510025,0.000055996137,0.0014236746,0.010136129,0.00002787922,0.0001993568,0.015987651],"study_design_scores_gemma":[0.000031849468,0.0010245806,0.97176975,0.000011882882,0.00030296767,0.0006479545,0.00006311045,0.016809404,0.008334886,0.00012381244,0.00085774314,0.000022164057],"about_ca_topic_score_codex":0.0014328026,"about_ca_topic_score_gemma":0.0017634118,"teacher_disagreement_score":0.0025588423,"about_ca_system_score_codex":0.00042613538,"about_ca_system_score_gemma":0.00032269422,"threshold_uncertainty_score":0.013532639},"labels":[],"label_agreement":null},{"id":"W1544307618","doi":"10.1054/bjoc.1999.0984","title":"Evidence of a founder BRCA1 mutation in Scotland","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; University of Toronto; Occupational Cancer Research Centre; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"University of St Andrews; Medical Research Council; National Cancer Institute; National Institutes of Health; University of Glasgow; University of Toronto","keywords":"Founder effect; Haplotype; Genealogy; Mutation; Ethnic group; Genetics; Population; Demography; Genotype; Breast cancer; Medicine; Geography; Biology; Cancer; History; Anthropology; Gene; Sociology","score_opus":0.01838225682872707,"score_gpt":0.3114991038513147,"score_spread":0.2931168470225876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1544307618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883467,0.00024975042,0.000047254278,0.000078385136,0.000009164076,0.0000029006358,0.000108765875,0.000004734393,0.000664367],"genre_scores_gemma":[0.99912614,0.00028363705,0.000065359825,0.00007905131,0.000018148332,0.0000024293965,0.00015041129,0.0000031163945,0.00027166962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938977,0.000094242336,0.00006117471,0.00008545445,0.00018578056,0.00018370057],"domain_scores_gemma":[0.99841595,0.00038069367,0.0005176397,0.00010759629,0.0002784027,0.00029973462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047851502,0.00023133699,0.0004839528,0.0021422226,0.0010305371,0.00061497197,0.00038732155,0.00044964877,0.003001351],"category_scores_gemma":[0.0025651911,0.00032267452,0.00028183084,0.0012685856,0.0006553761,0.00021679154,0.0007674858,0.0002245769,0.0003632746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051489123,0.000059255814,0.93738586,0.00009620213,0.000057182886,0.022632873,0.0038125562,0.0001335898,0.015053485,0.00039145857,0.0010241967,0.018838592],"study_design_scores_gemma":[0.000065521395,0.00050805206,0.96589303,0.000042421758,0.00008075557,0.026741512,0.001528056,0.00015204978,0.0014436856,0.00017719076,0.003344467,0.000023244873],"about_ca_topic_score_codex":0.033256814,"about_ca_topic_score_gemma":0.03025402,"teacher_disagreement_score":0.033256814,"about_ca_system_score_codex":0.00055599556,"about_ca_system_score_gemma":0.0007359255,"threshold_uncertainty_score":0.066126525},"labels":[],"label_agreement":null},{"id":"W1546193247","doi":"10.1054/bjoc.2000.1495","title":"Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"Hydro-Québec; Université de Sherbrooke; Université Laval","keywords":"Medicine; Odds ratio; Risk factor; Pediatrics; Population; Etiology; Breast cancer; Breast feeding; Pregnancy; Case-control study; Cancer; Internal medicine","score_opus":0.005391761235841223,"score_gpt":0.26282444549451867,"score_spread":0.25743268425867744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546193247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939824,0.004495459,0.00009887454,0.00013461165,0.000011650095,0.000012724257,0.0006560599,0.00000841253,0.00059996784],"genre_scores_gemma":[0.99776506,0.0012513701,0.00015485093,0.000034501434,0.000007837646,0.000006962383,0.0004326641,0.0000017363001,0.00034511028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996207,0.000086271015,0.000024486195,0.000049366583,0.000100262216,0.00011897852],"domain_scores_gemma":[0.99835277,0.00026974472,0.0007254347,0.000050012906,0.00021560611,0.00038646997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045066167,0.00032104575,0.00033029722,0.0007785362,0.00067230384,0.0008549833,0.00042517652,0.0004976618,0.0013015777],"category_scores_gemma":[0.0020432684,0.00024411036,0.00029339103,0.0018165965,0.00044024855,0.00022558599,0.00022676535,0.00069463375,0.00012796803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011056612,0.000022303862,0.9976833,0.000020294327,0.00004749552,0.000112264126,0.000037933998,0.00005334013,0.00022472545,0.000013101377,0.00008453139,0.001590071],"study_design_scores_gemma":[0.0000025838185,0.000036984973,0.9995702,0.000007362593,0.000014486977,0.000095843934,0.000027036627,0.000047255715,0.000028221228,0.0000072729795,0.00016126866,0.000001539645],"about_ca_topic_score_codex":0.4771779,"about_ca_topic_score_gemma":0.51958656,"teacher_disagreement_score":0.4771779,"about_ca_system_score_codex":0.0022661423,"about_ca_system_score_gemma":0.0017370789,"threshold_uncertainty_score":0.9488008},"labels":[],"label_agreement":null},{"id":"W1547816603","doi":"10.1054/bjoc.1999.0993","title":"No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôtel-Dieu de Montréal; Montreal Heart Institute; Jewish General Hospital; Montreal General Hospital","funders":"Cancer Research Society","keywords":"Head and neck squamous-cell carcinoma; Head and neck; Basal cell; Epidermoid carcinoma; Medicine; Oncology; Head and neck cancer; Pathology; Internal medicine; Cancer; Surgery","score_opus":0.006620101483053699,"score_gpt":0.2256495858015179,"score_spread":0.2190294843184642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547816603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983254,0.00062353065,0.00010566189,0.000070205395,0.000009845546,0.0000039108454,0.00008517998,0.0000056454483,0.00077041995],"genre_scores_gemma":[0.9993304,0.00018982212,0.00007032802,0.000018763236,0.000015548712,0.0000025522027,0.00007275047,0.0000024990889,0.000297334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995677,0.00012840859,0.000043745982,0.0000992031,0.000090888054,0.00007003366],"domain_scores_gemma":[0.99720925,0.001187907,0.00073023955,0.00018887137,0.00016765409,0.00051613664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006263464,0.00025026643,0.00029482527,0.0008122807,0.00035000255,0.00032797866,0.0002797633,0.0006356733,0.0047702123],"category_scores_gemma":[0.0032718081,0.00022617911,0.00023907337,0.0005122928,0.0005915369,0.00023889837,0.00022698603,0.00039042946,0.00042016726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011246341,0.000052659383,0.9903702,0.000032461292,0.00011452023,0.00061608787,0.00008522027,0.000035244735,0.0049498463,0.000067464236,0.00008954666,0.0024621552],"study_design_scores_gemma":[0.000024487725,0.00046153992,0.9953224,0.00001016807,0.00008792814,0.0027689426,0.00007888995,0.00014776441,0.0005743133,0.00013267765,0.00038430275,0.0000065559275],"about_ca_topic_score_codex":0.0017873055,"about_ca_topic_score_gemma":0.0021862565,"teacher_disagreement_score":0.0047702123,"about_ca_system_score_codex":0.00015358876,"about_ca_system_score_gemma":0.0002518028,"threshold_uncertainty_score":0.015957952},"labels":[],"label_agreement":null},{"id":"W1547880281","doi":"10.1038/bjc.2015.220","title":"BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Gemcitabine; Pancreatic cancer; Cisplatin; Medicine; Oncology; Cancer research; Internal medicine; Chemotherapy; BRCA mutation; Germline mutation; Cancer; Germline; Mutation; Ovarian cancer; Biology; Genetics; Gene","score_opus":0.03079712940837903,"score_gpt":0.35476318512389077,"score_spread":0.32396605571551174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547880281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971282,0.0006129303,0.0007048973,0.00005285288,0.000013808802,0.000047516154,0.00045171785,0.000030922005,0.0009572009],"genre_scores_gemma":[0.9958133,0.0006350903,0.0013515917,0.000052167496,0.000005802063,0.00004273791,0.0013717721,0.000024031433,0.0007034698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967444,0.000107711465,0.000046779758,0.000049926948,0.000083564395,0.00003753486],"domain_scores_gemma":[0.9992514,0.0003377647,0.000095776646,0.00014612748,0.000071027884,0.00009785642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005107024,0.00028718848,0.00053838216,0.00025387667,0.00019264033,0.00054178044,0.0002731932,0.00042144913,0.0024591275],"category_scores_gemma":[0.00076688087,0.0002359857,0.00031102623,0.00037875146,0.00019951139,0.00031976524,0.00027547972,0.00094690925,0.0005500029],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011572676,0.0005494591,0.01754349,0.00015752525,0.00010773765,0.00087182404,0.00030596243,0.001758893,0.9723741,0.00032430366,0.0006421338,0.0042072865],"study_design_scores_gemma":[0.00024591415,0.009144914,0.1097775,0.000058724585,0.0002342382,0.017243598,0.00043869595,0.0072491644,0.84420633,0.00034741074,0.011015629,0.00003784074],"about_ca_topic_score_codex":0.00057275046,"about_ca_topic_score_gemma":0.0006892275,"teacher_disagreement_score":0.0024591275,"about_ca_system_score_codex":0.00037293727,"about_ca_system_score_gemma":0.00021364358,"threshold_uncertainty_score":0.008226633},"labels":[],"label_agreement":null},{"id":"W1550139395","doi":"10.1038/bjc.2015.151","title":"18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; St. Joseph’s Healthcare Hamilton; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University Health Network; Hamilton Health Sciences; University of Toronto; Thunder Bay Regional Health Sciences Centre; Ontario Clinical Oncology Group; London Health Sciences Centre; McMaster University","funders":"American Society of Clinical Oncology","keywords":"Medicine; Positron emission tomography; Breast cancer; Prospective cohort study; Fluorodeoxyglucose; Cancer; Radiology; Lymphoma; Lung cancer; Malignancy; Confidence interval; Nuclear medicine; Internal medicine","score_opus":0.02320160797071249,"score_gpt":0.34285535143968415,"score_spread":0.3196537434689717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550139395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964504,0.0018183928,0.00020118139,0.000095144176,0.000024232684,0.000044221935,0.00035766108,0.000009665772,0.0009990426],"genre_scores_gemma":[0.9986979,0.00047917606,0.00024166837,0.000058981186,0.000021875883,0.000015780639,0.00031351225,0.000002835098,0.00016823165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993845,0.00016402919,0.0000736838,0.00013309687,0.00014589127,0.000098786826],"domain_scores_gemma":[0.99746656,0.0007095678,0.0010013747,0.00017053193,0.000355664,0.0002963272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013309042,0.00027967023,0.0004038675,0.00071272854,0.0003022674,0.00059529894,0.00048415447,0.00046903978,0.0016530575],"category_scores_gemma":[0.0044798427,0.00020665623,0.00039196925,0.00063430134,0.00026956294,0.00030899607,0.00027963344,0.00044007716,0.0004338618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108717686,0.00001732455,0.9974681,0.000010457366,0.000020026731,0.00013961892,0.000020682555,0.000019714835,0.000119079836,0.000002981694,0.00009331685,0.0019799965],"study_design_scores_gemma":[0.000027199394,0.00029310508,0.9953075,0.00003547449,0.000073600466,0.002931368,0.00011100396,0.00031192426,0.00028813523,0.000015997723,0.0005972989,0.00000729774],"about_ca_topic_score_codex":0.011398699,"about_ca_topic_score_gemma":0.018678127,"teacher_disagreement_score":0.011398699,"about_ca_system_score_codex":0.00063446123,"about_ca_system_score_gemma":0.00049887266,"threshold_uncertainty_score":0.022664726},"labels":[],"label_agreement":null},{"id":"W1561709169","doi":"10.1054/bjoc.2000.1221","title":"True","year":2000,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Hôtel-Dieu de Montréal; Montreal General Hospital; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine","score_opus":0.005702731378127752,"score_gpt":0.24619075542878752,"score_spread":0.24048802405065978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1561709169","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008528711,0.0020430505,0.002136398,0.035936028,0.017061051,0.00006118015,0.0020048344,0.0010360408,0.93886864],"genre_scores_gemma":[0.0057737986,0.000794404,0.00093563646,0.008015789,0.0016064774,0.000042695563,0.00077461236,0.00043156723,0.981625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827564,0.00029418332,0.00006916342,0.0002949269,0.00081050664,0.0002555473],"domain_scores_gemma":[0.99687815,0.0004380864,0.00012285606,0.00045262315,0.0014612987,0.0006469467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016528277,0.00055053475,0.0004316443,0.0011734411,0.0019905695,0.004635824,0.001000332,0.0017499878,0.56679785],"category_scores_gemma":[0.008265306,0.00033030886,0.0004960712,0.00070911366,0.0010627193,0.002899126,0.002492237,0.0028643804,0.39509335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032503365,0.000008743258,0.00029788687,0.000046394303,0.0000036463034,0.00007029691,0.00016148435,0.000010408494,0.00013331477,0.021049015,0.9232368,0.054949503],"study_design_scores_gemma":[0.0000038691487,0.0000029871874,0.00019901655,0.000021990509,0.0000020235868,0.000114287104,0.00007171444,0.000009283942,0.00004739561,0.0023438947,0.99718,0.0000037097734],"about_ca_topic_score_codex":0.008135076,"about_ca_topic_score_gemma":0.012306819,"teacher_disagreement_score":0.56679785,"about_ca_system_score_codex":0.0015259411,"about_ca_system_score_gemma":0.002428577,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W1564728191","doi":"10.1038/bjc.2015.196","title":"Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Hospital Foundation","funders":"Astellas Pharma; GlaxoSmithKline; Exelixis; Genentech; AstraZeneca; Royal Marsden NHS Foundation Trust; Pfizer; Bristol-Myers Squibb","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Neutropenia; Expanded access; Internal medicine; Adverse effect; Clear cell renal cell carcinoma; Tyrosine-kinase inhibitor; Oncology; Confidence interval; Surgery; Cancer; Chemotherapy","score_opus":0.1058398097867058,"score_gpt":0.3561710599735537,"score_spread":0.2503312501868479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564728191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9390024,0.026348252,0.0039705103,0.002571679,0.00050667784,0.0026967905,0.015112599,0.0003349286,0.009456182],"genre_scores_gemma":[0.94889796,0.0030856659,0.0036899461,0.0027978516,0.0003905324,0.0024750244,0.034176223,0.00015756545,0.0043292004],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9969241,0.00185877,0.00017637202,0.00024824828,0.000427,0.00036549833],"domain_scores_gemma":[0.99574393,0.0014305948,0.00081430713,0.00043502773,0.00051551784,0.0010606083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010310159,0.0012226828,0.002302667,0.00037058527,0.0005386074,0.001371221,0.0006451873,0.0010108814,0.0025007117],"category_scores_gemma":[0.004900476,0.00026370355,0.0026112949,0.00052178325,0.0004978879,0.00073704775,0.00086994335,0.0017879034,0.0006957551],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6144797,0.008333357,0.07367681,0.0039418084,0.0140685495,0.002110194,0.0006757783,0.011922866,0.020785457,0.0004786633,0.055426195,0.19410057],"study_design_scores_gemma":[0.2684162,0.22608988,0.42105347,0.0006024993,0.0149769345,0.0035090293,0.00021957424,0.003169447,0.011135661,0.0015341522,0.04906681,0.00022645011],"about_ca_topic_score_codex":0.0011168038,"about_ca_topic_score_gemma":0.0029410045,"teacher_disagreement_score":0.010310159,"about_ca_system_score_codex":0.0009000191,"about_ca_system_score_gemma":0.0012138931,"threshold_uncertainty_score":0.05452597},"labels":[],"label_agreement":null},{"id":"W1565078991","doi":"10.1038/bjc.2015.190","title":"A clinically applicable molecular-based classification for endometrial cancers","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":944,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Foundation","keywords":"Oncology; Internal medicine; Endometrial cancer; Survival analysis; Immunohistochemistry; Biology; Bioinformatics; Medicine; Cancer","score_opus":0.07945659241102301,"score_gpt":0.38652456061108775,"score_spread":0.30706796820006477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1565078991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74540234,0.010158402,0.22104345,0.004029589,0.0005709752,0.0013971635,0.008375701,0.0013535001,0.007668915],"genre_scores_gemma":[0.8731576,0.00092035293,0.12003226,0.0003296123,0.00017525138,0.00048701087,0.004274141,0.000065522574,0.00055808714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987,0.00048143804,0.00017522764,0.00022574341,0.00031585825,0.000101661775],"domain_scores_gemma":[0.99494153,0.0019345967,0.0009923254,0.00059384067,0.0013003035,0.00023736677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042588697,0.0008916788,0.00054678804,0.003458541,0.00044383912,0.001627415,0.001008479,0.0007044217,0.0020415345],"category_scores_gemma":[0.0125903655,0.0001493527,0.00065510016,0.0012667038,0.00065366697,0.0006422878,0.0009637755,0.0011912674,0.0011522225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009923164,0.0002116548,0.7002237,0.00061376486,0.00026443176,0.00027443923,0.00022980102,0.011583008,0.024565924,0.0037536,0.0067092986,0.25057814],"study_design_scores_gemma":[0.00037096822,0.0021587228,0.6732885,0.0007506932,0.0009283935,0.0053252024,0.00072488456,0.21378227,0.034220137,0.0251599,0.043118265,0.00017208228],"about_ca_topic_score_codex":0.0011282483,"about_ca_topic_score_gemma":0.0011394047,"teacher_disagreement_score":0.0042588697,"about_ca_system_score_codex":0.0009646215,"about_ca_system_score_gemma":0.0012500397,"threshold_uncertainty_score":0.022523344},"labels":[],"label_agreement":null},{"id":"W1590931923","doi":"10.1038/bjc.2015.147","title":"Effect of specialized diagnostic assessment units on the time to diagnosis in screen-detected breast cancer patients","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Kingston General Hospital; Cancer Care Ontario; Queen's University","funders":"Canadian Institutes of Health Research; Queen's University; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Breast cancer; Cancer; Cancer registry; Retrospective cohort study; Percentile; Population; Cohort; Biopsy; Psychosocial; Medical diagnosis; Internal medicine; Radiology","score_opus":0.03334209656528978,"score_gpt":0.3421570833477593,"score_spread":0.3088149867824695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1590931923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977143,0.00079904863,0.00006295229,0.00030783587,0.000011441483,0.000007749317,0.00045049586,0.000006361892,0.000639854],"genre_scores_gemma":[0.9994974,0.00010648454,0.000045948444,0.000031713786,0.00000632428,0.000004391727,0.00020541197,0.0000017976233,0.00010045466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990559,0.00022429161,0.00007715202,0.0001277071,0.00021127814,0.00030367874],"domain_scores_gemma":[0.99334794,0.0014182602,0.003458764,0.00019036286,0.0004384022,0.0011461786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055336376,0.00014034449,0.00021249676,0.00037647365,0.00046082985,0.0006054891,0.0006107294,0.00039945083,0.0033715118],"category_scores_gemma":[0.008560601,0.0001740655,0.0005521886,0.0008426861,0.00033644578,0.00021459187,0.00047361318,0.0005757375,0.00017083646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029826481,0.000046339628,0.99519956,0.000023717925,0.000057284487,0.00006007916,0.000102481616,0.00013987834,0.00012501443,0.000030310819,0.00032434534,0.0035926022],"study_design_scores_gemma":[0.0000067798246,0.000039447546,0.99948764,0.00000921338,0.000013965584,0.00004366129,0.00009498943,0.00017308556,0.000019582632,0.000008450351,0.00010090861,0.0000023735142],"about_ca_topic_score_codex":0.2709731,"about_ca_topic_score_gemma":0.22991216,"teacher_disagreement_score":0.2709731,"about_ca_system_score_codex":0.0037756301,"about_ca_system_score_gemma":0.0019262488,"threshold_uncertainty_score":0.53879166},"labels":[],"label_agreement":null},{"id":"W1597735813","doi":"10.1038/bjc.2015.206","title":"miR-30e* is an independent subtype-specific prognostic marker in breast cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; BC Cancer Agency; Ministero della Salute; Cancer Research UK","keywords":"Breast cancer; Oncology; Medicine; Cancer; Internal medicine; Carcinogenesis; Lymph node; Metastasis; Proportional hazards model; Pathology","score_opus":0.01636811051352493,"score_gpt":0.2714049934706052,"score_spread":0.25503688295708027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597735813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948874,0.002414119,0.0008958046,0.00012982212,0.00001829545,0.00000874725,0.0005502094,0.000028025415,0.0010676641],"genre_scores_gemma":[0.9983802,0.00033153887,0.00063637766,0.000021340664,0.000010782627,0.0000053886274,0.00033418857,0.0000072004036,0.00027285953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997787,0.00004780594,0.00002902504,0.00005861788,0.000058734942,0.000027096272],"domain_scores_gemma":[0.99908435,0.00022381572,0.00038636534,0.000092277776,0.00010057042,0.00011266328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060424674,0.00015858343,0.00032675214,0.0003471659,0.00016819169,0.0003861961,0.00017129561,0.00021426455,0.0015618184],"category_scores_gemma":[0.0014731978,0.0001097889,0.00023643115,0.00043482342,0.00016124846,0.0001201823,0.0002105921,0.00028969094,0.00043394574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018667601,0.00005434849,0.93651885,0.000093950104,0.00014364478,0.00027699166,0.00008385569,0.00033699756,0.040473916,0.00013362327,0.0004702127,0.01954679],"study_design_scores_gemma":[0.00001583599,0.00016197197,0.98690504,0.000015692192,0.00013027528,0.0016286982,0.000059751008,0.0011911493,0.007754717,0.00030922372,0.0018190993,0.000008603329],"about_ca_topic_score_codex":0.00044581637,"about_ca_topic_score_gemma":0.0007529336,"teacher_disagreement_score":0.0015618184,"about_ca_system_score_codex":0.00017241153,"about_ca_system_score_gemma":0.00025187052,"threshold_uncertainty_score":0.005224824},"labels":[],"label_agreement":null},{"id":"W1662191918","doi":"10.1054/bjoc.2001.1895","title":"Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"DMBA; Mammary gland; Endocrinology; Genetically modified mouse; Internal medicine; Breast cancer; Hormone; Transgene; Carcinogen; Carcinogenesis; Biology; Antagonist; Cancer; Receptor; Medicine; Genetics","score_opus":0.016819899564213554,"score_gpt":0.2667064441661971,"score_spread":0.24988654460198353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1662191918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954527,0.0007679104,0.0017189833,0.00018577116,0.00002975444,0.00001724165,0.0007343154,0.00016941359,0.00092378905],"genre_scores_gemma":[0.9866367,0.0012794298,0.0021929564,0.000112693975,0.000029894552,0.00007238226,0.0014174726,0.00015109027,0.008107402],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996822,0.000051235285,0.0000270254,0.00008100553,0.00008891338,0.00006959006],"domain_scores_gemma":[0.9993006,0.00012072558,0.0002487886,0.00006237083,0.000045201385,0.00022246482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027806172,0.00048406588,0.00044751161,0.0012218073,0.0002478321,0.00047962787,0.00025219395,0.0005974316,0.0034214228],"category_scores_gemma":[0.000337858,0.00043096568,0.0003524986,0.0003649018,0.0005124117,0.00028682017,0.00027883265,0.0010196111,0.00061887916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027962998,0.00005530934,0.0005251076,0.000010946191,0.000007920721,0.00006423532,0.000025838382,0.000023857727,0.9984303,0.00008300042,0.00003254338,0.00046133465],"study_design_scores_gemma":[0.00017026078,0.0019610096,0.059994996,0.000025891137,0.00012290587,0.0020762049,0.00019527608,0.0016531122,0.9287303,0.00036558227,0.0046694656,0.00003505116],"about_ca_topic_score_codex":0.0011762057,"about_ca_topic_score_gemma":0.001858747,"teacher_disagreement_score":0.0034214228,"about_ca_system_score_codex":0.00037972414,"about_ca_system_score_gemma":0.00022456577,"threshold_uncertainty_score":0.01144582},"labels":[],"label_agreement":null},{"id":"W1753041476","doi":"10.1054/bjoc.2001.2123","title":"Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Radiosensitivity; Cancer research; Yield (engineering); Perfusion; Medicine; Radiation tolerance; Biology; Pathology; Radiation therapy; Internal medicine","score_opus":0.010259938105367775,"score_gpt":0.2264933631284711,"score_spread":0.21623342502310333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1753041476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959162,0.0010484282,0.0017182508,0.000047900918,0.00001554998,0.00002781572,0.00025650556,0.000054616987,0.00091478636],"genre_scores_gemma":[0.9969758,0.0005275832,0.0012254323,0.000028568433,0.0000065320837,0.00002992847,0.00028267325,0.000020668187,0.000902947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998839,0.000023205406,0.000009623681,0.000025842017,0.000023082952,0.000034213634],"domain_scores_gemma":[0.99987125,0.000055743738,0.000029872263,0.000012990326,0.000009252813,0.000020729896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012308973,0.00023840711,0.00028515802,0.000116443254,0.00008231289,0.00026894605,0.00011416887,0.00024546846,0.0015600882],"category_scores_gemma":[0.00022529408,0.0001701248,0.0001551357,0.000120773715,0.00019904283,0.00018058831,0.0001721436,0.00051671756,0.0002131516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009191331,0.000012079535,0.00010623186,0.000015075247,0.0000028298873,0.000012878958,0.000009034066,0.00006477001,0.99917895,0.000018773117,0.000012105367,0.00047528252],"study_design_scores_gemma":[0.0000109615485,0.00044767756,0.0024092905,0.0000011822823,0.000007626051,0.000075495176,0.000008896171,0.000395527,0.9961175,0.000012037322,0.00051137694,0.000002486611],"about_ca_topic_score_codex":0.00060138584,"about_ca_topic_score_gemma":0.0007555402,"teacher_disagreement_score":0.0015600882,"about_ca_system_score_codex":0.00022178255,"about_ca_system_score_gemma":0.00013368094,"threshold_uncertainty_score":0.0052190423},"labels":[],"label_agreement":null},{"id":"W1873761649","doi":"10.1038/bjc.2015.318","title":"Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Imperial Experimental Cancer Medicine Centre; University of Birmingham; National Institute for Health and Care Research; Children's Cancer and Leukaemia Group; Cancer Research UK; Wellcome Trust","keywords":"Retinoblastoma; Choline; Pathology; Metabolite; Phosphocholine; Medicine; Taurine; Histopathology; Magnetic resonance imaging; In vivo magnetic resonance spectroscopy; In vivo; Biology; Internal medicine; Radiology; Biochemistry; Phospholipid; Genetics","score_opus":0.049683860724277405,"score_gpt":0.3612110967685064,"score_spread":0.311527236044229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1873761649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985122,0.00035350648,0.00061433675,0.000046597837,0.0000019637087,0.000011011294,0.00011480599,0.000017547936,0.00032801452],"genre_scores_gemma":[0.99879116,0.00013344616,0.00071569084,0.000011362725,0.0000062264257,0.000013256175,0.00019520422,0.0000071991517,0.0001265715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977905,0.00005228836,0.000031843967,0.000056929348,0.00004928361,0.00003059138],"domain_scores_gemma":[0.99918276,0.00021111684,0.00037176535,0.00006947322,0.00007514964,0.00008974638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055999885,0.00036692782,0.00040365776,0.0015929055,0.000352871,0.0005156585,0.00022257696,0.00042131837,0.00092135544],"category_scores_gemma":[0.0013420723,0.00013313444,0.00027357636,0.00081680156,0.0004787344,0.00033482496,0.0003868153,0.00026753053,0.00028055476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002077639,0.000060980303,0.9106166,0.000061231236,0.00008295591,0.0010408604,0.00024548688,0.00045125387,0.07142493,0.00016415358,0.0001515466,0.013622373],"study_design_scores_gemma":[0.00003454033,0.00036072914,0.9798201,0.000012153473,0.00011197965,0.0059968433,0.00043033206,0.0017731361,0.009679901,0.00097169564,0.0007895293,0.000019113842],"about_ca_topic_score_codex":0.00087606144,"about_ca_topic_score_gemma":0.0009259343,"teacher_disagreement_score":0.0015929055,"about_ca_system_score_codex":0.000404787,"about_ca_system_score_gemma":0.00030345327,"threshold_uncertainty_score":0.0030822754},"labels":[],"label_agreement":null},{"id":"W1875720097","doi":"10.1038/bjc.2015.223","title":"Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Cancer Research UK; Myriad Genetics; National Institutes of Health; Queen Mary University of London","keywords":"Medicine; Hazard ratio; Prostate cancer; Cohort; Internal medicine; Cancer; Prostate; Univariate analysis; Oncology; Framingham Risk Score; Proportional hazards model; Biopsy; Multivariate analysis; Confidence interval; Disease","score_opus":0.033035862704172345,"score_gpt":0.3263623784245855,"score_spread":0.29332651572041313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875720097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944395,0.00007373485,0.00023338103,0.000011325175,0.000002953284,0.000011560467,0.00006828639,0.000004315483,0.00015051753],"genre_scores_gemma":[0.99948955,0.000018760658,0.00021307233,0.0000075719786,0.000003753513,0.0000070380793,0.00022128799,0.0000012895272,0.00003751454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954575,0.00016225122,0.000026875094,0.000098229946,0.00012606925,0.000040703897],"domain_scores_gemma":[0.9983809,0.0005424143,0.00045969023,0.00015162748,0.00022009258,0.00024532576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001193518,0.00034361187,0.00027139747,0.00041041695,0.00017166907,0.0004232347,0.0003235133,0.00029701652,0.00064691994],"category_scores_gemma":[0.004383439,0.000118035176,0.00020710281,0.00020078849,0.00026657165,0.00018498182,0.00037055966,0.00027396946,0.00022937501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037525577,0.000028318093,0.9956475,0.000005849445,0.00002613297,0.0000514326,0.000046479574,0.00015606338,0.0009376359,0.000009234328,0.00007557514,0.0026403475],"study_design_scores_gemma":[0.00005035788,0.0006532789,0.99565244,0.000007823693,0.000043231576,0.0004964555,0.000051606094,0.0021662086,0.0006380852,0.000034383298,0.000201157,0.000004881623],"about_ca_topic_score_codex":0.0027633063,"about_ca_topic_score_gemma":0.0038151012,"teacher_disagreement_score":0.0027633063,"about_ca_system_score_codex":0.00029622982,"about_ca_system_score_gemma":0.00035517747,"threshold_uncertainty_score":0.0063120127},"labels":[],"label_agreement":null},{"id":"W1882337125","doi":"10.1054/bjoc.1999.0975","title":"Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Alberta Cancer Foundation","funders":"National Cancer Institute","keywords":"Glioma; Hypoxia (environmental); Vascular endothelial growth factor; Pathology; Vascular endothelial growth factor A; Cancer research; Angiogenesis; Biology; Medicine; VEGF receptors; Chemistry; Oxygen","score_opus":0.007008418123244916,"score_gpt":0.2431157245418058,"score_spread":0.2361073064185609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1882337125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864986,0.0031587267,0.005972877,0.00011638167,0.00004326172,0.000056869983,0.0011949337,0.00014986075,0.002808405],"genre_scores_gemma":[0.98982143,0.0010729393,0.0033966652,0.000035543115,0.000011048411,0.000044455213,0.0023473573,0.00002247325,0.0032480704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985075,0.000022757968,0.00001605613,0.00003000367,0.00006226767,0.000018179515],"domain_scores_gemma":[0.9998223,0.000038154652,0.000037945527,0.00003121561,0.00003294059,0.000037569782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014714175,0.0001672601,0.00022386029,0.00021065275,0.0001482812,0.00026150502,0.00011898012,0.00015382942,0.0006315771],"category_scores_gemma":[0.00016778675,0.00012521709,0.00017564205,0.00018953894,0.0001588869,0.00015716029,0.0001722262,0.00029274725,0.00048138303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008955672,0.000014913228,0.000523563,0.000034397402,0.0000052785103,0.00010359891,0.00004781777,0.00004021276,0.99806815,0.000076127675,0.00007690892,0.00091948477],"study_design_scores_gemma":[0.000022846687,0.00073685887,0.04562665,0.000011109733,0.000021914919,0.0017029224,0.00013621259,0.001364277,0.94186133,0.00012516402,0.008380091,0.000010657596],"about_ca_topic_score_codex":0.0016737641,"about_ca_topic_score_gemma":0.0020448072,"teacher_disagreement_score":0.0016737641,"about_ca_system_score_codex":0.00022878246,"about_ca_system_score_gemma":0.00014949989,"threshold_uncertainty_score":0.0033280253},"labels":[],"label_agreement":null},{"id":"W1900170853","doi":"10.1038/sj.bjc.6603295","title":"Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Strong; CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Oestrogen receptor; Phenotype; Estrogen receptor; Basal (medicine); Receptor; Progesterone receptor; Internal medicine; Breast cancer; Tissue microarray; Biology; Mammary gland; Gene isoform; Estrogen receptor alpha; Endocrinology; Estrogen; Cancer research; Immunohistochemistry; Medicine; Gene; Cancer; Genetics","score_opus":0.018497775031478175,"score_gpt":0.3388497727771877,"score_spread":0.32035199774570955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1900170853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955271,0.0023020674,0.00047490376,0.00001950429,0.000006727087,0.0000074303875,0.0002715546,0.0000115094745,0.0013791035],"genre_scores_gemma":[0.99489224,0.0014913166,0.00054000394,0.000027133288,0.0000058404667,0.00001967529,0.0008144533,0.0000044818053,0.0022049448],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993527,0.000009245467,0.000007885775,0.000012889125,0.000022623923,0.000012048453],"domain_scores_gemma":[0.9999285,0.000017755077,0.00001656585,0.000008359802,0.000016303948,0.0000124668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010894479,0.00009557846,0.00010101698,0.00045892494,0.00011612678,0.00025284593,0.000063427884,0.0001375292,0.000902288],"category_scores_gemma":[0.00018043512,0.00012467903,0.00008437335,0.00034567362,0.0001031514,0.000107579726,0.00008367315,0.00010495231,0.00044589903],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033955552,0.000021339729,0.028080598,0.000092614086,0.00002323716,0.00037442107,0.00014679728,0.000083667306,0.9660994,0.000069934125,0.00009167855,0.004576742],"study_design_scores_gemma":[0.000034370198,0.00066389906,0.7900259,0.000043104126,0.00009971187,0.008776858,0.0006055795,0.0010346255,0.1904967,0.00017589342,0.00802834,0.00001499974],"about_ca_topic_score_codex":0.00065622275,"about_ca_topic_score_gemma":0.00081626925,"teacher_disagreement_score":0.000902288,"about_ca_system_score_codex":0.000111458634,"about_ca_system_score_gemma":0.00009074821,"threshold_uncertainty_score":0.0030184984},"labels":[],"label_agreement":null},{"id":"W1921977259","doi":"10.1038/sj.bjc.6605571","title":"Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Sanofi","keywords":"PTEN; Prostate cancer; ErbB; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Tissue microarray; Epidermal growth factor receptor; Biochemical recurrence; ERBB3; Medicine; Prostate; Oncology; Cancer; Biology; Internal medicine; Signal transduction; Prostatectomy; Cell biology","score_opus":0.006430402495050277,"score_gpt":0.24938403526240227,"score_spread":0.242953632767352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921977259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96948606,0.0012958526,0.026592812,0.00008080366,0.000021722743,0.000231639,0.0008221413,0.0002575457,0.0012114731],"genre_scores_gemma":[0.9855665,0.00015943662,0.012766698,0.0000103961265,0.000011199429,0.00010862259,0.0010082843,0.00002218128,0.00034674798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991553,0.00020803498,0.00007328605,0.00017847845,0.0002725289,0.00011246848],"domain_scores_gemma":[0.99892265,0.0002961463,0.0002504269,0.00011340366,0.0003334969,0.00008376172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011642278,0.00031678434,0.00042838336,0.0025538113,0.0004389951,0.0005729355,0.00039090315,0.00022368472,0.0007147663],"category_scores_gemma":[0.002043068,0.0001315245,0.000578482,0.0012868544,0.0003171288,0.00017038778,0.0003846931,0.00026281702,0.00027933926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023331987,0.00047762282,0.5796368,0.0010372491,0.0017436205,0.0009300963,0.0018218252,0.0437165,0.17241532,0.0015021912,0.0045715477,0.18981399],"study_design_scores_gemma":[0.000057119356,0.00040542177,0.8742768,0.00006396222,0.00040180632,0.0008711826,0.00084631075,0.09310886,0.023694934,0.0030139727,0.003160783,0.000098947],"about_ca_topic_score_codex":0.0046282546,"about_ca_topic_score_gemma":0.005138285,"teacher_disagreement_score":0.0046282546,"about_ca_system_score_codex":0.0006934901,"about_ca_system_score_gemma":0.00061343855,"threshold_uncertainty_score":0.0092025995},"labels":[],"label_agreement":null},{"id":"W192747251","doi":"10.1054/bjoc.2001.2170","title":"Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Conjugate; Cytotoxicity; Monoclonal antibody; Molecular biology; Carcinoembryonic antigen; Chemistry; Cell culture; Antigen; Incubation; Antibody; Monoclonal; Biology; Biochemistry; In vitro; Medicine; Immunology; Cancer; Internal medicine","score_opus":0.02649090783885711,"score_gpt":0.36613529755553115,"score_spread":0.33964438971667404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W192747251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995619,0.00044913156,0.0028624504,0.000030230849,0.00000743252,0.00002058127,0.000026309666,0.00005534798,0.00092947093],"genre_scores_gemma":[0.99655473,0.00038808206,0.0018565448,0.000025462317,0.0000054085835,0.000021718055,0.00005550291,0.00002113763,0.0010712744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972564,0.00006534517,0.000012951709,0.00005040737,0.000076797216,0.00006886737],"domain_scores_gemma":[0.99979705,0.0000731361,0.0000584584,0.000019843374,0.000029278259,0.000022312099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025430473,0.00045582574,0.00029531925,0.00020836809,0.00009687963,0.00031442806,0.00024336345,0.0003652909,0.0009614803],"category_scores_gemma":[0.00025440683,0.00016634336,0.00027249576,0.00018767337,0.00023427227,0.0002699487,0.0003389964,0.00039941008,0.00027263662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002467104,0.000009721394,0.00005237424,0.000022762517,0.0000024782616,0.000019068539,0.000009823509,0.00010398165,0.99929273,0.00004874191,0.000006413431,0.00040722365],"study_design_scores_gemma":[0.0000030213182,0.0001245531,0.00040540227,0.0000013257219,0.0000033206431,0.000043716624,0.0000025923741,0.00031955153,0.99886453,0.000006852113,0.00022406394,0.000001088294],"about_ca_topic_score_codex":0.00031488042,"about_ca_topic_score_gemma":0.00038204197,"teacher_disagreement_score":0.0009614803,"about_ca_system_score_codex":0.00033056026,"about_ca_system_score_gemma":0.00015333194,"threshold_uncertainty_score":0.003216505},"labels":[],"label_agreement":null},{"id":"W1955289205","doi":"10.1054/bjoc.2000.1426","title":"Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Case Western Reserve University","keywords":"Photodynamic therapy; Photosensitizer; Apoptosis; Pathology; Terminal deoxynucleotidyl transferase; TUNEL assay; Karyorrhexis; Necrosis; In vivo; Biology; Coagulative necrosis; Programmed cell death; Protoporphyrin IX; Cancer research; Chemistry; Medicine; Biochemistry","score_opus":0.008638387065204253,"score_gpt":0.3033632616231661,"score_spread":0.29472487455796187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955289205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951911,0.0021628635,0.0011675655,0.000024900639,0.000015206859,0.00002780886,0.00017715768,0.000039724142,0.0011937093],"genre_scores_gemma":[0.99316,0.001762232,0.0017769376,0.000015632711,0.000014630496,0.00009324304,0.00057486503,0.00001817247,0.0025842323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985003,0.000027459499,0.0000132662935,0.000029599705,0.00003985728,0.000039785922],"domain_scores_gemma":[0.999895,0.00004185158,0.000020750185,0.0000105664485,0.000014033718,0.000017783595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024172942,0.00027804158,0.00022440868,0.00041204403,0.00019066477,0.0002818838,0.00018432282,0.00031154946,0.0012254063],"category_scores_gemma":[0.00023035008,0.00015270177,0.00013145592,0.00029988526,0.00029789456,0.00020438663,0.00015348232,0.00040080302,0.00023698545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006160498,0.00004861031,0.00041756465,0.00006077871,0.000010215798,0.00016110645,0.00007032859,0.0001282718,0.99699485,0.00008954065,0.000029594185,0.001373183],"study_design_scores_gemma":[0.000060323422,0.0021968826,0.012774027,0.00001096392,0.000044779725,0.0011087005,0.00008218559,0.0012587502,0.9808302,0.00009830034,0.0015266333,0.000008324668],"about_ca_topic_score_codex":0.0021815712,"about_ca_topic_score_gemma":0.0015846526,"teacher_disagreement_score":0.0021815712,"about_ca_system_score_codex":0.00043276307,"about_ca_system_score_gemma":0.00027143216,"threshold_uncertainty_score":0.0043377876},"labels":[],"label_agreement":null},{"id":"W1956692029","doi":"10.1038/bjc.2015.265","title":"Is England closing the international gap in cancer survival?","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Monash University; Macquarie University; Barts Health NHS Trust; Uppsala Universitet; Syddansk Universitet; London School of Hygiene and Tropical Medicine; Cancer Research UK; King's College London; University of Alberta; Karolinska Institutet; McMaster University","keywords":"Medicine; Context (archaeology); Cancer registry; Relative survival; Population; Cancer; Lung cancer; Colorectal cancer; Breast cancer; Demography; Oncology; Internal medicine; Geography; Environmental health","score_opus":0.20828662729198472,"score_gpt":0.4165390833955539,"score_spread":0.20825245610356918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1956692029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7156026,0.11515974,0.0017961691,0.089553714,0.0022041653,0.00006934494,0.015977692,0.000087567474,0.059549015],"genre_scores_gemma":[0.97289914,0.017004585,0.00062646705,0.003963536,0.00029088807,0.000055751898,0.0035240268,0.000025319052,0.0016102075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982583,0.0006263425,0.0002900024,0.00017953194,0.00022400804,0.00042191037],"domain_scores_gemma":[0.9947237,0.0014345447,0.0018904143,0.00032410584,0.0010481059,0.00057911227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037051241,0.00020134405,0.00065136224,0.0010283608,0.00042314775,0.0016498467,0.00036860877,0.0004738963,0.0055068345],"category_scores_gemma":[0.009583764,0.00010913632,0.00039904285,0.0023588615,0.00072547054,0.0033055095,0.0021221754,0.00056377205,0.0005827048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022277334,0.00010006238,0.6226991,0.005825854,0.00068309566,0.0010976415,0.013626066,0.0011997246,0.0009693981,0.036382016,0.05246187,0.26272747],"study_design_scores_gemma":[0.00006900765,0.00047476188,0.81548065,0.003082945,0.00028389733,0.0012196081,0.013752543,0.00018142072,0.0004751353,0.0042910823,0.1606214,0.000067517954],"about_ca_topic_score_codex":0.018914156,"about_ca_topic_score_gemma":0.020530526,"teacher_disagreement_score":0.018914156,"about_ca_system_score_codex":0.001564365,"about_ca_system_score_gemma":0.0018208632,"threshold_uncertainty_score":0.037608147},"labels":[],"label_agreement":null},{"id":"W1962449772","doi":"10.1054/bjoc.2000.1119","title":"Nested case–control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health; McGill University; Jewish General Hospital","funders":"","keywords":"Nested case-control study; Breast cancer; Medicine; Stage (stratigraphy); Oncology; Case-control study; Inflammatory breast cancer; Cancer; Internal medicine; Biology","score_opus":0.002517698831784702,"score_gpt":0.23536576988531172,"score_spread":0.232848071053527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1962449772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968265,0.0006509541,0.0015832667,0.000033217515,0.000019689194,0.00011699738,0.0003295655,0.000010445977,0.00042936427],"genre_scores_gemma":[0.9969356,0.00014709054,0.0017357497,0.000046792757,0.000019134623,0.00013603094,0.00046498625,0.000007060359,0.00050761265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739045,0.0013174062,0.00013702623,0.00061376416,0.00038718758,0.00015431612],"domain_scores_gemma":[0.996449,0.0011990296,0.0006208225,0.00088730897,0.00048556278,0.00035824653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027726633,0.00040211302,0.0008962896,0.0004594244,0.00082322524,0.00045685272,0.00067506137,0.00047233436,0.0010085622],"category_scores_gemma":[0.0069325822,0.0009002554,0.0005482401,0.0005180316,0.0005550097,0.00024482477,0.0004019239,0.0005989487,0.0002152236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034267423,0.00072379806,0.9784274,0.00010699954,0.0012716415,0.0012320664,0.0011076676,0.0002048894,0.008707738,0.0003980261,0.00048499336,0.0039080232],"study_design_scores_gemma":[0.0006182787,0.0023243665,0.98817015,0.000030222847,0.0006193249,0.0027146726,0.00025914868,0.0013282901,0.0009596813,0.00032155873,0.0026310757,0.00002319632],"about_ca_topic_score_codex":0.0146039175,"about_ca_topic_score_gemma":0.018020133,"teacher_disagreement_score":0.0146039175,"about_ca_system_score_codex":0.0006594311,"about_ca_system_score_gemma":0.0006438522,"threshold_uncertainty_score":0.029037833},"labels":[],"label_agreement":null},{"id":"W1963500271","doi":"10.1054/bjoc.2001.2165","title":"Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Sensitization; Poloxamer; Copolymer; Mechanism (biology); Cancer; Chemistry; Block (permutation group theory); Cancer research; Medicine; Immunology; Internal medicine","score_opus":0.005091498015092187,"score_gpt":0.23247845445354914,"score_spread":0.22738695643845697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963500271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415991,0.0138785625,0.036255185,0.0010102825,0.00010301673,0.00026852245,0.00034222656,0.00046406253,0.006078956],"genre_scores_gemma":[0.992195,0.0028965268,0.0028645017,0.00009179365,0.000013028598,0.00006778898,0.00010569819,0.000018387256,0.0017472225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991035,0.000021053229,0.000006176683,0.000016769514,0.000021835494,0.000023785853],"domain_scores_gemma":[0.9999405,0.000018647053,0.000016038288,0.000011010064,0.000007902574,0.000005902121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017697972,0.00038584875,0.0002585659,0.00019404879,0.00015670374,0.00020475333,0.00025254066,0.0003883809,0.0010942764],"category_scores_gemma":[0.00011088142,0.00015894798,0.00024243523,0.00009006577,0.00021192193,0.0004639492,0.00021419408,0.0003856038,0.0003247868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065651824,0.00002522238,0.00009832429,0.000090815774,0.0000055389737,0.000120179364,0.00002696466,0.0001628373,0.99443024,0.00063853385,0.00009876421,0.0042368704],"study_design_scores_gemma":[0.0000111916115,0.00015864712,0.0005259792,0.000003841229,0.000006354169,0.0003314841,0.0000062740346,0.0005477913,0.9965963,0.00009175025,0.0017175305,0.0000030195097],"about_ca_topic_score_codex":0.00016054965,"about_ca_topic_score_gemma":0.00016622143,"teacher_disagreement_score":0.0010942764,"about_ca_system_score_codex":0.00022908695,"about_ca_system_score_gemma":0.00009976008,"threshold_uncertainty_score":0.0036607385},"labels":[],"label_agreement":null},{"id":"W1963523058","doi":"10.1038/sj.bjc.6604558","title":"Fusion in the ETS gene family and prostate cancer","year":2008,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"TMPRSS2; Prostate cancer; Fusion gene; Chromoplexy; Biology; Prostate; Carcinogenesis; Cancer research; Cancer; Genetics; PCA3; Gene; Pathology; Medicine; Disease","score_opus":0.06031547168416199,"score_gpt":0.39752636842868,"score_spread":0.337210896744518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963523058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008797574,0.9988135,0.000055755543,0.0001836969,0.00009432039,0.0000013429725,0.0000066032985,0.000005127453,0.00075166835],"genre_scores_gemma":[0.0008678277,0.99752194,0.00011447489,0.00017758174,0.00012839692,0.0000028828538,0.000021812813,0.000001191351,0.0011639245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998398,0.000024943054,0.000017669705,0.000030337445,0.00007423363,0.000012990264],"domain_scores_gemma":[0.9998393,0.000075927426,0.00002804467,0.0000051550883,0.000034710232,0.000016881844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003554125,0.00075617875,0.0012036642,0.0018685627,0.000212877,0.0006110004,0.00063592877,0.0009070586,0.0040806388],"category_scores_gemma":[0.00046090392,0.00020105246,0.0003099851,0.0024597978,0.0005307518,0.0010115891,0.00045578406,0.0012701821,0.0028546073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007225367,0.000052478157,0.00037688724,0.008992415,0.00007888656,0.0008517961,0.000065516986,0.0004889611,0.0018767889,0.0031520396,0.047824934,0.9361671],"study_design_scores_gemma":[0.000016564829,0.000040780636,0.0013036663,0.0017936835,0.00005619571,0.0062217517,0.00005357928,0.000047405996,0.00026161698,0.0021838457,0.9880091,0.0000117495065],"about_ca_topic_score_codex":0.0013429155,"about_ca_topic_score_gemma":0.0022431763,"teacher_disagreement_score":0.0040806388,"about_ca_system_score_codex":0.00059480185,"about_ca_system_score_gemma":0.0006710335,"threshold_uncertainty_score":0.013651133},"labels":[],"label_agreement":null},{"id":"W1963863438","doi":"10.1038/bjc.2016.441","title":"Erratum: Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis","year":2017,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; York University; St. Michael's Hospital","funders":"","keywords":"Cancer research; PI3K/AKT/mTOR pathway; Clear cell renal cell carcinoma; Protein kinase B; Biology; Renal cell carcinoma; Galectin-1; Metastasis; Immunohistochemistry; Targeted therapy; Galectin-3; P70-S6 Kinase 1; Signal transduction; Cancer; Medicine; Pathology; Internal medicine; Immunology; Cell biology","score_opus":0.016317400778053937,"score_gpt":0.264368342216069,"score_spread":0.24805094143801504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963863438","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005148041,0.0018667752,0.00045594265,0.063759625,0.93064976,0.000020826168,0.00053633563,0.00015696006,0.0020390232],"genre_scores_gemma":[0.035445843,0.019376377,0.0057514776,0.16643403,0.5372591,0.00016173685,0.0029389826,0.0012353746,0.23139712],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980432,0.00025407944,0.00043973947,0.00025649092,0.0007827296,0.0002237578],"domain_scores_gemma":[0.98843026,0.0027261358,0.0009423749,0.0005747817,0.006521266,0.0008050588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022423356,0.0013610363,0.0012500999,0.0022321586,0.0016649948,0.0022210598,0.0020206769,0.004462841,0.019396104],"category_scores_gemma":[0.025098614,0.00081623317,0.0011281617,0.0014778818,0.0018892895,0.0016239269,0.0011277625,0.007789664,0.0159957],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008410952,0.000014502411,0.00035046588,0.00018166513,0.000017080538,0.0010390371,0.00003607917,0.00006306263,0.00016596308,0.00050089223,0.98722744,0.0103196725],"study_design_scores_gemma":[0.00004556764,0.000039177045,0.0016160787,0.0003557515,0.00005682998,0.0028500005,0.00013869972,0.00025039222,0.00081316504,0.00084514264,0.99294347,0.00004567802],"about_ca_topic_score_codex":0.0100813545,"about_ca_topic_score_gemma":0.011558416,"teacher_disagreement_score":0.019396104,"about_ca_system_score_codex":0.0028822098,"about_ca_system_score_gemma":0.003602728,"threshold_uncertainty_score":0.06488639},"labels":[],"label_agreement":null},{"id":"W1964113171","doi":"10.1038/sj.bjc.6600659","title":"Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grey Nuns Community Hospital; Alberta Ministry of Agriculture and Forestry; University of Alberta","funders":"Killam Trusts","keywords":"Fish oil; Fish <Actinopterygii>; Medicine; Cancer; Composition (language); Internal medicine; Biology; Fishery","score_opus":0.016031808941839008,"score_gpt":0.3145401840697231,"score_spread":0.2985083751278841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964113171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980179,0.0014418392,0.000053712192,0.000035529192,0.0000050822673,0.00002204882,0.00010170847,0.0000052071828,0.00031688757],"genre_scores_gemma":[0.99880147,0.00038042504,0.00013213619,0.000055825312,0.0000065885183,0.000024521676,0.00026098845,0.0000013396279,0.00033668694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998677,0.000034652174,0.000016620445,0.000027641645,0.000031450225,0.000021966584],"domain_scores_gemma":[0.9996706,0.00004908334,0.00011049188,0.000013564337,0.00005441026,0.000101840276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016741073,0.00024901447,0.0005603915,0.0002989783,0.00020984648,0.00021771438,0.0001150631,0.00039084483,0.00066350633],"category_scores_gemma":[0.00071989134,0.00013392924,0.00018611482,0.0002962558,0.00013224775,0.00014521283,0.00018513588,0.0003048428,0.00013819938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026393788,0.00064725365,0.8536363,0.0001940046,0.0002593955,0.0016085204,0.00048980897,0.0004407642,0.0751475,0.000036680696,0.00031362398,0.04083239],"study_design_scores_gemma":[0.00014267712,0.006585798,0.9875345,0.000026315156,0.00009341898,0.001186035,0.00024156817,0.0002917024,0.002869893,0.000037829548,0.0009779611,0.000012342419],"about_ca_topic_score_codex":0.0013377303,"about_ca_topic_score_gemma":0.0016999277,"teacher_disagreement_score":0.0013377303,"about_ca_system_score_codex":0.0002745905,"about_ca_system_score_gemma":0.00014033605,"threshold_uncertainty_score":0.0026598573},"labels":[],"label_agreement":null},{"id":"W1964160901","doi":"10.1038/sj.bjc.6605245","title":"Increased expression of class III β-tubulin in castration-resistant human prostate cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Association pour la Recherche sur les Tumeurs de la Prostate; Institut National de la Santé et de la Recherche Médicale; Université Laval; Association pour la Recherche sur le Cancer","keywords":"Prostate cancer; Prostate; Castration; Oncology; Cancer; Tubulin; Medicine; Cancer research; Biology; Internal medicine; Microtubule; Genetics; Hormone","score_opus":0.006683826579094448,"score_gpt":0.27090882952416895,"score_spread":0.2642250029450745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964160901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965148,0.002193175,0.0002753476,0.000019915982,0.0000064620317,0.000013893935,0.00019617923,0.000026833055,0.0007534109],"genre_scores_gemma":[0.9979146,0.00076510815,0.00030667332,0.000021821235,0.000006989481,0.000008950311,0.00045333582,0.000004752694,0.0005176921],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990773,0.0000096385975,0.000009492913,0.000020633825,0.000036105725,0.000016359789],"domain_scores_gemma":[0.99988806,0.000014244509,0.00003883508,0.000011804203,0.000020769405,0.00002628515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011161455,0.00017256266,0.00015883161,0.00056391367,0.00019899823,0.00023949567,0.0001115889,0.00016174401,0.0011595654],"category_scores_gemma":[0.00013740272,0.000103200284,0.00014828658,0.00037836045,0.00017744169,0.00007376481,0.00013146293,0.00019051865,0.00023814698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003767172,0.000035671746,0.035150282,0.00015456976,0.000037691283,0.0006447207,0.000102555634,0.0000739195,0.9579462,0.000028635484,0.00013751129,0.0053115026],"study_design_scores_gemma":[0.0000400265,0.0011076548,0.7111211,0.000020904046,0.00012403635,0.012395312,0.00018502418,0.0003989577,0.26921347,0.000042649906,0.005339242,0.000011661236],"about_ca_topic_score_codex":0.0019057917,"about_ca_topic_score_gemma":0.0019557143,"teacher_disagreement_score":0.0019057917,"about_ca_system_score_codex":0.00021889269,"about_ca_system_score_gemma":0.00017447279,"threshold_uncertainty_score":0.0038791895},"labels":[],"label_agreement":null},{"id":"W1964176895","doi":"10.1038/bjc.2013.769","title":"FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Royal Victoria Regional Health Centre; Université de Montréal; Université Laval; Royal Victoria Hospital; Centre hospitalier universitaire de Québec; Amgen (Canada); Public Health Ontario; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Medical Research and Materiel Command; National Cancer Institute; Institute of Biomedical Sciences, Academia Sinica; Universitätsklinikum Hamburg-Eppendorf; Canadian Institutes of Health Research; U.S. Army; National Institutes of Health; National University Health System; Biomedical Research Council; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Ministero dello Sviluppo Economico; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Institut National Du Cancer; Medizinischen Hochschule Hannover; Associazione Italiana per la Ricerca sul Cancro; KWF Kankerbestrijding; National Health and Medical Research Council; Universiti Malaya; Academia Sinica; Kuopion Yliopistollinen Sairaala; Yale University; Karolinska Institutet; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Robert Bosch Stiftung; Kementerian Sains, Teknologi dan Inovasi; King's College London; Academy of Finland; Agence Nationale de la Recherche; Medical Research Council; University of Galway; Cancerfonden; National University of Ireland; National Science Council; Stockholms Läns Landsting; Singapore Eye Research Institute; Seoul National University; National Breast Cancer Foundation; European Commission; Deutsche Krebshilfe; University of Oxford; Wellcome Trust; Fondation du cancer du sein du Québec; Rheinische Friedrich-Wilhelms-Universität Bonn; Breast Cancer Research Trust; CHIST-ERA; Cancer Council Tasmania; World Health Organization; National University of Singapore; Cancer Research UK; Norges Forskningsråd; QIMR Berghofer Medical Research Institute; National Institute for Health and Care Research; Itä-Suomen Yliopisto; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Deutsche Gesetzliche Unfallversicherung; Cancer Research UK Cambridge Institute, University of Cambridge; David F. and Margaret T. Grohne Family Foundation; Ligue Contre le Cancer; Deutsches Krebsforschungszentrum; College of Medicine, Seoul National University; Virginia Department of Health; University of Toronto; Ohio State University; Peter MacCallum Cancer Centre; Helsingin ja Uudenmaan Sairaanhoitopiiri; Fondation de France; California Breast Cancer Research Program; Breast Cancer Research Foundation; Cancer Council Victoria; California Department of Public Health; National Medical Research Council; Ministério da Ciência, Tecnologia e Inovação; European Social Fund; Menzies Centre for Australian Studies, King's College London, University of London; Cancer Research Institute","keywords":"Breast cancer; Odds ratio; Single-nucleotide polymorphism; Cancer; Oncology; Case-control study; Risk factor; Internal medicine; Breast disease; Medicine; Biology; Genotype; Genetics; Gene","score_opus":0.008639210369057255,"score_gpt":0.26798794142068116,"score_spread":0.2593487310516239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964176895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.854423,0.0668215,0.004082045,0.0045547886,0.00033140738,0.00031198337,0.05619708,0.00014384619,0.01313432],"genre_scores_gemma":[0.94752765,0.010646488,0.0023201576,0.0006763041,0.0002007278,0.00036552356,0.036481943,0.0000828127,0.0016983923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99338335,0.0028838248,0.0005676265,0.0011014804,0.0018101198,0.0002535573],"domain_scores_gemma":[0.9864477,0.005090983,0.0022304484,0.0015132374,0.003588507,0.0011292567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010372272,0.0005631958,0.0008995489,0.0025326828,0.0006468176,0.0011656459,0.0010569104,0.0009230043,0.0038504624],"category_scores_gemma":[0.019618936,0.0003097742,0.0015499198,0.007959393,0.00035284,0.0002830599,0.0014632313,0.0007216095,0.0005233433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024986388,0.000042984215,0.9665513,0.00057105627,0.005727235,0.0004005939,0.0002557592,0.00039444893,0.00090869283,0.00013262729,0.007117148,0.015399511],"study_design_scores_gemma":[0.00020743831,0.00007655524,0.991504,0.00011776049,0.0024292923,0.00039734374,0.00010026347,0.00010114327,0.00014206943,0.00009459705,0.004807555,0.000021965767],"about_ca_topic_score_codex":0.03601545,"about_ca_topic_score_gemma":0.030333305,"teacher_disagreement_score":0.03601545,"about_ca_system_score_codex":0.0005785178,"about_ca_system_score_gemma":0.0010854525,"threshold_uncertainty_score":0.07161164},"labels":[],"label_agreement":null},{"id":"W1964256573","doi":"10.1038/sj.bjc.6601837","title":"A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Single-nucleotide polymorphism; RAD51; Breast cancer; Proportional hazards model; Genetics; Hazard ratio; Penetrance; Logistic regression; Medicine; Odds ratio; Oncology; Internal medicine; Biology; Genotype; Cancer; Confidence interval; Gene; Homologous recombination","score_opus":0.012139143511998907,"score_gpt":0.26181067978431927,"score_spread":0.24967153627232036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964256573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996635,0.000100164056,0.000052064977,0.000013903637,0.0000021521143,0.0000019188967,0.000035128513,0.0000036777503,0.00012750502],"genre_scores_gemma":[0.9995567,0.00006588393,0.00009316926,0.000013106477,0.0000046423156,0.0000017537125,0.000051532017,0.0000022532033,0.00021089856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979,0.00007385365,0.000015577403,0.000067429646,0.000026473128,0.000026600374],"domain_scores_gemma":[0.9995608,0.00016413761,0.00016276541,0.000046068602,0.000020807247,0.00004542155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036734223,0.00030793707,0.00023212112,0.00061335234,0.00021464733,0.0002514084,0.00016139999,0.00028604595,0.001622007],"category_scores_gemma":[0.0010079814,0.00020471682,0.00024242947,0.00037800762,0.00021803199,0.000102742626,0.00010796151,0.00019119143,0.00017399083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014328838,0.00013484854,0.96881884,0.000020539084,0.00027286954,0.0006411967,0.00020510163,0.000118563774,0.02248277,0.000059945254,0.0001246516,0.005687773],"study_design_scores_gemma":[0.000029184968,0.00020381593,0.99733967,0.000003984217,0.00009791476,0.00084566855,0.000046790385,0.00030457118,0.0009141272,0.000045150777,0.00016521974,0.0000037898353],"about_ca_topic_score_codex":0.0042921454,"about_ca_topic_score_gemma":0.003161355,"teacher_disagreement_score":0.0042921454,"about_ca_system_score_codex":0.00014661514,"about_ca_system_score_gemma":0.00009501216,"threshold_uncertainty_score":0.008534312},"labels":[],"label_agreement":null},{"id":"W1964777676","doi":"10.1038/bjc.2013.417","title":"Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trials","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clinical trial; Cancer; Pharmacodynamics; Reporting bias; MEDLINE; Oncology; Internal medicine","score_opus":0.8412142510138525,"score_gpt":0.7353133138146231,"score_spread":0.10590093719922944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964777676","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35085693,0.12405767,0.3627763,0.06360887,0.0034520007,0.053875994,0.009125703,0.0008103476,0.031436063],"genre_scores_gemma":[0.7577821,0.014465964,0.18292022,0.010293095,0.0016707008,0.029006142,0.0026328869,0.00027260734,0.0009561582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.06644238,0.6559223,0.23758605,0.009435844,0.029402884,0.0012105388],"domain_scores_gemma":[0.019458702,0.6170389,0.23673084,0.0725364,0.052760854,0.0014743588],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.78651434,0.0014397969,0.0024422759,0.011623118,0.0028667143,0.008279456,0.0049501485,0.003803374,0.0015531265],"category_scores_gemma":[0.8846075,0.0017863554,0.003369913,0.013821644,0.007972389,0.008232671,0.008781756,0.0033977765,0.00069318345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005832332,0.00039276795,0.46323696,0.057457477,0.007973982,0.0011820197,0.08408107,0.0038717736,0.006439779,0.017842967,0.016842451,0.33484638],"study_design_scores_gemma":[0.0034027286,0.0066472106,0.460651,0.13987266,0.009229675,0.008482405,0.033205282,0.014897986,0.030929223,0.08860248,0.20247743,0.0016019533],"about_ca_topic_score_codex":0.002809874,"about_ca_topic_score_gemma":0.0023777254,"teacher_disagreement_score":0.21348566,"about_ca_system_score_codex":0.0061123758,"about_ca_system_score_gemma":0.014343346,"threshold_uncertainty_score":0.2632659},"labels":[],"label_agreement":null},{"id":"W1965495456","doi":"10.1038/sj.bjc.6600059","title":"Local hypoxia is produced at sites of intratumour injection","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Tirapazamine; Hypoxia (environmental); Oxygenation; Pathology; Biopsy; Biodistribution; Medicine; Chemistry; Cytotoxicity; Oxygen; Internal medicine; In vitro","score_opus":0.01069703295424153,"score_gpt":0.2403006668577579,"score_spread":0.22960363390351635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965495456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96617126,0.0035272934,0.022658203,0.00017715678,0.00008024014,0.00015142246,0.0004954423,0.0005301681,0.0062088063],"genre_scores_gemma":[0.9846718,0.0013208878,0.0052928356,0.00006312677,0.000025965772,0.000117009164,0.0004319481,0.000057729616,0.008018706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984217,0.000022262986,0.00000602753,0.000035959074,0.000046482426,0.000047056677],"domain_scores_gemma":[0.9997749,0.00004440812,0.00007952668,0.000040908377,0.000023673738,0.000036588986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016477122,0.00024615397,0.00035897727,0.00019617927,0.00016449683,0.0003467519,0.00019767672,0.00028670425,0.0026078061],"category_scores_gemma":[0.0001927877,0.00016312869,0.0001693003,0.0001763556,0.00028286077,0.0002451581,0.00023127437,0.0006593768,0.0008856192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013784289,0.000016289398,0.00021877876,0.000039079216,0.0000030590616,0.00008780547,0.000019903178,0.00003543165,0.99704295,0.0001420309,0.00008459218,0.0021721788],"study_design_scores_gemma":[0.000018097608,0.00067231443,0.0046523763,0.000009185154,0.000014906688,0.0004876376,0.000026761378,0.00042341725,0.9898801,0.000061940904,0.0037491894,0.0000041555163],"about_ca_topic_score_codex":0.00060213625,"about_ca_topic_score_gemma":0.00076443696,"teacher_disagreement_score":0.0026078061,"about_ca_system_score_codex":0.00031686772,"about_ca_system_score_gemma":0.00018077694,"threshold_uncertainty_score":0.008723915},"labels":[],"label_agreement":null},{"id":"W1965568377","doi":"10.1038/bjc.2012.272","title":"PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Gertrude von Meissner-Stiftung; Ontario Ministry of Economic Development and Innovation; Canadian Institutes of Health Research; Genome Canada; Wellcome Trust; GlaxoSmithKline; Pfizer; Eli Lilly and Company","keywords":"PIM1; Cancer research; Diffuse large B-cell lymphoma; Biology; Kinase; Lymphoma; Tissue microarray; Signal transduction; Cell growth; Cell biology; Phosphorylation; Immunohistochemistry; Immunology; Serine","score_opus":0.010186483452341643,"score_gpt":0.2936566803929901,"score_spread":0.28347019694064846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965568377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8869223,0.1005171,0.0034609386,0.0009539522,0.000052165375,0.00007590582,0.00039962246,0.0001409774,0.0074769394],"genre_scores_gemma":[0.97642356,0.019154886,0.0026565578,0.00012904237,0.000081392434,0.00003711737,0.00048952247,0.000011990568,0.0010160722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999224,0.000020904214,0.000004850491,0.000011411255,0.000022912895,0.000017486289],"domain_scores_gemma":[0.9999082,0.000027692819,0.000031684936,0.000005574811,0.000011076034,0.0000156699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024705427,0.00025714198,0.00028010306,0.0003336504,0.00014939172,0.00043057842,0.0001476608,0.00018289285,0.0010986337],"category_scores_gemma":[0.00022161409,0.00010592618,0.00013407042,0.00027843151,0.00021241208,0.00024554876,0.00016433724,0.0005030353,0.00032474718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023437229,0.00025602875,0.020606296,0.0010933778,0.000060600152,0.0012294526,0.00013189767,0.0013097187,0.750721,0.0013445634,0.0018172842,0.21908613],"study_design_scores_gemma":[0.0006683646,0.005466967,0.18887424,0.000225249,0.00042136185,0.01699425,0.00037405035,0.0064948434,0.6930431,0.001912639,0.085478716,0.00004615759],"about_ca_topic_score_codex":0.00019884972,"about_ca_topic_score_gemma":0.00044213817,"teacher_disagreement_score":0.0010986337,"about_ca_system_score_codex":0.00041292582,"about_ca_system_score_gemma":0.00016666882,"threshold_uncertainty_score":0.003675282},"labels":[],"label_agreement":null},{"id":"W1965713922","doi":"10.1038/bjc.2015.83","title":"Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"Universitat de Barcelona; Bundesamt für Strahlenschutz; Associazione Italiana per la Ricerca sul Cancro; Ministerio de Economía y Competitividad; Fondation de France; Ministero dell’Istruzione, dell’Università e della Ricerca; European Commission; World Health Organization","keywords":"Endocrine system; Lymphoma; Medicine; Occupational exposure; Incidence (geometry); Internal medicine; Physiology; Oncology; Environmental health; Hormone","score_opus":0.02028289842986274,"score_gpt":0.3108551157700091,"score_spread":0.2905722173401464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965713922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988589,0.00027475256,0.00008848992,0.000019178762,0.000002368341,0.0000075883395,0.00042744965,0.0000025825511,0.00031864533],"genre_scores_gemma":[0.99912447,0.00013568353,0.00004723419,0.000022652841,0.0000042447896,0.0000071048216,0.0004763397,0.0000017842578,0.0001804347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935323,0.0002111772,0.000072252355,0.00019586022,0.00008090245,0.00008659293],"domain_scores_gemma":[0.9988673,0.00013642196,0.00043225297,0.00013874099,0.0001622138,0.0002631717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091382663,0.00030963836,0.00040409167,0.0012217776,0.0004516504,0.0007534716,0.00033936487,0.00044051744,0.0014213604],"category_scores_gemma":[0.0011163454,0.00033025473,0.0005761725,0.0019221652,0.00024051142,0.0002652973,0.00060666347,0.00030139636,0.00028559743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020563237,0.000032049742,0.99822146,0.000007664989,0.00015178235,0.00011968995,0.00010067271,0.00003199898,0.00037244838,0.000008898831,0.00007483922,0.0006728782],"study_design_scores_gemma":[0.000009750641,0.00006609973,0.99918205,0.000004612527,0.00005764397,0.00022846147,0.00014298908,0.000045836274,0.000054735192,0.0000059439853,0.0001997429,0.0000022572701],"about_ca_topic_score_codex":0.015531569,"about_ca_topic_score_gemma":0.0129451435,"teacher_disagreement_score":0.015531569,"about_ca_system_score_codex":0.0004230413,"about_ca_system_score_gemma":0.00028031413,"threshold_uncertainty_score":0.030882359},"labels":[],"label_agreement":null},{"id":"W1965930974","doi":"10.1038/sj.bjc.6605876","title":"Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Medical Research Council; National Cancer Institute; National Institutes of Health; University of Melbourne; Huntsman Cancer Institute; Medical Research Council; National Health and Medical Research Council; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Cancer; Ovarian cancer; Internal medicine; Oncology; Gynecology; Prostate cancer; Incidence (geometry); Population; Lung cancer; Male breast cancer; Family history","score_opus":0.013921684513501335,"score_gpt":0.3100951462656065,"score_spread":0.2961734617521052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965930974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897015,0.0005748656,0.000057457288,0.000027174752,0.0000047376006,0.0000017664466,0.00010751832,0.000002001568,0.00025436905],"genre_scores_gemma":[0.9995691,0.00016042007,0.000054050844,0.0000115775165,0.0000064131805,0.0000016299682,0.00009404617,9.65332e-7,0.00010176014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938536,0.00024753212,0.000054632423,0.00014384683,0.0000841419,0.00008444513],"domain_scores_gemma":[0.99812776,0.00055809884,0.0008037523,0.00012496804,0.00013180412,0.00025360106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006075117,0.0002521728,0.0003505457,0.0007699241,0.00043021532,0.00033487187,0.00020313139,0.00041936958,0.0015466573],"category_scores_gemma":[0.0030051,0.00021840485,0.0004872808,0.00058151135,0.00030023427,0.0002707604,0.00035545914,0.00032043114,0.00018336902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017341132,0.000013519817,0.99764085,0.000010220312,0.000058675905,0.000396556,0.00014640472,0.000034345678,0.00028168302,0.000016897788,0.00005863054,0.0011688272],"study_design_scores_gemma":[0.0000064962937,0.00014790673,0.99541485,0.000012958835,0.00007104138,0.0034613942,0.00035712126,0.00007855147,0.0001375438,0.00006367604,0.00024232134,0.0000060312764],"about_ca_topic_score_codex":0.0044973255,"about_ca_topic_score_gemma":0.005267692,"teacher_disagreement_score":0.0044973255,"about_ca_system_score_codex":0.00027335814,"about_ca_system_score_gemma":0.00017855522,"threshold_uncertainty_score":0.008942306},"labels":[],"label_agreement":null},{"id":"W1966268953","doi":"10.1038/sj.bjc.6603184","title":"Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Protein kinase B; Prostate cancer; Medicine; Cancer; PI3K/AKT/mTOR pathway; Internal medicine; Perineural invasion; Biochemical recurrence; Oncology; Pathology; Cancer research; Prostatectomy; Biology; Phosphorylation; Signal transduction","score_opus":0.009590674987163629,"score_gpt":0.2921222671562387,"score_spread":0.28253159216907503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966268953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909353,0.00042492675,0.000086893175,0.00001939169,0.0000027725634,0.000002026608,0.000099166624,0.0000029431824,0.0002683949],"genre_scores_gemma":[0.9996824,0.00006971336,0.00003218695,0.0000049692994,0.000003981039,0.000002032899,0.0001056042,9.006544e-7,0.000098362616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999083,0.000020459132,0.0000073511897,0.000019466688,0.000020880369,0.000023469196],"domain_scores_gemma":[0.9996921,0.000058918577,0.00012173741,0.000013958853,0.000033242613,0.00008000716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014305975,0.00014733268,0.00016884712,0.0003137564,0.00018580027,0.00026662272,0.00009488033,0.0002266586,0.0010667127],"category_scores_gemma":[0.00054138014,0.000092335074,0.0001466448,0.00042141075,0.00020718973,0.00015056899,0.00018560178,0.00031161096,0.00018896008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000412745,0.000029492505,0.99246514,0.000016727032,0.00003443015,0.00018042828,0.00004951936,0.00012864376,0.0030168328,0.000018765608,0.00009642648,0.0035507963],"study_design_scores_gemma":[0.00000427458,0.00008127878,0.9987638,0.0000020209816,0.000020468638,0.00051003223,0.000031380652,0.00011762297,0.0002718592,0.00003151486,0.00016287126,0.000002915222],"about_ca_topic_score_codex":0.00062328076,"about_ca_topic_score_gemma":0.0011443321,"teacher_disagreement_score":0.0010667127,"about_ca_system_score_codex":0.00012825266,"about_ca_system_score_gemma":0.00014593687,"threshold_uncertainty_score":0.00356853},"labels":[],"label_agreement":null},{"id":"W1966385112","doi":"10.1038/bjc.2013.517","title":"Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute on Aging; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Capecitabine; Colorectal cancer; Medicine; Internal medicine; Oncology; Fluorouracil; Cancer","score_opus":0.006457078922198525,"score_gpt":0.255815041071987,"score_spread":0.24935796214978848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966385112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940836,0.00021394338,0.000033694643,0.000016050433,0.00000382677,0.000002653306,0.00012281846,0.0000021335575,0.00019640525],"genre_scores_gemma":[0.9994667,0.000085615524,0.00006610437,0.000033461656,0.0000073095307,0.0000034423879,0.00023423388,0.0000012381646,0.000101920356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999045,0.000015577301,0.000011498926,0.000023962119,0.000022858772,0.000021595202],"domain_scores_gemma":[0.9995646,0.0000580203,0.00020179378,0.000013829373,0.00004584381,0.00011585677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022191307,0.00018893594,0.00029640834,0.0002688663,0.0002166153,0.00028303586,0.000070397116,0.0002080445,0.0008736178],"category_scores_gemma":[0.0006575139,0.000085048174,0.00025059044,0.0004451452,0.00010032579,0.00014792998,0.00016144216,0.00023769941,0.00018211552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007686326,0.000026216781,0.99096745,0.00001914654,0.000030331998,0.0004953357,0.00004945345,0.00004675269,0.004297461,0.000008611722,0.00012873132,0.003161775],"study_design_scores_gemma":[0.000017877106,0.00039959353,0.9977748,0.000003368154,0.000027418633,0.0010053873,0.000053748652,0.00008019377,0.0002797909,0.000010286675,0.00034502792,0.0000024323124],"about_ca_topic_score_codex":0.0020695233,"about_ca_topic_score_gemma":0.002899833,"teacher_disagreement_score":0.0020695233,"about_ca_system_score_codex":0.0002459827,"about_ca_system_score_gemma":0.00021903694,"threshold_uncertainty_score":0.0041149855},"labels":[],"label_agreement":null},{"id":"W1966796326","doi":"10.1038/bjc.2013.691","title":"HDAC inhibitor confers radiosensitivity to prostate stem-like cells","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Radioresistance; Radiosensitivity; Stem cell; Cancer research; Trichostatin A; Comet assay; Biology; Prostate cancer; Cancer stem cell; Population; Prostate; Molecular biology; Pathology; DNA damage; Histone deacetylase; Cell culture; Radiation therapy; Cancer; Histone; Medicine; Cell biology; Internal medicine; Genetics; DNA","score_opus":0.0072465360454552165,"score_gpt":0.259111076767119,"score_spread":0.25186454072166375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966796326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916998,0.0032258455,0.001352108,0.000075983764,0.000041016992,0.000050516228,0.0008491841,0.00022438845,0.0024811993],"genre_scores_gemma":[0.9934896,0.0011642815,0.0008137535,0.000066244946,0.000019974263,0.000036085512,0.0018426767,0.000026125168,0.0025411653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990404,0.000009413795,0.000011655922,0.000019378198,0.000024066676,0.00003141833],"domain_scores_gemma":[0.99985194,0.000041266154,0.000021279222,0.000024327002,0.000014780368,0.00004636056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009543329,0.00027842383,0.00032499465,0.00028963736,0.00010308748,0.00024342471,0.00020866093,0.00020191312,0.003814764],"category_scores_gemma":[0.00009760877,0.00013006394,0.00035950384,0.00014999021,0.00011828972,0.00008584137,0.00017370174,0.0005716686,0.0006794565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018505234,0.00008866707,0.00042684472,0.00006627418,0.000015353373,0.000054276712,0.000012819967,0.000076030694,0.996523,0.000046977464,0.00011493756,0.002389728],"study_design_scores_gemma":[0.000032378906,0.0013954857,0.013760182,0.0000087489225,0.000051044743,0.00036443453,0.000021465905,0.00065791496,0.98076093,0.000029922983,0.002911639,0.000005814371],"about_ca_topic_score_codex":0.0006640447,"about_ca_topic_score_gemma":0.00095018477,"teacher_disagreement_score":0.003814764,"about_ca_system_score_codex":0.00016703665,"about_ca_system_score_gemma":0.00020819293,"threshold_uncertainty_score":0.0127616525},"labels":[],"label_agreement":null},{"id":"W1966868760","doi":"10.1054/bjoc.2000.1538","title":"Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Apoptosis; Programmed cell death; Biology; Cancer cell; Chinese hamster ovary cell; Cancer research; Transfection; Cell culture; Cancer; Ovarian cancer; Immunology; Genetics","score_opus":0.02986125080838409,"score_gpt":0.30980188662445707,"score_spread":0.279940635816073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966868760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93495023,0.034370176,0.022227097,0.0004772651,0.00026973404,0.00017936759,0.0009432113,0.00026591052,0.0063170553],"genre_scores_gemma":[0.9836797,0.007873839,0.0040976326,0.00023095084,0.000064431966,0.00011055187,0.0011414175,0.000015002662,0.0027865868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950707,0.000094862,0.00007631919,0.00008399676,0.0001715365,0.000066129425],"domain_scores_gemma":[0.9980661,0.00078641356,0.00041674974,0.0002303722,0.00040136455,0.00009896078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042477567,0.0002909864,0.0004015354,0.00058011076,0.00019429298,0.0003555408,0.00041574935,0.0005040682,0.0031761397],"category_scores_gemma":[0.0006653579,0.0001426579,0.00051984616,0.00042116336,0.00036955441,0.00038910165,0.00022918635,0.0008144625,0.00069888344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007900486,0.00017590784,0.0051278244,0.0006847608,0.00008475512,0.00069148897,0.00016400589,0.000081589154,0.9830305,0.00050783233,0.00016705714,0.00849431],"study_design_scores_gemma":[0.000056537818,0.0022430697,0.047844414,0.00007313614,0.00010562363,0.0045595546,0.00012640601,0.0005440137,0.9372634,0.0002938767,0.006874743,0.000015218238],"about_ca_topic_score_codex":0.00029746062,"about_ca_topic_score_gemma":0.00026556608,"teacher_disagreement_score":0.0031761397,"about_ca_system_score_codex":0.00026770553,"about_ca_system_score_gemma":0.00019439361,"threshold_uncertainty_score":0.010625303},"labels":[],"label_agreement":null},{"id":"W1966945481","doi":"10.1054/bjoc.2001.2196","title":"The surgical management of women with ovarian cancer in the south west of England","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Malignancy; Cancer; Stage (stratigraphy); Gynecology; Epithelial ovarian cancer; Multivariate analysis; Surgery; Internal medicine","score_opus":0.010527599922157781,"score_gpt":0.26899921502353485,"score_spread":0.25847161510137706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966945481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985154,0.0007523102,0.000036340665,0.00019667004,0.0000073211495,0.000010339177,0.00017825294,9.4767245e-7,0.00030228734],"genre_scores_gemma":[0.9989679,0.00051088963,0.000041958494,0.00008273744,0.000008245241,0.000011812272,0.00011949386,6.3279043e-7,0.00025637867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933606,0.00023469226,0.00009394832,0.00008331747,0.00011012905,0.00014186314],"domain_scores_gemma":[0.99698704,0.0004898654,0.0019429754,0.00006802238,0.00016845274,0.0003437163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042129733,0.00017236879,0.0002699451,0.00044978788,0.0004505552,0.00063207815,0.00036818034,0.00034057559,0.0010838328],"category_scores_gemma":[0.0027710104,0.00030183778,0.0002099169,0.0008947201,0.00060520665,0.0006005501,0.0008981071,0.00045138184,0.00016207872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097964585,0.000021702195,0.9942603,0.00006390436,0.000027306687,0.0007303221,0.0014885709,0.00004864481,0.0003428564,0.000048441812,0.00030372266,0.0025661816],"study_design_scores_gemma":[0.000007255174,0.000088255816,0.9965726,0.000032331915,0.000007948107,0.0005841057,0.0020672681,0.00006497486,0.00003669917,0.000020279796,0.0005137764,0.0000044473873],"about_ca_topic_score_codex":0.07081477,"about_ca_topic_score_gemma":0.13158876,"teacher_disagreement_score":0.07081477,"about_ca_system_score_codex":0.001065088,"about_ca_system_score_gemma":0.00088796276,"threshold_uncertainty_score":0.14080518},"labels":[],"label_agreement":null},{"id":"W1967036025","doi":"10.1038/sj.bjc.6604901","title":"Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Faculty of Medicine, McGill University; McGill University","keywords":"Focal adhesion; Proto-oncogene tyrosine-protein kinase Src; Cell biology; Cell migration; Extracellular matrix; Biology; ErbB; Receptor tyrosine kinase; Tyrosine kinase; Motility; Kinase; Signal transduction; Cell; Cancer research; Biochemistry","score_opus":0.012257391740921946,"score_gpt":0.29410036280405977,"score_spread":0.2818429710631378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967036025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994786,0.0028784533,0.000617134,0.00005989833,0.000008624895,0.000009049033,0.0001591775,0.000029916893,0.0014517256],"genre_scores_gemma":[0.9969549,0.001021878,0.000422076,0.000022026912,0.0000039136717,0.000015305746,0.00016689705,0.000004389923,0.0013886445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988925,0.000017946762,0.000008378318,0.000012655914,0.000036766327,0.00003505331],"domain_scores_gemma":[0.99995756,0.000008386725,0.000011302665,0.000005499624,0.000006797881,0.000010445265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092223665,0.0001563047,0.00018968215,0.0001718607,0.000121383906,0.00034295148,0.00009078465,0.00021169937,0.0006687122],"category_scores_gemma":[0.00010021497,0.00012142153,0.00012330012,0.00014075472,0.00010967935,0.00012637753,0.00013721561,0.00027013253,0.00025213792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008667996,0.00001250798,0.00019697612,0.000021569394,0.0000021507205,0.00003874324,0.000010190175,0.00004518667,0.9985942,0.000073766794,0.000022533546,0.0008954059],"study_design_scores_gemma":[0.000031190757,0.00030161763,0.026048893,0.0000081530625,0.000016030703,0.00071614474,0.000057320678,0.002174152,0.96747535,0.000108229186,0.0030550482,0.000007960659],"about_ca_topic_score_codex":0.00079445064,"about_ca_topic_score_gemma":0.0009442236,"teacher_disagreement_score":0.00079445064,"about_ca_system_score_codex":0.0003570918,"about_ca_system_score_gemma":0.00010959111,"threshold_uncertainty_score":0.0025908947},"labels":[],"label_agreement":null},{"id":"W1967649543","doi":"10.1038/sj.bjc.6602063","title":"Interstitial lung disease associated with drug therapy","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"AstraZeneca","keywords":"Medicine; Interstitial lung disease; Gefitinib; Lung cancer; Diffuse alveolar damage; Disease; Radiation therapy; Internal medicine; Chemotherapy; Intensive care medicine; Oncology; Pathology; Cancer; Lung; Epidermal growth factor receptor; Acute respiratory distress","score_opus":0.01802343363430449,"score_gpt":0.32297866921994367,"score_spread":0.3049552355856392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967649543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001774569,0.9978079,0.0000725569,0.00014702493,0.00013270641,0.00000403469,0.000010527311,0.0000052243054,0.0016425696],"genre_scores_gemma":[0.0026436273,0.99556845,0.0001249113,0.00022556476,0.00025582712,0.000005962994,0.000029114446,0.0000012621954,0.0011453524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999668,0.00006594722,0.00005849703,0.000053115553,0.000122059275,0.000032376156],"domain_scores_gemma":[0.99948525,0.00023621682,0.00011814429,0.000019333484,0.0001052985,0.00003558815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043572942,0.00076996186,0.0016614746,0.002499273,0.00030996825,0.0008396827,0.0005823952,0.00092024304,0.0036488755],"category_scores_gemma":[0.0010680341,0.00019581037,0.00049517566,0.0026802577,0.00045991444,0.0009508541,0.0004674122,0.00081659254,0.0017764922],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007817007,0.000059504215,0.0011728234,0.010934602,0.00010679243,0.0014865809,0.000053300137,0.000235302,0.00078533107,0.0010373283,0.029248018,0.95480233],"study_design_scores_gemma":[0.000045919387,0.00016069131,0.006988302,0.007550231,0.00025144633,0.0298129,0.00012524182,0.00016470246,0.0008092587,0.0017339856,0.9523308,0.000026560598],"about_ca_topic_score_codex":0.0014133771,"about_ca_topic_score_gemma":0.0029638784,"teacher_disagreement_score":0.0036488755,"about_ca_system_score_codex":0.0005945063,"about_ca_system_score_gemma":0.0009521786,"threshold_uncertainty_score":0.012206733},"labels":[],"label_agreement":null},{"id":"W1967961552","doi":"10.1038/bjc.2014.173","title":"Common infection-related conditions and risk of lymphoid malignancies in older individuals","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Cancer Institute; National Institutes of Health; Department for Employment and Learning, Northern Ireland; Queen's University; Queen's University Belfast","keywords":"Medicine; Immunology; Oncology; Internal medicine","score_opus":0.006098518011183291,"score_gpt":0.2657300370907459,"score_spread":0.2596315190795626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967961552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703217,0.0015674285,0.00007111712,0.00006695518,0.000009269554,0.000007077236,0.0005700846,0.00000437236,0.0006715556],"genre_scores_gemma":[0.99897707,0.00048450785,0.000056362103,0.000023353055,0.00001845461,0.0000042118018,0.00031455688,8.381158e-7,0.00012057927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998443,0.000029719382,0.000018746567,0.000037395024,0.000032617016,0.00003717354],"domain_scores_gemma":[0.9992829,0.00007214875,0.00042523455,0.00003329305,0.00004984874,0.00013659148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706582,0.00014571716,0.00017102291,0.0006055976,0.00027056428,0.0002812272,0.0001431202,0.00026958736,0.0018470348],"category_scores_gemma":[0.0010831135,0.00010209803,0.0002627356,0.0006997528,0.00014660186,0.00017739854,0.0002595163,0.00030476987,0.0001429906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002476514,0.000009551992,0.9987562,0.000010423178,0.000023880493,0.000044925077,0.000019893714,0.000016594593,0.000107419655,0.000011592762,0.0000499004,0.0009248305],"study_design_scores_gemma":[0.0000012703744,0.000028934799,0.9995573,0.000006179126,0.0000113317865,0.00019119073,0.000030440437,0.000035844412,0.000014805027,0.000016808513,0.00010520912,7.526863e-7],"about_ca_topic_score_codex":0.0040821237,"about_ca_topic_score_gemma":0.003890707,"teacher_disagreement_score":0.0040821237,"about_ca_system_score_codex":0.00015075847,"about_ca_system_score_gemma":0.00017116418,"threshold_uncertainty_score":0.008116722},"labels":[],"label_agreement":null},{"id":"W1968818485","doi":"10.1038/bjc.2013.380","title":"A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Progressive disease; Pharmacology; Nausea; Angiogenesis; Internal medicine; Adverse effect; Vascular endothelial growth factor; Phases of clinical research; Gastroenterology; Oncology; Chemotherapy; VEGF receptors","score_opus":0.004725087741611764,"score_gpt":0.2583241261718354,"score_spread":0.25359903843022363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968818485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942116,0.0014022567,0.00041943358,0.00021002861,0.00006740477,0.001738217,0.0005338664,0.000072118266,0.0013450519],"genre_scores_gemma":[0.9909809,0.001255426,0.0017664399,0.000488738,0.000099723125,0.0017195137,0.0018183867,0.000026095635,0.0018447601],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996331,0.00014962695,0.000020883022,0.00007060998,0.000046990925,0.0000789246],"domain_scores_gemma":[0.99952245,0.000054653778,0.00007058561,0.00004814943,0.000033086028,0.0002711501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010112228,0.0011710682,0.002009927,0.0005582263,0.00041917892,0.00082128687,0.0009588795,0.0011106574,0.0026293134],"category_scores_gemma":[0.0005813614,0.0005679054,0.000968481,0.0004883161,0.0008109713,0.00052726676,0.0003506443,0.002318459,0.00088030763],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49775475,0.14328976,0.013548582,0.0010927276,0.002036465,0.0007453624,0.00055983895,0.0046982914,0.1924341,0.00047034665,0.004907252,0.13846253],"study_design_scores_gemma":[0.30518547,0.6632355,0.019231563,0.000028710054,0.0004185389,0.0006039408,0.00006873116,0.001230081,0.005914282,0.00012588504,0.0039261943,0.000031041964],"about_ca_topic_score_codex":0.0013037508,"about_ca_topic_score_gemma":0.0024976959,"teacher_disagreement_score":0.0026293134,"about_ca_system_score_codex":0.0009070807,"about_ca_system_score_gemma":0.0013695856,"threshold_uncertainty_score":0.008795917},"labels":[],"label_agreement":null},{"id":"W1968864885","doi":"10.1038/sj.bjc.6604803","title":"Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Paclitaxel; Bioluminescence imaging; Ovarian cancer; Bioluminescence; Medicine; Luciferase; Cancer research; Apoptosis; Ovarian carcinoma; Chemotherapy; Cytotoxicity; In vivo; Oncology; Internal medicine; Cancer; Pathology; In vitro; Biology; Cell culture","score_opus":0.02210422114630125,"score_gpt":0.293406102279716,"score_spread":0.27130188113341475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968864885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98870087,0.0026155424,0.0066145966,0.0001869824,0.00006202905,0.0002071217,0.00024413165,0.00018871562,0.001180064],"genre_scores_gemma":[0.98934245,0.0018137735,0.00619544,0.00006580805,0.00003518906,0.00018658432,0.0002798586,0.00005247001,0.002028401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998072,0.000035977126,0.000010988331,0.000037716367,0.000053008378,0.00005509276],"domain_scores_gemma":[0.9997967,0.00004364015,0.00008047876,0.000024259447,0.000022052252,0.00003295948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042496115,0.0005465536,0.00055054604,0.00046393127,0.00014578387,0.00042379406,0.00032664122,0.0005115852,0.00082212506],"category_scores_gemma":[0.00029066642,0.0002235197,0.00025533268,0.00023899859,0.0004433488,0.00041713106,0.00016064536,0.0010725494,0.00019694884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006898504,0.00037121342,0.00019443163,0.00005816157,0.0000066244797,0.000024489773,0.000029179893,0.00023839035,0.99335915,0.00004701267,0.00005566598,0.0049258056],"study_design_scores_gemma":[0.00013677942,0.008031083,0.0016688908,0.0000072875696,0.000043565833,0.00009192617,0.000016267584,0.0016245414,0.9873431,0.000029989367,0.0009993673,0.000007298468],"about_ca_topic_score_codex":0.0007943666,"about_ca_topic_score_gemma":0.0009981941,"teacher_disagreement_score":0.00082212506,"about_ca_system_score_codex":0.00041148372,"about_ca_system_score_gemma":0.00038676406,"threshold_uncertainty_score":0.002985537},"labels":[],"label_agreement":null},{"id":"W1969069350","doi":"10.1038/bjc.2011.256","title":"Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Leukopenia; Medicine; Carboplatin; Internal medicine; Gastroenterology; Chemotherapy; Oncology; Surgery; Cisplatin","score_opus":0.03812314010986336,"score_gpt":0.3147218956654109,"score_spread":0.2765987555555476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969069350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998329,0.0012608732,0.000052132913,0.000053643478,0.0000046635005,0.000027124412,0.00010193927,0.0000026070832,0.00016806112],"genre_scores_gemma":[0.99940896,0.00015887669,0.00007526256,0.00002561935,0.000010428977,0.000016065605,0.00024105937,7.801059e-7,0.000062878455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996431,0.00020090977,0.0000318342,0.00004784963,0.000042173262,0.000034173372],"domain_scores_gemma":[0.9984048,0.0005747841,0.00064454036,0.00007350185,0.00006437099,0.00023802972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012042985,0.00016189183,0.00038518023,0.0001874609,0.000105735744,0.00035593522,0.00023402556,0.00027781448,0.0008553976],"category_scores_gemma":[0.0022087365,0.000093101,0.00048920594,0.00028495147,0.0001992422,0.0001753121,0.00021654343,0.00044402832,0.00006134166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046312362,0.00031981603,0.9152396,0.0002531983,0.0008237885,0.00006590588,0.00005501398,0.0015865574,0.001960035,0.000046798887,0.0004320097,0.032904964],"study_design_scores_gemma":[0.00356622,0.009164853,0.9815444,0.00004270875,0.0007102502,0.00035605344,0.000036754907,0.0028893477,0.0007224726,0.00013228756,0.0008248029,0.000009864346],"about_ca_topic_score_codex":0.0008588777,"about_ca_topic_score_gemma":0.001477862,"teacher_disagreement_score":0.0012042985,"about_ca_system_score_codex":0.00038106678,"about_ca_system_score_gemma":0.00035782962,"threshold_uncertainty_score":0.0063689947},"labels":[],"label_agreement":null},{"id":"W1969252475","doi":"10.1038/sj.bjc.6600895","title":"Construct validation of the Health Utilities Index and the Child Health Questionnaire in children undergoing cancer chemotherapy","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Health Utilities Index; Psychosocial; Construct validity; Psychometrics; Quality of life (healthcare); Medicine; Physical therapy; EQ-5D; Visual analogue scale; Psychology; Health related quality of life; Clinical psychology; Psychiatry; Internal medicine; Nursing","score_opus":0.012257078044795467,"score_gpt":0.3115146192791826,"score_spread":0.29925754123438714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969252475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936465,0.0012034817,0.0021081213,0.00021290456,0.000056248144,0.00022263553,0.0007374423,0.000019788371,0.0017928439],"genre_scores_gemma":[0.9966827,0.00024785704,0.0019677032,0.00004777686,0.000019057154,0.00024285408,0.00063166546,0.000009764989,0.00015064131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928075,0.0038900815,0.0007295882,0.00033294657,0.0018791839,0.0003605828],"domain_scores_gemma":[0.97656393,0.012672366,0.0060255304,0.00084120326,0.0031855074,0.0007114914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015439166,0.00034337642,0.00055711356,0.0014948118,0.00025906658,0.00079594535,0.0005236177,0.0004472191,0.0010266443],"category_scores_gemma":[0.04610361,0.00024662618,0.001133318,0.0016343467,0.00061008276,0.000688241,0.00095177494,0.0010834612,0.00022229784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016757939,0.00007921418,0.9872723,0.000053158205,0.00008805383,0.00003382265,0.00031627013,0.00031175517,0.00012288886,0.000098182725,0.00020079708,0.011256077],"study_design_scores_gemma":[0.00002285894,0.0004093956,0.99714065,0.00004335048,0.000037152087,0.0001232741,0.0002525412,0.0011463129,0.00014605903,0.000065489054,0.00060432893,0.000008489746],"about_ca_topic_score_codex":0.0029374184,"about_ca_topic_score_gemma":0.003289052,"teacher_disagreement_score":0.015439166,"about_ca_system_score_codex":0.0007173711,"about_ca_system_score_gemma":0.0009025064,"threshold_uncertainty_score":0.08165109},"labels":[],"label_agreement":null},{"id":"W1969696346","doi":"10.1038/sj.bjc.6601099","title":"Oestradiol enhances tumour regression induced by B7-1/IL-2 adenoviral gene transfer in a murine model of breast cancer","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Svenska Läkaresällskapet; Turner Foundation; Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Breast cancer; Gene transfer; Cancer research; Cancer; Medicine; Gene; Biology; Pathology; Internal medicine; Genetics","score_opus":0.02421727473901761,"score_gpt":0.29863187512381856,"score_spread":0.2744146003848009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969696346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941942,0.0018480159,0.0014259437,0.00016289462,0.00010248408,0.00010892854,0.00049008237,0.00014046855,0.0015269036],"genre_scores_gemma":[0.991172,0.0013942842,0.002126572,0.000086408676,0.000031577558,0.00012197517,0.0005726121,0.000047114456,0.0044474714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995809,0.00008018418,0.00003821273,0.00007400352,0.000104889914,0.00012182932],"domain_scores_gemma":[0.999718,0.000057983954,0.00008755985,0.00003131247,0.00001766833,0.00008749331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031540744,0.00068143476,0.00041219904,0.00075050496,0.00015883268,0.00041886835,0.00032723875,0.00061878713,0.0014496035],"category_scores_gemma":[0.00014572577,0.00028247997,0.00044407294,0.00027967556,0.00040560335,0.00028781837,0.00024423908,0.0013653024,0.00048376905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024524707,0.00013420537,0.00006292372,0.000027601876,0.0000040998793,0.000025021616,0.000020680087,0.0000914464,0.99877006,0.000052997846,0.000022964192,0.0005427815],"study_design_scores_gemma":[0.000096442294,0.0023857192,0.0014165376,0.00001019886,0.000020796075,0.000119806515,0.000026253123,0.0008337988,0.9937219,0.000028354441,0.0013341467,0.0000059676718],"about_ca_topic_score_codex":0.0010427475,"about_ca_topic_score_gemma":0.0011816516,"teacher_disagreement_score":0.0014496035,"about_ca_system_score_codex":0.00041049896,"about_ca_system_score_gemma":0.00031989423,"threshold_uncertainty_score":0.004849434},"labels":[],"label_agreement":null},{"id":"W1970053010","doi":"10.1038/sj.bjc.6604896","title":"Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; University of South Carolina","keywords":"Photodynamic therapy; Ceramide; In vivo; Cancer research; Cancer; In vitro; Sphingolipid; Biology; Pathology; Medicine; Internal medicine; Apoptosis; Chemistry; Biochemistry","score_opus":0.005406259888965835,"score_gpt":0.2166880040697486,"score_spread":0.21128174418078277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970053010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915917,0.0035329321,0.0014571816,0.00010870351,0.000053030886,0.00005895516,0.00062656106,0.000110354915,0.002460438],"genre_scores_gemma":[0.9936976,0.0010638925,0.0012028631,0.000048080623,0.000015798645,0.000041379408,0.000495849,0.000031487118,0.003403193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982196,0.000028995695,0.0000145130025,0.00003613284,0.000054465483,0.00004391413],"domain_scores_gemma":[0.9998305,0.000031706746,0.000033017972,0.000025134086,0.000021626352,0.00005807737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018988282,0.0003705743,0.00039927856,0.0004169905,0.000112745554,0.00021898265,0.0001758267,0.00041917633,0.0017856352],"category_scores_gemma":[0.00013557107,0.0001302028,0.000286172,0.00020664363,0.0002176714,0.00026520932,0.00016080274,0.0007497872,0.00042662086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001352246,0.000019495374,0.000035449633,0.000015091402,0.000002193924,0.000014254743,0.0000054697275,0.000022674505,0.9992372,0.000008998555,0.000013319004,0.000490797],"study_design_scores_gemma":[0.000010248311,0.0005499056,0.0017749984,0.0000017156692,0.000009447925,0.00009510395,0.000008105783,0.0001716175,0.99663734,0.000008775699,0.000730015,0.0000026060334],"about_ca_topic_score_codex":0.00090576237,"about_ca_topic_score_gemma":0.0009842555,"teacher_disagreement_score":0.0017856352,"about_ca_system_score_codex":0.0002541668,"about_ca_system_score_gemma":0.00021052627,"threshold_uncertainty_score":0.005973518},"labels":[],"label_agreement":null},{"id":"W1970080542","doi":"10.1038/bjc.2013.670","title":"ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"CIHR Skin Research Training Centre; Canadian Institutes of Health Research; Cancer Research Society; National Natural Science Foundation of China; Canadian Dermatology Foundation","keywords":"Angiogenesis; Melanoma; Cancer research; Metastasis; Biology; Cancer; Medicine; Internal medicine","score_opus":0.004236368533769617,"score_gpt":0.2107123923744515,"score_spread":0.20647602384068187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970080542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720347,0.0014885112,0.0002769045,0.00007215499,0.000011872109,0.000012090758,0.000294486,0.000012135882,0.00062837935],"genre_scores_gemma":[0.99832565,0.00033111667,0.00033926446,0.000024666917,0.000020751373,0.000013748441,0.00049446645,0.0000038399394,0.00044649348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998977,0.000022112334,0.000008924858,0.000020784862,0.000019580992,0.00003089522],"domain_scores_gemma":[0.99973375,0.00003320506,0.00011858607,0.000012801348,0.00003162025,0.00007002366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028271924,0.0002450978,0.000254838,0.00041274304,0.00022296375,0.00032728649,0.00017799868,0.00025894903,0.0014603407],"category_scores_gemma":[0.00051884697,0.000097873,0.00030129292,0.00047639624,0.00015264792,0.00023471114,0.00020333602,0.00039968945,0.00025573955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026555988,0.00011360102,0.9691445,0.000074820135,0.00012021327,0.0005533956,0.000053362422,0.00021910643,0.013398869,0.00007703824,0.00045357668,0.013135885],"study_design_scores_gemma":[0.00003979925,0.00036364395,0.9913072,0.000016405203,0.00021530011,0.0012293542,0.00010635963,0.0011091271,0.0038600615,0.00020173965,0.0015401295,0.000010905453],"about_ca_topic_score_codex":0.00037188552,"about_ca_topic_score_gemma":0.00057635707,"teacher_disagreement_score":0.0014603407,"about_ca_system_score_codex":0.0001913512,"about_ca_system_score_gemma":0.00014364164,"threshold_uncertainty_score":0.004885316},"labels":[],"label_agreement":null},{"id":"W1971081363","doi":"10.1038/sj.bjc.6603924","title":"FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":293,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Prostate Cancer Research Initiative; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"PTEN; Prostate cancer; Biology; Prostate; Fluorescence in situ hybridization; Cancer research; Tissue microarray; Oncology; Pathology; Internal medicine; Medicine; Cancer; Gene; Genetics; Chromosome; PI3K/AKT/mTOR pathway","score_opus":0.057729583069028256,"score_gpt":0.39167460119885167,"score_spread":0.3339450181298234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971081363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912304,0.00024535292,0.00018253646,0.000013501659,0.0000014674813,0.0000037472446,0.00011509049,0.000010532264,0.00030475986],"genre_scores_gemma":[0.9991602,0.0001551883,0.0001526469,0.000007916646,0.0000017474051,0.0000052389346,0.0003211234,0.0000026580892,0.00019315229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985254,0.000024489118,0.000011787944,0.000024544439,0.000051067364,0.00003557679],"domain_scores_gemma":[0.99975365,0.00010223625,0.00004618074,0.00002337268,0.00002486626,0.000049658654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001893957,0.00013412182,0.00032720133,0.00046714008,0.00015530633,0.00015375316,0.000071306524,0.00019166965,0.00090143643],"category_scores_gemma":[0.00053762214,0.00012056901,0.0001444782,0.00038150078,0.00021290765,0.000082520375,0.00019371288,0.00014228823,0.0001936272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012256455,0.00008186433,0.8784823,0.000064560954,0.00011004666,0.0011689733,0.00028141067,0.00064492313,0.09699293,0.00005374439,0.00036701292,0.02052661],"study_design_scores_gemma":[0.000013537164,0.00047960607,0.9914147,0.0000031812306,0.00003422008,0.0026974226,0.00006388198,0.0002864133,0.0043436782,0.00003370031,0.00062322314,0.0000064091496],"about_ca_topic_score_codex":0.0019479397,"about_ca_topic_score_gemma":0.002478571,"teacher_disagreement_score":0.0019479397,"about_ca_system_score_codex":0.00021643219,"about_ca_system_score_gemma":0.00013189198,"threshold_uncertainty_score":0.003873229},"labels":[],"label_agreement":null},{"id":"W1971239528","doi":"10.1038/sj.bjc.6603614","title":"Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"National Cancer Institute; Swedish Foundation for International Cooperation in Research and Higher Education","keywords":"DDR1; Discoidin domain; Lung cancer; Biology; Receptor; Carcinoma; Receptor tyrosine kinase; Hazard ratio; Survival analysis; Cancer research; Adenocarcinoma; Pathology; Internal medicine; Oncology; Medicine; Cancer; Confidence interval","score_opus":0.008987139302141976,"score_gpt":0.28817825274685654,"score_spread":0.2791911134447146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971239528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991518,0.0005480473,0.000094885996,0.0000079206575,0.0000016783782,0.000005501558,0.000061672115,0.0000025196857,0.00012604373],"genre_scores_gemma":[0.9993925,0.0001604716,0.00017948398,0.0000064993346,0.000001934673,0.0000066647026,0.000116603034,8.8058135e-7,0.0001350398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997968,0.00004204468,0.000021083124,0.00004039201,0.000070347895,0.000029299956],"domain_scores_gemma":[0.99977297,0.00007098664,0.00006941879,0.00002307623,0.000032986616,0.0000306313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030123722,0.0001059682,0.00023747672,0.00062220026,0.00016396251,0.00028546515,0.00014853578,0.00028126527,0.0005230984],"category_scores_gemma":[0.0007263269,0.00015416804,0.00017706597,0.00031489966,0.00023286861,0.0001280127,0.00014246772,0.00013830616,0.00015967972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001093152,0.000060943854,0.45992643,0.00011860344,0.000067609406,0.001232675,0.00024470093,0.0002757071,0.52995527,0.00006292845,0.000081027596,0.006880935],"study_design_scores_gemma":[0.000018480196,0.00027699218,0.9632855,0.0000047835365,0.00003398205,0.003166938,0.00017262365,0.0006137829,0.031936042,0.000041558913,0.0004433137,0.0000060486177],"about_ca_topic_score_codex":0.0006994335,"about_ca_topic_score_gemma":0.0010272313,"teacher_disagreement_score":0.0006994335,"about_ca_system_score_codex":0.00021231975,"about_ca_system_score_gemma":0.00011146725,"threshold_uncertainty_score":0.0017499328},"labels":[],"label_agreement":null},{"id":"W1971399507","doi":"10.1038/sj.bjc.6602064","title":"Diagnosis and management of drug-associated interstitial lung disease","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Lung cancer; Interstitial lung disease; Chest radiograph; Radiology; Differential diagnosis; Medical diagnosis; Lung; High-resolution computed tomography; Disease; Intensive care medicine; Internal medicine; Pathology; Radiography","score_opus":0.01661454196836549,"score_gpt":0.32714509747887927,"score_spread":0.3105305555105138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971399507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031173727,0.99678963,0.00031758,0.00045734114,0.00022418718,0.000009417763,0.00001533715,0.000013934408,0.0018609004],"genre_scores_gemma":[0.0026514186,0.9950106,0.0007798331,0.0002908211,0.0003422608,0.000011612716,0.000048087164,0.0000025915817,0.00086270523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966717,0.00006383814,0.00005695404,0.00004537997,0.00014256981,0.000024137462],"domain_scores_gemma":[0.99967146,0.00011827341,0.000062115294,0.000011676662,0.000100326324,0.000036185742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051885785,0.000744191,0.0015823925,0.0027512214,0.0003295653,0.00069656584,0.0011402327,0.0010926458,0.002462255],"category_scores_gemma":[0.001050605,0.00019877011,0.00049850193,0.0015362749,0.0005342644,0.0008972334,0.0005039229,0.0016930776,0.0021306179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032865937,0.00006850241,0.00043833518,0.005544475,0.000040459887,0.00083763874,0.000047972993,0.00025821864,0.00065180956,0.0006404047,0.017543117,0.97389627],"study_design_scores_gemma":[0.000051659015,0.00021827512,0.0084526045,0.012983508,0.00015372696,0.030578148,0.00022998164,0.00029790855,0.0009364018,0.0034304473,0.9426259,0.00004143712],"about_ca_topic_score_codex":0.0015137101,"about_ca_topic_score_gemma":0.002693498,"teacher_disagreement_score":0.0027512214,"about_ca_system_score_codex":0.0006547731,"about_ca_system_score_gemma":0.00072239665,"threshold_uncertainty_score":0.0082371235},"labels":[],"label_agreement":null},{"id":"W1971546178","doi":"10.1038/sj.bjc.6601478","title":"Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital","funders":"","keywords":"Gefitinib; Medicine; Oncology; Radiation therapy; Chemotherapy; Quality of life (healthcare); Lung cancer; Internal medicine; Brain metastasis; Clinical trial; Epidermal growth factor receptor; Cancer; Metastasis","score_opus":0.08069286411793578,"score_gpt":0.42054096828390813,"score_spread":0.33984810416597233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971546178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004086405,0.99816126,0.000037079233,0.00019687327,0.000071406546,0.0000028729974,0.000014773002,0.0000032359264,0.0011038309],"genre_scores_gemma":[0.004342054,0.9946344,0.00012065908,0.00019343775,0.000105301864,0.0000072462926,0.00003614398,0.0000012186848,0.00055958045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997737,0.000056254317,0.000044553104,0.000023831391,0.000087093744,0.00001458954],"domain_scores_gemma":[0.9995602,0.00024295087,0.00008006621,0.000007521599,0.00008549372,0.000023880786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059347646,0.00039733163,0.0017629352,0.0016881251,0.0001714569,0.00059231295,0.00046614348,0.00075232337,0.0029565657],"category_scores_gemma":[0.0011245705,0.00014864006,0.00038348476,0.002040937,0.00028817478,0.0005147159,0.00020937482,0.0006271322,0.0011147801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028699226,0.00005342063,0.0011608796,0.018069077,0.00019776693,0.0006728704,0.00006107546,0.00017884637,0.00086358644,0.0005704486,0.016261335,0.9616238],"study_design_scores_gemma":[0.00020987164,0.0004160673,0.020723794,0.012529074,0.00076975836,0.015096838,0.00018197726,0.00016811954,0.00079691573,0.0010495444,0.9480267,0.000031362844],"about_ca_topic_score_codex":0.0011747507,"about_ca_topic_score_gemma":0.0028997834,"teacher_disagreement_score":0.0029565657,"about_ca_system_score_codex":0.0005242167,"about_ca_system_score_gemma":0.00074653886,"threshold_uncertainty_score":0.009890735},"labels":[],"label_agreement":null},{"id":"W1971549450","doi":"10.1038/bjc.2014.25","title":"First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Dalhousie University; University of Toronto; University Health Network; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Clinical trial; Population; Proportional hazards model; Progression-free survival; Hazard ratio; Renal cell carcinoma; Oncology; Overall survival; Surgery; Confidence interval","score_opus":0.04437082598213789,"score_gpt":0.30390294821716096,"score_spread":0.2595321222350231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971549450","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21356489,0.29261616,0.1342066,0.21562769,0.00807538,0.05874946,0.026086677,0.0016307918,0.04944233],"genre_scores_gemma":[0.6045858,0.0322047,0.23030661,0.028669735,0.003240149,0.07703407,0.021757403,0.0006509369,0.0015505375],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.67254436,0.29513186,0.014776768,0.0022958517,0.012769784,0.002481319],"domain_scores_gemma":[0.6655673,0.2026884,0.05184082,0.02000952,0.041675422,0.01821854],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.33196306,0.0012077494,0.005363263,0.0016487301,0.00082905265,0.006317803,0.003835006,0.0023426097,0.0033242966],"category_scores_gemma":[0.35837615,0.00056565163,0.0030171229,0.0028273666,0.001328422,0.0026916284,0.0051109474,0.005171527,0.0009253699],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07289962,0.0027981275,0.13569778,0.020277113,0.0077238698,0.00014731975,0.001347316,0.020807793,0.0015015912,0.020961747,0.10552603,0.6103117],"study_design_scores_gemma":[0.118242055,0.072544284,0.34068528,0.063411765,0.012246673,0.0007413218,0.0020359121,0.043675765,0.0033645306,0.07479294,0.26742896,0.00083057035],"about_ca_topic_score_codex":0.0042080944,"about_ca_topic_score_gemma":0.007999516,"teacher_disagreement_score":0.66803694,"about_ca_system_score_codex":0.005736191,"about_ca_system_score_gemma":0.016716292,"threshold_uncertainty_score":0.8238085},"labels":[],"label_agreement":null},{"id":"W1971781813","doi":"10.1038/sj.bjc.6604453","title":"Rapid progression of prostate cancer in men with a BRCA2 mutation","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; University of Toronto; University Health Network; Women's College Hospital","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; Canadian Breast Cancer Research Alliance","keywords":"Prostate cancer; Medicine; BRCA2 Protein; Oncology; Prostate; Cancer; Mutation; Internal medicine; Germline mutation; Biology; Genetics; Gene","score_opus":0.008813128673983065,"score_gpt":0.28261027456261856,"score_spread":0.2737971458886355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971781813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983187,0.0009215545,0.000107081876,0.000030034706,0.0000054269635,0.0000039297815,0.00013888715,0.000004425377,0.00047000175],"genre_scores_gemma":[0.9991179,0.00030570317,0.000109216075,0.000018105327,0.000010733161,0.0000022346917,0.00017809433,0.0000010094161,0.00025700574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992144,0.000017244569,0.0000038301187,0.000021197735,0.000016562146,0.00001967231],"domain_scores_gemma":[0.99964213,0.00006763464,0.00013403402,0.00002440731,0.000027416138,0.0001043218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024835413,0.000109580455,0.00019224767,0.00042445812,0.0003262491,0.00024420326,0.00006322196,0.00017337891,0.0013696202],"category_scores_gemma":[0.000634101,0.00010790439,0.0001947888,0.00024370386,0.00015610586,0.00019645519,0.00025286086,0.00038389882,0.00015181038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007446084,0.000055928533,0.98238385,0.000029527071,0.000056157343,0.0006888581,0.00019523305,0.0002973705,0.0045007244,0.000105487496,0.00019030877,0.010751903],"study_design_scores_gemma":[0.00001254383,0.00042348835,0.99580693,0.000005374575,0.000022445183,0.0022065975,0.000087217464,0.00012995028,0.000513663,0.00008650967,0.00069902075,0.0000060812877],"about_ca_topic_score_codex":0.0014206073,"about_ca_topic_score_gemma":0.0024171097,"teacher_disagreement_score":0.0014206073,"about_ca_system_score_codex":0.00013932167,"about_ca_system_score_gemma":0.00020310446,"threshold_uncertainty_score":0.0045818686},"labels":[],"label_agreement":null},{"id":"W1972415660","doi":"10.1038/bjc.2014.494","title":"Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Erlotinib; Medicine; Gemcitabine; Rash; Pancreatic cancer; Erlotinib Hydrochloride; Internal medicine; Hazard ratio; Adverse effect; Clinical endpoint; Gastroenterology; Oncology; Confidence interval; Cancer; Epidermal growth factor receptor; Clinical trial","score_opus":0.05602157314813496,"score_gpt":0.43344776619419956,"score_spread":0.3774261930460646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972415660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949008,0.001805187,0.0003324394,0.0003402897,0.000053666972,0.001245041,0.00025486245,0.00004163897,0.0010259826],"genre_scores_gemma":[0.98904383,0.0025902593,0.0017858782,0.0009297344,0.0001839578,0.0027660578,0.00082943286,0.000022362525,0.0018484527],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99914443,0.0005792066,0.00003527315,0.000076357595,0.000079491845,0.00008526627],"domain_scores_gemma":[0.9989779,0.00027793823,0.00035777324,0.000085483276,0.000044650722,0.0002563282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026702327,0.0009791319,0.0016285573,0.00037413574,0.000234608,0.0007236735,0.0007563845,0.0008744464,0.003494668],"category_scores_gemma":[0.0014226658,0.00032508202,0.0015195545,0.0003664175,0.0008489325,0.0005899972,0.0004271853,0.0025298994,0.000566786],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.830619,0.053368654,0.005364418,0.0015209623,0.002119462,0.00021719822,0.00030514604,0.0036189174,0.023830896,0.0003409082,0.0025654617,0.07612894],"study_design_scores_gemma":[0.7171066,0.269821,0.006689275,0.000056666257,0.00070544897,0.00021244852,0.000041296604,0.0009280025,0.00213005,0.00015665822,0.0021244914,0.000028191258],"about_ca_topic_score_codex":0.00044613372,"about_ca_topic_score_gemma":0.0012166087,"teacher_disagreement_score":0.003494668,"about_ca_system_score_codex":0.00073812,"about_ca_system_score_gemma":0.001151416,"threshold_uncertainty_score":0.014121711},"labels":[],"label_agreement":null},{"id":"W1972466496","doi":"10.1038/sj.bjc.6603829","title":"Comparative analysis of xanafide cytotoxicity in breast cancer cell lines","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Docetaxel; Vinorelbine; Topoisomerase; Paclitaxel; Doxorubicin; Cytotoxicity; Cell culture; In vivo; Pharmacology; Gemcitabine; Cancer research; MCF-7; Chemistry; Biology; Internal medicine; Medicine; In vitro; Breast cancer; Cancer; Chemotherapy; Cisplatin; Biochemistry","score_opus":0.01310169827237698,"score_gpt":0.31017053105226666,"score_spread":0.29706883277988966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972466496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790419,0.01131798,0.0038187094,0.0001100426,0.000076438155,0.00009366578,0.0015339769,0.0001135026,0.0038937908],"genre_scores_gemma":[0.9649998,0.012772165,0.008887845,0.00012222331,0.000054852244,0.00042649504,0.004734575,0.00004301528,0.007958989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996486,0.00007840069,0.00006243504,0.00005482701,0.0001130984,0.000042667078],"domain_scores_gemma":[0.9996049,0.00014656989,0.00003971832,0.00004396258,0.00014121065,0.000023740835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031392305,0.00035449077,0.0005732706,0.00044704284,0.00021236004,0.00030774777,0.00024884526,0.00033047612,0.001163019],"category_scores_gemma":[0.00025041084,0.00013774392,0.00032771798,0.00055979844,0.00013209802,0.00024014823,0.00015827766,0.00040773884,0.0004456855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035142887,0.00013924875,0.0007817541,0.00026805978,0.000038213257,0.00009756515,0.0001470206,0.0002864199,0.9909621,0.00010244446,0.00017237959,0.006653527],"study_design_scores_gemma":[0.00001448441,0.0014265242,0.006189343,0.0000146719285,0.00005049701,0.0003327364,0.0000746533,0.00069972925,0.9884791,0.000024421435,0.0026829992,0.000010719296],"about_ca_topic_score_codex":0.0011372697,"about_ca_topic_score_gemma":0.0013906341,"teacher_disagreement_score":0.001163019,"about_ca_system_score_codex":0.00024232293,"about_ca_system_score_gemma":0.0001518127,"threshold_uncertainty_score":0.0038906336},"labels":[],"label_agreement":null},{"id":"W1972668078","doi":"10.1038/bjc.2013.533","title":"The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Immunohistochemistry; Hypoxia (environmental); Stromal cell; Cancer research; Proliferation Marker; Pathology; Univariate analysis; Internal medicine; Biology; Medicine; Oncology; Multivariate analysis","score_opus":0.004195678493158846,"score_gpt":0.23103135046292828,"score_spread":0.22683567196976942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972668078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883515,0.0007369349,0.00008568309,0.000019580639,0.0000032131236,0.0000041351936,0.000060651077,0.000005325471,0.00024938377],"genre_scores_gemma":[0.9996947,0.00009557637,0.000071723065,0.000003988593,0.0000044470694,0.0000019814709,0.000069060035,9.228933e-7,0.000057676298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998596,0.000020029138,0.000015487149,0.000021433889,0.000051289895,0.00003216166],"domain_scores_gemma":[0.9992655,0.0001380028,0.00025769608,0.000027006974,0.00015313266,0.00015868446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004052026,0.00021274916,0.00023774541,0.0009160536,0.00024850052,0.00050660694,0.00020471898,0.00031218602,0.0012255452],"category_scores_gemma":[0.0010291468,0.00010569976,0.00015426597,0.0005840801,0.00029163132,0.00023451341,0.0003904611,0.00021527616,0.00023885054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070402666,0.000018400066,0.98267764,0.00003636618,0.000051725518,0.00016481566,0.000043546705,0.00011369553,0.009094091,0.000013692728,0.0000773368,0.0070047122],"study_design_scores_gemma":[0.000010652757,0.00019607935,0.99604815,0.000008469605,0.00007829844,0.001090598,0.00014918849,0.00054004707,0.0016109745,0.000052238847,0.00020986046,0.000005525249],"about_ca_topic_score_codex":0.001271711,"about_ca_topic_score_gemma":0.0029900868,"teacher_disagreement_score":0.001271711,"about_ca_system_score_codex":0.00030337632,"about_ca_system_score_gemma":0.00025532438,"threshold_uncertainty_score":0.0040997863},"labels":[],"label_agreement":null},{"id":"W1972670768","doi":"10.1038/sj.bjc.6604119","title":"How do patients want to learn of results of clinical trials? A survey of 1431 breast cancer patients","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Cancer Research UK; Sanofi; Pfizer","keywords":"Tact; Medicine; Breast cancer; Clinical trial; Family medicine; Next of kin; Telephone survey; Cancer; Internal medicine; Psychology","score_opus":0.3680018666523295,"score_gpt":0.5429190339267637,"score_spread":0.17491716727443418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972670768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95783055,0.0057250466,0.0003287166,0.029637212,0.00012033434,0.000104647945,0.00037716163,0.000022876435,0.005853492],"genre_scores_gemma":[0.9845883,0.003082893,0.0003680918,0.010980549,0.00015081944,0.00007313043,0.000132763,0.00001246486,0.00061088544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98042136,0.012884211,0.002193243,0.0005899995,0.0028124866,0.001098625],"domain_scores_gemma":[0.9315156,0.03441647,0.021303449,0.0012435885,0.0039015994,0.007619262],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015173237,0.00016473023,0.0005437477,0.00070598425,0.0010819728,0.0026193662,0.00047642915,0.0020142263,0.004384072],"category_scores_gemma":[0.082734086,0.0005031612,0.0005722168,0.00093304535,0.0014336687,0.0026099042,0.0012276045,0.00214117,0.0008463484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011414338,0.000509186,0.84864026,0.001539077,0.00038995096,0.0012011348,0.033672076,0.0002763316,0.0010776446,0.0005720364,0.028914584,0.08206621],"study_design_scores_gemma":[0.0003349254,0.0038125515,0.86263734,0.0015253382,0.00030537532,0.005840189,0.07595122,0.0006074976,0.0004865856,0.0008510441,0.04745937,0.00018859022],"about_ca_topic_score_codex":0.0031461676,"about_ca_topic_score_gemma":0.0032326875,"teacher_disagreement_score":0.98482674,"about_ca_system_score_codex":0.0014924464,"about_ca_system_score_gemma":0.0018979937,"threshold_uncertainty_score":0.08024472},"labels":[],"label_agreement":null},{"id":"W1972719755","doi":"10.1038/sj.bjc.6601766","title":"Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Extracellular; Fibrosarcoma; Hypoxia (environmental); Cell culture; Melanoma; In vivo; Cancer research; Metastasis; Hyperthermia; Cell; Chemistry; Pathology; Biology; Medicine; Internal medicine; Oxygen; Cancer; Biochemistry","score_opus":0.004500252891964359,"score_gpt":0.229531440434076,"score_spread":0.22503118754211165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972719755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759465,0.00066709286,0.0006990803,0.000041015956,0.000014688889,0.00002692389,0.0002455584,0.000024533614,0.000686371],"genre_scores_gemma":[0.99492574,0.00061923114,0.0021232122,0.000034659693,0.00000997926,0.00004784023,0.00051914406,0.000019081976,0.0017011109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976414,0.00008827633,0.000021235795,0.000028068864,0.000046852096,0.000051471878],"domain_scores_gemma":[0.99965954,0.0001398196,0.000056064575,0.000041033447,0.000029209561,0.00007445861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031073194,0.00035738794,0.00027556324,0.00025467938,0.00013692584,0.00023013889,0.00016031285,0.00024272132,0.00093267736],"category_scores_gemma":[0.00019589759,0.00013256061,0.00021491008,0.0001408913,0.0001856085,0.00014020792,0.00017397873,0.00047305098,0.00014426866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004591015,0.00008475083,0.00035864892,0.000023733544,0.000008281968,0.000040944422,0.000030084326,0.00010329999,0.99816823,0.00004915693,0.000028238142,0.00064549386],"study_design_scores_gemma":[0.00002125339,0.0016089436,0.004322922,0.0000021399962,0.000012662931,0.00011412986,0.00002290242,0.0005602747,0.9927471,0.000015878904,0.00056767586,0.0000040316518],"about_ca_topic_score_codex":0.0015230349,"about_ca_topic_score_gemma":0.0021115388,"teacher_disagreement_score":0.0015230349,"about_ca_system_score_codex":0.00022368557,"about_ca_system_score_gemma":0.00017394355,"threshold_uncertainty_score":0.0031200647},"labels":[],"label_agreement":null},{"id":"W1973293106","doi":"10.1038/bjc.2013.766","title":"Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Biopsy; Surgical pathology; Histology; Hysterectomy; Adenocarcinoma; Lymphovascular invasion; Concordance; Cancer; Clear cell; Anatomical pathology; Carcinoma; Pathology; Radiology; Internal medicine; Metastasis","score_opus":0.0462073817853215,"score_gpt":0.37294596797226964,"score_spread":0.3267385861869481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973293106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993445,0.00026469905,0.00011116927,0.000020762787,0.0000042080587,0.000007185466,0.0000608134,0.0000034072307,0.00018317741],"genre_scores_gemma":[0.99970466,0.000038888735,0.00014496023,0.0000040123823,0.0000046576733,0.0000029452383,0.000079159116,9.933807e-7,0.00001971819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986706,0.00054617174,0.00023562285,0.00012399352,0.00030414955,0.00011950285],"domain_scores_gemma":[0.9861649,0.005423713,0.0057551377,0.0004681578,0.0012129658,0.0009750814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022699663,0.00020071804,0.00027585082,0.0009900762,0.00028172985,0.00063410547,0.00044142583,0.0003570615,0.0008855602],"category_scores_gemma":[0.011499572,0.00021663532,0.00023000441,0.0008306345,0.00046334256,0.00028917412,0.0006426289,0.00040987195,0.00018023049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072493625,0.000003351499,0.9992499,0.000004727043,0.0000052239975,0.00003897959,0.00002690891,0.0000236644,0.00010771009,0.0000018086776,0.000010157364,0.00045509567],"study_design_scores_gemma":[0.000003652512,0.00014492046,0.9984101,0.000005839721,0.0000123196605,0.0006799012,0.00012945828,0.00035680804,0.0001747433,0.0000070890997,0.000073029485,0.000002070188],"about_ca_topic_score_codex":0.0016210829,"about_ca_topic_score_gemma":0.0019242832,"teacher_disagreement_score":0.0022699663,"about_ca_system_score_codex":0.00032180388,"about_ca_system_score_gemma":0.00040286122,"threshold_uncertainty_score":0.012004912},"labels":[],"label_agreement":null},{"id":"W1973416725","doi":"10.1054/bjoc.2001.1793","title":"Lactation and breast cancer risk: a case–control study in Connecticut","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Breast cancer; Lactation; Medicine; Case-control study; Risk assessment; Cancer; Oncology; Gynecology; Obstetrics; Environmental health; Pregnancy; Internal medicine; Biology; Computer science; Genetics","score_opus":0.011160383580517949,"score_gpt":0.31092907381066975,"score_spread":0.2997686902301518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973416725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719054,0.0014376704,0.00020519366,0.00009619995,0.000013735507,0.000055719654,0.0002689396,0.000004465714,0.00072735955],"genre_scores_gemma":[0.997593,0.00077741634,0.00028266382,0.00013967381,0.000023325612,0.00007966346,0.00053833035,0.000003997661,0.0005619174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884295,0.0005639892,0.00007121748,0.00022236803,0.00017660232,0.00012281301],"domain_scores_gemma":[0.99906355,0.00026798173,0.0002757203,0.00011024411,0.00014449129,0.00013808798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011782404,0.00044723827,0.0003986987,0.0016636979,0.001743045,0.000984777,0.00043353086,0.0006175028,0.0014221267],"category_scores_gemma":[0.0024700111,0.0006531062,0.00031976678,0.0024349957,0.00071513734,0.00029805533,0.00063100434,0.0005524189,0.00018035239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028138378,0.000108848624,0.9960252,0.00003349199,0.00016492019,0.0006561448,0.0004891858,0.000051586532,0.00063554116,0.00006508182,0.00024912207,0.0012394994],"study_design_scores_gemma":[0.00008045306,0.00016425029,0.99672467,0.000046627007,0.00012789168,0.0009746577,0.00036069495,0.00012549016,0.00012816333,0.000030024004,0.0012300224,0.0000071279264],"about_ca_topic_score_codex":0.10469471,"about_ca_topic_score_gemma":0.14704253,"teacher_disagreement_score":0.10469471,"about_ca_system_score_codex":0.0013480862,"about_ca_system_score_gemma":0.0008296639,"threshold_uncertainty_score":0.20817065},"labels":[],"label_agreement":null},{"id":"W1973461633","doi":"10.1038/sj.bjc.6605665","title":"Adipose tissue pathways involved in weight loss of cancer cachexia","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"European Commission; Vetenskapsrådet; Karolinska Institutet; Swedish Cancer Foundation","keywords":"Adipose tissue; Cachexia; Endocrinology; Adipocyte; Biology; Internal medicine; Extracellular matrix; White adipose tissue; Adipose tissue macrophages; Cancer research; Cancer; Cell biology; Medicine","score_opus":0.027457205559181186,"score_gpt":0.34126982576105713,"score_spread":0.31381262020187595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973461633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006045,0.0068783765,0.001268989,0.00020183498,0.000012367524,0.000030544245,0.00038390688,0.000031278778,0.0011321917],"genre_scores_gemma":[0.9948807,0.0026511012,0.00096963585,0.000104193794,0.00001228992,0.000037588296,0.00052493636,0.0000058291917,0.0008137308],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994254,0.000012699923,0.000002884263,0.000012352887,0.000009469543,0.00002017266],"domain_scores_gemma":[0.99991584,0.0000123736845,0.000036681708,0.0000046433815,0.000013649739,0.000016719545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008406568,0.00027217434,0.00020792591,0.0003195038,0.00016804486,0.00025599447,0.00008503171,0.00014308239,0.00126372],"category_scores_gemma":[0.00012232111,0.0000794626,0.00017328653,0.00032435762,0.00021248036,0.00014256421,0.00021838758,0.0002699585,0.00014965136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043364437,0.0002310097,0.15131822,0.00077413284,0.0002589541,0.0016249123,0.00037744056,0.0010781854,0.7859913,0.0008907292,0.00076619536,0.052352533],"study_design_scores_gemma":[0.00014981456,0.0010680854,0.9325596,0.00010327888,0.00027315423,0.0025578216,0.00053273217,0.001670856,0.05407791,0.0021072656,0.004878307,0.000021094533],"about_ca_topic_score_codex":0.00050117617,"about_ca_topic_score_gemma":0.00093589176,"teacher_disagreement_score":0.00126372,"about_ca_system_score_codex":0.00022140268,"about_ca_system_score_gemma":0.00021496644,"threshold_uncertainty_score":0.004227519},"labels":[],"label_agreement":null},{"id":"W1973823907","doi":"10.1038/sj.bjc.6605039","title":"Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of Toronto; Hillman Foundation; U.S. Public Health Service; Texas Tech University","keywords":"Curcumin; CHEK1; Cyclin B1; Cell cycle; Apoptosis; Cyclin-dependent kinase 1; Molecular biology; Cancer research; Biology; Cell cycle checkpoint; DNA damage; Phosphorylation; Pancreatic cancer; Chemistry; Cell biology; Cancer; DNA; Biochemistry","score_opus":0.005620806136872605,"score_gpt":0.26648107389500786,"score_spread":0.26086026775813526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973823907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881175,0.006118509,0.0014746006,0.00016383381,0.00007810526,0.00006373319,0.001082306,0.00017400544,0.0027274184],"genre_scores_gemma":[0.9888418,0.0041435384,0.0014745322,0.00007039112,0.000020158068,0.000092962815,0.0016544888,0.000017955188,0.0036842076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999912,0.000014398009,0.000011034915,0.000021277356,0.000018593375,0.000022586277],"domain_scores_gemma":[0.9999418,0.000015063581,0.000012896292,0.000013345097,0.0000072058165,0.000009754165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010258343,0.00033947456,0.00028689456,0.00021181912,0.00018845682,0.00020483046,0.00012086394,0.00017794219,0.0019476495],"category_scores_gemma":[0.000090195805,0.00016625978,0.00028357282,0.0003217772,0.00012538915,0.00012327873,0.00014888008,0.00049852993,0.0005847101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051983615,0.000090429865,0.00031654615,0.00011449408,0.000016915295,0.00013313045,0.000030725783,0.00009889935,0.995544,0.00003952322,0.00019138673,0.0029040887],"study_design_scores_gemma":[0.00004676564,0.00083930866,0.008857743,0.000010338081,0.000027618398,0.0005191908,0.000037510366,0.000476586,0.9851671,0.000027768569,0.0039850073,0.0000051123893],"about_ca_topic_score_codex":0.0010326343,"about_ca_topic_score_gemma":0.0012165305,"teacher_disagreement_score":0.0019476495,"about_ca_system_score_codex":0.00027209573,"about_ca_system_score_gemma":0.0001948267,"threshold_uncertainty_score":0.006515503},"labels":[],"label_agreement":null},{"id":"W1974447083","doi":"10.1038/sj.bjc.6600099","title":"A cyclin-dependent kinase inhibitor (p21WAF1/CIP1) affects thymidine incorporation in human liver cancer cells","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Manitoba Medical Service Foundation","keywords":"Thymidine; Cancer research; Thymidine kinase; Cancer; Kinase; Cyclin-dependent kinase; Cancer cell; Biology; Cyclin-dependent kinase 4; Medicine; Cell biology; Internal medicine; Biochemistry; Cyclin-dependent kinase 2; Cell cycle; Genetics; Protein kinase A; DNA","score_opus":0.017655658945861002,"score_gpt":0.2664471450855874,"score_spread":0.24879148613972643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974447083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781833,0.010089968,0.0023987168,0.00017769184,0.0001420032,0.00010719067,0.0011169886,0.00020170258,0.007582347],"genre_scores_gemma":[0.98091483,0.0058985553,0.0036487603,0.00007342425,0.000033649554,0.0001378139,0.0019000145,0.000044000994,0.0073489957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998294,0.000038275484,0.00001702369,0.000030907697,0.000047369685,0.000036986694],"domain_scores_gemma":[0.9998965,0.000038095815,0.00001548149,0.0000136607005,0.000017273504,0.000018872326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016338617,0.0003023651,0.00029477157,0.00030486548,0.0002547928,0.00026330308,0.0001514726,0.00026088097,0.0021274902],"category_scores_gemma":[0.00018304796,0.00018537416,0.0001737594,0.00032913982,0.00014388605,0.00014084548,0.000097489974,0.00032781297,0.0006434369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014894853,0.000048689824,0.00009497325,0.000054131775,0.0000033011686,0.000045229226,0.000017788261,0.00004322311,0.9981744,0.000056284494,0.000093637,0.0012192103],"study_design_scores_gemma":[0.000023171626,0.00030680717,0.0019375016,0.0000032320636,0.000008967695,0.00014357686,0.000010136757,0.00028843645,0.99349964,0.000013306674,0.0037623888,0.0000027370745],"about_ca_topic_score_codex":0.0022534858,"about_ca_topic_score_gemma":0.0024013286,"teacher_disagreement_score":0.0022534858,"about_ca_system_score_codex":0.00039153104,"about_ca_system_score_gemma":0.00024109276,"threshold_uncertainty_score":0.007117212},"labels":[],"label_agreement":null},{"id":"W1974784556","doi":"10.1038/bjc.2011.207","title":"Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lung cancer; Medicine; Epidermal growth factor receptor; Oncology; Chemotherapy; Internal medicine; Disease; Targeted therapy; Cancer; Tyrosine kinase; Receptor","score_opus":0.057280688703651786,"score_gpt":0.4023850470155091,"score_spread":0.3451043583118573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974784556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019212233,0.9990464,0.000034803175,0.00016395476,0.00006012297,0.0000036025442,0.00001746426,0.0000020570417,0.0004795085],"genre_scores_gemma":[0.0023559611,0.9967686,0.0001951198,0.00020949497,0.000080157384,0.000010128549,0.00004341596,0.0000011285163,0.00033595506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999785,0.000058028887,0.000041736974,0.000030285892,0.000072810355,0.000012177188],"domain_scores_gemma":[0.999403,0.00038939988,0.00008543423,0.000007705957,0.00009307191,0.00002139511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074295735,0.00054987974,0.0020868727,0.0012117104,0.00011890935,0.00054712716,0.0006450754,0.0007953892,0.0025116547],"category_scores_gemma":[0.0012803442,0.00020095202,0.0005760885,0.0013366656,0.0002771285,0.0005359197,0.00025349812,0.0010502597,0.0010771063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037551462,0.000051057053,0.0006329519,0.018832715,0.00033088427,0.00016453874,0.00002724939,0.00020387347,0.000893385,0.00095720566,0.017154638,0.960376],"study_design_scores_gemma":[0.00043858105,0.0006511457,0.015809847,0.024218252,0.0018614716,0.003925554,0.00014250107,0.0003341956,0.001533622,0.0029270973,0.94809395,0.00006385203],"about_ca_topic_score_codex":0.0006878492,"about_ca_topic_score_gemma":0.001934249,"teacher_disagreement_score":0.0025116547,"about_ca_system_score_codex":0.0004675123,"about_ca_system_score_gemma":0.0005610585,"threshold_uncertainty_score":0.008402288},"labels":[],"label_agreement":null},{"id":"W1975186639","doi":"10.1038/bjc.2014.565","title":"A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mucositis; Tolerability; Neutropenia; Internal medicine; Pharmacodynamics; Pharmacokinetics; Rash; Febrile neutropenia; Dosing; Cancer; Gastroenterology; Toxicity; Refractory (planetary science); Pharmacology; Response Evaluation Criteria in Solid Tumors; Adverse effect; Phases of clinical research","score_opus":0.03146655708732439,"score_gpt":0.3865964881331453,"score_spread":0.3551299310458209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975186639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779468,0.007892759,0.0008301202,0.00062509364,0.00011678643,0.005756101,0.001999124,0.00015648361,0.0046766684],"genre_scores_gemma":[0.9785066,0.004788177,0.0034820302,0.0011692413,0.00023786949,0.004863142,0.003996758,0.000027505866,0.0029286547],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999713,0.00010748166,0.000012444338,0.000046303794,0.00005426234,0.00006661288],"domain_scores_gemma":[0.99964404,0.00004538922,0.00005384462,0.000019049701,0.000029935909,0.00020779025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009391959,0.0010174604,0.0014308317,0.00044802064,0.00043190253,0.0006605375,0.0008540783,0.0008974903,0.0035480405],"category_scores_gemma":[0.00046669634,0.00023884415,0.0005656133,0.0006686109,0.0006235054,0.00032546747,0.00022855266,0.0018069984,0.0006031389],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52382314,0.056875173,0.014776338,0.0023701135,0.001626597,0.0009770463,0.0004927406,0.0044592884,0.0953233,0.0008681333,0.019896714,0.27851146],"study_design_scores_gemma":[0.57831293,0.3782082,0.022335296,0.00008924257,0.0005478393,0.00077312783,0.00006904206,0.0016482433,0.006474567,0.00024081138,0.0112593565,0.00004128355],"about_ca_topic_score_codex":0.0024788599,"about_ca_topic_score_gemma":0.00605421,"teacher_disagreement_score":0.0035480405,"about_ca_system_score_codex":0.00095356535,"about_ca_system_score_gemma":0.0020637223,"threshold_uncertainty_score":0.011869311},"labels":[],"label_agreement":null},{"id":"W1975220436","doi":"10.1038/bjc.2011.307","title":"Genetic architecture of prostate cancer in the Ashkenazi Jewish population","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Prostate cancer; Single-nucleotide polymorphism; Population; Cancer; Prostate; Medicine; Oncology; Genetics; Biology; Internal medicine; Genotype; Gene","score_opus":0.017237836515079315,"score_gpt":0.27832016292425454,"score_spread":0.2610823264091752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975220436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989945,0.00029287042,0.00023496493,0.00007607148,0.0000028444344,0.0000052518612,0.00003995392,0.000006988095,0.0003463808],"genre_scores_gemma":[0.9995766,0.00010072135,0.0001719084,0.000021432097,0.000007981582,0.0000028370027,0.000058080845,0.000002006693,0.00005834805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991592,0.00031005903,0.000057656514,0.00020266487,0.0001721504,0.000098339835],"domain_scores_gemma":[0.99911374,0.0002639241,0.00030513335,0.00009854452,0.00011604164,0.00010264634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012665084,0.00025197378,0.00038330074,0.0013387983,0.00071785704,0.0005037988,0.0003898147,0.00039174454,0.0017019648],"category_scores_gemma":[0.0018482554,0.0002034394,0.00037230054,0.0011884696,0.0008965006,0.00016577824,0.0003821086,0.00035467214,0.00012846441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037002366,0.000037921764,0.9886727,0.000017019334,0.00027251692,0.00030437636,0.00037132276,0.00027809304,0.003428428,0.00027007583,0.00013939592,0.0058380933],"study_design_scores_gemma":[0.000017820328,0.00008546729,0.99857104,0.000005126541,0.00008566044,0.00043921743,0.00009284972,0.00023425286,0.000113281494,0.00021530718,0.0001351855,0.0000047043245],"about_ca_topic_score_codex":0.015698064,"about_ca_topic_score_gemma":0.015515692,"teacher_disagreement_score":0.015698064,"about_ca_system_score_codex":0.0004398947,"about_ca_system_score_gemma":0.00040195358,"threshold_uncertainty_score":0.031213403},"labels":[],"label_agreement":null},{"id":"W1975442922","doi":"10.1038/sj.bjc.6603514","title":"Reply: Evaluating the activity of temsirolimus in neuroendocrine cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temsirolimus; Clinical trial; Internal medicine; Oncology; Medicine; Biology; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","score_opus":0.035967408200075275,"score_gpt":0.3969696250004598,"score_spread":0.3610022168003845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975442922","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011139234,0.006119919,0.0004927739,0.91384685,0.077483,0.000046297497,0.00024012492,0.00006532556,0.00059173035],"genre_scores_gemma":[0.004894721,0.0040774173,0.0010844618,0.91170096,0.07395345,0.00010888199,0.00010321253,0.000034246998,0.0040427377],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968637,0.0009812242,0.00084828073,0.00035311593,0.0007153974,0.00023834643],"domain_scores_gemma":[0.97968733,0.012239878,0.001204586,0.0005273836,0.005257332,0.00108358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006925619,0.00090425846,0.0015849319,0.00064813136,0.0014605521,0.0017895655,0.0025402121,0.029333537,0.0031064276],"category_scores_gemma":[0.036006223,0.0006523429,0.001570929,0.0008567962,0.0020439131,0.0037875837,0.0012445392,0.028477032,0.0027801106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043998114,0.0000687564,0.0013989474,0.00044940456,0.00008314647,0.0015428636,0.00020363866,0.00018962989,0.0009921589,0.0016113715,0.97789043,0.015129555],"study_design_scores_gemma":[0.00038919644,0.00044046526,0.0037424644,0.00042903656,0.00027030933,0.004203771,0.0006458537,0.0007203501,0.0022826076,0.005798131,0.98089385,0.00018392212],"about_ca_topic_score_codex":0.002216415,"about_ca_topic_score_gemma":0.0021554213,"teacher_disagreement_score":0.029333537,"about_ca_system_score_codex":0.0019193069,"about_ca_system_score_gemma":0.0020615347,"threshold_uncertainty_score":0.036626577},"labels":[],"label_agreement":null},{"id":"W1975585168","doi":"10.1038/sj.bjc.6604826","title":"Identification of paediatric cancer patients with poor quality of life","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hospital for Sick Children; University of British Columbia; Children's Hospital of Eastern Ontario; University of Manitoba; SickKids Foundation","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Quality of life (healthcare); Sibling; Cross-sectional study; Cancer; Pediatric cancer; Pediatrics; Public health; Gerontology; Internal medicine; Psychology; Pathology","score_opus":0.02416408503876524,"score_gpt":0.3129698030310393,"score_spread":0.28880571799227406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975585168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892104,0.00031750542,0.000035411318,0.000046197714,0.0000023082891,0.000010796641,0.00026421415,0.0000019396005,0.00040068864],"genre_scores_gemma":[0.99917537,0.0002587973,0.00011645169,0.000018220642,0.000003343498,0.000011851356,0.00035041798,0.0000010116464,0.000064480344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995223,0.00008752609,0.00003840023,0.000049107144,0.00015299187,0.00014972728],"domain_scores_gemma":[0.998914,0.00015293593,0.0005608146,0.000024810544,0.0001364325,0.00021097795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005034296,0.00018208113,0.0003768232,0.0006917706,0.00055747025,0.0006069358,0.0002708048,0.00026406508,0.0011984708],"category_scores_gemma":[0.0024821055,0.00019195606,0.00025456116,0.001370582,0.00039605342,0.0004132182,0.0004265184,0.00054935715,0.00008763878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012188803,0.0000061633327,0.99881065,0.000007913869,0.000004010687,0.00006251505,0.00011706982,0.0000142952895,0.000028956729,0.000008755819,0.000054975273,0.00087258354],"study_design_scores_gemma":[0.0000015451244,0.00003312032,0.99914527,0.000007029491,0.0000041857325,0.00032912428,0.00029120778,0.000045109617,0.00001909699,0.000008218661,0.00011415416,0.0000020467758],"about_ca_topic_score_codex":0.07447981,"about_ca_topic_score_gemma":0.1283009,"teacher_disagreement_score":0.07447981,"about_ca_system_score_codex":0.0013620387,"about_ca_system_score_gemma":0.0015870316,"threshold_uncertainty_score":0.14809257},"labels":[],"label_agreement":null},{"id":"W1975927169","doi":"10.1038/bjc.2014.466","title":"Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; BC Cancer Agency; Alberta Health Services; University of British Columbia; University of Victoria; University of Alberta","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Aerobic exercise; Breast cancer; Overweight; Physical therapy; Body mass index; Internal medicine; Psychological intervention; Cancer; Randomized controlled trial; Chemotherapy","score_opus":0.004702921879807613,"score_gpt":0.25046256354289553,"score_spread":0.24575964166308792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975927169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542712,0.021934649,0.0024008143,0.0019399917,0.003409893,0.010978461,0.0010067204,0.00028459862,0.0037736609],"genre_scores_gemma":[0.98162854,0.0022259334,0.002519999,0.0013831058,0.0007311425,0.009979433,0.00035691832,0.000023882796,0.001150956],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98803943,0.00847394,0.0013895801,0.0010306382,0.00044613593,0.0006202023],"domain_scores_gemma":[0.99332196,0.0040760497,0.001194219,0.00052967865,0.00022135077,0.00065683835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071851937,0.0021263822,0.0056207348,0.0007300855,0.00061547826,0.0015723956,0.0010684904,0.0039745006,0.008720147],"category_scores_gemma":[0.018467356,0.00093693915,0.006753607,0.00062124955,0.0011032057,0.0015268553,0.001299701,0.0037100133,0.00059932447],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98240364,0.0011604219,0.00050384365,0.0011335359,0.005434088,0.000020459536,0.000070521775,0.00036905115,0.0003765865,0.00013067738,0.00023079383,0.008166382],"study_design_scores_gemma":[0.95829576,0.030171452,0.0026474397,0.00028945386,0.006250321,0.000021417158,0.000046108184,0.0007640669,0.0001794821,0.0008148503,0.0004947292,0.00002492441],"about_ca_topic_score_codex":0.0019178056,"about_ca_topic_score_gemma":0.0025921047,"teacher_disagreement_score":0.008720147,"about_ca_system_score_codex":0.0014466895,"about_ca_system_score_gemma":0.0015479435,"threshold_uncertainty_score":0.03799939},"labels":[],"label_agreement":null},{"id":"W1976201942","doi":"10.1038/bjc.2012.554","title":"Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Survivorship curve; Cancer survivorship; Medicine; Cancer; Health care; MEDLINE; Family medicine; Gerontology; Nursing; Economic growth; Political science","score_opus":0.053863825643566204,"score_gpt":0.36948779165784734,"score_spread":0.3156239660142811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976201942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017549153,0.998382,0.000010322506,0.0008886065,0.000118355274,0.000005211094,0.000012712613,0.0000016352556,0.00040567524],"genre_scores_gemma":[0.0016591863,0.99742633,0.000076753255,0.0005095634,0.000028261133,0.000007176696,0.000018189874,8.496661e-7,0.0002736128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992415,0.00018000843,0.00014196055,0.000055599503,0.00028495776,0.00009603984],"domain_scores_gemma":[0.997551,0.00077165547,0.00024491528,0.000032560456,0.001183971,0.00021583603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028511917,0.00045689198,0.0010956565,0.0017523426,0.0005471955,0.0013586994,0.00086754607,0.001234291,0.0018857438],"category_scores_gemma":[0.0055810953,0.00024744487,0.0004939168,0.0040378496,0.00062390545,0.0011174717,0.00076879055,0.0011731196,0.0003007944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014546864,0.000042683725,0.00054592197,0.07466715,0.0001273591,0.00018741048,0.0011752531,0.00031644164,0.00030522826,0.002767065,0.062090453,0.8576295],"study_design_scores_gemma":[0.00008122172,0.00016628623,0.012834793,0.06994945,0.00037858254,0.0006793831,0.0013039578,0.00008968588,0.00018273476,0.00062273047,0.91366833,0.000042964217],"about_ca_topic_score_codex":0.37455237,"about_ca_topic_score_gemma":0.56128514,"teacher_disagreement_score":0.62544763,"about_ca_system_score_codex":0.008594265,"about_ca_system_score_gemma":0.025407359,"threshold_uncertainty_score":0.7447444},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"split"},{"id":"W1976301747","doi":"10.1038/bjc.2012.307","title":"Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stornoway Diamond (Canada)","funders":"","keywords":"Carboplatin; Medicine; Hazard ratio; Paclitaxel; Internal medicine; Confidence interval; Ovarian cancer; Chemotherapy; Clinical endpoint; Oncology; Urology; Surgery; Gastroenterology; Randomized controlled trial; Cancer; Cisplatin","score_opus":0.022326826636536557,"score_gpt":0.30727154723815603,"score_spread":0.28494472060161946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976301747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870477,0.005103452,0.00029940606,0.001116578,0.0001963158,0.00088872743,0.002125683,0.000033945424,0.0031883058],"genre_scores_gemma":[0.9891271,0.0014681169,0.0005390017,0.0010497454,0.00018764996,0.0008016388,0.005183937,0.000021206042,0.0016217148],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988476,0.0007465374,0.00005328009,0.00013791128,0.00009211155,0.00012257078],"domain_scores_gemma":[0.9976495,0.0006204463,0.00049720414,0.00017687627,0.00014359561,0.0009124412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003542995,0.0006757601,0.0014001724,0.00028364395,0.0003024369,0.0011465155,0.000652213,0.0011140073,0.0028203428],"category_scores_gemma":[0.0025972677,0.00023249388,0.0016642237,0.00043334803,0.00065767183,0.00051642855,0.00050497934,0.0026160781,0.00028869588],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9603276,0.0024989087,0.0045749173,0.00032289987,0.001387425,0.000046180747,0.000070236005,0.0012842638,0.0024865707,0.00010908941,0.003015773,0.02387608],"study_design_scores_gemma":[0.8327206,0.12094051,0.03844286,0.000102583836,0.0022363581,0.00012918771,0.00006549638,0.0013569625,0.0009653265,0.00024167642,0.0027736987,0.000024818024],"about_ca_topic_score_codex":0.0018019171,"about_ca_topic_score_gemma":0.0041327747,"teacher_disagreement_score":0.003542995,"about_ca_system_score_codex":0.001483007,"about_ca_system_score_gemma":0.0012655756,"threshold_uncertainty_score":0.018737316},"labels":[],"label_agreement":null},{"id":"W1976577798","doi":"10.1038/bjc.2012.147","title":"Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Fluconazole; Meta-analysis; Medicine; Transplantation; Chemotherapy; Haematopoiesis; Hematopoietic stem cell transplantation; Stem cell; Randomized controlled trial; Oncology; Cancer; Internal medicine; Surgery; Antifungal; Biology; Dermatology","score_opus":0.07631400875532027,"score_gpt":0.36905139411310184,"score_spread":0.2927373853577816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976577798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031749727,0.9957443,0.0002288791,0.00010838406,0.000111677895,0.00030913993,0.00016609406,0.000012330668,0.00014423032],"genre_scores_gemma":[0.10303073,0.8918415,0.0020524247,0.0007594406,0.00022610449,0.0014306987,0.0003599461,0.00002138179,0.00027790168],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9899867,0.004797102,0.0029904973,0.0008886017,0.0010774967,0.00025961714],"domain_scores_gemma":[0.9825044,0.01250929,0.00343832,0.00028681196,0.0010018054,0.00025944778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01204206,0.0028559838,0.025245817,0.0058514634,0.0006312428,0.0034485955,0.0022798032,0.0026404634,0.0038536682],"category_scores_gemma":[0.030883657,0.001586858,0.030173384,0.0063111368,0.0008683876,0.0019171048,0.001343694,0.0020010113,0.00028182226],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031842175,0.00003399843,0.0011259828,0.63561916,0.34750372,0.000089963105,0.000077666286,0.00028906076,0.00019392598,0.000109647626,0.00036480813,0.011407913],"study_design_scores_gemma":[0.0019849122,0.00048565585,0.00204593,0.055870056,0.937398,0.00011017577,0.000056831548,0.00015866007,0.00013508367,0.0001851174,0.0015436194,0.000026002634],"about_ca_topic_score_codex":0.005114448,"about_ca_topic_score_gemma":0.012841586,"teacher_disagreement_score":0.025245817,"about_ca_system_score_codex":0.0034095647,"about_ca_system_score_gemma":0.003776165,"threshold_uncertainty_score":0.06368524},"labels":[],"label_agreement":null},{"id":"W1977081777","doi":"10.1038/bjc.2011.101","title":"Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Institute for Clinical Evaluative Sciences; Canada Research Chairs; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Antibiotics; Ambulatory care; Willingness to pay; Emergency medicine; Internal medicine; Intensive care medicine; Health care","score_opus":0.04261533414015744,"score_gpt":0.3299494410942128,"score_spread":0.28733410695405537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977081777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96981716,0.0038701238,0.01169037,0.003252175,0.00006129172,0.000337692,0.002016873,0.00008744303,0.008866968],"genre_scores_gemma":[0.998041,0.00040721652,0.0008662198,0.00013836261,0.000007558834,0.00005333402,0.00024529954,0.0000044163426,0.00023666208],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9984388,0.001107691,0.000052115927,0.00009686321,0.00012899701,0.00017546806],"domain_scores_gemma":[0.9931846,0.0054064766,0.00075315085,0.00009229438,0.00022101938,0.00034245144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002426966,0.0006717591,0.0010297147,0.00055304344,0.0002996883,0.0013592953,0.00091522513,0.0013191736,0.0033113556],"category_scores_gemma":[0.014813107,0.00043709914,0.0015350503,0.00066488504,0.00050836534,0.0007181581,0.0005737257,0.0011122385,0.000116789975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014934022,0.0002150537,0.01839073,0.0001839022,0.00047623098,0.00017224226,0.00003523196,0.9665198,0.00014955121,0.001969838,0.0008178175,0.009576245],"study_design_scores_gemma":[0.0011591393,0.0016253984,0.016582495,0.00030816722,0.00077125983,0.00035841216,0.00012364678,0.9715214,0.0003750815,0.0058576567,0.0012675732,0.000049838985],"about_ca_topic_score_codex":0.048913304,"about_ca_topic_score_gemma":0.02371756,"teacher_disagreement_score":0.048913304,"about_ca_system_score_codex":0.0056813746,"about_ca_system_score_gemma":0.0037827648,"threshold_uncertainty_score":0.0972572},"labels":[],"label_agreement":null},{"id":"W1977313875","doi":"10.1038/bjc.2013.502","title":"Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Cancer; Cancer research; Metastasis; Mammary gland; Cancer cell; Lung cancer; Pathology; Medicine; Biology; Breast cancer; Internal medicine","score_opus":0.006324325791044212,"score_gpt":0.24689436630654527,"score_spread":0.24057004051550104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977313875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98312485,0.009609067,0.0026488507,0.00020376236,0.00011258236,0.00009949439,0.0010401245,0.00024748722,0.0029136343],"genre_scores_gemma":[0.98472196,0.0036126669,0.0029979723,0.00013501255,0.000037855294,0.00017510021,0.0014815944,0.00004369472,0.0067943567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998369,0.000025322539,0.000009723618,0.000033706234,0.000043284694,0.000051018375],"domain_scores_gemma":[0.99989736,0.000017868453,0.00002559086,0.00001686773,0.000010219718,0.000031995896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015915104,0.0005725141,0.0003605541,0.00035850465,0.00011177912,0.00017127863,0.00017585907,0.0003493723,0.003124355],"category_scores_gemma":[0.00007133176,0.00014167886,0.00049871195,0.00016370944,0.00016916395,0.00012141504,0.00017726615,0.0007663366,0.00071032875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030512456,0.0001089818,0.00021119462,0.000059669394,0.0000065211466,0.000032310712,0.000010369856,0.00003750325,0.99817157,0.000027426895,0.000081102015,0.0009481845],"study_design_scores_gemma":[0.00003842214,0.0023723275,0.009309897,0.00001811166,0.00002830006,0.00021393965,0.000027293201,0.00034320678,0.98547167,0.000031099775,0.0021400913,0.0000055499763],"about_ca_topic_score_codex":0.00037869185,"about_ca_topic_score_gemma":0.00083176827,"teacher_disagreement_score":0.003124355,"about_ca_system_score_codex":0.0002165705,"about_ca_system_score_gemma":0.00017799632,"threshold_uncertainty_score":0.010452032},"labels":[],"label_agreement":null},{"id":"W1977356115","doi":"10.1038/sj.bjc.6604311","title":"A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Irinotecan; Medicine; Colorectal cancer; Pharmacodynamics; Pharmacokinetics; Oncology; Internal medicine; Pharmacology; Camptothecin; Cancer; Biology","score_opus":0.014253542016320852,"score_gpt":0.3037113305033121,"score_spread":0.2894577884869913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977356115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991959,0.00045082314,0.000104725295,0.000017912096,0.000002168934,0.000016555336,0.0000390127,0.0000035408448,0.00016942596],"genre_scores_gemma":[0.9992735,0.00016811748,0.00022162807,0.000030348381,0.000006900096,0.000017273826,0.00010013491,0.0000012977861,0.00018082201],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998776,0.000036773858,0.0000065963777,0.000027185251,0.00003510924,0.000016689435],"domain_scores_gemma":[0.9998547,0.000025006782,0.00004428263,0.000008896906,0.000013560057,0.000053499523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018619257,0.00017952215,0.0005238341,0.000112612746,0.00014557398,0.00018172522,0.00007805645,0.00017416579,0.00060401094],"category_scores_gemma":[0.00039116075,0.00009745457,0.0001532742,0.00014808947,0.0001273578,0.00016644126,0.000086968525,0.00030709067,0.000095972275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050202955,0.0023961677,0.38508543,0.00034359054,0.0006776344,0.0017260809,0.00041608428,0.002739959,0.45511022,0.00021003488,0.0008457208,0.100246064],"study_design_scores_gemma":[0.0011216892,0.0850643,0.87261885,0.000016298845,0.00035060412,0.0043954463,0.00013577756,0.004378343,0.027588548,0.00009830878,0.004202097,0.000029799246],"about_ca_topic_score_codex":0.00044409346,"about_ca_topic_score_gemma":0.00095052534,"teacher_disagreement_score":0.00060401094,"about_ca_system_score_codex":0.00030777886,"about_ca_system_score_gemma":0.00023152411,"threshold_uncertainty_score":0.0022331476},"labels":[],"label_agreement":null},{"id":"W1977392502","doi":"10.1054/bjoc.2000.1316","title":"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":939,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Temozolomide; Medicine; Procarbazine; Internal medicine; Chemotherapy; Adverse effect; Quality of life (healthcare); Phases of clinical research; Cancer; Dacarbazine; Progression-free survival; Oncology; Surgery; Vincristine; Cyclophosphamide","score_opus":0.00595770731350117,"score_gpt":0.25678295623552244,"score_spread":0.2508252489220213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977392502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949319,0.0020177546,0.0003589956,0.00023832485,0.00013822522,0.001354267,0.0003125979,0.00004564026,0.0006023713],"genre_scores_gemma":[0.9926594,0.001735366,0.0011928485,0.00053907983,0.00019925593,0.0018800597,0.0007343318,0.000014930306,0.0010447346],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994728,0.00030285574,0.000027021026,0.00008347355,0.00003966122,0.00007421771],"domain_scores_gemma":[0.9991708,0.0001908172,0.00018973208,0.00005923391,0.000039992003,0.00034943593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001542822,0.0013326394,0.0028963524,0.00042780372,0.00023601788,0.00060532236,0.00085338106,0.001113129,0.0025624766],"category_scores_gemma":[0.0012089653,0.00056045695,0.0013653225,0.00042394918,0.0008140831,0.0006843151,0.00029587894,0.0021598171,0.0005034563],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9445935,0.016824534,0.0018205083,0.0003008698,0.0006577319,0.00005034459,0.0000772688,0.0006031167,0.009096193,0.000088031076,0.0006708817,0.025217108],"study_design_scores_gemma":[0.7197989,0.27285644,0.004860677,0.00001386432,0.00034444127,0.00006148157,0.000022372216,0.0006267557,0.00079091906,0.00007893163,0.00053249346,0.00001274739],"about_ca_topic_score_codex":0.0011800909,"about_ca_topic_score_gemma":0.0029978973,"teacher_disagreement_score":0.0028963524,"about_ca_system_score_codex":0.00095525663,"about_ca_system_score_gemma":0.0011518005,"threshold_uncertainty_score":0.00857228},"labels":[],"label_agreement":null},{"id":"W1977532013","doi":"10.1038/sj.bjc.6603826","title":"Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Lustgarten Foundation","keywords":"Pancreatic cancer; Internal medicine; Prospective cohort study; Medicine; Quartile; Insulin-like growth factor; Risk factor; Endocrinology; Oncology; Cancer; Case-control study; Proportional hazards model; Relative risk; Confidence interval; Gastroenterology; Growth factor; Receptor","score_opus":0.010367883521818206,"score_gpt":0.2608032210156316,"score_spread":0.25043533749381336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977532013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903834,0.00021378402,0.0003016247,0.000024739296,0.00000927775,0.00002068067,0.00023187054,0.0000077283985,0.00015199614],"genre_scores_gemma":[0.9989359,0.000094343646,0.00030161938,0.000021082999,0.0000061822025,0.000028234159,0.00041644814,0.000005307349,0.00019085896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853325,0.00050592027,0.00012009991,0.00046011477,0.00020373006,0.00017675663],"domain_scores_gemma":[0.9975802,0.0004515751,0.0005451879,0.00064939435,0.00032022936,0.0004534796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023343796,0.00068577623,0.0005648524,0.0009217146,0.0008963284,0.0012624982,0.0008474091,0.00073093025,0.0010366066],"category_scores_gemma":[0.0039884727,0.0009030965,0.0013271746,0.00096716516,0.00057526655,0.00036229103,0.0010905686,0.0010615406,0.00017859116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013528055,0.000066551074,0.9961313,0.00001107185,0.00038608766,0.00012514401,0.00014685503,0.00009591473,0.00065365294,0.00004016765,0.00010139923,0.00088902056],"study_design_scores_gemma":[0.00017429884,0.00036692483,0.99748284,0.000008902165,0.00040711186,0.00033041462,0.00019308217,0.00047299112,0.00017435719,0.00006592781,0.00030787752,0.000015329953],"about_ca_topic_score_codex":0.012287208,"about_ca_topic_score_gemma":0.008072565,"teacher_disagreement_score":0.012287208,"about_ca_system_score_codex":0.0005412816,"about_ca_system_score_gemma":0.0007308202,"threshold_uncertainty_score":0.024431348},"labels":[],"label_agreement":null},{"id":"W1978311359","doi":"10.1054/bjoc.2001.2061","title":"Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Medicine; Thyroid cancer; Incidence (geometry); Cohort; Cohort effect; Cohort study; Demography; Thyroid; Internal medicine","score_opus":0.014282228670194349,"score_gpt":0.2907149439135352,"score_spread":0.27643271524334084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978311359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587269,0.006160806,0.00096959824,0.001119548,0.00004666302,0.00007484351,0.028661244,0.00009915627,0.004141269],"genre_scores_gemma":[0.98230803,0.0032494392,0.00094094576,0.00011141732,0.000016703078,0.000032604166,0.010375174,0.000022524106,0.0029432513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992391,0.000058351827,0.000051910873,0.000119735094,0.00026616274,0.00026475996],"domain_scores_gemma":[0.9980248,0.00016771935,0.00041107569,0.00010682436,0.0010207781,0.00026882446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011650398,0.00038559444,0.00047915583,0.0022296314,0.0008843531,0.0010432896,0.0007980091,0.00038245175,0.0019332028],"category_scores_gemma":[0.0029574444,0.0003270008,0.0010059845,0.0065572443,0.00034896153,0.0003922287,0.0005452587,0.0007934074,0.00022935882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002221486,0.000017744105,0.9861266,0.00006995265,0.0002709543,0.00011157377,0.00030842223,0.0011465369,0.00017803238,0.00021031665,0.001361695,0.009976098],"study_design_scores_gemma":[0.000010571336,0.000018261833,0.99623704,0.000022471802,0.00012052535,0.000054065367,0.00015086531,0.00094551826,0.000099700104,0.000040311843,0.0022919173,0.000008717482],"about_ca_topic_score_codex":0.9903211,"about_ca_topic_score_gemma":0.9901162,"teacher_disagreement_score":0.017039383,"about_ca_system_score_codex":0.017039383,"about_ca_system_score_gemma":0.020996474,"threshold_uncertainty_score":0.12362993},"labels":[],"label_agreement":null},{"id":"W1978713285","doi":"10.1038/bjc.2012.144","title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Fondation pour la Recherche Médicale; Alberta Health Services","keywords":"Selumetinib; Wasting; Cachexia; Skeletal muscle; Anabolism; Medicine; Internal medicine; Endocrinology; Cancer; Sarcopenia; Oncology; Colorectal cancer","score_opus":0.003100686230026315,"score_gpt":0.2228247894269122,"score_spread":0.21972410319688587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978713285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997654,0.0015991419,0.00010676349,0.000095822,0.000004270169,0.0000080989985,0.000051760857,0.000010186243,0.0004698911],"genre_scores_gemma":[0.99942434,0.0002664516,0.00012026832,0.000034249148,0.00000707708,0.0000040043433,0.00006876655,0.0000016885504,0.00007315186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998043,0.00006965667,0.00001931667,0.0000259992,0.00005179318,0.000028868842],"domain_scores_gemma":[0.99952614,0.00013388752,0.00019711653,0.000018845016,0.000043604257,0.00008042408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004144769,0.00020026861,0.0004853406,0.0002327474,0.0001867699,0.00026860062,0.00009535779,0.00022752944,0.0009405252],"category_scores_gemma":[0.0009777802,0.000099238045,0.00027636098,0.0003421241,0.00021925507,0.00017574876,0.00018053544,0.0003289052,0.00011660392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010590443,0.00018542183,0.892778,0.0002070008,0.000346345,0.0024664367,0.00012806404,0.00049837807,0.040423565,0.00004940705,0.00051184377,0.051815145],"study_design_scores_gemma":[0.00012927705,0.0020434149,0.9887989,0.000013621439,0.00014574568,0.0048858146,0.00007708604,0.00043912904,0.0029584449,0.00004844234,0.00045348823,0.000006569627],"about_ca_topic_score_codex":0.00064114167,"about_ca_topic_score_gemma":0.0017394638,"teacher_disagreement_score":0.0009405252,"about_ca_system_score_codex":0.0003251654,"about_ca_system_score_gemma":0.00017056709,"threshold_uncertainty_score":0.00314641},"labels":[],"label_agreement":null},{"id":"W1978729129","doi":"10.1038/sj.bjc.6603523","title":"Wait times for breast cancer care","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Nova Scotia Cancer Centre; Queen Elizabeth II Health Sciences Centre; Cancer Care Nova Scotia; Nova Scotia Health Authority","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Referral; Breast cancer; Adjuvant; Cancer; Psychological intervention; Retrospective cohort study; Stage (stratigraphy); Adjuvant therapy; Adjuvant chemotherapy; Oncology; Internal medicine; Surgery; Family medicine; Nursing","score_opus":0.023190268124800344,"score_gpt":0.3306351704090039,"score_spread":0.30744490228420357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978729129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821162,0.008196275,0.0022317213,0.0010973959,0.00008395734,0.000057467056,0.00222734,0.00005878829,0.003930818],"genre_scores_gemma":[0.99736637,0.0006927386,0.0010314061,0.00006134752,0.000030226603,0.000042710533,0.0005575465,0.0000069867733,0.00021081546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689937,0.0009922247,0.0006677006,0.00030547238,0.000780671,0.0003546887],"domain_scores_gemma":[0.9712261,0.011719759,0.013745598,0.0005612408,0.0014888664,0.0012583103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035278595,0.00012451698,0.00022393759,0.0017678839,0.0004624865,0.0008878367,0.00041293234,0.0002911851,0.001996516],"category_scores_gemma":[0.028876295,0.00017687428,0.0004671657,0.0020415373,0.00024144657,0.00097195257,0.00057699846,0.00064048823,0.00017552418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029485405,0.00003141344,0.96649206,0.00019689807,0.00012860206,0.00012864891,0.0011223778,0.0008513378,0.00025405624,0.0008557191,0.00091191556,0.028732115],"study_design_scores_gemma":[0.000008282177,0.00016921223,0.99404776,0.00009645028,0.00005980247,0.00044577234,0.0007835786,0.00090989,0.0002530008,0.0006063744,0.0025960193,0.000023913586],"about_ca_topic_score_codex":0.012272026,"about_ca_topic_score_gemma":0.015598724,"teacher_disagreement_score":0.012272026,"about_ca_system_score_codex":0.001556313,"about_ca_system_score_gemma":0.0012852632,"threshold_uncertainty_score":0.024401188},"labels":[],"label_agreement":null},{"id":"W1978916413","doi":"10.1038/bjc.2013.579","title":"γ-Glutamyl hydrolase modulation and folate influence chemosensitivity of cancer cells to 5-fluorouracil and methotrexate","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Methotrexate; Antifolate; Cancer cell; In vivo; In vitro; Cytotoxicity; Cancer research; Chemosensitivity assay; Cancer; Intracellular; Chemistry; Folate receptor; Biology; Pharmacology; Antimetabolite; Biochemistry; Immunology; Genetics","score_opus":0.0128582839721783,"score_gpt":0.3100236801526774,"score_spread":0.2971653961804991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978916413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931785,0.0037137854,0.0013923296,0.00009495419,0.000020218515,0.000019461431,0.00021070769,0.000030223742,0.0013397293],"genre_scores_gemma":[0.99625224,0.0012019019,0.001177699,0.00001911954,0.0000030628655,0.000011762693,0.00019454857,0.000004262929,0.0011353905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998963,0.000026730282,0.000013227655,0.000017727181,0.00002695458,0.000019131494],"domain_scores_gemma":[0.99993134,0.000017719216,0.000020919835,0.00001037316,0.00000847105,0.000011146694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105307496,0.00020516764,0.00019144244,0.00012194332,0.00009685136,0.00023743961,0.00012889264,0.00027666177,0.00070136384],"category_scores_gemma":[0.00011542563,0.00009003296,0.00013942733,0.00014570076,0.00018150391,0.00011344772,0.0001316909,0.0002777843,0.0001522984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013298258,0.00001447911,0.0003782586,0.00003844521,0.0000049681603,0.000036197864,0.00001400087,0.00009988366,0.99815315,0.00006165708,0.000022464214,0.0010435061],"study_design_scores_gemma":[0.000012801075,0.00024108887,0.0062304847,0.00000852846,0.000019306477,0.00015425906,0.00002489895,0.00074345426,0.98982716,0.000025180876,0.0027089517,0.0000039429615],"about_ca_topic_score_codex":0.0024301764,"about_ca_topic_score_gemma":0.0024977992,"teacher_disagreement_score":0.0024301764,"about_ca_system_score_codex":0.00040042016,"about_ca_system_score_gemma":0.00016124033,"threshold_uncertainty_score":0.004832089},"labels":[],"label_agreement":null},{"id":"W1979276629","doi":"10.1038/sj.bjc.6600796","title":"Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Manitoba","funders":"Medical Research and Materiel Command; Medical Research Council; Medical Research Council Canada; Wellcome Trust","keywords":"Breast cancer; Immunohistochemistry; Hypoxia (environmental); Biology; Univariate analysis; Internal medicine; Carcinoma; Pathology; Cancer research; Carbonic anhydrase; Mammary gland; Cancer; Oncology; Medicine; Enzyme; Multivariate analysis; Chemistry","score_opus":0.006357992248124134,"score_gpt":0.22729281655223796,"score_spread":0.22093482430411382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979276629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795157,0.0010413083,0.0002040651,0.00003169818,0.000006085743,0.0000049909368,0.00006112677,0.000007447347,0.0006918351],"genre_scores_gemma":[0.9994642,0.00017187973,0.000087693275,0.0000062842637,0.000009129783,0.0000023887683,0.000075250064,0.000001097688,0.00018190738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998418,0.000030775667,0.00001668325,0.00002773776,0.000052419862,0.000030543855],"domain_scores_gemma":[0.99927884,0.0002169938,0.0002490424,0.000053354663,0.00008498644,0.00011675021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033054576,0.00012952532,0.00024712327,0.0005163752,0.00015844633,0.00026172353,0.00014594076,0.00026519466,0.0011634234],"category_scores_gemma":[0.001305128,0.00009661089,0.00011902529,0.0004713426,0.00025697483,0.00013720777,0.00018375846,0.00020499965,0.00025736788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040848862,0.000017207642,0.98717284,0.000023285846,0.000024087924,0.0004030175,0.00005078937,0.00006227552,0.0070397086,0.00001394243,0.00009394118,0.004690369],"study_design_scores_gemma":[0.0000031518803,0.00008623709,0.9972113,0.000002890974,0.000017074954,0.0016483628,0.000041456162,0.00013444484,0.00063946587,0.000020006131,0.0001937134,0.0000018362713],"about_ca_topic_score_codex":0.0009997345,"about_ca_topic_score_gemma":0.0013353085,"teacher_disagreement_score":0.0011634234,"about_ca_system_score_codex":0.00020728042,"about_ca_system_score_gemma":0.00012937866,"threshold_uncertainty_score":0.003892064},"labels":[],"label_agreement":null},{"id":"W1979687843","doi":"10.1038/sj.bjc.6604960","title":"Cancer neurology in clinical practice, neurological complications of cancer and its treatment (2nd Edn)","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Neurology; Medicine; Cancer; Clinical Practice; Clinical neurology; Internal medicine; Physical therapy; Psychology; Psychiatry; Neuroscience","score_opus":0.0573256548277383,"score_gpt":0.45236094634042867,"score_spread":0.39503529151269035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979687843","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051126006,0.8395183,0.002171434,0.020936187,0.03716373,0.0001021958,0.00028316613,0.00029873312,0.09901498],"genre_scores_gemma":[0.0049639577,0.6812106,0.0039435253,0.024349023,0.02353067,0.00028324738,0.0005835741,0.00019601888,0.26093942],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930763,0.00012881619,0.0000858922,0.00006967434,0.000352139,0.000055806646],"domain_scores_gemma":[0.9990753,0.00031472946,0.0001350344,0.000039739476,0.0002256235,0.00020963262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010669626,0.0012077154,0.0012464023,0.0027629328,0.00081100455,0.0034995486,0.0011083964,0.0026051535,0.041602544],"category_scores_gemma":[0.0028735483,0.0007115405,0.0007783274,0.0027607675,0.0009793708,0.0032317794,0.0018021102,0.0037580887,0.027515767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027549602,0.000045724806,0.0002259788,0.00091030914,0.000010753183,0.00027943138,0.00035256092,0.00023302386,0.0002554032,0.0044644065,0.8013346,0.19186011],"study_design_scores_gemma":[0.000008233975,0.000033270662,0.0006912832,0.00090161397,0.0000051350885,0.0013553494,0.00012763086,0.00007581382,0.000024674297,0.0027795024,0.9939866,0.0000109251105],"about_ca_topic_score_codex":0.002954895,"about_ca_topic_score_gemma":0.009429807,"teacher_disagreement_score":0.041602544,"about_ca_system_score_codex":0.0018805519,"about_ca_system_score_gemma":0.0029720326,"threshold_uncertainty_score":0.1391744},"labels":[],"label_agreement":null},{"id":"W1979782687","doi":"10.1038/sj.bjc.6604995","title":"Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Medicine; Pancreatic cancer; Ribosomal protein s6; Cancer research; Pharmacology; Internal medicine; Cancer; P70-S6 Kinase 1; Phosphorylation; Biology; Signal transduction","score_opus":0.02621350793459556,"score_gpt":0.34372713953262185,"score_spread":0.3175136315980263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979782687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442154,0.0020506196,0.0014665528,0.00007674127,0.00005864328,0.000060599985,0.00057863275,0.00009450895,0.001192047],"genre_scores_gemma":[0.99402446,0.0016067504,0.0022130776,0.000034886478,0.000016624934,0.00003926303,0.00097012444,0.000013227152,0.0010816143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992037,0.000012611705,0.000007353957,0.000019904675,0.000020491598,0.000019261406],"domain_scores_gemma":[0.9999546,0.000008077727,0.000008000706,0.000005652159,0.0000051263887,0.00001862995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105922736,0.00032147882,0.00044827478,0.00018423407,0.00012070867,0.00029133004,0.00019505512,0.000144534,0.00067067257],"category_scores_gemma":[0.00008890823,0.000115793395,0.0002566215,0.00019069966,0.00014149133,0.00013324406,0.00010128792,0.0005716444,0.0001730024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015456632,0.00049390964,0.00042135682,0.000105501465,0.000032694144,0.0000781917,0.000018690205,0.00087012496,0.98634535,0.000079621044,0.00028313335,0.009725863],"study_design_scores_gemma":[0.0003558569,0.009013941,0.0054608295,0.000008270418,0.00010359701,0.0005737218,0.000023193721,0.002713899,0.9780115,0.000042846605,0.003682722,0.000009598923],"about_ca_topic_score_codex":0.0013900846,"about_ca_topic_score_gemma":0.0029766709,"teacher_disagreement_score":0.0013900846,"about_ca_system_score_codex":0.00029964547,"about_ca_system_score_gemma":0.00036043866,"threshold_uncertainty_score":0.0027640462},"labels":[],"label_agreement":null},{"id":"W1979791033","doi":"10.1038/bjc.2011.355","title":"Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; McGill University; Université du Québec","funders":"National Institute of General Medical Sciences; Winship Cancer Institute; National Cancer Institute; National Institutes of Health; Georgia Research Alliance; Emory University","keywords":"Breast cancer; Bead; Pathology; Medicine; Cancer; Biology; Materials science; Internal medicine","score_opus":0.05657751986548907,"score_gpt":0.3345027286124366,"score_spread":0.2779252087469475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979791033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9009459,0.0011412011,0.08113962,0.0001858456,0.000053219763,0.00036275684,0.01120826,0.0008713328,0.004091866],"genre_scores_gemma":[0.824471,0.0010673144,0.13672711,0.00049831707,0.000035236713,0.0014620981,0.028763892,0.0002185738,0.006756422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955934,0.00004239663,0.000035691945,0.00018046488,0.00013416307,0.00004791786],"domain_scores_gemma":[0.999782,0.000060167295,0.000036804195,0.000049332473,0.00005312192,0.000018509507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040675915,0.00028139135,0.0002585632,0.00047117932,0.00019239602,0.0004088388,0.0002599395,0.00030749087,0.0018951287],"category_scores_gemma":[0.000522889,0.00016655667,0.00024008917,0.00044759866,0.00019436654,0.00014386397,0.00023870688,0.0002801984,0.0014344881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016924414,0.00002491668,0.0048219147,0.00009150251,0.00001694251,0.00004265993,0.00004042934,0.0005984094,0.98774916,0.00009355539,0.00035501816,0.005996282],"study_design_scores_gemma":[0.00004700896,0.0005651859,0.11061652,0.000030529045,0.00009473386,0.0010040832,0.0000750211,0.009601835,0.8638756,0.00029430466,0.013759824,0.000035370365],"about_ca_topic_score_codex":0.00036120816,"about_ca_topic_score_gemma":0.00088949455,"teacher_disagreement_score":0.0018951287,"about_ca_system_score_codex":0.00023292078,"about_ca_system_score_gemma":0.00025590928,"threshold_uncertainty_score":0.006339848},"labels":[],"label_agreement":null},{"id":"W1980208656","doi":"10.1038/bjc.2014.66","title":"Breast cancer: trends in international incidence in men and women","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Male Breast Health Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Provincial Laboratory of Public Health","funders":"University of Canterbury","keywords":"Incidence (geometry); Breast cancer; Medicine; Cancer; Gynecology; Oncology; Demography; Internal medicine","score_opus":0.009184822938600998,"score_gpt":0.3195259888368601,"score_spread":0.3103411658982591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980208656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73476887,0.13249269,0.0031358534,0.0071883914,0.0007559216,0.00012875219,0.07433777,0.00070406805,0.046487655],"genre_scores_gemma":[0.92795956,0.041350547,0.0024675278,0.00071490183,0.00053958956,0.00012738262,0.022604093,0.00007110502,0.0041652853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991757,0.00021670814,0.00015433793,0.00016445317,0.00020108183,0.000087659435],"domain_scores_gemma":[0.99839514,0.00021570432,0.00069430616,0.00007747646,0.0005122506,0.000105057436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011695103,0.00025827863,0.00042101447,0.0036014174,0.000185742,0.000778416,0.00032457104,0.00036670576,0.0035049089],"category_scores_gemma":[0.003076408,0.00016073268,0.0005493027,0.0062824343,0.00020551261,0.0007924273,0.0004213784,0.00044272654,0.0012219283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022064532,0.00003304654,0.9099261,0.0008542116,0.00037211552,0.00005261353,0.00066014717,0.00038363054,0.00029502978,0.0009260162,0.01572679,0.070549615],"study_design_scores_gemma":[0.000008402095,0.000103118386,0.9759554,0.00022239015,0.000086054424,0.0004503938,0.00053200114,0.00022965252,0.00012866745,0.00015805312,0.022116018,0.000009873214],"about_ca_topic_score_codex":0.014301985,"about_ca_topic_score_gemma":0.014413149,"teacher_disagreement_score":0.014301985,"about_ca_system_score_codex":0.00068667874,"about_ca_system_score_gemma":0.00045312155,"threshold_uncertainty_score":0.028437495},"labels":[],"label_agreement":null},{"id":"W1980208663","doi":"10.1054/bjoc.2000.1315","title":"Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Testosterone (patch); Prostate cancer; Cancer; Internal medicine; Antibody; Hormone; Prostate; Endocrinology; Prostate-specific antigen; Urology; Immunology","score_opus":0.01890449417211312,"score_gpt":0.31046679837093255,"score_spread":0.29156230419881946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980208663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992092,0.0004344184,0.000050035665,0.000021700404,0.0000043204477,0.000011310299,0.000008980934,0.000005438263,0.00025470255],"genre_scores_gemma":[0.99956614,0.00015315624,0.000046365563,0.00004874163,0.000010341601,0.000006635941,0.000024292416,7.589002e-7,0.0001435371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998765,0.00004839048,0.000007855078,0.000010542961,0.000028769122,0.000027981141],"domain_scores_gemma":[0.99964416,0.00010877795,0.00009587479,0.000013499582,0.000015103352,0.000122446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022109489,0.00018864972,0.00037795684,0.00015127686,0.00019392336,0.00020852847,0.00009473748,0.00024513542,0.0007940366],"category_scores_gemma":[0.0008458574,0.00013289854,0.00018102449,0.00016684501,0.00020626724,0.00014025297,0.00009983345,0.00031773953,0.00015826242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021798566,0.0034879453,0.7897456,0.00037178624,0.00018867783,0.005997313,0.0013700194,0.0007266763,0.07540877,0.00012012978,0.00076388154,0.10002055],"study_design_scores_gemma":[0.0010119865,0.07386897,0.90844584,0.000023586656,0.000117660195,0.009620195,0.00034562338,0.00051333936,0.004109226,0.000094242765,0.0018333116,0.000016060469],"about_ca_topic_score_codex":0.0005254884,"about_ca_topic_score_gemma":0.0009130025,"teacher_disagreement_score":0.0007940366,"about_ca_system_score_codex":0.00013838887,"about_ca_system_score_gemma":0.000153943,"threshold_uncertainty_score":0.002656281},"labels":[],"label_agreement":null},{"id":"W1981010480","doi":"10.1038/bjc.2015.54","title":"Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Toronto Public Health; St. Michael's Hospital; University of Toronto; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Prostate cancer; Surgery; Incidence (geometry); Comorbidity; Cumulative incidence; Prostate; Retrospective cohort study; Prostatectomy; Cancer; Hazard ratio; Cohort; Internal medicine","score_opus":0.05088168441984392,"score_gpt":0.3550951065472629,"score_spread":0.304213422127419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981010480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954117,0.002338856,0.00012993786,0.00015518101,0.00001639844,0.000020146725,0.0005853556,0.000009031275,0.0013334664],"genre_scores_gemma":[0.99830174,0.00071739376,0.000089707704,0.000049713813,0.000024588679,0.000006924466,0.0006398825,0.0000019671722,0.00016796424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920565,0.00015658751,0.00009022937,0.00009392926,0.00030091635,0.00015269929],"domain_scores_gemma":[0.99687225,0.00046170352,0.0020907326,0.00008349283,0.00013364121,0.00035814825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000425858,0.0001977263,0.00034095455,0.0006054551,0.00052577246,0.00044879084,0.00040625717,0.0002864652,0.0027188123],"category_scores_gemma":[0.002721943,0.000174547,0.00066343456,0.0012321062,0.00049582723,0.00019260084,0.00055631844,0.0004732192,0.0001479747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014069662,0.000025560204,0.99549025,0.00006941579,0.00009321677,0.00023542908,0.00005118629,0.00007057688,0.00009180965,0.000016330097,0.0002038468,0.003511711],"study_design_scores_gemma":[0.0000067096976,0.00010476942,0.9982679,0.000023603703,0.000032477445,0.0011566201,0.000062330386,0.00003646029,0.000056336165,0.000020804464,0.00022750617,0.000004384338],"about_ca_topic_score_codex":0.021098142,"about_ca_topic_score_gemma":0.03492043,"teacher_disagreement_score":0.021098142,"about_ca_system_score_codex":0.00102881,"about_ca_system_score_gemma":0.0013748006,"threshold_uncertainty_score":0.041950643},"labels":[],"label_agreement":null},{"id":"W1981255635","doi":"10.1054/bjoc.2001.1776","title":"MDR1 causes resistance to the antitumour drug miltefosine","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Cancer Institute; Austrian Science Fund","keywords":"Miltefosine; Vinblastine; P-glycoprotein; Pharmacology; Biology; IC50; Drug resistance; Cancer research; Multiple drug resistance; Molecular biology; In vitro; Chemistry; Immunology; Chemotherapy; Biochemistry; Microbiology; Visceral leishmaniasis; Leishmaniasis","score_opus":0.01082683677644481,"score_gpt":0.27235188527555226,"score_spread":0.26152504849910746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981255635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590755,0.0015438462,0.00070228317,0.0001619276,0.000033400862,0.00002632668,0.0004056582,0.00014403497,0.0010750128],"genre_scores_gemma":[0.99700624,0.0008422494,0.00026309877,0.000059665133,0.000015614147,0.000016608403,0.00042214364,0.000021249418,0.0013531959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998516,0.000027572642,0.00001202075,0.00002972898,0.000035602145,0.000043366108],"domain_scores_gemma":[0.99984264,0.000043489177,0.000054554308,0.000019895764,0.000011467268,0.000027886315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101548845,0.00039042628,0.0003739797,0.00023209631,0.00013799068,0.0002980528,0.00016353502,0.0005333707,0.0026966725],"category_scores_gemma":[0.00025890337,0.00021207232,0.00031176757,0.00019718877,0.00023692625,0.0001238614,0.0001649042,0.0007082816,0.00072235777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001530731,0.00004239173,0.0009836031,0.00003613447,0.0000099309445,0.0009296925,0.000022514163,0.000055411703,0.9948754,0.00012797899,0.0002185408,0.0025452885],"study_design_scores_gemma":[0.0000947305,0.0013680713,0.039312694,0.00002665992,0.00008293884,0.015262855,0.000070666516,0.0013260915,0.9314489,0.00017407544,0.010811329,0.000021011738],"about_ca_topic_score_codex":0.00043827173,"about_ca_topic_score_gemma":0.00027789976,"teacher_disagreement_score":0.0026966725,"about_ca_system_score_codex":0.0003149426,"about_ca_system_score_gemma":0.000089409936,"threshold_uncertainty_score":0.009021223},"labels":[],"label_agreement":null},{"id":"W1982014175","doi":"10.1054/bjoc.2001.1857","title":"Tcf-3 expression and β -catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Medical Research Council; Vlaamse regering; Medical Research Council Canada","keywords":"Cancer research; Immunoprecipitation; Beta-catenin; Fibromatosis; Catenin; Aggressive fibromatosis; Biology; Cell culture; Pathology; Medicine; Wnt signaling pathway; Signal transduction; Cell biology; Genetics","score_opus":0.015646336883165406,"score_gpt":0.2827128031109853,"score_spread":0.2670664662278199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982014175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952101,0.0006173418,0.00042044924,0.00007921576,0.000004760063,0.00003278294,0.0000732156,0.00002098156,0.0035412197],"genre_scores_gemma":[0.99877053,0.00022273583,0.00020060617,0.00001369457,0.0000065884587,0.0000063984576,0.000045841083,0.000002157776,0.00073138427],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981636,0.000028434928,0.000013555528,0.000029738056,0.00005595147,0.000056062567],"domain_scores_gemma":[0.999821,0.00006444717,0.000034913533,0.000015300904,0.000019783532,0.000044611246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020562121,0.0002242027,0.00014066415,0.0012696402,0.00034362776,0.0003027525,0.0001451583,0.00066692475,0.0023027775],"category_scores_gemma":[0.0004891873,0.00024223422,0.00017402403,0.00039363583,0.0006534795,0.0002093814,0.00022150739,0.00035003724,0.00032423116],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009595048,0.00022487235,0.11880168,0.0002465439,0.00004129855,0.52764773,0.002358416,0.00024677927,0.33549446,0.0014009647,0.00054650084,0.012031209],"study_design_scores_gemma":[0.00005023993,0.0005342999,0.22279537,0.000020163825,0.00007487327,0.70819813,0.0004899595,0.0006928744,0.062490527,0.0004952504,0.004138645,0.000019653236],"about_ca_topic_score_codex":0.0033230816,"about_ca_topic_score_gemma":0.0037347975,"teacher_disagreement_score":0.0033230816,"about_ca_system_score_codex":0.00044522755,"about_ca_system_score_gemma":0.00017178616,"threshold_uncertainty_score":0.0077035427},"labels":[],"label_agreement":null},{"id":"W1982388744","doi":"10.1038/sj.bjc.6601259","title":"Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Chemotherapy; Vincristine; Neuroblastoma; Cyclophosphamide; Surgery","score_opus":0.009485818501001077,"score_gpt":0.2838486978984315,"score_spread":0.2743628793974304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982388744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712306,0.002455431,0.00011413115,0.00001733219,0.0000048309557,0.00001048387,0.000031745465,0.000006047195,0.00023687481],"genre_scores_gemma":[0.9987613,0.0007968405,0.0001648495,0.000022800436,0.000013728153,0.00001238186,0.00015889143,0.0000023585083,0.00006691573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984515,0.00006770233,0.000016361402,0.000019412384,0.00002334639,0.000028019009],"domain_scores_gemma":[0.99958426,0.00012525546,0.00009976907,0.000030141862,0.000031254196,0.00012940243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032462337,0.00020178995,0.00065672665,0.0001758153,0.00013325433,0.0002178886,0.00017026305,0.00021957641,0.00033041218],"category_scores_gemma":[0.0009158842,0.000051084662,0.00022359687,0.00014068226,0.00021074657,0.00015797219,0.00017232688,0.00021182798,0.00011249007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02335445,0.0010694391,0.76608753,0.00046427612,0.00030837435,0.018139727,0.00046816363,0.0014034949,0.030352568,0.00016073608,0.0006135676,0.15757768],"study_design_scores_gemma":[0.00087642943,0.052466374,0.89042366,0.00016556086,0.00036892176,0.044297636,0.0002887543,0.0013076569,0.0076343687,0.00012683477,0.0020180026,0.000025989373],"about_ca_topic_score_codex":0.00053211517,"about_ca_topic_score_gemma":0.00089354394,"teacher_disagreement_score":0.00065672665,"about_ca_system_score_codex":0.00027384303,"about_ca_system_score_gemma":0.00013876667,"threshold_uncertainty_score":0.0019868612},"labels":[],"label_agreement":null},{"id":"W1983294325","doi":"10.1038/bjc.2014.28","title":"Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Alberta Cancer Foundation; University of Calgary","funders":"BC Cancer Agency; Yonsei University; Alberta Health Services","keywords":"Medicine; Internal medicine; Cohort; Retrospective cohort study; Renal cell carcinoma; Toxicity; Cohort study; Asian americans; Targeted therapy; Ethnic group; Oncology; Cancer","score_opus":0.015125402951028693,"score_gpt":0.2651320945689757,"score_spread":0.250006691617947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983294325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986407,0.000646373,0.000042070384,0.000038674865,0.000005406704,0.000005027764,0.00010623217,0.0000017738663,0.00051369664],"genre_scores_gemma":[0.9996099,0.00015931026,0.000023371414,0.000026572918,0.0000056333697,0.0000037074572,0.00009617132,0.0000011546061,0.00007426294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996164,0.00008806216,0.000057996753,0.00007752597,0.00008242192,0.00007755356],"domain_scores_gemma":[0.9987149,0.00020645103,0.00062778644,0.000069636735,0.00010966737,0.00027162433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006676456,0.00015304201,0.00039157693,0.0003698346,0.00026238663,0.00062582636,0.00020788786,0.00026897376,0.0014293683],"category_scores_gemma":[0.0013759519,0.00008817981,0.00046336817,0.00072071265,0.00024251107,0.00041510878,0.00028341738,0.00037727685,0.0002755903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008782137,0.000059811715,0.99292034,0.000032101856,0.00013006138,0.00027279524,0.0001785888,0.00005805731,0.00086308987,0.000032091266,0.00007669568,0.004498146],"study_design_scores_gemma":[0.000031119318,0.00052888587,0.99734855,0.000012605145,0.0000875301,0.00094274845,0.0003583983,0.00010666212,0.00017996102,0.00004236253,0.00035596738,0.0000052353034],"about_ca_topic_score_codex":0.0018996611,"about_ca_topic_score_gemma":0.002692968,"teacher_disagreement_score":0.0018996611,"about_ca_system_score_codex":0.0003549116,"about_ca_system_score_gemma":0.0003591236,"threshold_uncertainty_score":0.004781723},"labels":[],"label_agreement":null},{"id":"W1984609427","doi":"10.1038/bjc.2011.204","title":"A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Economic and Social Research Council; Queen's University; Queen's University Belfast","keywords":"Ductal carcinoma; Breast cancer; Medicine; Carcinoma in situ; Oncology; Cancer; Internal medicine; Pathology; Immunohistochemistry; Carcinoma; Breast disease; Carcinogenesis","score_opus":0.01170429034964729,"score_gpt":0.2615554241101634,"score_spread":0.24985113376051613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984609427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028770515,0.99406165,0.00032166915,0.00021268376,0.00014743194,0.00063580624,0.0013459293,0.000013855344,0.00038391518],"genre_scores_gemma":[0.06380469,0.92970455,0.002074552,0.00076771487,0.00018496574,0.0021598798,0.0010466588,0.000013929954,0.00024305152],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9867828,0.004759289,0.005249805,0.001013722,0.0018634924,0.00033101608],"domain_scores_gemma":[0.96330285,0.025850669,0.006812603,0.0007578624,0.0029792886,0.0002967467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010227394,0.0017915018,0.014302981,0.013657163,0.0007091205,0.002481121,0.0019326104,0.0019473392,0.0042956946],"category_scores_gemma":[0.046201862,0.0012058308,0.012960507,0.01626959,0.00086112996,0.0022062087,0.0013647551,0.0010172805,0.00034062934],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002947711,0.000009634949,0.002783701,0.92930853,0.05291669,0.00015842599,0.0001039532,0.00012410781,0.0001777703,0.00013845373,0.0009110206,0.013072944],"study_design_scores_gemma":[0.0005969516,0.00025590477,0.014081822,0.52279437,0.4505385,0.000686007,0.00018615603,0.00019618298,0.00023327919,0.0003794314,0.010007213,0.00004422854],"about_ca_topic_score_codex":0.009167781,"about_ca_topic_score_gemma":0.0247832,"teacher_disagreement_score":0.014302981,"about_ca_system_score_codex":0.00414522,"about_ca_system_score_gemma":0.0089885285,"threshold_uncertainty_score":0.054088295},"labels":[],"label_agreement":null},{"id":"W1985388571","doi":"10.1038/bjc.2012.350","title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":812,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Health Services; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Sarcopenia; Medicine; Odds ratio; Confidence interval; Rehabilitation; Colorectal cancer; Multivariate analysis; Internal medicine; Inpatient care; Cancer; Physical therapy; Surgery; Health care","score_opus":0.02848923601270954,"score_gpt":0.32341952104034755,"score_spread":0.294930285027638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985388571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945396,0.00023471324,0.00003047464,0.0000329249,0.0000048259285,0.0000031843706,0.0000629629,0.0000015538457,0.00017542449],"genre_scores_gemma":[0.9997389,0.00007108889,0.000034982586,0.000010133225,0.0000063081925,0.0000030388862,0.000092621856,5.194669e-7,0.00004243042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967515,0.000082879604,0.00005735933,0.000057971796,0.00005935499,0.00006736406],"domain_scores_gemma":[0.9972494,0.00033670838,0.0017592695,0.00008679948,0.00016706357,0.0004006947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046267812,0.0002556703,0.00025107808,0.00046245343,0.00033335248,0.0004896179,0.00020297535,0.0003578731,0.0019802963],"category_scores_gemma":[0.00293723,0.0001844895,0.00036618437,0.000536374,0.0002692162,0.00022752902,0.0005145236,0.0005337539,0.00018874885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066216395,0.000012598823,0.9991192,0.000006479526,0.000018427443,0.000028572547,0.000011396936,0.000014130696,0.000055244356,0.0000021078633,0.00002370806,0.0006418118],"study_design_scores_gemma":[0.000002271795,0.00005364487,0.9995858,0.000006319329,0.000011830235,0.00016965362,0.00004359925,0.00007205859,0.000013867704,0.000006144848,0.00003347586,0.0000012804551],"about_ca_topic_score_codex":0.0018959868,"about_ca_topic_score_gemma":0.003594089,"teacher_disagreement_score":0.0019802963,"about_ca_system_score_codex":0.00019078425,"about_ca_system_score_gemma":0.0003059962,"threshold_uncertainty_score":0.0066247582},"labels":[],"label_agreement":null},{"id":"W1986352449","doi":"10.1038/bjc.2013.492","title":"‘Being there’ for women with metastatic breast cancer: a pan-European patient survey","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Society for Medical Oncology; Eisai Canada; Medical Research Council; Eisai; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Family medicine; Quality of life (healthcare); Cancer; Breast cancer awareness; Oncology; Nursing; Internal medicine","score_opus":0.013551594533720786,"score_gpt":0.25990416932231547,"score_spread":0.24635257478859468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986352449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539727,0.00046170386,0.00006882248,0.0009124469,0.000009320596,0.000058867998,0.0017845185,0.000004993973,0.001301928],"genre_scores_gemma":[0.99703276,0.00053782464,0.00017005428,0.0010467687,0.000007919023,0.000083932944,0.00084976153,0.00000353,0.0002674763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860615,0.000699111,0.00020165143,0.00014425801,0.00014814647,0.00020078904],"domain_scores_gemma":[0.9976494,0.0004259233,0.0010090488,0.0000947764,0.0002761102,0.00054476113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002150179,0.00017404825,0.0002983493,0.0006993028,0.0005124513,0.0007575492,0.0003644799,0.00078864454,0.0017726329],"category_scores_gemma":[0.003927402,0.00022236738,0.00038886603,0.0014511276,0.00041863442,0.0011937153,0.001146118,0.00060882315,0.0002862997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112550144,0.000115495444,0.98463446,0.00016744657,0.00006529607,0.00029094925,0.0038815178,0.000058094916,0.00030123483,0.000066715686,0.0022301853,0.008075994],"study_design_scores_gemma":[0.000010644117,0.00017539889,0.9887505,0.00006581844,0.000015344112,0.0006058037,0.007713335,0.00008005006,0.000054638775,0.00002343237,0.0024926853,0.000012332611],"about_ca_topic_score_codex":0.007356359,"about_ca_topic_score_gemma":0.008012741,"teacher_disagreement_score":0.007356359,"about_ca_system_score_codex":0.0005678499,"about_ca_system_score_gemma":0.00056609145,"threshold_uncertainty_score":0.014627039},"labels":[],"label_agreement":null},{"id":"W1986462840","doi":"10.1038/bjc.2013.695","title":"Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Dalhousie University","funders":"Canadian Institutes of Health Research; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Oncolytic virus; Immune system; Gemcitabine; Cancer research; Medicine; Tumor microenvironment; Cancer; Immunology; Context (archaeology); Biology; Internal medicine","score_opus":0.013177078510222807,"score_gpt":0.30753223080611247,"score_spread":0.29435515229588965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986462840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943797,0.0027920955,0.00088421075,0.0000721262,0.00004693319,0.000048142316,0.00017377484,0.000079102196,0.0015239157],"genre_scores_gemma":[0.99665785,0.0010610343,0.0008712482,0.000029998866,0.0000121381045,0.000033621305,0.00023730165,0.000010245726,0.0010866171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999237,0.000017568955,0.000008060332,0.000010807344,0.000018780767,0.000020984335],"domain_scores_gemma":[0.9999242,0.000018859966,0.000018136207,0.000010869325,0.000006618564,0.000021339207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088222965,0.00029564212,0.00028700783,0.00023616171,0.00008458223,0.00021994143,0.00014565104,0.00022164198,0.0012032349],"category_scores_gemma":[0.0000996021,0.00006342105,0.00020743956,0.00011541419,0.00014628322,0.00018707431,0.00011774538,0.0005680724,0.00016810751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017631799,0.0005181446,0.0005268646,0.0001565123,0.0000233468,0.000066204775,0.000027455944,0.00039222825,0.98502237,0.00013348897,0.0001903546,0.0111797685],"study_design_scores_gemma":[0.00015917986,0.0054160166,0.005610633,0.000018782597,0.000070424976,0.00025606685,0.000019882413,0.0010927999,0.9836932,0.000057365884,0.0035982956,0.0000073582755],"about_ca_topic_score_codex":0.00022088314,"about_ca_topic_score_gemma":0.00046751875,"teacher_disagreement_score":0.0012032349,"about_ca_system_score_codex":0.00017479733,"about_ca_system_score_gemma":0.00016252442,"threshold_uncertainty_score":0.004025221},"labels":[],"label_agreement":null},{"id":"W1986709694","doi":"10.1038/sj.bjc.6600114","title":"FDG–PET. A possible prognostic factor in head and neck cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Standardized uptake value; Medicine; Positron emission tomography; Head and neck cancer; Stage (stratigraphy); Head and neck squamous-cell carcinoma; Nuclear medicine; Univariate analysis; Cancer; Multivariate analysis; Head and neck; Carcinoma; Oncology; Internal medicine; Surgery; Biology","score_opus":0.03192314064905917,"score_gpt":0.34140979116885034,"score_spread":0.3094866505197912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986709694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732747,0.020368386,0.0007251309,0.00077143643,0.000119809374,0.00004015554,0.0009999329,0.0000448046,0.0036557138],"genre_scores_gemma":[0.99613625,0.001982842,0.00044938267,0.00010260616,0.00010252799,0.000013179245,0.0005697646,0.0000034135182,0.0006401053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998963,0.000035474266,0.000008145173,0.000016163702,0.000016898979,0.000026995433],"domain_scores_gemma":[0.9997451,0.00008540913,0.000068838235,0.000011872076,0.00003130394,0.000057396446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003304878,0.00024548155,0.00027414164,0.00033814507,0.00019898154,0.00025410164,0.0001585033,0.00038571504,0.0021447816],"category_scores_gemma":[0.0007403094,0.000112348134,0.00017154326,0.00072907977,0.00021055376,0.00014441746,0.00009953507,0.00027984896,0.00055120524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011748222,0.000042226737,0.94914454,0.00011941187,0.000053771535,0.0019890661,0.000029669645,0.00019097928,0.0034109585,0.000066819375,0.0011861629,0.04259162],"study_design_scores_gemma":[0.000036589936,0.00031311405,0.98550445,0.00003210798,0.00011754359,0.008055877,0.000051425188,0.0006180366,0.0009709174,0.00019841488,0.004091531,0.000010041315],"about_ca_topic_score_codex":0.002509844,"about_ca_topic_score_gemma":0.0030068634,"teacher_disagreement_score":0.002509844,"about_ca_system_score_codex":0.00031083063,"about_ca_system_score_gemma":0.00023835528,"threshold_uncertainty_score":0.0071750283},"labels":[],"label_agreement":null},{"id":"W1988330920","doi":"10.1038/bjc.2012.599","title":"Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Genetic predisposition; Breast cancer; Anxiety; Cancer; Medicine; Depression (economics); Genetic testing; Distress; Internal medicine; Clinical psychology; Psychology; Oncology; Psychiatry; Disease","score_opus":0.01153879146308891,"score_gpt":0.3014702609902837,"score_spread":0.2899314695271948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988330920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995751,0.000100751844,0.000015829424,0.000052153053,0.0000031060843,0.000003756176,0.000043306965,7.758356e-7,0.00020528906],"genre_scores_gemma":[0.9998504,0.000031768275,0.000015580485,0.000015949281,0.0000033726478,0.000002745643,0.000039534676,2.7071505e-7,0.000040346626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933016,0.00030931548,0.00004964785,0.000061241866,0.00015244808,0.0000971094],"domain_scores_gemma":[0.9960741,0.0014015508,0.0015811861,0.000100823345,0.0002163963,0.00062611594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086975726,0.00016037446,0.00021064372,0.00036735993,0.00026749098,0.00043675452,0.00016505363,0.00037168295,0.001241487],"category_scores_gemma":[0.0072858143,0.00014034247,0.0004447777,0.00033480005,0.0003552252,0.00025784975,0.0004097286,0.0005733275,0.00013660998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017845676,0.00006496082,0.9980901,0.000006867734,0.000041928302,0.000039578146,0.00023872114,0.000045123128,0.000102348415,0.0000062434897,0.000032723,0.0011530949],"study_design_scores_gemma":[0.0000046033288,0.00015005031,0.999241,0.0000024688063,0.00001292573,0.000082731494,0.00033491306,0.00010535964,0.000018184117,0.000008338087,0.000036443627,0.0000029725293],"about_ca_topic_score_codex":0.0029667586,"about_ca_topic_score_gemma":0.0046160547,"teacher_disagreement_score":0.0029667586,"about_ca_system_score_codex":0.00028531195,"about_ca_system_score_gemma":0.00020409648,"threshold_uncertainty_score":0.005899012},"labels":[],"label_agreement":null},{"id":"W1988471743","doi":"10.1038/sj.bjc.6601221","title":"Glucocorticoid use and skin cancers","year":2003,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Glucocorticoid; Asthma; Medicine; Hay fever; Confounding; Allergy; Cancer; Immunology; Lung cancer; Relative risk; Skin cancer; Basal cell carcinoma; Internal medicine; Basal cell; Confidence interval","score_opus":0.01848235734466415,"score_gpt":0.26175948252172604,"score_spread":0.2432771251770619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988471743","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15323141,0.8121958,0.0002078953,0.015063764,0.0039702724,0.00004487852,0.008354297,0.00004922144,0.00688242],"genre_scores_gemma":[0.7304558,0.2546034,0.00034169832,0.0025235305,0.007998182,0.000021492875,0.0020210918,0.000012378897,0.0020224415],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996061,0.00011191276,0.000053063664,0.00006340419,0.00012326158,0.000042402495],"domain_scores_gemma":[0.999046,0.00024912378,0.00041524952,0.00004419195,0.00009351493,0.00015189384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033476844,0.00037298724,0.0005893475,0.0009154314,0.00017352842,0.0005156322,0.00020321875,0.00055436685,0.0027145285],"category_scores_gemma":[0.001318676,0.00013941682,0.0004411011,0.0016441044,0.00019194525,0.0002664192,0.00024870367,0.00077060814,0.00047554143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001445655,0.00010749554,0.73425746,0.005126793,0.0013652998,0.0015907106,0.00032398544,0.00031811904,0.0017314027,0.0006446471,0.053319667,0.19976874],"study_design_scores_gemma":[0.000049198217,0.00031725928,0.92985696,0.00086655654,0.00060337665,0.0042333305,0.0001467018,0.00017595252,0.00032788352,0.00020333388,0.06319076,0.000028764387],"about_ca_topic_score_codex":0.004347915,"about_ca_topic_score_gemma":0.0057331296,"teacher_disagreement_score":0.004347915,"about_ca_system_score_codex":0.00040121647,"about_ca_system_score_gemma":0.00027790427,"threshold_uncertainty_score":0.009080946},"labels":[],"label_agreement":null},{"id":"W1989143916","doi":"10.1038/sj.bjc.6601159","title":"Quality of life and understanding of disease status among cancer patients of different ethnic origin","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ethnic group; Medicine; Disease; Quality of life (healthcare); Cancer; Portuguese; Family medicine; Gerontology; Internal medicine; Linguistics; Nursing","score_opus":0.14436851668895487,"score_gpt":0.39455765336344784,"score_spread":0.25018913667449294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989143916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994024,0.0001646933,0.000014312396,0.000040120052,0.000001998422,0.000002535721,0.000048445323,5.4128174e-7,0.00032485178],"genre_scores_gemma":[0.99965966,0.000080417405,0.000025055966,0.000038844802,0.0000032001212,0.000004906415,0.00009116336,5.4180435e-7,0.00009613485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918956,0.00030121152,0.000067123925,0.0000840276,0.00017250389,0.00018550079],"domain_scores_gemma":[0.9973815,0.0006867789,0.00093543966,0.00007858366,0.00026072457,0.00065686007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008948483,0.00022702993,0.00030369175,0.00059487385,0.00057751103,0.00085114094,0.00018722743,0.0004610254,0.0018408763],"category_scores_gemma":[0.004567885,0.00016441544,0.00034824136,0.0007218812,0.0005185691,0.0007086414,0.0007342593,0.0006916404,0.0003532451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014983384,0.00009020058,0.9961365,0.000010620398,0.000044502158,0.000071405724,0.00079086423,0.000042011976,0.00008312155,0.000012526078,0.00011378056,0.0024546222],"study_design_scores_gemma":[0.000011987796,0.00023438007,0.99800867,0.000009052316,0.000015687578,0.00024323513,0.0010953026,0.00013667827,0.00002978473,0.000020670035,0.00018672264,0.000007964922],"about_ca_topic_score_codex":0.009243339,"about_ca_topic_score_gemma":0.010541688,"teacher_disagreement_score":0.009243339,"about_ca_system_score_codex":0.0006154956,"about_ca_system_score_gemma":0.00024950213,"threshold_uncertainty_score":0.018379092},"labels":[],"label_agreement":null},{"id":"W1989313702","doi":"10.1038/sj.bjc.6604830","title":"Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Family history; Medicine; Cancer; Ovarian cancer; Oncology; Gynecology; Proband; Internal medicine; Incidence (geometry); Obstetrics; First-degree relatives; Mutation; Genetics; Biology","score_opus":0.023951235829560647,"score_gpt":0.28945842533159866,"score_spread":0.265507189502038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989313702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952355,0.0012809817,0.0004613782,0.000043755972,0.000006175924,0.000024974142,0.0017021096,0.000009590175,0.0012354729],"genre_scores_gemma":[0.9959376,0.00067869277,0.0008282309,0.000026661603,0.000007750788,0.000036319336,0.0015414329,0.0000043884806,0.00093897583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997135,0.00010007893,0.000033881377,0.00006579982,0.00005048657,0.000036186397],"domain_scores_gemma":[0.9994036,0.00016950774,0.00025466006,0.00006345086,0.00004488377,0.000063825384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068517035,0.00022854286,0.00021829993,0.00080929074,0.00025358444,0.0003488962,0.00031915976,0.00034442474,0.0015566709],"category_scores_gemma":[0.001933326,0.0003076495,0.0007180031,0.0008580634,0.00016144017,0.00026096878,0.00037885434,0.0003858822,0.00026902836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008816672,0.000012278483,0.9978555,0.000013544473,0.000069636146,0.00006524521,0.000061709456,0.00016002399,0.000080221456,0.00004056615,0.000084448475,0.0014685761],"study_design_scores_gemma":[0.0000090420335,0.00009506514,0.9983639,0.000009739311,0.000068007736,0.00041270006,0.00011209148,0.00037459692,0.000063220476,0.000083537336,0.00040417173,0.000003834641],"about_ca_topic_score_codex":0.018904073,"about_ca_topic_score_gemma":0.031260114,"teacher_disagreement_score":0.018904073,"about_ca_system_score_codex":0.0003049434,"about_ca_system_score_gemma":0.00035845698,"threshold_uncertainty_score":0.03758806},"labels":[],"label_agreement":null},{"id":"W1989399572","doi":"10.1038/bjc.2012.464","title":"Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Université de Montréal","funders":"","keywords":"Nomogram; Lymphovascular invasion; Cystectomy; Medicine; Cohort; Bladder cancer; Concordance; Internal medicine; Oncology; Cancer; Surgery","score_opus":0.01130117259524235,"score_gpt":0.28863928669110867,"score_spread":0.27733811409586634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989399572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993267,0.0001666476,0.00011992558,0.00007452565,0.000004558176,0.0000060206667,0.00008451034,0.0000026357284,0.00021456993],"genre_scores_gemma":[0.9996076,0.00004758749,0.00012621791,0.000014760783,0.000005132949,0.000003449657,0.00014409152,7.859256e-7,0.000050457013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997664,0.00009089866,0.000021106001,0.000043269672,0.000045312077,0.000033046228],"domain_scores_gemma":[0.99867296,0.0005335899,0.00045079977,0.00006060885,0.00008526726,0.00019679037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007995927,0.0001748982,0.00018005977,0.0003312641,0.0002290055,0.0003715014,0.00029384368,0.00030662055,0.0009980919],"category_scores_gemma":[0.0036818255,0.00007267546,0.0003489386,0.00041374343,0.00016976279,0.00016078204,0.00025756867,0.0003113072,0.00014306125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010969807,0.000012320607,0.99680567,0.0000044613644,0.00000963538,0.000063375315,0.000035030364,0.00013067843,0.00009743136,0.000010127631,0.000087693705,0.002633835],"study_design_scores_gemma":[0.000009748497,0.00011249408,0.9971835,0.0000101386995,0.000029914898,0.0004711439,0.00006477666,0.0016119421,0.0001897354,0.00009098613,0.00022207356,0.0000035211726],"about_ca_topic_score_codex":0.0023018157,"about_ca_topic_score_gemma":0.0038119957,"teacher_disagreement_score":0.0023018157,"about_ca_system_score_codex":0.0002956517,"about_ca_system_score_gemma":0.00043760904,"threshold_uncertainty_score":0.0045768023},"labels":[],"label_agreement":null},{"id":"W1989604070","doi":"10.1038/sj.bjc.6605380","title":"Family history and the risk of gastric cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; SickKids Foundation; Hospital for Sick Children; Women's College Hospital; University of Toronto","funders":"","keywords":"Odds ratio; Cancer; Family history; Etiology; Population; Genome-wide association study; Risk factor; Genetic association; Genetic predisposition; Case-control study; Genetics; Medicine; Biology; Oncology; Internal medicine; Genotype; Environmental health; Gene; Single-nucleotide polymorphism","score_opus":0.012126981570175917,"score_gpt":0.2527010709617574,"score_spread":0.2405740893915815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989604070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676797,0.023077685,0.0002691749,0.0021882376,0.00007647371,0.000006264236,0.0003866879,0.000017868017,0.006297883],"genre_scores_gemma":[0.9961976,0.0028590448,0.00010896177,0.00011538208,0.000054858538,0.0000022210506,0.000098446544,0.0000018791998,0.00056156615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996345,0.00018829535,0.000017994353,0.00005699928,0.000059287628,0.000042883497],"domain_scores_gemma":[0.9982364,0.00068341434,0.00056766503,0.00007114573,0.00010667311,0.0003347803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004784457,0.00014475564,0.00022429807,0.0008254935,0.00032103353,0.0004047758,0.00019506834,0.000577639,0.004226796],"category_scores_gemma":[0.003986787,0.00015506767,0.00022716072,0.0008057991,0.0003183915,0.00036850496,0.00022652464,0.00046492158,0.00027322522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001734816,0.00005609149,0.98328054,0.000064093314,0.0002567234,0.00084252656,0.00013912823,0.00024040374,0.000302349,0.00020711175,0.00075490255,0.0136826215],"study_design_scores_gemma":[0.000009354272,0.00009382188,0.99426234,0.000056958837,0.00011646394,0.0029125179,0.00013809468,0.0003376581,0.00005248465,0.00053355086,0.0014777775,0.000009050506],"about_ca_topic_score_codex":0.006949085,"about_ca_topic_score_gemma":0.0055133537,"teacher_disagreement_score":0.006949085,"about_ca_system_score_codex":0.00027458605,"about_ca_system_score_gemma":0.0001698988,"threshold_uncertainty_score":0.0141400695},"labels":[],"label_agreement":null},{"id":"W1989911288","doi":"10.1038/sj.bjc.6604910","title":"Measuring, and identifying predictors of, women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Medical Research Council; National Cancer Institute; Norris Cotton Cancer Center; National Institutes of Health; University of Melbourne; Michael Smith Health Research BC; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario","keywords":"Absolute risk reduction; Population; Breast cancer; Risk assessment; Risk perception; Medicine; Relative risk; Demography; Risk factor; Family history; Gynecology; Cancer; Environmental health; Psychology; Internal medicine; Perception; Confidence interval","score_opus":0.017975801757354096,"score_gpt":0.28185212196530146,"score_spread":0.2638763202079474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989911288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867,0.00022363735,0.00033433724,0.00007964747,0.000002582225,0.000018094259,0.000061816216,0.0000033795259,0.0006063981],"genre_scores_gemma":[0.9990029,0.00009205614,0.0006868635,0.000018564248,0.000004732468,0.000019733572,0.000063726155,6.75881e-7,0.000110808374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847454,0.0009057829,0.00012765786,0.000086347485,0.0003195956,0.00008597894],"domain_scores_gemma":[0.9920283,0.0037459412,0.0028512299,0.0003522738,0.00057480944,0.00044737564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004191831,0.00026193645,0.0002460383,0.0006236132,0.00028477926,0.0005780025,0.0002559476,0.0003670517,0.0010990446],"category_scores_gemma":[0.011778243,0.00021796423,0.00030656965,0.00053412106,0.00044970945,0.00049258175,0.00063852285,0.0005730063,0.00017122753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007569845,0.000059456976,0.9918882,0.000025157475,0.00004383823,0.000015031028,0.0008460334,0.00009265988,0.00025645332,0.000039284572,0.000057337355,0.0066007515],"study_design_scores_gemma":[0.0000063366183,0.00037244844,0.9976573,0.000013611272,0.000024677594,0.000108323264,0.0010967862,0.00028429713,0.00015264713,0.00010878882,0.00016524178,0.000009582518],"about_ca_topic_score_codex":0.0034663626,"about_ca_topic_score_gemma":0.006296525,"teacher_disagreement_score":0.004191831,"about_ca_system_score_codex":0.00039503007,"about_ca_system_score_gemma":0.00037939576,"threshold_uncertainty_score":0.022168756},"labels":[],"label_agreement":null},{"id":"W1990378122","doi":"10.1038/bjc.2014.214","title":"Sunitinib re-challenge in advanced renal-cell carcinoma","year":2014,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Pfizer","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Carcinoma; Kidney cancer; Pathology; Oncology; Internal medicine; Cancer research","score_opus":0.05057340882865962,"score_gpt":0.34380958598262956,"score_spread":0.29323617715396993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990378122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009976061,0.99947757,0.000019884346,0.000053885684,0.00005464846,0.0000032111423,0.000008369639,0.0000024743813,0.00028017967],"genre_scores_gemma":[0.00089348765,0.99870205,0.000050313374,0.000080917074,0.000046511544,0.0000044560024,0.00001757519,9.274445e-7,0.00020390135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977225,0.00005060571,0.000053447486,0.00003514809,0.00007323073,0.000015487303],"domain_scores_gemma":[0.99962854,0.0002118996,0.00007433873,0.0000069209186,0.00005775207,0.000020419184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006267638,0.00061325997,0.0021600092,0.0022956773,0.00022549952,0.00075049273,0.0008001183,0.0008960249,0.0028032507],"category_scores_gemma":[0.0009008075,0.00026807463,0.00080660573,0.0020492724,0.00032017677,0.000854228,0.00042960572,0.00096729555,0.0008808874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019427013,0.000051690502,0.00015151835,0.064649664,0.0003431746,0.00019374005,0.00005345216,0.00028749622,0.00060288236,0.0008380364,0.018295957,0.9143381],"study_design_scores_gemma":[0.00015093802,0.00031238687,0.002725282,0.029304909,0.0013897604,0.0039970037,0.00012802225,0.00020194754,0.00080877065,0.0012448564,0.9597025,0.000033661036],"about_ca_topic_score_codex":0.0014744961,"about_ca_topic_score_gemma":0.0033802153,"teacher_disagreement_score":0.0028032507,"about_ca_system_score_codex":0.00064587547,"about_ca_system_score_gemma":0.0008262789,"threshold_uncertainty_score":0.009377778},"labels":[],"label_agreement":null},{"id":"W1991282910","doi":"10.1038/bjc.2015.95","title":"Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Papanicolaou stain; Cost effectiveness; Aneuploidy; Medicine; Cost-effectiveness analysis; Ploidy; Cytology; Oncology; Biology; Cervical cancer; Internal medicine; Pathology; Cancer; Genetics; Chromosome","score_opus":0.10456966712261172,"score_gpt":0.42402618358091804,"score_spread":0.3194565164583063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991282910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9026775,0.02299916,0.03656143,0.0053029032,0.0003175723,0.0034679985,0.0041889516,0.00010753767,0.024376972],"genre_scores_gemma":[0.9935002,0.0017253989,0.0032396123,0.00020384148,0.000023506367,0.00044454765,0.00027356306,0.000010007312,0.0005794142],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9924189,0.0061315624,0.00017368143,0.00026955982,0.00060117594,0.00040514147],"domain_scores_gemma":[0.9783146,0.01908528,0.0012021264,0.00030304928,0.0006638053,0.00043117284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010124212,0.0013659085,0.0015463372,0.0015541221,0.0003280356,0.0021096084,0.0014886454,0.0019142969,0.005849498],"category_scores_gemma":[0.03937245,0.00073756947,0.003119485,0.0013541908,0.0009268104,0.0020226913,0.0011621303,0.0018586877,0.00018875983],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016346509,0.00074815226,0.005913241,0.0025545845,0.0022257187,0.00025480601,0.00007722163,0.9236009,0.0008282527,0.0105417725,0.0012378412,0.03567099],"study_design_scores_gemma":[0.006954471,0.016335616,0.01710832,0.0021955469,0.007176581,0.0005956288,0.0003706185,0.91455096,0.002365368,0.02615258,0.0059682233,0.00022605319],"about_ca_topic_score_codex":0.011160589,"about_ca_topic_score_gemma":0.0050588315,"teacher_disagreement_score":0.011160589,"about_ca_system_score_codex":0.00925341,"about_ca_system_score_gemma":0.00439858,"threshold_uncertainty_score":0.06713849},"labels":[],"label_agreement":null},{"id":"W1991488995","doi":"10.1038/bjc.2011.451","title":"TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fondation Medic; Amis de l'Institut Bordet","keywords":"Melanoma; Breslow Thickness; Tissue microarray; Medicine; Immunohistochemistry; Population; Oncology; Pathology; Metastasis; Lymph node; Survival analysis; Internal medicine; Cancer; Cancer research; Sentinel lymph node","score_opus":0.04884439496947994,"score_gpt":0.3292777412253414,"score_spread":0.28043334625586147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991488995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994937,0.00017141794,0.00011305403,0.000014144758,0.0000016310768,0.0000036558033,0.00008941084,0.0000046493105,0.000108274864],"genre_scores_gemma":[0.9995223,0.000066057764,0.00009584392,0.0000071251743,0.0000042051,0.000007845889,0.00017126564,0.0000013972231,0.00012395343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999323,0.00001264724,0.000003936952,0.000020842548,0.000014643239,0.000015645941],"domain_scores_gemma":[0.99960476,0.00014020062,0.0001196984,0.000011776889,0.000042976222,0.00008048442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017545474,0.00018363989,0.00016304161,0.00033209985,0.00011251936,0.00015701201,0.00006926799,0.00018768894,0.0012844463],"category_scores_gemma":[0.00065877184,0.00007620625,0.000076887736,0.00013317826,0.00014673991,0.000087358094,0.00011686216,0.00026609324,0.0002504727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015926944,0.00011256478,0.8084183,0.000077745404,0.000042489508,0.0003268821,0.000076789096,0.0002900527,0.1786943,0.000020922178,0.00023808953,0.010109174],"study_design_scores_gemma":[0.0000132193645,0.00044144236,0.98896337,0.000004533128,0.000023599014,0.0007863192,0.0000413453,0.00045206086,0.009079955,0.000028189668,0.000163001,0.000002784455],"about_ca_topic_score_codex":0.00028005659,"about_ca_topic_score_gemma":0.00030485878,"teacher_disagreement_score":0.0012844463,"about_ca_system_score_codex":0.00011344589,"about_ca_system_score_gemma":0.00007878768,"threshold_uncertainty_score":0.004296899},"labels":[],"label_agreement":null},{"id":"W1991652053","doi":"10.1038/sj.bjc.6604540","title":"Dietary intake of selected B vitamins in relation to risk of major cancers in women","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Niacin; Riboflavin; Medicine; Physiology; Internal medicine; Breast cancer; B vitamins; Cancer; Vitamin; Endocrinology; Methionine; Methylenetetrahydrofolate reductase; Micronutrient; Biology; Pathology; Food science; Biochemistry","score_opus":0.01593278232751421,"score_gpt":0.29431748176186645,"score_spread":0.27838469943435223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991652053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993715,0.0028983606,0.000066570276,0.00018718158,0.000010616194,0.00001950354,0.0018470978,0.00001602565,0.0012396118],"genre_scores_gemma":[0.99716187,0.0010046045,0.00019843262,0.000032517197,0.0000075486337,0.0000099591425,0.0007986443,0.000004341286,0.0007820548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972934,0.000030540945,0.000018353448,0.000056363406,0.000082039485,0.00008340663],"domain_scores_gemma":[0.99934953,0.00009965379,0.0002020513,0.000053730797,0.00013354917,0.00016143722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033234057,0.00026197443,0.0004376789,0.0011661651,0.0006803355,0.0005431548,0.00047840286,0.00045008576,0.0015739602],"category_scores_gemma":[0.0018206354,0.0003804965,0.00036510467,0.002275313,0.0003365374,0.00013711465,0.00033391867,0.00043182267,0.00014620317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000807154,0.00003203109,0.9940876,0.000043902433,0.00021548291,0.000088350556,0.00018490579,0.000086969194,0.00077140355,0.000044052114,0.0002797754,0.0033584256],"study_design_scores_gemma":[0.000015105061,0.00005774772,0.9990996,0.000010123124,0.00007431526,0.00007462875,0.00006602258,0.00009042783,0.00005569769,0.000026440319,0.00042651925,0.0000034915554],"about_ca_topic_score_codex":0.7226684,"about_ca_topic_score_gemma":0.69680053,"teacher_disagreement_score":0.7226684,"about_ca_system_score_codex":0.0028639855,"about_ca_system_score_gemma":0.0024391343,"threshold_uncertainty_score":0.5579297},"labels":[],"label_agreement":null},{"id":"W1991836995","doi":"10.1038/sj.bjc.6602098","title":"Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Canada; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Epidermal growth factor receptor; A431 cells; Biology; Epidermal growth factor; Tyrosine kinase; Epidermoid carcinoma; Cancer research; Autophosphorylation; DNA synthesis; Molecular biology; Biochemistry; DNA; Kinase; Receptor; Cell cycle; Cancer; Cell; Protein kinase A; Oncogene","score_opus":0.018930168018259818,"score_gpt":0.2920890244876561,"score_spread":0.2731588564693963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991836995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616903,0.0017235456,0.0011429003,0.0000307922,0.000012901424,0.000017808004,0.000083424056,0.000047783076,0.0007717687],"genre_scores_gemma":[0.9953892,0.000832764,0.0014464466,0.000013668657,0.0000055166206,0.000027647518,0.00014729875,0.000008168297,0.0021293135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999087,0.000013480149,0.000007582924,0.000019257855,0.000029172405,0.000021725327],"domain_scores_gemma":[0.9999604,0.0000055120418,0.000013024134,0.0000073797687,0.0000067495225,0.0000068719737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091263784,0.0003389557,0.00022193887,0.0001743868,0.00010164689,0.00023150315,0.00018668854,0.00021143291,0.00086952647],"category_scores_gemma":[0.00006664098,0.00010953742,0.0002751196,0.000096808064,0.00011031918,0.0001581971,0.00012754118,0.00036358854,0.00022150042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050434242,0.000015399628,0.000047308968,0.000013692012,0.0000033921146,0.000024530767,0.000007815636,0.000056023433,0.9988716,0.00003534941,0.000009507434,0.00086483255],"study_design_scores_gemma":[0.0000058772252,0.00034330675,0.0007436474,0.0000011997494,0.000008068732,0.00010670019,0.0000074188456,0.00021010003,0.9977597,0.000007198922,0.00080553285,0.0000012750078],"about_ca_topic_score_codex":0.00049152784,"about_ca_topic_score_gemma":0.0007389368,"teacher_disagreement_score":0.00086952647,"about_ca_system_score_codex":0.0001626759,"about_ca_system_score_gemma":0.0001691246,"threshold_uncertainty_score":0.0029088259},"labels":[],"label_agreement":null},{"id":"W1992316647","doi":"10.1054/bjoc.2001.1844","title":"p53 missense but not truncation mutations are associated with low levels of p21CIP1/WAF1mRNA expression in primary human sarcomas","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Biology; Missense mutation; Cancer research; Exon; Nonsense mutation; Cyclin-dependent kinase; Gene; Mutation; Tumor suppressor gene; Genetics; Cell cycle; Carcinogenesis","score_opus":0.019720371527357217,"score_gpt":0.2786494499669078,"score_spread":0.2589290784395506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992316647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974704,0.00091881095,0.00056918187,0.00002946335,0.000008966809,0.000017000768,0.0002724531,0.00003423674,0.0006795396],"genre_scores_gemma":[0.99719965,0.0006294944,0.000392695,0.000021068745,0.000007749206,0.000022485345,0.0006005741,0.000010741525,0.0011155863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973816,0.000034868386,0.000030730364,0.00005486116,0.00008914362,0.000052200226],"domain_scores_gemma":[0.99945444,0.00012053673,0.00012895066,0.000076240314,0.000076106575,0.00014373101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014150806,0.00032913138,0.0004386406,0.00072832033,0.00028853904,0.00025201656,0.00009079737,0.00028399326,0.0021532797],"category_scores_gemma":[0.0005201612,0.00038697463,0.0001842701,0.00031528928,0.00042155743,0.00011719482,0.00027740316,0.00029370587,0.0008487614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002459044,0.00003330081,0.004815925,0.000045447676,0.000012022905,0.0009645642,0.000045084365,0.000059683753,0.99259865,0.000047885947,0.000079308964,0.0010523062],"study_design_scores_gemma":[0.000113171925,0.0018851234,0.33717594,0.00002147287,0.000103859435,0.033064164,0.00022948263,0.00084102276,0.62173295,0.00033708624,0.0044710813,0.000024713707],"about_ca_topic_score_codex":0.0008828389,"about_ca_topic_score_gemma":0.0012805376,"teacher_disagreement_score":0.0021532797,"about_ca_system_score_codex":0.00024053713,"about_ca_system_score_gemma":0.00019078169,"threshold_uncertainty_score":0.0072034597},"labels":[],"label_agreement":null},{"id":"W1992374037","doi":"10.1038/sj.bjc.6603451","title":"A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Health and Medical Research Council; National Cancer Institute; Medical Research Council; Michael Smith Health Research BC","keywords":"Genetic counseling; Genetic testing; Medicine; Test (biology); Cancer; Family medicine; Cancer genetics; Judaism; Psychology; Genetics; Biology","score_opus":0.009572423306660553,"score_gpt":0.2820222334585997,"score_spread":0.2724498101519392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992374037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972128,0.00002097488,0.0005333247,0.00011596532,0.00002284684,0.0012047393,0.00007516954,0.000004856322,0.0008092863],"genre_scores_gemma":[0.98247325,0.00010038188,0.0073771444,0.0003979726,0.000046536647,0.007198611,0.000109926455,0.0000034376974,0.002292756],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995226,0.0036830034,0.00020284763,0.00018670595,0.0003632211,0.0003380747],"domain_scores_gemma":[0.97951186,0.017492568,0.0011727139,0.00051823276,0.00039453094,0.00091015035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009328833,0.00058672234,0.00093751337,0.00020606989,0.0009964359,0.0011203971,0.00061910006,0.0015633367,0.0088349655],"category_scores_gemma":[0.01567546,0.0005667606,0.00053572515,0.0003223873,0.0010076339,0.00051400985,0.00048854656,0.0015198446,0.0007098689],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3913398,0.25063848,0.099315315,0.0019210728,0.00087819353,0.001368286,0.039135758,0.009777343,0.088140294,0.0093135,0.002968694,0.1052033],"study_design_scores_gemma":[0.12390555,0.52436167,0.21351913,0.00036626257,0.0010066172,0.00043770226,0.021501819,0.05633496,0.02395864,0.018577715,0.01537341,0.00065653893],"about_ca_topic_score_codex":0.0016903832,"about_ca_topic_score_gemma":0.0025991783,"teacher_disagreement_score":0.009328833,"about_ca_system_score_codex":0.0006706396,"about_ca_system_score_gemma":0.0010223069,"threshold_uncertainty_score":0.049336135},"labels":[],"label_agreement":null},{"id":"W1992461749","doi":"10.1038/sj.bjc.6600792","title":"Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Photodynamic therapy; Medicine; Xanthine oxidase; Ischemia; Pharmacology; Necrosis; Proinflammatory cytokine; Pathology; Inflammation; Cancer research; Internal medicine; Enzyme; Biology; Chemistry; Biochemistry","score_opus":0.011819677532497188,"score_gpt":0.3149650246525794,"score_spread":0.30314534712008223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992461749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98465246,0.0036306528,0.008470467,0.00010672236,0.000071005285,0.00015654412,0.0006759943,0.00025060234,0.0019855034],"genre_scores_gemma":[0.98383915,0.0019838295,0.006261885,0.000084666426,0.000024068566,0.00023452066,0.0007717348,0.000047821024,0.006752402],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997491,0.000038882972,0.00002790257,0.00006989924,0.000057104688,0.000057081113],"domain_scores_gemma":[0.9997712,0.000037630252,0.0000954333,0.000032629192,0.000016548163,0.00004652862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038360615,0.0006194852,0.00032710837,0.00069238665,0.0001552939,0.00028424276,0.00024909354,0.00055607327,0.0016365165],"category_scores_gemma":[0.00012295261,0.00029030305,0.00046285984,0.0003067752,0.0002664875,0.00035876484,0.00023431872,0.0010578285,0.0004666085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019045419,0.000065256194,0.000087186134,0.000038035694,0.000004563314,0.00005357661,0.000026799942,0.000062655134,0.9988661,0.00008132223,0.000012547387,0.00051160663],"study_design_scores_gemma":[0.000027016154,0.0016985256,0.0027561472,0.000012333713,0.00001932489,0.00026864483,0.00002985899,0.0009176562,0.99311346,0.0000616086,0.0010882373,0.000007258136],"about_ca_topic_score_codex":0.0003961369,"about_ca_topic_score_gemma":0.0004896286,"teacher_disagreement_score":0.0016365165,"about_ca_system_score_codex":0.00022178424,"about_ca_system_score_gemma":0.000155174,"threshold_uncertainty_score":0.005474627},"labels":[],"label_agreement":null},{"id":"W1992584926","doi":"10.1038/bjc.2013.6","title":"Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; BC Cancer Agency","funders":"Public Health Agency; National Institute for Health and Care Research; Cancer Research UK; London School of Hygiene and Tropical Medicine","keywords":"Breast cancer; Medicine; Stage (stratigraphy); Population; Demography; Danish; Cancer registry; Cancer; Environmental health; Biology; Internal medicine; Sociology","score_opus":0.04409165956299617,"score_gpt":0.327210861293424,"score_spread":0.28311920173042787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992584926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974716,0.00054890837,0.00004750714,0.00003695022,0.0000042669576,0.000019016932,0.0013959996,0.0000028013512,0.00047297272],"genre_scores_gemma":[0.99740404,0.00045475017,0.00011011842,0.000031870368,0.0000042423203,0.00001739527,0.0016611156,0.0000023368027,0.00031396424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909127,0.00013390931,0.00009874418,0.0001935352,0.0003010854,0.0001814518],"domain_scores_gemma":[0.9982285,0.00018841284,0.00057905714,0.000109114684,0.00058607536,0.0003089029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085912447,0.00025981088,0.00055705546,0.0012050271,0.0008135123,0.0007639596,0.0005499523,0.00043563888,0.0007867137],"category_scores_gemma":[0.002417067,0.000388384,0.0004896239,0.0029826162,0.0005373355,0.00037870667,0.0008425328,0.00051606464,0.00015088129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008840115,0.000019668387,0.997366,0.000034799556,0.00009284775,0.000109170025,0.00038501102,0.0000726723,0.00007438929,0.0000247867,0.00028707416,0.0014451663],"study_design_scores_gemma":[0.000005336357,0.000020818536,0.99914026,0.000013617251,0.000031131964,0.00010271291,0.00024878661,0.00006787115,0.000015529262,0.000007014489,0.0003424505,0.000004405084],"about_ca_topic_score_codex":0.72004426,"about_ca_topic_score_gemma":0.75333333,"teacher_disagreement_score":0.27995574,"about_ca_system_score_codex":0.004095156,"about_ca_system_score_gemma":0.0034474717,"threshold_uncertainty_score":0.56320894},"labels":[],"label_agreement":null},{"id":"W1992935310","doi":"10.1038/bjc.2013.506","title":"Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO)","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Toronto Public Health; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Regione Lombardia; Fondazione Cariplo","keywords":"Medicine; Lung cancer; Odds ratio; Internal medicine; Confidence interval; Hormone replacement therapy (female-to-male); Oncology; Cancer; Adenocarcinoma; Gynecology; Epidemiology; Testosterone (patch)","score_opus":0.010477942706757021,"score_gpt":0.31886773180015293,"score_spread":0.3083897890933959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992935310","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12518732,0.8587795,0.0027442845,0.00046952622,0.0003270094,0.00046947968,0.010888328,0.00013447533,0.0010001177],"genre_scores_gemma":[0.85901695,0.12432664,0.003557152,0.0009936078,0.00039289048,0.0008802701,0.010039515,0.00009810466,0.0006948716],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9911281,0.0045665856,0.0016382091,0.0014498013,0.0009279524,0.0002893633],"domain_scores_gemma":[0.9885521,0.0059013963,0.0027745746,0.0012618481,0.0012460331,0.00026408312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013704623,0.0018938567,0.007663554,0.0058045518,0.00042534032,0.0021781519,0.0010039744,0.0013600386,0.0020846685],"category_scores_gemma":[0.020577077,0.00088319945,0.025412435,0.0069421222,0.00041217628,0.0005304291,0.0011339572,0.0007179692,0.00021935107],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008049735,0.000036354348,0.08415137,0.02779734,0.8685896,0.00021525161,0.00005973628,0.0007620282,0.0008199035,0.00006180215,0.0014052261,0.008051662],"study_design_scores_gemma":[0.0011565954,0.00030550867,0.06035135,0.0013229852,0.93478495,0.00015503392,0.000032154992,0.00020210692,0.00015738077,0.000077927936,0.0014250756,0.00002899586],"about_ca_topic_score_codex":0.013761373,"about_ca_topic_score_gemma":0.02028832,"teacher_disagreement_score":0.013761373,"about_ca_system_score_codex":0.001121396,"about_ca_system_score_gemma":0.0015810777,"threshold_uncertainty_score":0.07247788},"labels":[],"label_agreement":null},{"id":"W1993163519","doi":"10.1038/sj.bjc.6600549","title":"Potential role of p53 on metallothionein induction in human epithelial breast cancer cells","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Trace Elements in Health","field":"Nursing","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Metallothionein; Apoptosis; Cytoplasm; Biology; Receptor; Immunohistochemistry; Molecular biology; Cancer research; Cell culture; TUNEL assay; Cancer cell; Pathology; Cancer; Cell biology; Medicine; Immunology; Biochemistry; Gene","score_opus":0.013527483921507513,"score_gpt":0.2901945862564314,"score_spread":0.2766671023349239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993163519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918195,0.005489945,0.0009099307,0.00008543301,0.000023078826,0.000016616621,0.00030572392,0.00003862957,0.0013110489],"genre_scores_gemma":[0.99615294,0.0018910861,0.00037987065,0.000024228799,0.000007791332,0.000018752138,0.00038325696,0.0000036849797,0.0011383465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983716,0.000051382256,0.000012318623,0.00002664329,0.00003878048,0.000033729295],"domain_scores_gemma":[0.99986243,0.00004716335,0.000023601464,0.000019643387,0.000032709126,0.000014470056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015817976,0.00022417578,0.00023159233,0.00027291544,0.00020380128,0.0002808944,0.000097050695,0.00024130319,0.0012372748],"category_scores_gemma":[0.00022084753,0.000104676656,0.00016768968,0.00028185558,0.00019334955,0.00012361952,0.00019632881,0.0001342366,0.00036221487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032067226,0.000015404472,0.0016241637,0.00007824752,0.000007997284,0.00023776584,0.00004586408,0.000030743508,0.9952485,0.000027558273,0.00003398692,0.0023291092],"study_design_scores_gemma":[0.000021251206,0.0006242019,0.051963113,0.000013745496,0.000037578906,0.00095932087,0.00016736104,0.0003103662,0.9424921,0.00004680478,0.003357813,0.0000063739144],"about_ca_topic_score_codex":0.00079797296,"about_ca_topic_score_gemma":0.0010786606,"teacher_disagreement_score":0.0012372748,"about_ca_system_score_codex":0.00017813977,"about_ca_system_score_gemma":0.00011166981,"threshold_uncertainty_score":0.0041390657},"labels":[],"label_agreement":null},{"id":"W1993263958","doi":"10.1038/bjc.2015.5","title":"OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"Government of Ontario; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"SLCO1B1; Irinotecan; Pharmacology; Toxicity; Multidrug resistance-associated protein 2; Internal medicine; Medicine; Pharmacogenetics; Doxorubicin; Chemotherapy; Drug; Oncology; Metabolite; Colorectal cancer; Biology; Cancer; ATP-binding cassette transporter; Transporter; Genotype","score_opus":0.014581520121555622,"score_gpt":0.2608983730471585,"score_spread":0.2463168529256029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993263958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981553,0.0012409299,0.00006357779,0.00005260811,0.00000279328,0.00000361468,0.00014140071,0.0000054176776,0.0003343747],"genre_scores_gemma":[0.999313,0.00025132665,0.000028985747,0.000015360674,0.000005450511,0.0000036911879,0.00015819365,0.0000027815026,0.00022118138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998311,0.000045680787,0.000011726975,0.000044359484,0.000033128425,0.000034035573],"domain_scores_gemma":[0.9993426,0.000085530715,0.00039944125,0.00002886308,0.00004862377,0.00009492349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027221898,0.00019839048,0.00038128992,0.00022878921,0.00017986397,0.0004995855,0.0001091152,0.00025674584,0.0016878408],"category_scores_gemma":[0.00088903407,0.00009594674,0.00025709686,0.0005333066,0.00018390449,0.00017449193,0.00015974215,0.00035635504,0.00027077485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053170905,0.00014271033,0.9598423,0.00007503349,0.00040134983,0.00034802436,0.00014573948,0.0003471069,0.017912924,0.0000569975,0.00038052347,0.015030094],"study_design_scores_gemma":[0.000021334054,0.00030490092,0.9978672,0.0000057829848,0.00011830825,0.00029386897,0.000039618848,0.00023140358,0.00072935433,0.00004682304,0.00033806634,0.00000326505],"about_ca_topic_score_codex":0.0013832425,"about_ca_topic_score_gemma":0.001254061,"teacher_disagreement_score":0.0016878408,"about_ca_system_score_codex":0.00028693504,"about_ca_system_score_gemma":0.00018224648,"threshold_uncertainty_score":0.0056464076},"labels":[],"label_agreement":null},{"id":"W1993463141","doi":"10.1038/bjc.2014.116","title":"A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Eisai; Public Health Agency; National Institute for Health and Care Research; Cancer Research UK; American Society of Clinical Oncology","keywords":"Carboplatin; Decitabine; Medicine; Hypomethylating agent; Azacitidine; Oncology; Ovarian cancer; Internal medicine; Neutropenia; Chemotherapy; Cisplatin; Cancer; DNA methylation; Biology","score_opus":0.008043018515239787,"score_gpt":0.2546705349677168,"score_spread":0.24662751645247702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993463141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98448455,0.0019186221,0.00069832837,0.0010498252,0.0012258937,0.0076411967,0.0010524667,0.00012544749,0.0018036088],"genre_scores_gemma":[0.9754338,0.0018162625,0.0022494823,0.0017464112,0.00092707074,0.010348516,0.0015505233,0.00005330575,0.0058744466],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99864525,0.00082735455,0.00005964558,0.0002134396,0.000065776665,0.00018845969],"domain_scores_gemma":[0.9975573,0.0008526706,0.00047820288,0.00023872867,0.00011413774,0.0007590096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003116688,0.0026775748,0.004011404,0.0006570357,0.00055525417,0.001718016,0.0016281131,0.0028198855,0.008749018],"category_scores_gemma":[0.0034686562,0.0011077013,0.001898274,0.0007031049,0.0024454715,0.0017464836,0.00082364585,0.0047261096,0.0015956889],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.985672,0.0065256567,0.00025306482,0.00021877409,0.00024100702,0.000027118256,0.00005202518,0.00025074274,0.0021048079,0.00007643707,0.00029962734,0.004278761],"study_design_scores_gemma":[0.9409884,0.057639193,0.0004906216,0.000009365722,0.00009577146,0.000019858306,0.000015111667,0.000202782,0.00018270328,0.00010950312,0.0002391323,0.000007450871],"about_ca_topic_score_codex":0.0014515048,"about_ca_topic_score_gemma":0.0022388785,"teacher_disagreement_score":0.008749018,"about_ca_system_score_codex":0.0013233577,"about_ca_system_score_gemma":0.0017910004,"threshold_uncertainty_score":0.029268324},"labels":[],"label_agreement":null},{"id":"W1993505171","doi":"10.1038/bjc.2014.75","title":"Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Ligue Contre le Cancer","keywords":"Chemotherapy; Ovarian cancer; Oncology; Medicine; Kinetics; Pharmacodynamics; Biomarker; Internal medicine; Cancer; Biology; Pharmacokinetics","score_opus":0.055971171319145946,"score_gpt":0.30789753157368654,"score_spread":0.2519263602545406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993505171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96749115,0.0006437775,0.03045779,0.00022397269,0.000008297955,0.000074844655,0.00049771235,0.00009023754,0.00051218696],"genre_scores_gemma":[0.9968652,0.00011295422,0.0023919924,0.000020283525,0.000003905241,0.000037639613,0.00044093322,0.0000046245727,0.00012243503],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996306,0.0001904168,0.000022920085,0.00008434325,0.00004266932,0.000029112716],"domain_scores_gemma":[0.99756646,0.0016478433,0.0005181644,0.00013328253,0.00008474094,0.00004950656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015125127,0.0005296463,0.00079439196,0.00033703796,0.00009750114,0.00063578266,0.0005224038,0.0006297715,0.00046297678],"category_scores_gemma":[0.0057237763,0.00034250712,0.0008204807,0.00031283466,0.00029072657,0.0003837746,0.00035693747,0.00060827506,0.00012611401],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017055746,0.00019778644,0.082466386,0.00015235176,0.00025467444,0.00011059561,0.000094753006,0.8849406,0.0047646784,0.00041693414,0.0003194892,0.024576161],"study_design_scores_gemma":[0.00010650439,0.0005393482,0.030095076,0.000016000075,0.000076837365,0.00017259036,0.000017576851,0.96508384,0.002578792,0.00087625254,0.00041875293,0.000018362714],"about_ca_topic_score_codex":0.004918595,"about_ca_topic_score_gemma":0.0019334521,"teacher_disagreement_score":0.004918595,"about_ca_system_score_codex":0.0009969675,"about_ca_system_score_gemma":0.00071723986,"threshold_uncertainty_score":0.00977993},"labels":[],"label_agreement":null},{"id":"W1993796592","doi":"10.1038/sj.bjc.6603205","title":"Nuclear ING2 expression is reduced in human cutaneous melanomas","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health; SKiN Health","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Melanoma; Tissue microarray; Cancer research; Cancer; Immunohistochemistry; Medicine; Skin cancer; Pathology; Oncology; Biology; Internal medicine","score_opus":0.0037335692949647305,"score_gpt":0.2361811451015519,"score_spread":0.23244757580658715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993796592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998116,0.00066632754,0.0004358834,0.000015005149,0.0000029496466,0.0000028949605,0.00018961188,0.000026283673,0.0005450504],"genre_scores_gemma":[0.9977551,0.00030737763,0.00036505875,0.000012374838,0.0000023739574,0.000007336864,0.00037621532,0.000008144499,0.0011661388],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999323,0.000008116526,0.000004084497,0.000020955236,0.000021308531,0.000013229013],"domain_scores_gemma":[0.99991,0.000013511456,0.000031875297,0.000011329603,0.00001339109,0.000020023654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006292735,0.000111271525,0.00018341465,0.0003338744,0.00012905584,0.00021992381,0.00006523637,0.00013640693,0.0012496427],"category_scores_gemma":[0.00014414615,0.000109769964,0.000095558324,0.00019219908,0.00013871348,0.00007371861,0.0001036428,0.0001232986,0.00020281556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003474353,0.000012863857,0.009651247,0.000043243206,0.000013220053,0.000231979,0.00006224932,0.0000381258,0.98750776,0.00003217128,0.000044187324,0.002015552],"study_design_scores_gemma":[0.000020552312,0.0003552579,0.62350875,0.0000105594045,0.00006644694,0.004733182,0.00033009742,0.0005412703,0.36672354,0.00010060189,0.0035968786,0.0000128417705],"about_ca_topic_score_codex":0.0008635272,"about_ca_topic_score_gemma":0.00086208485,"teacher_disagreement_score":0.0012496427,"about_ca_system_score_codex":0.000109486034,"about_ca_system_score_gemma":0.00008603511,"threshold_uncertainty_score":0.004180491},"labels":[],"label_agreement":null},{"id":"W1993873445","doi":"10.1038/bjc.2013.553","title":"A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Cancer Institute, University of Pittsburgh; Hospital for Sick Children; V Foundation for Cancer Research","keywords":"Medicine; Bevacizumab; Cyclophosphamide; Imatinib; Nausea; Internal medicine; Oncology; Gastroenterology; Chemotherapy; Pharmacology","score_opus":0.010802426090970953,"score_gpt":0.3192174602099995,"score_spread":0.3084150341190286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993873445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914833,0.0038881288,0.00048942753,0.0005544198,0.000100606376,0.0017652465,0.00046731532,0.00006800827,0.001183539],"genre_scores_gemma":[0.9877862,0.002376522,0.0023028704,0.0009086526,0.00023637929,0.0030985167,0.0016696414,0.000024246729,0.001597033],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99944013,0.00030336383,0.000027463768,0.00009192742,0.00005979288,0.00007718081],"domain_scores_gemma":[0.9991517,0.00016432443,0.00025214837,0.00003503541,0.000040750143,0.00035601167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017250126,0.0013721328,0.0015759239,0.00045658177,0.00031556233,0.0006265628,0.00069606316,0.0009271147,0.0034676555],"category_scores_gemma":[0.0009788385,0.00044572607,0.00072250137,0.00034135397,0.0006347691,0.00054690975,0.0003356471,0.0024634404,0.00058094267],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7838263,0.038810566,0.0064053307,0.0014033995,0.0013481184,0.00031924006,0.00020549774,0.003107924,0.040200684,0.00027082587,0.005784123,0.11831797],"study_design_scores_gemma":[0.6713076,0.31410143,0.0072180377,0.000050550832,0.00037436062,0.00039377567,0.000022323808,0.0015255206,0.0027349642,0.00013708301,0.0021112843,0.000023120208],"about_ca_topic_score_codex":0.000504847,"about_ca_topic_score_gemma":0.001687231,"teacher_disagreement_score":0.0034676555,"about_ca_system_score_codex":0.0008396079,"about_ca_system_score_gemma":0.001350814,"threshold_uncertainty_score":0.011600435},"labels":[],"label_agreement":null},{"id":"W1994831520","doi":"10.1054/bjoc.2000.1157","title":"Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Photodynamic therapy; Nitric oxide; Superoxide; Superoxide dismutase; Nitric oxide synthase; Blood flow; Medicine; Endogeny; Pathology; Cancer research; Internal medicine; Chemistry; Biochemistry; Enzyme; Oxidative stress","score_opus":0.012273894465228911,"score_gpt":0.34004494478239256,"score_spread":0.32777105031716364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994831520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931965,0.004774039,0.0011410244,0.00005313956,0.000027715088,0.00003309229,0.00012006289,0.000031903644,0.00062250043],"genre_scores_gemma":[0.9971705,0.0011481427,0.00079355424,0.000027307226,0.000013455612,0.000034748464,0.000104475446,0.000005195458,0.00070262543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998368,0.000047969574,0.000011881639,0.00002447986,0.000039603387,0.000039216422],"domain_scores_gemma":[0.9998074,0.0000612432,0.00004411539,0.000016164824,0.000021253125,0.00004987876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003544073,0.00027682853,0.00033292596,0.00016733796,0.000093288414,0.00025469394,0.00014448591,0.00037832742,0.0005974182],"category_scores_gemma":[0.00024848536,0.00009175165,0.00018276002,0.000117101445,0.00023107819,0.00019620023,0.00013097208,0.0004596802,0.000101691396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005263656,0.000030224455,0.0002685532,0.00004160451,0.0000034044078,0.000027595606,0.000011273479,0.0000742132,0.99794155,0.000024963361,0.0000089553005,0.0010412715],"study_design_scores_gemma":[0.000028703718,0.0015672087,0.0074089877,0.000006255132,0.00002673374,0.00014382291,0.000024277686,0.0010136383,0.98889166,0.00003312302,0.0008495038,0.000006168006],"about_ca_topic_score_codex":0.00041828878,"about_ca_topic_score_gemma":0.00032831653,"teacher_disagreement_score":0.0005974182,"about_ca_system_score_codex":0.00020571417,"about_ca_system_score_gemma":0.00016860741,"threshold_uncertainty_score":0.0019985437},"labels":[],"label_agreement":null},{"id":"W1995048156","doi":"10.1038/sj.bjc.6601052","title":"Follow-up of patients with Hodgkin's disease following curative treatment: the routine CT scan is of little value","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Vetenskapsrådet","keywords":"Medicine; Radiological weapon; Retrospective cohort study; Disease; Surgery; Radiology; Pediatrics; Internal medicine","score_opus":0.009867171702763702,"score_gpt":0.26549342799210357,"score_spread":0.2556262562893399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995048156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878963,0.010002411,0.00023393572,0.00036561172,0.00002346638,0.000026509666,0.00017799267,0.000013668329,0.0012600481],"genre_scores_gemma":[0.9966581,0.002511811,0.00023781824,0.00012791532,0.00005619438,0.00001242785,0.00017705592,0.000003981122,0.00021469807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999602,0.00015308156,0.00006084404,0.00003543259,0.000095253505,0.000053431908],"domain_scores_gemma":[0.9975623,0.0009513159,0.0008617835,0.0001193156,0.00027872843,0.00022658301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062300754,0.00018128322,0.0003857875,0.00089282525,0.00029657967,0.00047040632,0.00027549756,0.00042032235,0.0013029595],"category_scores_gemma":[0.004694538,0.00013626795,0.00017015156,0.0007628912,0.0002504125,0.0004570745,0.00022152302,0.0003232395,0.0003075835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044147644,0.0000565424,0.9469985,0.00018452825,0.000030121113,0.002747395,0.0002162316,0.000090825255,0.0011251655,0.0000329886,0.000766696,0.047309734],"study_design_scores_gemma":[0.000020644828,0.00047164608,0.9837495,0.00012766893,0.00007096521,0.012386165,0.00033038922,0.00020046525,0.0006536599,0.00006291067,0.0019143173,0.000011632545],"about_ca_topic_score_codex":0.0028551233,"about_ca_topic_score_gemma":0.004270912,"teacher_disagreement_score":0.0028551233,"about_ca_system_score_codex":0.0003170581,"about_ca_system_score_gemma":0.00031239892,"threshold_uncertainty_score":0.005676985},"labels":[],"label_agreement":null},{"id":"W1995318670","doi":"10.1038/sj.bjc.6605283","title":"An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Breast cancer; Cohort; Adjuvant; Internal medicine; Oncology; Cancer; Cohort study; Cancer registry; Adjuvant therapy","score_opus":0.01210410022630315,"score_gpt":0.27328071782547947,"score_spread":0.2611766175991763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995318670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996126,0.000062941865,0.000025025416,0.000042145482,0.0000027002072,0.0000042245174,0.00012992535,9.51982e-7,0.0001194912],"genre_scores_gemma":[0.999554,0.000049167465,0.00003458611,0.000033413522,0.0000025512281,0.0000066497473,0.00023840895,0.0000013948986,0.00007988998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893564,0.0003351709,0.00011123162,0.00017754058,0.00020707348,0.00023332775],"domain_scores_gemma":[0.99614465,0.001054432,0.0011920861,0.00030053974,0.00084438507,0.00046384346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010708016,0.00024028956,0.00037999882,0.0005484322,0.00045369077,0.0009769766,0.00040373584,0.00049302663,0.0011720317],"category_scores_gemma":[0.0062568816,0.00024335,0.00040803786,0.0009080881,0.00036916812,0.0004930106,0.00089189893,0.00040338887,0.0003432007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013484071,0.000016234324,0.9980913,0.000008278258,0.000014072595,0.00012404162,0.00026093275,0.000044286855,0.00014197116,0.000008336083,0.000083358485,0.0010722311],"study_design_scores_gemma":[0.000011308703,0.00017109513,0.99854714,0.000007633891,0.000012689991,0.00032343544,0.0004299619,0.00018936157,0.000063754575,0.000004398335,0.00023388094,0.000005337041],"about_ca_topic_score_codex":0.04217939,"about_ca_topic_score_gemma":0.035432927,"teacher_disagreement_score":0.04217939,"about_ca_system_score_codex":0.0013943233,"about_ca_system_score_gemma":0.0007071145,"threshold_uncertainty_score":0.08386779},"labels":[],"label_agreement":null},{"id":"W1995752721","doi":"10.1038/sj.bjc.6604635","title":"Mammographic density, lobular involution, and risk of breast cancer","year":2008,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Involution (esoterism); Breast cancer; Breast tissue; Mammography; Medicine; Oncology; Internal medicine; Biology; Cancer","score_opus":0.014109221055429017,"score_gpt":0.28945237575471455,"score_spread":0.27534315469928555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995752721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018602468,0.99895144,0.00004820221,0.00012566369,0.00007069506,0.000002252956,0.000010205357,0.0000032553023,0.0006021946],"genre_scores_gemma":[0.001133943,0.99828076,0.00008872813,0.00004862536,0.00009223838,0.0000036906188,0.000017679678,4.4193146e-7,0.00033393424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998029,0.000036560225,0.000029901374,0.000038381568,0.000078787365,0.000013500735],"domain_scores_gemma":[0.99969935,0.00015957728,0.000056376717,0.000006434872,0.000059138325,0.00001922696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040461626,0.00070646213,0.0013639701,0.0020947333,0.00018853499,0.0006107489,0.00056328037,0.00084731827,0.0030552258],"category_scores_gemma":[0.0010261402,0.00020959793,0.00029923124,0.002308961,0.00038202267,0.0006648958,0.0003418413,0.0006253375,0.0015782514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007542955,0.000051305426,0.0015867947,0.013572213,0.00010432424,0.00032879857,0.000074922464,0.00031603756,0.0006829368,0.0018054196,0.014254442,0.9671475],"study_design_scores_gemma":[0.000023237844,0.00025809908,0.020230137,0.009727511,0.00036401447,0.007861641,0.00029461365,0.00019817207,0.00061160047,0.0031715408,0.95721626,0.000043148935],"about_ca_topic_score_codex":0.002028111,"about_ca_topic_score_gemma":0.0020875698,"teacher_disagreement_score":0.0030552258,"about_ca_system_score_codex":0.00041407725,"about_ca_system_score_gemma":0.0007136246,"threshold_uncertainty_score":0.010220706},"labels":[],"label_agreement":null},{"id":"W1996270518","doi":"10.1054/bjoc.2001.2125","title":"First do no harm: extending the debate on the provision of preventive tamoxifen","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Ottawa; Statistics Canada","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Gynecology; Endometrial cancer; Population; Internal medicine; Cancer; Demography; Oncology; Obstetrics; Environmental health","score_opus":0.019349140794071087,"score_gpt":0.30899005761449994,"score_spread":0.28964091682042886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996270518","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015655573,0.035696745,0.0022949008,0.920623,0.0011863343,0.00003090831,0.0001899955,0.00002921059,0.024293419],"genre_scores_gemma":[0.70157,0.055263903,0.0030803923,0.22865874,0.0076214815,0.00012859335,0.00012784281,0.00006774662,0.003481409],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9802491,0.014327157,0.0003985326,0.0006933987,0.0031731955,0.0011586711],"domain_scores_gemma":[0.8874587,0.10000299,0.0029949544,0.002841784,0.0040536844,0.0026479564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037737336,0.00055134605,0.0012036035,0.0008286609,0.0018672921,0.004537142,0.002905283,0.0095474925,0.0060223425],"category_scores_gemma":[0.131621,0.00028285163,0.0013455726,0.0009942837,0.008702976,0.004911692,0.002558206,0.010059365,0.0006358423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054355995,0.0002443349,0.0098477965,0.0019893777,0.00081652036,0.0005503983,0.0036846546,0.02792492,0.00061069947,0.4793256,0.11033475,0.35923544],"study_design_scores_gemma":[0.0019726944,0.0012507875,0.011764232,0.0074724555,0.0011918645,0.0004557719,0.003360023,0.014153958,0.00074905035,0.5176439,0.43978187,0.0002034252],"about_ca_topic_score_codex":0.12175642,"about_ca_topic_score_gemma":0.10129861,"teacher_disagreement_score":0.12175642,"about_ca_system_score_codex":0.01447622,"about_ca_system_score_gemma":0.026277626,"threshold_uncertainty_score":0.24209547},"labels":[],"label_agreement":null},{"id":"W1996273831","doi":"10.1038/sj.bjc.6605722","title":"Insulin-like growth factors and risk of kidney cancer in men","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Renal function; Kidney cancer; Odds ratio; Internal medicine; Cancer; Risk factor; Prospective cohort study; Kidney; Endocrinology; Cohort study; Kidney disease","score_opus":0.00815073961386248,"score_gpt":0.257471031834554,"score_spread":0.24932029222069152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996273831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966061,0.0025584537,0.000075851196,0.00007061793,0.000010453861,0.0000038836715,0.00019447983,0.0000071152076,0.00047310884],"genre_scores_gemma":[0.9990945,0.00045287478,0.00007550908,0.000023838084,0.000012583202,0.000002756765,0.000120637276,9.486426e-7,0.00021627019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989283,0.00002669753,0.000007400737,0.000022572922,0.00002545733,0.000024958033],"domain_scores_gemma":[0.9996393,0.00006828228,0.00015176156,0.000015903224,0.000027787155,0.00009697052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023435203,0.00017992263,0.0002113674,0.00041350035,0.00022920297,0.00033567942,0.0001427839,0.0002922347,0.0013593192],"category_scores_gemma":[0.0009801012,0.00018603286,0.00022900941,0.0006241796,0.00018603144,0.00012678743,0.00018438135,0.00028643594,0.00016240653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023158362,0.00002140676,0.9974177,0.000015316853,0.0000624287,0.00007199739,0.000040020797,0.000032370044,0.0003000492,0.000016960243,0.00008366966,0.0017064647],"study_design_scores_gemma":[0.0000102365075,0.00010459097,0.9992199,0.00000556006,0.000041890504,0.00024716897,0.00002797824,0.00007837791,0.00006224078,0.000025269843,0.00017516442,0.0000015920103],"about_ca_topic_score_codex":0.005541567,"about_ca_topic_score_gemma":0.004918649,"teacher_disagreement_score":0.005541567,"about_ca_system_score_codex":0.00017068716,"about_ca_system_score_gemma":0.00018923629,"threshold_uncertainty_score":0.011018634},"labels":[],"label_agreement":null},{"id":"W1996330154","doi":"10.1038/bjc.2012.319","title":"A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Regeneron Pharmaceuticals","keywords":"Medicine; Aflibercept; Pemetrexed; Neutropenia; Internal medicine; Febrile neutropenia; Adverse effect; Cisplatin; Gastroenterology; Pharmacology; Bevacizumab; Chemotherapy","score_opus":0.015153943021905881,"score_gpt":0.3460659373982292,"score_spread":0.33091199437632335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996330154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995593,0.0010235431,0.00046685178,0.00019110415,0.00004990168,0.0016311745,0.00029073755,0.000048456302,0.0007053044],"genre_scores_gemma":[0.99374783,0.00088519993,0.0017262974,0.00045454083,0.00007882962,0.0015949653,0.0007791417,0.000022621105,0.00071066286],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99928904,0.00026846587,0.000047950696,0.00017669011,0.000102488164,0.00011535952],"domain_scores_gemma":[0.99897385,0.00013136346,0.0002821167,0.000111587986,0.00006744931,0.00043373165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015446749,0.0013825913,0.0024882557,0.00049873337,0.00039291842,0.0011110414,0.0009233131,0.0010750433,0.00243974],"category_scores_gemma":[0.0014009932,0.00069714425,0.001104,0.00069497176,0.0009420422,0.0009303143,0.00040204273,0.0044766115,0.00079252897],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5328284,0.16166207,0.019079668,0.0012352522,0.0021989797,0.00048276072,0.00093692413,0.005932955,0.10901236,0.00025545846,0.0034827755,0.16289237],"study_design_scores_gemma":[0.36568904,0.60177445,0.021542756,0.0000317614,0.00050076796,0.0005901915,0.00006732165,0.0016705238,0.00494843,0.00015623194,0.0029957527,0.00003275737],"about_ca_topic_score_codex":0.00065566134,"about_ca_topic_score_gemma":0.0011760097,"teacher_disagreement_score":0.0024882557,"about_ca_system_score_codex":0.0013838473,"about_ca_system_score_gemma":0.001605855,"threshold_uncertainty_score":0.010040522},"labels":[],"label_agreement":null},{"id":"W1996412513","doi":"10.1038/sj.bjc.6604377","title":"SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Canadian Association of Gastroenterology","keywords":"Demethylating agent; DNA methylation; Cancer research; CpG site; Methylation; Colorectal cancer; Deoxycytidine; Cell growth; DNMT1; Cell culture; Biology; Promoter; Apoptosis; Molecular biology; Cancer; Gene expression; DNA; Gene; Genetics","score_opus":0.017669555800618048,"score_gpt":0.28004060186077956,"score_spread":0.2623710460601615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996412513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98574,0.007615729,0.004052314,0.00014844691,0.00004292667,0.000041248877,0.000766334,0.00021323252,0.0013797723],"genre_scores_gemma":[0.992649,0.0023765173,0.0024268879,0.00006767328,0.000009414226,0.000035457702,0.0007086855,0.000017114042,0.0017091876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998877,0.00001733203,0.000012025266,0.000033527955,0.000030568975,0.000018857443],"domain_scores_gemma":[0.99994063,0.000012717812,0.00001799341,0.000009874876,0.000008451457,0.000010307019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013358805,0.00019201537,0.0003202311,0.00017086123,0.000090331894,0.00015666669,0.0001236458,0.00014147474,0.001207199],"category_scores_gemma":[0.00014435123,0.00014241556,0.0001790546,0.00015240519,0.00011764583,0.000071563954,0.000110281,0.00032319606,0.0002101971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004273533,0.0000066024877,0.00026856604,0.000039711118,0.0000063852926,0.00001880549,0.000008389539,0.00006228976,0.99761426,0.000019052564,0.000027403297,0.001885859],"study_design_scores_gemma":[0.000010039973,0.00037270578,0.014595953,0.000008515704,0.000027612705,0.00025096128,0.000018748893,0.00066247233,0.98056084,0.00002339708,0.0034647472,0.0000039394417],"about_ca_topic_score_codex":0.0013221577,"about_ca_topic_score_gemma":0.0030989896,"teacher_disagreement_score":0.0013221577,"about_ca_system_score_codex":0.00022353993,"about_ca_system_score_gemma":0.00020746053,"threshold_uncertainty_score":0.0040385127},"labels":[],"label_agreement":null},{"id":"W1997464162","doi":"10.1038/sj.bjc.6603010","title":"Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bafilomycin; Cytotoxicity; Endosome; Pharmacology; Chloroquine; Doxorubicin; Clonogenic assay; Chemistry; Mitoxantrone; Cancer research; Biology; Apoptosis; Chemotherapy; Cell; Immunology; Biochemistry; In vitro; Autophagy","score_opus":0.006219305817989429,"score_gpt":0.25551595677361855,"score_spread":0.2492966509556291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997464162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935626,0.0035448475,0.0016765951,0.00010353438,0.000010344284,0.000024296009,0.00008581993,0.000041962092,0.0009500623],"genre_scores_gemma":[0.99738365,0.0010919804,0.0009786875,0.000022157492,0.0000068466343,0.000012024884,0.00008227335,0.000007129103,0.00041515855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998622,0.000042806387,0.000013964105,0.000019931173,0.000027482442,0.000033598284],"domain_scores_gemma":[0.9997565,0.00010381168,0.000064238746,0.00002238639,0.000025278425,0.000027738888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018071041,0.00031572665,0.00040793887,0.00013186758,0.00009701591,0.00020220807,0.00017979402,0.00029927347,0.00080472557],"category_scores_gemma":[0.0002486906,0.000108762935,0.00017880193,0.0001141165,0.00023094493,0.00020643174,0.00015417009,0.0003032112,0.00016410032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017015057,0.000021565953,0.00018188856,0.000047519155,0.000005072592,0.000035668454,0.000009835738,0.000058257956,0.9977914,0.000041777676,0.000014340683,0.0016225572],"study_design_scores_gemma":[0.000015530537,0.00049401907,0.0031141068,0.0000022077818,0.000012360233,0.00016429374,0.0000060053803,0.00025723933,0.99507517,0.000013843306,0.00084230973,0.0000029338787],"about_ca_topic_score_codex":0.00049459003,"about_ca_topic_score_gemma":0.00067108555,"teacher_disagreement_score":0.00080472557,"about_ca_system_score_codex":0.00022045117,"about_ca_system_score_gemma":0.00012697038,"threshold_uncertainty_score":0.0026920438},"labels":[],"label_agreement":null},{"id":"W1998087959","doi":"10.1038/sj.bjc.6605616","title":"Risks of second primary cancer among patients with major histological types of lung cancers in both men and women","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Manitoba; Manitoba Health; University of British Columbia; Saskatchewan Cancer Agency; CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; European Commission; Centre International de Recherche sur le Cancer","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Adenocarcinoma; Cancer; Incidence (geometry); Lung; Carcinoma; Etiology; Gynecology","score_opus":0.010131867342530949,"score_gpt":0.2672691298764386,"score_spread":0.2571372625339076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998087959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964896,0.0014228855,0.00009637108,0.00019324213,0.00001735524,0.000008695643,0.00059000385,0.0000094927245,0.0011723019],"genre_scores_gemma":[0.99918276,0.00028013735,0.00004198137,0.000033501092,0.000021059008,0.000005670053,0.00024034425,0.0000014338353,0.0001931386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999708,0.00006469155,0.000021457205,0.0000803179,0.000060749368,0.00006476488],"domain_scores_gemma":[0.999033,0.00016159246,0.00041885683,0.000063738225,0.00007425547,0.0002485195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004704099,0.0002363613,0.00030607582,0.0005742402,0.00021579237,0.00043006428,0.00018331553,0.00038383223,0.0025701004],"category_scores_gemma":[0.0018737662,0.0002413324,0.0006747549,0.0004495241,0.0001669666,0.00021243539,0.00038240707,0.0004819057,0.00026468743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063946405,0.0000048804154,0.99853325,0.000007646879,0.0000429589,0.0000619447,0.00002656144,0.000020761054,0.000062122126,0.000012456626,0.000115121875,0.001048403],"study_design_scores_gemma":[0.000007489293,0.00006354284,0.99870396,0.000008739818,0.0000344655,0.0007017423,0.00009877154,0.00009813317,0.00003610455,0.000036998623,0.00020786189,0.0000021479968],"about_ca_topic_score_codex":0.0044149547,"about_ca_topic_score_gemma":0.005567105,"teacher_disagreement_score":0.0044149547,"about_ca_system_score_codex":0.00020451237,"about_ca_system_score_gemma":0.00028484393,"threshold_uncertainty_score":0.0087785125},"labels":[],"label_agreement":null},{"id":"W1998742701","doi":"10.1038/bjc.2013.146","title":"Independent contributors to overall quality of life in people with advanced cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Université du Québec; McGill University","funders":"Terry Fox Research Institute","keywords":"Quality of life (healthcare); Cancer; Medicine; Construct (python library); Gerontology; Ranking (information retrieval); Social support; Medical diagnosis; Multivariate statistics; Perception; Multivariate analysis; Stepwise regression; Clinical psychology; Psychology; Pathology; Internal medicine; Social psychology; Statistics","score_opus":0.011668088114702147,"score_gpt":0.30067899496873585,"score_spread":0.2890109068540337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998742701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982343,0.00051999366,0.00021290075,0.00016785937,0.000010137011,0.00001795827,0.00027098067,0.0000059262966,0.0005599501],"genre_scores_gemma":[0.9993119,0.00013633777,0.00020387085,0.000011897642,0.0000064888523,0.000010914642,0.00023503129,0.0000018884609,0.00008174537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990176,0.00038802697,0.00008429426,0.00009911919,0.00027973176,0.0001311429],"domain_scores_gemma":[0.99369746,0.0027558343,0.0020570366,0.0002984641,0.0005875708,0.0006037149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016873128,0.00046398214,0.000422123,0.001083404,0.00040681096,0.000568726,0.00037105771,0.00035176775,0.0028523703],"category_scores_gemma":[0.010750021,0.0001989047,0.0010464725,0.0009384759,0.00055650825,0.00044664394,0.0013014607,0.0009897641,0.00018459544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007664551,0.000036916703,0.99307173,0.000034569413,0.00010978806,0.000024466768,0.0002224607,0.00011877147,0.000058899128,0.000028412875,0.00007547372,0.0061418777],"study_design_scores_gemma":[0.0000036859174,0.00008060321,0.9991259,0.000011977079,0.0000651663,0.00007479324,0.00021177386,0.00019874724,0.000027366046,0.000075312164,0.00012093573,0.000003797184],"about_ca_topic_score_codex":0.002227105,"about_ca_topic_score_gemma":0.0036758168,"teacher_disagreement_score":0.0028523703,"about_ca_system_score_codex":0.00040254433,"about_ca_system_score_gemma":0.0005230498,"threshold_uncertainty_score":0.009542167},"labels":[],"label_agreement":null},{"id":"W1998796510","doi":"10.1038/bjc.2013.50","title":"ING1b-inducible microRNA203 inhibits cell proliferation","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Alberta Heritage Foundation for Medical Research; Alberta Cancer Foundation","keywords":"microRNA; Ectopic expression; Biology; Epigenetics; Cyclin-dependent kinase 6; Cell growth; Cancer research; Cell cycle; Histone deacetylase; Transfection; Molecular biology; Histone; Cancer; Cell culture; Cyclin D1; Genetics; Gene","score_opus":0.006144464768496926,"score_gpt":0.23553048947610494,"score_spread":0.22938602470760802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998796510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289365,0.0049278433,0.0025002428,0.00039693137,0.00022255123,0.00007901063,0.001087371,0.00045015913,0.00744224],"genre_scores_gemma":[0.9863942,0.0019565139,0.0027914387,0.0001870671,0.000024856483,0.00013784796,0.0020540394,0.000051859784,0.006402241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998503,0.000022215616,0.000013600846,0.000026794438,0.00004538231,0.00004171216],"domain_scores_gemma":[0.99993217,0.000012485836,0.000014322456,0.000010200073,0.0000074743566,0.000023373508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015488782,0.00038110168,0.00033540017,0.00022721443,0.00017813385,0.0002412489,0.00022714231,0.00028635323,0.0026034825],"category_scores_gemma":[0.00010516109,0.00013779095,0.00024889628,0.0001976739,0.00020491309,0.00008922528,0.00018451482,0.0005806106,0.001135451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027755395,0.00009724709,0.0001103825,0.00006571638,0.00000519479,0.00003329436,0.0000127663,0.000042181884,0.99706227,0.00007227885,0.00033281615,0.0018882464],"study_design_scores_gemma":[0.000043340176,0.00053228455,0.0020763257,0.000007845801,0.000017015072,0.00012934816,0.00002376819,0.0008045102,0.9912941,0.00003108219,0.0050363643,0.0000040114337],"about_ca_topic_score_codex":0.0005982695,"about_ca_topic_score_gemma":0.0010906133,"teacher_disagreement_score":0.0026034825,"about_ca_system_score_codex":0.00036175555,"about_ca_system_score_gemma":0.0004006684,"threshold_uncertainty_score":0.00870949},"labels":[],"label_agreement":null},{"id":"W1998858050","doi":"10.1038/sj.bjc.6605358","title":"Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"LNCaP; Androgen; Endocrinology; Prostate cancer; Internal medicine; Cancer research; Biology; Protein kinase B; Autocrine signalling; Medicine; Cancer; Signal transduction; Cell biology; Hormone","score_opus":0.010719101627815602,"score_gpt":0.30383232770995106,"score_spread":0.29311322608213547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998858050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319214,0.0029897476,0.0016824133,0.00010267314,0.000050984083,0.000027310381,0.0007095079,0.0000943229,0.0011509527],"genre_scores_gemma":[0.99294186,0.0014378806,0.0014039836,0.000072047056,0.000023364057,0.00004930987,0.0014173444,0.000012962083,0.0026414308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984825,0.000021818567,0.000014321363,0.000022843627,0.0000600517,0.000032716587],"domain_scores_gemma":[0.99989617,0.000019717869,0.000021710372,0.000015585389,0.000017952827,0.000028867942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103821345,0.00032471094,0.00021626428,0.00023272011,0.00014989871,0.00030749055,0.00014227995,0.00016631339,0.0013254995],"category_scores_gemma":[0.00008083741,0.000115550516,0.00035027208,0.000206851,0.00012816172,0.00016258813,0.0001713487,0.00059422787,0.0004689334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008646861,0.00003464702,0.00030297073,0.00003972319,0.0000047390627,0.00006319908,0.000011717933,0.000036598518,0.99883825,0.000019018922,0.000037651902,0.00052503066],"study_design_scores_gemma":[0.000012503902,0.00056064,0.011836957,0.000005621259,0.000022396158,0.00059511553,0.000035974048,0.00051603053,0.9837804,0.000020356065,0.002607223,0.0000067742435],"about_ca_topic_score_codex":0.0006081721,"about_ca_topic_score_gemma":0.0006957335,"teacher_disagreement_score":0.0013254995,"about_ca_system_score_codex":0.00017218316,"about_ca_system_score_gemma":0.00020189829,"threshold_uncertainty_score":0.004434228},"labels":[],"label_agreement":null},{"id":"W1998892163","doi":"10.1038/sj.bjc.6601388","title":"Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Yale University; State of Connecticut Department of Public Health","keywords":"Medicine; Follicular lymphoma; Lymphoma; Internal medicine; Population; Hodgkin lymphoma; Non-Hodgkin's lymphoma; Epidemiology; Risk factor; Etiology; Oncology; Environmental health","score_opus":0.005941546187466647,"score_gpt":0.24532152094221069,"score_spread":0.23937997475474404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998892163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758506,0.0015249131,0.00003123795,0.00008066917,0.000008453221,0.000007512495,0.00014839311,0.0000033379981,0.0006104724],"genre_scores_gemma":[0.9988555,0.0005667577,0.000040835064,0.00004922555,0.00001421504,0.0000070241626,0.00010645493,0.0000014073414,0.00035863701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997681,0.0000838155,0.000015189428,0.000042624022,0.000049180435,0.000041152187],"domain_scores_gemma":[0.9994948,0.00014188298,0.00019898983,0.00002802386,0.000044929926,0.00009139083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041128136,0.00017692421,0.00019487018,0.0008459525,0.0003032786,0.00046343272,0.00025859475,0.0004685192,0.0012528552],"category_scores_gemma":[0.0014056131,0.0003578482,0.00022601873,0.0009908122,0.00024258022,0.00024899025,0.00020163109,0.0003136541,0.00020168068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008389696,0.000021023703,0.9981329,0.000006257151,0.0000277168,0.00007342957,0.00007751043,0.000014001026,0.000154632,0.000010881303,0.000043140844,0.0013545476],"study_design_scores_gemma":[0.000007505358,0.00007217037,0.9992803,0.00000831292,0.000021442911,0.00021732236,0.00010204848,0.00006175119,0.00003577725,0.000018295936,0.00017320021,0.0000019369663],"about_ca_topic_score_codex":0.009002344,"about_ca_topic_score_gemma":0.01038433,"teacher_disagreement_score":0.009002344,"about_ca_system_score_codex":0.00026794735,"about_ca_system_score_gemma":0.00016496127,"threshold_uncertainty_score":0.01789993},"labels":[],"label_agreement":null},{"id":"W1999458378","doi":"10.1038/sj.bjc.6604518","title":"Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Tissue microarray; Breast cancer; Cancer research; Estrogen receptor alpha; Breast carcinoma; Carcinogenesis; Estrogen receptor; Immunohistochemistry; Biology; Alpha (finance); Cancer; Pathology; Internal medicine; Medicine","score_opus":0.008742125638781696,"score_gpt":0.2522497094700075,"score_spread":0.24350758383122584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999458378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148387,0.005432007,0.0015726482,0.00012474714,0.000014802305,0.000012352959,0.0002968221,0.00007322073,0.0009895335],"genre_scores_gemma":[0.99443287,0.001990561,0.0009969742,0.000043444998,0.000014933178,0.000023217446,0.0005733181,0.000010717128,0.0019140545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990904,0.000011275879,0.000007756549,0.000023106064,0.000025194573,0.00002367048],"domain_scores_gemma":[0.99984527,0.000016060392,0.00007489514,0.000008994683,0.000022231889,0.00003255738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013155524,0.00021472736,0.00021110194,0.0005561634,0.0001921936,0.00030096938,0.00016470872,0.000261516,0.0012386652],"category_scores_gemma":[0.00017109305,0.00018535189,0.00018817042,0.0003564286,0.00021921287,0.00016104565,0.00015847504,0.0002963233,0.00057968934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044444337,0.000022742568,0.012354601,0.00010036463,0.000034317207,0.00052316836,0.0000847903,0.00006026218,0.9821555,0.0000830762,0.00019244215,0.0039443057],"study_design_scores_gemma":[0.00002744261,0.00028358985,0.6036158,0.00002091929,0.00012492128,0.0087385895,0.00032726722,0.0012596452,0.3758611,0.00017996112,0.009543827,0.000016940343],"about_ca_topic_score_codex":0.00035034324,"about_ca_topic_score_gemma":0.00034273934,"teacher_disagreement_score":0.0012386652,"about_ca_system_score_codex":0.00028815554,"about_ca_system_score_gemma":0.00008706769,"threshold_uncertainty_score":0.0041437745},"labels":[],"label_agreement":null},{"id":"W2000159893","doi":"10.1038/sj.bjc.6603579","title":"The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"DKK1; Breast cancer; Cancer; Wnt signaling pathway; Cancer research; Lung cancer; CA 15-3; Medicine; Biology; Internal medicine; Oncology; CA15-3; Pathology; Gene","score_opus":0.006650725839693632,"score_gpt":0.24461588944960352,"score_spread":0.23796516360990988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000159893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897249,0.006908878,0.001522786,0.000052439857,0.000009443437,0.000013441455,0.00079978205,0.000058100348,0.0009103413],"genre_scores_gemma":[0.99167144,0.0039305105,0.0016091003,0.000028848875,0.000011104131,0.000011388944,0.0012564763,0.000017764634,0.0014633829],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998111,0.00001933289,0.00002272278,0.000060626793,0.000048010996,0.000038136255],"domain_scores_gemma":[0.9996902,0.000033796103,0.00016441643,0.000029540692,0.000034990793,0.000047069185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017560537,0.00025007493,0.00034574742,0.0011221942,0.00022410334,0.00054137246,0.00011664996,0.00022168404,0.0012078718],"category_scores_gemma":[0.00031032428,0.00019671179,0.00022972103,0.0008444513,0.0002559264,0.000253524,0.00028369017,0.00024758175,0.00035097037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006435321,0.000015352603,0.09369382,0.0003199823,0.00010090347,0.0012315699,0.00017650587,0.00010291923,0.8866704,0.0001761791,0.00023677328,0.016632054],"study_design_scores_gemma":[0.000024805438,0.0002722654,0.68432313,0.000040878385,0.00025229287,0.01651181,0.00031568218,0.0005642403,0.28257588,0.00022394284,0.014867618,0.000027499807],"about_ca_topic_score_codex":0.0012606136,"about_ca_topic_score_gemma":0.0024079918,"teacher_disagreement_score":0.0012606136,"about_ca_system_score_codex":0.00042275403,"about_ca_system_score_gemma":0.00021174157,"threshold_uncertainty_score":0.004040718},"labels":[],"label_agreement":null},{"id":"W2000442055","doi":"10.1038/sj.bjc.6603837","title":"A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Colorectal cancer; Dietary iron; Medicine; Cohort; Heme; Hemochromatosis; Internal medicine; Cohort study; Cancer; Oncology; Physiology; Environmental health; Iron deficiency; Chemistry; Anemia; Biochemistry","score_opus":0.006531333075278448,"score_gpt":0.2719238950775675,"score_spread":0.26539256200228906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000442055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951416,0.0006669932,0.00023212744,0.00017117668,0.000022539354,0.00012673656,0.0026938028,0.000012962719,0.00093208917],"genre_scores_gemma":[0.9938415,0.00077120267,0.0006338818,0.00017629948,0.000023912593,0.00008435402,0.0019933644,0.000007766111,0.0024676085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994815,0.00006219162,0.000021291491,0.000109278226,0.00014034694,0.00018539511],"domain_scores_gemma":[0.99929523,0.00004291263,0.0001045131,0.00006442809,0.00024197233,0.00025097656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067160255,0.00056310295,0.0006679307,0.0010507116,0.0029839126,0.00072274095,0.0007745539,0.0006159598,0.0012210115],"category_scores_gemma":[0.0013227666,0.0007697766,0.00073242374,0.0029482308,0.00055734994,0.00030044015,0.0005052973,0.0009160911,0.00027515314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005914734,0.00012320935,0.99170846,0.000040562143,0.00032385334,0.000394127,0.000927035,0.000065480315,0.00096863107,0.00009314122,0.0012684257,0.0034955572],"study_design_scores_gemma":[0.00007557059,0.00013825853,0.99709356,0.000017311095,0.00012822679,0.0002035885,0.0003720843,0.00013896152,0.00006547098,0.000024112109,0.0017299873,0.000013033273],"about_ca_topic_score_codex":0.9266179,"about_ca_topic_score_gemma":0.94268715,"teacher_disagreement_score":0.9266179,"about_ca_system_score_codex":0.0054281685,"about_ca_system_score_gemma":0.007730869,"threshold_uncertainty_score":0.14762843},"labels":[],"label_agreement":null},{"id":"W2000457925","doi":"10.1038/bjc.2015.55","title":"Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Fondation pour la Recherche Nuovo-Soldati","keywords":"Erlotinib; Medicine; Gemcitabine; Placebo; Internal medicine; Randomized controlled trial; Pairwise comparison; Erlotinib Hydrochloride; Pancreatic cancer; Oncology; Cancer; Statistics; Alternative medicine","score_opus":0.15114447591656663,"score_gpt":0.4478693342757278,"score_spread":0.2967248583591612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000457925","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18937784,0.04639668,0.7366782,0.005772107,0.0031382956,0.008246281,0.0030492565,0.00056982855,0.0067716106],"genre_scores_gemma":[0.7714855,0.003265706,0.21544737,0.0016741778,0.0005314524,0.0060796165,0.00042045396,0.00019537157,0.0009002374],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.3868523,0.58470285,0.0075273793,0.007910508,0.011964203,0.0010427932],"domain_scores_gemma":[0.28008294,0.67762727,0.020962304,0.017883161,0.0027374434,0.0007068279],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.36512697,0.0037549837,0.007770313,0.0038065547,0.00069436803,0.002419759,0.0039536045,0.0032371355,0.005730203],"category_scores_gemma":[0.45586416,0.0010509659,0.02174554,0.003254752,0.004624994,0.004595233,0.0049500195,0.008431901,0.00035760214],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.080120094,0.0008474309,0.03349786,0.04568735,0.34450984,0.0026252712,0.003504014,0.1304425,0.007356612,0.05012413,0.005837946,0.29544696],"study_design_scores_gemma":[0.021409389,0.04879801,0.047963414,0.008712908,0.12187885,0.00325935,0.0013991297,0.24370249,0.012605918,0.4615071,0.027446415,0.0013169661],"about_ca_topic_score_codex":0.000856957,"about_ca_topic_score_gemma":0.0012209644,"teacher_disagreement_score":0.36512697,"about_ca_system_score_codex":0.0023845898,"about_ca_system_score_gemma":0.0018878101,"threshold_uncertainty_score":0.7829115},"labels":[],"label_agreement":null},{"id":"W2000968839","doi":"10.1038/bjc.2013.805","title":"Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Fonds NutsOhra","keywords":"Medicine; Breast cancer; Mastectomy; Odds ratio; Confidence interval; Genetic testing; Prophylactic Mastectomy; Randomized controlled trial; Genetic counseling; Cancer; Internal medicine; Prophylactic Surgery; Surgery; Gynecology","score_opus":0.010340221807835451,"score_gpt":0.27343468642933894,"score_spread":0.2630944646215035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000968839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742656,0.014585405,0.0007497733,0.0012421054,0.0012052339,0.005397784,0.00063170854,0.00008212019,0.001840272],"genre_scores_gemma":[0.9856602,0.003965609,0.0018143653,0.0008782746,0.0005488518,0.0058032363,0.00030229008,0.000010795309,0.0010163765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99524575,0.0033141111,0.00044354497,0.0004530747,0.00026699665,0.0002766438],"domain_scores_gemma":[0.99301827,0.004510351,0.0012525916,0.00028807297,0.00017691929,0.0007538323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045137033,0.0012196347,0.0036608465,0.00049546413,0.00038826908,0.0011808955,0.0011290906,0.0032490056,0.0076475777],"category_scores_gemma":[0.012412393,0.00066521746,0.0033474555,0.00064086163,0.00116494,0.0011391107,0.0006289545,0.0028254313,0.0004438296],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98294765,0.0029628596,0.00062111777,0.0018324173,0.0015162571,0.000031419524,0.000058868027,0.00019574212,0.00023510793,0.000050970913,0.00020354056,0.009344157],"study_design_scores_gemma":[0.9609785,0.03506038,0.0014781292,0.00019556787,0.0015975941,0.00001826294,0.000025782127,0.00024570234,0.000083857674,0.00010664038,0.00019635279,0.0000132467685],"about_ca_topic_score_codex":0.0021561298,"about_ca_topic_score_gemma":0.0026419407,"teacher_disagreement_score":0.0076475777,"about_ca_system_score_codex":0.0011496596,"about_ca_system_score_gemma":0.0017907292,"threshold_uncertainty_score":0.025583684},"labels":[],"label_agreement":null},{"id":"W2001071815","doi":"10.1038/sj.bjc.6603086","title":"Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council","keywords":"Anxiety; Medicine; Psychosocial; Psychological intervention; Cervical cancer; Hospital Anxiety and Depression Scale; Depression (economics); Psychiatry; Clinical psychology; Obstetrics; Cancer; Internal medicine","score_opus":0.009112005470159414,"score_gpt":0.2750419750220685,"score_spread":0.2659299695519091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001071815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979905,0.0007894644,0.000027373711,0.00016778028,0.0000050264653,0.00001929246,0.000061462466,0.0000024715482,0.0009366561],"genre_scores_gemma":[0.9995395,0.00024626788,0.000026440206,0.000036771697,0.00000939286,0.0000044435724,0.000032041506,3.585362e-7,0.0001046903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960655,0.00015668098,0.000026832498,0.000016542961,0.0001118153,0.00008171367],"domain_scores_gemma":[0.99871826,0.0004337311,0.00038291787,0.00002939299,0.000091792805,0.00034393903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004929056,0.000121920886,0.0002479654,0.00039698163,0.00036228084,0.00046532,0.00009509038,0.00022165802,0.0016975462],"category_scores_gemma":[0.003504534,0.000104398736,0.00024517003,0.00037109648,0.00026325538,0.00015702203,0.0002800996,0.00039106904,0.000093433984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049828907,0.0003284077,0.9793133,0.00009846154,0.00008621901,0.00033355123,0.00043363112,0.000052994583,0.0006099601,0.000035551544,0.00023227884,0.017977312],"study_design_scores_gemma":[0.000007084355,0.00035056256,0.99874336,0.000009560993,0.000028925717,0.00035819513,0.0002668364,0.000040943876,0.00003620217,0.000016345088,0.00013875171,0.0000032955993],"about_ca_topic_score_codex":0.0035711655,"about_ca_topic_score_gemma":0.0061034453,"teacher_disagreement_score":0.0035711655,"about_ca_system_score_codex":0.00027938507,"about_ca_system_score_gemma":0.00024471973,"threshold_uncertainty_score":0.007100761},"labels":[],"label_agreement":null},{"id":"W2001111741","doi":"10.1038/sj.bjc.6601254","title":"Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells","year":2003,"lang":"es","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Kamillo Eisner Stiftung; Oesterreichische Nationalbank; Austrian Science Fund","keywords":"Bcl-xL; Clonogenic assay; Apoptosis; Colorectal cancer; Cancer research; Cisplatin; Oligonucleotide; Programmed cell death; Cancer; Cancer cell; Biology; Chemotherapy; Gene; Biochemistry","score_opus":0.005848662692833701,"score_gpt":0.25097583574026416,"score_spread":0.24512717304743045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001111741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036354,0.0026230558,0.0039498797,0.0002223885,0.00010139593,0.000075374344,0.00033716022,0.00014046935,0.002186765],"genre_scores_gemma":[0.98131585,0.0032522813,0.0069708847,0.00015203899,0.00004315527,0.00010121551,0.00082590076,0.00003440894,0.0073042093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991035,0.0000137246925,0.000009798143,0.0000188528,0.00003198246,0.0000153188],"domain_scores_gemma":[0.9999192,0.000026579997,0.000021059097,0.000009543582,0.000010682782,0.000012849056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010240272,0.00022987177,0.00023944999,0.00013211869,0.00010393387,0.00018487268,0.00011564994,0.00019781437,0.0013659553],"category_scores_gemma":[0.000084436695,0.000112104026,0.00010538324,0.0001036254,0.00014965962,0.0001100395,0.00012041231,0.0004191204,0.00033310437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037918748,0.000015942214,0.000027184546,0.000020896076,0.0000015082913,0.000017065846,0.0000073673773,0.00002542959,0.9991167,0.000053055694,0.000028032928,0.0006489138],"study_design_scores_gemma":[0.000039810784,0.0006579991,0.00076287927,0.000004235656,0.000008476827,0.0001838311,0.000017147751,0.00045509203,0.99391395,0.00003326544,0.003920941,0.0000023223165],"about_ca_topic_score_codex":0.0006479362,"about_ca_topic_score_gemma":0.0013219134,"teacher_disagreement_score":0.0013659553,"about_ca_system_score_codex":0.00018646439,"about_ca_system_score_gemma":0.00016729377,"threshold_uncertainty_score":0.00456959},"labels":[],"label_agreement":null},{"id":"W2001272106","doi":"10.1038/bjc.2013.618","title":"Validation of the Children’s International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Canada Research Chairs; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Dental and Craniofacial Research; Canadian Institutes of Health Research; National Institutes of Health; World Health Organization","keywords":"Mucositis; Medicine; Construct validity; Respondent; Prospective cohort study; Pediatrics; Surgery; Chemotherapy","score_opus":0.014355359556321032,"score_gpt":0.3329554070576263,"score_spread":0.3186000475013052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001272106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839618,0.0036166804,0.0030957388,0.00040231468,0.00013243328,0.0011479456,0.001608878,0.000054004027,0.0059803072],"genre_scores_gemma":[0.98753464,0.0011328538,0.007382708,0.00014175083,0.000051697898,0.0010684711,0.002242456,0.000018301553,0.00042714796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9903278,0.003677675,0.0015256461,0.00068926753,0.0033496725,0.00042990022],"domain_scores_gemma":[0.97868836,0.0067903628,0.008215125,0.0009609914,0.0041270717,0.0012181266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014337266,0.0005084903,0.00063195045,0.001859786,0.0003917584,0.0008344122,0.0007305845,0.00061017985,0.0012709396],"category_scores_gemma":[0.03447005,0.00020703056,0.0010440601,0.0014598602,0.0009332907,0.0008876214,0.0016547707,0.0012346902,0.00031788254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021551676,0.00011484322,0.9767146,0.00019477021,0.00014255117,0.00006672287,0.00045016938,0.00035277815,0.00024452244,0.00011014124,0.00065291417,0.020740535],"study_design_scores_gemma":[0.000025565028,0.000535621,0.995965,0.00014598452,0.000042388852,0.00041097717,0.00033053663,0.00044858054,0.00024997635,0.000058265505,0.0017774035,0.000009712232],"about_ca_topic_score_codex":0.0029782169,"about_ca_topic_score_gemma":0.0046603116,"teacher_disagreement_score":0.014337266,"about_ca_system_score_codex":0.001047407,"about_ca_system_score_gemma":0.0015783566,"threshold_uncertainty_score":0.075823665},"labels":[],"label_agreement":null},{"id":"W2001293876","doi":"10.1038/sj.bjc.6600087","title":"Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hypoxia (environmental); Mitochondrion; Oxygen tension; Cell biology; Biology; Oxygen; Cell culture; Membrane potential; Cell; Inner mitochondrial membrane; Biochemistry; Chemistry; Genetics","score_opus":0.011131458195491481,"score_gpt":0.2350591613640777,"score_spread":0.22392770316858623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001293876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766123,0.0005566064,0.0008153781,0.000027925671,0.0000052102737,0.0000088055485,0.000361449,0.000019506904,0.00054381246],"genre_scores_gemma":[0.99763775,0.00028231388,0.0004492922,0.000019190787,0.000001914687,0.000011870667,0.0009621129,0.000008951856,0.0006266167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998672,0.000021056478,0.00002128324,0.000025784178,0.000041262065,0.000023354767],"domain_scores_gemma":[0.9998741,0.0000142581175,0.000031658365,0.000021419079,0.00002499885,0.000033467604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001144444,0.00013930493,0.00016577903,0.00031771229,0.0001380074,0.00025299398,0.00013179681,0.00018681408,0.0006380633],"category_scores_gemma":[0.00026325465,0.00009924212,0.00011766153,0.00029038556,0.00011494904,0.00012578422,0.00017196889,0.00015774701,0.00024821897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018333293,0.000018574103,0.0023806707,0.000014766062,0.000010242227,0.00009708598,0.00008444264,0.000053317628,0.99579877,0.000112742484,0.000034526696,0.0012115684],"study_design_scores_gemma":[0.00003699214,0.0012939821,0.19458762,0.000012424432,0.000067932684,0.0041578733,0.00049583067,0.0012763352,0.79242826,0.00035273883,0.005263847,0.000026189287],"about_ca_topic_score_codex":0.0017616693,"about_ca_topic_score_gemma":0.0018645835,"teacher_disagreement_score":0.0017616693,"about_ca_system_score_codex":0.0002239833,"about_ca_system_score_gemma":0.00008785869,"threshold_uncertainty_score":0.0035028458},"labels":[],"label_agreement":null},{"id":"W2002199128","doi":"10.1038/sj.bjc.6604895","title":"Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; University of Toronto; Pediatric Oncology Group of Ontario; American Lebanese Syrian Associated Charities","keywords":"Medicine; Socioeconomic status; Incidence (geometry); Demographics; Cumulative incidence; Pediatrics; Demography; Internal medicine; Environmental health; Population; Cohort","score_opus":0.010764385697023472,"score_gpt":0.3154169474961295,"score_spread":0.304652561799106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002199128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982862,0.00089956046,0.000025009303,0.00021970201,0.0000039233632,0.0000040967047,0.000194038,0.0000052933215,0.00036218643],"genre_scores_gemma":[0.99892634,0.0005980014,0.000039166553,0.000026407688,0.000014156224,0.000008810226,0.0003256739,0.0000015693942,0.000059784943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969685,0.000093637806,0.000045034212,0.00003060272,0.000079867874,0.000054002776],"domain_scores_gemma":[0.99899334,0.00011411275,0.00065925816,0.000026495181,0.00009116832,0.00011558049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032673345,0.00014341937,0.00018915802,0.00063718,0.0001483812,0.00038030613,0.00026134975,0.00017870529,0.0006677611],"category_scores_gemma":[0.0021391984,0.00012362022,0.00017854707,0.0007863475,0.00022530525,0.00017605604,0.00036684197,0.00032155792,0.000071781295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016379294,0.0000061481423,0.9983235,0.000011086114,0.000014769712,0.000072419716,0.0000663097,0.00007101106,0.000044142977,0.000015141409,0.00014369673,0.0012153824],"study_design_scores_gemma":[0.0000030367491,0.000017515713,0.99923885,0.000009156592,0.000006552651,0.00019393853,0.00014659295,0.00013813592,0.000026981052,0.000013578988,0.00020448097,0.0000011112043],"about_ca_topic_score_codex":0.01440887,"about_ca_topic_score_gemma":0.014425728,"teacher_disagreement_score":0.01440887,"about_ca_system_score_codex":0.00081746565,"about_ca_system_score_gemma":0.00042388335,"threshold_uncertainty_score":0.028649986},"labels":[],"label_agreement":null},{"id":"W2002555910","doi":"10.1054/bjoc.2001.2068","title":"No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"CDKN2A; Loss of heterozygosity; Cancer research; Head and neck cancer; Germline; Cancer; Germline mutation; Biology; Medicine; Oncology; Allele; Mutation; Pathology; Genetics; Gene","score_opus":0.004690030542003254,"score_gpt":0.226430711792654,"score_spread":0.22174068125065075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002555910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838376,0.0005542982,0.00005821859,0.000081412516,0.0000130567605,0.000006340531,0.000103771905,0.00000625001,0.0007929399],"genre_scores_gemma":[0.9993662,0.00016097286,0.000037152044,0.00004271841,0.000012902802,0.0000043807945,0.000082172686,0.0000025490879,0.00029093653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954563,0.000054056123,0.00004193218,0.00013707047,0.00011128733,0.00010993207],"domain_scores_gemma":[0.9987068,0.000352124,0.0003615098,0.00010504404,0.0001158173,0.00035875605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002582365,0.000341546,0.0004775292,0.0009732832,0.0007890411,0.0006003807,0.0003343946,0.0011461605,0.0051979693],"category_scores_gemma":[0.003961109,0.00040607803,0.0002658929,0.00077543344,0.0006408817,0.00044927196,0.00029381984,0.00044482434,0.000576623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028530942,0.000056157824,0.987847,0.000025270996,0.00005116438,0.005640648,0.00033239683,0.000049444297,0.0025528255,0.000058567683,0.00021876975,0.0028824094],"study_design_scores_gemma":[0.000056033932,0.0004545584,0.9470136,0.00001838613,0.00010821288,0.049823474,0.0004036683,0.00016224674,0.00081075693,0.00021533594,0.0009162733,0.000017393731],"about_ca_topic_score_codex":0.0043943822,"about_ca_topic_score_gemma":0.0046579055,"teacher_disagreement_score":0.0051979693,"about_ca_system_score_codex":0.00034626515,"about_ca_system_score_gemma":0.00048931927,"threshold_uncertainty_score":0.01738894},"labels":[],"label_agreement":null},{"id":"W2002561481","doi":"10.1038/bjc.2011.120","title":"Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; Women's College Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oophorectomy; Cancer; Internal medicine; Oncology; Family history; BRCA mutation; Mastectomy; Gynecology; Prophylactic Surgery; First-degree relatives; Obstetrics; Surgery; Hysterectomy","score_opus":0.007360750393747948,"score_gpt":0.24859131119566943,"score_spread":0.24123056080192148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002561481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991602,0.0005067236,0.00006370756,0.000027912818,0.000004986979,0.0000023439238,0.000052107844,0.000003407918,0.00017860736],"genre_scores_gemma":[0.9995951,0.00013684253,0.00006214147,0.000008893672,0.000010844494,0.000001718983,0.00009105478,0.0000015201427,0.000091919144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975234,0.00009060001,0.000015576878,0.00005140926,0.000046059024,0.000044026423],"domain_scores_gemma":[0.99836797,0.000464287,0.0007636712,0.000059841397,0.000072925,0.0002712476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006457167,0.0004028055,0.00029536404,0.0007090046,0.00024899477,0.00041842696,0.00021078858,0.00043838774,0.0016612618],"category_scores_gemma":[0.0031435515,0.0002081949,0.00034220357,0.00034645354,0.00029640042,0.00026648474,0.00034615,0.00038999383,0.00021873579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010010423,0.000010203117,0.9986578,0.0000041857456,0.00001557127,0.00010298033,0.000012730856,0.000045494875,0.00008771106,0.000007228369,0.000029488636,0.0009264122],"study_design_scores_gemma":[0.000010618921,0.00013256885,0.99684095,0.000010361595,0.00006421502,0.002016436,0.00007541892,0.00051515346,0.00011875566,0.000048438633,0.00016341818,0.000003697956],"about_ca_topic_score_codex":0.0027331158,"about_ca_topic_score_gemma":0.0021146578,"teacher_disagreement_score":0.0027331158,"about_ca_system_score_codex":0.00012949925,"about_ca_system_score_gemma":0.00028854702,"threshold_uncertainty_score":0.0055574775},"labels":[],"label_agreement":null},{"id":"W2002783201","doi":"10.1038/bjc.2012.366","title":"Projections of cancer prevalence in the United Kingdom, 2010–2040","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":448,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research; King's College London; Macmillan Cancer Support","keywords":"Medicine; Demography; Cancer registry; Cancer; Incidence (geometry); Population; Cancer incidence; Prostate cancer; Projections of population growth; Colorectal cancer; Quarter (Canadian coin); Lung cancer; Gerontology; Relative survival; Environmental health; Geography; Population growth; Pathology; Internal medicine","score_opus":0.049573930463883004,"score_gpt":0.3510223883193181,"score_spread":0.30144845785543506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002783201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7306114,0.026740769,0.05677664,0.017730594,0.00084666675,0.0002781038,0.12501837,0.0010195492,0.04097788],"genre_scores_gemma":[0.95008725,0.0074432148,0.0109892655,0.00065324036,0.000051266015,0.00024817057,0.026881749,0.000036494457,0.0036093858],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993166,0.00023991382,0.00008893649,0.00007891406,0.00017327542,0.00010234175],"domain_scores_gemma":[0.99866474,0.0002629169,0.00022259356,0.000037724065,0.0007061956,0.00010584699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001227937,0.0005173619,0.0002921411,0.0010211802,0.00020605004,0.00078726595,0.00046175928,0.0006997142,0.0045871176],"category_scores_gemma":[0.0038883698,0.00029514305,0.0012365868,0.000821157,0.0001732178,0.0011294553,0.0009860501,0.00055439584,0.0011984874],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015412159,0.00012737022,0.44981852,0.003930206,0.00095681276,0.0022391097,0.0013370195,0.30471224,0.003419678,0.011469905,0.09985235,0.120595485],"study_design_scores_gemma":[0.00025100357,0.0008252398,0.63045484,0.0023941095,0.00087420526,0.0053011295,0.0037009222,0.16855367,0.0021010197,0.010848376,0.1743629,0.00033262273],"about_ca_topic_score_codex":0.10620335,"about_ca_topic_score_gemma":0.07976645,"teacher_disagreement_score":0.10620335,"about_ca_system_score_codex":0.0034192384,"about_ca_system_score_gemma":0.0016468108,"threshold_uncertainty_score":0.21117038},"labels":[],"label_agreement":null},{"id":"W2002876811","doi":"10.1038/sj.bjc.6601147","title":"Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"University Health Network","keywords":"Epirubicin; Irinotecan; Cisplatin; Medicine; Solid tumor; Camptothecin; Chemotherapy; Oncology; Internal medicine; Cancer; Cyclophosphamide; Chemistry; Colorectal cancer","score_opus":0.008783136715454705,"score_gpt":0.28836142954853355,"score_spread":0.27957829283307883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002876811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933918,0.0024584206,0.0010242672,0.00018431684,0.000057641762,0.0015928035,0.00026038097,0.00008098336,0.000949443],"genre_scores_gemma":[0.988181,0.0023074234,0.0040385714,0.00041796506,0.00012379183,0.0021676752,0.0013306636,0.000037543472,0.0013953383],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99939346,0.00026652493,0.000028925559,0.00011455216,0.000100444406,0.00009609852],"domain_scores_gemma":[0.9992799,0.000086846994,0.00015362489,0.00005678064,0.000046758447,0.00037594297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011081944,0.0013104709,0.00285697,0.0004972327,0.00041071756,0.0006908328,0.000995513,0.000827041,0.0013204583],"category_scores_gemma":[0.00069985987,0.0006499221,0.00088119216,0.00063026,0.0009173799,0.00065521593,0.00035895163,0.0030361575,0.00047628494],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29946294,0.1440014,0.017430596,0.0011011435,0.0015511762,0.00089012994,0.0006934246,0.009581618,0.30377802,0.00052752864,0.004148523,0.21683353],"study_design_scores_gemma":[0.16618477,0.7894774,0.018015893,0.000031226733,0.00038699628,0.0009883017,0.00006967565,0.0023720248,0.017553559,0.00016736712,0.004717015,0.00003577511],"about_ca_topic_score_codex":0.00069736585,"about_ca_topic_score_gemma":0.0015134844,"teacher_disagreement_score":0.00285697,"about_ca_system_score_codex":0.0010229221,"about_ca_system_score_gemma":0.0015615722,"threshold_uncertainty_score":0.007421851},"labels":[],"label_agreement":null},{"id":"W2002931314","doi":"10.1038/sj.bjc.6600874","title":"Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Endoglin; Angiogenesis; Medicine; Colorectal cancer; Metastasis; CD34; Pathology; Internal medicine; Carcinoma; Gastroenterology; Cancer; Biology; Stem cell","score_opus":0.008583511918195627,"score_gpt":0.2547344994738327,"score_spread":0.24615098755563708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002931314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992557,0.00038343333,0.00012509423,0.000010364816,0.000002196303,0.0000023034231,0.000034231165,0.000004581551,0.00018196362],"genre_scores_gemma":[0.9995421,0.00009384975,0.00017559562,0.000009570784,0.000005887219,0.00000403144,0.000069444286,7.3401026e-7,0.000098920165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987423,0.000029161167,0.000012329022,0.000028367773,0.000030320789,0.000025618569],"domain_scores_gemma":[0.99967444,0.00009296774,0.00012459194,0.000016340055,0.000024151452,0.000067499444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014997105,0.00017488869,0.00022391965,0.00051264133,0.00017818854,0.00029777983,0.00006708118,0.00026951102,0.0010666101],"category_scores_gemma":[0.00046170247,0.0001532666,0.00009646729,0.00039209056,0.00018059071,0.00015658917,0.0001535526,0.00027881935,0.00017123618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006367787,0.00004527731,0.96182644,0.000029069979,0.00005254063,0.00029405876,0.00009917978,0.00008679645,0.031279687,0.00002515082,0.00009288732,0.0055320994],"study_design_scores_gemma":[0.000010871591,0.00032129348,0.99537224,0.000003321788,0.000028731689,0.0014074885,0.00006689102,0.00027044347,0.0022306591,0.000022256057,0.00026138988,0.000004360823],"about_ca_topic_score_codex":0.00041302916,"about_ca_topic_score_gemma":0.000603483,"teacher_disagreement_score":0.0010666101,"about_ca_system_score_codex":0.00015831117,"about_ca_system_score_gemma":0.000061053026,"threshold_uncertainty_score":0.0035681129},"labels":[],"label_agreement":null},{"id":"W2003048954","doi":"10.1038/bjc.2012.400","title":"International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostatectomy; Nomogram; Medicine; Logistic regression; Prostate cancer; Receiver operating characteristic; Disease; Watchful waiting; Gynecology; Internal medicine; Oncology; Cancer; Demography","score_opus":0.030629199984379022,"score_gpt":0.35476231148256393,"score_spread":0.3241331114981849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003048954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991468,0.00020979323,0.000038257083,0.00002823751,0.0000030486826,0.000024927216,0.0001844266,0.000001758009,0.00036265273],"genre_scores_gemma":[0.9996518,0.000044974542,0.000043090164,0.000018433626,0.000004572256,0.000011632553,0.00018425095,8.410118e-7,0.000040444615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992092,0.00031057143,0.000081597565,0.00015170698,0.00013247573,0.000114528964],"domain_scores_gemma":[0.9959096,0.0008570955,0.0017633919,0.00024288216,0.00052725576,0.00069987826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014149009,0.00026065248,0.00039441406,0.00064914767,0.00048980437,0.0006919186,0.00046185168,0.0004638459,0.0010506936],"category_scores_gemma":[0.005256754,0.00023297765,0.0004345895,0.0016897082,0.00045196913,0.00038086576,0.00052992377,0.00044410193,0.00014909799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012610728,0.000012510698,0.99922,0.0000075911257,0.000020473595,0.00003362413,0.00013309844,0.00001392177,0.000042243508,0.000006150026,0.000055121673,0.00032916866],"study_design_scores_gemma":[0.000011383978,0.00008923648,0.9994747,0.000005053908,0.000018963283,0.00009548374,0.00014830305,0.000051204624,0.000011505619,0.0000045307042,0.00008728902,0.0000023717819],"about_ca_topic_score_codex":0.031807885,"about_ca_topic_score_gemma":0.0297442,"teacher_disagreement_score":0.031807885,"about_ca_system_score_codex":0.0007071542,"about_ca_system_score_gemma":0.0007574643,"threshold_uncertainty_score":0.063245535},"labels":[],"label_agreement":null},{"id":"W2003394553","doi":"10.1038/bjc.2012.452","title":"Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"National Cancer Institute; McGill University","keywords":"MSH6; MSH2; MLH1; Ovarian cancer; Germline mutation; Lynch syndrome; Biology; Genetics; Population; Cancer; Germline; DNA mismatch repair; Colorectal cancer; Mutation frequency; Mutation; Oncology; Cancer research; Medicine; Gene","score_opus":0.01700810875316382,"score_gpt":0.3006949185728887,"score_spread":0.2836868098197249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003394553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899596,0.00022792735,0.00007441663,0.00006485171,0.000005134223,0.000007878066,0.00031954024,0.000002534315,0.0003017572],"genre_scores_gemma":[0.99951386,0.00010415435,0.000042928405,0.000034592307,0.000006716592,0.000010738254,0.000202222,0.0000013746511,0.00008351504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940205,0.00019696241,0.000048561134,0.00016092675,0.00012160486,0.00006979665],"domain_scores_gemma":[0.9988464,0.00033390938,0.00038935526,0.000091193506,0.00013054747,0.00020856273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005302444,0.000180667,0.0003517572,0.001101374,0.0005417993,0.00050611224,0.00035900777,0.0006164719,0.0017882346],"category_scores_gemma":[0.0030286224,0.0003127148,0.00018476995,0.0012098956,0.00043413712,0.00035053515,0.00037417462,0.00043302838,0.0003090117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003572104,0.00001634217,0.99905854,0.0000050738836,0.000022083286,0.000085019106,0.00009700147,0.0000112430625,0.00014374139,0.000009146439,0.000067963214,0.00044812748],"study_design_scores_gemma":[0.0000061676737,0.00006702028,0.9987919,0.0000040949203,0.000017069198,0.0006759993,0.0001711475,0.00006618441,0.000031688043,0.000014784747,0.00015117953,0.00000292316],"about_ca_topic_score_codex":0.0074772574,"about_ca_topic_score_gemma":0.005826684,"teacher_disagreement_score":0.0074772574,"about_ca_system_score_codex":0.00029882413,"about_ca_system_score_gemma":0.00024332751,"threshold_uncertainty_score":0.014867485},"labels":[],"label_agreement":null},{"id":"W2003411025","doi":"10.1038/sj.bjc.6603127","title":"Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of Nottingham","keywords":"Medicine; Gallbladder cancer; Gallbladder; Biliary tract; Gastroenterology; Intrahepatic bile ducts; Liver cancer; Bile duct; Internal medicine; Cancer registry; Incidence (geometry); Cancer; Bile duct cancer; Intrahepatic Cholangiocarcinoma; Population","score_opus":0.019393586575322783,"score_gpt":0.2717813328617017,"score_spread":0.2523877462863789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003411025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789571,0.004059158,0.0002659434,0.000589907,0.000058727026,0.000047567617,0.010697557,0.00003840354,0.00528574],"genre_scores_gemma":[0.9784694,0.0041752676,0.00037734373,0.0004605536,0.00005768483,0.00008575773,0.010610993,0.000016086562,0.005746816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990396,0.000139143,0.00024013135,0.00017357216,0.00025160678,0.00015593623],"domain_scores_gemma":[0.99821556,0.00014233279,0.0007362628,0.000059197882,0.00068996445,0.00015673788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005422232,0.00021447528,0.00038622663,0.002393666,0.00028352145,0.00072671776,0.00042815803,0.00045484872,0.002333901],"category_scores_gemma":[0.0024305673,0.00032978813,0.0005742695,0.0031720991,0.00025129746,0.0005050046,0.00064554956,0.0004523905,0.0010014118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020375455,0.00004423359,0.96846616,0.00088082795,0.00020787907,0.000684774,0.0013558561,0.000580366,0.0015588849,0.00019024295,0.005532821,0.020294175],"study_design_scores_gemma":[0.0000050697936,0.00002507346,0.99626935,0.000038898695,0.000014522619,0.00029184623,0.00015812585,0.00006128238,0.000066921624,0.0000056931735,0.0030574142,0.000005960014],"about_ca_topic_score_codex":0.21612708,"about_ca_topic_score_gemma":0.30400142,"teacher_disagreement_score":0.21612708,"about_ca_system_score_codex":0.0026778688,"about_ca_system_score_gemma":0.0009935441,"threshold_uncertainty_score":0.42973822},"labels":[],"label_agreement":null},{"id":"W2003704622","doi":"10.1038/bjc.2013.688","title":"Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Dermatology Foundation","keywords":"Melanoma; Cancer research; Protein kinase B; Medicine; PI3K/AKT/mTOR pathway; Eukaryotic initiation factor; Eukaryotic translation; Tissue microarray; Cell; Pathology; Biology; Immunohistochemistry; Signal transduction; Translation (biology); Cell biology","score_opus":0.004266176620538545,"score_gpt":0.2217760721020288,"score_spread":0.21750989548149025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003704622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98818666,0.00834336,0.001316348,0.000100733276,0.000033216085,0.00001737012,0.0003509205,0.00005225455,0.0015991029],"genre_scores_gemma":[0.9970323,0.001234494,0.00090403605,0.00001938125,0.000010242834,0.000009877473,0.00016138826,0.0000030498588,0.00062530517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999429,0.0000094025145,0.000005074269,0.000011760734,0.000014302898,0.000016493274],"domain_scores_gemma":[0.9999372,0.00000721142,0.000022935359,0.0000036821057,0.000010673218,0.000018293284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017395767,0.00035324995,0.0001293514,0.0003298727,0.00018456974,0.00029304298,0.00007803963,0.00019101887,0.0008672556],"category_scores_gemma":[0.00012517639,0.00011000741,0.00025501783,0.00016316291,0.00012059374,0.00017857226,0.00015953834,0.00021483345,0.00020505732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012855543,0.0001387572,0.02973338,0.00033620672,0.00006728167,0.00043557707,0.000037585272,0.000491473,0.95532113,0.00020977022,0.00033292646,0.011610421],"study_design_scores_gemma":[0.000082587954,0.0011413895,0.5122564,0.00006999871,0.00017452135,0.0018024037,0.00017906522,0.0058540995,0.47057107,0.00033298094,0.0075135296,0.000021948066],"about_ca_topic_score_codex":0.0003218763,"about_ca_topic_score_gemma":0.00040146208,"teacher_disagreement_score":0.0008672556,"about_ca_system_score_codex":0.00020566492,"about_ca_system_score_gemma":0.00016730222,"threshold_uncertainty_score":0.002901256},"labels":[],"label_agreement":null},{"id":"W2004303134","doi":"10.1038/bjc.2012.467","title":"Functional genomic screening to enhance oncolytic virotherapy","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Alberta Children's Hospital","funders":"","keywords":"RNA interference; Oncolytic virus; Virotherapy; Biology; Computational biology; Genome; Cancer; Bioinformatics; Gene; Genetics; RNA","score_opus":0.049016797144411296,"score_gpt":0.3897149546037802,"score_spread":0.3406981574593689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004303134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012812865,0.98784465,0.0043537924,0.0003528762,0.00030466952,0.000044306264,0.00005799091,0.000078800345,0.0056816386],"genre_scores_gemma":[0.006335449,0.9867133,0.002865676,0.000313773,0.00010358213,0.00004983195,0.000095400486,0.000012842492,0.003510129],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99974006,0.000046092115,0.000020027659,0.000043128955,0.000121999525,0.000028634395],"domain_scores_gemma":[0.99983466,0.000075727265,0.000021552733,0.000007958185,0.000045175624,0.000014865309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068173965,0.00097261573,0.0010726138,0.002396781,0.0002304254,0.00093980733,0.0009133318,0.0011438772,0.0023769452],"category_scores_gemma":[0.0005206411,0.00044771814,0.00047631946,0.0014478051,0.00067150756,0.00096798147,0.0005990435,0.0016650464,0.0019201081],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009171422,0.000183916,0.0001438424,0.008610559,0.000070665476,0.0004133602,0.0000725688,0.0012321364,0.028945848,0.009763957,0.014556602,0.9359148],"study_design_scores_gemma":[0.000038721933,0.0001883827,0.00065401435,0.00071682705,0.00007341856,0.0018772783,0.00003272839,0.00043316596,0.019647876,0.0023514314,0.97394866,0.000037464288],"about_ca_topic_score_codex":0.0007466791,"about_ca_topic_score_gemma":0.0011450223,"teacher_disagreement_score":0.002396781,"about_ca_system_score_codex":0.00094674504,"about_ca_system_score_gemma":0.00045960658,"threshold_uncertainty_score":0.007951677},"labels":[],"label_agreement":null},{"id":"W2004516600","doi":"10.1038/bjc.2014.164","title":"Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital","funders":"Ministry of Science and Technology of the People's Republic of China; Leukemia and Lymphoma Society","keywords":"Downregulation and upregulation; Apoptosis; Puma; Cancer research; Multiple myeloma; In vivo; Gene knockdown; Unfolded protein response; XBP1; Bortezomib; Endoplasmic reticulum; Dexamethasone; Doxorubicin; Biology; Medicine; Immunology; Chemotherapy; Internal medicine; Cell biology; RNA splicing; Biochemistry","score_opus":0.013532566386534968,"score_gpt":0.25949235392176534,"score_spread":0.24595978753523037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004516600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797968,0.011302085,0.0026905008,0.0003743573,0.00023874053,0.00013503552,0.00080773584,0.00039750055,0.004257262],"genre_scores_gemma":[0.99027985,0.0035741013,0.0021306232,0.00014676181,0.00006688259,0.00012275526,0.0013847818,0.000032079413,0.0022620296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978226,0.000050258677,0.00001794094,0.00003115265,0.000072255396,0.000046075467],"domain_scores_gemma":[0.99981767,0.000048445494,0.000044005417,0.00002456002,0.000018891149,0.00004652484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003055752,0.0004973977,0.0005083425,0.00050709466,0.00016444444,0.0003634731,0.00031705777,0.00043675408,0.002308614],"category_scores_gemma":[0.00024873283,0.00020443457,0.00043439295,0.00021763281,0.0002588945,0.0002370788,0.00017767718,0.0011303201,0.00078554277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008920172,0.00082736724,0.00022804867,0.00015677964,0.000040692605,0.00005583709,0.000020135389,0.0002039528,0.98997843,0.00011256502,0.0003654115,0.0071187406],"study_design_scores_gemma":[0.00022915751,0.007491662,0.0042725913,0.000016219472,0.000072430434,0.00038931204,0.000019310351,0.0008069403,0.98006433,0.000062875086,0.006566475,0.0000087799235],"about_ca_topic_score_codex":0.00022325643,"about_ca_topic_score_gemma":0.0005291235,"teacher_disagreement_score":0.002308614,"about_ca_system_score_codex":0.00027849895,"about_ca_system_score_gemma":0.00026429805,"threshold_uncertainty_score":0.0077230334},"labels":[],"label_agreement":null},{"id":"W2004861918","doi":"10.1038/bjc.2012.41","title":"HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Breast-conserving surgery; Breast cancer; Ductal carcinoma; Oncology; Radiation therapy; Internal medicine; Progesterone receptor; Immunohistochemistry; Mammary gland; Mastectomy; Cancer; Estrogen receptor","score_opus":0.009591687012722406,"score_gpt":0.2673764975972009,"score_spread":0.2577848105844785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004861918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932635,0.00042481182,0.00005665384,0.00003134214,0.00000239565,0.000003958299,0.000024052542,0.000002494507,0.00012802705],"genre_scores_gemma":[0.9997434,0.000094346826,0.000036235382,0.000006617191,0.000005480521,0.0000023273005,0.000052105057,7.6056523e-7,0.000058744357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998294,0.0000495058,0.000016999938,0.00002013056,0.00005147043,0.00003240749],"domain_scores_gemma":[0.9984269,0.0005784742,0.0006840867,0.000046875448,0.00009782418,0.00016574125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052177673,0.00012917219,0.00018037182,0.00030436364,0.00013494065,0.00024075576,0.0002020462,0.00020675577,0.0011425687],"category_scores_gemma":[0.0024823593,0.0000927255,0.00029857238,0.0002213252,0.00012706993,0.00015710814,0.00014486127,0.0002985969,0.000122002755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022941604,0.000029202742,0.9952867,0.000011746318,0.00003166547,0.00007412639,0.000022206255,0.00008000677,0.0003407766,0.0000038596377,0.000053657895,0.0038365969],"study_design_scores_gemma":[0.000009952519,0.00019525737,0.9981279,0.000006273581,0.0000663587,0.000682618,0.00006072836,0.00038225966,0.00032975976,0.000016897207,0.0001200381,0.0000020069058],"about_ca_topic_score_codex":0.0009816964,"about_ca_topic_score_gemma":0.0017588992,"teacher_disagreement_score":0.0011425687,"about_ca_system_score_codex":0.00018333092,"about_ca_system_score_gemma":0.00018797837,"threshold_uncertainty_score":0.003822267},"labels":[],"label_agreement":null},{"id":"W2005410969","doi":"10.1038/sj.bjc.6600609","title":"Choroid plexus tumours","year":2002,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Choroid plexus papilloma; Choroid plexus; Medicine; Papilloma; Choroid; Radiation therapy; Pathology; Carcinoma; Radiology; Internal medicine; Central nervous system; Biology","score_opus":0.047842467371327406,"score_gpt":0.35708976964753825,"score_spread":0.30924730227621083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005410969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.081461266,0.899531,0.001842876,0.0004558372,0.00034428734,0.0001846455,0.009219474,0.00006905722,0.0068915114],"genre_scores_gemma":[0.6483267,0.33736035,0.002091461,0.0006385288,0.00027480294,0.00025848323,0.0083399825,0.000036907993,0.0026727677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987268,0.00030895896,0.00024255115,0.0003071926,0.00033043284,0.000084132014],"domain_scores_gemma":[0.9979931,0.0010247305,0.00062990095,0.00015955989,0.0001357221,0.00005686674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00149965,0.0006900175,0.001362481,0.0019162311,0.00042519314,0.0009960064,0.0005088717,0.00040713744,0.0041479096],"category_scores_gemma":[0.004389981,0.00025377938,0.0038281276,0.0032238325,0.00033146155,0.00059442443,0.00044361915,0.0005369692,0.00046518398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065339836,0.000066350214,0.35203817,0.07103659,0.10083471,0.0042142724,0.0002107924,0.0029793005,0.0026385637,0.0020289472,0.01831645,0.4391019],"study_design_scores_gemma":[0.0017611136,0.0012372667,0.63336253,0.021752886,0.11551913,0.033660203,0.00051442697,0.0014128427,0.0037869567,0.0061601326,0.1807031,0.00012941285],"about_ca_topic_score_codex":0.0068008834,"about_ca_topic_score_gemma":0.012331511,"teacher_disagreement_score":0.0068008834,"about_ca_system_score_codex":0.000991863,"about_ca_system_score_gemma":0.0011348607,"threshold_uncertainty_score":0.01387614},"labels":[],"label_agreement":null},{"id":"W2005464272","doi":"10.1038/sj.bjc.6603389","title":"Familial breast cancer: management of ‘lower risk’ referrals","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Family history; Family medicine; Population; Quarter (Canadian coin); Cancer; Relative risk; Gynecology; Surgery; Environmental health; Internal medicine","score_opus":0.007194686131789714,"score_gpt":0.2718769470057392,"score_spread":0.2646822608739495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005464272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979514,0.009394839,0.0003984478,0.003397728,0.000084503976,0.00024162736,0.00007039285,0.000043912558,0.0068544215],"genre_scores_gemma":[0.99361056,0.0028502091,0.0010053886,0.0012146733,0.00016673708,0.00021849768,0.00013818798,0.0000047103763,0.0007909784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99883217,0.00077948143,0.00008914382,0.00008470778,0.00009053934,0.00012391487],"domain_scores_gemma":[0.9987219,0.00047562222,0.0003765321,0.00006016217,0.00007975317,0.0002859865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011435864,0.00017022637,0.0005121253,0.0004681872,0.0006806669,0.00029309103,0.00027730083,0.0006516094,0.0043601105],"category_scores_gemma":[0.0039363625,0.00011898783,0.00042501505,0.00061682344,0.00027893315,0.00032551092,0.00047497786,0.0005649234,0.00036398423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023406537,0.006244038,0.15424669,0.004725156,0.0004862099,0.0041986946,0.003769715,0.0017670279,0.0058538504,0.00079719786,0.016605305,0.7778996],"study_design_scores_gemma":[0.010380933,0.034504153,0.90082467,0.003067597,0.00067742134,0.012352989,0.003588692,0.0016231821,0.0016775479,0.0018987784,0.029290913,0.00011317117],"about_ca_topic_score_codex":0.004418504,"about_ca_topic_score_gemma":0.0072303778,"teacher_disagreement_score":0.004418504,"about_ca_system_score_codex":0.0006116775,"about_ca_system_score_gemma":0.0006574769,"threshold_uncertainty_score":0.014586031},"labels":[],"label_agreement":null},{"id":"W2005592863","doi":"10.1038/sj.bjc.6600424","title":"Cytostatic potential of novel agents that inhibit the regulation of intracellular pH","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Amiloride; Antiporter; Sodium–hydrogen antiporter; Intracellular pH; Extracellular; Clonogenic assay; Intracellular; Cytotoxicity; Chemistry; Pharmacology; Cell culture; Biochemistry; In vitro; Biology; Sodium; Membrane","score_opus":0.016065953527741143,"score_gpt":0.2316348415009436,"score_spread":0.21556888797320245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005592863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98428136,0.009543976,0.00104476,0.00013937628,0.00006948504,0.000110250025,0.00027496438,0.000078546735,0.0044572917],"genre_scores_gemma":[0.9853337,0.008721404,0.0025230935,0.00009564452,0.00006058243,0.00007399095,0.00054838386,0.000011745056,0.0026314103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999542,0.000006667329,0.000003887213,0.000008417529,0.000013188163,0.0000134782185],"domain_scores_gemma":[0.9999145,0.000023199345,0.000014257171,0.000007876156,0.000017635066,0.00002241813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010007164,0.0003112223,0.0003054101,0.000244176,0.00012090267,0.00024397703,0.00020915613,0.00028277747,0.0013721191],"category_scores_gemma":[0.00011919496,0.000067301145,0.00015955689,0.0001468341,0.00014744948,0.0001501797,0.00010844169,0.00043439955,0.00025322396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047151197,0.0001652164,0.00026030836,0.00013427234,0.000014701891,0.00011214381,0.000024466877,0.00023724006,0.98429227,0.00022479931,0.000119884055,0.0139432335],"study_design_scores_gemma":[0.00008701643,0.0021197177,0.0021635466,0.00001117561,0.000042596617,0.00033986892,0.000016870532,0.00049351604,0.9886291,0.000028237306,0.0060635153,0.0000048410166],"about_ca_topic_score_codex":0.00058916473,"about_ca_topic_score_gemma":0.0014713521,"teacher_disagreement_score":0.0013721191,"about_ca_system_score_codex":0.0002268642,"about_ca_system_score_gemma":0.00027631276,"threshold_uncertainty_score":0.0045902133},"labels":[],"label_agreement":null},{"id":"W2006122379","doi":"10.1038/sj.bjc.6605280","title":"KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre; St. Michael's Hospital; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Kallikrein; Ovarian cancer; Proportional hazards model; Ovarian carcinoma; Ovary; Oncology; Gene expression; Survival analysis; Internal medicine; Cancer; Biology; Medicine; Cancer research; Pathology; Gene; Enzyme; Genetics","score_opus":0.011050602803560914,"score_gpt":0.2696305466118003,"score_spread":0.2585799438082394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006122379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925154,0.00037472678,0.00011612619,0.000027426735,0.0000046535733,0.0000042173247,0.00008190727,0.0000060566717,0.00013339338],"genre_scores_gemma":[0.99948883,0.00008157246,0.00013686964,0.000008319398,0.0000057165576,0.0000048348866,0.00015043617,0.0000014168714,0.00012195968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998641,0.000026874937,0.000020223815,0.000023762532,0.00003794751,0.000027065553],"domain_scores_gemma":[0.99921894,0.00024367135,0.00027482174,0.000027342192,0.0000979879,0.00013723977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033225789,0.00017247022,0.00021881798,0.00042764263,0.00015183253,0.00031653768,0.0001666013,0.00034630988,0.0014760696],"category_scores_gemma":[0.0015240925,0.000101598045,0.00023940594,0.0003597804,0.00018160224,0.00016091012,0.0002418154,0.00029370672,0.0002227744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003061035,0.000013617833,0.99569666,0.000013361677,0.000018119115,0.00005654289,0.00001758456,0.00008223341,0.001341199,0.000004762599,0.00005899931,0.002390866],"study_design_scores_gemma":[0.000009397946,0.00009382933,0.99777526,0.0000034682882,0.00003454943,0.0006206574,0.00005480783,0.00050526817,0.0007113572,0.00002642462,0.00016271858,0.000002210007],"about_ca_topic_score_codex":0.00078561506,"about_ca_topic_score_gemma":0.0011779947,"teacher_disagreement_score":0.0014760696,"about_ca_system_score_codex":0.00018360067,"about_ca_system_score_gemma":0.00014990686,"threshold_uncertainty_score":0.0049380064},"labels":[],"label_agreement":null},{"id":"W2006367336","doi":"10.1038/sj.bjc.6604819","title":"A prospective study of peri-diagnostic and surgical wait times for patients with presumptive colorectal, lung, or prostate cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; Nova Scotia Cancer Centre; Cancer Care Nova Scotia; University of Ottawa; Hamilton Health Sciences; Dalhousie University","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Colorectal cancer; Prospective cohort study; Prostate cancer; Lung cancer; Referral; Cancer; Prostate; Confidence interval; Rectum; Internal medicine","score_opus":0.010746182329297254,"score_gpt":0.2801294330620345,"score_spread":0.2693832507327373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006367336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993481,0.00018246497,0.000022112852,0.000021441609,0.000003366417,0.000011797805,0.00021924777,8.0853357e-7,0.00019069352],"genre_scores_gemma":[0.99931455,0.00008143264,0.000062613784,0.000033903438,0.0000048819525,0.00001583952,0.00033749288,7.898844e-7,0.00014841523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995246,0.00008805945,0.000057880923,0.00010032909,0.00008982179,0.000139337],"domain_scores_gemma":[0.9967368,0.00052656536,0.0015553669,0.00014626955,0.00031552004,0.0007195363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049342785,0.00021319183,0.00027063675,0.00042014825,0.0008049667,0.000672415,0.00036848002,0.00034873723,0.001637203],"category_scores_gemma":[0.0032255645,0.0003222014,0.00032407264,0.0009467635,0.00032648712,0.0004576092,0.00035519607,0.0006961845,0.0003171687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014690835,0.000034901714,0.99918133,0.0000073058964,0.000012071307,0.00003544951,0.000095536765,0.000009542826,0.000043602355,0.0000062352415,0.000048130292,0.00037901988],"study_design_scores_gemma":[0.000013075752,0.0002207834,0.999041,0.00000562439,0.000012023623,0.00014662824,0.00031725116,0.000036150195,0.000017676615,0.000006162309,0.00017898079,0.0000045247752],"about_ca_topic_score_codex":0.09253385,"about_ca_topic_score_gemma":0.16351888,"teacher_disagreement_score":0.09253385,"about_ca_system_score_codex":0.0015305884,"about_ca_system_score_gemma":0.0017530326,"threshold_uncertainty_score":0.18399048},"labels":[],"label_agreement":null},{"id":"W2006709656","doi":"10.1038/sj.bjc.6603055","title":"Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Erlotinib; Medicine; Rash; Internal medicine; Colorectal cancer; Cancer; Epidermal growth factor receptor; Adverse effect; Oncology; Gastroenterology; Progressive disease; Phases of clinical research; Chemotherapy","score_opus":0.011757581329705306,"score_gpt":0.30578929820612233,"score_spread":0.29403171687641705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006709656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413174,0.0017996702,0.00046219927,0.00021859602,0.00007582409,0.0016236787,0.0005803858,0.000056757082,0.0010512015],"genre_scores_gemma":[0.9887299,0.0021169144,0.0013207665,0.0005057849,0.00017197407,0.0023901295,0.0021263675,0.000020323929,0.002617936],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996879,0.00014371156,0.000013680872,0.000043055938,0.00003483765,0.00007689567],"domain_scores_gemma":[0.9996145,0.000054068507,0.00005916427,0.000028423223,0.000031194777,0.00021266958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010222971,0.0015226362,0.0022082638,0.0003906543,0.00030821728,0.0006198457,0.0005150749,0.0007614379,0.0021852239],"category_scores_gemma":[0.00062591163,0.00050550833,0.0007531794,0.00034103275,0.0006459518,0.00041546172,0.00025584563,0.0014685001,0.0005656543],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6186276,0.07345847,0.018274853,0.0012477927,0.0014315917,0.0009113355,0.00033816835,0.004135467,0.10790319,0.00036704465,0.0048593082,0.16844529],"study_design_scores_gemma":[0.3582563,0.5991831,0.027239667,0.000028229751,0.00045189666,0.00066692627,0.00007042079,0.0017812637,0.00785981,0.000121241035,0.004304735,0.00003646365],"about_ca_topic_score_codex":0.0011106435,"about_ca_topic_score_gemma":0.0025014658,"teacher_disagreement_score":0.0022082638,"about_ca_system_score_codex":0.00075459655,"about_ca_system_score_gemma":0.0012836056,"threshold_uncertainty_score":0.007310331},"labels":[],"label_agreement":null},{"id":"W2006827588","doi":"10.1038/bjc.2014.497","title":"A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Medicine; Rash; Internal medicine; PI3K/AKT/mTOR pathway; Cancer; Oncology; Pharmacology; Biology; Signal transduction; Genetics","score_opus":0.006350034164310448,"score_gpt":0.2746686210074111,"score_spread":0.2683185868431006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006827588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946136,0.00076883135,0.00035406297,0.00021530886,0.00014009961,0.0019902582,0.0006327736,0.00005348417,0.0012315944],"genre_scores_gemma":[0.9903211,0.0009737018,0.0013323886,0.000512571,0.00017298851,0.0026836854,0.0014781471,0.000021070535,0.002504284],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995845,0.00014195283,0.000020839512,0.000106122854,0.000035870013,0.00011070691],"domain_scores_gemma":[0.99911577,0.00009813432,0.00019116988,0.00010167888,0.000038699534,0.00045449482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016261969,0.0021116291,0.001968582,0.00040783058,0.000331748,0.001253587,0.0010589971,0.0010835846,0.004164302],"category_scores_gemma":[0.00088822126,0.00063778396,0.0013798696,0.00038833736,0.0014086337,0.0009483592,0.00057366444,0.0031071482,0.0010624137],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9116564,0.038486663,0.0021074857,0.00031143706,0.0005286312,0.00007531503,0.00013262319,0.0017592437,0.017773129,0.00021378786,0.0010861062,0.025869254],"study_design_scores_gemma":[0.6405167,0.35048816,0.004232303,0.000013866906,0.00027615036,0.000111645335,0.000040400344,0.00074118277,0.0021636917,0.00016949298,0.0012251649,0.000021144971],"about_ca_topic_score_codex":0.00082979165,"about_ca_topic_score_gemma":0.0016232954,"teacher_disagreement_score":0.004164302,"about_ca_system_score_codex":0.0012377193,"about_ca_system_score_gemma":0.0016276675,"threshold_uncertainty_score":0.013930976},"labels":[],"label_agreement":null},{"id":"W2007476566","doi":"10.1038/sj.bjc.6600329","title":"CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Council Canada; Associazione Italiana per la Ricerca sul Cancro; Regione Calabria; Consiglio Nazionale delle Ricerche","keywords":"Apoptosis; Cancer research; Internal medicine; Medicine; Biology; Genetics","score_opus":0.01599779813696848,"score_gpt":0.24349139082618032,"score_spread":0.22749359268921185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007476566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204296,0.0020467218,0.0005356145,0.000065084954,0.00002280256,0.00002293702,0.00018035017,0.00004086857,0.005042662],"genre_scores_gemma":[0.9967734,0.0007833711,0.0005411494,0.00002855438,0.000023248045,0.000021545717,0.0003511557,0.000008507753,0.0014690459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997631,0.000039793238,0.000023423687,0.000028095883,0.00004849457,0.00009709284],"domain_scores_gemma":[0.9996619,0.000092049064,0.000085638945,0.0000201113,0.000075181306,0.000065033346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025166935,0.00026537827,0.00021920177,0.0014292499,0.0002874287,0.0005451428,0.00032692318,0.00046153195,0.0029614388],"category_scores_gemma":[0.000600575,0.00019242188,0.0001433491,0.0006894088,0.00027299376,0.00024690427,0.00029111322,0.0003775103,0.0004232359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027341626,0.00014392986,0.5987938,0.00029045393,0.00005288964,0.008120228,0.0008055971,0.0004640352,0.3342037,0.0010205164,0.0016600483,0.051710572],"study_design_scores_gemma":[0.000045598466,0.0008783615,0.8610232,0.00016545845,0.000120826044,0.042942572,0.0019412745,0.0018014302,0.06476067,0.00088741456,0.025401961,0.00003129552],"about_ca_topic_score_codex":0.0022833028,"about_ca_topic_score_gemma":0.0025319988,"teacher_disagreement_score":0.0029614388,"about_ca_system_score_codex":0.00039624545,"about_ca_system_score_gemma":0.00018221729,"threshold_uncertainty_score":0.009906948},"labels":[],"label_agreement":null},{"id":"W2007533011","doi":"10.1038/sj.bjc.6605603","title":"Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; McGill University","keywords":"Lung cancer; C-reactive protein; Medicine; Oncology; Cancer; Value (mathematics); Internal medicine; Pathology; Cancer research; Bioinformatics; Biology; Inflammation; Statistics; Mathematics","score_opus":0.0075983236790452624,"score_gpt":0.30493553638063153,"score_spread":0.29733721270158625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007533011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9196761,0.0011236187,0.076674744,0.000753807,0.000032439642,0.00005750116,0.00047582522,0.00019615956,0.0010097418],"genre_scores_gemma":[0.99684805,0.0000921125,0.002757356,0.000028934302,0.000008680829,0.000013333999,0.00012077836,0.000009987885,0.00012076972],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972133,0.0019994443,0.00008375638,0.0003171277,0.00021787763,0.00016842766],"domain_scores_gemma":[0.9868788,0.010394202,0.0012988226,0.00088920275,0.00028630393,0.0002526284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059582633,0.0008153862,0.00091551134,0.00072179147,0.00037600167,0.001294878,0.0007161833,0.0007219535,0.00084055046],"category_scores_gemma":[0.01843014,0.00033135983,0.0011161217,0.0007927918,0.0005979335,0.00071287865,0.0011379778,0.001106117,0.00017332983],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001480066,0.00024181181,0.25873953,0.00019244962,0.000723474,0.00059822894,0.0004249642,0.67443275,0.0018613966,0.003075238,0.0009818132,0.057248265],"study_design_scores_gemma":[0.000045571298,0.00041028942,0.059123375,0.000047116908,0.00012410586,0.00021537008,0.00009773844,0.93021786,0.00051530846,0.008631608,0.000532891,0.000038834158],"about_ca_topic_score_codex":0.008909287,"about_ca_topic_score_gemma":0.0059289276,"teacher_disagreement_score":0.008909287,"about_ca_system_score_codex":0.001037055,"about_ca_system_score_gemma":0.0012757787,"threshold_uncertainty_score":0.03151065},"labels":[],"label_agreement":null},{"id":"W2007806401","doi":"10.1038/sj.bjc.6604376","title":"Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Temsirolimus; Ketoconazole; Medicine; Pharmacology; Discovery and development of mTOR inhibitors; Chemistry; Antifungal; Dermatology","score_opus":0.010775008666487833,"score_gpt":0.27536502817667446,"score_spread":0.2645900195101866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007806401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982711,0.00091333146,0.00024510772,0.00004602426,0.000026843407,0.000019696094,0.000073214775,0.000023898781,0.00038074955],"genre_scores_gemma":[0.99917454,0.00022259995,0.0001732754,0.00005577607,0.000020147134,0.000011989422,0.00014363352,0.000005162698,0.00019280097],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996394,0.00011075343,0.000022404718,0.000068371955,0.00007137738,0.000087704975],"domain_scores_gemma":[0.99941754,0.00020124465,0.00013759416,0.0000504957,0.000051876832,0.00014134019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033296883,0.00028954018,0.00085311075,0.00012044147,0.00009531906,0.0004531654,0.00016842697,0.00034113223,0.0007458264],"category_scores_gemma":[0.0011773183,0.00013557028,0.00032664,0.00021251703,0.00029676408,0.00024483923,0.00012477169,0.0009796097,0.00014732707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17703357,0.0024785958,0.024192864,0.0002781776,0.00038451783,0.001399885,0.00041099553,0.0014762359,0.68894196,0.0001694804,0.0009031428,0.10233056],"study_design_scores_gemma":[0.0021227289,0.11875567,0.37371147,0.000045486322,0.00073050486,0.002830304,0.00026189676,0.012461364,0.4847502,0.00015657881,0.0041081635,0.000065700624],"about_ca_topic_score_codex":0.00083969993,"about_ca_topic_score_gemma":0.0010129001,"teacher_disagreement_score":0.00085311075,"about_ca_system_score_codex":0.00030182826,"about_ca_system_score_gemma":0.00033677442,"threshold_uncertainty_score":0.0024950504},"labels":[],"label_agreement":null},{"id":"W2007940855","doi":"10.1038/sj.bjc.6600939","title":"Characterisation of integrin-linked kinase signalling in sporadic human colon cancer","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; Bell (Canada)","funders":"National Cancer Institute; Cancer Research Society","keywords":"Integrin-linked kinase; Cancer research; Colorectal cancer; Kinase; Cancer; Biology; Oncogene; Medicine; Cell cycle; Internal medicine; Cell biology; Cyclin-dependent kinase 2","score_opus":0.032281339854553136,"score_gpt":0.3487986929386659,"score_spread":0.3165173530841128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007940855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997334,0.0014074711,0.00032201392,0.000028222832,0.0000039235324,0.000010064341,0.00021624519,0.0000180571,0.0006600668],"genre_scores_gemma":[0.9975809,0.00073433697,0.0004886544,0.00001999386,0.0000063354923,0.000013027884,0.0005751931,0.0000039778943,0.00057754485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999938,0.0000100965,0.000004449424,0.000010595885,0.000018413792,0.000018523557],"domain_scores_gemma":[0.9999068,0.000022580341,0.000020709864,0.000009081909,0.000016434678,0.000024337689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008572946,0.00013977248,0.00015292194,0.0006360833,0.00017672678,0.00023088924,0.000053925447,0.00018930092,0.00093192],"category_scores_gemma":[0.0002126804,0.00009699139,0.00011050575,0.00038205765,0.00012472042,0.00007636418,0.0001019869,0.00012620736,0.00025445974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040873318,0.000017476566,0.015125366,0.0000896792,0.000011267525,0.0011914314,0.00007271979,0.00008315735,0.97965,0.00006156506,0.000070756476,0.0032178895],"study_design_scores_gemma":[0.00009742487,0.0017685863,0.6524569,0.000028141543,0.00010604405,0.029710943,0.0005797182,0.0020954187,0.2990977,0.000254159,0.013784882,0.000020110705],"about_ca_topic_score_codex":0.0012327185,"about_ca_topic_score_gemma":0.0014402097,"teacher_disagreement_score":0.0012327185,"about_ca_system_score_codex":0.00016910926,"about_ca_system_score_gemma":0.00014962725,"threshold_uncertainty_score":0.0031175613},"labels":[],"label_agreement":null},{"id":"W2008309936","doi":"10.1038/bjc.2013.347","title":"NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Bone marrow; Cancer research; Cytokine; Homing (biology); Tumor necrosis factor alpha; Vascular endothelial growth factor; Lewis lung carcinoma; Medicine; Angiogenesis; Chemokine; Progenitor cell; Immunology; Biology; Immune system; Internal medicine; Stem cell; Cell biology; Cancer; Metastasis","score_opus":0.03179472477592168,"score_gpt":0.28317936001224736,"score_spread":0.2513846352363257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008309936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888508,0.004628773,0.003856308,0.00007237911,0.000051611667,0.000050434213,0.00023654244,0.00011254086,0.0021406503],"genre_scores_gemma":[0.9930583,0.0010530378,0.002919339,0.00003972325,0.000019677867,0.000034731296,0.00057717616,0.000015262334,0.002282786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984217,0.000032878783,0.000019352952,0.000029887751,0.00005297021,0.000022793634],"domain_scores_gemma":[0.999806,0.000049133636,0.00006269275,0.000032817014,0.000016624634,0.000032779666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015006088,0.0002157609,0.0002024776,0.000099991885,0.00006173944,0.00017112274,0.00015948007,0.0002516204,0.0012048928],"category_scores_gemma":[0.00016833915,0.000053728083,0.00011415798,0.0000827425,0.00018176196,0.00019846464,0.00008157672,0.00031107754,0.00042199547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004006043,0.00012393313,0.00022955854,0.00009324733,0.000005925129,0.00007798183,0.000013043658,0.0001071696,0.99447376,0.000072764735,0.00007816476,0.0043237875],"study_design_scores_gemma":[0.0000793647,0.001728757,0.001465912,0.000010794139,0.0000145458525,0.0010634364,0.000010571176,0.00061580155,0.9907703,0.000022802471,0.004215303,0.0000024240057],"about_ca_topic_score_codex":0.00019538608,"about_ca_topic_score_gemma":0.00035210178,"teacher_disagreement_score":0.0012048928,"about_ca_system_score_codex":0.00020299685,"about_ca_system_score_gemma":0.00013937481,"threshold_uncertainty_score":0.0040307045},"labels":[],"label_agreement":null},{"id":"W2008511767","doi":"10.1038/bjc.2011.402","title":"Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Ki-67; Internal medicine; Oncology; Breast cancer; Adjuvant chemotherapy; Chemotherapy; Gynecology; Lymph node; Cancer; Immunohistochemistry","score_opus":0.026595215300208325,"score_gpt":0.27327682555671606,"score_spread":0.24668161025650773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008511767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970029,0.0014117653,0.00029787974,0.000094480965,0.0000071830686,0.0000050166136,0.00006223609,0.000004894169,0.0011136666],"genre_scores_gemma":[0.9995987,0.00013422057,0.000056744288,0.00000903999,0.000006901269,0.0000020123696,0.000047719863,0.0000013180273,0.0001433419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995974,0.00014526989,0.000041562842,0.000057387475,0.00009991721,0.000058375586],"domain_scores_gemma":[0.99758685,0.000997884,0.0008932426,0.00010455216,0.00020861842,0.00020896728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007652766,0.00018518973,0.00023486874,0.0004929646,0.00014332627,0.00038590832,0.0001956109,0.00020821477,0.0025512339],"category_scores_gemma":[0.003014548,0.00012539227,0.00018585307,0.00043503608,0.00023571764,0.00015380845,0.0002745795,0.00028501995,0.00036090234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029701408,0.000013835884,0.9920352,0.00001932102,0.000056565274,0.00007654106,0.00002562306,0.00005881616,0.0017745291,0.000025806396,0.00007979029,0.0055369353],"study_design_scores_gemma":[0.0000045173197,0.0001266657,0.99751955,0.000006528638,0.00007908709,0.00090798107,0.000050945873,0.00014198487,0.0008211453,0.000038460363,0.00030080308,0.0000023457349],"about_ca_topic_score_codex":0.00092113647,"about_ca_topic_score_gemma":0.0013443629,"teacher_disagreement_score":0.0025512339,"about_ca_system_score_codex":0.00016006814,"about_ca_system_score_gemma":0.0001830572,"threshold_uncertainty_score":0.0085347295},"labels":[],"label_agreement":null},{"id":"W2008546211","doi":"10.1038/sj.bjc.6604746","title":"Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Gene signature; Proportional hazards model; Microarray; Microarray analysis techniques; Oncology; Breast cancer; Cancer; Multivariate statistics; Bioinformatics; Survival analysis; Biology; Medicine; Internal medicine; Computational biology; Gene expression; Computer science; Gene; Machine learning; Genetics","score_opus":0.026078401594578873,"score_gpt":0.3049250044833589,"score_spread":0.27884660288878005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008546211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943555,0.0016929181,0.00613863,0.00034821514,0.000029980813,0.000028495302,0.0014524048,0.00008224436,0.00079161813],"genre_scores_gemma":[0.9952656,0.00019667692,0.0026983325,0.000056907775,0.000036583122,0.000022905362,0.0016289523,0.000007581793,0.000086460015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965407,0.0014492493,0.00036297968,0.00074296136,0.0006512732,0.0002528615],"domain_scores_gemma":[0.978837,0.014929921,0.0027964811,0.0020143306,0.0010046563,0.000417468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063272216,0.00037783524,0.0010714184,0.002280083,0.0004364515,0.0017052467,0.00045203138,0.0009157499,0.0007352067],"category_scores_gemma":[0.020759411,0.0002080096,0.0005100403,0.0023350203,0.0005812121,0.0009344692,0.0008488423,0.0006186683,0.00026009962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019000539,0.00014823652,0.8991542,0.00019261528,0.0013710089,0.0002743166,0.00015190881,0.006420084,0.01839499,0.00024332972,0.00089480286,0.07085449],"study_design_scores_gemma":[0.00007671553,0.0005660375,0.96301985,0.000045118348,0.00088401284,0.0010304116,0.00020431231,0.023579689,0.00705362,0.0020862173,0.0013892798,0.00006459651],"about_ca_topic_score_codex":0.0006359069,"about_ca_topic_score_gemma":0.0010138019,"teacher_disagreement_score":0.0063272216,"about_ca_system_score_codex":0.0005073732,"about_ca_system_score_gemma":0.00042969667,"threshold_uncertainty_score":0.033461988},"labels":[],"label_agreement":null},{"id":"W2008601705","doi":"10.1054/bjoc.2001.1795","title":"Differential cell death response to photodynamic therapy is dependent on dose and cell type","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University","keywords":"Programmed cell death; Photodynamic therapy; Necrosis; Apoptosis; Cell; Cell type; Medicine; Cancer research; Pathology; Biology; Chemistry; Biochemistry","score_opus":0.018619768672443977,"score_gpt":0.3261069551576371,"score_spread":0.30748718648519313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008601705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917304,0.0027579055,0.0025969457,0.000073731404,0.00003100496,0.00003891802,0.00030128993,0.000044814322,0.002425057],"genre_scores_gemma":[0.994148,0.0012045623,0.0017186485,0.00005277372,0.000009383734,0.00005712091,0.00044693262,0.0000184694,0.00234412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995765,0.000098104334,0.000043968463,0.000070177695,0.00013435332,0.000076885786],"domain_scores_gemma":[0.9993376,0.0003193832,0.000065677865,0.00009554505,0.0001290228,0.000052759402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033277238,0.00021278081,0.0003762193,0.0003427529,0.0001983969,0.00035642638,0.00020285732,0.00041117962,0.0021168948],"category_scores_gemma":[0.00049192744,0.0001751983,0.00024588563,0.00027432726,0.00026368193,0.0002150429,0.00019770538,0.00044497402,0.0005419062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001745723,0.00002773969,0.0005379224,0.000038787945,0.000008771189,0.00003195204,0.000029218982,0.000051207706,0.99779475,0.00003976879,0.000022664282,0.001242565],"study_design_scores_gemma":[0.000013567463,0.00049180904,0.014865523,0.000009058104,0.000017262331,0.0003654626,0.000051828083,0.00024537308,0.98261684,0.00006349195,0.001254275,0.000005508866],"about_ca_topic_score_codex":0.0002907432,"about_ca_topic_score_gemma":0.00042253913,"teacher_disagreement_score":0.0021168948,"about_ca_system_score_codex":0.0002583412,"about_ca_system_score_gemma":0.00012481085,"threshold_uncertainty_score":0.0070816875},"labels":[],"label_agreement":null},{"id":"W2009497825","doi":"10.1038/bjc.2011.13","title":"Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Histone deacetylase inhibitor; Histone deacetylase; Medicine; Pharmacology; Internal medicine; Histone; Chemistry; Biochemistry","score_opus":0.023074027725210004,"score_gpt":0.392730181775085,"score_spread":0.369656154049875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009497825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918161,0.0026325698,0.0010146456,0.0003032182,0.000053168184,0.0015144177,0.0011029313,0.000100357414,0.001462584],"genre_scores_gemma":[0.9909995,0.0016899334,0.0019809545,0.00035280132,0.000064916,0.001188446,0.0019200336,0.000027427197,0.0017759465],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99972063,0.000104383835,0.00001721646,0.00005655336,0.000048535447,0.00005274722],"domain_scores_gemma":[0.9995467,0.000057809277,0.00012761274,0.000039528437,0.000042045594,0.00018622572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074298953,0.00115279,0.0015476857,0.00032774112,0.00039453027,0.00057167764,0.00053099444,0.0006341608,0.0024111564],"category_scores_gemma":[0.0005472463,0.0004316978,0.00070199376,0.0004493664,0.00065337983,0.00045969617,0.00028111888,0.0023169774,0.0007730924],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33449337,0.083087906,0.01962218,0.0013255161,0.0015829696,0.00081167853,0.0006556414,0.009019801,0.3302326,0.00036846957,0.0071225436,0.21167734],"study_design_scores_gemma":[0.113024406,0.8196191,0.036903158,0.000048514943,0.00054990785,0.0009334161,0.00008237706,0.0022077258,0.019800898,0.00021088426,0.0065787244,0.0000409948],"about_ca_topic_score_codex":0.0008298213,"about_ca_topic_score_gemma":0.0017503193,"teacher_disagreement_score":0.0024111564,"about_ca_system_score_codex":0.00080261304,"about_ca_system_score_gemma":0.001278875,"threshold_uncertainty_score":0.008066118},"labels":[],"label_agreement":null},{"id":"W2009692616","doi":"10.1038/sj.bjc.6600708","title":"Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Breast cancer; Genotype; Medicine; Internal medicine; Oncology; Glutathione S-transferase; Case-control study; Cancer; Alcohol consumption; Physiology; Gynecology; Alcohol; Glutathione; Biology; Genetics; Gene","score_opus":0.0076932823097798295,"score_gpt":0.24831744716643142,"score_spread":0.24062416485665158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009692616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575955,0.0033141195,0.00008765248,0.00012690248,0.000006969732,0.000010610073,0.0002768138,0.0000037458728,0.0004136489],"genre_scores_gemma":[0.99702364,0.0018429374,0.0002567979,0.000057638663,0.00002235464,0.000012208862,0.00033312207,0.0000022230215,0.000449097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961084,0.00016799502,0.000026883507,0.00006768866,0.000088269015,0.00003822397],"domain_scores_gemma":[0.9985378,0.0003577577,0.00076856115,0.000064801876,0.00013463882,0.00013640842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075630884,0.0002603013,0.0002140373,0.0011249064,0.0002706484,0.00043923745,0.00027732173,0.00034779147,0.0013634826],"category_scores_gemma":[0.0025340675,0.00025963408,0.00019415186,0.0015239989,0.0002935796,0.00021005727,0.00021761497,0.00032032852,0.00017800514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032828073,0.000028501658,0.9964922,0.00002718019,0.0001027926,0.00006948692,0.000054815922,0.0000691842,0.00056831306,0.000021885327,0.00008347723,0.0021538602],"study_design_scores_gemma":[0.0000091194715,0.0000742735,0.99925643,0.000011816901,0.000039105245,0.0001637356,0.000029385448,0.00008179347,0.00011315597,0.000023852683,0.0001952674,0.0000019982292],"about_ca_topic_score_codex":0.016494231,"about_ca_topic_score_gemma":0.018933255,"teacher_disagreement_score":0.016494231,"about_ca_system_score_codex":0.00041194865,"about_ca_system_score_gemma":0.00031742224,"threshold_uncertainty_score":0.032796502},"labels":[],"label_agreement":null},{"id":"W2010194189","doi":"10.1038/sj.bjc.6602092","title":"Reduced Apaf-1 expression in human cutaneous melanomas","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"National Cancer Institute; Canadian Dermatology Foundation","keywords":"Melanoma; Cancer research; Loss of heterozygosity; Cancer; Apoptosis; Immunohistochemistry; Tumor suppressor gene; Medicine; Pathology; Biology; Internal medicine; Gene; Carcinogenesis","score_opus":0.006537865322123385,"score_gpt":0.2581312182511441,"score_spread":0.25159335292902074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010194189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974275,0.0011873593,0.00071568496,0.000014053971,0.000005379513,0.0000075897237,0.00027145693,0.000016698054,0.00035428806],"genre_scores_gemma":[0.99748623,0.0006219291,0.0005882169,0.000014152515,0.0000049780733,0.000013655924,0.00051773153,0.0000038688686,0.0007491412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999107,0.000008764794,0.0000060451503,0.000027412783,0.000029994026,0.000016989814],"domain_scores_gemma":[0.9999006,0.000018194332,0.00003135124,0.000009951366,0.00001876927,0.00002124951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075595446,0.00012586341,0.00016939057,0.00043228024,0.00012942728,0.0002452944,0.000081112,0.00016577018,0.0012583853],"category_scores_gemma":[0.00016911895,0.000096074735,0.000117172916,0.0002832375,0.000093993935,0.00010626125,0.00009702145,0.00022745873,0.00026013658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001933484,0.000019997766,0.007852249,0.000039710918,0.000013252641,0.00014040034,0.00003818528,0.00002760892,0.9887061,0.000018952003,0.00003745114,0.0029127647],"study_design_scores_gemma":[0.0000145210015,0.00062288,0.50376946,0.000011866669,0.00007237376,0.00486174,0.00020451118,0.00079410395,0.48643768,0.00012039269,0.0030795408,0.0000110306455],"about_ca_topic_score_codex":0.00032241252,"about_ca_topic_score_gemma":0.00023879703,"teacher_disagreement_score":0.0012583853,"about_ca_system_score_codex":0.00009651062,"about_ca_system_score_gemma":0.00006766899,"threshold_uncertainty_score":0.0042096972},"labels":[],"label_agreement":null},{"id":"W2010201867","doi":"10.1038/bjc.2011.593","title":"CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Tumor progression; Carboplatin; Hazard ratio; Progression-free survival; Confidence interval; Internal medicine; Radiological weapon; Response Evaluation Criteria in Solid Tumors; Ovarian cancer; Chemotherapy; Cancer; Oncology; Surgery; Phases of clinical research; Cisplatin","score_opus":0.10808988722431266,"score_gpt":0.4141243571881464,"score_spread":0.3060344699638337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010201867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8351636,0.108042575,0.0019876922,0.029087933,0.0010826532,0.0027384986,0.00279356,0.00012679945,0.018976698],"genre_scores_gemma":[0.9612584,0.016003951,0.004910676,0.00817375,0.0009545352,0.0022911304,0.0036394077,0.000084370135,0.0026837548],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99051464,0.008018658,0.00027441938,0.0003600799,0.0005585958,0.00027356597],"domain_scores_gemma":[0.98926324,0.0060950536,0.0018825579,0.00071401795,0.0005867445,0.0014585266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01908829,0.00058267673,0.0012279734,0.00021953309,0.00027802913,0.001101651,0.00053619867,0.0015654266,0.0016551717],"category_scores_gemma":[0.017846173,0.00019456087,0.0013055053,0.0007602869,0.0007722449,0.00072632765,0.0005629207,0.0028365378,0.00025634814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6519873,0.002701728,0.024128675,0.0022883292,0.0050276984,0.0002302947,0.00046567703,0.0031013635,0.0048979437,0.0023464758,0.037763502,0.26506108],"study_design_scores_gemma":[0.77193874,0.08304435,0.071821816,0.0011197107,0.0034402022,0.00049464626,0.00017090833,0.0024640376,0.0016634444,0.0021647373,0.06158794,0.00008955157],"about_ca_topic_score_codex":0.0019155527,"about_ca_topic_score_gemma":0.0036897473,"teacher_disagreement_score":0.01908829,"about_ca_system_score_codex":0.0017449977,"about_ca_system_score_gemma":0.0016077765,"threshold_uncertainty_score":0.100949705},"labels":[],"label_agreement":null},{"id":"W2010336330","doi":"10.1038/sj.bjc.6600278","title":"A prospective cohort study of cigarette smoking and the risk of endometrial cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Endometrial cancer; Medicine; Prospective cohort study; Hazard ratio; Cohort study; Cohort; Breast cancer; Cancer; Gynecology; Proportional hazards model; Relative risk; Hormone replacement therapy (female-to-male); Cancer prevention; Internal medicine; Obstetrics; Oncology; Confidence interval","score_opus":0.015164301804682668,"score_gpt":0.28611859249425226,"score_spread":0.2709542906895696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010336330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98171,0.0048734704,0.003020262,0.0004991071,0.0002165837,0.0006190861,0.00713886,0.000046728994,0.0018758402],"genre_scores_gemma":[0.98429626,0.0032401732,0.0031324434,0.00030880596,0.00016613015,0.00070397084,0.0050463313,0.000021535003,0.0030843618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805343,0.00091233145,0.00018646836,0.00032865585,0.00033859714,0.00018052598],"domain_scores_gemma":[0.9966144,0.00073622336,0.00072153885,0.00089266984,0.00044197903,0.00059321895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033423968,0.0005412349,0.0009306396,0.0012013762,0.0013717734,0.000849516,0.0005838041,0.0008700519,0.0017034829],"category_scores_gemma":[0.007540383,0.0010418097,0.000956401,0.002659999,0.00041160887,0.0006206432,0.0007460525,0.0014619206,0.00046044914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020300022,0.00041735388,0.9848103,0.00018875068,0.0018896763,0.00042584448,0.00038497275,0.00011690738,0.0011068026,0.00037187582,0.0012417969,0.0070157046],"study_design_scores_gemma":[0.00040556592,0.00096146157,0.9919704,0.000061048675,0.0010009066,0.0008643281,0.00016298864,0.00028006677,0.00011355621,0.00019630768,0.0039617987,0.00002155429],"about_ca_topic_score_codex":0.012578995,"about_ca_topic_score_gemma":0.014431329,"teacher_disagreement_score":0.012578995,"about_ca_system_score_codex":0.00039834558,"about_ca_system_score_gemma":0.0014311117,"threshold_uncertainty_score":0.02501154},"labels":[],"label_agreement":null},{"id":"W2010490561","doi":"10.1038/sj.bjc.6606053","title":"Attenuated reovirus displays oncolysis with reduced host toxicity","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University; University of Calgary","funders":"National Cancer Institute; Fondation pour la Recherche Médicale; Canadian Institutes of Health Research; Terry Fox Foundation; University of Calgary","keywords":"Oncolytic virus; Biology; Virology; Cell culture; In vitro; Cancer cell; Pancreatic cancer; Cancer research; Virus; Cancer; Molecular biology","score_opus":0.009718381219689641,"score_gpt":0.30013185053712804,"score_spread":0.2904134693174384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010490561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909389,0.0013617387,0.005888057,0.000051712912,0.000021891194,0.000023744771,0.00023037114,0.00011371791,0.0013699579],"genre_scores_gemma":[0.99372125,0.00040583295,0.0031849395,0.0000193821,0.000007044128,0.000015733749,0.00067534245,0.00004083804,0.001929704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986994,0.000019415404,0.000011408415,0.000026363956,0.000043875796,0.00002891215],"domain_scores_gemma":[0.9998122,0.000054663313,0.00004991464,0.000027444716,0.000024147963,0.000031555133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012700827,0.00037385797,0.00022408411,0.00019062604,0.00007103688,0.0003498254,0.00019273697,0.00037832433,0.0008797663],"category_scores_gemma":[0.00017031452,0.00010074291,0.00021860152,0.00009872581,0.00020365519,0.00018132245,0.00013426872,0.0005177403,0.00030150558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050987725,0.000016253509,0.00006190125,0.000012747759,0.0000023353668,0.000016632428,0.00000434753,0.00007171959,0.999223,0.00005056735,0.000012235373,0.00047723835],"study_design_scores_gemma":[0.000008579178,0.00033826655,0.0007780001,0.0000031305058,0.000010066412,0.00022491619,0.0000053288636,0.0005470243,0.99701905,0.000023517878,0.0010399306,0.0000022531979],"about_ca_topic_score_codex":0.00036411177,"about_ca_topic_score_gemma":0.00032864316,"teacher_disagreement_score":0.0008797663,"about_ca_system_score_codex":0.00023744366,"about_ca_system_score_gemma":0.00014461162,"threshold_uncertainty_score":0.0029430985},"labels":[],"label_agreement":null},{"id":"W2010666032","doi":"10.1038/sj.bjc.6603043","title":"Towards third generation matrix metalloproteinase inhibitors for cancer therapy","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Matrix metalloproteinase inhibitor; Matrix metalloproteinase; Cancer; Tissue inhibitor of metalloproteinase; Drug; Pharmacology; Metalloproteinase; Medicine; Clinical trial; Cancer research; Internal medicine","score_opus":0.03517154971347457,"score_gpt":0.3501934623059883,"score_spread":0.3150219125925137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010666032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038542642,0.99440867,0.0014318068,0.000770622,0.00062324613,0.000013121491,0.000016919983,0.000033926164,0.0023161608],"genre_scores_gemma":[0.0023111615,0.9913052,0.0017625679,0.0006482248,0.00039070818,0.000029857994,0.000049298214,0.000007966586,0.003494897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996953,0.00005669189,0.000028827099,0.000049294053,0.00013403501,0.00003581526],"domain_scores_gemma":[0.9997012,0.00009668647,0.000047365418,0.000020230744,0.00009213806,0.00004244958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014955584,0.0011183508,0.0015751964,0.001864083,0.00031960465,0.0012940753,0.0013677302,0.001911148,0.004800431],"category_scores_gemma":[0.0006337306,0.00049091,0.0006573284,0.0012954491,0.0009290118,0.0024398318,0.0009457042,0.0035632302,0.0050382856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023794743,0.0001976757,0.00018742995,0.009187012,0.00011032413,0.00075098354,0.00014973589,0.0013718967,0.016168695,0.022024116,0.056887213,0.89272696],"study_design_scores_gemma":[0.000079543504,0.00013439689,0.00023440196,0.0008016512,0.000034068467,0.0018077596,0.000031121086,0.0002040682,0.0017997108,0.003806349,0.9910488,0.000018128585],"about_ca_topic_score_codex":0.0006453146,"about_ca_topic_score_gemma":0.0014001889,"teacher_disagreement_score":0.004800431,"about_ca_system_score_codex":0.0011752163,"about_ca_system_score_gemma":0.00081034296,"threshold_uncertainty_score":0.016059041},"labels":[],"label_agreement":null},{"id":"W2010741280","doi":"10.1038/sj.bjc.6601850","title":"Is there a role for chemotherapy in prostate cancer?","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mitoxantrone; Docetaxel; Medicine; Estramustine; Oncology; Chemotherapy; Internal medicine; Context (archaeology); Prostate cancer; Cancer; Clinical trial; Prednisone; Prostate; Cardiotoxicity; Paclitaxel; Prostate disease","score_opus":0.04388279243030324,"score_gpt":0.414976426730879,"score_spread":0.37109363430057574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010741280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025996074,0.9985808,0.000020313357,0.0009403759,0.00018264021,0.0000019565305,0.0000032282228,0.0000013685838,0.00024340732],"genre_scores_gemma":[0.0004650179,0.9983707,0.000049087488,0.00073824025,0.0002116481,0.0000037374127,0.0000046535747,9.841482e-7,0.00015600269],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999054,0.00043172666,0.00011944298,0.00011544595,0.0002331812,0.00004621523],"domain_scores_gemma":[0.99758387,0.0018331949,0.00026959533,0.000073892304,0.00017016224,0.00006929316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021720468,0.00071514386,0.0039502913,0.0013432852,0.0003648265,0.0016607036,0.0015316417,0.002887017,0.008190977],"category_scores_gemma":[0.0038062148,0.00041133096,0.0014455334,0.0021435583,0.0019146584,0.0032601971,0.00061260624,0.003553885,0.0019891774],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037752732,0.000058147234,0.00014927002,0.07189461,0.0005074856,0.00017090015,0.000100702135,0.00025449847,0.00030602264,0.007315565,0.040046215,0.87881905],"study_design_scores_gemma":[0.00035669527,0.0003632781,0.0014642223,0.06228747,0.00089084875,0.0014298965,0.0002198691,0.000077761884,0.0001418817,0.0076287007,0.92510694,0.000032425836],"about_ca_topic_score_codex":0.0030897653,"about_ca_topic_score_gemma":0.0052387123,"teacher_disagreement_score":0.008190977,"about_ca_system_score_codex":0.0015442704,"about_ca_system_score_gemma":0.0019121523,"threshold_uncertainty_score":0.027401567},"labels":[],"label_agreement":null},{"id":"W2010780607","doi":"10.1038/bjc.2012.542","title":"Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Partnership Against Cancer","funders":"Cancer Council Victoria; Partenariat Canadien Contre Le Cancer; Novo Nordisk Fonden; National Institute for Health and Care Research; Cancer Institute NSW; Tenovus; Medical Research Council; Public Health Agency; Cancer Research UK","keywords":"Benchmarking; General partnership; Cancer; Cancer survival; Medicine; Cancer genetics; Demography; Environmental health; Oncology; Internal medicine; Political science; Business; Sociology","score_opus":0.10633033644429923,"score_gpt":0.3607831343611841,"score_spread":0.25445279791688485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010780607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98938274,0.0026170728,0.00023023301,0.001192227,0.000042198877,0.000039282175,0.00096980913,0.0000062641616,0.00552008],"genre_scores_gemma":[0.99865794,0.0005185192,0.000118573975,0.0000788434,0.000003377265,0.00001527352,0.00037479607,0.0000021555252,0.0002305886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979773,0.00063525577,0.00020456352,0.00015545552,0.0006220279,0.0004053894],"domain_scores_gemma":[0.99500024,0.0010881074,0.0011896547,0.00015275499,0.0016052178,0.000963983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034302836,0.00010642329,0.00025819344,0.001020339,0.0007496714,0.001013333,0.00039645782,0.00024354846,0.0012737317],"category_scores_gemma":[0.010958833,0.00011892522,0.00028245494,0.0018214926,0.00054728176,0.0005066239,0.0009310973,0.00038111222,0.00007244794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054683343,0.000021247435,0.976851,0.00016251551,0.00006816838,0.00005459908,0.002562881,0.00012936087,0.000104332095,0.00022463356,0.0010264803,0.018740218],"study_design_scores_gemma":[0.0000020868397,0.000023796676,0.9960872,0.000104313986,0.000018356372,0.000038098595,0.0025791565,0.00008595155,0.000048993057,0.000035179037,0.0009707151,0.0000060259413],"about_ca_topic_score_codex":0.5071258,"about_ca_topic_score_gemma":0.49289775,"teacher_disagreement_score":0.4928742,"about_ca_system_score_codex":0.0029793468,"about_ca_system_score_gemma":0.0059880535,"threshold_uncertainty_score":0.99155366},"labels":[],"label_agreement":null},{"id":"W2011619648","doi":"10.1038/sj.bjc.6600654","title":"Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Medical Research and Materiel Command; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Tamoxifen; Oestrogen receptor; Breast cancer; Antiestrogen; Gene isoform; Mammary gland; Human breast; Internal medicine; Cancer research; Oncology; Medicine; Cancer; Biology; Endocrinology; Gynecology; Genetics; Gene","score_opus":0.0076214476503989464,"score_gpt":0.2557485524608742,"score_spread":0.24812710481047523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011619648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827135,0.0009877047,0.00021529081,0.000016802986,0.0000019581207,0.0000057435086,0.000047623103,0.000006800931,0.0004468231],"genre_scores_gemma":[0.9982494,0.0005542242,0.00015135975,0.000017913126,0.0000057754755,0.000009756805,0.00020238495,0.0000034311006,0.00080568186],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998534,0.000029387471,0.000016763139,0.00003413017,0.000037895243,0.000028376571],"domain_scores_gemma":[0.99961805,0.000115971416,0.00012549058,0.00004995285,0.00004787157,0.00004257128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017443667,0.00008423338,0.00015075,0.00047707444,0.00010680769,0.00018628205,0.00009950109,0.00023767629,0.0014180568],"category_scores_gemma":[0.00045744827,0.00011267902,0.00007939951,0.00023593642,0.00014086213,0.00014487702,0.00013716341,0.00017994855,0.00026807538],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001262666,0.00007355434,0.12699103,0.00007839219,0.000053805405,0.0010954881,0.00020039426,0.00011177771,0.85724705,0.00013339566,0.00007766391,0.012674775],"study_design_scores_gemma":[0.000021200633,0.0008684714,0.92894053,0.0000060271764,0.000048000144,0.0065304413,0.00015403348,0.000424632,0.06088799,0.000086586435,0.00202569,0.0000062677796],"about_ca_topic_score_codex":0.00028794573,"about_ca_topic_score_gemma":0.000312156,"teacher_disagreement_score":0.0014180568,"about_ca_system_score_codex":0.00011035706,"about_ca_system_score_gemma":0.000044223427,"threshold_uncertainty_score":0.004743874},"labels":[],"label_agreement":null},{"id":"W2011640324","doi":"10.1038/sj.bjc.6601301","title":"The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Ubiquitin ligase; Biology; Ubiquitin; Molecular biology; Immunoprecipitation; Complementary DNA; Nuclear protein; Cancer research; Psychological repression; Gene; Transcription factor; Gene expression; Biochemistry","score_opus":0.006848971644092133,"score_gpt":0.24331561688664946,"score_spread":0.23646664524255734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011640324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371946,0.0022134485,0.002300288,0.0001206287,0.00001777323,0.000010942087,0.0005158537,0.00010599777,0.0009955353],"genre_scores_gemma":[0.9915643,0.0010421629,0.002308538,0.00003234459,0.000008141334,0.000014410636,0.001432226,0.0000152329785,0.0035826878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998734,0.000019057561,0.000007925289,0.000027917404,0.00003705251,0.00003472946],"domain_scores_gemma":[0.99990046,0.000015656024,0.00003003906,0.000009730201,0.0000091159545,0.000035014076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113082344,0.00039439922,0.00026273684,0.00031983902,0.00022442002,0.00027018355,0.00013247342,0.00030048398,0.0012309126],"category_scores_gemma":[0.00013291893,0.00021119355,0.00017690515,0.00029897486,0.00018280325,0.00011148905,0.00014892095,0.00027234203,0.00077018235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009190006,0.000006413392,0.00079068635,0.000028458207,0.000007284491,0.00022407224,0.0000066917432,0.000039928225,0.9977448,0.000036166322,0.000064333464,0.00095928233],"study_design_scores_gemma":[0.000019847566,0.00012388216,0.04004168,0.0000052380087,0.00002693668,0.0032451332,0.00003874619,0.0011015632,0.9501265,0.00005575818,0.005208006,0.0000066571934],"about_ca_topic_score_codex":0.0011322809,"about_ca_topic_score_gemma":0.0016330502,"teacher_disagreement_score":0.0012309126,"about_ca_system_score_codex":0.00046157595,"about_ca_system_score_gemma":0.0001977146,"threshold_uncertainty_score":0.0041178465},"labels":[],"label_agreement":null},{"id":"W2012062654","doi":"10.1038/sj.bjc.6603067","title":"COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Breast Cancer Research Alliance","keywords":"Lymphangiogenesis; Cancer research; Breast cancer; Downregulation and upregulation; Angiogenesis; Cancer; Vascular endothelial growth factor C; Vascular endothelial growth factor; Biology; Medicine; Internal medicine; Vascular endothelial growth factor A; Endocrinology; Metastasis; VEGF receptors; Biochemistry","score_opus":0.006965603652572542,"score_gpt":0.2673795443986101,"score_spread":0.2604139407460376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012062654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98036975,0.013458914,0.0022310563,0.00016485895,0.0001059824,0.00009570084,0.00081878697,0.00004506516,0.0027099971],"genre_scores_gemma":[0.98416567,0.0066487296,0.0021303778,0.000094867944,0.00004557334,0.00011901477,0.00221408,0.000008706431,0.0045731077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998516,0.000041588606,0.000009740448,0.000015757818,0.000041173917,0.00004020287],"domain_scores_gemma":[0.9999455,0.000011547841,0.000008973924,0.000008299009,0.000012784428,0.000012972695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026290197,0.00023304495,0.0001889172,0.00027679687,0.0001238888,0.00019388879,0.00008343093,0.0001428802,0.0018068358],"category_scores_gemma":[0.00015328663,0.00011748372,0.00022159485,0.00022318836,0.000106647196,0.00010275212,0.00014544092,0.000324863,0.0005095454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044407818,0.00010640337,0.0008277087,0.00015292072,0.000011628852,0.00017169907,0.000024561341,0.000058708585,0.9941438,0.00009537891,0.00022557969,0.0037375719],"study_design_scores_gemma":[0.00007769467,0.0008830468,0.021593656,0.000016985983,0.00003796121,0.0013491933,0.000057854297,0.0010032221,0.9658274,0.000064822474,0.009081496,0.0000065395184],"about_ca_topic_score_codex":0.0009363305,"about_ca_topic_score_gemma":0.0013635572,"teacher_disagreement_score":0.0018068358,"about_ca_system_score_codex":0.0002987532,"about_ca_system_score_gemma":0.0002607002,"threshold_uncertainty_score":0.0060444474},"labels":[],"label_agreement":null},{"id":"W2012308231","doi":"10.1054/bjoc.2001.1822","title":"A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Follicular lymphoma; Medicine; Randomized controlled trial; Maintenance therapy; Chlorambucil; Follicular phase; Internal medicine; Lymphoma; Interferon alfa; Gastroenterology; Alpha interferon; Chemotherapy; Interferon; Surgery; Immunology; Cyclophosphamide","score_opus":0.008052774753800444,"score_gpt":0.28113286387969433,"score_spread":0.2730800891258939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012308231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97247756,0.012909719,0.0010376495,0.0021447658,0.0017559007,0.0065177283,0.0006873593,0.00015658382,0.002312812],"genre_scores_gemma":[0.9780009,0.0033345863,0.0025234951,0.0020296276,0.0011228923,0.010197228,0.0006803438,0.000018642237,0.0020923372],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972614,0.0020211197,0.00015727336,0.00023798354,0.00011649306,0.00020570318],"domain_scores_gemma":[0.9953731,0.0026150597,0.00071627216,0.00023969242,0.00015814143,0.00089782756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036494583,0.0012319819,0.0044769556,0.00050525164,0.00048972125,0.00083498406,0.0010580074,0.0030153936,0.0069989255],"category_scores_gemma":[0.0064871693,0.000591914,0.0018245444,0.0004710147,0.0013597471,0.0012136752,0.000468358,0.0034916857,0.00077769277],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9912048,0.0015181565,0.00031421328,0.00019711386,0.00030141152,0.000017057731,0.000013246042,0.00007831486,0.00029207484,0.00005108409,0.00016413878,0.0058483644],"study_design_scores_gemma":[0.95790297,0.040876407,0.00044460606,0.00002350735,0.00021102167,0.000015957407,0.0000072765856,0.00016237018,0.00007506786,0.00006502842,0.0002116178,0.0000043431996],"about_ca_topic_score_codex":0.00073926605,"about_ca_topic_score_gemma":0.0013703424,"teacher_disagreement_score":0.0069989255,"about_ca_system_score_codex":0.0008567268,"about_ca_system_score_gemma":0.001583357,"threshold_uncertainty_score":0.023413718},"labels":[],"label_agreement":null},{"id":"W2013102726","doi":"10.1038/bjc.2011.157","title":"Statistical issues in the use of dynamic allocation methods for balancing baseline covariates","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Ontario Clinical Oncology Group; McMaster University","funders":"","keywords":"Clinical trial; Credibility; Statistical inference; Baseline (sea); Covariate; Inference; Computer science; Medicine; Statistics; Artificial intelligence; Machine learning; Mathematics","score_opus":0.5326053452684013,"score_gpt":0.5987837027161158,"score_spread":0.0661783574477145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013102726","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016726336,0.004297368,0.97858894,0.010555438,0.0010976185,0.0010990555,0.00012587037,0.00022261374,0.0023404565],"genre_scores_gemma":[0.05844762,0.0020362244,0.91967475,0.0073302886,0.0013928332,0.009600165,0.00011618526,0.00038212008,0.001019765],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.19915043,0.7565068,0.016436078,0.006216149,0.021047514,0.00064310024],"domain_scores_gemma":[0.10530865,0.8456799,0.013354642,0.028216172,0.0069440925,0.0004966019],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.56965095,0.0026247706,0.0038068064,0.0042347633,0.0024841144,0.0077119414,0.006623646,0.006658885,0.0061950423],"category_scores_gemma":[0.80434686,0.0017756924,0.00396903,0.008017123,0.01800866,0.007823554,0.007822955,0.016757261,0.0018207862],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001639848,0.00016970547,0.003756643,0.003802691,0.0019374386,0.00035582756,0.0031478654,0.015219848,0.00058815867,0.63802004,0.019463882,0.31189814],"study_design_scores_gemma":[0.0007318077,0.0007894472,0.0016352596,0.002793218,0.0004305474,0.00063146686,0.00036600124,0.04886589,0.001364135,0.9020412,0.040167607,0.00018338568],"about_ca_topic_score_codex":0.0013275493,"about_ca_topic_score_gemma":0.0011131783,"teacher_disagreement_score":0.43034905,"about_ca_system_score_codex":0.0042872736,"about_ca_system_score_gemma":0.0073700696,"threshold_uncertainty_score":0.53069705},"labels":[],"label_agreement":null},{"id":"W2013426357","doi":"10.1038/bjc.2012.486","title":"An inherited NBN mutation is associated with poor prognosis prostate cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"Ministerstwo Edukacji i Nauki","keywords":"Prostate cancer; Medicine; CHEK2; Cancer; Prostate; Mutation; Nijmegen breakage syndrome; Allele; Internal medicine; Oncology; Genetics; Germline mutation; Biology; DNA damage; Gene; DNA","score_opus":0.02492486793701148,"score_gpt":0.34331637563185075,"score_spread":0.31839150769483926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013426357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994825,0.00024758687,0.000068573434,0.000014919657,0.0000025888353,0.0000020024665,0.000045328205,0.0000035518153,0.0001328896],"genre_scores_gemma":[0.99969375,0.00010459438,0.0000772955,0.000007378279,0.000004496028,0.0000012224484,0.000052643685,0.0000012504621,0.00005743276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977356,0.00003660775,0.00002362454,0.000076591125,0.000056357785,0.000033306347],"domain_scores_gemma":[0.99914455,0.00009554928,0.0005285599,0.00005507747,0.000055688663,0.00012051981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028230928,0.0002703933,0.00028051648,0.00059525156,0.00029134896,0.00026725366,0.00027380232,0.00027448608,0.0017397394],"category_scores_gemma":[0.0013177169,0.00015701035,0.00016127524,0.00056475465,0.00035218368,0.00014968333,0.00029651943,0.0002847603,0.00015603146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018249007,0.000016504468,0.9954666,0.000016009224,0.00004728918,0.00038256758,0.000037423913,0.00003456716,0.0018521528,0.000015027202,0.00005697966,0.0018924929],"study_design_scores_gemma":[0.000008271155,0.000051973773,0.9969145,0.0000067077235,0.00003478088,0.0023983354,0.00004453802,0.00008814458,0.00027867366,0.00002660108,0.00014508559,0.0000022980964],"about_ca_topic_score_codex":0.0038553653,"about_ca_topic_score_gemma":0.0039814683,"teacher_disagreement_score":0.0038553653,"about_ca_system_score_codex":0.00022018356,"about_ca_system_score_gemma":0.00022506736,"threshold_uncertainty_score":0.0076658726},"labels":[],"label_agreement":null},{"id":"W2014664970","doi":"10.1038/bjc.2013.675","title":"Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Fondation du cancer du sein du Québec","keywords":"Breast cancer; Focal adhesion; Cancer; Metastasis; Cancer cell; Cancer research; In vivo; Chemistry; Motility; Cell migration; Integrin; Cell biology; Cell; Pathology; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.010636584766940753,"score_gpt":0.27809688696001783,"score_spread":0.2674603021930771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014664970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066764,0.0059737745,0.001270994,0.00011861215,0.000024813613,0.00003460248,0.00017499541,0.00008384369,0.0016507612],"genre_scores_gemma":[0.9949498,0.0025135104,0.0012398969,0.000030010668,0.000012723881,0.000024992654,0.0001594006,0.000011455092,0.0010582642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999305,0.000015062032,0.000005380396,0.000012621505,0.000019127625,0.000017332937],"domain_scores_gemma":[0.99986756,0.000048062266,0.000038845254,0.000017681608,0.000011166965,0.000016576612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011993319,0.00026447602,0.00023678625,0.0001976068,0.0001114581,0.00017449341,0.00017554946,0.00023524144,0.0009940634],"category_scores_gemma":[0.0001379082,0.000083730374,0.00013493306,0.00011338585,0.00013807187,0.00012697086,0.00011415035,0.00039703838,0.00016201568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017604939,0.00004776147,0.00011320335,0.000071581424,0.0000053461417,0.00007727562,0.00001872356,0.00019124421,0.9956227,0.00007018144,0.000056455552,0.00354956],"study_design_scores_gemma":[0.000024449248,0.0008588475,0.0013930982,0.000005945339,0.000016194184,0.00035130032,0.0000121180165,0.0004774229,0.99409026,0.000024623529,0.0027417191,0.0000039237875],"about_ca_topic_score_codex":0.0004179926,"about_ca_topic_score_gemma":0.0006952132,"teacher_disagreement_score":0.0009940634,"about_ca_system_score_codex":0.0001569457,"about_ca_system_score_gemma":0.00013189651,"threshold_uncertainty_score":0.0033254623},"labels":[],"label_agreement":null},{"id":"W2015481921","doi":"10.1038/bjc.2011.260","title":"Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Stromal cell; Cancer research; Cancer cell; Cancer; Zymography; Biology; Cell; Pathology; Matrix metalloproteinase; Medicine; Chemistry; Internal medicine","score_opus":0.008656387187380035,"score_gpt":0.24197327331071763,"score_spread":0.2333168861233376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015481921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98612887,0.0088728815,0.00203657,0.00014968448,0.000100321435,0.000051992098,0.0005047089,0.00010471628,0.0020503167],"genre_scores_gemma":[0.986741,0.005721156,0.0024100086,0.00009230123,0.000038543938,0.000112340604,0.0011867718,0.000020533138,0.0036772573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989104,0.00002098301,0.000009181724,0.000015075405,0.000027073665,0.000036666457],"domain_scores_gemma":[0.9999318,0.00001873407,0.000016389262,0.00000965306,0.000008803196,0.000014687176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013642409,0.00032339702,0.0003060595,0.0001641961,0.000085020205,0.0001467136,0.00014717024,0.00017052657,0.0022679316],"category_scores_gemma":[0.000093891904,0.00010928827,0.00037785634,0.00011661003,0.00011515146,0.000094896706,0.00010806595,0.0005053761,0.00041724497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047205685,0.00012893131,0.00012464933,0.0001116394,0.000012845946,0.000043885,0.000016020951,0.00005083016,0.99738413,0.00003512625,0.00010889977,0.001511071],"study_design_scores_gemma":[0.000058788617,0.001596868,0.0047009974,0.00001760113,0.00003397139,0.00027906516,0.000021122867,0.00050589285,0.9895773,0.000023236662,0.0031799306,0.0000053401627],"about_ca_topic_score_codex":0.0003683343,"about_ca_topic_score_gemma":0.0007382062,"teacher_disagreement_score":0.0022679316,"about_ca_system_score_codex":0.00012425367,"about_ca_system_score_gemma":0.00021319001,"threshold_uncertainty_score":0.007586956},"labels":[],"label_agreement":null},{"id":"W2015690088","doi":"10.1038/sj.bjc.6601682","title":"Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Autocrine signalling; Cancer research; Receptor tyrosine kinase; Receptor; Cell growth; Insulin-like growth factor; Growth factor; Apoptosis; Stem cell factor; Tyrosine kinase; Biology; Signal transduction; Cell biology; Stem cell; Biochemistry; Progenitor cell","score_opus":0.008516542123459677,"score_gpt":0.27185778807605315,"score_spread":0.26334124595259345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015690088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932619,0.0021963501,0.0009992555,0.000120611796,0.000054033608,0.00006398465,0.00026343964,0.000102924765,0.0029375604],"genre_scores_gemma":[0.99461704,0.00092730194,0.001688232,0.000046641653,0.00001631509,0.000045594017,0.00029101787,0.000012821344,0.0023549597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979705,0.00003560679,0.000017200953,0.000023037624,0.0000670679,0.000060097955],"domain_scores_gemma":[0.9998926,0.000022093673,0.000017069964,0.000016413753,0.000010131323,0.000041749267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016925109,0.0004342162,0.0007062821,0.00038019556,0.00019699334,0.00026901244,0.00023948538,0.00029222915,0.0010391194],"category_scores_gemma":[0.00011704975,0.00019201501,0.0003096118,0.0003403221,0.00021800997,0.00015959021,0.00032544544,0.00051671756,0.0003714044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009647855,0.0002570798,0.00053325406,0.00010374242,0.000046934114,0.00024342844,0.000034555404,0.000397418,0.9887841,0.000121598016,0.00038913183,0.008124041],"study_design_scores_gemma":[0.00022197535,0.002922423,0.0051021213,0.000008638653,0.00008425057,0.0007533811,0.00003479346,0.001726645,0.9854374,0.000037534544,0.003661586,0.000009186147],"about_ca_topic_score_codex":0.0013287182,"about_ca_topic_score_gemma":0.0037223876,"teacher_disagreement_score":0.0013287182,"about_ca_system_score_codex":0.00031503628,"about_ca_system_score_gemma":0.00036669793,"threshold_uncertainty_score":0.0034762025},"labels":[],"label_agreement":null},{"id":"W2015753784","doi":"10.1038/bjc.2013.732","title":"Breast cancer survival and prognosis by screening history","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Internal medicine; Cancer; Oncology; Survival analysis; Breast cancer screening; Survival rate; Disease; Gynecology; Mammography","score_opus":0.052734457417432504,"score_gpt":0.31101139877082945,"score_spread":0.25827694135339696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015753784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975721,0.00074606563,0.000026398258,0.00010580624,0.000002945325,0.0000022101915,0.00040217026,0.000003699003,0.0011385634],"genre_scores_gemma":[0.999546,0.00012931987,0.000011355989,0.000007352774,0.0000026255755,6.988136e-7,0.00018853543,6.982753e-7,0.00011328109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978,0.00003182496,0.000012647799,0.000032682547,0.000050847313,0.0000919615],"domain_scores_gemma":[0.9986314,0.00028299636,0.00056673354,0.00004025038,0.00017775044,0.0003007578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028941873,0.00013462114,0.0001642058,0.0008316189,0.00027640947,0.0004008737,0.00019551467,0.0002264143,0.0026731216],"category_scores_gemma":[0.0022947327,0.00008324625,0.00019134134,0.0009579559,0.00043587317,0.00019798118,0.0002733469,0.00027156572,0.00021175854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054629127,0.000003585569,0.99796695,0.000007210821,0.0000178363,0.00006961717,0.000059834707,0.00009782033,0.000068665104,0.000013263439,0.00010184965,0.0015387317],"study_design_scores_gemma":[9.317749e-7,0.0000151114045,0.99947244,0.0000072869866,0.000008136674,0.00020116955,0.00005389918,0.000076958764,0.000019586012,0.000016247692,0.00012662231,0.0000017295124],"about_ca_topic_score_codex":0.10803913,"about_ca_topic_score_gemma":0.14054385,"teacher_disagreement_score":0.10803913,"about_ca_system_score_codex":0.0010153735,"about_ca_system_score_gemma":0.00060211105,"threshold_uncertainty_score":0.21482056},"labels":[],"label_agreement":null},{"id":"W2015943054","doi":"10.1038/bjc.2014.418","title":"Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pancreatic cancer; Malignancy; BRCA mutation; Internal medicine; Oncology; Adenocarcinoma; Stage (stratigraphy); Cancer; Pancreatic ductal adenocarcinoma; Gastroenterology; Breast cancer; Biology","score_opus":0.029042815528843104,"score_gpt":0.38768398371729446,"score_spread":0.3586411681884514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015943054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939334,0.00023406865,0.000019062876,0.000014620253,0.0000019924971,0.000002379795,0.0001908395,0.0000015534788,0.00014208142],"genre_scores_gemma":[0.9995202,0.000065982764,0.000021924756,0.000007369158,0.0000042336283,0.0000035654327,0.00032379507,8.4345675e-7,0.000051931613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997718,0.00003966276,0.00003160252,0.000072938805,0.00003228624,0.000051789717],"domain_scores_gemma":[0.9989102,0.00024079712,0.0004645932,0.000038821974,0.00007148418,0.0002741563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006917208,0.00020302586,0.00029708084,0.0013088351,0.00027008745,0.0004989666,0.00023945935,0.0004516287,0.0016226728],"category_scores_gemma":[0.0021826895,0.0001562637,0.00033662884,0.00085214793,0.00027401673,0.00046162173,0.00041970934,0.00031449492,0.00024968418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001790465,0.000010334728,0.9987305,0.0000042680103,0.000017613847,0.00011491479,0.000029046641,0.00002881862,0.00013827476,0.0000040156083,0.000035383033,0.0007078014],"study_design_scores_gemma":[0.0000046377195,0.00011952511,0.99890804,0.00000390594,0.000022418068,0.00062386034,0.00010958434,0.000070064576,0.000040147926,0.00001745586,0.00007829414,0.0000022056504],"about_ca_topic_score_codex":0.0012796426,"about_ca_topic_score_gemma":0.0010497031,"teacher_disagreement_score":0.0016226728,"about_ca_system_score_codex":0.00026169958,"about_ca_system_score_gemma":0.00017322093,"threshold_uncertainty_score":0.005428374},"labels":[],"label_agreement":null},{"id":"W2016203746","doi":"10.1038/sj.bjc.6605051","title":"Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunology; Medicine; Immune system; Chemotherapy; Immunity; Mesenteric lymph nodes; Cellular immunity; Internal medicine","score_opus":0.027220027059184287,"score_gpt":0.3052629971746325,"score_spread":0.2780429701154482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016203746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998278,0.0005321981,0.00051516085,0.000049880793,0.000027600934,0.000023418645,0.00016017666,0.000050117254,0.0003634892],"genre_scores_gemma":[0.99582833,0.00068812404,0.00082833436,0.000044025765,0.00001811263,0.000051889525,0.0003394276,0.000016939048,0.0021847466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983215,0.00001931568,0.000012319031,0.000032360946,0.000033422435,0.00007054576],"domain_scores_gemma":[0.9996302,0.00002997206,0.00010963073,0.000040719337,0.000041367755,0.00014815011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012735682,0.0005206979,0.00058584946,0.00036837818,0.00014918874,0.00020610937,0.00021345403,0.00031477,0.0014997649],"category_scores_gemma":[0.00023175095,0.00020053038,0.00021929918,0.00013719834,0.00041382448,0.00026858933,0.00016700942,0.001106779,0.00026856654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021382452,0.00030616348,0.00055704504,0.000047717454,0.0000064400992,0.00005998607,0.000025351468,0.00011717483,0.99428505,0.000033598404,0.000045956964,0.0023773906],"study_design_scores_gemma":[0.00015704433,0.01635459,0.015571154,0.000014651723,0.000054196214,0.00026724229,0.00008009604,0.000872632,0.96536005,0.000042307758,0.0012072962,0.00001879545],"about_ca_topic_score_codex":0.00091323955,"about_ca_topic_score_gemma":0.0016723401,"teacher_disagreement_score":0.0014997649,"about_ca_system_score_codex":0.00029478423,"about_ca_system_score_gemma":0.00043332882,"threshold_uncertainty_score":0.005017221},"labels":[],"label_agreement":null},{"id":"W2016345267","doi":"10.1038/sj.bjc.6603863","title":"MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Matrix metalloproteinase; Gelatinase; Motility; Ovarian cancer; Biology; Cancer research; Ectopic expression; Metastasis; Cell culture; Matrix metalloproteinase inhibitor; Cell; Cancer cell; Cell biology; Gelatinase A; Cancer; Biochemistry; Genetics","score_opus":0.0077445142826772,"score_gpt":0.28416903815834355,"score_spread":0.27642452387566635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016345267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500716,0.0028338758,0.0008127282,0.000060350107,0.0000063629595,0.000012390214,0.00023246689,0.000023159537,0.0010114451],"genre_scores_gemma":[0.996917,0.00097132777,0.00056757854,0.000009532003,0.000004301248,0.000010300047,0.0004390546,0.0000034088225,0.0010775566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999244,0.000011543171,0.000006764106,0.000010068171,0.000025605152,0.00002149204],"domain_scores_gemma":[0.99992466,0.000014484267,0.000026665552,0.000007331202,0.000011972785,0.000014946014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007211192,0.00018437466,0.00016357104,0.00016778515,0.00017339527,0.00022687609,0.00006881529,0.00014713852,0.00083634927],"category_scores_gemma":[0.00013667408,0.00009535952,0.00009824741,0.00014756748,0.00012380944,0.00010489178,0.00010859184,0.0001567553,0.00035365263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006976234,0.0000070779447,0.00092220353,0.000026688762,0.0000012190752,0.00007764729,0.000016164044,0.000025620258,0.99780256,0.00003856274,0.000024517205,0.000988099],"study_design_scores_gemma":[0.00001733368,0.00027450855,0.064141855,0.000009462243,0.000011105463,0.0017275441,0.00007571603,0.000625579,0.9273377,0.000059355934,0.005714439,0.000005444716],"about_ca_topic_score_codex":0.0010962737,"about_ca_topic_score_gemma":0.001180318,"teacher_disagreement_score":0.0010962737,"about_ca_system_score_codex":0.00022240343,"about_ca_system_score_gemma":0.00015472088,"threshold_uncertainty_score":0.002797842},"labels":[],"label_agreement":null},{"id":"W2016636564","doi":"10.1038/sj.bjc.6605519","title":"Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; Emory University","keywords":"TMPRSS2; Erg; Prostate cancer; Biochemical recurrence; Fusion gene; Prostatectomy; Oncology; Proportional hazards model; Nomogram; Internal medicine; Medicine; Prostate; PCA3; Cohort; Biology; Cancer; Gene; Genetics","score_opus":0.0157146526414504,"score_gpt":0.2990337131224295,"score_spread":0.2833190604809791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016636564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904996,0.00032482177,0.00011760911,0.000029917606,0.000004930112,0.0000030228418,0.00032022197,0.0000050706617,0.00014445114],"genre_scores_gemma":[0.99925226,0.00010570392,0.00008435709,0.00001414118,0.0000069694433,0.00000453126,0.00042539937,0.0000035683815,0.0001030154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996828,0.000044894427,0.000019046223,0.00013447813,0.000071693554,0.000046997204],"domain_scores_gemma":[0.99944466,0.00011300655,0.00018740281,0.00007627077,0.00006281807,0.0001158622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049522595,0.00019718146,0.00041624287,0.0006834463,0.0003762123,0.00046058744,0.00024739015,0.00023130744,0.0011723316],"category_scores_gemma":[0.00079731666,0.0001296186,0.0005111042,0.0007678911,0.0002239585,0.00016612874,0.00040263528,0.0003620987,0.00017043343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049662526,0.000017141178,0.9915603,0.000014119432,0.00020231702,0.00023564906,0.000082704115,0.00011255388,0.0045053614,0.000020292347,0.00019041939,0.0025625061],"study_design_scores_gemma":[0.000014131071,0.00008781075,0.99767834,0.0000036567228,0.00013612826,0.000783432,0.000084350104,0.00021405343,0.000588823,0.000041959516,0.0003622591,0.0000051285856],"about_ca_topic_score_codex":0.0021461046,"about_ca_topic_score_gemma":0.002805543,"teacher_disagreement_score":0.0021461046,"about_ca_system_score_codex":0.00021705565,"about_ca_system_score_gemma":0.0002682623,"threshold_uncertainty_score":0.0042672753},"labels":[],"label_agreement":null},{"id":"W2017082986","doi":"10.1038/sj.bjc.6603419","title":"A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Temsirolimus; Medicine; Pharmacodynamics; Rash; Internal medicine; Sirolimus; Everolimus; Adverse effect; Oncology; Pharmacology; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Biology; Pharmacokinetics","score_opus":0.025426725496395658,"score_gpt":0.41002983679405325,"score_spread":0.38460311129765756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017082986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977375,0.0005156252,0.00040121004,0.00011372913,0.00002466819,0.00065140426,0.00018030524,0.000024968995,0.00035068812],"genre_scores_gemma":[0.99417335,0.00070211774,0.0015542092,0.0003022122,0.000063985855,0.0010879078,0.0011327462,0.00001588038,0.000967596],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996686,0.0001678545,0.000015953452,0.00004987678,0.00004079273,0.00005693685],"domain_scores_gemma":[0.99952805,0.000074291354,0.000067735156,0.000050933446,0.000032033135,0.0002470467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010968106,0.0009172741,0.0017274569,0.00031395062,0.00026530237,0.0004966148,0.00044175395,0.00065720285,0.0014021918],"category_scores_gemma":[0.00057304313,0.00036434596,0.00063647353,0.00029104855,0.0006332422,0.00035916385,0.00023852556,0.0017382627,0.00034647598],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35187542,0.107415475,0.023901422,0.0005132961,0.0010462316,0.000889383,0.00052351435,0.007062239,0.37359747,0.00042800466,0.0025958274,0.1301517],"study_design_scores_gemma":[0.17355731,0.7556289,0.04209594,0.0000196373,0.00029255627,0.0009490868,0.00009334213,0.003860116,0.019749591,0.00021951298,0.0034874424,0.000046607616],"about_ca_topic_score_codex":0.0004588729,"about_ca_topic_score_gemma":0.00088751613,"teacher_disagreement_score":0.0017274569,"about_ca_system_score_codex":0.00045279146,"about_ca_system_score_gemma":0.0009018913,"threshold_uncertainty_score":0.005800605},"labels":[],"label_agreement":null},{"id":"W2017157952","doi":"10.1038/bjc.2012.345","title":"Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canada Research Chairs; Ontario Ministry of Health and Long-Term Care; Cancer Research Institute","keywords":"Osteopontin; Medicine; Prostate cancer; Oncology; Biomarker; Prostatectomy; Internal medicine; Metastasis; Prostate-specific antigen; Chemotherapy; Urology; Androgen deprivation therapy; Cancer; Biology","score_opus":0.027080322783702353,"score_gpt":0.3286458796795494,"score_spread":0.301565556895847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017157952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982041,0.00094867044,0.0002975361,0.000056647616,0.0000051492107,0.000010093141,0.000095083466,0.000008569876,0.0003742021],"genre_scores_gemma":[0.9996251,0.000060633665,0.00012613181,0.00001533283,0.00000929709,0.0000067566402,0.00008697764,0.0000015721401,0.00006832783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994972,0.00017025624,0.000037251433,0.000115155555,0.00013442419,0.00004568888],"domain_scores_gemma":[0.9973437,0.0011400839,0.0009810664,0.00009291141,0.0001985703,0.0002437007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008155983,0.0001932327,0.00042319213,0.00037895804,0.00014688997,0.00041083776,0.00020095031,0.00037270624,0.0012544105],"category_scores_gemma":[0.003609012,0.00007943844,0.00020826461,0.00038105846,0.00023100969,0.00023499865,0.00028258233,0.00052508013,0.00018724582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008465013,0.000046596062,0.98813176,0.000030416357,0.00013469049,0.000036109122,0.0000692251,0.00025565806,0.001676075,0.000015292919,0.00008360531,0.008674073],"study_design_scores_gemma":[0.000016180951,0.000460526,0.99713314,0.000007691557,0.00006400893,0.00043368514,0.000051708383,0.0010326616,0.00050613383,0.00008167939,0.0002072365,0.000005388445],"about_ca_topic_score_codex":0.00071276113,"about_ca_topic_score_gemma":0.0007158649,"teacher_disagreement_score":0.0012544105,"about_ca_system_score_codex":0.0002760555,"about_ca_system_score_gemma":0.00015954624,"threshold_uncertainty_score":0.0043133497},"labels":[],"label_agreement":null},{"id":"W2018009395","doi":"10.1038/sj.bjc.6601716","title":"Methylation analysis of the glypican 3 gene in embryonal tumours","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; HEC Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Methylation; DNA methylation; Biology; Molecular biology; Epigenetics; Gene expression; Gene; Regulation of gene expression; Promoter; Gene silencing; Cancer research; Genetics","score_opus":0.005382517639364735,"score_gpt":0.2567698863523647,"score_spread":0.25138736871299994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018009395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948013,0.0010582994,0.0025675057,0.000045122702,0.0000076198094,0.000015561765,0.0004673038,0.000030437554,0.0010069057],"genre_scores_gemma":[0.9951845,0.00062578113,0.0017530618,0.000024017267,0.0000037021766,0.000014841649,0.0006191268,0.0000119227,0.0017630368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999505,0.000007563134,0.0000026147616,0.000012998221,0.000017713559,0.000008567106],"domain_scores_gemma":[0.9999168,0.000022199365,0.000018141416,0.0000093617455,0.00001506908,0.000018522156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007992809,0.00014517724,0.000112702015,0.00033349395,0.00014033886,0.00010963721,0.00009512783,0.00016676611,0.0008200965],"category_scores_gemma":[0.00018808791,0.00009828124,0.000105612206,0.00015130313,0.0001515379,0.000067723864,0.00012398986,0.0002263927,0.00021369616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000613196,0.0000020340558,0.0015619806,0.000013494109,0.0000046500004,0.00010368017,0.000029746425,0.000034051118,0.9971426,0.000028303011,0.000012554379,0.0010055341],"study_design_scores_gemma":[0.000011332558,0.00020140976,0.22075646,0.000009006687,0.00004424609,0.0017810365,0.000099281606,0.0011582619,0.7721376,0.00017070716,0.00362042,0.000010210237],"about_ca_topic_score_codex":0.0024989566,"about_ca_topic_score_gemma":0.0027017223,"teacher_disagreement_score":0.0024989566,"about_ca_system_score_codex":0.00021696133,"about_ca_system_score_gemma":0.00012883575,"threshold_uncertainty_score":0.0049688816},"labels":[],"label_agreement":null},{"id":"W2018476933","doi":"10.1038/bjc.2013.64","title":"In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"American Society of Clinical Oncology","keywords":"Sorafenib; Medicine; Pharmacodynamics; Biomarker; Oncology; Cyclophosphamide; Internal medicine; Pharmacokinetics; Pharmacology; Clinical trial; In vivo; Chemotherapy; Hepatocellular carcinoma; Biology","score_opus":0.009560983902794555,"score_gpt":0.2940602698108349,"score_spread":0.28449928590804036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018476933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991345,0.0002539075,0.00022451147,0.000022900342,0.000003073699,0.0000130443905,0.000059018395,0.0000059633185,0.0002831146],"genre_scores_gemma":[0.9996013,0.000038283288,0.00017227158,0.000014578625,0.0000037074817,0.000010106835,0.000078954465,0.0000010559813,0.00007988279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997545,0.00009425237,0.000024115985,0.000046737307,0.0000492887,0.00003113875],"domain_scores_gemma":[0.99909306,0.00038284372,0.00028659494,0.000028177483,0.000061016854,0.00014842692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071915117,0.00026685593,0.00033802277,0.00033127642,0.00014321617,0.0003636478,0.000120531084,0.00029209934,0.0011925153],"category_scores_gemma":[0.0012566551,0.00010952018,0.00018118956,0.00017928779,0.00024165981,0.00029338486,0.00015232919,0.0005704875,0.00022659915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012020875,0.00053524814,0.860708,0.00009168927,0.00013514904,0.0004970203,0.00023247246,0.001585385,0.09872637,0.000077464036,0.0002394312,0.02515086],"study_design_scores_gemma":[0.00024210203,0.010052465,0.9494543,0.00001082249,0.0001341981,0.0020692516,0.00015135527,0.0052104746,0.03169789,0.0001449014,0.0008116439,0.000020633694],"about_ca_topic_score_codex":0.00023269681,"about_ca_topic_score_gemma":0.00038104155,"teacher_disagreement_score":0.0011925153,"about_ca_system_score_codex":0.00029655395,"about_ca_system_score_gemma":0.0001436348,"threshold_uncertainty_score":0.003989339},"labels":[],"label_agreement":null},{"id":"W2018971639","doi":"10.1038/sj.bjc.6604554","title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","year":2008,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":651,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Capital District Health Authority","funders":"","keywords":"Warburg effect; Glycolysis; Pyruvate dehydrogenase kinase; Mitochondrion; Pyruvate dehydrogenase complex; Cancer; Anaerobic glycolysis; Cancer cell; Cancer research; Citric acid cycle; Apoptosis; In vivo; Biology; Biochemistry; Medicine; Metabolism; Internal medicine; Enzyme; Genetics","score_opus":0.020254691862175978,"score_gpt":0.3297046630877982,"score_spread":0.30944997122562223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018971639","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002553012,0.9963599,0.00026266207,0.00037326824,0.00025105133,0.000009139532,0.00001714684,0.0000112177195,0.0024603],"genre_scores_gemma":[0.0013795798,0.99554235,0.00036152004,0.000283243,0.00018312412,0.000012652023,0.00003776065,0.000002939158,0.0021967916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988437,0.00002225429,0.000012273821,0.000021699518,0.000046544894,0.000012941109],"domain_scores_gemma":[0.9998765,0.000050708488,0.0000177725,0.000004743704,0.00003089309,0.000019445808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004273313,0.00078485627,0.0011864167,0.0018538313,0.00033308662,0.000773246,0.00070455065,0.0013252918,0.0046783662],"category_scores_gemma":[0.00028522653,0.00024639818,0.000317372,0.0017601061,0.0005035268,0.0010929477,0.0004991267,0.0017409084,0.0035959408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014855203,0.00013770889,0.000111424815,0.006349558,0.00005106009,0.00045300648,0.000046339534,0.00044014934,0.0065080323,0.0048728785,0.030302245,0.95057905],"study_design_scores_gemma":[0.000034718905,0.00014618725,0.00040687734,0.00067910773,0.00004187192,0.0018630591,0.000028657836,0.000078486126,0.0015758919,0.0013753133,0.99375534,0.000014451214],"about_ca_topic_score_codex":0.0014147143,"about_ca_topic_score_gemma":0.003261752,"teacher_disagreement_score":0.0046783662,"about_ca_system_score_codex":0.0008891213,"about_ca_system_score_gemma":0.0006283946,"threshold_uncertainty_score":0.01565069},"labels":[],"label_agreement":null},{"id":"W2019832083","doi":"10.1038/sj.bjc.6605017","title":"Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis","year":2009,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Mayo Clinic","keywords":"Hepatocellular carcinoma; Medicine; Internal medicine; Hazard ratio; Vascular endothelial growth factor; Meta-analysis; Oncology; Survival analysis; Gastroenterology; Pathology; VEGF receptors; Confidence interval","score_opus":0.0715324370404567,"score_gpt":0.3007726055922088,"score_spread":0.2292401685517521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019832083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062099113,0.991634,0.0005396669,0.00019931702,0.00010558857,0.00020201431,0.00087147596,0.00002542911,0.00021259436],"genre_scores_gemma":[0.24905655,0.7443145,0.0023476249,0.00076408166,0.0002637118,0.0012736875,0.0015484199,0.000036942954,0.00039447483],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99263203,0.0033366056,0.0021740631,0.0008297749,0.0007531669,0.0002743901],"domain_scores_gemma":[0.98212117,0.012941029,0.0027790293,0.00058826164,0.0013511862,0.00021933705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010319164,0.0019921768,0.014036717,0.005548875,0.00058504794,0.0024871803,0.0017942172,0.0016529779,0.0028730948],"category_scores_gemma":[0.02592832,0.0011247403,0.026272338,0.008137834,0.00059735647,0.0013989432,0.0012654823,0.0012660379,0.00027554695],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012365223,0.000016667489,0.008405269,0.45707336,0.52239954,0.00016793096,0.00008935253,0.00066958123,0.00028395903,0.0001201917,0.0007758457,0.008761673],"study_design_scores_gemma":[0.00029170973,0.00013961285,0.007023332,0.027316459,0.9628691,0.00013399638,0.00004610582,0.000246501,0.00012498582,0.00015642654,0.0016262266,0.000025627562],"about_ca_topic_score_codex":0.007474564,"about_ca_topic_score_gemma":0.015988916,"teacher_disagreement_score":0.014036717,"about_ca_system_score_codex":0.0021987264,"about_ca_system_score_gemma":0.0031780996,"threshold_uncertainty_score":0.054573596},"labels":[],"label_agreement":null},{"id":"W2020301278","doi":"10.1054/bjoc.2000.1621","title":"Comparison of99mTc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; BC Cancer Agency; University of Toronto; McGill University","keywords":"Doxorubicin; P-glycoprotein; Flow cytometry; Medicine; Chemotherapy; Pathology; Cell culture; Efflux; Cancer research; Multiple drug resistance; Internal medicine; Biology; Immunology; Drug resistance; Biochemistry","score_opus":0.013684665925206684,"score_gpt":0.2939991486008324,"score_spread":0.28031448267562575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020301278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821485,0.006531279,0.008996655,0.000114439084,0.00004150662,0.00005988444,0.00022233247,0.000082200124,0.0018031753],"genre_scores_gemma":[0.98065776,0.0031681005,0.012971461,0.00007305456,0.000023015078,0.000109077824,0.0006276163,0.000042959422,0.0023269502],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996445,0.00011311402,0.00002824961,0.00007262538,0.00009042944,0.00005099805],"domain_scores_gemma":[0.99975795,0.000104372906,0.000038342303,0.00002280789,0.000042134965,0.000034340337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033848858,0.0004088873,0.0006080412,0.00036027547,0.000116932606,0.0003150291,0.00029678698,0.00051912444,0.00054851634],"category_scores_gemma":[0.00035909607,0.0002524475,0.00020638292,0.00035972806,0.00023419519,0.00028729418,0.00020754698,0.00041673775,0.0002765386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002675543,0.000024489358,0.00032896054,0.00004031403,0.000011090557,0.000031098243,0.000015475765,0.000097554694,0.996867,0.00004868498,0.000021991302,0.002245913],"study_design_scores_gemma":[0.000014882524,0.00038907744,0.003602667,0.0000029199223,0.0000145562635,0.00021317591,0.000011868483,0.0016426288,0.9934841,0.00001535477,0.0006033286,0.00000540781],"about_ca_topic_score_codex":0.00079347997,"about_ca_topic_score_gemma":0.0013650787,"teacher_disagreement_score":0.00079347997,"about_ca_system_score_codex":0.00048346067,"about_ca_system_score_gemma":0.00022421723,"threshold_uncertainty_score":0.0035077333},"labels":[],"label_agreement":null},{"id":"W2020339402","doi":"10.1054/bjoc.2000.1681","title":"Codon 89 polymorphism in the human 5 α -reductase gene in primary breast cancer","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Genotype; Biology; Allele; Exon; Androgen receptor; Prostate cancer; Molecular biology; Genetics; Gene; Cancer","score_opus":0.010743845701263617,"score_gpt":0.2798356079173419,"score_spread":0.2690917622160783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020339402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982291,0.0007676812,0.00019339679,0.00006261106,0.000014968757,0.000010136252,0.00013593675,0.0000105550225,0.00057563465],"genre_scores_gemma":[0.99912137,0.00021049634,0.00011355284,0.00002773774,0.000017062997,0.0000051331635,0.00013774952,0.0000024422563,0.0003645176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984646,0.000033623786,0.000014404179,0.000038310318,0.0000421886,0.000024919394],"domain_scores_gemma":[0.9997495,0.00005276112,0.00011613221,0.000019092271,0.000023586827,0.000038940987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012577127,0.00015916424,0.0002309608,0.0005832796,0.00023473777,0.00021276926,0.00012864498,0.00027075832,0.0014648826],"category_scores_gemma":[0.000465186,0.00015601091,0.00028932054,0.0005858358,0.00015625657,0.000050838462,0.00009858921,0.00018871592,0.00041908765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092290767,0.00012304145,0.9356967,0.00006599175,0.00012786392,0.0077692126,0.00020824412,0.00012647339,0.04489304,0.00009679413,0.0004138827,0.009555791],"study_design_scores_gemma":[0.000014563336,0.00017281325,0.98620254,0.000009723169,0.000071182134,0.010589371,0.0000491838,0.00016986992,0.0018858153,0.000051830128,0.00077883375,0.0000043081045],"about_ca_topic_score_codex":0.0024110682,"about_ca_topic_score_gemma":0.002166502,"teacher_disagreement_score":0.0024110682,"about_ca_system_score_codex":0.00017336254,"about_ca_system_score_gemma":0.00014156717,"threshold_uncertainty_score":0.004900515},"labels":[],"label_agreement":null},{"id":"W2020684281","doi":"10.1038/bjc.2011.100","title":"Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":473,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Pfizer Australia; Pfizer","keywords":"Medicine; Internal medicine; Colorectal cancer; Oncology; Chemotherapy; Neutrophil to lymphocyte ratio; Cohort; Biomarker; Progression-free survival; Cancer; Lymphocyte","score_opus":0.007573937637656779,"score_gpt":0.24328955711300027,"score_spread":0.23571561947534347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020684281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895823,0.000364276,0.00009388782,0.00006813536,0.000009373586,0.00000794213,0.00017520542,0.000004924345,0.00031796782],"genre_scores_gemma":[0.9994649,0.00007034138,0.00005620633,0.000015049105,0.000009201983,0.0000051790535,0.0003014075,9.903645e-7,0.00007680458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987686,0.000031538908,0.000017148552,0.00003012838,0.000025209289,0.000019098856],"domain_scores_gemma":[0.999071,0.00025145878,0.00036712966,0.00004714337,0.000098453515,0.00016472726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004175806,0.00025564936,0.00022700701,0.0003170883,0.00017129202,0.0004141183,0.00021281347,0.00031222563,0.0012333562],"category_scores_gemma":[0.0022273762,0.000087093096,0.00014618714,0.0003086769,0.00019703711,0.00026100237,0.00026305843,0.00050665304,0.00029472803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043002324,0.000033429136,0.99684554,0.0000090109315,0.000019431804,0.000038890914,0.0000140785605,0.00012894947,0.00032874462,0.0000058249566,0.00012121158,0.0020248706],"study_design_scores_gemma":[0.000022710024,0.00025499464,0.998206,0.0000062172617,0.000034948946,0.00028738033,0.000032608943,0.000720421,0.00016758047,0.000034930352,0.00022944495,0.0000027894926],"about_ca_topic_score_codex":0.0009168805,"about_ca_topic_score_gemma":0.0011283739,"teacher_disagreement_score":0.0012333562,"about_ca_system_score_codex":0.00020995917,"about_ca_system_score_gemma":0.00020088423,"threshold_uncertainty_score":0.0041260123},"labels":[],"label_agreement":null},{"id":"W2020769895","doi":"10.1038/sj.bjc.6604234","title":"Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; Sanofi","keywords":"Helicobacter pylori; Adenocarcinoma; Gene; Metalloproteinase; Inflammation; Medicine; Helicobacter pylori infection; Biology; Gastroenterology; Immunology; Internal medicine; Microbiology; Cancer; Matrix metalloproteinase; Genetics","score_opus":0.010288710079028419,"score_gpt":0.2301443297107634,"score_spread":0.21985561963173497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020769895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972765,0.0022234465,0.00005825738,0.000081718565,0.000008864965,0.0000016113967,0.000060582657,0.0000018524947,0.00028710015],"genre_scores_gemma":[0.99902487,0.0006075303,0.00007504489,0.000018854113,0.000017550685,0.0000017616948,0.00006572854,0.0000013153137,0.00018749568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997682,0.0001199176,0.000021651356,0.000030406727,0.000031831198,0.000028005927],"domain_scores_gemma":[0.9985745,0.00060633867,0.00042672033,0.00006459638,0.00006765577,0.00026021298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005240621,0.00022222748,0.00026982802,0.00047132533,0.0001707648,0.0003245958,0.00017790012,0.00043692498,0.0018100205],"category_scores_gemma":[0.0025583801,0.00019113219,0.00024695112,0.0006367056,0.00026512917,0.00020573044,0.00015755385,0.0003687177,0.00013383821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002248318,0.000108851855,0.99120027,0.000042746764,0.00028764925,0.00028688356,0.00006125738,0.000086038475,0.0020370132,0.00006127328,0.00013654788,0.003443156],"study_design_scores_gemma":[0.00003342414,0.0002151208,0.9983662,0.00001202333,0.00016460287,0.00061932846,0.000038589413,0.0001382424,0.0001655176,0.000059450165,0.00018456884,0.0000028998782],"about_ca_topic_score_codex":0.0027387517,"about_ca_topic_score_gemma":0.0028541053,"teacher_disagreement_score":0.0027387517,"about_ca_system_score_codex":0.000120422876,"about_ca_system_score_gemma":0.00016664546,"threshold_uncertainty_score":0.0060551167},"labels":[],"label_agreement":null},{"id":"W2021052544","doi":"10.1038/sj.bjc.6605634","title":"Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Government of Ontario","keywords":"microRNA; Kallikrein; Cell growth; Ovarian cancer; Cancer research; Cancer; Biology; Medicine; Bioinformatics; Gene; Genetics; Enzyme; Biochemistry","score_opus":0.008271594817374363,"score_gpt":0.25875401312362784,"score_spread":0.25048241830625345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021052544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911924,0.0031871926,0.002890099,0.000095602234,0.00006599169,0.00004517748,0.00053255184,0.00013094395,0.0018602152],"genre_scores_gemma":[0.99518603,0.00067329005,0.0024161127,0.00006217637,0.000008321748,0.00004984704,0.00046971295,0.000020681004,0.0011139055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997881,0.00002147602,0.000019471068,0.000054115146,0.00007183533,0.00004507132],"domain_scores_gemma":[0.99984515,0.00003612265,0.00004912919,0.000012946058,0.00003081174,0.000025737596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017187855,0.0002085957,0.00030950585,0.00022765486,0.00023857354,0.0005085997,0.00014560937,0.00027488702,0.0010114069],"category_scores_gemma":[0.00030065418,0.00016040092,0.00031143008,0.00019023076,0.00019414947,0.00014566451,0.00018925453,0.00040640513,0.00035894394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006798049,0.000055493343,0.0087865675,0.00014639327,0.00002585617,0.00019118976,0.00010193394,0.00022169687,0.9822067,0.00025410764,0.0002545379,0.0070756953],"study_design_scores_gemma":[0.000056902532,0.00057249726,0.049327087,0.000015106715,0.00010377768,0.00077696546,0.00012713445,0.0024195341,0.93660885,0.00019675148,0.00978017,0.000015161749],"about_ca_topic_score_codex":0.00035995603,"about_ca_topic_score_gemma":0.00051564525,"teacher_disagreement_score":0.0010114069,"about_ca_system_score_codex":0.00038020336,"about_ca_system_score_gemma":0.00029489555,"threshold_uncertainty_score":0.0033834577},"labels":[],"label_agreement":null},{"id":"W2021429060","doi":"10.1038/bjc.2014.201","title":"Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada","keywords":"DU145; Prostate cancer; Carcinogenesis; Stem cell; Aldehyde dehydrogenase; Cancer research; Pathology; Cancer stem cell; Prostate; Biology; Immunohistochemistry; Metastasis; Cancer; Medicine; Internal medicine; Enzyme","score_opus":0.023573555516500415,"score_gpt":0.33459036111354323,"score_spread":0.3110168055970428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021429060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794941,0.015214419,0.0020121806,0.00025928882,0.000025776255,0.000016615853,0.00070476497,0.00017187964,0.0021008675],"genre_scores_gemma":[0.9967115,0.0016921103,0.0004147925,0.000017984066,0.000026903956,0.000004842991,0.00032481053,0.000008007795,0.000799083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998652,0.000020793981,0.0000075506555,0.00003543384,0.000045016797,0.000026041529],"domain_scores_gemma":[0.9993554,0.00006239638,0.00034785183,0.000034176377,0.00007052604,0.00012963067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017423306,0.0003244176,0.00018894458,0.00079217745,0.0002471273,0.00033507976,0.00019056698,0.0001748695,0.0027825972],"category_scores_gemma":[0.000290909,0.00012494362,0.00025557308,0.0011139053,0.0002543154,0.00011964318,0.00027780124,0.0004430702,0.00035365668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026401929,0.00016601659,0.7104449,0.0005235612,0.0004853821,0.0021126117,0.00026212496,0.00033171175,0.24981587,0.0004060607,0.0011052869,0.031706337],"study_design_scores_gemma":[0.000006640276,0.00016500984,0.97129726,0.000011995124,0.00015150994,0.004116459,0.00006404936,0.0002476014,0.020331675,0.0002491719,0.0033476849,0.000011069158],"about_ca_topic_score_codex":0.001703779,"about_ca_topic_score_gemma":0.0013852695,"teacher_disagreement_score":0.0027825972,"about_ca_system_score_codex":0.0003242602,"about_ca_system_score_gemma":0.00023825552,"threshold_uncertainty_score":0.009308696},"labels":[],"label_agreement":null},{"id":"W2021926444","doi":"10.1038/sj.bjc.6601104","title":"A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Hypercalcaemia; Chemotherapy; Internal medicine; Progressive disease; Gastroenterology; Toxicity; Cancer; Oncology; Vitamin D and neurology; Surgery; Calcium","score_opus":0.013446570007913201,"score_gpt":0.2953229735743543,"score_spread":0.28187640356644106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021926444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453837,0.002067896,0.00038548827,0.0002251286,0.00009314575,0.0016677068,0.0003164777,0.000047660793,0.00065811956],"genre_scores_gemma":[0.99278945,0.0018953471,0.0007324996,0.00040458122,0.00014853473,0.0017137917,0.0007786219,0.000016984703,0.0015201601],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997203,0.00013849474,0.000012940935,0.000043126784,0.000021916538,0.000063144704],"domain_scores_gemma":[0.9993605,0.00014067914,0.00007009331,0.0000654235,0.000050024442,0.00031333038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008219802,0.0010221598,0.002445341,0.0003774691,0.00034938363,0.00068563834,0.00052311335,0.0009831692,0.0025232923],"category_scores_gemma":[0.00085018325,0.00040345406,0.0007912747,0.0004280605,0.0007671253,0.000445626,0.00027914837,0.0016590087,0.00060879264],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7953604,0.058293223,0.008322662,0.0010604783,0.0011573742,0.00055104215,0.00044786677,0.0017250663,0.05094526,0.00018095161,0.0014824875,0.08047312],"study_design_scores_gemma":[0.38250422,0.6022445,0.009519089,0.00002026904,0.00028487146,0.00022827041,0.00011229944,0.0005384234,0.0023314557,0.00010349062,0.0020911712,0.000021909163],"about_ca_topic_score_codex":0.0011222509,"about_ca_topic_score_gemma":0.0015432539,"teacher_disagreement_score":0.0025232923,"about_ca_system_score_codex":0.00050992874,"about_ca_system_score_gemma":0.0009839972,"threshold_uncertainty_score":0.008441269},"labels":[],"label_agreement":null},{"id":"W2022540212","doi":"10.1038/sj.bjc.6601314","title":"Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"University of Toronto","keywords":"Relative risk; Medicine; Breast cancer; Confidence interval; Cohort study; Cohort; Meta-analysis; Cancer; Internal medicine","score_opus":0.04609238137663645,"score_gpt":0.34487777377553536,"score_spread":0.2987853923988989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022540212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006565579,0.9900857,0.0016298078,0.00071745465,0.00039022032,0.00007556938,0.00030039978,0.000059009737,0.00017625994],"genre_scores_gemma":[0.24693643,0.74220437,0.005953181,0.0020708328,0.0010523804,0.00042008952,0.0008129796,0.00012483752,0.00042491598],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97470504,0.015382771,0.004387944,0.002742066,0.0023496605,0.0004324373],"domain_scores_gemma":[0.9553675,0.035464227,0.00440312,0.0020565295,0.0022557585,0.00045284032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037085146,0.005300904,0.023342332,0.013488927,0.0008076783,0.0059594666,0.003545939,0.0032433681,0.0022666566],"category_scores_gemma":[0.079006135,0.0023043489,0.059827443,0.0137655875,0.00090163614,0.00288751,0.002235946,0.003883794,0.00043117214],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018249706,0.000014591398,0.006392472,0.03813902,0.9411941,0.00022136407,0.000056558274,0.00062289176,0.0002203621,0.000113289985,0.00051427865,0.01068619],"study_design_scores_gemma":[0.0003715242,0.0001173433,0.0034501585,0.003990863,0.9902194,0.00017805258,0.00003126224,0.00027114767,0.0001205211,0.00043478908,0.0007941591,0.000020857637],"about_ca_topic_score_codex":0.006456178,"about_ca_topic_score_gemma":0.011884196,"teacher_disagreement_score":0.037085146,"about_ca_system_score_codex":0.0029971646,"about_ca_system_score_gemma":0.0025243259,"threshold_uncertainty_score":0.19612736},"labels":[],"label_agreement":null},{"id":"W2023408161","doi":"10.1038/bjc.2013.807","title":"Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Environmental Health Sciences; Cancer Care Ontario; National Health and Medical Research Council; National Institutes of Health; National Cancer Institute; National Center for Research Resources; Medical Research Council","keywords":"Breast cancer; Medicine; Breastfeeding; Gynecology; Odds ratio; Obstetrics; Population; Cancer; Parity (physics); Cancer registry; Confidence interval; Breast feeding; Oncology; Internal medicine; Pediatrics","score_opus":0.01200590687469941,"score_gpt":0.27865279961555445,"score_spread":0.266646892740855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023408161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292964,0.00055000745,0.00014231008,0.000103316685,0.000009190258,0.000023174216,0.005396729,0.000008122217,0.00083750027],"genre_scores_gemma":[0.99602085,0.00034556654,0.00015037584,0.000032746222,0.000008619391,0.000035745335,0.003214872,0.0000028917889,0.00018813695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992894,0.00024341886,0.000098192286,0.00016002561,0.00013247006,0.000076522934],"domain_scores_gemma":[0.9958703,0.0013117341,0.001829675,0.00036387972,0.00037743224,0.00024699932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014711944,0.0001294026,0.00024757916,0.00082525326,0.00033214575,0.00041027475,0.00039235078,0.00023580238,0.0020948648],"category_scores_gemma":[0.0062434687,0.0001704939,0.00025952913,0.0015604857,0.00013009706,0.00035070782,0.00028935226,0.00027824365,0.00027820226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027280972,0.000009495238,0.99897265,0.000011769296,0.00002100925,0.000035621193,0.00002918504,0.000032701624,0.000036796155,0.000010927275,0.00023662696,0.0005760365],"study_design_scores_gemma":[0.0000040441937,0.000016884718,0.9992944,0.000012535073,0.000027355787,0.00015093051,0.00006355063,0.00009156756,0.00004921924,0.00000893604,0.00027825122,0.0000022829918],"about_ca_topic_score_codex":0.026286718,"about_ca_topic_score_gemma":0.027955974,"teacher_disagreement_score":0.026286718,"about_ca_system_score_codex":0.00038059155,"about_ca_system_score_gemma":0.0006332346,"threshold_uncertainty_score":0.052267432},"labels":[],"label_agreement":null},{"id":"W2023959957","doi":"10.1038/sj.bjc.6604395","title":"Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lung cancer; Chemotherapy; Oncology; Stage (stratigraphy); Internal medicine; Anxiety; Performance status; Cancer; Intensive care medicine; Psychiatry","score_opus":0.13633444190166571,"score_gpt":0.4358898854765684,"score_spread":0.29955544357490266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023959957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883527,0.000046846388,0.00021016931,0.00010790037,0.000009156123,0.00038262413,0.000024649707,0.000006626329,0.00037674492],"genre_scores_gemma":[0.9929784,0.0001790394,0.0053712875,0.00022160047,0.000034107823,0.0007793407,0.00006696731,0.0000037272546,0.000365486],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977737,0.0016978908,0.00009187976,0.000087406464,0.00017965781,0.00016955241],"domain_scores_gemma":[0.9859195,0.011423696,0.0004911062,0.00031982528,0.00043260268,0.0014132377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004163529,0.00041451206,0.0004704415,0.00027192532,0.00052020204,0.0007425351,0.00045015247,0.00056001777,0.0027496663],"category_scores_gemma":[0.014189311,0.00025618638,0.0005064689,0.00031515735,0.00053253555,0.0006583563,0.0005272725,0.0012512911,0.0002608061],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041483924,0.344689,0.13960972,0.001752179,0.00050457794,0.0020444805,0.01810448,0.0061331047,0.008689564,0.0007258457,0.0025155826,0.43374753],"study_design_scores_gemma":[0.03219953,0.74881727,0.17950827,0.00017257707,0.00048001343,0.001205128,0.0057263123,0.019219926,0.0052060937,0.0008015185,0.0065099853,0.00015345737],"about_ca_topic_score_codex":0.0013443871,"about_ca_topic_score_gemma":0.0022509121,"teacher_disagreement_score":0.004163529,"about_ca_system_score_codex":0.0005723529,"about_ca_system_score_gemma":0.0012757744,"threshold_uncertainty_score":0.022019148},"labels":[],"label_agreement":null},{"id":"W2024159061","doi":"10.1038/sj.bjc.6602505","title":"Second primary malignancies in patients with male breast cancer","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Male Breast Health Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Male breast cancer; Prostate; Rectum; Incidence (geometry); Pancreatic cancer; Prostate cancer; Gynecology","score_opus":0.005861139639701475,"score_gpt":0.25164474699158373,"score_spread":0.24578360735188226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024159061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941989,0.0037562037,0.00009925901,0.00011426515,0.00002089223,0.000019051695,0.00071145745,0.0000053960134,0.001074615],"genre_scores_gemma":[0.99806434,0.0008608722,0.000083043065,0.000118560245,0.000051282783,0.000020696358,0.00052934524,0.0000018665845,0.00026995986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901116,0.00041830042,0.0001024538,0.00015103545,0.00017762481,0.00013954622],"domain_scores_gemma":[0.9984854,0.00031042757,0.00073562586,0.00017577705,0.000092188246,0.00020059597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084452285,0.00020769725,0.0006569965,0.0011594925,0.00035615196,0.0006341025,0.00021085049,0.00044688155,0.001684484],"category_scores_gemma":[0.0030608228,0.0003611811,0.0007153834,0.00169812,0.00014863737,0.00038045007,0.0004926111,0.000534488,0.00023513449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037627673,0.000033313245,0.995911,0.00004269851,0.0001362411,0.0002689136,0.0001539383,0.000018926816,0.00014526778,0.000024653977,0.00025192904,0.0026367125],"study_design_scores_gemma":[0.00003630037,0.00021325573,0.9974596,0.000016196718,0.000088178145,0.001292705,0.00011828855,0.000026958654,0.000078013625,0.000025049942,0.00064061437,0.000004846053],"about_ca_topic_score_codex":0.003221449,"about_ca_topic_score_gemma":0.004066295,"teacher_disagreement_score":0.003221449,"about_ca_system_score_codex":0.0002684181,"about_ca_system_score_gemma":0.00030167637,"threshold_uncertainty_score":0.006405413},"labels":[],"label_agreement":null},{"id":"W2024862214","doi":"10.1038/bjc.2014.653","title":"A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pharmacokinetics; Adverse effect; Pharmacodynamics; Toxicity; Internal medicine; Gastroenterology; Pharmacology","score_opus":0.01714316983249088,"score_gpt":0.3379790717243566,"score_spread":0.3208359018918657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024862214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592304,0.00086430414,0.00067634,0.00021110465,0.0000374314,0.0013924201,0.00040481274,0.000059670318,0.00043098588],"genre_scores_gemma":[0.9924461,0.0009521032,0.0019160369,0.0005498862,0.00010850643,0.0015441203,0.0013732171,0.000028429986,0.001081675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99910635,0.0005322216,0.000040308907,0.00011274723,0.00007815293,0.00013027209],"domain_scores_gemma":[0.99858654,0.0002305042,0.00031743,0.00015238592,0.0000859185,0.00062722166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002562767,0.0018579245,0.0021197775,0.00047962833,0.00048411184,0.0008644134,0.0008758144,0.000981005,0.002288783],"category_scores_gemma":[0.0015650518,0.00071490905,0.0011970771,0.0006151341,0.0012443905,0.000828334,0.0005532227,0.0031312378,0.0007719432],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59847105,0.15628578,0.022826297,0.0012683079,0.0016975696,0.00070482655,0.0011147589,0.0061457152,0.098895445,0.00023555408,0.0037422045,0.10861247],"study_design_scores_gemma":[0.24486312,0.72259885,0.024472749,0.000020570704,0.00032305028,0.0004591039,0.000068238856,0.0010357671,0.0040070517,0.00008915197,0.0020290972,0.00003323001],"about_ca_topic_score_codex":0.0007046598,"about_ca_topic_score_gemma":0.0011393847,"teacher_disagreement_score":0.002562767,"about_ca_system_score_codex":0.0009969011,"about_ca_system_score_gemma":0.00160682,"threshold_uncertainty_score":0.013553321},"labels":[],"label_agreement":null},{"id":"W2025238642","doi":"10.1038/sj.bjc.6605179","title":"Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; McGill University; McGill University Health Centre; McGill University and Génome Québec Innovation Centre; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research; Hungarian Scientific Research Fund","keywords":"Gene duplication; Medicine; Pilocytic astrocytoma; Biology; Cancer research; Gene; Pathology; Genetics; Astrocytoma; Glioma","score_opus":0.011652785172964388,"score_gpt":0.26292750329688397,"score_spread":0.2512747181239196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025238642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978186,0.00054759136,0.00059254817,0.000027637872,0.000004170367,0.000013098093,0.00028248463,0.000033968947,0.0006799237],"genre_scores_gemma":[0.99877614,0.00016212862,0.0006094685,0.0000149857615,0.000005938625,0.000009536155,0.00027604427,0.000008622982,0.0001371996],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99953604,0.00004187144,0.000044149285,0.00014050526,0.0001498176,0.000087580396],"domain_scores_gemma":[0.99931014,0.00014011934,0.000346426,0.000053329473,0.000065971915,0.00008402603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002327525,0.00035314978,0.00039345122,0.0012975476,0.0002760968,0.0003027352,0.0002936342,0.00043637163,0.0020743317],"category_scores_gemma":[0.0009452133,0.00019603586,0.00023924529,0.0009276483,0.0005587137,0.00017219385,0.0004886553,0.00026689513,0.0003513979],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006341876,0.000041442934,0.47078893,0.0002307792,0.0001512624,0.01307582,0.00032511985,0.00036071774,0.49972287,0.00019186399,0.0004026842,0.014074286],"study_design_scores_gemma":[0.000019705074,0.00020390084,0.91805285,0.000018945484,0.00011758993,0.057604413,0.00017136472,0.00038351733,0.02102272,0.00023882181,0.0021542308,0.000011917575],"about_ca_topic_score_codex":0.0009349212,"about_ca_topic_score_gemma":0.0018937386,"teacher_disagreement_score":0.0020743317,"about_ca_system_score_codex":0.00029824692,"about_ca_system_score_gemma":0.00026239263,"threshold_uncertainty_score":0.0069393516},"labels":[],"label_agreement":null},{"id":"W2025764144","doi":"10.1038/sj.bjc.6604104","title":"Reply: Breast cancer, human papilloma virus and sexual activities","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Human papilloma virus; Incidence (geometry); Gynecology; Medicine; Intraductal papilloma; Cervical cancer; Oncology; Internal medicine","score_opus":0.033847181325989045,"score_gpt":0.34809853328247353,"score_spread":0.31425135195648446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025764144","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003807534,0.0055378424,0.00013982669,0.91156524,0.08072835,0.000027702601,0.00038661202,0.000048155543,0.0011855745],"genre_scores_gemma":[0.0026471028,0.0095368335,0.00039031327,0.8524304,0.12422441,0.0000880142,0.00036293868,0.000033895692,0.010286092],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840623,0.00048480163,0.00035628388,0.00020375215,0.00038865645,0.00016039457],"domain_scores_gemma":[0.98727036,0.0076866834,0.00063498167,0.0004061399,0.002950455,0.0010514504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029634852,0.0010798665,0.001691597,0.0014831454,0.0012822645,0.0016368772,0.0023328906,0.017360292,0.015978012],"category_scores_gemma":[0.017482271,0.00091097254,0.0014232037,0.0014686226,0.0017031116,0.003973998,0.0013548027,0.021248959,0.010692844],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056428315,0.00002283004,0.00055677694,0.00017700883,0.00001578618,0.00028697768,0.000050016657,0.000029257599,0.00007010827,0.00037079368,0.99189055,0.00647339],"study_design_scores_gemma":[0.00013736612,0.00011249302,0.004996651,0.0005377503,0.0000698192,0.0027232426,0.00077418657,0.00017958377,0.00021152209,0.003422657,0.9867539,0.00008070264],"about_ca_topic_score_codex":0.0038199988,"about_ca_topic_score_gemma":0.0042196773,"teacher_disagreement_score":0.017360292,"about_ca_system_score_codex":0.0014343468,"about_ca_system_score_gemma":0.0017938908,"threshold_uncertainty_score":0.053451777},"labels":[],"label_agreement":null},{"id":"W2025843504","doi":"10.1038/sj.bjc.6602363","title":"Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Inhibitor of apoptosis; Molecular biology; Cancer research; Biology; Fusion protein; Apoptosis; Chemistry; Recombinant DNA; Programmed cell death; Biochemistry; Caspase","score_opus":0.0203745548329204,"score_gpt":0.3432954736120303,"score_spread":0.3229209187791099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025843504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8887522,0.0063904314,0.08566943,0.00079698075,0.00051061885,0.005045355,0.0044557634,0.0012171351,0.007161907],"genre_scores_gemma":[0.94989026,0.0025425444,0.03128717,0.0005773087,0.00014560668,0.004921277,0.0046077506,0.00024160664,0.005786512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99472094,0.0023610403,0.00030423392,0.0005196342,0.0018475568,0.00024649597],"domain_scores_gemma":[0.99722004,0.0011120284,0.0005502328,0.00028962153,0.0006815163,0.00014654367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069691893,0.0013356108,0.0011768305,0.0007683508,0.0003420072,0.0011046876,0.0006418362,0.00092462206,0.0019348945],"category_scores_gemma":[0.0052184523,0.00048941025,0.0007741252,0.00073440414,0.00084173115,0.00033035676,0.00038133626,0.001481305,0.00074326043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004618025,0.0013388279,0.0036360177,0.00032464028,0.0002652933,0.00009878028,0.0002101727,0.0040251305,0.96537346,0.00022005543,0.0010166813,0.018872999],"study_design_scores_gemma":[0.0015133283,0.067647934,0.04586331,0.00004915769,0.0005957707,0.0009887494,0.00013684755,0.013007158,0.8572691,0.00033123948,0.012478325,0.000119006385],"about_ca_topic_score_codex":0.00049865374,"about_ca_topic_score_gemma":0.00072946126,"teacher_disagreement_score":0.0069691893,"about_ca_system_score_codex":0.0006810354,"about_ca_system_score_gemma":0.00076765695,"threshold_uncertainty_score":0.03685701},"labels":[],"label_agreement":null},{"id":"W2025983332","doi":"10.1038/bjc.2014.584","title":"Reply to Comment on: ‘Possible pro-carcinogenic association of endotoxin on lung cancer among Shanghai women textile workers’","year":2014,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Indoor Air Quality and Microbial Exposure","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Occupational Safety and Health","keywords":"Lung cancer; Carcinogen; Medicine; Association (psychology); Environmental health; Textile; Occupational exposure; Cancer; Oncology; Internal medicine; Biology; Psychology; Geography; Genetics","score_opus":0.011011125487132735,"score_gpt":0.2522688003738904,"score_spread":0.24125767488675764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025983332","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046940416,0.000731546,0.000070542956,0.97834295,0.019380912,0.000009781678,0.0001154956,0.000041639603,0.00083781587],"genre_scores_gemma":[0.0025192609,0.00039473677,0.0001013722,0.9768843,0.016731702,0.00002522906,0.00004211973,0.000017812281,0.0032834776],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758255,0.00071743026,0.00036064663,0.00032961892,0.0006388732,0.00037089575],"domain_scores_gemma":[0.9930668,0.0033102678,0.00066259864,0.00023279728,0.001810855,0.00091665797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034835981,0.0008327775,0.0014675,0.000857325,0.0028305545,0.0019859807,0.0020838392,0.038122404,0.005102076],"category_scores_gemma":[0.023780908,0.0008298015,0.0012101306,0.00081036106,0.0020399836,0.0025156958,0.0014161963,0.02920221,0.005757399],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006930445,0.000026607082,0.0010759977,0.000044641674,0.00001698918,0.0009133582,0.0001221393,0.00004063539,0.00013389265,0.00039552443,0.99394083,0.0032201284],"study_design_scores_gemma":[0.00020922528,0.000261158,0.009644007,0.0005785027,0.0001113556,0.004087022,0.0011634995,0.00072760344,0.00072201487,0.0052700634,0.9769985,0.00022704476],"about_ca_topic_score_codex":0.01056337,"about_ca_topic_score_gemma":0.012219771,"teacher_disagreement_score":0.038122404,"about_ca_system_score_codex":0.0033394692,"about_ca_system_score_gemma":0.00281784,"threshold_uncertainty_score":0.024229646},"labels":[],"label_agreement":null},{"id":"W2026697154","doi":"10.1038/bjc.2011.334","title":"Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"Cancer Research UK","keywords":"Medicine; Carboplatin; Internal medicine; Placebo; Chemotherapy; Ovarian cancer; Adverse effect; Oncology; Toxicity; Surgery; Cancer; Gastroenterology; Cisplatin; Pathology","score_opus":0.035242061252903516,"score_gpt":0.3413820964353197,"score_spread":0.30614003518241617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026697154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97977245,0.005445726,0.0007262841,0.0006915206,0.0003647882,0.008290357,0.0009152741,0.00011145993,0.0036821666],"genre_scores_gemma":[0.98325205,0.002564934,0.0013853378,0.0009311075,0.00040855445,0.006992833,0.0013379955,0.00002313301,0.0031040306],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99697304,0.002231392,0.00015955696,0.00022447084,0.00015563803,0.00025583425],"domain_scores_gemma":[0.997227,0.0007569388,0.0007036228,0.00022712052,0.00016352358,0.0009217046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042048586,0.0019323556,0.0033317872,0.000580786,0.00044103258,0.0011211524,0.0011027493,0.002571664,0.0071508144],"category_scores_gemma":[0.0040485426,0.0005553328,0.002369236,0.0005911264,0.0014996699,0.00081921596,0.00067037635,0.0033246456,0.00071827916],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98572356,0.0029114888,0.00044686612,0.00036206807,0.00033515663,0.00003920615,0.000045302968,0.0003204379,0.0014165808,0.00008188902,0.00036766866,0.007949879],"study_design_scores_gemma":[0.91777414,0.07954062,0.0011067243,0.000029796978,0.00026839747,0.00003398803,0.000008549305,0.0002402025,0.00031057114,0.000084898675,0.00059293077,0.000009160701],"about_ca_topic_score_codex":0.0012747579,"about_ca_topic_score_gemma":0.0031215542,"teacher_disagreement_score":0.0071508144,"about_ca_system_score_codex":0.001444313,"about_ca_system_score_gemma":0.0021956395,"threshold_uncertainty_score":0.023921907},"labels":[],"label_agreement":null},{"id":"W2027176779","doi":"10.1038/bjc.2011.201","title":"XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"","keywords":"Folinic acid; Oxaliplatin; Medicine; Bevacizumab; Capecitabine; Internal medicine; FOLFOX; Colorectal cancer; Population; Placebo; Hazard ratio; Fluorouracil; Oncology; Neutropenia; Gastroenterology; Surgery; Chemotherapy; Cancer; Confidence interval; Pathology","score_opus":0.04379543442494756,"score_gpt":0.3317247483501661,"score_spread":0.28792931392521853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027176779","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040952843,0.88941205,0.001925014,0.006926526,0.0047582597,0.0013368274,0.033113383,0.00017518645,0.021399915],"genre_scores_gemma":[0.31543294,0.55610174,0.006146017,0.02162877,0.009201923,0.0028149143,0.07556511,0.00049742707,0.012611199],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9919734,0.0036826744,0.0013889536,0.0005756797,0.0018987831,0.00048050808],"domain_scores_gemma":[0.9805577,0.0075406963,0.0073641436,0.0007498425,0.002743948,0.0010436914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012637675,0.0012384758,0.0039224043,0.002195299,0.0003267892,0.0030047302,0.0013159028,0.0011380597,0.012049022],"category_scores_gemma":[0.024531826,0.0006987173,0.00670453,0.003085217,0.0003684565,0.0015838569,0.001417076,0.0026487946,0.0019291128],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11678814,0.0007298752,0.0076746037,0.08348391,0.029027596,0.00021983661,0.00022796844,0.0015138767,0.0026832188,0.0012341288,0.06686598,0.6895508],"study_design_scores_gemma":[0.08573972,0.037676603,0.10908697,0.052762654,0.13282603,0.0020059908,0.00030121356,0.0008375889,0.0036826918,0.0034466481,0.571193,0.00044090635],"about_ca_topic_score_codex":0.0025683371,"about_ca_topic_score_gemma":0.005294082,"teacher_disagreement_score":0.012637675,"about_ca_system_score_codex":0.0016155243,"about_ca_system_score_gemma":0.0026279958,"threshold_uncertainty_score":0.066835225},"labels":[],"label_agreement":null},{"id":"W2027177342","doi":"10.1038/sj.bjc.6602171","title":"Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"National Cancer Institute; Canadian Institutes of Health Research; American Institute for Cancer Research","keywords":"Dicoumarol; In vivo; Mitomycin C; Pharmacology; Toxicity; Ratón; NAD+ kinase; In vitro; Chemistry; Biology; Enzyme; Biochemistry; Medicine; Immunology; Internal medicine","score_opus":0.08621952986380309,"score_gpt":0.42144747229488816,"score_spread":0.33522794243108506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027177342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956245,0.0016626655,0.0011425464,0.000106630054,0.000046028923,0.000052036372,0.0003031762,0.000089818925,0.00097259507],"genre_scores_gemma":[0.9955486,0.0009802564,0.0011453999,0.000036441023,0.000016323349,0.000041726205,0.00054592564,0.000019124831,0.0016661355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998592,0.000028386536,0.000011013842,0.0000314933,0.000032007127,0.00003780984],"domain_scores_gemma":[0.99981767,0.000041617426,0.000039027076,0.000025209529,0.00002222269,0.000054404565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018670723,0.00030553734,0.0004091544,0.0002828311,0.00012993353,0.00020904787,0.00014264131,0.00029223,0.0015271759],"category_scores_gemma":[0.00017149631,0.00017440775,0.00019588097,0.00020443127,0.00019326071,0.00015015893,0.00015388736,0.0005890005,0.00031397515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030293944,0.000073510455,0.00014776696,0.000025771076,0.0000050503368,0.000014880162,0.000011090017,0.000047795496,0.99837697,0.000019725725,0.000047557696,0.0009270499],"study_design_scores_gemma":[0.00007339247,0.0031395557,0.0051094843,0.0000057885863,0.00002598905,0.00014429544,0.000019490199,0.0005455779,0.9889242,0.000016264665,0.001991782,0.000004181332],"about_ca_topic_score_codex":0.0017470355,"about_ca_topic_score_gemma":0.00334291,"teacher_disagreement_score":0.0017470355,"about_ca_system_score_codex":0.00034359779,"about_ca_system_score_gemma":0.00025216388,"threshold_uncertainty_score":0.0051089525},"labels":[],"label_agreement":null},{"id":"W2028021497","doi":"10.1038/bjc.2011.172","title":"Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute; National Institutes of Health","keywords":"PMS2; MLH1; MSH2; MSH6; Medicine; Germline mutation; Hazard ratio; Lynch syndrome; Internal medicine; Colorectal cancer; Body mass index; Oncology; Cancer; DNA mismatch repair; Genetics; Confidence interval; Mutation; Biology; Gene","score_opus":0.011324568619395283,"score_gpt":0.270149731711336,"score_spread":0.2588251630919407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028021497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906474,0.0004408216,0.00005233044,0.000024746936,0.000004454714,0.000002267921,0.00027575062,0.0000029583775,0.00013194268],"genre_scores_gemma":[0.9992306,0.00014994088,0.00006436559,0.000008698292,0.0000075667185,0.0000030367794,0.00038047635,0.0000012934295,0.0001539746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998186,0.000045574998,0.000017850201,0.000049047554,0.000027228403,0.000041682684],"domain_scores_gemma":[0.99865603,0.00029402948,0.0006222254,0.00007306795,0.000078707046,0.00027591866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005524581,0.00025504534,0.00023418582,0.0005318677,0.00016117546,0.00033282218,0.00020467781,0.00034829066,0.0011646498],"category_scores_gemma":[0.0019641004,0.00021347989,0.00046999395,0.0005031137,0.00011978233,0.0002267805,0.00028975806,0.00045109258,0.00016093835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001808653,0.000012189613,0.99914,0.0000045091633,0.00004101541,0.00002123165,0.000011190502,0.000025627067,0.000078550256,0.0000052370606,0.000023314335,0.0004562423],"study_design_scores_gemma":[0.000004204238,0.00007244551,0.9995633,0.0000028535387,0.000027337977,0.000114323535,0.00002053345,0.00011285335,0.000025838905,0.0000069716925,0.000048262475,0.0000010679137],"about_ca_topic_score_codex":0.0042556636,"about_ca_topic_score_gemma":0.0050963406,"teacher_disagreement_score":0.0042556636,"about_ca_system_score_codex":0.00017673706,"about_ca_system_score_gemma":0.00013029097,"threshold_uncertainty_score":0.008461773},"labels":[],"label_agreement":null},{"id":"W2028149292","doi":"10.1038/bjc.2013.637","title":"DICER1 hotspot mutations in non-epithelial gonadal tumours","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Vancouver General Hospital; McGill University; BC Cancer Agency; Jewish General Hospital","funders":"Medical Research Council; Sparks; Children's Cancer and Leukaemia Group; Susan G. Komen; McGill University; TD Bank","keywords":"Biology; Somatic cell; Germline mutation; Sanger sequencing; Cancer research; Mutation; Germline; Gene; Disorders of sex development; Genetics","score_opus":0.008994248972996262,"score_gpt":0.2765955895335263,"score_spread":0.26760134056053003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028149292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817216,0.0008155265,0.00015911726,0.000014036954,0.000003648206,0.000010665317,0.00018118981,0.00000962609,0.0006339563],"genre_scores_gemma":[0.99900347,0.00023401192,0.00036067728,0.000014827957,0.000004896769,0.0000040643404,0.00017882955,0.0000046666287,0.00019455001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977726,0.000029181092,0.000035284047,0.000059864065,0.00006806577,0.000030400653],"domain_scores_gemma":[0.9995542,0.00013445647,0.00016779001,0.000027162547,0.00004708204,0.00006928464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026443746,0.00019627358,0.00019333903,0.0009206487,0.00017501262,0.00019423297,0.00017458662,0.00026486942,0.0018393445],"category_scores_gemma":[0.00066144933,0.000097960394,0.00013685628,0.00053533283,0.00034477806,0.00011079233,0.00021895384,0.00013363392,0.0002693415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006060889,0.000041001596,0.8372707,0.00038153725,0.00012276518,0.022600055,0.0003588965,0.0002735196,0.11927599,0.00017936638,0.0005089007,0.01838118],"study_design_scores_gemma":[0.000056008448,0.00031992598,0.85436106,0.000038097383,0.000116420786,0.105655186,0.00016098676,0.00028914152,0.035934385,0.00018211508,0.0028734584,0.000013227508],"about_ca_topic_score_codex":0.0004029044,"about_ca_topic_score_gemma":0.0008630102,"teacher_disagreement_score":0.0018393445,"about_ca_system_score_codex":0.00021619129,"about_ca_system_score_gemma":0.00014154018,"threshold_uncertainty_score":0.006153226},"labels":[],"label_agreement":null},{"id":"W2028944115","doi":"10.1038/bjc.2014.305","title":"Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Mount Sinai Hospital; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Neutrophil to lymphocyte ratio; Proportional hazards model; Internal medicine; Urology; Bladder cancer; Receiver operating characteristic; Cohort; Gastroenterology; Log-rank test; Oncology; Lymphocyte; Cancer","score_opus":0.0068621890917840616,"score_gpt":0.2576992877885423,"score_spread":0.25083709869675824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028944115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994998,0.00026737183,0.000033692264,0.00003435518,0.0000044497733,0.0000039347387,0.000054434488,0.0000014742274,0.00010047415],"genre_scores_gemma":[0.99978966,0.00004687058,0.000030006271,0.000010181847,0.000005645043,0.0000032991177,0.00008599421,5.713058e-7,0.000027842298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997466,0.00006590499,0.00003216735,0.00004254457,0.000057047444,0.00005560342],"domain_scores_gemma":[0.99755245,0.0005945325,0.0011586053,0.00007271168,0.00019376857,0.00042796446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006609884,0.00016238564,0.0002791827,0.00035164185,0.00022730327,0.00052027224,0.00031849986,0.00034180807,0.00077039667],"category_scores_gemma":[0.0031957033,0.00012999438,0.0002154895,0.00040004763,0.0002714073,0.00032065666,0.00030930023,0.00057964155,0.00013965325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017534557,0.0000123931795,0.9989453,0.000004734457,0.000009830223,0.00005436767,0.000016207714,0.00004295381,0.000110869965,0.000003428182,0.000035862256,0.00058878073],"study_design_scores_gemma":[0.0000074896907,0.0001445459,0.99900097,0.0000047870612,0.000018566729,0.00031764834,0.000064354965,0.0002759006,0.00007143473,0.000013996335,0.00007748437,0.0000027460326],"about_ca_topic_score_codex":0.0014499789,"about_ca_topic_score_gemma":0.0020091503,"teacher_disagreement_score":0.0014499789,"about_ca_system_score_codex":0.0003877708,"about_ca_system_score_gemma":0.00047419613,"threshold_uncertainty_score":0.0034956932},"labels":[],"label_agreement":null},{"id":"W2029374754","doi":"10.1038/sj.bjc.6603508","title":"Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulin","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Inulin; Photodynamic therapy; Complement system; Adjuvant; Cancer research; Medicine; Immunology; Immune system; Chemistry; Biochemistry","score_opus":0.0071004572068327065,"score_gpt":0.3192214247781015,"score_spread":0.3121209675712688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029374754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923638,0.00498923,0.0009040698,0.000062299725,0.00002056579,0.000026111646,0.000049299728,0.000022895783,0.0015616531],"genre_scores_gemma":[0.9964456,0.0016601036,0.000751399,0.000022942846,0.000007921035,0.000012422547,0.00004992479,0.0000036716497,0.0010459917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994767,0.0000150566175,0.0000028260697,0.0000061647966,0.000009612618,0.000018543515],"domain_scores_gemma":[0.9999629,0.000009809841,0.000008878687,0.0000038716225,0.0000055764926,0.000008911168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009352527,0.0002760755,0.00015651363,0.00014624542,0.00008758774,0.00014244979,0.0001531782,0.00019040261,0.0008079377],"category_scores_gemma":[0.00006863532,0.000047298603,0.00012567955,0.00009705588,0.00013138186,0.000121323144,0.000106179505,0.00020288286,0.00010228444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019595781,0.000048041908,0.00010341841,0.000057053465,0.0000046386726,0.0000384935,0.000008727698,0.00008860064,0.99689096,0.000059942126,0.000020233738,0.0024839744],"study_design_scores_gemma":[0.000011012843,0.00078038994,0.0015353402,0.0000063635653,0.000012089659,0.00016814751,0.0000071317636,0.00018925844,0.99598193,0.000017804254,0.001288157,0.0000023541643],"about_ca_topic_score_codex":0.000704461,"about_ca_topic_score_gemma":0.00089245103,"teacher_disagreement_score":0.0008079377,"about_ca_system_score_codex":0.00019732908,"about_ca_system_score_gemma":0.00015860188,"threshold_uncertainty_score":0.0027028322},"labels":[],"label_agreement":null},{"id":"W2029712223","doi":"10.1038/bjc.2012.21","title":"A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Carboplatin; Medicine; Etoposide; Adverse effect; Clinical endpoint; Internal medicine; Chemotherapy; Anesthesia; Clinical trial; Cisplatin","score_opus":0.02277835739252881,"score_gpt":0.3474266205460649,"score_spread":0.32464826315353607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029712223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963898,0.00093531696,0.00020544992,0.0001800064,0.00005409254,0.0012243646,0.00025600594,0.000038041544,0.0007169355],"genre_scores_gemma":[0.99355066,0.0011684294,0.0009282873,0.00047189096,0.00010887568,0.0016325468,0.0009202415,0.000015292404,0.0012038776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997907,0.000091013215,0.0000126236055,0.000039887655,0.000016289812,0.000049446324],"domain_scores_gemma":[0.9992409,0.00011490336,0.0001481824,0.00004262581,0.000033117674,0.00042034793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010370906,0.0013490706,0.0017231405,0.0003047443,0.00042213954,0.0007557127,0.0008832167,0.0010555685,0.0028462235],"category_scores_gemma":[0.0006420852,0.0004217431,0.0008828313,0.0003809687,0.0010415412,0.00065827725,0.00031621312,0.0029187915,0.0005693796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83513814,0.058432586,0.005506434,0.00068272476,0.0008304688,0.00025571263,0.00026880615,0.0023905642,0.03671749,0.00017871242,0.0021148445,0.057483405],"study_design_scores_gemma":[0.5412202,0.4461374,0.007096237,0.000027743281,0.00027989273,0.00022017043,0.000049743026,0.0009497427,0.002804885,0.00013145448,0.001063605,0.000018930048],"about_ca_topic_score_codex":0.00081861275,"about_ca_topic_score_gemma":0.0021726938,"teacher_disagreement_score":0.0028462235,"about_ca_system_score_codex":0.0007657891,"about_ca_system_score_gemma":0.0016781898,"threshold_uncertainty_score":0.009521544},"labels":[],"label_agreement":null},{"id":"W2029739752","doi":"10.1038/sj.bjc.6602933","title":"Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University Health Centre; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Burroughs Wellcome Fund","keywords":"Gene expression profiling; Ovarian cancer; Epithelial ovarian cancer; Biology; Gene expression; Cancer research; Gene; Profiling (computer programming); Pathology; Computational biology; Oncology; Cancer; Medicine; Genetics; Computer science","score_opus":0.007671174781372509,"score_gpt":0.2647239156067567,"score_spread":0.25705274082538415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029739752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930266,0.00084023026,0.004830808,0.000059269405,0.000016543181,0.000035743153,0.0006689368,0.000039486153,0.00048243967],"genre_scores_gemma":[0.98870707,0.0007283377,0.0076289913,0.000053137104,0.000021420043,0.00008204324,0.0021398503,0.0000100982725,0.0006290273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998171,0.00002760034,0.000015086803,0.000041326704,0.00005781471,0.000041045983],"domain_scores_gemma":[0.99969494,0.00015239426,0.00003150777,0.000029152181,0.000059752027,0.0000324061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026706693,0.0001593872,0.00049174903,0.0003368783,0.00017569949,0.00038617145,0.00008651441,0.0001996265,0.0004306556],"category_scores_gemma":[0.00066349114,0.00010210494,0.00019991395,0.0003743944,0.00021365052,0.00012881082,0.00013158836,0.0003032913,0.00023397895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013027347,0.000028862509,0.011899725,0.00003963334,0.000009998598,0.00003273977,0.000040969702,0.00027333418,0.9832013,0.000029290031,0.00006434158,0.0042496123],"study_design_scores_gemma":[0.000018044371,0.0007085435,0.32338023,0.000010146949,0.000075212134,0.00038511126,0.00027253153,0.009213443,0.6635031,0.00018124266,0.0022374005,0.00001497321],"about_ca_topic_score_codex":0.00072424405,"about_ca_topic_score_gemma":0.0014432246,"teacher_disagreement_score":0.00072424405,"about_ca_system_score_codex":0.00022183415,"about_ca_system_score_gemma":0.00020652032,"threshold_uncertainty_score":0.0016095042},"labels":[],"label_agreement":null},{"id":"W2029743705","doi":"10.1038/sj.bjc.6602796","title":"Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Vancouver General Hospital; Université de Montréal; Concordia University; Hôpital du Sacré-Cœur de Montréal; University of British Columbia; MAB-Mackay Rehabilitation Centre","funders":"Canadian Prostate Cancer Research Initiative; Cancer Research Society","keywords":"RELB; Prostate cancer; Transcription factor; Cancer research; Immunohistochemistry; Cell nucleus; Biology; P50; Cancer; Protein subunit; Pathology; Medicine; Internal medicine; Nucleus; Cell biology; Gene; Genetics","score_opus":0.012822568527421509,"score_gpt":0.27426325665098655,"score_spread":0.261440688123565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029743705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95386356,0.03926141,0.0041158237,0.00012271745,0.000032307747,0.000023565886,0.00017290511,0.000047328132,0.0023603889],"genre_scores_gemma":[0.98829263,0.00829305,0.0020267966,0.000036593403,0.000040212573,0.00002249727,0.00022623879,0.000006466571,0.0010555371],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998715,0.000021083213,0.000011923256,0.000031261952,0.000039130213,0.000025177631],"domain_scores_gemma":[0.99989617,0.000019934816,0.000018735886,0.00001050487,0.00002821022,0.000026463518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027660455,0.00014977399,0.00013190418,0.0006752589,0.00023662127,0.00022861281,0.00016845395,0.00016727748,0.0010247568],"category_scores_gemma":[0.00016444287,0.0001703509,0.00011645957,0.0006752447,0.00035078105,0.00029515853,0.00022323453,0.00019175411,0.00031246178],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038273743,0.00007268235,0.04622448,0.00041652573,0.000063022744,0.00088046736,0.0002644278,0.00013529422,0.9340543,0.00026689188,0.00024213846,0.016997052],"study_design_scores_gemma":[0.00010475684,0.001577135,0.7345739,0.00009595992,0.0003357911,0.028440956,0.0011761041,0.0023413724,0.200042,0.00077557226,0.030481702,0.000054687942],"about_ca_topic_score_codex":0.00092173397,"about_ca_topic_score_gemma":0.0010582826,"teacher_disagreement_score":0.0010247568,"about_ca_system_score_codex":0.00021045239,"about_ca_system_score_gemma":0.0001612877,"threshold_uncertainty_score":0.0034281611},"labels":[],"label_agreement":null},{"id":"W2029833118","doi":"10.1054/bjoc.1999.1127","title":"Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council","keywords":"Activin type 2 receptors; Antibody; SMAD; Ovarian carcinoma; Receptor; Biology; Endocrinology; Internal medicine; Activin receptor; Cancer research; Western blot; Polyclonal antibodies; Cell culture; Signal transduction; Messenger RNA; Ovarian cancer; Molecular biology; Transforming growth factor; Cancer; Cell biology; Medicine; Immunology; TGF beta signaling pathway; Gene; Biochemistry","score_opus":0.005415904962909668,"score_gpt":0.2275070726240145,"score_spread":0.22209116766110484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029833118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595684,0.0017315116,0.0007605046,0.000057718666,0.0000140871125,0.000009992766,0.000114737915,0.000021943208,0.001332612],"genre_scores_gemma":[0.9963331,0.00083507696,0.00050722534,0.00002390533,0.0000070050487,0.000018686811,0.00035065718,0.000005381678,0.0019189314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998872,0.00001727415,0.000009237337,0.00001626132,0.000047189358,0.00002281978],"domain_scores_gemma":[0.9998821,0.00002991986,0.000020606316,0.000023611743,0.000018062794,0.000025667681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010378561,0.00015645992,0.00014155867,0.0002804518,0.00012814191,0.0003112986,0.000073836454,0.00015701214,0.0014211615],"category_scores_gemma":[0.00018549828,0.00008637634,0.0000977966,0.00018578078,0.00021912028,0.00015385187,0.00015527273,0.00024570283,0.00034344385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109698856,0.000013570821,0.0014155847,0.000026245525,0.0000025002357,0.00017833378,0.000044504093,0.000018691653,0.99662364,0.00012962124,0.000022134844,0.0014155038],"study_design_scores_gemma":[0.00003290355,0.0005400588,0.052350752,0.000010833348,0.000031957217,0.0027220284,0.0003205642,0.00071011164,0.93315554,0.00020450522,0.009913244,0.00000762987],"about_ca_topic_score_codex":0.0004918147,"about_ca_topic_score_gemma":0.00035395956,"teacher_disagreement_score":0.0014211615,"about_ca_system_score_codex":0.00018500404,"about_ca_system_score_gemma":0.00014671822,"threshold_uncertainty_score":0.0047542453},"labels":[],"label_agreement":null},{"id":"W2030074595","doi":"10.1038/sj.bjc.6600012","title":"Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"Medicine; Relative risk; Miscarriage; Confidence interval; Pediatrics; Cohort study; Cohort; Gestation; Risk factor; Pregnancy; Obstetrics; Internal medicine","score_opus":0.016442534108378773,"score_gpt":0.2749635731068426,"score_spread":0.25852103899846385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030074595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732274,0.0009128185,0.00011162965,0.00007313887,0.000012605108,0.000008254491,0.000741912,0.0000042698457,0.00081273704],"genre_scores_gemma":[0.9980506,0.0007664526,0.000054115513,0.000026966549,0.000012261994,0.000007889247,0.00048441594,0.000004253293,0.00059308484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935967,0.00015920769,0.0000568676,0.00015611657,0.000074640135,0.00019354677],"domain_scores_gemma":[0.9982786,0.00023069345,0.0005141944,0.00024975615,0.00019608633,0.00053062604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061459636,0.0003175984,0.00043663732,0.0010672886,0.0011247243,0.00087418023,0.00043020837,0.00052438135,0.0029329124],"category_scores_gemma":[0.0023024192,0.00076639216,0.0004775021,0.0018086822,0.0005365474,0.0007069939,0.0007702282,0.0010877568,0.0004313473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024190656,0.00007226601,0.99706954,0.000017378945,0.000117839416,0.00027445532,0.00041795772,0.000042125866,0.0003147621,0.000059382866,0.00013855881,0.0012338834],"study_design_scores_gemma":[0.000008796907,0.00013299203,0.9981394,0.000009979797,0.000059959297,0.0006025486,0.00032820928,0.00002734583,0.000064938824,0.00001922895,0.00060051406,0.000006025419],"about_ca_topic_score_codex":0.031105762,"about_ca_topic_score_gemma":0.028684538,"teacher_disagreement_score":0.031105762,"about_ca_system_score_codex":0.00063826126,"about_ca_system_score_gemma":0.0005177813,"threshold_uncertainty_score":0.061849415},"labels":[],"label_agreement":null},{"id":"W2030522586","doi":"10.1038/sj.bjc.6600013","title":"The effects of tricyclic antidepressants on breast cancer risk","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Cancer Research Institute","keywords":"Tricyclic; Breast cancer; Medicine; Tricyclic antidepressant; Population; Internal medicine; Cancer; Cancer registry; Confidence interval; Medical prescription; Antidepressant; Oncology; Pharmacology; Environmental health","score_opus":0.005066163343384773,"score_gpt":0.25140190104961263,"score_spread":0.24633573770622785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030522586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477661,0.04029236,0.00024510396,0.0008575701,0.00006593487,0.00003195608,0.0013105827,0.000014499103,0.009415898],"genre_scores_gemma":[0.98615175,0.010990132,0.0002541431,0.00019805484,0.00007298806,0.000007921967,0.0003588626,0.0000036235456,0.0019626373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950945,0.0002820828,0.000034169003,0.000036361267,0.0001001555,0.000037678532],"domain_scores_gemma":[0.9972882,0.0015466707,0.0005395619,0.00013197462,0.00031819192,0.00017547105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000598077,0.0002557098,0.00032924308,0.00050576957,0.00020427966,0.00035241107,0.00017628382,0.0005865071,0.0031446638],"category_scores_gemma":[0.0035942977,0.00020693288,0.00059096835,0.0003556396,0.00017276402,0.00015088734,0.00019579973,0.0003625237,0.00040376015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02496334,0.00030862304,0.80506194,0.0005121549,0.001817415,0.0010523449,0.00019003516,0.00085003744,0.012938928,0.00042466866,0.00090298045,0.15097754],"study_design_scores_gemma":[0.000054620825,0.001634164,0.99296266,0.000043192482,0.0006855666,0.0007796896,0.00005175323,0.0002308031,0.0017302303,0.0001134016,0.0017068489,0.0000070328197],"about_ca_topic_score_codex":0.0063683176,"about_ca_topic_score_gemma":0.0085752355,"teacher_disagreement_score":0.0063683176,"about_ca_system_score_codex":0.00036175555,"about_ca_system_score_gemma":0.00026229082,"threshold_uncertainty_score":0.01266247},"labels":[],"label_agreement":null},{"id":"W2030646983","doi":"10.1038/sj.bjc.6605727","title":"Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Terry Fox Foundation; Michael Smith Health Research BC","keywords":"Gemcitabine; Pancreatic cancer; Medicine; Hypoxia (environmental); Oncology; Internal medicine; Pancreatic ductal adenocarcinoma; Cancer; Apoptosis; Cancer research; Biology; Chemistry","score_opus":0.004677069748060372,"score_gpt":0.23605263962634418,"score_spread":0.2313755698782838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030646983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985903,0.000802661,0.00022101488,0.000030034253,0.0000068989634,0.0000077064415,0.00006101418,0.000017739249,0.0002625959],"genre_scores_gemma":[0.99885154,0.00041410475,0.00025854452,0.000015081637,0.0000029337132,0.000011344268,0.00013247516,0.0000053119693,0.00030865092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999429,0.000014304726,0.000006847609,0.000007735832,0.000015914608,0.000012311985],"domain_scores_gemma":[0.999964,0.000007624184,0.000010919973,0.000005330148,0.0000033461977,0.000008712574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071743045,0.00013485177,0.0002175328,0.00010776249,0.00008968036,0.00015929922,0.0000919867,0.00013554831,0.0005713685],"category_scores_gemma":[0.00011588718,0.000091224276,0.0000911688,0.00013571372,0.0000933622,0.000100534184,0.0000964832,0.0002508857,0.00009719805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009835042,0.00012956993,0.0010282887,0.0000659619,0.000012877885,0.00004777784,0.00001997105,0.00024828184,0.9903852,0.00003414206,0.00009687611,0.0069476585],"study_design_scores_gemma":[0.00019907209,0.007624859,0.042836774,0.000009004706,0.000059407328,0.0010380147,0.00006529784,0.0014585727,0.9429922,0.00006007149,0.0036481468,0.000008615243],"about_ca_topic_score_codex":0.00032600906,"about_ca_topic_score_gemma":0.0007271306,"teacher_disagreement_score":0.0005713685,"about_ca_system_score_codex":0.00019218388,"about_ca_system_score_gemma":0.0001069413,"threshold_uncertainty_score":0.0019114017},"labels":[],"label_agreement":null},{"id":"W2030988924","doi":"10.1038/sj.bjc.6600332","title":"Prognostic impact of chromosomal aberrations in Ewing tumours","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"Hospital for Sick Children; Sick Kids Foundation","keywords":"Cytogenetics; Pathognomonic; Survival analysis; Internal medicine; Chromosome; Adverse effect; Oncology; Biology; Medicine; Pathology; Disease; Genetics; Gene","score_opus":0.027262936804394025,"score_gpt":0.31805423932157695,"score_spread":0.29079130251718294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030988924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843305,0.0008596119,0.00016668286,0.000029423296,0.0000034138893,0.0000026555645,0.00007714805,0.0000057941106,0.00042217525],"genre_scores_gemma":[0.9994623,0.00022339445,0.00008870717,0.000004373388,0.000006459049,0.0000016436547,0.000098795936,0.0000020753544,0.00011225226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977297,0.00005338181,0.000028449642,0.000041545536,0.000063747604,0.00003988436],"domain_scores_gemma":[0.99883574,0.00045804025,0.00039536916,0.00004984307,0.000102801336,0.00015827893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037036752,0.00020319725,0.00026814645,0.00096609915,0.00018422601,0.00034191628,0.00014513033,0.00023412802,0.0011991913],"category_scores_gemma":[0.0025964058,0.00012687597,0.00010356268,0.0006104195,0.00039357823,0.0003431493,0.0003835215,0.00022895419,0.00018031368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058164663,0.000013565437,0.9668132,0.00003441175,0.000042395448,0.0009831139,0.00010548911,0.00042223866,0.012871339,0.00007544937,0.00009705933,0.017960213],"study_design_scores_gemma":[0.000008229135,0.00013367037,0.9943474,0.0000070772335,0.000032810047,0.0031611999,0.000077021636,0.00032395017,0.0013256754,0.00020655073,0.000368879,0.000007558692],"about_ca_topic_score_codex":0.00050016947,"about_ca_topic_score_gemma":0.0010158491,"teacher_disagreement_score":0.0011991913,"about_ca_system_score_codex":0.00019241747,"about_ca_system_score_gemma":0.00009967668,"threshold_uncertainty_score":0.0040116906},"labels":[],"label_agreement":null},{"id":"W2031505107","doi":"10.1038/bjc.2014.215","title":"Oncogenic KRAS signalling in pancreatic cancer","year":2014,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":501,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutschen Konsortium für Translationale Krebsforschung; Partenariat Canadien Contre Le Cancer; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"KRAS; Pancreatic cancer; Context (archaeology); Druggability; Cancer research; Cancer; Biology; Pancreatic Intraepithelial Neoplasia; Effector; Medicine; Bioinformatics; Oncology; Internal medicine; Colorectal cancer; Immunology; Gene; Genetics","score_opus":0.06952848065448751,"score_gpt":0.4345967426747374,"score_spread":0.3650682620202499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031505107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009839493,0.99890316,0.000039457806,0.00017793925,0.00012687164,0.0000022280703,0.000012386607,0.0000056323893,0.0006338762],"genre_scores_gemma":[0.0004532447,0.99891746,0.000048526064,0.0000791127,0.00007156902,0.000002171931,0.000017605624,6.874767e-7,0.00040965097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998436,0.000021630824,0.000024411323,0.000023733961,0.00006854498,0.000017986415],"domain_scores_gemma":[0.99981076,0.00006234062,0.000031332795,0.0000058637565,0.00006375871,0.000025911295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004180534,0.00063630944,0.0010044255,0.002332944,0.00026402128,0.00083833485,0.0006215755,0.00083585817,0.003226009],"category_scores_gemma":[0.00050165795,0.00026512993,0.00039434608,0.0021902744,0.00035435663,0.00087613484,0.00063972134,0.0013251102,0.0029163463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010477132,0.000056523604,0.0002113883,0.013310998,0.000073440555,0.00023346394,0.000044964778,0.0002726343,0.0018878018,0.0017661902,0.032419905,0.94961786],"study_design_scores_gemma":[0.000017917295,0.0000813931,0.0009567066,0.0029417041,0.00009120673,0.0016809446,0.00004689962,0.000057862013,0.00059218414,0.0011951496,0.9923218,0.000016237655],"about_ca_topic_score_codex":0.001093745,"about_ca_topic_score_gemma":0.0019156192,"teacher_disagreement_score":0.003226009,"about_ca_system_score_codex":0.0006682573,"about_ca_system_score_gemma":0.0010312005,"threshold_uncertainty_score":0.010792077},"labels":[],"label_agreement":null},{"id":"W2032045378","doi":"10.1038/bjc.2013.34","title":"Innovative estimation of survival using log-normal survival modelling on ACCENT database","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health; Queen's University","keywords":"Proportional hazards model; Survival analysis; Medicine; Internal medicine; Relative survival; Hazard ratio; Colorectal cancer; Cancer; Surgery; Oncology; Cancer registry; Confidence interval","score_opus":0.17798926306323487,"score_gpt":0.416067982778762,"score_spread":0.23807871971552713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032045378","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3593654,0.0012054368,0.59756064,0.0012497068,0.00011485636,0.0006879011,0.030346287,0.0051080463,0.004361656],"genre_scores_gemma":[0.82554215,0.0004894756,0.1427525,0.00021671,0.0000823822,0.0005985804,0.028815305,0.00020101204,0.0013018644],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99376255,0.004353174,0.00031974306,0.0008481383,0.00056577986,0.00015064394],"domain_scores_gemma":[0.96493584,0.027565055,0.0018800831,0.0037074117,0.0016301796,0.0002814124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015166924,0.00064127153,0.0008844172,0.0017876958,0.00026105414,0.0016702525,0.0016162089,0.00076295703,0.002642212],"category_scores_gemma":[0.04195227,0.0003553817,0.0013479815,0.001774328,0.00042297092,0.0011888519,0.0010553584,0.0012394553,0.0006780965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025010288,0.00038831934,0.18558462,0.00051798404,0.00090375205,0.0004497209,0.0005664029,0.59059566,0.0012636548,0.021952841,0.014222939,0.18105312],"study_design_scores_gemma":[0.000108566215,0.00021784542,0.01853192,0.000051642055,0.000097516015,0.00024821472,0.00007630338,0.9618372,0.0007959173,0.012015588,0.0059750983,0.000044208755],"about_ca_topic_score_codex":0.011693577,"about_ca_topic_score_gemma":0.0077197975,"teacher_disagreement_score":0.015166924,"about_ca_system_score_codex":0.0012134279,"about_ca_system_score_gemma":0.0016105054,"threshold_uncertainty_score":0.08021134},"labels":[],"label_agreement":null},{"id":"W2032063018","doi":"10.1038/sj.bjc.6600933","title":"Smoking and breast cancer","year":2003,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.014309255255431735,"score_gpt":0.2900620670236459,"score_spread":0.27575281176821415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032063018","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001987136,0.02282054,0.000107050015,0.9235544,0.04570978,0.000024937237,0.000101639715,0.00003905811,0.005655301],"genre_scores_gemma":[0.018831516,0.023136176,0.00035881405,0.7979489,0.14395489,0.00006671919,0.00009908732,0.000026620126,0.015577264],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998889,0.00030221764,0.00020713234,0.00015857627,0.0003385873,0.00010457449],"domain_scores_gemma":[0.9974578,0.0012894409,0.00024674178,0.00012235437,0.00049160956,0.0003921521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011453704,0.00071685686,0.0012970003,0.0004679731,0.0012691922,0.0011913895,0.00077279145,0.016486088,0.0050359317],"category_scores_gemma":[0.008463863,0.00051263184,0.00088690623,0.0006668567,0.00081900327,0.0018925528,0.0005829428,0.014070485,0.004356891],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019903932,0.00009218281,0.0048912237,0.0003747444,0.00005446021,0.007875026,0.00020751244,0.0000632532,0.00043599616,0.0015613899,0.933678,0.05056727],"study_design_scores_gemma":[0.00018069783,0.000230465,0.010673808,0.0010813302,0.000104103536,0.025452763,0.00034824273,0.00036223567,0.00026567344,0.0045051905,0.95674485,0.00005072416],"about_ca_topic_score_codex":0.002936783,"about_ca_topic_score_gemma":0.005813628,"teacher_disagreement_score":0.016486088,"about_ca_system_score_codex":0.0014417142,"about_ca_system_score_gemma":0.0010142085,"threshold_uncertainty_score":0.016846895},"labels":[],"label_agreement":null},{"id":"W2032397328","doi":"10.1038/sj.bjc.6605187","title":"Societal preference values for advanced melanoma health states in the United Kingdom and Australia","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Preference; Medicine; Unintended consequences; Environmental health; Population; Health economics; Melanoma; Demography; Family medicine; Public economics; Public health; Political science; Economics; Pathology; Sociology; Cancer research","score_opus":0.423800755621011,"score_gpt":0.47890601611921435,"score_spread":0.05510526049820336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032397328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943856,0.0007486816,0.00045363454,0.0003793146,0.000006059285,0.000027005037,0.0005886223,0.0000022101856,0.0034090148],"genre_scores_gemma":[0.9994449,0.00011391843,0.00013388289,0.00003147016,0.0000013694769,0.000009794011,0.00013683632,5.949766e-7,0.00012739997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737763,0.0017742072,0.00021240667,0.000120745295,0.0003750844,0.00013998822],"domain_scores_gemma":[0.9950121,0.002225722,0.001393108,0.0001863279,0.0008086983,0.00037400462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036390317,0.00015084186,0.00033780822,0.0013267247,0.00022725583,0.00094181707,0.00016160759,0.00033388016,0.0020314036],"category_scores_gemma":[0.018602993,0.0001008699,0.0005741584,0.001070667,0.0003864867,0.0007358589,0.00078528235,0.00038622887,0.00011950737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009771816,0.000114352835,0.9151658,0.0003857977,0.0009394113,0.0005702694,0.0038279195,0.009757239,0.0003563237,0.0058313156,0.0026633411,0.059410997],"study_design_scores_gemma":[0.000047102196,0.00039018365,0.9779846,0.00019977688,0.00013517954,0.0006676335,0.0029121514,0.010113927,0.00013585662,0.0052269166,0.002142004,0.00004467038],"about_ca_topic_score_codex":0.017329019,"about_ca_topic_score_gemma":0.027791029,"teacher_disagreement_score":0.017329019,"about_ca_system_score_codex":0.0018768294,"about_ca_system_score_gemma":0.00041805973,"threshold_uncertainty_score":0.034456253},"labels":[],"label_agreement":null},{"id":"W2032402100","doi":"10.1038/sj.bjc.6603978","title":"Reply: Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Mutation; Breast cancer; Cancer; Cancer research; Medicine; DNA repair; Oncology; Genetics; DNA; Biology; Internal medicine; Gene","score_opus":0.006853715373333404,"score_gpt":0.2793265579012389,"score_spread":0.2724728425279055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032402100","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015376793,0.003967918,0.0003761196,0.9633315,0.029936895,0.00002663883,0.00026598456,0.00004431381,0.00051292503],"genre_scores_gemma":[0.009431004,0.0041477666,0.0008334289,0.93912005,0.04287163,0.00007856629,0.00015488948,0.000029334762,0.0033333674],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978034,0.00077830587,0.00054602046,0.00035185952,0.0003459931,0.00017448993],"domain_scores_gemma":[0.97655016,0.016694712,0.0010436052,0.00064101786,0.004103397,0.00096708705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006381783,0.0010688966,0.0016757279,0.000833089,0.0011223456,0.0012692835,0.0028798087,0.024556154,0.005554566],"category_scores_gemma":[0.041830637,0.00067475776,0.0010937403,0.00091302075,0.0020706938,0.0036362337,0.0011721597,0.022928137,0.00450611],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047211876,0.00009228711,0.005867407,0.0006692477,0.000116687654,0.0036487943,0.00043426867,0.00019137129,0.0009995593,0.001979088,0.9647767,0.020752456],"study_design_scores_gemma":[0.0007860269,0.00071590685,0.02679311,0.0011821846,0.0004859332,0.026231857,0.0037590947,0.001830304,0.0034286242,0.01902539,0.91516614,0.0005954062],"about_ca_topic_score_codex":0.0035306416,"about_ca_topic_score_gemma":0.0026486986,"teacher_disagreement_score":0.024556154,"about_ca_system_score_codex":0.0011298815,"about_ca_system_score_gemma":0.0010808773,"threshold_uncertainty_score":0.033750474},"labels":[],"label_agreement":null},{"id":"W2032698893","doi":"10.1038/sj.bjc.6603528","title":"DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Coalition for Research in Women's Health; London Health Sciences Centre; Women's College Hospital","funders":"Cancer Research UK; London Health Sciences Centre","keywords":"DNA damage; DNA repair; Comet assay; Breast cancer; Biology; Cancer; Cancer research; Biomarker; Mutation; Synthetic lethality; DNA; Genetics; Molecular biology; Gene","score_opus":0.010906726076006179,"score_gpt":0.2888021234281337,"score_spread":0.27789539735212754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032698893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903095,0.0006078412,0.000089843554,0.000029090535,0.0000023260545,0.0000036113117,0.000057685404,0.000004892483,0.00017360377],"genre_scores_gemma":[0.99949765,0.00012070529,0.00012931731,0.00001206684,0.000004522243,0.000005165717,0.000055436893,0.0000014987971,0.0001735981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997769,0.00008147925,0.000017730035,0.00004437709,0.000050537223,0.000028904582],"domain_scores_gemma":[0.99898976,0.0004912301,0.00029345002,0.000040976636,0.000081234466,0.00010331878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051105476,0.000315246,0.0004710053,0.0013449372,0.00020889383,0.00036749634,0.00016074463,0.0004778158,0.0017470889],"category_scores_gemma":[0.0027899023,0.00016868427,0.000098585915,0.00045933216,0.00022323687,0.00017926386,0.0001851408,0.00023644106,0.000251792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016864365,0.0001477522,0.94624484,0.0000656964,0.00006752684,0.00062265707,0.00040924049,0.00012850763,0.03804266,0.000052790198,0.0001598236,0.012372091],"study_design_scores_gemma":[0.000016431675,0.0009256173,0.988437,0.000013620687,0.000079914484,0.0023282494,0.0002333276,0.00033909653,0.0070041455,0.00010580761,0.00050700246,0.000009733524],"about_ca_topic_score_codex":0.00089724705,"about_ca_topic_score_gemma":0.00057389744,"teacher_disagreement_score":0.0017470889,"about_ca_system_score_codex":0.00013392846,"about_ca_system_score_gemma":0.00009826024,"threshold_uncertainty_score":0.0058446527},"labels":[],"label_agreement":null},{"id":"W2032778349","doi":"10.1038/sj.bjc.6604072","title":"In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Breast Cancer Alliance","keywords":"Matrigel; Basement membrane; Breast cancer; Cancer research; Cancer cell; Matrix metalloproteinase; Pathology; Cancer; Biology; Downregulation and upregulation; Cell culture; Medicine; Internal medicine; Angiogenesis","score_opus":0.005180198040301306,"score_gpt":0.24855747926222857,"score_spread":0.24337728122192726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032778349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818252,0.010563826,0.0033175047,0.000106142164,0.00011741586,0.000060653805,0.00048329536,0.000105272775,0.0034207231],"genre_scores_gemma":[0.9786099,0.008290891,0.0056483643,0.0000878863,0.000060742575,0.0001061151,0.001906713,0.000036702135,0.0052525373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996966,0.00009251315,0.000025077523,0.000042500185,0.00007679894,0.00006667274],"domain_scores_gemma":[0.99987376,0.000047497593,0.000022839396,0.000020092515,0.000016057542,0.000019682575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034359092,0.0005732155,0.00045383268,0.00024315402,0.000159329,0.00028615072,0.0001933619,0.00022473434,0.0016781284],"category_scores_gemma":[0.00012588993,0.00026134326,0.0006069848,0.0002683321,0.00012260734,0.00013656258,0.00019668984,0.0006851736,0.0005141221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010665595,0.000087040506,0.0000926757,0.000084892396,0.000011403725,0.000047180165,0.000036269073,0.00007630459,0.9986681,0.000030644755,0.000051630566,0.0007072022],"study_design_scores_gemma":[0.000030242643,0.0018430327,0.0050077518,0.000018383036,0.000045870172,0.00021827158,0.00002400288,0.0008263284,0.98945695,0.000031237305,0.0024905193,0.0000074551654],"about_ca_topic_score_codex":0.0009907485,"about_ca_topic_score_gemma":0.0016841135,"teacher_disagreement_score":0.0016781284,"about_ca_system_score_codex":0.00022559718,"about_ca_system_score_gemma":0.00015442402,"threshold_uncertainty_score":0.005613923},"labels":[],"label_agreement":null},{"id":"W2032931702","doi":"10.1038/sj.bjc.6600906","title":"Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca; University of Alberta","keywords":"Angiogenesis; Nitric oxide; Chemistry; Pharmacology; In vivo; Biochemistry; Cell growth; Endothelial stem cell; Cancer research; In vitro; Biology","score_opus":0.04903399066040607,"score_gpt":0.2568546937617395,"score_spread":0.20782070310133346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032931702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955382,0.0020562278,0.0011334055,0.00004103341,0.000016342445,0.000023025428,0.00008927342,0.000034803023,0.0010676048],"genre_scores_gemma":[0.9966047,0.0007611002,0.0015845273,0.00003063807,0.000008983925,0.000012928168,0.00014408756,0.0000065658255,0.0008465267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993277,0.00002533893,0.000004990954,0.000009073799,0.00001284308,0.000014929409],"domain_scores_gemma":[0.99993944,0.000013484537,0.00001912152,0.00000487479,0.000010559001,0.000012457356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013235825,0.00022336184,0.00015582953,0.00012310945,0.000058725625,0.00010128618,0.0001257191,0.000185186,0.0007358186],"category_scores_gemma":[0.00012263295,0.000071543756,0.00011611627,0.00007749649,0.00008197426,0.00007761801,0.000064011336,0.00017019878,0.00013842464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017637189,0.000029695113,0.0000722608,0.000048690665,0.0000055602113,0.0000294826,0.000007188137,0.00008535484,0.9978357,0.000040905496,0.000040211522,0.0016285086],"study_design_scores_gemma":[0.00003612481,0.0011152115,0.0014034567,0.000004859731,0.00001814757,0.00019132433,0.000006771021,0.0005354202,0.99534,0.0000147783,0.0013304976,0.0000034088584],"about_ca_topic_score_codex":0.00020922894,"about_ca_topic_score_gemma":0.00023499932,"teacher_disagreement_score":0.0007358186,"about_ca_system_score_codex":0.000090815556,"about_ca_system_score_gemma":0.000057847374,"threshold_uncertainty_score":0.0024615526},"labels":[],"label_agreement":null},{"id":"W2033008724","doi":"10.1038/sj.bjc.6606074","title":"Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genentech","keywords":"Bevacizumab; Medicine; Colorectal cancer; Adverse effect; Placebo; Internal medicine; Surgery; Clinical trial; Lung cancer; Cancer; Oncology; Chemotherapy; Pathology","score_opus":0.028596045017725023,"score_gpt":0.2997507750314482,"score_spread":0.2711547300137232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033008724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938205,0.0041337213,0.000102682265,0.00014251357,0.000042737687,0.00020950417,0.00035910675,0.000007710642,0.001181483],"genre_scores_gemma":[0.99806017,0.00063510076,0.0001350585,0.0002483587,0.00004615407,0.00016743985,0.0005116807,0.0000018117483,0.00019419196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990324,0.0004641102,0.00014333038,0.000113685855,0.000159384,0.000087100576],"domain_scores_gemma":[0.9974763,0.00070283725,0.00097326585,0.00012322309,0.00020258976,0.000521788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013903427,0.0001944481,0.0011063557,0.00028111596,0.0004403623,0.00065562857,0.00018414047,0.00065817224,0.0015861569],"category_scores_gemma":[0.0052039023,0.00017916373,0.00089522963,0.00064452353,0.00024499896,0.0003187833,0.00025483774,0.0008340335,0.00013700748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14904004,0.0033035323,0.78747505,0.000803589,0.0030305248,0.00094396336,0.00043698424,0.000308273,0.0041072527,0.00013468208,0.0018668029,0.048549335],"study_design_scores_gemma":[0.0260514,0.0633677,0.897181,0.00017828334,0.0025843033,0.0022127412,0.00016848311,0.0007791679,0.001189765,0.00025565518,0.0059760227,0.00005548464],"about_ca_topic_score_codex":0.00075954606,"about_ca_topic_score_gemma":0.0010746778,"teacher_disagreement_score":0.0015861569,"about_ca_system_score_codex":0.00050942495,"about_ca_system_score_gemma":0.00064761826,"threshold_uncertainty_score":0.0073528886},"labels":[],"label_agreement":null},{"id":"W2033102749","doi":"10.1038/sj.bjc.6602331","title":"Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University Health Network; McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Princess Margaret Hospital Foundation","keywords":"Photodynamic therapy; Singlet oxygen; In vivo; Luminescence; Photochemistry; Biophysics; Oxygen; Reactive oxygen species; Chemistry; Materials science; Optoelectronics; Biochemistry; Biology; Organic chemistry","score_opus":0.01651773018169987,"score_gpt":0.32523683970004047,"score_spread":0.3087191095183406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033102749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583791,0.0028739278,0.03655532,0.00009646776,0.00006749832,0.0003074127,0.0004091402,0.0003144802,0.0009966063],"genre_scores_gemma":[0.97040176,0.0023074541,0.024297696,0.00007244872,0.000026140979,0.00044077056,0.00046361896,0.00013329732,0.0018567622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901617,0.0002892872,0.000061894876,0.00027211336,0.00025974208,0.00010077611],"domain_scores_gemma":[0.99942684,0.0001289536,0.00013999666,0.000097150194,0.00013396502,0.00007322945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012760711,0.0011564586,0.0006063068,0.00063347793,0.0003632298,0.00053348095,0.0007460073,0.0011873099,0.00079340284],"category_scores_gemma":[0.0005600885,0.00039586847,0.00053160137,0.0004985998,0.0006908999,0.00042127783,0.0005127503,0.00097417,0.00033242104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058284368,0.000027123262,0.000104675506,0.000024380774,0.0000027750814,0.000007518603,0.000015528416,0.0001075405,0.9992249,0.000013771433,0.0000058023456,0.00040772973],"study_design_scores_gemma":[0.0000057607017,0.00069329824,0.00096907653,0.000003560246,0.000013323353,0.000025659916,0.000011534614,0.00059175445,0.9973429,0.000008859782,0.00033047,0.000003910105],"about_ca_topic_score_codex":0.0010843844,"about_ca_topic_score_gemma":0.0008742056,"teacher_disagreement_score":0.0012760711,"about_ca_system_score_codex":0.0005420995,"about_ca_system_score_gemma":0.00035083137,"threshold_uncertainty_score":0.0067486167},"labels":[],"label_agreement":null},{"id":"W2033119689","doi":"10.1038/bjc.2013.735","title":"A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Aflibercept; Pemetrexed; Internal medicine; Nausea; Lung cancer; Adverse effect; Phases of clinical research; Oncology; Cisplatin; Progressive disease; Gastroenterology; Surgery; Chemotherapy; Bevacizumab","score_opus":0.008271514152304687,"score_gpt":0.2689566194956499,"score_spread":0.2606851053433452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033119689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398106,0.0018197559,0.00042921017,0.00025997992,0.0000737373,0.0024303754,0.00034038667,0.000047419697,0.0006180452],"genre_scores_gemma":[0.9927999,0.0012623682,0.0014429579,0.00044206204,0.00014372896,0.0021362468,0.0009834352,0.000020319963,0.0007690107],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99911076,0.0004896466,0.000054822238,0.00013896261,0.00008908403,0.00011677555],"domain_scores_gemma":[0.99885213,0.0001920291,0.0003239674,0.00008071565,0.000063897016,0.0004871473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022985667,0.0015263116,0.0026491536,0.0004442726,0.00038231505,0.0009157346,0.0011973663,0.0011070421,0.0032310684],"category_scores_gemma":[0.0014796568,0.00072617223,0.00142052,0.00053593377,0.0009751437,0.0008314608,0.00043218446,0.003458669,0.0008051966],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7910669,0.07840488,0.013055826,0.0011730924,0.0023544075,0.00028134396,0.000389575,0.002253392,0.0419815,0.00012666745,0.001902241,0.06701011],"study_design_scores_gemma":[0.6245638,0.3612029,0.010347826,0.00001687901,0.00040757653,0.00020455857,0.000032827524,0.0005917106,0.0016419572,0.00004428203,0.0009290649,0.000016700273],"about_ca_topic_score_codex":0.000710429,"about_ca_topic_score_gemma":0.0016755149,"teacher_disagreement_score":0.0032310684,"about_ca_system_score_codex":0.0010301336,"about_ca_system_score_gemma":0.0015439522,"threshold_uncertainty_score":0.012156129},"labels":[],"label_agreement":null},{"id":"W2033168622","doi":"10.1038/bjc.2013.2","title":"The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Alberta Health Services","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Uterine sarcoma; Odds ratio; Epidemiology; Sarcoma; Uterine cancer; Endometrial cancer; Gynecology; Incidence (geometry); Risk factor; Body mass index; Internal medicine; Cancer; Oncology; Pathology","score_opus":0.026187519758832906,"score_gpt":0.3474204163849416,"score_spread":0.32123289662610865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033168622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68899506,0.2534321,0.01170843,0.0007036476,0.00044594426,0.00070155336,0.041353904,0.0002442784,0.0024151956],"genre_scores_gemma":[0.9640021,0.018345872,0.0034494412,0.00025498637,0.00017054316,0.00055069313,0.012748561,0.0000739367,0.00040395625],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.980881,0.010990013,0.002935008,0.0028304434,0.0016988321,0.0006646273],"domain_scores_gemma":[0.9818412,0.0069772177,0.004691111,0.0033673854,0.002672736,0.00045030887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018462595,0.0015703493,0.005532451,0.0056420346,0.00042913793,0.001914734,0.0010441581,0.0011229883,0.0012257285],"category_scores_gemma":[0.029949995,0.0011027089,0.017597942,0.008621398,0.00035808774,0.0006142161,0.0023327922,0.0005484228,0.0001841805],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039107716,0.000028957613,0.6351885,0.005001657,0.34236988,0.00022754347,0.00013184914,0.0014902606,0.00062823476,0.0001787253,0.0018697296,0.008973795],"study_design_scores_gemma":[0.0005274593,0.000531969,0.719898,0.0012132426,0.2706577,0.00052712444,0.00021256034,0.0013671941,0.00036077303,0.00029938787,0.0043319734,0.00007266229],"about_ca_topic_score_codex":0.02095425,"about_ca_topic_score_gemma":0.019448208,"teacher_disagreement_score":0.02095425,"about_ca_system_score_codex":0.0009329835,"about_ca_system_score_gemma":0.0015503885,"threshold_uncertainty_score":0.09764069},"labels":[],"label_agreement":null},{"id":"W2034052150","doi":"10.1038/sj.bjc.6603288","title":"A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Amgen","keywords":"Cardiotoxicity; Medicine; Toxicity; Daunorubicin; Neutropenia; Pharmacokinetics; Adverse effect; Cardiac toxicity; Cumulative dose; Internal medicine; Pharmacology; Anthracycline; Chemotherapy; Cancer; Breast cancer","score_opus":0.00777165921795052,"score_gpt":0.2701121673968785,"score_spread":0.26234050817892796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034052150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935923,0.0019985517,0.0006363603,0.00015116554,0.00004496179,0.002381142,0.0003417583,0.000033933728,0.00081981835],"genre_scores_gemma":[0.9853876,0.0043391963,0.0035296446,0.0003692661,0.00011233555,0.0035626376,0.0012780033,0.000019807612,0.0014014351],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966836,0.00016564027,0.000016386239,0.00005129481,0.000034929253,0.000063336825],"domain_scores_gemma":[0.9992982,0.00011404171,0.00015795494,0.000052855426,0.000043114458,0.00033379227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094712526,0.001154406,0.0019277986,0.00032325863,0.00028715315,0.00048739646,0.0006527832,0.00072769355,0.0018585993],"category_scores_gemma":[0.0007154656,0.000362792,0.00077229715,0.00045142273,0.0007962958,0.00042961928,0.0003537162,0.0021386307,0.0004485122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4261092,0.13374172,0.026741128,0.002441375,0.0013167837,0.002594615,0.0012033199,0.006926953,0.2104601,0.0010237216,0.0045016417,0.18293947],"study_design_scores_gemma":[0.15979424,0.7985398,0.024797956,0.00004315035,0.00026431432,0.0013517658,0.00011643441,0.00095794233,0.007920575,0.00015541572,0.0060339165,0.000024397323],"about_ca_topic_score_codex":0.0007813125,"about_ca_topic_score_gemma":0.0013113525,"teacher_disagreement_score":0.0019277986,"about_ca_system_score_codex":0.00072813814,"about_ca_system_score_gemma":0.0014323381,"threshold_uncertainty_score":0.006217599},"labels":[],"label_agreement":null},{"id":"W2034728055","doi":"10.1038/sj.bjc.6605046","title":"Optimisation and molecular signalling of apoptosis in sequential cryotherapy and chemotherapy combination in human A549 lung cancer xenografts in SCID mice","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cryotherapy; Apoptosis; Chemotherapy; Vinorelbine; Oncogene; Cancer research; Puma; Biology; Etoposide; Lung cancer; Cancer; Cisplatin; Medicine; Pathology; Surgery; Internal medicine; Cell cycle","score_opus":0.005980208851277828,"score_gpt":0.2747257075849991,"score_spread":0.2687454987337213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034728055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939334,0.002020551,0.0024457017,0.00006603907,0.000036254336,0.00008434629,0.00029100955,0.000050437186,0.0010722906],"genre_scores_gemma":[0.99378794,0.0012967439,0.0026963877,0.000029905239,0.000014339061,0.00013300989,0.00027921188,0.000014031242,0.001748526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983275,0.000030662537,0.0000138977975,0.00003778105,0.00004970115,0.000035117442],"domain_scores_gemma":[0.9999428,0.000011861432,0.000015277235,0.000012018923,0.0000052703244,0.00001278143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019107532,0.00025564936,0.00029214335,0.000247654,0.00011578368,0.000181542,0.00019621557,0.00024949713,0.0007685408],"category_scores_gemma":[0.00008104396,0.0001506033,0.0002740473,0.00014800209,0.00018226283,0.00016547802,0.00012477253,0.00041595407,0.00016667311],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035720132,0.000109071916,0.00011482536,0.000025541518,0.000005345126,0.000017857368,0.000010595246,0.0003015144,0.99759173,0.000039337967,0.000028290064,0.0013986552],"study_design_scores_gemma":[0.00007316802,0.0028183185,0.002699497,0.0000055504875,0.000023887573,0.00012605569,0.000013507436,0.0012904594,0.99141085,0.000033119602,0.0015000207,0.000005569385],"about_ca_topic_score_codex":0.00090832566,"about_ca_topic_score_gemma":0.0015485066,"teacher_disagreement_score":0.00090832566,"about_ca_system_score_codex":0.00028621292,"about_ca_system_score_gemma":0.00022418263,"threshold_uncertainty_score":0.0025710464},"labels":[],"label_agreement":null},{"id":"W2035608162","doi":"10.1038/sj.bjc.6603822","title":"Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council","keywords":"Medicine; Human papillomavirus; Gynecology; Multivariate analysis; Obstetrics; HPV infection; Pregnancy; Childbirth; Young adult; Demography; Cervical cancer; Gerontology; Internal medicine; Cancer","score_opus":0.0143832739657256,"score_gpt":0.29909157417968923,"score_spread":0.28470830021396365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035608162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877673,0.0005611085,0.00001900408,0.00006874953,0.000008538121,0.000007020234,0.00022141905,0.0000013471265,0.00033607855],"genre_scores_gemma":[0.99940276,0.00022983747,0.000021989457,0.000028051467,0.0000057334432,0.0000070486917,0.00015502302,8.6590694e-7,0.0001486475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996221,0.00011381341,0.00005497687,0.00005690728,0.000077722216,0.00007446306],"domain_scores_gemma":[0.99880576,0.00019373119,0.0005343267,0.0000585068,0.00011565703,0.00029200333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000286856,0.00019094895,0.00034739086,0.00076007284,0.00035827182,0.0005236479,0.00020532265,0.0004993651,0.0019226383],"category_scores_gemma":[0.0027541523,0.00035845168,0.00025639604,0.0012694207,0.00034659725,0.00036754753,0.0004020272,0.00038260053,0.0003022942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010988183,0.000024037838,0.9981269,0.00001722648,0.00002124721,0.00017079087,0.00023537759,0.000014992124,0.00016082967,0.000009043879,0.00010176354,0.0010079151],"study_design_scores_gemma":[0.0000032002822,0.00005995973,0.99947923,0.000008170749,0.000006023446,0.00017290839,0.00016679977,0.000026093914,0.000008749598,0.0000058202845,0.00006091093,0.0000021252624],"about_ca_topic_score_codex":0.03231723,"about_ca_topic_score_gemma":0.030070845,"teacher_disagreement_score":0.03231723,"about_ca_system_score_codex":0.0004444647,"about_ca_system_score_gemma":0.00025385755,"threshold_uncertainty_score":0.06425822},"labels":[],"label_agreement":null},{"id":"W2035754366","doi":"10.1038/sj.bjc.6601327","title":"Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Matrix metalloproteinase; Extracellular matrix; Cell biology; Cancer research; Biology; Metastasis; Carcinogenesis; Cell migration; Cell adhesion; Cell growth; Matrix metalloproteinase inhibitor; Cancer cell; Cancer; Cell; Biochemistry; Genetics","score_opus":0.012954151224905303,"score_gpt":0.28810227680804096,"score_spread":0.27514812558313567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035754366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038900352,0.996451,0.0005213535,0.00048152416,0.00043588813,0.000006111404,0.00003471194,0.000016853075,0.0016635334],"genre_scores_gemma":[0.0022388247,0.9938379,0.0005901626,0.00023980251,0.0002968472,0.000015557567,0.00006459763,0.000004113089,0.0027121664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999762,0.000026390035,0.000035693934,0.00004616897,0.00010048614,0.000029311568],"domain_scores_gemma":[0.99963105,0.00014283031,0.000040478426,0.000017182738,0.00012727687,0.000041115047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007471609,0.0010163084,0.0016121698,0.0012034688,0.00034695148,0.0013295461,0.0010160214,0.0014317516,0.0024507735],"category_scores_gemma":[0.0006589153,0.00046700894,0.00030899135,0.0018601125,0.0009211329,0.0012466694,0.0005628861,0.0022071954,0.002380112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030581112,0.000075558695,0.0002731427,0.0057681524,0.000067221816,0.00049084943,0.00007782094,0.000663929,0.010997962,0.005457231,0.040966388,0.9348558],"study_design_scores_gemma":[0.000056096385,0.00006640996,0.0011654048,0.0005623364,0.0000761343,0.0015996902,0.000060164733,0.00012084853,0.0032522841,0.0025485363,0.9904705,0.00002145739],"about_ca_topic_score_codex":0.0016525893,"about_ca_topic_score_gemma":0.003825946,"teacher_disagreement_score":0.0024507735,"about_ca_system_score_codex":0.0012282904,"about_ca_system_score_gemma":0.00097301847,"threshold_uncertainty_score":0.008911908},"labels":[],"label_agreement":null},{"id":"W2035801850","doi":"10.1038/bjc.2012.483","title":"The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; McGill University; Université de Montréal; University of Toronto; Cancer Care Ontario; Women's College Hospital","funders":"Canadian Cancer Society Research Institute","keywords":"Pancreatic cancer; Medicine; BRCA mutation; Germline mutation; Cancer; Internal medicine; Incidence (geometry); Oncology; BRCA2 Protein; Breast cancer; Mutation; Genetics; Biology","score_opus":0.019886564809976505,"score_gpt":0.3595286960281431,"score_spread":0.33964213121816655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035801850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981026,0.0009523624,0.000111425405,0.000031745818,0.0000034258553,0.0000038071246,0.00037343733,0.000007750899,0.00041349092],"genre_scores_gemma":[0.99876356,0.00041908427,0.00015299502,0.00000937209,0.000009729079,0.000004593273,0.0005047351,0.0000023546168,0.00013363668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949324,0.00012493008,0.0000626594,0.00014663726,0.000104586565,0.000067893125],"domain_scores_gemma":[0.99805295,0.0005384098,0.0009747976,0.000116204894,0.00012860281,0.00018900487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078429666,0.0002328666,0.00024915364,0.0018074078,0.00020014567,0.00048790942,0.00030368858,0.0005845443,0.00188576],"category_scores_gemma":[0.0034049351,0.00031870368,0.0003256773,0.0010169907,0.00028698865,0.00042838606,0.00044302183,0.00035806827,0.00035886062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012786576,0.0000053676254,0.9973194,0.000011464965,0.000036370457,0.00016899715,0.000043732165,0.00008253555,0.00015966782,0.000015189755,0.00007625912,0.001953198],"study_design_scores_gemma":[0.000005460012,0.00007452473,0.9967397,0.0000072780554,0.000037695434,0.002489889,0.00007365733,0.00016904945,0.00009826256,0.000044859305,0.000256314,0.0000033782765],"about_ca_topic_score_codex":0.0028850029,"about_ca_topic_score_gemma":0.0017834736,"teacher_disagreement_score":0.0028850029,"about_ca_system_score_codex":0.00034450126,"about_ca_system_score_gemma":0.00014128991,"threshold_uncertainty_score":0.0063085556},"labels":[],"label_agreement":null},{"id":"W2035888142","doi":"10.1038/bjc.2014.474","title":"Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role","year":2014,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Cancer Society Research Institute","keywords":"Biology; Gene silencing; Cancer research; PTEN; Cancer; Gene; Transcriptome; Clusterin; CDKN2A; Gene expression; Genetics; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.08497990341358552,"score_gpt":0.4082376150283377,"score_spread":0.3232577116147522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035888142","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9394401,0.00815672,0.014711129,0.0002447547,0.000033171236,0.000109095476,0.035520546,0.00035251834,0.0014320561],"genre_scores_gemma":[0.93758935,0.0021972433,0.016337022,0.00023623243,0.000030592284,0.00013033111,0.04271437,0.00014966723,0.00061514205],"study_design_codex":"bench_or_experimental","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9994216,0.00009492076,0.00003189484,0.0002474276,0.00013332146,0.000070823175],"domain_scores_gemma":[0.9994137,0.00021232008,0.00011647069,0.00011106369,0.00009623336,0.00005013653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008144807,0.0005667115,0.0008219238,0.0021028905,0.00036392888,0.00070242945,0.0003524349,0.00031730332,0.0009768636],"category_scores_gemma":[0.0011265449,0.0001815029,0.0015662198,0.0021816378,0.00024805666,0.00026381016,0.00078919897,0.00032914014,0.00016566573],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013679628,0.00010749286,0.3315842,0.0020503714,0.008486596,0.0006622143,0.00039154236,0.008209397,0.5981043,0.0011200352,0.0017595622,0.046156377],"study_design_scores_gemma":[0.00005010364,0.00045657033,0.87480795,0.00012598265,0.00580921,0.0015177269,0.0004530842,0.018082052,0.08116125,0.0021344165,0.01531894,0.00008258812],"about_ca_topic_score_codex":0.0034580543,"about_ca_topic_score_gemma":0.0055598393,"teacher_disagreement_score":0.0034580543,"about_ca_system_score_codex":0.00047440885,"about_ca_system_score_gemma":0.00066669186,"threshold_uncertainty_score":0.0068758726},"labels":[],"label_agreement":null},{"id":"W2036147404","doi":"10.1038/sj.bjc.6605033","title":"The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"General Secretariat for Research and Technology","keywords":"Colorectal cancer; Kallikrein; Medicine; Cancer; Internal medicine; Oncology; Stage (stratigraphy); Univariate analysis; Survival analysis; Cancer biomarkers; Gastroenterology; Pathology; Multivariate analysis; Biology","score_opus":0.018931964548935632,"score_gpt":0.287669215680338,"score_spread":0.26873725113140234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036147404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976756,0.019162403,0.0028026402,0.00017652403,0.000048408656,0.000021777829,0.00023803454,0.00007338034,0.00072085194],"genre_scores_gemma":[0.99602914,0.0015872137,0.0020279805,0.000021847784,0.000038344566,0.000007028858,0.00014023666,0.0000027855388,0.00014544971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995142,0.00022206825,0.000046657857,0.000070751485,0.000101523474,0.000044715398],"domain_scores_gemma":[0.99857116,0.00062421995,0.00041097,0.000071757335,0.00017568472,0.00014625992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012952974,0.0005200179,0.00057043554,0.000943675,0.0001289417,0.0006212723,0.0001996638,0.00026202213,0.00025199325],"category_scores_gemma":[0.002614271,0.000138691,0.00025704002,0.0006188762,0.00020651876,0.0003966633,0.00039848214,0.00041793086,0.00012963045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003051447,0.00011521593,0.8276895,0.00028256685,0.00023795014,0.00015643104,0.00006527025,0.0022371036,0.027741274,0.000051950115,0.000249693,0.13812143],"study_design_scores_gemma":[0.00005339102,0.0020383531,0.9671888,0.00006659528,0.00041031433,0.0010430455,0.000086025335,0.01092186,0.015976125,0.00024299958,0.0019367693,0.000035733905],"about_ca_topic_score_codex":0.0005729863,"about_ca_topic_score_gemma":0.001264119,"teacher_disagreement_score":0.0012952974,"about_ca_system_score_codex":0.00022549093,"about_ca_system_score_gemma":0.00024970656,"threshold_uncertainty_score":0.006850302},"labels":[],"label_agreement":null},{"id":"W2036319230","doi":"10.1038/sj.bjc.6603020","title":"Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Ovarian cancer; Relative risk; Cohort study; Prospective cohort study; Body mass index; Cohort; Internal medicine; Proportional hazards model; Oncology; Cancer; Physiology; Confidence interval","score_opus":0.01753804341093503,"score_gpt":0.3200312903753389,"score_spread":0.3024932469644039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036319230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6490421,0.3302265,0.0074462015,0.00040658738,0.0002630205,0.0007016911,0.010687349,0.00021928537,0.0010072155],"genre_scores_gemma":[0.9457977,0.04290948,0.0037930796,0.00018733274,0.00012775556,0.00070315367,0.006073843,0.000059736543,0.0003479758],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9887213,0.006175822,0.0020973978,0.0014722422,0.001212962,0.00032026193],"domain_scores_gemma":[0.9840921,0.008985597,0.0033731002,0.0017050748,0.0015510225,0.0002930772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013938891,0.0016567775,0.005826425,0.004547018,0.00035415366,0.0016301258,0.00080971693,0.0011205818,0.0012179594],"category_scores_gemma":[0.027323138,0.0012469485,0.013717854,0.005553605,0.00035250446,0.000581362,0.0011528048,0.0006590406,0.00016387702],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014573936,0.00009711601,0.3132362,0.009053715,0.63797605,0.0003976533,0.00013259736,0.0019753755,0.00090826076,0.00007254851,0.0012086439,0.02036791],"study_design_scores_gemma":[0.0019824617,0.0010861155,0.2863694,0.0010455571,0.7046344,0.00051156746,0.0001299029,0.0013466636,0.00036468406,0.00022311503,0.002247135,0.000058920177],"about_ca_topic_score_codex":0.008495343,"about_ca_topic_score_gemma":0.010029954,"teacher_disagreement_score":0.013938891,"about_ca_system_score_codex":0.0008963788,"about_ca_system_score_gemma":0.0012270093,"threshold_uncertainty_score":0.07371676},"labels":[],"label_agreement":null},{"id":"W2036551301","doi":"10.1038/bjc.2014.662","title":"Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canada Research Chairs","keywords":"Aerobic exercise; Erythropoietin; Medicine; Internal medicine; Cytokine; Immune system; Aerobic capacity; VO2 max; Immunology; Oncology; Blood pressure","score_opus":0.022593246680641325,"score_gpt":0.2905265655931172,"score_spread":0.26793331891247585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036551301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986608,0.0008337293,0.00007445809,0.000016444721,0.0000070537635,0.000057586763,0.000051382038,0.0000017491789,0.00029681475],"genre_scores_gemma":[0.9989454,0.00038349617,0.0001634505,0.000044059285,0.000060420833,0.00008018182,0.00015130431,0.0000012672305,0.00017052924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996099,0.00015956254,0.000026525797,0.00008432003,0.000050334616,0.00006945151],"domain_scores_gemma":[0.99883145,0.00048605737,0.00025020016,0.00008798311,0.00011648956,0.00022783679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088472856,0.00032911944,0.00062282884,0.000337362,0.00041583017,0.00049530406,0.00022812071,0.00045548455,0.0023701503],"category_scores_gemma":[0.0012275279,0.00015162968,0.00027092462,0.00040603452,0.0006086749,0.00025005013,0.00034408277,0.0004368084,0.0004158373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041124415,0.009443289,0.9043741,0.00042429133,0.00042999524,0.0010659407,0.00069560384,0.00020453981,0.011580061,0.00007564518,0.0002546372,0.030327503],"study_design_scores_gemma":[0.0010689454,0.07088445,0.9222144,0.000051393363,0.00028789928,0.0016518544,0.00061224843,0.0002416737,0.0015652333,0.000078091274,0.0013297297,0.00001403566],"about_ca_topic_score_codex":0.00032343555,"about_ca_topic_score_gemma":0.0004318021,"teacher_disagreement_score":0.0023701503,"about_ca_system_score_codex":0.0002600701,"about_ca_system_score_gemma":0.00041388976,"threshold_uncertainty_score":0.0079289675},"labels":[],"label_agreement":null},{"id":"W2036753674","doi":"10.1038/bjc.2013.444","title":"Celebrities and screening: a measurable impact on high-grade cervical neoplasia diagnosis from the ‘Jade Goody effect’ in the UK","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Colposcopy; Incidence (geometry); Odds ratio; Rate ratio; Cervical cancer; Quarter (Canadian coin); Medical diagnosis; Obstetrics; Gynecology; Internal medicine; Pediatrics; Confidence interval; Cancer; Pathology","score_opus":0.02189963832578633,"score_gpt":0.3182348104078243,"score_spread":0.29633517208203797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036753674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945374,0.0014835169,0.00003277397,0.0010725944,0.000044030756,0.0000111290665,0.000716327,0.0000035996864,0.0020987648],"genre_scores_gemma":[0.9989073,0.00037873996,0.000029679102,0.00010609962,0.000028055561,0.0000036314643,0.00018577783,0.0000019357337,0.00035882086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989687,0.00032014586,0.00007587252,0.00012961253,0.00023348974,0.0002721952],"domain_scores_gemma":[0.9946437,0.00067758677,0.0031437534,0.00024023831,0.00028046258,0.0010142413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009968517,0.00017631255,0.00028546868,0.0007093279,0.00046478663,0.0012113301,0.00028498354,0.0005081267,0.0046574483],"category_scores_gemma":[0.004837706,0.00023310632,0.0005332903,0.000826896,0.0007954581,0.00051251776,0.001935544,0.00066131854,0.00026446368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036746505,0.00003193799,0.9899787,0.00009758691,0.0000634886,0.00025259887,0.00074353436,0.00004764477,0.0002797063,0.00008530689,0.0010305935,0.0070214854],"study_design_scores_gemma":[0.0000017538251,0.000026402848,0.99942833,0.000014053507,0.000005210197,0.000050206832,0.0001804789,0.000008613444,0.0000099267,0.000004788771,0.00026822815,0.0000019847039],"about_ca_topic_score_codex":0.04312777,"about_ca_topic_score_gemma":0.066150375,"teacher_disagreement_score":0.04312777,"about_ca_system_score_codex":0.0012451919,"about_ca_system_score_gemma":0.0008431877,"threshold_uncertainty_score":0.0857535},"labels":[],"label_agreement":null},{"id":"W2037269181","doi":"10.1038/sj.bjc.6603294","title":"The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Lægeforeningen; Kræftens Bekæmpelse","keywords":"Medicine; Breast cancer; Socioeconomic status; Odds ratio; Confidence interval; Demography; Gynecology; Cancer; Internal medicine; Obstetrics; Population; Environmental health","score_opus":0.013443231115502576,"score_gpt":0.27032888826357515,"score_spread":0.2568856571480726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037269181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998626,0.00038563437,0.000027073034,0.000037116206,0.000007742564,0.000004213535,0.00061522756,9.734657e-7,0.00029611622],"genre_scores_gemma":[0.9989415,0.00017596153,0.000028384751,0.000013930666,0.000004225689,0.000004100614,0.0006240145,8.1440515e-7,0.00020705652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962234,0.00007478204,0.000063102634,0.000080757556,0.000071638984,0.00008735955],"domain_scores_gemma":[0.9991658,0.00013303437,0.0003327019,0.000049895927,0.00015221573,0.00016638242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052264385,0.00016587011,0.00033102417,0.0006608315,0.0005284363,0.00053961977,0.00034908816,0.00044836517,0.0006952079],"category_scores_gemma":[0.0017866556,0.00035356564,0.00038364617,0.000952842,0.00020781692,0.00021728966,0.00044077222,0.00036177158,0.0001455794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001424386,0.000018561477,0.99890804,0.000009055541,0.000052469743,0.000059039918,0.00008774676,0.00004319568,0.00010833068,0.000009548263,0.0000975957,0.00046380513],"study_design_scores_gemma":[0.000004583995,0.000019743431,0.99960107,0.0000032598305,0.000015472857,0.00005242699,0.000081148326,0.000048645114,0.00001702469,0.0000041641333,0.00015084111,0.0000016033845],"about_ca_topic_score_codex":0.058633737,"about_ca_topic_score_gemma":0.07214739,"teacher_disagreement_score":0.058633737,"about_ca_system_score_codex":0.0009117294,"about_ca_system_score_gemma":0.00045950778,"threshold_uncertainty_score":0.1165849},"labels":[],"label_agreement":null},{"id":"W2037737757","doi":"10.1038/bjc.2012.204","title":"Long-term results of screening with magnetic resonance imaging in women with BRCA mutations","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Mammography; Breast cancer; Magnetic resonance imaging; BRCA mutation; Stage (stratigraphy); Cancer; Oncology; Internal medicine; Breast MRI; Prospective cohort study; Mastectomy; Radiology; Gynecology","score_opus":0.007518906663478972,"score_gpt":0.26141951993968654,"score_spread":0.25390061327620755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037737757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638724,0.0025999215,0.000040683226,0.00016864562,0.000019664007,0.0000082684055,0.0002258698,0.0000043000896,0.00054543384],"genre_scores_gemma":[0.9990232,0.00035862302,0.000046605503,0.000054353713,0.00003927838,0.0000069765024,0.00037636093,0.000001448371,0.00009313481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991215,0.00033294706,0.00010008703,0.00011964966,0.00017887045,0.0001470149],"domain_scores_gemma":[0.99199706,0.0027963165,0.002880795,0.00036713635,0.0007758576,0.0011828273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029523799,0.00027468606,0.000444684,0.000690225,0.00032232798,0.000522187,0.00037359685,0.000716174,0.0007905712],"category_scores_gemma":[0.008911518,0.00015201447,0.00048318005,0.00050344545,0.00029661696,0.0005023568,0.00042095504,0.0005886912,0.00019646043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016947291,0.0001500778,0.9924441,0.00002562861,0.00013702702,0.00012429566,0.00003822871,0.00009988608,0.0001677709,0.0000068391887,0.00012396088,0.004987429],"study_design_scores_gemma":[0.000038987982,0.001750061,0.9968587,0.000023130742,0.00021139551,0.0004189459,0.00005459834,0.00019163928,0.00020829921,0.000026440912,0.0002108149,0.000007032177],"about_ca_topic_score_codex":0.0012573291,"about_ca_topic_score_gemma":0.0021164233,"teacher_disagreement_score":0.0029523799,"about_ca_system_score_codex":0.0004120519,"about_ca_system_score_gemma":0.0003218947,"threshold_uncertainty_score":0.015613854},"labels":[],"label_agreement":null},{"id":"W2037911234","doi":"10.1038/sj.bjc.6605038","title":"Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"CHEK2; Cancer; Breast cancer; Proband; Medicine; Prostate cancer; Family history; Colorectal cancer; Internal medicine; Oncology; First-degree relatives; Prostate; Mutation; Gynecology; Germline mutation; Genetics; Biology; Gene","score_opus":0.015211476474332887,"score_gpt":0.3080242400064988,"score_spread":0.2928127635321659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037911234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842095,0.00081616396,0.0001480258,0.000072935196,0.00000989725,0.000002983973,0.00013032247,0.000010788034,0.00038792027],"genre_scores_gemma":[0.99931824,0.00020740798,0.00009992693,0.000013647775,0.000007545964,0.000002527408,0.00007214937,0.000004954941,0.00027371044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992742,0.00025070694,0.000041894138,0.00022616827,0.00009162309,0.0001153556],"domain_scores_gemma":[0.99852425,0.0005856416,0.000374546,0.00014577404,0.00008687547,0.00028291714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007584904,0.0006820653,0.00063388556,0.0010412292,0.0008004317,0.00064359204,0.00034484564,0.0008163249,0.0027465064],"category_scores_gemma":[0.0042257207,0.00038287786,0.00085873576,0.00078577903,0.0003358883,0.00048196662,0.00045910676,0.00065402186,0.00036281813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010043359,0.00007759411,0.98693955,0.000025284506,0.00022181436,0.004449051,0.00035912805,0.0002012928,0.0026938908,0.000054026303,0.00016150008,0.0038125892],"study_design_scores_gemma":[0.000016163702,0.00030232134,0.99091786,0.00002132618,0.00023995066,0.006864004,0.0003184838,0.00041099568,0.00040134482,0.0001554895,0.00033593999,0.00001616839],"about_ca_topic_score_codex":0.010901155,"about_ca_topic_score_gemma":0.006672767,"teacher_disagreement_score":0.010901155,"about_ca_system_score_codex":0.00032625004,"about_ca_system_score_gemma":0.00025419638,"threshold_uncertainty_score":0.021675408},"labels":[],"label_agreement":null},{"id":"W2038781838","doi":"10.1038/sj.bjc.6605298","title":"Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Centre Hospitalier Universitaire de Rennes; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Clear cell renal cell carcinoma; Cancer research; Vascular endothelial growth factor; Angiogenesis; Multiplex ligation-dependent probe amplification; Biology; Renal cell carcinoma; DNA methylation; Pathology; Medicine; Gene expression; Gene; VEGF receptors; Genetics","score_opus":0.012262583784001049,"score_gpt":0.24258670978154637,"score_spread":0.23032412599754531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038781838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995229,0.0002654329,0.00006918291,0.000011668004,0.0000012280406,0.0000016961236,0.000036508776,0.000002108116,0.000089225214],"genre_scores_gemma":[0.99982363,0.000041127987,0.000045878216,0.0000028989068,0.000003439659,0.0000011175802,0.000047286587,5.6071474e-7,0.000034091583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998579,0.000026154683,0.000017511595,0.00003263504,0.00004188189,0.000023907749],"domain_scores_gemma":[0.99928856,0.00018757003,0.00031465737,0.000028841929,0.0000677314,0.00011258898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021153354,0.00014742037,0.00022381934,0.0004214389,0.00021387634,0.0002544345,0.00013941988,0.00022453173,0.0010456383],"category_scores_gemma":[0.0010025654,0.000085793334,0.00013198747,0.00033441884,0.00025987084,0.00014010315,0.00017729354,0.00020860306,0.00010619884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018656929,0.000010360409,0.993415,0.000012648269,0.000021186957,0.00014778366,0.000037004134,0.00007873546,0.0042658933,0.000010434032,0.000023949173,0.0017905827],"study_design_scores_gemma":[0.0000042182637,0.00005111901,0.9977227,0.0000025279971,0.000025660142,0.0011712741,0.0000385605,0.0002018213,0.00062786735,0.000030586973,0.00012139265,0.0000022196512],"about_ca_topic_score_codex":0.0010976269,"about_ca_topic_score_gemma":0.001421726,"teacher_disagreement_score":0.0010976269,"about_ca_system_score_codex":0.00019702358,"about_ca_system_score_gemma":0.00018350878,"threshold_uncertainty_score":0.0034980178},"labels":[],"label_agreement":null},{"id":"W2039063575","doi":"10.1054/bjoc.2001.1743","title":"Relationship of hypoxia to metastatic ability in rodent tumours","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; University of Toronto","keywords":"Pathology; Metastasis; Oxygenation; Hypoxia (environmental); Fibrosarcoma; Lung; In vivo; Biology; Lung cancer; Cancer; Cancer research; Medicine; Internal medicine; Oxygen; Chemistry","score_opus":0.01759644752512282,"score_gpt":0.29318588735420187,"score_spread":0.275589439829079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039063575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239725,0.003259826,0.0023425128,0.000085187356,0.000020960044,0.000035094603,0.00040382572,0.00006260964,0.001392761],"genre_scores_gemma":[0.99338466,0.0023040527,0.0017845248,0.00004781836,0.00001074223,0.00006475886,0.000707535,0.000024002862,0.0016718222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997527,0.00007641428,0.000020456475,0.000043212338,0.000048349713,0.000058731854],"domain_scores_gemma":[0.9993592,0.0002055611,0.0001986284,0.00004885494,0.000061401486,0.00012643338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003080554,0.00028220407,0.00022036524,0.0005068523,0.00012314737,0.00030152654,0.00014522224,0.00028631638,0.0013235599],"category_scores_gemma":[0.00046677823,0.00023582464,0.00020820882,0.00022579214,0.00029511997,0.0002758963,0.0002620731,0.0006358403,0.00019941723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000882421,0.00009521979,0.0020484114,0.00009077707,0.000020508216,0.000117829724,0.000037321515,0.0002674746,0.9938975,0.00019182333,0.000102098165,0.0022485086],"study_design_scores_gemma":[0.00005488954,0.005933574,0.034570053,0.0000202474,0.00007375482,0.0012476888,0.00011088573,0.002189479,0.9526933,0.00028390755,0.0027999287,0.000022339063],"about_ca_topic_score_codex":0.00085932715,"about_ca_topic_score_gemma":0.0010184854,"teacher_disagreement_score":0.0013235599,"about_ca_system_score_codex":0.0002842376,"about_ca_system_score_gemma":0.00012797353,"threshold_uncertainty_score":0.004427731},"labels":[],"label_agreement":null},{"id":"W2039310969","doi":"10.1038/sj.bjc.6600261","title":"Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Paclitaxel; Oncology; Internal medicine; Breast cancer; Chemotherapy; Phases of clinical research; Cancer; Colorectal cancer","score_opus":0.022443216307930947,"score_gpt":0.3270490110939391,"score_spread":0.30460579478600813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039310969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796983,0.00398765,0.0008379287,0.0009637972,0.0007394152,0.008066513,0.001630608,0.00017089873,0.0039048754],"genre_scores_gemma":[0.966866,0.0042638057,0.002838877,0.002413187,0.000902639,0.010919366,0.003417829,0.000051604202,0.008326642],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993492,0.0003924714,0.000038857634,0.000103907434,0.000037312613,0.00007829705],"domain_scores_gemma":[0.99860805,0.0004509351,0.00030326884,0.00007785284,0.000054044784,0.00050578587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001753852,0.00181949,0.002948682,0.00047595432,0.00034913322,0.0010020718,0.0010493237,0.0018841928,0.009262909],"category_scores_gemma":[0.002324738,0.0007454779,0.0012209354,0.0005126428,0.0010959165,0.0008955029,0.00043308764,0.0028948835,0.0011341464],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9789413,0.00622574,0.000350252,0.00030776192,0.00028738758,0.000050291084,0.000035706027,0.0002626993,0.0035323058,0.00008859596,0.000601729,0.009316088],"study_design_scores_gemma":[0.948104,0.05045126,0.0005367275,0.000012170592,0.00010484989,0.000026374233,0.000007659267,0.00015085905,0.0001884807,0.000051371673,0.00036178023,0.000004349576],"about_ca_topic_score_codex":0.0011569638,"about_ca_topic_score_gemma":0.0027310292,"teacher_disagreement_score":0.009262909,"about_ca_system_score_codex":0.0009071901,"about_ca_system_score_gemma":0.0014824711,"threshold_uncertainty_score":0.03098756},"labels":[],"label_agreement":null},{"id":"W2040122586","doi":"10.1038/sj.bjc.6601416","title":"Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Université Laval","keywords":"Nonsteroidal; Medicine; Prostate cancer; Meta-analysis; Cancer; Oncology; Anti-inflammatory; Prostate; MEDLINE; Internal medicine; Pharmacology","score_opus":0.034264359352461325,"score_gpt":0.332148677920477,"score_spread":0.29788431856801567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040122586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035683105,0.99498355,0.0005260679,0.0001417298,0.00010241014,0.0001589139,0.00031696405,0.000018744706,0.00018322373],"genre_scores_gemma":[0.08358112,0.9127385,0.0020607437,0.00023569382,0.00011608644,0.00057809264,0.00041401584,0.0000138364385,0.00026200782],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9938129,0.0035650234,0.0012589315,0.00045372432,0.0007535719,0.00015583109],"domain_scores_gemma":[0.9876009,0.009407898,0.0016328081,0.00030922168,0.00087675,0.00017237554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00874968,0.0023050737,0.012989244,0.005586149,0.00041353996,0.0018110211,0.001597548,0.0015382707,0.0025426634],"category_scores_gemma":[0.027386134,0.0014020377,0.018095607,0.0077232425,0.00047333696,0.00095801154,0.0009802361,0.0010582155,0.00027112954],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00234661,0.00003553849,0.006610714,0.4264821,0.5304986,0.00029666035,0.0000965981,0.0012935739,0.0003131307,0.0002163142,0.0016880526,0.030122064],"study_design_scores_gemma":[0.00067280035,0.00026900982,0.006168099,0.023708953,0.9646332,0.0002670877,0.00004816929,0.00029527198,0.00021561726,0.00027209672,0.0034252398,0.00002442773],"about_ca_topic_score_codex":0.008504996,"about_ca_topic_score_gemma":0.019695118,"teacher_disagreement_score":0.012989244,"about_ca_system_score_codex":0.002241524,"about_ca_system_score_gemma":0.003371672,"threshold_uncertainty_score":0.04627329},"labels":[],"label_agreement":null},{"id":"W2040291607","doi":"10.1038/sj.bjc.6605243","title":"CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"Pfizer","keywords":"Gemcitabine; Medicine; Axitinib; Internal medicine; Pancreatic cancer; Biomarker; Oncology; Gastroenterology; Population; Confidence interval; Cancer","score_opus":0.02325453379314503,"score_gpt":0.3661477160749084,"score_spread":0.3428931822817634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040291607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965576,0.0021543715,0.00011971206,0.00017852226,0.00013254747,0.00024563997,0.00018220951,0.000007120767,0.00042238345],"genre_scores_gemma":[0.9980039,0.00044609932,0.00017622509,0.00020027049,0.00012186584,0.00038796352,0.00027996005,0.000002405371,0.0003814258],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998744,0.00069926755,0.00009500389,0.0002015295,0.00008751917,0.00017261748],"domain_scores_gemma":[0.99824643,0.00055002334,0.00046838357,0.000076593176,0.000056120887,0.0006024095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022621977,0.0006181823,0.0019523295,0.0003795544,0.00021040645,0.0009184635,0.00047095318,0.0012149897,0.0023537457],"category_scores_gemma":[0.0027088365,0.0003855487,0.0019841017,0.0004858308,0.0006527842,0.000792174,0.000649291,0.0016687171,0.00023817377],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9702486,0.0011060262,0.018944534,0.00015598435,0.001118808,0.000035118326,0.00004583474,0.0004354919,0.0012864758,0.0000381023,0.00021816125,0.006366887],"study_design_scores_gemma":[0.3711867,0.4391097,0.17528212,0.00013006109,0.005287677,0.00019531057,0.00015723269,0.0038969351,0.0017796225,0.00066279015,0.002238415,0.0000734773],"about_ca_topic_score_codex":0.0006264001,"about_ca_topic_score_gemma":0.00078366353,"teacher_disagreement_score":0.0023537457,"about_ca_system_score_codex":0.000774155,"about_ca_system_score_gemma":0.0007324803,"threshold_uncertainty_score":0.011963844},"labels":[],"label_agreement":null},{"id":"W2041053765","doi":"10.1054/bjoc.1999.1254","title":"Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials","year":2000,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Colorectal cancer; Meta-analysis; Randomized controlled trial; Internal medicine; Chemotherapy; Relative risk; Oncology; Confidence interval; Cancer; Clinical trial; Surgery","score_opus":0.10356721154314862,"score_gpt":0.419892512357432,"score_spread":0.3163253008142834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041053765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040809335,0.9941843,0.0006328942,0.00019265486,0.00017080225,0.00029457852,0.00022509461,0.000027183707,0.00019153333],"genre_scores_gemma":[0.13935135,0.8540106,0.0034618822,0.0006838058,0.0002854923,0.0013045734,0.00052527845,0.000033823104,0.0003432258],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98904794,0.0069393897,0.0021143425,0.0007126823,0.00095582823,0.00022984603],"domain_scores_gemma":[0.9762641,0.019476218,0.0027100462,0.00043013415,0.0008687333,0.0002507943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016527347,0.0030915167,0.01857635,0.0054552862,0.00042584052,0.002647855,0.001769054,0.0021008493,0.0032966435],"category_scores_gemma":[0.037622236,0.0015116143,0.03170271,0.0053155953,0.00063959754,0.0015915622,0.0011402712,0.0022002943,0.00024040598],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007075948,0.000033787346,0.0016713807,0.29385477,0.67676896,0.00013550003,0.00005459852,0.0011780746,0.00022636587,0.00020569553,0.0008064534,0.017988434],"study_design_scores_gemma":[0.0025178452,0.00039993064,0.0019837967,0.017554449,0.97492754,0.00010319994,0.00002702833,0.00036266306,0.0001398118,0.00036439393,0.0015977116,0.000021672337],"about_ca_topic_score_codex":0.0049705068,"about_ca_topic_score_gemma":0.008856806,"teacher_disagreement_score":0.01857635,"about_ca_system_score_codex":0.0034312308,"about_ca_system_score_gemma":0.0025904113,"threshold_uncertainty_score":0.08740598},"labels":[],"label_agreement":null},{"id":"W2041158359","doi":"10.1038/sj.bjc.6600057","title":"A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast cancer; Medical prescription; Conformity; Colorectal cancer; Family medicine; Cancer; Medical record; Clinical Practice; Internal medicine; Nursing; Psychology","score_opus":0.23981626029705966,"score_gpt":0.5537257032086796,"score_spread":0.31390944291162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041158359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970246,0.00019945651,0.00018501419,0.00009066503,0.00009905513,0.0015647073,0.00015119437,0.000011731723,0.0006735295],"genre_scores_gemma":[0.99320954,0.000105364015,0.00085923466,0.00030727356,0.00026077672,0.0033081966,0.00048284937,0.000008884508,0.0014578828],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9728968,0.018949829,0.0010856645,0.0030313071,0.0021583717,0.0018780376],"domain_scores_gemma":[0.963959,0.01770399,0.00795692,0.005105373,0.0017922521,0.0034824454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01483877,0.0015181343,0.0016413751,0.0015558478,0.0017509417,0.001924756,0.0018961944,0.0026893483,0.005077565],"category_scores_gemma":[0.019524802,0.0013046607,0.0024590911,0.001262265,0.0045053614,0.0018409297,0.0013267101,0.0027727543,0.00054661214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5706632,0.23356363,0.16741349,0.0007168249,0.0030244559,0.0005569984,0.0018609655,0.00065786514,0.0034014147,0.00095944735,0.0014132429,0.015768383],"study_design_scores_gemma":[0.059014298,0.53768694,0.395633,0.000048030226,0.0011294642,0.00010588666,0.00091162696,0.0011014536,0.0017108631,0.0002943632,0.0022369085,0.00012716703],"about_ca_topic_score_codex":0.006618308,"about_ca_topic_score_gemma":0.0077160946,"teacher_disagreement_score":0.01483877,"about_ca_system_score_codex":0.003709474,"about_ca_system_score_gemma":0.003442642,"threshold_uncertainty_score":0.07847583},"labels":[],"label_agreement":null},{"id":"W2041257997","doi":"10.1038/sj.bjc.6601293","title":"Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Cancer Institute; National Institutes of Health; University of Melbourne; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario; University of Otago","keywords":"Oestrogen receptor; Breast cancer; Progesterone receptor; Medicine; Internal medicine; Oncology; Gynecology; Population; Cancer; Endocrinology; Physiology; Estrogen receptor; Environmental health","score_opus":0.008221190300679502,"score_gpt":0.2728402483328303,"score_spread":0.2646190580321508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041257997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896,0.00028349744,0.00006245396,0.000010688332,0.0000034200655,0.00001495518,0.0004523248,0.0000016154321,0.00021087361],"genre_scores_gemma":[0.9980192,0.00027148976,0.00018002672,0.000017451843,0.0000074611526,0.000029014967,0.00088788767,0.0000017803713,0.0005857092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993432,0.00016260495,0.00007774775,0.00013269327,0.00016794684,0.00011566553],"domain_scores_gemma":[0.9988263,0.00035411224,0.00039574323,0.00010333025,0.00012754169,0.00019287004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084026624,0.00026826124,0.00059979875,0.0012968632,0.00048577128,0.00037615563,0.00026286612,0.00038490823,0.0012037382],"category_scores_gemma":[0.0034190107,0.00056732114,0.00048483544,0.0013183565,0.00031729392,0.0002799426,0.00034402683,0.00037786155,0.000259743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019155859,0.000025093828,0.99770266,0.000014173201,0.00004480798,0.00015435764,0.00021783017,0.00004602455,0.0004168851,0.00001689392,0.000053590706,0.0011161629],"study_design_scores_gemma":[0.000009325116,0.00006999529,0.9992848,0.00000494259,0.000020277454,0.00024422392,0.00007898586,0.000056513665,0.00005821848,0.000012779234,0.00015733612,0.0000026871703],"about_ca_topic_score_codex":0.035513956,"about_ca_topic_score_gemma":0.037894264,"teacher_disagreement_score":0.035513956,"about_ca_system_score_codex":0.00043448983,"about_ca_system_score_gemma":0.00041665195,"threshold_uncertainty_score":0.07061452},"labels":[],"label_agreement":null},{"id":"W2041772218","doi":"10.1038/bjc.2014.428","title":"The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University of Toronto; Women's College Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Medicine; Prostate; BRCA2 Protein; Cancer; Mutation; Rectal examination; Oncology; Internal medicine; Germline mutation; Biology; Gene; Genetics","score_opus":0.016026473434308474,"score_gpt":0.3323389348483007,"score_spread":0.3163124614139922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041772218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564856,0.0023750407,0.000053731746,0.00037974727,0.000016183445,0.0000025261122,0.00032113696,0.0000064698947,0.0011966842],"genre_scores_gemma":[0.99955505,0.00017284023,0.000014531008,0.000022453005,0.000018729137,8.944942e-7,0.000138057,0.0000013769934,0.00007598195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999203,0.00029588013,0.000043317938,0.00008901768,0.00015422562,0.00021451061],"domain_scores_gemma":[0.99610573,0.0017727417,0.0010594658,0.00013775547,0.00023104377,0.00069321896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080056634,0.00017851949,0.00026959684,0.00063262624,0.00024031362,0.00046756535,0.00033685227,0.0005434015,0.0026996841],"category_scores_gemma":[0.006189472,0.00013917654,0.0005316551,0.0004744344,0.00037448027,0.00032193091,0.0003910685,0.00065649423,0.0002707888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002865835,0.000018585199,0.99517053,0.000011722611,0.00007385111,0.00014948909,0.000016384154,0.00022535422,0.00009384535,0.00001820912,0.00021008088,0.00372541],"study_design_scores_gemma":[0.0000034060624,0.000064666565,0.9992106,0.0000056521244,0.000031851756,0.000346639,0.000022159586,0.00015533742,0.000036080313,0.000023275814,0.00009827992,0.000002015919],"about_ca_topic_score_codex":0.006044189,"about_ca_topic_score_gemma":0.0068241525,"teacher_disagreement_score":0.006044189,"about_ca_system_score_codex":0.0004789362,"about_ca_system_score_gemma":0.00037573327,"threshold_uncertainty_score":0.012018025},"labels":[],"label_agreement":null},{"id":"W2041991343","doi":"10.1038/sj.bjc.6604223","title":"Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa","funders":"Canadian Institutes of Health Research; Ministry of Health and Medical Education","keywords":"Cisplatin; Protein kinase B; Apoptosis; Apoptosis-inducing factor; Cancer research; UVB-induced apoptosis; Caspase; Ovarian cancer; Biology; Programmed cell death; Cell biology; Chemistry; Cancer; Chemotherapy; Biochemistry","score_opus":0.012753619048402201,"score_gpt":0.2440335178067487,"score_spread":0.2312798987583465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041991343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771812,0.0096465,0.006389062,0.00035390694,0.00006935598,0.00007017627,0.00047749173,0.00014918046,0.0056631435],"genre_scores_gemma":[0.9895169,0.004744818,0.0029575382,0.000046251567,0.0000074172854,0.000047105004,0.0004077436,0.000011529429,0.00226072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990714,0.000020327248,0.000009332765,0.000014307298,0.000030696505,0.000018122724],"domain_scores_gemma":[0.99995327,0.000009964494,0.000014060687,0.000006603423,0.000007966116,0.000008069623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105944964,0.00023207553,0.00016599367,0.00022894415,0.0001424089,0.00033087304,0.00016086409,0.00014336563,0.0009331084],"category_scores_gemma":[0.0001109289,0.00010371824,0.00011748138,0.00018625436,0.0002366542,0.00023129025,0.00015616808,0.00041587342,0.00025033756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015670265,0.000057362566,0.0004018108,0.00008185437,0.000007518707,0.000074026735,0.00001874104,0.00022482353,0.99223447,0.001049485,0.00017396211,0.005519249],"study_design_scores_gemma":[0.00004634631,0.0002038633,0.0074446714,0.000010351828,0.000011066961,0.0003889796,0.000023108614,0.0017626468,0.9825487,0.00038065147,0.0071720956,0.0000075270077],"about_ca_topic_score_codex":0.0003536963,"about_ca_topic_score_gemma":0.0005295577,"teacher_disagreement_score":0.0009331084,"about_ca_system_score_codex":0.00048878806,"about_ca_system_score_gemma":0.0002546927,"threshold_uncertainty_score":0.0035464168},"labels":[],"label_agreement":null},{"id":"W2042306244","doi":"10.1038/bjc.2015.56","title":"Development and economic trends in cancer therapeutic drugs: a 5-year update 2010–2014","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health","funders":"","keywords":"Medicine; Formulary; Cancer drugs; Per capita; Cancer; Drug; Internal medicine; Environmental health; Pharmacology; Population","score_opus":0.036956095699909854,"score_gpt":0.26781527467637173,"score_spread":0.23085917897646188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042306244","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017570542,0.83272547,0.0018959193,0.044358194,0.004781802,0.00015677072,0.06252025,0.00043517904,0.0355559],"genre_scores_gemma":[0.07923285,0.83095014,0.0038084176,0.010466394,0.003966319,0.00025393238,0.06193237,0.00014951538,0.00924012],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99677306,0.00040178644,0.00092571194,0.00022193919,0.0014125132,0.00026498782],"domain_scores_gemma":[0.9889052,0.0022255657,0.004140284,0.00013770327,0.0038867826,0.0007044933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003091859,0.0008009906,0.00094050245,0.012277877,0.00035385377,0.002997186,0.0007998686,0.0012267745,0.011119993],"category_scores_gemma":[0.014550108,0.000494291,0.0012340959,0.023566656,0.0005670573,0.0033514523,0.0014048751,0.001962785,0.0032944258],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003744834,0.000097206575,0.026107801,0.010226527,0.00029249946,0.00017095172,0.00014902499,0.0012374144,0.0001386223,0.0033941292,0.36217242,0.59563893],"study_design_scores_gemma":[0.00006547385,0.0001293744,0.10853846,0.009529065,0.00040375578,0.000940067,0.00030178865,0.0008474081,0.0003407905,0.00073144137,0.87811786,0.00005444126],"about_ca_topic_score_codex":0.04182232,"about_ca_topic_score_gemma":0.040693346,"teacher_disagreement_score":0.04182232,"about_ca_system_score_codex":0.0063714143,"about_ca_system_score_gemma":0.006616838,"threshold_uncertainty_score":0.08315778},"labels":[],"label_agreement":null},{"id":"W2042593536","doi":"10.1038/bjc.2013.764","title":"Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Occupational Cancer Research Centre","funders":"World Health Organization","keywords":"Medulloblastoma; microRNA; Gene silencing; Biology; Cancer research; Epigenetics; DNA methylation; HES1; Downregulation and upregulation; Genetics; Gene expression; Gene","score_opus":0.0058357235548174465,"score_gpt":0.231199060969836,"score_spread":0.22536333741501854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042593536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865687,0.00047884256,0.000347386,0.000026781197,0.0000040071186,0.0000031399245,0.00017106139,0.000014792832,0.00029696958],"genre_scores_gemma":[0.99941945,0.00009551816,0.00018971144,0.0000055882742,0.0000036063238,0.000003060828,0.00013693192,0.0000035437456,0.00014257379],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988127,0.000021724029,0.000016883874,0.00003109272,0.00003003903,0.000018895684],"domain_scores_gemma":[0.99925214,0.00011847199,0.00041916713,0.000039957824,0.00006530252,0.00010493784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020155669,0.00012280227,0.0002340626,0.0004359575,0.00013279896,0.0002518064,0.00013775087,0.00015530383,0.0014851452],"category_scores_gemma":[0.0007462018,0.00009804114,0.000103843515,0.000352948,0.00022344725,0.00010758321,0.00015950958,0.00021894445,0.0002051653],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018514208,0.00004048656,0.8523567,0.000057882102,0.000098009405,0.0006094844,0.00011421148,0.0002297365,0.13545525,0.00011462657,0.00022576294,0.008846402],"study_design_scores_gemma":[0.000007919395,0.00011304424,0.985873,0.000006090894,0.000058434933,0.0014099301,0.000054350337,0.0005838951,0.011155955,0.00012103393,0.00061062723,0.0000057059215],"about_ca_topic_score_codex":0.0004553211,"about_ca_topic_score_gemma":0.00065101625,"teacher_disagreement_score":0.0014851452,"about_ca_system_score_codex":0.00016722885,"about_ca_system_score_gemma":0.0001303285,"threshold_uncertainty_score":0.0049682856},"labels":[],"label_agreement":null},{"id":"W2043218413","doi":"10.1038/bjc.2013.309","title":"A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Breast Cancer Research Alliance; DNA Genotek","keywords":"Genetic testing; Genetic counseling; Medicine; Population; Referral; BRCA mutation; Medical genetics; Genetics; Cancer; Mutation; Family medicine; Internal medicine; Biology; Breast cancer; Environmental health; Gene","score_opus":0.026392977516959376,"score_gpt":0.30983565488000114,"score_spread":0.28344267736304174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043218413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804604,0.0003710224,0.00015387613,0.00021148447,0.000009243254,0.000027569218,0.00012386967,0.000012474912,0.0010443936],"genre_scores_gemma":[0.9990646,0.0001813795,0.00029006484,0.000076776305,0.000016369817,0.000025121495,0.00017564351,0.0000031615048,0.00016696146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99486405,0.0030903975,0.00023352374,0.00039730885,0.0010280827,0.00038658324],"domain_scores_gemma":[0.98534214,0.0068537947,0.00410995,0.0006124207,0.0019530071,0.0011286475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049865055,0.00024140834,0.00029001178,0.0012527162,0.00031254103,0.0006180492,0.0007362721,0.0007486955,0.0017746625],"category_scores_gemma":[0.028475793,0.00023775178,0.00041367006,0.0011834173,0.00054617494,0.0006188372,0.00089275086,0.00032772488,0.00022487603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028614034,0.0005145089,0.93918407,0.00017687796,0.00018557344,0.00020645728,0.0011078762,0.00055502105,0.00079949753,0.00019867833,0.00067313714,0.053536963],"study_design_scores_gemma":[0.000075391355,0.0013097251,0.9967885,0.000029410485,0.0000796492,0.00024767,0.00032710153,0.00060243043,0.00014647759,0.000042254032,0.00034164474,0.000009822516],"about_ca_topic_score_codex":0.018551057,"about_ca_topic_score_gemma":0.024908807,"teacher_disagreement_score":0.018551057,"about_ca_system_score_codex":0.001019818,"about_ca_system_score_gemma":0.001244132,"threshold_uncertainty_score":0.036886156},"labels":[],"label_agreement":null},{"id":"W2043385216","doi":"10.1038/bjc.2012.479","title":"EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Jewish General Hospital; St Mary's Hospital Centre; McGill University","funders":"","keywords":"Cetuximab; Epidermal growth factor receptor; Cancer research; Chemistry; Exon; Head and neck squamous-cell carcinoma; EGFR inhibitors; Immunohistochemistry; Pathology; Molecular biology; Cancer; Gene; Internal medicine; Receptor; Head and neck cancer; Colorectal cancer; Medicine; Biology","score_opus":0.00944423111436195,"score_gpt":0.26335878365063004,"score_spread":0.2539145525362681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043385216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8448818,0.14792328,0.00061288266,0.0013528804,0.00010147604,0.000027062251,0.00018083972,0.00004139389,0.0048783673],"genre_scores_gemma":[0.982052,0.016310306,0.00047701874,0.00017125784,0.00014137272,0.000012267473,0.00013129368,0.000013246718,0.00069117034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996126,0.00009161611,0.000040623087,0.00008715699,0.0001145196,0.00005352464],"domain_scores_gemma":[0.99873,0.00056617655,0.00034232554,0.00008524685,0.00013929183,0.00013699534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009043282,0.00023219218,0.0010352466,0.00036839556,0.00023935185,0.00072747265,0.0003036457,0.0006931908,0.0027213243],"category_scores_gemma":[0.0020379918,0.0001790838,0.00040674716,0.0005992788,0.00040567026,0.00066830195,0.00019612635,0.00041377006,0.00039659106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009658703,0.0003977171,0.6552656,0.001290922,0.0006846032,0.0039609517,0.0002636945,0.0004563408,0.03701546,0.00039213776,0.001327262,0.28928667],"study_design_scores_gemma":[0.00013574118,0.003272701,0.94759923,0.00036980357,0.0012740764,0.023604276,0.00048596231,0.00084686995,0.00804123,0.00050792214,0.013822169,0.000039949336],"about_ca_topic_score_codex":0.0011499209,"about_ca_topic_score_gemma":0.002003056,"teacher_disagreement_score":0.0027213243,"about_ca_system_score_codex":0.00039056383,"about_ca_system_score_gemma":0.0005353323,"threshold_uncertainty_score":0.009103715},"labels":[],"label_agreement":null},{"id":"W2043605505","doi":"10.1038/bjc.2013.609","title":"Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Cancer Research UK; Government of Ontario; Ontario Institute for Cancer Research; Pfizer","keywords":"Tamoxifen; Exemestane; Hazard ratio; Internal medicine; Oncology; Medicine; Breast cancer; Subgroup analysis; Tissue microarray; Confidence interval; Estrogen receptor; Prospective cohort study; Cancer","score_opus":0.0407244504869702,"score_gpt":0.3703711812747373,"score_spread":0.3296467307877671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043605505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893902,0.0028588597,0.0013160679,0.0011300266,0.0002893213,0.00056843966,0.0026522144,0.000045630608,0.0017494109],"genre_scores_gemma":[0.99428743,0.00056420255,0.0011344049,0.00058269274,0.00022333518,0.00061603455,0.0017622667,0.000030459545,0.00079917803],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9841277,0.013314915,0.0005220502,0.0010501565,0.00035235364,0.0006328195],"domain_scores_gemma":[0.9681846,0.018215518,0.007224908,0.004191457,0.0006376585,0.0015458218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01082221,0.0012869867,0.0035513225,0.00026059532,0.00062036375,0.0018362453,0.001042675,0.0025599955,0.006387613],"category_scores_gemma":[0.0257535,0.00059577404,0.005057195,0.00087032386,0.0012439834,0.002197183,0.0007423826,0.0033134618,0.0010487405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94494313,0.0013738137,0.026190653,0.00054004864,0.008581981,0.0001283977,0.00016503736,0.0014703309,0.00073983346,0.0007009283,0.002463836,0.012701951],"study_design_scores_gemma":[0.63527673,0.19055341,0.10270924,0.00066714274,0.04264762,0.0006106917,0.00054704107,0.00914783,0.0021508713,0.008606997,0.006729423,0.00035299288],"about_ca_topic_score_codex":0.0009911073,"about_ca_topic_score_gemma":0.0015211008,"teacher_disagreement_score":0.01082221,"about_ca_system_score_codex":0.0009694268,"about_ca_system_score_gemma":0.0020058632,"threshold_uncertainty_score":0.05723399},"labels":[],"label_agreement":null},{"id":"W2043758546","doi":"10.1054/bjoc.2000.1755","title":"‘Background to clinical guidelines in cancer’: SOR, a programmatic approach to guideline development and aftercare","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Guideline; Medicine; Cancer; Family medicine; Internal medicine; Pathology","score_opus":0.3369478932033216,"score_gpt":0.5519357513726665,"score_spread":0.2149878581693449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043758546","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034586976,0.01403026,0.016296407,0.9481818,0.004817875,0.00026246958,0.000059489346,0.00014247907,0.012750481],"genre_scores_gemma":[0.19122724,0.055587687,0.19938767,0.50137717,0.02336838,0.002239851,0.00041810778,0.00042741964,0.025966514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9519056,0.03499766,0.003871792,0.0018977037,0.0054255193,0.0019017187],"domain_scores_gemma":[0.87759966,0.07925108,0.006982675,0.0029901906,0.018099895,0.015076588],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.060894515,0.0005678402,0.00061926915,0.0026339202,0.0033716897,0.009753599,0.0029921061,0.010306107,0.0053640516],"category_scores_gemma":[0.09405746,0.0013548726,0.0006647301,0.0033118136,0.011657361,0.008305651,0.0078479545,0.027976494,0.0009912212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049452385,0.0006456888,0.0026256503,0.0035056262,0.00004164301,0.00082825974,0.026270961,0.00082521874,0.0008660743,0.28200102,0.26960275,0.41273773],"study_design_scores_gemma":[0.000084963416,0.0003919212,0.00702257,0.006108892,0.000035119014,0.0015968845,0.01004619,0.0015990697,0.00056436757,0.08572583,0.8867162,0.00010798245],"about_ca_topic_score_codex":0.011730777,"about_ca_topic_score_gemma":0.034950275,"teacher_disagreement_score":0.9391055,"about_ca_system_score_codex":0.010800756,"about_ca_system_score_gemma":0.045045022,"threshold_uncertainty_score":0.32204485},"labels":[],"label_agreement":null},{"id":"W2043857622","doi":"10.1038/bjc.2012.574","title":"Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Biology; AMPK; Clear cell renal cell carcinoma; Cancer research; Cell growth; Gene knockdown; In vivo; Clear cell; Cell culture; Protein kinase A; Kinase; Immunohistochemistry; Renal cell carcinoma; Pathology; Cell biology; Medicine; Immunology","score_opus":0.004800920872776112,"score_gpt":0.22341556116002473,"score_spread":0.2186146402872486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043857622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948026,0.0029942768,0.00074698887,0.000108311,0.000021290289,0.0000141362625,0.00039904658,0.00007235796,0.00084089726],"genre_scores_gemma":[0.9970831,0.00093094166,0.0004021683,0.000032507345,0.0000084215935,0.000016036598,0.0006243523,0.000014176319,0.00088822516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981755,0.000026883708,0.000017262802,0.000036485457,0.00006418963,0.00003759032],"domain_scores_gemma":[0.99971837,0.000056427918,0.00009574887,0.000036331086,0.000024584295,0.000068590794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018767534,0.00022663784,0.00040844784,0.0003218677,0.00021585554,0.00035426609,0.00013916407,0.0002711311,0.0017083869],"category_scores_gemma":[0.00023856854,0.00017870631,0.00018615316,0.00025912194,0.0003039849,0.0001550721,0.00017730182,0.00039747372,0.00062759826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022841824,0.000025218778,0.0023018748,0.000058793044,0.00000936287,0.0003058965,0.000019549696,0.000048619924,0.9956546,0.000062986226,0.00011801743,0.0011667458],"study_design_scores_gemma":[0.00008475532,0.0013755461,0.11476695,0.000014914078,0.000084651845,0.009147986,0.00014606147,0.0011873305,0.86511844,0.00013057029,0.007925496,0.00001728564],"about_ca_topic_score_codex":0.0010459666,"about_ca_topic_score_gemma":0.0013504649,"teacher_disagreement_score":0.0017083869,"about_ca_system_score_codex":0.00035916697,"about_ca_system_score_gemma":0.00035475346,"threshold_uncertainty_score":0.0057151318},"labels":[],"label_agreement":null},{"id":"W2044367685","doi":"10.1038/bjc.2011.123","title":"Early toxicity predicts long-term survival in high-grade glioma","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; American Society of Clinical Oncology","keywords":"Glioma; Toxicity; Medicine; Term (time); Oncology; Internal medicine; Cancer research","score_opus":0.027540024557539258,"score_gpt":0.27858821122785116,"score_spread":0.2510481866703119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044367685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985858,0.00078170607,0.00019708609,0.00006875934,0.0000028117836,0.00000468921,0.00009979934,0.0000032484365,0.00025606464],"genre_scores_gemma":[0.9994394,0.00017361513,0.00008803146,0.000013113141,0.0000053944627,0.0000029869088,0.00019241706,0.0000016860735,0.00008334802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997471,0.00011880964,0.000030276886,0.000023704957,0.000045943223,0.000034265537],"domain_scores_gemma":[0.9963182,0.0012836612,0.0018713452,0.00007963562,0.00016521274,0.00028190712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007526101,0.00016852302,0.00021880359,0.00020951201,0.00011383524,0.0002785494,0.0001719056,0.00020900102,0.0014731601],"category_scores_gemma":[0.0037858027,0.000096032796,0.00033023962,0.00033926492,0.00019273312,0.00018389116,0.00023107864,0.00034961305,0.00014408829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006898599,0.00002965148,0.9931573,0.00003935799,0.000073129195,0.00008475453,0.000012936218,0.00036432056,0.00037545862,0.000012590646,0.00008834552,0.00507236],"study_design_scores_gemma":[0.000019795987,0.00032156598,0.99848217,0.000007866952,0.00005703265,0.00043212093,0.000011987858,0.00030760514,0.00016725413,0.000049999548,0.00014006534,0.0000024885712],"about_ca_topic_score_codex":0.0008538394,"about_ca_topic_score_gemma":0.001747938,"teacher_disagreement_score":0.0014731601,"about_ca_system_score_codex":0.0002485503,"about_ca_system_score_gemma":0.00024705214,"threshold_uncertainty_score":0.0049282312},"labels":[],"label_agreement":null},{"id":"W2044745832","doi":"10.1038/bjc.2011.533","title":"Cytology of the vulva: feasibility and preliminary results of a new brush","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Biopsy; Vulvar intraepithelial neoplasia; Malignancy; Vulva; Cytology; Lichen sclerosus; Vulvar cancer; Brush; Lesion; Intraepithelial neoplasia; Squamous intraepithelial lesion; Pathology; Dermatology; Cancer; Cervical intraepithelial neoplasia; Internal medicine; Prostate; Cervical cancer","score_opus":0.08948381832282823,"score_gpt":0.3576722011553569,"score_spread":0.26818838283252866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044745832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98216414,0.0059842183,0.008590464,0.0003373886,0.00009299562,0.0003953098,0.00010245413,0.00010510295,0.0022279678],"genre_scores_gemma":[0.9836745,0.0016178024,0.013711758,0.00013680846,0.00007767824,0.00008051112,0.00016608507,0.00001830697,0.0005165238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842274,0.0006692167,0.00012524863,0.0002372191,0.0004437389,0.000101919104],"domain_scores_gemma":[0.9980323,0.0010133187,0.00009007358,0.0002972027,0.00035831242,0.00020882585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028917897,0.0005415285,0.000284246,0.000791498,0.0003395885,0.0008119479,0.00060667476,0.00087650184,0.0011763547],"category_scores_gemma":[0.0052042454,0.00030196697,0.00036340315,0.00021606723,0.0006448968,0.00083100103,0.0006588425,0.0004738069,0.00046458826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009785999,0.0021930104,0.43852708,0.00077680155,0.00016436695,0.010854313,0.0017034059,0.0007586376,0.3008027,0.0002571035,0.00051218056,0.23366438],"study_design_scores_gemma":[0.0008755251,0.053477127,0.6836194,0.00035934628,0.0005282638,0.070849955,0.0027980944,0.011408497,0.16067556,0.00070659176,0.0145569695,0.00014459954],"about_ca_topic_score_codex":0.000985356,"about_ca_topic_score_gemma":0.001344138,"teacher_disagreement_score":0.0028917897,"about_ca_system_score_codex":0.00025642195,"about_ca_system_score_gemma":0.00027611395,"threshold_uncertainty_score":0.015293479},"labels":[],"label_agreement":null},{"id":"W2044752132","doi":"10.1038/bjc.2013.115","title":"Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Wallonie-Bruxelles International; Fondation Medic; Amis de l'Institut Bordet; Université Libanaise","keywords":"Melanoma; Lymph node; Medicine; Breslow Thickness; Lymph; Proportional hazards model; Pathology; Survival analysis; Internal medicine; Oncology; Gastroenterology; Cancer; Cancer research; Sentinel lymph node","score_opus":0.007043574127679635,"score_gpt":0.22654930398742232,"score_spread":0.21950572985974268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044752132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99951077,0.00021318864,0.000056664023,0.000012400183,0.0000023621833,0.0000020362982,0.000057238212,0.000002390755,0.00014301376],"genre_scores_gemma":[0.9996878,0.000062187195,0.000049111244,0.000005403863,0.0000053792646,0.0000031435586,0.00008734153,9.124847e-7,0.00009878958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999527,0.000009919082,0.0000032470962,0.000014282238,0.000008578644,0.000011316318],"domain_scores_gemma":[0.99970657,0.000072361356,0.00009746539,0.000010334013,0.000025700134,0.000087540975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017109956,0.00021231531,0.00017368354,0.00028830944,0.0001359155,0.00024703637,0.000110710156,0.00022829958,0.0013078812],"category_scores_gemma":[0.0005683061,0.00010578667,0.00013287838,0.00016578914,0.00013281961,0.00013849277,0.00015900846,0.00026938462,0.00024511135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046357908,0.000023544631,0.99319,0.000014275393,0.000019081068,0.00014859578,0.000031405612,0.00008507817,0.0039730077,0.000006576348,0.00007590558,0.0019689912],"study_design_scores_gemma":[0.000009756465,0.00013744441,0.9985935,0.000003453866,0.000022852,0.00042834922,0.000043158696,0.00026086395,0.00038046483,0.000017100429,0.000101224796,0.000001826662],"about_ca_topic_score_codex":0.0005802123,"about_ca_topic_score_gemma":0.00087553187,"teacher_disagreement_score":0.0013078812,"about_ca_system_score_codex":0.00011389844,"about_ca_system_score_gemma":0.00009492168,"threshold_uncertainty_score":0.004375279},"labels":[],"label_agreement":null},{"id":"W2044866803","doi":"10.1038/bjc.2013.592","title":"A reanalysis of cancer mortality in Canadian nuclear workers (1956–1994) based on revised exposure and cohort data","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Nuclear Safety Commission","funders":"National Cancer Institute; Canadian Nuclear Safety Commission; National Institutes of Health; National Strength and Conditioning Association","keywords":"Poisson regression; Confidence interval; Medicine; Relative risk; Cohort; Risk assessment; Environmental health; Cohort study; Population; Internal radiation; Nuclear medicine; Demography; Internal medicine","score_opus":0.020245472631789937,"score_gpt":0.30948762209441383,"score_spread":0.2892421494626239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044866803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65692466,0.014771823,0.008258659,0.0011620028,0.00032601587,0.0005808692,0.31161517,0.00078477757,0.0055760015],"genre_scores_gemma":[0.8439036,0.005417105,0.008668512,0.00024434345,0.00006202522,0.00030120925,0.13737513,0.000109462795,0.003918528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687284,0.00022909742,0.0002452153,0.0004974825,0.0017397535,0.00041563902],"domain_scores_gemma":[0.99441344,0.00026696423,0.0005600055,0.0006359539,0.0038925777,0.00023110505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003845489,0.0011520013,0.0011177894,0.008034465,0.001318283,0.0013445063,0.0018794772,0.00044508453,0.0018217649],"category_scores_gemma":[0.0070296666,0.0005477267,0.003152894,0.012102494,0.00034134532,0.0003293388,0.0009757385,0.00077177555,0.00043273726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011434669,0.00003393691,0.91748863,0.0011633135,0.00451248,0.00032523077,0.00060135743,0.007778059,0.0014189965,0.0005918722,0.019885395,0.045057368],"study_design_scores_gemma":[0.00003512545,0.00003201862,0.9877642,0.00007826228,0.00061096775,0.00006724059,0.00012579783,0.0014152089,0.00021623958,0.00003362993,0.009591298,0.000030128604],"about_ca_topic_score_codex":0.99345374,"about_ca_topic_score_gemma":0.98774546,"teacher_disagreement_score":0.023221372,"about_ca_system_score_codex":0.023221372,"about_ca_system_score_gemma":0.039545532,"threshold_uncertainty_score":0.16848367},"labels":[],"label_agreement":null},{"id":"W2045406141","doi":"10.1038/bjc.2013.287","title":"Reply: Comment on ‘Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage’ – Psychological distress in patients with cancer: is screening the effective solution?","year":2013,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Triage; Medicine; Distress; Psychological distress; Physical therapy; Clinical trial; Randomized controlled trial; Cancer; Internal medicine; Emergency medicine; Psychiatry; Anxiety; Clinical psychology","score_opus":0.019340450941538825,"score_gpt":0.3144049672509227,"score_spread":0.2950645163093839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045406141","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005091693,0.0005461131,0.00006257203,0.9788264,0.018906623,0.00005608744,0.00032394816,0.00004528894,0.00072373386],"genre_scores_gemma":[0.001640707,0.00030064658,0.00012734439,0.98300123,0.012149734,0.00017119742,0.000055400593,0.000020367099,0.0025333671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994663,0.0019326685,0.0009861672,0.0006388106,0.0010064899,0.0007728308],"domain_scores_gemma":[0.9781562,0.014919801,0.0019742972,0.00047612676,0.0027504384,0.0017231725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069132866,0.0012048768,0.0032251321,0.0010748125,0.003809042,0.0028677434,0.0028810536,0.062357157,0.013228249],"category_scores_gemma":[0.052796517,0.00125484,0.0025388629,0.001317075,0.0033012251,0.0032527773,0.0019065058,0.04308439,0.009532966],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042957845,0.000044454875,0.0006371418,0.00021082805,0.000052662148,0.0004292627,0.0001126679,0.00006062827,0.00012899759,0.00054045144,0.9941506,0.0032026109],"study_design_scores_gemma":[0.0025630784,0.000706105,0.007297458,0.001671557,0.00048380927,0.0013480242,0.0012328821,0.001035974,0.0007804921,0.006565696,0.97599083,0.00032408998],"about_ca_topic_score_codex":0.016896218,"about_ca_topic_score_gemma":0.018542675,"teacher_disagreement_score":0.062357157,"about_ca_system_score_codex":0.0061267866,"about_ca_system_score_gemma":0.0067726183,"threshold_uncertainty_score":0.044453204},"labels":[],"label_agreement":null},{"id":"W2045650818","doi":"10.1038/sj.bjc.6605097","title":"Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Canada; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Cancer Care Ontario","funders":"National Cancer Institute; Canadian Institutes of Health Research; American Institute for Cancer Research","keywords":"Apolipoprotein E; Colorectal cancer; Red meat; Single-nucleotide polymorphism; Genotype; Internal medicine; Allele; Logistic regression; Medicine; Cancer; Gastroenterology; Biology; Oncology; Disease; Genetics; Pathology; Gene","score_opus":0.012065249491466675,"score_gpt":0.27837172383737135,"score_spread":0.26630647434590465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045650818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850523,0.0007929049,0.0001572798,0.00004893419,0.00000806282,0.0000046188147,0.00009156333,0.000005208568,0.0003861668],"genre_scores_gemma":[0.9993839,0.00018410849,0.00015083581,0.000016310167,0.000009001781,0.000002606699,0.000060053128,0.0000020820544,0.00019097171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943966,0.00020816305,0.00006876781,0.00012721865,0.00009421801,0.00006201584],"domain_scores_gemma":[0.99779797,0.0008706512,0.0007141103,0.0001612527,0.0001787429,0.0002772755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089210586,0.00026398126,0.00033760988,0.0009180072,0.0003055347,0.0004372986,0.000268679,0.0005458416,0.0013439116],"category_scores_gemma":[0.0026823452,0.00024077023,0.0004470567,0.0010419645,0.00028961667,0.00018923594,0.0002306417,0.0003974682,0.00016104779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050071545,0.000036153575,0.99611557,0.000015823123,0.0001972254,0.0002432651,0.000025732546,0.00006188136,0.0010937991,0.000021271231,0.000034335415,0.001654227],"study_design_scores_gemma":[0.000013373924,0.000109514884,0.99872726,0.000004840879,0.00008296867,0.0004489125,0.00003147619,0.00027876536,0.00015102046,0.00003036337,0.00011777547,0.0000037610307],"about_ca_topic_score_codex":0.005192274,"about_ca_topic_score_gemma":0.0050027543,"teacher_disagreement_score":0.005192274,"about_ca_system_score_codex":0.00019325591,"about_ca_system_score_gemma":0.00021906178,"threshold_uncertainty_score":0.0103241205},"labels":[],"label_agreement":null},{"id":"W2045707438","doi":"10.1038/sj.bjc.6604676","title":"Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Dasatinib; EPH receptor A2; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Tyrosine kinase; Pancreatic cancer; Receptor tyrosine kinase; Cortactin; Biology; Erythropoietin-producing hepatocellular (Eph) receptor; Kinase; Chemistry; Internal medicine; Signal transduction; Cell biology; Medicine; Cancer; Biochemistry; Cell","score_opus":0.02414531854458201,"score_gpt":0.27888338343537067,"score_spread":0.25473806489078865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045707438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991581,0.0052369847,0.00032802325,0.000228711,0.00007508222,0.0000431779,0.00034071133,0.000045440327,0.0021208597],"genre_scores_gemma":[0.99623895,0.0022720103,0.0003030747,0.000060939055,0.000012870402,0.000027344204,0.00038471294,0.000008617818,0.0006915762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972373,0.0000903013,0.000037343045,0.000027687394,0.000045148907,0.00007581367],"domain_scores_gemma":[0.99987555,0.00004476741,0.000018325944,0.000016478325,0.000011718451,0.00003309702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002894971,0.00033594962,0.00097258284,0.00022813788,0.00023035622,0.00043476373,0.00023517148,0.00033100366,0.0014640599],"category_scores_gemma":[0.00046537296,0.000177686,0.00041951495,0.0004485977,0.00028337605,0.00029461368,0.0002281738,0.0007146754,0.00023227652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012600916,0.0011262206,0.0019331006,0.00063314725,0.00019961565,0.00061535457,0.0001309562,0.0013867414,0.9523708,0.00057064934,0.00082501775,0.027607454],"study_design_scores_gemma":[0.0016130608,0.015296486,0.02022785,0.000027979393,0.0002281919,0.0017875426,0.00026486025,0.002866269,0.9493822,0.00042477035,0.007841442,0.00003927683],"about_ca_topic_score_codex":0.0005783935,"about_ca_topic_score_gemma":0.0012840715,"teacher_disagreement_score":0.0014640599,"about_ca_system_score_codex":0.00037807482,"about_ca_system_score_gemma":0.0003646952,"threshold_uncertainty_score":0.0048977733},"labels":[],"label_agreement":null},{"id":"W2046216743","doi":"10.1038/sj.bjc.6603841","title":"The context influences doctors' support of shared decision-making in cancer care","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; Multivariate analysis; Context (archaeology); Breast cancer; Family medicine; Cancer; Univariate; Patient participation; Multivariate statistics; Gynecology; MEDLINE; Internal medicine","score_opus":0.10442398818538914,"score_gpt":0.47898740714787463,"score_spread":0.37456341896248546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046216743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886687,0.0011981588,0.00038734605,0.004153956,0.00004896683,0.000031174106,0.00002789487,0.0000087044955,0.005276879],"genre_scores_gemma":[0.9992163,0.0002354267,0.00025472502,0.00015533548,0.000013401059,0.00000764292,0.000010506712,0.000001963199,0.00010456377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9727911,0.022460379,0.0011303689,0.00048051795,0.0019661686,0.0011714838],"domain_scores_gemma":[0.8994178,0.07404386,0.016210113,0.001596679,0.002218056,0.0065134866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008005285,0.00014169455,0.0002648015,0.00057390373,0.0017186865,0.0026777047,0.0004844181,0.00088941073,0.0038520652],"category_scores_gemma":[0.10380433,0.00034023484,0.0003274316,0.0005086326,0.0019706686,0.0011342074,0.0027192042,0.0013628997,0.00026763714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012624525,0.0006794004,0.7613189,0.0007605369,0.00031713056,0.0015379934,0.15089971,0.00082298677,0.0018045376,0.001862604,0.0028811346,0.0758525],"study_design_scores_gemma":[0.00035167998,0.0013207193,0.84557694,0.00091046677,0.00016724356,0.002981345,0.12481146,0.0023752258,0.00083843805,0.0045428337,0.015954275,0.00016930843],"about_ca_topic_score_codex":0.0051179496,"about_ca_topic_score_gemma":0.005661884,"teacher_disagreement_score":0.008005285,"about_ca_system_score_codex":0.0018749919,"about_ca_system_score_gemma":0.0033314768,"threshold_uncertainty_score":0.042336524},"labels":[],"label_agreement":null},{"id":"W2046299412","doi":"10.1038/sj.bjc.6605791","title":"Differential effects of smoking on lung cancer mortality before and after household stove improvement in Xuanwei, China","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Energy and Environment Impacts","field":"Environmental Science","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; National Institutes of Health; U.S. Environmental Protection Agency","keywords":"Stove; Lung cancer; Medicine; Environmental health; Hazard ratio; Proportional hazards model; Smoke; Cohort; Confidence interval; Cohort study; Demography; Cancer; Surgery; Internal medicine; Waste management; Engineering","score_opus":0.0036487589901406004,"score_gpt":0.22768689508477857,"score_spread":0.22403813609463796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046299412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998055,0.000050437317,0.000020207672,0.0000149349435,0.0000013282747,0.0000017161733,0.000051761985,7.846349e-7,0.000053338816],"genre_scores_gemma":[0.99974245,0.000028052413,0.000020354624,0.000009015167,0.0000018613255,0.0000027641067,0.00009938721,4.2510928e-7,0.00009562414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994916,0.00013481113,0.000028199558,0.00011424743,0.00007355891,0.00015758794],"domain_scores_gemma":[0.9989472,0.0002202483,0.00031929926,0.00010124954,0.0001378957,0.00027419574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083699863,0.0002563249,0.00026415498,0.0005025103,0.00043069624,0.00031502548,0.0003195556,0.00028714165,0.0006874763],"category_scores_gemma":[0.0011367623,0.00021825745,0.0005887221,0.0005365957,0.00034202187,0.00019746668,0.0004721579,0.00036383123,0.00005097886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026234647,0.000032550477,0.9971825,0.0000060261737,0.000071330884,0.00008506898,0.000111218484,0.00009027446,0.000510504,0.000013638544,0.000030047737,0.0016044194],"study_design_scores_gemma":[0.0000024182098,0.00004049904,0.99971277,9.233731e-7,0.000014610664,0.000018680821,0.000043866265,0.000077751436,0.000057038113,0.000005209881,0.000024898582,0.0000013877277],"about_ca_topic_score_codex":0.03296701,"about_ca_topic_score_gemma":0.054644126,"teacher_disagreement_score":0.03296701,"about_ca_system_score_codex":0.00079214724,"about_ca_system_score_gemma":0.00085829967,"threshold_uncertainty_score":0.06555021},"labels":[],"label_agreement":null},{"id":"W2046530370","doi":"10.1038/sj.bjc.6602452","title":"Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC; National Cancer Institute; Genome Canada","keywords":"Biology; Comparative genomic hybridization; Isochromosome; Gene; Molecular biology; Chromosome; Lung cancer; genomic DNA; Genetics; Cancer research; Karyotype; Pathology; Medicine","score_opus":0.007135902796587672,"score_gpt":0.21823842214936695,"score_spread":0.21110251935277927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046530370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508697,0.0009880329,0.0020732933,0.000054176126,0.000007710896,0.000018758421,0.0009255255,0.000048059996,0.0007974998],"genre_scores_gemma":[0.99213177,0.00078747334,0.003416646,0.000039623297,0.000006724038,0.0000504567,0.0020087839,0.000014308367,0.0015441827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998833,0.000013819357,0.0000054293037,0.000028458913,0.000048557835,0.000020370117],"domain_scores_gemma":[0.9999113,0.000033929475,0.000016564376,0.000012206634,0.000012174604,0.000013879418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006767234,0.00013915863,0.00020904907,0.00026035865,0.00014546006,0.00023690525,0.00011610575,0.00018011677,0.0006015518],"category_scores_gemma":[0.0001726229,0.000111632864,0.00011717739,0.0003457402,0.00013871587,0.0000892229,0.00010445939,0.00022677294,0.0002635266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021565815,0.000004140584,0.00024236242,0.000008757429,0.0000016889411,0.000021469612,0.000009318271,0.00004927076,0.999181,0.000014166059,0.000011930338,0.00043441443],"study_design_scores_gemma":[0.000012431873,0.00020820413,0.07161702,0.000003593018,0.00002805191,0.0003766848,0.000084018735,0.0022562335,0.9228464,0.00007082202,0.0024880837,0.000008459032],"about_ca_topic_score_codex":0.0011413074,"about_ca_topic_score_gemma":0.0022558672,"teacher_disagreement_score":0.0011413074,"about_ca_system_score_codex":0.00021214026,"about_ca_system_score_gemma":0.00010932475,"threshold_uncertainty_score":0.0022693276},"labels":[],"label_agreement":null},{"id":"W2046739711","doi":"10.1038/bjc.2012.221","title":"An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"European Commission","keywords":"Bladder cancer; microRNA; Urinary system; Medicine; Cancer; Urinary Bladder Cancer; Urinary bladder; Oncology; Pathology; Urology; Internal medicine; Biology; Genetics; Gene","score_opus":0.020924764698696998,"score_gpt":0.32953205970025085,"score_spread":0.30860729500155387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046739711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859605,0.0037056839,0.006065925,0.0001699345,0.00007190116,0.000045640954,0.00040066315,0.00016072037,0.00341901],"genre_scores_gemma":[0.99522495,0.00021493042,0.0038872429,0.00008795216,0.000024836785,0.000022273742,0.00018869663,0.000013278208,0.00033578603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827874,0.00043677384,0.00020286915,0.0004138144,0.0005509783,0.00011675556],"domain_scores_gemma":[0.9968207,0.0017443424,0.00042229154,0.000212753,0.00060662563,0.00019320386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020450416,0.00044490045,0.00047609888,0.0013902693,0.00029771,0.00080150366,0.00022838752,0.0008033756,0.0017682086],"category_scores_gemma":[0.004662685,0.00033559542,0.00037522014,0.0005786791,0.00046262846,0.00030270286,0.00044472064,0.00049671397,0.0008057422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008986047,0.00011756228,0.8301778,0.00019618854,0.00023395376,0.00031014445,0.00020813062,0.00031560365,0.13985112,0.00010236856,0.00035787738,0.027230654],"study_design_scores_gemma":[0.000029365814,0.0014603537,0.80173534,0.00007435033,0.00043975207,0.0066052857,0.000306063,0.0040589413,0.18119459,0.0003782781,0.0036748322,0.000042872558],"about_ca_topic_score_codex":0.00020198514,"about_ca_topic_score_gemma":0.0003083654,"teacher_disagreement_score":0.0020450416,"about_ca_system_score_codex":0.00020060994,"about_ca_system_score_gemma":0.00016462972,"threshold_uncertainty_score":0.010815322},"labels":[],"label_agreement":null},{"id":"W2046952440","doi":"10.1038/sj.bjc.6603619","title":"A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Jewish General Hospital; McGill University; Novartis Foundation","keywords":"Medicine; Receiver operating characteristic; Epidermal growth factor receptor; Colorectal cancer; Brachytherapy; Oncology; Internal medicine; Radiation therapy; Rectum; Multivariate analysis; Immunohistochemistry; Cancer; Pathology","score_opus":0.015900640538464246,"score_gpt":0.3248877173513774,"score_spread":0.30898707681291315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046952440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9351896,0.0033966843,0.05817815,0.00021617782,0.000081568825,0.00030111053,0.00057158014,0.0003680175,0.0016970679],"genre_scores_gemma":[0.9527147,0.00038816498,0.045775414,0.000039583538,0.00004603671,0.0001605041,0.00045218752,0.000029325456,0.00039407826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953454,0.0025193524,0.0004981536,0.00029082852,0.0012014443,0.00014480916],"domain_scores_gemma":[0.99057895,0.0042903535,0.0022436997,0.00066774123,0.0019975815,0.00022160452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007107151,0.0004904217,0.0005346702,0.0022434283,0.00017759435,0.0005520407,0.0005068214,0.0005231924,0.00070518645],"category_scores_gemma":[0.012545688,0.00017891005,0.00039988707,0.0010112514,0.00035110675,0.00044138564,0.0005127254,0.00043334163,0.00037607786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017912255,0.00019585443,0.7707549,0.00039715637,0.00041874946,0.00025098133,0.00023964662,0.0033010151,0.042721815,0.00024584212,0.001435265,0.17824756],"study_design_scores_gemma":[0.0001093933,0.0015311388,0.9577613,0.00006573587,0.00024816598,0.002783128,0.00014812098,0.02212304,0.012612172,0.00028079646,0.0022657602,0.00007125938],"about_ca_topic_score_codex":0.0008396555,"about_ca_topic_score_gemma":0.0015303988,"teacher_disagreement_score":0.007107151,"about_ca_system_score_codex":0.00030497246,"about_ca_system_score_gemma":0.0003900344,"threshold_uncertainty_score":0.03758669},"labels":[],"label_agreement":null},{"id":"W2047924643","doi":"10.1038/sj.bjc.6601662","title":"Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Health Canada","funders":"","keywords":"Medicine; Stage (stratigraphy); Breast cancer; Lobular carcinoma; Histology; Cancer; Radiation therapy; Survival rate; Confounding; Internal medicine; Gynecology; Ductal carcinoma; Biology","score_opus":0.0060959448408825995,"score_gpt":0.23072439656453228,"score_spread":0.22462845172364967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047924643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917462,0.0017407261,0.000098236385,0.00039340992,0.000016776556,0.000024367162,0.0043960954,0.000013872978,0.0015702158],"genre_scores_gemma":[0.99566984,0.00077513367,0.00011338331,0.000086093605,0.0000061685396,0.000013678145,0.0022949793,0.0000043761193,0.0010362784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994203,0.000045648303,0.000040440573,0.00007304387,0.00016402442,0.00025660856],"domain_scores_gemma":[0.9984395,0.000119867,0.0003364816,0.00004632373,0.0007033904,0.00035435878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033949933,0.00035200675,0.00042045876,0.0010074227,0.0017511992,0.0007623665,0.00093310483,0.0005076668,0.0011472305],"category_scores_gemma":[0.0016314898,0.00028963076,0.00043247585,0.0025024095,0.0007001584,0.00027539436,0.0006138816,0.00048096472,0.00024980205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013932386,0.000010347959,0.9951609,0.00002081612,0.00003961225,0.00011378887,0.00034978264,0.00018916771,0.00012261154,0.000043691904,0.00075564254,0.0030543867],"study_design_scores_gemma":[0.000007333097,0.000023788141,0.99834,0.000016998009,0.000021427291,0.000107574655,0.00040818163,0.00018844288,0.00004395136,0.000018057894,0.0008142635,0.0000099102],"about_ca_topic_score_codex":0.98967385,"about_ca_topic_score_gemma":0.9930646,"teacher_disagreement_score":0.021297975,"about_ca_system_score_codex":0.021297975,"about_ca_system_score_gemma":0.012238715,"threshold_uncertainty_score":0.15452838},"labels":[],"label_agreement":null},{"id":"W2048733214","doi":"10.1038/sj.bjc.6602072","title":"Anxiety and support in breast cancer: is this different for affluent and deprived women? A questionnaire study","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Anxiety; Medicine; Psychosocial; Distress; Health care; Cancer; Family medicine; Gerontology; Psychiatry; Clinical psychology; Internal medicine","score_opus":0.00823651011783391,"score_gpt":0.27988361367736775,"score_spread":0.27164710355953386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048733214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981115,0.00067144004,0.000020928792,0.0003425386,0.00001057286,0.000013613237,0.00008973313,5.518463e-7,0.00073911017],"genre_scores_gemma":[0.9992142,0.00037246605,0.000016700293,0.00015167013,0.000013033245,0.000011403999,0.00005142625,5.420294e-7,0.00016859974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993963,0.00018999819,0.000056519813,0.00003682152,0.00013499269,0.0001854145],"domain_scores_gemma":[0.9985843,0.00036136687,0.00038853282,0.00003087557,0.00015608354,0.00047895205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081814214,0.00012205815,0.0003494736,0.0010115958,0.0006011783,0.00070462254,0.00014186597,0.00040369466,0.0015215506],"category_scores_gemma":[0.004713669,0.00017069773,0.00041266653,0.0013613132,0.0005659946,0.00062901864,0.00072910887,0.00043993516,0.00014676957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000276318,0.00025756579,0.9710533,0.000167972,0.00010013456,0.00035702766,0.012432569,0.000040198876,0.00018697235,0.00014596083,0.0005571895,0.014424906],"study_design_scores_gemma":[0.000015922607,0.00035177244,0.98514265,0.000030331661,0.000019787114,0.00033263816,0.012969556,0.000039235805,0.0000112566195,0.00008797607,0.000990259,0.000008619941],"about_ca_topic_score_codex":0.019368066,"about_ca_topic_score_gemma":0.021925168,"teacher_disagreement_score":0.019368066,"about_ca_system_score_codex":0.0006889185,"about_ca_system_score_gemma":0.0005046442,"threshold_uncertainty_score":0.03851062},"labels":[],"label_agreement":null},{"id":"W2049441387","doi":"10.1038/bjc.2012.309","title":"Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Baker Hughes (Canada); Alberta Health Services","funders":"Fondation pour la Recherche Médicale; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Triage; Medicine; Anxiety; Distress; Randomized controlled trial; Depression (economics); Clinical trial; Physical therapy; Emergency medicine; Psychiatry; Internal medicine; Clinical psychology","score_opus":0.026132662005150298,"score_gpt":0.3263087388110574,"score_spread":0.3001760768059071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049441387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98578566,0.0041961577,0.0005660115,0.0010017038,0.0021392659,0.0036741209,0.00047048394,0.000093632734,0.0020730481],"genre_scores_gemma":[0.98607683,0.0020652777,0.001264091,0.00096247345,0.0009989251,0.0056045684,0.00028655567,0.00001550916,0.002725704],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980843,0.0009859351,0.00018377544,0.00036556792,0.00013462068,0.0002458172],"domain_scores_gemma":[0.9965109,0.0018316562,0.00061918853,0.0002039558,0.00012118938,0.00071313686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019262708,0.0018847648,0.004898579,0.000623571,0.00073889067,0.0014944011,0.0015300674,0.004125463,0.016450135],"category_scores_gemma":[0.006657784,0.0013999816,0.0026366299,0.000653824,0.0021150773,0.00165157,0.0010879257,0.005933724,0.0014674328],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98588854,0.006206912,0.0003702538,0.0006002859,0.00048798727,0.00002050161,0.00007567059,0.00013586743,0.00026196128,0.000055595276,0.00023901484,0.0056574275],"study_design_scores_gemma":[0.9416854,0.05469624,0.001898915,0.00009520833,0.00065739907,0.000015484176,0.0000671369,0.00043610574,0.000093861876,0.00012727545,0.00020706694,0.000019976917],"about_ca_topic_score_codex":0.004421267,"about_ca_topic_score_gemma":0.0039049848,"teacher_disagreement_score":0.016450135,"about_ca_system_score_codex":0.0012528952,"about_ca_system_score_gemma":0.0015280487,"threshold_uncertainty_score":0.05503118},"labels":[],"label_agreement":null},{"id":"W2050229870","doi":"10.1038/sj.bjc.6602770","title":"A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; St. Michael's Hospital","funders":"Cancer Research Society; Dartmouth College; GlaxoSmithKline; Cancer Research Institute","keywords":"Medicine; Insulin resistance; Colorectal cancer; Internal medicine; Gastroenterology; Vitamin B12; Randomized controlled trial; Cancer; Homocysteine; Eicosapentaenoic acid; Vitamin; Insulin; Endocrinology; Polyunsaturated fatty acid; Fatty acid; Biology; Biochemistry","score_opus":0.010816714537933614,"score_gpt":0.2892551283907073,"score_spread":0.2784384138527737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050229870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94961107,0.0037207054,0.0016707686,0.0020767488,0.0021700284,0.036016047,0.0016807327,0.00032323596,0.0027307002],"genre_scores_gemma":[0.9280383,0.0026214416,0.0068104113,0.0026483967,0.001194112,0.048925497,0.0014988235,0.000048471607,0.008214438],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981489,0.0011510259,0.00013775963,0.000233882,0.00010764375,0.00022076408],"domain_scores_gemma":[0.99570674,0.001715262,0.0005395631,0.00042862436,0.00031828534,0.001291598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034794689,0.0023151902,0.0040235617,0.0008943183,0.00089473283,0.0011226797,0.0012464224,0.0035051103,0.012461279],"category_scores_gemma":[0.006643784,0.0010187998,0.0020543153,0.0006611723,0.0023725857,0.0015174471,0.0011354294,0.0031790228,0.0014015584],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98895735,0.006287301,0.00010312804,0.0003023154,0.00027865372,0.00003769633,0.000033104752,0.00009574804,0.00073012355,0.000058162746,0.00023725773,0.0028791728],"study_design_scores_gemma":[0.93934035,0.059567958,0.00041897644,0.000013513133,0.00014221009,0.000012354784,0.00001232373,0.00009358253,0.000076002645,0.0000976545,0.00021833982,0.0000067895967],"about_ca_topic_score_codex":0.0023975587,"about_ca_topic_score_gemma":0.0032943396,"teacher_disagreement_score":0.012461279,"about_ca_system_score_codex":0.000791857,"about_ca_system_score_gemma":0.0021460871,"threshold_uncertainty_score":0.04168713},"labels":[],"label_agreement":null},{"id":"W2050689883","doi":"10.1038/bjc.2011.165","title":"Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Memorial University of Newfoundland; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; University of Toronto","keywords":"Microsatellite instability; Colorectal cancer; DNA methylation; Epigenetics; Methylation; Biology; Oncology; V600E; Wnt signaling pathway; Internal medicine; Context (archaeology); Cancer; Cancer research; Medicine; Mutation; Genetics; Microsatellite; Gene; Allele; Gene expression","score_opus":0.015254169623061632,"score_gpt":0.27514090008034253,"score_spread":0.2598867304572809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050689883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992156,0.00010386273,0.000045177716,0.000028214876,0.0000015441768,0.000008942267,0.00037417264,0.0000030543317,0.0002192969],"genre_scores_gemma":[0.99925715,0.00007391276,0.000051611874,0.000019559455,0.0000023961236,0.0000075626194,0.00044592874,0.000002738545,0.0001391567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995845,0.000040739847,0.00002686222,0.0001423977,0.0001032846,0.00010222197],"domain_scores_gemma":[0.99913377,0.000077698554,0.00025810822,0.00006794668,0.0002288054,0.00023375089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024791787,0.00034860344,0.0004799309,0.0009867413,0.0013934366,0.0007820875,0.00060203584,0.00043316794,0.0010014633],"category_scores_gemma":[0.0011809039,0.00034731286,0.00035736442,0.0016278327,0.0007483235,0.00016124478,0.0007127132,0.00037788425,0.00013490372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001595118,0.000008746475,0.99724233,0.0000076182178,0.000048866474,0.0001322104,0.00037996017,0.000027086078,0.0011439305,0.000013825326,0.00010279055,0.0007331841],"study_design_scores_gemma":[0.0000071469753,0.000022156359,0.9991253,0.0000027424749,0.000025656449,0.00023326348,0.0002932523,0.000054374665,0.000072712166,0.000006659325,0.00015300052,0.0000037222926],"about_ca_topic_score_codex":0.76284426,"about_ca_topic_score_gemma":0.80184907,"teacher_disagreement_score":0.76284426,"about_ca_system_score_codex":0.004337268,"about_ca_system_score_gemma":0.0036358242,"threshold_uncertainty_score":0.47710478},"labels":[],"label_agreement":null},{"id":"W2051165279","doi":"10.1038/bjc.2013.301","title":"Comment on ‘Estimating the asbestos-related lung cancer burden from mesothelioma mortality’ – IARC and Chrysotile Risks","year":2013,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chrysotile; Mesothelioma; Asbestos; Lung cancer; Medicine; Environmental health; Cancer; Pathology; Oncology; Internal medicine; Metallurgy","score_opus":0.022519089946690555,"score_gpt":0.3153437612809574,"score_spread":0.2928246713342669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051165279","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027153842,0.0006101321,0.00008497522,0.9787886,0.019127354,0.000010182036,0.00015667955,0.000028287937,0.00092233956],"genre_scores_gemma":[0.0012375215,0.0002810263,0.00011192803,0.98182696,0.014628004,0.00002162684,0.00003513152,0.000019046762,0.0018386426],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935463,0.0017491615,0.0011638356,0.0009686245,0.0016329436,0.00093915523],"domain_scores_gemma":[0.9845616,0.009075111,0.0014215134,0.0004553252,0.0027767308,0.0017096284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074627376,0.0011229347,0.002104353,0.0010827477,0.0039502895,0.0034451494,0.0030277371,0.06976692,0.005282549],"category_scores_gemma":[0.04221967,0.0014105204,0.0027088197,0.0015142319,0.003494215,0.004357832,0.002285296,0.051452212,0.0062184567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006978105,0.000019618763,0.0007409214,0.000052505027,0.000021664731,0.00037140006,0.00009431736,0.000070644084,0.00013908409,0.00079032703,0.9944284,0.003201298],"study_design_scores_gemma":[0.0001888551,0.00011999736,0.005760519,0.00061979477,0.000122045814,0.0012574507,0.00063742336,0.0006136952,0.0005723984,0.006711637,0.98318774,0.00020841451],"about_ca_topic_score_codex":0.039273817,"about_ca_topic_score_gemma":0.044470742,"teacher_disagreement_score":0.06976692,"about_ca_system_score_codex":0.005650982,"about_ca_system_score_gemma":0.0069058887,"threshold_uncertainty_score":0.07809043},"labels":[],"label_agreement":null},{"id":"W2052123873","doi":"10.1038/sj.bjc.6604110","title":"Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort study","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Endometrial cancer; Medicine; Prospective cohort study; Red meat; Dietary iron; Cohort; Cohort study; Proportional hazards model; Cancer; Physiology; Internal medicine; Iron deficiency; Environmental health; Anemia; Pathology","score_opus":0.014794592424804997,"score_gpt":0.2986917503940733,"score_spread":0.2838971579692683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052123873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556524,0.00086591643,0.00021326075,0.00015049739,0.00001088095,0.00011937862,0.0023542088,0.000009273171,0.00071136834],"genre_scores_gemma":[0.9947125,0.0010881828,0.0008268642,0.00012554653,0.000017411396,0.00007874151,0.0021510634,0.00000641895,0.0009932776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992901,0.000109732726,0.00003591284,0.00011396945,0.00024186127,0.00020846244],"domain_scores_gemma":[0.998789,0.0001169761,0.00018382524,0.00012328444,0.00042800445,0.00035891664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011971246,0.00046349957,0.0004916169,0.0012182781,0.0017848774,0.00080128456,0.00077798293,0.0004547195,0.00082621747],"category_scores_gemma":[0.0021111912,0.0007228577,0.0005574296,0.0033366042,0.00042868487,0.0002888038,0.0006300981,0.0008038618,0.0001468096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003787371,0.00009134473,0.9934063,0.00004049009,0.0002523755,0.00023298505,0.0006427404,0.000063537555,0.0005355517,0.0000720299,0.0006716106,0.0036122773],"study_design_scores_gemma":[0.00003405345,0.000076282035,0.99848515,0.000013292668,0.00007314929,0.00012111455,0.00017465428,0.00008670356,0.000032976848,0.000015182702,0.00087877194,0.0000087350545],"about_ca_topic_score_codex":0.8914829,"about_ca_topic_score_gemma":0.9096375,"teacher_disagreement_score":0.8914829,"about_ca_system_score_codex":0.003575198,"about_ca_system_score_gemma":0.0073818243,"threshold_uncertainty_score":0.21831232},"labels":[],"label_agreement":null},{"id":"W2052141774","doi":"10.1038/bjc.2011.503","title":"Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Anxiety; Medicine; Depression (economics); Internal medicine; Cancer; Breast cancer; Stage (stratigraphy); Lung cancer; Disease; Prostate cancer; Distress; Oncology; Psychiatry; Clinical psychology","score_opus":0.015125218643715,"score_gpt":0.2763474800655354,"score_spread":0.26122226142182037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052141774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854517,0.0004878838,0.000070939444,0.00007935898,0.000011865859,0.0000095343685,0.0002484718,0.0000029664054,0.0005438462],"genre_scores_gemma":[0.99951005,0.000082757324,0.00005318704,0.000024303776,0.000010794501,0.0000029068412,0.000239974,8.728469e-7,0.000075201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999684,0.00007635389,0.000041619878,0.000062483836,0.000059768525,0.0000758254],"domain_scores_gemma":[0.9973545,0.00051499216,0.0013450687,0.00012379316,0.00018347564,0.00047827326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054969214,0.00021226997,0.0002722174,0.00043289489,0.00031851293,0.00060172554,0.0002862102,0.00044644132,0.0014984381],"category_scores_gemma":[0.0035569072,0.00019125763,0.0005481753,0.0005825945,0.00028630652,0.00028521783,0.00042778515,0.0005231597,0.00018485523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057552585,0.000005314763,0.9991147,0.000006494821,0.000017171717,0.000021959902,0.000017256378,0.000016912878,0.00009984449,0.0000053522494,0.00004028619,0.0005971714],"study_design_scores_gemma":[0.0000032535936,0.000041577106,0.99966,0.0000025617758,0.000012630215,0.000119362456,0.000026445437,0.00006229421,0.00001692563,0.00001182376,0.00004223902,0.0000010046898],"about_ca_topic_score_codex":0.005613575,"about_ca_topic_score_gemma":0.013710812,"teacher_disagreement_score":0.005613575,"about_ca_system_score_codex":0.00035632428,"about_ca_system_score_gemma":0.00031802442,"threshold_uncertainty_score":0.011161804},"labels":[],"label_agreement":null},{"id":"W2052207496","doi":"10.1038/sj.bjc.6604172","title":"Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Radiation therapy; Receiver operating characteristic; Univariate analysis; Epidermal growth factor receptor; Internal medicine; Predictive marker; Oncology; Vascular endothelial growth factor; Colorectal cancer; Odds ratio; Cancer; Pathology; Multivariate analysis; VEGF receptors","score_opus":0.020629972510804836,"score_gpt":0.2937921139123036,"score_spread":0.27316214140149875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052207496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993499,0.00037860597,0.00014528504,0.000018403154,0.0000022182896,0.000002119248,0.000018903605,0.0000035603612,0.0000810302],"genre_scores_gemma":[0.9998035,0.000051525916,0.00007389854,0.0000052249584,0.0000032014912,0.0000014357266,0.000030073581,7.4448513e-7,0.000030525767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998079,0.00009084342,0.000018457897,0.000020202631,0.00003590856,0.000026703688],"domain_scores_gemma":[0.99924636,0.0003405459,0.00021727083,0.00003602343,0.000054470067,0.00010539397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036601946,0.00015542516,0.00030073905,0.00028858168,0.00010277486,0.00024469945,0.000103615916,0.00021415099,0.00043586318],"category_scores_gemma":[0.0015735233,0.000107394,0.0002924853,0.0001844751,0.00014393587,0.00014840653,0.00015289673,0.00027799333,0.00009138204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012735608,0.000045162415,0.984242,0.000022043048,0.0000647906,0.0001703341,0.000042310363,0.0005128913,0.0046568955,0.000009562474,0.000060356637,0.00890003],"study_design_scores_gemma":[0.000010015034,0.0004677271,0.99567777,0.0000053059034,0.00006108726,0.0007149389,0.000061581646,0.0016362993,0.0011925909,0.000022584665,0.00014601635,0.000004068748],"about_ca_topic_score_codex":0.0005003912,"about_ca_topic_score_gemma":0.0008200755,"teacher_disagreement_score":0.0005003912,"about_ca_system_score_codex":0.00012062479,"about_ca_system_score_gemma":0.00013631707,"threshold_uncertainty_score":0.0019357204},"labels":[],"label_agreement":null},{"id":"W2052283407","doi":"10.1038/bjc.2011.115","title":"Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Arthritis Network; McGill University Health Centre; McGill University","keywords":"Medicine; Endometrial cancer; Ovarian cancer; Oncology; Breast cancer; Internal medicine; Population; Incidence (geometry); Standardized mortality ratio; Relative risk; Gynecology; Cancer; Confidence interval","score_opus":0.10221180755632271,"score_gpt":0.3645129247595522,"score_spread":0.2623011172032295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052283407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07913729,0.916408,0.0017578778,0.00039154096,0.0002842319,0.00015804174,0.0011663502,0.000060928433,0.0006356704],"genre_scores_gemma":[0.84147745,0.15383925,0.002124812,0.00047606102,0.00028835185,0.00035783357,0.0009969778,0.000043899752,0.0003953343],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.991532,0.004910693,0.0014684955,0.0011878331,0.0006112022,0.00028970992],"domain_scores_gemma":[0.97657937,0.018196583,0.0025823547,0.0012544494,0.0010057115,0.00038147846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012522329,0.001981106,0.008678755,0.0038909065,0.0006516066,0.0027712358,0.0015501111,0.0016351092,0.0033095086],"category_scores_gemma":[0.020654412,0.0012232861,0.0377038,0.0051249205,0.0005362217,0.0009509814,0.0012638922,0.0015359299,0.00022649353],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005153457,0.00002637464,0.04096799,0.02740598,0.91854334,0.00022256353,0.000045774443,0.0009307419,0.0003762232,0.00008136033,0.00040720418,0.005838894],"study_design_scores_gemma":[0.0006639534,0.00024422756,0.020493431,0.0019829955,0.97497684,0.00018116803,0.000030672305,0.00041550965,0.00011739094,0.00016312253,0.00071435206,0.000016318687],"about_ca_topic_score_codex":0.005110625,"about_ca_topic_score_gemma":0.00779273,"teacher_disagreement_score":0.012522329,"about_ca_system_score_codex":0.001070894,"about_ca_system_score_gemma":0.0012013299,"threshold_uncertainty_score":0.06622517},"labels":[],"label_agreement":null},{"id":"W2052299248","doi":"10.1038/sj.bjc.6605846","title":"Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Gary Bennett Family Fund; National Institutes of Health; Uehara Memorial Foundation; National Cancer Institute; Entertainment Industry Foundation","keywords":"Colorectal cancer; Protein kinase A; Cancer research; Protein expression; Kinase; Oncology; Immunohistochemistry; Medicine; Internal medicine; Biology; Cancer; Cell biology; Biochemistry; Gene","score_opus":0.006107953102943957,"score_gpt":0.2599063714650868,"score_spread":0.2537984183621429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052299248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985852,0.0007723888,0.00011964487,0.000044748715,0.0000067389738,0.0000029813718,0.00016754966,0.000008072213,0.0002925838],"genre_scores_gemma":[0.999731,0.00007490123,0.00006341671,0.000004826774,0.0000062880335,0.0000015965492,0.00007996893,0.000001339133,0.000036566278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985015,0.000042045882,0.000014847049,0.00003422279,0.000023991226,0.000034677418],"domain_scores_gemma":[0.99894685,0.0002710136,0.00046417626,0.00005372851,0.00007624914,0.00018802393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041726822,0.00024277435,0.00019607306,0.00041136058,0.00019569894,0.00027558688,0.00019879456,0.0003241687,0.0013496791],"category_scores_gemma":[0.0016959785,0.00011244524,0.00031503028,0.0004953874,0.0002677326,0.00023866638,0.0002049807,0.00032609922,0.00019106695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084869383,0.000011641628,0.993493,0.000024787816,0.00004139946,0.00016032257,0.000020206026,0.000120754405,0.0023752546,0.000015769729,0.00007742704,0.0028107008],"study_design_scores_gemma":[0.000009638046,0.00009932509,0.9978806,0.00000444867,0.00006122715,0.0007012708,0.00003226013,0.0004167887,0.0005915573,0.00006584469,0.00013309938,0.0000039627826],"about_ca_topic_score_codex":0.0005075596,"about_ca_topic_score_gemma":0.00075165473,"teacher_disagreement_score":0.0013496791,"about_ca_system_score_codex":0.00022089072,"about_ca_system_score_gemma":0.00016295706,"threshold_uncertainty_score":0.004515171},"labels":[],"label_agreement":null},{"id":"W2052562958","doi":"10.1038/bjc.2013.372","title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Concordance; Medicine; Proportional hazards model; Oncology; Disease; Internal medicine; Bladder cancer; Hazard ratio; Cohort; Retrospective cohort study; Cancer; Confidence interval","score_opus":0.013127931856085167,"score_gpt":0.2676740225934418,"score_spread":0.2545460907373566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052562958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002403,0.00064703124,0.0057777083,0.00019019292,0.00005232096,0.000042121257,0.00095353957,0.00006904708,0.0022440464],"genre_scores_gemma":[0.99847156,0.00006538301,0.00078238326,0.000013609292,0.000016207185,0.000009835367,0.00050762825,0.000012575572,0.0001208117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99416476,0.003254967,0.00043413075,0.0008294543,0.0009538252,0.00036292864],"domain_scores_gemma":[0.96169627,0.027259257,0.0045416956,0.002984425,0.0023529816,0.0011654242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014690487,0.0011806469,0.00073081773,0.0029317304,0.0003507548,0.002062554,0.00094480405,0.00075006945,0.0013134279],"category_scores_gemma":[0.05576747,0.0003952649,0.0014424484,0.0013343272,0.00062953687,0.001029492,0.0012044212,0.0007996892,0.00048591042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056084956,0.000050053422,0.9803258,0.000021927593,0.00032876292,0.00005302909,0.00008822127,0.009588126,0.0000860679,0.00016634571,0.00044845312,0.0082823355],"study_design_scores_gemma":[0.00010666803,0.00053622684,0.637212,0.00011031812,0.00052555045,0.0006734976,0.00025238717,0.35676342,0.00066125,0.001952059,0.001136853,0.00006978475],"about_ca_topic_score_codex":0.0050539216,"about_ca_topic_score_gemma":0.0030189883,"teacher_disagreement_score":0.014690487,"about_ca_system_score_codex":0.0007005072,"about_ca_system_score_gemma":0.00087229273,"threshold_uncertainty_score":0.077691674},"labels":[],"label_agreement":null},{"id":"W2052847579","doi":"10.1038/sj.bjc.6606078","title":"Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Statistical Methods and Bayesian Inference","field":"Mathematics","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"NIHR Cambridge Biomedical Research Centre; BC Cancer Agency; Cancer Council Victoria; National Institute for Health and Care Research; National Health and Medical Research Council; Cancer Research UK","keywords":"Missing data; Imputation (statistics); Proportional hazards model; Breast cancer; Hazard ratio; Statistics; Oncology; Medicine; Data mining; Computer science; Internal medicine; Cancer; Mathematics; Confidence interval","score_opus":0.3276888214765711,"score_gpt":0.579606906818396,"score_spread":0.2519180853418249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052847579","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28039086,0.0060918448,0.7090771,0.001027007,0.0002734219,0.0010846581,0.0006463079,0.0006882744,0.000720435],"genre_scores_gemma":[0.5565383,0.002173709,0.43700823,0.00026970945,0.00018415877,0.0020128048,0.0010636766,0.00029424054,0.00045518356],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.83987695,0.14605679,0.0044285506,0.0033044515,0.0056032436,0.0007300056],"domain_scores_gemma":[0.37398472,0.59632486,0.011222298,0.009203429,0.008529007,0.0007356819],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18164945,0.0015918859,0.0021087904,0.0047164527,0.000711705,0.0017459773,0.0029355409,0.0020774463,0.0014058421],"category_scores_gemma":[0.28094396,0.0011470945,0.0068357475,0.003510524,0.0014852406,0.002670315,0.0031833034,0.002697364,0.00026039092],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020076951,0.0010715771,0.17421992,0.0038265528,0.03531883,0.0002792594,0.0023857513,0.2926443,0.0024030304,0.008745641,0.0023472277,0.45668095],"study_design_scores_gemma":[0.0021567189,0.004160268,0.07098396,0.0006725569,0.004699814,0.0004160976,0.00069016975,0.893856,0.0022827475,0.017935717,0.0017883562,0.00035757525],"about_ca_topic_score_codex":0.0033402261,"about_ca_topic_score_gemma":0.003349766,"teacher_disagreement_score":0.81835055,"about_ca_system_score_codex":0.0019803047,"about_ca_system_score_gemma":0.0025871634,"threshold_uncertainty_score":0.9606656},"labels":[],"label_agreement":null},{"id":"W2054071295","doi":"10.1038/sj.bjc.6604375","title":"Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Chinese University of Hong Kong","keywords":"Cisplatin; Downregulation and upregulation; Apoptosis; Cancer research; Ovarian cancer; Nitric oxide synthase; Nitric oxide; Gene knockdown; Chemistry; Biology; Cell biology; Endocrinology; Cancer; Biochemistry; Chemotherapy; Gene","score_opus":0.02880168302085476,"score_gpt":0.2915930241685952,"score_spread":0.26279134114774044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054071295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729866,0.0013852008,0.0005970122,0.00004793764,0.000010667178,0.000019743336,0.00015941846,0.0000151126715,0.00046615722],"genre_scores_gemma":[0.99788994,0.0006664985,0.0005255168,0.000044321227,0.0000038842268,0.000035781006,0.00029277155,0.0000036802414,0.0005375975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999056,0.000017172366,0.000013848083,0.000023853614,0.000024411022,0.000015160053],"domain_scores_gemma":[0.99993956,0.000009555762,0.000019700885,0.000008485318,0.000010307618,0.000012518931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001101698,0.00017428157,0.00021867051,0.00019168318,0.00012821831,0.0001964979,0.00010786087,0.00028475974,0.0007764661],"category_scores_gemma":[0.00012659983,0.000111860034,0.00020245175,0.00027809804,0.00015509369,0.00020430752,0.000119936616,0.0003108321,0.00015699599],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030231546,0.000054743898,0.0022831159,0.000046830428,0.000009306555,0.00010167358,0.000036628644,0.00004713552,0.99530727,0.000041457188,0.00003385044,0.0017357678],"study_design_scores_gemma":[0.00005069917,0.0010401312,0.07676377,0.000009295043,0.00004845543,0.0011199481,0.00011300788,0.0010121565,0.9169254,0.0001233827,0.0027831267,0.000010623253],"about_ca_topic_score_codex":0.00049812143,"about_ca_topic_score_gemma":0.0006447109,"teacher_disagreement_score":0.0007764661,"about_ca_system_score_codex":0.0001985996,"about_ca_system_score_gemma":0.00014621306,"threshold_uncertainty_score":0.0025975704},"labels":[],"label_agreement":null},{"id":"W2054420426","doi":"10.1038/bjc.2012.548","title":"Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Vlaamse regering; Hellenic Society of Medical Oncology; Vlaamse Liga Tegen Kanker","keywords":"Sunitinib; Medicine; Single-nucleotide polymorphism; Internal medicine; Oncology; Renal cell carcinoma; Clear cell renal cell carcinoma; Proportional hazards model; Progression-free survival; Kidney cancer; Genotype; Biology; Chemotherapy; Gene","score_opus":0.029628351071134377,"score_gpt":0.2537770313473713,"score_spread":0.2241486802762369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054420426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956375,0.00014686299,0.000059597707,0.000023637227,0.0000038039777,0.0000018842428,0.00011650384,0.0000027373587,0.000081194536],"genre_scores_gemma":[0.99977607,0.000022547825,0.000034718993,0.000007536703,0.0000061199025,0.0000027673966,0.00011642895,0.0000014263213,0.000032360487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996582,0.00008837327,0.000044341366,0.00010402177,0.000060035763,0.000045031567],"domain_scores_gemma":[0.9985501,0.00045405256,0.00062209595,0.000073733645,0.00009195599,0.00020795994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000489504,0.00026398804,0.0004434057,0.0003148603,0.0002972823,0.00034465845,0.00021986009,0.0004493189,0.0012435599],"category_scores_gemma":[0.0015769815,0.000112154616,0.0005283653,0.0005137824,0.00026375585,0.00012238038,0.00021411342,0.00045588397,0.00014763026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011975792,0.00004524373,0.99284476,0.000021076277,0.0002904409,0.00022059171,0.000049057868,0.00039896948,0.002863431,0.000021716378,0.000093152834,0.001954039],"study_design_scores_gemma":[0.000038670478,0.00019450868,0.99805427,0.00000382242,0.00013058557,0.00040446545,0.000024579256,0.0005744409,0.00040018602,0.000060767852,0.000109118846,0.0000045796523],"about_ca_topic_score_codex":0.0013139222,"about_ca_topic_score_gemma":0.0016254267,"teacher_disagreement_score":0.0013139222,"about_ca_system_score_codex":0.00024444037,"about_ca_system_score_gemma":0.00022595796,"threshold_uncertainty_score":0.004160106},"labels":[],"label_agreement":null},{"id":"W2055011486","doi":"10.1038/bjc.2011.325","title":"Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Terry Fox Research Institute; Fondation pour la Recherche Médicale; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Oncolytic virus; Apoptosis; Annexin; Biology; Cell culture; Cancer research; Gene knockdown; Virology; Viral replication; Cancer cell; Virus; Molecular biology; Cancer","score_opus":0.038731203454883144,"score_gpt":0.31587490404076213,"score_spread":0.277143700585879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055011486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180377,0.0033241576,0.0033667146,0.000091791684,0.000041997926,0.000035473284,0.00038225693,0.000113912945,0.0008398741],"genre_scores_gemma":[0.9957859,0.0009607676,0.0018091974,0.00002925246,0.000007010621,0.000034640336,0.00040577946,0.000018155768,0.0009493149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986494,0.00001902867,0.000017552717,0.00003212566,0.000038081427,0.000028351013],"domain_scores_gemma":[0.99989283,0.000024241242,0.000036599973,0.000016018601,0.000011802751,0.000018473887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012950556,0.00040990865,0.00030365554,0.00022131443,0.00011192332,0.0002853405,0.00022245177,0.0002844393,0.0013118902],"category_scores_gemma":[0.00015202216,0.00013456558,0.0003881871,0.00012897624,0.0002140475,0.00028805254,0.00017879903,0.0005956528,0.00032382156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008857828,0.000013196042,0.00007299048,0.000032636824,0.0000042392667,0.000017604783,0.0000056208205,0.000027969158,0.99926335,0.000028654114,0.000016878044,0.0004281865],"study_design_scores_gemma":[0.000016051816,0.00021904052,0.0012686102,0.000006138985,0.000014571198,0.00017928975,0.00000806858,0.00041071742,0.9968688,0.000024810803,0.000981554,0.00000227861],"about_ca_topic_score_codex":0.00037225173,"about_ca_topic_score_gemma":0.0004310378,"teacher_disagreement_score":0.0013118902,"about_ca_system_score_codex":0.00032711338,"about_ca_system_score_gemma":0.00013869973,"threshold_uncertainty_score":0.0043887496},"labels":[],"label_agreement":null},{"id":"W2055264437","doi":"10.1054/bjoc.2000.1514","title":"Characterization of DNA-strand breakage induced in V79 cells by F 11782, a catalytic inhibitor of topoisomerases","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Topoisomerase; DNA; Chemistry; Molecular biology; Biology; Cell biology; Biochemistry","score_opus":0.005840493849363004,"score_gpt":0.2325158587353968,"score_spread":0.2266753648860338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055264437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929403,0.0020393422,0.0021510292,0.000030842948,0.000015376896,0.000047923357,0.0007063251,0.000068076915,0.0020008276],"genre_scores_gemma":[0.99120903,0.0017320092,0.002154288,0.000036911155,0.000013131452,0.00007417597,0.0019602675,0.000020798356,0.0027994881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990237,0.000014032657,0.000009211753,0.000018081273,0.000036397978,0.00001997881],"domain_scores_gemma":[0.9998447,0.000035730674,0.00003390237,0.000019955396,0.000035292716,0.000030471352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010719358,0.00030025604,0.0003673657,0.00037030503,0.00013392055,0.00018515406,0.00014857006,0.0003610372,0.0010300934],"category_scores_gemma":[0.00015560814,0.00012333282,0.00021743121,0.0003148264,0.000118483425,0.00016661957,0.00008638655,0.00032298354,0.00046342585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044766613,0.000013463338,0.00019257123,0.000017597993,0.0000034702543,0.000030832176,0.0000098737455,0.00003132619,0.998936,0.000024194105,0.000007867533,0.0006880839],"study_design_scores_gemma":[0.000009346325,0.00046763945,0.0086849015,0.0000035016442,0.000011976884,0.00015786746,0.00002294113,0.0004304066,0.9894936,0.00001661957,0.00069842435,0.000002765536],"about_ca_topic_score_codex":0.001114693,"about_ca_topic_score_gemma":0.00080793345,"teacher_disagreement_score":0.001114693,"about_ca_system_score_codex":0.00016850294,"about_ca_system_score_gemma":0.00018569117,"threshold_uncertainty_score":0.003445983},"labels":[],"label_agreement":null},{"id":"W2055340778","doi":"10.1038/bjc.2014.538","title":"TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; Institut National Du Cancer; Collegio Ghislieri di Pavia; Advanced Remanufacturing and Technology Centre; Ligue Contre le Cancer","keywords":"Telomerase reverse transcriptase; Molecular biology; Biology; Telomerase; Mutation; Cancer research; Genetics; Gene","score_opus":0.019402354782506924,"score_gpt":0.3127777742327413,"score_spread":0.2933754194502344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055340778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980028,0.0012741328,0.0001510379,0.00003676997,0.0000039148126,0.0000037912412,0.00025136772,0.000008393255,0.00026777765],"genre_scores_gemma":[0.99924016,0.00037473414,0.000119486656,0.0000062818544,0.000007939872,0.0000028761249,0.00017132396,0.0000021104802,0.000075197335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985766,0.00002523524,0.000020791325,0.00004333338,0.00003308374,0.000019892608],"domain_scores_gemma":[0.9989711,0.00028134589,0.0005054687,0.000057256322,0.00008675369,0.00009811534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033377224,0.00021984812,0.00020941853,0.0009562725,0.00012560253,0.00031955072,0.0001552822,0.00022934374,0.0012745024],"category_scores_gemma":[0.0016818045,0.00009207568,0.00015426568,0.00080608245,0.00026750145,0.00013303914,0.00018014049,0.00020399374,0.00022060823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008380922,0.000022081154,0.98354405,0.00007454046,0.00012788475,0.00086384336,0.000056996807,0.00034158435,0.0050657117,0.00007152043,0.00010353509,0.0088901725],"study_design_scores_gemma":[0.000033679153,0.00013827084,0.9885318,0.00002511638,0.00016985221,0.0076795095,0.0000978939,0.000551613,0.0016979803,0.0004707878,0.0005945841,0.000008814056],"about_ca_topic_score_codex":0.00079163106,"about_ca_topic_score_gemma":0.0008073001,"teacher_disagreement_score":0.0012745024,"about_ca_system_score_codex":0.00012821476,"about_ca_system_score_gemma":0.00017812451,"threshold_uncertainty_score":0.0042636395},"labels":[],"label_agreement":null},{"id":"W2055376801","doi":"10.1038/sj.bjc.6600862","title":"Antitumour effect of cyclin-dependent kinase inhibitors (p16INK4A, p18INK4C, p19INK4D, p21WAF1/CIP1 and p27KIP1) on malignant glioma cells","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Cancer research; Glioma; Biology; Cyclin D1; Apoptosis; Cell cycle; Kinase; Autophagy; Cyclin-dependent kinase; Cyclin-dependent kinase 4; Cyclin; Cell cycle checkpoint; Cell biology; Cyclin-dependent kinase 2; Genetics","score_opus":0.005614852411264531,"score_gpt":0.251530167905328,"score_spread":0.24591531549406348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055376801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941241,0.0033854118,0.0005697343,0.0000499069,0.00003742627,0.000024045092,0.00020073813,0.000047814727,0.0015608318],"genre_scores_gemma":[0.99365705,0.0029587473,0.0009089483,0.000021667072,0.000016956234,0.000023948682,0.00028583047,0.000013393646,0.0021134054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998982,0.00001931677,0.000011380995,0.000012800377,0.000025576997,0.00003276862],"domain_scores_gemma":[0.9999031,0.000030804094,0.000016258353,0.000010946291,0.000016707505,0.00002226069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110674475,0.0004759568,0.00039025713,0.00029920498,0.00013735189,0.00016123756,0.00015638312,0.0001784235,0.00077756564],"category_scores_gemma":[0.00008786111,0.00008801919,0.00029042378,0.00021724863,0.00015149137,0.0001169713,0.00012011643,0.00035332187,0.0002127305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035097406,0.00010391596,0.00020799543,0.00010333251,0.000009605098,0.000059300062,0.000024719473,0.00013657035,0.99582833,0.000070387665,0.00005719411,0.0030476134],"study_design_scores_gemma":[0.000013165221,0.00078557833,0.0014851972,0.0000027012675,0.00001591982,0.0000474186,0.000009783991,0.00023508917,0.99661773,0.000009506549,0.00077638566,0.0000015391859],"about_ca_topic_score_codex":0.002143852,"about_ca_topic_score_gemma":0.0025436636,"teacher_disagreement_score":0.002143852,"about_ca_system_score_codex":0.00022512852,"about_ca_system_score_gemma":0.00024925938,"threshold_uncertainty_score":0.0042627454},"labels":[],"label_agreement":null},{"id":"W2055443426","doi":"10.1038/bjc.2013.753","title":"Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; St. Boniface Hospital; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"Bristol-Myers Squibb","keywords":"Epiregulin; Cetuximab; Colorectal cancer; Biomarker; Medicine; Oncology; Internal medicine; Hazard ratio; Cancer; Epidermal growth factor receptor; Biology; Amphiregulin","score_opus":0.014471277158109046,"score_gpt":0.2991732421950126,"score_spread":0.2847019650369036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055443426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831307,0.001299971,0.00012073171,0.000039202765,0.0000046706054,0.000009289583,0.00004887273,0.000003308956,0.00016084449],"genre_scores_gemma":[0.99951255,0.00015843028,0.00016944813,0.000018086157,0.000006828453,0.000006458862,0.00006400112,8.452089e-7,0.00006341736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996131,0.00019997053,0.000021226151,0.000046256624,0.00008999275,0.000029521825],"domain_scores_gemma":[0.9993944,0.000284372,0.00020157997,0.000020643696,0.0000308515,0.00006808994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010420141,0.00015891949,0.00044824294,0.0003277983,0.00008809199,0.00023721899,0.00013473416,0.00020815026,0.0005598355],"category_scores_gemma":[0.0012732756,0.000084807645,0.00018428187,0.0002996606,0.00023550379,0.00014073607,0.00013977369,0.00032252536,0.000075408185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050814353,0.0005671757,0.79033947,0.00031172077,0.00077044946,0.00023401217,0.00010578934,0.002548845,0.08135646,0.00007695752,0.00044281365,0.07243196],"study_design_scores_gemma":[0.00039636856,0.007087908,0.9754853,0.000012911676,0.00044803513,0.000519301,0.000040579584,0.002833586,0.012163002,0.00008923878,0.0009143098,0.000009403143],"about_ca_topic_score_codex":0.00036759992,"about_ca_topic_score_gemma":0.0010268742,"teacher_disagreement_score":0.0010420141,"about_ca_system_score_codex":0.00034415838,"about_ca_system_score_gemma":0.00021795052,"threshold_uncertainty_score":0.0055107474},"labels":[],"label_agreement":null},{"id":"W2055557358","doi":"10.1038/bjc.2013.725","title":"Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":470,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"Cancer Care Ontario","keywords":"Observational study; Population; Medicine; Randomized controlled trial; MEDLINE; Family medicine; Internal medicine; Biology; Environmental health","score_opus":0.8739839157445691,"score_gpt":0.6345413603989247,"score_spread":0.2394425553456444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055557358","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045854185,0.67379224,0.010727876,0.3035373,0.009703546,0.00015239992,0.00013325279,0.000059944887,0.0014348374],"genre_scores_gemma":[0.029635735,0.6560761,0.08420547,0.19711006,0.030461866,0.0013508712,0.00022761969,0.00020688878,0.0007255616],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.3174078,0.54851985,0.06545548,0.014157841,0.05205521,0.0024038805],"domain_scores_gemma":[0.054028627,0.90153265,0.012474771,0.010138687,0.02022597,0.0015992424],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.60752547,0.002061407,0.011237333,0.020408867,0.0028746529,0.02747322,0.00864941,0.027375285,0.0059262356],"category_scores_gemma":[0.79407805,0.0033336338,0.0066257734,0.024952454,0.024357596,0.047305286,0.01345108,0.036180176,0.0013688672],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011770148,0.00012886267,0.004192337,0.10599895,0.007023154,0.00051831687,0.0060940986,0.0020915687,0.0005728693,0.29933044,0.10229943,0.47057298],"study_design_scores_gemma":[0.0009794077,0.0003569725,0.0029717113,0.22642095,0.0040305015,0.0010363127,0.0029512732,0.0027486735,0.000512852,0.4862437,0.2712022,0.0005454805],"about_ca_topic_score_codex":0.0057170475,"about_ca_topic_score_gemma":0.0090782745,"teacher_disagreement_score":0.39247453,"about_ca_system_score_codex":0.017364034,"about_ca_system_score_gemma":0.028876053,"threshold_uncertainty_score":0.48399103},"labels":[],"label_agreement":null},{"id":"W2055645461","doi":"10.1038/sj.bjc.6603167","title":"Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health; Genome British Columbia; National Cancer Institute; Genome Canada","keywords":"Downregulation and upregulation; Biology; Cell cycle; Wnt signaling pathway; Lung cancer; Cancer research; CDKN2A; Cell; Transcriptome; Cell growth; Cancer; Cell biology; Gene expression; Gene; Signal transduction; Genetics; Pathology; Medicine","score_opus":0.005985744317921311,"score_gpt":0.22437835360233088,"score_spread":0.21839260928440957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055645461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966487,0.0015155731,0.0009926971,0.00002167278,0.000005451679,0.000016716089,0.00024502698,0.00002032179,0.000533809],"genre_scores_gemma":[0.99612135,0.0009587605,0.0010373725,0.000036039222,0.000002695893,0.00003211729,0.00095858314,0.000010486571,0.0008426695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998621,0.00001889642,0.000010113937,0.000030388448,0.000050625324,0.000027833772],"domain_scores_gemma":[0.9999057,0.000026284311,0.00002207206,0.000013104016,0.000017472628,0.000015318934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010705015,0.00014451236,0.00026703207,0.00046495371,0.00016559151,0.00023863134,0.00010766172,0.00017987151,0.00066758925],"category_scores_gemma":[0.00017167332,0.00009789699,0.00021269156,0.00026689155,0.00021402873,0.00012884325,0.00016511756,0.0001859293,0.0001904845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007087235,0.000008616163,0.0020122102,0.000018750976,0.0000056825934,0.000034696688,0.000013391469,0.00004591657,0.99643326,0.000029464478,0.000010060038,0.001317022],"study_design_scores_gemma":[0.000016968785,0.00060850056,0.20696612,0.0000073371393,0.000053673233,0.00085680425,0.00014046175,0.0008272754,0.7876082,0.00017497777,0.0027300545,0.000009578143],"about_ca_topic_score_codex":0.0010971361,"about_ca_topic_score_gemma":0.0033952568,"teacher_disagreement_score":0.0010971361,"about_ca_system_score_codex":0.0002492406,"about_ca_system_score_gemma":0.00024748922,"threshold_uncertainty_score":0.0022333264},"labels":[],"label_agreement":null},{"id":"W2055781154","doi":"10.1038/bjc.2013.3","title":"Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Academy of Medical Sciences; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Cytarabine; MSH2; DNA mismatch repair; Cancer research; DNA repair; DNA damage; Biology; Oxidative stress; Nucleoside analogue; Cytosine; Nucleoside; Cytotoxicity; DNA; Biochemistry; In vitro","score_opus":0.011987442337051965,"score_gpt":0.25710423677813854,"score_spread":0.24511679444108658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055781154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392575,0.0030201494,0.0010869789,0.000050887284,0.000014817916,0.00007335264,0.00027648275,0.000051641146,0.0015000581],"genre_scores_gemma":[0.9951644,0.0015683044,0.0020594154,0.000027590524,0.000007906266,0.000028473944,0.000437268,0.000011397798,0.0006953172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998617,0.000038059778,0.000015121529,0.000019906314,0.0000457133,0.000019355528],"domain_scores_gemma":[0.99978906,0.00007303557,0.000054127435,0.000023373552,0.000026076374,0.00003434723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013634918,0.00035602055,0.0002849849,0.0003702542,0.0001413461,0.00019963525,0.00018147174,0.00036322355,0.0016925024],"category_scores_gemma":[0.00021600543,0.00012215991,0.0001210382,0.00028114437,0.00014459921,0.000113685855,0.00011757495,0.00031039442,0.0002616704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019159335,0.000037070266,0.00040893446,0.000075964075,0.000009503405,0.000070896305,0.000010437,0.00013737514,0.99646866,0.0000365969,0.000030248224,0.002522732],"study_design_scores_gemma":[0.000020397274,0.001219236,0.002790324,0.000006851054,0.000018352093,0.00054055767,0.0000120410605,0.00021954182,0.9940749,0.000015466278,0.0010792129,0.0000031598859],"about_ca_topic_score_codex":0.0003373549,"about_ca_topic_score_gemma":0.0010792383,"teacher_disagreement_score":0.0016925024,"about_ca_system_score_codex":0.00016262225,"about_ca_system_score_gemma":0.00013338287,"threshold_uncertainty_score":0.0056619644},"labels":[],"label_agreement":null},{"id":"W2056464795","doi":"10.1054/bjoc.1999.1243","title":"Mortality from cutaneous melanoma: evidence for contrasting trends between populations","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Demography; Mortality rate; Cohort; Medicine; Cohort study; Pathology","score_opus":0.09397237790815856,"score_gpt":0.37478923204837905,"score_spread":0.2808168541402205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056464795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942701,0.0032200017,0.0007174353,0.00016509811,0.000020844487,0.000010518616,0.00042625496,0.000020357935,0.001149515],"genre_scores_gemma":[0.9985183,0.00057281426,0.00020255282,0.00005914692,0.00002049857,0.000006811519,0.00048594226,0.000009066791,0.00012492193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976198,0.00081219646,0.00024568875,0.0007918781,0.00032656017,0.00020385918],"domain_scores_gemma":[0.991606,0.0039774445,0.002109733,0.001001219,0.00086952245,0.00043605137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034536566,0.00022743944,0.0005802872,0.0024245013,0.00031875505,0.0010113375,0.0005839268,0.0006395896,0.0014394198],"category_scores_gemma":[0.010182077,0.0002665325,0.00083037495,0.0020089,0.0008156014,0.0008604176,0.0009776251,0.0004767303,0.00030666232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003802482,0.000022230523,0.9864291,0.00007887194,0.0005155971,0.000079084806,0.0011780079,0.00018085004,0.0012088186,0.00018407962,0.00011343759,0.009629583],"study_design_scores_gemma":[0.000005067468,0.00009481883,0.9987207,0.000011827845,0.000049307935,0.000105614454,0.00035996703,0.00013823913,0.000088402194,0.00016932616,0.00024920664,0.00000763859],"about_ca_topic_score_codex":0.0017019575,"about_ca_topic_score_gemma":0.0014975778,"teacher_disagreement_score":0.0034536566,"about_ca_system_score_codex":0.00025200742,"about_ca_system_score_gemma":0.0002146418,"threshold_uncertainty_score":0.01826489},"labels":[],"label_agreement":null},{"id":"W2056661251","doi":"10.1038/sj.bjc.6605905","title":"Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Ontario Ministry of Health and Long-Term Care; Nathaniel Wharton Fund; Princess Margaret Hospital Foundation","keywords":"Epithelial dysplasia; Dysplasia; Carcinoma; Pathology; Cancer; Medicine; Cytometry; Carcinoma in situ; Biology; Internal medicine; Flow cytometry; Immunology","score_opus":0.018164626215802983,"score_gpt":0.3106900109999077,"score_spread":0.29252538478410467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056661251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986998,0.00049040257,0.00009147912,0.000040511863,0.0000024857688,0.000006515513,0.00011659957,0.000007039765,0.0005451558],"genre_scores_gemma":[0.9995246,0.00014820327,0.000060714126,0.0000046371133,0.0000034143118,0.0000022617899,0.000115950395,0.0000013686329,0.000138798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973136,0.0000412781,0.000019239793,0.000045682853,0.00011249749,0.000049947077],"domain_scores_gemma":[0.99821484,0.0002913314,0.0009126,0.00008821394,0.00021967267,0.0002734421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038451247,0.00016327854,0.00024826016,0.0009899762,0.00033564024,0.0004648963,0.00026857655,0.00037467203,0.0020969512],"category_scores_gemma":[0.0021986135,0.00019086356,0.00025098378,0.0007823697,0.00041768095,0.00018475532,0.00029600144,0.0003982687,0.00019218554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026966297,0.00001943361,0.99652666,0.000012635168,0.000022120958,0.00015491735,0.000047994956,0.00006147988,0.0011505801,0.000014066998,0.000049812712,0.0016706082],"study_design_scores_gemma":[0.000003455789,0.0000532653,0.99912757,0.000003872737,0.00001680079,0.00037593552,0.00003398238,0.000110231405,0.00013043846,0.000022821177,0.0001198563,0.000001856829],"about_ca_topic_score_codex":0.016370554,"about_ca_topic_score_gemma":0.014971686,"teacher_disagreement_score":0.016370554,"about_ca_system_score_codex":0.0006043003,"about_ca_system_score_gemma":0.00066484674,"threshold_uncertainty_score":0.032550573},"labels":[],"label_agreement":null},{"id":"W2057149497","doi":"10.1038/sj.bjc.6603248","title":"Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Health Technology Assessment Programme","keywords":"Genetic counseling; Medicine; Family medicine; Breast cancer; Randomized controlled trial; Intervention (counseling); Anxiety; Clinical trial; Nursing; Cancer; Psychiatry; Surgery; Internal medicine","score_opus":0.03675228449937733,"score_gpt":0.3913376078677502,"score_spread":0.35458532336837284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057149497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6842496,0.2863444,0.0018431997,0.006738805,0.0032091516,0.0058130315,0.0009151447,0.00010331809,0.010783301],"genre_scores_gemma":[0.9595088,0.03111611,0.0022203869,0.00228423,0.00057715864,0.002541439,0.0003317262,0.000011914516,0.0014082217],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9863028,0.011220824,0.00080938183,0.0005614241,0.00083729095,0.000268333],"domain_scores_gemma":[0.9899351,0.007265507,0.0016303711,0.00031342078,0.00025253644,0.0006030194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006090668,0.0008134391,0.0024410263,0.0010475098,0.00040329003,0.0012016068,0.0011118419,0.0031391229,0.0081147775],"category_scores_gemma":[0.020925114,0.00042952425,0.003176028,0.0009748121,0.0013731518,0.0014368239,0.0007471378,0.0022975204,0.00041407172],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73645055,0.007176306,0.0016766249,0.03672738,0.011641758,0.00018275258,0.00033561245,0.0008392008,0.00069568073,0.0014839264,0.0021170042,0.20067306],"study_design_scores_gemma":[0.8674439,0.09885933,0.010170376,0.006408866,0.007900419,0.00018394878,0.0002967482,0.0006994281,0.0002768898,0.0017734023,0.0059105577,0.00007602839],"about_ca_topic_score_codex":0.004272326,"about_ca_topic_score_gemma":0.0072072595,"teacher_disagreement_score":0.0081147775,"about_ca_system_score_codex":0.0017315891,"about_ca_system_score_gemma":0.0014075455,"threshold_uncertainty_score":0.032210946},"labels":[],"label_agreement":null},{"id":"W2057213394","doi":"10.1038/sj.bjc.6604730","title":"Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Phytase and its Applications","field":"Agricultural and Biological Sciences","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Urological Oncology Group; Institute of Cancer Research; AstraZeneca","keywords":"MG132; Cycloheximide; DU145; Proteasome inhibitor; Proteasome; Biology; Transcription factor; Cancer research; Cancer cell; Protein biosynthesis; LNCaP; Chemistry; Cell biology; Molecular biology; Biochemistry; Cancer; Gene; Genetics","score_opus":0.013456864244208206,"score_gpt":0.23656348893129908,"score_spread":0.2231066246870909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057213394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747755,0.016741678,0.003463406,0.00022435006,0.000105878695,0.000079176294,0.00044826238,0.00022818273,0.00393355],"genre_scores_gemma":[0.9892536,0.005567993,0.0021597475,0.00006843306,0.000031362208,0.00003357987,0.00045676765,0.000016331502,0.0024122302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991226,0.000012982759,0.0000076830265,0.000013782877,0.000030222975,0.000023105673],"domain_scores_gemma":[0.9999671,0.000005541764,0.0000072160456,0.000004743993,0.0000041422854,0.000011165542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079615515,0.00028093375,0.00032305098,0.00021711922,0.000102311846,0.00026792538,0.00017412676,0.00014998406,0.0010081001],"category_scores_gemma":[0.00006037355,0.000087074,0.00031242633,0.0002153782,0.000106991174,0.00016023811,0.00019430391,0.0005189882,0.00028760196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027920544,0.0000829583,0.00013889164,0.000109648754,0.000016388667,0.00004185731,0.000012949379,0.000137738,0.9920122,0.000036989746,0.00011069627,0.007020439],"study_design_scores_gemma":[0.000054048265,0.0013917201,0.00501988,0.000009605781,0.000044686567,0.0003441846,0.000023055469,0.0008486755,0.9876308,0.000038931918,0.004588023,0.000006390249],"about_ca_topic_score_codex":0.00044088857,"about_ca_topic_score_gemma":0.0013565471,"teacher_disagreement_score":0.0010081001,"about_ca_system_score_codex":0.00015447837,"about_ca_system_score_gemma":0.000198881,"threshold_uncertainty_score":0.0033724308},"labels":[],"label_agreement":null},{"id":"W2057510061","doi":"10.1038/sj.bjc.6602841","title":"A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer","year":2005,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Medical Research Council","keywords":"Medicine; Hazard ratio; Asymptomatic; Colorectal cancer; Internal medicine; Confidence interval; Chemotherapy; Randomized controlled trial; Surgery; Cancer; Quality of life (healthcare); Fluorouracil","score_opus":0.15649570192656467,"score_gpt":0.4504292015240024,"score_spread":0.29393349959743775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057510061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11015479,0.8805208,0.0031048304,0.0008292416,0.0011390367,0.0011594183,0.0016517197,0.0001313652,0.0013087485],"genre_scores_gemma":[0.87096536,0.118825644,0.0043234695,0.0016919781,0.00039465984,0.0013059796,0.001491294,0.000070946044,0.00093073753],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9747781,0.018861193,0.0028855188,0.0018437968,0.0011370856,0.00049432967],"domain_scores_gemma":[0.9760962,0.017767759,0.0029834872,0.0013997026,0.0012373046,0.00051562523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025264427,0.0035954313,0.017139735,0.003287164,0.0007596025,0.0035568126,0.0018194268,0.0028246911,0.0029593445],"category_scores_gemma":[0.040022872,0.0014901153,0.042578343,0.0036122184,0.0008166516,0.0013256163,0.0013454298,0.0031743753,0.00029677115],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026210006,0.000038969156,0.0032581757,0.026754526,0.93883765,0.00011566204,0.000039485145,0.0009543248,0.00027841332,0.00009054424,0.00034019825,0.0030819795],"study_design_scores_gemma":[0.0060779625,0.00066519645,0.0031219323,0.001373199,0.9874177,0.00006740889,0.000023852155,0.00032443926,0.00010216463,0.00018213509,0.0006245011,0.000019601188],"about_ca_topic_score_codex":0.0116984155,"about_ca_topic_score_gemma":0.021486668,"teacher_disagreement_score":0.025264427,"about_ca_system_score_codex":0.0038030343,"about_ca_system_score_gemma":0.0022807156,"threshold_uncertainty_score":0.13361263},"labels":[],"label_agreement":null},{"id":"W2057750876","doi":"10.1038/bjc.2013.730","title":"BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genome Canada; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Cancer Research UK; Medical Research Council","keywords":"Breast cancer; Cancer; Pathology; Medicine; Interface (matter); Oncology; Computer science; Internal medicine","score_opus":0.00573871593396774,"score_gpt":0.26534285518559714,"score_spread":0.2596041392516294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057750876","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03720441,0.0007353586,0.8847389,0.0029174462,0.00042302257,0.000549613,0.021787303,0.03538421,0.016259704],"genre_scores_gemma":[0.34481344,0.0013632531,0.5767769,0.0013985473,0.00040334882,0.0022844046,0.034544345,0.0051584556,0.033257224],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986835,0.00040315086,0.000099980876,0.00023928488,0.0004981734,0.00007593438],"domain_scores_gemma":[0.9955303,0.002287948,0.00020373992,0.00050751294,0.0013032673,0.00016712713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030268633,0.000868386,0.0010669775,0.0011744637,0.00031187994,0.0015926249,0.0032296665,0.0011426351,0.02196099],"category_scores_gemma":[0.017238883,0.000819786,0.0011637432,0.0011449979,0.00025337466,0.0017749666,0.0012183604,0.0018470084,0.009926755],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011557289,0.0003402049,0.024367211,0.0003098413,0.00037518053,0.0004051662,0.0002177612,0.5411689,0.0014997214,0.011079736,0.09757437,0.32150617],"study_design_scores_gemma":[0.00017239612,0.00005671964,0.0024062034,0.000030394163,0.000072944706,0.00032564843,0.000018956984,0.9463328,0.0009415364,0.0075109364,0.04207326,0.000058176556],"about_ca_topic_score_codex":0.029997103,"about_ca_topic_score_gemma":0.018489866,"teacher_disagreement_score":0.029997103,"about_ca_system_score_codex":0.0012969719,"about_ca_system_score_gemma":0.0018513465,"threshold_uncertainty_score":0.0734669},"labels":[],"label_agreement":null},{"id":"W2057805403","doi":"10.1038/bjc.2013.261","title":"A personalised approach to prostate cancer screening based on genotyping of risk founder alleles","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"Ministerstwo Edukacji i Nauki","keywords":"Prostate cancer; CHEK2; Single-nucleotide polymorphism; Genotyping; Rectal examination; Allele; Prostate; Medicine; Cancer; Prostate cancer screening; Genotype; Internal medicine; Oncology; Prostate-specific antigen; Germline mutation; Biology; Genetics; Mutation; Gene","score_opus":0.021123688022015783,"score_gpt":0.28190107136303694,"score_spread":0.26077738334102113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057805403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8131231,0.0077394415,0.14223357,0.0031680604,0.00030917328,0.00153906,0.001024633,0.002261504,0.028601477],"genre_scores_gemma":[0.8959794,0.0026694527,0.09039851,0.001414883,0.00045312254,0.0006379628,0.00065689324,0.0000671389,0.007722763],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984592,0.0007438137,0.000056746936,0.00035902232,0.00030304387,0.00007816043],"domain_scores_gemma":[0.99763286,0.0010211215,0.00035775403,0.0006275768,0.0001623697,0.00019831026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020501395,0.00036683024,0.00053949817,0.000871891,0.00031659595,0.0005026816,0.0007845224,0.000623991,0.0055537554],"category_scores_gemma":[0.0038926476,0.000257154,0.00028900322,0.00060154835,0.00049967744,0.00033184,0.0012230129,0.0007270638,0.0017574815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020836974,0.0016149272,0.25715017,0.00030299916,0.00018048703,0.0007692939,0.0006542227,0.00268564,0.018850291,0.0006609674,0.00794363,0.70710355],"study_design_scores_gemma":[0.0024086323,0.013862217,0.82083315,0.00050859933,0.0007262959,0.032928776,0.0005273645,0.027320046,0.027005583,0.009595545,0.063994914,0.00028888555],"about_ca_topic_score_codex":0.0011459684,"about_ca_topic_score_gemma":0.0017516745,"teacher_disagreement_score":0.0055537554,"about_ca_system_score_codex":0.0002412811,"about_ca_system_score_gemma":0.00031969635,"threshold_uncertainty_score":0.018579125},"labels":[],"label_agreement":null},{"id":"W2057851318","doi":"10.1038/sj.bjc.6604612","title":"Estimation of renal function and its potential impact on carboplatin dosing in children with cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Engineering and Physical Sciences Research Council; University College London; Cancer Research UK; Hospital for Sick Children; Children's Cancer and Leukaemia Group","keywords":"Carboplatin; Dosing; Medicine; Renal function; Urology; Cancer; Internal medicine; Oncology; Chemotherapy; Cisplatin","score_opus":0.008832073011949012,"score_gpt":0.26880527464174797,"score_spread":0.259973201629799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057851318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636155,0.0015197652,0.0004945398,0.000276114,0.00000514277,0.00002222356,0.00019106244,0.000010161761,0.0011194922],"genre_scores_gemma":[0.998511,0.0005173114,0.00072438084,0.000041629242,0.0000061897777,0.000007654472,0.000089504225,0.0000037161603,0.00009851372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.991784,0.004632501,0.00056131044,0.0004928996,0.0020840012,0.00044523628],"domain_scores_gemma":[0.9770195,0.010986651,0.008996489,0.00074051594,0.0017204661,0.0005364042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003986327,0.0002920058,0.0004059751,0.0009970312,0.0002983052,0.0010726526,0.00052540225,0.0004046884,0.00079574774],"category_scores_gemma":[0.024698768,0.00020737057,0.00046664357,0.0019285604,0.00079590967,0.00069630926,0.0008102016,0.0006621917,0.0001526552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011905839,0.000022842341,0.99150556,0.000029527673,0.000017588098,0.00014135204,0.00022047535,0.00030841457,0.0002677146,0.00003035397,0.00004381397,0.00729334],"study_design_scores_gemma":[0.0000025150866,0.00030547206,0.9974137,0.000020836142,0.000020819714,0.0005654848,0.0003803509,0.00041478814,0.00055030343,0.000021995224,0.00029655604,0.0000072114576],"about_ca_topic_score_codex":0.021147048,"about_ca_topic_score_gemma":0.019437188,"teacher_disagreement_score":0.021147048,"about_ca_system_score_codex":0.0017746378,"about_ca_system_score_gemma":0.0011330853,"threshold_uncertainty_score":0.042047918},"labels":[],"label_agreement":null},{"id":"W2058736678","doi":"10.1038/bjc.2012.543","title":"Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cilag; Genentech; Bayer HealthCare; Exelixis; Sanofi; Pfizer","keywords":"Sorafenib; Tolerability; Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Cumulative incidence; Incidence (geometry); Dosing; Population; Oncology; Confidence interval; Cohort; Hepatocellular carcinoma","score_opus":0.0068845273697906014,"score_gpt":0.23108474868871218,"score_spread":0.2242002213189216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058736678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8881468,0.10092906,0.0027122512,0.00018828944,0.00010332288,0.00023633231,0.0064133047,0.000082888175,0.0011876806],"genre_scores_gemma":[0.98847675,0.006914704,0.0006283232,0.00015652526,0.00013712361,0.00014934549,0.0033261129,0.000022871987,0.00018820794],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99431074,0.0032187393,0.0008701162,0.0008745257,0.0005816049,0.00014418001],"domain_scores_gemma":[0.991723,0.0037196418,0.0026971658,0.0009984522,0.0006568577,0.00020496795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010174771,0.00094184704,0.0031815155,0.0015056444,0.00022373059,0.0011461442,0.00046324538,0.00053941616,0.0015731106],"category_scores_gemma":[0.009462176,0.00049058464,0.0074543324,0.002595644,0.00026842832,0.0005145393,0.0007452236,0.000399723,0.00026787253],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042565577,0.00021387251,0.4847223,0.006276221,0.41882458,0.00037075323,0.00026436822,0.0027332506,0.0024997054,0.00007892023,0.0021197898,0.039330684],"study_design_scores_gemma":[0.0037316934,0.0021615876,0.78448486,0.00037795576,0.20382132,0.00045924998,0.00011000472,0.0012158422,0.0004592673,0.00016919647,0.0029357697,0.00007320868],"about_ca_topic_score_codex":0.0023784065,"about_ca_topic_score_gemma":0.0040791105,"teacher_disagreement_score":0.010174771,"about_ca_system_score_codex":0.0005829881,"about_ca_system_score_gemma":0.0005200759,"threshold_uncertainty_score":0.05380994},"labels":[],"label_agreement":null},{"id":"W2059066343","doi":"10.1038/bjc.2012.279","title":"Microbubble and ultrasound radioenhancement of bladder cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Terry Fox Foundation","keywords":"Microbubbles; Ultrasound; Medicine; Pathology; Bladder cancer; Radiation therapy; Mechanical index; Fibrosis; Nuclear medicine; Cancer; Radiology; Internal medicine","score_opus":0.0071292405800608034,"score_gpt":0.23506329302477347,"score_spread":0.22793405244471265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059066343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857846,0.010027484,0.0032412498,0.00009602818,0.000016686337,0.000029055123,0.000053570922,0.000044618773,0.0007066077],"genre_scores_gemma":[0.9944818,0.0024984283,0.0016506847,0.000032757074,0.000010954326,0.000028919683,0.000107096195,0.000009054491,0.0011804086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999031,0.000030509249,0.0000052024366,0.00001218497,0.000024892446,0.000024099336],"domain_scores_gemma":[0.99990106,0.000031151274,0.000027884329,0.000009040508,0.000011113622,0.000019782607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002425881,0.00023325748,0.00022183076,0.00025847324,0.000104412466,0.00016439991,0.00018989242,0.00031995767,0.0010345002],"category_scores_gemma":[0.0002139728,0.00013195086,0.00020639788,0.00012784656,0.00026665677,0.00023546786,0.00019339453,0.00033352608,0.00015057142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025635705,0.000042581316,0.00041173203,0.00014512296,0.0000076320075,0.00004666503,0.000024749315,0.00018971317,0.99517435,0.00006468809,0.00003380012,0.003602696],"study_design_scores_gemma":[0.00001941196,0.002089156,0.009510506,0.00001645476,0.000039581257,0.00046591062,0.000021013107,0.0010274365,0.98480797,0.000053977063,0.0019434227,0.0000051780657],"about_ca_topic_score_codex":0.00078004296,"about_ca_topic_score_gemma":0.0008726735,"teacher_disagreement_score":0.0010345002,"about_ca_system_score_codex":0.00028089172,"about_ca_system_score_gemma":0.00022769893,"threshold_uncertainty_score":0.003460765},"labels":[],"label_agreement":null},{"id":"W2059370935","doi":"10.1038/bjc.2013.523","title":"Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GLS Industries (Canada)","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"FOLFIRI; Aflibercept; Medicine; Internal medicine; Oxaliplatin; Population; Irinotecan; Placebo; Colorectal cancer; Survival analysis; Oncology; Regimen; Surgery; Bevacizumab; Cancer; Chemotherapy","score_opus":0.011769297903893437,"score_gpt":0.26168183645577364,"score_spread":0.2499125385518802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059370935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943989,0.0029909133,0.0012370867,0.0002692967,0.000026758746,0.00006646841,0.00018569666,0.000036085556,0.00078879914],"genre_scores_gemma":[0.99919075,0.00022150176,0.00027232998,0.000052548246,0.00001713239,0.000032789907,0.00011778721,0.0000027693,0.000092405084],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992157,0.00046714104,0.000048296148,0.000105691084,0.000104989675,0.000058218782],"domain_scores_gemma":[0.9975496,0.0015843024,0.0005474934,0.0001351544,0.00007157803,0.000111813075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041746786,0.00034756973,0.0007523664,0.00031069256,0.00010300209,0.0005270279,0.00023345483,0.00030811943,0.000916215],"category_scores_gemma":[0.006095696,0.000085110725,0.0010849294,0.0002562174,0.0002954333,0.0005007283,0.0003084095,0.000866918,0.000091426235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42916986,0.0023717468,0.16048872,0.0016198173,0.007031819,0.00019660831,0.00059666747,0.035139468,0.018412398,0.001008074,0.001602015,0.34236282],"study_design_scores_gemma":[0.0325533,0.2924167,0.60765314,0.00030731293,0.00872345,0.00078895676,0.00030468975,0.03480015,0.014499253,0.0036636472,0.0041783177,0.000111131354],"about_ca_topic_score_codex":0.00039789642,"about_ca_topic_score_gemma":0.0005348435,"teacher_disagreement_score":0.0041746786,"about_ca_system_score_codex":0.0005738786,"about_ca_system_score_gemma":0.0003549862,"threshold_uncertainty_score":0.022078097},"labels":[],"label_agreement":null},{"id":"W2060435066","doi":"10.1038/bjc.2013.152","title":"An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China; McGill University","keywords":"Bcl-2 family; Immunoprecipitation; Blot; Bcl-xL; Apoptosis; Phosphorylation; Chemistry; Cancer research; Cell culture; Molecular biology; Biology; Programmed cell death; Biochemistry; Genetics; Gene","score_opus":0.005631975957412326,"score_gpt":0.23373877293893694,"score_spread":0.2281067969815246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060435066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956155,0.0011992697,0.0018919369,0.000038200807,0.000007855572,0.000036727866,0.00045121214,0.000089850066,0.0006695684],"genre_scores_gemma":[0.99694014,0.00039523066,0.0012686508,0.000033315566,0.000010543174,0.000041645766,0.0008966677,0.000007861659,0.00040587128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980026,0.00003790379,0.000026201356,0.000044870936,0.00006512093,0.000025626008],"domain_scores_gemma":[0.99925655,0.00028762213,0.00020487106,0.00004529631,0.000101395526,0.00010426893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039382704,0.00032195362,0.0003473854,0.00071371946,0.00011034717,0.00043676363,0.0001612108,0.0005456086,0.0020229241],"category_scores_gemma":[0.00075960904,0.00015261983,0.00016800784,0.00038726325,0.0002260795,0.00022783379,0.00024091374,0.00049203134,0.00060337776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015061259,0.0001797002,0.087011226,0.00009141926,0.000042886997,0.00007791715,0.000056074536,0.0008706058,0.89951926,0.000046621506,0.00018251145,0.010415555],"study_design_scores_gemma":[0.000051010033,0.002633261,0.34092736,0.000015010342,0.00010246424,0.0016352978,0.0000786356,0.0063143945,0.6459574,0.000102439146,0.0021664216,0.00001635215],"about_ca_topic_score_codex":0.00014447958,"about_ca_topic_score_gemma":0.00016507662,"teacher_disagreement_score":0.0020229241,"about_ca_system_score_codex":0.00026832035,"about_ca_system_score_gemma":0.0000962732,"threshold_uncertainty_score":0.0067673326},"labels":[],"label_agreement":null},{"id":"W2061460324","doi":"10.1038/sj.bjc.6604729","title":"Two-marker protein profile predicts poor prognosis in patients with early rectal cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Universitätsspital Basel; Novartis Foundation","keywords":"Medicine; Colorectal cancer; Internal medicine; Gastroenterology; Immunohistochemistry; Stage (stratigraphy); Oncology; Cancer; Tissue microarray; Biology","score_opus":0.010925899522709517,"score_gpt":0.2552812456886944,"score_spread":0.24435534616598492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061460324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992478,0.00028150165,0.00016571181,0.000032853663,0.000003912667,0.0000022664356,0.00008673156,0.000004808658,0.00017452169],"genre_scores_gemma":[0.9995141,0.00006453987,0.0001605534,0.000012913833,0.000007613061,0.0000026400319,0.00013982366,0.0000012081057,0.00009664063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998902,0.000031558313,0.00001291522,0.000017936787,0.00002201903,0.000025355279],"domain_scores_gemma":[0.99955446,0.00009892704,0.00018616609,0.00002779243,0.000053953692,0.00007874841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002267163,0.00021510154,0.00026595197,0.00046995658,0.00015955856,0.0003632921,0.00015190653,0.0002921481,0.0007578315],"category_scores_gemma":[0.00094580784,0.000101049256,0.000216574,0.0003748201,0.00015315178,0.00021898995,0.00028713892,0.00030160276,0.00024513237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027874185,0.000016303438,0.99526113,0.00000972705,0.00002389264,0.000083310835,0.000015794256,0.00008584334,0.0019013283,0.0000067616315,0.000060105285,0.0022571136],"study_design_scores_gemma":[0.000006155345,0.00012810458,0.99791867,0.000002761802,0.00003298282,0.0005128799,0.000048970596,0.0006325414,0.00050366676,0.000029013896,0.00018084192,0.000003438669],"about_ca_topic_score_codex":0.000598227,"about_ca_topic_score_gemma":0.0009176413,"teacher_disagreement_score":0.0007578315,"about_ca_system_score_codex":0.00013168425,"about_ca_system_score_gemma":0.00013684192,"threshold_uncertainty_score":0.002535224},"labels":[],"label_agreement":null},{"id":"W2061547059","doi":"10.1038/bjc.2015.17","title":"RETRACTED ARTICLE: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":54,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Autophagy; Docetaxel; Pantoprazole; Pharmacology; Apoptosis; Chemistry; Chemotherapy; Cancer research; Medicine; Internal medicine; Biochemistry","score_opus":0.010968436238068697,"score_gpt":0.3358028560096915,"score_spread":0.3248344197716228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061547059","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10737086,0.06523609,0.005127719,0.1862443,0.6043873,0.00031213046,0.002980326,0.0015148469,0.0268264],"genre_scores_gemma":[0.3822061,0.051830012,0.0055533145,0.07740212,0.12267025,0.00016563661,0.0039134054,0.00073205074,0.35552707],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999534,0.00006210569,0.00008019066,0.000052772437,0.00019450247,0.00007648753],"domain_scores_gemma":[0.99858344,0.0005799874,0.00013652621,0.00009312649,0.00043781396,0.00016913908],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00076359895,0.00047792832,0.00066902203,0.00077383715,0.0006791163,0.00083862647,0.0009121656,0.003621434,0.012884871],"category_scores_gemma":[0.0030542936,0.00022495752,0.0006072286,0.000406135,0.0005181916,0.00063683547,0.0005100829,0.0019452401,0.0058682724],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033492574,0.00027501283,0.0040396135,0.0020528962,0.0001803077,0.06116846,0.00045597556,0.00047042442,0.033436224,0.0015656248,0.7211721,0.17183413],"study_design_scores_gemma":[0.00020641787,0.0008616829,0.0082852105,0.00025287256,0.00020014399,0.03294707,0.00021004895,0.0008372715,0.029542062,0.0006712611,0.9259258,0.00006014687],"about_ca_topic_score_codex":0.0023866042,"about_ca_topic_score_gemma":0.0047648298,"teacher_disagreement_score":0.9992364,"about_ca_system_score_codex":0.0010877852,"about_ca_system_score_gemma":0.00080874417,"threshold_uncertainty_score":0.04310423},"labels":[],"label_agreement":null},{"id":"W2061613070","doi":"10.1038/bjc.2014.309","title":"Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Colorectal cancer; Lynch syndrome; Medicine; Internal medicine; Cancer; Oncology; Epidemiology; Logistic regression; Gastroenterology; DNA mismatch repair","score_opus":0.009733273010589297,"score_gpt":0.27109778722111894,"score_spread":0.26136451421052964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061613070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999338,0.00024105904,0.00004968698,0.000021576609,0.0000014869526,0.000003920173,0.00008201081,0.000001346207,0.00026099195],"genre_scores_gemma":[0.99967134,0.00006654598,0.00007338399,0.000004786538,0.000002955869,0.0000033051704,0.00012729315,6.401721e-7,0.00004967839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996061,0.00012294002,0.000049919105,0.00007548271,0.00008552676,0.00006004958],"domain_scores_gemma":[0.99799734,0.00055088283,0.0010225808,0.000081998165,0.0001301115,0.00021707211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048545023,0.00016550074,0.00021566547,0.0011922477,0.00030169822,0.0002671831,0.00022447735,0.00028740073,0.0022534784],"category_scores_gemma":[0.0034005742,0.000108413056,0.00018886282,0.0010493547,0.0002890437,0.00020420198,0.0002894069,0.00019962803,0.00015706322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004568557,0.000005670096,0.9988084,0.000006318245,0.000009157859,0.00024691332,0.0000387687,0.000019888948,0.0001768426,0.000013832228,0.000029300203,0.0005991775],"study_design_scores_gemma":[0.0000018174835,0.000037498638,0.997358,0.0000036689744,0.000008852367,0.0022668273,0.000100297206,0.00006590096,0.000049705104,0.000014165373,0.000092062386,0.0000011790958],"about_ca_topic_score_codex":0.006280854,"about_ca_topic_score_gemma":0.007996554,"teacher_disagreement_score":0.006280854,"about_ca_system_score_codex":0.00024201862,"about_ca_system_score_gemma":0.00028137874,"threshold_uncertainty_score":0.012488544},"labels":[],"label_agreement":null},{"id":"W2062905872","doi":"10.1038/bjc.2012.596","title":"Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; University of New Brunswick; Toronto Metropolitan University","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; University of Cambridge","keywords":"Medicine; Breast cancer; Cancer; Demography; Obstetrics; Gynecology; Mammography; Breast disease; Internal medicine; Oncology","score_opus":0.06252360899457941,"score_gpt":0.37747870782693477,"score_spread":0.31495509883235534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062905872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8637065,0.0108820135,0.030721055,0.0034684583,0.00024024102,0.0011808112,0.08099075,0.00062094344,0.008189246],"genre_scores_gemma":[0.9587637,0.001245722,0.006351546,0.00020931997,0.000032776956,0.00035861038,0.030657161,0.00007075927,0.0023104118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938439,0.002509997,0.00038842522,0.0013434483,0.0012489868,0.00066523947],"domain_scores_gemma":[0.9649867,0.020305067,0.004261687,0.003313537,0.0056731007,0.0014599168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02572939,0.0011859117,0.0017869881,0.0030874806,0.001258387,0.001984975,0.0038215541,0.0015027663,0.0065983054],"category_scores_gemma":[0.067332074,0.0006076443,0.004397068,0.003497507,0.0013591704,0.0009668823,0.0013975725,0.0036417593,0.0005634513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012813159,0.00009042211,0.8655518,0.00060502894,0.0043669087,0.00024259283,0.0007513287,0.08604909,0.00018575118,0.006453192,0.011271667,0.023150798],"study_design_scores_gemma":[0.0003632345,0.00020114367,0.85171884,0.00057038123,0.0018982072,0.0003937064,0.0010309536,0.12838472,0.00019429789,0.007558738,0.0074690273,0.00021662023],"about_ca_topic_score_codex":0.91935086,"about_ca_topic_score_gemma":0.81496364,"teacher_disagreement_score":0.08064914,"about_ca_system_score_codex":0.013084393,"about_ca_system_score_gemma":0.016834635,"threshold_uncertainty_score":0.16224813},"labels":[],"label_agreement":null},{"id":"W2063290052","doi":"10.1054/bjoc.2001.2167","title":"Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Medical Research Council; Medical Research Council","keywords":"Progesterone receptor; Transfection; Mifepristone; Receptor; Internal medicine; Endocrinology; Chemistry; Medicine; Biology; Cell culture; Cancer; Estrogen receptor; Pregnancy; Genetics","score_opus":0.020824708777164743,"score_gpt":0.24799194697882246,"score_spread":0.2271672382016577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063290052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98930883,0.0022856055,0.0055678794,0.00017710357,0.00003168311,0.000028095123,0.00051462895,0.00008960497,0.0019965305],"genre_scores_gemma":[0.99163085,0.00096066407,0.0032269508,0.000046707137,0.000011135798,0.0000539205,0.00049474597,0.000025089857,0.003550008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997991,0.000037064245,0.000018280034,0.000035253906,0.00006524991,0.000045164452],"domain_scores_gemma":[0.99988234,0.000026506343,0.000026708913,0.000020999722,0.000023244264,0.000020194504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012018414,0.00020678357,0.00029976663,0.00020751357,0.000183834,0.00027762304,0.00015324191,0.00029036176,0.0009455051],"category_scores_gemma":[0.00012895264,0.00015654619,0.00022618083,0.00019467888,0.00013752711,0.0001819109,0.00012074781,0.00040102107,0.00043655263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034020803,0.0000062688596,0.000093417904,0.000017210134,0.0000020579384,0.000059150618,0.000019893727,0.00000959287,0.99931705,0.000055664616,0.000013751415,0.0003718839],"study_design_scores_gemma":[0.000005752945,0.00013127664,0.004282632,0.0000023849445,0.000011012454,0.0003716402,0.00004795257,0.00043503355,0.9930332,0.000023541657,0.0016525355,0.0000030790945],"about_ca_topic_score_codex":0.0012725845,"about_ca_topic_score_gemma":0.001048298,"teacher_disagreement_score":0.0012725845,"about_ca_system_score_codex":0.00017758268,"about_ca_system_score_gemma":0.00010913893,"threshold_uncertainty_score":0.0031630397},"labels":[],"label_agreement":null},{"id":"W2063513563","doi":"10.1038/bjc.2012.87","title":"Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; University of Ottawa; McGill University Health Centre; Children's Hospital of Eastern Ontario; McGill University","funders":"Vlaamse regering; Universiteit Gent; Susan G. Komen; Fonds Wetenschappelijk Onderzoek; McGill University","keywords":"Ovarian cancer; Breast cancer; Missense mutation; Proband; Oncology; Biology; Ovarian carcinoma; Allele; Genetics; Cancer; Mutation; Internal medicine; Cancer research; Medicine; Gene","score_opus":0.006294149648827082,"score_gpt":0.27679331241116634,"score_spread":0.27049916276233926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063513563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999108,0.00026938837,0.00008228821,0.000019866002,0.0000026628597,0.000008072335,0.00016491207,0.000005351254,0.00033948984],"genre_scores_gemma":[0.9992575,0.00013268455,0.00024470288,0.000020515858,0.0000028069076,0.000004790154,0.00018323379,0.0000024059614,0.00015131508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974114,0.00005998065,0.000022958566,0.00006557936,0.00006093648,0.000049345323],"domain_scores_gemma":[0.9997391,0.00008986994,0.0000786101,0.000013382878,0.000022000213,0.000056864727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002167868,0.0003938126,0.00021438574,0.0014380238,0.00067887496,0.00019238722,0.00032690947,0.0003988867,0.0017522783],"category_scores_gemma":[0.0008050604,0.00016177856,0.00022099561,0.00088164443,0.00038416366,0.000063241736,0.00030316296,0.00016865147,0.00020541114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096592336,0.00014782096,0.891316,0.0001606486,0.00014427156,0.035937212,0.0013542515,0.0005253904,0.05295755,0.00020057494,0.00063962844,0.015650684],"study_design_scores_gemma":[0.000065212604,0.0002221412,0.9498811,0.000027652099,0.00010351165,0.040146787,0.00030136152,0.00039539946,0.006720451,0.00009305354,0.002031948,0.00001139287],"about_ca_topic_score_codex":0.016059605,"about_ca_topic_score_gemma":0.013973926,"teacher_disagreement_score":0.016059605,"about_ca_system_score_codex":0.0006736931,"about_ca_system_score_gemma":0.00037239693,"threshold_uncertainty_score":0.031932235},"labels":[],"label_agreement":null},{"id":"W2063648710","doi":"10.1038/bjc.2012.367","title":"Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Novartis Pharmaceuticals Corporation","keywords":"Renal cell carcinoma; Hazard ratio; Medicine; Internal medicine; Confidence interval; Oncology; Progression-free survival; Proportional hazards model; Chemotherapy","score_opus":0.035887020276444595,"score_gpt":0.34489422547890264,"score_spread":0.30900720520245806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063648710","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032030575,0.9657907,0.0005320614,0.00033576635,0.00010521778,0.00018450734,0.0005865505,0.000007372358,0.0004272368],"genre_scores_gemma":[0.7511872,0.24231116,0.0022066764,0.0012017742,0.0005018774,0.0010909843,0.0012615512,0.000021448861,0.00021733872],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9370778,0.040909674,0.013736226,0.0031487544,0.0047040363,0.00042348861],"domain_scores_gemma":[0.69411623,0.25624654,0.04239132,0.0024070556,0.00422765,0.0006112482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057400085,0.0008104163,0.0054838574,0.0040991562,0.00040226505,0.002284473,0.0011085754,0.0014546051,0.0018556118],"category_scores_gemma":[0.113105804,0.0005475388,0.012005931,0.0055116075,0.001206788,0.0014022078,0.0009137814,0.0017628538,0.00013111504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023469646,0.0001451169,0.16349046,0.30631396,0.44735554,0.00029302368,0.00032108277,0.0012682591,0.0008635947,0.0004978496,0.0008380979,0.05514342],"study_design_scores_gemma":[0.007120098,0.0059562824,0.29349232,0.061500717,0.61785436,0.0011283878,0.00034193453,0.00081764424,0.00092301547,0.0015489334,0.009180931,0.00013538722],"about_ca_topic_score_codex":0.0012306911,"about_ca_topic_score_gemma":0.0032343992,"teacher_disagreement_score":0.057400085,"about_ca_system_score_codex":0.0013416677,"about_ca_system_score_gemma":0.0016686758,"threshold_uncertainty_score":0.3035643},"labels":[],"label_agreement":null},{"id":"W2063726066","doi":"10.1054/bjoc.2001.1854","title":"Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Medical Research Council Canada","keywords":"Glioma; Biology; Matrix metalloproteinase; Pathology; In situ hybridization; Malignancy; Matrigel; Phenotype; U87; Gene expression; Cancer research; Angiogenesis; Medicine; Gene","score_opus":0.005942036515029781,"score_gpt":0.25398271958678786,"score_spread":0.24804068307175808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063726066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312097,0.004098558,0.0013383012,0.000061644045,0.000013218973,0.000009915247,0.00039926602,0.00003939812,0.00091855705],"genre_scores_gemma":[0.99190086,0.0027681524,0.0021352663,0.000032456814,0.000025874311,0.000020825777,0.0009596926,0.000016869346,0.0021399388],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989045,0.00001771508,0.000010871373,0.000020602067,0.000027668199,0.00003273663],"domain_scores_gemma":[0.9997825,0.000047488815,0.00007418982,0.000021186463,0.00004084639,0.000033838765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001345639,0.00020933848,0.00018831131,0.0010379431,0.00013574673,0.00034454526,0.00010610329,0.00019156058,0.001101291],"category_scores_gemma":[0.0004437186,0.0001372592,0.00016673781,0.00029174643,0.00018038902,0.00015665399,0.00014135527,0.00019224381,0.00049149175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005065081,0.000017618757,0.005135852,0.00010005571,0.000021122274,0.0006438235,0.000137365,0.00007571951,0.9866998,0.0001279028,0.000083435756,0.006450706],"study_design_scores_gemma":[0.0000794089,0.0010351891,0.2434898,0.00006059719,0.00027939418,0.017172562,0.00057485775,0.0010398445,0.7184384,0.0012928047,0.016491028,0.000046223748],"about_ca_topic_score_codex":0.0005530037,"about_ca_topic_score_gemma":0.00051959004,"teacher_disagreement_score":0.001101291,"about_ca_system_score_codex":0.00021477978,"about_ca_system_score_gemma":0.00017867702,"threshold_uncertainty_score":0.003684163},"labels":[],"label_agreement":null},{"id":"W2064747770","doi":"10.1038/bjc.2012.10","title":"Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Medicine; Response Evaluation Criteria in Solid Tumors; Retrospective cohort study; Clinical trial; Internal medicine; Lesion; Progressive disease; Target lesion; Oncology; Disease; Radiology; Nuclear medicine; Surgery","score_opus":0.01646098267440435,"score_gpt":0.3153818528380368,"score_spread":0.29892087016363245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064747770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806229,0.0102452645,0.0021659457,0.00078550546,0.000050219278,0.00025978748,0.0007059575,0.00008159769,0.005082816],"genre_scores_gemma":[0.99613214,0.00082677713,0.0021135116,0.000114168644,0.000084154184,0.00010303434,0.00036957726,0.00001789328,0.0002386763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99410963,0.0042702206,0.0004976538,0.00037027837,0.00060694065,0.00014530403],"domain_scores_gemma":[0.9786468,0.012007154,0.006129689,0.0008132,0.0015595931,0.00084368273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008870185,0.00044822905,0.0017325603,0.0012255271,0.00020693523,0.0009338537,0.0004716217,0.00047841217,0.0011792369],"category_scores_gemma":[0.020480556,0.0002011167,0.0007660427,0.000871751,0.0003051522,0.0009073235,0.0006549247,0.0007718914,0.00023401353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051071003,0.0003627482,0.744653,0.0007360339,0.0012419192,0.0002473138,0.00029426662,0.0038700816,0.0034644143,0.00020815786,0.0012634271,0.19258763],"study_design_scores_gemma":[0.0017702179,0.019827226,0.95646137,0.0001668378,0.002049264,0.0021364249,0.00017216482,0.0080315685,0.0039186287,0.0007885336,0.004586351,0.000091393325],"about_ca_topic_score_codex":0.00035433704,"about_ca_topic_score_gemma":0.00081909297,"teacher_disagreement_score":0.008870185,"about_ca_system_score_codex":0.00060475955,"about_ca_system_score_gemma":0.000405967,"threshold_uncertainty_score":0.046910584},"labels":[],"label_agreement":null},{"id":"W2065233640","doi":"10.1038/sj.bjc.6604744","title":"Portable stove use is associated with lower lung cancer mortality risk in lifetime smoky coal users","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Energy and Environment Impacts","field":"Environmental Science","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"National Cancer Institute; Yale University; National Institutes of Health; U.S. Environmental Protection Agency","keywords":"Stove; Lung cancer; Medicine; Environmental health; Hazard ratio; Confidence interval; Proportional hazards model; Cancer; Toxicology; Surgery; Internal medicine; Waste management; Biology; Engineering","score_opus":0.013064790047113571,"score_gpt":0.2428297880473803,"score_spread":0.22976499800026673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065233640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941754,0.000171192,0.000052901323,0.00004157828,0.0000036818492,0.0000022454337,0.000100225494,0.0000031791385,0.00020756751],"genre_scores_gemma":[0.9996031,0.000063775755,0.00003111441,0.000009706938,0.000004733573,0.0000015836291,0.000079344696,0.0000011717487,0.00020545092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998202,0.000043314816,0.00001576529,0.00005085062,0.00003518351,0.00003473735],"domain_scores_gemma":[0.9989071,0.0001728249,0.00053940946,0.00008648265,0.000095856565,0.00019836558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030355976,0.00017059653,0.00022206355,0.00034954803,0.000235093,0.00041133742,0.00027186493,0.00038256662,0.001832348],"category_scores_gemma":[0.0021051792,0.0002136839,0.00051300623,0.00033292468,0.00020195355,0.00028595707,0.00032005712,0.00047815617,0.00014683174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021005874,0.000054549637,0.9970253,0.000009745362,0.000052468327,0.00004714664,0.00006216962,0.000039369508,0.00025318115,0.000014056452,0.000057697605,0.002174276],"study_design_scores_gemma":[0.0000026792052,0.00005996856,0.99957865,0.0000033075312,0.000016084095,0.000047570415,0.000046153153,0.00013082172,0.000027422242,0.000017998203,0.00006772961,0.0000016070089],"about_ca_topic_score_codex":0.0072854343,"about_ca_topic_score_gemma":0.0077378517,"teacher_disagreement_score":0.0072854343,"about_ca_system_score_codex":0.00019617553,"about_ca_system_score_gemma":0.00018008672,"threshold_uncertainty_score":0.014486074},"labels":[],"label_agreement":null},{"id":"W2065284533","doi":"10.1038/sj.bjc.6605316","title":"Overexpression of FOXG1 contributes to TGF-β resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Hong Kong; McGill University; University of Ottawa; Thomas Jefferson University","keywords":"Gene knockdown; Ovarian cancer; Biology; Cell growth; Cancer research; Transforming growth factor; Downregulation and upregulation; Small hairpin RNA; Western blot; Cancer; Molecular biology; Cell culture; Endocrinology; Gene; Genetics","score_opus":0.009454196064547688,"score_gpt":0.2791322032378598,"score_spread":0.26967800717331214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065284533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324894,0.0046156603,0.0008233155,0.00021213386,0.000025975956,0.000019572277,0.00015282896,0.000079844875,0.00082181446],"genre_scores_gemma":[0.9964026,0.0017376282,0.00048337402,0.00007155228,0.000010538623,0.00001966433,0.00020836918,0.000011642155,0.0010545838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999486,0.0000051746956,0.0000031991542,0.0000104318415,0.0000145920385,0.000018053455],"domain_scores_gemma":[0.9999305,0.0000115318635,0.000021330043,0.000006136026,0.00000797857,0.000022513746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014344385,0.000244031,0.00024053597,0.00026738798,0.00018773583,0.00023887992,0.00011424313,0.0002154472,0.0011298228],"category_scores_gemma":[0.00012889129,0.00010792537,0.00020775273,0.00022841757,0.00028516917,0.00011819073,0.00015475716,0.0003153885,0.0002279935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035554872,0.00006049319,0.0048351954,0.00012574506,0.00002398564,0.00022712862,0.000040304305,0.00012213716,0.98823905,0.00015151442,0.00022033259,0.0055984845],"study_design_scores_gemma":[0.00013224993,0.0008449572,0.08023603,0.000022681877,0.00016823823,0.0013952223,0.0001262653,0.0025884653,0.90083665,0.0002681564,0.0133693945,0.000011611017],"about_ca_topic_score_codex":0.00083107507,"about_ca_topic_score_gemma":0.001116855,"teacher_disagreement_score":0.0011298228,"about_ca_system_score_codex":0.0003702586,"about_ca_system_score_gemma":0.00027416935,"threshold_uncertainty_score":0.0037796497},"labels":[],"label_agreement":null},{"id":"W2065948425","doi":"10.1038/bjc.2014.572","title":"The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Bowel Disease Research Foundation; Medical Research Council; National Institute for Health and Care Research; Pfizer","keywords":"Colorectal cancer; Chemokine; Chemokine receptor; Infiltration (HVAC); Cancer research; Chemokine receptor CCR5; Immunology; Biology; Chemotaxis; Flow cytometry; Receptor; Cancer; Inflammation","score_opus":0.010550592706517972,"score_gpt":0.28035184701896204,"score_spread":0.26980125431244406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065948425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132687,0.0058389492,0.00038285606,0.0001842859,0.00007957895,0.000031817326,0.00014824915,0.000039136656,0.0019683023],"genre_scores_gemma":[0.99757665,0.0011484328,0.00026934026,0.00008624335,0.000023381579,0.000017487428,0.00018336203,0.000006132713,0.0006888978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980193,0.00005318685,0.000015422294,0.000017446373,0.000029248038,0.00008291549],"domain_scores_gemma":[0.9998628,0.000039307302,0.000023055843,0.000015552354,0.00001459645,0.000044772903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002728652,0.00021196679,0.00026981492,0.00012956842,0.00012708241,0.00028591207,0.0002633435,0.00025483215,0.0020002697],"category_scores_gemma":[0.00024403543,0.00008633253,0.00021645095,0.000087448774,0.00020607872,0.0001958033,0.00012002037,0.00070630806,0.00034600397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048200823,0.00068770593,0.0011326487,0.00033773665,0.00004554408,0.00013386917,0.000048962094,0.0005073607,0.9740184,0.00037246707,0.00077974424,0.017115546],"study_design_scores_gemma":[0.00047845242,0.016442169,0.018959424,0.000041280968,0.00013151708,0.0007215775,0.000083595754,0.00201497,0.95219135,0.000085718006,0.008832137,0.000017814185],"about_ca_topic_score_codex":0.0009587913,"about_ca_topic_score_gemma":0.0020356297,"teacher_disagreement_score":0.0020002697,"about_ca_system_score_codex":0.00034233375,"about_ca_system_score_gemma":0.0002821134,"threshold_uncertainty_score":0.006691575},"labels":[],"label_agreement":null},{"id":"W2065957423","doi":"10.1038/sj.bjc.6600552","title":"Treatment of paediatric pontine glioma with oral trophosphamide and etoposide","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Glioma; Etoposide; Medicine; Oncology; Internal medicine; Chemotherapy; Cancer research","score_opus":0.011964350240452807,"score_gpt":0.25110478655416557,"score_spread":0.23914043631371276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065957423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952846,0.0037892486,0.00019207016,0.000042246647,0.0000087070375,0.000022352582,0.00011942342,0.0000062232807,0.00053522474],"genre_scores_gemma":[0.9959044,0.0026458576,0.00043936828,0.00007426816,0.000020855068,0.00005901111,0.00062191027,0.0000034415937,0.0002308973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983835,0.00006259226,0.000013471542,0.000020377049,0.00003704298,0.000028150273],"domain_scores_gemma":[0.99962914,0.0000946288,0.0001439364,0.000015201402,0.0000224078,0.00009461977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026609754,0.0002561964,0.00061263255,0.000111620626,0.00011008789,0.00017397077,0.00016429399,0.00026928703,0.0006115104],"category_scores_gemma":[0.00065951404,0.00006748572,0.00029513153,0.00018358245,0.00021619335,0.00019318535,0.00018571332,0.00033799084,0.00013793989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055333134,0.0015991983,0.6300414,0.0013938097,0.0012077359,0.011201706,0.00082086603,0.0052112546,0.05593987,0.000373416,0.0019516356,0.23492602],"study_design_scores_gemma":[0.0027933393,0.087509826,0.85508484,0.00015430308,0.00079951104,0.027450297,0.00035076778,0.0018152425,0.009991344,0.0001965655,0.013817534,0.00003636332],"about_ca_topic_score_codex":0.0006239292,"about_ca_topic_score_gemma":0.0012781487,"teacher_disagreement_score":0.0006239292,"about_ca_system_score_codex":0.000367772,"about_ca_system_score_gemma":0.00036288003,"threshold_uncertainty_score":0.0026684403},"labels":[],"label_agreement":null},{"id":"W2066652089","doi":"10.1038/sj.bjc.6606042","title":"Long-term psychosocial impact of alternative management policies in women with low-grade abnormal cervical cytology referred for colposcopy: a randomised controlled trial","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council","keywords":"Medicine; Colposcopy; Anxiety; Hospital Anxiety and Depression Scale; Psychosocial; Obstetrics; Depression (economics); Randomized controlled trial; Distress; Odds ratio; Cervical cancer; Gynecology; Surgery; Internal medicine; Psychiatry; Cancer; Clinical psychology","score_opus":0.018235415304761696,"score_gpt":0.38593005349204257,"score_spread":0.3676946381872809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066652089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96616304,0.021184452,0.000440782,0.0013514447,0.001145575,0.0072964896,0.0008750716,0.00006415632,0.001478985],"genre_scores_gemma":[0.97264713,0.0080816345,0.0013770671,0.0011639645,0.00094131037,0.01362748,0.00049621786,0.000009534062,0.0016557934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997543,0.001478324,0.00025208524,0.00031377,0.0001507091,0.00026213663],"domain_scores_gemma":[0.9965411,0.0015433674,0.0008758339,0.00018094032,0.00015166434,0.00070700754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028488773,0.0013289866,0.0040797903,0.0006448554,0.0007599682,0.0015245113,0.0012739883,0.004091805,0.009237747],"category_scores_gemma":[0.006478336,0.00072421436,0.0034777233,0.00078516296,0.0015737705,0.0013488213,0.00077103055,0.0034119277,0.0007376612],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98370093,0.0045915134,0.00061772513,0.0017605443,0.0012735991,0.000035551253,0.000052750605,0.00011310821,0.00025518515,0.000043286527,0.00016644217,0.0073893145],"study_design_scores_gemma":[0.94221646,0.05449179,0.0015762865,0.00021667512,0.00091014773,0.000017312605,0.00004269138,0.00011381393,0.000055769713,0.00009959497,0.00024715217,0.000012283807],"about_ca_topic_score_codex":0.0023846691,"about_ca_topic_score_gemma":0.0035554052,"teacher_disagreement_score":0.009237747,"about_ca_system_score_codex":0.0013755582,"about_ca_system_score_gemma":0.0019998404,"threshold_uncertainty_score":0.03090328},"labels":[],"label_agreement":null},{"id":"W2067006079","doi":"10.1038/sj.bjc.6603876","title":"The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"National Cancer Institute; European Organisation for Research and Treatment of Cancer","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Glioblastoma; Oncology; Proportional hazards model; Cancer; Radiation therapy; Brain cancer; Survival analysis","score_opus":0.10010030332051865,"score_gpt":0.47856269791547484,"score_spread":0.3784623945949562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067006079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927724,0.004681097,0.0007451627,0.00047897734,0.00007603084,0.0003951277,0.00049601204,0.000015776848,0.00033943064],"genre_scores_gemma":[0.9961234,0.0015980199,0.0007126589,0.00019468505,0.000063740576,0.00029085332,0.0008583066,0.000008404192,0.00014992275],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930565,0.0059968173,0.0002971132,0.00018190248,0.00028618643,0.00018156313],"domain_scores_gemma":[0.9872357,0.008369172,0.0020295365,0.0009579914,0.00049765204,0.0009098748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017214632,0.0009015515,0.001936186,0.00040317993,0.00023504368,0.00087266107,0.0006847258,0.00087242573,0.00097589474],"category_scores_gemma":[0.01803151,0.00026544408,0.0025910498,0.0005796305,0.00073902134,0.0007512169,0.00053895847,0.0015830608,0.00018946666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7544297,0.0056982213,0.1547153,0.00096742716,0.0092894975,0.0000970135,0.00023664552,0.0038220147,0.0015055897,0.00015731927,0.0013168575,0.06776445],"study_design_scores_gemma":[0.23393588,0.23837467,0.49310926,0.00038203804,0.014954902,0.00033129042,0.00023410848,0.013029445,0.0016669431,0.0009033673,0.002881662,0.00019645295],"about_ca_topic_score_codex":0.001986887,"about_ca_topic_score_gemma":0.0025541794,"teacher_disagreement_score":0.017214632,"about_ca_system_score_codex":0.0007684588,"about_ca_system_score_gemma":0.0010144424,"threshold_uncertainty_score":0.09104073},"labels":[],"label_agreement":null},{"id":"W2068138131","doi":"10.1038/bjc.2011.34","title":"Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada","keywords":"Downregulation and upregulation; Epithelial–mesenchymal transition; Cancer research; Mesenchymal stem cell; Ovarian carcinoma; Carcinoma; Cell; Cell growth; Signalling; Medicine; Chemistry; Pathology; Cell biology; Biology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.01688090347514298,"score_gpt":0.2520357346927184,"score_spread":0.2351548312175754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068138131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499774,0.0014510406,0.00093838683,0.0001310629,0.000037638096,0.00005308916,0.00080825837,0.00011978908,0.0014629681],"genre_scores_gemma":[0.99402976,0.0008949394,0.0014231289,0.000057129477,0.0000068050513,0.00006689956,0.0011454907,0.000023670242,0.002352197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988604,0.000008641732,0.000015086792,0.000017658362,0.000036011785,0.00003648016],"domain_scores_gemma":[0.99992204,0.000009136831,0.00002294083,0.000011748539,0.000011409532,0.000022708316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011067384,0.0002849781,0.00026547443,0.00017335924,0.00015406354,0.00025140098,0.00020495236,0.00027160585,0.0014286423],"category_scores_gemma":[0.00009896164,0.00011015447,0.0003170977,0.00020090837,0.00018130068,0.00015099355,0.00014543871,0.0005898676,0.00037082966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099608464,0.00003109901,0.00014572444,0.00004434856,0.000005428092,0.000043695072,0.000013226019,0.000039567665,0.9989073,0.000046139092,0.00006336833,0.00056049944],"study_design_scores_gemma":[0.000052076277,0.0003819626,0.005521626,0.000007989903,0.000023497072,0.00022647192,0.000032553366,0.000802814,0.98940736,0.000021383232,0.003516812,0.0000053600456],"about_ca_topic_score_codex":0.0024761327,"about_ca_topic_score_gemma":0.0029900442,"teacher_disagreement_score":0.0024761327,"about_ca_system_score_codex":0.00032814164,"about_ca_system_score_gemma":0.0003357252,"threshold_uncertainty_score":0.004923463},"labels":[],"label_agreement":null},{"id":"W2068164466","doi":"10.1038/sj.bjc.6602618","title":"Guidelines for confidentiality and cancer registration","year":2005,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Patient Dignity and Privacy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; National Institutes of Health","keywords":"Confidentiality; Bioethics; Informed consent; Legislation; Political science; Medicine; Library science; Family medicine; Alternative medicine; Law; Pathology","score_opus":0.13681704520690713,"score_gpt":0.41515254888409214,"score_spread":0.278335503677185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068164466","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028280844,0.032383803,0.044722337,0.2798902,0.023118263,0.021327417,0.01565165,0.0024627373,0.5776155],"genre_scores_gemma":[0.03660216,0.06500725,0.16765243,0.19395296,0.009729367,0.04926635,0.049004737,0.0027332802,0.4260516],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8775096,0.06428811,0.026120022,0.002910545,0.023818828,0.005352878],"domain_scores_gemma":[0.8142007,0.08662278,0.013073781,0.025690142,0.053259667,0.00715286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.080674015,0.0009137631,0.0019793522,0.006497011,0.005248676,0.01053575,0.006575534,0.02045539,0.043073464],"category_scores_gemma":[0.18655741,0.0018644993,0.0026052154,0.00874321,0.003975705,0.008203368,0.007997348,0.019629918,0.037173595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000697045,0.00008090068,0.00055899617,0.001176874,0.000014776757,0.0002779645,0.0023445236,0.0001822141,0.00023803237,0.051947974,0.8461462,0.096961856],"study_design_scores_gemma":[0.000028622342,0.000024251654,0.00069914403,0.001905366,0.000008483606,0.0003515757,0.0004002212,0.00008172212,0.00012294188,0.0064417724,0.9899108,0.000024998564],"about_ca_topic_score_codex":0.015498307,"about_ca_topic_score_gemma":0.01855734,"teacher_disagreement_score":0.080674015,"about_ca_system_score_codex":0.0066338503,"about_ca_system_score_gemma":0.04185653,"threshold_uncertainty_score":0.42665005},"labels":[],"label_agreement":null},{"id":"W2068786165","doi":"10.1038/bjc.2014.208","title":"Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; European Organisation for Research and Treatment of Cancer; Pfizer","keywords":"Medicine; Internal medicine; Lung cancer; Proportional hazards model; Quality of life (healthcare); Hazard ratio; Survival analysis; Cancer; Oncology; Confidence interval","score_opus":0.04807912975397806,"score_gpt":0.36512531584002983,"score_spread":0.3170461860860518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068786165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989052,0.005472447,0.00025091533,0.00060938107,0.00006904312,0.00014979795,0.0027848154,0.00001532755,0.0015963538],"genre_scores_gemma":[0.994863,0.00046767917,0.00013979782,0.0003049586,0.00005962193,0.00015045048,0.0036641075,0.0000057036063,0.00034463164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962864,0.0026251636,0.00023951732,0.00035438797,0.00029143097,0.00020298686],"domain_scores_gemma":[0.9948837,0.0023497094,0.0017204175,0.0003763104,0.00016336446,0.0005065336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00881158,0.00039991166,0.0014029453,0.00032331934,0.00019980302,0.0009157852,0.00085479056,0.0009094952,0.0030466225],"category_scores_gemma":[0.0059734625,0.00016517802,0.002530116,0.0007811364,0.00039577828,0.00082612614,0.0004964451,0.0013497202,0.00035109383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31734312,0.0012290212,0.6125605,0.001258332,0.0128473565,0.00022123974,0.00012612413,0.004097964,0.0012208391,0.00052365067,0.005834578,0.042737253],"study_design_scores_gemma":[0.03131155,0.021543523,0.92589533,0.00033454565,0.008068277,0.00023872056,0.00016010579,0.007512805,0.00068865216,0.00082790694,0.0033611648,0.000057468755],"about_ca_topic_score_codex":0.0009934296,"about_ca_topic_score_gemma":0.0016803873,"teacher_disagreement_score":0.00881158,"about_ca_system_score_codex":0.0005993022,"about_ca_system_score_gemma":0.0005302734,"threshold_uncertainty_score":0.04660064},"labels":[],"label_agreement":null},{"id":"W2068888322","doi":"10.1038/sj.bjc.6604762","title":"Estimation of lead time and overdiagnosis in breast cancer screening","year":2009,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overdiagnosis; Breast cancer; Medicine; Mammography; Estimation; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.028787931316795533,"score_gpt":0.3239645096213897,"score_spread":0.29517657830459415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068888322","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6735082,0.034181897,0.27264085,0.0031216757,0.0010056717,0.00095252134,0.0055541005,0.00048176968,0.008553313],"genre_scores_gemma":[0.9441872,0.0041349777,0.0455512,0.00048736326,0.00029413708,0.00035598397,0.0021235954,0.000089349676,0.0027760372],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97891587,0.014146079,0.0017729179,0.0019621446,0.0027403338,0.00046258722],"domain_scores_gemma":[0.8262641,0.13147715,0.02688721,0.009777989,0.004629898,0.00096372433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030105628,0.0009995427,0.0014362931,0.0033268363,0.00040471062,0.0018301777,0.0012233119,0.0013614972,0.002547481],"category_scores_gemma":[0.13547383,0.001047676,0.002563986,0.004378932,0.0007427832,0.0014650912,0.0022585606,0.0014531313,0.0005461346],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015263546,0.000081216094,0.91705394,0.00070620235,0.0015766034,0.00018221361,0.00065136724,0.011765024,0.00022193961,0.0041586086,0.0017199172,0.060356576],"study_design_scores_gemma":[0.00024314968,0.0017600558,0.7903988,0.001321462,0.004099217,0.0028277459,0.0009869074,0.13663472,0.0026422914,0.036833536,0.022034746,0.00021736325],"about_ca_topic_score_codex":0.007500315,"about_ca_topic_score_gemma":0.0056298543,"teacher_disagreement_score":0.030105628,"about_ca_system_score_codex":0.0014762495,"about_ca_system_score_gemma":0.0011197259,"threshold_uncertainty_score":0.15921575},"labels":[],"label_agreement":null},{"id":"W2069036425","doi":"10.1038/sj.bjc.6602380","title":"Specific fatty acid intake and the risk of pancreatic cancer in Canada","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institute of Population and Public Health; Health Canada; University of Ottawa","funders":"National Cancer Institute; Health Canada; BC Cancer Agency; Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Cancer Care Ontario","keywords":"Quartile; Medicine; Body mass index; Confidence interval; Odds ratio; Internal medicine; Saturated fatty acid; Gastroenterology; Pancreatic cancer; Population; Logistic regression; Case-control study; Cancer; Endocrinology; Fatty acid; Animal science; Chemistry; Biology; Environmental health; Biochemistry","score_opus":0.01647423348957774,"score_gpt":0.3005340926269793,"score_spread":0.28405985913740156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069036425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992134,0.002703498,0.00020738789,0.00030472563,0.000014232106,0.000028508888,0.0027727243,0.000019792154,0.0018152911],"genre_scores_gemma":[0.996283,0.0011367918,0.0002569772,0.00006881964,0.0000043202695,0.000011023949,0.0011303822,0.0000053334265,0.0011034615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992956,0.00005059157,0.00004536587,0.00013280418,0.00029966127,0.00017585361],"domain_scores_gemma":[0.9989135,0.00006597114,0.00020839601,0.00004443062,0.00056658505,0.0002011566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047829017,0.00029100443,0.00044668972,0.0013240018,0.0016155834,0.0009388506,0.000759147,0.000397115,0.0015139644],"category_scores_gemma":[0.0015839685,0.000431314,0.0006148993,0.003296224,0.00051773636,0.00019600279,0.00056178734,0.00047229946,0.00013766947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020264008,0.000017396505,0.9928301,0.000040979085,0.00012176582,0.00018544294,0.00025296526,0.00014364578,0.0004049722,0.00009456597,0.0005519892,0.005153589],"study_design_scores_gemma":[0.000015758234,0.000023310002,0.9982297,0.000021017524,0.000050964107,0.00016344823,0.00019817281,0.00029810666,0.000088004184,0.000038560378,0.00086525525,0.000007838732],"about_ca_topic_score_codex":0.991008,"about_ca_topic_score_gemma":0.9904957,"teacher_disagreement_score":0.01416556,"about_ca_system_score_codex":0.01416556,"about_ca_system_score_gemma":0.015872398,"threshold_uncertainty_score":0.10277879},"labels":[],"label_agreement":null},{"id":"W2069136947","doi":"10.1038/bjc.2011.401","title":"miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; York University; University of Toronto; Western University; St. Michael's Hospital","funders":"Kidney Foundation of Canada; Government of Ontario; Cancer Research Society","keywords":"microRNA; Renal cell carcinoma; Metastasis; Gene expression profiling; Kidney cancer; Cancer research; Medicine; Microarray; Cancer; Carcinoma; Microarray analysis techniques; Oncology; Biology; Pathology; Internal medicine; Gene expression; Gene","score_opus":0.01611616043464681,"score_gpt":0.2681088941853504,"score_spread":0.2519927337507036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069136947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970311,0.0010422311,0.001041494,0.000044050823,0.000015004987,0.000017012786,0.00032671035,0.000028274326,0.00045402427],"genre_scores_gemma":[0.9961389,0.0004401638,0.002151201,0.000040533683,0.0000076099764,0.000021426158,0.0005973037,0.00001258563,0.00059036404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998535,0.000015427355,0.000010751127,0.000027668759,0.00007122239,0.000021381333],"domain_scores_gemma":[0.9998721,0.000032006836,0.000026412052,0.000011052758,0.000028940654,0.00002935357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016007028,0.00017624954,0.0003108543,0.000292752,0.00022751946,0.0002588054,0.00010430401,0.00020077528,0.0007025087],"category_scores_gemma":[0.00034069363,0.000121131954,0.00029567903,0.00020168819,0.00014725825,0.00006583061,0.00011511468,0.00027111094,0.00037656608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032617504,0.00001859772,0.002390255,0.000040627197,0.000012514804,0.00015841943,0.000028098462,0.00008343326,0.99547064,0.000031359887,0.00005417262,0.0013858236],"study_design_scores_gemma":[0.000041532825,0.00078210613,0.059711024,0.000009334247,0.00009784562,0.0028226878,0.00007165431,0.0019569444,0.93142635,0.000088296736,0.0029817508,0.000010521934],"about_ca_topic_score_codex":0.00067008863,"about_ca_topic_score_gemma":0.0009754103,"teacher_disagreement_score":0.0007025087,"about_ca_system_score_codex":0.00026481994,"about_ca_system_score_gemma":0.0002219006,"threshold_uncertainty_score":0.002350092},"labels":[],"label_agreement":null},{"id":"W2069162303","doi":"10.1038/bjc.2013.381","title":"Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Chronic lymphocytic leukemia; Medicine; Follicular lymphoma; Lymphoma; Incidence (geometry); Internal medicine; Immunosuppression; Cohort; Population; Cancer; Oncology; Gastroenterology; Leukemia","score_opus":0.007210907487999676,"score_gpt":0.2524244376014164,"score_spread":0.24521353011341673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069162303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970445,0.00058168813,0.000039172333,0.0001221073,0.00000650082,0.000025574878,0.0010254498,0.000004201013,0.0011507593],"genre_scores_gemma":[0.9987972,0.00034271396,0.00004090315,0.000052761457,0.000005436907,0.000007859001,0.00050579966,0.000002309989,0.0002449473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992041,0.0000556467,0.000036502453,0.00015056382,0.00027669425,0.00027659588],"domain_scores_gemma":[0.9989796,0.00005932444,0.00025224852,0.000052812175,0.0003222562,0.00033371928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004470064,0.0004329944,0.0005105362,0.0013102532,0.002488186,0.0011853769,0.00080376264,0.00066996535,0.0028754373],"category_scores_gemma":[0.0013085733,0.00049146626,0.0007816949,0.002868682,0.0006828217,0.00032519177,0.00066961785,0.00083886104,0.00022798483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012965268,0.000024564546,0.997514,0.00002035121,0.00006600121,0.00012020546,0.00032584585,0.000032338485,0.0002643394,0.0000366948,0.0003175351,0.0011485157],"study_design_scores_gemma":[0.000017654218,0.000051865874,0.9985215,0.000014623486,0.000037778344,0.00025449594,0.00046762967,0.00008210738,0.000036357003,0.000013834112,0.00049150485,0.000010673283],"about_ca_topic_score_codex":0.943161,"about_ca_topic_score_gemma":0.93940264,"teacher_disagreement_score":0.05683899,"about_ca_system_score_codex":0.0078361975,"about_ca_system_score_gemma":0.00859076,"threshold_uncertainty_score":0.1143474},"labels":[],"label_agreement":null},{"id":"W2069225985","doi":"10.1038/sj.bjc.6603993","title":"Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Cure Brain Cancer Foundation","keywords":"Autocrine signalling; Cancer research; Cell migration; Receptor; Biology; Metastasis; Neuropilin 1; Receptor tyrosine kinase; Vascular endothelial growth factor; Cancer cell; Cell biology; Internal medicine; Cell; Cancer; Medicine; Biochemistry; VEGF receptors","score_opus":0.007922465934891548,"score_gpt":0.2827490453369675,"score_spread":0.27482657940207594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069225985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816814,0.011491303,0.0018413985,0.00019694807,0.000053752563,0.00005903204,0.0006826085,0.000054877542,0.003938727],"genre_scores_gemma":[0.98541254,0.0041239406,0.0029481554,0.00011812752,0.000018004781,0.00012222765,0.0015656154,0.000008639967,0.0056826887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998266,0.000032990527,0.000015369962,0.00003136097,0.00004493867,0.00004881034],"domain_scores_gemma":[0.99995184,0.000010100838,0.0000061061637,0.000006509612,0.00001529074,0.000010196714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018036546,0.000185159,0.00023306362,0.00016158276,0.0001534946,0.00020396186,0.000112670205,0.00019384778,0.0010727885],"category_scores_gemma":[0.000096590906,0.00009861375,0.00017510995,0.00021589939,0.0000998762,0.0000838101,0.000123436,0.0002501388,0.0005177576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002362524,0.000060962957,0.00043379847,0.00010793989,0.000007347861,0.00010876563,0.000059084054,0.000060015464,0.9950864,0.0001625868,0.00017957661,0.0034972825],"study_design_scores_gemma":[0.00006923634,0.0009943654,0.01973172,0.000024583604,0.000052069652,0.001100605,0.00011485061,0.0018275353,0.959894,0.00006795135,0.016109776,0.0000133385465],"about_ca_topic_score_codex":0.0033489557,"about_ca_topic_score_gemma":0.002398039,"teacher_disagreement_score":0.0033489557,"about_ca_system_score_codex":0.00031026127,"about_ca_system_score_gemma":0.0003142962,"threshold_uncertainty_score":0.0066589117},"labels":[],"label_agreement":null},{"id":"W2069320638","doi":"10.1038/sj.bjc.6605879","title":"Arsenic-related DNA copy-number alterations in lung squamous cell carcinomas","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"Government of Canada; Canadian Cancer Society Research Institute; Genome Canada; Canadian Institutes of Health Research; Genome British Columbia; Corporación de Fomento de la Producción","keywords":"Lung cancer; Biology; Arsenic; Lung; Population; Somatic cell; Cancer research; Genetics; Oncology; Pathology; Medicine; Internal medicine; Gene; Chemistry","score_opus":0.003917785795877276,"score_gpt":0.22939774123779108,"score_spread":0.2254799554419138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069320638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885166,0.00030445776,0.00019500579,0.000011210661,8.783691e-7,0.000005269441,0.00036861905,0.000008952422,0.0002540291],"genre_scores_gemma":[0.9987424,0.00016841797,0.00028803453,0.00000771238,0.000002139254,0.000010448632,0.0005132627,0.0000037826487,0.00026388894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999859,0.000013039827,0.000015117536,0.00004754189,0.000043603184,0.000021701015],"domain_scores_gemma":[0.9997247,0.00009011307,0.00008401793,0.000022868377,0.000045671266,0.00003270234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017837196,0.00015123838,0.00016327247,0.0009964035,0.00024968703,0.00029477102,0.00018757803,0.0001932093,0.0026482593],"category_scores_gemma":[0.00061462895,0.00012337681,0.00013853397,0.0006995722,0.00027122622,0.00012734017,0.00027645926,0.00013049066,0.00033437263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004671934,0.000028108485,0.74522257,0.00017105242,0.00012183413,0.0009121626,0.00037227274,0.00054945826,0.24042046,0.0000747436,0.00016777325,0.011492349],"study_design_scores_gemma":[0.0000059570852,0.00005841701,0.9884688,0.0000060696793,0.000037699952,0.0012422734,0.0000745117,0.0002593796,0.0093218135,0.00005841394,0.00046254977,0.0000041641647],"about_ca_topic_score_codex":0.0044193286,"about_ca_topic_score_gemma":0.004923989,"teacher_disagreement_score":0.0044193286,"about_ca_system_score_codex":0.00034058857,"about_ca_system_score_gemma":0.00023126663,"threshold_uncertainty_score":0.008859336},"labels":[],"label_agreement":null},{"id":"W2069485773","doi":"10.1038/sj.bjc.6602654","title":"Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; Manitoba Health; CancerCare Manitoba; BC Cancer Agency","funders":"National Cancer Institute; Centre International de Recherche sur le Cancer","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Oncology; Pathology","score_opus":0.008630476264784581,"score_gpt":0.26716797460924036,"score_spread":0.2585374983444558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069485773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97515213,0.009253594,0.00086153514,0.00007237086,0.000053484902,0.00007148223,0.012003282,0.00009163405,0.0024405227],"genre_scores_gemma":[0.98078215,0.0038873747,0.00044526716,0.00007689735,0.00007955623,0.00009904181,0.01303407,0.000022897166,0.0015729023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825865,0.0005248834,0.0002947568,0.00039431613,0.00030781562,0.00021958178],"domain_scores_gemma":[0.9989278,0.00020649935,0.0004521713,0.00017217554,0.00013450324,0.00010676603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012742032,0.00033598504,0.0009768654,0.0020748975,0.00019388863,0.00062655716,0.00033727885,0.0004157836,0.0024393003],"category_scores_gemma":[0.0022254242,0.00061691925,0.001791234,0.0026738287,0.00020116637,0.0003811407,0.00067031564,0.00050705747,0.0006810595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045818073,0.00003700723,0.98967385,0.00023365411,0.0011414464,0.0002697364,0.0001060151,0.00026219504,0.00051159936,0.000057569036,0.0011722095,0.0060764765],"study_design_scores_gemma":[0.00003476548,0.00010944875,0.9962612,0.00004413341,0.0004961771,0.00074406347,0.00012725795,0.00020779311,0.00021737628,0.0000387061,0.0017121016,0.0000068624886],"about_ca_topic_score_codex":0.013360616,"about_ca_topic_score_gemma":0.016531054,"teacher_disagreement_score":0.013360616,"about_ca_system_score_codex":0.000590501,"about_ca_system_score_gemma":0.0003864716,"threshold_uncertainty_score":0.02656573},"labels":[],"label_agreement":null},{"id":"W2069922776","doi":"10.1038/bjc.2011.140","title":"Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Discontinuation; Medicine; Breast cancer; Cohort; Internal medicine; Population; Gynecology; Cohort study; Cancer; Aromatase inhibitor; Oncology; Obstetrics","score_opus":0.023316978828095407,"score_gpt":0.2744574982820403,"score_spread":0.2511405194539449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069922776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988937,0.00025675455,0.00003579965,0.000060266353,0.000005017569,0.000011948937,0.00051828905,0.000002659908,0.00021560569],"genre_scores_gemma":[0.9990615,0.00018525076,0.000041952942,0.000057593777,0.000012055847,0.000019983398,0.00048525055,0.0000015284886,0.00013486009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914634,0.00025004763,0.000106890155,0.00019063301,0.00019869844,0.000107507236],"domain_scores_gemma":[0.99815184,0.0003446128,0.0008892162,0.00017752958,0.00018562582,0.00025116705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008306876,0.00019507579,0.0004507326,0.00082017155,0.00049276726,0.0006882151,0.00035840587,0.0006546292,0.0011992953],"category_scores_gemma":[0.0034278983,0.0004012914,0.0004066863,0.0014221789,0.00029401854,0.00058871007,0.0004557097,0.00054569414,0.00031988783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004464175,0.000018621433,0.99930406,0.0000048689662,0.000026750038,0.000049324834,0.000052725292,0.000009552913,0.000050508843,0.0000028612012,0.00005380803,0.0003822472],"study_design_scores_gemma":[0.0000065110203,0.00004774072,0.9995055,0.0000034662507,0.000014265126,0.00018523696,0.000093467606,0.000044653778,0.000007759699,0.000004086692,0.00008549075,0.0000018992218],"about_ca_topic_score_codex":0.01782807,"about_ca_topic_score_gemma":0.016471667,"teacher_disagreement_score":0.01782807,"about_ca_system_score_codex":0.0004442152,"about_ca_system_score_gemma":0.00047697328,"threshold_uncertainty_score":0.03544861},"labels":[],"label_agreement":null},{"id":"W2070267699","doi":"10.1038/bjc.2015.13","title":"A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WiLAN (Canada)","funders":"Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Penetrance; Wilms' tumor; Germline mutation; Biology; Loss of heterozygosity; Germline; Genetics; Uniparental disomy; Mutation; Incidence (geometry); Cancer research; Allele; Gene; Phenotype; Chromosome; Karyotype","score_opus":0.003999266435862699,"score_gpt":0.23631967361743636,"score_spread":0.23232040718157365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070267699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997154,0.00009852754,0.000038862716,0.00001132702,0.0000010576985,0.0000011190845,0.000034708213,0.0000025532222,0.00009641271],"genre_scores_gemma":[0.9997938,0.000066329325,0.00003895977,0.000006269686,0.0000029141456,0.0000016320863,0.000052747055,0.0000018091858,0.000035691362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996364,0.00004582206,0.000042045074,0.000116135125,0.00010195904,0.00005759324],"domain_scores_gemma":[0.99914694,0.0001172013,0.00041135272,0.00004639375,0.000079202975,0.00019881417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032425372,0.00023664655,0.0002087294,0.0009541969,0.00036306257,0.00035256194,0.00017870699,0.00034850743,0.0011951136],"category_scores_gemma":[0.0012658366,0.00025328287,0.00016388843,0.00069793465,0.00050644955,0.00030731736,0.00032226808,0.00026590252,0.00013451041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025304382,0.000004386917,0.9962114,0.000009040755,0.000012094256,0.00070504926,0.00022255511,0.00002047992,0.0014695337,0.000010009618,0.000043881373,0.0012661824],"study_design_scores_gemma":[0.0000016582771,0.000022101676,0.99572456,0.0000020454233,0.000009671092,0.0037530183,0.00019935437,0.000039175244,0.00014665471,0.000008862099,0.000090481124,0.0000024753447],"about_ca_topic_score_codex":0.006460217,"about_ca_topic_score_gemma":0.007097742,"teacher_disagreement_score":0.006460217,"about_ca_system_score_codex":0.00031075327,"about_ca_system_score_gemma":0.00031657057,"threshold_uncertainty_score":0.012845218},"labels":[],"label_agreement":null},{"id":"W2070811342","doi":"10.1038/bjc.2012.74","title":"Mitochondrial D310 mutations in the early development of breast cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Breast Cancer Research Alliance; University Health Network","keywords":"Pathology; Biology; Ductal carcinoma; Breast cancer; Mitochondrial DNA; Carcinoma; Cancer; Mammary gland; Medicine; Gene; Genetics","score_opus":0.012938547930129454,"score_gpt":0.276282682448277,"score_spread":0.26334413451814753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070811342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990144,0.00059620425,0.00010254925,0.000014704926,0.0000018429733,0.0000032791042,0.000025608013,0.0000035502433,0.00023797572],"genre_scores_gemma":[0.9996458,0.00013601857,0.00011814896,0.0000059732647,0.0000031645088,0.0000013564861,0.00003107028,8.5960687e-7,0.00005758554],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998367,0.000032605323,0.000018523711,0.000037943326,0.000040360155,0.00003381015],"domain_scores_gemma":[0.99937016,0.00019310466,0.000218621,0.000027303307,0.000088026034,0.00010280123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000266578,0.00017602263,0.00015538085,0.0009437181,0.00029969518,0.0002703938,0.00017351651,0.00039030644,0.0007987642],"category_scores_gemma":[0.000986122,0.00011537732,0.000091334565,0.0004984344,0.00027355208,0.00014878031,0.00022402321,0.00018048949,0.00018925904],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004025294,0.000028126391,0.9666131,0.00003833468,0.000020584655,0.0021204285,0.00015567133,0.00008877281,0.023803376,0.00004046957,0.000084560386,0.006603982],"study_design_scores_gemma":[0.000011195836,0.00023436347,0.9722926,0.000014246029,0.000038566024,0.017267017,0.00015672315,0.00027673136,0.008826164,0.00008949109,0.0007859208,0.0000069904777],"about_ca_topic_score_codex":0.0009740986,"about_ca_topic_score_gemma":0.00115811,"teacher_disagreement_score":0.0009740986,"about_ca_system_score_codex":0.0002715305,"about_ca_system_score_gemma":0.00014881209,"threshold_uncertainty_score":0.0026721358},"labels":[],"label_agreement":null},{"id":"W2070855246","doi":"10.1038/sj.bjc.6602304","title":"Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Term (time); Cancer; Surgery; Oncology; Internal medicine","score_opus":0.009585676431239868,"score_gpt":0.28726506979981525,"score_spread":0.2776793933685754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070855246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990996,0.0003032553,0.000026679096,0.000078770994,0.000009600106,0.000008815285,0.00020473637,0.0000023714526,0.00026618625],"genre_scores_gemma":[0.9992874,0.00014068066,0.000024106903,0.000038614307,0.000009494681,0.000010406031,0.00029648084,6.824504e-7,0.00019213477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996406,0.000073223884,0.000044199616,0.000044015163,0.00009132382,0.00010670688],"domain_scores_gemma":[0.9985568,0.00018664639,0.0005292182,0.00007743109,0.00028498066,0.00036485575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059411547,0.00016733125,0.0005071964,0.000721437,0.00069255027,0.0004948933,0.00032874942,0.0005843987,0.0009963418],"category_scores_gemma":[0.0028138196,0.0002030706,0.00052602735,0.0008755324,0.00020571533,0.00058803736,0.00044639155,0.0008426656,0.0003349322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014884367,0.000078238554,0.9965875,0.000008210892,0.000031088577,0.00028697483,0.00016739334,0.00002039916,0.00016253823,0.0000036452047,0.00008183097,0.002423209],"study_design_scores_gemma":[0.0000051266957,0.00020503001,0.9990146,0.0000053921544,0.000028318798,0.00031902004,0.0002442543,0.000037876132,0.000028873013,0.000006931572,0.00010069142,0.0000038837416],"about_ca_topic_score_codex":0.007182256,"about_ca_topic_score_gemma":0.008350398,"teacher_disagreement_score":0.007182256,"about_ca_system_score_codex":0.00037043038,"about_ca_system_score_gemma":0.00031970855,"threshold_uncertainty_score":0.014280915},"labels":[],"label_agreement":null},{"id":"W2071876402","doi":"10.1038/sj.bjc.6603629","title":"A cohort study of reproductive and hormonal factors and renal cell cancer risk in women","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Cohort study; Obstetrics; Gynecology; Cohort; Confidence interval; Pregnancy; Parity (physics); Relative risk; Cancer; Internal medicine; Biology","score_opus":0.011923008972024597,"score_gpt":0.2728643878861293,"score_spread":0.26094137891410474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071876402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967334,0.0005655736,0.00015553385,0.00011537249,0.000015032356,0.00006856023,0.0016176448,0.000007852642,0.0007209912],"genre_scores_gemma":[0.9961786,0.0007141729,0.00031838543,0.00009904142,0.000015838437,0.000048032125,0.0012346711,0.000004780042,0.001386413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955565,0.000054126307,0.000020286237,0.000081737555,0.0001290672,0.00015921431],"domain_scores_gemma":[0.99923635,0.0000619781,0.00012581826,0.000077379664,0.0002244406,0.0002740748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056295586,0.00039497172,0.00063213956,0.0009973011,0.0022851469,0.0007191813,0.00062187243,0.00047286996,0.0013737953],"category_scores_gemma":[0.0013722223,0.0005803934,0.0006722253,0.0023310613,0.00044234982,0.00023936326,0.00047731167,0.00066308153,0.00020870093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025011273,0.000059232516,0.9955662,0.00001867305,0.00016462171,0.0002272471,0.00040335118,0.00003378706,0.00044427862,0.00005168885,0.00053979753,0.0022410257],"study_design_scores_gemma":[0.000047685073,0.00013060385,0.9975981,0.000014884783,0.00011501625,0.00024956852,0.00036643463,0.00012732268,0.0000575403,0.000021703878,0.0012613526,0.000009895055],"about_ca_topic_score_codex":0.858405,"about_ca_topic_score_gemma":0.88604,"teacher_disagreement_score":0.858405,"about_ca_system_score_codex":0.0033797158,"about_ca_system_score_gemma":0.005798223,"threshold_uncertainty_score":0.28485775},"labels":[],"label_agreement":null},{"id":"W2072532597","doi":"10.1038/sj.bjc.6603048","title":"Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nausea and vomiting management","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Dexamethasone; Medicine; Nausea; Vomiting; Chemotherapy; Internal medicine; Corticosteroid; Anesthesia; Antiemetic; Gastroenterology","score_opus":0.019470147078291877,"score_gpt":0.26396643186383717,"score_spread":0.2444962847855453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072532597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918772,0.006136365,0.00070470676,0.0001715278,0.000030735886,0.00013666262,0.00005746196,0.000017203887,0.0008681087],"genre_scores_gemma":[0.99764156,0.0011901851,0.0008638458,0.000077897894,0.000027651238,0.000033105654,0.00004426618,0.0000023873154,0.00011900733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99893886,0.00064151303,0.00013880534,0.000033006592,0.00019366833,0.000054163163],"domain_scores_gemma":[0.99377835,0.0035876906,0.0017257973,0.00016954592,0.00031522143,0.0004233877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012321667,0.00016575074,0.00053825567,0.00016496301,0.00014174129,0.00020683819,0.00015080233,0.00018608606,0.0007385274],"category_scores_gemma":[0.0071987617,0.000070400536,0.00037158572,0.00018301915,0.00018601121,0.00021294704,0.0001844021,0.0004382448,0.000091360525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021717336,0.0028600418,0.30854493,0.0022265364,0.00081931683,0.001400786,0.0007261352,0.0017761774,0.043786578,0.00020109679,0.000678896,0.6152621],"study_design_scores_gemma":[0.0020210235,0.0876814,0.87542313,0.00026736766,0.00070806243,0.00904661,0.00041656097,0.0014785265,0.017876064,0.00020059127,0.0048188027,0.000061899904],"about_ca_topic_score_codex":0.00029927006,"about_ca_topic_score_gemma":0.00079817,"teacher_disagreement_score":0.0012321667,"about_ca_system_score_codex":0.00026491113,"about_ca_system_score_gemma":0.00021643219,"threshold_uncertainty_score":0.006516397},"labels":[],"label_agreement":null},{"id":"W2072884377","doi":"10.1038/bjc.2011.391","title":"Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Eicosapentaenoic acid; Cachexia; Cancer cachexia; Clinical trial; Lean body mass; Cancer; Appetite; Medicine; Polyunsaturated fatty acid; Internal medicine; Oncology; Bioinformatics; Endocrinology; Fatty acid; Biology; Body weight; Biochemistry","score_opus":0.08672535062207809,"score_gpt":0.4434882364426714,"score_spread":0.3567628858205933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072884377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021082109,0.9993944,0.000023723504,0.000038652044,0.000040352115,0.000005743465,0.00001408186,0.0000019024312,0.00027038666],"genre_scores_gemma":[0.0011189119,0.99849844,0.00009814966,0.00005337506,0.000025051266,0.000008260613,0.000019582329,8.5135196e-7,0.00017743665],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997813,0.00005224656,0.00005237147,0.000029359024,0.000068677,0.000016084487],"domain_scores_gemma":[0.9996828,0.0001795212,0.00005579098,0.000006590478,0.000057510508,0.000017826767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007446414,0.00072802894,0.0026276582,0.0020079683,0.00020523592,0.00077026384,0.0007968943,0.0009896415,0.003757366],"category_scores_gemma":[0.00094852824,0.00027532293,0.000990851,0.0020479944,0.00025344448,0.00058438524,0.00045351262,0.00083616487,0.0012305891],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006533372,0.00014444083,0.00024403476,0.100492366,0.00066783,0.0002441912,0.00006728842,0.00025769114,0.002208709,0.00081779336,0.007895428,0.88630694],"study_design_scores_gemma":[0.0007619664,0.0016468201,0.008355214,0.06233518,0.0047854455,0.0047985637,0.0002880862,0.0003073146,0.004158016,0.0017372742,0.910753,0.00007319849],"about_ca_topic_score_codex":0.001355578,"about_ca_topic_score_gemma":0.0025414194,"teacher_disagreement_score":0.003757366,"about_ca_system_score_codex":0.0004001235,"about_ca_system_score_gemma":0.0007566206,"threshold_uncertainty_score":0.012569606},"labels":[],"label_agreement":null},{"id":"W2073492934","doi":"10.1038/sj.bjc.6605842","title":"Insulin-like growth factors and liver cancer risk in male smokers","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Odds ratio; Medicine; Internal medicine; Liver cancer; Cohort; Cancer; Confidence interval; Endocrinology; Risk factor; Oncology; Gastroenterology","score_opus":0.010632519940437278,"score_gpt":0.2546554373241684,"score_spread":0.2440229173837311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073492934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992673,0.00036096436,0.00005368714,0.00003331162,0.000003200806,0.0000023839511,0.00008119081,0.0000027840397,0.00019526115],"genre_scores_gemma":[0.99952245,0.00014234663,0.00004735433,0.000012822246,0.000007396239,0.0000022274498,0.000072803174,9.0628265e-7,0.00019174791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998629,0.000032981032,0.000010378426,0.000026063133,0.000038153834,0.000029463126],"domain_scores_gemma":[0.99946874,0.00011519774,0.00024060915,0.000033664848,0.00004288105,0.0000989079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003105569,0.00018422425,0.00023198882,0.00052360725,0.00018591547,0.00035759463,0.00016096489,0.00033692372,0.0017990926],"category_scores_gemma":[0.0010838143,0.00025641365,0.00024748736,0.00050440733,0.00021629312,0.00014105192,0.00016407028,0.00034132384,0.00020913698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012077807,0.000015278025,0.99847454,0.000004273461,0.000031483683,0.00005555688,0.000026075291,0.000010999228,0.00048249256,0.0000074167588,0.000023343933,0.0007477871],"study_design_scores_gemma":[0.000004789458,0.00007059454,0.99932396,0.0000022428737,0.000029457584,0.0002769347,0.000022650796,0.0000613971,0.00011722609,0.000015006469,0.00007469814,0.0000010741064],"about_ca_topic_score_codex":0.0038066127,"about_ca_topic_score_gemma":0.0051401085,"teacher_disagreement_score":0.0038066127,"about_ca_system_score_codex":0.00014911634,"about_ca_system_score_gemma":0.00016620145,"threshold_uncertainty_score":0.0075689554},"labels":[],"label_agreement":null},{"id":"W2074503147","doi":"10.1038/bjc.2012.545","title":"Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"National Institute for Health and Care Research; AstraZeneca","keywords":"Bevacizumab; Medicine; Colorectal cancer; Internal medicine; Adverse effect; Gastroenterology; Pharmacology; Oncology; Chemotherapy; Cancer","score_opus":0.011498500264287243,"score_gpt":0.2740689947198434,"score_spread":0.2625704944555562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074503147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820771,0.0153891975,0.00020998842,0.00041897333,0.00026875915,0.00030576307,0.00015438204,0.000020258922,0.0011556535],"genre_scores_gemma":[0.9941514,0.0038215746,0.0003089935,0.0003293098,0.00019140849,0.00020515754,0.00028702815,0.0000056327067,0.0006994197],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99923825,0.0003960356,0.000064009444,0.0000938785,0.000094814604,0.000113077636],"domain_scores_gemma":[0.9990482,0.00041033843,0.0002460098,0.00004183297,0.00003172236,0.00022194926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021590476,0.000532468,0.0018324616,0.00034610313,0.00022945025,0.00069669663,0.00050348195,0.0009581042,0.0024991753],"category_scores_gemma":[0.0020838531,0.0002927213,0.0024325347,0.0003005046,0.00046250125,0.00059201074,0.00033760283,0.001547676,0.0002536004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9206804,0.0027459867,0.005990244,0.0009838344,0.004295501,0.000111453315,0.00008273176,0.0022353902,0.003218185,0.00017195978,0.0006185306,0.058865786],"study_design_scores_gemma":[0.41098186,0.50378907,0.059416894,0.0004429381,0.0090235025,0.0005458217,0.0001323149,0.0057872063,0.0033987893,0.00075381453,0.005665465,0.00006233161],"about_ca_topic_score_codex":0.0016174475,"about_ca_topic_score_gemma":0.0048434166,"teacher_disagreement_score":0.0024991753,"about_ca_system_score_codex":0.001544277,"about_ca_system_score_gemma":0.0008011108,"threshold_uncertainty_score":0.011418283},"labels":[],"label_agreement":null},{"id":"W2074952360","doi":"10.1038/bjc.2012.451","title":"Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of California, San Francisco; University of Texas MD Anderson Cancer Center; U.S. Public Health Service; National Cancer Institute; U.S. Department of Health and Human Services; Science Foundation Ireland; Conquer Cancer Foundation; National Institutes of Health; Stand Up To Cancer; Entertainment Industry Foundation","keywords":"Loss of heterozygosity; Homologous recombination; Ovarian cancer; Biology; Homologous chromosome; Cancer research; Breast cancer; DNA repair; BRCA2 Protein; Genome instability; Cancer; Genetics; Oncology; Allele; DNA; Gene; Medicine; DNA damage; Mutation; Germline mutation","score_opus":0.017011516756691564,"score_gpt":0.2972541560484307,"score_spread":0.28024263929173915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074952360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919635,0.00021596698,0.00021535163,0.000015480688,0.0000012183763,0.00000450122,0.0001258275,0.000007233198,0.0002181074],"genre_scores_gemma":[0.9993623,0.000071593306,0.00023582538,0.000007282071,0.000002287185,0.0000049634364,0.00026291894,0.0000023419555,0.000050605133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996697,0.00006962896,0.000056176257,0.0000705818,0.00008095925,0.00005310369],"domain_scores_gemma":[0.9967739,0.0013927295,0.0012111466,0.000157876,0.00021539451,0.00024885562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060825155,0.00013602675,0.00024180017,0.0014213922,0.00013848128,0.00042785937,0.00019141816,0.0003982167,0.0017065614],"category_scores_gemma":[0.0029354556,0.00014658706,0.0001652122,0.00076731906,0.00030944624,0.0001913291,0.00043333624,0.0003224697,0.00022617911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033151623,0.000024783203,0.984711,0.000022814553,0.00004101422,0.00013677444,0.000038633683,0.00014216137,0.011563205,0.000018027775,0.00006235109,0.0029077367],"study_design_scores_gemma":[0.000006220098,0.00010780229,0.9959688,0.000002964214,0.000027419295,0.0014405677,0.000060415292,0.00027400802,0.0019134637,0.000041868887,0.00015383905,0.000002541115],"about_ca_topic_score_codex":0.0004742741,"about_ca_topic_score_gemma":0.0006186904,"teacher_disagreement_score":0.0017065614,"about_ca_system_score_codex":0.0001418485,"about_ca_system_score_gemma":0.000109123524,"threshold_uncertainty_score":0.005709052},"labels":[],"label_agreement":null},{"id":"W2075330581","doi":"10.1038/sj.bjc.6601195","title":"Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; BioPhage Pharma (Canada); McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Norges Forskningsråd; Susan G. Komen; Kreftforeningen","keywords":"Germline; Breast cancer; Germline mutation; Oncology; Internal medicine; Chemotherapy; Medicine; Cancer; Adverse effect; Cancer research; Mutation; Biology; Genetics; Gene","score_opus":0.007865768143918764,"score_gpt":0.2772444342573136,"score_spread":0.26937866611339484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075330581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976012,0.0017901589,0.000114058,0.00011979115,0.000008601527,0.000001753088,0.00003616284,0.0000040053683,0.0003242703],"genre_scores_gemma":[0.9994823,0.00032091307,0.000046378656,0.000014447597,0.000020979674,0.0000012657878,0.000031823067,7.446691e-7,0.00008118095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956805,0.00024262794,0.000019683315,0.00004294711,0.00007412843,0.000052611325],"domain_scores_gemma":[0.9975419,0.00078796496,0.001185767,0.00011858738,0.00008417923,0.0002816782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077064004,0.00019532687,0.00022157286,0.0005483953,0.00023543282,0.00025227477,0.00020123449,0.00036666836,0.0011066693],"category_scores_gemma":[0.0023712981,0.00015448898,0.0003378947,0.00048233473,0.00032602492,0.0001811614,0.0003596636,0.00062562834,0.0000682994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013705165,0.0000454208,0.98572147,0.000050400336,0.0002050941,0.0003951686,0.000024797944,0.0001879219,0.0019485034,0.000052137664,0.00013500557,0.009863552],"study_design_scores_gemma":[0.000014093726,0.00016178822,0.99699473,0.00001427322,0.00013658799,0.0017355448,0.00003763262,0.00024376207,0.00035796006,0.00010995572,0.00018975938,0.000003820956],"about_ca_topic_score_codex":0.0014676404,"about_ca_topic_score_gemma":0.002254539,"teacher_disagreement_score":0.0014676404,"about_ca_system_score_codex":0.00023247219,"about_ca_system_score_gemma":0.00019910376,"threshold_uncertainty_score":0.004075587},"labels":[],"label_agreement":null},{"id":"W2075723261","doi":"10.1054/bjoc.2001.2008","title":"Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Medical Research Council; Alder Hey Children's NHS Foundation Trust","keywords":"Alveolar rhabdomyosarcoma; PAX3; Rhabdomyosarcoma; Ganglioneuroblastoma; Fusion gene; Chromosomal translocation; Pathology; Biology; Medicine; Oncology; Sarcoma; Gene; Neuroblastoma; Transcription factor; Genetics; Ganglioneuroma","score_opus":0.01888359842424582,"score_gpt":0.28167081553189355,"score_spread":0.26278721710764774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075723261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739575,0.0011740827,0.0004955091,0.00011945632,0.000015928115,0.000006498417,0.0001333688,0.000012862706,0.0006466203],"genre_scores_gemma":[0.99932754,0.00025860014,0.00015232008,0.000014677656,0.000018579014,0.00000590314,0.00015890783,0.0000052311493,0.000058276797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932647,0.0001946801,0.00010086924,0.00012480517,0.00014201745,0.00011111332],"domain_scores_gemma":[0.9959708,0.0013836843,0.0014135988,0.0002704531,0.0004076726,0.0005537029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012209738,0.00030371983,0.00048719396,0.00061935035,0.00023817424,0.00052517344,0.00043280926,0.00073897204,0.0010172554],"category_scores_gemma":[0.006646595,0.00020247568,0.0002955139,0.000815577,0.00074406405,0.00072614633,0.00045771588,0.0006770003,0.00060993654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000699487,0.0000057486586,0.99582845,0.000012394316,0.000009084304,0.0003890294,0.000038213973,0.00008589137,0.00093362917,0.000015696449,0.000042325642,0.002569507],"study_design_scores_gemma":[0.0000052189766,0.00016553236,0.99388844,0.00001737376,0.0000354446,0.003999478,0.00016591261,0.00045541878,0.0008427703,0.00011812117,0.00029849212,0.000007897875],"about_ca_topic_score_codex":0.0009957213,"about_ca_topic_score_gemma":0.001144028,"teacher_disagreement_score":0.0012209738,"about_ca_system_score_codex":0.00022103987,"about_ca_system_score_gemma":0.00039851025,"threshold_uncertainty_score":0.0064572096},"labels":[],"label_agreement":null},{"id":"W2076172881","doi":"10.1038/sj.bjc.6604020","title":"Expression of thymidylate synthase in human cells is an early G1 event regulated by CDK4 and p16INK4A but not E2F","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Thymidylate synthase; E2F; Cancer research; Biology; Gene expression; Molecular biology; Genetics; Cell biology; Gene; Cancer; Fluorouracil","score_opus":0.010560168883799886,"score_gpt":0.2813980103055241,"score_spread":0.2708378414217242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076172881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758364,0.011885409,0.007097559,0.00010309853,0.00005379241,0.000059020895,0.0019111332,0.00020035694,0.002853241],"genre_scores_gemma":[0.9851306,0.0037183913,0.004389047,0.000031915195,0.0000127529665,0.000041048177,0.0024258022,0.000023711546,0.0042267176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989784,0.00001232333,0.000011232286,0.000033712142,0.000025177718,0.000019703351],"domain_scores_gemma":[0.99992454,0.000015719912,0.000021825354,0.000013532387,0.000011869724,0.000012478575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011306163,0.00026122568,0.00030190652,0.00030724704,0.0001771151,0.00037012663,0.00011066373,0.00017292422,0.0019708485],"category_scores_gemma":[0.00014433898,0.00013364665,0.00017894758,0.00030209371,0.00017955877,0.00013090605,0.00014613292,0.00022390173,0.0006333448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016126907,0.000008760596,0.00063809374,0.00003904461,0.0000055152727,0.00003282566,0.000014873595,0.00004428129,0.997065,0.00006273655,0.000034167842,0.0018934893],"study_design_scores_gemma":[0.000012448873,0.00015082049,0.011999669,0.0000063430125,0.000011528016,0.00026002544,0.000016925962,0.00036789716,0.9815969,0.000045619847,0.00552762,0.000004199586],"about_ca_topic_score_codex":0.0013775581,"about_ca_topic_score_gemma":0.0011500326,"teacher_disagreement_score":0.0019708485,"about_ca_system_score_codex":0.00038388927,"about_ca_system_score_gemma":0.0002640379,"threshold_uncertainty_score":0.006593168},"labels":[],"label_agreement":null},{"id":"W2076203534","doi":"10.1038/sj.bjc.6602080","title":"Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Gemcitabine; Pancreatic cancer; Cancer research; Molecular biology; Oligonucleotide; Endonuclease; Biology; Chemistry; Cancer; Enzyme; Biochemistry; DNA; Genetics","score_opus":0.0037793965493451965,"score_gpt":0.22458517359847016,"score_spread":0.22080577704912496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076203534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99164456,0.0049310694,0.001434086,0.00011832445,0.00008766224,0.000040460935,0.000362989,0.000038432576,0.0013422547],"genre_scores_gemma":[0.9932886,0.0024603722,0.0019404762,0.00007263104,0.000017433078,0.00004667665,0.00048102127,0.000010263206,0.0016825486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986374,0.000031324023,0.000023716293,0.000030016394,0.00003274063,0.000018392086],"domain_scores_gemma":[0.9999093,0.000030491896,0.000019283412,0.000011642942,0.000015046681,0.0000141953105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016929852,0.00035743974,0.00031822186,0.00013080011,0.00011106025,0.00024348855,0.00010552392,0.00029194148,0.00057335536],"category_scores_gemma":[0.00015608397,0.00011756139,0.00021692946,0.00012699676,0.00012425533,0.00017681527,0.00008191323,0.0005611537,0.0001347091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019932874,0.000059600385,0.00014904623,0.00004298102,0.0000075546814,0.00002100573,0.000012855604,0.00012392407,0.9979132,0.000039378087,0.000030119925,0.0014009611],"study_design_scores_gemma":[0.000020801474,0.0010572105,0.0023511902,0.0000045684537,0.000024669567,0.000079557896,0.000015420355,0.00065518444,0.9944114,0.000018597733,0.0013575623,0.0000039283354],"about_ca_topic_score_codex":0.00065889995,"about_ca_topic_score_gemma":0.001015702,"teacher_disagreement_score":0.00065889995,"about_ca_system_score_codex":0.00017994683,"about_ca_system_score_gemma":0.00012957139,"threshold_uncertainty_score":0.0019180775},"labels":[],"label_agreement":null},{"id":"W2076423158","doi":"10.1038/sj.bjc.6600168","title":"Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research","keywords":"Oxaliplatin; Irinotecan; Tolerability; Medicine; Circadian rhythm; Chemotherapy; Camptothecin; Internal medicine; Anesthesia; Adverse effect; Colorectal cancer; Cancer; Biology","score_opus":0.011768452023314998,"score_gpt":0.2397905785101323,"score_spread":0.2280221264868173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076423158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962767,0.00092292787,0.0012827663,0.00007452848,0.000040467254,0.000046722067,0.00048825392,0.00008328394,0.0007843185],"genre_scores_gemma":[0.99329066,0.0008118277,0.0014958363,0.00007468689,0.0000147252185,0.0001364077,0.00063440466,0.000035535242,0.0035059804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970335,0.000036900477,0.000016368773,0.00006903418,0.00007614746,0.00009825836],"domain_scores_gemma":[0.99978274,0.000014465978,0.00009240465,0.000025402362,0.000021341479,0.00006369105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002895065,0.0003983027,0.00046944767,0.00044228276,0.00013011442,0.00032387927,0.0002463463,0.00029518275,0.0010843244],"category_scores_gemma":[0.0001538394,0.0002562054,0.0003962015,0.00030268528,0.00039270642,0.00029707828,0.0002422959,0.00083111,0.00026578442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016999138,0.0001422283,0.0007292311,0.000027223554,0.000007562369,0.000051703322,0.0000426503,0.0001132337,0.9951357,0.00007089525,0.000060513175,0.0019190348],"study_design_scores_gemma":[0.00022691229,0.012990791,0.032387894,0.000013160226,0.00007883571,0.0002931592,0.0001897012,0.0012941576,0.9495466,0.0001422685,0.0028073075,0.000029199495],"about_ca_topic_score_codex":0.0013083527,"about_ca_topic_score_gemma":0.002867648,"teacher_disagreement_score":0.0013083527,"about_ca_system_score_codex":0.00056952424,"about_ca_system_score_gemma":0.0003073206,"threshold_uncertainty_score":0.004132211},"labels":[],"label_agreement":null},{"id":"W2076480857","doi":"10.1038/sj.bjc.6605154","title":"Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Science Foundation of Heilongjiang Province; Fondation pour la Recherche Médicale; National Natural Science Foundation of China","keywords":"RHOA; PI3K/AKT/mTOR pathway; Protein kinase B; Focal adhesion; Fibronectin; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Cell migration; Biology; Cell biology; Signal transduction; Chemistry; Extracellular matrix; Cell; Biochemistry","score_opus":0.018061569810196083,"score_gpt":0.28980031742530415,"score_spread":0.2717387476151081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076480857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862651,0.0041175755,0.004277177,0.00010839772,0.000018877847,0.00009812157,0.0011805606,0.000049719336,0.0038844307],"genre_scores_gemma":[0.980825,0.0027199949,0.008015125,0.000069570335,0.000014528624,0.00027463483,0.0036298204,0.000010200281,0.0044411104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991095,0.000012045483,0.000006715615,0.000009497145,0.00003162245,0.000029267467],"domain_scores_gemma":[0.99993885,0.000015234852,0.000011184837,0.000003864827,0.000015785878,0.000015136922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001403327,0.00030250294,0.00012157561,0.00040335252,0.0002252391,0.0001556442,0.00014222761,0.0002064717,0.0016330183],"category_scores_gemma":[0.00007472912,0.000091004986,0.00023805982,0.00032329466,0.000098659366,0.00013477051,0.00009132072,0.0003776008,0.00039327572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095509095,0.000020991272,0.0002774422,0.0000641315,0.000003023993,0.000046406425,0.00001333073,0.000039529645,0.9983197,0.00004819379,0.000030770632,0.0010409685],"study_design_scores_gemma":[0.000040030445,0.00062486914,0.055611752,0.000023110402,0.000042593212,0.0009792969,0.00007682624,0.0025483184,0.9343511,0.00010084904,0.005588967,0.000012329921],"about_ca_topic_score_codex":0.0009512084,"about_ca_topic_score_gemma":0.0015631744,"teacher_disagreement_score":0.0016330183,"about_ca_system_score_codex":0.00026193896,"about_ca_system_score_gemma":0.00022674959,"threshold_uncertainty_score":0.005463004},"labels":[],"label_agreement":null},{"id":"W2076838198","doi":"10.1038/bjc.2012.209","title":"Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Sorafenib; Clusterin; Apoptosis; In vivo; Downregulation and upregulation; Renal cell carcinoma; Cancer research; Medicine; Internal medicine; Pharmacology; Endocrinology; Biology; Hepatocellular carcinoma; Biochemistry","score_opus":0.03720430961535985,"score_gpt":0.33376301152986076,"score_spread":0.2965587019145009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076838198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587184,0.0015224505,0.0015425554,0.000077053395,0.000031347012,0.000046166017,0.00014961,0.000056721467,0.0007021873],"genre_scores_gemma":[0.9956031,0.0009808777,0.0018681117,0.000023251285,0.000008165302,0.00004720698,0.00024863298,0.000006607192,0.0012140037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985313,0.000027916092,0.00001244149,0.0000306198,0.0000382634,0.00003769095],"domain_scores_gemma":[0.99994755,0.000008183525,0.0000135580185,0.0000064775854,0.000009239524,0.000014953742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001888196,0.00038824964,0.000407963,0.0001761583,0.00015258767,0.00023968205,0.00018701974,0.00024105507,0.0007980623],"category_scores_gemma":[0.000076653836,0.00010572757,0.0003064829,0.00015273702,0.0001928962,0.00017161948,0.00014395715,0.00043336413,0.00022501264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003858926,0.00010913903,0.00022490036,0.00007867627,0.0000129812815,0.00003637331,0.000015416008,0.0001290434,0.9969022,0.000034515946,0.000054409593,0.0020164824],"study_design_scores_gemma":[0.000049057235,0.0013328166,0.002731681,0.000002622945,0.000028703056,0.00015568976,0.000016575372,0.00067634875,0.99355185,0.000009388792,0.0014412303,0.0000041541584],"about_ca_topic_score_codex":0.0012364226,"about_ca_topic_score_gemma":0.0025830003,"teacher_disagreement_score":0.0012364226,"about_ca_system_score_codex":0.000381912,"about_ca_system_score_gemma":0.00042116139,"threshold_uncertainty_score":0.00277102},"labels":[],"label_agreement":null},{"id":"W2076908467","doi":"10.1038/bjc.2013.187","title":"Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":268,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; McMaster University; Juravinski Cancer Centre","funders":"Canadian Institutes of Health Research; University of Toronto; Institut National de la Santé et de la Recherche Médicale; McMaster University","keywords":"Metformin; AMPK; Lung cancer; Medicine; Oncology; Internal medicine; Cell growth; Cancer research; non-small cell lung cancer (NSCLC); Biology; Kinase; Protein kinase A; A549 cell; Cell biology","score_opus":0.005009198573266756,"score_gpt":0.2446573350131916,"score_spread":0.23964813643992483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076908467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891973,0.008474372,0.00048706148,0.00016559537,0.000066544875,0.00004404926,0.00030136268,0.000047631875,0.001216101],"genre_scores_gemma":[0.9910492,0.005306034,0.0006931152,0.000085882566,0.00002636163,0.00007091981,0.0005791603,0.0000083370805,0.0021810771],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992156,0.000012711215,0.000010349748,0.000012754128,0.000020991536,0.000021592525],"domain_scores_gemma":[0.9999628,0.0000052733412,0.000014412259,0.0000028667378,0.0000047131193,0.000009825662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001167882,0.00029488487,0.00027553042,0.0001944533,0.00012647639,0.00019285774,0.00017435072,0.00025486373,0.0015831725],"category_scores_gemma":[0.00007360748,0.00009996024,0.00033372518,0.00013716328,0.00011246819,0.00018375024,0.00013877977,0.00046995337,0.0002578301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006993481,0.00019548865,0.0008922289,0.00026206163,0.000019796973,0.00012989843,0.000014280891,0.00009041446,0.99243695,0.000087346096,0.00014717341,0.005025174],"study_design_scores_gemma":[0.00017620623,0.0057986164,0.025577504,0.000030472267,0.00010454868,0.0008901405,0.00007078855,0.0007163084,0.9578661,0.000075885735,0.008681292,0.000012141994],"about_ca_topic_score_codex":0.00021814885,"about_ca_topic_score_gemma":0.0007401352,"teacher_disagreement_score":0.0015831725,"about_ca_system_score_codex":0.00016421113,"about_ca_system_score_gemma":0.00014919712,"threshold_uncertainty_score":0.0052961707},"labels":[],"label_agreement":null},{"id":"W2076952890","doi":"10.1038/bjc.2012.524","title":"Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":269,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; University of Victoria; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Office of Defense Programs; BC Cancer Foundation; Natural Sciences and Engineering Research Council of Canada; U.S. Department of Defense","keywords":"FOXP3; Breast cancer; Tumor-infiltrating lymphocytes; Immune system; Cytotoxic T cell; CD8; Medicine; Cancer research; Oncology; Cancer; Internal medicine; IL-2 receptor; Immunology; Biology; T cell; In vitro","score_opus":0.023032510732416127,"score_gpt":0.29431198321791685,"score_spread":0.2712794724855007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076952890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913615,0.0004354439,0.00009855482,0.000018503973,0.0000031477052,0.0000038224925,0.00009802763,0.0000070640294,0.00019935369],"genre_scores_gemma":[0.9996419,0.00007410994,0.000057614816,0.00000810067,0.0000074884806,0.0000035754017,0.00012998728,0.000001966474,0.00007527349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987257,0.000023760558,0.000014672027,0.00003623042,0.000023357987,0.000029360694],"domain_scores_gemma":[0.99881315,0.0002680848,0.00060223724,0.00007245261,0.000083678366,0.00016042186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047982752,0.0001763571,0.00024265029,0.00043188114,0.00022898147,0.00034369904,0.00018616559,0.00029702758,0.0015475972],"category_scores_gemma":[0.0013285214,0.000112815775,0.00017219745,0.00050265883,0.0003122295,0.00020655949,0.00023908545,0.00036821052,0.00023577339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009967976,0.000033750777,0.98886526,0.00002820954,0.00003968509,0.0002219521,0.00005312331,0.00011519413,0.004826466,0.000016006039,0.00009565014,0.0047079036],"study_design_scores_gemma":[0.0000122780675,0.00014131921,0.9979463,0.0000045336446,0.00004634392,0.00075039646,0.000049806094,0.0001894414,0.00060371746,0.00006294556,0.00018975654,0.0000030411538],"about_ca_topic_score_codex":0.00056475005,"about_ca_topic_score_gemma":0.0007278208,"teacher_disagreement_score":0.0015475972,"about_ca_system_score_codex":0.000167588,"about_ca_system_score_gemma":0.00015397118,"threshold_uncertainty_score":0.0051772594},"labels":[],"label_agreement":null},{"id":"W2077080354","doi":"10.1038/sj.bjc.6603745","title":"The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; York University; Ontario Institute for Cancer Research; University of Toronto","funders":"National Cancer Institute; Turun Yliopisto","keywords":"Apoptosis; Biology; Cancer research; Terminal deoxynucleotidyl transferase; Programmed cell death; Immunohistochemistry; Mutation; Cell growth; Gene; TUNEL assay; Genetics; Immunology","score_opus":0.010769437075153643,"score_gpt":0.2510579462707686,"score_spread":0.24028850919561495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077080354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974119,0.0019982813,0.0002532334,0.000016758317,0.0000025276338,0.0000036022698,0.000041391802,0.0000048466995,0.00026758233],"genre_scores_gemma":[0.99867934,0.0006969361,0.0002674284,0.000012123512,0.000003037235,0.0000057643188,0.000085426036,0.0000012592237,0.00024853554],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989355,0.000020648611,0.000010890023,0.00001574915,0.000043039214,0.000016189251],"domain_scores_gemma":[0.9997962,0.00006870704,0.00006779276,0.000012233336,0.000022301487,0.000032754095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017263721,0.00011233968,0.00016314485,0.00088652346,0.0001205451,0.0002630228,0.000073253585,0.00019069039,0.0005745564],"category_scores_gemma":[0.00047481785,0.00010290362,0.00007794473,0.0004582913,0.00027895495,0.000118943244,0.00015890872,0.00016505505,0.000120728124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018945378,0.00015367012,0.10267702,0.00018324378,0.00005238644,0.0015117873,0.00014575623,0.0003168328,0.86948675,0.00026962743,0.00019036338,0.023118125],"study_design_scores_gemma":[0.00006900673,0.0008633804,0.81307334,0.000023340966,0.000060547176,0.0070426846,0.00020929225,0.0014050996,0.17410392,0.00047884454,0.002654139,0.000016412041],"about_ca_topic_score_codex":0.00034000233,"about_ca_topic_score_gemma":0.00043386407,"teacher_disagreement_score":0.00088652346,"about_ca_system_score_codex":0.00031277083,"about_ca_system_score_gemma":0.00012459989,"threshold_uncertainty_score":0.0022693276},"labels":[],"label_agreement":null},{"id":"W2077413329","doi":"10.1038/sj.bjc.6603110","title":"Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Telomerase reverse transcriptase; Telomerase; Adenocarcinoma; Cancer research; Carcinogenesis; Biology; Lung cancer; Gene duplication; Cancer; Pathology; Gene; Medicine","score_opus":0.009228636025640275,"score_gpt":0.2663810444292169,"score_spread":0.2571524084035766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077413329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845003,0.013664006,0.00045696372,0.00009934715,0.000014574862,0.00000879247,0.000247261,0.000020014193,0.0009887498],"genre_scores_gemma":[0.9958741,0.0029894973,0.00022659014,0.000014554077,0.000017423088,0.000006927154,0.00040172183,0.0000031220568,0.00046614307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998092,0.000032104606,0.000023444456,0.000033495922,0.000080304744,0.000021378426],"domain_scores_gemma":[0.9994837,0.00018205064,0.00019624516,0.000022644004,0.000067954985,0.00004736984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032296535,0.0001720499,0.00033550122,0.0005365154,0.00019589142,0.00028147802,0.00013005911,0.00024585822,0.0011838762],"category_scores_gemma":[0.001195577,0.00012598072,0.000080685924,0.00077059964,0.00022434685,0.00017681746,0.00019560399,0.00024887017,0.00045921418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011711771,0.000065035965,0.84365314,0.00031688757,0.000056359502,0.000925623,0.00019438902,0.00028735027,0.085872106,0.00006336446,0.00065665453,0.066737846],"study_design_scores_gemma":[0.0000093773215,0.00022966314,0.9922935,0.000014095458,0.000035067784,0.0027460288,0.00005583923,0.00027651986,0.0031497942,0.000058477726,0.0011271061,0.0000046637874],"about_ca_topic_score_codex":0.0012844678,"about_ca_topic_score_gemma":0.0019886314,"teacher_disagreement_score":0.0012844678,"about_ca_system_score_codex":0.00021520944,"about_ca_system_score_gemma":0.00018984517,"threshold_uncertainty_score":0.0039604306},"labels":[],"label_agreement":null},{"id":"W2077666724","doi":"10.1038/sj.bjc.6603501","title":"Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"GlaxoSmithKline","keywords":"Cervical cancer; Vaccination; Medicine; Context (archaeology); Cervical screening; Incidence (geometry); Transmission (telecommunications); Cohort; Public health; Demography; Cancer; Environmental health; HPV infection; Human papillomavirus; Population; Cohort study; Immunology; Internal medicine; Pathology; Geography","score_opus":0.03456881327959199,"score_gpt":0.389495270925728,"score_spread":0.354926457646136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077666724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986376,0.0007296307,0.009107094,0.00063486525,0.000036251597,0.000043884935,0.00136008,0.00003907378,0.0016731751],"genre_scores_gemma":[0.99657995,0.0003308562,0.001818172,0.000039278362,0.000008582148,0.000022259572,0.0005812122,0.0000054755933,0.00061425875],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99934775,0.00037652915,0.000055379227,0.00007460764,0.0000548423,0.0000909003],"domain_scores_gemma":[0.9946385,0.004010111,0.0005914829,0.00018858402,0.00041096093,0.00016046182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018710145,0.00048915023,0.00058469083,0.00067125895,0.00017126556,0.0007932845,0.00051505625,0.0009578673,0.0014749075],"category_scores_gemma":[0.014561926,0.00053263863,0.00068679266,0.00047015326,0.0002880443,0.0009738601,0.0007259895,0.0005977494,0.0002514192],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038832176,0.00004760184,0.069857344,0.000076819946,0.00017059201,0.00030713654,0.000050364906,0.9207088,0.00057362625,0.0008342926,0.00040058096,0.006584509],"study_design_scores_gemma":[0.000098799916,0.00042567396,0.071925834,0.00005702069,0.000181391,0.00026430067,0.00017036419,0.92397803,0.0006264839,0.0014854578,0.0007450736,0.000041538973],"about_ca_topic_score_codex":0.09911096,"about_ca_topic_score_gemma":0.031639617,"teacher_disagreement_score":0.09911096,"about_ca_system_score_codex":0.0026058794,"about_ca_system_score_gemma":0.0009579312,"threshold_uncertainty_score":0.19706815},"labels":[],"label_agreement":null},{"id":"W2078122892","doi":"10.1038/bjc.2014.430","title":"Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Breast Cancer Research Foundation; U.S. Department of Health and Human Services","keywords":"Bevacizumab; Medicine; Genome-wide association study; Internal medicine; Oncology; Blood pressure; SNP; Single-nucleotide polymorphism; Genotype; Biology; Chemotherapy; Genetics","score_opus":0.01655960237681365,"score_gpt":0.28424061643413523,"score_spread":0.2676810140573216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078122892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863845,0.00016456503,0.00019111703,0.000053856158,0.000010146029,0.0000066684443,0.00048097977,0.000007752709,0.0004464717],"genre_scores_gemma":[0.99910444,0.00003082026,0.00017529474,0.000030119407,0.000009353775,0.0000046320442,0.00050669303,0.0000051282523,0.00013334933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997321,0.00006932407,0.000028255128,0.00009610092,0.000037479935,0.00003680299],"domain_scores_gemma":[0.9990859,0.00033171347,0.0003033894,0.00006415147,0.000048280388,0.00016661761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005108533,0.00040731812,0.0002647687,0.0004265895,0.00029724286,0.00049783237,0.0002542068,0.00066558464,0.0029650566],"category_scores_gemma":[0.0014870472,0.00012699919,0.00065010454,0.0007672386,0.00030654247,0.00013069213,0.0002591679,0.0005243606,0.00034793076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023006967,0.000052630785,0.9889783,0.00002251187,0.00020453347,0.0002967383,0.000035743993,0.00025151257,0.004957307,0.00009232234,0.00025313807,0.0025546274],"study_design_scores_gemma":[0.00013685599,0.00024605528,0.9955585,0.00001387024,0.00026122702,0.0010039504,0.000039908537,0.0013593822,0.0007204583,0.00026194096,0.00038912834,0.0000086980135],"about_ca_topic_score_codex":0.003528319,"about_ca_topic_score_gemma":0.0041546216,"teacher_disagreement_score":0.003528319,"about_ca_system_score_codex":0.0002433145,"about_ca_system_score_gemma":0.0002651663,"threshold_uncertainty_score":0.009919107},"labels":[],"label_agreement":null},{"id":"W2078648764","doi":"10.1038/bjc.2011.107","title":"Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour)","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children; Discovery Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Aggressive fibromatosis; Testosterone (patch); Fibromatosis; Androgen; Androgen receptor; Orchiectomy; Internal medicine; Biology; Endocrinology; Cancer research; Dihydrotestosterone; Medicine; Pathology; Hormone; Cancer; Prostate cancer","score_opus":0.02174352005441693,"score_gpt":0.26607817497710334,"score_spread":0.2443346549226864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078648764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939055,0.0025237661,0.0002835915,0.000062108804,0.000012002324,0.000023144177,0.00008044324,0.0000225598,0.0030868943],"genre_scores_gemma":[0.99812347,0.0006657672,0.00016755926,0.00001795643,0.000014953563,0.0000044380645,0.000044608703,0.000002566013,0.0009586649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992394,0.00001629775,0.0000055599257,0.000011571823,0.000026034566,0.000016647873],"domain_scores_gemma":[0.9998834,0.00004133299,0.000032490756,0.000007608491,0.000010562136,0.000024513149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013594815,0.000114233546,0.0001332189,0.0005097436,0.00023390265,0.00016271872,0.000097344695,0.00025214272,0.0013659702],"category_scores_gemma":[0.00026092003,0.000071936374,0.00008198935,0.00023902277,0.00029737895,0.00009989544,0.000092525624,0.000165039,0.00023152985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035876876,0.0005744305,0.16673326,0.00070408423,0.00005391648,0.16688947,0.0017223601,0.0005679462,0.61203045,0.0019081042,0.0014416146,0.04378658],"study_design_scores_gemma":[0.00012691654,0.0034968883,0.54549026,0.00003945999,0.00010558218,0.2727215,0.0005246611,0.0008781745,0.1556166,0.0005908703,0.020377522,0.000031519165],"about_ca_topic_score_codex":0.0011813905,"about_ca_topic_score_gemma":0.0016565961,"teacher_disagreement_score":0.0013659702,"about_ca_system_score_codex":0.00023758136,"about_ca_system_score_gemma":0.00011477106,"threshold_uncertainty_score":0.00456959},"labels":[],"label_agreement":null},{"id":"W2078770747","doi":"10.1054/bjoc.2000.1524","title":"No evidence of linkage to chromosome 1q42.2–43 in 131 prostate cancer families from the ACTANE Consortium","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; National Cancer Institute; Medical Research Council","keywords":"Genetic linkage; Locus (genetics); Genetics; Biology; Prostate cancer; Linkage (software); Recombination Fraction; Genetic heterogeneity; Gene mapping; Cancer; Gene; Chromosome; Phenotype","score_opus":0.012050635579032442,"score_gpt":0.2872604915103971,"score_spread":0.27520985593136466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078770747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973236,0.00055657537,0.000425563,0.000086160144,0.0000052668115,0.000013811666,0.00023881916,0.000009949251,0.0013403365],"genre_scores_gemma":[0.9971259,0.00041261895,0.00043619706,0.00006584334,0.000008799197,0.00002245938,0.0010258275,0.000009763184,0.0008926154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976058,0.00078919774,0.00012571338,0.00049885036,0.00069652696,0.00028389506],"domain_scores_gemma":[0.99687827,0.0015013092,0.00053650903,0.00040383806,0.00027788838,0.00040221226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022861701,0.00030714777,0.0005380433,0.0012729397,0.0012110376,0.00071686064,0.00046103043,0.0004965627,0.0055615744],"category_scores_gemma":[0.0056739664,0.0003476143,0.00032389903,0.0010092172,0.000860753,0.00017738165,0.0009699769,0.00040642178,0.00028114382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015820572,0.0002056043,0.9451529,0.00014119931,0.00043854304,0.0044985227,0.003099703,0.00070464285,0.016509833,0.0012312516,0.001785651,0.024650123],"study_design_scores_gemma":[0.00009205838,0.00023378593,0.9842396,0.00005058898,0.00015151393,0.00764836,0.00049052376,0.00049663236,0.0012204986,0.00019110298,0.0051532895,0.00003210667],"about_ca_topic_score_codex":0.020749858,"about_ca_topic_score_gemma":0.03037841,"teacher_disagreement_score":0.020749858,"about_ca_system_score_codex":0.00067967054,"about_ca_system_score_gemma":0.0010721383,"threshold_uncertainty_score":0.041258156},"labels":[],"label_agreement":null},{"id":"W2078978161","doi":"10.1038/sj.bjc.6600537","title":"The association of breast mitogens with mammographic densities","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Health Sciences Centre; Sunnybrook Health Science Centre; Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Prolactin; Internal medicine; Endocrinology; Sex hormone-binding globulin; Hormone; Risk factors for breast cancer; Anthropometry; Risk factor; Globulin; Mammography; MAMMOGRAPHIC DENSITY; Cancer","score_opus":0.005265437800796183,"score_gpt":0.2095724450219589,"score_spread":0.2043070072211627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078978161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895453,0.00050968275,0.00009153851,0.000024720359,0.0000023007533,0.0000027493033,0.000057951114,0.000003146995,0.00035340682],"genre_scores_gemma":[0.999584,0.00015098722,0.000072449366,0.00000628994,0.00000562033,0.0000024529315,0.00006116181,6.480682e-7,0.0001164088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997843,0.00007767399,0.000016419803,0.000028662602,0.000059047652,0.000033894412],"domain_scores_gemma":[0.99809474,0.0007221642,0.00072682725,0.00009245649,0.00014308775,0.00022061067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024902206,0.00014793209,0.0001448697,0.0005787089,0.00015814959,0.00025003246,0.00014354347,0.00018592169,0.0013640346],"category_scores_gemma":[0.0037123251,0.0001287854,0.00008598237,0.00037174037,0.00024465303,0.000117870855,0.00022143772,0.00025276854,0.00014842917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014451065,0.000019806352,0.9961565,0.000009489371,0.000020161839,0.00006894694,0.00003918312,0.00002863698,0.0011769299,0.000018730114,0.000028240689,0.002288825],"study_design_scores_gemma":[0.0000015361137,0.000050640396,0.99932265,0.0000013474851,0.000006830816,0.0003354519,0.00002550763,0.000044796245,0.00012034637,0.000015567286,0.00007408797,0.0000012916428],"about_ca_topic_score_codex":0.0016356325,"about_ca_topic_score_gemma":0.0016589446,"teacher_disagreement_score":0.0016356325,"about_ca_system_score_codex":0.00010181326,"about_ca_system_score_gemma":0.000080549704,"threshold_uncertainty_score":0.004563093},"labels":[],"label_agreement":null},{"id":"W2079023951","doi":"10.1038/sj.bjc.6601405","title":"Variation in RNA expression and genomic DNA content acquired during cell culture","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Biology; Gene; Chromosome; Comparative genomic hybridization; Genetics; RNA; DNA; Copy-number variation; Gene expression; genomic DNA; Complementary DNA; Molecular biology; Genome","score_opus":0.007039667260675517,"score_gpt":0.2080975013199045,"score_spread":0.201057834059229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079023951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93828505,0.004131613,0.041833736,0.00024328694,0.00016053271,0.00051842246,0.0050471798,0.0004837141,0.009296474],"genre_scores_gemma":[0.92543435,0.0036626584,0.039583303,0.00038539132,0.00011232687,0.0017388418,0.017098498,0.00032986142,0.011654798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918455,0.00012854827,0.000111783665,0.00026221492,0.0002100502,0.00010290886],"domain_scores_gemma":[0.9992617,0.00034260054,0.000059930277,0.00014608147,0.00014636134,0.000043368596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004843553,0.00039009348,0.00049951364,0.00045714332,0.00032555344,0.00066968356,0.00043611982,0.00034488508,0.001321186],"category_scores_gemma":[0.0007197168,0.00022266927,0.000344376,0.000529823,0.00044160595,0.0002500792,0.00041226624,0.0009419341,0.0012819867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038213686,0.000015123056,0.00046074865,0.000022317756,0.000007080433,0.000049775823,0.000060156537,0.00008335516,0.99806863,0.000031807347,0.000029488585,0.0011332491],"study_design_scores_gemma":[0.000008314168,0.00046675655,0.020562865,0.00001275652,0.000055134107,0.0002485351,0.00012349414,0.0009500826,0.9728749,0.00009530626,0.0045829606,0.000018801671],"about_ca_topic_score_codex":0.0012183905,"about_ca_topic_score_gemma":0.001987637,"teacher_disagreement_score":0.001321186,"about_ca_system_score_codex":0.0003321904,"about_ca_system_score_gemma":0.00029463336,"threshold_uncertainty_score":0.004419863},"labels":[],"label_agreement":null},{"id":"W2079711247","doi":"10.1038/bjc.2014.308","title":"Possible pro-carcinogenic association of endotoxin on lung cancer among Shanghai women textile workers","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Indoor Air Quality and Microbial Exposure","field":"Environmental Science","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Lung cancer; Carcinogen; Medicine; Environmental health; Association (psychology); Oncology; Internal medicine; Biology; Psychology; Genetics","score_opus":0.0057153320566776,"score_gpt":0.23864870813885541,"score_spread":0.23293337608217782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079711247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993349,0.00024610478,0.000073963354,0.000031414795,0.0000029199755,0.000001822415,0.000108724904,0.0000027438846,0.00019732537],"genre_scores_gemma":[0.9996878,0.000075787444,0.000034334324,0.000006101333,0.0000034917223,0.0000014429711,0.000097642645,5.590721e-7,0.000092901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997485,0.0000828122,0.000016480195,0.000038590442,0.000050880786,0.00006274609],"domain_scores_gemma":[0.99897325,0.0002482424,0.0003376451,0.00010401644,0.00017636984,0.0001605322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005945346,0.00025571955,0.00011490137,0.00055844826,0.00017376867,0.00024988185,0.00017794286,0.00021602355,0.0016934338],"category_scores_gemma":[0.0010048413,0.0001458577,0.00026850766,0.0005144954,0.00021407464,0.00010688838,0.0002103116,0.000172118,0.00012120936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023002912,0.00001346539,0.9973671,0.000012276102,0.000026809228,0.000095763746,0.00006901769,0.00006176142,0.0009988489,0.000020003268,0.000046483096,0.0010585841],"study_design_scores_gemma":[0.0000027531178,0.000061070314,0.99943835,0.0000024270819,0.00002463732,0.00006678029,0.00003841143,0.00008969694,0.00016996264,0.00001326154,0.00009145541,0.0000011912584],"about_ca_topic_score_codex":0.009096949,"about_ca_topic_score_gemma":0.0076450994,"teacher_disagreement_score":0.009096949,"about_ca_system_score_codex":0.00026171203,"about_ca_system_score_gemma":0.00036293105,"threshold_uncertainty_score":0.018087983},"labels":[],"label_agreement":null},{"id":"W2080171736","doi":"10.1038/sj.bjc.6604503","title":"High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Breast cancer; Tissue microarray; Carcinogenesis; Metastasis; Cancer; Cancer research; Oncology; Immunohistochemistry; Biology; Polymerase chain reaction; Medicine; Internal medicine; Pathology; Gene; Genetics","score_opus":0.011767282349523475,"score_gpt":0.3057789251668985,"score_spread":0.294011642817375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080171736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912196,0.00029975214,0.00011935796,0.0000151464965,0.000004090894,0.000004404344,0.00023825456,0.0000041856943,0.00019279304],"genre_scores_gemma":[0.99834514,0.00040785744,0.00031201122,0.000019018908,0.000012648691,0.00001325392,0.0005346149,0.0000025060524,0.00035295618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983585,0.000021624075,0.00002099268,0.000043741697,0.000044402314,0.000033350443],"domain_scores_gemma":[0.99978644,0.000044897886,0.000072862764,0.000023823037,0.00004181205,0.000030253574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016471594,0.00021234486,0.00035199957,0.001150494,0.00036451535,0.0004226926,0.00012599106,0.0002409473,0.0010100944],"category_scores_gemma":[0.00035948172,0.00022008092,0.00022671284,0.0012382381,0.00022388506,0.00014157487,0.00026293757,0.00017126427,0.00032571363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000549297,0.000051981082,0.9376937,0.000070722315,0.00007288196,0.0006615533,0.00023899807,0.000054917837,0.054554984,0.000026620175,0.00017384313,0.0058504553],"study_design_scores_gemma":[0.0000025848688,0.000055911572,0.99642193,0.000002335535,0.000031078667,0.0009428674,0.00012747456,0.00012643864,0.0019672825,0.000010899073,0.00030825858,0.000003073574],"about_ca_topic_score_codex":0.0021158373,"about_ca_topic_score_gemma":0.0027275963,"teacher_disagreement_score":0.0021158373,"about_ca_system_score_codex":0.00019938605,"about_ca_system_score_gemma":0.00021088225,"threshold_uncertainty_score":0.0042070746},"labels":[],"label_agreement":null},{"id":"W2080370558","doi":"10.1038/bjc.2014.567","title":"Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Alberta Health Services; University of British Columbia; University of Toronto; Calgary Laboratory Services; Princess Margaret Cancer Centre; BC Cancer Agency; Foothills Medical Centre; University of Calgary","funders":"Cancer Council South Australia; Medical Research Council; Canadian Institutes of Health Research; National Institute for Health and Care Research; Fred C. and Katherine B. Andersen Foundation; National Cancer Institute; University College London; Cancer Council Victoria; Calgary Laboratory Services; Mayo Foundation for Medical Education and Research; Cancer Council Tasmania; National Institutes of Health; Cancer Council NSW; National Health and Medical Research Council; Cancer Research UK; University of Sydney; NIHR Cambridge Biomedical Research Centre; U.S. Department of Defense","keywords":"Ovarian carcinoma; Ovarian cancer; Survival analysis; Oncology; Medicine; Ovarian carcinomas; Carcinoma; Ovarian tissue; Ovary; Pathology; Gynecology; Internal medicine; Biology; Cancer","score_opus":0.14634467256947445,"score_gpt":0.44882921154727534,"score_spread":0.3024845389778009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080370558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498343,0.0014222165,0.0010844357,0.0002223868,0.00001545074,0.00004091144,0.0015504268,0.000027561025,0.0006532118],"genre_scores_gemma":[0.9976291,0.00013385853,0.00044121846,0.000058603353,0.0000139391905,0.00003799881,0.001497964,0.000018484398,0.0001688241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945749,0.0027560445,0.0004123475,0.0011984626,0.00072197383,0.00033621653],"domain_scores_gemma":[0.974534,0.010382811,0.0061158594,0.00533258,0.001725699,0.0019091994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013349037,0.00033297073,0.00062669243,0.0010443178,0.0006215939,0.0010027407,0.00095791713,0.0005784216,0.0022990173],"category_scores_gemma":[0.016859997,0.00026560863,0.0014273599,0.0019984038,0.00065773324,0.00057138456,0.0013771527,0.0006263413,0.00028332986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015985856,0.0000302128,0.99123704,0.00005098461,0.0008467424,0.00020298071,0.00015531621,0.00015607393,0.0014193925,0.00006148956,0.00026583168,0.00397543],"study_design_scores_gemma":[0.00005284715,0.0002082499,0.99731016,0.0000099652125,0.0003798436,0.00048759772,0.000110624635,0.0004982611,0.00021878627,0.00006601637,0.0006486832,0.000008987609],"about_ca_topic_score_codex":0.0073295715,"about_ca_topic_score_gemma":0.008559107,"teacher_disagreement_score":0.013349037,"about_ca_system_score_codex":0.0006112215,"about_ca_system_score_gemma":0.0011065108,"threshold_uncertainty_score":0.07059735},"labels":[],"label_agreement":null},{"id":"W2080529956","doi":"10.1038/sj.bjc.6601802","title":"Chemotherapy in metastatic gastric cancer: population-based perceptions and practice patterns of medical oncologists","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Cancer; Chemotherapy; Oncology; Quality of life (healthcare); Internal medicine; Population; Clinical trial; Intensive care medicine","score_opus":0.024568666769851654,"score_gpt":0.3680627352064086,"score_spread":0.34349406843655694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080529956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939587,0.0009774382,0.00008261017,0.0035497341,0.000021871863,0.000017016435,0.000057746594,0.000002886201,0.0013318806],"genre_scores_gemma":[0.99879944,0.00048730284,0.000069440146,0.0004578773,0.00001885698,0.00000988239,0.000033909495,0.0000018345675,0.00012139277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676126,0.0015703049,0.000331018,0.00020136432,0.0008206999,0.00031536358],"domain_scores_gemma":[0.9824318,0.0056961523,0.007086972,0.00028515194,0.0017409018,0.0027589959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035555486,0.00008031852,0.00029506147,0.00086259266,0.00069778267,0.0012757793,0.00033177042,0.0008534506,0.0013151198],"category_scores_gemma":[0.022669755,0.0002316915,0.00031624569,0.0011380912,0.0008542707,0.0012327654,0.0009865994,0.0010522051,0.00016548653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018762097,0.00014057256,0.95474964,0.00011799019,0.00010477095,0.00019574871,0.024011422,0.000108898945,0.00047841112,0.00018207685,0.0011210223,0.018601838],"study_design_scores_gemma":[0.00003706226,0.00034889078,0.9509327,0.00014392364,0.000029941144,0.0005736604,0.044479016,0.00037482314,0.00008937206,0.00022893303,0.0027151064,0.000046552144],"about_ca_topic_score_codex":0.010933089,"about_ca_topic_score_gemma":0.013098821,"teacher_disagreement_score":0.010933089,"about_ca_system_score_codex":0.0012921842,"about_ca_system_score_gemma":0.0013461616,"threshold_uncertainty_score":0.021738946},"labels":[],"label_agreement":null},{"id":"W2082067798","doi":"10.1038/sj.bjc.6602902","title":"mTOR signaling: implications for cancer and anticancer therapy","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research Society; McGill University; Howard Hughes Medical Institute","keywords":"PI3K/AKT/mTOR pathway; EIF4E; Carcinogenesis; Translation (biology); Cancer research; Biology; RPTOR; Sirolimus; Signal transduction; Cancer; Cell biology; Genetics; Gene; Messenger RNA; Biochemistry","score_opus":0.021032777966903952,"score_gpt":0.32679862031722945,"score_spread":0.3057658423503255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082067798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017044246,0.9314901,0.0012184755,0.053087506,0.0018422662,0.000009509274,0.00008557024,0.000063131956,0.010498928],"genre_scores_gemma":[0.033138413,0.9483086,0.0016910546,0.006576403,0.004296395,0.00003527557,0.000081115744,0.000019489882,0.00585334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997173,0.00008296036,0.000021040676,0.000043518656,0.000073506795,0.0000615869],"domain_scores_gemma":[0.99956447,0.00014315476,0.00005216115,0.000019030174,0.00009508347,0.0001261012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014886601,0.0007081513,0.0013437349,0.001257495,0.0005274246,0.002203006,0.0009187922,0.0029407204,0.0061360067],"category_scores_gemma":[0.0008267565,0.0002167874,0.000355472,0.0011905165,0.0027052653,0.0027343468,0.000965175,0.0032851463,0.002023948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080745795,0.00025452478,0.0009396506,0.0033222688,0.00008531938,0.001051348,0.00019915504,0.002365786,0.009128035,0.2134521,0.13321845,0.6351759],"study_design_scores_gemma":[0.00009304989,0.0003684212,0.0016683652,0.0010660138,0.000060693194,0.0017026024,0.00040797022,0.0010910501,0.0022819522,0.17636988,0.8148344,0.000055516655],"about_ca_topic_score_codex":0.0009132482,"about_ca_topic_score_gemma":0.0014797645,"teacher_disagreement_score":0.0061360067,"about_ca_system_score_codex":0.002814526,"about_ca_system_score_gemma":0.0016353227,"threshold_uncertainty_score":0.020526946},"labels":[],"label_agreement":null},{"id":"W2082357643","doi":"10.1038/sj.bjc.6601809","title":"Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Autocrine signalling; NOS1; Immunohistochemistry; Pathology; Nitric oxide synthase; Biology; Kidney; Nitric oxide; Cancer research; Endocrinology; Medicine; Biochemistry; Receptor","score_opus":0.008747623237597335,"score_gpt":0.23959643989487428,"score_spread":0.23084881665727694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082357643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976725,0.001382914,0.00029278622,0.000038086993,0.0000075094713,0.0000047109916,0.00005567491,0.000010034016,0.0005358209],"genre_scores_gemma":[0.998933,0.00033502065,0.000119043936,0.000009823129,0.0000034711672,0.000002978022,0.0000570971,0.0000021468613,0.00053741934],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998381,0.000019176669,0.000015118692,0.00003073179,0.00006402295,0.000032792348],"domain_scores_gemma":[0.99973243,0.00003930956,0.00008387144,0.000025508041,0.000040491494,0.00007837273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014408678,0.00010572143,0.00023564618,0.00042809578,0.00017171688,0.00031727095,0.0001467872,0.00030202055,0.0010859739],"category_scores_gemma":[0.00025893745,0.000122068275,0.000102094615,0.00034606765,0.00031078025,0.00013130245,0.00017406004,0.0002615033,0.00018204503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006186838,0.000030182562,0.018923154,0.00007801171,0.000015316653,0.0016302114,0.00011165041,0.000056314075,0.9742923,0.00009437625,0.00005361753,0.0040961606],"study_design_scores_gemma":[0.000030888183,0.0004629842,0.7416075,0.000015097792,0.00006319706,0.015314457,0.00031924056,0.00095898885,0.23761846,0.0002589064,0.0033340598,0.000016238275],"about_ca_topic_score_codex":0.0012418092,"about_ca_topic_score_gemma":0.0010150356,"teacher_disagreement_score":0.0012418092,"about_ca_system_score_codex":0.0002538307,"about_ca_system_score_gemma":0.00018628189,"threshold_uncertainty_score":0.003632903},"labels":[],"label_agreement":null},{"id":"W2083008315","doi":"10.1038/sj.bjc.6602994","title":"Tumours and tremors: how PTEN regulation underlies both","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"PTEN; Tensin; Disease; Suppressor; Cancer research; Phosphatase; Biology; Tumor suppressor gene; Cancer; Genetics; Medicine; Pathology; PI3K/AKT/mTOR pathway; Carcinogenesis; Signal transduction; Phosphorylation","score_opus":0.02369870367206538,"score_gpt":0.3125894481061461,"score_spread":0.2888907444340807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083008315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017946278,0.99750644,0.00022493303,0.0004941959,0.00026855234,0.0000028281156,0.000008211983,0.000011648929,0.0013037581],"genre_scores_gemma":[0.0011863373,0.99670583,0.00020124331,0.0003259248,0.00025974883,0.000005289918,0.00001807354,0.0000018789217,0.0012956414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998561,0.000022393871,0.000021002817,0.00003109633,0.00005396931,0.000015401567],"domain_scores_gemma":[0.99987996,0.00004198263,0.000018732868,0.0000060290745,0.000031809326,0.00002144911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039021365,0.0007665648,0.001340985,0.0011782577,0.00027967078,0.000887421,0.00080060447,0.001777036,0.0020374137],"category_scores_gemma":[0.0003764891,0.00024813827,0.00033902438,0.0011576656,0.0007364387,0.0013074727,0.00064887456,0.001674165,0.002197393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011475363,0.000055819728,0.00026572487,0.0053434586,0.00007317763,0.000883297,0.000090868714,0.0004585444,0.004880363,0.007818086,0.034625858,0.9453901],"study_design_scores_gemma":[0.000036584664,0.00010874904,0.0016934496,0.0011131584,0.000059456328,0.007939405,0.000092494214,0.00010842428,0.0010667316,0.0049176677,0.98283607,0.000027916705],"about_ca_topic_score_codex":0.0010587778,"about_ca_topic_score_gemma":0.0023189124,"teacher_disagreement_score":0.0020374137,"about_ca_system_score_codex":0.0008127142,"about_ca_system_score_gemma":0.00071731955,"threshold_uncertainty_score":0.006815791},"labels":[],"label_agreement":null},{"id":"W2083053655","doi":"10.1038/sj.bjc.6601881","title":"HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society","keywords":"Medicine; Lymph node; Trastuzumab; Breast cancer; Immunohistochemistry; Oncology; Cancer; CISH; Pathology; Cancer research; Internal medicine; Gene expression; Biology; Gene; In situ hybridization","score_opus":0.05765193668666164,"score_gpt":0.4376919582824539,"score_spread":0.38004002159579225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083053655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026766787,0.99894935,0.000029849502,0.00004475355,0.000049127742,0.0000043225796,0.000057912635,0.0000029846242,0.00059404166],"genre_scores_gemma":[0.0017550905,0.997497,0.00011310301,0.00007205897,0.0000578012,0.000007611281,0.00011227015,0.0000013460589,0.000383706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964416,0.000043926255,0.00009936579,0.00006126438,0.00012735443,0.00002381488],"domain_scores_gemma":[0.99925464,0.00035778055,0.00015398947,0.000022650263,0.000183224,0.000027674561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005944978,0.0007522688,0.002030388,0.004988931,0.00018410133,0.0009097518,0.00074748317,0.00065060286,0.0054182764],"category_scores_gemma":[0.0013744994,0.00030750287,0.0005953954,0.006892092,0.00034481473,0.0010442054,0.00035085494,0.00046107813,0.0017128941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022528911,0.000049573577,0.0011473949,0.08366677,0.00020885692,0.0014232899,0.00011546545,0.00019238562,0.0029217566,0.00053531525,0.017163714,0.89235014],"study_design_scores_gemma":[0.00007556513,0.0003265804,0.018643588,0.043414827,0.001988547,0.029743992,0.00033325245,0.00013932568,0.0030689677,0.0009658151,0.90124255,0.000056960896],"about_ca_topic_score_codex":0.002576521,"about_ca_topic_score_gemma":0.0043791067,"teacher_disagreement_score":0.0054182764,"about_ca_system_score_codex":0.0005547157,"about_ca_system_score_gemma":0.0013269958,"threshold_uncertainty_score":0.018125951},"labels":[],"label_agreement":null},{"id":"W2083797461","doi":"10.1038/sj.bjc.6605168","title":"EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"H. Lundbeck A/S; Lundbeckfonden; Sundhed og Sygdom, Det Frie Forskningsråd; Kræftens Bekæmpelse; National Center for Chronic Disease Prevention and Health Promotion; Aarhus Universitetshospital; Medical Research Council; Aarhus Universitet","keywords":"Nasopharyngeal carcinoma; Gastric carcinoma; Incidence (geometry); Epstein–Barr virus; Carcinoma; Medicine; Population; Pathology; Internal medicine; Oncology; Virus; Gastroenterology; Cancer; Immunology; Radiation therapy","score_opus":0.009236911274914944,"score_gpt":0.2590383335599919,"score_spread":0.24980142228507696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083797461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995427,0.00014139309,0.000029478197,0.0000118925045,0.0000020112534,0.000005402182,0.00004175225,0.0000010795569,0.0002241934],"genre_scores_gemma":[0.9998368,0.00003138777,0.000028830767,0.0000057758007,0.000002708272,0.0000030274334,0.000047305297,6.520838e-7,0.00004340196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951816,0.00014230219,0.000050343588,0.000109743334,0.00007115974,0.00010825892],"domain_scores_gemma":[0.9990343,0.0001564417,0.00036986213,0.000056298715,0.00011539634,0.0002676291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058632065,0.00020671102,0.00031043848,0.0011937823,0.00081764685,0.0007297443,0.00038681366,0.00041718353,0.002395958],"category_scores_gemma":[0.001929326,0.00026073004,0.00026027253,0.0007474479,0.00065931765,0.00048081393,0.00061659596,0.00036962802,0.00016383047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013538713,0.000026264346,0.9984585,0.0000082473425,0.000021511185,0.00019228469,0.00018712509,0.000011766302,0.00047398373,0.000022667142,0.000024301045,0.00043807365],"study_design_scores_gemma":[0.000006748789,0.0000668155,0.9985654,0.000005693645,0.000023427598,0.0006677487,0.00048826405,0.000044530374,0.00004758945,0.000015784475,0.00006563988,0.0000025051907],"about_ca_topic_score_codex":0.019461958,"about_ca_topic_score_gemma":0.022677114,"teacher_disagreement_score":0.019461958,"about_ca_system_score_codex":0.00054659107,"about_ca_system_score_gemma":0.00036742995,"threshold_uncertainty_score":0.038697362},"labels":[],"label_agreement":null},{"id":"W2084065248","doi":"10.1038/sj.bjc.6602161","title":"Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Immunostaining; Biology; Immunohistochemistry; Epitope; Tumor suppressor gene; Gene; Exon; Glioma; Pathology; Single-strand conformation polymorphism; Cancer research; Antibody; Gene expression; Monoclonal antibody; Immunology; Genetics; Medicine; Carcinogenesis","score_opus":0.02536595954045023,"score_gpt":0.3470325229637638,"score_spread":0.32166656342331357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084065248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999328,0.00031420408,0.000069707196,0.000010717916,0.0000012900371,0.0000018534063,0.000052393127,0.0000027062226,0.00021905151],"genre_scores_gemma":[0.9997178,0.000068204536,0.000035756988,0.0000039799083,0.0000025084455,0.0000014489191,0.00009979468,9.916075e-7,0.00006960143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999864,0.00004178528,0.000013763811,0.000025085215,0.000019019291,0.000036370802],"domain_scores_gemma":[0.99949217,0.00014724839,0.00018906563,0.000029078416,0.000028890368,0.00011356303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045917238,0.00015701004,0.00018285257,0.00045482896,0.00014001073,0.0003008876,0.00012139918,0.00024485416,0.00042497757],"category_scores_gemma":[0.001194631,0.00007943298,0.00018878358,0.00024059998,0.00022110628,0.0002590162,0.00019069768,0.00018522576,0.000108325214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050078807,0.00006816409,0.9563996,0.000035491485,0.00007356791,0.0013312602,0.00019928096,0.000422294,0.018961966,0.00007066831,0.00008546545,0.017344305],"study_design_scores_gemma":[0.000029534916,0.0011376565,0.99418724,0.000007378858,0.00003970611,0.0022536106,0.00007443916,0.00039730786,0.0015086234,0.000084872365,0.00027322044,0.000006525085],"about_ca_topic_score_codex":0.00091303774,"about_ca_topic_score_gemma":0.0016569826,"teacher_disagreement_score":0.00091303774,"about_ca_system_score_codex":0.00017048788,"about_ca_system_score_gemma":0.00011885369,"threshold_uncertainty_score":0.0024284124},"labels":[],"label_agreement":null},{"id":"W2084330540","doi":"10.1038/sj.bjc.6601676","title":"Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Hazard ratio; Fluorouracil; Regimen; Confidence interval; Gastroenterology; Population; Proportional hazards model; Colorectal cancer; Oncology; Surgery; Chemotherapy; Cancer","score_opus":0.10041048255055936,"score_gpt":0.4197499322979251,"score_spread":0.3193394497473658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084330540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94861764,0.042153496,0.003326769,0.00057962636,0.00018519507,0.0025555517,0.0012846857,0.00005937961,0.0012376009],"genre_scores_gemma":[0.9812236,0.008817631,0.0031123676,0.0007593737,0.00023527238,0.0027060453,0.002691083,0.000028299903,0.00042645086],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9846252,0.012771942,0.0009018266,0.00066602573,0.00070034375,0.00033462868],"domain_scores_gemma":[0.98554415,0.008472464,0.003530178,0.001235822,0.00048638906,0.00073097023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020636618,0.001323376,0.003823995,0.000599419,0.00027300676,0.0015222715,0.0009237266,0.0016518524,0.0015078872],"category_scores_gemma":[0.02129958,0.0004067497,0.003536399,0.0013285378,0.0012804638,0.0010976191,0.0009030053,0.0017611478,0.00024694146],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91548926,0.0030475094,0.009674299,0.0023874822,0.013668087,0.00009061756,0.00016635457,0.0014338656,0.0056452337,0.00020053104,0.0004957221,0.047701057],"study_design_scores_gemma":[0.75485843,0.16964099,0.045613576,0.0004858714,0.02034037,0.00031154408,0.0001281801,0.0017526326,0.0023694355,0.0006256077,0.0037827345,0.000090610985],"about_ca_topic_score_codex":0.00045427846,"about_ca_topic_score_gemma":0.0012211889,"teacher_disagreement_score":0.020636618,"about_ca_system_score_codex":0.0010766264,"about_ca_system_score_gemma":0.0010735318,"threshold_uncertainty_score":0.10913819},"labels":[],"label_agreement":null},{"id":"W2084375742","doi":"10.1038/sj.bjc.6600196","title":"A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Odds ratio; Incidence (geometry); Family planning; Gynecology; Demography; Population; Meta-analysis; Case-control study; Melanoma; Obstetrics; Internal medicine; Environmental health; Research methodology","score_opus":0.019551637615485708,"score_gpt":0.2633265008370647,"score_spread":0.243774863221579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084375742","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3578365,0.60849166,0.019892095,0.00045384569,0.00059755106,0.0033503105,0.007210053,0.00023261421,0.0019353292],"genre_scores_gemma":[0.9109334,0.06312152,0.0147126,0.00044467693,0.00034918738,0.0035426915,0.0059731514,0.000076229946,0.0008464736],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.95806587,0.024255041,0.010025635,0.0040204404,0.0029138073,0.0007192006],"domain_scores_gemma":[0.9483234,0.03420988,0.008166304,0.005718622,0.0032111774,0.0003705787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040603746,0.0024868594,0.010306014,0.011088425,0.0007425287,0.0024070356,0.0014738629,0.0020730481,0.0020840317],"category_scores_gemma":[0.08204189,0.0021256914,0.02224302,0.008405753,0.0007020051,0.00090597774,0.0014367192,0.00095754425,0.00028780164],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013069348,0.00013593056,0.08400418,0.022129988,0.8566807,0.0005144222,0.00015782061,0.0011825212,0.0014163168,0.00015996536,0.0006741457,0.01987471],"study_design_scores_gemma":[0.0021407765,0.0018639421,0.069253705,0.0017447217,0.92043865,0.0005573371,0.00011555173,0.0005639474,0.00062180543,0.000349019,0.0022982934,0.000052359348],"about_ca_topic_score_codex":0.00465481,"about_ca_topic_score_gemma":0.0068648057,"teacher_disagreement_score":0.040603746,"about_ca_system_score_codex":0.0016831597,"about_ca_system_score_gemma":0.0014847162,"threshold_uncertainty_score":0.21473569},"labels":[],"label_agreement":null},{"id":"W2084457650","doi":"10.1038/bjc.2011.213","title":"Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children; Canada Research Chairs","funders":"","keywords":"Interquartile range; Medicine; Quality of life (healthcare); Visual analogue scale; Inpatient care; Ambulatory care; Pediatrics; Emergency medicine; Health care; Family medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.05565188155210633,"score_gpt":0.3262071854759241,"score_spread":0.27055530392381777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084457650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886644,0.00048729253,0.00008942694,0.00005374735,0.0000034730288,0.000012978818,0.00014204782,0.0000013566208,0.0003433069],"genre_scores_gemma":[0.9994661,0.00019296781,0.00014327903,0.000014708503,0.0000024909145,0.000010915421,0.00012858362,4.338744e-7,0.000040457744],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99920386,0.00032764344,0.00011212877,0.0000696515,0.00016538055,0.00012150355],"domain_scores_gemma":[0.9970591,0.00075690664,0.0016625352,0.000042432788,0.00016282385,0.0003162123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014176125,0.00022261706,0.00022391666,0.00042442957,0.0001512078,0.00040765508,0.00017579988,0.0002807723,0.0014056494],"category_scores_gemma":[0.005173002,0.000078752826,0.00045463888,0.00037916633,0.00020812308,0.0003931867,0.00035951516,0.00039430958,0.000102853584],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013764878,0.00008189925,0.99159193,0.000074795105,0.000071636685,0.00009279888,0.00046645524,0.00015133528,0.00017958746,0.000021945392,0.00010969379,0.0070201885],"study_design_scores_gemma":[0.0000062862932,0.00047523377,0.99770397,0.000035361365,0.000025252451,0.00046206708,0.0006939337,0.00018591253,0.000116043346,0.000022869452,0.0002676977,0.0000053451254],"about_ca_topic_score_codex":0.000730329,"about_ca_topic_score_gemma":0.0010729985,"teacher_disagreement_score":0.0014176125,"about_ca_system_score_codex":0.0004178149,"about_ca_system_score_gemma":0.00022185425,"threshold_uncertainty_score":0.007497132},"labels":[],"label_agreement":null},{"id":"W2085115464","doi":"10.1038/sj.bjc.6604054","title":"Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"TMPRSS2; Prostate cancer; Fusion gene; Medicine; Prostate; Erg; PCA3; Oncology; Hazard ratio; Internal medicine; Cancer; Cancer research; Disease; Gene; Biology; Genetics; Ophthalmology","score_opus":0.023943174988314376,"score_gpt":0.3299856356982167,"score_spread":0.3060424607099023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085115464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994079,0.00040292324,0.000044339948,0.000025424775,0.0000030661772,0.0000017888232,0.000021494116,0.0000032619962,0.00008968087],"genre_scores_gemma":[0.9998221,0.00006546258,0.000023867004,0.000006651474,0.0000048289126,7.277182e-7,0.00003838567,7.098709e-7,0.000037343016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975055,0.00008061262,0.000024019282,0.000039557013,0.000059332586,0.000045854744],"domain_scores_gemma":[0.9984634,0.0004614263,0.0006224721,0.00007128036,0.0001129208,0.00026844084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005514173,0.0001925265,0.00029395436,0.00056613376,0.00019575346,0.00039658466,0.00027587026,0.0004495879,0.0009196637],"category_scores_gemma":[0.0025568814,0.00018231673,0.00036285998,0.00046104103,0.0003716959,0.00022976639,0.00029071493,0.0005241375,0.00019152385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017533202,0.000017563032,0.9975107,0.000008417358,0.00002768006,0.00010637813,0.00003171262,0.00007407385,0.0006302699,0.0000043419427,0.000044500524,0.0013690111],"study_design_scores_gemma":[0.0000058402243,0.00013348197,0.9986552,0.000003250683,0.000030374007,0.0006263015,0.00006551751,0.00028059087,0.00013249258,0.000009974552,0.000053425203,0.0000035421333],"about_ca_topic_score_codex":0.0021351369,"about_ca_topic_score_gemma":0.0028910735,"teacher_disagreement_score":0.0021351369,"about_ca_system_score_codex":0.00019578873,"about_ca_system_score_gemma":0.00018754261,"threshold_uncertainty_score":0.00424546},"labels":[],"label_agreement":null},{"id":"W2085251527","doi":"10.1038/bjc.2015.24","title":"Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2)","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gynecological conditions and treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; Medical Research Council; Regione Piemonte; Cancerfonden; Alberta Innovates; National Health and Medical Research Council; Karolinska Institutet; U.S. Department of Health and Human Services; National Institutes of Health; Canada Research Chairs; Alberta Cancer Foundation; Vetenskapsrådet","keywords":"Infertility; Medicine; Endometrial cancer; Gynecology; Obstetrics; Odds ratio; Unexplained infertility; Female infertility; Cancer; Internal medicine; Pregnancy; Biology","score_opus":0.06290100789887197,"score_gpt":0.3674113204230854,"score_spread":0.3045103125242134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085251527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56611973,0.3917895,0.008865441,0.0006650108,0.0005720927,0.0007108746,0.02842928,0.00024115997,0.0026068971],"genre_scores_gemma":[0.9690177,0.018472228,0.0028446398,0.0003096435,0.00021193767,0.00057848694,0.007912153,0.000065124914,0.00058795215],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98510134,0.008848979,0.002331821,0.0018944432,0.0014000916,0.000423298],"domain_scores_gemma":[0.98797345,0.005660979,0.0024336148,0.0020587882,0.0015354911,0.0003377565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014313715,0.0014665128,0.00450106,0.005804918,0.0004755272,0.0017880208,0.00096308294,0.0013318602,0.002223717],"category_scores_gemma":[0.024570538,0.0012273015,0.017668564,0.006829318,0.0003219137,0.0005559818,0.001449805,0.00064725423,0.0002240448],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009021376,0.000046504563,0.42748046,0.007711717,0.5415646,0.00030020723,0.000107844695,0.0009918779,0.00078614027,0.00012042469,0.002366448,0.009502387],"study_design_scores_gemma":[0.0017145353,0.000633278,0.47518733,0.0010638403,0.5158772,0.0005245302,0.00012812627,0.00090508774,0.00031657348,0.00022008539,0.0033614254,0.00006792319],"about_ca_topic_score_codex":0.01908992,"about_ca_topic_score_gemma":0.01941303,"teacher_disagreement_score":0.01908992,"about_ca_system_score_codex":0.00074174727,"about_ca_system_score_gemma":0.0011582628,"threshold_uncertainty_score":0.07569903},"labels":[],"label_agreement":null},{"id":"W2085491990","doi":"10.1038/sj.bjc.6602239","title":"Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"Cancer Council Tasmania; Medical Research Council; National Cancer Institute; National Institutes of Health; Wellcome Trust; National Breast Cancer Foundation; University of Melbourne; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario","keywords":"Ovarian cancer; Medicine; Odds ratio; Gynecology; Confidence interval; Cancer; BRCA mutation; Obstetrics; Population; Demography; Oncology; Internal medicine; Environmental health","score_opus":0.019340837229207666,"score_gpt":0.3000147470173663,"score_spread":0.28067390978815865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085491990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982256,0.0012473707,0.000024885001,0.00005896392,0.0000028066843,0.0000022836882,0.00008589007,0.0000018754998,0.00035020144],"genre_scores_gemma":[0.9989998,0.00055632804,0.000055517925,0.000017131695,0.000009058169,0.0000027397462,0.00012857794,0.000001077539,0.00022981275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998172,0.00006700954,0.000013992776,0.00002217517,0.000042301013,0.000037335503],"domain_scores_gemma":[0.9986033,0.00057084626,0.0005841865,0.00004819148,0.000049417187,0.0001441069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027243266,0.00008090999,0.00017519812,0.00061089674,0.00014776955,0.00026681166,0.000107532855,0.0002537922,0.0018629975],"category_scores_gemma":[0.002963057,0.00017905937,0.00015540012,0.00043095968,0.00018991741,0.00016206296,0.00015990536,0.00027595577,0.00012345931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002488899,0.00003136881,0.99555176,0.000011187603,0.00003396354,0.000080670914,0.000045196855,0.00002708951,0.00027514942,0.000017422713,0.00007588607,0.0036014148],"study_design_scores_gemma":[0.000010853245,0.000108338805,0.99878293,0.000007670662,0.000025987902,0.00062318373,0.000039154318,0.00009128525,0.00008425558,0.000018705337,0.00020563445,0.0000019542222],"about_ca_topic_score_codex":0.0043730633,"about_ca_topic_score_gemma":0.0051056985,"teacher_disagreement_score":0.0043730633,"about_ca_system_score_codex":0.00018785652,"about_ca_system_score_gemma":0.000139445,"threshold_uncertainty_score":0.008695245},"labels":[],"label_agreement":null},{"id":"W2085502397","doi":"10.1038/bjc.2013.295","title":"Tumour morphology predicts PALB2 germline mutation status","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; Cancer Australia; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario; Peter MacCallum Cancer Centre; National Breast Cancer Foundation; University of Melbourne; Susan G. Komen; University of Utah","keywords":"PALB2; Germline mutation; Breast cancer; Mutation; Odds ratio; Population; Germline; Medicine; Oncology; Internal medicine; Genetics; Cancer; Biology; Gene","score_opus":0.007574670298178448,"score_gpt":0.2662748782126502,"score_spread":0.2587002079144718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085502397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98470956,0.012681639,0.00035694722,0.00020519368,0.000013819218,0.000028100421,0.0005469815,0.000011146642,0.0014465183],"genre_scores_gemma":[0.9963946,0.0027187106,0.00038384012,0.000022925115,0.00000997746,0.000010431985,0.0003007247,0.0000027763804,0.00015609726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995945,0.00010641874,0.00007658515,0.00007256041,0.0001230802,0.000026802585],"domain_scores_gemma":[0.99700445,0.0012206555,0.001241775,0.000093399954,0.00031473162,0.00012497246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074983755,0.0001813171,0.00027579349,0.0013937751,0.00019424481,0.0004657333,0.000260528,0.00028663292,0.0019727112],"category_scores_gemma":[0.005215839,0.00019018089,0.0002655924,0.0009744569,0.0003468326,0.0003899329,0.00039079454,0.00021866738,0.00023293566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012748627,0.000007798168,0.98413956,0.0004644106,0.00007152648,0.00039400934,0.00013320484,0.00010213199,0.0014213775,0.00002506557,0.00021956867,0.012893825],"study_design_scores_gemma":[0.0000047742124,0.000048487644,0.99616003,0.00014850085,0.000064803484,0.0024715425,0.00014265846,0.0001283638,0.00025651528,0.00005796485,0.0005135304,0.0000029012015],"about_ca_topic_score_codex":0.0017240708,"about_ca_topic_score_gemma":0.0032334463,"teacher_disagreement_score":0.0019727112,"about_ca_system_score_codex":0.00015547303,"about_ca_system_score_gemma":0.0002853239,"threshold_uncertainty_score":0.0065993667},"labels":[],"label_agreement":null},{"id":"W2086055140","doi":"10.1038/sj.bjc.6604088","title":"A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Trabectedin; Ovarian cancer; Medicine; Oncology; Internal medicine; Cancer; Phases of clinical research; Chemotherapy; Pathology; Sarcoma; Soft tissue sarcoma","score_opus":0.01891746772662693,"score_gpt":0.2959323091599805,"score_spread":0.27701484143335353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086055140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966869,0.001350009,0.0002718082,0.00011821937,0.000034569293,0.00096541265,0.0001761344,0.000028083417,0.00036891006],"genre_scores_gemma":[0.99366534,0.0010649512,0.0015624536,0.00037206782,0.0001904524,0.001653716,0.0008056548,0.000016113056,0.0006692528],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99911374,0.0005496535,0.000048414153,0.00011481469,0.000073479445,0.00009988334],"domain_scores_gemma":[0.9986066,0.0003401374,0.00038544837,0.0001374647,0.000058630798,0.0004717058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020209795,0.00076241815,0.0028123963,0.00034746423,0.00027882998,0.00049588893,0.0005331343,0.0008185827,0.0014167987],"category_scores_gemma":[0.0019802775,0.0004211423,0.0011008191,0.0003982218,0.00063595054,0.00049546984,0.00025138134,0.0014729784,0.000293183],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66388136,0.042109534,0.07030408,0.00069577777,0.0020975112,0.0005975455,0.0005022877,0.0028224734,0.06758489,0.00024621116,0.0021413586,0.14701696],"study_design_scores_gemma":[0.3376621,0.58388007,0.06980886,0.000021372245,0.0005512037,0.000747732,0.0000620145,0.0016178583,0.0036281915,0.00010590077,0.0018883842,0.000026309048],"about_ca_topic_score_codex":0.00058723957,"about_ca_topic_score_gemma":0.0013374175,"teacher_disagreement_score":0.0028123963,"about_ca_system_score_codex":0.0006122242,"about_ca_system_score_gemma":0.00096900703,"threshold_uncertainty_score":0.010688126},"labels":[],"label_agreement":null},{"id":"W2086097535","doi":"10.1038/sj.bjc.6604541","title":"A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Tolerability; Bolus (digestion); Tegafur; Internal medicine; Colorectal cancer; Phases of clinical research; Fluorouracil; Gastroenterology; Surgery; Cancer; Clinical trial; Adverse effect","score_opus":0.030373312189483113,"score_gpt":0.3328121462832735,"score_spread":0.30243883409379035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086097535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519485,0.00084112055,0.00048313977,0.00019654163,0.00008319009,0.002314933,0.00024245222,0.000046186404,0.0005975304],"genre_scores_gemma":[0.9906,0.0010472228,0.0021906428,0.0005066695,0.00016744078,0.003119456,0.00095968926,0.00002140419,0.0013874407],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99955136,0.00021503527,0.000023508142,0.00007904054,0.000051353167,0.000079724465],"domain_scores_gemma":[0.99912304,0.00015126051,0.00015286935,0.000092930284,0.000049970553,0.00042996928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015096212,0.0014359724,0.002068414,0.00056872173,0.0004002246,0.0006187765,0.00058235746,0.0012096852,0.0015553375],"category_scores_gemma":[0.0011996912,0.00050908345,0.001096306,0.00052218104,0.0010230542,0.0007231995,0.00027815506,0.0024321447,0.00036838712],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57932246,0.17282523,0.01130412,0.00062637625,0.0010500296,0.0004324492,0.0004919954,0.0023913942,0.09186387,0.00037876214,0.0018126853,0.13750058],"study_design_scores_gemma":[0.2711132,0.7142085,0.009587079,0.000009269885,0.0001622847,0.00017793715,0.000032674743,0.00069159834,0.0026868132,0.000085624124,0.0012249495,0.000020038979],"about_ca_topic_score_codex":0.0007480063,"about_ca_topic_score_gemma":0.0011175137,"teacher_disagreement_score":0.002068414,"about_ca_system_score_codex":0.00060405815,"about_ca_system_score_gemma":0.0013183163,"threshold_uncertainty_score":0.007983744},"labels":[],"label_agreement":null},{"id":"W2086422578","doi":"10.1038/bjc.2013.755","title":"Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Partenariat Canadien Contre Le Cancer; Krebsliga Schweiz; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"CCL7; CCR2; Metastasis; Chemokine receptor; Brain metastasis; Pathology; Medicine; Chemokine; Cancer research; Cancer; Renal cell carcinoma; CXCR4; Biology; Receptor; Internal medicine","score_opus":0.010586164574241141,"score_gpt":0.27713526792189325,"score_spread":0.2665491033476521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086422578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902976,0.000520872,0.00008965677,0.000019924191,0.0000020169405,0.0000041533563,0.00012157695,0.0000023499047,0.0002095467],"genre_scores_gemma":[0.99956924,0.00015079546,0.0000772463,0.000005485432,0.000008010058,0.000003549763,0.00011807334,5.751121e-7,0.00006704098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999,0.000019525465,0.000009043542,0.000019024656,0.000028561595,0.00002376928],"domain_scores_gemma":[0.9996886,0.000075856784,0.00012046957,0.000013464002,0.000053641335,0.000047999845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016646791,0.00010947027,0.00019787057,0.000538209,0.00019632897,0.00017801397,0.00010263451,0.00018659084,0.0016868495],"category_scores_gemma":[0.00082368386,0.000060307324,0.000107978085,0.0003763653,0.00016778547,0.00015901406,0.00013310487,0.00013014172,0.00023997178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026092434,0.000015437767,0.99260396,0.00002467786,0.000022705535,0.00039065562,0.000054172157,0.000041063784,0.002290424,0.000016384845,0.000157014,0.0041225804],"study_design_scores_gemma":[0.000010604538,0.00016130414,0.99219984,0.000008237222,0.00002755838,0.006008487,0.00010412532,0.00022251587,0.000860681,0.00003865345,0.00035350936,0.0000045548863],"about_ca_topic_score_codex":0.0013931738,"about_ca_topic_score_gemma":0.0018019695,"teacher_disagreement_score":0.0016868495,"about_ca_system_score_codex":0.000143822,"about_ca_system_score_gemma":0.00014977368,"threshold_uncertainty_score":0.0056430697},"labels":[],"label_agreement":null},{"id":"W2087086368","doi":"10.1038/bjc.2012.496","title":"High expression of N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"Choriocarcinoma; Gene knockdown; Biology; Trophoblast; Extracellular matrix; Integrin; Molecular biology; Cancer research; Andrology; Placenta; Cell culture; Cell biology; Cell; Biochemistry; Medicine; Fetus; Pregnancy","score_opus":0.016243868325963407,"score_gpt":0.2758320594697294,"score_spread":0.25958819114376597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087086368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135596,0.0029627536,0.0021047764,0.00017968535,0.000055243072,0.00004016751,0.00025068206,0.000151773,0.002899054],"genre_scores_gemma":[0.9948763,0.0011196872,0.0011065713,0.000052296054,0.0000075519306,0.00005018923,0.0004057399,0.000016690308,0.0023648506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984145,0.000015706948,0.000013621624,0.00002927216,0.000048652124,0.000051303938],"domain_scores_gemma":[0.9998896,0.000014389765,0.000024157596,0.000010670206,0.000014357045,0.000046781082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111806396,0.00030501751,0.00019165137,0.00029018687,0.00019070004,0.00033720813,0.00011881641,0.00022874953,0.0013798184],"category_scores_gemma":[0.00014675726,0.00015955993,0.00024843987,0.00019493965,0.00028954347,0.00017956752,0.00023153602,0.00066388526,0.00029282933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011009727,0.000029636067,0.00093619677,0.00006915067,0.000012751627,0.00013338754,0.000037361595,0.00005208797,0.99731714,0.00009773548,0.00016602993,0.0010385282],"study_design_scores_gemma":[0.000045421217,0.0005093486,0.03143397,0.00002768991,0.000070295435,0.0008278338,0.0002707404,0.0031595954,0.9548581,0.00011455224,0.00867203,0.000010453647],"about_ca_topic_score_codex":0.0021618404,"about_ca_topic_score_gemma":0.0025678924,"teacher_disagreement_score":0.0021618404,"about_ca_system_score_codex":0.00040289905,"about_ca_system_score_gemma":0.00033934932,"threshold_uncertainty_score":0.0046159625},"labels":[],"label_agreement":null},{"id":"W2087672388","doi":"10.1038/sj.bjc.6603964","title":"Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McMaster University Medical Centre; McGill University","funders":"Cancer Research Society","keywords":"Tetraspanin; Mitotic catastrophe; Prostate cancer; Mitosis; Cancer research; Cancer cell; Biology; Immunoprecipitation; Cancer; Fusion protein; Cell; Cell biology; Immunology; Gene; Antibody; Genetics","score_opus":0.020026125853080255,"score_gpt":0.3479827625714604,"score_spread":0.3279566367183801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087672388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926071,0.002553828,0.002193701,0.000095571566,0.00001900565,0.000019581374,0.00034838315,0.00006252347,0.002100278],"genre_scores_gemma":[0.99434847,0.00064823695,0.0016152647,0.000034208246,0.000005939515,0.000018479253,0.0005383363,0.000010802233,0.0027804174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998982,0.0000149200405,0.000006037844,0.000024010644,0.000036400186,0.000020410323],"domain_scores_gemma":[0.99992716,0.000015160438,0.000015976873,0.000007994408,0.000009710011,0.000024008501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009415146,0.00016517722,0.00018149838,0.00037573255,0.00028093776,0.00032185265,0.00010854163,0.00024098452,0.0017247094],"category_scores_gemma":[0.00008189043,0.00015201462,0.00018542614,0.0002173856,0.00019715494,0.00011852818,0.0002480924,0.00037084855,0.0005152679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096416115,0.000008128064,0.00021814827,0.000028005648,0.000006809651,0.00015989914,0.000022260248,0.000030721047,0.9989091,0.00008799624,0.000037265287,0.0003951677],"study_design_scores_gemma":[0.00004128861,0.0002665901,0.037473843,0.0000115220155,0.00003038943,0.0027619551,0.00010614401,0.0011014418,0.95303094,0.00008249745,0.005081818,0.000011633964],"about_ca_topic_score_codex":0.0014553928,"about_ca_topic_score_gemma":0.0013736285,"teacher_disagreement_score":0.0017247094,"about_ca_system_score_codex":0.00035727807,"about_ca_system_score_gemma":0.00015064022,"threshold_uncertainty_score":0.005769789},"labels":[],"label_agreement":null},{"id":"W2087737791","doi":"10.1038/sj.bjc.6603363","title":"The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary","funders":"National Cancer Institute; Fondation pour la Recherche Médicale","keywords":"Oncolytic virus; Raji cell; In vivo; In vitro; Cell culture; Virology; Biology; Lymphoma; Reoviridae; Virus; Cancer cell; Cell; Cancer research; Immunology; Cancer","score_opus":0.009758346366126757,"score_gpt":0.28035318042002155,"score_spread":0.2705948340538948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087737791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066144,0.0021853857,0.00424951,0.000043521075,0.00004134048,0.000037211033,0.0002889778,0.00005549056,0.0024371927],"genre_scores_gemma":[0.9919264,0.0008528322,0.003528926,0.000017850523,0.000009410226,0.00002591585,0.00078610843,0.000035895595,0.0028166464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998186,0.00003383876,0.0000150897895,0.000029297913,0.00004824231,0.000054912533],"domain_scores_gemma":[0.9997869,0.00008801891,0.000025956408,0.00004834883,0.000022149772,0.00002852622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019576184,0.00040532777,0.00030895896,0.00017228647,0.00010620239,0.00032351576,0.00022538626,0.0002916883,0.0010452335],"category_scores_gemma":[0.00019051901,0.00016232216,0.00024860384,0.00014331138,0.00022203644,0.00027168018,0.00019402252,0.0007277417,0.00040236206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007480698,0.000027335465,0.00009384025,0.000027479826,0.000004922536,0.000027006437,0.0000300001,0.000111700014,0.9986664,0.00012374339,0.000020796044,0.00079204416],"study_design_scores_gemma":[0.000011229594,0.00042802223,0.0011721135,0.0000032863375,0.000009065271,0.00010954297,0.000011848242,0.00058064674,0.99664056,0.000029062005,0.001002113,0.0000024550725],"about_ca_topic_score_codex":0.0013120763,"about_ca_topic_score_gemma":0.0010352185,"teacher_disagreement_score":0.0013120763,"about_ca_system_score_codex":0.0002430555,"about_ca_system_score_gemma":0.00021286543,"threshold_uncertainty_score":0.0034966469},"labels":[],"label_agreement":null},{"id":"W2087918707","doi":"10.1038/sj.bjc.6605934","title":"A systematic review and meta-analysis of the relationship between body size and testicular cancer","year":2010,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada; National Institutes of Health; Università degli Studi di Torino; Universitetet i Bergen; Public Health Agency","keywords":"Meta-analysis; Overweight; Medicine; Odds ratio; Confidence interval; Testicular cancer; Body mass index; Internal medicine; Anthropometry; Cancer; Oncology; Demography","score_opus":0.08243679587950156,"score_gpt":0.3974073534401348,"score_spread":0.3149705575606332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087918707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028561295,0.9952354,0.0004856339,0.00024610845,0.00020653223,0.0003018491,0.00044511876,0.000018344155,0.00020492674],"genre_scores_gemma":[0.0841054,0.90964055,0.003079377,0.00066968816,0.00026196078,0.00139473,0.0006201952,0.00001884406,0.00020921977],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9825151,0.010229614,0.004043005,0.0011592591,0.0016830977,0.00036988355],"domain_scores_gemma":[0.9706824,0.022208376,0.0041125696,0.0007055209,0.0020113434,0.00027977768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018589733,0.0030581858,0.019453254,0.009523223,0.0007196424,0.003048574,0.002310958,0.0026342385,0.0034988536],"category_scores_gemma":[0.058515325,0.0017067216,0.025976613,0.011533732,0.0008876654,0.0016728066,0.0013165089,0.0017217114,0.0003448994],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012941478,0.000024627057,0.0039203195,0.5364148,0.44203353,0.00022310374,0.00010338234,0.000669392,0.0002450197,0.00017525638,0.0011398535,0.013756587],"study_design_scores_gemma":[0.0005421419,0.00023142376,0.0040755295,0.051054407,0.9411731,0.00018319771,0.000055092394,0.00016566942,0.00012530907,0.00025179598,0.0021185935,0.00002376256],"about_ca_topic_score_codex":0.007869645,"about_ca_topic_score_gemma":0.018197738,"teacher_disagreement_score":0.019453254,"about_ca_system_score_codex":0.0033778532,"about_ca_system_score_gemma":0.0060440376,"threshold_uncertainty_score":0.09831309},"labels":[],"label_agreement":null},{"id":"W2088386079","doi":"10.1038/sj.bjc.6605835","title":"Expression of parvin-β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chang Gung Medical Foundation; Hospital for Sick Children; National Science Council","keywords":"Urothelial carcinoma; Upper urinary tract; Carcinoma; Urinary system; Medicine; Oncology; Urothelium; Risk factor; Internal medicine; Urothelial Cell; Pathology; Urology; Cancer research; Cancer; Bladder cancer","score_opus":0.009652573629109361,"score_gpt":0.2665012435821361,"score_spread":0.25684866995302674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088386079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716115,0.0020169532,0.00032604788,0.00006871161,0.000012615752,0.000008336189,0.00013611325,0.000014020222,0.00025599674],"genre_scores_gemma":[0.9992924,0.00027774373,0.00015992341,0.000011934274,0.000012303671,0.000005197475,0.00013362471,0.0000019631896,0.000104956984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998944,0.00002172021,0.000012117398,0.000029242516,0.000022303188,0.000020164149],"domain_scores_gemma":[0.999508,0.00011448162,0.00018632918,0.000022999488,0.00005441345,0.000113700946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002356109,0.00020005752,0.00033086672,0.0003900803,0.00028717562,0.00034479238,0.00014487481,0.00028560343,0.0011585233],"category_scores_gemma":[0.000824047,0.00011426939,0.00018837253,0.0005406152,0.00020972866,0.00021986155,0.00020664146,0.00035371367,0.00014273531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059402577,0.000034659195,0.9819343,0.00004336318,0.00004216147,0.00022185278,0.000032442385,0.00007709994,0.010925592,0.000012788984,0.00016573703,0.005915939],"study_design_scores_gemma":[0.000011026501,0.00014474454,0.9952258,0.000009287406,0.00006680297,0.0011740488,0.000054157594,0.0005112489,0.0022975856,0.000028282704,0.00047299478,0.000004057336],"about_ca_topic_score_codex":0.00034461753,"about_ca_topic_score_gemma":0.00038261822,"teacher_disagreement_score":0.0011585233,"about_ca_system_score_codex":0.00015611002,"about_ca_system_score_gemma":0.00012820156,"threshold_uncertainty_score":0.0038756728},"labels":[],"label_agreement":null},{"id":"W2088661059","doi":"10.1038/sj.bjc.6603684","title":"Brief smoking cessation advice from practice nurses during routine cervical smear tests appointments: a cluster randomised controlled trial assessing feasibility, acceptability and potential effectiveness","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council; Cancer Research UK","keywords":"Medicine; Smoking cessation; Randomized controlled trial; Physical therapy; Intervention (counseling); Cluster randomised controlled trial; Cervical screening; Cluster (spacecraft); Psychological intervention; Family medicine; Cervical cancer; Internal medicine; Nursing","score_opus":0.0163348335902607,"score_gpt":0.3572049236193045,"score_spread":0.3408700900290438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088661059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975988,0.0038942962,0.00093032606,0.0003819325,0.000427519,0.0173278,0.00017640558,0.000061130064,0.000812594],"genre_scores_gemma":[0.9549587,0.0031447886,0.006271931,0.0005533212,0.0004801874,0.03296855,0.00022390317,0.000011171982,0.0013875237],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930194,0.0046740817,0.00064195634,0.0006128149,0.00070397643,0.00034772142],"domain_scores_gemma":[0.9951357,0.002905634,0.0007658137,0.0002477491,0.0002958223,0.00064912305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066856304,0.00088355003,0.0033055898,0.0006782975,0.00067056937,0.0008473683,0.0009908996,0.0027390942,0.0049881544],"category_scores_gemma":[0.011691401,0.0007367851,0.0018277647,0.00081373827,0.0010968173,0.00087183947,0.0008255167,0.001525896,0.00039088508],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8918479,0.027370213,0.002031581,0.005818418,0.0016656467,0.00004904075,0.00035480107,0.00046236758,0.0020085913,0.000098925884,0.00034317703,0.06794932],"study_design_scores_gemma":[0.8589268,0.13459778,0.0041489513,0.00022308626,0.0010662152,0.00002051866,0.000077719305,0.00032953697,0.00021951225,0.00007166177,0.0002960993,0.000022080021],"about_ca_topic_score_codex":0.0038507753,"about_ca_topic_score_gemma":0.005496404,"teacher_disagreement_score":0.0066856304,"about_ca_system_score_codex":0.0011275026,"about_ca_system_score_gemma":0.0029790082,"threshold_uncertainty_score":0.035357416},"labels":[],"label_agreement":null},{"id":"W2089000681","doi":"10.1038/bjc.2013.713","title":"Nuclear worker studies: promise and pitfalls","year":2013,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"International agency; Medicine; Environmental health; Agency (philosophy); Publicity; Nuclear power; Commission; Political science; Cancer; Law; Social science; Sociology","score_opus":0.022405284380990997,"score_gpt":0.30773102566861443,"score_spread":0.28532574128762345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089000681","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018153986,0.028978417,0.00056830386,0.9526321,0.0167891,0.00001637818,0.00004047199,0.0000342698,0.0007593986],"genre_scores_gemma":[0.006069897,0.039951634,0.0041012154,0.8164004,0.13203388,0.00014284039,0.00006447107,0.000053541247,0.0011821202],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.893693,0.057720814,0.01494684,0.0063118655,0.025474355,0.0018531039],"domain_scores_gemma":[0.43655914,0.44118315,0.01624068,0.025655972,0.06284304,0.017518047],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21637331,0.0021120915,0.0046287514,0.006558431,0.005966431,0.00762912,0.010821781,0.047703106,0.006692217],"category_scores_gemma":[0.32083207,0.0020813013,0.0039561326,0.004409921,0.032333173,0.032853026,0.008401946,0.07292498,0.006626134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047652874,0.00024354518,0.0040190117,0.0030192863,0.00027301087,0.004489718,0.0023233648,0.0001866909,0.0003307347,0.03858067,0.75023615,0.19582126],"study_design_scores_gemma":[0.00038647218,0.0002791819,0.0028031028,0.010808868,0.00016868365,0.007001017,0.0039843754,0.0005154925,0.00017319432,0.17218688,0.80142206,0.00027057691],"about_ca_topic_score_codex":0.008203577,"about_ca_topic_score_gemma":0.01625977,"teacher_disagreement_score":0.21637331,"about_ca_system_score_codex":0.009569943,"about_ca_system_score_gemma":0.012941988,"threshold_uncertainty_score":0.9663512},"labels":[],"label_agreement":null},{"id":"W2089164477","doi":"10.1038/sj.bjc.6600459","title":"Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumour lines","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Methionine; Methylenetetrahydrofolate reductase; Biology; Methionine synthase; Reductase; Cancer research; Molecular biology; Homocysteine; Cell culture; Biochemistry; Enzyme; Genetics; Amino acid","score_opus":0.03999828002745998,"score_gpt":0.33198152682292065,"score_spread":0.29198324679546067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089164477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598074,0.0013150906,0.0013212598,0.00006270713,0.000029473182,0.000019517458,0.00025012073,0.00007924104,0.00094183447],"genre_scores_gemma":[0.9894518,0.0015748992,0.0018989391,0.000058596965,0.000009449966,0.00004571704,0.0010273168,0.00003045266,0.005902769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985707,0.000019347945,0.000019832929,0.000033474567,0.00004426555,0.000026054606],"domain_scores_gemma":[0.9998191,0.00005327955,0.000037157824,0.000017303722,0.000029516283,0.000043596952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013032017,0.0002894364,0.0003320897,0.00018825369,0.00010894168,0.00020775529,0.00017705129,0.00025647623,0.0012756706],"category_scores_gemma":[0.00013206125,0.00013369636,0.000228403,0.00012405147,0.00013545813,0.000106414765,0.00012825891,0.00044066214,0.000282888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052001284,0.000019346182,0.00007074933,0.000012993343,0.0000035225228,0.00001234955,0.000011445761,0.000024953486,0.9993255,0.000019406014,0.00001915313,0.00042845946],"study_design_scores_gemma":[0.000010401278,0.00073476374,0.003066603,0.000003445169,0.000014960437,0.000094116906,0.0000267932,0.0005494793,0.99437153,0.000010954469,0.001114507,0.0000024370545],"about_ca_topic_score_codex":0.0017005256,"about_ca_topic_score_gemma":0.0026726935,"teacher_disagreement_score":0.0017005256,"about_ca_system_score_codex":0.00028768642,"about_ca_system_score_gemma":0.00020397332,"threshold_uncertainty_score":0.0042675138},"labels":[],"label_agreement":null},{"id":"W2090227074","doi":"10.1038/bjc.2014.445","title":"Refinement of the Symptom Screening in Pediatrics Tool (SSPedi)","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Health Sciences Centre; London Health Sciences Centre; McMaster Children's Hospital; Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario; Toronto General Hospital; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Cognition; Pediatrics; Family medicine; Pediatric cancer; MEDLINE; Cancer; Psychiatry","score_opus":0.016328677220310343,"score_gpt":0.300228054269207,"score_spread":0.2838993770488967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090227074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93898326,0.0019145748,0.028547725,0.0030364401,0.0004973959,0.007441542,0.008486737,0.00048383433,0.010608465],"genre_scores_gemma":[0.79870784,0.0022037835,0.17158982,0.00070293754,0.00012559205,0.011413541,0.012584875,0.00007430815,0.0025972861],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9876716,0.0058851657,0.0028179442,0.00047314187,0.0025756338,0.0005764936],"domain_scores_gemma":[0.97548306,0.012987382,0.004038522,0.0011387988,0.0051457603,0.0012064662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016611464,0.000675518,0.00073317206,0.0023601165,0.00031175892,0.0007180643,0.0012530384,0.00057796994,0.003516245],"category_scores_gemma":[0.034779593,0.00035164185,0.0013314576,0.0017933412,0.00052631425,0.0013279313,0.0021106566,0.0017158035,0.00055889634],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056037883,0.0009113916,0.63337016,0.0014813824,0.00017563619,0.0004062196,0.0031807963,0.0019421837,0.0023353072,0.0010482838,0.012361444,0.3422268],"study_design_scores_gemma":[0.000293588,0.002493024,0.95543885,0.0009037608,0.00015801722,0.0016821526,0.0019371894,0.0030262454,0.002928298,0.0006420063,0.030400807,0.000096118354],"about_ca_topic_score_codex":0.0021911187,"about_ca_topic_score_gemma":0.0042303842,"teacher_disagreement_score":0.016611464,"about_ca_system_score_codex":0.001110231,"about_ca_system_score_gemma":0.0037425302,"threshold_uncertainty_score":0.08785093},"labels":[],"label_agreement":null},{"id":"W2090283697","doi":"10.1038/sj.bjc.6601451","title":"Kallikrein gene downregulation in breast cancer","year":2004,"lang":"de","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Breast cancer; Downregulation and upregulation; Cancer; Biology; Gene; Gene expression; Cancer research; In silico; Molecular biology; Genetics; Enzyme; Biochemistry","score_opus":0.01083030475192253,"score_gpt":0.27622129517292987,"score_spread":0.26539099042100733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090283697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526864,0.0019481671,0.0013811301,0.000038438808,0.00001216699,0.000011504215,0.0003730463,0.000079611455,0.00088725035],"genre_scores_gemma":[0.99486023,0.0010908706,0.0015690763,0.00006678423,0.0000064410974,0.000018590501,0.00089605275,0.00001480415,0.0014771193],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998909,0.000012443739,0.000007859388,0.000031184783,0.000039083123,0.000018507499],"domain_scores_gemma":[0.99989915,0.000023674107,0.000024076682,0.0000115341645,0.000021775506,0.0000197814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009384939,0.000114811344,0.00019331306,0.00024763794,0.00011655545,0.0002885569,0.000107607426,0.00016887418,0.0009058344],"category_scores_gemma":[0.0001720417,0.000070069276,0.00015283872,0.00026277092,0.00012183534,0.000119266944,0.00014328377,0.00019652038,0.0003356452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113880174,0.000011468882,0.006457055,0.00005744551,0.0000108299455,0.000110548266,0.00003689938,0.00006565547,0.98879427,0.000034322962,0.00006172521,0.0042460035],"study_design_scores_gemma":[0.00001536207,0.0005328513,0.36581373,0.000013255112,0.00007473482,0.002748378,0.00017397026,0.0009869646,0.62062734,0.00016124596,0.008841045,0.000011134643],"about_ca_topic_score_codex":0.00043154656,"about_ca_topic_score_gemma":0.0005050703,"teacher_disagreement_score":0.0009058344,"about_ca_system_score_codex":0.00016269235,"about_ca_system_score_gemma":0.00014137158,"threshold_uncertainty_score":0.0030303597},"labels":[],"label_agreement":null},{"id":"W2091194126","doi":"10.1038/sj.bjc.6603304","title":"Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; University of Birmingham; Cancer Research UK","keywords":"Ubiquitin ligase; Biology; Cell biology; Embryonic stem cell; Transformation (genetics); Malignant transformation; Ubiquitin; Genetics; Gene","score_opus":0.01430287038572891,"score_gpt":0.2866593822973404,"score_spread":0.2723565119116115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091194126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003128754,0.9970086,0.00034462343,0.00015991395,0.00016555979,0.0000051614793,0.000015977635,0.000012913739,0.0019744053],"genre_scores_gemma":[0.0013451265,0.99634415,0.00038987465,0.00011277003,0.00011510756,0.00000969527,0.00003375914,0.000002124184,0.0016473922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986756,0.000014501766,0.000020302887,0.00002670322,0.00005602001,0.000014952887],"domain_scores_gemma":[0.99984896,0.000057607846,0.00002430972,0.0000061668334,0.00003788297,0.000024969604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044804005,0.0007162061,0.0009981114,0.0016585799,0.00022789832,0.0006646636,0.00085724494,0.0009432696,0.0021181894],"category_scores_gemma":[0.00038020153,0.00027672772,0.00023548851,0.0015345702,0.0004399656,0.0009905207,0.0004669502,0.0009964596,0.002471171],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010867251,0.000072259965,0.000178317,0.006095836,0.000053707645,0.00039399226,0.000051557767,0.00046027233,0.006007585,0.003924469,0.017107826,0.9655456],"study_design_scores_gemma":[0.00002233173,0.00009229571,0.0011415993,0.00072271295,0.000050598144,0.0020307594,0.00005204116,0.000093887844,0.0015705654,0.0015120157,0.99269617,0.000015032301],"about_ca_topic_score_codex":0.00090952724,"about_ca_topic_score_gemma":0.0015768334,"teacher_disagreement_score":0.0021181894,"about_ca_system_score_codex":0.00067461305,"about_ca_system_score_gemma":0.0005670903,"threshold_uncertainty_score":0.007086098},"labels":[],"label_agreement":null},{"id":"W2091658544","doi":"10.1038/sj.bjc.6601424","title":"Germline truncating mutations in both MSH2 and BRCA2 in a single kindred","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; McGill University; University of Toronto; Jewish General Hospital; Sunnybrook Health Science Centre; North York General Hospital; McGill University Health Centre","funders":"Myriad Genetics; Cancer Research Society; Memorial Sloan-Kettering Cancer Center","keywords":"Germline mutation; Biology; MSH2; Mutation; Genetics; Exon; BRCA2 Protein; Microsatellite instability; Cancer research; Cancer; Microsatellite; Colorectal cancer; Gene; DNA mismatch repair; Allele","score_opus":0.017340784063021634,"score_gpt":0.295565854118558,"score_spread":0.27822507005553637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091658544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973738,0.00045697528,0.0006055007,0.00019033258,0.00003953749,0.000024667925,0.00019066304,0.00006790809,0.0010505626],"genre_scores_gemma":[0.9967591,0.00032271896,0.0008745827,0.00017618817,0.00006717653,0.000016132764,0.00019168922,0.000036420846,0.0015560114],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99951375,0.000053699714,0.00007366915,0.00016840617,0.00011793557,0.00007251713],"domain_scores_gemma":[0.99917847,0.00022314601,0.00015478645,0.000093825714,0.000059203812,0.00029050457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002698337,0.0017207888,0.0007397097,0.001755048,0.0014464869,0.0005491894,0.00064974744,0.0009878362,0.0024364395],"category_scores_gemma":[0.0013616385,0.00069317356,0.0008195802,0.0007943011,0.0009373267,0.00025772516,0.0009748497,0.0006749185,0.0007682154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001019319,0.00033590646,0.12595491,0.00019698894,0.0003709127,0.76607245,0.004492399,0.00036538168,0.07437625,0.0007236925,0.0025598663,0.023531912],"study_design_scores_gemma":[0.00009938581,0.0006112997,0.13725446,0.00005350629,0.00022273332,0.850913,0.00062263967,0.0003595454,0.0052018035,0.0003069944,0.004292229,0.00006236309],"about_ca_topic_score_codex":0.0034233842,"about_ca_topic_score_gemma":0.0044876942,"teacher_disagreement_score":0.0034233842,"about_ca_system_score_codex":0.00060060766,"about_ca_system_score_gemma":0.00035030415,"threshold_uncertainty_score":0.008150697},"labels":[],"label_agreement":null},{"id":"W2091756209","doi":"10.1038/sj.bjc.6601661","title":"Invasion and MMP expression profile in desmoid tumours","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Vlaamse regering; Kom op tegen Kanker","keywords":"MMP3; TIMP1; MMP1; Matrix metalloproteinase; MMP2; Cancer research; Downregulation and upregulation; Transcription factor; Biology; Metalloproteinase; Gene expression; Pathology; Medicine; Gene; Genetics","score_opus":0.01589524333331587,"score_gpt":0.29519530589321036,"score_spread":0.2793000625598945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091756209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954651,0.0013195007,0.00036257785,0.000031547097,0.000007412175,0.000030606105,0.0001866899,0.000015536476,0.0025809968],"genre_scores_gemma":[0.99707854,0.000901119,0.00052708306,0.000013005723,0.0000141058845,0.000021105963,0.00026613718,0.0000062459235,0.0011725391],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998311,0.00002218779,0.000017066764,0.000030889714,0.000059388993,0.00003935921],"domain_scores_gemma":[0.99970156,0.000106283675,0.000048482292,0.000017599761,0.000062738356,0.00006338195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001766097,0.00022147191,0.00022291292,0.0019286429,0.00024055318,0.00038712632,0.000098723736,0.00030010578,0.001825783],"category_scores_gemma":[0.00063452416,0.00018554003,0.00011007676,0.0007054994,0.0003303032,0.0002249146,0.000170063,0.00025624427,0.00035680222],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024379427,0.00023551262,0.18113936,0.0003416905,0.000048035203,0.062829934,0.0019174744,0.00018525166,0.736966,0.0005365827,0.00028297963,0.01307917],"study_design_scores_gemma":[0.000062735424,0.001400487,0.7348603,0.00004876316,0.00015730961,0.12708704,0.0017055697,0.0011239051,0.12618229,0.0003825315,0.006953288,0.00003587124],"about_ca_topic_score_codex":0.00086113776,"about_ca_topic_score_gemma":0.0009312477,"teacher_disagreement_score":0.0019286429,"about_ca_system_score_codex":0.00019351259,"about_ca_system_score_gemma":0.000103572755,"threshold_uncertainty_score":0.0061078668},"labels":[],"label_agreement":null},{"id":"W2091924611","doi":"10.1038/sj.bjc.6600959","title":"In vivo evolution of tumour cells after the generation of double-strand DNA breaks","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microbial Inactivation Methods","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Institut Gustave-Roussy; Centre National de la Recherche Scientifique","keywords":"Programmed cell death; Apoptosis; In vivo; Mitosis; TUNEL assay; Bleomycin; Biology; Cell; DNA damage; In vitro; Mitotic catastrophe; Cell biology; Cancer research; Molecular biology; DNA; Genetics; Chemotherapy","score_opus":0.013536771673313302,"score_gpt":0.28112863663488213,"score_spread":0.26759186496156884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091924611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97884595,0.0044882298,0.011856178,0.000100681915,0.00007531118,0.00013583747,0.000866388,0.00018384942,0.0034476705],"genre_scores_gemma":[0.9810173,0.0017680813,0.0071985186,0.0000524495,0.000019655512,0.00017337866,0.0012455793,0.00006603879,0.008459139],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979264,0.000049239323,0.00001584669,0.0000550416,0.000051845895,0.00003535057],"domain_scores_gemma":[0.9996728,0.00014091015,0.00005803543,0.000036493115,0.000028188777,0.00006356184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031513002,0.00028667692,0.00027148184,0.00034450126,0.00012604645,0.00028182092,0.0001565732,0.00043301252,0.0019704856],"category_scores_gemma":[0.00022668666,0.00016008035,0.0001880723,0.00019250372,0.00020421561,0.00023204919,0.0001837145,0.0007820439,0.00067664427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001330524,0.000050195475,0.00011845036,0.000025908197,0.000003805203,0.000025716705,0.000027395112,0.000053514857,0.99862397,0.00007690223,0.000019215404,0.0008417547],"study_design_scores_gemma":[0.000015661946,0.0010410286,0.0024501125,0.0000041064795,0.000011759692,0.00017709735,0.000015074866,0.00048670158,0.99441683,0.000045750123,0.0013318235,0.0000041268945],"about_ca_topic_score_codex":0.00028113794,"about_ca_topic_score_gemma":0.0004085725,"teacher_disagreement_score":0.0019704856,"about_ca_system_score_codex":0.0001923254,"about_ca_system_score_gemma":0.00011369204,"threshold_uncertainty_score":0.0065919757},"labels":[],"label_agreement":null},{"id":"W2092134714","doi":"10.1038/sj.bjc.6604547","title":"Poorer outcome in stromal HIF-2α- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Stromal cell; Cancer research; DNA methylation; Apoptosis; Adenocarcinoma; Colorectal cancer; Biology; Medicine; Oncology; Pathology; Internal medicine; Cancer; Gene; Genetics; Gene expression","score_opus":0.014332202287242054,"score_gpt":0.24776568666548646,"score_spread":0.2334334843782444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092134714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997621,0.000098984594,0.000057059486,0.0000039076613,9.924472e-7,0.0000011369557,0.000023871786,0.0000018466867,0.000050151088],"genre_scores_gemma":[0.9997751,0.0000417828,0.000037144564,0.0000036721988,0.0000016045832,0.0000011114952,0.000056508245,5.533046e-7,0.00008260624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991405,0.000017624836,0.000008704498,0.000023063536,0.00001689799,0.000019635372],"domain_scores_gemma":[0.9995214,0.00009053514,0.0002073028,0.000035687524,0.000033198638,0.000111842666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015078191,0.00016337667,0.00017621643,0.0003368614,0.00013239335,0.00014723677,0.000082173996,0.0001671764,0.00078685756],"category_scores_gemma":[0.0005645154,0.00011560816,0.00013121271,0.00018834506,0.00023055685,0.00009143705,0.00014201186,0.00016617405,0.00013262698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010038764,0.000041571348,0.9572602,0.000022996424,0.00006405696,0.00047670488,0.00006815883,0.00010822574,0.037489988,0.000015407326,0.000049305512,0.003399505],"study_design_scores_gemma":[0.000007115967,0.00022852274,0.9964768,0.0000018225069,0.000023477198,0.0011779284,0.000035099547,0.00017682613,0.0017452945,0.000021038622,0.000103843515,0.0000022147365],"about_ca_topic_score_codex":0.00090353197,"about_ca_topic_score_gemma":0.0016046155,"teacher_disagreement_score":0.00090353197,"about_ca_system_score_codex":0.00013924863,"about_ca_system_score_gemma":0.00008885856,"threshold_uncertainty_score":0.00263232},"labels":[],"label_agreement":null},{"id":"W2092202241","doi":"10.1038/bjc.2014.357","title":"Updated investigations of cancer excesses in individuals born or resident in the vicinity of Sellafield and Dounreay","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Research Council of Thailand; CHILDREN with CANCER UK; Scottish Government; Children's Cancer Research Fund; Newcastle University; National Institute for Health and Care Research","keywords":"Demography; Incidence (geometry); Medicine; Cancer incidence; Population; Cancer; Cohort; Cohort study; Environmental health; Pathology","score_opus":0.025357601663741867,"score_gpt":0.3417014061684248,"score_spread":0.31634380450468297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092202241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893277,0.0012504411,0.00016064927,0.00006113834,0.000013182771,0.000028028486,0.006729352,0.000009704008,0.0024196713],"genre_scores_gemma":[0.986336,0.001450801,0.00058382837,0.00007068559,0.000022921393,0.000054915134,0.009978383,0.0000077821705,0.001494719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961936,0.000048696504,0.000054968652,0.00009952066,0.00011091938,0.000066496024],"domain_scores_gemma":[0.99846494,0.0002659119,0.0006442876,0.00011332683,0.00038620317,0.00012535013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051577104,0.00021841942,0.00028007478,0.002387291,0.0005511992,0.00061078207,0.00048897776,0.00023061421,0.001964554],"category_scores_gemma":[0.0018358967,0.0001582315,0.00039018926,0.0030722355,0.00020703886,0.00033377353,0.0006537289,0.00021908518,0.00019237529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045789056,0.0000056408016,0.99570364,0.00006719274,0.00005453981,0.00008426805,0.00022840749,0.000050339102,0.00029072326,0.000017123995,0.00029358073,0.0031587626],"study_design_scores_gemma":[9.681041e-7,0.000007740355,0.9988877,0.000010009793,0.000018534833,0.00006981617,0.00018029168,0.000012837332,0.000050844923,0.0000029108774,0.0007568813,0.000001424217],"about_ca_topic_score_codex":0.19583929,"about_ca_topic_score_gemma":0.27484736,"teacher_disagreement_score":0.19583929,"about_ca_system_score_codex":0.00094592903,"about_ca_system_score_gemma":0.0010439178,"threshold_uncertainty_score":0.38939875},"labels":[],"label_agreement":null},{"id":"W2092228974","doi":"10.1038/bjc.2014.244","title":"Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health","funders":"Genentech; Eisai; GlaxoSmithKline; Pfizer; Astellas Pharma; Bristol-Myers Squibb","keywords":"Axitinib; Sorafenib; Medicine; Sunitinib; Internal medicine; Oncology; Renal cell carcinoma; Urology; Hepatocellular carcinoma","score_opus":0.025548564476173617,"score_gpt":0.3147698027311995,"score_spread":0.2892212382550259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092228974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95546466,0.03269367,0.0016587357,0.0008690656,0.0009962654,0.0032022188,0.0023286208,0.00013313089,0.002653695],"genre_scores_gemma":[0.98028255,0.008409685,0.0010597631,0.00083218614,0.00066632184,0.0037103537,0.0023571963,0.00005249566,0.0026294019],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99759823,0.0015650261,0.00019499823,0.00026511995,0.00015365036,0.00022299503],"domain_scores_gemma":[0.99729306,0.0010054704,0.00074122514,0.00029708064,0.00017933134,0.00048382996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050844424,0.0020603626,0.0041374834,0.00033936196,0.00039728978,0.001395392,0.00068114063,0.0009469214,0.007257114],"category_scores_gemma":[0.004442644,0.0006895823,0.0066368203,0.00057513005,0.00079111074,0.00087173557,0.00065530493,0.0026035295,0.0007125319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9815724,0.0006622865,0.0011702203,0.0008418896,0.007306892,0.00002458341,0.000031637333,0.0003076517,0.0009600282,0.00004268525,0.0005680798,0.006511779],"study_design_scores_gemma":[0.96275216,0.022337755,0.00609211,0.00007628352,0.0068142503,0.000053483614,0.000022493437,0.00037812418,0.00029848068,0.00022843356,0.0009281066,0.000018212753],"about_ca_topic_score_codex":0.0011467744,"about_ca_topic_score_gemma":0.0038351167,"teacher_disagreement_score":0.007257114,"about_ca_system_score_codex":0.0011004568,"about_ca_system_score_gemma":0.00145645,"threshold_uncertainty_score":0.026889384},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2093012990","doi":"10.1038/sj.bjc.6603025","title":"The place of VEGF inhibition in the current management of renal cell carcinoma","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Autocrine signalling; Renal cell carcinoma; Vascular endothelial growth factor; Angiogenesis; Kidney cancer; Medicine; Cancer research; Carcinoma; Vascular endothelial growth factor A; Kidney; Oncology; VEGF receptors; Internal medicine; Pathology; Receptor","score_opus":0.033300005009721634,"score_gpt":0.32474219692272216,"score_spread":0.2914421919130005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093012990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008257399,0.99909127,0.000039739767,0.00019372466,0.00008199807,0.0000017194869,0.0000051750044,0.0000031893835,0.00050071697],"genre_scores_gemma":[0.0007294817,0.99862933,0.00010027451,0.00014815727,0.000084574036,0.0000026146959,0.000011583124,9.542107e-7,0.00029302647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997465,0.000062769184,0.000034898618,0.00003748598,0.00009924762,0.000019015459],"domain_scores_gemma":[0.99970835,0.0001426052,0.00004958741,0.000010152822,0.000061881314,0.000027392762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077152404,0.0005912495,0.0019251298,0.0018566339,0.00027842144,0.000806273,0.00095936295,0.0010999176,0.0033046342],"category_scores_gemma":[0.0007722622,0.00022218512,0.00042933656,0.0025278293,0.00061118504,0.0011145375,0.00047435347,0.0016455106,0.0022296899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010167629,0.000035953763,0.00011164176,0.012208103,0.00006803061,0.00024703346,0.000050902934,0.00025208385,0.00079784944,0.0016405567,0.016127242,0.96835893],"study_design_scores_gemma":[0.00005064451,0.00014001464,0.0014973417,0.0057288744,0.00014748143,0.0024599424,0.000099218894,0.00008356144,0.00032506514,0.0017183551,0.9877293,0.000020152564],"about_ca_topic_score_codex":0.0017371386,"about_ca_topic_score_gemma":0.0036200667,"teacher_disagreement_score":0.0033046342,"about_ca_system_score_codex":0.0008099743,"about_ca_system_score_gemma":0.00097484456,"threshold_uncertainty_score":0.011055112},"labels":[],"label_agreement":null},{"id":"W2093082116","doi":"10.1038/sj.bjc.6600799","title":"Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Embarrassment; Health professionals; Health care; Perspective (graphical); Medicine; Reproductive health; Affect (linguistics); Quarter (Canadian coin); Gynecology; Family medicine; Nursing; Psychology; Social psychology; Population","score_opus":0.037093437747435024,"score_gpt":0.37851081253503394,"score_spread":0.3414173747875989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093082116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986648,0.0029748897,0.00017727424,0.0051040356,0.00009634154,0.000027073598,0.00002589908,0.0000057931193,0.0049406835],"genre_scores_gemma":[0.9947537,0.0024911696,0.00022390643,0.0014200654,0.00007252116,0.00003389323,0.00002259939,0.0000041610406,0.0009778661],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.98954237,0.0070639146,0.00065740716,0.00032745753,0.0014776926,0.0009311616],"domain_scores_gemma":[0.95606786,0.02952932,0.009019609,0.0006732767,0.0020344174,0.0026755151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057252664,0.00020987589,0.0006253461,0.0011884827,0.0036495086,0.002569615,0.0005259552,0.0015685367,0.0056652403],"category_scores_gemma":[0.044379443,0.0005793745,0.0002843799,0.00091557926,0.0026168558,0.0020327594,0.002764267,0.0011717153,0.0004909135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003782328,0.00019569421,0.38664874,0.00095551676,0.00009452213,0.0045654047,0.5306259,0.00006953585,0.0016443782,0.00072039204,0.0034314187,0.070670284],"study_design_scores_gemma":[0.000049451166,0.00068596104,0.1972084,0.0011945775,0.000083763116,0.008552426,0.7757662,0.000152275,0.00042441214,0.0006652494,0.015151737,0.000065523775],"about_ca_topic_score_codex":0.009581099,"about_ca_topic_score_gemma":0.009762197,"teacher_disagreement_score":0.009581099,"about_ca_system_score_codex":0.0020809576,"about_ca_system_score_gemma":0.0031898043,"threshold_uncertainty_score":0.030278444},"labels":[],"label_agreement":null},{"id":"W2093178920","doi":"10.1038/sj.bjc.6600236","title":"Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo; McGill University","keywords":"Proteolysis; Myogenesis; Myocyte; Biology; Proteasome; Protein degradation; Ubiquitin; Biochemistry; Cell biology; Molecular biology; Enzyme","score_opus":0.017664290354230235,"score_gpt":0.24258552086069088,"score_spread":0.22492123050646065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093178920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7698936,0.039351247,0.17037512,0.00083910633,0.0015312262,0.0009590982,0.006827825,0.0016997148,0.008523122],"genre_scores_gemma":[0.8251449,0.018489009,0.12967975,0.00029265904,0.00035399795,0.0014663512,0.012528039,0.00031971303,0.011725547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994868,0.00011867771,0.0000755164,0.00014239845,0.000109496104,0.00006700547],"domain_scores_gemma":[0.99951494,0.00015063377,0.000104970255,0.00008097096,0.00006669255,0.00008181877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075570977,0.0014891422,0.0017752385,0.00054960226,0.00049516954,0.0009964638,0.0012133261,0.000988448,0.0015208189],"category_scores_gemma":[0.0003501731,0.00060170254,0.0009641263,0.00042831397,0.0004506372,0.00072462135,0.00072480744,0.0018380423,0.0016105513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014892455,0.00006918551,0.00008395625,0.00016885536,0.000015363234,0.00007262745,0.00001618482,0.00016003638,0.99851066,0.00015026775,0.00006465974,0.00053926994],"study_design_scores_gemma":[0.000042883767,0.00083027605,0.0010962922,0.000022369282,0.00010249226,0.00037955644,0.000026291082,0.0019072552,0.98969764,0.00008501179,0.0057952106,0.000014694022],"about_ca_topic_score_codex":0.0019438011,"about_ca_topic_score_gemma":0.0039852876,"teacher_disagreement_score":0.0019438011,"about_ca_system_score_codex":0.0010188965,"about_ca_system_score_gemma":0.0005549703,"threshold_uncertainty_score":0.007392645},"labels":[],"label_agreement":null},{"id":"W2093182480","doi":"10.1038/bjc.2013.741","title":"Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; McGill University; Sunnybrook Health Science Centre; McGill University Health Centre; Université de Montréal; University of Toronto; Cancer Care Ontario; Women's College Hospital","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health","keywords":"Colorectal cancer; Medicine; Incidence (geometry); Ovarian cancer; Cancer; Germline mutation; Breast cancer; Internal medicine; Oncology; Population; Gynecology; Mutation; Genetics; Biology; Gene","score_opus":0.008825550818224165,"score_gpt":0.2792668362178696,"score_spread":0.2704412853996454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093182480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908817,0.00023555799,0.000049890576,0.000015007866,0.00000297665,0.0000055582673,0.00042411417,0.0000026692826,0.00017601573],"genre_scores_gemma":[0.99892515,0.00013557757,0.000057536126,0.00001532582,0.000005461552,0.0000077223,0.00066143455,0.000002100343,0.00018962882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994962,0.00010657961,0.000055706674,0.00015233403,0.000111166104,0.00007789757],"domain_scores_gemma":[0.99815196,0.00033545168,0.0007114646,0.00015576722,0.00031116555,0.00033418453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006925011,0.00024391632,0.00038732454,0.0011283697,0.00040452043,0.00048345208,0.00035509703,0.0005373668,0.001074277],"category_scores_gemma":[0.002705698,0.00036387565,0.0005783042,0.00102404,0.00020875546,0.00045092616,0.0003396858,0.0004656958,0.0003147511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007659464,0.000017928303,0.99914086,0.000004582317,0.000043865384,0.00006770376,0.000056119716,0.000012435448,0.00008192999,0.0000022866257,0.00004005497,0.00045569107],"study_design_scores_gemma":[0.0000042084666,0.0000603593,0.9995597,0.0000023179448,0.000026456808,0.00017803209,0.0000464978,0.000034191093,0.000024293997,0.0000031702225,0.00005930581,0.0000015112902],"about_ca_topic_score_codex":0.00988684,"about_ca_topic_score_gemma":0.008097387,"teacher_disagreement_score":0.00988684,"about_ca_system_score_codex":0.00039706263,"about_ca_system_score_gemma":0.00022408622,"threshold_uncertainty_score":0.019658566},"labels":[],"label_agreement":null},{"id":"W2093307943","doi":"10.1038/bjc.2014.264","title":"Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of Toronto","funders":"Medical Research Council; University of Dundee","keywords":"Medicine; Aspirin; Breast cancer; Internal medicine; Population; Cancer; Hazard ratio; Cancer registry; Gynecology; Cohort study; Surgery; Cohort; Oncology; Confidence interval","score_opus":0.009338513048600455,"score_gpt":0.27015924961911647,"score_spread":0.260820736570516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093307943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853766,0.00023752892,0.000071327544,0.00006905436,0.000010467053,0.000022464468,0.0008732595,0.000002800593,0.00017550652],"genre_scores_gemma":[0.99839526,0.0003000556,0.00013085389,0.000058787853,0.000019657897,0.000030023777,0.0008745846,0.0000019396523,0.00018873262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922574,0.00021057052,0.00008534244,0.00018165058,0.00015514552,0.00014164014],"domain_scores_gemma":[0.9982918,0.00022821329,0.00068636774,0.00026217834,0.00023037243,0.0003009547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012944734,0.00033064443,0.00042675954,0.0008400201,0.0006377456,0.00088509114,0.0005420493,0.00070936,0.0010795472],"category_scores_gemma":[0.0029311338,0.0006002574,0.00076869427,0.0019709761,0.00031556294,0.00062330574,0.00060528575,0.0009962659,0.00031171137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018909133,0.000072635274,0.99848384,0.00001141595,0.0001539235,0.00010807792,0.00015056867,0.000018740118,0.00012057826,0.00001043802,0.0001548477,0.00052584056],"study_design_scores_gemma":[0.000026891343,0.00015135782,0.9991234,0.0000076046513,0.00007856835,0.00018023931,0.00012898417,0.0000772556,0.000014480723,0.000010177488,0.00019616974,0.0000048710444],"about_ca_topic_score_codex":0.023397865,"about_ca_topic_score_gemma":0.024668848,"teacher_disagreement_score":0.023397865,"about_ca_system_score_codex":0.0005511257,"about_ca_system_score_gemma":0.0007278447,"threshold_uncertainty_score":0.046523333},"labels":[],"label_agreement":null},{"id":"W2093759824","doi":"10.1038/sj.bjc.6602393","title":"Comparison of 1- and 2-year screening intervals for women undergoing screening mammography","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mammography; Medicine; Mammography screening; Breast cancer; Cancer; Confidence interval; Gynecology; Breast cancer screening; Attendance; Demography; Oncology; Internal medicine; Obstetrics","score_opus":0.0764999125268508,"score_gpt":0.39516683079922793,"score_spread":0.31866691827237714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093759824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734974,0.0011106351,0.000114139024,0.000265303,0.000019100358,0.0000072292555,0.00038797132,0.0000067786914,0.00073898246],"genre_scores_gemma":[0.9990804,0.00020439162,0.00004482606,0.000034128647,0.000021932401,0.000005086271,0.000439519,0.0000019500897,0.00016764138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985306,0.00081539777,0.000068920315,0.00010079295,0.00020733288,0.0002768418],"domain_scores_gemma":[0.9851719,0.010080412,0.002709088,0.00045939238,0.00065334083,0.0009258438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004000738,0.0002862178,0.00034527146,0.0006368424,0.0001717886,0.000550402,0.0003622368,0.000509807,0.0013793488],"category_scores_gemma":[0.025294324,0.00013404383,0.001055836,0.000669922,0.00017904435,0.00046654418,0.00045186855,0.00050945336,0.00015256104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076514375,0.00025822298,0.9611224,0.00008548234,0.0006432716,0.00019295221,0.00018141574,0.0050770245,0.00029391356,0.00026104195,0.00041149458,0.023821421],"study_design_scores_gemma":[0.00007987002,0.0013168437,0.9942557,0.000023682082,0.00029003096,0.00010089116,0.00012340028,0.0032853659,0.00010470231,0.00013370995,0.0002738583,0.0000119059405],"about_ca_topic_score_codex":0.011020902,"about_ca_topic_score_gemma":0.016591785,"teacher_disagreement_score":0.011020902,"about_ca_system_score_codex":0.00078757404,"about_ca_system_score_gemma":0.00059588393,"threshold_uncertainty_score":0.021913528},"labels":[],"label_agreement":null},{"id":"W2094188569","doi":"10.1038/bjc.2011.182","title":"Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Medicine; Cetuximab; Pharmacodynamics; Pharmacokinetics; Internal medicine; Nausea; Response Evaluation Criteria in Solid Tumors; Adverse effect; Oncology; Gastroenterology; Cancer; Pharmacology; Colorectal cancer; Chemotherapy; Phases of clinical research","score_opus":0.015736151302106108,"score_gpt":0.2929622665639344,"score_spread":0.27722611526182833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094188569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963695,0.00084562093,0.0006506609,0.00016131603,0.000036062567,0.0006953779,0.00021480076,0.0000915709,0.0009351061],"genre_scores_gemma":[0.9943268,0.00051958684,0.0019814037,0.00036654205,0.000055131262,0.00086072314,0.00094629085,0.000029628867,0.00091400737],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995109,0.00024533208,0.000022025355,0.00007054576,0.00006363245,0.00008752475],"domain_scores_gemma":[0.9993411,0.00010564216,0.00020459102,0.000078858146,0.000043008793,0.00022691238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012752624,0.00095918553,0.0018271167,0.00036868927,0.0002865564,0.0007103989,0.0008975707,0.0007875961,0.0024779271],"category_scores_gemma":[0.0010175529,0.0004967277,0.0007780986,0.00042494983,0.0005652916,0.0005498145,0.0003081817,0.0030448893,0.00068063545],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36073795,0.12005905,0.021463368,0.0009844186,0.0030123997,0.0006660325,0.00069427263,0.009526314,0.2854191,0.00037556386,0.0054274467,0.19163415],"study_design_scores_gemma":[0.25876778,0.6762613,0.035057463,0.000037757774,0.00063721027,0.0011843138,0.00008653753,0.0038451664,0.019233149,0.0001943145,0.004648937,0.000046060126],"about_ca_topic_score_codex":0.00038992526,"about_ca_topic_score_gemma":0.0009982698,"teacher_disagreement_score":0.0024779271,"about_ca_system_score_codex":0.0007573972,"about_ca_system_score_gemma":0.0008528564,"threshold_uncertainty_score":0.008289456},"labels":[],"label_agreement":null},{"id":"W2094772566","doi":"10.1038/sj.bjc.6600951","title":"Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Council Canada; Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Lotta al Neuroblastoma","keywords":"CD40; CD80; CD86; Flow cytometry; Neuroblastoma; Biology; Molecular biology; Cell culture; Apoptosis; Transfection; Cancer research; Cell biology; T cell; In vitro; Immune system; Immunology; Cytotoxic T cell","score_opus":0.02973724825859501,"score_gpt":0.3260230338346965,"score_spread":0.29628578557610147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094772566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889548,0.006238389,0.0012002381,0.000049402126,0.000019879582,0.00003065348,0.0010536462,0.00002797963,0.0024251004],"genre_scores_gemma":[0.9788815,0.0061474005,0.0031587481,0.000042686002,0.000013037779,0.000073192845,0.0037344748,0.000011772048,0.00793715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989104,0.000013392099,0.000009134204,0.000019215653,0.000046634737,0.000020569823],"domain_scores_gemma":[0.9999243,0.000017234821,0.000010098335,0.000010707193,0.000024556455,0.000013106446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010362165,0.00012730704,0.0001820249,0.00018083678,0.0001527577,0.00024747674,0.00007391486,0.00013108566,0.0018241474],"category_scores_gemma":[0.00016142493,0.0000699543,0.000101385805,0.0001522743,0.0001125611,0.00012404,0.00012137719,0.00020955574,0.0005592683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109555134,0.000010318527,0.0010097539,0.000053311494,0.0000042001498,0.00013582756,0.0000732032,0.000041042018,0.9961392,0.000067337896,0.00005717149,0.0022990531],"study_design_scores_gemma":[0.000031640593,0.0006375039,0.047083054,0.000040805753,0.000055866145,0.002398565,0.0002301067,0.0004603984,0.923172,0.00012630146,0.025752127,0.000011541898],"about_ca_topic_score_codex":0.0032796895,"about_ca_topic_score_gemma":0.004578919,"teacher_disagreement_score":0.0032796895,"about_ca_system_score_codex":0.00041246848,"about_ca_system_score_gemma":0.00027402115,"threshold_uncertainty_score":0.0065211654},"labels":[],"label_agreement":null},{"id":"W2095293611","doi":"10.1038/sj.bjc.6605972","title":"Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":85,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Institutes of Health; Pfizer","keywords":"Medicine; Internal medicine; Biomarker; Oncology; Lung cancer; Proportional hazards model; Carboplatin; Progression-free survival; Clinical trial; non-small cell lung cancer (NSCLC); Chemotherapy; Biology; Cisplatin","score_opus":0.028793649387729322,"score_gpt":0.33747207351955105,"score_spread":0.3086784241318217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095293611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991787,0.00035405566,0.00012470307,0.000029306819,0.000004145419,0.000008149642,0.000060976126,0.000006765162,0.00023313738],"genre_scores_gemma":[0.99944395,0.000074658674,0.00016013098,0.000034913617,0.000009262116,0.0000064760216,0.00017381903,0.000001316886,0.00009547952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998516,0.00004065939,0.0000117034515,0.000031590942,0.000031326843,0.000033094962],"domain_scores_gemma":[0.99932146,0.00031837204,0.00018311238,0.00002120345,0.000028211945,0.00012759992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042252438,0.00031324534,0.00048397822,0.00017330934,0.00015616823,0.0004600225,0.00014767151,0.00038411573,0.001284184],"category_scores_gemma":[0.0011775553,0.00013875755,0.0002750839,0.00015228243,0.00022932822,0.00028621047,0.00015265883,0.00056231715,0.00020610998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01214324,0.00056132744,0.93409944,0.000057645302,0.00016525242,0.0002036388,0.000059489455,0.0008397001,0.020009505,0.000058834066,0.00035449237,0.031447545],"study_design_scores_gemma":[0.00024867812,0.003970094,0.9886348,0.000007388938,0.00013912284,0.000671242,0.000038512655,0.0019717596,0.0036654915,0.00009365651,0.0005516333,0.0000075520957],"about_ca_topic_score_codex":0.00048614742,"about_ca_topic_score_gemma":0.0009281058,"teacher_disagreement_score":0.001284184,"about_ca_system_score_codex":0.00035190128,"about_ca_system_score_gemma":0.00026102178,"threshold_uncertainty_score":0.004296005},"labels":[],"label_agreement":null},{"id":"W2097211264","doi":"10.1038/sj.bjc.6602956","title":"Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Immunohistochemistry; Biology; Cancer; Lung cancer; Pathology; Mammary gland; Medicine; Internal medicine","score_opus":0.008560901377213518,"score_gpt":0.26521641961723064,"score_spread":0.25665551824001714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097211264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990212,0.00054190174,0.00020907662,0.000011218789,0.000003183535,0.0000028516156,0.000043987806,0.0000060782736,0.0001605217],"genre_scores_gemma":[0.99925953,0.00023635905,0.00017721309,0.0000065540366,0.0000036008294,0.000003878135,0.00009823825,0.0000025050251,0.00021209751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998271,0.000032197164,0.000019634115,0.000040608407,0.000045978108,0.00003443467],"domain_scores_gemma":[0.9995403,0.000114440576,0.00017864448,0.00003683459,0.000061352905,0.00006844516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020853424,0.00017718892,0.00021119998,0.00049699197,0.00013023906,0.0003572895,0.00013833822,0.00023278936,0.00075799366],"category_scores_gemma":[0.00068686006,0.00019143804,0.00016609168,0.00041485697,0.000249884,0.000164916,0.00023182364,0.00021334089,0.00022843653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014169691,0.00004292175,0.7552065,0.00012313582,0.00010285411,0.00046094166,0.00016049038,0.00013706564,0.23448512,0.00003733355,0.00008652433,0.007740168],"study_design_scores_gemma":[0.000006644071,0.00013569498,0.9867776,0.0000040145815,0.000058404778,0.0010789006,0.000090362686,0.000223177,0.011260339,0.000038321712,0.00032187454,0.00000482542],"about_ca_topic_score_codex":0.0008282338,"about_ca_topic_score_gemma":0.0009677643,"teacher_disagreement_score":0.0008282338,"about_ca_system_score_codex":0.00022382318,"about_ca_system_score_gemma":0.00013234475,"threshold_uncertainty_score":0.0025357604},"labels":[],"label_agreement":null},{"id":"W2097983921","doi":"10.1038/sj.bjc.6600215","title":"The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Vascular endothelial growth factor; Pathology; Biology; Angiogenesis; Immunostaining; Vascular endothelial growth factor A; Hypoxia (environmental); Hypoxia-inducible factors; Growth factor; Cancer research; Medicine; Immunohistochemistry; Chemistry; Gene; VEGF receptors; Receptor","score_opus":0.012731529573630006,"score_gpt":0.23742184501673014,"score_spread":0.22469031544310014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097983921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989415,0.0004697864,0.00025924874,0.000012508321,0.0000013284489,0.0000037236914,0.000028449249,0.0000065578956,0.0002769906],"genre_scores_gemma":[0.9990175,0.0002572614,0.00025288027,0.000009886329,0.0000027705578,0.000007595706,0.00007733978,0.0000025533752,0.00037231692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999058,0.000020211277,0.0000065972313,0.000014397618,0.000023674334,0.000029263996],"domain_scores_gemma":[0.99969935,0.000071563656,0.00011330874,0.000013186965,0.000045995435,0.000056635323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001176354,0.00010925044,0.00017070066,0.00026820242,0.00011544291,0.00024332007,0.000099884106,0.00017819535,0.00044114885],"category_scores_gemma":[0.0004876644,0.00011451526,0.000077399,0.00022311111,0.00026827684,0.00014478658,0.00017438697,0.00014751684,0.00010042486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085656287,0.000026623542,0.094011016,0.000102983184,0.00001797257,0.00057966204,0.0003626889,0.00012491592,0.8952534,0.00015195317,0.00006363911,0.008448612],"study_design_scores_gemma":[0.00002991233,0.00056554336,0.8965862,0.000014667861,0.000068373694,0.0027145976,0.00046385627,0.0007302075,0.096966006,0.0003205716,0.0015261823,0.000013930095],"about_ca_topic_score_codex":0.0009602783,"about_ca_topic_score_gemma":0.0012624225,"teacher_disagreement_score":0.0009602783,"about_ca_system_score_codex":0.00021762242,"about_ca_system_score_gemma":0.00013393907,"threshold_uncertainty_score":0.0019093752},"labels":[],"label_agreement":null},{"id":"W2099091477","doi":"10.1038/bjc.2014.552","title":"Increased stomach cancer risk following radiotherapy for testicular cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"University of Texas MD Anderson Cancer Center; National Institute of Environmental Health Sciences; KWF Kankerbestrijding; National Institute of Allergy and Infectious Diseases; Lance Armstrong Foundation; Karolinska Institutet; Cancer Care Ontario; Armstrong Foundation; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Stomach; Radiation therapy; Stomach cancer; Cancer; Odds ratio; Internal medicine; Gastroenterology; Confidence interval","score_opus":0.008635559453689082,"score_gpt":0.3117807845559687,"score_spread":0.3031452251022796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099091477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998072,0.0012545618,0.00010290354,0.000034842957,0.000005341853,0.000004241544,0.00013254941,0.000008312377,0.0003850863],"genre_scores_gemma":[0.99921143,0.00041984316,0.000065001994,0.000012720614,0.000009375256,0.0000015947292,0.00016681473,0.0000018138313,0.00011132643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985147,0.000040413557,0.000011602742,0.000033222903,0.000038012156,0.000025242085],"domain_scores_gemma":[0.99923503,0.00012306574,0.00044984807,0.0000432381,0.000056849938,0.00009211143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022300669,0.00013576278,0.00020771232,0.0005438106,0.0001596237,0.00026161724,0.0001535009,0.00018401306,0.0015941239],"category_scores_gemma":[0.0010317906,0.00011291629,0.00033823517,0.00064043724,0.00021089008,0.0001142219,0.00022802046,0.00023461672,0.00014665724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009383681,0.0000051703014,0.99742955,0.000015072034,0.00004630398,0.00020419247,0.00003325064,0.000037502574,0.00036872347,0.000007268299,0.00005259212,0.0017065437],"study_design_scores_gemma":[0.0000024812678,0.00007757557,0.9984937,0.0000057375273,0.00003251219,0.0010698116,0.000029005709,0.00003725089,0.00012058152,0.000007930521,0.000121803736,0.0000015874572],"about_ca_topic_score_codex":0.004480355,"about_ca_topic_score_gemma":0.0048461617,"teacher_disagreement_score":0.004480355,"about_ca_system_score_codex":0.00027579506,"about_ca_system_score_gemma":0.00019962042,"threshold_uncertainty_score":0.00890857},"labels":[],"label_agreement":null},{"id":"W2099552271","doi":"10.1038/sj.bjc.6600439","title":"Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Biology; Cancer; Cancer research; Breast cancer; Heat shock protein; Antigen; Immunology; Gene; Genetics","score_opus":0.01719396713597242,"score_gpt":0.2769171152518821,"score_spread":0.2597231481159097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099552271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804042,0.00081080425,0.015466607,0.00013398362,0.000027316484,0.00013869387,0.0010573419,0.000114998904,0.0018460358],"genre_scores_gemma":[0.97101295,0.0014879833,0.012542165,0.00021232627,0.000045194374,0.00016177629,0.009246737,0.000048536633,0.005242396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974257,0.0000535171,0.000021738215,0.000037351085,0.00008612977,0.000058723585],"domain_scores_gemma":[0.99980396,0.00007021931,0.000029251698,0.000026907966,0.00004112408,0.000028583485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021815675,0.0003924847,0.00033372105,0.00052615325,0.00014695343,0.0003558709,0.00019411338,0.00020646262,0.0012333274],"category_scores_gemma":[0.00040943222,0.00015552522,0.00034839215,0.0005971905,0.00013653758,0.00013782486,0.00025309675,0.0004769417,0.00072537235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006615412,0.000031806303,0.00070793263,0.000025314075,0.0000068245454,0.00005922427,0.000014306136,0.00004743855,0.99709594,0.000035900273,0.000042868975,0.0018663153],"study_design_scores_gemma":[0.000047076002,0.0009101937,0.030527981,0.000018443669,0.00014709267,0.0018350655,0.000102852864,0.0036312337,0.9550715,0.000120960285,0.007575442,0.0000121822695],"about_ca_topic_score_codex":0.0003381507,"about_ca_topic_score_gemma":0.0002962007,"teacher_disagreement_score":0.0012333274,"about_ca_system_score_codex":0.00015893525,"about_ca_system_score_gemma":0.00015590175,"threshold_uncertainty_score":0.0041259527},"labels":[],"label_agreement":null},{"id":"W2099836603","doi":"10.1038/bjc.2014.311","title":"Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Lymph node; Dissection (medical); Prostate cancer; Lymph; Radiology; Pathological staging; Lymphadenectomy; Cohort; Urology; Cancer; Surgery; Internal medicine; Pathology","score_opus":0.021615992552288934,"score_gpt":0.3907936973937461,"score_spread":0.3691777048414572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099836603","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17726764,0.0020194233,0.81011546,0.006702297,0.00025963126,0.0004253695,0.00079107244,0.00038767396,0.0020314523],"genre_scores_gemma":[0.8311522,0.00060713326,0.16559981,0.00040571464,0.00022950549,0.0004920988,0.0006884781,0.000056321802,0.0007688608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955864,0.0025813777,0.00021973623,0.0005247464,0.00094053097,0.00014724281],"domain_scores_gemma":[0.98305064,0.01238537,0.0017357516,0.0008383462,0.0014513484,0.0005385031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013315252,0.0013570937,0.0008614787,0.0017542721,0.0003526226,0.0015361425,0.002163067,0.0009024466,0.0015543308],"category_scores_gemma":[0.031213155,0.00052217155,0.0014610313,0.0012009712,0.0016239138,0.0010940394,0.0012803759,0.002296868,0.0004958291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093313894,0.00028927703,0.5951792,0.0002695492,0.00076753786,0.00024664935,0.0005536954,0.19803795,0.0009966628,0.026036246,0.0080300495,0.16866001],"study_design_scores_gemma":[0.0002638748,0.0011153489,0.07759055,0.00019958436,0.00028095543,0.00066454377,0.00021171295,0.8551058,0.000461064,0.059713952,0.0042506587,0.00014189734],"about_ca_topic_score_codex":0.0038942287,"about_ca_topic_score_gemma":0.0025677665,"teacher_disagreement_score":0.013315252,"about_ca_system_score_codex":0.0010823888,"about_ca_system_score_gemma":0.0018711677,"threshold_uncertainty_score":0.070418596},"labels":[],"label_agreement":null},{"id":"W2100532998","doi":"10.1038/bjc.2015.268","title":"Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Lymphovascular invasion; Cohort; Endometrial cancer; Oncology; Internal medicine; Medicine; Concordance; Cancer; Adjuvant therapy; Stage (stratigraphy); Prognostic variable; Proportional hazards model; Biology; Metastasis","score_opus":0.15084996540408976,"score_gpt":0.3570143717754342,"score_spread":0.20616440637134445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100532998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452884,0.00045553196,0.012809205,0.00044150744,0.00006165702,0.000070760805,0.0007320957,0.00022601603,0.00067436515],"genre_scores_gemma":[0.9963076,0.00007358819,0.0024129492,0.0000348362,0.00002779366,0.000047778783,0.00070088386,0.0000094158395,0.0003851525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968135,0.00012992634,0.000027621658,0.000063500105,0.000045797813,0.00005177293],"domain_scores_gemma":[0.9978315,0.0014479887,0.00022045408,0.00007904267,0.00026884492,0.00015218797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024386668,0.00068670395,0.00080707547,0.0012537511,0.00024282919,0.00072872546,0.0006988232,0.000544261,0.0023573807],"category_scores_gemma":[0.005346526,0.00023357528,0.0006762681,0.00036977656,0.0002023022,0.0002445595,0.0004576969,0.00072825234,0.0006182354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020485106,0.0003923244,0.864782,0.00006085672,0.0004355944,0.00034364592,0.000073580966,0.08320582,0.0008195124,0.00016893347,0.00221406,0.045455128],"study_design_scores_gemma":[0.00016663942,0.0005713211,0.13087657,0.000044868706,0.00031336746,0.00038153917,0.00006271308,0.86586905,0.0005398001,0.00070206885,0.00044461768,0.000027389973],"about_ca_topic_score_codex":0.0047807866,"about_ca_topic_score_gemma":0.0030776586,"teacher_disagreement_score":0.0047807866,"about_ca_system_score_codex":0.000476537,"about_ca_system_score_gemma":0.0007890309,"threshold_uncertainty_score":0.012897015},"labels":[],"label_agreement":null},{"id":"W2102509283","doi":"10.1038/sj.bjc.6601880","title":"Somatic mutations of KIT in familial testicular germ cell tumours","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Hungarian Scientific Research Fund; Cancer Research UK","keywords":"Somatic cell; Missense mutation; Germline mutation; Biology; Germline; Exon; Genetics; Germline mosaicism; Mutation; Cancer research; Germ cell; Proto-Oncogene Proteins c-kit; Gene","score_opus":0.005753231176069389,"score_gpt":0.22487229197666533,"score_spread":0.21911906080059596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102509283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884546,0.0004946607,0.00023741869,0.000018640707,0.000003987585,0.0000023501075,0.000030956948,0.000011309956,0.0003552322],"genre_scores_gemma":[0.99961996,0.00013841956,0.000101929276,0.0000071915947,0.0000060450125,8.541374e-7,0.000029064664,0.0000020773925,0.00009442303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998161,0.00003408964,0.00001449701,0.000038648737,0.000059087444,0.000037564536],"domain_scores_gemma":[0.9995467,0.00011838175,0.0001683727,0.00003096291,0.000031527983,0.00010392113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020710539,0.00018752097,0.00019085921,0.00078760856,0.00026826456,0.0002466765,0.00013512504,0.00024445925,0.0017173019],"category_scores_gemma":[0.0010103696,0.00015541523,0.00015277766,0.0005506736,0.00036427513,0.000115935036,0.00020220596,0.00019706265,0.00018398972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044028758,0.000045818004,0.8313972,0.00014967944,0.00013638986,0.051464044,0.0010318982,0.00036534542,0.08389727,0.00041351904,0.0007840795,0.029874485],"study_design_scores_gemma":[0.000052009505,0.00026568785,0.773693,0.00004062838,0.00013005991,0.20839472,0.0004071627,0.00059603754,0.014269988,0.0004098725,0.0017244632,0.000016347765],"about_ca_topic_score_codex":0.0011636707,"about_ca_topic_score_gemma":0.0019889902,"teacher_disagreement_score":0.0017173019,"about_ca_system_score_codex":0.00020327748,"about_ca_system_score_gemma":0.00012602757,"threshold_uncertainty_score":0.005744934},"labels":[],"label_agreement":null},{"id":"W2104203198","doi":"10.1054/bjoc.2000.1376","title":"A pooled analysis of magnetic fields and childhood leukaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Electromagnetic Fields and Biological Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":735,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council","keywords":"Relative risk; Confounding; Childhood leukaemia; Medicine; Demography; Estimation; Risk factor; Environmental health; Pediatrics; Confidence interval; Internal medicine","score_opus":0.00251755663583781,"score_gpt":0.22133618756366347,"score_spread":0.21881863092782566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104203198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60201204,0.32097474,0.033492684,0.00075429433,0.0010733942,0.0018922075,0.035016194,0.00066532224,0.0041191084],"genre_scores_gemma":[0.9618342,0.018006923,0.008782158,0.00031060167,0.00031907158,0.0014322492,0.008000517,0.00008419675,0.0012301111],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9761791,0.014574704,0.00403397,0.0027633698,0.001735867,0.00071290304],"domain_scores_gemma":[0.98130167,0.010475004,0.0028348633,0.002999228,0.0021527275,0.00023653166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018469032,0.0016172011,0.008001299,0.008640141,0.00040988074,0.001989723,0.0010176174,0.0015541199,0.0033099568],"category_scores_gemma":[0.044348706,0.0011124563,0.02032188,0.0073452042,0.00030489397,0.0009097881,0.001613569,0.00061503676,0.00042100585],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016408728,0.00009865251,0.11671416,0.017671857,0.81077576,0.0006018743,0.00021632809,0.0031370234,0.0027371391,0.00035687414,0.0027249863,0.028556578],"study_design_scores_gemma":[0.0020199956,0.0026770753,0.19748457,0.0016156553,0.7841598,0.0004623845,0.0003001644,0.002540281,0.0010789565,0.0007595202,0.0067806016,0.000121022094],"about_ca_topic_score_codex":0.005605569,"about_ca_topic_score_gemma":0.005246314,"teacher_disagreement_score":0.018469032,"about_ca_system_score_codex":0.00085938117,"about_ca_system_score_gemma":0.0009852762,"threshold_uncertainty_score":0.09767479},"labels":[],"label_agreement":null},{"id":"W2105145042","doi":"10.1038/sj.bjc.6602753","title":"Do septins have a role in cancer?","year":2005,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Fungal and yeast genetics research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Pathological Society of Great Britain and Ireland","keywords":"Septin; Cytokinesis; Biology; Gene; Cell biology; Genetics; Microtubule; Alternative splicing; Cell division; Cell; Gene isoform","score_opus":0.03522322916562986,"score_gpt":0.3934724014999978,"score_spread":0.3582491723343679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105145042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001268598,0.99814343,0.000043620414,0.00078568433,0.00027308558,0.0000015001763,0.0000067935644,0.0000033398028,0.0006156996],"genre_scores_gemma":[0.0006967487,0.9981047,0.00006182337,0.00033458453,0.00027298543,0.0000023272223,0.000011799286,6.5616473e-7,0.0005142768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998901,0.000020489004,0.000016784454,0.000019189427,0.000039421302,0.000013998255],"domain_scores_gemma":[0.9997801,0.000086478205,0.000028625522,0.000008082943,0.00005843667,0.000038347036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049374026,0.0005223321,0.0011316123,0.0010327923,0.00032814723,0.00076085544,0.00066026585,0.0014687729,0.0029285413],"category_scores_gemma":[0.0005866628,0.00021428213,0.00025845153,0.0010699665,0.0007121222,0.0016014292,0.00059551914,0.0013168914,0.0021511314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014597348,0.000034396908,0.00037626436,0.0066743353,0.000060873266,0.00058073463,0.00008555264,0.0002422927,0.0016291533,0.0045715314,0.03805367,0.9475453],"study_design_scores_gemma":[0.000023669792,0.00009240587,0.0010197854,0.0015274077,0.000044783366,0.0024773884,0.000090164205,0.000044628854,0.0003363774,0.0027374125,0.9915946,0.0000112410435],"about_ca_topic_score_codex":0.0008018516,"about_ca_topic_score_gemma":0.0015684799,"teacher_disagreement_score":0.0029285413,"about_ca_system_score_codex":0.0006286513,"about_ca_system_score_gemma":0.0006397853,"threshold_uncertainty_score":0.009796977},"labels":[],"label_agreement":null},{"id":"W2105555634","doi":"10.1038/sj.bjc.6603220","title":"Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Biomarker; Pharmacodynamics; Cytokeratin; Surrogate endpoint; Medicine; Internal medicine; Apoptosis; Pharmacology; Oncology; Pharmacokinetics; Biology; Immunology; Programmed cell death; Caspase; Immunohistochemistry","score_opus":0.03403173599688246,"score_gpt":0.41665160155999836,"score_spread":0.3826198655631159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105555634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7398035,0.0019180723,0.24858217,0.0003249964,0.00022840568,0.002939666,0.00182687,0.0012628619,0.0031135196],"genre_scores_gemma":[0.86056733,0.00066477223,0.12861273,0.0005207951,0.00007500969,0.0033740783,0.0027415592,0.0002547941,0.003188935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9923118,0.002706938,0.0006975076,0.0013848945,0.0026199825,0.00027897506],"domain_scores_gemma":[0.99483854,0.0019576373,0.0007570197,0.00067979156,0.0016116889,0.00015532969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076708207,0.0012942158,0.00068328023,0.0008378237,0.00050711643,0.0009693173,0.00057554815,0.0010222144,0.0012861927],"category_scores_gemma":[0.010025547,0.000437975,0.000691939,0.0007075267,0.001175561,0.00025616,0.0004887242,0.00096595,0.00087160646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018394531,0.0002957638,0.009563119,0.00013996044,0.00013970546,0.0001229652,0.00026247112,0.002091236,0.96381664,0.00017704049,0.0003686619,0.021182993],"study_design_scores_gemma":[0.00016091364,0.0074507818,0.025830328,0.000025111447,0.00017020683,0.00093157595,0.00005849136,0.0067440392,0.9550144,0.00016561848,0.0033956221,0.000053011783],"about_ca_topic_score_codex":0.0009582895,"about_ca_topic_score_gemma":0.0011877115,"teacher_disagreement_score":0.0076708207,"about_ca_system_score_codex":0.0007760171,"about_ca_system_score_gemma":0.0010588585,"threshold_uncertainty_score":0.040567636},"labels":[],"label_agreement":null},{"id":"W2105649578","doi":"10.1038/bjc.2012.76","title":"Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Colorectal cancer; Body mass index; Internal medicine; Proportional hazards model; Relative risk; Magnesium; Confidence interval; Cancer; Incidence (geometry); Gastroenterology; Prospective cohort study; Endocrinology; Chemistry","score_opus":0.013278408012720186,"score_gpt":0.2927676394467558,"score_spread":0.27948923143403565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105649578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884343,0.0004140402,0.00005396367,0.000038413764,0.0000066002476,0.000010774491,0.00046523585,0.0000032900286,0.00016432293],"genre_scores_gemma":[0.99896383,0.00016071419,0.000088682726,0.000036951613,0.000009122245,0.000017593014,0.0005208464,0.0000015874566,0.00020064788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966764,0.00009896071,0.00003163409,0.00008693332,0.000061042854,0.000053864995],"domain_scores_gemma":[0.9992569,0.000091987735,0.0002739827,0.000087876826,0.00011756125,0.00017167635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068557006,0.00035455904,0.00059121253,0.00065731345,0.0004705691,0.0004556967,0.0004334381,0.0006388997,0.0007304884],"category_scores_gemma":[0.0015944389,0.0004967488,0.00069369934,0.0011529251,0.00022613406,0.0003625246,0.00038600672,0.0007008644,0.00025160456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018095001,0.000041154148,0.9990114,0.0000067905485,0.00012778156,0.000049230934,0.00004058774,0.000015016993,0.00011956541,0.0000027553635,0.00005744728,0.0003473642],"study_design_scores_gemma":[0.00001405848,0.000099287216,0.9995065,0.0000030328995,0.000074400356,0.000066108965,0.000045334742,0.00005795759,0.00001817076,0.0000049495925,0.000108425666,0.0000018892142],"about_ca_topic_score_codex":0.0117125055,"about_ca_topic_score_gemma":0.013295615,"teacher_disagreement_score":0.0117125055,"about_ca_system_score_codex":0.00041365824,"about_ca_system_score_gemma":0.00035308802,"threshold_uncertainty_score":0.023288608},"labels":[],"label_agreement":null},{"id":"W2109602297","doi":"10.1038/sj.bjc.6603556","title":"Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Downregulation and upregulation; Gene expression; Biology; Ovarian cancer; Regulation of gene expression; Cancer research; Gene; Cancer; Genetics","score_opus":0.030060278993326254,"score_gpt":0.3668676916118777,"score_spread":0.33680741261855146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109602297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98983556,0.0071461196,0.0016165586,0.00019584635,0.000023236962,0.000034430155,0.00014018013,0.000026071413,0.0009819231],"genre_scores_gemma":[0.9964863,0.0018667257,0.0008263666,0.00006480377,0.00004030532,0.000013789757,0.00019540603,0.00000416352,0.0005022746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998852,0.000028212951,0.000011289901,0.00002418725,0.00003183802,0.000019200297],"domain_scores_gemma":[0.9998281,0.000057979836,0.00004446888,0.000018322384,0.0000256499,0.000025538793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024580478,0.00012519823,0.0001841331,0.00022837076,0.0001112415,0.00022571077,0.00008679752,0.0001963097,0.0008475048],"category_scores_gemma":[0.000392224,0.0000731382,0.00011161136,0.00026634758,0.00029869794,0.00014880272,0.00012632922,0.0002531588,0.00018684169],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001970154,0.00011530629,0.07818914,0.00039493633,0.000018834762,0.0014314399,0.00018675407,0.00015696752,0.88949335,0.0001258062,0.00013825715,0.027779],"study_design_scores_gemma":[0.0000719247,0.0022311893,0.5936095,0.000024163337,0.00010445368,0.010186514,0.00039286423,0.00083883567,0.38402164,0.00039975604,0.008102018,0.000017073009],"about_ca_topic_score_codex":0.0001739371,"about_ca_topic_score_gemma":0.00018355445,"teacher_disagreement_score":0.0008475048,"about_ca_system_score_codex":0.00015852325,"about_ca_system_score_gemma":0.0001385974,"threshold_uncertainty_score":0.0028352141},"labels":[],"label_agreement":null},{"id":"W2112053462","doi":"10.1038/sj.bjc.6605966","title":"A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants","year":2010,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Instituto de Salud Carlos III; Medical Research Council; Association Anne de Bretagne Genetique; Conseil Régional des Pays de la Loire; National Cancer Institute; Cancer Research UK; Vetenskapsrådet; Cancerfonden","keywords":"MUTYH; Odds ratio; Allele; Colorectal cancer; Medicine; Oncology; Internal medicine; Genetics; Cancer; Biology; DNA repair; Gene; DNA glycosylase","score_opus":0.044855573910172496,"score_gpt":0.35821469340445616,"score_spread":0.3133591194942837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112053462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08116123,0.8730131,0.028765172,0.0016808013,0.0011530744,0.0013091017,0.010470692,0.00085210544,0.0015947811],"genre_scores_gemma":[0.8801683,0.08388444,0.023242345,0.0015171559,0.00057265355,0.0020755364,0.0073117088,0.00036528468,0.000862516],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9659683,0.024508929,0.0038971659,0.0035863228,0.001534353,0.00050479436],"domain_scores_gemma":[0.94320834,0.045365512,0.0039581032,0.004730431,0.002251479,0.0004861391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0396348,0.0039926064,0.016354367,0.0070207254,0.0007578268,0.0035328332,0.0028001321,0.0024543025,0.0048893387],"category_scores_gemma":[0.07609043,0.0020451993,0.052354,0.0075728856,0.00066161767,0.0017699064,0.0023975233,0.0026843867,0.0006579906],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034211592,0.000020138597,0.007330155,0.018275157,0.9636035,0.000120314704,0.000033717442,0.0018059612,0.000404716,0.00011177247,0.00065951236,0.004213941],"study_design_scores_gemma":[0.0010605708,0.00016464695,0.0046834666,0.000984081,0.99093,0.000075324955,0.000016438342,0.00083054765,0.00011106082,0.00033285393,0.00079202635,0.000019101282],"about_ca_topic_score_codex":0.0063745547,"about_ca_topic_score_gemma":0.009365865,"teacher_disagreement_score":0.0396348,"about_ca_system_score_codex":0.0016869089,"about_ca_system_score_gemma":0.002344322,"threshold_uncertainty_score":0.20961142},"labels":[],"label_agreement":null},{"id":"W2112495854","doi":"10.1038/sj.bjc.6600323","title":"Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Tamoxifen; Breast cancer; Biology; Endocrinology; Internal medicine; Cancer research; Cancer; Medicine; Biochemistry; Enzyme","score_opus":0.019506552153429925,"score_gpt":0.29031418740335446,"score_spread":0.2708076352499245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112495854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908555,0.00043348712,0.00017058666,0.000016557156,0.0000031305688,0.0000029646105,0.000076154196,0.000008589355,0.00020289338],"genre_scores_gemma":[0.99937856,0.0001656513,0.00014303453,0.0000082068555,0.0000041582466,0.0000027021042,0.0001135223,0.0000010901632,0.0001831473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999093,0.00002272384,0.000010183317,0.000019191719,0.000020931348,0.000017739554],"domain_scores_gemma":[0.9995827,0.00009899818,0.00020079555,0.000019908335,0.00003421429,0.00006341456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018002851,0.00016197984,0.00019638853,0.00048938015,0.00008704685,0.00023916319,0.00011608758,0.00026186506,0.0011824887],"category_scores_gemma":[0.0006954816,0.00009661587,0.00014455634,0.00028143238,0.00014212904,0.0001163924,0.00011559471,0.00022077785,0.00027143268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010654479,0.000054757387,0.9127099,0.00004890888,0.00008464304,0.00037445192,0.00007171576,0.00015904906,0.07897513,0.000032978067,0.00013861184,0.0062844465],"study_design_scores_gemma":[0.000004983306,0.00011601045,0.99473095,0.0000029212124,0.00003157296,0.0010381665,0.00003968874,0.00031529888,0.003460796,0.000026303502,0.0002306501,0.000002610402],"about_ca_topic_score_codex":0.00045564436,"about_ca_topic_score_gemma":0.00052728085,"teacher_disagreement_score":0.0011824887,"about_ca_system_score_codex":0.00010977571,"about_ca_system_score_gemma":0.0000664778,"threshold_uncertainty_score":0.003955841},"labels":[],"label_agreement":null},{"id":"W2112508921","doi":"10.1038/sj.bjc.6601246","title":"A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the α-fetoprotein promoter","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Japan Society for the Promotion of Science; Uehara Memorial Foundation; F. Hoffmann-La Roche","keywords":"Midkine; Biology; Molecular biology; Transfection; Enhancer; Suicide gene; Gene; Gene expression; Promoter; Hepatocellular carcinoma; Thymidine kinase; Cancer research; Cell culture; Reporter gene; Genetic enhancement; Virus; Virology; Herpes simplex virus; Growth factor; Genetics","score_opus":0.02263377778941602,"score_gpt":0.2862450341669571,"score_spread":0.2636112563775411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112508921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907782,0.0008711163,0.0075847777,0.000038270457,0.000013855645,0.00002844686,0.00011939216,0.000050029983,0.00051590917],"genre_scores_gemma":[0.99193996,0.0003832902,0.0063340063,0.000015600217,0.0000049143387,0.00002711409,0.0004061662,0.000013431769,0.00087549567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998956,0.000019557061,0.000007975765,0.00001998399,0.00003681417,0.000020061554],"domain_scores_gemma":[0.9998919,0.000036314977,0.00002621808,0.000016958124,0.000014312989,0.000014266056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017368635,0.00014541624,0.00017762333,0.00014229162,0.00007961385,0.0001693074,0.00009148196,0.00015503455,0.00048155285],"category_scores_gemma":[0.0003002122,0.00012612459,0.00016349526,0.00009999666,0.00017681123,0.00011229629,0.00014184146,0.00029082774,0.00024581884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063644875,0.000009526546,0.00039423467,0.000015060433,0.0000019401587,0.000048274662,0.000016436396,0.00005057723,0.9982247,0.00007002854,0.000009440959,0.0010962348],"study_design_scores_gemma":[0.000015804893,0.00031770876,0.004610521,0.000005686062,0.000014760611,0.0011596194,0.000030784624,0.0011225201,0.991002,0.000074388285,0.0016425097,0.0000037029317],"about_ca_topic_score_codex":0.0003375293,"about_ca_topic_score_gemma":0.0004432324,"teacher_disagreement_score":0.00048155285,"about_ca_system_score_codex":0.00020529424,"about_ca_system_score_gemma":0.00018563116,"threshold_uncertainty_score":0.0016109347},"labels":[],"label_agreement":null},{"id":"W2112708133","doi":"10.1054/bjoc.1999.0985","title":"Reducing DCO registrations through electronic matching of cancer registry data and routine hospital data","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Medicine; Lung cancer; Cancer registry; Cancer; Colorectal cancer; Breast cancer; Propensity score matching; Surgery; Internal medicine","score_opus":0.06283408088926952,"score_gpt":0.37845735772372274,"score_spread":0.31562327683445324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112708133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9041419,0.0010949472,0.06669276,0.0021308747,0.00020232519,0.0061580134,0.003993286,0.0005097828,0.015076015],"genre_scores_gemma":[0.92827606,0.00074759085,0.06022702,0.00067167333,0.0001733816,0.0020726123,0.0053014206,0.00011936417,0.0024108167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9302098,0.045121796,0.008482168,0.0045148646,0.009825231,0.0018460345],"domain_scores_gemma":[0.86717284,0.06274374,0.029707579,0.029487541,0.009658427,0.0012298397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04199436,0.0005849843,0.0008364142,0.005797396,0.0009856378,0.0024282213,0.0021410435,0.0007405151,0.0029044845],"category_scores_gemma":[0.1716251,0.00075574947,0.00093472295,0.012803488,0.0006635484,0.0024883351,0.0057411077,0.0007059096,0.0014261351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078682177,0.00041378613,0.78319514,0.0005198814,0.00022811138,0.00016217657,0.0020440344,0.002880532,0.001382018,0.0028264157,0.0023529597,0.20320816],"study_design_scores_gemma":[0.00022623304,0.0012911157,0.94866896,0.00047152943,0.00038268048,0.0007329021,0.00303648,0.019285979,0.0049305055,0.0023181024,0.01856008,0.000095393065],"about_ca_topic_score_codex":0.011502248,"about_ca_topic_score_gemma":0.01056036,"teacher_disagreement_score":0.04199436,"about_ca_system_score_codex":0.0016364473,"about_ca_system_score_gemma":0.0034744132,"threshold_uncertainty_score":0.22209007},"labels":[],"label_agreement":null},{"id":"W2114961850","doi":"10.1038/bjc.2013.278","title":"Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors","year":2013,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Temsirolimus; Everolimus; Medicine; Internal medicine; Renal cell carcinoma; Relative risk; Incidence (geometry); Oncology; Hazard ratio; Cancer; Genitourinary system; Discovery and development of mTOR inhibitors; Kidney cancer; Sirolimus; Confidence interval; PI3K/AKT/mTOR pathway; Biology","score_opus":0.007158168420119823,"score_gpt":0.2473748003285787,"score_spread":0.24021663190845888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114961850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15950125,0.8349454,0.0008428133,0.00040303756,0.00023898607,0.0001627704,0.0028996891,0.000022072089,0.0009839527],"genre_scores_gemma":[0.9113633,0.084698305,0.0010396669,0.00037722982,0.00024334092,0.00026688105,0.0016979942,0.00002051047,0.00029271844],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.99247676,0.0031291822,0.0020293486,0.001160746,0.0009403675,0.00026363312],"domain_scores_gemma":[0.9831632,0.010212106,0.0051595625,0.0005029814,0.0006737403,0.00028833043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070940503,0.000841912,0.004839773,0.0027673116,0.00028813575,0.0012659372,0.00094598945,0.0012460088,0.001387923],"category_scores_gemma":[0.018875042,0.00077606185,0.018485947,0.0039813207,0.0002730664,0.000770686,0.0008364724,0.0014417116,0.000101215126],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023264885,0.00008237578,0.40927422,0.07131823,0.46410993,0.0004768954,0.00022336422,0.0011739471,0.00063938374,0.00026684842,0.0016330163,0.027536897],"study_design_scores_gemma":[0.0021636197,0.001873146,0.41455886,0.00873505,0.5629271,0.0020080542,0.00030357356,0.0013137436,0.00075728906,0.00095971,0.00427931,0.000120542594],"about_ca_topic_score_codex":0.0025195228,"about_ca_topic_score_gemma":0.0029882793,"teacher_disagreement_score":0.0070940503,"about_ca_system_score_codex":0.00065521593,"about_ca_system_score_gemma":0.00076696376,"threshold_uncertainty_score":0.03751743},"labels":[],"label_agreement":null},{"id":"W2115785123","doi":"10.1038/sj.bjc.6605642","title":"Guidelines for the welfare and use of animals in cancer research","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":1445,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Centre for the Replacement, Refinement and Reduction of Animals in Research; University of Leicester; Cancer Research UK; AstraZeneca","keywords":"Medicine; Cancer; Underpinning; Animal welfare; Animal testing; Welfare; Intensive care medicine; Medical physics; Biology; Internal medicine","score_opus":0.5279977563874871,"score_gpt":0.5586178454881463,"score_spread":0.030620089100659165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115785123","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01899994,0.016470755,0.67954123,0.016871441,0.013061444,0.07280003,0.02159417,0.009158625,0.15150242],"genre_scores_gemma":[0.015624302,0.015979666,0.7755136,0.006656423,0.002081448,0.087300226,0.015274102,0.0020999205,0.07947032],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9632436,0.01608476,0.006191625,0.0022311383,0.010535489,0.0017134977],"domain_scores_gemma":[0.9365269,0.016568147,0.004385668,0.01614995,0.023848625,0.002520731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0408623,0.0023948892,0.003555552,0.0054864977,0.0044055725,0.003745794,0.008786498,0.00852282,0.040665116],"category_scores_gemma":[0.03710646,0.0023291649,0.0025055513,0.005029361,0.00428232,0.0028911065,0.0029201466,0.012783042,0.024453692],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031256543,0.0026810945,0.0019497742,0.0062693562,0.00024954087,0.0018381452,0.003228595,0.0017093614,0.067834295,0.03195242,0.58654255,0.29261926],"study_design_scores_gemma":[0.00030493562,0.0009943976,0.00412511,0.002777836,0.00018691947,0.0014183798,0.00025038724,0.0010456119,0.011255484,0.0049190912,0.9725532,0.00016862563],"about_ca_topic_score_codex":0.0049756668,"about_ca_topic_score_gemma":0.019456921,"teacher_disagreement_score":0.0408623,"about_ca_system_score_codex":0.002681613,"about_ca_system_score_gemma":0.01006392,"threshold_uncertainty_score":0.21610314},"labels":[],"label_agreement":null},{"id":"W2115899860","doi":"10.1038/bjc.2014.6","title":"Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Newfoundland and Labrador Centre for Applied Health Research; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Medicine; Microsatellite instability; Hazard ratio; Internal medicine; Colorectal cancer; Proportional hazards model; Confidence interval; Cohort; Cancer; Oncology; Gastroenterology; Microsatellite; Allele","score_opus":0.007947417274073987,"score_gpt":0.26597383263192337,"score_spread":0.25802641535784937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115899860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986319,0.00063335,0.00004922941,0.00004989919,0.000003785969,0.0000032921312,0.0002826526,0.0000039533993,0.00034194803],"genre_scores_gemma":[0.99955815,0.000095951524,0.00002034664,0.0000105537465,0.0000037131174,0.0000015731987,0.00020669115,0.0000013199665,0.00010172981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996716,0.00006614486,0.00001914088,0.00006403385,0.00007128947,0.00010781774],"domain_scores_gemma":[0.99848866,0.00040088268,0.00047706734,0.00012383398,0.00016373217,0.00034576774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064943975,0.00018517525,0.00023722011,0.00044120435,0.00019634975,0.00044059812,0.00028260658,0.00033430217,0.001175536],"category_scores_gemma":[0.0018024954,0.0001211999,0.00051999313,0.00039948625,0.0002659824,0.00022680797,0.00027771332,0.00042868694,0.0001473334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029906188,0.000009365915,0.9981692,0.0000048687966,0.0000618135,0.00002386416,0.000012871342,0.000039420764,0.00017427644,0.0000040318346,0.000035396144,0.0011659326],"study_design_scores_gemma":[0.0000015128617,0.000034512956,0.99976057,0.0000010988934,0.00002379125,0.000048838592,0.000012244093,0.000056629666,0.00002111665,0.0000039699603,0.000035046658,7.5411407e-7],"about_ca_topic_score_codex":0.018035099,"about_ca_topic_score_gemma":0.034955736,"teacher_disagreement_score":0.018035099,"about_ca_system_score_codex":0.00050187245,"about_ca_system_score_gemma":0.0004566403,"threshold_uncertainty_score":0.0358603},"labels":[],"label_agreement":null},{"id":"W2116372322","doi":"10.1038/sj.bjc.6602121","title":"Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Multiplex ligation-dependent probe amplification; Familial adenomatous polyposis; Colorectal cancer; Proband; Gene duplication; Mutation; Adenomatous polyposis coli; Cancer; Germline mutation; Genetics; Mutation testing; Medicine; Point mutation; Multiplex; Biology; Gene; Exon","score_opus":0.012370022740910541,"score_gpt":0.3013767852610982,"score_spread":0.28900676252018764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116372322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8545911,0.004261934,0.13383396,0.00019565922,0.000042233765,0.0002642779,0.0018939029,0.0011198501,0.0037971225],"genre_scores_gemma":[0.9153907,0.0011130829,0.07786738,0.000079849466,0.000026952654,0.00034474005,0.0017324,0.000051400984,0.0033935588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999175,0.00016879328,0.00004822477,0.0003270156,0.00021205591,0.000068904315],"domain_scores_gemma":[0.99956566,0.00016327211,0.00010313374,0.00007566257,0.00005887052,0.000033285007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005775322,0.000489785,0.00036935258,0.0016996404,0.00020475725,0.00034284816,0.0003304941,0.00034312528,0.0016851993],"category_scores_gemma":[0.0010970973,0.0003022818,0.00020221907,0.0005851307,0.0002728358,0.00020231568,0.00031689246,0.0003614863,0.0006359787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023736377,0.000050592003,0.012584318,0.00009746044,0.00007417724,0.00033687064,0.0001376086,0.00033142124,0.94848454,0.00027874287,0.00027784926,0.037109062],"study_design_scores_gemma":[0.000052866642,0.0007216231,0.10784006,0.000020910149,0.00016205464,0.004756215,0.00006082372,0.009958374,0.86448777,0.00048166345,0.011411204,0.000046345423],"about_ca_topic_score_codex":0.0005747985,"about_ca_topic_score_gemma":0.0009324543,"teacher_disagreement_score":0.0016996404,"about_ca_system_score_codex":0.00028736377,"about_ca_system_score_gemma":0.00010183637,"threshold_uncertainty_score":0.005637586},"labels":[],"label_agreement":null},{"id":"W2117461801","doi":"10.1054/bjoc.2000.1649","title":"Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Biology; Ovarian cancer; Cancer; Internal medicine; Oncology; Molecular biology; Medicine; Genetics","score_opus":0.027338105157517993,"score_gpt":0.32242244239590157,"score_spread":0.29508433723838356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117461801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988003,0.0006862204,0.00020502218,0.000014730279,0.0000034546833,0.000003849037,0.00007788684,0.0000048455468,0.00020368156],"genre_scores_gemma":[0.9995053,0.00015761836,0.00010228321,0.0000076251067,0.000003557439,0.0000021904502,0.00011810216,6.826284e-7,0.00010262273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998884,0.000023054808,0.00001245342,0.000020134476,0.000030767736,0.00002526884],"domain_scores_gemma":[0.99973816,0.00007246779,0.000106567495,0.000013106057,0.000024803277,0.00004490766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024787724,0.00010175784,0.00015902195,0.00040888556,0.00014788908,0.00024021626,0.00007715486,0.0001783774,0.00060745527],"category_scores_gemma":[0.00054684276,0.00008037476,0.00013019721,0.00042829523,0.0001761561,0.0001282808,0.00021442518,0.00014947978,0.000096786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004301811,0.000016463773,0.9750861,0.000037671398,0.000041823172,0.00016989055,0.00007171945,0.000118959884,0.018280128,0.000018390221,0.00009223559,0.005636531],"study_design_scores_gemma":[0.0000038760927,0.00007045976,0.9976063,0.0000030265562,0.000024164965,0.00031036642,0.000039382383,0.00025047452,0.0014642626,0.000020642481,0.00020510446,0.0000019762847],"about_ca_topic_score_codex":0.0010004654,"about_ca_topic_score_gemma":0.0013296391,"teacher_disagreement_score":0.0010004654,"about_ca_system_score_codex":0.00015573445,"about_ca_system_score_gemma":0.000103483704,"threshold_uncertainty_score":0.0020321608},"labels":[],"label_agreement":null},{"id":"W2119841327","doi":"10.1038/sj.bjc.6604426","title":"Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Cancer Research UK","keywords":"Immunohistochemistry; Pathology; Medicine; Angiogenesis; Combretastatin; Internal medicine; Biology","score_opus":0.09715634343784149,"score_gpt":0.3529410901311647,"score_spread":0.2557847466933232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119841327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988444,0.0004607988,0.00028699863,0.000009119797,0.0000016449869,0.000015824187,0.00007616726,0.0000048208794,0.00030018657],"genre_scores_gemma":[0.99915624,0.00017598458,0.0002763203,0.000011459166,0.000004197495,0.000012936656,0.00017618375,0.0000024732674,0.00018425078],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985814,0.000047563164,0.000009949872,0.000026636126,0.000028746901,0.000029070343],"domain_scores_gemma":[0.9996233,0.00014103668,0.00009300537,0.00004697326,0.00003682556,0.000058930313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003282333,0.00012302144,0.00031828255,0.00022180157,0.00012062904,0.00028486105,0.00008742285,0.00016098362,0.0012634685],"category_scores_gemma":[0.00057963625,0.00008032963,0.00010499275,0.00024693017,0.00019541981,0.00015840134,0.00008777552,0.00023295164,0.0002992809],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015216222,0.0010731876,0.16371451,0.00019151524,0.000114609655,0.0012577365,0.00026148037,0.00047847314,0.7884005,0.0001531891,0.00025420377,0.02888444],"study_design_scores_gemma":[0.0003140884,0.022091495,0.6112486,0.00001281783,0.00019393394,0.00980904,0.00032396003,0.0041559488,0.34607345,0.00016319993,0.0055842856,0.000029128805],"about_ca_topic_score_codex":0.000526524,"about_ca_topic_score_gemma":0.0003787731,"teacher_disagreement_score":0.0012634685,"about_ca_system_score_codex":0.0002280907,"about_ca_system_score_gemma":0.0001373528,"threshold_uncertainty_score":0.004226744},"labels":[],"label_agreement":null},{"id":"W2120225922","doi":"10.1038/sj.bjc.6600869","title":"Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Prostate cancer; Prostate; Cytokine; PCA3; Cancer; Gene expression; Prostatectomy; Tissue microarray; Pathology; Medicine; Biomarker; Biology; Prostate-specific antigen; Cancer research; Immunohistochemistry; Gene; Internal medicine","score_opus":0.013539525066377534,"score_gpt":0.3192453480533851,"score_spread":0.3057058229870076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120225922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798925,0.0037251,0.013614048,0.00005237528,0.00003575439,0.0001081043,0.0010869118,0.00011157569,0.0013735763],"genre_scores_gemma":[0.96803814,0.002339966,0.023648994,0.000094179384,0.00004805911,0.0005720471,0.0021292816,0.00003544796,0.0030938184],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995427,0.000105717205,0.000031223582,0.00010885128,0.00015540326,0.000056095567],"domain_scores_gemma":[0.999663,0.00014376965,0.000058580255,0.000025762765,0.00008268446,0.000026179627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040381786,0.00020844619,0.00022548813,0.00073088286,0.0002057118,0.0002951999,0.00012557858,0.00022351417,0.0009343432],"category_scores_gemma":[0.00045631203,0.00018144336,0.00014680653,0.0007717424,0.0002607867,0.00013858234,0.00015255653,0.00031552862,0.00026772238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035507575,0.00005916781,0.005768266,0.00013042249,0.000015563724,0.000056863322,0.00012632484,0.00009533364,0.9880419,0.000047339217,0.00003613546,0.0052675055],"study_design_scores_gemma":[0.000029362976,0.001327058,0.16377148,0.000028811171,0.0000853624,0.0010436651,0.00031693198,0.002537755,0.8271661,0.00015336684,0.0035133336,0.000026650298],"about_ca_topic_score_codex":0.00026110467,"about_ca_topic_score_gemma":0.00039194143,"teacher_disagreement_score":0.0009343432,"about_ca_system_score_codex":0.00011925522,"about_ca_system_score_gemma":0.00014555622,"threshold_uncertainty_score":0.0031256676},"labels":[],"label_agreement":null},{"id":"W2120755219","doi":"10.1038/sj.bjc.6605937","title":"Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences; University of Guelph; University of Ottawa; National Research Council Canada","funders":"Canadian Institutes of Health Research","keywords":"Single-domain antibody; In vivo; Biodistribution; Ex vivo; Antibody; Molecular biology; Surface plasmon resonance; Chemistry; Molecular imaging; In vitro; Pathology; Biology; Biophysics; Materials science; Biochemistry; Medicine; Immunology; Nanotechnology; Nanoparticle","score_opus":0.012132804098043288,"score_gpt":0.26521721690828254,"score_spread":0.25308441281023925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120755219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95715696,0.005874168,0.033343192,0.0002002201,0.000045580182,0.00005941404,0.00015893398,0.00023142737,0.0029301161],"genre_scores_gemma":[0.95903563,0.003246311,0.034348015,0.000218312,0.00002017973,0.000079207435,0.00035433672,0.000024507664,0.0026734003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990237,0.000017164877,0.0000040328077,0.000023265598,0.000030017583,0.000023140687],"domain_scores_gemma":[0.99993753,0.000012774734,0.000014245947,0.0000036700576,0.000021077949,0.000010578715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019852672,0.00036636228,0.00018732387,0.00032200888,0.00007398002,0.00017313787,0.00031016662,0.00045838387,0.0008452068],"category_scores_gemma":[0.00012321069,0.00014644428,0.00032944875,0.00010180977,0.00010397461,0.00018108127,0.00016011378,0.00029333984,0.00036195564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042816162,0.000017243818,0.00013455647,0.00007315959,0.000009406872,0.000043404565,0.000005524026,0.0001335008,0.996988,0.000055797394,0.00007386267,0.0024228191],"study_design_scores_gemma":[0.000017663719,0.00042494523,0.0030433107,0.000016459875,0.00003383395,0.0006431813,0.000015279562,0.00547142,0.98762286,0.00006011483,0.0026432083,0.0000076768865],"about_ca_topic_score_codex":0.00058766955,"about_ca_topic_score_gemma":0.0010836651,"teacher_disagreement_score":0.0008452068,"about_ca_system_score_codex":0.00036809628,"about_ca_system_score_gemma":0.00015924424,"threshold_uncertainty_score":0.0028274655},"labels":[],"label_agreement":null},{"id":"W2121199363","doi":"10.1054/bjoc.1999.0927","title":"Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Prostate; Mammary gland; Internal medicine; Medicine; Prostate-specific antigen; Endocrinology; Receptor; Kallikrein; Progesterone receptor; Breast cancer; Biology; Pathology; Estrogen receptor; Cancer; Enzyme","score_opus":0.0065162042821127,"score_gpt":0.25067196213105103,"score_spread":0.24415575784893834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121199363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804795,0.0009983695,0.00043491198,0.00002166241,0.0000054129846,0.0000052058795,0.0001633532,0.0000129064065,0.00031034515],"genre_scores_gemma":[0.9970662,0.0005860708,0.00070455304,0.000015227607,0.000013250456,0.000008348132,0.0005575151,0.000004320953,0.0010446806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998845,0.000017801378,0.0000090135245,0.00003608275,0.000024484298,0.00002812624],"domain_scores_gemma":[0.99986684,0.000031291518,0.000027312291,0.000014607664,0.000017918725,0.00004207057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102518985,0.00015824553,0.0001110754,0.000434714,0.00014980912,0.00025980544,0.00010954379,0.0001818079,0.0009431536],"category_scores_gemma":[0.00034743242,0.00015950183,0.00010923148,0.0003349737,0.00028342387,0.00018219958,0.0001492445,0.00015203665,0.00027033454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009849109,0.00003514823,0.037153605,0.000102980506,0.000032179138,0.00035679218,0.00015049323,0.00006790471,0.95747316,0.000096111864,0.000115340066,0.0034313549],"study_design_scores_gemma":[0.00004215428,0.00077168253,0.72145313,0.000009834922,0.00008273464,0.005714404,0.00035156822,0.0012168746,0.26652664,0.00018145768,0.0036309764,0.000018549377],"about_ca_topic_score_codex":0.0012329884,"about_ca_topic_score_gemma":0.0008491085,"teacher_disagreement_score":0.0012329884,"about_ca_system_score_codex":0.00019851327,"about_ca_system_score_gemma":0.00014109201,"threshold_uncertainty_score":0.0031551719},"labels":[],"label_agreement":null},{"id":"W2121322385","doi":"10.1038/bjc.2011.364","title":"Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Dalhousie University; Juravinski Cancer Centre; Hôtel-Dieu de Québec","funders":"","keywords":"Nomogram; Medicine; Oncology; Concordance; Ovarian cancer; Cohort; Internal medicine; Chemotherapy; Progression-free survival; Confidence interval; Cancer; Surgery","score_opus":0.016965124006928674,"score_gpt":0.27703905316030875,"score_spread":0.26007392915338007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121322385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97126937,0.0030048871,0.020496856,0.0006018831,0.00017744194,0.00019419169,0.0011534784,0.00022361006,0.0028782368],"genre_scores_gemma":[0.9927233,0.00026394922,0.005924243,0.000041496634,0.000038713068,0.00005943999,0.0008052457,0.000015916821,0.00012772175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895096,0.0005919386,0.00008754098,0.000094425544,0.00021540266,0.00005974253],"domain_scores_gemma":[0.99358374,0.003661686,0.0009925091,0.0004177677,0.00090803957,0.00043622658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055014235,0.00064402155,0.0006995275,0.002021425,0.00036426922,0.0008393087,0.00053683226,0.00040970003,0.0009790163],"category_scores_gemma":[0.016687434,0.00013570843,0.00077263545,0.0008920944,0.00028672063,0.0006013855,0.000672882,0.00080179056,0.00027178487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008545865,0.00006365072,0.9383583,0.00006776069,0.00023149424,0.00011457413,0.00009074449,0.008662683,0.00035320123,0.00016924711,0.0020836082,0.048950136],"study_design_scores_gemma":[0.000259268,0.0011638408,0.7613183,0.0001677889,0.0007015214,0.0015801205,0.0002469806,0.22533603,0.0015157002,0.0014230196,0.0062159975,0.00007149413],"about_ca_topic_score_codex":0.0011626867,"about_ca_topic_score_gemma":0.0013305772,"teacher_disagreement_score":0.0055014235,"about_ca_system_score_codex":0.00051744084,"about_ca_system_score_gemma":0.0005461294,"threshold_uncertainty_score":0.029094636},"labels":[],"label_agreement":null},{"id":"W2122503009","doi":"10.1038/bjc.2011.552","title":"Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Health and Medical Research Council; Cancer Australia; Medical Research Council; Australian Government; U.S. Department of Veterans Affairs","keywords":"Medicine; Prostate cancer; Prostatectomy; Population; Androgen deprivation therapy; Radiation therapy; Urology; Internal medicine; Gynecology; Surgery; Cancer","score_opus":0.024364774139992027,"score_gpt":0.3181302098515638,"score_spread":0.29376543571157177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122503009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968245,0.00038792656,0.0017743668,0.00017501651,0.000010417523,0.00012776574,0.00013730577,0.000011813498,0.00055092195],"genre_scores_gemma":[0.9987344,0.00009766412,0.00086132163,0.000044391065,0.0000054016086,0.00009033195,0.00005959905,0.0000011380357,0.0001058982],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99638015,0.0029017308,0.00013407886,0.00021017321,0.00020593381,0.00016793088],"domain_scores_gemma":[0.98604286,0.011589401,0.0014770632,0.00041235433,0.00015089798,0.0003273854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009609928,0.00029709755,0.0007196444,0.00031486334,0.00014678342,0.00039442535,0.00026098595,0.0004473453,0.0031230608],"category_scores_gemma":[0.013529323,0.00011752608,0.0007982087,0.00028296438,0.0008210591,0.0004724069,0.00068660517,0.00074814307,0.000117673546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17299895,0.017729502,0.24231045,0.003677836,0.0035358018,0.00035242244,0.0010623978,0.14438494,0.02049371,0.010926654,0.0014071163,0.38112012],"study_design_scores_gemma":[0.02168239,0.24385147,0.57190824,0.00052801054,0.0027622276,0.0007274762,0.00096954976,0.096109964,0.017557984,0.038511395,0.0052346783,0.00015657488],"about_ca_topic_score_codex":0.0005545708,"about_ca_topic_score_gemma":0.0005945995,"teacher_disagreement_score":0.009609928,"about_ca_system_score_codex":0.0007159202,"about_ca_system_score_gemma":0.0006566378,"threshold_uncertainty_score":0.050822735},"labels":[],"label_agreement":null},{"id":"W2122516297","doi":"10.1038/sj.bjc.6600590","title":"The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Prostate-specific antigen; Kallikrein; Breast cancer; Prostate cancer; Hazard ratio; Androgen receptor; Oncology; Progesterone receptor; Biology; Cancer; Internal medicine; Prostate; Cancer research; Medicine; Estrogen receptor","score_opus":0.023587726819291242,"score_gpt":0.28315108858733234,"score_spread":0.2595633617680411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122516297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068755,0.0064403745,0.0008962957,0.00010180366,0.000027648743,0.000010409902,0.00076963264,0.00003964463,0.0010267],"genre_scores_gemma":[0.99698216,0.0012538864,0.00033678015,0.00002504189,0.000030229658,0.000004551004,0.0006884189,0.0000028947595,0.00067598216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998691,0.000026920628,0.000010193771,0.000028555076,0.000047280035,0.000017846593],"domain_scores_gemma":[0.999684,0.00006284042,0.00012442784,0.000017910936,0.000040393763,0.00007047848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020901897,0.00019545635,0.0002619672,0.00047580284,0.00013707843,0.00026002128,0.00013090704,0.00013876773,0.0017377391],"category_scores_gemma":[0.00044998518,0.000082255996,0.00019336134,0.0005652102,0.00017230256,0.000102056074,0.00017046659,0.00024231462,0.00034980357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010834867,0.000053450483,0.93776345,0.00012880344,0.00017651543,0.00031326248,0.000053851007,0.00022014132,0.036153134,0.00009263272,0.00060127414,0.023359956],"study_design_scores_gemma":[0.000010810113,0.00013787535,0.992281,0.000008949505,0.000078415964,0.0011325817,0.000028954093,0.00033864018,0.0042987852,0.00008394261,0.0015945503,0.000005433412],"about_ca_topic_score_codex":0.00093319773,"about_ca_topic_score_gemma":0.0012296331,"teacher_disagreement_score":0.0017377391,"about_ca_system_score_codex":0.00018244679,"about_ca_system_score_gemma":0.00019413188,"threshold_uncertainty_score":0.00581336},"labels":[],"label_agreement":null},{"id":"W2123889466","doi":"10.1038/bjc.2012.160","title":"Association of PHB 1630 C&gt;T and MTHFR 677 C&gt;T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Cancer Care Ontario; Centre hospitalier universitaire de Québec; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Sahlgrenska Universitetssjukhuset; Cancer Care Ontario; Akademiska Sjukhuset; Odense Universitetshospital; Mayo Clinic; Istituto Toscano Tumori; Lunds Universitet; ZonMw; Ministerio de Ciencia e Innovación; National Institute for Health and Care Research; Uppsala Universitet; Cancer Australia; National Health and Medical Research Council; Cancer Research UK; University of Pennsylvania; Susan G. Komen; Deutsches Krebsforschungszentrum; Royal Marsden NHS Foundation Trust; Medical Research Council; Breast Cancer Research Foundation; National Breast Cancer Foundation","keywords":"Methylenetetrahydrofolate reductase; Ovarian cancer; Breast cancer; Oncology; Genotype; Mutation; Medicine; Internal medicine; Genetics; Cancer research; Gynecology; Biology; Cancer; Gene","score_opus":0.006185870280546171,"score_gpt":0.2531326242416453,"score_spread":0.2469467539610991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123889466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992586,0.00029260578,0.00007693855,0.000027221718,0.0000032621651,0.000009284558,0.00024319766,0.0000024147564,0.000086624204],"genre_scores_gemma":[0.99925715,0.00011846309,0.00013708176,0.000029040846,0.000012342547,0.000012018761,0.0003475007,0.0000048458496,0.00008144288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989505,0.00039672625,0.00008290313,0.00034493854,0.0001405541,0.00008445025],"domain_scores_gemma":[0.9972727,0.00060520094,0.0010199514,0.000422593,0.00023033134,0.0004493167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019304969,0.00059507065,0.0006953961,0.0005758086,0.0005208471,0.0005811645,0.0005245003,0.00073595357,0.0013038744],"category_scores_gemma":[0.0028333918,0.00042462826,0.00093816785,0.0012270071,0.00042385567,0.00025830668,0.000412672,0.0004762525,0.00020963128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013956333,0.00005649688,0.9949433,0.00001988338,0.00065184967,0.00016557015,0.00009953037,0.000037739333,0.001476663,0.000011391223,0.00010052954,0.0010413231],"study_design_scores_gemma":[0.00012068778,0.0002541165,0.99827623,0.000008557346,0.00041601202,0.00042615962,0.00006798023,0.00010974933,0.00015454908,0.000015747628,0.00014568224,0.0000045514867],"about_ca_topic_score_codex":0.0055539347,"about_ca_topic_score_gemma":0.00407643,"teacher_disagreement_score":0.0055539347,"about_ca_system_score_codex":0.00024689577,"about_ca_system_score_gemma":0.00029155568,"threshold_uncertainty_score":0.011043191},"labels":[],"label_agreement":null},{"id":"W2125348134","doi":"10.1038/sj.bjc.6605247","title":"Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"University College Dublin; Science Foundation Ireland; Higher Education Authority; Health Research Board","keywords":"Photodynamic therapy; In vivo; Biodistribution; Positron emission tomography; Magnetic resonance imaging; Medicine; Pathology; Nuclear medicine; Chemistry; Radiology; Biology","score_opus":0.01937040422838076,"score_gpt":0.348057357219539,"score_spread":0.32868695299115824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125348134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88340396,0.018248267,0.091751136,0.00041542458,0.000074224234,0.00026437631,0.00022429985,0.00045424726,0.0051640603],"genre_scores_gemma":[0.91114724,0.006951896,0.07824554,0.0000888701,0.000037129765,0.00011999394,0.0001783463,0.000039251077,0.0031916748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998834,0.000032874872,0.000005052056,0.00003173877,0.000027749289,0.000019135443],"domain_scores_gemma":[0.9999254,0.000023259525,0.000019501473,0.000008996701,0.0000117813615,0.000010972288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003824204,0.00034094707,0.0002619497,0.000312877,0.000119320524,0.00037017922,0.00035129188,0.0005479922,0.0011626916],"category_scores_gemma":[0.00020373135,0.00017308127,0.00016343246,0.00020019873,0.0002833342,0.00052327715,0.00027602917,0.00057763956,0.0002955277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007554803,0.00002233168,0.00009363779,0.00005642621,0.000004593033,0.000028072885,0.000010666073,0.00019372675,0.99510056,0.00017727862,0.000043262986,0.0041938666],"study_design_scores_gemma":[0.000018722258,0.00044963445,0.001180749,0.0000064289798,0.000017269938,0.00051707274,0.0000071445743,0.0031415736,0.99138004,0.000073146206,0.0032011475,0.0000071503546],"about_ca_topic_score_codex":0.00036108782,"about_ca_topic_score_gemma":0.00040881286,"teacher_disagreement_score":0.0011626916,"about_ca_system_score_codex":0.00039368347,"about_ca_system_score_gemma":0.000143342,"threshold_uncertainty_score":0.0038895607},"labels":[],"label_agreement":null},{"id":"W2127027577","doi":"10.1038/bjc.2011.82","title":"Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"DNA methylation; Colorectal cancer; Methylation; microRNA; Oncology; Cancer research; Gene silencing; Biology; Internal medicine; Medicine; Cancer; Gene expression; Gene; Genetics","score_opus":0.018687962807275492,"score_gpt":0.2813667076425773,"score_spread":0.26267874483530185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127027577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915023,0.0043594344,0.0026574288,0.00010004352,0.0000252194,0.000044796107,0.0003070808,0.000070090384,0.0009337705],"genre_scores_gemma":[0.9948879,0.00065149297,0.0036823647,0.000047717025,0.000015026575,0.000029071909,0.00026691818,0.0000062089225,0.00041330297],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998049,0.000052428077,0.000013890626,0.000039781546,0.00006871773,0.000020177118],"domain_scores_gemma":[0.99968517,0.000080834594,0.00010534939,0.000016387437,0.00006841683,0.000043920936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032842925,0.00025099886,0.00030829603,0.0008369692,0.0001400811,0.00031014506,0.00015556869,0.00027308095,0.0009481758],"category_scores_gemma":[0.00068901107,0.00014914322,0.0001474076,0.00035305973,0.00017806134,0.00014249557,0.00020753176,0.00030411012,0.00020936642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027286161,0.00020343062,0.3137378,0.0004976373,0.000122616,0.00066652417,0.00014384084,0.0003940389,0.63275826,0.00010751401,0.0004838855,0.048155688],"study_design_scores_gemma":[0.000105750485,0.003063842,0.7361814,0.00008721417,0.0004026883,0.007766234,0.00022151787,0.008002699,0.23919393,0.00023315915,0.004701936,0.000039722447],"about_ca_topic_score_codex":0.00027680214,"about_ca_topic_score_gemma":0.00061321206,"teacher_disagreement_score":0.0009481758,"about_ca_system_score_codex":0.00017533566,"about_ca_system_score_gemma":0.00013540195,"threshold_uncertainty_score":0.0031719208},"labels":[],"label_agreement":null},{"id":"W2127958425","doi":"10.1038/bjc.2013.454","title":"Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alteration","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Gene; Epigenetics; Cancer; Somatic cell; Cancer research; Lung cancer; Gene duplication; Biomarker; Genetics; Pathology; Medicine","score_opus":0.009375384420853316,"score_gpt":0.30702985745197425,"score_spread":0.2976544730311209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127958425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733186,0.00041027935,0.0008050381,0.000034616416,0.0000017478526,0.000017033879,0.00094548735,0.000028622548,0.00042525615],"genre_scores_gemma":[0.99816126,0.00011666925,0.0007785055,0.00000899329,0.0000025427748,0.000008476661,0.0008158163,0.0000034913678,0.0001042581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977297,0.000027643691,0.000028168382,0.00005682849,0.00007133493,0.000043051394],"domain_scores_gemma":[0.99932206,0.00026333396,0.0002202883,0.00005446198,0.00007373472,0.00006617118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028604927,0.00015072498,0.00021426637,0.001434846,0.00023380856,0.00032799772,0.0001970435,0.00026715634,0.002639802],"category_scores_gemma":[0.001004679,0.00008480619,0.00019797776,0.0014641073,0.00025462644,0.00015345246,0.0003798393,0.0002473425,0.0003919874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010589792,0.00007526067,0.7445371,0.00024501502,0.00016745071,0.0012871557,0.00017520506,0.00038876687,0.22562486,0.00015695968,0.0004228779,0.025860375],"study_design_scores_gemma":[0.000016929194,0.00019472947,0.9338983,0.000015194811,0.000117673604,0.005376138,0.00015445115,0.0017782483,0.056879576,0.00025834588,0.0013023599,0.0000081024145],"about_ca_topic_score_codex":0.0013824775,"about_ca_topic_score_gemma":0.0018826356,"teacher_disagreement_score":0.002639802,"about_ca_system_score_codex":0.00026717136,"about_ca_system_score_gemma":0.00025385272,"threshold_uncertainty_score":0.008831024},"labels":[],"label_agreement":null},{"id":"W2129685551","doi":"10.1038/sj.bjc.6604717","title":"Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Cancer research; Gene knockdown; Pancreatic cancer; Gene silencing; Immunohistochemistry; Tissue microarray; Cancer; Adenocarcinoma; Biology; Pathology; Medicine; Internal medicine; Gene; Genetics","score_opus":0.026604184542228557,"score_gpt":0.29858961185981714,"score_spread":0.27198542731758857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129685551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780864,0.0012725656,0.0003624234,0.0000374069,0.000010362844,0.0000035188466,0.00018917694,0.00001594351,0.0002999702],"genre_scores_gemma":[0.99870706,0.00030428602,0.000376714,0.000010858227,0.000009365957,0.0000051875486,0.0002696002,0.0000032182527,0.00031363717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997559,0.00005472377,0.00002905789,0.000052545638,0.00006337083,0.00004434439],"domain_scores_gemma":[0.99947494,0.00012266837,0.00018428458,0.000038952945,0.00006672252,0.00011244911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034190938,0.00020878017,0.00030555337,0.0005617044,0.00016738758,0.0005438544,0.00013318752,0.00025131856,0.0009906272],"category_scores_gemma":[0.00060905644,0.00012185859,0.00033091687,0.0007128674,0.0001585553,0.00017750819,0.00022944632,0.0003290479,0.00025109437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028583144,0.000102341524,0.8577967,0.00016392073,0.00027431746,0.00062805426,0.00010663058,0.000643245,0.12272113,0.00007211862,0.000310511,0.014322642],"study_design_scores_gemma":[0.000017562514,0.0003181967,0.9757759,0.000009521485,0.00024602408,0.0017012256,0.00019414056,0.0033047474,0.016928287,0.00013155378,0.0013564822,0.000016387323],"about_ca_topic_score_codex":0.0006240062,"about_ca_topic_score_gemma":0.00083694514,"teacher_disagreement_score":0.0009906272,"about_ca_system_score_codex":0.00022230887,"about_ca_system_score_gemma":0.00018363462,"threshold_uncertainty_score":0.0033139586},"labels":[],"label_agreement":null},{"id":"W2131784126","doi":"10.1038/bjc.2015.343","title":"A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Eribulin; Neutropenia; Internal medicine; Cohort; Oncology; Chemotherapy; Metastatic breast cancer; Cancer; Gastroenterology; Breast cancer","score_opus":0.017153020109714832,"score_gpt":0.34147396194387003,"score_spread":0.3243209418341552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131784126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472696,0.0012921304,0.0002877426,0.0006179568,0.00003124815,0.0015248621,0.00030289535,0.000027754963,0.0011883632],"genre_scores_gemma":[0.98730475,0.00229782,0.0023031621,0.0015188423,0.00017340099,0.0028399585,0.0015797686,0.000024551216,0.0019578773],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986033,0.00084686157,0.00006063642,0.0001778146,0.00017192306,0.00013953687],"domain_scores_gemma":[0.99799687,0.00027883472,0.00038941443,0.00019077031,0.00017425815,0.0009698368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005192562,0.0011985559,0.0017109627,0.0004903682,0.00056869973,0.00075365516,0.001000738,0.0012463637,0.0023462342],"category_scores_gemma":[0.001467692,0.0005714483,0.001339128,0.00071458553,0.0010924996,0.00083127036,0.00058640423,0.002840163,0.0005911182],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60932255,0.11376889,0.033053197,0.001070434,0.0038152596,0.00061042985,0.0012288379,0.0037983651,0.05868541,0.00046610122,0.006947687,0.16723289],"study_design_scores_gemma":[0.421223,0.51950693,0.04808042,0.000035625315,0.00072565983,0.0004885721,0.00010823756,0.0010654308,0.0029692212,0.0001745103,0.0055770413,0.000045396537],"about_ca_topic_score_codex":0.0021278346,"about_ca_topic_score_gemma":0.0040210094,"teacher_disagreement_score":0.005192562,"about_ca_system_score_codex":0.0014881861,"about_ca_system_score_gemma":0.0025536765,"threshold_uncertainty_score":0.02746123},"labels":[],"label_agreement":null},{"id":"W2132378346","doi":"10.1038/sj.bjc.6601839","title":"Role of osteopontin in tumour progression","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":412,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Osteopontin; Metastasis; Cancer; Biology; Cancer research; Malignant transformation; Tumor progression; Pathology; Medicine; Bioinformatics; Immunology; Genetics","score_opus":0.020874727590489955,"score_gpt":0.3671525670849019,"score_spread":0.34627783949441193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132378346","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088152054,0.99902153,0.00005855126,0.00012004879,0.000076338736,0.0000019914805,0.000006511487,0.0000032573816,0.0006236049],"genre_scores_gemma":[0.0005331149,0.99876547,0.000085477244,0.00006584509,0.00006849628,0.000003653192,0.000010755622,6.231787e-7,0.00046661406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979585,0.000034324737,0.00003157605,0.000041253454,0.00008105484,0.000015898555],"domain_scores_gemma":[0.9997435,0.000109270906,0.00003679548,0.000009394661,0.000073303956,0.000027637447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005358962,0.00070011104,0.0014162118,0.0020857835,0.0002951487,0.0009300705,0.00069830555,0.001117857,0.003089034],"category_scores_gemma":[0.0006518796,0.00024261468,0.0002904318,0.002039079,0.0005394699,0.0011020618,0.0006063565,0.0010510274,0.0029171407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009181011,0.0000474416,0.00020487941,0.010739686,0.00005096808,0.00039198156,0.000069589805,0.00030570175,0.0030294002,0.0026265814,0.013936012,0.96850586],"study_design_scores_gemma":[0.000017691544,0.00009095876,0.0012764354,0.002553354,0.000061140774,0.0019868303,0.00007195396,0.000049988193,0.0009331426,0.0018089276,0.991137,0.000012620855],"about_ca_topic_score_codex":0.0014728864,"about_ca_topic_score_gemma":0.0019558987,"teacher_disagreement_score":0.003089034,"about_ca_system_score_codex":0.0007013047,"about_ca_system_score_gemma":0.0009971102,"threshold_uncertainty_score":0.010333896},"labels":[],"label_agreement":null},{"id":"W2132798572","doi":"10.1038/sj.bjc.6605279","title":"The TP53 Arg72Pro and MDM2 309G&gt;T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; Cancer Care Ontario; Centre Hospitalier Universitaire Sainte-Justine; Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"Medical Research Council; Canadian Institutes of Health Research; National Institute for Health and Care Research; Ministerio de Ciencia e Innovación; National Breast Cancer Foundation; National Cancer Institute; KWF Kankerbestrijding; National Institutes of Health; National Health and Medical Research Council; Cancer Research UK; Deutsche Krebshilfe; Cancer Care Ontario; Royal Marsden NHS Foundation Trust; Deutsches Krebsforschungszentrum; Helsingin ja Uudenmaan Sairaanhoitopiiri","keywords":"Breast cancer; Single-nucleotide polymorphism; Genotype; SNP; Oncology; Hazard ratio; Internal medicine; Carcinogenesis; Medicine; Allele; Cancer; Confidence interval; Genetics; Biology; Cancer research; Gene","score_opus":0.005273202937819501,"score_gpt":0.23216079520773003,"score_spread":0.22688759226991054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132798572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782205,0.0009811737,0.00040536883,0.000036098514,0.000019797943,0.000010634534,0.00038328272,0.000014992806,0.0003265787],"genre_scores_gemma":[0.9991385,0.00013116452,0.00014760533,0.000014649026,0.000018568539,0.000009911544,0.00033839451,0.000009235069,0.00019205852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910164,0.0002651364,0.00009406155,0.00029469613,0.0001409178,0.00010359923],"domain_scores_gemma":[0.99818355,0.0006852695,0.0005277296,0.00026263966,0.0000852767,0.0002555064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013493353,0.00065093284,0.0010908741,0.0015098684,0.00042999125,0.0005907963,0.0004921406,0.00090558245,0.0031325207],"category_scores_gemma":[0.0029165165,0.00038421626,0.0013641262,0.0015289292,0.00034598485,0.00030331445,0.0004229546,0.00043448966,0.00033571353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072115394,0.00006898961,0.97221404,0.00008391245,0.0025270851,0.0012573609,0.00020036314,0.00030844958,0.009620017,0.00007455957,0.00021725599,0.006216365],"study_design_scores_gemma":[0.00012425325,0.00045027968,0.9931639,0.000020781225,0.0021135837,0.0020705005,0.00010417392,0.0005514543,0.0005365961,0.00024285438,0.0006073732,0.000014235634],"about_ca_topic_score_codex":0.0023744826,"about_ca_topic_score_gemma":0.0019026444,"teacher_disagreement_score":0.0031325207,"about_ca_system_score_codex":0.00016391829,"about_ca_system_score_gemma":0.00027072348,"threshold_uncertainty_score":0.010479331},"labels":[],"label_agreement":null},{"id":"W2132799739","doi":"10.1038/sj.bjc.6604838","title":"Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials","year":2009,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Medical Research Council; Associazione Italiana per la Ricerca sul Cancro; Cancer Research UK","keywords":"Folinic acid; Pancreatic cancer; Medicine; Hazard ratio; Adjuvant; Fluorouracil; Internal medicine; Gastroenterology; Randomized controlled trial; Adjuvant therapy; Cancer; Oncology; Surgery; Confidence interval","score_opus":0.28562900025022264,"score_gpt":0.48651150674616983,"score_spread":0.2008825064959472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132799739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014930611,0.9831039,0.00033953405,0.00020036998,0.00016024448,0.00016290524,0.00045093527,0.000016024132,0.0006355599],"genre_scores_gemma":[0.20202067,0.7936402,0.0014943987,0.00051355263,0.00018853991,0.00036410327,0.000800484,0.000015115514,0.0009629443],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99900085,0.0006066204,0.0001589503,0.0000891951,0.0001043434,0.000040014613],"domain_scores_gemma":[0.99783546,0.0016769161,0.0002869588,0.000036023026,0.00009813212,0.00006658042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028882227,0.0010974758,0.0053360052,0.00084604643,0.00013874458,0.00076200697,0.0006405938,0.00078512065,0.003079419],"category_scores_gemma":[0.005512648,0.00038669384,0.0064755534,0.0014084412,0.00018332759,0.0004723706,0.00032962562,0.0013023168,0.0002657753],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10982418,0.00022635245,0.0034657663,0.35190323,0.22368602,0.00024763815,0.00013830593,0.0030707386,0.0019191047,0.0006151548,0.0054508275,0.29945266],"study_design_scores_gemma":[0.07912241,0.011633152,0.015933193,0.03906281,0.81174135,0.00080817216,0.00014948285,0.0014917831,0.001826039,0.0015773163,0.03657194,0.00008233205],"about_ca_topic_score_codex":0.002794669,"about_ca_topic_score_gemma":0.008111811,"teacher_disagreement_score":0.0053360052,"about_ca_system_score_codex":0.0010312349,"about_ca_system_score_gemma":0.00084666896,"threshold_uncertainty_score":0.015274525},"labels":[],"label_agreement":null},{"id":"W2133476042","doi":"10.1038/bjc.2015.231","title":"MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Brookhaven National Laboratory; BC Cancer Agency; Yale School of Public Health, Yale University; Cancer Council NSW; University of California, Irvine; National Institutes of Health; National Cancer Institute; Menzies Institute for Medical Research; Associazione Italiana per la Ricerca sul Cancro; Universidad de Murcia; Memorial Sloan-Kettering Cancer Center; Università degli Studi di Genova; Purdue University; Cancer Research UK; University of Sydney; University of Tasmania; Cancer Care Ontario; University of Edinburgh; INCLIVA Instituto de Investigación Sanitaria; University of Leeds; Menzies Research Institute Tasmania; Università degli Studi dell'Aquila; Universiteit Leiden; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; University of Ottawa; National and Kapodistrian University of Athens; Karolinska Institutet; University of Michigan; University of Pennsylvania; Leids Universitair Medisch Centrum; Missouri Department of Health and Senior Services; Yale University; Moffitt Cancer Center; University of North Carolina at Chapel Hill; Brigham and Women's Hospital; State of New Jersey Department of Health","keywords":"Melanocortin 1 receptor; Skin cancer; Basal cell carcinoma; Melanoma; Odds ratio; Phenotype; Cancer; Medicine; Basal cell; Genotype; Pooled analysis; Eye color; Dermatology; Biology; Internal medicine; Genetics; Gene; Confidence interval","score_opus":0.013750017902563057,"score_gpt":0.28668227018009645,"score_spread":0.27293225227753337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133476042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97603464,0.005589868,0.0062804865,0.00005927043,0.000045078697,0.00015435665,0.011019103,0.000109431974,0.0007077926],"genre_scores_gemma":[0.982643,0.00093749503,0.0028265307,0.000067521374,0.000046393347,0.000278474,0.012491979,0.00008430107,0.0006242976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99286276,0.003761374,0.00053480756,0.0019122356,0.0006625624,0.0002661524],"domain_scores_gemma":[0.9955304,0.0015141672,0.0008214927,0.0014497283,0.00048538472,0.00019888466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076461704,0.0016243615,0.0028037492,0.0015379405,0.0004827639,0.000774503,0.0010368446,0.000828974,0.0028742205],"category_scores_gemma":[0.008610084,0.00091672014,0.006780719,0.002111991,0.0003112692,0.00035399938,0.0016342035,0.00045318095,0.0003903647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020487396,0.00013005751,0.8008372,0.0017023884,0.15391792,0.00077647145,0.00035163047,0.0022336908,0.0043194178,0.00023019596,0.0035257256,0.011488009],"study_design_scores_gemma":[0.001276361,0.0018685457,0.8964403,0.00018270555,0.0919697,0.00086061493,0.00025330158,0.002789028,0.0008153992,0.0002020028,0.0032857095,0.00005628428],"about_ca_topic_score_codex":0.007476726,"about_ca_topic_score_gemma":0.0063064764,"teacher_disagreement_score":0.0076461704,"about_ca_system_score_codex":0.0003570241,"about_ca_system_score_gemma":0.0005069898,"threshold_uncertainty_score":0.04043734},"labels":[],"label_agreement":null},{"id":"W2133961775","doi":"10.1038/sj.bjc.6601438","title":"The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK","keywords":"Medicine; Transdermal; Hormone replacement therapy (female-to-male); Estrogen replacement therapy; Colorectal cancer; Postmenopausal women; Oncology; Internal medicine; Menopause; Estrogen therapy; Cancer; Gynecology; Pharmacology","score_opus":0.009949123474481038,"score_gpt":0.30821048047919486,"score_spread":0.29826135700471385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133961775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545384,0.013504424,0.000079992744,0.00012483941,0.000011392798,0.0000090912945,0.00020092289,0.0000035564624,0.00061187835],"genre_scores_gemma":[0.9975877,0.0019424512,0.000120547265,0.00005800725,0.0000132307105,0.000006082143,0.00008583583,0.0000013390289,0.00018488453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902856,0.00052532903,0.0000719687,0.00012334305,0.00018230261,0.000068563604],"domain_scores_gemma":[0.99642795,0.0016993727,0.0012511063,0.00019633358,0.00022760719,0.000197587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013233067,0.00021383862,0.00034527507,0.0004220743,0.00016047618,0.0006267309,0.000225012,0.00034523723,0.00062933017],"category_scores_gemma":[0.005881467,0.00021973561,0.0005354791,0.00052208797,0.0003522866,0.00019866001,0.00032106505,0.00039154748,0.000084083076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015025041,0.0000328085,0.9910648,0.000067671994,0.000566882,0.0001351966,0.000072009876,0.00004859388,0.0008338118,0.000019387038,0.000041585085,0.005614734],"study_design_scores_gemma":[0.000023939345,0.00021165493,0.99876946,0.000012207098,0.00022153382,0.00029385881,0.000053692485,0.00007946148,0.00012724359,0.000016406031,0.00018789626,0.0000026848625],"about_ca_topic_score_codex":0.011246385,"about_ca_topic_score_gemma":0.016172161,"teacher_disagreement_score":0.011246385,"about_ca_system_score_codex":0.00037831388,"about_ca_system_score_gemma":0.0003597085,"threshold_uncertainty_score":0.022361815},"labels":[],"label_agreement":null},{"id":"W2134428662","doi":"10.1038/sj.bjc.6604059","title":"Photodynamic therapy-generated vaccines: relevance of tumour cell death expression","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Photodynamic therapy; Cancer research; Cytotoxic T cell; Cancer; CD8; Immunotherapy; Immunology; Ex vivo; Antigen; Biology; In vivo; Medicine; In vitro; Immune system; Chemistry; Internal medicine","score_opus":0.01633999605438702,"score_gpt":0.3204597724209386,"score_spread":0.3041197763665516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134428662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922544,0.0028335678,0.0037332803,0.00007399886,0.000018335839,0.000045703513,0.00007113686,0.000026045302,0.0009435399],"genre_scores_gemma":[0.9966377,0.00092771463,0.0012354591,0.00001657287,0.000005757189,0.000019926361,0.000136411,0.0000064216897,0.0010139883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999058,0.000020776111,0.000006477717,0.000017522443,0.000024763565,0.000024667563],"domain_scores_gemma":[0.9999169,0.000029273728,0.000021600292,0.000011134869,0.0000116859355,0.000009471956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013389501,0.00023248237,0.00018467836,0.00011856628,0.0000684574,0.00024857302,0.000090290545,0.00025619223,0.00080326875],"category_scores_gemma":[0.00014665682,0.00007618809,0.000112207235,0.00007532898,0.00018106832,0.00025346165,0.00012921667,0.0004035856,0.0001591178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058975398,0.000018910296,0.00010304627,0.000027270897,0.0000018017975,0.000014580587,0.000009434606,0.000076063705,0.99843806,0.00009965353,0.000008027674,0.0011443337],"study_design_scores_gemma":[0.0000075596463,0.00029010707,0.000992174,0.0000028746806,0.0000063568627,0.00015168556,0.000007781382,0.00035058224,0.9972518,0.000041614272,0.00089644606,9.924829e-7],"about_ca_topic_score_codex":0.00015336105,"about_ca_topic_score_gemma":0.0001395276,"teacher_disagreement_score":0.00080326875,"about_ca_system_score_codex":0.00024017572,"about_ca_system_score_gemma":0.00011945156,"threshold_uncertainty_score":0.0026871562},"labels":[],"label_agreement":null},{"id":"W2135074415","doi":"10.1038/bjc.2011.427","title":"Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences; Université de Montréal; Angiochem (Canada); Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"LRP1; Glioma; Cancer research; Endocytosis; Abcg2; Tumor microenvironment; Gene silencing; Calcein; Transcytosis; Biology; Receptor; Chemistry; LDL receptor; Lipoprotein; ATP-binding cassette transporter; Biochemistry; Transporter","score_opus":0.013478454946882969,"score_gpt":0.2089404019426498,"score_spread":0.19546194699576683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135074415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835277,0.00066004315,0.0002350154,0.000034238346,0.0000066483403,0.000005988755,0.00005395054,0.000019540857,0.00063183147],"genre_scores_gemma":[0.998933,0.00034774246,0.0002481491,0.000020849939,0.0000019329134,0.00000673144,0.000067880705,0.000004177303,0.00036950526],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999559,0.000009760826,0.0000022074378,0.000006542012,0.000008605385,0.000016915807],"domain_scores_gemma":[0.9999671,0.000008600591,0.000008430477,0.000001978468,0.0000031274885,0.000010804741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004988155,0.00015345028,0.00012392449,0.00008177376,0.00006370418,0.00020876303,0.000081821345,0.00011331658,0.00070271833],"category_scores_gemma":[0.00007073438,0.00005655006,0.00007433991,0.000057948026,0.000112336784,0.000113844784,0.000090817375,0.00019106988,0.00018470037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033639552,0.00004070638,0.00032998074,0.00004390974,0.0000046885098,0.000085899715,0.00001430701,0.00008513067,0.997917,0.00004730118,0.000047891437,0.0010467353],"study_design_scores_gemma":[0.000025620939,0.0006847041,0.009475858,0.00000564044,0.00002471284,0.00023198311,0.0000519565,0.0013427818,0.9863093,0.000028066304,0.0018146537,0.0000046966616],"about_ca_topic_score_codex":0.0011627764,"about_ca_topic_score_gemma":0.0015903512,"teacher_disagreement_score":0.0011627764,"about_ca_system_score_codex":0.00025629852,"about_ca_system_score_gemma":0.00014826424,"threshold_uncertainty_score":0.0023508072},"labels":[],"label_agreement":null},{"id":"W2136365117","doi":"10.1038/bjc.2014.396","title":"Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prostate cancer; Prostatectomy; Medicine; Biopsy; Sampling (signal processing); Prostate biopsy; Prostate; Cancer; Biomarker; Oncology; Stage (stratigraphy); Pathology; Internal medicine; Biology","score_opus":0.02041064757438845,"score_gpt":0.3224703898355973,"score_spread":0.30205974226120885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136365117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773456,0.00047381537,0.020974807,0.00017703601,0.000007894562,0.000053312262,0.00045385095,0.0000884464,0.00042524657],"genre_scores_gemma":[0.9851989,0.00009763411,0.013866394,0.000057166097,0.000013185974,0.000036657726,0.00058169983,0.000011874243,0.00013659436],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99904376,0.00023908055,0.000074734045,0.00023773637,0.00032523263,0.0000793509],"domain_scores_gemma":[0.9970276,0.0012300548,0.0009923537,0.0001921179,0.00039836697,0.00015954101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025568728,0.00059969473,0.00054780394,0.0010027599,0.0002802211,0.00089960935,0.00035623123,0.00056953885,0.00071028917],"category_scores_gemma":[0.0059952782,0.00020817129,0.00039418216,0.0006669238,0.00051479414,0.0004143795,0.00062352885,0.0005139438,0.00027321273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012069738,0.0002907427,0.44008982,0.00027079237,0.00029394423,0.00023778535,0.00018996278,0.014925473,0.4969653,0.00053966185,0.0004605837,0.04452903],"study_design_scores_gemma":[0.00010977829,0.0021763286,0.6110957,0.00004217326,0.0005084299,0.0016474276,0.0002200366,0.0978905,0.28139684,0.0027192628,0.0021025094,0.00009101035],"about_ca_topic_score_codex":0.0005253855,"about_ca_topic_score_gemma":0.0005710198,"teacher_disagreement_score":0.0025568728,"about_ca_system_score_codex":0.0004880225,"about_ca_system_score_gemma":0.00061232026,"threshold_uncertainty_score":0.013522208},"labels":[],"label_agreement":null},{"id":"W2138376272","doi":"10.1038/bjc.2013.515","title":"Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Centre hospitalier universitaire de Québec","funders":"Lady Davis Institute for Medical Research; McGill University Health Centre; Canadian Institutes of Health Research; Jewish General Hospital; Terry Fox Research Institute; McGill University","keywords":"Lung cancer; Medicine; Oncology; Internal medicine; Survival analysis; Cancer; Pathology","score_opus":0.01910628567510611,"score_gpt":0.31224568203143777,"score_spread":0.2931393963563317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138376272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8875441,0.007081059,0.07476905,0.0022394704,0.00024659195,0.000876246,0.018222004,0.0009274856,0.008094018],"genre_scores_gemma":[0.9726341,0.00073463365,0.02010909,0.00008770722,0.00013562951,0.00026221774,0.005305177,0.000025553532,0.0007058643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987387,0.0005376265,0.00008691287,0.00015422673,0.0003943946,0.000088063585],"domain_scores_gemma":[0.9956245,0.0015312928,0.0015071887,0.0002318926,0.000758859,0.00034625392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003113454,0.0011992377,0.0006504872,0.0033576475,0.00027060867,0.0007317171,0.0008905135,0.00044154114,0.0014979488],"category_scores_gemma":[0.015324318,0.00018093611,0.00078346493,0.0019627055,0.00033904068,0.00071182876,0.0007547087,0.0005607936,0.00038736366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064173137,0.00003591692,0.91474074,0.000105742634,0.00045482663,0.00004626749,0.000044959994,0.006795451,0.00047053903,0.0003980176,0.004594883,0.071670964],"study_design_scores_gemma":[0.00022133523,0.0009037882,0.90438026,0.00010078299,0.00044256428,0.0004907367,0.000076536286,0.084170915,0.0010176605,0.00230515,0.0058017187,0.000088588524],"about_ca_topic_score_codex":0.03058521,"about_ca_topic_score_gemma":0.029037302,"teacher_disagreement_score":0.03058521,"about_ca_system_score_codex":0.0014095689,"about_ca_system_score_gemma":0.0019674618,"threshold_uncertainty_score":0.06081432},"labels":[],"label_agreement":null},{"id":"W2139475741","doi":"10.1038/sj.bjc.6601296","title":"Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–Control Study of Cervical Cancer","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Adenocarcinoma; Cervix; Cervical cancer; Gynecology; Cancer; Squamous carcinoma; Oncology; Population; Risk factor; Epidermoid carcinoma; Case-control study; Basal cell; Carcinoma; Internal medicine; Obstetrics; Environmental health","score_opus":0.021816315076982132,"score_gpt":0.30507381853606214,"score_spread":0.28325750345908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139475741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108726,0.0060263746,0.0002255651,0.00012712795,0.000059194055,0.000057406014,0.0015249135,0.000007031711,0.00088518125],"genre_scores_gemma":[0.994825,0.0017701897,0.00030990018,0.00010019372,0.000064218286,0.00008427008,0.0021854518,0.0000053795666,0.0006554051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974234,0.0008146909,0.00033063383,0.0003965756,0.00075418665,0.00028053334],"domain_scores_gemma":[0.99642557,0.00089090405,0.0012946794,0.00037350526,0.0005394125,0.00047593086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012634101,0.00051608926,0.0010445287,0.0018986929,0.00060707325,0.0007566196,0.0006082321,0.00094443455,0.0014003676],"category_scores_gemma":[0.006974511,0.0007790903,0.00082713476,0.0025361425,0.00053054694,0.0005197989,0.00072702183,0.0007801422,0.00023035426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028461244,0.000033601664,0.99722195,0.000052106447,0.00023075781,0.00031471954,0.00015294604,0.000026604437,0.00032693712,0.000019320452,0.00021806537,0.0011184497],"study_design_scores_gemma":[0.000028499002,0.00008978259,0.99853396,0.000017670338,0.00008608293,0.0006568512,0.000051621566,0.00003800619,0.000033344106,0.00001263377,0.00044529993,0.0000061000005],"about_ca_topic_score_codex":0.046053357,"about_ca_topic_score_gemma":0.052382536,"teacher_disagreement_score":0.046053357,"about_ca_system_score_codex":0.000735192,"about_ca_system_score_gemma":0.0004225552,"threshold_uncertainty_score":0.091570556},"labels":[],"label_agreement":null},{"id":"W2140307236","doi":"10.1038/sj.bjc.6604630","title":"Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Oncology; Medicine; Internal medicine; Ovarian cancer; Hazard ratio; Receiver operating characteristic; Chemotherapy; Biomarker; Survival analysis; Cancer; Confidence interval; Biology","score_opus":0.0440023028744207,"score_gpt":0.2906049006289954,"score_spread":0.24660259775457471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140307236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929598,0.002089398,0.0039514666,0.00011813771,0.000013222035,0.000024097642,0.00034942245,0.00006890511,0.0004255942],"genre_scores_gemma":[0.9967384,0.00024878597,0.0025304144,0.000034735425,0.000015342404,0.000013496153,0.00033134743,0.0000029056666,0.00008459328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927324,0.00035499156,0.00007173209,0.00009101262,0.0001579757,0.000051153896],"domain_scores_gemma":[0.99787486,0.0010842968,0.0005959221,0.0001145379,0.00019388039,0.00013648072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013547022,0.00033115264,0.0005545584,0.0010201378,0.000075885655,0.0005627909,0.00016169451,0.00037104837,0.00026612522],"category_scores_gemma":[0.0034861963,0.000118045886,0.00030665856,0.00057634775,0.00012058834,0.0002993902,0.00029812183,0.00041525386,0.00013774904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015993555,0.00014654902,0.916354,0.000063642845,0.0002906919,0.000096597956,0.000054861255,0.004065714,0.019170938,0.00005132373,0.00031019974,0.057796072],"study_design_scores_gemma":[0.00007947273,0.0018464372,0.94945407,0.000031700554,0.00029589888,0.0010073282,0.00007209795,0.035452154,0.010234724,0.00029504788,0.0011937281,0.00003739793],"about_ca_topic_score_codex":0.0003929422,"about_ca_topic_score_gemma":0.00054556335,"teacher_disagreement_score":0.0013547022,"about_ca_system_score_codex":0.0001714798,"about_ca_system_score_gemma":0.00018448423,"threshold_uncertainty_score":0.0071644783},"labels":[],"label_agreement":null},{"id":"W2140465264","doi":"10.1038/bjc.2011.33","title":"Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Academy of Medical Sciences; Queen's University; Cancer Research UK","keywords":"Osteopontin; Colorectal cancer; Medicine; Metastasis; Cancer; Oncology; Cancer research; Pathology; Internal medicine; Biology","score_opus":0.019318373880200867,"score_gpt":0.2603141133543458,"score_spread":0.24099573947414493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140465264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881893,0.0006036414,0.00016277589,0.000009489035,0.0000013910974,0.000006241403,0.000082487655,0.000010503645,0.00030445826],"genre_scores_gemma":[0.9995584,0.00009982835,0.00012403146,0.0000035229941,0.0000017820732,0.0000053950635,0.000095308955,0.0000010610278,0.00011052743],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999918,0.00001001448,0.000006144868,0.000019443609,0.000029219342,0.000017119486],"domain_scores_gemma":[0.9997534,0.00003956139,0.000090620255,0.000012604789,0.00004704878,0.0000567364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104042054,0.00012649073,0.00013406045,0.000427133,0.000091372276,0.0001336403,0.000059454214,0.000118979784,0.0010653137],"category_scores_gemma":[0.00048225245,0.00007515807,0.00007230466,0.0002536422,0.00015489344,0.00006678686,0.00014429205,0.000116609364,0.0001370889],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018210496,0.00004790835,0.47254148,0.0002443686,0.00006542958,0.0019423416,0.00015901458,0.00026505176,0.5118436,0.000078080324,0.00019007322,0.010801654],"study_design_scores_gemma":[0.0000150720125,0.0003842667,0.9682989,0.000005562686,0.000034274064,0.0030644243,0.00007382442,0.00040742994,0.027254995,0.000037219474,0.00042046543,0.0000034986992],"about_ca_topic_score_codex":0.002028,"about_ca_topic_score_gemma":0.0025273268,"teacher_disagreement_score":0.002028,"about_ca_system_score_codex":0.00034837038,"about_ca_system_score_gemma":0.00018251117,"threshold_uncertainty_score":0.0040323734},"labels":[],"label_agreement":null},{"id":"W2142148410","doi":"10.1038/sj.bjc.6600533","title":"Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Hazard ratio; Debulking; Serous fluid; Immunohistochemistry; Pathology; Biology; Medicine; Survival analysis; Univariate analysis; Internal medicine; Ovarian cancer; Cancer; Multivariate analysis; Confidence interval; Enzyme","score_opus":0.031447423706217455,"score_gpt":0.2940202029017501,"score_spread":0.2625727791955327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142148410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945363,0.0017710723,0.003145453,0.000030389372,0.000007299078,0.000008067694,0.00013266166,0.000027891694,0.0003409024],"genre_scores_gemma":[0.99697816,0.000468104,0.002156217,0.000008122285,0.00001061116,0.000009465678,0.00014667142,0.0000020304685,0.0002206019],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997644,0.00008209856,0.000011506485,0.0000459092,0.00006472654,0.000031371583],"domain_scores_gemma":[0.9995679,0.00016257825,0.00014337494,0.000030733332,0.000054806434,0.000040581774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048217387,0.00015625001,0.00017448793,0.0005164733,0.00007699948,0.00023418963,0.00016568026,0.00028970503,0.0006535452],"category_scores_gemma":[0.00081949314,0.00010760794,0.0001028894,0.00034380733,0.00033875185,0.0003101551,0.00020705859,0.00029466706,0.00025598958],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017384052,0.0000857742,0.3795253,0.00017032359,0.00010596893,0.00017287451,0.00009839858,0.0007595225,0.595426,0.00013586841,0.00015902195,0.021622598],"study_design_scores_gemma":[0.000024169356,0.001216114,0.80631644,0.000010491338,0.00008815484,0.0020558585,0.0001188163,0.006172321,0.18214276,0.00024036234,0.0015978275,0.000016785925],"about_ca_topic_score_codex":0.00020740081,"about_ca_topic_score_gemma":0.00021184656,"teacher_disagreement_score":0.0006535452,"about_ca_system_score_codex":0.00017123079,"about_ca_system_score_gemma":0.00007874216,"threshold_uncertainty_score":0.002550006},"labels":[],"label_agreement":null},{"id":"W2143584015","doi":"10.1038/sj.bjc.6601887","title":"High levels of untreated distress and fatigue in cancer patients","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":941,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Cancer Foundation","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psychosocial; Distress; Anxiety; Depression (economics); Lung cancer; Social support; Prostate cancer; Breast cancer; Cancer; Internal medicine; Psychiatry; Clinical psychology; Psychology","score_opus":0.019432739183712577,"score_gpt":0.2948988533097637,"score_spread":0.2754661141260511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143584015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993579,0.00016174879,0.00002625804,0.00005787657,0.000002953542,0.000008722202,0.00011346984,0.0000016655475,0.0002693666],"genre_scores_gemma":[0.99963725,0.00007615972,0.00003894189,0.00005108315,0.0000059597965,0.000008243027,0.00011932799,4.9262525e-7,0.00006250655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957794,0.0001335137,0.000056041452,0.00005358432,0.00009747273,0.000081509126],"domain_scores_gemma":[0.9988319,0.00017998973,0.00060255965,0.00003002803,0.000107395535,0.00024808635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035603822,0.00014404625,0.0003063009,0.00050779025,0.0004947223,0.00052116415,0.00013914469,0.00030957285,0.0011704576],"category_scores_gemma":[0.0024983587,0.00015034259,0.00020388058,0.0007317192,0.00022570346,0.00041521346,0.00046841957,0.00033824617,0.00013903859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046860776,0.00002427056,0.99662966,0.000015650387,0.000020501831,0.00007700268,0.00039525397,0.000019707,0.00019479012,0.000007901131,0.00012512712,0.002443162],"study_design_scores_gemma":[0.0000029997161,0.000099916426,0.99895394,0.0000046528485,0.0000070252772,0.00025305353,0.00043959668,0.00003838498,0.000020201976,0.00000908634,0.00016859475,0.0000024752062],"about_ca_topic_score_codex":0.002882957,"about_ca_topic_score_gemma":0.004133271,"teacher_disagreement_score":0.002882957,"about_ca_system_score_codex":0.0002889123,"about_ca_system_score_gemma":0.00019067749,"threshold_uncertainty_score":0.0057323575},"labels":[],"label_agreement":null},{"id":"W2143602377","doi":"10.1038/sj.bjc.6605416","title":"Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Mount Sinai Hospital; Université Laval; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; National Health and Medical Research Council; National Institutes of Health; Fondazione Italiana per la Ricerca sul Cancro; Università degli Studi di Torino; Radboud Universitair Medisch Centrum; Deutsche Krebshilfe; Medical Research Council; lékařská fakulta Univerzity Karlovy; Leids Universitair Medisch Centrum; Associazione Italiana per la Ricerca sul Cancro; Odense Universitetshospital; Lunds Universitet; Vlaamse regering; Sahlgrenska Universitetssjukhuset; Erasmus Medisch Centrum; Vrije Universiteit Amsterdam; Universiteit Leiden; Aarhus Universitetshospital; National Institute for Health and Care Research; Russian Foundation for Basic Research; KWF Kankerbestrijding; Cancer Research UK; Université Laval; Royal Marsden NHS Foundation Trust; Compagnia di San Paolo; Huntsman Cancer Institute; National Breast Cancer Foundation; Breast Cancer Research Foundation; Istituto Oncologico Veneto; Aarhus Universitet; Univerzita Karlova v Praze; Alleanza Contro il Cancro; Uppsala Universitet; Ministero dell’Istruzione, dell’Università e della Ricerca; Memorial Sloan-Kettering Cancer Center; Instituto de Salud Carlos III; Radboud Universiteit; Ohio State University; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Universiteit Gent; University of Pennsylvania; Ministero della Salute; Akademiska Sjukhuset; Cancer Care Ontario","keywords":"Breast cancer; Oncology; Medicine; BRCA mutation; SNP; Internal medicine; Allele; Population; Mutation; Cancer; BRCA2 Protein; Genotype; Genetics; Biology; Single-nucleotide polymorphism; Germline mutation; Gene","score_opus":0.01815313764229086,"score_gpt":0.30354838217498803,"score_spread":0.28539524453269716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143602377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985827,0.00042743195,0.00056897866,0.000055057524,0.000010212007,0.000021235779,0.00016560387,0.000010797555,0.00015798325],"genre_scores_gemma":[0.9983217,0.00010530268,0.0009348712,0.000039619437,0.0000106407315,0.000025086061,0.0002517727,0.0000069589764,0.00030406998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998599,0.00070021703,0.000114369,0.00027553533,0.00021009997,0.00010074642],"domain_scores_gemma":[0.99669075,0.0017266846,0.0006443921,0.00042847224,0.00030880468,0.00020081543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035968602,0.0006839582,0.00057076325,0.0009652803,0.00048519997,0.0005129275,0.00084496517,0.00087194535,0.0021772203],"category_scores_gemma":[0.0072012027,0.0004049626,0.0008451041,0.00083040586,0.00029761947,0.00020552124,0.00038603987,0.00045201046,0.0002013362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045906934,0.00018391506,0.9686415,0.000095675205,0.0014652909,0.0008048935,0.00017188214,0.00078244857,0.013706633,0.00011127409,0.00014872903,0.0092970235],"study_design_scores_gemma":[0.0004976884,0.00209472,0.98185813,0.00002219963,0.0029622242,0.002452608,0.00011839944,0.002635418,0.006097806,0.00022419142,0.0010141298,0.000022497414],"about_ca_topic_score_codex":0.004429532,"about_ca_topic_score_gemma":0.0028554192,"teacher_disagreement_score":0.004429532,"about_ca_system_score_codex":0.0003229712,"about_ca_system_score_gemma":0.0005685548,"threshold_uncertainty_score":0.019022226},"labels":[],"label_agreement":null},{"id":"W2143681410","doi":"10.1038/bjc.2011.516","title":"Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Terry Fox Foundation; Boehringer Ingelheim","keywords":"Trastuzumab; Lapatinib; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Bevacizumab; Adjuvant; Cancer; Cancer research; Chemotherapy","score_opus":0.0989027358661728,"score_gpt":0.4448493664120509,"score_spread":0.3459466305458781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143681410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013477058,0.9990404,0.00006058035,0.0001503922,0.000077252946,0.0000031814052,0.0000069296425,0.0000034129378,0.0005230767],"genre_scores_gemma":[0.0008155997,0.9983589,0.00010286619,0.00015321099,0.000100488665,0.0000047246253,0.000016869039,9.831421e-7,0.00044630058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999856,0.000031783973,0.000019083456,0.000020736756,0.00005547274,0.0000169526],"domain_scores_gemma":[0.99987566,0.000057982757,0.000020255009,0.0000040096106,0.000026889016,0.000015079429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004799423,0.0006413669,0.00140547,0.0018140579,0.00019943036,0.0008162265,0.0007417416,0.0009071494,0.0026690555],"category_scores_gemma":[0.00040112255,0.00020225515,0.0004057416,0.0015965521,0.0003827886,0.0010885451,0.0005405739,0.0017335014,0.0015122634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111193964,0.00009994348,0.00011098727,0.010142877,0.0000806793,0.00029642816,0.000060722523,0.00039623296,0.0020127466,0.0028940835,0.018328993,0.965465],"study_design_scores_gemma":[0.00006316381,0.00017365915,0.0008049516,0.0029031713,0.000093906514,0.0020232052,0.000054224565,0.0001285158,0.00059707207,0.0021018041,0.99103945,0.000016923215],"about_ca_topic_score_codex":0.0006565643,"about_ca_topic_score_gemma":0.0016781728,"teacher_disagreement_score":0.0026690555,"about_ca_system_score_codex":0.00053698657,"about_ca_system_score_gemma":0.0005117233,"threshold_uncertainty_score":0.008928895},"labels":[],"label_agreement":null},{"id":"W2145762305","doi":"10.1038/bjc.2015.312","title":"International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Fonds Wetenschappelijk Onderzoek; Fédération Wallonie-Bruxelles; Vlaamse regering; Institut National de la Santé et de la Recherche Médicale","keywords":"Place of death; Death certificate; Demography; Odds; Health care; Medicine; Cause of death; Population; End-of-life care; Logistic regression; Public health; Geography; Gerontology; Palliative care; Environmental health; Economic growth; Disease; Nursing; Sociology","score_opus":0.45399133644216305,"score_gpt":0.5092754873852535,"score_spread":0.05528415094309047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145762305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559975,0.0005326142,0.00019665329,0.000062598316,0.000014780847,0.000023666016,0.0029430331,0.00000568006,0.0006211612],"genre_scores_gemma":[0.9968081,0.00020908732,0.00012812162,0.00001832511,0.000006909307,0.000026190144,0.0027281756,0.000002796558,0.00007225499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898,0.0003432263,0.0001679702,0.00023024956,0.00015961673,0.00011907441],"domain_scores_gemma":[0.99677104,0.00050718,0.0016673845,0.00027734088,0.0004287988,0.00034826854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017167422,0.00035744536,0.00045725427,0.0024261835,0.00039525254,0.00093020394,0.0004482325,0.000402013,0.0009979112],"category_scores_gemma":[0.003782222,0.00026640904,0.00080319797,0.0037347886,0.0005514228,0.0008494541,0.0012460325,0.00056471344,0.00021540487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040884963,0.000010540169,0.9987245,0.000020515125,0.00010855844,0.00002100375,0.00012481399,0.00004993986,0.00003175309,0.000016525682,0.000097813216,0.0007530446],"study_design_scores_gemma":[0.0000040562563,0.000033392073,0.9992095,0.00000880743,0.000019111041,0.0000631917,0.00042251626,0.00005915751,0.000012952271,0.00001068132,0.00015354918,0.0000030518938],"about_ca_topic_score_codex":0.009484593,"about_ca_topic_score_gemma":0.008008534,"teacher_disagreement_score":0.009484593,"about_ca_system_score_codex":0.0005228833,"about_ca_system_score_gemma":0.0003938212,"threshold_uncertainty_score":0.01885879},"labels":[],"label_agreement":null},{"id":"W2147711740","doi":"10.1038/sj.bjc.6604352","title":"Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Angiogenesis; In vivo; Vascular endothelial growth factor; Cancer research; Colorectal cancer; Irinotecan; Medicine; Apoptosis; Cancer; Cell growth; Pharmacology; Angiogenesis inhibitor; Biology; Internal medicine; VEGF receptors","score_opus":0.005146888277233859,"score_gpt":0.23552637050277056,"score_spread":0.2303794822255367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147711740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966595,0.0014238333,0.00043842974,0.00006950482,0.000030744166,0.000035658246,0.00011307165,0.0000396093,0.0011895638],"genre_scores_gemma":[0.99748766,0.000608623,0.0008752186,0.00001970699,0.000012130128,0.000021532675,0.00016116688,0.000004441036,0.00080936344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998958,0.00002993294,0.000010337565,0.000015904148,0.000023016577,0.000025022411],"domain_scores_gemma":[0.99994946,0.0000072884272,0.0000122051315,0.0000063024845,0.0000061218284,0.000018695759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013124612,0.0002453339,0.00037790893,0.00026272607,0.00009651836,0.00017242056,0.00014462568,0.00014361081,0.00085376744],"category_scores_gemma":[0.000112716945,0.00008662974,0.0001614862,0.00016650395,0.00012984869,0.00014118501,0.000096590906,0.000372589,0.0001144621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054257885,0.0013014828,0.0016326804,0.00022086647,0.000074448835,0.00018359451,0.00004306114,0.0012817446,0.94252104,0.00028494283,0.00055360084,0.046476707],"study_design_scores_gemma":[0.00073288014,0.031291034,0.025944816,0.000023984012,0.00016570302,0.0015322614,0.000059925125,0.0039849174,0.927537,0.00008564319,0.00861519,0.000026622063],"about_ca_topic_score_codex":0.00045152128,"about_ca_topic_score_gemma":0.0020697666,"teacher_disagreement_score":0.00085376744,"about_ca_system_score_codex":0.00023916912,"about_ca_system_score_gemma":0.000285476,"threshold_uncertainty_score":0.002856195},"labels":[],"label_agreement":null},{"id":"W2149771219","doi":"10.1038/bjc.2012.269","title":"Independent and functional validation of a multi-tumour-type proliferation signature","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Breast cancer; Oncology; Hazard ratio; Gene signature; Cancer; Lung cancer; Internal medicine; Microarray; Adenocarcinoma; Medicine; Proportional hazards model; Microarray analysis techniques; Cancer research; Biology; Gene expression; Gene; Confidence interval; Genetics","score_opus":0.013275442058503553,"score_gpt":0.28275670382202817,"score_spread":0.2694812617635246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149771219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9172494,0.0006677405,0.075383835,0.00016544547,0.000059850016,0.00018714774,0.004198208,0.00054269837,0.0015457332],"genre_scores_gemma":[0.9580825,0.00018127328,0.036045585,0.00006897676,0.000021906462,0.00020430669,0.0046899254,0.00005805568,0.0006475026],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898154,0.00020422468,0.00007092843,0.00030327323,0.00037076185,0.00006929462],"domain_scores_gemma":[0.9976363,0.0010318904,0.00043221837,0.00032565463,0.0004391215,0.00013482654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018632164,0.0004002906,0.0005275385,0.0007544887,0.00028273973,0.0006859086,0.00042705503,0.0004084216,0.0014607537],"category_scores_gemma":[0.003203872,0.0001566728,0.00046657203,0.0005883584,0.0005041992,0.00026399156,0.0005201401,0.00063131296,0.0005575805],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007772433,0.0001684686,0.051835682,0.0002951774,0.00010487842,0.0000765252,0.00006599596,0.006842211,0.9081114,0.0003573293,0.00032602783,0.031039076],"study_design_scores_gemma":[0.00006035924,0.0013792795,0.17958991,0.000030471527,0.00021785733,0.00089943665,0.00007324869,0.07042809,0.7432377,0.00075251726,0.0032570644,0.00007405857],"about_ca_topic_score_codex":0.0005959782,"about_ca_topic_score_gemma":0.0009591267,"teacher_disagreement_score":0.0018632164,"about_ca_system_score_codex":0.00053671846,"about_ca_system_score_gemma":0.0007757546,"threshold_uncertainty_score":0.009853721},"labels":[],"label_agreement":null},{"id":"W2150577437","doi":"10.1038/sj.bjc.6605338","title":"COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; University of Ottawa; University of Toronto; Ontario Institute for Cancer Research","funders":"Instituto de Salud Carlos III; Universität Greifswald; Xunta de Galicia; Deutsche Krebshilfe; Siemens; Bundesministerium für Bildung und Forschung; Associazione Italiana per la Ricerca sul Cancro; Fonds NutsOhra; Grantová Agentura České Republiky; European Commission; Fondazione Italiana per la Ricerca sul Cancro; Vetenskapsrådet; Ontario Institute for Cancer Research; National Health and Medical Research Council; Cancer Research UK; Universidad del Tolima; Swedish Cancer Foundation; National Cancer Institute; KWF Kankerbestrijding; Ministry of Cultural Affairs; Genome Canada","keywords":"Penetrance; Colorectal cancer; Cancer genetics; Multifactorial Inheritance; Cancer; Genetics; Inheritance (genetic algorithm); Human genetics; Biology; Genetic variants; Medicine; Oncology; Bioinformatics; Single-nucleotide polymorphism; Genotype; Gene; Phenotype","score_opus":0.016332999656887805,"score_gpt":0.30299343038444293,"score_spread":0.28666043072755515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150577437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4465125,0.10395457,0.11474048,0.09510741,0.009652862,0.028439675,0.07955655,0.0052376073,0.1167984],"genre_scores_gemma":[0.5048762,0.02728092,0.28068963,0.01878156,0.0060212337,0.02797779,0.102598645,0.0018648031,0.029909285],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98780096,0.006752457,0.0005879392,0.0013106818,0.0022068347,0.0013411259],"domain_scores_gemma":[0.96138126,0.007870441,0.004867208,0.004248178,0.0071668117,0.014466047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028430987,0.0014820138,0.0019963526,0.0068154926,0.0019286723,0.002851593,0.0026602282,0.0026258868,0.005703879],"category_scores_gemma":[0.025946403,0.0005844,0.0010491932,0.010348336,0.0018346327,0.0011548008,0.007912103,0.0027576277,0.0014050464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012379683,0.0016451263,0.27206853,0.0019789326,0.0019754611,0.0025337248,0.002383051,0.002563413,0.009902183,0.022122864,0.18111596,0.48933098],"study_design_scores_gemma":[0.0060409075,0.0027147504,0.54927355,0.0010910546,0.001745108,0.0037775936,0.00077316386,0.0029646682,0.0030869008,0.010826925,0.41749373,0.00021171583],"about_ca_topic_score_codex":0.015154807,"about_ca_topic_score_gemma":0.01212801,"teacher_disagreement_score":0.028430987,"about_ca_system_score_codex":0.0020717275,"about_ca_system_score_gemma":0.015714105,"threshold_uncertainty_score":0.15035921},"labels":[],"label_agreement":null},{"id":"W2151382914","doi":"10.1038/sj.bjc.6604305","title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":535,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"National Health and Medical Research Council; Fondazione Italiana per la Ricerca sul Cancro; Medical Research Council; Hungarian Scientific Research Fund; Helsingin ja Uudenmaan Sairaanhoitopiiri; National Cancer Institute; Office of Defense Programs; Cancer Research UK; U.S. Department of Defense","keywords":"Breast cancer; Population; Ovarian cancer; Oncology; Medicine; Cancer; Demography; Internal medicine; Environmental health","score_opus":0.011943602200427483,"score_gpt":0.2618691185324316,"score_spread":0.24992551633200413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151382914","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06626239,0.005261417,0.8942585,0.0035280592,0.0005572599,0.00028636932,0.0069460315,0.0009991569,0.021900857],"genre_scores_gemma":[0.6488632,0.00982899,0.24522552,0.0018137184,0.00118861,0.0019133587,0.013224006,0.0010983419,0.07684419],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981862,0.00096541,0.00008464226,0.00033191888,0.00024559506,0.00018632872],"domain_scores_gemma":[0.99345785,0.0046473523,0.00036315335,0.0003723383,0.0007908221,0.0003684661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005652388,0.0014492971,0.0023004003,0.002617182,0.0007249978,0.0019153511,0.004961732,0.0018428216,0.017093176],"category_scores_gemma":[0.014748943,0.0012129252,0.0035098037,0.002515757,0.0013960627,0.0023763708,0.002607795,0.0029652412,0.0026743526],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004751682,0.00016151513,0.016979655,0.000436494,0.00064857857,0.00078309193,0.00053350313,0.7206801,0.0005334647,0.2004111,0.009989238,0.048368126],"study_design_scores_gemma":[0.000105936306,0.00006208661,0.0025901606,0.00009174783,0.00013577282,0.0003340456,0.00007811506,0.8560596,0.00008892302,0.12571976,0.0146604935,0.00007340862],"about_ca_topic_score_codex":0.05224862,"about_ca_topic_score_gemma":0.02981405,"teacher_disagreement_score":0.05224862,"about_ca_system_score_codex":0.0019457614,"about_ca_system_score_gemma":0.0018784971,"threshold_uncertainty_score":0.10388899},"labels":[],"label_agreement":null},{"id":"W2152734037","doi":"10.1038/sj.bjc.6605560","title":"Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of New Brunswick","funders":"","keywords":"NONMEM; Dosing; Medicine; Pharmacokinetics; Population; Breast cancer; Covariate; Monoclonal antibody; Oncology; Cancer; Pharmacology; Antibody; Internal medicine; Immunology; Statistics; Mathematics","score_opus":0.03689079871606183,"score_gpt":0.4347484097484792,"score_spread":0.3978576110324174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152734037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772271,0.00048540503,0.019709611,0.000101640915,0.000010019818,0.00030504505,0.0012306236,0.00017263586,0.00075791037],"genre_scores_gemma":[0.98354834,0.0003823295,0.010610676,0.00011594733,0.000016582882,0.000375227,0.004200881,0.000036879537,0.00071306416],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99928623,0.0004204528,0.00002687624,0.000106061045,0.00012784512,0.000032534892],"domain_scores_gemma":[0.99875176,0.0007062535,0.00022790163,0.00014059505,0.000115255716,0.000058291782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031380532,0.00046998143,0.00094689976,0.00023694523,0.00011693194,0.0005644807,0.00045289245,0.00047852984,0.0014390231],"category_scores_gemma":[0.0036560455,0.00027225298,0.0006170633,0.00034510545,0.00027677204,0.0003239222,0.00024230538,0.0009974213,0.00030403535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051499583,0.0053946422,0.09493023,0.0016456174,0.003460007,0.00095350493,0.0012582119,0.34699506,0.29726622,0.0015413383,0.0067721833,0.18828346],"study_design_scores_gemma":[0.0066349925,0.10895961,0.21775691,0.00007779517,0.0036030973,0.005229739,0.00016476873,0.46404877,0.17022914,0.0027711648,0.020236684,0.00028733353],"about_ca_topic_score_codex":0.0010672448,"about_ca_topic_score_gemma":0.00083072163,"teacher_disagreement_score":0.0031380532,"about_ca_system_score_codex":0.0006982819,"about_ca_system_score_gemma":0.00088568125,"threshold_uncertainty_score":0.01659578},"labels":[],"label_agreement":null},{"id":"W2154401489","doi":"10.1038/bjc.2011.448","title":"Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Cancer Care Ontario","funders":"National Cancer Institute; KWF Kankerbestrijding; National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust","keywords":"Breast cancer; Odds ratio; Oncology; Internal medicine; Medicine; Single-nucleotide polymorphism; Germline mutation; Cancer; Cancer research; Biology; Genotype; Mutation; Genetics; Gene","score_opus":0.02197608497636926,"score_gpt":0.28537586401692505,"score_spread":0.2633997790405558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154401489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973488,0.0005420019,0.00045020028,0.00008165749,0.000015827263,0.000005612207,0.0003331913,0.000010876778,0.0012118397],"genre_scores_gemma":[0.9989593,0.00007240443,0.0001529318,0.000015864724,0.00000630352,0.00000595705,0.00016430563,0.0000072683542,0.0006156807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880874,0.0006162792,0.00007320176,0.00019873571,0.00018858351,0.0001143952],"domain_scores_gemma":[0.9986337,0.0007248704,0.0002192342,0.00012574023,0.000118759745,0.00017763661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008435143,0.00025892362,0.00035516964,0.0009172488,0.0003112437,0.00042890394,0.0003207004,0.0005621564,0.0025160057],"category_scores_gemma":[0.0027404113,0.00022779992,0.00046655576,0.001028497,0.0002421631,0.00018513676,0.00032528167,0.0004813023,0.00034996952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033106839,0.00012368562,0.969186,0.00003242384,0.00059040484,0.00065217254,0.00026097338,0.00039169088,0.014607157,0.0003259583,0.00022751045,0.010291272],"study_design_scores_gemma":[0.000014475525,0.00027541295,0.99676466,0.0000037990096,0.00008815983,0.0006776789,0.00007144577,0.00043776276,0.0010121808,0.000081767816,0.000566986,0.0000056848517],"about_ca_topic_score_codex":0.0044819694,"about_ca_topic_score_gemma":0.002740509,"teacher_disagreement_score":0.0044819694,"about_ca_system_score_codex":0.00037643703,"about_ca_system_score_gemma":0.00016718869,"threshold_uncertainty_score":0.008911788},"labels":[],"label_agreement":null},{"id":"W2154466617","doi":"10.1038/sj.bjc.6604652","title":"Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Eli Lilly and Company","keywords":"Ependymoma; Telomere; Telomerase; Telomerase reverse transcriptase; Biology; Oncology; Mitotic index; Anaplasia; Pathology; Cancer research; Medicine; Internal medicine; Mitosis; DNA; Genetics","score_opus":0.013600649574765403,"score_gpt":0.2492805203171823,"score_spread":0.23567987074241692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154466617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990023,0.0006097714,0.000139533,0.000014504798,0.0000034020059,0.000003286757,0.000069569796,0.00000404905,0.00015355951],"genre_scores_gemma":[0.9992392,0.0002939272,0.00016908704,0.000007715393,0.000006747324,0.00000531505,0.0001802504,0.0000030235904,0.00009474419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998266,0.000026462007,0.000028047925,0.000035866175,0.000053850807,0.000029179582],"domain_scores_gemma":[0.9989122,0.00031226853,0.00049356703,0.00005359206,0.00010308145,0.00012524839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003412456,0.00024992737,0.00041540802,0.000535463,0.00017556854,0.00031469436,0.00024658503,0.00031549402,0.00081013213],"category_scores_gemma":[0.00266802,0.00015815065,0.00022218215,0.0005422542,0.00022064401,0.00031409878,0.00034752782,0.00048456655,0.00015257196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019966046,0.000008650461,0.99150753,0.000017183473,0.000017001332,0.0015590807,0.0000755458,0.00013941963,0.0015043713,0.000016348182,0.00007925457,0.0048758737],"study_design_scores_gemma":[0.000006391815,0.00011481673,0.99164736,0.000009037764,0.000027861219,0.0069809197,0.00007604107,0.0003108107,0.00058501324,0.000034576566,0.000203564,0.0000035647058],"about_ca_topic_score_codex":0.0011047123,"about_ca_topic_score_gemma":0.0013110789,"teacher_disagreement_score":0.0011047123,"about_ca_system_score_codex":0.00014706067,"about_ca_system_score_gemma":0.00017149288,"threshold_uncertainty_score":0.0027102232},"labels":[],"label_agreement":null},{"id":"W2155381516","doi":"10.1038/bjc.2011.323","title":"Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Single-nucleotide polymorphism; Medicine; Cancer cachexia; Cancer; Internal medicine; Bioinformatics; Biology; Gene; Genetics; Genotype","score_opus":0.20834475573194852,"score_gpt":0.4694923327377807,"score_spread":0.26114757700583213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155381516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991667,0.000117553995,0.00009627594,0.000022150729,0.0000050372582,0.00005000034,0.00028095156,0.0000018554362,0.00025959697],"genre_scores_gemma":[0.99769896,0.00010627722,0.00028854256,0.00009412112,0.000013014027,0.000103732586,0.0014245858,0.0000062469026,0.00026447847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991436,0.00030437924,0.00007816091,0.0002565106,0.0001343574,0.000082944774],"domain_scores_gemma":[0.9978846,0.0008830077,0.00037708352,0.00027882514,0.0003230054,0.00025349288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015192393,0.00048148673,0.000832196,0.00056374224,0.0011884647,0.00072168343,0.0005863735,0.0008609978,0.0020761113],"category_scores_gemma":[0.0041118776,0.00046574438,0.00045764018,0.0009795938,0.0008812052,0.00032805654,0.0005670005,0.0006958164,0.0010339923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065673894,0.00026167103,0.9952679,0.000029508712,0.00009126908,0.0004922849,0.00029875705,0.000056051817,0.0010613262,0.000031463096,0.0002064421,0.0015464866],"study_design_scores_gemma":[0.00019897989,0.0008866905,0.9954335,0.000015809122,0.000097108874,0.0016364284,0.0002775592,0.00028274243,0.0002945709,0.00003974318,0.0008246213,0.0000121274725],"about_ca_topic_score_codex":0.003029505,"about_ca_topic_score_gemma":0.0035098768,"teacher_disagreement_score":0.003029505,"about_ca_system_score_codex":0.00054779166,"about_ca_system_score_gemma":0.0005098381,"threshold_uncertainty_score":0.008034587},"labels":[],"label_agreement":null},{"id":"W2155863110","doi":"10.1038/sj.bjc.6604485","title":"The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Glutathione; Pancreatic cancer; Cystine; Oxidative stress; Biology; Cell growth; Cancer research; Cancer cell; Biochemistry; Pharmacology; Endocrinology; Cell biology; Cancer; Cysteine; Enzyme","score_opus":0.0031854243321911236,"score_gpt":0.21140125475272947,"score_spread":0.20821583042053834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155863110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754767,0.017898282,0.002600364,0.00047694394,0.000029095794,0.00002201672,0.00022651153,0.000075446726,0.0031946553],"genre_scores_gemma":[0.99044096,0.00491936,0.0012839736,0.000055938668,0.000008437401,0.00000789315,0.00024780285,0.000009522554,0.0030262577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994695,0.000010619065,0.0000047362937,0.000012990777,0.000015135514,0.000009499008],"domain_scores_gemma":[0.9999529,0.000007108869,0.000015202352,0.000003190667,0.000008766761,0.000012733854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007919746,0.00025932855,0.00018843578,0.00017216003,0.00016447408,0.00052100746,0.00014572452,0.00039534218,0.0006598667],"category_scores_gemma":[0.00009561183,0.00008654453,0.00008786337,0.00024350549,0.00024201215,0.00033055712,0.00016201027,0.00031420632,0.00021273234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025992232,0.0000213224,0.0016974015,0.00009009812,0.000005991308,0.00025714145,0.00004147168,0.000088642846,0.99364614,0.00023660013,0.000080564656,0.0035747383],"study_design_scores_gemma":[0.000033542477,0.00060109346,0.071106575,0.00003405361,0.000049608894,0.0039447728,0.00032903216,0.002054147,0.9070734,0.00038255003,0.014373536,0.000017751798],"about_ca_topic_score_codex":0.0013262243,"about_ca_topic_score_gemma":0.0012172485,"teacher_disagreement_score":0.0013262243,"about_ca_system_score_codex":0.0004748276,"about_ca_system_score_gemma":0.00022482607,"threshold_uncertainty_score":0.0034450889},"labels":[],"label_agreement":null},{"id":"W2156216526","doi":"10.1038/sj.bjc.6603660","title":"Temozolomide as salvage treatment in primary brain lymphomas","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Chemotherapy; Methotrexate; Oncology; Internal medicine; Lymphoma; Primary central nervous system lymphoma; Dacarbazine; Confidence interval; Radiation therapy; Surgery","score_opus":0.009949082091629684,"score_gpt":0.3013391835404073,"score_spread":0.2913901014487776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156216526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856,0.012523335,0.00043972422,0.00013451127,0.0000336452,0.00005273086,0.00007645934,0.00005123148,0.0010885096],"genre_scores_gemma":[0.99453664,0.004309042,0.00045438847,0.00006596135,0.00004834381,0.000025797159,0.00013914342,0.00000770555,0.0004130696],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99984705,0.00006443976,0.000012323539,0.000019638197,0.000025996815,0.00003059751],"domain_scores_gemma":[0.9998031,0.000054687167,0.000039192557,0.000023620283,0.000011142439,0.00006828071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003172546,0.00022196067,0.0010038543,0.00021571646,0.00011666131,0.00024016037,0.00027925352,0.00021011155,0.0011639722],"category_scores_gemma":[0.0006474948,0.00008973195,0.0002235862,0.00024336182,0.00023572752,0.00016499101,0.00015902787,0.00049176003,0.0002791332],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05342317,0.0037419416,0.03043181,0.0014562058,0.0005503814,0.005441965,0.0004499489,0.0037107544,0.10588259,0.0003076419,0.0032663671,0.79133713],"study_design_scores_gemma":[0.02914422,0.30426216,0.47867468,0.0005509794,0.0016977788,0.044756886,0.00038271147,0.010095733,0.09766479,0.00152411,0.031159485,0.000086497996],"about_ca_topic_score_codex":0.0005736409,"about_ca_topic_score_gemma":0.0016422996,"teacher_disagreement_score":0.0011639722,"about_ca_system_score_codex":0.0003812116,"about_ca_system_score_gemma":0.00022144995,"threshold_uncertainty_score":0.0038938522},"labels":[],"label_agreement":null},{"id":"W2156285623","doi":"10.1038/sj.bjc.6605352","title":"Impaired TNFα-induced A20 expression in E1A/Ras-transformed cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; York University; University of Toronto; Ontario Institute for Cancer Research","funders":"National Health Research Institutes; National Science Council","keywords":"FADD; Tumor necrosis factor alpha; Transactivation; Apoptosis; Biology; Programmed cell death; TRAF2; Cell biology; Molecular biology; Signal transduction; Cancer research; Caspase; Immunology; Transcription factor; Gene; Genetics; Tumor necrosis factor receptor","score_opus":0.010281128375806891,"score_gpt":0.26429977737806704,"score_spread":0.2540186490022601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156285623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993828,0.0010177077,0.002794825,0.0000618274,0.000035866928,0.000030005176,0.0011354493,0.00012760928,0.00096872257],"genre_scores_gemma":[0.990754,0.00079693814,0.0023002743,0.000038083985,0.000011565706,0.00004322157,0.0023131524,0.00005748344,0.0036853175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977237,0.0000315985,0.000045335342,0.00004458441,0.00006643361,0.000039816383],"domain_scores_gemma":[0.9996301,0.00005444231,0.00012379242,0.00006478157,0.000044036537,0.00008276726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017616719,0.0005809089,0.00028193727,0.00035330452,0.00018129619,0.00034416924,0.00021462073,0.00036880194,0.0018350352],"category_scores_gemma":[0.0001515522,0.00016533874,0.00037378081,0.00027398954,0.0002723485,0.00024460614,0.00021316258,0.0005756533,0.0014185963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006186432,0.000017430719,0.00006716486,0.00001233182,0.0000021442838,0.000033134333,0.0000090374715,0.00001704933,0.9995414,0.000021913578,0.0000081853905,0.00020840016],"study_design_scores_gemma":[0.000008512706,0.00019036577,0.002322785,0.0000042706383,0.0000079926,0.00030760875,0.000020494668,0.00032740846,0.9956488,0.000018714018,0.0011403151,0.0000027071967],"about_ca_topic_score_codex":0.0004924606,"about_ca_topic_score_gemma":0.00030938664,"teacher_disagreement_score":0.0018350352,"about_ca_system_score_codex":0.0002674948,"about_ca_system_score_gemma":0.00014735713,"threshold_uncertainty_score":0.006138861},"labels":[],"label_agreement":null},{"id":"W2156980365","doi":"10.1038/bjc.2013.219","title":"Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"European Commission; National Institute for Health and Care Research","keywords":"Menarche; Medicine; Breast cancer; Odds ratio; Gynecology; Obstetrics; Pregnancy; Radiation therapy; Cancer; Menopause; Confidence interval; Internal medicine","score_opus":0.009008912330090843,"score_gpt":0.2825341204406243,"score_spread":0.2735252081105335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156980365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813485,0.0014154058,0.000045674842,0.000037176822,0.0000038603825,0.0000028529032,0.00013228344,0.0000028119694,0.00022502687],"genre_scores_gemma":[0.9994067,0.00036316898,0.0000314608,0.00001032327,0.0000062176673,0.0000020942334,0.00009171323,7.931368e-7,0.00008750779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979347,0.00006876179,0.000019247522,0.0000456424,0.00003566981,0.00003730749],"domain_scores_gemma":[0.99894243,0.00034809482,0.0005028444,0.00005997144,0.000050708386,0.000095933116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044410047,0.00010466947,0.0001595718,0.0003538737,0.00015802056,0.0003260722,0.00014573967,0.00019514201,0.0012597026],"category_scores_gemma":[0.0020229695,0.00012258794,0.00029229937,0.00044236117,0.00017842793,0.00014341978,0.00022700333,0.00022214762,0.00010160222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000151461,0.000008353673,0.99776614,0.00001020564,0.000041324096,0.00004840168,0.000038337726,0.00002855955,0.00009851283,0.000006772641,0.00003873708,0.0017632514],"study_design_scores_gemma":[0.0000038306,0.000051276038,0.99955505,0.00000423784,0.000023336323,0.00016130497,0.000032575877,0.000034004606,0.000037995636,0.000007473526,0.00008806129,8.606164e-7],"about_ca_topic_score_codex":0.0038331517,"about_ca_topic_score_gemma":0.0039383844,"teacher_disagreement_score":0.0038331517,"about_ca_system_score_codex":0.00020204292,"about_ca_system_score_gemma":0.00018556515,"threshold_uncertainty_score":0.007621646},"labels":[],"label_agreement":null},{"id":"W2157768953","doi":"10.1038/bjc.2014.530","title":"Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Oncology; Medicine; Proportional hazards model; Internal medicine; Breast cancer; Exemestane; Tamoxifen; Adjuvant; Cancer","score_opus":0.0029053005113203125,"score_gpt":0.2337852177898039,"score_spread":0.2308799172784836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157768953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98737466,0.0027374376,0.008307783,0.0003607196,0.000029087227,0.000038166494,0.0003265682,0.000036991813,0.0007886151],"genre_scores_gemma":[0.9987256,0.000109126144,0.00073262077,0.000025287545,0.00001783305,0.000010658862,0.00014438016,0.000008685567,0.0002258644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99356586,0.0043525924,0.000247262,0.0006629569,0.0007429348,0.00042827686],"domain_scores_gemma":[0.9207044,0.062049456,0.009803365,0.005225234,0.0013181765,0.0008994117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021967491,0.00048001966,0.0005384504,0.0006761173,0.00025096152,0.0008428013,0.00082869007,0.00066590507,0.0020667452],"category_scores_gemma":[0.053291105,0.00023695655,0.0012800425,0.00088909804,0.0005932164,0.0011823276,0.0008245065,0.0012781079,0.0002402071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008747354,0.00020882368,0.941122,0.00012376359,0.0009345736,0.00015736267,0.00013551806,0.0048312596,0.0022486327,0.00025320012,0.0001749374,0.041062612],"study_design_scores_gemma":[0.00010998016,0.0021408617,0.9645288,0.000027650392,0.0008779604,0.0004967916,0.000081943224,0.027061246,0.00222038,0.0014274963,0.0010006061,0.000026367034],"about_ca_topic_score_codex":0.0016484077,"about_ca_topic_score_gemma":0.001529787,"teacher_disagreement_score":0.021967491,"about_ca_system_score_codex":0.00041613812,"about_ca_system_score_gemma":0.00078585686,"threshold_uncertainty_score":0.116176546},"labels":[],"label_agreement":null},{"id":"W2159334966","doi":"10.1038/sj.bjc.6601856","title":"Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Doxorubicin; Pharmacology; Toxicity; Medicine; Maximum tolerated dose; Poloxamer; Chemotherapy; Internal medicine; Chemistry","score_opus":0.008120481377496757,"score_gpt":0.304287108893021,"score_spread":0.29616662751552425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159334966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996496,0.00084467884,0.00060122984,0.00014743442,0.00003340263,0.00083308003,0.00021052887,0.00005824311,0.0007754924],"genre_scores_gemma":[0.9934923,0.001023696,0.001991241,0.00023837591,0.000055870023,0.001128429,0.00080755475,0.000027734583,0.0012346595],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965787,0.00015629575,0.0000146672255,0.00005462898,0.000042337375,0.00007418977],"domain_scores_gemma":[0.99948955,0.00009301669,0.00011463366,0.0000650488,0.0000391954,0.00019854901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079824677,0.0010508867,0.0019539914,0.00040287734,0.0003690054,0.00056191935,0.00048797968,0.00087050215,0.0016066313],"category_scores_gemma":[0.0009768393,0.00040775808,0.0005408878,0.0005197726,0.00074876647,0.0005009424,0.00030314302,0.002699706,0.00046029207],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31807223,0.12378118,0.013481166,0.0006161957,0.00087884255,0.00087953795,0.0010810514,0.0088698855,0.29355174,0.00058678014,0.0048801564,0.23332126],"study_design_scores_gemma":[0.10764583,0.83704525,0.020789562,0.00003194906,0.00029556663,0.0009323941,0.000103079634,0.0025894528,0.024763688,0.00031302363,0.0054490427,0.000041079154],"about_ca_topic_score_codex":0.0005360298,"about_ca_topic_score_gemma":0.00085857784,"teacher_disagreement_score":0.0019539914,"about_ca_system_score_codex":0.0008748694,"about_ca_system_score_gemma":0.0009482747,"threshold_uncertainty_score":0.0063475966},"labels":[],"label_agreement":null},{"id":"W2159482884","doi":"10.1038/bjc.2012.489","title":"Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Centre for Disease Control; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Cytology; Cervical intraepithelial neoplasia; Triage; Colposcopy; Cervical cancer; Gynecology; Randomized controlled trial; Cervical screening; Internal medicine; Obstetrics; Cancer; Pathology; Emergency medicine","score_opus":0.05744963594375095,"score_gpt":0.35182950360197934,"score_spread":0.2943798676582284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159482884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635716,0.022224754,0.0010069748,0.0009645542,0.000901617,0.006628782,0.0019261773,0.00016355207,0.0026120497],"genre_scores_gemma":[0.9799849,0.0059669297,0.0017703843,0.0008127873,0.00056992413,0.007273737,0.0013151724,0.000027223186,0.0022788586],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959329,0.002755751,0.00027699617,0.00045823303,0.00024246269,0.00033373965],"domain_scores_gemma":[0.9956203,0.0019646904,0.0011498594,0.00043447808,0.0002925796,0.00053806114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040822495,0.0021587403,0.004889142,0.0005783921,0.0003003233,0.0013005969,0.0012569375,0.002813683,0.009037806],"category_scores_gemma":[0.008517281,0.00081955676,0.004038089,0.00048925023,0.0011846042,0.0010119192,0.0006672093,0.002466801,0.00091723574],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9850641,0.0015347023,0.00031217912,0.0022596503,0.002123163,0.000023837478,0.00006328166,0.00019986265,0.0006552798,0.00006178162,0.00042218462,0.007280001],"study_design_scores_gemma":[0.9344512,0.059333604,0.0021906784,0.00026853874,0.0027189902,0.000025180983,0.000030900086,0.00019551783,0.0002039476,0.00013016522,0.00042813347,0.000023045946],"about_ca_topic_score_codex":0.0031952658,"about_ca_topic_score_gemma":0.003836498,"teacher_disagreement_score":0.009037806,"about_ca_system_score_codex":0.0014018627,"about_ca_system_score_gemma":0.0018841191,"threshold_uncertainty_score":0.030234456},"labels":[],"label_agreement":null},{"id":"W2161706255","doi":"10.1038/sj.bjc.6602449","title":"State-of-the-art management of nasopharyngeal carcinoma: current and future directions","year":2005,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Radiation therapy; Oncology; Head and neck; Disease; Immunotherapy; Chemotherapy; Carcinoma; Head and neck cancer; Internal medicine; Clinical trial; Cancer; Intensive care medicine; Surgery","score_opus":0.031172998257666323,"score_gpt":0.35102067379239343,"score_spread":0.3198476755347271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161706255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004699254,0.9991184,0.00003107786,0.0004661688,0.000076231845,0.0000021494968,0.000004719592,0.0000032745077,0.00025103125],"genre_scores_gemma":[0.00035497308,0.9992155,0.000093692826,0.0001503493,0.00008739613,0.0000033427204,0.000007499148,6.7752734e-7,0.000086605854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992397,0.00024449558,0.00013807137,0.0000957421,0.0002323082,0.000049780076],"domain_scores_gemma":[0.9976107,0.0015014182,0.00031859663,0.00005438365,0.00039233305,0.00012257203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027022376,0.0008839984,0.0027591952,0.0018415388,0.0003535884,0.001679135,0.0017914217,0.0017304996,0.0064900713],"category_scores_gemma":[0.0031778987,0.00031199172,0.00086860487,0.002761844,0.00096349313,0.0033324033,0.00076538854,0.0019647887,0.0018210696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016149643,0.000057414272,0.00019364848,0.028900938,0.00010971587,0.0001211299,0.00006322555,0.0003118711,0.0003037493,0.0019619162,0.018218722,0.94959617],"study_design_scores_gemma":[0.000102971026,0.00025458197,0.0020441932,0.04894423,0.00057724613,0.0011961224,0.0004673808,0.00023126627,0.00022783938,0.0046107634,0.9413025,0.000041015915],"about_ca_topic_score_codex":0.0021334167,"about_ca_topic_score_gemma":0.00563018,"teacher_disagreement_score":0.0064900713,"about_ca_system_score_codex":0.0011720741,"about_ca_system_score_gemma":0.0023773431,"threshold_uncertainty_score":0.021711469},"labels":[],"label_agreement":null},{"id":"W2161722719","doi":"10.1038/bjc.2012.232","title":"Chromosome instability and benefit from adjuvant anthracyclines in breast cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Chromosome instability; Oncology; Medicine; Adjuvant; Genome instability; Chromosome; Cancer; Cancer research; Internal medicine; Bioinformatics; Biology; Genetics; DNA; DNA damage; Gene","score_opus":0.006655329400887406,"score_gpt":0.26089282592261054,"score_spread":0.2542374965217231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161722719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833137,0.0011739312,0.000037339152,0.000071675684,0.0000035083087,0.000003691288,0.00006876214,0.0000029705402,0.00030677303],"genre_scores_gemma":[0.99955887,0.00017849436,0.000037671518,0.000021222873,0.000008004706,0.0000033608583,0.00010463373,8.4137326e-7,0.00008703278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992216,0.000026159507,0.0000059901954,0.000011614634,0.000018220355,0.000015916587],"domain_scores_gemma":[0.9994746,0.00021777794,0.00016122263,0.000016276666,0.000026138523,0.00010404968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027130722,0.0001035685,0.0002589725,0.0002702312,0.00011922726,0.00017970198,0.00007832899,0.00025291488,0.0015246295],"category_scores_gemma":[0.0011193575,0.00006122181,0.000087927074,0.00028413706,0.00012080528,0.000105185056,0.00012797682,0.00023996858,0.00011302295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0109467385,0.00015771939,0.93604076,0.00010651838,0.00008688091,0.00046143046,0.000078409634,0.0008086384,0.011781109,0.000064027154,0.00042183153,0.039045937],"study_design_scores_gemma":[0.00020180007,0.0012117474,0.99477416,0.000016462942,0.000069068345,0.0010702965,0.000031336924,0.00059242547,0.0012526251,0.00016238255,0.0006131183,0.00000464701],"about_ca_topic_score_codex":0.00042940327,"about_ca_topic_score_gemma":0.0009269472,"teacher_disagreement_score":0.0015246295,"about_ca_system_score_codex":0.0002203417,"about_ca_system_score_gemma":0.0001240969,"threshold_uncertainty_score":0.0051003695},"labels":[],"label_agreement":null},{"id":"W2165688222","doi":"10.1054/bjoc.2001.1883","title":"Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Prostate cancer; Androgen; Identification (biology); Prostate; Biology; Gene expression; Cancer; Cancer research; Differential (mechanical device); Differential display; Medicine; Endocrinology; Gene; Genetics; Hormone","score_opus":0.019773230577731435,"score_gpt":0.30706366908218485,"score_spread":0.2872904385044534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165688222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745729,0.018435966,0.002845138,0.00023525793,0.000053908654,0.00006451541,0.0011130405,0.00007672823,0.0026024666],"genre_scores_gemma":[0.9893919,0.0047334647,0.0020193052,0.00010453538,0.00002812279,0.000040403498,0.0016445803,0.000016751088,0.0020209602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999846,0.00002545701,0.000008157433,0.000035999496,0.000057842357,0.000026585987],"domain_scores_gemma":[0.9999013,0.000027639253,0.000025548166,0.000009791441,0.000014946291,0.000020824658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010526673,0.00014829647,0.00024452218,0.0005653059,0.00018595411,0.00035781544,0.000168757,0.00025098116,0.0011969798],"category_scores_gemma":[0.00026948864,0.00015929026,0.00024676046,0.00049519597,0.00025704686,0.00011408876,0.0001667143,0.0003581518,0.00027081618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021347358,0.00001939861,0.004241991,0.00013635884,0.0000119428305,0.00025520608,0.000068639456,0.00013514307,0.98813885,0.000095868534,0.00012703957,0.006556141],"study_design_scores_gemma":[0.000039275084,0.0007845379,0.54140633,0.000039899744,0.00009443273,0.008518658,0.0002459872,0.0013063815,0.43149006,0.0002947398,0.015745817,0.00003386987],"about_ca_topic_score_codex":0.0006823803,"about_ca_topic_score_gemma":0.00091073435,"teacher_disagreement_score":0.0011969798,"about_ca_system_score_codex":0.00023077017,"about_ca_system_score_gemma":0.00023412511,"threshold_uncertainty_score":0.0040042996},"labels":[],"label_agreement":null},{"id":"W2165939716","doi":"10.1038/sj.bjc.6602020","title":"Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Carboplatin; Medicine; Cisplatin; Seminoma; Chemotherapy; Oncology; Internal medicine; Clinical endpoint; Radiation therapy; Clinical trial; Surgery","score_opus":0.030786319824425798,"score_gpt":0.32923925708860613,"score_spread":0.2984529372641803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165939716","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3260997,0.6545323,0.006517535,0.000838443,0.0018200385,0.0053415755,0.0027344222,0.00018305621,0.0019328055],"genre_scores_gemma":[0.9160407,0.0698965,0.004603491,0.0010669703,0.00071602396,0.0045902054,0.002209014,0.000055119774,0.00082191493],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98208874,0.012326976,0.0029339874,0.0013273314,0.0009353802,0.00038760056],"domain_scores_gemma":[0.98857343,0.006120477,0.0033139056,0.00094417075,0.0006676163,0.00038051736],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.018730927,0.0021721458,0.01445624,0.0019389358,0.00026923468,0.0022472227,0.000871844,0.002072909,0.0027556457],"category_scores_gemma":[0.02306114,0.0009544939,0.019601082,0.0024822825,0.0006948827,0.0013877143,0.0010213155,0.0017346595,0.00031974696],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47010794,0.00029486165,0.0051673735,0.038246106,0.45930567,0.00014046424,0.00008148759,0.0013441471,0.001394853,0.00017281302,0.00066620496,0.023078062],"study_design_scores_gemma":[0.3362784,0.019792102,0.014143706,0.002596393,0.6217688,0.0002363665,0.000085710344,0.0010662462,0.0005314419,0.0006795255,0.0027348706,0.00008653355],"about_ca_topic_score_codex":0.0013005729,"about_ca_topic_score_gemma":0.0026215906,"teacher_disagreement_score":0.9978278,"about_ca_system_score_codex":0.0013409135,"about_ca_system_score_gemma":0.0013379507,"threshold_uncertainty_score":0.09905976},"labels":[],"label_agreement":null},{"id":"W2166119663","doi":"10.1038/sj.bjc.6603740","title":"Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Zoledronic acid; Medicine; Breast cancer; Bisphosphonate; Bone metastasis; Bone resorption; Internal medicine; Metastasis; Doxycycline; Oncology; Cancer; Osteoporosis; Antibiotics; Biology","score_opus":0.022502513674917776,"score_gpt":0.351250639085034,"score_spread":0.3287481254101162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166119663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98566955,0.008745327,0.0012666316,0.00029828827,0.00023359012,0.00018971517,0.0011125526,0.00013420593,0.0023500877],"genre_scores_gemma":[0.9890865,0.0038079983,0.002229926,0.000116520176,0.00003705492,0.00012981544,0.001143147,0.000021702306,0.0034271998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999765,0.000053630396,0.000025364026,0.000038558665,0.000057521378,0.00005986573],"domain_scores_gemma":[0.9998802,0.000019196907,0.000025161768,0.000011226519,0.000017456527,0.0000468176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022027889,0.00040915248,0.0008124301,0.00046218,0.00020092273,0.00028966524,0.00027513062,0.00035569214,0.0011516365],"category_scores_gemma":[0.00014173127,0.0001708433,0.0004020057,0.00037343267,0.00019205565,0.00017069951,0.00020966766,0.00089271215,0.00024977728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00196533,0.0006166145,0.00017754524,0.00019722123,0.000026611562,0.000067052715,0.000038985152,0.00022543657,0.9924941,0.00008503754,0.00022118358,0.0038848608],"study_design_scores_gemma":[0.00051476253,0.01187007,0.0059855534,0.000027317723,0.00009897226,0.00021950189,0.00005734448,0.0018463352,0.9742522,0.000062597006,0.0050439476,0.000021389133],"about_ca_topic_score_codex":0.001894209,"about_ca_topic_score_gemma":0.0039300146,"teacher_disagreement_score":0.001894209,"about_ca_system_score_codex":0.00031615407,"about_ca_system_score_gemma":0.00046441532,"threshold_uncertainty_score":0.0038526654},"labels":[],"label_agreement":null},{"id":"W2168362647","doi":"10.1038/sj.bjc.6605736","title":"BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":325,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Cancer Council Victoria; National Health and Medical Research Council; Cancer Research UK","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Hazard ratio; Univariate analysis; Proportional hazards model; Lymph node; Confidence interval; Stage (stratigraphy); Progesterone receptor; Multivariate analysis; Cancer; Prognostic variable; Estrogen receptor; Biology","score_opus":0.005290732897433089,"score_gpt":0.2664471361402568,"score_spread":0.2611564032428237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168362647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743095,0.024019958,0.00033417068,0.00015071814,0.000020132948,0.00001533145,0.00022892002,0.000006468514,0.0009149076],"genre_scores_gemma":[0.9985368,0.001112803,0.000058702677,0.000017411907,0.000024012737,0.0000038402463,0.00013694089,0.0000012982957,0.00010803141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928075,0.0003393954,0.000051520936,0.0001154988,0.00015231149,0.00006044682],"domain_scores_gemma":[0.99680567,0.0015251677,0.0009561674,0.0002461862,0.00025337483,0.00021340005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030602654,0.00020349487,0.00036312695,0.0007758944,0.00017909303,0.00063893286,0.00033738883,0.00045724813,0.001353557],"category_scores_gemma":[0.0051609743,0.00014919313,0.000356579,0.0010546127,0.00039087338,0.0004811218,0.00040388427,0.00034870647,0.00016573067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028881626,0.000027863443,0.9800136,0.00012361327,0.0003277671,0.00014594638,0.00004120358,0.00023545648,0.0009765861,0.000039433136,0.00011242115,0.0150679005],"study_design_scores_gemma":[0.00007283625,0.00068628823,0.9958994,0.0000401724,0.0005007947,0.00087442936,0.0000778221,0.0003239166,0.00042676803,0.00015595125,0.0009357833,0.000005716462],"about_ca_topic_score_codex":0.0009595183,"about_ca_topic_score_gemma":0.0011224108,"teacher_disagreement_score":0.0030602654,"about_ca_system_score_codex":0.00024525463,"about_ca_system_score_gemma":0.00024910376,"threshold_uncertainty_score":0.01618445},"labels":[],"label_agreement":null},{"id":"W2168380142","doi":"10.1038/bjc.2012.227","title":"Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute; National Institutes of Health; Division of Cancer Prevention, National Cancer Institute","keywords":"Medicine; Aspirin; Prostate cancer; Internal medicine; Prostate; Hazard ratio; Cancer; Confidence interval; Epidemiology; Ibuprofen; Confounding; Relative risk; Oncology; Gynecology; Pharmacology","score_opus":0.01776664014134578,"score_gpt":0.2907683792282006,"score_spread":0.2730017390868548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168380142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676514,0.0009160823,0.000083720806,0.0001684122,0.000016209555,0.000037913043,0.0009122703,0.0000066838597,0.0010936954],"genre_scores_gemma":[0.99829406,0.00034946177,0.000056760226,0.000120943754,0.000047123696,0.000021103458,0.00065695617,0.000004638309,0.00044904012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990821,0.00040101784,0.00008181485,0.00018144824,0.000121348174,0.00013219436],"domain_scores_gemma":[0.9966204,0.00059935235,0.0013504444,0.00053439057,0.00025638455,0.0006389556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012611378,0.000401548,0.00052486017,0.00070968014,0.00061820063,0.0012709245,0.00040537317,0.0008558032,0.0033206001],"category_scores_gemma":[0.0033112848,0.00058123487,0.0010090051,0.0017355252,0.00044446616,0.00041030018,0.0005941488,0.0007680221,0.00054360233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026845678,0.00018547088,0.99409395,0.000064402164,0.0005574425,0.0002715482,0.00013540823,0.000022281723,0.0002788276,0.00003574027,0.00030729713,0.0013631247],"study_design_scores_gemma":[0.0005121641,0.0005148145,0.9970272,0.000027163393,0.0006638393,0.00027643977,0.00014356313,0.000118074466,0.00004412562,0.000036605437,0.0006241229,0.000011803882],"about_ca_topic_score_codex":0.015671024,"about_ca_topic_score_gemma":0.016216626,"teacher_disagreement_score":0.015671024,"about_ca_system_score_codex":0.00046396954,"about_ca_system_score_gemma":0.0006850058,"threshold_uncertainty_score":0.03115958},"labels":[],"label_agreement":null},{"id":"W2168773053","doi":"10.1038/sj.bjc.6600283","title":"Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Breast cancer; Gene expression; Real-time polymerase chain reaction; Cancer; Gene; Biology; Mammary gland; Polymerase chain reaction; Human breast; Medicine; Oncology; Pathology; Cancer research; Internal medicine; Genetics; Enzyme","score_opus":0.025809272270025847,"score_gpt":0.3069127058125378,"score_spread":0.281103433542512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168773053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558854,0.0011607212,0.0023412758,0.000040103332,0.000013195459,0.000019313726,0.000423966,0.00004012456,0.00037274158],"genre_scores_gemma":[0.99663144,0.00030228004,0.0021907985,0.000028927465,0.000015189646,0.00003443175,0.0003810246,0.000007543503,0.00040833632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997125,0.00007264418,0.00002208527,0.00006203212,0.00008532509,0.000045392244],"domain_scores_gemma":[0.99933136,0.00035012444,0.00014514038,0.000025094529,0.00009352086,0.00005488619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050478516,0.00018919678,0.0002593832,0.00058506214,0.00011130398,0.00036197892,0.00014828784,0.00030940995,0.0010470967],"category_scores_gemma":[0.0009947825,0.00013280187,0.00016915056,0.00059559295,0.0002712035,0.00016392609,0.00015435572,0.00035435508,0.00030031902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029317555,0.00014916674,0.7176449,0.0001922043,0.00014455653,0.0002799541,0.00023151057,0.00077578845,0.25426218,0.00008795769,0.0003638737,0.022936253],"study_design_scores_gemma":[0.000033145236,0.00049028784,0.95623076,0.0000148384015,0.00008645376,0.0011861329,0.00008992589,0.003005843,0.03794984,0.00013730145,0.0007555412,0.000019892497],"about_ca_topic_score_codex":0.00043497514,"about_ca_topic_score_gemma":0.0007195947,"teacher_disagreement_score":0.0010470967,"about_ca_system_score_codex":0.00024105002,"about_ca_system_score_gemma":0.00018077936,"threshold_uncertainty_score":0.0035029054},"labels":[],"label_agreement":null},{"id":"W2169344399","doi":"10.1038/bjc.2012.338","title":"PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; McGill University; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Cancer Research UK; Academy of Finland; National Institutes of Health; Kuopion Yliopistollinen Sairaala; Breast Cancer Campaign; Michael Smith Health Research BC; Susan G. Komen; Helsingin ja Uudenmaan Sairaanhoitopiiri; National Cancer Institute; Itä-Suomen Yliopisto; KWF Kankerbestrijding; National Institute for Health and Care Research","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Hazard ratio; Proportional hazards model; Stage (stratigraphy); Cancer; Adjuvant; Confidence interval","score_opus":0.0205935707063703,"score_gpt":0.2789817684969163,"score_spread":0.258388197790546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169344399","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85485435,0.001243273,0.12904671,0.0009913192,0.00021989517,0.0004344948,0.008292187,0.0022645895,0.0026530987],"genre_scores_gemma":[0.9329356,0.00040035666,0.0549079,0.00017262863,0.000101760495,0.00039152725,0.00910451,0.0001210609,0.0018646718],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995907,0.0001737892,0.000029376473,0.00007226615,0.00010220399,0.00003154513],"domain_scores_gemma":[0.99805754,0.0013582566,0.00014293921,0.00010361154,0.00026319595,0.0000744457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033152278,0.00084202754,0.00074857066,0.0006848299,0.00021608226,0.00067701587,0.0007576098,0.00039527926,0.0023676811],"category_scores_gemma":[0.0056738397,0.00032265543,0.0006932879,0.00037567256,0.00015919188,0.00041005167,0.0006132249,0.0005222539,0.0007397922],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006261843,0.0006762329,0.29042292,0.00040000398,0.0008114439,0.00037979742,0.00013291596,0.44136152,0.0046314495,0.0011016551,0.018880563,0.23493968],"study_design_scores_gemma":[0.00025997576,0.0009844761,0.032980684,0.00004836047,0.00030216822,0.00038168253,0.000027369228,0.95753115,0.0023996206,0.0012804611,0.003763233,0.0000408029],"about_ca_topic_score_codex":0.005358686,"about_ca_topic_score_gemma":0.003720229,"teacher_disagreement_score":0.005358686,"about_ca_system_score_codex":0.0005288558,"about_ca_system_score_gemma":0.0011834325,"threshold_uncertainty_score":0.017532825},"labels":[],"label_agreement":null},{"id":"W2169647448","doi":"10.1038/sj.bjc.6603289","title":"Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epirubicin; Radiation therapy; Chemotherapy; Internal medicine; Surgery; Cisplatin; Induction chemotherapy; Phases of clinical research; Gastroenterology; Oncology; Cyclophosphamide","score_opus":0.01137640728690949,"score_gpt":0.29716569295313766,"score_spread":0.2857892856662282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169647448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440247,0.001695168,0.00037312123,0.0003111233,0.00010030209,0.0015562323,0.00043915608,0.000050393322,0.0010720568],"genre_scores_gemma":[0.99041533,0.0012264362,0.0017240264,0.0006185156,0.0001478856,0.0021047394,0.0017431233,0.000019808454,0.002000107],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99947137,0.00034287974,0.00001774708,0.00006539581,0.000026273645,0.00007624866],"domain_scores_gemma":[0.9992374,0.00008459132,0.00018573485,0.000060589464,0.000031207346,0.00040050875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017051444,0.0011373,0.0014025164,0.00021534697,0.00027694073,0.0006906715,0.00078348245,0.0009815061,0.0022886035],"category_scores_gemma":[0.0007298663,0.00044736703,0.0007637656,0.00030860747,0.00066806853,0.00046169828,0.00035310938,0.0021500417,0.0004992737],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8429056,0.041099153,0.008295696,0.00046105727,0.0009799162,0.00028135485,0.0002507326,0.0019202083,0.039895535,0.00023641015,0.0036032917,0.06007109],"study_design_scores_gemma":[0.6461998,0.33289662,0.014346271,0.000028754463,0.00027952017,0.00025626423,0.000034351957,0.0008209868,0.0027227525,0.0001005578,0.0022982277,0.000015766727],"about_ca_topic_score_codex":0.0010193634,"about_ca_topic_score_gemma":0.0029479675,"teacher_disagreement_score":0.0022886035,"about_ca_system_score_codex":0.00089959946,"about_ca_system_score_gemma":0.0013087341,"threshold_uncertainty_score":0.0090177655},"labels":[],"label_agreement":null},{"id":"W2169912183","doi":"10.1038/sj.bjc.6600623","title":"Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Gene expression; Gene; Biology; Breast cancer; Association (psychology); Mammary gland; Genetic association; Pathology; Medicine; Internal medicine; Oncology; Bioinformatics; Genetics; Cancer research; Genotype; Cancer; Single-nucleotide polymorphism; Psychology","score_opus":0.018877763044691315,"score_gpt":0.28850639442133885,"score_spread":0.26962863137664755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169912183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992083,0.00020281383,0.00028058622,0.00000843075,0.000002028233,0.0000033466422,0.00009283333,0.00000829971,0.00019346135],"genre_scores_gemma":[0.9986846,0.000110893576,0.0005090787,0.000009756601,0.000004723454,0.000013925435,0.00025052507,0.00000290684,0.00041360635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998324,0.000042197666,0.0000135144655,0.000033041313,0.00004131421,0.0000374897],"domain_scores_gemma":[0.9994093,0.00024621608,0.00019236411,0.00002855387,0.00006356909,0.000059866354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002456314,0.0001403928,0.00015802433,0.00057116756,0.00008113017,0.00022109826,0.00010570268,0.0002361016,0.0010990148],"category_scores_gemma":[0.0005674444,0.00011578843,0.00010725513,0.0003791293,0.00024403985,0.000106737934,0.00012902533,0.00018725492,0.0002693235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016289569,0.000080647864,0.6662146,0.00007315441,0.00007335232,0.000288561,0.00017281277,0.00022474446,0.32196832,0.000057127556,0.00011296844,0.009104709],"study_design_scores_gemma":[0.00001002646,0.0003462936,0.98167497,0.0000038093256,0.000020272963,0.00075364945,0.00008196796,0.00052872224,0.01618617,0.000054150605,0.00033421515,0.000005738268],"about_ca_topic_score_codex":0.0002189624,"about_ca_topic_score_gemma":0.00031839847,"teacher_disagreement_score":0.0010990148,"about_ca_system_score_codex":0.000112655915,"about_ca_system_score_gemma":0.00006161275,"threshold_uncertainty_score":0.0036765933},"labels":[],"label_agreement":null},{"id":"W2170051100","doi":"10.1038/bjc.2012.231","title":"Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Imperial College Healthcare Charity; Cancer Research UK; Brain Tumour Research; Canadian Institutes of Health Research; Imperial College Healthcare NHS Trust; Imperial College London","keywords":"DNA methylation; CpG site; Methylation; Cancer research; Breast cancer; Biology; Cancer; Epigenetics; Gene silencing; Gene expression; Gene; Genetics","score_opus":0.013194726982021851,"score_gpt":0.2330074876359368,"score_spread":0.21981276065391495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170051100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870074,0.00042995482,0.00018473002,0.000035872148,0.0000053131384,0.0000059772437,0.00018299988,0.000014194944,0.00044016266],"genre_scores_gemma":[0.99945444,0.00008936794,0.000074856165,0.00000921957,0.000002226037,0.00000351501,0.00016601026,0.000002746022,0.00019754197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999018,0.000015385343,0.000008329823,0.00003213196,0.000022580507,0.000019850582],"domain_scores_gemma":[0.9996123,0.00010255995,0.00011044581,0.0000288008,0.00005287632,0.00009308199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023351627,0.00015350443,0.0002756899,0.0004056289,0.0001699108,0.0002715222,0.00020801177,0.00043692667,0.002483421],"category_scores_gemma":[0.0008111997,0.00010997845,0.00016483173,0.00031432346,0.00024658503,0.000089900845,0.00015362802,0.00029383358,0.00038280795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009923611,0.000035818586,0.9480377,0.00003181375,0.00003352929,0.00038734413,0.00008251631,0.00014626987,0.0453289,0.000029376004,0.00024016466,0.00465434],"study_design_scores_gemma":[0.0000097946795,0.00007922769,0.99436957,0.000004251458,0.000030894003,0.0014404617,0.000064535125,0.00033202974,0.0032793279,0.0000467209,0.00034058566,0.0000027410993],"about_ca_topic_score_codex":0.0028580774,"about_ca_topic_score_gemma":0.0023617889,"teacher_disagreement_score":0.0028580774,"about_ca_system_score_codex":0.00027083038,"about_ca_system_score_gemma":0.00013857178,"threshold_uncertainty_score":0.008307874},"labels":[],"label_agreement":null},{"id":"W2170674868","doi":"10.1038/sj.bjc.6601150","title":"Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Axillary Lymph Node Dissection; Breast cancer; Sentinel lymph node; Biopsy; Lymph node; Axillary Dissection; Axilla; Dissection (medical); Quality of life (healthcare); Surgery; Mammary gland; Radiology; Cancer; Pathology; Internal medicine","score_opus":0.012620976819395469,"score_gpt":0.2985745248092951,"score_spread":0.28595354798989964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170674868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990972,0.00046948832,0.00001599243,0.000035025743,0.0000066706802,0.0000057714515,0.00010141958,9.569256e-7,0.00026753137],"genre_scores_gemma":[0.99948126,0.00012848763,0.000019662602,0.00002645153,0.0000078373705,0.0000075128614,0.00022617588,7.8334057e-7,0.000101874895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993892,0.000199194,0.00006623927,0.000068477115,0.0001470055,0.00012989952],"domain_scores_gemma":[0.9980952,0.0005667394,0.00061424915,0.000047652768,0.00020423562,0.00047184387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090425846,0.0002026387,0.00053838856,0.0007331664,0.00029591194,0.00066231005,0.00023104339,0.00057808956,0.0011966234],"category_scores_gemma":[0.0040351828,0.00014216726,0.0006052906,0.000922163,0.00024577737,0.00045924482,0.0004168329,0.0004815887,0.00022696459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019874785,0.00020592523,0.9912208,0.000043861655,0.0001638613,0.00014690562,0.00023257847,0.000094879615,0.00023770028,0.000012240517,0.00012707463,0.005526874],"study_design_scores_gemma":[0.00003277707,0.0007787662,0.9985929,0.0000060864377,0.000040114366,0.00015138945,0.00015952626,0.000083128805,0.000024779589,0.000012130604,0.00011246897,0.000006000322],"about_ca_topic_score_codex":0.002467301,"about_ca_topic_score_gemma":0.0026329071,"teacher_disagreement_score":0.002467301,"about_ca_system_score_codex":0.00044513567,"about_ca_system_score_gemma":0.00018496242,"threshold_uncertainty_score":0.00490582},"labels":[],"label_agreement":null},{"id":"W2181053294","doi":"10.1038/bjc.2015.368","title":"Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Neutropenia; Oncology; Internal medicine; Chemotherapy","score_opus":0.03413820746168045,"score_gpt":0.2742318485938646,"score_spread":0.24009364113218418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181053294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963702,0.0021009324,0.00048810354,0.00010579411,0.000015958756,0.000013407489,0.0003545434,0.000010687312,0.0005404488],"genre_scores_gemma":[0.99938023,0.00012015273,0.00020612235,0.000013984394,0.000017378516,0.0000054188044,0.00020985965,0.0000012244005,0.00004551424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990213,0.00041142807,0.00010450158,0.00016110248,0.00022216458,0.00007960555],"domain_scores_gemma":[0.99688905,0.0010324001,0.0013568482,0.000117379685,0.00028005245,0.00032416618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022465708,0.00036046165,0.000704312,0.00057268684,0.00025614924,0.00076385366,0.00027346707,0.00030188178,0.0005418975],"category_scores_gemma":[0.003828639,0.00010088797,0.00064112974,0.00082261837,0.00017073612,0.0004671492,0.00038952456,0.00042780596,0.00010418303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006912674,0.000023365244,0.9908648,0.000029833915,0.000195643,0.000041389765,0.000018793578,0.00080217456,0.00020611686,0.00002535555,0.00010757025,0.006993632],"study_design_scores_gemma":[0.000035305122,0.00039756295,0.98934513,0.00002058397,0.00033212657,0.00029003434,0.000047008827,0.008492067,0.00038858052,0.0001787489,0.00046107578,0.000011805238],"about_ca_topic_score_codex":0.0019275905,"about_ca_topic_score_gemma":0.0036984344,"teacher_disagreement_score":0.0022465708,"about_ca_system_score_codex":0.0005752712,"about_ca_system_score_gemma":0.00062179985,"threshold_uncertainty_score":0.011881173},"labels":[],"label_agreement":null},{"id":"W2184585808","doi":"10.1038/bjc.2015.352","title":"RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Vlaamse regering; Institut National Du Cancer; GlaxoSmithKline","keywords":"Medicine; Clear cell renal cell carcinoma; Internal medicine; Renal cell carcinoma; Metastasis; Proportional hazards model; Osteoprotegerin; DKK1; Carcinoma; Oncology; Cancer research; Cancer; Receptor; Wnt signaling pathway; Biology; Signal transduction; Activator (genetics)","score_opus":0.011860528270357489,"score_gpt":0.2347705929940472,"score_spread":0.2229100647236897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184585808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987526,0.0007474555,0.00009401138,0.000015326854,0.0000033283488,0.0000058802016,0.00020774378,0.000003888393,0.00016982481],"genre_scores_gemma":[0.99958545,0.000082977815,0.00005275483,0.000005837982,0.000005129351,0.0000043004356,0.00017819669,8.218969e-7,0.000084604166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997619,0.00003609564,0.000020301399,0.00006093368,0.00007835135,0.000042575903],"domain_scores_gemma":[0.99912065,0.00016006987,0.0004895308,0.00003345639,0.00007507362,0.000121254525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037728474,0.00015853657,0.0004435086,0.0003944942,0.00014530604,0.00036729005,0.00021016884,0.00022944568,0.0013138258],"category_scores_gemma":[0.00088732585,0.00013619235,0.00037687097,0.0004355768,0.00022674851,0.00015635985,0.00020367347,0.0003088488,0.00015716748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009943962,0.00002981088,0.9938128,0.000023982218,0.00009657906,0.00012461327,0.000017922615,0.00009375871,0.0026199298,0.000012548426,0.00006499079,0.0021085946],"study_design_scores_gemma":[0.000018943821,0.00029470536,0.9980786,0.0000034865438,0.000080680526,0.00053579774,0.00002853737,0.00023000079,0.0005466341,0.00001763345,0.00016190542,0.0000030564504],"about_ca_topic_score_codex":0.0012089814,"about_ca_topic_score_gemma":0.0017003816,"teacher_disagreement_score":0.0013138258,"about_ca_system_score_codex":0.00036584592,"about_ca_system_score_gemma":0.00027086263,"threshold_uncertainty_score":0.0043952465},"labels":[],"label_agreement":null},{"id":"W2190726683","doi":"10.1054/bjoc.2000.1615","title":"Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministerstvo Zdravotnictví Ceské Republiky; Terry Fox Foundation; Grantová Agentura České Republiky","keywords":"Transformation (genetics); Human papillomavirus; Virology; Biology; Major histocompatibility complex; Immunology; MHC class I; Papillomaviridae; Medicine; Antigen; Cervical cancer; Genetics; Cancer; Gene; Internal medicine","score_opus":0.012411508695902086,"score_gpt":0.26128233641426446,"score_spread":0.2488708277183624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190726683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98869145,0.0010627653,0.0046390607,0.00012041595,0.00011053403,0.00012582997,0.0013269519,0.00021994102,0.0037030624],"genre_scores_gemma":[0.9770083,0.0012506169,0.0052470276,0.00008433557,0.00003049254,0.00022899195,0.0025219126,0.000098601275,0.013529719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996044,0.000034827994,0.00004027627,0.00009648019,0.000108713786,0.000115326504],"domain_scores_gemma":[0.9996841,0.000040887655,0.00008384196,0.00007131417,0.000029249222,0.000090651054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023478387,0.0006288101,0.00042834808,0.0005212359,0.0002270726,0.00050429004,0.0003601297,0.00044945767,0.0039459276],"category_scores_gemma":[0.00016920976,0.00035034557,0.0003709175,0.0002947019,0.0003065156,0.0002688053,0.00028853188,0.0013499144,0.002277725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014749375,0.000056205823,0.000162345,0.000022262304,0.0000029667872,0.000063062056,0.000018933328,0.00002595561,0.9988356,0.00016263027,0.000038580878,0.00046394335],"study_design_scores_gemma":[0.00006481931,0.0010935584,0.0032756214,0.000013608949,0.000019433519,0.0012350447,0.00004336951,0.00071576587,0.98886406,0.00015406503,0.0045131356,0.000007368124],"about_ca_topic_score_codex":0.0006092506,"about_ca_topic_score_gemma":0.00054567674,"teacher_disagreement_score":0.0039459276,"about_ca_system_score_codex":0.00031329342,"about_ca_system_score_gemma":0.00022766896,"threshold_uncertainty_score":0.013200402},"labels":[],"label_agreement":null},{"id":"W2193923663","doi":"10.1038/bjc.2015.414","title":"1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta; University of Alberta Hospital","funders":"Alberta Innovates; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; University of Alberta; Alberta Innovates - Health Solutions; Government of Canada","keywords":"Metabolomics; Receiver operating characteristic; Metabolite; Biomarker; Urine; Logistic regression; Medicine; Urinary system; Area under the curve; Internal medicine; Chromatography; Chemistry","score_opus":0.024920823519499744,"score_gpt":0.30396059332623454,"score_spread":0.2790397698067348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2193923663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856732,0.006254615,0.0058531533,0.0005117417,0.000027605247,0.000040929513,0.00046840677,0.00007542224,0.0010948492],"genre_scores_gemma":[0.99165076,0.0010730845,0.006702895,0.000099583085,0.00003620559,0.000018482591,0.00024196788,0.000008716065,0.00016834779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996711,0.00015700131,0.000020580132,0.000052692318,0.00006979626,0.000028732124],"domain_scores_gemma":[0.9991922,0.00032968668,0.00026321082,0.000043245112,0.000090572146,0.00008110446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010806271,0.000433904,0.0005075887,0.0009289414,0.00020620885,0.00043889158,0.00018469966,0.0004682281,0.0007598331],"category_scores_gemma":[0.0020395091,0.00014597499,0.00028037935,0.0006319122,0.0002970477,0.00021015664,0.00035980457,0.00038827184,0.00018337251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031064544,0.00027850113,0.7896539,0.00037813876,0.00025161213,0.0005115276,0.0001617334,0.0025397316,0.121384166,0.00020307691,0.00092692603,0.08060423],"study_design_scores_gemma":[0.00009874558,0.0019753797,0.8925977,0.0001230662,0.00042146438,0.0034997647,0.00035997503,0.032255832,0.062349197,0.0014105256,0.0048402944,0.00006802463],"about_ca_topic_score_codex":0.0005696589,"about_ca_topic_score_gemma":0.0012393679,"teacher_disagreement_score":0.0010806271,"about_ca_system_score_codex":0.00027224983,"about_ca_system_score_gemma":0.0002716051,"threshold_uncertainty_score":0.0057150126},"labels":[],"label_agreement":null},{"id":"W2196018385","doi":"10.1038/bjc.2015.402","title":"Aristolochic acid exposure in Romania and implications for renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nephrotoxicity and Medicinal Plants","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"National Cancer Institute; Medical Research Council; National Institute of Environmental Health Sciences; lékařská fakulta Univerzity Karlovy; European Commission; Univerzita Karlova v Praze; World Health Organization","keywords":"Aristolochic acid; Renal cell carcinoma; Aristolochia; Biology; Medicine; Pathology; Genetics; Traditional medicine","score_opus":0.027832125731379182,"score_gpt":0.29504470512085595,"score_spread":0.2672125793894768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196018385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931861,0.003407984,0.00014879415,0.00031399756,0.000014800282,0.000008533198,0.0001603845,0.0000048515276,0.0027546328],"genre_scores_gemma":[0.99845386,0.001087523,0.00015696694,0.00006374102,0.000012651059,0.0000028429383,0.000059212187,0.0000012755919,0.00016195532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997516,0.0000935899,0.000024658279,0.00003681698,0.000044305267,0.00004893429],"domain_scores_gemma":[0.9996414,0.00005786936,0.00018111317,0.000024134355,0.00006222845,0.000033201293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039178267,0.00011372631,0.0001839371,0.00079447863,0.00038678967,0.0003113342,0.00016875345,0.0001759936,0.0015221925],"category_scores_gemma":[0.0007962427,0.000075795615,0.00018305074,0.00089303456,0.00047372672,0.000108178014,0.00033703682,0.00020133446,0.00014254775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020100865,0.000037818972,0.9778553,0.00012190976,0.000040691368,0.00169647,0.00040433524,0.00010441467,0.0033615713,0.0002622262,0.00036074387,0.015553416],"study_design_scores_gemma":[0.000005070071,0.000070816815,0.99316204,0.00004575789,0.000029644496,0.0026471347,0.00056769873,0.00011626751,0.00067166483,0.000107231564,0.0025726962,0.000004062173],"about_ca_topic_score_codex":0.0073075327,"about_ca_topic_score_gemma":0.007145502,"teacher_disagreement_score":0.0073075327,"about_ca_system_score_codex":0.00040326908,"about_ca_system_score_gemma":0.0004662388,"threshold_uncertainty_score":0.014530003},"labels":[],"label_agreement":null},{"id":"W2232773455","doi":"10.1054/bjoc.1999.1045","title":"The United Kingdom Childhood Cancer Study: objectives, materials and methods","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Moorfields Eye Hospital NHS Foundation Trust; Hospital for Sick Children; Great Ormond Street Hospital for Children; Trent University; University of Southampton; Middlesex University; Queen Mary University of London; National Research Program for Biopharmaceuticals; University of Oxford; Alder Hey Children's NHS Foundation Trust","keywords":"Residence; Medicine; Ionizing radiation; Childhood cancer; Cancer; Population; Pediatrics; Demography; Disease; Environmental health; Family medicine; Pathology; Internal medicine; Physics","score_opus":0.030012509791039536,"score_gpt":0.38884936910249324,"score_spread":0.3588368593114537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2232773455","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5551918,0.033471134,0.0033731905,0.0024673974,0.0006109084,0.03531633,0.32329246,0.00013074938,0.04614599],"genre_scores_gemma":[0.7057734,0.020375617,0.009848279,0.0031758891,0.00047194236,0.07668971,0.1502292,0.00014209977,0.03329388],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971073,0.0009828268,0.0006057224,0.0005128423,0.0003161055,0.00047517696],"domain_scores_gemma":[0.99844944,0.00020113717,0.00050700794,0.00017585506,0.00036118922,0.0003052604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014840963,0.0014382005,0.0016384138,0.0026847164,0.0016268279,0.0014587819,0.0013569186,0.0012807912,0.012019315],"category_scores_gemma":[0.0032438985,0.0016948695,0.0006399741,0.0073882355,0.0006792772,0.0010023038,0.001817789,0.0010061048,0.004631388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003398748,0.0007559165,0.88721293,0.0035170752,0.00028516332,0.002591173,0.004615146,0.0005296092,0.00076962984,0.0027637123,0.06713327,0.026427627],"study_design_scores_gemma":[0.0010876349,0.0008937901,0.87897253,0.000998344,0.00020253232,0.0014861757,0.0035705024,0.00015406567,0.00022387091,0.00037778812,0.111972325,0.000060424652],"about_ca_topic_score_codex":0.10855491,"about_ca_topic_score_gemma":0.16248879,"teacher_disagreement_score":0.10855491,"about_ca_system_score_codex":0.002793399,"about_ca_system_score_gemma":0.0027661116,"threshold_uncertainty_score":0.21584606},"labels":[],"label_agreement":null},{"id":"W2278983443","doi":"10.1038/bjc.2016.22","title":"Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Mount Sinai Hospital; Credit Valley Hospital; Ottawa Hospital; Princess Margaret Cancer Centre; Toronto General Hospital; Toronto East General Hospital; York Central Hospital; University Health Network","funders":"University of Toronto; University Health Network","keywords":"Hazard ratio; Medicine; Internal medicine; Odds ratio; Oncology; Epidermal growth factor receptor; Mutation; Cohort; Population; Proportional hazards model; Confidence interval; Cancer; Biology; Genetics; Gene","score_opus":0.015872836115168393,"score_gpt":0.385789185036649,"score_spread":0.3699163489214806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278983443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995634,0.0001393557,0.000030340341,0.000014347544,0.0000016540598,0.0000021575372,0.00012084846,0.0000017021864,0.00012621078],"genre_scores_gemma":[0.9998385,0.000020627596,0.000015921662,0.000005146272,0.0000020412908,0.0000017710162,0.000089378496,6.778044e-7,0.000025958907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997578,0.000043093216,0.000027426164,0.00007773611,0.000048209757,0.00004569783],"domain_scores_gemma":[0.9989379,0.0002789199,0.00047692572,0.000053025917,0.00007039607,0.00018279668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046145057,0.00017741884,0.00032264992,0.0004974887,0.00029623572,0.00056496565,0.00022670245,0.00041257014,0.0012602991],"category_scores_gemma":[0.0019167364,0.00013364755,0.0002748658,0.0004979422,0.00024054539,0.0003780262,0.00025597203,0.00037407348,0.00023244934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018842854,0.000011065965,0.9986363,0.000003997082,0.000015979762,0.000106833046,0.000019532914,0.00003828899,0.00033229069,0.000005235269,0.00002028833,0.0006218773],"study_design_scores_gemma":[0.0000037433906,0.00015966105,0.9984125,0.0000025999611,0.000018187988,0.0009768992,0.00006667225,0.0001342665,0.000115262395,0.000023939074,0.00008357144,0.000002639656],"about_ca_topic_score_codex":0.0010095537,"about_ca_topic_score_gemma":0.0011671036,"teacher_disagreement_score":0.0012602991,"about_ca_system_score_codex":0.00021932722,"about_ca_system_score_gemma":0.00018287505,"threshold_uncertainty_score":0.0042161345},"labels":[],"label_agreement":null},{"id":"W2284575850","doi":"10.1038/bjc.2016.21","title":"Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Internal medicine; Hazard ratio; Oncology; Biomarker; Urology; Confidence interval","score_opus":0.027802235006813142,"score_gpt":0.29442682614684274,"score_spread":0.26662459114002957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284575850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591947,0.002168159,0.0001518587,0.00021827416,0.00007954061,0.00039869457,0.0006638819,0.0000138960195,0.00038614823],"genre_scores_gemma":[0.99705887,0.0003960762,0.00018042025,0.00022438272,0.00010563266,0.0004931721,0.0011166107,0.000004499003,0.00042034744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99819106,0.0010674362,0.0001588922,0.00021752605,0.00018504207,0.00018007043],"domain_scores_gemma":[0.9972451,0.0009512397,0.0010465224,0.00017749215,0.00011901973,0.00046067435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036674247,0.00090935006,0.0022807722,0.0002704539,0.0003678907,0.0010382052,0.0005042057,0.0011815885,0.002931907],"category_scores_gemma":[0.003783212,0.00036165712,0.002385948,0.0003947929,0.0006305709,0.00077702274,0.00044217843,0.0016044689,0.000338296],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9715997,0.0012287048,0.012989275,0.00030589462,0.0021167584,0.00004223961,0.000048244117,0.0005081335,0.0014758639,0.000036481153,0.00041023185,0.009238544],"study_design_scores_gemma":[0.7118952,0.16209914,0.11581538,0.00007879216,0.0045235143,0.00021134818,0.000062385574,0.001419969,0.001909674,0.00038930273,0.0015422748,0.000052904055],"about_ca_topic_score_codex":0.00051427283,"about_ca_topic_score_gemma":0.0011037188,"teacher_disagreement_score":0.0036674247,"about_ca_system_score_codex":0.0010517611,"about_ca_system_score_gemma":0.001033367,"threshold_uncertainty_score":0.01939547},"labels":[],"label_agreement":null},{"id":"W2295297667","doi":"10.1038/bjc.2016.28","title":"Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis","year":2016,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Ottawa; Hospital for Sick Children","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Confidence interval; Logistic regression; Febrile neutropenia; Mucositis; Neutropenia; Internal medicine; Chemotherapy","score_opus":0.10499446424668663,"score_gpt":0.3575099082461568,"score_spread":0.2525154439994702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295297667","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1302245,0.8472168,0.012495647,0.0012187825,0.00059181056,0.0005626914,0.0062435204,0.00042133717,0.0010250071],"genre_scores_gemma":[0.9178335,0.06857919,0.0075937845,0.0009114215,0.0002715379,0.0009514126,0.0031353605,0.00013799994,0.0005857533],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9894671,0.007415272,0.0010029135,0.0012665236,0.00054520497,0.00030301893],"domain_scores_gemma":[0.97984743,0.015978705,0.001705435,0.0012999544,0.0008747687,0.0002937724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021725971,0.0026819217,0.010627548,0.0031492978,0.00047132198,0.0024883058,0.0023760453,0.0018004605,0.0024300527],"category_scores_gemma":[0.02858675,0.0011987305,0.04913072,0.0041201124,0.00055097725,0.0011995907,0.0018682611,0.002651464,0.00026291976],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005863515,0.00003116812,0.0231323,0.018167796,0.94346696,0.0001112349,0.000055579454,0.0023864987,0.00022747168,0.00011627428,0.0006710214,0.0057701054],"study_design_scores_gemma":[0.00091273536,0.00033255672,0.01221641,0.0010223652,0.9824156,0.000095058276,0.00002698946,0.0016293898,0.000105096165,0.0002962332,0.0009232716,0.000024347628],"about_ca_topic_score_codex":0.0066378987,"about_ca_topic_score_gemma":0.007046018,"teacher_disagreement_score":0.021725971,"about_ca_system_score_codex":0.0010796244,"about_ca_system_score_gemma":0.001261813,"threshold_uncertainty_score":0.11489928},"labels":[],"label_agreement":null},{"id":"W2297139589","doi":"10.1038/bjc.2016.18","title":"Arpin downregulation in breast cancer is associated with poor prognosis","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Council Canada; Institut National Du Cancer; Ligue Contre le Cancer; Fondation ARC pour la Recherche sur le Cancer; Russian Foundation for Basic Research; Agence Nationale de la Recherche","keywords":"Downregulation and upregulation; Breast cancer; Medicine; Cancer; Oncology; Internal medicine; Pathology; Biology; Genetics","score_opus":0.005909351375411245,"score_gpt":0.2330615791105795,"score_spread":0.22715222773516827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297139589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971813,0.0014770539,0.0003103502,0.00011955439,0.000009520282,0.0000047395283,0.0002795061,0.000021166234,0.00059689244],"genre_scores_gemma":[0.99887365,0.00040558018,0.0001909157,0.000019687373,0.0000139085205,0.00000656727,0.0002398077,0.0000037247137,0.00024610173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998703,0.000025416775,0.000013231234,0.000029808574,0.000037497062,0.000023735998],"domain_scores_gemma":[0.99921703,0.00015132394,0.0004003421,0.000037147845,0.00009260619,0.0001015629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030259322,0.00018028087,0.00027197044,0.0005210526,0.00022845111,0.00033699055,0.00013517607,0.00025822644,0.0016630248],"category_scores_gemma":[0.0008091685,0.00010612646,0.00011520363,0.00051365164,0.0002734731,0.00013392247,0.00018805654,0.00037944896,0.0003429668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001033777,0.000041867665,0.9400663,0.000067747176,0.00006313448,0.00033688295,0.00006360089,0.00016980113,0.051210105,0.000046793517,0.00030726727,0.0065926476],"study_design_scores_gemma":[0.0000055486635,0.00008808135,0.9929763,0.0000056588565,0.000053043892,0.000860824,0.000052404364,0.00021242339,0.0051877634,0.00008208816,0.00047179474,0.000003961966],"about_ca_topic_score_codex":0.0004530924,"about_ca_topic_score_gemma":0.0005795852,"teacher_disagreement_score":0.0016630248,"about_ca_system_score_codex":0.00020611429,"about_ca_system_score_gemma":0.00015440579,"threshold_uncertainty_score":0.0055633783},"labels":[],"label_agreement":null},{"id":"W2299393310","doi":"10.1038/bjc.2016.3","title":"Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Occupational Cancer Research Centre; University of Alberta; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Terry Fox Research Institute; Canadian Institutes of Health Research; Cancer Research Society; McGill University","keywords":"Cachexia; Medicine; Internal medicine; Cancer; Proteases; Wasting; Endocrinology; Cytokine; Gastroenterology; Biology; Enzyme","score_opus":0.021445345647760437,"score_gpt":0.3363336739466974,"score_spread":0.3148883282989369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299393310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937737,0.0046186387,0.0007402973,0.000051468942,0.000010822937,0.000023564808,0.00045352642,0.000014016089,0.00031403534],"genre_scores_gemma":[0.9960294,0.0011861162,0.0018324052,0.00004821243,0.0000195218,0.00003718891,0.00053890445,0.0000025933523,0.00030579345],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990475,0.000024835577,0.000007596966,0.000022904364,0.000022452936,0.000017443841],"domain_scores_gemma":[0.9997856,0.000049434377,0.000082497914,0.000008954154,0.0000382822,0.00003527906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002110482,0.00025913207,0.00031132647,0.0004482564,0.00011951284,0.00047402282,0.00010686392,0.00017629053,0.00074337557],"category_scores_gemma":[0.00028677422,0.00010527426,0.0001629701,0.00034280255,0.0001456055,0.00012469212,0.00017018855,0.00034717284,0.00015814975],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003119775,0.00021203929,0.54993445,0.0004427167,0.00022864796,0.0003871532,0.00020488266,0.00052137073,0.4139338,0.000110995534,0.00039618084,0.0305079],"study_design_scores_gemma":[0.00007280904,0.0015738644,0.93576986,0.000049944134,0.00021741386,0.0018162631,0.0002184741,0.0016876028,0.056302913,0.00018724865,0.0020878848,0.00001566975],"about_ca_topic_score_codex":0.00018713516,"about_ca_topic_score_gemma":0.00033227215,"teacher_disagreement_score":0.00074337557,"about_ca_system_score_codex":0.00012432359,"about_ca_system_score_gemma":0.00014355496,"threshold_uncertainty_score":0.0024868846},"labels":[],"label_agreement":null},{"id":"W2299537488","doi":"10.1038/bjc.2016.32","title":"Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Breast Cancer Foundation; National Institute for Health and Care Research; Cancer Research UK","keywords":"Mammography; Medicine; BRCA mutation; Breast cancer; Mutation; Oncology; Breast cancer screening; Cancer; Internal medicine; Genetics; Biology","score_opus":0.04558454609485871,"score_gpt":0.3541114611240218,"score_spread":0.3085269150291631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299537488","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027203818,0.995719,0.00068416836,0.00018927561,0.00010406988,0.000030455121,0.00034963037,0.000016912414,0.00018607017],"genre_scores_gemma":[0.1999727,0.79332685,0.0028002583,0.00096883264,0.00046522196,0.0002733861,0.0016181525,0.00006749508,0.0005070722],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99326247,0.004249901,0.0010573226,0.00079881644,0.00048125183,0.00015029154],"domain_scores_gemma":[0.97051233,0.025471872,0.001993105,0.0009185427,0.0008980415,0.00020612056],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.012686552,0.0019600433,0.009001931,0.002590207,0.00023524479,0.0018342503,0.0015395075,0.0015507628,0.003017506],"category_scores_gemma":[0.029628517,0.00086908747,0.020471977,0.003565869,0.0003323035,0.00093831,0.00090866064,0.0014469243,0.00030541763],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054301475,0.000031145828,0.015294862,0.13005902,0.7827158,0.00019881985,0.000051940882,0.0014842132,0.00037911773,0.00028427783,0.0020498235,0.062020816],"study_design_scores_gemma":[0.00053487835,0.00025737815,0.012941089,0.009366719,0.9689246,0.0002778273,0.000024662924,0.00061902293,0.0002583929,0.00076290197,0.0060014413,0.00003112864],"about_ca_topic_score_codex":0.002646051,"about_ca_topic_score_gemma":0.0049616587,"teacher_disagreement_score":0.9909981,"about_ca_system_score_codex":0.0009170846,"about_ca_system_score_gemma":0.0011373477,"threshold_uncertainty_score":0.06709367},"labels":[],"label_agreement":null},{"id":"W2301004704","doi":"10.1038/bjc.2016.58","title":"The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Women's College Hospital","funders":"","keywords":"Incidence (geometry); Medicine; Prospective cohort study; Oncology; Cohort; Cohort study; Internal medicine; Gynecology","score_opus":0.005350874409664672,"score_gpt":0.2798680364894681,"score_spread":0.2745171620798034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301004704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977448,0.00041904426,0.00016384364,0.000047809892,0.000008412864,0.000024420882,0.0011887247,0.000005519891,0.0003973886],"genre_scores_gemma":[0.9974948,0.00044225855,0.00023030204,0.00006165239,0.000013925023,0.000038503815,0.0014207901,0.000006369646,0.00029148132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992912,0.00016772746,0.000081989376,0.00024445687,0.00010616418,0.00010856681],"domain_scores_gemma":[0.9981944,0.00021603002,0.0007051156,0.0003305989,0.00021919377,0.0003345894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015308158,0.0005048631,0.00044674822,0.0012375219,0.0006512024,0.0009988173,0.0006637527,0.0007666065,0.0018363843],"category_scores_gemma":[0.0025976473,0.00078588387,0.0008613426,0.0020064942,0.00034442934,0.0007994366,0.00067023904,0.0010745995,0.00036618632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012424351,0.00002617372,0.9988801,0.000008254539,0.00011660061,0.00006702032,0.00009931332,0.000022688504,0.000088606816,0.000011874855,0.000081636215,0.0004734394],"study_design_scores_gemma":[0.0000163621,0.0000909962,0.99904054,0.00001044344,0.00008078987,0.00030981653,0.00013812141,0.000086079795,0.000022683342,0.000014495204,0.00018408753,0.000005525167],"about_ca_topic_score_codex":0.014485195,"about_ca_topic_score_gemma":0.0098494375,"teacher_disagreement_score":0.014485195,"about_ca_system_score_codex":0.00037205484,"about_ca_system_score_gemma":0.00039347206,"threshold_uncertainty_score":0.02880174},"labels":[],"label_agreement":null},{"id":"W2306896657","doi":"10.1038/bjc.2016.94","title":"Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"European Social Fund; National Cancer Institute; Instituto de Salud Carlos III; Medical Research Council; Prostate Cancer UK; Xunta de Galicia; Royal Marsden NHS Foundation Trust; Francis Crick Institute; Royal College of Radiologists; National Institute for Health and Care Research; Cancer Research UK; American Cancer Society; National Institutes of Health; NIHR Cambridge Biomedical Research Centre; European Regional Development Fund; U.S. Department of Defense","keywords":"Prostate cancer; Genetic predisposition; Radiation therapy; Medicine; Single-nucleotide polymorphism; Oncology; Toxicity; Genome-wide association study; Prostate; Internal medicine; Cancer; Biology; Genetics; Genotype; Gene; Disease","score_opus":0.007831549296548515,"score_gpt":0.2679854492678708,"score_spread":0.2601538999713223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306896657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8962972,0.089703314,0.0077758203,0.0010662612,0.000195304,0.00008428938,0.0020315347,0.000110057226,0.002736136],"genre_scores_gemma":[0.99576294,0.002749047,0.00074466004,0.00013599526,0.00006417985,0.000018636636,0.00039003164,0.000015499309,0.00011896916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669206,0.0013969169,0.000426486,0.0009508247,0.00037470896,0.00015903472],"domain_scores_gemma":[0.99099255,0.0053412765,0.0021063888,0.0010312815,0.00030687876,0.00022161397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027303267,0.00049126905,0.0015065294,0.00083943154,0.00034098868,0.0010231516,0.0005826928,0.0009180847,0.0030722283],"category_scores_gemma":[0.008820576,0.00037633535,0.0041875876,0.002261666,0.0006897706,0.00034429197,0.00044516413,0.00071627606,0.00018108041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061136843,0.000110259876,0.82265645,0.0034986685,0.11727344,0.001258957,0.00021085021,0.003941763,0.009582702,0.0007461827,0.00094227254,0.033664837],"study_design_scores_gemma":[0.00061996846,0.00068891456,0.91408575,0.00046404937,0.07395895,0.0018948849,0.000070460665,0.002190193,0.0012870594,0.0022898868,0.002407699,0.000042003543],"about_ca_topic_score_codex":0.003848378,"about_ca_topic_score_gemma":0.003761307,"teacher_disagreement_score":0.003848378,"about_ca_system_score_codex":0.00039793758,"about_ca_system_score_gemma":0.00065561006,"threshold_uncertainty_score":0.014439523},"labels":[],"label_agreement":null},{"id":"W2308659819","doi":"10.1038/bjc.2016.41","title":"Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Cancer Research UK","keywords":"PARP inhibitor; Medicine; BRCA mutation; Ovarian cancer; Tolerability; Breast cancer; Olaparib; Dosing; Cancer; Pharmacodynamics; Internal medicine; Oncology; Pharmacology; Cancer research; Adverse effect; Pharmacokinetics; Biology; Poly ADP ribose polymerase; Polymerase; Genetics","score_opus":0.01034263473245879,"score_gpt":0.3000696872213802,"score_spread":0.28972705248892144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308659819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949458,0.0010389137,0.00046084684,0.0001986051,0.00007936855,0.001943005,0.0005455753,0.000067982495,0.0007199648],"genre_scores_gemma":[0.9905319,0.0007247386,0.0016268292,0.00045252792,0.00014995445,0.0033893667,0.0015488865,0.000025212987,0.0015506785],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99933547,0.00032161624,0.000026994803,0.00014646501,0.000052863346,0.00011649001],"domain_scores_gemma":[0.99891293,0.0002257646,0.00027039714,0.000114430055,0.00007500449,0.00040143586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021350363,0.0016220533,0.0015917146,0.0005037128,0.00034244783,0.00087586907,0.0011428805,0.0017611622,0.0036610847],"category_scores_gemma":[0.0014834194,0.0006941381,0.001063336,0.00050244376,0.00095297454,0.0008393623,0.00035591624,0.0028735483,0.00065535365],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89225674,0.0448523,0.0028020595,0.0003584143,0.0006060544,0.00012739196,0.00016388681,0.0012365801,0.022276312,0.000110860914,0.0012078962,0.03400146],"study_design_scores_gemma":[0.5734581,0.4170739,0.005614858,0.000014173708,0.00021742203,0.00014752957,0.000024226272,0.0006592078,0.0018598441,0.00006822345,0.0008467504,0.000015829386],"about_ca_topic_score_codex":0.0010319946,"about_ca_topic_score_gemma":0.0014500632,"teacher_disagreement_score":0.0036610847,"about_ca_system_score_codex":0.00095920026,"about_ca_system_score_gemma":0.0012149608,"threshold_uncertainty_score":0.012247562},"labels":[],"label_agreement":null},{"id":"W2316917175","doi":"10.1038/bjc.2014.391","title":"BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; Women's College Hospital; Ontario Institute for Cancer Research","funders":"Cancer Care Ontario","keywords":"Haploinsufficiency; Downregulation and upregulation; Medicine; Messenger RNA; Breast cancer; Cancer; Internal medicine; Biology; Oncology; Phenotype; Gene; Genetics","score_opus":0.0160760138488231,"score_gpt":0.2954893353750299,"score_spread":0.2794133215262068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316917175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989184,0.00015348103,0.00020076719,0.00003716714,0.000022571623,0.00011383811,0.00009169788,0.000033154316,0.00042896287],"genre_scores_gemma":[0.9939155,0.00013163332,0.0010416595,0.0000601186,0.000022288881,0.00039509477,0.00022055433,0.0000069852654,0.004206123],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99982303,0.000039004215,0.000011190807,0.000054213997,0.000030191271,0.00004239516],"domain_scores_gemma":[0.9997849,0.000039938805,0.0000663095,0.000018637216,0.000036425266,0.0000537803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032725531,0.0004003929,0.00063886377,0.00022340189,0.00019787475,0.00019134299,0.0002271579,0.00044151148,0.0032513957],"category_scores_gemma":[0.00035207593,0.00020441666,0.0002547758,0.00012658015,0.00025538576,0.00017688103,0.00021275625,0.0006340363,0.00036672817],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16081123,0.038440473,0.011875405,0.0003947468,0.00010150836,0.00026048135,0.000775226,0.00022204497,0.71245307,0.000052968742,0.0006649036,0.07394788],"study_design_scores_gemma":[0.0058216373,0.36553583,0.23058717,0.000045911453,0.00038481294,0.00030120177,0.0007130306,0.001697757,0.390788,0.00013033893,0.0039456887,0.000048653776],"about_ca_topic_score_codex":0.0005930578,"about_ca_topic_score_gemma":0.0007828955,"teacher_disagreement_score":0.0032513957,"about_ca_system_score_codex":0.0001872919,"about_ca_system_score_gemma":0.00018529534,"threshold_uncertainty_score":0.010877013},"labels":[],"label_agreement":null},{"id":"W2339914653","doi":"10.1038/bjc.2016.71","title":"Adjuvant ovarian function suppression and cognitive function in women with breast cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Medical Research Council; ECOG-ACRIN Cancer Research Group; Canadian Cancer Society Research Institute; National Institutes of Health; National Cancer Institute; Breast Cancer Trials; National Breast Cancer Foundation; Ipsen; Swiss Cancer Research Foundation; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Pfizer; Oncosuisse; American College of Radiology Imaging Network","keywords":"Exemestane; Tamoxifen; Medicine; Breast cancer; Internal medicine; Oncology; Aromatase inhibitor; Gynecology; Cancer","score_opus":0.007049452502438039,"score_gpt":0.2521743627771369,"score_spread":0.24512491027469885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339914653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691685,0.028776588,0.000064637665,0.0004430947,0.000092614246,0.00017374996,0.00031578957,0.0000065363947,0.00095837977],"genre_scores_gemma":[0.9940929,0.004803665,0.000090878515,0.00029282836,0.00014205268,0.000119864846,0.0002297805,9.3131996e-7,0.00022702248],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99948186,0.0003001382,0.000049069677,0.000039507857,0.00006911899,0.00006038459],"domain_scores_gemma":[0.998398,0.0007580829,0.00051562756,0.00007045901,0.00008379369,0.00017409427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018298434,0.00040861376,0.00093331205,0.00025548608,0.00016246199,0.00035341602,0.0002670458,0.00059744524,0.0013359027],"category_scores_gemma":[0.0030769678,0.0001548992,0.0010960668,0.00036202173,0.00027781684,0.00017697635,0.00023563563,0.00063179113,0.00011789671],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58027744,0.00636216,0.22694206,0.004677156,0.0087359445,0.00012664466,0.00020669303,0.0008569194,0.0024813868,0.00011880565,0.0013444374,0.16787036],"study_design_scores_gemma":[0.114956886,0.18570489,0.681088,0.0007421412,0.01017172,0.00041126081,0.00012966085,0.0007563004,0.001485195,0.00040965786,0.0041112103,0.00003308056],"about_ca_topic_score_codex":0.0019535962,"about_ca_topic_score_gemma":0.0032731441,"teacher_disagreement_score":0.0019535962,"about_ca_system_score_codex":0.00039586224,"about_ca_system_score_gemma":0.0006455474,"threshold_uncertainty_score":0.009677291},"labels":[],"label_agreement":null},{"id":"W2340482034","doi":"10.1038/bjc.2015.347","title":"Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; National Cancer Institute; National Institutes of Health; Damon Runyon Cancer Research Foundation; State of Connecticut Department of Public Health; Gary Bennett Family Fund; Uehara Memorial Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; Entertainment Industry Foundation","keywords":"CDH1; Colorectal cancer; Medicine; Oncology; Microsatellite instability; Metastasis; Pathology; Cancer; Odds ratio; Internal medicine; Cancer research; Cadherin; Biology; Cell","score_opus":0.008716596819252777,"score_gpt":0.2376419024685291,"score_spread":0.22892530564927632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340482034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999432,0.00027545818,0.00010179889,0.000016897047,0.0000011336305,0.0000017477355,0.000048787402,0.0000026865898,0.00011943008],"genre_scores_gemma":[0.9997944,0.00007348968,0.000042018084,0.000002506146,0.00000286905,7.639357e-7,0.000041767627,5.5297085e-7,0.000041643212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998006,0.00004339811,0.000022345655,0.00004930583,0.000052282652,0.0000321258],"domain_scores_gemma":[0.9982609,0.00035716276,0.0010284614,0.00008664739,0.0000808595,0.00018608605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002650503,0.00016847355,0.0001912961,0.00056201045,0.00014834527,0.0002516444,0.00018012467,0.00018508045,0.0013518867],"category_scores_gemma":[0.0014933391,0.000110525885,0.00013785574,0.0005718512,0.0003227785,0.00016069699,0.000302045,0.00027711794,0.00011999805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009664278,0.0000060797324,0.9972874,0.000010064744,0.000022404289,0.00010116647,0.000017363769,0.000043933334,0.0010302494,0.000007793409,0.000017568582,0.001359351],"study_design_scores_gemma":[0.00000300914,0.000029080054,0.9985967,0.0000028938393,0.000018267403,0.0007138588,0.000032478696,0.00018126688,0.00034133554,0.000020966483,0.000058844536,0.000001317304],"about_ca_topic_score_codex":0.0015173993,"about_ca_topic_score_gemma":0.0017859185,"teacher_disagreement_score":0.0015173993,"about_ca_system_score_codex":0.00014693144,"about_ca_system_score_gemma":0.00012825891,"threshold_uncertainty_score":0.004522562},"labels":[],"label_agreement":null},{"id":"W2342252157","doi":"10.1038/bjc.2016.79","title":"Hypoxia-activated prodrugs: paths forward in the era of personalised medicine","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prodrug; Hypoxia (environmental); Drug; Pharmacology; Tumor hypoxia; Cancer research; Tirapazamine; Effector; Biology; Medicine; Immunology; Internal medicine; In vitro; Cytotoxicity; Chemistry; Radiation therapy; Biochemistry; Oxygen","score_opus":0.01965660309295139,"score_gpt":0.3163151735600061,"score_spread":0.2966585704670547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342252157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020656567,0.9974482,0.0002664962,0.0005692121,0.0002394495,0.000004672517,0.0000119912265,0.000010143441,0.0012433185],"genre_scores_gemma":[0.0012951051,0.99674547,0.00038786142,0.00033219584,0.00015863669,0.000009094343,0.000019586725,0.0000033358633,0.0010485775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981934,0.000037494792,0.000019333713,0.000028764078,0.00007213304,0.00002299827],"domain_scores_gemma":[0.9997259,0.00013942222,0.00003272606,0.000011202575,0.00006142214,0.000029367167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006123121,0.0005812783,0.0011185745,0.0013242175,0.00026310107,0.0009971362,0.0007120164,0.0013603366,0.0031270387],"category_scores_gemma":[0.0006951748,0.0003103583,0.0003797826,0.0014139686,0.0006643286,0.0018494573,0.00067803345,0.0029432785,0.0018902754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012425047,0.0001029288,0.00012088991,0.012363347,0.000056345438,0.0003686943,0.00014898514,0.00070021825,0.005829429,0.015350453,0.030830713,0.93400383],"study_design_scores_gemma":[0.000017346005,0.0000872254,0.0002576258,0.0012438798,0.000024268047,0.0009245426,0.000037729846,0.00007793768,0.0008021145,0.0031532631,0.99336123,0.000012766295],"about_ca_topic_score_codex":0.0007002208,"about_ca_topic_score_gemma":0.0013561466,"teacher_disagreement_score":0.0031270387,"about_ca_system_score_codex":0.0009044032,"about_ca_system_score_gemma":0.0008114255,"threshold_uncertainty_score":0.010460973},"labels":[],"label_agreement":null},{"id":"W2342916871","doi":"10.1038/bjc.2016.75","title":"Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Cancer Institute NSW; Cancer Australia","keywords":"Medicine; Cancer; Gerontology; End-of-life care; Health care; Cohort; Demography; Epidemiology; Health economics; Cohort study; Public health; Environmental health; Intensive care medicine; Emergency medicine; Palliative care; Internal medicine; Pathology; Nursing","score_opus":0.030503970559503768,"score_gpt":0.2649838652299107,"score_spread":0.23447989467040692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342916871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684995,0.0009471969,0.0001884991,0.0002697968,0.0000049359337,0.000016901326,0.0014118294,0.000002635545,0.0003080888],"genre_scores_gemma":[0.9974113,0.0004912867,0.00013879016,0.00005162602,0.000018313547,0.000017170289,0.0017146219,0.0000016816783,0.0001551753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998982,0.00040466868,0.00013132996,0.00009694734,0.00020124139,0.00018371687],"domain_scores_gemma":[0.99603075,0.0013107923,0.0017718383,0.00012337608,0.00029883327,0.0004644125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018541578,0.00031638562,0.0007780304,0.0025722808,0.00037032657,0.0010555957,0.00045739615,0.00069803576,0.0014658245],"category_scores_gemma":[0.0054135765,0.00035708246,0.0025557275,0.0031479702,0.0003883261,0.00089369377,0.0013481536,0.00093693874,0.00016649568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011052672,0.00007288946,0.9941854,0.00006914521,0.0006336982,0.00020691413,0.00022678198,0.0015166115,0.000042111667,0.00018039868,0.00033941245,0.0024161062],"study_design_scores_gemma":[0.0000056408026,0.0000736243,0.9964533,0.00004174684,0.00012239086,0.00015879238,0.0003616961,0.0024182692,0.000015266625,0.00011561219,0.00022548379,0.000008259164],"about_ca_topic_score_codex":0.049189106,"about_ca_topic_score_gemma":0.0423839,"teacher_disagreement_score":0.049189106,"about_ca_system_score_codex":0.0016091458,"about_ca_system_score_gemma":0.0007088728,"threshold_uncertainty_score":0.09780556},"labels":[],"label_agreement":null},{"id":"W2344227124","doi":"10.1038/bjc.2015.415","title":"Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Cohort; Cancer; Cohort study; Internal medicine; Nuclear medicine; Oncology; Pathology; Radiology","score_opus":0.037087759392889344,"score_gpt":0.37425454398414176,"score_spread":0.33716678459125243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344227124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994659,0.0023050974,0.0007680804,0.00018104436,0.000014212009,0.000032534343,0.0010679694,0.000014089111,0.0009579763],"genre_scores_gemma":[0.9987394,0.00030474513,0.000389269,0.000032675165,0.000016931745,0.00001785881,0.0003970288,0.000007477782,0.00009467639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99592704,0.0017098462,0.00047310218,0.0007605801,0.00083940866,0.0002900338],"domain_scores_gemma":[0.97890866,0.010860364,0.0071835765,0.0014619109,0.0009277427,0.0006576805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003697254,0.0004123928,0.0004668583,0.0015422932,0.00026230683,0.0007321255,0.00081747153,0.0006405892,0.0036880982],"category_scores_gemma":[0.019487478,0.00035140562,0.0015646934,0.0017603575,0.0005449319,0.0006768097,0.00092727545,0.0012200228,0.00021998967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001228239,0.0000075951316,0.9985581,0.000030407453,0.00018628547,0.00007332961,0.000025864718,0.00008719342,0.000075161275,0.000016314665,0.000038736078,0.0007782664],"study_design_scores_gemma":[0.0000042472816,0.000072134026,0.99882466,0.000014899574,0.00010284639,0.0004654652,0.000034975674,0.00023962563,0.00007353507,0.00002964796,0.00013526848,0.0000026237958],"about_ca_topic_score_codex":0.004697844,"about_ca_topic_score_gemma":0.003540471,"teacher_disagreement_score":0.004697844,"about_ca_system_score_codex":0.00048245615,"about_ca_system_score_gemma":0.00056576566,"threshold_uncertainty_score":0.019553244},"labels":[],"label_agreement":null},{"id":"W2345027487","doi":"10.1038/bjc.2016.72","title":"Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WSP (Canada)","funders":"","keywords":"Refractory (planetary science); Prodrug; Medicine; Internal medicine; Oncology; Clinical trial; Phases of clinical research; Cancer research; Pharmacology; Materials science","score_opus":0.024082570526278997,"score_gpt":0.33491649223630054,"score_spread":0.31083392171002155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345027487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263966,0.0035989818,0.0007431949,0.0002789406,0.000044104938,0.000835191,0.00060035393,0.000097507065,0.0011620155],"genre_scores_gemma":[0.98916817,0.0034753776,0.0017662952,0.0005203427,0.00009254663,0.000749623,0.0025524811,0.00004096983,0.0016341972],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997665,0.00009629405,0.000013806073,0.000033927732,0.000023506545,0.000065940076],"domain_scores_gemma":[0.9995815,0.00007047778,0.00008331465,0.000034159413,0.000033787564,0.00019675275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00119115,0.0013435755,0.001253532,0.00024334026,0.00024889605,0.00069349044,0.0005629939,0.0009062038,0.0013805788],"category_scores_gemma":[0.00053888425,0.00029379857,0.00092369836,0.00026475126,0.0005857356,0.00054402964,0.0002721458,0.002175316,0.00043154598],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36356154,0.07047037,0.01154161,0.0019976182,0.0025614973,0.0013912467,0.0012224048,0.011210596,0.27199855,0.00050804805,0.007576788,0.25595984],"study_design_scores_gemma":[0.2302565,0.68859464,0.029385427,0.000086855944,0.0011667971,0.0018555908,0.00013214529,0.0027964755,0.037649564,0.0002814943,0.0077331257,0.00006148093],"about_ca_topic_score_codex":0.0006676682,"about_ca_topic_score_gemma":0.0011811779,"teacher_disagreement_score":0.0013805788,"about_ca_system_score_codex":0.00073459843,"about_ca_system_score_gemma":0.0007744801,"threshold_uncertainty_score":0.0062994957},"labels":[],"label_agreement":null},{"id":"W2346159484","doi":"10.1038/bjc.2016.120","title":"First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Bayer","keywords":"Pharmacokinetics; Medicine; Radiation therapy; Adverse effect; Toxicity; Melanoma; Chemotherapy; Internal medicine; Surgery; Urology; Pathology; Oncology; Cancer research","score_opus":0.004820713414701175,"score_gpt":0.24263595231626423,"score_spread":0.23781523890156306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346159484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316734,0.0030887937,0.00071927125,0.00022749329,0.00006549439,0.0012435968,0.00043233842,0.00008656521,0.0009692098],"genre_scores_gemma":[0.9912977,0.0022728948,0.001728167,0.00030122112,0.00014029056,0.001324184,0.000999485,0.000042701176,0.0018933857],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996797,0.00016028488,0.000014419009,0.00004874391,0.000031403073,0.000065397595],"domain_scores_gemma":[0.9993642,0.00011140909,0.00015352813,0.000059082653,0.00003264569,0.00027913103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001068288,0.0015227107,0.0021333487,0.00038235114,0.00040443157,0.0007511163,0.0008172515,0.000855652,0.0030581322],"category_scores_gemma":[0.0007536713,0.00064458646,0.00090405863,0.00041091535,0.00077016145,0.00050988205,0.00031606844,0.002375409,0.00080055225],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5042036,0.09309222,0.011022622,0.0019858954,0.0016822139,0.0010105858,0.0007008151,0.0049452377,0.20640142,0.00026203887,0.003987977,0.17070538],"study_design_scores_gemma":[0.21288024,0.7552293,0.013001522,0.000049250622,0.00048553906,0.0009842862,0.000050155617,0.0010727892,0.013093842,0.00010187347,0.0030175867,0.000033566826],"about_ca_topic_score_codex":0.0007041422,"about_ca_topic_score_gemma":0.0017053175,"teacher_disagreement_score":0.0030581322,"about_ca_system_score_codex":0.00074579444,"about_ca_system_score_gemma":0.0011323069,"threshold_uncertainty_score":0.010230482},"labels":[],"label_agreement":null},{"id":"W2396983630","doi":"10.1038/bjc.2015.443","title":"CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ottawa Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; Damon Runyon Cancer Research Foundation; Canadian Institutes of Health Research; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; Canadian Cancer Society Research Institute; U.S. Department of Health and Human Services; National Institutes of Health; Sociedad Española de Oncología Médica; Ministerio de Economía y Competitividad; National Human Genome Research Institute; Ontario Institute for Cancer Research; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; Division of Cancer Prevention, National Cancer Institute","keywords":"CYP24A1; Medicine; Colorectal cancer; Internal medicine; Progestogen; Logistic regression; Oncology; Cancer; Vitamin D and neurology; Hormone; Calcitriol receptor","score_opus":0.02386945472366439,"score_gpt":0.29910306347991517,"score_spread":0.2752336087562508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396983630","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943041,0.0030928687,0.000686816,0.00013602762,0.000022552604,0.000023505205,0.001037827,0.000033768756,0.00066256773],"genre_scores_gemma":[0.9990181,0.0002035312,0.00030898544,0.000044151624,0.000021425452,0.000012218826,0.00021455294,0.000010583008,0.00016643367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988594,0.00042408524,0.0001272014,0.00038449618,0.00012974712,0.00007501528],"domain_scores_gemma":[0.9982034,0.0007647365,0.0006769629,0.0001904482,0.00007022627,0.00009426404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010733722,0.00050885836,0.00062928704,0.0006857027,0.0002875822,0.00078198884,0.0003836515,0.0007241067,0.0040803873],"category_scores_gemma":[0.0031678563,0.00027714015,0.0013127971,0.0017257533,0.00033067123,0.00021037678,0.0002654266,0.0005006173,0.00039587077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005650636,0.00009411647,0.9541353,0.00025719695,0.0052930727,0.0010555247,0.00013665934,0.0007114732,0.017223287,0.00017235387,0.00041953806,0.014850765],"study_design_scores_gemma":[0.0001559354,0.00047703265,0.99172395,0.00002498962,0.001870397,0.001953794,0.00003507564,0.0009937735,0.0015482339,0.0002838889,0.0009189417,0.000013952954],"about_ca_topic_score_codex":0.001670336,"about_ca_topic_score_gemma":0.0013134199,"teacher_disagreement_score":0.0040803873,"about_ca_system_score_codex":0.00020677214,"about_ca_system_score_gemma":0.0001912494,"threshold_uncertainty_score":0.0136502385},"labels":[],"label_agreement":null},{"id":"W2409151805","doi":"10.1038/bjc.2015.432","title":"Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Saskatchewan; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Biomarker; Internal medicine; Proportional hazards model; Neutrophil to lymphocyte ratio; Receiver operating characteristic; Complete blood count; Oncology; Cohort; Absolute neutrophil count; Gastroenterology; Urology; Cancer; Lymphocyte; Neutropenia; Chemotherapy","score_opus":0.020662572961699693,"score_gpt":0.28863703082779735,"score_spread":0.26797445786609764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409151805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984144,0.0005502885,0.0004827005,0.00009512517,0.000005119093,0.000011054615,0.0002995721,0.0000072521584,0.0001344286],"genre_scores_gemma":[0.99911827,0.00007488667,0.00034341362,0.000018031773,0.0000121996745,0.00000895201,0.00038980402,0.0000019438892,0.00003248119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952686,0.00016967647,0.000049610757,0.00008942916,0.00010331726,0.0000611596],"domain_scores_gemma":[0.995994,0.0015274235,0.001523388,0.00021495213,0.000404441,0.00033575384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017397825,0.00041220573,0.0005834356,0.00091245206,0.00021169048,0.00077432586,0.00045953252,0.00042100844,0.0006591697],"category_scores_gemma":[0.007816321,0.00017609213,0.00033442743,0.00092390523,0.00022824234,0.0005319217,0.0005016936,0.0005876085,0.00017463374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014839364,0.000013420069,0.997442,0.000008258857,0.000028783556,0.000015060842,0.000012487889,0.00020896463,0.00009761628,0.000007213279,0.000061159335,0.001956714],"study_design_scores_gemma":[0.000020946358,0.00022511277,0.99401045,0.000017786728,0.00008492326,0.00019385642,0.00008448953,0.004644262,0.00030978228,0.00010311694,0.0002981529,0.0000071120558],"about_ca_topic_score_codex":0.0018810055,"about_ca_topic_score_gemma":0.0025021154,"teacher_disagreement_score":0.0018810055,"about_ca_system_score_codex":0.00034393437,"about_ca_system_score_gemma":0.0007700422,"threshold_uncertainty_score":0.00920099},"labels":[],"label_agreement":null},{"id":"W2418450403","doi":"10.1038/bjc.2016.119","title":"Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"Direction Générale de l’offre de Soins","keywords":"Medicine; Sorafenib; Toxicity; Quality of life (healthcare); Internal medicine; Adverse effect; Clinical endpoint; Melanoma; Phases of clinical research; Surgery; Progression-free survival; Oncology; Clinical trial; Chemotherapy; Hepatocellular carcinoma","score_opus":0.05332202115739489,"score_gpt":0.400707147021521,"score_spread":0.3473851258641261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418450403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580115,0.0018469067,0.00041562557,0.00018964376,0.00003400388,0.0010434765,0.00034378222,0.00002631428,0.00029912387],"genre_scores_gemma":[0.991915,0.0014322653,0.0012967685,0.00045822782,0.00018192068,0.0022715908,0.0015830413,0.000018252136,0.0008429704],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99838984,0.0010364777,0.00008666502,0.00013571573,0.00018889384,0.00016245153],"domain_scores_gemma":[0.99793637,0.00029268384,0.00052643794,0.00017659538,0.0001419731,0.0009260431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054588835,0.0016105605,0.0024874464,0.00032762898,0.0005161894,0.0008832487,0.00074584206,0.0011179524,0.0021853652],"category_scores_gemma":[0.0020818866,0.0005701393,0.0017638752,0.0005003349,0.00087769196,0.00050548016,0.00042741178,0.0016900565,0.00057585957],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7502991,0.07810902,0.03645281,0.0020588574,0.003350128,0.0011629034,0.0005902667,0.0026901942,0.061273646,0.00016793603,0.0029467694,0.060898308],"study_design_scores_gemma":[0.47117385,0.43760818,0.08306572,0.00007426685,0.0010215301,0.0011934328,0.00008198293,0.0012394387,0.0024022919,0.00012640459,0.0019580435,0.000054784497],"about_ca_topic_score_codex":0.0007022848,"about_ca_topic_score_gemma":0.001234043,"teacher_disagreement_score":0.0054588835,"about_ca_system_score_codex":0.0008491785,"about_ca_system_score_gemma":0.0019371113,"threshold_uncertainty_score":0.028869629},"labels":[],"label_agreement":null},{"id":"W2422966071","doi":"10.1038/bjc.2015.471","title":"Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Cancer Institute NSW","keywords":"Serous fluid; Ovarian cancer; Cancer research; Immunohistochemistry; Cancer; Biology; Cell growth; Cell culture; Medicine; Pathology; Immunology; Internal medicine; Biochemistry","score_opus":0.016944504501309826,"score_gpt":0.2887340898848981,"score_spread":0.27178958538358833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422966071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957111,0.0014932146,0.0013064976,0.00008291247,0.00001651901,0.00003017258,0.000442794,0.00007049492,0.0008463095],"genre_scores_gemma":[0.996689,0.0007731125,0.0009275285,0.000028222095,0.000003157963,0.00001900506,0.00066454953,0.000010541834,0.0008847694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999138,0.000014424091,0.000007606691,0.0000143986235,0.000034412442,0.000015334024],"domain_scores_gemma":[0.9998863,0.00003096891,0.000024427456,0.000017305892,0.000013634842,0.00002739894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019022495,0.00023723053,0.0002745408,0.00024834205,0.00012552063,0.0003002397,0.00011176217,0.00026057867,0.0015155842],"category_scores_gemma":[0.00011128861,0.00011002357,0.00021422267,0.00024077529,0.00018409114,0.00015584558,0.0001368431,0.0006101723,0.00026345978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003573552,0.00012698016,0.003864049,0.000119296485,0.00002433213,0.00031233733,0.000060065842,0.00028416247,0.9908428,0.00010738778,0.00027727874,0.003623894],"study_design_scores_gemma":[0.00007718946,0.0019898503,0.038327638,0.000019674388,0.00007812571,0.004254796,0.00015331323,0.0029209503,0.94649774,0.00008624453,0.005587101,0.000007433215],"about_ca_topic_score_codex":0.0009175456,"about_ca_topic_score_gemma":0.001334096,"teacher_disagreement_score":0.0015155842,"about_ca_system_score_codex":0.00025659267,"about_ca_system_score_gemma":0.00021746189,"threshold_uncertainty_score":0.00507015},"labels":[],"label_agreement":null},{"id":"W24231946","doi":"10.1038/bjc.2013.592","title":"Binary circular calculations method for the objects classification using their form","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Advanced Scientific Research Methods","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Binary number; Mathematics; Computer science; Artificial intelligence; Pattern recognition (psychology); Arithmetic","score_opus":0.14101413715624586,"score_gpt":0.4272705887020305,"score_spread":0.2862564515457846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W24231946","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016958062,0.00036778196,0.9393376,0.0004811373,0.001313181,0.002037587,0.009645186,0.0056710835,0.024188416],"genre_scores_gemma":[0.059508383,0.00024031,0.8930078,0.00023386507,0.00027417473,0.0038211881,0.008484701,0.0014910966,0.03293855],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9927585,0.001791826,0.0008895923,0.0020967256,0.0020943894,0.00036897796],"domain_scores_gemma":[0.98829556,0.0041467645,0.000951162,0.003360052,0.0030868095,0.0001597117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005862256,0.0011113648,0.0010431196,0.0049216812,0.001681606,0.002970839,0.0022114045,0.0012767185,0.09873192],"category_scores_gemma":[0.033528224,0.0007133391,0.0020495425,0.0041320664,0.001259137,0.0021956144,0.0026428392,0.0020170049,0.03763403],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010513143,0.00021176055,0.014137912,0.0008326457,0.0002982136,0.00019950344,0.000704541,0.003962465,0.004859159,0.10285642,0.084233284,0.78665286],"study_design_scores_gemma":[0.00045837037,0.0008617068,0.04174961,0.000669359,0.00049387245,0.0017400034,0.0013311807,0.13734296,0.020140884,0.16814758,0.626701,0.0003634518],"about_ca_topic_score_codex":0.0058608577,"about_ca_topic_score_gemma":0.0050044516,"teacher_disagreement_score":0.09873192,"about_ca_system_score_codex":0.001056702,"about_ca_system_score_gemma":0.0020876564,"threshold_uncertainty_score":0.33029115},"labels":[],"label_agreement":null},{"id":"W2461857735","doi":"10.1038/bjc.2016.212","title":"Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Nordic Pharma Group","keywords":"Nomogram; Pancreatic cancer; Medicine; Oncology; Internal medicine; Overall survival; Survival analysis; Cancer","score_opus":0.01888264858534303,"score_gpt":0.3256208548997112,"score_spread":0.30673820631436816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461857735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862585,0.001350204,0.010033075,0.0003179633,0.000036589518,0.00011466203,0.0006915395,0.00010509985,0.0010923904],"genre_scores_gemma":[0.99404055,0.00019913321,0.004462934,0.000046870136,0.000030046589,0.000073391,0.0009656679,0.000011934098,0.00016947844],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990783,0.0005649501,0.000062251434,0.00007517181,0.00016263039,0.000056615096],"domain_scores_gemma":[0.99641305,0.0019436717,0.00072680565,0.00022283805,0.0003929072,0.00030073227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005151665,0.0006757099,0.00056624744,0.0011586259,0.00019518983,0.00085950934,0.0004206139,0.0002907191,0.00095788646],"category_scores_gemma":[0.008992726,0.00012671298,0.0006210838,0.00060897256,0.0003327638,0.0004719428,0.0008934792,0.0006975978,0.00030867278],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016172146,0.000096656695,0.90868497,0.000096082564,0.0002678374,0.00010784654,0.00007332449,0.007151751,0.0005498128,0.00012962769,0.0012985232,0.07992636],"study_design_scores_gemma":[0.00070649217,0.0044500805,0.8410351,0.00017319898,0.00059601496,0.0018927212,0.00019687224,0.14315724,0.0017244414,0.0015421166,0.0044680643,0.0000576129],"about_ca_topic_score_codex":0.0005425238,"about_ca_topic_score_gemma":0.0005321002,"teacher_disagreement_score":0.005151665,"about_ca_system_score_codex":0.0003087634,"about_ca_system_score_gemma":0.00047911907,"threshold_uncertainty_score":0.027244925},"labels":[],"label_agreement":null},{"id":"W2462587944","doi":"10.1038/bjc.2016.195","title":"Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Texas MD Anderson Cancer Center; Curtin University of Technology; Melanoma Research Alliance","keywords":"Melanoma; Immune checkpoint; Immune system; Disease; Computational biology; Medicine; Precision medicine; Biology; Bioinformatics; Cancer research; Immunotherapy; Immunology; Genetics; Internal medicine","score_opus":0.013800042175460794,"score_gpt":0.29672233756004146,"score_spread":0.2829222953845807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462587944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017495797,0.9969766,0.00070951186,0.0009190772,0.0002260493,0.0000067497695,0.000020807674,0.000009472318,0.0009567679],"genre_scores_gemma":[0.0019705635,0.9951826,0.0013040907,0.0004457808,0.0004044273,0.000011747341,0.00006017533,0.000004207091,0.00061644363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995741,0.00009524221,0.00006256868,0.00007471449,0.00015349494,0.000039871335],"domain_scores_gemma":[0.99909365,0.0004496315,0.00009411608,0.00004620446,0.00024452488,0.00007186934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014539998,0.000790477,0.0016556673,0.004066778,0.0002933172,0.0017074205,0.0011052034,0.0018224986,0.0015745447],"category_scores_gemma":[0.0015942468,0.0003562195,0.0006446842,0.0015579195,0.0012592964,0.0022981337,0.0009358569,0.003751211,0.0013233747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008944298,0.00006850014,0.0008262391,0.010347781,0.00012100861,0.0007804218,0.000117896874,0.0008882581,0.00823859,0.015436261,0.02165191,0.94143355],"study_design_scores_gemma":[0.000016333657,0.000088922905,0.0024886446,0.003931036,0.00012592715,0.006675483,0.0001704693,0.00035533277,0.0023824153,0.011003492,0.97272146,0.000040461135],"about_ca_topic_score_codex":0.0013862468,"about_ca_topic_score_gemma":0.001666158,"teacher_disagreement_score":0.004066778,"about_ca_system_score_codex":0.0013209878,"about_ca_system_score_gemma":0.001347997,"threshold_uncertainty_score":0.0095844865},"labels":[],"label_agreement":null},{"id":"W2471425782","doi":"10.1038/bjc.2016.188","title":"Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"FP7 Health; National Center for Chronic Disease Prevention and Health Promotion; Kuopion Yliopistollinen Sairaala; National Cancer Institute; Academy of Finland; National Institute on Alcohol Abuse and Alcoholism; Medical Research Council; National Institutes of Health; Goddard Space Flight Center; Centers for Disease Control and Prevention; NordForsk; China Scholarship Council; Jane ja Aatos Erkon Säätiö; Opetus- ja Kulttuuriministeriö; Wellcome Trust; University of Southern California; Cancer Research UK; Netherlands eScience Center; European Commission; Cancer Research Wales; California Department of Public Health; McKnight Foundation; National Institute for Social Care and Health Research; Tenovus","keywords":"Medicine; Body mass index; Odds ratio; Confounding; Internal medicine; Obesity; Waist–hip ratio; Colorectal cancer; Overweight; Waist; Oncology; Cancer","score_opus":0.014888602128018262,"score_gpt":0.3190005981402095,"score_spread":0.30411199601219124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471425782","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32189572,0.010952182,0.64173937,0.0058240173,0.0015645127,0.0052438504,0.002229629,0.0014910585,0.009059681],"genre_scores_gemma":[0.9177172,0.0012945285,0.07311404,0.0017158027,0.00034580845,0.0034501457,0.0007628572,0.00016714598,0.0014325122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.84358495,0.12508981,0.0055645467,0.014180693,0.009668521,0.0019113998],"domain_scores_gemma":[0.8317405,0.12758687,0.015566369,0.021268336,0.0031635095,0.0006744236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10738713,0.0016837696,0.0037079395,0.0020269619,0.00094824267,0.0018680717,0.0017226305,0.0021869515,0.004776036],"category_scores_gemma":[0.20410728,0.0010127872,0.0034888228,0.002319515,0.0032957725,0.0016790336,0.001312162,0.002274508,0.00060587237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02480297,0.0006527224,0.65208876,0.0050123744,0.061730877,0.006955416,0.0029989998,0.016709618,0.008694064,0.0762983,0.013451102,0.13060476],"study_design_scores_gemma":[0.01487318,0.009263773,0.43723276,0.002320568,0.038550228,0.01612281,0.00085031515,0.15169008,0.0070556323,0.28401932,0.03738564,0.00063571706],"about_ca_topic_score_codex":0.0023601141,"about_ca_topic_score_gemma":0.0017374951,"teacher_disagreement_score":0.10738713,"about_ca_system_score_codex":0.001157365,"about_ca_system_score_gemma":0.0019932047,"threshold_uncertainty_score":0.56792426},"labels":[],"label_agreement":null},{"id":"W2472707660","doi":"10.1038/bjc.2016.185","title":"Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"Celgene","keywords":"Gemcitabine; Medicine; Internal medicine; Capecitabine; Oncology; Pancreatic cancer; Regimen; Cancer; Gastroenterology; Performance status; Fluorouracil; Neutropenia; Chemotherapy; Colorectal cancer","score_opus":0.026351328569758692,"score_gpt":0.3404186780141752,"score_spread":0.3140673494444165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472707660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949892,0.00338973,0.00020737192,0.00019652705,0.00003065289,0.00031280323,0.00038430604,0.000019808782,0.0004696648],"genre_scores_gemma":[0.9961402,0.0009715571,0.0004448081,0.0003251244,0.00008848959,0.00037587815,0.0013378457,0.0000069375874,0.0003092425],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992348,0.00042688017,0.00003862384,0.00012125878,0.00007584621,0.000102623635],"domain_scores_gemma":[0.9986588,0.00036315323,0.00047858048,0.000056031047,0.000049943195,0.00039342148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002105647,0.0005163318,0.0013272315,0.00033590014,0.00025993603,0.0008707681,0.00045905006,0.0004917706,0.0019642566],"category_scores_gemma":[0.0017790959,0.00018162787,0.001774149,0.00042086557,0.00030851597,0.0005744266,0.0003703068,0.0010535938,0.00023170056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48980403,0.0076911426,0.32840598,0.0016229046,0.0043487856,0.0005852899,0.0002234165,0.0038587728,0.0088680405,0.00016909446,0.0021801577,0.15224236],"study_design_scores_gemma":[0.12650666,0.3431072,0.5040241,0.00037855192,0.0038965677,0.0018110997,0.00018822913,0.005489908,0.0053291647,0.0004202452,0.008780792,0.0000674166],"about_ca_topic_score_codex":0.0005251159,"about_ca_topic_score_gemma":0.0021085206,"teacher_disagreement_score":0.002105647,"about_ca_system_score_codex":0.0012797748,"about_ca_system_score_gemma":0.0015047844,"threshold_uncertainty_score":0.011135876},"labels":[],"label_agreement":null},{"id":"W2480793872","doi":"10.1038/bjc.2016.222","title":"FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"FOLFIRINOX; Medicine; Pancreatic cancer; Retrospective cohort study; Cancer; Gemcitabine; Adverse effect; Internal medicine; Surgery; Oncology; Irinotecan; Colorectal cancer","score_opus":0.026805956087333185,"score_gpt":0.3727332787228895,"score_spread":0.34592732263555637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480793872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881764,0.008725454,0.00024467648,0.00084252504,0.00001840953,0.00003620634,0.00006981498,0.000011892887,0.0018745405],"genre_scores_gemma":[0.9916849,0.0066644377,0.00044177027,0.0003485215,0.00005748568,0.000019417826,0.00014172263,0.000009303474,0.00063246523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940324,0.00022009641,0.00006267724,0.00008319666,0.00015216335,0.00007871765],"domain_scores_gemma":[0.9985304,0.0004180947,0.00042199722,0.00007831994,0.00013862453,0.0004124824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000820433,0.00026541445,0.00025687733,0.000347951,0.00048040462,0.000646138,0.00037212687,0.00048102732,0.0011240548],"category_scores_gemma":[0.0018250047,0.00023072836,0.00025109437,0.00093525794,0.00036596958,0.00048498288,0.00063445856,0.00050720875,0.0002393457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032886444,0.0011710228,0.71845376,0.0015117222,0.00042121715,0.035589963,0.0074276673,0.0015870492,0.01001148,0.000581971,0.008558876,0.21139659],"study_design_scores_gemma":[0.0006425654,0.0116976015,0.83056,0.00051941536,0.00030937276,0.108979054,0.0032077848,0.0012673448,0.0045097563,0.00021973428,0.03799909,0.00008822557],"about_ca_topic_score_codex":0.002828554,"about_ca_topic_score_gemma":0.0058704983,"teacher_disagreement_score":0.002828554,"about_ca_system_score_codex":0.0010424779,"about_ca_system_score_gemma":0.00086516654,"threshold_uncertainty_score":0.00756377},"labels":[],"label_agreement":null},{"id":"W2501897050","doi":"10.1038/bjc.2016.225","title":"Response to ‘Comments on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study’’","year":2016,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Incidence (geometry); Prospective cohort study; Medicine; Cohort; Cohort study; Oncology; Internal medicine; Pediatrics","score_opus":0.008450640374822252,"score_gpt":0.2928092350950046,"score_spread":0.2843585947201824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501897050","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00083510595,0.0007176836,0.00006067158,0.9534546,0.04269841,0.000022553548,0.00051252736,0.000039041013,0.0016594718],"genre_scores_gemma":[0.0041892654,0.0006499612,0.00013509797,0.9473025,0.037713647,0.00008304069,0.00022186441,0.000029949924,0.0096747475],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950151,0.0013056903,0.0009234379,0.0005371894,0.0013309927,0.00088765984],"domain_scores_gemma":[0.9846266,0.0074983477,0.0025241736,0.00050297304,0.0026683938,0.0021794315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044951416,0.0008226101,0.0019033842,0.001056078,0.002771104,0.002553402,0.001928027,0.031206809,0.010345621],"category_scores_gemma":[0.036288004,0.0010275176,0.0013712288,0.0013197176,0.0019384596,0.0018959037,0.0019384624,0.023870073,0.008318071],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007782748,0.000018681874,0.001358196,0.00006100878,0.000014018322,0.0004793146,0.000105658495,0.000027050133,0.000075421405,0.0002480342,0.99516124,0.0023734753],"study_design_scores_gemma":[0.00027934383,0.00024671317,0.018478129,0.0010994873,0.00009604955,0.0019979186,0.0013915156,0.00044491884,0.0004835106,0.0019993957,0.9732906,0.00019230192],"about_ca_topic_score_codex":0.0128895305,"about_ca_topic_score_gemma":0.01925825,"teacher_disagreement_score":0.031206809,"about_ca_system_score_codex":0.0038882128,"about_ca_system_score_gemma":0.0036651953,"threshold_uncertainty_score":0.034609497},"labels":[],"label_agreement":null},{"id":"W2514715491","doi":"10.1038/bjc.2016.243","title":"A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"Alberta Cancer Foundation; University of Calgary","keywords":"Metabolomics; Colorectal cancer; Receiver operating characteristic; Medicine; Biomarker; Internal medicine; Stage (stratigraphy); Oncology; Cancer; Adenoma; Bioinformatics; Biology","score_opus":0.023198479378307997,"score_gpt":0.3248935800824965,"score_spread":0.30169510070418853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514715491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973975,0.0017524526,0.021815015,0.00034456488,0.000024249699,0.00009051833,0.0013618678,0.00018212476,0.00045419848],"genre_scores_gemma":[0.9820899,0.00038437606,0.016063986,0.00009891572,0.000024661973,0.000036920497,0.0011244755,0.000013218177,0.0001635528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995548,0.00012948786,0.000031658823,0.00014040315,0.000108563036,0.000035060573],"domain_scores_gemma":[0.9988539,0.00044151803,0.00030101536,0.00009295701,0.00020972133,0.000100901765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001358676,0.0006438909,0.0007216618,0.0010642542,0.00017170377,0.0006531713,0.00025019702,0.0005134886,0.0004648263],"category_scores_gemma":[0.0026704913,0.00011748687,0.00045876292,0.00078399293,0.00036231417,0.00031032073,0.00044099765,0.00045621372,0.00023060037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031622532,0.00046429655,0.49805346,0.00057678175,0.0007246796,0.000330799,0.00012813491,0.010196938,0.3828198,0.000392407,0.00090229133,0.10224814],"study_design_scores_gemma":[0.00018304412,0.0043864194,0.62220883,0.00009110358,0.0010387031,0.0024037496,0.00015877448,0.13457091,0.22827692,0.0026561376,0.0038992884,0.00012606222],"about_ca_topic_score_codex":0.00072469487,"about_ca_topic_score_gemma":0.0010374152,"teacher_disagreement_score":0.001358676,"about_ca_system_score_codex":0.00044609825,"about_ca_system_score_gemma":0.0005481374,"threshold_uncertainty_score":0.007185459},"labels":[],"label_agreement":null},{"id":"W2515981989","doi":"10.1038/bjc.2016.272","title":"Increased pancreatic cancer risk following radiotherapy for testicular cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"University of Texas MD Anderson Cancer Center; KWF Kankerbestrijding; National Institute of Allergy and Infectious Diseases; Lance Armstrong Foundation; Karolinska Institutet; Cancer Care Ontario; Armstrong Foundation; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Radiation therapy; Pancreatic cancer; Pancreas; Odds ratio; Cancer; Chemotherapy; Testicular cancer; Internal medicine; Confidence interval; Incidence (geometry); Pancreatic disease; Gastroenterology; Oncology; Surgery; Urology","score_opus":0.02156252843213384,"score_gpt":0.3622311090299166,"score_spread":0.34066858059778277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515981989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965323,0.0022719165,0.00023444172,0.000062592924,0.000008394311,0.0000057912484,0.00023124194,0.000014140275,0.0006391063],"genre_scores_gemma":[0.99879384,0.0007227817,0.000092230795,0.000014127873,0.00001651292,0.0000021009446,0.000239383,0.0000025362924,0.00011643164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978584,0.00007326833,0.000016787779,0.000040962776,0.000051356103,0.000031731288],"domain_scores_gemma":[0.9984291,0.00037065492,0.00087293354,0.00008446962,0.00009285175,0.00014992453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036044227,0.00015633585,0.00020791758,0.0006459268,0.00019155674,0.000418812,0.00020875128,0.00018806334,0.0023032092],"category_scores_gemma":[0.0019930967,0.0001141999,0.0003637277,0.0009607244,0.0002201718,0.00016678424,0.00025395537,0.00029067448,0.00018517861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000989015,0.0000055081077,0.9970298,0.000017447432,0.000054179804,0.00014421379,0.000023283139,0.00005451935,0.00016251252,0.00001118968,0.00006252695,0.0023359137],"study_design_scores_gemma":[0.000004054651,0.00008426697,0.9980552,0.000010167363,0.000060006525,0.0012969985,0.000033741122,0.00007656893,0.00016114175,0.000022023794,0.00019339795,0.0000023132006],"about_ca_topic_score_codex":0.0035675874,"about_ca_topic_score_gemma":0.0035838545,"teacher_disagreement_score":0.0035675874,"about_ca_system_score_codex":0.00030829545,"about_ca_system_score_gemma":0.00026374654,"threshold_uncertainty_score":0.007705033},"labels":[],"label_agreement":null},{"id":"W2517029840","doi":"10.1038/bjc.2016.249","title":"Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Proportional hazards model; Hazard ratio; Univariate analysis; Cancer; Gynecology; Multivariate analysis; Confidence interval","score_opus":0.007243945685576175,"score_gpt":0.26830293288121104,"score_spread":0.26105898719563486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517029840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858606,0.0009721137,0.000014235134,0.000044484605,0.0000035233486,0.000001186969,0.00012717678,7.853785e-7,0.00025040482],"genre_scores_gemma":[0.9992944,0.0003150922,0.000027352238,0.000019478406,0.0000050443537,0.000001821634,0.00020960582,9.56546e-7,0.00012630985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999293,0.000021329572,0.000007194719,0.000012924226,0.00001015038,0.000019140009],"domain_scores_gemma":[0.9997218,0.000101796264,0.00010872095,0.00001516493,0.000017046423,0.000035467398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038161592,0.00010317943,0.00020197763,0.00037712939,0.00018547954,0.00025402315,0.00011682917,0.00021176801,0.0011793919],"category_scores_gemma":[0.00076887995,0.00008338162,0.00013925937,0.00032112107,0.0002136719,0.0001291983,0.00013677786,0.00014646242,0.0001226789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050257915,0.000030340561,0.99493706,0.000014461777,0.00003464148,0.00026186832,0.00007081772,0.00021748814,0.00055029534,0.000027383318,0.00022140366,0.0031316816],"study_design_scores_gemma":[0.000008770475,0.000098110686,0.9988722,0.000008925138,0.000024155168,0.00038541193,0.00006468384,0.00012886903,0.00010216452,0.00001821268,0.0002868137,0.0000016799371],"about_ca_topic_score_codex":0.011017358,"about_ca_topic_score_gemma":0.010411875,"teacher_disagreement_score":0.011017358,"about_ca_system_score_codex":0.00045575728,"about_ca_system_score_gemma":0.0002608827,"threshold_uncertainty_score":0.021906435},"labels":[],"label_agreement":null},{"id":"W2519636597","doi":"10.1038/bjc.2016.273","title":"Ovarian carcinoma diagnosis: the clinical impact of 15 years of change","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Carcinoma; Ovarian carcinoma; Medicine; Pathology; Oncology; Gynecology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.0846219215148308,"score_gpt":0.3866383915693564,"score_spread":0.3020164700545256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519636597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761367,0.014042713,0.0007007235,0.0025706773,0.00045380063,0.000028293365,0.0013847683,0.000031819516,0.004650551],"genre_scores_gemma":[0.99832886,0.0006887383,0.00015565108,0.000098020006,0.00015813751,0.0000046914292,0.00044700742,0.0000041547546,0.00011467615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684465,0.0009339938,0.00048787237,0.00062354346,0.0007619917,0.00034796374],"domain_scores_gemma":[0.98165214,0.0061442927,0.0071377247,0.0012144909,0.0023357999,0.0015156211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060937023,0.00022159104,0.00043595792,0.001841722,0.00063187967,0.0019389441,0.00059428735,0.00081990904,0.0014266702],"category_scores_gemma":[0.032920077,0.00012467238,0.00056709995,0.0026252375,0.0008168093,0.0018177141,0.0013575747,0.0010302523,0.0002460071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015912733,0.000012255729,0.9849613,0.000032979824,0.000066961984,0.00022634614,0.00016579685,0.00018576602,0.000059411548,0.0000765634,0.00031290657,0.0137405135],"study_design_scores_gemma":[0.000002637123,0.0000786521,0.9957684,0.000048684506,0.000052633528,0.00087113876,0.0005249174,0.0005772641,0.000063875195,0.00027026286,0.0017313259,0.00001018276],"about_ca_topic_score_codex":0.0045661596,"about_ca_topic_score_gemma":0.005101321,"teacher_disagreement_score":0.0060937023,"about_ca_system_score_codex":0.0010981922,"about_ca_system_score_gemma":0.0009543147,"threshold_uncertainty_score":0.03222692},"labels":[],"label_agreement":null},{"id":"W2519828822","doi":"10.1038/bjc.2016.293","title":"Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"National Center for Advancing Translational Sciences; Eli Lilly and Company","keywords":"Ramucirumab; Medicine; Biomarker; Immunohistochemistry; Internal medicine; Cancer; Oncology; Vascular endothelial growth factor; Angiogenesis; Gastroenterology; VEGF receptors; Biology","score_opus":0.016792335087465637,"score_gpt":0.29909963420634667,"score_spread":0.282307299118881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519828822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480116,0.0031965217,0.00011621176,0.00012761053,0.000045861176,0.000018991903,0.00032788212,0.000019268,0.001346458],"genre_scores_gemma":[0.99822825,0.00033741514,0.00021036374,0.00015787869,0.000028659835,0.00001568044,0.00043449778,0.0000046712466,0.000582607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997137,0.00004438013,0.000033908087,0.00007395592,0.00006499015,0.00006895763],"domain_scores_gemma":[0.9997645,0.000046316425,0.00005771488,0.000017050694,0.000060814127,0.000053706324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041226525,0.00026551797,0.0007181632,0.00046246315,0.00031216105,0.00090298767,0.00019907641,0.00042452873,0.00088534376],"category_scores_gemma":[0.00075486914,0.00016161082,0.00045963132,0.00048690173,0.0001913698,0.00029128118,0.00019457868,0.0005443194,0.00022194946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019970909,0.00040911933,0.8737062,0.00030160928,0.00083236105,0.0022985165,0.00033779736,0.00074494234,0.03456963,0.00022059561,0.0015981537,0.06501024],"study_design_scores_gemma":[0.00034289152,0.0046365336,0.9665118,0.00007323371,0.001366757,0.004705725,0.0004639917,0.0020772754,0.010782287,0.00028044876,0.008704936,0.00005422352],"about_ca_topic_score_codex":0.0012806639,"about_ca_topic_score_gemma":0.0020255337,"teacher_disagreement_score":0.0012806639,"about_ca_system_score_codex":0.00050370995,"about_ca_system_score_gemma":0.00033768473,"threshold_uncertainty_score":0.0036546588},"labels":[],"label_agreement":null},{"id":"W2529040040","doi":"10.1038/bjc.2016.308","title":"Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Pembrolizumab; Complete response; Radiological weapon; Response Evaluation Criteria in Solid Tumors; Oncology; Hazard ratio; Immunotherapy; Melanoma; Lung cancer; Proportional hazards model; Progressive disease; Cancer; Surgery; Chemotherapy; Confidence interval; Cancer research","score_opus":0.04788620324865843,"score_gpt":0.3419081425565475,"score_spread":0.29402193930788906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529040040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995503,0.00019422315,0.000048025075,0.0000160625,0.0000010203322,0.000004850462,0.000068206566,0.0000016483394,0.000115698],"genre_scores_gemma":[0.999783,0.000023078926,0.00003780703,0.0000103371285,0.0000027325486,0.000004834861,0.00009012675,8.50341e-7,0.000047332625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916184,0.00039475007,0.00009463211,0.00013739339,0.00012318576,0.00008825175],"domain_scores_gemma":[0.99787486,0.0007112115,0.00089394796,0.00013513197,0.0001328559,0.0002519794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337191,0.000201648,0.0005438404,0.0005634806,0.00019535441,0.00040369813,0.00024355426,0.00040141022,0.000985021],"category_scores_gemma":[0.0024875363,0.0001490626,0.00041477373,0.00040952762,0.00026685008,0.0003602813,0.0003648691,0.00039087542,0.00021175045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028215973,0.00008927681,0.9898078,0.000024680401,0.00011050403,0.00008452252,0.000087793676,0.00019427732,0.0018649264,0.000016739248,0.000060925748,0.0048370413],"study_design_scores_gemma":[0.00007928409,0.0013494493,0.99695516,0.0000042202555,0.00004522756,0.0003721856,0.000097815515,0.0005025745,0.00037626104,0.000040083156,0.0001708908,0.000006799546],"about_ca_topic_score_codex":0.0003420268,"about_ca_topic_score_gemma":0.00063549884,"teacher_disagreement_score":0.001337191,"about_ca_system_score_codex":0.00023512013,"about_ca_system_score_gemma":0.00015316858,"threshold_uncertainty_score":0.007071793},"labels":[],"label_agreement":null},{"id":"W2550709057","doi":"10.1038/bjc.2016.368","title":"Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute; Canadian Centre for Applied Research in Cancer Control; McGill University; University of British Columbia; BC Centre for Disease Control; BC Cancer Agency","funders":"","keywords":"Colposcopy; Medicine; Referral; Cervical intraepithelial neoplasia; Gynecology; Cervical screening; Cervical cancer; Obstetrics; Internal medicine; Cancer; Family medicine","score_opus":0.026313958836227037,"score_gpt":0.31362751073428374,"score_spread":0.2873135518980567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550709057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97792983,0.012771112,0.0006859887,0.0017826194,0.00042870594,0.0010295946,0.0012752886,0.000054684566,0.004042151],"genre_scores_gemma":[0.99519485,0.0011413146,0.00043375557,0.0004749461,0.00020264734,0.0010784306,0.0007471217,0.0000059187246,0.0007210032],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9907748,0.0069582374,0.00046918928,0.000768178,0.0004453898,0.00058422267],"domain_scores_gemma":[0.99273396,0.0038790815,0.0016541856,0.0005055181,0.0003346488,0.00089257804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007673463,0.0012731482,0.0021925913,0.0006124606,0.00039968258,0.0013688476,0.0011365998,0.0025522728,0.008509557],"category_scores_gemma":[0.022547878,0.0005819249,0.0031204163,0.0006380502,0.0013939788,0.0015657262,0.0011960611,0.002141441,0.00038470974],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9399915,0.0053783357,0.011933895,0.003589649,0.006036441,0.00011823878,0.00018539833,0.0012053767,0.00033958055,0.0010829779,0.0021656407,0.027973032],"study_design_scores_gemma":[0.7968098,0.12802847,0.049302064,0.0018025999,0.013154715,0.00024240548,0.000282531,0.0032542963,0.00074053765,0.004042645,0.0022277615,0.0001122482],"about_ca_topic_score_codex":0.0024426954,"about_ca_topic_score_gemma":0.0013041955,"teacher_disagreement_score":0.008509557,"about_ca_system_score_codex":0.001076453,"about_ca_system_score_gemma":0.002061001,"threshold_uncertainty_score":0.040581584},"labels":[],"label_agreement":null},{"id":"W2551017385","doi":"10.1038/bjc.2016.383","title":"Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Public Health Ontario; Ontario Institute for Cancer Research","funders":"Canadian Association of Radiation Oncology","keywords":"Medicine; Cervical cancer; Vismodegib; Cisplatin; Metastasis; Hedgehog signaling pathway; Toxicity; Oncology; Radiation therapy; Cancer; Internal medicine; Hedgehog; Urology; Pharmacology; Chemotherapy; Basal cell carcinoma; Signal transduction; Biology","score_opus":0.009739334376773006,"score_gpt":0.27777978992574925,"score_spread":0.26804045554897626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551017385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952088,0.0012547856,0.00052027125,0.00007399833,0.000038930208,0.00009310913,0.00057114824,0.00007771839,0.0021612504],"genre_scores_gemma":[0.994228,0.0009650439,0.0011264696,0.000028060924,0.000008732395,0.00007855259,0.0007121154,0.00002946124,0.002823532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981743,0.000048549173,0.000015678494,0.000029350063,0.000045958026,0.0000429466],"domain_scores_gemma":[0.99984694,0.000040473507,0.000027749176,0.000024889101,0.000014814047,0.000045167304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024426891,0.0003865912,0.00082626357,0.00040403905,0.00014734856,0.0002699989,0.00031333312,0.00026692744,0.0017733892],"category_scores_gemma":[0.0001618937,0.00021562312,0.0003683269,0.00026896322,0.00021604045,0.00022326602,0.00018700425,0.00075091555,0.00027129296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016641747,0.00081340835,0.0004652783,0.00012382356,0.000037379297,0.000056788165,0.00007711451,0.000777844,0.98968303,0.00012310343,0.0003535459,0.0058244606],"study_design_scores_gemma":[0.00023122148,0.009579639,0.009470534,0.000015171649,0.00005844818,0.00017970576,0.000053304884,0.002518766,0.97558266,0.000044697204,0.002254758,0.000011036115],"about_ca_topic_score_codex":0.0032287608,"about_ca_topic_score_gemma":0.0054823547,"teacher_disagreement_score":0.0032287608,"about_ca_system_score_codex":0.00043421678,"about_ca_system_score_gemma":0.0004666623,"threshold_uncertainty_score":0.006419897},"labels":[],"label_agreement":null},{"id":"W2551083370","doi":"10.1038/bjc.2016.380","title":"Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Children’s Oncology Group; National Institutes of Health; Jazz Pharmaceuticals","keywords":"Mucositis; Medicine; Placebo; Transplantation; Internal medicine; Population; Clinical endpoint; Clinical trial; Surgery; Toxicity","score_opus":0.023773989533237935,"score_gpt":0.34638597403771537,"score_spread":0.3226119845044774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551083370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97504485,0.023015345,0.00022263678,0.00018382896,0.00014701816,0.00065614434,0.00013804874,0.000022271079,0.0005699148],"genre_scores_gemma":[0.98702615,0.010049372,0.0010687818,0.00027471434,0.0003078175,0.0007490345,0.00016530236,0.000004000354,0.0003548283],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99963737,0.00018853847,0.00004890761,0.000037818183,0.000051625753,0.000035817488],"domain_scores_gemma":[0.9992385,0.0002834083,0.00028044943,0.000021643207,0.000037243175,0.00013879547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009061326,0.00043283176,0.0013549887,0.00034420515,0.00019469578,0.0003252829,0.00043441966,0.000612681,0.0021425448],"category_scores_gemma":[0.0008796154,0.00019742413,0.00056563003,0.00025687096,0.00040122162,0.00024345,0.00022935576,0.00093864265,0.00015500262],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5996655,0.019126248,0.015651112,0.010307773,0.00177952,0.00048731093,0.00023261277,0.0011592065,0.041385386,0.0003155613,0.0012850533,0.30860475],"study_design_scores_gemma":[0.31958294,0.617927,0.044023,0.00079538015,0.0014544199,0.00089382695,0.00012787635,0.0006184436,0.010283727,0.00013459091,0.0041337097,0.000025032592],"about_ca_topic_score_codex":0.0002978153,"about_ca_topic_score_gemma":0.00073518255,"teacher_disagreement_score":0.0021425448,"about_ca_system_score_codex":0.00024125256,"about_ca_system_score_gemma":0.00050516997,"threshold_uncertainty_score":0.007167518},"labels":[],"label_agreement":null},{"id":"W2554303407","doi":"10.1038/bjc.2016.360","title":"Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Trastuzumab; Breast cancer; Clinical trial; Systemic therapy; Oncology; Internal medicine; Population; Intensive care medicine; Adjuvant therapy; Randomized controlled trial; Cancer; Stage (stratigraphy); Adjuvant; Chemotherapy","score_opus":0.053753720127942994,"score_gpt":0.4222511520062968,"score_spread":0.3684974318783538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554303407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013718983,0.9995939,0.000018226276,0.000058529913,0.00002970712,0.000004052677,0.000009218331,9.434747e-7,0.00014827591],"genre_scores_gemma":[0.0010864426,0.9986266,0.00008000348,0.0000718711,0.000030394029,0.0000060004786,0.000014152786,3.9427658e-7,0.00008424127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972695,0.0000912672,0.00006940078,0.000030309848,0.000067335815,0.000014726885],"domain_scores_gemma":[0.9994265,0.00040383422,0.00009921245,0.00000794255,0.000047506368,0.0000150319165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007526073,0.00046510133,0.0017471395,0.0016299566,0.00014066925,0.00053324667,0.00048671052,0.00073943875,0.0023343929],"category_scores_gemma":[0.0016392767,0.000183443,0.00096266094,0.0015455738,0.0002079949,0.00053182105,0.0003507327,0.0006954551,0.00040230263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019252149,0.00004477798,0.0003194893,0.08080661,0.0005080413,0.00012072104,0.000045039145,0.00025717964,0.00040062715,0.0006116564,0.007902324,0.9087909],"study_design_scores_gemma":[0.00041997398,0.00080705737,0.012030145,0.16598591,0.0063878493,0.0043521416,0.00028400132,0.0004632084,0.0010920789,0.0025645383,0.80555004,0.0000631471],"about_ca_topic_score_codex":0.001370467,"about_ca_topic_score_gemma":0.003938953,"teacher_disagreement_score":0.0023343929,"about_ca_system_score_codex":0.00040483213,"about_ca_system_score_gemma":0.0008391528,"threshold_uncertainty_score":0.0078092813},"labels":[],"label_agreement":null},{"id":"W2554584411","doi":"10.1038/bjc.2016.378","title":"Impact of cause of death adjudication on the results of the European prostate cancer screening trial","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Cancer; Adjudication; Prostate; Prostate cancer; Oncology; Cause of death; Clinical trial; Internal medicine; Gynecology; Disease; Political science","score_opus":0.041484834964517235,"score_gpt":0.3363100666499876,"score_spread":0.29482523168547037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554584411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6747117,0.15129541,0.08340061,0.031722676,0.0055993362,0.008767928,0.007533785,0.000695272,0.0362733],"genre_scores_gemma":[0.9825811,0.0024592534,0.007393799,0.0034469622,0.0004334023,0.0017272854,0.0011027753,0.00010813782,0.0007472886],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.26043728,0.69052523,0.02345114,0.008986486,0.014171457,0.0024284206],"domain_scores_gemma":[0.23279019,0.6676678,0.058118988,0.029667607,0.010089157,0.001666358],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.4480601,0.0014652543,0.005785263,0.0013846859,0.0010433377,0.005849364,0.0021891773,0.0055015646,0.0031186664],"category_scores_gemma":[0.6485452,0.00071430573,0.012038872,0.0028146799,0.0031739995,0.004381076,0.0038546,0.0058873002,0.0005298298],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5411595,0.0007791822,0.101598576,0.01624798,0.09549568,0.00034571782,0.0029227848,0.021711953,0.00078159914,0.01577016,0.009311812,0.19387509],"study_design_scores_gemma":[0.19402564,0.036880385,0.28098747,0.028918706,0.18187577,0.0015374193,0.0013482117,0.10348724,0.0058719176,0.111562066,0.052206818,0.0012983095],"about_ca_topic_score_codex":0.0020740614,"about_ca_topic_score_gemma":0.001430517,"teacher_disagreement_score":0.4480601,"about_ca_system_score_codex":0.0029229731,"about_ca_system_score_gemma":0.0039849263,"threshold_uncertainty_score":0.6806402},"labels":[],"label_agreement":null},{"id":"W2554614845","doi":"10.1038/bjc.2016.375","title":"The use of drugs acting on the renin–angiotensin system and the incidence of pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Renin–angiotensin system; Pancreatic cancer; Incidence (geometry); Medicine; Cancer; Internal medicine; Endocrinology; Pharmacology; Blood pressure","score_opus":0.02939141161726176,"score_gpt":0.280203789548143,"score_spread":0.25081237793088124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554614845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742776,0.0013165863,0.00013057905,0.00005414517,0.000011883639,0.000010932989,0.00060756935,0.000004367779,0.00043613484],"genre_scores_gemma":[0.99843115,0.000641271,0.00018854042,0.000020357435,0.000028081178,0.000009474872,0.0005279038,0.0000022440179,0.00015104437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897575,0.00024669932,0.00015021389,0.00026292505,0.00026170476,0.000102676415],"domain_scores_gemma":[0.99398416,0.0010964329,0.003801077,0.00031636862,0.00034890074,0.00045292737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010774805,0.00022491932,0.0003511645,0.0008716177,0.0002746756,0.0007215573,0.00047224632,0.0003340973,0.0014345188],"category_scores_gemma":[0.0045339204,0.00033476079,0.00061278907,0.0012144806,0.00032323273,0.00041495662,0.00041913855,0.00059427036,0.00020927403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001997353,0.000017956405,0.9986286,0.00001639041,0.0000917963,0.000041300496,0.000016431854,0.00003674691,0.00013478995,0.0000075251096,0.000028394647,0.0007802685],"study_design_scores_gemma":[0.000009519358,0.000087547574,0.99922526,0.0000059530694,0.00006275633,0.00028857257,0.000017601042,0.00009490917,0.000065810724,0.00000938042,0.00013042173,0.0000022111913],"about_ca_topic_score_codex":0.003913537,"about_ca_topic_score_gemma":0.003440266,"teacher_disagreement_score":0.003913537,"about_ca_system_score_codex":0.00045306998,"about_ca_system_score_gemma":0.00042212504,"threshold_uncertainty_score":0.007781565},"labels":[],"label_agreement":null},{"id":"W2555854562","doi":"10.1038/bjc.2016.367","title":"miR-146a-5p mediates epithelial–mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Science and Technology Development Plan of Shandong Province; National Natural Science Foundation of China","keywords":"Epithelial–mesenchymal transition; Basal cell; Cancer research; Mesenchymal stem cell; Transition (genetics); Pathology; Carcinoma; Medicine; Biology; Cancer; Internal medicine; Metastasis; Gene","score_opus":0.0043282026176133335,"score_gpt":0.22009015253309297,"score_spread":0.21576194991547964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555854562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98006666,0.0077461433,0.0059797126,0.0001946279,0.000106988555,0.00007647629,0.0005645641,0.00017286082,0.0050919764],"genre_scores_gemma":[0.99415565,0.0016564454,0.0016916743,0.000080499565,0.000013525523,0.00004075918,0.00045897526,0.00001437751,0.0018881928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998186,0.000036343114,0.000025871499,0.000029875931,0.00005816448,0.00003110798],"domain_scores_gemma":[0.99993074,0.000009180241,0.000021229736,0.0000083877385,0.000011465303,0.00001903188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022090945,0.00027768605,0.00026795018,0.00019730125,0.00016475614,0.00033352067,0.00020220538,0.00023177237,0.001493761],"category_scores_gemma":[0.00016304642,0.0001410374,0.0003752727,0.00010915277,0.00020338198,0.00016843322,0.00025994718,0.00044417437,0.000620333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022720899,0.000048923517,0.0008123204,0.00015187015,0.000016839029,0.00014614238,0.000018556986,0.00012383312,0.9949551,0.00015971826,0.00013158277,0.0032078081],"study_design_scores_gemma":[0.00003500764,0.00039751414,0.0091643445,0.000015452748,0.0000513267,0.0007927173,0.00003862482,0.0020844347,0.98174644,0.00007124396,0.0055965562,0.000006241153],"about_ca_topic_score_codex":0.00024349063,"about_ca_topic_score_gemma":0.00034039104,"teacher_disagreement_score":0.001493761,"about_ca_system_score_codex":0.00019716115,"about_ca_system_score_gemma":0.00022527475,"threshold_uncertainty_score":0.0049970746},"labels":[],"label_agreement":null},{"id":"W2565574808","doi":"10.1038/bjc.2016.400","title":"Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; University of Calgary; University of Alberta; Canadian Centre for Applied Research in Cancer Control; The King's University; Alberta Health Services","funders":"National Cancer Institute; WorkSafe Victoria","keywords":"Medicine; Odds ratio; Gynecology; Case-control study; Obstetrics; Ovarian cancer; Pregnancy; Population; Tubal ligation; Confidence interval; Family planning; Cancer; Internal medicine; Environmental health","score_opus":0.012046660517742693,"score_gpt":0.2637765782554249,"score_spread":0.2517299177376822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565574808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975932,0.014700037,0.000199489,0.00054627756,0.00006243623,0.00005769442,0.0045235725,0.000022618704,0.0039557465],"genre_scores_gemma":[0.9954194,0.002240018,0.0002802977,0.00006787218,0.000030013898,0.000012594016,0.0010783857,0.0000045971515,0.00086684665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924123,0.00007359401,0.00004665054,0.00012414355,0.00035205772,0.00016229542],"domain_scores_gemma":[0.9979069,0.0003441135,0.0010118458,0.00011912688,0.0003367585,0.00028115875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006034232,0.00029450725,0.0003849385,0.00115556,0.00045928705,0.00064569205,0.00063754205,0.00036081267,0.004961557],"category_scores_gemma":[0.0030412364,0.0002308111,0.0006868908,0.0014234858,0.0003974436,0.00018483303,0.0002541816,0.0006950582,0.00022303496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029581325,0.000029999417,0.9914772,0.00013927024,0.00025455406,0.00011029787,0.00006982002,0.00007126557,0.000286944,0.00005722026,0.00042118464,0.006786409],"study_design_scores_gemma":[0.0000127326075,0.000063938365,0.99858475,0.000049091595,0.00009270518,0.0002886407,0.000037470032,0.00006647118,0.00008182889,0.00001582581,0.0007026453,0.000003902557],"about_ca_topic_score_codex":0.5072429,"about_ca_topic_score_gemma":0.5311482,"teacher_disagreement_score":0.5072429,"about_ca_system_score_codex":0.0025725854,"about_ca_system_score_gemma":0.0034982169,"threshold_uncertainty_score":0.99131805},"labels":[],"label_agreement":null},{"id":"W2565711919","doi":"10.1038/bjc.2016.420","title":"EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Afatinib; Medicine; Lung cancer; Adenocarcinoma; Internal medicine; Epidermal growth factor receptor; Oncology; Liquid biopsy; Lung; Mutation; Pathology; Cancer; Biology; Gefitinib; Gene","score_opus":0.005319400910376899,"score_gpt":0.276573494396567,"score_spread":0.27125409348619006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565711919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818367,0.00063368306,0.00064098276,0.000064053515,0.0000070675737,0.000028076762,0.00022436843,0.000022934191,0.00019527199],"genre_scores_gemma":[0.9981073,0.00008614927,0.0010024743,0.000069223155,0.000007382838,0.000026161031,0.0005371821,0.00000494371,0.00015923184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993617,0.00019860656,0.000042548632,0.0001720095,0.0001754155,0.000049758622],"domain_scores_gemma":[0.9984475,0.00050437206,0.0004953982,0.000072056675,0.00019367166,0.00028710547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001240874,0.00022856158,0.00047580668,0.0003259152,0.00015643472,0.0004465345,0.00030260565,0.00055346056,0.0011174835],"category_scores_gemma":[0.0026277006,0.00014561508,0.00026664714,0.0002537939,0.00038090846,0.00029472072,0.00024388911,0.00042974867,0.00035038797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01580794,0.00040376748,0.85530883,0.00015130066,0.00019442364,0.00022672467,0.00017003875,0.0009221798,0.086741686,0.00008452666,0.00037647045,0.03961216],"study_design_scores_gemma":[0.0014141472,0.022827132,0.91055703,0.000041437186,0.00025846527,0.0044347025,0.00014908961,0.0072291596,0.050123718,0.00029543656,0.0026177987,0.00005182223],"about_ca_topic_score_codex":0.00045072613,"about_ca_topic_score_gemma":0.0006434007,"teacher_disagreement_score":0.001240874,"about_ca_system_score_codex":0.00036133023,"about_ca_system_score_gemma":0.0002825581,"threshold_uncertainty_score":0.0065624714},"labels":[],"label_agreement":null},{"id":"W2567825448","doi":"10.1038/bjc.2016.429","title":"Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute on Minority Health and Health Disparities; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Blockade; Breast cancer; Oncology; Chemotherapy; Cancer; CTLA-4; Internal medicine; Immunology; Receptor; T cell; Immune system","score_opus":0.01793608759319667,"score_gpt":0.35102083915400556,"score_spread":0.3330847515608089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567825448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700874,0.0008486469,0.00037197905,0.00009480689,0.000049037775,0.000044228145,0.00024586255,0.000069104244,0.0012676158],"genre_scores_gemma":[0.9964768,0.0005492756,0.0006970311,0.000035202836,0.000011099248,0.000052837448,0.00037233517,0.000018711351,0.0017867401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998379,0.000043054843,0.0000111302725,0.000020535723,0.000034008775,0.000053456955],"domain_scores_gemma":[0.9998311,0.000042742075,0.000032461798,0.000019921565,0.00001195625,0.00006189003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016936731,0.0004172541,0.00042383544,0.00021487483,0.00012844273,0.00026586882,0.00023892822,0.00022950824,0.001449506],"category_scores_gemma":[0.00019242299,0.0001619681,0.0002014128,0.00014608681,0.00018680803,0.00016141968,0.00017081219,0.0007312622,0.00029998246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027540033,0.0011060527,0.0005268312,0.00007758002,0.000019843701,0.000078214,0.000032899796,0.001147682,0.9875408,0.00010990786,0.0002805014,0.0063256538],"study_design_scores_gemma":[0.00019855188,0.012428994,0.0034435247,0.000010489909,0.00003020562,0.00019781759,0.000022960541,0.002017877,0.97962326,0.000033475702,0.0019859287,0.0000067975584],"about_ca_topic_score_codex":0.0012170821,"about_ca_topic_score_gemma":0.0025451328,"teacher_disagreement_score":0.001449506,"about_ca_system_score_codex":0.00034438734,"about_ca_system_score_gemma":0.0003968834,"threshold_uncertainty_score":0.0048490167},"labels":[],"label_agreement":null},{"id":"W2577051512","doi":"10.1038/bjc.2016.448","title":"Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Triple-negative breast cancer; Metastasis; Breast cancer; Cancer research; Lung cancer; Matrix metalloproteinase; Medicine; Pathology; Lung; Cancer; Oncology; Biology; Internal medicine","score_opus":0.016165578986429282,"score_gpt":0.29439491750346775,"score_spread":0.27822933851703846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577051512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98951447,0.0023146404,0.0038955414,0.00026997706,0.00006678259,0.00016366382,0.0017742808,0.0001977588,0.0018029402],"genre_scores_gemma":[0.97641534,0.002697198,0.0048936387,0.00014102773,0.00002695633,0.0003849431,0.0021232225,0.0000652402,0.0132524185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956435,0.000059557176,0.00004872495,0.00010096101,0.00013627468,0.000090011614],"domain_scores_gemma":[0.9996774,0.000028358403,0.000119084034,0.00004268614,0.000028139595,0.00010434966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004298335,0.0010306735,0.00054609816,0.001229356,0.00035805823,0.0004643403,0.00045690394,0.00093910116,0.0029476378],"category_scores_gemma":[0.000110290894,0.0004890041,0.0008147594,0.0003949555,0.00045701265,0.0003650152,0.0003053338,0.0015524189,0.00086459913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000439706,0.00025480834,0.00035325898,0.00006838977,0.000012096056,0.00010656591,0.000027679329,0.00007823417,0.99769175,0.000115052055,0.00007804555,0.0007743806],"study_design_scores_gemma":[0.000122877,0.0033664848,0.006827431,0.000035757097,0.000073262665,0.0009848865,0.00007595478,0.0012821556,0.98348874,0.00010743094,0.0036160501,0.000019016185],"about_ca_topic_score_codex":0.00094537134,"about_ca_topic_score_gemma":0.0015259404,"teacher_disagreement_score":0.0029476378,"about_ca_system_score_codex":0.0006035152,"about_ca_system_score_gemma":0.00035372243,"threshold_uncertainty_score":0.009860814},"labels":[],"label_agreement":null},{"id":"W2577415758","doi":"10.1038/bjc.2016.426","title":"Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council Queensland; Cancer Council NSW; Cancer Council Victoria; Cancer Council South Australia; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; Helse Vest; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Lon V. Smith Foundation; Norges Forskningsråd; University of Cambridge; Cancer Research UK; American Cancer Society; Minnesota Ovarian Cancer Alliance; Imperial College London; Kreftforeningen; Helsingin ja Uudenmaan Sairaanhoitopiiri; WorkSafeBC; Rutgers Cancer Institute of New Jersey; Francis Crick Institute; Mayo Foundation for Medical Education and Research; European Commission; Oregon Health and Science University; Universität Ulm; Kræftens Bekæmpelse; National Center for Research Resources; Oak Foundation; Roswell Park Cancer Institute; Ovarian Cancer Research Fund","keywords":"PAX8; Genome-wide association study; Biology; Gene; Genetics; Carcinogenesis; Serous fluid; Transcriptome; Cancer research; Single-nucleotide polymorphism; Transcription factor; Gene expression; Genotype","score_opus":0.010092243727289996,"score_gpt":0.28862542018609755,"score_spread":0.27853317645880754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577415758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975573,0.00054237555,0.00075623085,0.000022874901,0.0000035247338,0.0000061060996,0.00065045914,0.000027269976,0.00043383488],"genre_scores_gemma":[0.99801683,0.00016832355,0.0007777091,0.0000227769,0.000003456648,0.000009966959,0.00067200477,0.000007035058,0.00032188243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997049,0.0000486542,0.000024977202,0.00009673248,0.000064642125,0.000060070124],"domain_scores_gemma":[0.9995608,0.00022276968,0.000095435236,0.000034478555,0.000032283093,0.000054206237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039724092,0.00020422337,0.00034866427,0.0009004621,0.00024341195,0.00040450675,0.0001457223,0.00021157347,0.0026591064],"category_scores_gemma":[0.00067612855,0.000158122,0.00047091508,0.00075744564,0.00025190102,0.00015855924,0.00041543914,0.00027389475,0.0002105076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020979173,0.00006257802,0.5365677,0.00039382753,0.00059248385,0.0015270112,0.00035366582,0.0013832876,0.43077534,0.0005869656,0.00043787,0.025221325],"study_design_scores_gemma":[0.00006484502,0.00018231542,0.97470266,0.000026445012,0.00028762664,0.0015618249,0.00016181977,0.0022119754,0.018845513,0.00045528222,0.0014844568,0.000015104311],"about_ca_topic_score_codex":0.0011533601,"about_ca_topic_score_gemma":0.0019154934,"teacher_disagreement_score":0.0026591064,"about_ca_system_score_codex":0.00014162564,"about_ca_system_score_gemma":0.00021602439,"threshold_uncertainty_score":0.008895636},"labels":[],"label_agreement":null},{"id":"W2579765256","doi":"10.1038/bjc.2016.443","title":"Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; SickKids Foundation; Hospital for Sick Children; McMaster Children's Hospital; London Health Sciences Centre","funders":"National Cancer Institute; Pediatric Oncology Group of Ontario","keywords":"Medicine; Cancer; Pediatrics; Population; Cancer registry; Cohort; Mortality rate; Internal medicine; Environmental health","score_opus":0.04512909757366945,"score_gpt":0.39329087251384354,"score_spread":0.3481617749401741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579765256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950597,0.00033737443,0.00021816438,0.000051399882,0.0000029666871,0.000033529865,0.0037986634,0.000011091871,0.00048709125],"genre_scores_gemma":[0.996664,0.0002230009,0.00015853236,0.000011039445,0.000006009815,0.000029543142,0.0028045876,0.000003887966,0.00009935387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905676,0.00022126811,0.00011371325,0.00016554682,0.00030681593,0.00013588503],"domain_scores_gemma":[0.9985257,0.00020602212,0.00085715257,0.00011525315,0.00018252862,0.00011347086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093223795,0.00021353563,0.00037235735,0.0017569412,0.000348982,0.0004901278,0.0005794286,0.00026205412,0.0014813098],"category_scores_gemma":[0.0026509622,0.00027785343,0.0009944532,0.0026303239,0.0003026847,0.0004585926,0.0005609307,0.0004311736,0.00014930144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004007645,0.0000054508832,0.9990306,0.000015151251,0.00006450477,0.000027244541,0.00003831646,0.00007668171,0.000032306827,0.000007826653,0.00007406837,0.0005878421],"study_design_scores_gemma":[0.0000029883097,0.000028479173,0.9995183,0.0000041017847,0.000017426311,0.0000946109,0.00006046211,0.000121081444,0.000013740641,0.0000064074866,0.00013087768,0.0000016145447],"about_ca_topic_score_codex":0.06663058,"about_ca_topic_score_gemma":0.07438474,"teacher_disagreement_score":0.06663058,"about_ca_system_score_codex":0.0017089531,"about_ca_system_score_gemma":0.0010209029,"threshold_uncertainty_score":0.13248545},"labels":[],"label_agreement":null},{"id":"W2585552374","doi":"10.1038/bjc.2017.1","title":"Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Trace Elements in Health","field":"Nursing","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; Institut Gustave-Roussy; Deutsche Krebshilfe; Associazione Italiana per la Ricerca sul Cancro; Cancerfonden; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; World Health Organization; European Commission; Bundesministerium für Bildung und Forschung; Ligue Contre le Cancer; National Institute for Health and Care Research; Cancer Research UK; Centre International de Recherche sur le Cancer; Hellenic Health Foundation; Health Research Board; Deutsches Krebsforschungszentrum","keywords":"Zinc; Medicine; Internal medicine; Copper; Pathology; Gastroenterology; Oncology; Chemistry","score_opus":0.030718807222261953,"score_gpt":0.33641816355205545,"score_spread":0.3056993563297935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585552374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987392,0.00056816795,0.00009833271,0.00004270195,0.0000056153704,0.0000045198894,0.00018247608,0.0000031568813,0.00035586132],"genre_scores_gemma":[0.9990895,0.00029763134,0.00008608426,0.000036227535,0.0000103945085,0.0000046479713,0.00020331275,0.0000019286786,0.00027030002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996202,0.00010945037,0.000050453753,0.00012187548,0.000049074686,0.000048980615],"domain_scores_gemma":[0.9995022,0.00006631276,0.0002003511,0.000046923873,0.00007506885,0.00010912031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076607085,0.00028720874,0.00043351972,0.0010114291,0.00042351682,0.00070789695,0.0003057215,0.000462507,0.0012891577],"category_scores_gemma":[0.0012780002,0.00032862936,0.0005303566,0.0014304802,0.00038361037,0.00028085156,0.00041619744,0.00027907253,0.0002243629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003889272,0.00003843398,0.9964418,0.000019235316,0.00014068518,0.00016288622,0.00018891078,0.00004265019,0.0006025653,0.000054646855,0.00009360542,0.0018257734],"study_design_scores_gemma":[0.000018435727,0.000090220135,0.99874604,0.000011260886,0.0000528239,0.00039931244,0.00018113102,0.0001204436,0.00006491338,0.00005636014,0.00025534292,0.0000037136265],"about_ca_topic_score_codex":0.010581367,"about_ca_topic_score_gemma":0.005248831,"teacher_disagreement_score":0.010581367,"about_ca_system_score_codex":0.00033856087,"about_ca_system_score_gemma":0.00019934405,"threshold_uncertainty_score":0.021039546},"labels":[],"label_agreement":null},{"id":"W2585568219","doi":"10.1038/bjc.2017.15","title":"Asporin is a stromally expressed marker associated with prostate cancer progression","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"University of Oxford; AstraZeneca; University College London; Cancer Research UK; Prostate Cancer Canada; Movember Foundation","keywords":"Prostate cancer; Stromal cell; Stroma; Prostate; Pathology; Tissue microarray; Medicine; Oncology; Cancer; Immunohistochemistry; PCA3; Cancer research; Biology; Internal medicine","score_opus":0.012553120564562774,"score_gpt":0.3185869427778974,"score_spread":0.30603382221333464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585568219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720347,0.0007845399,0.0011330228,0.000016062872,0.000002158489,0.000011544599,0.00030062115,0.00002106995,0.00052758865],"genre_scores_gemma":[0.9983236,0.0002326346,0.00066445715,0.000006365152,0.0000037883608,0.000008430245,0.00049378333,0.0000033647625,0.00026365556],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986887,0.000025533502,0.000012923359,0.000027036736,0.000047415622,0.00001827723],"domain_scores_gemma":[0.9993753,0.00010883543,0.00030588254,0.000027375749,0.000088419314,0.00009417143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002745248,0.00020762795,0.00017153278,0.0004465207,0.0001438641,0.00033500118,0.0001233714,0.00013066386,0.001090418],"category_scores_gemma":[0.00042995805,0.000091911206,0.00016443095,0.0005278081,0.00024173335,0.00014694783,0.00019155326,0.0002716807,0.00017225723],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009812417,0.000055170243,0.57235307,0.00018033886,0.0001122189,0.00032052386,0.00010540432,0.00082756754,0.41148293,0.00011656484,0.00013946915,0.013325502],"study_design_scores_gemma":[0.0000088664665,0.00051630667,0.92988986,0.000010705879,0.000069636815,0.0022498,0.000053872314,0.0018062175,0.0637928,0.00012529021,0.0014657232,0.000010940463],"about_ca_topic_score_codex":0.0006826499,"about_ca_topic_score_gemma":0.00085722405,"teacher_disagreement_score":0.001090418,"about_ca_system_score_codex":0.00022366403,"about_ca_system_score_gemma":0.00020620765,"threshold_uncertainty_score":0.0036478043},"labels":[],"label_agreement":null},{"id":"W2586745916","doi":"10.1038/bjc.2017.19","title":"Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Oncology; BRCA mutation; Stage (stratigraphy); Medicine; Internal medicine; Mutation; Cancer; Cancer research; Biology; Genetics; Breast cancer; Gene","score_opus":0.04312976694103765,"score_gpt":0.40540402854847196,"score_spread":0.3622742616074343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586745916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999713,0.00007648284,0.000018066474,0.0000035720466,0.0000015943479,0.0000020570133,0.00006709578,0.000001033784,0.000117055184],"genre_scores_gemma":[0.99968255,0.00003216253,0.000016141412,0.0000044371945,0.0000059171152,0.0000030917645,0.0001863658,7.6274875e-7,0.00006860705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997422,0.00004392449,0.000044040884,0.000076144905,0.00003733199,0.000056347046],"domain_scores_gemma":[0.9991629,0.00018133801,0.00032868685,0.000063069194,0.00006030019,0.00020370207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047567723,0.00024228297,0.00029873982,0.0012178005,0.0003279474,0.000459066,0.00025813363,0.0003764591,0.0015669112],"category_scores_gemma":[0.0015155958,0.00023123554,0.00033471262,0.00061397406,0.00031781892,0.00041825746,0.0003858018,0.00030566438,0.00027965318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035578368,0.00004037321,0.9980248,0.0000035339438,0.00002747679,0.00021617509,0.000049735205,0.00003135444,0.000350303,0.000008103686,0.000032852153,0.00085949776],"study_design_scores_gemma":[0.00001028888,0.00027438282,0.9982666,0.0000022102374,0.00002351369,0.0010085306,0.00013813398,0.00010157105,0.00006627121,0.00001665282,0.00008834304,0.0000034461527],"about_ca_topic_score_codex":0.0016990588,"about_ca_topic_score_gemma":0.0012758906,"teacher_disagreement_score":0.0016990588,"about_ca_system_score_codex":0.00022723502,"about_ca_system_score_gemma":0.00014551166,"threshold_uncertainty_score":0.005241871},"labels":[],"label_agreement":null},{"id":"W2588578960","doi":"10.1038/bjc.2017.35","title":"Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Women's College Hospital","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"Medicine; Ovarian cancer; National Death Index; Hazard ratio; Internal medicine; Proportional hazards model; Epidemiology; Cancer; Cancer registry; Confidence interval; Oncology; Gynecology","score_opus":0.06172330484195055,"score_gpt":0.3526062796316627,"score_spread":0.29088297478971215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588578960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976629,0.00090742845,0.00006076094,0.00013917287,0.000006123793,0.000007437748,0.0005345543,0.0000029812697,0.0006786468],"genre_scores_gemma":[0.99910283,0.00022438663,0.000029111725,0.000018554334,0.000008943935,0.0000030351343,0.00045925574,8.0104786e-7,0.00015314629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971896,0.000049643484,0.000029634884,0.000036064877,0.00007780778,0.00008780016],"domain_scores_gemma":[0.9983217,0.00032210973,0.0006870068,0.00009061432,0.00021797528,0.00036041977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040511106,0.00011962333,0.00016010998,0.0004749672,0.00042141136,0.0004237072,0.00030732233,0.0003444768,0.0012734691],"category_scores_gemma":[0.0027807953,0.00014168264,0.00025282978,0.00079364586,0.00033343036,0.0002514005,0.00034641853,0.00044419468,0.00011372684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028477116,0.0000055268883,0.9994299,0.0000028653683,0.000011142337,0.000021755613,0.000018152741,0.000021913138,0.00003939801,0.0000044438902,0.000033556607,0.00038290193],"study_design_scores_gemma":[0.0000010179895,0.000009759265,0.9997893,0.0000028805775,0.000005247405,0.00003432193,0.00003694693,0.000041089257,0.0000047629223,0.0000065561235,0.000067308494,7.654741e-7],"about_ca_topic_score_codex":0.14457156,"about_ca_topic_score_gemma":0.2233046,"teacher_disagreement_score":0.14457156,"about_ca_system_score_codex":0.0010085611,"about_ca_system_score_gemma":0.0010368974,"threshold_uncertainty_score":0.2874601},"labels":[],"label_agreement":null},{"id":"W2588715080","doi":"10.1038/bjc.2017.38","title":"Oncogenic role of PDK4 in human colon cancer cells","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"PDK4; Cancer research; Downregulation and upregulation; Apoptosis; Biology; Colorectal cancer; DNA methylation; Cancer; Methylation; Gene; Gene expression; Biochemistry; Genetics","score_opus":0.010647611262014115,"score_gpt":0.3322914874620145,"score_spread":0.32164387620000034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588715080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895912,0.0038268706,0.002474597,0.00015253693,0.000029315983,0.000047276593,0.0014406814,0.000114211005,0.0023233246],"genre_scores_gemma":[0.99372286,0.0011366877,0.0019111708,0.00004649106,0.0000030384747,0.00004730748,0.0013526444,0.000010659883,0.0017690652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999864,0.000023059432,0.000011032175,0.00003036145,0.00004865387,0.000022817947],"domain_scores_gemma":[0.9999317,0.000015128617,0.000012891304,0.000012791629,0.000016429602,0.000011107372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014525687,0.00020527566,0.00018202524,0.0003540527,0.00023755485,0.00026301178,0.000115921,0.00021740487,0.0014881323],"category_scores_gemma":[0.00020915973,0.00011505914,0.00016124816,0.00038266508,0.00019246664,0.000093354276,0.00020342288,0.00034633433,0.00036362247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000611098,0.000048520156,0.0024854252,0.00015450381,0.000018506847,0.0001582367,0.000042426596,0.00028975846,0.98935086,0.00015547432,0.00023424931,0.0064509124],"study_design_scores_gemma":[0.000058921014,0.0007951217,0.025021559,0.000015650992,0.00004974553,0.0015460585,0.000083230974,0.0024044542,0.957739,0.00018825152,0.012088638,0.000009410986],"about_ca_topic_score_codex":0.001755464,"about_ca_topic_score_gemma":0.0013653263,"teacher_disagreement_score":0.001755464,"about_ca_system_score_codex":0.0005390255,"about_ca_system_score_gemma":0.00034858746,"threshold_uncertainty_score":0.0049782395},"labels":[],"label_agreement":null},{"id":"W2590708113","doi":"10.1038/bjc.2017.28","title":"Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"Health Technology Assessment Programme; University College London; National Institute for Health and Care Research","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Human Epidermal Growth Factor Receptor 2; Cancer; Confidence interval; Clinical trial; Gynecology","score_opus":0.02109252661607599,"score_gpt":0.33229147070401877,"score_spread":0.3111989440879428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590708113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8238729,0.077912904,0.016707016,0.0077248686,0.0047387844,0.04516357,0.0056836624,0.0006924376,0.017503891],"genre_scores_gemma":[0.96888036,0.002074037,0.008983882,0.0025340482,0.00083588384,0.0136970095,0.0016526417,0.00010018097,0.0012420012],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.73532754,0.21686433,0.0203522,0.014142281,0.011246943,0.0020666386],"domain_scores_gemma":[0.6460296,0.18844612,0.09337715,0.043470666,0.023292717,0.0053837686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15732343,0.001179507,0.007136566,0.0010739748,0.001141849,0.0045507383,0.0027532263,0.0039762375,0.005485603],"category_scores_gemma":[0.23540093,0.0017946818,0.004758053,0.0014070724,0.0020991256,0.0031770528,0.0033749666,0.0030608592,0.001166918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85757184,0.001606212,0.021451196,0.013444597,0.00790387,0.00044895805,0.0012440013,0.0018898777,0.0026310454,0.0013131712,0.008387357,0.082107954],"study_design_scores_gemma":[0.6022981,0.14279781,0.14757395,0.010041742,0.024125034,0.0030943619,0.00080283725,0.009455343,0.009266802,0.006084137,0.04377175,0.00068821333],"about_ca_topic_score_codex":0.0011917476,"about_ca_topic_score_gemma":0.0014218761,"teacher_disagreement_score":0.15732343,"about_ca_system_score_codex":0.0033641816,"about_ca_system_score_gemma":0.0056918436,"threshold_uncertainty_score":0.8320158},"labels":[],"label_agreement":null},{"id":"W2591999938","doi":"10.1038/bjc.2017.53","title":"Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Colorectal cancer; Odds ratio; Odds; Internal medicine; Blood test; Cancer; Population; Surgery; Oncology; Logistic regression; Environmental health","score_opus":0.02384627535080266,"score_gpt":0.35205221176684676,"score_spread":0.3282059364160441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591999938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709666,0.00024257546,0.000999755,0.0001489514,0.000008463429,0.000025585632,0.0008788431,0.000018099881,0.00058106513],"genre_scores_gemma":[0.9981255,0.00008186094,0.00087495346,0.000019258963,0.000012887668,0.000015161782,0.00077607814,0.0000015333067,0.00009277882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985612,0.0005953819,0.00015909216,0.00018721377,0.00036102094,0.000136193],"domain_scores_gemma":[0.9903706,0.004428374,0.0036674475,0.0004995408,0.00058550807,0.00044863104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031127674,0.00037068632,0.00033889204,0.0017802843,0.00028810912,0.0008278078,0.00044215965,0.00043552904,0.001628065],"category_scores_gemma":[0.014894563,0.00017220402,0.0006012847,0.0012544648,0.00025451407,0.0005245121,0.0005784836,0.00041026593,0.0003990839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059729984,0.000019652445,0.99814034,0.000009626755,0.00003899439,0.000013522923,0.000021917696,0.00020196433,0.00004677105,0.0000062155364,0.000060541068,0.0013807319],"study_design_scores_gemma":[0.000009725894,0.00017647528,0.995402,0.000019746047,0.00008155128,0.000117340576,0.000108111686,0.0037049907,0.00014061519,0.00007210491,0.00016196366,0.000005458283],"about_ca_topic_score_codex":0.009550045,"about_ca_topic_score_gemma":0.010741484,"teacher_disagreement_score":0.009550045,"about_ca_system_score_codex":0.00043203574,"about_ca_system_score_gemma":0.00050887483,"threshold_uncertainty_score":0.018988907},"labels":[],"label_agreement":null},{"id":"W2596331703","doi":"10.1038/bjc.2017.51","title":"VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Canada Research Chairs; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Cancer research; Vascular endothelial growth factor A; Protein kinase B; Ovarian cancer; Angiogenesis; VEGF receptors; Interleukin 8; PI3K/AKT/mTOR pathway; Medicine; Biology; Cell biology; Signal transduction; Internal medicine; Cancer; Vascular endothelial growth factor; Inflammation","score_opus":0.01356968945570387,"score_gpt":0.29278360644267254,"score_spread":0.2792139169869687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596331703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932991,0.0016179632,0.0015927225,0.00018227917,0.000029697203,0.00002115146,0.00053509854,0.00013312766,0.002588852],"genre_scores_gemma":[0.99323493,0.0008029086,0.0011759547,0.000055785335,0.000005009163,0.000027641961,0.0006521264,0.000024461528,0.0040211896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999218,0.000010403882,0.000005137021,0.000012908621,0.000025046314,0.00002473559],"domain_scores_gemma":[0.9999398,0.000014911714,0.000017433777,0.0000049207065,0.00000548303,0.000017475524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009844773,0.00017845992,0.00016430025,0.0001600744,0.00008997949,0.0001999515,0.00013536736,0.00023630068,0.0015472384],"category_scores_gemma":[0.000081227794,0.00010826017,0.00014133491,0.000105357205,0.00015945698,0.00013381727,0.000108452135,0.0005683025,0.00024350063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012840508,0.000038721042,0.0001405076,0.000038105278,0.000003947554,0.000023657647,0.000011323018,0.00011516196,0.9974826,0.00008721413,0.00013407087,0.0017963684],"study_design_scores_gemma":[0.000029878383,0.00032905285,0.0025326412,0.000005951738,0.0000088611905,0.00020711502,0.000027702145,0.00086455845,0.9916038,0.000043043543,0.004344706,0.000002762304],"about_ca_topic_score_codex":0.00054414425,"about_ca_topic_score_gemma":0.0009772079,"teacher_disagreement_score":0.0015472384,"about_ca_system_score_codex":0.000230764,"about_ca_system_score_gemma":0.00017469485,"threshold_uncertainty_score":0.0051760674},"labels":[],"label_agreement":null},{"id":"W2601140727","doi":"10.1038/bjc.2017.85","title":"Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses’ Health Study","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sleep and related disorders","field":"Psychology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Hazard ratio; Internal medicine; Cancer; Proportional hazards model; Population; Oncology; Confidence interval; Gynecology","score_opus":0.010539461242535079,"score_gpt":0.30766813891818656,"score_spread":0.2971286776756515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601140727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928992,0.0018708963,0.00008076585,0.000194946,0.000044608754,0.000020662661,0.0040822923,0.0000052704386,0.0008012869],"genre_scores_gemma":[0.995994,0.00045459365,0.000042627038,0.00006364562,0.000016993356,0.000025003617,0.002988852,0.000002386161,0.00041195523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955076,0.00010049232,0.00006598792,0.000101499485,0.000084101426,0.00009706565],"domain_scores_gemma":[0.9985903,0.00015095726,0.00059346785,0.00012875871,0.00022085581,0.0003157877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094095775,0.00018343829,0.0004334292,0.00053069135,0.0004312408,0.00046306595,0.00046437792,0.00050501304,0.00094800146],"category_scores_gemma":[0.002317772,0.00033443636,0.0007480989,0.0009475085,0.00014659502,0.00053547934,0.00064294494,0.0007263989,0.00023134383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015109005,0.000029032395,0.998393,0.000015927537,0.00014746567,0.000033936743,0.00006937688,0.000036387217,0.00004583993,0.000010313123,0.0003277165,0.00073980243],"study_design_scores_gemma":[0.000010016338,0.000040916555,0.99948573,0.000009609772,0.00003889646,0.000031834108,0.00009172459,0.000065508044,0.0000062664512,0.000008652116,0.00020799306,0.0000027701915],"about_ca_topic_score_codex":0.030825065,"about_ca_topic_score_gemma":0.04419468,"teacher_disagreement_score":0.030825065,"about_ca_system_score_codex":0.00039565738,"about_ca_system_score_gemma":0.00041198372,"threshold_uncertainty_score":0.061291337},"labels":[],"label_agreement":null},{"id":"W2601749821","doi":"10.1038/bjc.2017.87","title":"Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Foothills Medical Centre; St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Logistic regression; Biopsy; Retrospective cohort study; Cancer; Breast biopsy; Anxiety; Breast cancer screening; Mammography; Gynecology; Obstetrics; Internal medicine","score_opus":0.0626489527466243,"score_gpt":0.4123612677679854,"score_spread":0.3497123150213611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601749821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942774,0.00018581456,0.000036969475,0.000056293822,0.0000033658473,0.000006953676,0.00015806148,0.0000021004303,0.000122768],"genre_scores_gemma":[0.99964476,0.0000565289,0.00005595211,0.000011810157,0.0000037215932,0.000008186495,0.00017524626,7.0326996e-7,0.00004311752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952507,0.00011906929,0.000057537854,0.00008589516,0.000077429926,0.00013493477],"domain_scores_gemma":[0.995269,0.0015366727,0.002157425,0.00008206823,0.00026470405,0.0006901031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011071144,0.00016707361,0.00019201958,0.0006931855,0.00031826735,0.00045570475,0.0003655238,0.00033559464,0.0015971093],"category_scores_gemma":[0.008261961,0.00018067338,0.00050347927,0.00065191905,0.00019227808,0.0004065489,0.000389256,0.0004588228,0.00012294897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012910145,0.000017749006,0.998909,0.00000769675,0.000018572191,0.000020225203,0.00006718532,0.000037406175,0.000022347285,0.000008679675,0.00005592469,0.0007060148],"study_design_scores_gemma":[0.0000114357945,0.0002664434,0.99837446,0.000014485539,0.00003959754,0.00011286638,0.00046396162,0.0005462791,0.000038204875,0.000024721112,0.00010382994,0.0000037858665],"about_ca_topic_score_codex":0.03514594,"about_ca_topic_score_gemma":0.037299234,"teacher_disagreement_score":0.03514594,"about_ca_system_score_codex":0.0011430575,"about_ca_system_score_gemma":0.0012856134,"threshold_uncertainty_score":0.06988275},"labels":[],"label_agreement":null},{"id":"W2602010827","doi":"10.1038/bjc.2017.97","title":"Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Terry Fox Research Institute; Sheffield Hallam University","keywords":"Breast cancer; Medicine; Univariate; Oncology; Neoadjuvant therapy; Internal medicine; Multivariate statistics; Pattern recognition (psychology); Nuclear medicine; Artificial intelligence; Cancer; Mathematics; Computer science; Statistics","score_opus":0.0130348895969007,"score_gpt":0.3626205744561454,"score_spread":0.3495856848592447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602010827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964064,0.0001638565,0.0029313932,0.00002123629,0.00000481868,0.000012005647,0.00007578097,0.000026747643,0.00035760162],"genre_scores_gemma":[0.9985807,0.00005885363,0.0011737514,0.0000049656264,0.0000030868728,0.00000526292,0.00007053228,0.0000023562566,0.000100412406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999908,0.000028696617,0.0000072448415,0.000016204329,0.000027307085,0.000012557517],"domain_scores_gemma":[0.9997385,0.00010470275,0.000067961875,0.000024078809,0.000044646084,0.000020051326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043621255,0.0002120335,0.00022905244,0.0003797341,0.00006432623,0.00023393745,0.00007734492,0.00018190587,0.00040952238],"category_scores_gemma":[0.0010841624,0.00007633367,0.00015636462,0.00017881607,0.00012669874,0.00013438541,0.00013112792,0.00013750888,0.000118303025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027301568,0.00028018578,0.5100841,0.00017579756,0.00017983472,0.00025974406,0.00025724023,0.01193059,0.23027693,0.00009786465,0.0006089169,0.24311875],"study_design_scores_gemma":[0.000020955778,0.0006890438,0.9203975,0.000017319815,0.000101378966,0.0006231228,0.0001907535,0.05365847,0.023592612,0.00018261603,0.00050241424,0.000023752507],"about_ca_topic_score_codex":0.0006632159,"about_ca_topic_score_gemma":0.0015082986,"teacher_disagreement_score":0.0006632159,"about_ca_system_score_codex":0.00008288844,"about_ca_system_score_gemma":0.000085990076,"threshold_uncertainty_score":0.0023069382},"labels":[],"label_agreement":null},{"id":"W2605610797","doi":"10.1038/bjc.2017.105","title":"Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Cancer research; Biology; Metastasis; Gene knockdown; Cancer; microRNA; Oncology; Medicine; Cell culture; Gene","score_opus":0.009011913103816376,"score_gpt":0.29293424955503117,"score_spread":0.2839223364512148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605610797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891242,0.005108834,0.0025450431,0.0002601535,0.000029225681,0.00006584526,0.0006064637,0.00015379416,0.0021064787],"genre_scores_gemma":[0.9947502,0.0015362694,0.0018805766,0.00007597741,0.0000056568956,0.000049074264,0.0006560068,0.000021123493,0.0010250639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989617,0.000017861377,0.0000068378786,0.000017080414,0.00003809624,0.00002394748],"domain_scores_gemma":[0.9999088,0.000024278692,0.000025630452,0.000008913218,0.000012761751,0.000019590698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022126613,0.0002629714,0.00020065221,0.00026011426,0.0001871439,0.00026855784,0.00011450129,0.0002577136,0.0014100657],"category_scores_gemma":[0.00021723662,0.00016602248,0.00022935838,0.00018069887,0.00018382049,0.00010270863,0.00021170138,0.00044311074,0.0005328747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033398432,0.000040753774,0.001308451,0.00009960514,0.000009808966,0.00009076246,0.000020804513,0.00022697271,0.99423707,0.00008587515,0.00025349774,0.0032923396],"study_design_scores_gemma":[0.0000833506,0.00068224827,0.033284925,0.000019138797,0.000058593934,0.0012221112,0.000047779937,0.0031390125,0.95337474,0.000110923145,0.007967798,0.000009344225],"about_ca_topic_score_codex":0.0011050196,"about_ca_topic_score_gemma":0.0014005282,"teacher_disagreement_score":0.0014100657,"about_ca_system_score_codex":0.00042384272,"about_ca_system_score_gemma":0.00030412432,"threshold_uncertainty_score":0.004717171},"labels":[],"label_agreement":null},{"id":"W2606399503","doi":"10.1038/bjc.2017.101","title":"Comment on ‘Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study’","year":2017,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario","funders":"","keywords":"Breast cancer; Cohort; Medicine; Cohort study; Demography; Population; Cohort effect; Gynecology; Oncology; Cancer; Internal medicine; Environmental health","score_opus":0.08496498256913693,"score_gpt":0.38388833214037577,"score_spread":0.29892334957123884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606399503","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072252244,0.000782242,0.00006296401,0.9763915,0.019857192,0.00001598177,0.0005648398,0.000053084157,0.0015496977],"genre_scores_gemma":[0.0025819351,0.00048343834,0.00010426024,0.9741406,0.018237904,0.00005391337,0.00013464577,0.000024696266,0.004238618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99254334,0.0021433095,0.0012522386,0.00095572765,0.0021112338,0.0009942708],"domain_scores_gemma":[0.97680646,0.014156208,0.002187575,0.0007759925,0.00388531,0.0021884786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076334383,0.00082612975,0.0019866338,0.00087186025,0.003067789,0.0026242537,0.0029024691,0.04569596,0.009624217],"category_scores_gemma":[0.04186917,0.0010760567,0.0018574435,0.0014216771,0.0026602927,0.0034129913,0.0022073563,0.03411458,0.011341416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074813004,0.000011936645,0.0006493039,0.00005939886,0.000013091274,0.00031671583,0.00012826239,0.000021446389,0.00006756967,0.00046488547,0.9954727,0.0027197646],"study_design_scores_gemma":[0.0002743379,0.00023342582,0.008568555,0.00095181336,0.00011264367,0.0011086826,0.0011696725,0.0003808067,0.0005165596,0.0053306622,0.98117644,0.00017641073],"about_ca_topic_score_codex":0.023930743,"about_ca_topic_score_gemma":0.02850871,"teacher_disagreement_score":0.04569596,"about_ca_system_score_codex":0.0038208847,"about_ca_system_score_gemma":0.006525534,"threshold_uncertainty_score":0.047582865},"labels":[],"label_agreement":null},{"id":"W2608603246","doi":"10.1038/bjc.2017.99","title":"A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute for Health and Care Research; McGill University","keywords":"Medicine; Colorectal cancer; Odds ratio; Confidence interval; Pathological; Internal medicine; Meta-analysis; Vascular invasion; Cancer; Gastroenterology; Pathology; Oncology; Radiology; Surgery","score_opus":0.14446345131528043,"score_gpt":0.3714095057249086,"score_spread":0.22694605440962817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608603246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050825674,0.9438298,0.0017128768,0.0004667566,0.00048342874,0.0002657908,0.0016962908,0.0000715508,0.0006479689],"genre_scores_gemma":[0.75886434,0.23157603,0.0036346815,0.0011426524,0.0004973856,0.0010165543,0.0022950761,0.00007570021,0.0008975836],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.988415,0.0059233895,0.0025639203,0.0017904531,0.000887466,0.00041976752],"domain_scores_gemma":[0.97450364,0.019390594,0.0033363632,0.0011170601,0.0012804097,0.00037190478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01359682,0.002855836,0.014223622,0.0058109635,0.0008691107,0.0033787459,0.002372843,0.003113759,0.0028572648],"category_scores_gemma":[0.03257627,0.0017680884,0.05893622,0.007016807,0.0006657921,0.0016115698,0.0015797723,0.0023395647,0.00034812005],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004269474,0.000024350345,0.018433282,0.050583888,0.9226627,0.0002128554,0.000054873668,0.0005348128,0.0002637435,0.000071682494,0.00032254463,0.0025658398],"study_design_scores_gemma":[0.00041018624,0.0001576458,0.0066251867,0.002376343,0.989514,0.00008361334,0.000025142917,0.0002217724,0.00007622845,0.000095376294,0.00040218732,0.000012240434],"about_ca_topic_score_codex":0.008625079,"about_ca_topic_score_gemma":0.011232623,"teacher_disagreement_score":0.014223622,"about_ca_system_score_codex":0.001804456,"about_ca_system_score_gemma":0.0016551868,"threshold_uncertainty_score":0.0719077},"labels":[],"label_agreement":null},{"id":"W2611286974","doi":"10.1038/bjc.2017.168","title":"Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University Belfast; Queen's University; Cancer Research UK; Health and Social Care Research and Development Division; Public Health Agency; Friends of the Cancer Centre","keywords":"Microsatellite instability; DNA methylation; Immune checkpoint; Colorectal cancer; Cancer research; Biology; Signet ring cell; Immunohistochemistry; Methylation; CpG site; Immune system; Cancer; Adenocarcinoma; Immunotherapy; Immunology; Genetics; Gene; Microsatellite; Gene expression; Allele","score_opus":0.013194118503054814,"score_gpt":0.2747363519693475,"score_spread":0.2615422334662927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611286974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99061453,0.0033196793,0.002380021,0.0006075058,0.000030042025,0.000058760732,0.00061259756,0.00007710337,0.00229981],"genre_scores_gemma":[0.9961463,0.00077429565,0.0020283323,0.000106576736,0.000028131912,0.000025377813,0.000500135,0.000010262466,0.00038055962],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980885,0.000046579746,0.000015569649,0.00003884186,0.000061620274,0.00002846331],"domain_scores_gemma":[0.99940264,0.0001658121,0.00020772482,0.00005274548,0.00007655599,0.000094449504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006131174,0.00027161025,0.000383385,0.0007075634,0.00018540051,0.00039982362,0.00023215277,0.00029050547,0.0019806977],"category_scores_gemma":[0.0013345897,0.00009612367,0.00019314299,0.00041910118,0.00029568383,0.00027258412,0.0002812991,0.0003795392,0.00039102038],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019098098,0.00013831252,0.64301926,0.00031618983,0.00011819005,0.001970911,0.00009174126,0.00092399935,0.2578164,0.0003826434,0.0011686836,0.092143826],"study_design_scores_gemma":[0.00008380982,0.0021519351,0.88738906,0.00009754168,0.00023816888,0.012142796,0.00026632624,0.003381257,0.083156645,0.0010038402,0.010062542,0.000025952873],"about_ca_topic_score_codex":0.00039632368,"about_ca_topic_score_gemma":0.00087702647,"teacher_disagreement_score":0.0019806977,"about_ca_system_score_codex":0.0003027248,"about_ca_system_score_gemma":0.000285953,"threshold_uncertainty_score":0.0066260695},"labels":[],"label_agreement":null},{"id":"W2616059421","doi":"10.1038/bjc.2017.147","title":"Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University and Génome Québec Innovation Centre; Hospital for Sick Children; University of Toronto; Canada Research Chairs; McGill University","funders":"Hospital for Sick Children; State Government of Victoria; Childhood Cancer Canada; Jewish General Hospital; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Embryonal rhabdomyosarcoma; Sarcoma; Biology; Sanger sequencing; Germline; Rhabdomyosarcoma; Germline mutation; Somatic cell; Chondrosarcoma; Missense mutation; Genetics; Cancer research; Mutation; Pathology; Medicine; Gene","score_opus":0.03209571357458726,"score_gpt":0.34342314619863995,"score_spread":0.3113274326240527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616059421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902,0.00017792443,0.00046821908,0.000013022388,0.0000013758731,0.0000050054414,0.000090571826,0.000007448831,0.00021638238],"genre_scores_gemma":[0.99869543,0.00009720083,0.0008962758,0.000014212492,0.0000023729224,0.0000030643712,0.00014245854,0.0000039582383,0.00014504098],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982893,0.000022567992,0.000028301503,0.00004759431,0.00004287348,0.000029671459],"domain_scores_gemma":[0.9995427,0.00018295583,0.00011396762,0.000028085777,0.000052149273,0.00008012271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032213016,0.0001882641,0.00013383859,0.00063847634,0.00016303554,0.00015488501,0.000118955504,0.00028937435,0.000928722],"category_scores_gemma":[0.00074086984,0.00016835214,0.00012759726,0.00022478234,0.00022711286,0.00010957533,0.00021838881,0.0001679284,0.00028443034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029681335,0.000039317405,0.45117664,0.00012337408,0.0000533628,0.021040512,0.000779537,0.00035773395,0.5069462,0.00012438571,0.00028174752,0.01878039],"study_design_scores_gemma":[0.00002444043,0.00046882834,0.77290994,0.000030473831,0.00007811351,0.11063936,0.00027162686,0.0010950855,0.11225795,0.00013850012,0.002066524,0.000019152729],"about_ca_topic_score_codex":0.0005876096,"about_ca_topic_score_gemma":0.0013304903,"teacher_disagreement_score":0.000928722,"about_ca_system_score_codex":0.00017815354,"about_ca_system_score_gemma":0.00012559665,"threshold_uncertainty_score":0.003106892},"labels":[],"label_agreement":null},{"id":"W2622052156","doi":"10.1038/bjc.2017.149","title":"Subcutaneous adiposity is an independent predictor of mortality in cancer patients","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Adipose tissue; Sarcopenia; Hazard ratio; Internal medicine; Proportional hazards model; Body mass index; Cachexia; Obesity; Obesity paradox; Cancer; Univariate analysis; Gastroenterology; Oncology; Multivariate analysis; Confidence interval; Overweight","score_opus":0.050808342916709034,"score_gpt":0.38600695047281697,"score_spread":0.3351986075561079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622052156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998444,0.0006898069,0.00008572562,0.0000985651,0.000010365961,0.000002819587,0.00016549611,0.0000048470897,0.0004984104],"genre_scores_gemma":[0.99957126,0.00013260779,0.000044549943,0.000014218392,0.000013421771,0.0000022776626,0.00014766757,0.0000010687546,0.000072940726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988997,0.000030598036,0.000012076079,0.000022310216,0.000027790096,0.00001734002],"domain_scores_gemma":[0.99906117,0.00020893551,0.00042392095,0.000048501443,0.00007202186,0.00018551163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002734676,0.00016597135,0.00022703232,0.00034854808,0.00016620306,0.0003484164,0.00011734411,0.00022375915,0.002008037],"category_scores_gemma":[0.0013897768,0.000104577484,0.00020197089,0.0006067465,0.00018394095,0.00014503293,0.00025682224,0.00044104792,0.00023370002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015904378,0.000009269525,0.9978929,0.000010210286,0.000025140944,0.000037679747,0.000008886345,0.00004518733,0.00016780054,0.000007668002,0.00007268858,0.0015635451],"study_design_scores_gemma":[0.0000059626714,0.000059419945,0.99929476,0.000005472683,0.000020458592,0.00025077068,0.000025037507,0.00018564865,0.000044015633,0.000024220019,0.00008304464,0.0000012292223],"about_ca_topic_score_codex":0.00089089456,"about_ca_topic_score_gemma":0.001286765,"teacher_disagreement_score":0.002008037,"about_ca_system_score_codex":0.000108347325,"about_ca_system_score_gemma":0.00016109449,"threshold_uncertainty_score":0.0067176223},"labels":[],"label_agreement":null},{"id":"W2624913702","doi":"10.1038/bjc.2017.161","title":"Prioritising action on occupational carcinogens in Europe: a socioeconomic and health impact assessment","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amec Foster Wheeler (Canada)","funders":"Cranfield University; European Commission; University of Warwick","keywords":"Environmental health; Directive; Health impact assessment; Socioeconomic status; Public health; Psychological intervention; European union; Business; Legislature; Medicine; Public economics; Political science; Population; Economics; Nursing","score_opus":0.056092271419687985,"score_gpt":0.44071620389850047,"score_spread":0.3846239324788125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624913702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8615335,0.042481143,0.020363621,0.019883182,0.00018421738,0.001369739,0.0045338394,0.00011292277,0.04953788],"genre_scores_gemma":[0.9771475,0.00853309,0.010836634,0.0014874878,0.00008718839,0.00028258603,0.0008804984,0.0000093088065,0.00073589094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97948235,0.01305078,0.0010572548,0.00047178587,0.0048746555,0.0010631453],"domain_scores_gemma":[0.98841757,0.0048398706,0.002551285,0.00037293555,0.0031371408,0.000681135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02502754,0.00090248144,0.00065392803,0.005736357,0.0007338214,0.0023847292,0.0008508616,0.0019741077,0.0028151255],"category_scores_gemma":[0.01364904,0.00021426637,0.0019455946,0.0045013535,0.0008872836,0.0013515532,0.0033528334,0.0005350625,0.00018202074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018799934,0.0013958273,0.45177266,0.004633187,0.0028914465,0.0013082544,0.00072822545,0.1380237,0.0025735751,0.01675739,0.006894434,0.3711413],"study_design_scores_gemma":[0.0005811695,0.0069945157,0.8391655,0.00437362,0.0030526787,0.001846812,0.005744658,0.03935394,0.0063270535,0.030687755,0.06164758,0.00022467812],"about_ca_topic_score_codex":0.01247124,"about_ca_topic_score_gemma":0.0106974365,"teacher_disagreement_score":0.02502754,"about_ca_system_score_codex":0.0060765976,"about_ca_system_score_gemma":0.006452267,"threshold_uncertainty_score":0.13235986},"labels":[],"label_agreement":null},{"id":"W2635752945","doi":"10.1038/bjc.2017.231","title":"Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium","year":2017,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; Francis Crick Institute; Ovarian Cancer Research Fund; National Cancer Institute; National Institutes of Health; Cancer Research UK; McGill University; European Commission; Breast Cancer Research Foundation","keywords":"Prostate cancer; Cancer; Prostate; Oncology; Medicine; Genetic marker; Bioinformatics; Internal medicine; Biology; Gynecology; Computational biology; Genetics; Gene","score_opus":0.01509033717269554,"score_gpt":0.29120461761633015,"score_spread":0.2761142804436346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2635752945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88048995,0.02925177,0.005848511,0.004135937,0.0014071562,0.00023427523,0.06135976,0.0002055681,0.017067073],"genre_scores_gemma":[0.9283242,0.0068704174,0.0034899313,0.0009995865,0.00044635427,0.00022142885,0.04805255,0.00018109797,0.0114144115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642473,0.0017172012,0.00038599115,0.00042001397,0.0009386471,0.000113340146],"domain_scores_gemma":[0.98437136,0.010052936,0.0016068316,0.001732804,0.0018257445,0.00041023953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006714776,0.00060458924,0.0005370478,0.0011284014,0.00034517454,0.0007767969,0.0007144715,0.0006445552,0.0070038256],"category_scores_gemma":[0.026226941,0.00022626475,0.0007659047,0.0033315734,0.00048995216,0.00030283074,0.0010687008,0.00045079962,0.00085319125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025313369,0.000057565117,0.9085314,0.000835893,0.0011369693,0.0008270508,0.0006959586,0.0008415592,0.0004333604,0.00047402285,0.033235997,0.050398856],"study_design_scores_gemma":[0.0002210463,0.0002251197,0.9689041,0.00029218936,0.00058263994,0.0016280011,0.0004925723,0.00024075332,0.00016479472,0.00022023599,0.026985923,0.00004254674],"about_ca_topic_score_codex":0.018587468,"about_ca_topic_score_gemma":0.017955923,"teacher_disagreement_score":0.018587468,"about_ca_system_score_codex":0.00038099667,"about_ca_system_score_gemma":0.00047216285,"threshold_uncertainty_score":0.036958575},"labels":[],"label_agreement":null},{"id":"W2667610","doi":"10.1038/bjc.1989.11","title":"Housing for People with Substance Use and Concurrent Disorders: Summary of Literature and Annotated Bibliography","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Cancer Institute","keywords":"Substance use; Annotated bibliography; Bibliography; Gerontology; Psychology; Computer science; Psychiatry; Library science; Medicine","score_opus":0.026124680648067077,"score_gpt":0.36816799572856,"score_spread":0.34204331508049296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2667610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019110099,0.9892294,0.0002693572,0.0006000611,0.0010125524,0.0000591,0.002762431,0.000038537506,0.004117602],"genre_scores_gemma":[0.0041959956,0.99191624,0.00059811695,0.00018602257,0.00024956797,0.00006899917,0.0018383485,0.00000958245,0.0009371165],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993624,0.00012676048,0.0002671559,0.000064024716,0.00014710282,0.00003258053],"domain_scores_gemma":[0.99757403,0.0014073808,0.00052630744,0.000035492267,0.00037881383,0.00007799133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074582105,0.0010157141,0.0016744112,0.017890582,0.00043365837,0.0009621049,0.00096462015,0.00074179994,0.013578503],"category_scores_gemma":[0.0025461002,0.00037290278,0.00063182914,0.025045812,0.00046211085,0.0013286194,0.00063358503,0.00042666338,0.0023869493],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020422616,0.000103835,0.0030215345,0.104584195,0.00021834155,0.00040387144,0.00061967387,0.00028171358,0.00032648604,0.00065355987,0.087307274,0.80227536],"study_design_scores_gemma":[0.00006369197,0.00041497406,0.07039511,0.157237,0.0011573547,0.0042333705,0.0023742563,0.00024717758,0.00044026112,0.0012588932,0.76207155,0.00010631149],"about_ca_topic_score_codex":0.007078094,"about_ca_topic_score_gemma":0.013589269,"teacher_disagreement_score":0.017890582,"about_ca_system_score_codex":0.00066513283,"about_ca_system_score_gemma":0.0015296384,"threshold_uncertainty_score":0.04542464},"labels":[],"label_agreement":null},{"id":"W2691308717","doi":"10.1038/bjc.2017.176","title":"Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?","year":2017,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Oncology; Chemotherapy; Adjuvant chemotherapy; Adjuvant; Cancer; Intensity (physics); Internal medicine; Physics","score_opus":0.01725695604834053,"score_gpt":0.309248619271904,"score_spread":0.29199166322356346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2691308717","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020481909,0.04419125,0.00018322773,0.9057976,0.019523753,0.000052868563,0.00028006625,0.000013599697,0.009475635],"genre_scores_gemma":[0.18649842,0.04311746,0.0011086883,0.661188,0.10082102,0.00021484152,0.0003038087,0.00006190924,0.006685825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99593997,0.0025148075,0.00056214764,0.00025742748,0.00047635497,0.00024937408],"domain_scores_gemma":[0.97625184,0.019439392,0.0012611215,0.0005034497,0.0011249369,0.0014193762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009726422,0.00025738383,0.0018291048,0.00038913748,0.0007072102,0.0015674641,0.0009832465,0.0076843416,0.008723858],"category_scores_gemma":[0.030159418,0.00026322325,0.0010042484,0.0011257377,0.0015230195,0.0015111435,0.0005283789,0.006914151,0.0016060813],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051825274,0.0007577911,0.027316917,0.0026902216,0.0010746507,0.0027491583,0.0004020503,0.00061759865,0.0033766807,0.012204751,0.46995082,0.42703408],"study_design_scores_gemma":[0.015847966,0.0073761637,0.053610973,0.003811801,0.0024622106,0.0033880721,0.0016749778,0.0010737175,0.0026218707,0.049721956,0.85822403,0.00018620912],"about_ca_topic_score_codex":0.001917636,"about_ca_topic_score_gemma":0.0076898383,"teacher_disagreement_score":0.009726422,"about_ca_system_score_codex":0.002994174,"about_ca_system_score_gemma":0.0020072218,"threshold_uncertainty_score":0.051438868},"labels":[],"label_agreement":null},{"id":"W2730119757","doi":"10.1038/bjc.2017.198","title":"Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"European Society for Medical Oncology","keywords":"Radiation therapy; Medicine; Chemotherapy; Multicenter study; Oncology; Pathology; Radiology; Internal medicine; Randomized controlled trial","score_opus":0.018004106672552853,"score_gpt":0.3234679987112252,"score_spread":0.30546389203867236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730119757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982133,0.0011379601,0.00010461951,0.000047968155,0.000010323025,0.000026497428,0.00015313592,0.0000031211523,0.00030313627],"genre_scores_gemma":[0.99927086,0.00021912986,0.00010167023,0.00003059251,0.000021995824,0.000023957762,0.00021749716,0.000004346317,0.0001100043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804,0.0010590468,0.00017208175,0.00039735017,0.00018264908,0.00014899879],"domain_scores_gemma":[0.9917583,0.0016488855,0.004616143,0.0008505278,0.00043834894,0.00068769214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002607305,0.00027993674,0.00045169564,0.00036015752,0.00033162846,0.0007533872,0.0004831234,0.0005866681,0.0022762918],"category_scores_gemma":[0.007921249,0.00028165517,0.0010110578,0.000869659,0.00027189526,0.00043832272,0.00058540405,0.0005394845,0.00032010963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044888286,0.00034094293,0.9900136,0.000042206222,0.0005642505,0.00006700267,0.0001130012,0.00009666205,0.0004986665,0.000020358195,0.00015038151,0.0036042328],"study_design_scores_gemma":[0.00019244233,0.0022069283,0.99600226,0.000021765196,0.00033616996,0.00030473855,0.00007993872,0.00013422908,0.00011852297,0.000019045341,0.00057642255,0.0000076329825],"about_ca_topic_score_codex":0.001436971,"about_ca_topic_score_gemma":0.0012448509,"teacher_disagreement_score":0.002607305,"about_ca_system_score_codex":0.00039202327,"about_ca_system_score_gemma":0.0004915056,"threshold_uncertainty_score":0.013788879},"labels":[],"label_agreement":null},{"id":"W2735904407","doi":"10.1038/bjc.2017.220","title":"HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immune system; Tumor microenvironment; Immune checkpoint; CD8; Cancer; Immunology; Immunotherapy; Cancer research; Cancer cell; Medicine; Biology; Internal medicine","score_opus":0.07567563179933269,"score_gpt":0.39825864361742486,"score_spread":0.3225830118180922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735904407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043982902,0.99898785,0.000062378494,0.00036801558,0.00021748203,0.000002631826,0.000010374893,0.0000029502728,0.000304389],"genre_scores_gemma":[0.00051371835,0.99857485,0.000113110065,0.00027386984,0.00023029055,0.0000044139542,0.000021256177,0.0000011443191,0.0002673818],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996233,0.000096300544,0.00006205499,0.000050044946,0.000141522,0.000026725864],"domain_scores_gemma":[0.9991621,0.0004957178,0.00007871885,0.00001952051,0.00020053024,0.000043353022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013324167,0.0006437488,0.0016735954,0.0020928292,0.0002353433,0.0010722879,0.00094431895,0.001316117,0.0024239062],"category_scores_gemma":[0.0018029312,0.00025772318,0.0006272078,0.0016648876,0.00070316147,0.001435567,0.0006972931,0.0023850664,0.0016497965],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009210122,0.00002947937,0.00031108863,0.014254152,0.00016865887,0.00010114047,0.00006350303,0.00023437211,0.00064803613,0.003416841,0.029156374,0.9515243],"study_design_scores_gemma":[0.000024691555,0.00011803028,0.0013921877,0.009106911,0.00022122702,0.001162056,0.00010115441,0.00010086022,0.0003346416,0.0037825075,0.9836234,0.00003229853],"about_ca_topic_score_codex":0.0009991651,"about_ca_topic_score_gemma":0.001603373,"teacher_disagreement_score":0.0024239062,"about_ca_system_score_codex":0.000677994,"about_ca_system_score_gemma":0.0010361222,"threshold_uncertainty_score":0.008108795},"labels":[],"label_agreement":null},{"id":"W2738694813","doi":"10.1038/bjc.2017.218","title":"Long-term outcomes of patients with 10 or more colorectal liver metastases","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Sanofi","keywords":"Medicine; Contraindication; Colorectal cancer; Multivariate analysis; Hepatectomy; Cohort; Internal medicine; Population; Surgery; Resection; Survival analysis; Gastroenterology; Cancer; Pathology","score_opus":0.05295032444628585,"score_gpt":0.30370739460487517,"score_spread":0.25075707015858933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738694813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916065,0.00036635238,0.000026286076,0.000051151495,0.0000073824226,0.0000030776393,0.00016544407,0.0000015479151,0.0002180944],"genre_scores_gemma":[0.9993303,0.00009886648,0.000023624427,0.00002197258,0.000018393055,0.0000040480427,0.00041610372,6.047068e-7,0.00008624028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998301,0.000026704105,0.00001896894,0.000033955006,0.000029637022,0.000060550054],"domain_scores_gemma":[0.99848866,0.00015856608,0.0007469142,0.000039090482,0.00008841512,0.00047825716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037815093,0.00018726243,0.00028439699,0.00035950606,0.00033448517,0.00045723005,0.00021370979,0.00032737825,0.0015493075],"category_scores_gemma":[0.0014512133,0.00008842813,0.0003088612,0.0003921311,0.0002530731,0.0004217851,0.00048685202,0.0004167419,0.00022778146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019738954,0.000023459452,0.99790156,0.000009364671,0.000024020517,0.0002166846,0.000025203073,0.000055298242,0.00015959714,0.000008090045,0.00007746548,0.0013018247],"study_design_scores_gemma":[0.0000137280795,0.0003857287,0.9975432,0.000010568533,0.000031334646,0.0014764258,0.00011436341,0.000116777286,0.00006293447,0.00003648549,0.0002026248,0.000005807615],"about_ca_topic_score_codex":0.0009349973,"about_ca_topic_score_gemma":0.0020719317,"teacher_disagreement_score":0.0015493075,"about_ca_system_score_codex":0.00029303823,"about_ca_system_score_gemma":0.00028379026,"threshold_uncertainty_score":0.005182922},"labels":[],"label_agreement":null},{"id":"W2739680515","doi":"10.1038/bjc.2017.242","title":"Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Public Health Ontario; University of Toronto; Memorial University of Newfoundland","funders":"Newfoundland and Labrador Centre for Applied Health Research; Canadian Institutes of Health Research; Memorial University of Newfoundland; Faculty of Medicine, Memorial University of Newfoundland; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Calcitriol receptor; Colorectal cancer; Haplotype; Vitamin D and neurology; Internal medicine; Medicine; CYP24A1; Population; Single-nucleotide polymorphism; Oncology; Endocrinology; Calcium-sensing receptor; Gastroenterology; Cohort; Cancer; Calcium; Biology; Genetics; Allele; Genotype; Calcium metabolism; Gene","score_opus":0.03776331224151212,"score_gpt":0.35007601582115133,"score_spread":0.3123127035796392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739680515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964311,0.0009846109,0.00012554176,0.0003624978,0.000016439424,0.000008921652,0.0011778862,0.000010981797,0.0008821118],"genre_scores_gemma":[0.9976858,0.0003267525,0.00010800585,0.00012539956,0.000010862662,0.000008205857,0.00090524694,0.0000033322153,0.00082642765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995316,0.00007490944,0.000033655666,0.00015767034,0.000063854684,0.00013836734],"domain_scores_gemma":[0.9989477,0.00014180747,0.00034417785,0.0001309093,0.00021321043,0.00022233368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069703563,0.00026407087,0.0004360194,0.00058354845,0.00093723106,0.00065451785,0.00051975995,0.00031167633,0.0015557233],"category_scores_gemma":[0.0012434811,0.00030421163,0.00044667078,0.00088356395,0.0005451951,0.00031693903,0.00044769509,0.0005326404,0.00018663194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022316315,0.00003104381,0.9946753,0.00001345774,0.0001622607,0.00014662233,0.00014795449,0.00012486531,0.00053403876,0.000036222693,0.0009945845,0.00291047],"study_design_scores_gemma":[0.000008868902,0.00001913886,0.9992316,0.0000057488132,0.000046294386,0.0000673022,0.00009153499,0.00011117293,0.000024240948,0.000007710037,0.00038263178,0.000003761186],"about_ca_topic_score_codex":0.85199517,"about_ca_topic_score_gemma":0.8743854,"teacher_disagreement_score":0.14800483,"about_ca_system_score_codex":0.0043172822,"about_ca_system_score_gemma":0.002326518,"threshold_uncertainty_score":0.29775286},"labels":[],"label_agreement":null},{"id":"W2744987279","doi":"10.1038/bjc.2017.236","title":"Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; TrygFonden; Vrije Universiteit Amsterdam; Medical Research Council; Aarhus Universitet; Novo Nordisk; Sundhed og Sygdom, Det Frie Forskningsråd; Alberta Cancer Foundation","keywords":"Colorectal cancer; Medicine; Stage (stratigraphy); Primary care; Cancer; Oncology; Internal medicine; Family medicine; Biology","score_opus":0.02531502552746173,"score_gpt":0.335631026037238,"score_spread":0.31031600050977626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744987279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774575,0.016426034,0.0010243157,0.000086881155,0.000047413563,0.00013249171,0.0043372484,0.000027074215,0.0004611032],"genre_scores_gemma":[0.9954111,0.0013880228,0.00042453894,0.00005483923,0.000026641967,0.00009406312,0.002534348,0.0000072647917,0.000059242775],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98605376,0.0067413845,0.002430872,0.002693801,0.001465937,0.0006141894],"domain_scores_gemma":[0.97379476,0.011004761,0.008409205,0.0037361574,0.0022466844,0.0008084247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012574286,0.0010189426,0.003890592,0.004381698,0.00053396757,0.0024927373,0.0011127589,0.0012049605,0.000971697],"category_scores_gemma":[0.020669816,0.0010915487,0.0077316957,0.0060635484,0.0006163374,0.00075954286,0.001772276,0.00059684966,0.0001294837],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013309261,0.000017854996,0.97211254,0.0005718985,0.023334874,0.00015158723,0.00014116957,0.00022784341,0.00013874243,0.000020779305,0.00017021513,0.0017815246],"study_design_scores_gemma":[0.0001697281,0.00032858938,0.9782995,0.00015910076,0.019655904,0.00027216453,0.0002504384,0.00029405588,0.00008295429,0.000035472796,0.00043093762,0.000021253021],"about_ca_topic_score_codex":0.015645396,"about_ca_topic_score_gemma":0.017051302,"teacher_disagreement_score":0.015645396,"about_ca_system_score_codex":0.0009710075,"about_ca_system_score_gemma":0.0010569859,"threshold_uncertainty_score":0.06649995},"labels":[],"label_agreement":null},{"id":"W2745775095","doi":"10.1038/bjc.2017.275","title":"Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV−ve Oropharynx cancer? A population-based study","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Queen's University","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Queen's University; Cancer Care Ontario","keywords":"Medicine; Radiation therapy; Internal medicine; Oncology; Chemoradiotherapy; Chemotherapy; Retrospective cohort study; Cancer; Population; Cohort; Gynecology","score_opus":0.017326038657880277,"score_gpt":0.33262057142297885,"score_spread":0.31529453276509856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745775095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792165,0.0013328803,0.000048619782,0.00007161532,0.000012974644,0.00004271907,0.00017234382,0.0000021435364,0.00039519012],"genre_scores_gemma":[0.99935573,0.00022719092,0.000044794135,0.00009335089,0.000033106004,0.000022430488,0.00015910278,0.0000012725601,0.00006287169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819046,0.0007738014,0.00018081062,0.00035625987,0.00030738948,0.00019136094],"domain_scores_gemma":[0.9960366,0.0016465421,0.0014533413,0.00025937668,0.00025015837,0.00035405325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002378075,0.00025341767,0.0008498949,0.00041894644,0.0003799528,0.00066211255,0.0004689117,0.0008890006,0.0015640551],"category_scores_gemma":[0.0064418856,0.00029488964,0.0013471871,0.0009028306,0.00060792523,0.00048415817,0.00027706908,0.0007410111,0.00018045455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019623231,0.0007188417,0.9663314,0.00018368251,0.0016779298,0.00008296869,0.00016239974,0.00012761046,0.00043345892,0.000026676107,0.00019181792,0.010439902],"study_design_scores_gemma":[0.0015158135,0.011121555,0.98455447,0.00003651,0.001413099,0.00023178734,0.00012539527,0.00017112603,0.0001377739,0.000039631796,0.0006388645,0.000014034574],"about_ca_topic_score_codex":0.009111987,"about_ca_topic_score_gemma":0.012619725,"teacher_disagreement_score":0.009111987,"about_ca_system_score_codex":0.0012226233,"about_ca_system_score_gemma":0.0009787215,"threshold_uncertainty_score":0.018117905},"labels":[],"label_agreement":null},{"id":"W2746022200","doi":"10.1038/bjc.2017.282","title":"Circulating resistin levels and risk of multiple myeloma in three prospective cohorts","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"U.S. Public Health Service; Terry Fox Foundation; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; American Cancer Society","keywords":"Resistin; Medicine; Prospective cohort study; Quartile; Odds ratio; Internal medicine; Confidence interval; Cohort; Cohort study; Endocrinology; Adipose tissue; Case-control study; Adiponectin; Obesity; Insulin resistance","score_opus":0.020704376483955317,"score_gpt":0.2945784047868466,"score_spread":0.2738740283028913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746022200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992176,0.00018513134,0.00011276678,0.000033209508,0.0000055956666,0.000013127196,0.0002391689,0.000005284146,0.00018791838],"genre_scores_gemma":[0.9990096,0.00012293781,0.00017427419,0.000025055082,0.000007465253,0.000022170068,0.0004689379,0.0000046758123,0.00016480748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989417,0.00032428053,0.00009338282,0.00030196246,0.0001764477,0.00016225265],"domain_scores_gemma":[0.99825627,0.0002616575,0.00050614076,0.00034339525,0.00018095883,0.00045153976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001527136,0.0006371254,0.0006700602,0.0012663292,0.0010776412,0.0011574124,0.00070316787,0.0008542695,0.0012017483],"category_scores_gemma":[0.0029546956,0.0008785512,0.0009540601,0.0013563132,0.00055045076,0.00043057557,0.001324348,0.001242821,0.00026857245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015798305,0.00007800557,0.9955681,0.000007824485,0.00018461584,0.00019981101,0.00026640645,0.000057129557,0.00084487075,0.000034317523,0.00009961557,0.0010794612],"study_design_scores_gemma":[0.000099089884,0.00029587265,0.99817383,0.000006120616,0.00012901286,0.0005257129,0.00019399582,0.0001678769,0.00014099451,0.000058864785,0.00019402025,0.000014516395],"about_ca_topic_score_codex":0.008218768,"about_ca_topic_score_gemma":0.0058974754,"teacher_disagreement_score":0.008218768,"about_ca_system_score_codex":0.00046107438,"about_ca_system_score_gemma":0.00048240813,"threshold_uncertainty_score":0.016341865},"labels":[],"label_agreement":null},{"id":"W2750806791","doi":"10.1038/bjc.2017.304","title":"Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health","keywords":"Aldehyde dehydrogenase; ALDH2; Tissue microarray; Biology; Colorectal cancer; CD44; Cancer research; Biomarker; Pathology; Cancer; Isozyme; Microarray; Cell; Gene expression; Enzyme; Gene; Medicine; Genetics; Biochemistry","score_opus":0.032290023957398634,"score_gpt":0.34795283776726865,"score_spread":0.31566281380987005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750806791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90131295,0.054847535,0.025753262,0.00202027,0.00040379053,0.00019479034,0.0015252314,0.0005064759,0.013435676],"genre_scores_gemma":[0.9735162,0.0056126234,0.014050284,0.00019660857,0.00014251591,0.00008178757,0.0008925408,0.000024846886,0.005482568],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998461,0.000028204988,0.000012282449,0.000037747122,0.000048497346,0.000027154623],"domain_scores_gemma":[0.99983275,0.000026638905,0.000042902884,0.000008742723,0.00004783881,0.0000411872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037370122,0.00032271544,0.00020686265,0.0017872645,0.00019086139,0.00033212264,0.00021236896,0.00043659925,0.002368409],"category_scores_gemma":[0.00025894115,0.00014704469,0.00013114279,0.00065556477,0.00026317057,0.00030596118,0.00019815586,0.00035733238,0.0006849581],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058223977,0.000064698244,0.05247028,0.0005967932,0.00006185767,0.0011859717,0.00007985335,0.00017625121,0.9010631,0.000505485,0.0016538908,0.041559633],"study_design_scores_gemma":[0.000102790575,0.0011320563,0.5433799,0.00016980903,0.00041764032,0.027103724,0.0003310992,0.00491471,0.34739417,0.0009610209,0.07402461,0.000068530644],"about_ca_topic_score_codex":0.000844743,"about_ca_topic_score_gemma":0.001334959,"teacher_disagreement_score":0.002368409,"about_ca_system_score_codex":0.00039065655,"about_ca_system_score_gemma":0.00016763611,"threshold_uncertainty_score":0.007923126},"labels":[],"label_agreement":null},{"id":"W2753773656","doi":"10.1038/bjc.2017.303","title":"Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Prostate cancer; Weight loss; Interquartile range; Overweight; Internal medicine; Prostate; Leptin; Obesity; Cancer; Prostatectomy; Endocrinology; Urology; Androgen suppression; Testosterone (patch); Gastroenterology","score_opus":0.011519466659057538,"score_gpt":0.2870053818559688,"score_spread":0.27548591519691124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753773656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969887,0.0023321337,0.00008914084,0.00008660302,0.000053672717,0.00018183584,0.000045270983,0.000009649215,0.00021301078],"genre_scores_gemma":[0.99804026,0.0009480648,0.00019099524,0.00018689728,0.00009275816,0.00016438476,0.00008537975,0.000001816002,0.00028950968],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996567,0.00015862126,0.00003297951,0.000043724765,0.000055773296,0.000052214295],"domain_scores_gemma":[0.9994746,0.0001445568,0.0001505187,0.000037803802,0.000028282704,0.00016439399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001089591,0.0005152048,0.0011312638,0.00024548554,0.00028029914,0.0004318204,0.0002756744,0.00058898365,0.0015952961],"category_scores_gemma":[0.000982195,0.00036284077,0.0008624143,0.00025791247,0.0006327071,0.00026535374,0.00032123865,0.0010669531,0.00013970427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8204813,0.022510909,0.024384448,0.0012064732,0.0017760546,0.000083005536,0.00017377936,0.0006589885,0.0250149,0.00008512214,0.00044063036,0.10318438],"study_design_scores_gemma":[0.12576252,0.7187864,0.14826699,0.00007754172,0.0013541009,0.00011699844,0.00012296508,0.00076800794,0.0036009473,0.00017701654,0.0009290907,0.000037452694],"about_ca_topic_score_codex":0.0008974223,"about_ca_topic_score_gemma":0.0014748253,"teacher_disagreement_score":0.0015952961,"about_ca_system_score_codex":0.0002466036,"about_ca_system_score_gemma":0.0005609315,"threshold_uncertainty_score":0.0057623386},"labels":[],"label_agreement":null},{"id":"W2754705845","doi":"10.1038/bjc.2017.326","title":"Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; HEC Montréal","funders":"Plan National Cancer","keywords":"Psychological intervention; Anxiety; Psychosocial; Distress; Breast cancer; Medicine; Quality of life (healthcare); Physical therapy; Randomized controlled trial; Clinical psychology; Depression (economics); Cancer; Psychiatry; Internal medicine; Nursing","score_opus":0.02615321036503586,"score_gpt":0.3409716552106199,"score_spread":0.314818444845584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754705845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748676,0.0055875224,0.00069228694,0.00063835003,0.0005264444,0.016005963,0.00058183353,0.00008324451,0.0010167316],"genre_scores_gemma":[0.9606853,0.00353326,0.0033884994,0.00093096326,0.00049549766,0.029005844,0.0006115989,0.000016046944,0.0013330397],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.997361,0.0015611826,0.0002783017,0.00028702398,0.00023074266,0.00028169103],"domain_scores_gemma":[0.99761343,0.00085657864,0.0005130223,0.0001994436,0.00019351617,0.000624052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031162954,0.001554946,0.0040173787,0.0010043115,0.0010995541,0.0010053369,0.0011722149,0.0031587712,0.006222831],"category_scores_gemma":[0.0046844785,0.0006946463,0.0032640237,0.0009062751,0.00091829465,0.0009103015,0.0011832719,0.0022491962,0.0006370331],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92639625,0.037069947,0.0008735189,0.0024326544,0.0022065965,0.00007652165,0.00018809941,0.00031815952,0.0010740348,0.000054461052,0.00033980265,0.028969958],"study_design_scores_gemma":[0.92450553,0.07131788,0.002792414,0.00011529358,0.0006758996,0.0000183557,0.000039990424,0.0001359989,0.00010985905,0.000051472714,0.00022678862,0.000010481899],"about_ca_topic_score_codex":0.0033013504,"about_ca_topic_score_gemma":0.0042719324,"teacher_disagreement_score":0.006222831,"about_ca_system_score_codex":0.0013201494,"about_ca_system_score_gemma":0.0019172337,"threshold_uncertainty_score":0.020817459},"labels":[],"label_agreement":null},{"id":"W2756366108","doi":"10.1038/bjc.2017.285","title":"Occupational solvent exposure and risk of glioma in the INTEROCC study","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université de Montréal; University of Ottawa","funders":"Cancer Council NSW; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Cancer Council Victoria; Agence Française de Sécurité Sanitaire de l'Environnement et du Travail","keywords":"Solvent exposure; Glioma; Medicine; Occupational exposure; Occupational safety and health; Occupational medicine; Environmental health; Toxicology; Oncology; Pathology; Biology; Cancer research","score_opus":0.013539792632718813,"score_gpt":0.3153726950987497,"score_spread":0.3018329024660309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756366108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980149,0.00059441925,0.00016312096,0.000037076803,0.0000047435447,0.0000142490435,0.0005193826,0.00000347318,0.0006484623],"genre_scores_gemma":[0.99912006,0.00019035132,0.00013025563,0.000017210567,0.0000035831724,0.000010677359,0.0003889028,0.0000021342257,0.00013690878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892956,0.00047397695,0.00011101475,0.00018423656,0.00018277248,0.000118425276],"domain_scores_gemma":[0.9983645,0.00026653023,0.00062816136,0.00028557895,0.0002695535,0.00018565226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018334491,0.00028978818,0.0002973574,0.0012320435,0.00040527558,0.0006114105,0.00034073132,0.00031641035,0.0009808765],"category_scores_gemma":[0.0026644038,0.00024569067,0.0004496584,0.0015518042,0.00026416202,0.00020728596,0.00086045946,0.00032422808,0.0001687203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007436082,0.000027556503,0.9954817,0.000045067565,0.0002479064,0.0001662726,0.00030168088,0.00005359803,0.0005427624,0.000049110073,0.00015744235,0.0021832548],"study_design_scores_gemma":[0.000015832653,0.00012517048,0.99847275,0.000011995498,0.00011362673,0.00025723517,0.00016030709,0.0000711754,0.00017593734,0.00003227035,0.00055940537,0.0000042687648],"about_ca_topic_score_codex":0.01603588,"about_ca_topic_score_gemma":0.01499474,"teacher_disagreement_score":0.01603588,"about_ca_system_score_codex":0.0004239664,"about_ca_system_score_gemma":0.00040681075,"threshold_uncertainty_score":0.031885087},"labels":[],"label_agreement":null},{"id":"W2757923756","doi":"10.1038/bjc.2017.339","title":"Dose–response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Adipose tissue; Medicine; Colorectal cancer; Aerobic exercise; Internal medicine; Cancer; Gastroenterology; Endocrinology","score_opus":0.009010026074516455,"score_gpt":0.2946859092756634,"score_spread":0.28567588320114695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757923756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97519207,0.013304307,0.00055410847,0.0010066401,0.0014441846,0.0056308354,0.00083850254,0.00013511104,0.0018941666],"genre_scores_gemma":[0.97714204,0.0066240677,0.0015012706,0.0011788283,0.0007608614,0.0092377765,0.00073826767,0.000021779248,0.0027951126],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983853,0.00096379436,0.00016250767,0.00020070616,0.00011207154,0.00017559843],"domain_scores_gemma":[0.99820864,0.00076846057,0.00038658004,0.00015439573,0.00010204312,0.00037977725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020147534,0.0014561302,0.0040066284,0.0007044624,0.0005582886,0.001162256,0.0011460251,0.0032024512,0.007946733],"category_scores_gemma":[0.0042123483,0.000753271,0.003084494,0.00076840795,0.0012300975,0.0008334705,0.0006138836,0.002872196,0.00084039435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9872069,0.0029135796,0.00032207018,0.0013290141,0.0013736314,0.000029362614,0.00003208425,0.00015853248,0.00050293625,0.000050155602,0.0002876229,0.0057941205],"study_design_scores_gemma":[0.96932966,0.027346594,0.0016533025,0.00010172601,0.00086121954,0.000016332027,0.000015633237,0.00018282518,0.00010108291,0.00008894804,0.00029030495,0.000012324264],"about_ca_topic_score_codex":0.0026750155,"about_ca_topic_score_gemma":0.0036555664,"teacher_disagreement_score":0.007946733,"about_ca_system_score_codex":0.00090022787,"about_ca_system_score_gemma":0.0010801496,"threshold_uncertainty_score":0.026584446},"labels":[],"label_agreement":null},{"id":"W2758687153","doi":"10.1038/bjc.2017.322","title":"Response to Morrell et al's reply","year":2017,"lang":"fr","type":"letter","venue":"British Journal of Cancer","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Gynecology","score_opus":0.06875678559840283,"score_gpt":0.4262246829575901,"score_spread":0.35746789735918727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758687153","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001958039,0.00082368584,0.00003480953,0.9759281,0.022183068,0.000011176574,0.00005803539,0.000037700585,0.0007275646],"genre_scores_gemma":[0.0017618493,0.00050714775,0.0000761426,0.9693496,0.025893582,0.000035780966,0.00002669662,0.00002267788,0.0023266117],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616575,0.0011945809,0.0004587239,0.0005386879,0.0011016384,0.00054063636],"domain_scores_gemma":[0.9866883,0.0063784467,0.0011946802,0.00048615984,0.003028091,0.0022243005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051730704,0.00098335,0.002029758,0.001132466,0.0034868259,0.004149125,0.0031111431,0.053319596,0.009462668],"category_scores_gemma":[0.04343813,0.0010344781,0.0014712556,0.0009333258,0.0037671404,0.0049519036,0.0021491384,0.056369573,0.009363632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003423234,0.000013756422,0.00028957526,0.000038861155,0.000009556134,0.00050496485,0.000091275884,0.000016813286,0.00004266573,0.00041873718,0.9966605,0.0018790693],"study_design_scores_gemma":[0.00014849668,0.00010599076,0.0015468634,0.00054013677,0.00004472921,0.0029450194,0.0010186207,0.00028420487,0.0002690523,0.0047364654,0.9882321,0.00012825898],"about_ca_topic_score_codex":0.0053149015,"about_ca_topic_score_gemma":0.0056076082,"teacher_disagreement_score":0.053319596,"about_ca_system_score_codex":0.004241976,"about_ca_system_score_gemma":0.004489171,"threshold_uncertainty_score":0.03165573},"labels":[],"label_agreement":null},{"id":"W2761998606","doi":"10.1038/bjc.2017.334","title":"International consensus guidelines for scoring the histopathological growth patterns of liver metastasis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Metastasis; Consensus conference; Pathology; Medicine; MEDLINE; Cancer; Internal medicine; Biology","score_opus":0.227342489823958,"score_gpt":0.37098292450673714,"score_spread":0.14364043468277915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761998606","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034824986,0.18519747,0.5324825,0.095120125,0.023504244,0.019096086,0.015682688,0.0045007304,0.089591175],"genre_scores_gemma":[0.056442257,0.04501199,0.8477294,0.005236408,0.0018344765,0.011276807,0.019973945,0.0005209839,0.011973703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95805854,0.019558975,0.010933969,0.0010695489,0.009255209,0.0011237921],"domain_scores_gemma":[0.90275246,0.019271161,0.006985696,0.0048381486,0.06372478,0.0024277607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.053623304,0.0021045392,0.002520646,0.011793159,0.0017984863,0.002996938,0.01027616,0.0051308386,0.0031838953],"category_scores_gemma":[0.05869756,0.0012615715,0.0051868903,0.007348306,0.0022727696,0.0016473416,0.0036676358,0.005987571,0.0033061316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053650327,0.00051676686,0.01854217,0.013465658,0.000942851,0.0015693613,0.0021319755,0.0043791085,0.006681356,0.00974705,0.36266914,0.578818],"study_design_scores_gemma":[0.00051066244,0.00068663654,0.050215174,0.029858325,0.0020630995,0.0060300687,0.0029876665,0.008689251,0.0070908205,0.021417426,0.86998034,0.00047041714],"about_ca_topic_score_codex":0.013075627,"about_ca_topic_score_gemma":0.014451961,"teacher_disagreement_score":0.053623304,"about_ca_system_score_codex":0.004475727,"about_ca_system_score_gemma":0.015267263,"threshold_uncertainty_score":0.2835905},"labels":[],"label_agreement":null},{"id":"W2766816570","doi":"10.1038/bjc.2017.357","title":"Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre; University of Waterloo; Princess Margaret Cancer Centre","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Internal medicine; Oncology; Proportional hazards model; Progression-free survival; Meta-analysis; Survival analysis; Cochrane Library; Surgery; Overall survival; Radiation therapy","score_opus":0.15958450411061575,"score_gpt":0.443895993522228,"score_spread":0.2843114894116123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766816570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011837932,0.9977475,0.00013403154,0.00012722047,0.000049626688,0.00029727578,0.00025537726,0.000007215756,0.00019802837],"genre_scores_gemma":[0.017291022,0.9807006,0.0006445056,0.00037935295,0.00006126044,0.0005979907,0.00022277965,0.000004577218,0.000097907905],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9947531,0.001993596,0.0018620329,0.000383965,0.00084376783,0.00016355017],"domain_scores_gemma":[0.9803516,0.014188096,0.0037252232,0.0002323429,0.001296362,0.0002062677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071609947,0.0014856396,0.008888276,0.008377934,0.0005384001,0.0020231197,0.0019134608,0.0016183632,0.004079676],"category_scores_gemma":[0.023477204,0.0008674229,0.008004542,0.009203612,0.00074787333,0.0019279032,0.0011772655,0.0009222443,0.0003081817],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019999401,0.000011925111,0.00055052066,0.9685221,0.010444223,0.000083716965,0.00009948834,0.00010262266,0.00009276765,0.00010575329,0.0007380338,0.01904887],"study_design_scores_gemma":[0.0003758625,0.00031373953,0.0039112954,0.8650331,0.11679235,0.00043406023,0.0002331901,0.00015212555,0.00013556611,0.00022465788,0.012362673,0.000031494175],"about_ca_topic_score_codex":0.0068061003,"about_ca_topic_score_gemma":0.021605317,"teacher_disagreement_score":0.008888276,"about_ca_system_score_codex":0.0030026038,"about_ca_system_score_gemma":0.0076681925,"threshold_uncertainty_score":0.03787142},"labels":[],"label_agreement":null},{"id":"W2767056572","doi":"10.1038/bjc.2017.360","title":"A systematic review and meta-analysis of the association between childhood infections and the risk of childhood acute lymphoblastic leukaemia","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children; Public Health Ontario","funders":"Canadian Institutes of Health Research","keywords":"Odds ratio; Medicine; Etiology; Meta-analysis; Odds; Childhood cancer; El Niño; Immunology; Pediatrics; Subgroup analysis; Internal medicine; Cancer; Logistic regression","score_opus":0.030811597510676227,"score_gpt":0.34930967165505034,"score_spread":0.3184980741443741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767056572","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010152018,0.99799013,0.00014864816,0.00013405737,0.00009532645,0.00014785219,0.0002755423,0.000008401221,0.0001848415],"genre_scores_gemma":[0.023912692,0.974069,0.0007114,0.00031615258,0.000100845595,0.00040067898,0.00034302022,0.000008414228,0.00013777295],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927093,0.0032826078,0.002172018,0.0006130792,0.00093629066,0.00028672713],"domain_scores_gemma":[0.98159134,0.014096439,0.002332376,0.00038182482,0.001390097,0.00020786666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008880147,0.0022993071,0.014228404,0.007228389,0.0007388259,0.0029125893,0.0019312643,0.0019363528,0.0042705573],"category_scores_gemma":[0.033380415,0.0012429807,0.016782658,0.009147658,0.000613393,0.0016339654,0.0014389786,0.0016544226,0.00034516025],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007020708,0.000017239954,0.0019483777,0.82854134,0.14154077,0.0001716147,0.000103667946,0.00035873678,0.00019690176,0.00022076063,0.0015487951,0.024649825],"study_design_scores_gemma":[0.00040250452,0.00026111063,0.005883846,0.21346113,0.7677892,0.0003782814,0.00010781954,0.0001720943,0.000211376,0.0004701399,0.010825383,0.000037232876],"about_ca_topic_score_codex":0.008795502,"about_ca_topic_score_gemma":0.021253763,"teacher_disagreement_score":0.014228404,"about_ca_system_score_codex":0.0031031054,"about_ca_system_score_gemma":0.00663462,"threshold_uncertainty_score":0.046963274},"labels":[],"label_agreement":null},{"id":"W2770226065","doi":"10.1038/bjc.2017.409","title":"Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Kansainvälisen Liikkuvuuden ja Yhteistyön Keskus; Karolinska Institutet","keywords":"Treponema denticola; Periodontitis; Carcinogenesis; Biology; Immunology; Pathology; Cancer research; Medicine; Porphyromonas gingivalis; Cancer; Internal medicine","score_opus":0.03138607066066604,"score_gpt":0.35624164077480464,"score_spread":0.32485557011413857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770226065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193157,0.014618106,0.0012059202,0.00030336756,0.000034417924,0.000049613544,0.00012598981,0.00005492661,0.0016761203],"genre_scores_gemma":[0.9937616,0.0040786746,0.0006727965,0.00006839089,0.000029608183,0.000022725426,0.00008281693,0.000003738735,0.0012797032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999211,0.000010534526,0.0000055556907,0.000014626927,0.000014600934,0.00003361655],"domain_scores_gemma":[0.99987495,0.000021584496,0.000051030776,0.000008780745,0.00001858437,0.000025044998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022437293,0.00038022202,0.0002125596,0.00030560055,0.00013605152,0.00034806613,0.00018752008,0.00036856963,0.0019412033],"category_scores_gemma":[0.00023954773,0.00008384687,0.00030371724,0.00013889269,0.00031459387,0.00022803851,0.0002055038,0.00040906062,0.00017088794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019761706,0.00021019953,0.042086564,0.0009031469,0.00008997382,0.0038186416,0.00017802624,0.00015919833,0.9280009,0.00042802724,0.00031018496,0.021839056],"study_design_scores_gemma":[0.00020608303,0.004344259,0.52025175,0.00025612712,0.000364253,0.017424198,0.00064833334,0.0023835944,0.4339955,0.0015478606,0.018541297,0.000036728095],"about_ca_topic_score_codex":0.0005392488,"about_ca_topic_score_gemma":0.0004207657,"teacher_disagreement_score":0.0019412033,"about_ca_system_score_codex":0.00027227504,"about_ca_system_score_gemma":0.00020785556,"threshold_uncertainty_score":0.0064939857},"labels":[],"label_agreement":null},{"id":"W2771164127","doi":"10.1038/bjc.2017.440","title":"Anthropometric measurements and survival after a prostate cancer diagnosis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; Alberta Health Services","funders":"National Cancer Institute; Alberta Cancer Foundation; Canadian Institutes of Health Research; Alberta Innovates; Fondation pour la Recherche Médicale; Canada Research Chairs","keywords":"Medicine; Prostate cancer; Anthropometry; Body mass index; Waist; Proportional hazards model; Cohort; Cancer; Prospective cohort study; Cohort study; Waist–hip ratio; Population; Relative survival; Oncology; Survival analysis; Internal medicine; Cancer registry","score_opus":0.04220580016837778,"score_gpt":0.3469454300764634,"score_spread":0.3047396299080856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771164127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962047,0.0020602846,0.00015436905,0.00016271906,0.00002047334,0.000004804994,0.0006289724,0.000008678743,0.00075512804],"genre_scores_gemma":[0.99893266,0.00037298645,0.00007502607,0.000021801437,0.0000219098,0.000003085806,0.00040643822,0.0000021401106,0.00016395892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999624,0.00012460073,0.000038177146,0.000071645736,0.00008741028,0.00005413171],"domain_scores_gemma":[0.99638784,0.0008388333,0.0019670988,0.00019446727,0.0002364538,0.00037529084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007789877,0.00019611158,0.00022396407,0.00053566566,0.00018686058,0.00034480143,0.00020770876,0.0002369929,0.0026909183],"category_scores_gemma":[0.0038435368,0.00011908648,0.00021889311,0.00072771293,0.00026181788,0.0002505625,0.0002816211,0.0006830947,0.00029023556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018829161,0.00002529613,0.9961117,0.000025162402,0.000061555984,0.00003095341,0.000035273464,0.00007264385,0.0001297483,0.000013929992,0.00008698005,0.0032185598],"study_design_scores_gemma":[0.0000028455022,0.00006318349,0.99952674,0.0000077998175,0.000018320425,0.000108303124,0.000020041498,0.000040510968,0.000035640845,0.000020136771,0.0001546117,0.0000018597282],"about_ca_topic_score_codex":0.0018306534,"about_ca_topic_score_gemma":0.002108376,"teacher_disagreement_score":0.0026909183,"about_ca_system_score_codex":0.00020785694,"about_ca_system_score_gemma":0.00020612334,"threshold_uncertainty_score":0.00900197},"labels":[],"label_agreement":null},{"id":"W2782277425","doi":"10.1038/bjc.2017.429","title":"Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; McGill University Health Centre","funders":"National Cancer Institute; European Regional Development Fund; Instituto de Salud Carlos III; Cancer Council Tasmania; Sidney Kimmel Center for Prostate and Urologic Cancers; Vetenskapsrådet; Javna Agencija za Raziskovalno Dejavnost RS; Royal Marsden NHS Foundation Trust; Prostate Cancer Foundation of Australia; Generalitat de Catalunya; National Institute for Health and Care Research; NorthShore University HealthSystem; Victorian Cancer Agency; Cancer Australia; Cancerfonden; Centro de Investigación Biomédica en Red de Cáncer; Prostate Cancer Foundation; Myriad Genetics; Cancer Research UK","keywords":"Prostate cancer; Prostate-specific antigen; Medicine; Genetic predisposition; Prostate; Prospective cohort study; Oncology; Antigen; Internal medicine; Cancer; Immunology; Disease","score_opus":0.013363397330363003,"score_gpt":0.28495939197612896,"score_spread":0.27159599464576595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782277425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984003,0.0006653224,0.000051666855,0.00007021206,0.000014216722,0.000016015005,0.00028873936,0.0000036858653,0.00048983324],"genre_scores_gemma":[0.9995016,0.00011037947,0.000034314115,0.000027472426,0.000009760225,0.0000076170472,0.00017994147,0.0000016753143,0.00012720832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990915,0.00038238429,0.00006681724,0.00017854877,0.0001602404,0.00012061965],"domain_scores_gemma":[0.9983463,0.00037557742,0.0004664747,0.00014001703,0.00013213191,0.00053944375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014436906,0.0003737126,0.00060357334,0.0008835496,0.0008577687,0.001049799,0.00048218857,0.0007720749,0.0020857519],"category_scores_gemma":[0.003389028,0.0006073641,0.0006223304,0.0015687615,0.0004310694,0.0005359997,0.0006500981,0.0011132954,0.00035453975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022353753,0.000057037112,0.998928,0.000008220518,0.00007148198,0.000094690025,0.0000720517,0.000025674315,0.000072118375,0.000017601882,0.000050407372,0.00037915225],"study_design_scores_gemma":[0.000020285113,0.0002401065,0.9990915,0.000004432263,0.000051555704,0.00027560288,0.00008879512,0.00007871794,0.00001701945,0.000022732404,0.00010552859,0.0000036379126],"about_ca_topic_score_codex":0.010355912,"about_ca_topic_score_gemma":0.008416682,"teacher_disagreement_score":0.010355912,"about_ca_system_score_codex":0.00037929794,"about_ca_system_score_gemma":0.00072873937,"threshold_uncertainty_score":0.020591259},"labels":[],"label_agreement":null},{"id":"W2783352225","doi":"10.1038/s41416-018-0004-2","title":"Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Social Fund; European Commission; Novartis Pharma; Deutsche Krebshilfe; Eli Lilly and Company; Alfried Krupp von Bohlen und Halbach-Stiftung; Pancreatic Cancer UK; Deutsche Forschungsgemeinschaft; Cancer Research UK; Region Östergötland; Astellas Pharma; Pfizer; NuCana; Mylan; Bundesministerium für Bildung und Forschung; Taiho Pharmaceutical; European Regional Development Fund; Sanofi; Baxalta; Amgen; Celgene; AstraZeneca; National Institute for Health and Care Research; Falk Foundation","keywords":"Gemcitabine; Dihydropyrimidine dehydrogenase; Medicine; Hazard ratio; Internal medicine; Folinic acid; Oncology; Fluorouracil; Chemotherapy; Pancreatic cancer; Gastroenterology; Confidence interval; Cancer; Thymidylate synthase","score_opus":0.028852628722255896,"score_gpt":0.3535944034438522,"score_spread":0.32474177472159627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783352225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982982,0.0012507797,0.0000955075,0.000039386705,0.000004609682,0.000004497062,0.00012868902,0.0000028037155,0.0001755317],"genre_scores_gemma":[0.99940705,0.00020976584,0.000072117735,0.000011707902,0.000006195225,0.000003892904,0.0002105276,9.705557e-7,0.00007782401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998196,0.00007103512,0.000016030293,0.000043147444,0.000025905865,0.000024430952],"domain_scores_gemma":[0.9993166,0.00023147154,0.00026407844,0.000041616368,0.000047933278,0.000098337034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007503601,0.00024133563,0.0003101672,0.00022729179,0.00012267962,0.00039417954,0.00016551021,0.0002867917,0.0010961504],"category_scores_gemma":[0.0011534672,0.00013421905,0.00027705455,0.0003737288,0.00021602913,0.00021497894,0.00029111985,0.00035960274,0.00014769967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010246511,0.000049883383,0.9735894,0.00008960233,0.0002076109,0.00006558748,0.000041195985,0.00046993955,0.004136458,0.000018839037,0.00019744676,0.010887505],"study_design_scores_gemma":[0.00027113795,0.001281234,0.993919,0.000018191771,0.00027950903,0.00053216825,0.00006879187,0.0010819746,0.0017420702,0.000112919144,0.0006860146,0.0000069143725],"about_ca_topic_score_codex":0.00050416146,"about_ca_topic_score_gemma":0.0006704927,"teacher_disagreement_score":0.0010961504,"about_ca_system_score_codex":0.00029004776,"about_ca_system_score_gemma":0.00014325182,"threshold_uncertainty_score":0.003968358},"labels":[],"label_agreement":null},{"id":"W2784065054","doi":"10.1054/bjoc.1999.1130","title":"Expression of αvβ6integrin in oral leukoplakia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Leukoplakia; Medicine; Oral leukoplakia; Pathology; Dermatology; Internal medicine; Cancer","score_opus":0.020866760188428188,"score_gpt":0.34733717667244585,"score_spread":0.32647041648401764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784065054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988668,0.0007622184,0.00005514124,0.0000059762765,0.0000010714791,0.000003014067,0.000022644408,0.0000035374921,0.0002796826],"genre_scores_gemma":[0.9988349,0.00047385885,0.00015591603,0.000005143367,0.00000246233,0.0000047045673,0.000078147124,0.0000013369212,0.00044346933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999007,0.000010455164,0.000010525214,0.000019859724,0.00003296234,0.000025410909],"domain_scores_gemma":[0.99990296,0.000010069856,0.00004534944,0.000006308019,0.000018033066,0.000017381306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015424495,0.00011743309,0.00016956283,0.0008312929,0.00027710185,0.0003314344,0.00008729323,0.00024070803,0.0006585854],"category_scores_gemma":[0.00020420215,0.00013767222,0.00014375235,0.00038156554,0.00017284164,0.00020831803,0.00018331343,0.00013173763,0.00017939862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007964162,0.000085629865,0.1724642,0.00014566493,0.00003431919,0.0037198758,0.0005876746,0.00011171042,0.8011859,0.00010565591,0.00009314574,0.020669766],"study_design_scores_gemma":[0.000023093426,0.00064608385,0.93872255,0.000014909286,0.000054697673,0.011166102,0.00045338593,0.0003238192,0.04601799,0.000104703475,0.0024630134,0.000009608116],"about_ca_topic_score_codex":0.0006462674,"about_ca_topic_score_gemma":0.0006473205,"teacher_disagreement_score":0.0008312929,"about_ca_system_score_codex":0.00022698016,"about_ca_system_score_gemma":0.00008418215,"threshold_uncertainty_score":0.0022031665},"labels":[],"label_agreement":null},{"id":"W2786737956","doi":"10.1038/bjc.2017.447","title":"Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical Research Council; Canadian Institutes of Health Research; Prostate Cancer UK; Cancer Research UK; Wellcome Trust","keywords":"Cancer research; Biology; Prostate cancer; Ex vivo; Prostate; Cancer; Gene silencing; Tissue microarray; Tumor suppressor gene; Cell growth; H3K4me3; Carcinogenesis; Gene expression; In vivo; Gene; Promoter; Genetics","score_opus":0.006896787882410925,"score_gpt":0.27716999775314566,"score_spread":0.2702732098707347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786737956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483696,0.0032924677,0.03322748,0.0003925961,0.00015288976,0.00021442042,0.004188289,0.0008017905,0.009360621],"genre_scores_gemma":[0.9703352,0.0013201628,0.014463859,0.00013657789,0.000014929951,0.00012874579,0.0032096268,0.000107673965,0.0102833845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999775,0.00003980153,0.000012656375,0.00005205018,0.00007608599,0.000044483233],"domain_scores_gemma":[0.9998803,0.000023153993,0.000017569533,0.000035326644,0.000012987979,0.00003068611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033575113,0.00037678904,0.00026056427,0.00037661326,0.00026062736,0.0003638937,0.00033108066,0.00036140913,0.0027818892],"category_scores_gemma":[0.00007344783,0.00021028171,0.0004201148,0.00032293826,0.00023651346,0.00017280177,0.00027924898,0.0010003058,0.00086783216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001529858,0.00010522003,0.00028798013,0.00004273863,0.000009646913,0.000106855914,0.000023550912,0.00011337909,0.99761814,0.00027293616,0.00020058408,0.0010660465],"study_design_scores_gemma":[0.000015012807,0.00039553727,0.002939871,0.000004171817,0.000026348349,0.00053281727,0.000026554242,0.0012014887,0.9885464,0.0000774647,0.006227914,0.0000064572973],"about_ca_topic_score_codex":0.0018660163,"about_ca_topic_score_gemma":0.003401814,"teacher_disagreement_score":0.0027818892,"about_ca_system_score_codex":0.0003136996,"about_ca_system_score_gemma":0.00033034352,"threshold_uncertainty_score":0.009306371},"labels":[],"label_agreement":null},{"id":"W2786964939","doi":"10.1038/bjc.2017.462","title":"Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital; Royal University Hospital; Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Izaak Walton Killam Health Centre; C17 Council; Pediatric Oncology Group; BC Children's Hospital","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Medicine; Pediatrics; Clinical trial; Population; Event (particle physics); Acute lymphocytic leukemia; Oncology; Internal medicine; Lymphoblastic Leukemia; Leukemia","score_opus":0.030352725937987303,"score_gpt":0.3743429652699999,"score_spread":0.34399023933201256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786964939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980414,0.00095953554,0.0001777025,0.00020781731,0.000015690337,0.00003073493,0.00025230474,0.000006958549,0.00030792507],"genre_scores_gemma":[0.999121,0.00030533233,0.0001593308,0.00008479113,0.000031979533,0.000022437156,0.00021652007,0.000004033386,0.00005452752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932793,0.0047254986,0.00033612037,0.00068721804,0.0005468279,0.0004249985],"domain_scores_gemma":[0.97172314,0.014199739,0.010053746,0.0018279912,0.000769424,0.0014260203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009890865,0.00031587956,0.0005694162,0.0006779756,0.00036321764,0.0014113077,0.00064056023,0.00087292586,0.0016087566],"category_scores_gemma":[0.03261625,0.00034356504,0.0016273747,0.0015103868,0.0006007259,0.0011653745,0.00071001373,0.0014603365,0.00018524729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002095166,0.00018525604,0.9928496,0.00004274156,0.00069506804,0.00005661943,0.00009016577,0.000118680604,0.000074984804,0.000041567902,0.00017273937,0.003577544],"study_design_scores_gemma":[0.0004937213,0.0024901507,0.99376005,0.000038057286,0.001104511,0.00032818716,0.000202058,0.00063781545,0.000103460094,0.00013196528,0.0006939431,0.000016092108],"about_ca_topic_score_codex":0.002010036,"about_ca_topic_score_gemma":0.0022304007,"teacher_disagreement_score":0.009890865,"about_ca_system_score_codex":0.0006184873,"about_ca_system_score_gemma":0.00093614275,"threshold_uncertainty_score":0.05230856},"labels":[],"label_agreement":null},{"id":"W2787764040","doi":"10.1038/bjc.2017.474","title":"Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Prostate Cancer Canada","keywords":"Docetaxel; Prostate cancer; Metastasis; Medicine; Cancer research; Oncology; Cancer; Lung cancer; Internal medicine","score_opus":0.009538169039921787,"score_gpt":0.2506398880355324,"score_spread":0.24110171899561061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787764040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690396,0.00065000955,0.00078216125,0.000050363702,0.000017089462,0.000035958456,0.00060531794,0.000057622347,0.0008974265],"genre_scores_gemma":[0.99540305,0.0005800596,0.0012868535,0.000023885339,0.0000054443353,0.000034666235,0.0009687933,0.000014566351,0.0016826725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990714,0.000014705958,0.000008550769,0.000015455309,0.00003163412,0.000022486654],"domain_scores_gemma":[0.99993587,0.0000155166,0.00001540422,0.000007281964,0.0000053525273,0.000020547648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013520932,0.0003314603,0.0002866616,0.0002494807,0.00013802225,0.00017660987,0.00015531124,0.00017142878,0.0014362665],"category_scores_gemma":[0.000048978935,0.000107902735,0.00025442237,0.00023011013,0.00013557429,0.00010299246,0.000095012336,0.00053789944,0.0002866955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038768095,0.00026118022,0.00036574277,0.00003622805,0.0000111107565,0.000045649336,0.000016009242,0.0002438583,0.9970734,0.00005513555,0.00011126232,0.0013927739],"study_design_scores_gemma":[0.000049944123,0.002569885,0.005577534,0.000004119907,0.000024050316,0.00027073798,0.000017018225,0.001116783,0.98883355,0.000021682916,0.0015091208,0.00000556823],"about_ca_topic_score_codex":0.001193376,"about_ca_topic_score_gemma":0.002185328,"teacher_disagreement_score":0.0014362665,"about_ca_system_score_codex":0.0003489627,"about_ca_system_score_gemma":0.0002617023,"threshold_uncertainty_score":0.00480479},"labels":[],"label_agreement":null},{"id":"W2791211520","doi":"10.1038/s41416-018-0005-1","title":"Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research; Region Östergötland; Cancer Research UK; Pancreatic Cancer UK","keywords":"Gemcitabine; Pancreatic cancer; Folinic acid; Internal medicine; Tissue microarray; Chemotherapy; Adenocarcinoma; Oncology; Biology; Medicine; Cancer research; Fluorouracil; Cancer","score_opus":0.018699508564711458,"score_gpt":0.32727253047265037,"score_spread":0.3085730219079389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791211520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99960846,0.00016683245,0.000028042232,0.000011648988,0.0000021436424,0.0000014109553,0.000045291486,9.233269e-7,0.00013533665],"genre_scores_gemma":[0.9997577,0.000044183555,0.000016836946,0.0000054831035,0.0000024473827,0.0000015092346,0.00011845587,5.5578107e-7,0.000052771866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998872,0.000022776929,0.000013581697,0.000027220614,0.000020867008,0.00002831217],"domain_scores_gemma":[0.9992004,0.00028668888,0.00026618113,0.000054736407,0.000051437506,0.00014049142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023780868,0.00011704695,0.00024636483,0.00021731679,0.00016692886,0.00029936992,0.00012351407,0.00030515454,0.0011236956],"category_scores_gemma":[0.0013488464,0.00012572318,0.00019768935,0.0002834736,0.00020432408,0.0002335784,0.0001591037,0.00032450454,0.00014683005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025374985,0.00003079343,0.9917841,0.000012783471,0.000039131148,0.00014067472,0.000045647015,0.00006372253,0.0033558866,0.000006455603,0.000032238884,0.0019509996],"study_design_scores_gemma":[0.000028297984,0.0003985232,0.9982498,0.0000027094611,0.000039274742,0.0004886274,0.000068569774,0.00013026832,0.00044092876,0.000018213072,0.00013320756,0.00000166048],"about_ca_topic_score_codex":0.0007063571,"about_ca_topic_score_gemma":0.00090304186,"teacher_disagreement_score":0.0011236956,"about_ca_system_score_codex":0.00019751507,"about_ca_system_score_gemma":0.0001533011,"threshold_uncertainty_score":0.0037591457},"labels":[],"label_agreement":null},{"id":"W2792109841","doi":"10.1038/bjc.2017.427","title":"EQUATOR-Oncology: reducing the latitude of cancer trial design and reporting","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Equator; Latitude; Medicine; Clinical Oncology; Oncology; Cancer; MEDLINE; Internal medicine; Geography; Biology; Geodesy","score_opus":0.0426827504740321,"score_gpt":0.33835435494495586,"score_spread":0.2956716044709238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792109841","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093914237,0.0036269722,0.016367543,0.9459133,0.022421857,0.00070695515,0.00012875476,0.00032327883,0.009572254],"genre_scores_gemma":[0.015698107,0.0032600213,0.040028818,0.8841137,0.046300024,0.0034293148,0.00020282851,0.00041967805,0.0065475567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.49805093,0.33087057,0.08419888,0.012598581,0.068408854,0.00587219],"domain_scores_gemma":[0.15462932,0.6207732,0.07302528,0.047476348,0.08655606,0.017539801],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.35551867,0.0014751055,0.0033312568,0.0040431283,0.0048518404,0.018461328,0.006484278,0.03715375,0.008878376],"category_scores_gemma":[0.70276916,0.0022807482,0.0032318977,0.0056080334,0.016177192,0.014287721,0.010774363,0.037790168,0.009012793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075633964,0.00006101858,0.003203984,0.0016557901,0.0001485532,0.0015241195,0.001995072,0.00057313946,0.000666888,0.04392756,0.8571437,0.08834392],"study_design_scores_gemma":[0.0005194599,0.00017983753,0.0022141174,0.002441401,0.00009463956,0.0015883426,0.0006575264,0.0023146465,0.0007772713,0.050937172,0.93811435,0.00016112156],"about_ca_topic_score_codex":0.0038049517,"about_ca_topic_score_gemma":0.0048012873,"teacher_disagreement_score":0.6444813,"about_ca_system_score_codex":0.014842054,"about_ca_system_score_gemma":0.021696988,"threshold_uncertainty_score":0.7947602},"labels":[],"label_agreement":null},{"id":"W2792814802","doi":"10.1038/s41416-018-0012-2","title":"Comment on ‘Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study’","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill University Health Centre","funders":"","keywords":"Monoclonal antibody; Colorectal cancer; Medicine; Cancer research; Oncology; Clinical significance; Antibody; Biomarker; Monoclonal; Cancer; Internal medicine; Immunology; Biology","score_opus":0.07379705001419633,"score_gpt":0.4074493872111625,"score_spread":0.33365233719696613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792814802","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070414785,0.0009808558,0.00006035482,0.9724946,0.023635317,0.000016827626,0.0003467468,0.00003648141,0.0017246015],"genre_scores_gemma":[0.0026519299,0.00057944056,0.0001190627,0.9583086,0.034751195,0.000048689264,0.00009433792,0.000017914377,0.0034288948],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947731,0.0014791974,0.00085280417,0.0007968173,0.0012496057,0.0008484965],"domain_scores_gemma":[0.98276526,0.011033841,0.0016918385,0.0004921226,0.0021272665,0.0018896066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054862504,0.00095199357,0.0022942089,0.00094214006,0.0028043706,0.003060449,0.0020807022,0.05328984,0.0055929474],"category_scores_gemma":[0.035887443,0.0011171938,0.0016190792,0.0012089285,0.0026086979,0.0026640797,0.001406083,0.035279267,0.0059019583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020729452,0.000036839938,0.0013658807,0.000077336896,0.00003399633,0.000828058,0.00010378114,0.00005417899,0.00014279954,0.0009851472,0.9911116,0.005053087],"study_design_scores_gemma":[0.0006456582,0.0003182237,0.0072154882,0.0006515605,0.00020446378,0.0014997178,0.0004982831,0.0006072528,0.0005949324,0.006450926,0.9811095,0.00020406599],"about_ca_topic_score_codex":0.010160154,"about_ca_topic_score_gemma":0.016246041,"teacher_disagreement_score":0.05328984,"about_ca_system_score_codex":0.0041890014,"about_ca_system_score_gemma":0.0052296105,"threshold_uncertainty_score":0.030393481},"labels":[],"label_agreement":null},{"id":"W2794196479","doi":"10.1038/s41416-018-0011-3","title":"Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study","year":2018,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; Public Health Ontario; University of British Columbia; University of Toronto","funders":"Medical Research and Materiel Command; National Cancer Institute; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Rutgers Cancer Institute of New Jersey; Radboud Universiteit; Helse Vest; Cancer Research UK; University College London; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; U.S. Public Health Service; U.S. Department of Defense; Lon V. Smith Foundation; Fred C. and Katherine B. Andersen Foundation; Helsingin ja Uudenmaan Sairaanhoitopiiri; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; Mayo Foundation for Medical Education and Research; European Commission; University of Cambridge; Breast Cancer Research Foundation; Oregon Health and Science University; Kræftens Bekæmpelse; Ovarian Cancer Research Fund; National Center for Research Resources; Oak Foundation; Norges Forskningsråd; Kreftforeningen; Minnesota Ovarian Cancer Alliance","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Mendelian inheritance; Internal medicine; Gynecology; Biology; Genetics; Gene","score_opus":0.024505662964782574,"score_gpt":0.328953653169278,"score_spread":0.3044479902044954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794196479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021148562,0.9660295,0.0083388,0.000952106,0.0005184381,0.001316256,0.0007347314,0.00006153312,0.0009000078],"genre_scores_gemma":[0.4577259,0.5233958,0.0100793205,0.0018260578,0.0004948006,0.0032776857,0.0019607367,0.00006511951,0.0011745984],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.98666114,0.0091364775,0.0019370451,0.0011036514,0.000947297,0.00021433049],"domain_scores_gemma":[0.9865193,0.009973068,0.002024498,0.0008309293,0.00056325295,0.00008902246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014947674,0.0011170475,0.0046996367,0.0010592095,0.00024948787,0.0008442847,0.0014048142,0.0012577813,0.002956154],"category_scores_gemma":[0.037962344,0.0006008893,0.006766773,0.0023466786,0.0005138409,0.00058159366,0.0004570054,0.00095673866,0.00022650605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020929959,0.00023309108,0.0548821,0.23083882,0.42600927,0.0012097895,0.00029139762,0.002911529,0.0011215464,0.003778543,0.008962382,0.24883148],"study_design_scores_gemma":[0.013154527,0.0026017055,0.0813376,0.04125926,0.82074916,0.0023293863,0.00016606282,0.0036897166,0.0009922937,0.009718225,0.023827547,0.00017450815],"about_ca_topic_score_codex":0.0034695414,"about_ca_topic_score_gemma":0.0033205163,"teacher_disagreement_score":0.014947674,"about_ca_system_score_codex":0.0011630612,"about_ca_system_score_gemma":0.0015597637,"threshold_uncertainty_score":0.07905179},"labels":[],"label_agreement":null},{"id":"W2794310103","doi":"10.1038/s41416-018-0045-6","title":"New opportunities for kinase drug repurposing and target discovery","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Ministry of Economic Development and Innovation; Deutschen Konsortium für Translationale Krebsforschung; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Novartis Pharma; Wellcome Trust; Genome Canada; Ontario Genomics; Pfizer","keywords":"Kinome; Drug repositioning; Repurposing; Drug discovery; Drug; Kinase; Drug action; Computational biology; Mode of action; Drug development; Pharmacology; Biology; Bioinformatics; Toxicology; Cell biology","score_opus":0.022640698747415262,"score_gpt":0.28291910222041144,"score_spread":0.2602784034729962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794310103","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011696194,0.039153177,0.002923944,0.93260473,0.018682873,0.000036799476,0.00007439514,0.00015880591,0.0051956787],"genre_scores_gemma":[0.018887766,0.05697035,0.006131961,0.69962686,0.20800245,0.00018460679,0.00029249766,0.00010731697,0.009796155],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9945592,0.0014464429,0.0005768702,0.00059482944,0.0023330317,0.0004895809],"domain_scores_gemma":[0.9856572,0.008806972,0.00076762354,0.0011758463,0.0016183547,0.0019740136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073652985,0.00077730377,0.0017590458,0.0009397844,0.0013070736,0.0034570817,0.0018748303,0.016827842,0.010039711],"category_scores_gemma":[0.018239914,0.0006659571,0.0017477052,0.00071474013,0.004176479,0.008884723,0.0031654148,0.029752053,0.008626923],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043552095,0.00026116945,0.0012504683,0.0005883838,0.000100203935,0.008578776,0.00023521745,0.0005324504,0.0025786865,0.036507793,0.7452152,0.20371614],"study_design_scores_gemma":[0.00019246357,0.00019418963,0.0006273706,0.00025822496,0.0000281159,0.006640655,0.00016281774,0.00076167216,0.0005360694,0.059464242,0.9310953,0.000038898754],"about_ca_topic_score_codex":0.00026602932,"about_ca_topic_score_gemma":0.00072948006,"teacher_disagreement_score":0.016827842,"about_ca_system_score_codex":0.0028821304,"about_ca_system_score_gemma":0.0014250618,"threshold_uncertainty_score":0.038951874},"labels":[],"label_agreement":null},{"id":"W2794881391","doi":"10.1038/s41416-018-0027-8","title":"Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Pharma; Sociedad Española de Oncología Médica; Fundación Josep Carreras Contra la Leucemia; Canada Excellence Research Chairs, Government of Canada; European Society of Cardiology","keywords":"Medicine; Internal medicine; Cancer; Venous thromboembolism; Thrombosis; Framingham Risk Score; Risk assessment; Population; Intensive care medicine; Disease","score_opus":0.0208750334443442,"score_gpt":0.32653334533695577,"score_spread":0.30565831189261156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794881391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779048,0.00088036765,0.015548953,0.0012591877,0.00015033461,0.00012417596,0.0026234405,0.0002876876,0.0012210746],"genre_scores_gemma":[0.99571157,0.00010752272,0.0023986292,0.00004660436,0.000049904862,0.000060594404,0.001124196,0.000011210303,0.00048985984],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986363,0.0007762799,0.00008182086,0.00022303514,0.00014515167,0.00013748846],"domain_scores_gemma":[0.99598074,0.0028303794,0.00037634184,0.00017267492,0.0003846538,0.00025508797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002893945,0.00072184653,0.00077013683,0.0016692184,0.0003308109,0.0010101479,0.0009732775,0.0007797512,0.003610055],"category_scores_gemma":[0.009530737,0.00024535359,0.001317116,0.0010855901,0.00019894759,0.00033126664,0.0006620939,0.0011365598,0.0005552444],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014954497,0.00027252312,0.9411163,0.00005095251,0.00097558345,0.00023809251,0.000055532626,0.03845774,0.00023143693,0.0003043937,0.001761752,0.015040377],"study_design_scores_gemma":[0.00019920425,0.000827532,0.2584254,0.000043782078,0.000736688,0.00065057573,0.00011120458,0.73607045,0.00021986864,0.0014762882,0.0011958589,0.00004307445],"about_ca_topic_score_codex":0.01073816,"about_ca_topic_score_gemma":0.005280843,"teacher_disagreement_score":0.01073816,"about_ca_system_score_codex":0.00061287754,"about_ca_system_score_gemma":0.0010341854,"threshold_uncertainty_score":0.021351337},"labels":[],"label_agreement":null},{"id":"W2795280927","doi":"10.1038/s41416-018-0071-4","title":"The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Regional Municipality of Durham; University of Toronto; University Health Network; Health Sciences Centre; North York General Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Government of Ontario; Institute for Clinical Evaluative Sciences; Health Research Board; Johns Hopkins University","keywords":"Medicine; Prostate cancer; Radiation oncologist; Radiation therapy; Odds ratio; Referral; Prostatectomy; Comorbidity; Cohort; Cancer; Internal medicine; Confounding; Watchful waiting; Surgery; Family medicine","score_opus":0.025837425287112116,"score_gpt":0.32372004040739666,"score_spread":0.2978826151202845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795280927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931218,0.0019613989,0.0013383873,0.0011797014,0.00012884517,0.00013462317,0.0005994764,0.0000139423255,0.0015218138],"genre_scores_gemma":[0.9986198,0.0001380206,0.00052322977,0.00032647874,0.000047493297,0.000035261182,0.00013078799,0.000005998023,0.00017294748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96953493,0.017041638,0.0025711,0.0036103218,0.0049501145,0.0022919076],"domain_scores_gemma":[0.9415012,0.024694113,0.023067098,0.005834061,0.0025109674,0.0023925637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018103754,0.00050677406,0.00058385916,0.0014184214,0.00218614,0.0014802959,0.0018275881,0.0012044212,0.002124844],"category_scores_gemma":[0.0639529,0.00042581392,0.0015059442,0.0021201032,0.00195155,0.00071507023,0.0015408561,0.00088904845,0.00017688812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015646854,0.000017776794,0.9973188,0.000027531794,0.00026630794,0.00006340032,0.00034417762,0.000039218437,0.000072218,0.00010771539,0.00018084113,0.0014055523],"study_design_scores_gemma":[0.000026814367,0.00008962757,0.99758303,0.000055696095,0.00022385993,0.0003396867,0.000519342,0.00043997474,0.0001519446,0.00015635516,0.00040331832,0.000010383428],"about_ca_topic_score_codex":0.14368586,"about_ca_topic_score_gemma":0.16151434,"teacher_disagreement_score":0.14368586,"about_ca_system_score_codex":0.0032581354,"about_ca_system_score_gemma":0.0051310454,"threshold_uncertainty_score":0.28569907},"labels":[],"label_agreement":null},{"id":"W2800495434","doi":"10.1038/s41416-018-0044-7","title":"Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cardiorespiratory fitness; Medicine; High-intensity interval training; Interval training; Quality of life (healthcare); Physical therapy; Aerobic exercise; Anxiety; Depression (economics); Psychosocial; Physical fitness; Internal medicine; Psychiatry","score_opus":0.04457199078118381,"score_gpt":0.32971009472795,"score_spread":0.2851381039467662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800495434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999074,0.00045637775,0.0000411572,0.000036172325,0.0000076067845,0.000027412187,0.00004529944,0.00000564464,0.0003063166],"genre_scores_gemma":[0.99944276,0.00020148978,0.00011781838,0.000023776201,0.000013401604,0.00003608567,0.00007329896,8.5498505e-7,0.000090584064],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998859,0.00004793068,0.000008198925,0.0000114988,0.000015526306,0.000030894207],"domain_scores_gemma":[0.99948263,0.00014907405,0.00012618313,0.000018440176,0.000044375116,0.00017930221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037696658,0.00014179171,0.00021776212,0.0001858561,0.00019789774,0.00014205735,0.00015261256,0.00014193104,0.0018704071],"category_scores_gemma":[0.0007984944,0.000048238155,0.00028412137,0.00019940945,0.00012159787,0.000087363595,0.00025795182,0.00026791645,0.00006827772],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019208733,0.018767705,0.5278408,0.0016783647,0.001241659,0.00016241574,0.0009801745,0.0029632288,0.010700151,0.00007388447,0.0013367507,0.4150462],"study_design_scores_gemma":[0.0005127019,0.025203431,0.9720514,0.000101376405,0.00026801057,0.000071942806,0.00022722107,0.000588174,0.00054009253,0.00002639915,0.0004021282,0.0000071836707],"about_ca_topic_score_codex":0.0021128855,"about_ca_topic_score_gemma":0.003399385,"teacher_disagreement_score":0.0021128855,"about_ca_system_score_codex":0.00015346447,"about_ca_system_score_gemma":0.00026159306,"threshold_uncertainty_score":0.006257117},"labels":[],"label_agreement":null},{"id":"W2803492840","doi":"10.1038/s41416-018-0108-8","title":"Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; Groupement des Entreprises Françaises dans la lutte contre le Cancer; National Institutes of Health; Florida Department of Health; Centre Hospitalier Universitaire de Nantes; Cancer Council Victoria; Deutsche Krebshilfe; Ministerio de Economía y Competitividad; Deutsche Forschungsgemeinschaft; Broad Institute; University of South Florida; Memorial Sloan-Kettering Cancer Center; Johns Hopkins University; Bundesministerium für Bildung und Forschung; Association Anne de Bretagne Genetique; National Institute on Aging; Division of Cancer Prevention, National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; Moffitt Cancer Center; National Health and Medical Research Council; American Cancer Society; Centers for Disease Control and Prevention; Génome Québec; Conseil Régional des Pays de la Loire; Ontario Institute for Cancer Research; U.S. Department of Health and Human Services","keywords":"Menarche; Odds ratio; Medicine; Menopause; Confidence interval; Confounding; Internal medicine; Body mass index; Oncology; Colorectal cancer; Gynecology; Demography; Cancer","score_opus":0.014230976188502482,"score_gpt":0.28543413347648394,"score_spread":0.27120315728798144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803492840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7712432,0.01086205,0.18179426,0.0012770232,0.0010951199,0.02627869,0.00330911,0.00060368254,0.0035368658],"genre_scores_gemma":[0.93719035,0.0011911282,0.04106873,0.0006594721,0.00011917768,0.016069409,0.0015237369,0.000057004036,0.0021209472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.938128,0.052365493,0.0026024722,0.0037074406,0.002307079,0.0008894769],"domain_scores_gemma":[0.9486059,0.030870412,0.0069025303,0.011371577,0.0016115435,0.000638093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05060491,0.0017237928,0.0030976138,0.00167544,0.0008459818,0.001035042,0.002069036,0.0023357004,0.004732664],"category_scores_gemma":[0.12590271,0.0010701866,0.0038826999,0.0018009029,0.0015399195,0.0007791908,0.00085170154,0.0013198935,0.00043768602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30359706,0.0034754826,0.4155136,0.007062463,0.089719824,0.0065008663,0.0024667974,0.022735808,0.008973308,0.03781715,0.012207568,0.08993018],"study_design_scores_gemma":[0.24248266,0.06332565,0.28973043,0.002113024,0.10132713,0.012954289,0.0007636557,0.1635178,0.0073307347,0.08662565,0.028903404,0.0009256459],"about_ca_topic_score_codex":0.004105585,"about_ca_topic_score_gemma":0.0024280665,"teacher_disagreement_score":0.05060491,"about_ca_system_score_codex":0.0016084472,"about_ca_system_score_gemma":0.0017247768,"threshold_uncertainty_score":0.26762754},"labels":[],"label_agreement":null},{"id":"W2803557794","doi":"10.1038/s41416-018-0082-1","title":"Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Leukemia and Lymphoma Society; AstraZeneca","keywords":"Medicine; Rash; Tolerability; Pharmacology; Dosing; Adverse effect; Pharmacokinetics; Pharmacodynamics; Internal medicine","score_opus":0.037934648469208444,"score_gpt":0.39010684905211895,"score_spread":0.3521722005829105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803557794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991951,0.0028373178,0.0010300246,0.00020477374,0.00005724154,0.001466962,0.0008267771,0.00011896657,0.0015069701],"genre_scores_gemma":[0.9895029,0.0022297164,0.0025947776,0.00022888342,0.00006412247,0.0014251204,0.0024609833,0.000034886725,0.0014585399],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996904,0.00012742568,0.000020822074,0.00004381123,0.000049717448,0.00006782931],"domain_scores_gemma":[0.99953544,0.00008833091,0.000119468976,0.0000380573,0.000045764413,0.00017298278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008784609,0.00094261864,0.001084776,0.0003781426,0.00024973968,0.0006088632,0.0008015407,0.0006324946,0.0024009566],"category_scores_gemma":[0.000647347,0.00028939667,0.0006203904,0.00042370803,0.00040588342,0.00036941684,0.00023794749,0.0017085319,0.0004969818],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29404217,0.053231664,0.011766384,0.0018155407,0.0015714352,0.00060496933,0.0006014246,0.007839569,0.4186652,0.00090264983,0.0070752,0.20188381],"study_design_scores_gemma":[0.2215104,0.6596444,0.024930295,0.00007818871,0.0009837097,0.0017041963,0.000095675,0.005276774,0.07572379,0.00042195237,0.0095810555,0.000049487364],"about_ca_topic_score_codex":0.0006539707,"about_ca_topic_score_gemma":0.0011648245,"teacher_disagreement_score":0.0024009566,"about_ca_system_score_codex":0.0007638642,"about_ca_system_score_gemma":0.00090093794,"threshold_uncertainty_score":0.008032024},"labels":[],"label_agreement":null},{"id":"W2808656778","doi":"10.1038/s41416-018-0036-7","title":"Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Etoposide; Chemotherapy; Debulking; Ovarian cancer; Cisplatin; Internal medicine; Clinical endpoint; Leukopenia; Gastroenterology; Surgery; Phases of clinical research; Chemotherapy regimen; Cancer; Oncology; Randomized controlled trial","score_opus":0.016098204122577453,"score_gpt":0.34985441520265376,"score_spread":0.3337562110800763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808656778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861605,0.0056978976,0.0005619538,0.00071556785,0.0006674811,0.0039466447,0.0006573553,0.00009428225,0.0014981868],"genre_scores_gemma":[0.983092,0.004431455,0.0017843748,0.001229665,0.00074052066,0.004956528,0.0010148587,0.000024063344,0.0027264806],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991284,0.00055234856,0.00005399848,0.00012849041,0.00005192968,0.00008486384],"domain_scores_gemma":[0.9986406,0.00045484482,0.00033449224,0.00011731049,0.00006980442,0.0003829111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002401,0.0014350257,0.002630523,0.0005060968,0.00030107558,0.0011130372,0.0008840233,0.0016178517,0.0064893668],"category_scores_gemma":[0.0028547933,0.0006446437,0.0020149404,0.0005077561,0.0010920215,0.0010088095,0.00059926364,0.0031543646,0.0008363911],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.978689,0.0048334417,0.00042051414,0.0005690956,0.00072750787,0.000023112823,0.000034795266,0.0002627884,0.0011087739,0.000048249374,0.0003333957,0.012949278],"study_design_scores_gemma":[0.9485399,0.04933405,0.00082779396,0.000037105234,0.00042898313,0.000022848473,0.000009604098,0.00019136613,0.00017584892,0.0000613819,0.0003645141,0.000006662805],"about_ca_topic_score_codex":0.0007082333,"about_ca_topic_score_gemma":0.0014802255,"teacher_disagreement_score":0.0064893668,"about_ca_system_score_codex":0.00080300553,"about_ca_system_score_gemma":0.0011994902,"threshold_uncertainty_score":0.021709085},"labels":[],"label_agreement":null},{"id":"W2883164443","doi":"10.1038/s41416-018-0176-9","title":"Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Genotyping; Anal cancer; Cytology; Men who have sex with men; Gynecology; Internal medicine; Cancer; Human immunodeficiency virus (HIV); Genotype; Virology; Pathology; Syphilis; Biology","score_opus":0.04340152142829211,"score_gpt":0.4138244997123991,"score_spread":0.370422978284107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883164443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767286,0.0017794167,0.00014810573,0.000046246598,0.0000068487507,0.00002376592,0.00004085925,0.0000037893155,0.0002780995],"genre_scores_gemma":[0.9993111,0.0003394996,0.00018246568,0.000026205125,0.000013644957,0.000014091635,0.00007214913,0.0000010784568,0.000039732255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974299,0.0016581586,0.00018188164,0.00022747112,0.0003518823,0.00015064776],"domain_scores_gemma":[0.9929951,0.0050321165,0.0010803747,0.00016421005,0.00034264906,0.00038547028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005384057,0.0005437645,0.0004965284,0.000643662,0.00017930302,0.000455523,0.0003001012,0.0005785917,0.0006659003],"category_scores_gemma":[0.013375183,0.00023727508,0.0008308538,0.00033375315,0.00021670062,0.0006998452,0.0006371087,0.00022184178,0.00008615768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068042204,0.00036836657,0.95672274,0.00027374836,0.0013665318,0.00010088616,0.0002756863,0.0012451019,0.00028595328,0.00007813801,0.00013880395,0.03233991],"study_design_scores_gemma":[0.0003111113,0.012965395,0.97793454,0.00020777795,0.0014556173,0.0005310172,0.0004305797,0.0050265295,0.00047689336,0.00014911675,0.0004936771,0.00001767681],"about_ca_topic_score_codex":0.00074573787,"about_ca_topic_score_gemma":0.0014886872,"teacher_disagreement_score":0.005384057,"about_ca_system_score_codex":0.00034139448,"about_ca_system_score_gemma":0.00044298993,"threshold_uncertainty_score":0.028473973},"labels":[],"label_agreement":null},{"id":"W2883606766","doi":"10.1038/s41416-018-0179-6","title":"25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"NIHR Oxford Biomedical Research Centre; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Cancer Research Institute","keywords":"Medicine; Vitamin D and neurology; Internal medicine; Confidence interval; Gastroenterology; Melanoma; Vitamin; Surgery","score_opus":0.01739024898045577,"score_gpt":0.30706469883670573,"score_spread":0.28967444985624996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883606766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969436,0.0076413453,0.00013029535,0.00052943197,0.00014005044,0.0003236098,0.0003654518,0.000021294101,0.001154087],"genre_scores_gemma":[0.9962076,0.0013981726,0.00021644037,0.00031692817,0.00010514132,0.00027928883,0.00064787274,0.0000038476264,0.0008247944],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996051,0.00020698355,0.000031055155,0.000060553637,0.00004727977,0.000048933973],"domain_scores_gemma":[0.9994398,0.00012449357,0.00017413123,0.000037814818,0.00004490278,0.00017881212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009800148,0.00039402177,0.0012231639,0.00015243454,0.00019669342,0.0007205534,0.00034816883,0.00067045854,0.0014633817],"category_scores_gemma":[0.0013337409,0.00020753592,0.0007753969,0.00020984447,0.00025401154,0.00024590603,0.00023648278,0.0013455772,0.00026714895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92950946,0.0029610991,0.024265815,0.0007269095,0.0021099842,0.00009452767,0.00007234249,0.0005623958,0.005767064,0.00011203535,0.0013295369,0.032488942],"study_design_scores_gemma":[0.7345168,0.12938128,0.12553436,0.00027657076,0.0032018689,0.00030293743,0.000072911134,0.0012465896,0.0010309827,0.0005023049,0.003904476,0.000028969593],"about_ca_topic_score_codex":0.0012508801,"about_ca_topic_score_gemma":0.0024648365,"teacher_disagreement_score":0.0014633817,"about_ca_system_score_codex":0.00050225004,"about_ca_system_score_gemma":0.00056675414,"threshold_uncertainty_score":0.005182922},"labels":[],"label_agreement":null},{"id":"W2883924148","doi":"10.1038/s41416-018-0187-6","title":"L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"L1; Medicine; Internal medicine; Endometrial cancer; Immunohistochemistry; Oncology; Immunostaining; Cohort; Carcinoma; Pathology; Cancer","score_opus":0.01346104051835793,"score_gpt":0.23077901870984774,"score_spread":0.21731797819148982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883924148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917114,0.00033037816,0.00010364241,0.000033305398,0.0000037062043,0.0000050033163,0.00008460144,0.000005326114,0.00026303518],"genre_scores_gemma":[0.9995491,0.00007485211,0.00013202679,0.000011702699,0.000008465665,0.0000029795885,0.00014465032,0.0000015134074,0.00007467686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985707,0.00003210011,0.000017370881,0.000033493183,0.000032402888,0.000027492786],"domain_scores_gemma":[0.9993326,0.00018663115,0.00024515737,0.000050432503,0.0000613995,0.00012383492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000473937,0.00026063458,0.0002793683,0.00080981996,0.00023884348,0.0005339564,0.00023475142,0.00042037357,0.001520974],"category_scores_gemma":[0.0018039811,0.00012896948,0.00027230463,0.00036844632,0.00019958634,0.00026013807,0.0003885253,0.00034516896,0.00033528046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002697412,0.000011142886,0.9951886,0.000011443143,0.000020991234,0.000098061755,0.000026379626,0.00006399923,0.0011494189,0.000009228048,0.00006604609,0.0030849748],"study_design_scores_gemma":[0.000011599424,0.000147699,0.9968154,0.0000106204725,0.00006838705,0.0011078935,0.00007860425,0.0008295872,0.0005760893,0.0000607505,0.00028917618,0.00000424909],"about_ca_topic_score_codex":0.0009058569,"about_ca_topic_score_gemma":0.0015562241,"teacher_disagreement_score":0.001520974,"about_ca_system_score_codex":0.00017996518,"about_ca_system_score_gemma":0.00019604222,"threshold_uncertainty_score":0.0050881505},"labels":[],"label_agreement":null},{"id":"W2884264032","doi":"10.1038/s41416-018-0188-5","title":"STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Canadian Institutes of Health Research; Imperial College London","keywords":"Carboplatin; Medicine; Chemotherapy; Agonist; Immune checkpoint; Cancer research; Internal medicine; Immunotherapy; Immunology; Oncology; Immune system; Receptor; Cisplatin","score_opus":0.010231777456984118,"score_gpt":0.2731240424598853,"score_spread":0.2628922650029012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884264032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998014,0.0009952399,0.00010637833,0.00005839729,0.000028989065,0.000030556042,0.00006523566,0.000030541098,0.000670604],"genre_scores_gemma":[0.9980044,0.00074343756,0.0002194371,0.000044033062,0.000017297734,0.000030970434,0.00017776151,0.0000051437046,0.00075754296],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999933,0.000016272303,0.0000064009823,0.0000067922315,0.000012430789,0.000025132733],"domain_scores_gemma":[0.9999372,0.000010586826,0.000012079378,0.000006079027,0.0000033947294,0.00003079821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012016524,0.0001607385,0.0004073793,0.00018570392,0.00008208659,0.00026237287,0.00014561132,0.00018087264,0.00095412746],"category_scores_gemma":[0.00012575496,0.00009610791,0.00015794374,0.00017533866,0.00014398419,0.00013157242,0.00011109711,0.0006808953,0.00014258255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016742196,0.0037475375,0.0030825047,0.00039686036,0.00009267303,0.00019707222,0.00014445363,0.0012619065,0.9093105,0.00017540423,0.0011545457,0.06369427],"study_design_scores_gemma":[0.0053005754,0.14423059,0.114446305,0.00010967079,0.00045430346,0.0013405897,0.00025578405,0.007956556,0.7080759,0.00022322287,0.017561166,0.000045377215],"about_ca_topic_score_codex":0.00044043807,"about_ca_topic_score_gemma":0.0015471624,"teacher_disagreement_score":0.00095412746,"about_ca_system_score_codex":0.0001801592,"about_ca_system_score_gemma":0.00020945887,"threshold_uncertainty_score":0.0031918287},"labels":[],"label_agreement":null},{"id":"W2887114221","doi":"10.1038/s41416-018-0200-0","title":"Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Institute for Research in Immunology and Cancer; Université de Montréal","funders":"Integrated BioBank of Luxembourg","keywords":"Lung cancer; Biomarker; Medicine; Tissue microarray; Immunohistochemistry; Oncology; Cancer; Adenocarcinoma; Pathology; Internal medicine; Biology","score_opus":0.009776238330703763,"score_gpt":0.3011209812806427,"score_spread":0.29134474294993895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887114221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827094,0.011853714,0.0032785179,0.0003266881,0.000027666138,0.000051678475,0.0005043532,0.00007414717,0.0011738982],"genre_scores_gemma":[0.9944348,0.0015263855,0.0031969754,0.000073292984,0.000029871782,0.000028933957,0.0003860934,0.00000556867,0.00031820143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981433,0.000045330155,0.000013814109,0.00004458645,0.00005440054,0.000027649026],"domain_scores_gemma":[0.99944955,0.0001774433,0.00018239231,0.000022425405,0.000106406456,0.0000618266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060800434,0.00028755396,0.00034802034,0.000919205,0.00014386643,0.0004560365,0.00022896816,0.0003609381,0.000666284],"category_scores_gemma":[0.0007714696,0.000101144986,0.0001877319,0.00038336377,0.00020969426,0.00018934514,0.00018492239,0.0004579413,0.00030341075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011459497,0.00017908453,0.30088153,0.00039132597,0.00010407068,0.0004952082,0.000106117936,0.0006387877,0.64702344,0.00018389629,0.00065107085,0.048199486],"study_design_scores_gemma":[0.00005516638,0.0019946992,0.608685,0.00009067527,0.00025147543,0.0058414806,0.00018098229,0.0066650603,0.36822447,0.0006614153,0.0073204394,0.000029075629],"about_ca_topic_score_codex":0.0003285006,"about_ca_topic_score_gemma":0.00045485544,"teacher_disagreement_score":0.000919205,"about_ca_system_score_codex":0.00033388397,"about_ca_system_score_gemma":0.0002471676,"threshold_uncertainty_score":0.0032154322},"labels":[],"label_agreement":null},{"id":"W2888519303","doi":"10.1038/s41416-018-0117-7","title":"Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Medical Research Council; Vetenskapsrådet; Cancerfonden; Cancer Research UK; Wellcome Trust","keywords":"Colorectal cancer; Medicine; Oncology; Single-nucleotide polymorphism; Hazard ratio; Internal medicine; Proportional hazards model; Cancer; Survival analysis; Bioinformatics; Genetics; Biology; Confidence interval; Genotype; Gene","score_opus":0.019647258447109215,"score_gpt":0.32190954559920776,"score_spread":0.3022622871520985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888519303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896203,0.0077634226,0.0008781179,0.000231669,0.000038137612,0.000013803428,0.0010937853,0.000023103828,0.00033764006],"genre_scores_gemma":[0.99737,0.0011573449,0.0004301656,0.00007555767,0.000025862464,0.000010411779,0.0008109731,0.000006937632,0.00011262043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824,0.00077697076,0.00017153517,0.00046109786,0.00023512672,0.000115331204],"domain_scores_gemma":[0.9957561,0.0024559742,0.0006766924,0.00054456334,0.00030647346,0.0002601597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035944355,0.00078318716,0.0013132823,0.0014597415,0.00054759067,0.00059572293,0.0005716828,0.0007307373,0.0016180143],"category_scores_gemma":[0.0062133907,0.00042965898,0.0032966153,0.0023961323,0.00047553238,0.00027479636,0.0005909531,0.00064982485,0.00013326031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071312566,0.00010030076,0.9090971,0.0009712591,0.05203519,0.0010950341,0.00026998014,0.0020482067,0.009887974,0.00028247925,0.00079430704,0.016287029],"study_design_scores_gemma":[0.0004714732,0.0007276293,0.97101116,0.000111254776,0.023092642,0.0005071162,0.000108070264,0.0011615164,0.00086940354,0.00038203318,0.0015274596,0.000030237177],"about_ca_topic_score_codex":0.014777172,"about_ca_topic_score_gemma":0.021282585,"teacher_disagreement_score":0.014777172,"about_ca_system_score_codex":0.00040038693,"about_ca_system_score_gemma":0.00063262717,"threshold_uncertainty_score":0.029382348},"labels":[],"label_agreement":null},{"id":"W2889696398","doi":"10.1038/s41416-018-0261-0","title":"Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Pazopanib; Everolimus; Medicine; Oncology; Internal medicine; Clinical endpoint; PI3K/AKT/mTOR pathway; Progression-free survival; Targeted therapy; Cancer; Sunitinib; Chemotherapy; Clinical trial; Biology","score_opus":0.008266148816195511,"score_gpt":0.2463326452171442,"score_spread":0.2380664964009487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889696398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697304,0.0016930429,0.00016257272,0.00013272963,0.0000073430706,0.000042418364,0.00009385122,0.000018101004,0.00087689736],"genre_scores_gemma":[0.99907804,0.00030249197,0.00028732407,0.000092368406,0.0000170557,0.000018049903,0.00011809492,0.000002562385,0.000084101186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998708,0.000046563797,0.000013695177,0.000024615469,0.000024691362,0.000019616069],"domain_scores_gemma":[0.9997428,0.00006540858,0.000090246205,0.000011427588,0.000014052647,0.0000760105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000372521,0.00023311873,0.000497961,0.00015579922,0.00015203186,0.0002834809,0.0001362638,0.00016715807,0.0006785079],"category_scores_gemma":[0.0005086947,0.00008879884,0.00025645056,0.00020958373,0.0001481314,0.00019604314,0.00017212014,0.0003632097,0.0000931422],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062602304,0.0041250484,0.3190104,0.00057231035,0.0015277016,0.0022241338,0.0001939775,0.005991221,0.15687247,0.00029519564,0.0030895623,0.44349572],"study_design_scores_gemma":[0.013859028,0.09488497,0.825919,0.00009787612,0.0018013878,0.012459811,0.00023015888,0.0077446145,0.030737696,0.0005441777,0.011670372,0.000050925082],"about_ca_topic_score_codex":0.00020653923,"about_ca_topic_score_gemma":0.00095958554,"teacher_disagreement_score":0.0006785079,"about_ca_system_score_codex":0.0002890707,"about_ca_system_score_gemma":0.00030124324,"threshold_uncertainty_score":0.002269864},"labels":[],"label_agreement":null},{"id":"W2890146531","doi":"10.1038/s41416-018-0207-6","title":"Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ipilimumab; Pembrolizumab; Medicine; Melanoma; Mucosal melanoma; Internal medicine; Post-hoc analysis; Oncology; Post hoc; Gastroenterology; Surgery; Immunotherapy; Cancer; Cancer research","score_opus":0.008059760952273861,"score_gpt":0.2830765343105181,"score_spread":0.27501677335824426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890146531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949286,0.0028079844,0.00031419136,0.000070419235,0.000064197535,0.0003403307,0.0008669776,0.000030420673,0.0005768548],"genre_scores_gemma":[0.99657285,0.00050907553,0.0003755268,0.00009340433,0.00008317081,0.00021358758,0.0011624445,0.000021026006,0.0009689172],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979086,0.001192689,0.00013594002,0.0003172157,0.00021264037,0.00023297184],"domain_scores_gemma":[0.99658597,0.0014775854,0.0006741202,0.00043652463,0.00036567976,0.00046018243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005555528,0.0012542772,0.0027575083,0.00045802293,0.0002630296,0.0010481686,0.0008593541,0.0006249772,0.0031409317],"category_scores_gemma":[0.003630411,0.0003286347,0.004472546,0.00039222118,0.0004292414,0.0007043154,0.0005806034,0.0014269019,0.00055064127],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.880514,0.0032689455,0.04787939,0.0013387536,0.026290761,0.00021724738,0.00014416079,0.0018946353,0.010838643,0.000079573816,0.0012732722,0.026260585],"study_design_scores_gemma":[0.09784778,0.3866743,0.44486928,0.00014505367,0.04593227,0.0007258247,0.0002681122,0.007721977,0.0095168995,0.00026499236,0.005907067,0.00012644737],"about_ca_topic_score_codex":0.00081454666,"about_ca_topic_score_gemma":0.0012479953,"teacher_disagreement_score":0.005555528,"about_ca_system_score_codex":0.0009452192,"about_ca_system_score_gemma":0.00086857297,"threshold_uncertainty_score":0.029380798},"labels":[],"label_agreement":null},{"id":"W2891078672","doi":"10.1038/s41416-018-0164-0","title":"Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Exelixis; Memorial Sloan-Kettering Cancer Center","keywords":"Cabozantinib; Pazopanib; Sunitinib; Medicine; Everolimus; Renal cell carcinoma; Internal medicine; Oncology; Urology; Progression-free survival; Tyrosine-kinase inhibitor; Surgery; Cancer; Chemotherapy","score_opus":0.03876065357668174,"score_gpt":0.34884107414325466,"score_spread":0.3100804205665729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891078672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914579,0.0055140955,0.00016943176,0.00022948944,0.00008710968,0.00020365343,0.00093665486,0.000014304335,0.0013874575],"genre_scores_gemma":[0.99644345,0.00072895543,0.00016590109,0.00021466248,0.00013787184,0.00023482177,0.0018236412,0.0000056536182,0.00024508842],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99840254,0.0008922431,0.00012509091,0.00021853934,0.00020383923,0.00015770127],"domain_scores_gemma":[0.99745613,0.00076993345,0.00094253273,0.00016741913,0.00011943154,0.0005445166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034870545,0.00070801907,0.0017648813,0.00027905684,0.00038189976,0.00087071664,0.0004490337,0.00077342254,0.0021244173],"category_scores_gemma":[0.0028734829,0.00020386347,0.002685181,0.00037506563,0.0003829397,0.0006555101,0.0005121063,0.0017767787,0.0001722252],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.852678,0.0018811834,0.09882253,0.0007642156,0.008897402,0.00013802772,0.00010530038,0.0026748078,0.0028721397,0.00021810863,0.0023764651,0.028571852],"study_design_scores_gemma":[0.24200062,0.11185013,0.6121951,0.00036928212,0.013912374,0.00092615734,0.00020249296,0.006459972,0.003576617,0.0017469792,0.0066269888,0.00013325598],"about_ca_topic_score_codex":0.0007415006,"about_ca_topic_score_gemma":0.0025133826,"teacher_disagreement_score":0.0034870545,"about_ca_system_score_codex":0.00071464514,"about_ca_system_score_gemma":0.00084932015,"threshold_uncertainty_score":0.018441498},"labels":[],"label_agreement":null},{"id":"W2896626889","doi":"10.1038/s41416-018-0274-8","title":"Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"NuCana; Myriad Genetics; AstraZeneca","keywords":"Olaparib; PARP inhibitor; Ovarian cancer; Medicine; BRCA mutation; Oncology; Cancer; Internal medicine; Cancer research; Population; Biology; Genetics; Gene; Poly ADP ribose polymerase; Polymerase","score_opus":0.015046316000926513,"score_gpt":0.31371684263174504,"score_spread":0.2986705266308185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896626889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124473,0.0066818045,0.0003352381,0.000079535486,0.000006892559,0.000031952008,0.0006620853,0.000011937066,0.0009457453],"genre_scores_gemma":[0.9982262,0.0005014616,0.00026091802,0.000034734137,0.0000114506065,0.000019352268,0.0006902397,0.0000026700338,0.00025297437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994342,0.00021339911,0.000052883643,0.0000965267,0.00014058006,0.000062435116],"domain_scores_gemma":[0.9983494,0.00053114037,0.0007990652,0.00007749427,0.00011254379,0.00013036262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010942661,0.00023453933,0.00074721116,0.00078212924,0.00018554942,0.0008086182,0.00022764619,0.00033002466,0.0011270086],"category_scores_gemma":[0.0018210211,0.00013963116,0.00033175366,0.0010954896,0.00022664238,0.00034049232,0.00038343103,0.0003946648,0.00019883303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061717657,0.00011328249,0.9529897,0.00013000889,0.000284708,0.00022043518,0.00007945079,0.0007781075,0.010805091,0.00006999796,0.00032928077,0.028028358],"study_design_scores_gemma":[0.000077073346,0.0010517025,0.99349785,0.000017211269,0.0001271327,0.0006796528,0.00004663371,0.0005866219,0.0027159357,0.00013248662,0.0010585258,0.000009086601],"about_ca_topic_score_codex":0.00054371555,"about_ca_topic_score_gemma":0.0008766292,"teacher_disagreement_score":0.0011270086,"about_ca_system_score_codex":0.00038398465,"about_ca_system_score_gemma":0.00022912101,"threshold_uncertainty_score":0.005787134},"labels":[],"label_agreement":null},{"id":"W2897015353","doi":"10.1038/s41416-018-0236-1","title":"Phenotype-independent DNA methylation changes in prostate cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; BC Cancer Agency; Provincial Health Services Authority; Yorkshire Cancer Research","keywords":"Prostate cancer; DNA methylation; Biology; Prostate; CpG site; Cancer; Cancer research; Methylation; Cancer cell; Phenotype; Pathology; DNA; Gene; Medicine; Genetics; Gene expression","score_opus":0.011136492820038452,"score_gpt":0.29409484997648155,"score_spread":0.28295835715644313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897015353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901391,0.0016234189,0.004226807,0.000048887097,0.000005864161,0.000022332315,0.002913086,0.00012507435,0.0008953998],"genre_scores_gemma":[0.99602854,0.0003224237,0.0012897392,0.000021507145,0.0000028386005,0.000014576005,0.0020982034,0.000013792732,0.00020835135],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990344,0.000013628459,0.0000046590703,0.000038025737,0.000028582566,0.000011671299],"domain_scores_gemma":[0.9998429,0.00004213027,0.00005545615,0.00002023062,0.000021842518,0.0000174856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016278049,0.00017753984,0.00019898628,0.0005037565,0.00011754805,0.00022343703,0.00015993968,0.0001447809,0.0007676281],"category_scores_gemma":[0.00046393878,0.00010208333,0.00016580005,0.00054481975,0.00014857786,0.00008134763,0.0002817516,0.00023131052,0.00015889858],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071002275,0.00006899319,0.56888926,0.00043268013,0.00034671847,0.00022128664,0.0001857753,0.00693039,0.35025194,0.00040663482,0.0008273181,0.07072898],"study_design_scores_gemma":[0.000017229268,0.00021957219,0.93677,0.000017375529,0.00019097696,0.00093965774,0.00006486149,0.007975238,0.048931196,0.0010744642,0.0037803815,0.000018862398],"about_ca_topic_score_codex":0.0021352752,"about_ca_topic_score_gemma":0.0042082723,"teacher_disagreement_score":0.0021352752,"about_ca_system_score_codex":0.00026295485,"about_ca_system_score_gemma":0.00022294374,"threshold_uncertainty_score":0.0042456985},"labels":[],"label_agreement":null},{"id":"W2897161745","doi":"10.1038/s41416-018-0225-4","title":"Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Denosumab; Breast cancer; Medicine; Hazard ratio; Oncology; Proportional hazards model; Internal medicine; Population; Cohort; Osteoporosis; Cohort study; Cancer; Gynecology; Confidence interval","score_opus":0.007708792042832116,"score_gpt":0.3088409880049742,"score_spread":0.30113219596214214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897161745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726677,0.00060589233,0.0001434372,0.00007251111,0.000011973871,0.000031974625,0.0014359563,0.00000527027,0.00042622472],"genre_scores_gemma":[0.9980521,0.00037832442,0.00014811075,0.000061986764,0.00001699586,0.00004491366,0.0009392561,0.000003510413,0.00035475494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993923,0.00014942125,0.00006345329,0.00016305706,0.00013735732,0.00009432323],"domain_scores_gemma":[0.999298,0.000087126726,0.00019618307,0.00015941556,0.00010114166,0.00015809326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009416568,0.0003277305,0.00065147964,0.00064018916,0.0006270643,0.0008605857,0.00039398833,0.00072112423,0.0015719907],"category_scores_gemma":[0.0016363716,0.0006401638,0.0008382237,0.0016344337,0.00022992153,0.00039691236,0.000537145,0.00091867405,0.00038998437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005786843,0.000098025506,0.99683976,0.00002461884,0.0004973116,0.00012895129,0.00011251559,0.00004051809,0.0004559951,0.000018746536,0.00020982647,0.000994932],"study_design_scores_gemma":[0.00009648733,0.00023009017,0.9982247,0.000013554099,0.00028265754,0.00031048123,0.00015141968,0.00012921248,0.00004501316,0.000026747482,0.00048188996,0.000007801939],"about_ca_topic_score_codex":0.014793377,"about_ca_topic_score_gemma":0.014636396,"teacher_disagreement_score":0.014793377,"about_ca_system_score_codex":0.00034090743,"about_ca_system_score_gemma":0.0005037942,"threshold_uncertainty_score":0.029414535},"labels":[],"label_agreement":null},{"id":"W2897283341","doi":"10.1038/s41416-018-0220-9","title":"Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Institute of Cancer Research; Institut Du Cancer de Montréal; Institut National Du Cancer","keywords":"Oncology; Lung cancer; Internal medicine; Medicine; Cohort; Immunotherapy; PD-L1; Immunohistochemistry; Cancer; Pathology","score_opus":0.006954791000340693,"score_gpt":0.27787800787922173,"score_spread":0.27092321687888105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897283341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994568,0.00020114935,0.00008767172,0.000012660265,0.0000023770992,0.0000030682345,0.00010990008,0.0000039657916,0.00012234789],"genre_scores_gemma":[0.9995609,0.00004554127,0.00007973891,0.000008597975,0.0000049856217,0.0000052019655,0.00022644557,0.0000011369449,0.00006734673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998599,0.000030508134,0.0000133021,0.000047188878,0.00002509119,0.000023798199],"domain_scores_gemma":[0.9994499,0.00020103536,0.00017453851,0.000029562616,0.000059949456,0.00008495544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030956842,0.00014856228,0.00020736699,0.0004150791,0.00016704398,0.00038291453,0.00016297291,0.00027007872,0.0008771155],"category_scores_gemma":[0.0010891488,0.000095618576,0.00012196473,0.00023849009,0.00018552304,0.00020127899,0.00019754746,0.00025653592,0.00020906523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060414855,0.00002361984,0.9921033,0.00001197999,0.000024747264,0.00010804946,0.000025940304,0.000111583024,0.0032388112,0.00000842597,0.000068150235,0.0036713174],"study_design_scores_gemma":[0.000025078154,0.00034529556,0.99470794,0.0000060295406,0.000050118033,0.0010825986,0.00007492968,0.00096498965,0.0022592447,0.000049799768,0.00043016742,0.0000036837632],"about_ca_topic_score_codex":0.00031126148,"about_ca_topic_score_gemma":0.00041403619,"teacher_disagreement_score":0.0008771155,"about_ca_system_score_codex":0.00018011952,"about_ca_system_score_gemma":0.00012026129,"threshold_uncertainty_score":0.0029342175},"labels":[],"label_agreement":null},{"id":"W2899462292","doi":"10.1038/s41416-018-0230-7","title":"Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Innovatiefonds Zorgverzekeraars; KWF Kankerbestrijding; ZonMw; Mach-Gaensslen Foundation of Canada; New York Stem Cell Foundation","keywords":"KRAS; Colorectal cancer; Tumor budding; Budding; Pathology; Cancer research; Biology; Epithelial–mesenchymal transition; Phenotype; Oncology; Tissue microarray; Immunohistochemistry; Medicine; Cancer; Internal medicine; Gene; Metastasis; Genetics","score_opus":0.02406353133911482,"score_gpt":0.3131442406647796,"score_spread":0.28908070932566476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899462292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993179,0.0000694497,0.000025904497,0.0000058457886,7.354613e-7,0.0000077824225,0.0004711634,0.000003159376,0.00009805697],"genre_scores_gemma":[0.99793327,0.00004164946,0.00008892839,0.00000961873,0.0000028066922,0.000012652955,0.0017808388,0.0000041814924,0.00012609054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995328,0.000041290376,0.000061482824,0.00017680383,0.00011104917,0.000076608914],"domain_scores_gemma":[0.9988794,0.00011581412,0.00037575522,0.0001798677,0.00018335249,0.0002657892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044625453,0.00025777382,0.00042593188,0.0013451749,0.0005030145,0.00047653107,0.00034874122,0.00032509814,0.0015835705],"category_scores_gemma":[0.0013841676,0.00031877877,0.0004071578,0.0015418768,0.00031386112,0.0001793538,0.000843655,0.00025227162,0.0004105829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029229996,0.000013981483,0.99730253,0.000014284381,0.0000584756,0.00008962775,0.00007117671,0.00002462106,0.0011497877,0.000006334051,0.00010098814,0.00087585684],"study_design_scores_gemma":[0.00001344199,0.00007546435,0.9989856,0.0000028009836,0.000026144255,0.00037067852,0.00010306789,0.00010305904,0.00013236678,0.000004433184,0.00018017252,0.0000028426628],"about_ca_topic_score_codex":0.017471619,"about_ca_topic_score_gemma":0.030527893,"teacher_disagreement_score":0.017471619,"about_ca_system_score_codex":0.0006331239,"about_ca_system_score_gemma":0.00058692874,"threshold_uncertainty_score":0.034739852},"labels":[],"label_agreement":null},{"id":"W2899843229","doi":"10.1038/s41416-018-0323-3","title":"North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Guideline; Prostate cancer; Lymph node; Cancer; Stage (stratigraphy); Population; Prostate-specific antigen; Prostate; Radiology; Internal medicine; Oncology; Surgery; Pathology","score_opus":0.022002389520070605,"score_gpt":0.3447491476882037,"score_spread":0.3227467581681331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899843229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698448,0.004648159,0.0026316326,0.002204,0.00014366806,0.00069544103,0.008320125,0.00009250792,0.011419556],"genre_scores_gemma":[0.9915507,0.0005348725,0.0023938725,0.0005469985,0.000042415588,0.0003726879,0.0043364856,0.00001020805,0.00021181075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98745394,0.006214672,0.0012973145,0.0011652749,0.003553474,0.00031533794],"domain_scores_gemma":[0.96414506,0.012311003,0.011698787,0.0017046886,0.009258797,0.000881602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014211727,0.00024494267,0.00048589378,0.0016056066,0.00041829556,0.00084644835,0.00085909374,0.0008944222,0.0011750355],"category_scores_gemma":[0.049526468,0.00022661513,0.000655497,0.002001234,0.00046095843,0.0005801376,0.00075476913,0.0006545868,0.00030925425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009088156,0.00004972116,0.988157,0.000087218745,0.00017322658,0.00002631269,0.0001032154,0.0002666098,0.00006978778,0.00005104478,0.0025712328,0.0083538415],"study_design_scores_gemma":[0.00004282095,0.00008979599,0.9959818,0.00013250197,0.00011140708,0.0001725046,0.00013670385,0.0012830828,0.000102834645,0.00009136887,0.0018446383,0.000010659872],"about_ca_topic_score_codex":0.012052439,"about_ca_topic_score_gemma":0.020616092,"teacher_disagreement_score":0.014211727,"about_ca_system_score_codex":0.0012323675,"about_ca_system_score_gemma":0.0020362458,"threshold_uncertainty_score":0.07515973},"labels":[],"label_agreement":null},{"id":"W2901896725","doi":"10.1038/s41416-018-0287-3","title":"Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Dasatinib; Paclitaxel; Cancer research; Breast cancer; Triple-negative breast cancer; Chemotherapy; Stem cell; Medicine; Cancer stem cell; Cancer; Oncology; Internal medicine; Biology; Imatinib","score_opus":0.01115178035035281,"score_gpt":0.2836793264439886,"score_spread":0.2725275460936358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901896725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005544,0.0032528362,0.002405254,0.00023319914,0.00005367694,0.00012490204,0.00044490604,0.00012881169,0.0033009602],"genre_scores_gemma":[0.99555796,0.0013978558,0.0013117866,0.000051730294,0.0000083752575,0.00003761137,0.00041703938,0.000013508636,0.0012040829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998754,0.000017181414,0.000017290098,0.00002101875,0.000042185715,0.00002693613],"domain_scores_gemma":[0.9999294,0.000020458316,0.000013797555,0.0000111642385,0.000010296352,0.000014844602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010490419,0.00021565169,0.00043271892,0.0002552375,0.0001507487,0.00032190728,0.00014695835,0.0001935255,0.0017857584],"category_scores_gemma":[0.00014996977,0.00011680824,0.00020168262,0.00022938858,0.00018142433,0.00012622049,0.00019704462,0.00038112182,0.00040348308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017004999,0.00006870149,0.0007029245,0.00015095407,0.000016646449,0.00010468197,0.000030758103,0.0002237978,0.9901738,0.0001413315,0.00020318225,0.008013116],"study_design_scores_gemma":[0.00007784168,0.0008792525,0.005861423,0.0000084416315,0.000031673073,0.0011051144,0.000041541938,0.0010454,0.9832692,0.000100683144,0.0075728535,0.0000066026873],"about_ca_topic_score_codex":0.00043428488,"about_ca_topic_score_gemma":0.0007900583,"teacher_disagreement_score":0.0017857584,"about_ca_system_score_codex":0.00027594523,"about_ca_system_score_gemma":0.00023399702,"threshold_uncertainty_score":0.005973935},"labels":[],"label_agreement":null},{"id":"W2902071034","doi":"10.1038/s41416-018-0297-1","title":"Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Genentech; Cure Brain Cancer Foundation; University of Toronto","keywords":"Medicine; Breast cancer; Disease; Metastatic breast cancer; Cancer; Oncology; Kidney cancer; Internal medicine; Cancer research; Pathology","score_opus":0.02330542606875529,"score_gpt":0.3082916745140264,"score_spread":0.2849862484452711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902071034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98138094,0.0044240816,0.0077752387,0.0005119701,0.00025148058,0.00029878106,0.001983114,0.00048297003,0.002891445],"genre_scores_gemma":[0.9760055,0.0031590124,0.009772665,0.00016823139,0.000043736327,0.00048368968,0.0016654044,0.000079666825,0.00862211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939,0.000100952646,0.000051104525,0.00013067383,0.0001682516,0.000159023],"domain_scores_gemma":[0.9997037,0.000033875487,0.00008463233,0.000048879705,0.00002863909,0.00010027169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076094025,0.00071580865,0.00068567524,0.00078184204,0.0002749612,0.0005241348,0.00052743766,0.0005296314,0.0018215949],"category_scores_gemma":[0.000127463,0.0003604538,0.0007207577,0.00034936334,0.00046212753,0.0005225517,0.00020780045,0.0019698301,0.0006324165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010637994,0.00086167787,0.0002298819,0.00011559574,0.000022547074,0.000047286776,0.00004006305,0.00035620906,0.99418074,0.00025347687,0.00020325331,0.0026254905],"study_design_scores_gemma":[0.00014616818,0.0039090137,0.0015066911,0.000007805452,0.000037458663,0.00018139489,0.00003207611,0.0014776026,0.9896142,0.00005659915,0.003021738,0.000009173051],"about_ca_topic_score_codex":0.0020074693,"about_ca_topic_score_gemma":0.0044004703,"teacher_disagreement_score":0.0020074693,"about_ca_system_score_codex":0.0008257736,"about_ca_system_score_gemma":0.0010382358,"threshold_uncertainty_score":0.0060938597},"labels":[],"label_agreement":null},{"id":"W29065105","doi":"10.1038/bjc.2017.360","title":"White-Nose SyndromeThe devastating disease of hibernating bats inNorth America","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bat Biology and Ecology Studies","field":"Agricultural and Biological Sciences","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"White (mutation); Disease; Nose; Geography; Biology; Medicine; Pathology; Anatomy","score_opus":0.011397613098117279,"score_gpt":0.2361648433797352,"score_spread":0.22476723028161794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W29065105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922908,0.0031887868,0.0003073687,0.000623872,0.00003668322,0.000016586793,0.000117802585,0.000009539557,0.00340865],"genre_scores_gemma":[0.9972408,0.0019206693,0.00017338328,0.00018196546,0.000026608797,0.0000049725168,0.000057506637,0.000002203532,0.0003919623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998267,0.000046619418,0.000012944165,0.000036897007,0.000035508623,0.00004124792],"domain_scores_gemma":[0.9996984,0.00009443089,0.00008603648,0.000029015293,0.000035990026,0.00005618419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003707586,0.00025073742,0.00025079385,0.0002511298,0.00041735475,0.0003348942,0.00011694834,0.00034035553,0.0018667947],"category_scores_gemma":[0.0007072611,0.00010381025,0.00013578466,0.0002726665,0.0006970772,0.0003881286,0.0002923961,0.00040913568,0.00011722177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048940594,0.00008736214,0.918812,0.00020814198,0.00022611445,0.006894096,0.0009922596,0.00014268901,0.023507083,0.0005558796,0.0013784978,0.046706595],"study_design_scores_gemma":[0.0000130958315,0.0002623719,0.9783594,0.00006055324,0.00007006302,0.016902147,0.001002373,0.000102195736,0.0007858058,0.00039761412,0.0020342781,0.00001008027],"about_ca_topic_score_codex":0.0059890044,"about_ca_topic_score_gemma":0.013384265,"teacher_disagreement_score":0.0059890044,"about_ca_system_score_codex":0.00031996102,"about_ca_system_score_gemma":0.00024640944,"threshold_uncertainty_score":0.011908293},"labels":[],"label_agreement":null},{"id":"W2913774914","doi":"10.1038/s41416-019-0382-0","title":"Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Université de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique; Korea University; Cancer Research UK","keywords":"Extracellular; Extracellular matrix; Cell biology; Biology; Intracellular; Elastin; Extracellular vesicle; Cell; Cancer cell; Biochemistry; Cancer; Microvesicles","score_opus":0.0028511838739615825,"score_gpt":0.20057441793620798,"score_spread":0.1977232340622464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913774914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98158973,0.010351148,0.005112626,0.00015879358,0.000025127409,0.000038209666,0.0003119494,0.00009134633,0.0023209653],"genre_scores_gemma":[0.9950277,0.0012115878,0.0017766404,0.000023399165,0.000008276075,0.000019079745,0.0002706801,0.000012590178,0.0016499356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988985,0.0000214059,0.000009917078,0.000026404714,0.0000270172,0.000025337456],"domain_scores_gemma":[0.9998838,0.000023526483,0.000043683343,0.000010589069,0.000012290799,0.000026163343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010693404,0.0003421008,0.00021765417,0.00012935979,0.00013355506,0.00024361305,0.0001025447,0.00031405597,0.0010955741],"category_scores_gemma":[0.00011395938,0.000093352945,0.00020522946,0.00009613577,0.00024649312,0.00021867406,0.00016554509,0.00034029584,0.0003326179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076473814,0.000005256407,0.00010399188,0.000047491143,0.000001999616,0.000064362044,0.000008995521,0.000023767538,0.9990395,0.000033690816,0.000009836964,0.000584704],"study_design_scores_gemma":[0.000008221629,0.00025070587,0.010409571,0.0000068678833,0.000009245158,0.00084055396,0.000028727962,0.0003999584,0.98615986,0.00005003017,0.0018325809,0.000003692835],"about_ca_topic_score_codex":0.00023369557,"about_ca_topic_score_gemma":0.00022811985,"teacher_disagreement_score":0.0010955741,"about_ca_system_score_codex":0.0001894795,"about_ca_system_score_gemma":0.0001251283,"threshold_uncertainty_score":0.00366503},"labels":[],"label_agreement":null},{"id":"W2914739834","doi":"10.1038/s41416-019-0376-y","title":"Oestrogen receptor status and survival in women with BRCA2-associated breast cancer","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sunnybrook Health Science Centre; McGill University; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Proportional hazards model; Cancer; Gynecology; Survival analysis; Multivariate analysis; Progesterone receptor; Estrogen receptor","score_opus":0.004280236852257831,"score_gpt":0.24151342960373887,"score_spread":0.23723319275148103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914739834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998212,0.0012260892,0.00002873123,0.00006196832,0.0000056272092,0.0000023912262,0.0002701497,0.0000016450463,0.00019151808],"genre_scores_gemma":[0.9991235,0.00030318502,0.000033312255,0.000027549648,0.000010687808,0.0000048513048,0.00034234402,8.801915e-7,0.0001536867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985194,0.000055202945,0.000013669343,0.000022530943,0.000022771825,0.000033845954],"domain_scores_gemma":[0.99912626,0.0002869165,0.0003624084,0.000042376403,0.000057980094,0.00012404242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006234516,0.00015035838,0.00023856945,0.00047462372,0.000186906,0.00029513997,0.00021097052,0.00044795076,0.0019110052],"category_scores_gemma":[0.0022442641,0.00017064661,0.000259201,0.00055367796,0.00016014677,0.00024395238,0.00027067703,0.0003364559,0.0003117726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036424884,0.00002695583,0.998281,0.000011254235,0.000032582608,0.000051463794,0.000028819828,0.000049223894,0.000080416394,0.0000059213535,0.000069796326,0.0009983499],"study_design_scores_gemma":[0.000027084096,0.00019772704,0.9987987,0.000010611768,0.00003666953,0.0003453624,0.00006293651,0.00017143865,0.00004218581,0.00003310002,0.00027110803,0.0000029475011],"about_ca_topic_score_codex":0.0026701537,"about_ca_topic_score_gemma":0.0028433017,"teacher_disagreement_score":0.0026701537,"about_ca_system_score_codex":0.00020757888,"about_ca_system_score_gemma":0.00018710269,"threshold_uncertainty_score":0.006392956},"labels":[],"label_agreement":null},{"id":"W2918113141","doi":"10.1038/s41416-019-0393-x","title":"Genome-wide association study of germline variants and breast cancer-specific mortality","year":2019,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; BC Cancer Agency; Centre hospitalier universitaire de Québec; Sinai Health System; University of British Columbia; Centre hospitalier de l'Université Laval; Vancouver General Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University Health Network; University of Toronto","funders":"Servicio Gallego de Salud; Programme Grants for Applied Research; Biotieteiden ja Ympäristön Tutkimuksen Toimikunta; Instituto de Salud Carlos III; Medical Research Council; Imperial Experimental Cancer Medicine Centre; National Institutes of Health; Hellenic Health Foundation; Freistaat Sachsen; Deutschen Konsortium für Translationale Krebsforschung; Xunta de Galicia; Rheinische Friedrich-Wilhelms-Universität Bonn; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; Ministero dello Sviluppo Economico; Centers for Disease Control and Prevention; Institut National Du Cancer; Canadian Institutes of Health Research; Sigrid Juséliuksen Säätiö; National Health and Medical Research Council; Oulun Yliopisto; Deutsche Krebshilfe; KWF Kankerbestrijding; Vetenskapsrådet; Stockholms Läns Landsting; Ligue Contre le Cancer; Kuopion Yliopistollinen Sairaala; Karolinska Institutet; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Air Force Materiel Command; European Regional Development Fund; King's College London; Academy of Finland; Russian Foundation for Basic Research; University of Crete; Institut National de la Santé et de la Recherche Médicale; Cancer Australia; Agence Nationale de la Recherche; National Institute on Aging; Robert Bosch Stiftung; University of Westminster; European Commission; Cancerfonden; National Cancer Institute; Breast Cancer Now; Cancer Institute NSW; Fondation de France; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Breast Cancer Campaign; Eberhard Karls Universität Tübingen; Fondation du cancer du sein du Québec; National Breast Cancer Foundation; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Swedish Cancer Foundation; Agency for Science, Technology and Research; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Gentofte Hospital; Deutsche Gesetzliche Unfallversicherung; University of California, Irvine; Kreftforeningen; David F. and Margaret T. Grohne Family Foundation; Cancer Research UK; U.S. Department of Defense; National Heart, Lung, and Blood Institute; Itä-Suomen Yliopisto; Genome Canada; Sundhed og Sygdom, Det Frie Forskningsråd; Centre International de Recherche sur le Cancer; Deutsches Krebsforschungszentrum; World Cancer Research Fund; Helsingin ja Uudenmaan Sairaanhoitopiiri; Susan G. Komen for the Cure; Stavros Niarchos Foundation; University of Southern California; Associazione Italiana per la Ricerca sul Cancro; Beckman Research Institute, City of Hope; Cancer Council Victoria; California Department of Public Health; Ministerio de Sanidad, Servicios Sociales e Igualdad; University of Cambridge; Government of Canada; U.S. Department of Health and Human Services; American Cancer Society; Breast Cancer Research Foundation; National Institute for Health and Care Research; Norges Forskningsråd; Division of Cancer Prevention, National Cancer Institute","keywords":"Breast cancer; Hazard ratio; Germline; Oncology; Genome-wide association study; Germline mutation; Cancer; Biology; Confidence interval; Internal medicine; Disease; Genetics; Medicine; Gene; Single-nucleotide polymorphism; Mutation; Genotype","score_opus":0.03285698338437489,"score_gpt":0.3435886946455268,"score_spread":0.31073171126115195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918113141","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8207625,0.16549742,0.007043415,0.0011771177,0.0004818486,0.00006511107,0.0035067836,0.00023657158,0.0012292741],"genre_scores_gemma":[0.9891115,0.008183014,0.0011526508,0.00023714108,0.00013765862,0.000038015736,0.00088659517,0.00002922653,0.00022431799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618703,0.001752931,0.00034717584,0.0011122307,0.0003664146,0.00023434103],"domain_scores_gemma":[0.99600047,0.0022710883,0.00066070637,0.0006272132,0.00026629347,0.00017416402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055552702,0.0013573284,0.0019084339,0.0023776102,0.00054253626,0.0014909067,0.00089865614,0.0013214445,0.0014294935],"category_scores_gemma":[0.008145412,0.0007119882,0.010161832,0.0032970214,0.00047876962,0.00048208795,0.0009112343,0.0011692697,0.00019475928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004551921,0.000080256774,0.6582117,0.0022878973,0.30806416,0.0008226582,0.00014421181,0.0037376084,0.0035154887,0.0004309755,0.0012191562,0.016933898],"study_design_scores_gemma":[0.0013901759,0.0011517375,0.56739277,0.00095332856,0.4113546,0.0014067934,0.00021206353,0.0074343896,0.0019208197,0.002196491,0.0045006997,0.000086152635],"about_ca_topic_score_codex":0.004470438,"about_ca_topic_score_gemma":0.00596437,"teacher_disagreement_score":0.0055552702,"about_ca_system_score_codex":0.00045198508,"about_ca_system_score_gemma":0.0005901592,"threshold_uncertainty_score":0.029379427},"labels":[],"label_agreement":null},{"id":"W2920675014","doi":"10.1038/s41416-019-0390-0","title":"The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Addiction and Mental Health; Women's College Hospital; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Institute for Work & Health; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Health Sciences Centre","funders":"National Cancer Institute; Astellas Pharma; Ontario Ministry of Health and Long-Term Care; Canadian Urological Oncology Group; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Canadian Urological Association","keywords":"Cancer; Medicine; Solid organ; Oncology; Psychiatry; Internal medicine; Organ transplantation; Transplantation","score_opus":0.015110196320796672,"score_gpt":0.32595559364100496,"score_spread":0.31084539732020827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920675014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795556,0.00045487104,0.00005585096,0.00025714602,0.000009185589,0.0000073968945,0.00071010663,0.0000031732986,0.000546805],"genre_scores_gemma":[0.9994248,0.00013328934,0.0000237988,0.000023328344,0.000008814715,0.0000027662527,0.000310324,7.82902e-7,0.000072213516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994369,0.00013980553,0.00004744258,0.00006907833,0.00012494365,0.00018182592],"domain_scores_gemma":[0.9967601,0.00052813144,0.0017423445,0.00012640786,0.00025628577,0.00058681355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000621913,0.00015138279,0.00018434513,0.0004997339,0.00043882566,0.0006175652,0.00033647468,0.00023653623,0.0019824216],"category_scores_gemma":[0.004309987,0.00012507665,0.00061886554,0.0007826642,0.0003508695,0.0003400709,0.0006968361,0.00062847487,0.00009891361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006859098,0.000010151461,0.99852437,0.000010501017,0.000041026975,0.000015776408,0.000028502098,0.00005860612,0.000026732125,0.000012530576,0.00007375397,0.0011295447],"study_design_scores_gemma":[0.0000014163729,0.000020655829,0.999731,0.0000062450167,0.000010333358,0.000023260569,0.000052018666,0.00008148079,0.000007949025,0.000010130594,0.00005458532,0.0000010301718],"about_ca_topic_score_codex":0.11532742,"about_ca_topic_score_gemma":0.21188702,"teacher_disagreement_score":0.11532742,"about_ca_system_score_codex":0.0013984777,"about_ca_system_score_gemma":0.0015206315,"threshold_uncertainty_score":0.2293123},"labels":[],"label_agreement":null},{"id":"W2938903157","doi":"10.1038/s41416-019-0446-1","title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; North York General Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"Peter Gilgan Foundation","keywords":"Medicine; BRCA mutation; Breast cancer; Prophylactic Mastectomy; Genetic testing; Ovarian cancer; Cohort; Mastectomy; Cancer; Gynecology; Breast MRI; Obstetrics; Internal medicine; Oncology; Mammography","score_opus":0.008740073433286425,"score_gpt":0.29334209267362016,"score_spread":0.28460201924033374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938903157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879987,0.006210618,0.00010561656,0.0009978184,0.000027692975,0.000012004393,0.0020015703,0.000012748947,0.0026333102],"genre_scores_gemma":[0.99588025,0.0020703,0.00014159697,0.00013875337,0.000012792103,0.000014230014,0.0013165087,0.0000057312054,0.0004197939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911815,0.00023029897,0.00012559311,0.00017334314,0.00019274597,0.00015993106],"domain_scores_gemma":[0.99663454,0.0005736055,0.0016332103,0.000118186894,0.0007120475,0.0003284535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010420579,0.0001404311,0.00028320213,0.0011278362,0.00020365695,0.000634715,0.00042658605,0.00059456297,0.0016545305],"category_scores_gemma":[0.004382482,0.00021156073,0.0003903965,0.001970615,0.00027668948,0.000585363,0.0005250443,0.0005544186,0.00035095296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013692779,0.000037341197,0.9856419,0.00012816508,0.00009606164,0.000092553266,0.0007334446,0.00016461071,0.00019307499,0.00006885312,0.0008936382,0.01181344],"study_design_scores_gemma":[0.0000043643454,0.000047364472,0.9979381,0.000048246908,0.000017208444,0.00021890084,0.0005886052,0.0000879471,0.000047231137,0.000012896854,0.0009844336,0.000004742637],"about_ca_topic_score_codex":0.0393937,"about_ca_topic_score_gemma":0.02729102,"teacher_disagreement_score":0.0393937,"about_ca_system_score_codex":0.0007793111,"about_ca_system_score_gemma":0.00041573466,"threshold_uncertainty_score":0.07832879},"labels":[],"label_agreement":null},{"id":"W2945221383","doi":"10.1038/s41416-019-0474-x","title":"A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"Pfizer Canada; Pfizer","keywords":"Paraganglioma; Sunitinib; SDHB; Medicine; Clinical endpoint; SDHA; Pheochromocytoma; Progressive disease; Internal medicine; Surgery; Metanephrines; Phases of clinical research; Oncology; Germline mutation; Randomized controlled trial; Chemotherapy; Cancer; Mutation","score_opus":0.014188885390452086,"score_gpt":0.31691925745473953,"score_spread":0.30273037206428743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945221383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98805064,0.0046803285,0.0004469565,0.0008115983,0.00018881865,0.00146082,0.0012022005,0.00010861354,0.0030501157],"genre_scores_gemma":[0.99013877,0.002114045,0.00087649794,0.0007315164,0.00018153743,0.0014738755,0.0020420977,0.00001692947,0.0024247225],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99968565,0.00017230371,0.000014721052,0.000047990598,0.000032313677,0.000047035945],"domain_scores_gemma":[0.9996182,0.000087359935,0.00009542115,0.000021577574,0.000028155482,0.00014926257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014198155,0.0010396324,0.001134364,0.00026064352,0.0002838019,0.00057079236,0.0004787066,0.0009003763,0.0040792692],"category_scores_gemma":[0.00074602437,0.00023624527,0.0009906971,0.00019103254,0.00035329274,0.0005869312,0.00028331717,0.0017979839,0.00049415935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.762888,0.014507675,0.011737065,0.002884864,0.0032206827,0.0006264817,0.0003161903,0.0061261165,0.017980648,0.00063507183,0.011772928,0.1673043],"study_design_scores_gemma":[0.7892978,0.17717344,0.019333702,0.00013269806,0.0009544981,0.0008573148,0.00008064448,0.002901841,0.0028529207,0.0005613043,0.0058128606,0.000041018262],"about_ca_topic_score_codex":0.0004910427,"about_ca_topic_score_gemma":0.0020228096,"teacher_disagreement_score":0.0040792692,"about_ca_system_score_codex":0.00061070116,"about_ca_system_score_gemma":0.00090296956,"threshold_uncertainty_score":0.013646543},"labels":[],"label_agreement":null},{"id":"W2948620437","doi":"10.1038/s41416-019-0494-6","title":"Reply to Comment on: “The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies’’","year":2019,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Centre for Addiction and Mental Health; Institute for Work & Health; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Solid organ; Cancer; Medicine; Psychiatry; Oncology; Intensive care medicine; Internal medicine; Organ transplantation; Transplantation","score_opus":0.20355364682130797,"score_gpt":0.4270784520811215,"score_spread":0.22352480525981352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948620437","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052639196,0.0006392613,0.00003283989,0.9849278,0.01254567,0.000008861372,0.00040592518,0.000012337329,0.0009010126],"genre_scores_gemma":[0.0018990785,0.00029551907,0.000040670333,0.9844848,0.009778864,0.000033069322,0.000096790995,0.000012176875,0.0033589946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99433124,0.0012567119,0.001043897,0.00069025124,0.0012119152,0.0014660014],"domain_scores_gemma":[0.97723764,0.014314354,0.0025311895,0.0005113275,0.0025644249,0.0028409658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066664238,0.0008623066,0.0018747072,0.0010429278,0.0040067374,0.004365981,0.0027234785,0.07720892,0.0093925595],"category_scores_gemma":[0.04553794,0.001201109,0.002017701,0.0019242128,0.0024376034,0.0035860226,0.0028409385,0.04772015,0.006412368],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010549137,0.000016376314,0.0013597227,0.00006232062,0.000027202557,0.00037686026,0.00013485862,0.000055265693,0.00004927462,0.0008246699,0.994888,0.0020999429],"study_design_scores_gemma":[0.00037829386,0.00014285235,0.016575556,0.0013371772,0.00018936922,0.0009951177,0.001435294,0.0007545935,0.00047003216,0.006715928,0.9707372,0.00026872166],"about_ca_topic_score_codex":0.04748501,"about_ca_topic_score_gemma":0.0747257,"teacher_disagreement_score":0.07720892,"about_ca_system_score_codex":0.008009553,"about_ca_system_score_gemma":0.011490853,"threshold_uncertainty_score":0.094417214},"labels":[],"label_agreement":null},{"id":"W2948836473","doi":"10.1038/s41416-019-0484-8","title":"Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?","year":2019,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BRCA mutation; Medicine; Ovarian cancer; Cancer; Oncology; Breast cancer; Cancer prevention; Mutation; Internal medicine; Gynecology; Genetics; Biology; Gene","score_opus":0.025781895547536016,"score_gpt":0.30671751785145696,"score_spread":0.28093562230392094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948836473","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001131834,0.003171618,0.00009876734,0.9853076,0.008271929,0.0000067948863,0.000024097755,0.00001443031,0.0019729456],"genre_scores_gemma":[0.024023302,0.012731226,0.0005823418,0.8615427,0.09210856,0.00004109051,0.000061153136,0.00002855288,0.008881028],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977181,0.00083221856,0.00035005913,0.00019602578,0.00056839467,0.00033527723],"domain_scores_gemma":[0.9928093,0.0038787655,0.00043796605,0.00021806823,0.0012253098,0.0014305405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023742544,0.00046174272,0.0011895472,0.0006212634,0.0018592372,0.0017709672,0.00082388293,0.022236679,0.0065071816],"category_scores_gemma":[0.017908378,0.00038578323,0.0006400052,0.00064590375,0.0015220469,0.0030553276,0.0009799625,0.016856859,0.004386185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017629884,0.000114146256,0.0049902177,0.00028508343,0.000020577552,0.016946934,0.00043113937,0.0001369209,0.0007367482,0.0034650026,0.9152775,0.057419393],"study_design_scores_gemma":[0.00028544103,0.0005077859,0.009838122,0.002170112,0.00006643386,0.063723765,0.0019151773,0.0010990578,0.0006305925,0.022754185,0.89689624,0.0001130823],"about_ca_topic_score_codex":0.0043867994,"about_ca_topic_score_gemma":0.006798971,"teacher_disagreement_score":0.022236679,"about_ca_system_score_codex":0.0024080835,"about_ca_system_score_gemma":0.0020044853,"threshold_uncertainty_score":0.02176869},"labels":[],"label_agreement":null},{"id":"W2949918164","doi":"10.1038/s41416-019-0395-8","title":"MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; National Health and Medical Research Council; Medical Research Council; University of Queensland; National Breast Cancer Foundation; Tenovus; National Institutes of Health; U.S. Department of Health and Human Services; Cancer Research UK; Cardiff University","keywords":"Breast cancer; microRNA; Biomarker; Oncology; Cancer research; Medicine; Cancer; Pathology; Internal medicine; Biology; Gene; Genetics","score_opus":0.004789210654814933,"score_gpt":0.24470176672865,"score_spread":0.23991255607383505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949918164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897244,0.0047092494,0.0016324534,0.00022177916,0.000048267884,0.000020164383,0.0007754722,0.00008745354,0.0027807753],"genre_scores_gemma":[0.99626535,0.0007549857,0.0016898068,0.00004029615,0.000023719811,0.00001350571,0.0004994219,0.000014819009,0.0006981344],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99980026,0.00004169226,0.000025600115,0.000047587135,0.00006102546,0.000023811419],"domain_scores_gemma":[0.9996444,0.00007684819,0.00017798046,0.00002348837,0.00003772245,0.000039482115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003007026,0.00017240677,0.00024696477,0.000525645,0.00014081204,0.00041415697,0.00013867288,0.00026472806,0.0014613102],"category_scores_gemma":[0.000793737,0.00014010769,0.00013130234,0.000587185,0.000225762,0.00015646499,0.000153599,0.000250923,0.00064562407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047959047,0.0001135013,0.2951634,0.00024039687,0.00008787982,0.0011937091,0.00015050337,0.00046769288,0.66234165,0.00036131957,0.00094343215,0.034140628],"study_design_scores_gemma":[0.0000588836,0.0008049951,0.8237225,0.000040246796,0.0001373154,0.008096748,0.00017551739,0.002028024,0.15441322,0.00063149905,0.009863095,0.000027930137],"about_ca_topic_score_codex":0.00017052301,"about_ca_topic_score_gemma":0.00020110577,"teacher_disagreement_score":0.0014613102,"about_ca_system_score_codex":0.00018531832,"about_ca_system_score_gemma":0.00010873276,"threshold_uncertainty_score":0.0048885345},"labels":[],"label_agreement":null},{"id":"W2952644236","doi":"10.1038/s41416-019-0492-8","title":"Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; University of Toronto; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Jonsson Comprehensive Cancer Center; National Center for Advancing Translational Sciences; European Regional Development Fund; Canadian Institutes of Health Research; lékařská fakulta Univerzity Karlovy; Manchester Biomedical Research Centre; University of California, San Francisco; National Institutes of Health; Kerry Group Kuok Foundation; Freistaat Sachsen; Centro de Investigación Biomédica en Red de Cáncer; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Medical Research Council; Uppsala Universitet; National Institute of General Medical Sciences; Institut National Du Cancer; Deutsche Krebshilfe; Sahlgrenska Universitetssjukhuset; Associazione Italiana per la Ricerca sul Cancro; Ovarian Cancer Research Fund; Ministerio de Economía y Competitividad; Landspítali Háskólasjúkrahús; Linköpings Universitet; Hungarian Scientific Research Fund; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Generalitat de Catalunya; Russian Foundation for Basic Research; Cancer Association of South Africa; Ministerstvo Školství, Mládeže a Tělovýchovy; National Breast Cancer Foundation; European Commission; National Institute for Health and Care Research; KWF Kankerbestrijding; Cancer Research UK; Government of Canada; National Cancer Institute; Liga Portuguesa Contra o Cancro; Hospital de Câncer de Barretos; NRG Oncology; Memorial Sloan-Kettering Cancer Center; Fondation du cancer du sein du Québec; Israel Cancer Association; Institut Català de la Salut; University of Pennsylvania; Fundación Mutua Madrileña; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Genome Canada; Breast Cancer Research Foundation; McGill University; Univerzita Karlova v Praze; Unicancer; Clalit Health Services; Deutsches Krebsforschungszentrum; American Cancer Society; Fonds Wetenschappelijk Onderzoek; Cancer Center, University of Kansas; Cancerfonden; Ministério da Ciência, Tecnologia e Inovação; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; Beth Israel Deaconess Medical Center; Alpha Omega Alpha Honor Medical Society; Georgetown University; Susan G. Komen for the Cure; Instituto de Salud Carlos III; Ohio State University; Cancer Australia; National Health and Medical Research Council; Jewish General Hospital; Fundación Cellex; Fisher Center for Alzheimer's Research Foundation; Istituto Oncologico Veneto; Umeå Universitet; Royal Marsden NHS Foundation Trust; European Social Fund; University of Chicago; Lietuvos Mokslo Taryba","keywords":"Ovarian cancer; Body mass index; Oncology; Medicine; Mendelian inheritance; Mutation; Internal medicine; Cancer; Genetics; Biology; Gynecology; Gene","score_opus":0.007762646086976757,"score_gpt":0.27740165255938026,"score_spread":0.2696390064724035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952644236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832185,0.0010060228,0.01341837,0.00011953932,0.00008809016,0.00095268205,0.0007076269,0.00008011282,0.00040890748],"genre_scores_gemma":[0.98936594,0.00020974076,0.00679691,0.00015738128,0.000045976885,0.0011078074,0.0011453286,0.000036949525,0.0011340415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98745245,0.009013765,0.0006260774,0.0016547086,0.00078879006,0.00046413625],"domain_scores_gemma":[0.98762286,0.006197327,0.0017362031,0.0035676558,0.00044719738,0.00042872725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015233657,0.0013393346,0.001724886,0.0012099941,0.000755891,0.00073779974,0.0015141014,0.0013582471,0.002487585],"category_scores_gemma":[0.030204752,0.0013036043,0.00244821,0.0015685151,0.00096566614,0.0005231071,0.0007313539,0.0012260957,0.0003644978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07782694,0.0016018413,0.8555046,0.0005417613,0.019283682,0.0030621162,0.0012613132,0.004093551,0.0065160017,0.0031502775,0.0026834325,0.02447448],"study_design_scores_gemma":[0.041575752,0.019685676,0.82993764,0.00015733382,0.01782301,0.005114745,0.00052122807,0.06720276,0.0029063574,0.0075311344,0.007240487,0.00030392903],"about_ca_topic_score_codex":0.007840421,"about_ca_topic_score_gemma":0.0042994227,"teacher_disagreement_score":0.015233657,"about_ca_system_score_codex":0.0008198735,"about_ca_system_score_gemma":0.00097171403,"threshold_uncertainty_score":0.0805642},"labels":[],"label_agreement":null},{"id":"W2954453700","doi":"10.1038/s41416-019-0497-3","title":"Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"Terry Fox Research Institute; Terry Fox Foundation; Princess Margaret Cancer Foundation; University Health Network","keywords":"Plerixafor; Medicine; CXCR4; CXCR4 antagonist; Adjuvant; Cervical cancer; Oncology; Pharmacology; Cancer; Cancer research; Internal medicine; Chemokine; Inflammation","score_opus":0.007337979713770473,"score_gpt":0.2382224553489057,"score_spread":0.23088447563513523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954453700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886375,0.0038535835,0.00346462,0.00039042975,0.00007658622,0.00028922525,0.000912895,0.00021146858,0.0021637073],"genre_scores_gemma":[0.9921606,0.0012708,0.003654463,0.000057094967,0.000012538106,0.00023648421,0.00065526634,0.000028539387,0.0019242623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999767,0.00005258793,0.00001583666,0.00003269475,0.00007177101,0.00006011604],"domain_scores_gemma":[0.9999013,0.000015021627,0.000024278323,0.00001495556,0.000013283014,0.00003114433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034098365,0.00039664778,0.00058488065,0.0003164333,0.00018110026,0.00039836153,0.00040570562,0.00036087958,0.0028238103],"category_scores_gemma":[0.00015386051,0.00018595092,0.0002640963,0.00028026282,0.00033608355,0.00021391141,0.00023151838,0.00108066,0.00050759397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016598309,0.00066323276,0.00063477905,0.00023499639,0.000028084016,0.000062275154,0.000055633463,0.0010039072,0.9866419,0.0001915771,0.00067797344,0.008145832],"study_design_scores_gemma":[0.00038453282,0.0073949494,0.0072882515,0.000020761256,0.00010396688,0.00054749846,0.00005477489,0.0034269996,0.9708421,0.000073379364,0.009847072,0.000015629954],"about_ca_topic_score_codex":0.0015743393,"about_ca_topic_score_gemma":0.002644774,"teacher_disagreement_score":0.0028238103,"about_ca_system_score_codex":0.0008234509,"about_ca_system_score_gemma":0.0006518932,"threshold_uncertainty_score":0.009446561},"labels":[],"label_agreement":null},{"id":"W2957828588","doi":"10.1038/s41416-019-0517-3","title":"Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; University of California, Los Angeles; University of Toronto; Princess Margaret Cancer Foundation; California Institute of Regenerative Medicine; California Institute for Regenerative Medicine","keywords":"Tolerability; Medicine; Dosing; Neutropenia; Pharmacokinetics; Cmax; Adverse effect; Pharmacodynamics; Response Evaluation Criteria in Solid Tumors; Internal medicine; Pharmacology; Clinical trial; Oncology; Phases of clinical research; Toxicity","score_opus":0.004839703614920863,"score_gpt":0.27295384514515486,"score_spread":0.268114141530234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957828588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581236,0.0008157548,0.00028596295,0.00018527942,0.00003486926,0.00075829856,0.00065984804,0.00007840976,0.0013691856],"genre_scores_gemma":[0.9952252,0.00057534996,0.0004723871,0.00033364596,0.000056026754,0.00067432673,0.0012542709,0.000018192555,0.0013905921],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995745,0.000174506,0.000024541778,0.00006488382,0.00006420892,0.00009736909],"domain_scores_gemma":[0.9995334,0.000087186156,0.00011953198,0.000040827803,0.000036629583,0.00018245232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012119602,0.00093667186,0.0012295839,0.0003880121,0.00035236336,0.0008135205,0.0006383285,0.0012169391,0.003371097],"category_scores_gemma":[0.00081106904,0.00033736505,0.0008597072,0.00033658856,0.0005966867,0.00063367747,0.0002504992,0.0020621342,0.0006186008],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66342306,0.048331425,0.0079733,0.0008709953,0.0009585409,0.00045726044,0.00031930467,0.0065694256,0.0766885,0.00050479104,0.0055871652,0.18831618],"study_design_scores_gemma":[0.38307315,0.56556785,0.026702845,0.000068116016,0.0005273041,0.0007559171,0.00008247644,0.0043680295,0.012879231,0.00055227225,0.0053601423,0.00006274675],"about_ca_topic_score_codex":0.0007198255,"about_ca_topic_score_gemma":0.001012247,"teacher_disagreement_score":0.003371097,"about_ca_system_score_codex":0.0011210862,"about_ca_system_score_gemma":0.0010197156,"threshold_uncertainty_score":0.011277437},"labels":[],"label_agreement":null},{"id":"W2965977634","doi":"10.1038/s41416-019-0543-1","title":"Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of Texas MD Anderson Cancer Center; University of Oxford; Kaiser Permanente","keywords":"Medicine; Hazard ratio; Chemotherapy; Internal medicine; Ovarian cancer; Confidence interval; EPIC; Surgery; Oncology; Cancer","score_opus":0.01479247279584464,"score_gpt":0.30574270759039074,"score_spread":0.2909502347945461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965977634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830088,0.009408051,0.0007335716,0.00045268878,0.00073433877,0.004115792,0.00051801826,0.00006669236,0.0009619866],"genre_scores_gemma":[0.985416,0.004556951,0.0015242047,0.00095807045,0.00074475544,0.005139714,0.00046531126,0.000014534855,0.0011804263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979419,0.0015002418,0.00013263314,0.00018937532,0.0001022778,0.00013350371],"domain_scores_gemma":[0.9979017,0.0010109704,0.00044891716,0.00018945278,0.00008612134,0.00036285128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002877033,0.0012243591,0.0031052334,0.00052642514,0.0003502604,0.0008927865,0.0008287817,0.0019434829,0.003890444],"category_scores_gemma":[0.0034372285,0.00054579193,0.002719181,0.00059410697,0.0011778163,0.0007183498,0.0004674138,0.0023859956,0.00032889453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9841319,0.0047817333,0.00030120372,0.0006627475,0.00095668505,0.000020545842,0.000021709617,0.0001369337,0.00080163695,0.000040038005,0.00014455593,0.00800027],"study_design_scores_gemma":[0.9490404,0.048804488,0.0010025474,0.00004354514,0.0005866036,0.000012860593,0.000008478652,0.00013605566,0.0001119789,0.000055098888,0.00019064317,0.00000721255],"about_ca_topic_score_codex":0.00075443514,"about_ca_topic_score_gemma":0.0013691657,"teacher_disagreement_score":0.003890444,"about_ca_system_score_codex":0.0006704291,"about_ca_system_score_gemma":0.0007995569,"threshold_uncertainty_score":0.015215337},"labels":[],"label_agreement":null},{"id":"W2972107575","doi":"10.1038/s41416-019-0565-8","title":"Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary; Cumming School of Medicine, University of Calgary; National Cancer Institute; U.S. Department of Health and Human Services; Government of Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Olaparib; Cancer research; Ataxia-telangiectasia; PARP inhibitor; Poly ADP ribose polymerase; Lung cancer; Adenocarcinoma; Cancer; Biology; Molecular biology; Medicine; DNA damage; Pathology; Polymerase; Genetics; DNA","score_opus":0.006268429481743964,"score_gpt":0.27431340489859357,"score_spread":0.26804497541684963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972107575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795091,0.008704658,0.004200075,0.00028038534,0.00012469415,0.00012416292,0.0012313706,0.00037799322,0.005447579],"genre_scores_gemma":[0.993299,0.0016116013,0.0020539863,0.00007929879,0.000015211042,0.000058205103,0.0009390916,0.000029763889,0.0019138423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979144,0.00001752463,0.000022859349,0.000047245037,0.0000785088,0.000042422897],"domain_scores_gemma":[0.99989545,0.00001993906,0.00002621835,0.000019578894,0.000014442575,0.000024361423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013760962,0.00033829146,0.00046991155,0.00025453785,0.00016535104,0.0004786325,0.0004067336,0.00038093948,0.0026296135],"category_scores_gemma":[0.00010318544,0.000114840695,0.0003963533,0.00029466537,0.00018365249,0.00017857226,0.00024419322,0.0007729616,0.0008867947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037270266,0.00030259622,0.0006120347,0.00012274325,0.000038640927,0.00011147691,0.00001245271,0.00029677348,0.9903756,0.00006659829,0.00034978538,0.007338696],"study_design_scores_gemma":[0.000089934285,0.0015020847,0.006093267,0.000009168679,0.000063204,0.0006893135,0.000016863492,0.0011130702,0.9857825,0.00003537186,0.0045978604,0.0000072816315],"about_ca_topic_score_codex":0.00050589856,"about_ca_topic_score_gemma":0.0011351893,"teacher_disagreement_score":0.0026296135,"about_ca_system_score_codex":0.0003117405,"about_ca_system_score_gemma":0.00021816633,"threshold_uncertainty_score":0.00879693},"labels":[],"label_agreement":null},{"id":"W2972995783","doi":"10.1038/s41416-020-01106-x","title":"Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Dental and Craniofacial Research; National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute","keywords":"Medicine; Internal medicine; Neutrophil to lymphocyte ratio; Proportional hazards model; Gastroenterology; Cancer; Radiation therapy; Oncology; Lymphocyte","score_opus":0.008582742535465118,"score_gpt":0.25138728573217484,"score_spread":0.24280454319670972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972995783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787796,0.0013710911,0.00008813147,0.000059400925,0.00000983027,0.000007244572,0.00019592578,0.000005545798,0.00038477522],"genre_scores_gemma":[0.9995198,0.00010547984,0.00005540683,0.000017115053,0.000009822528,0.0000055266323,0.00021070142,0.0000013216137,0.000074974945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997496,0.00006646151,0.000031713407,0.000047511672,0.00005510914,0.000049646947],"domain_scores_gemma":[0.99865866,0.0003591257,0.0006379579,0.00006421865,0.00012466195,0.00015530078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043635312,0.00016216142,0.00027118073,0.00027437642,0.000195505,0.00039887757,0.00029151427,0.00029174087,0.0011565199],"category_scores_gemma":[0.0023069892,0.00009412382,0.00024927626,0.00038130372,0.00020845432,0.00031705506,0.00022451546,0.00050557725,0.00022209255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022036387,0.000013493337,0.9977068,0.000010448254,0.0000186366,0.00004584859,0.0000135275595,0.000044716515,0.00014806881,0.0000059634813,0.000066093846,0.0017059919],"study_design_scores_gemma":[0.000009254662,0.00014036747,0.9986186,0.000006947788,0.00003019666,0.00050444197,0.000052724612,0.00018306583,0.00013678163,0.000022662305,0.00029124282,0.0000036485083],"about_ca_topic_score_codex":0.0010000275,"about_ca_topic_score_gemma":0.0014740054,"teacher_disagreement_score":0.0011565199,"about_ca_system_score_codex":0.00030793148,"about_ca_system_score_gemma":0.00027668604,"threshold_uncertainty_score":0.0038689375},"labels":[],"label_agreement":null},{"id":"W2975219771","doi":"10.1038/s41416-019-0586-3","title":"Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Memorial University of Newfoundland; Canadian Cancer Society Research Institute; Terry Fox Foundation; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Photodynamic therapy; Medicine; Cancer research; Pharmacology; Dermatology; Chemistry","score_opus":0.01561563260470442,"score_gpt":0.32755857130427307,"score_spread":0.31194293869956863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975219771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135345,0.0036485782,0.0019684255,0.00011317215,0.00004076133,0.00004508255,0.00014071708,0.00015925411,0.0025305075],"genre_scores_gemma":[0.9972385,0.0007692095,0.0007071789,0.000018515599,0.000007677939,0.000017101394,0.00010466807,0.000011973977,0.0011250833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999902,0.000014247777,0.00000670538,0.000020080193,0.000026396852,0.000030689353],"domain_scores_gemma":[0.99993813,0.00001495216,0.000014163564,0.0000065154477,0.000007824057,0.000018290999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001201327,0.00032301893,0.00043528207,0.00017620735,0.00009306478,0.0002778746,0.00018373289,0.00020811215,0.0017955748],"category_scores_gemma":[0.00008161772,0.000076235476,0.00017461841,0.00008932471,0.00017052024,0.00017176715,0.00016573477,0.00052259903,0.0003193296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005443884,0.00016489343,0.0001953059,0.00012370916,0.000014654215,0.00003085141,0.000011806681,0.0002276786,0.9917853,0.000102108315,0.00016162886,0.0066377567],"study_design_scores_gemma":[0.00004322737,0.001529734,0.002318167,0.000008677127,0.000039186947,0.00016710031,0.000009513887,0.0009943481,0.99257326,0.00002162753,0.002291567,0.0000036411773],"about_ca_topic_score_codex":0.0005240179,"about_ca_topic_score_gemma":0.0008879881,"teacher_disagreement_score":0.0017955748,"about_ca_system_score_codex":0.00031008056,"about_ca_system_score_gemma":0.0002234628,"threshold_uncertainty_score":0.0060067177},"labels":[],"label_agreement":null},{"id":"W2975775173","doi":"10.1038/s41416-019-0580-9","title":"Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Health and Medical Research Council; Cedars-Sinai Medical Center; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Medical Research Council; California Department of Public Health; University of Southern California","keywords":"Lynch syndrome; Medicine; Colorectal cancer; Internal medicine; Diabetes mellitus; Triglyceride; Cholesterol; Metabolic syndrome; Type 2 Diabetes Mellitus; Type 2 diabetes; Endocrinology; Oncology; Cancer; Gastroenterology","score_opus":0.006566736898579511,"score_gpt":0.25219068415677515,"score_spread":0.24562394725819564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975775173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949479,0.0037981297,0.000111014975,0.00022512682,0.000020424493,0.000004974468,0.00034431924,0.000005467903,0.0005425779],"genre_scores_gemma":[0.9986203,0.00075919984,0.00012861284,0.000034703968,0.000017284838,0.0000041023227,0.00022152714,0.0000014021542,0.00021299647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987423,0.00004794036,0.000012740372,0.000021475043,0.000023576413,0.00001996899],"domain_scores_gemma":[0.9993697,0.00019157276,0.00028250477,0.00003295932,0.000032605232,0.00009068072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037054642,0.00015464389,0.0001937598,0.00045519005,0.00015894024,0.00029045145,0.000134179,0.00034920414,0.002323388],"category_scores_gemma":[0.0017319451,0.0001598514,0.0003175524,0.00065206626,0.000113526075,0.00012867135,0.00019734226,0.0003307163,0.00013815406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023564874,0.000021836815,0.99692374,0.00003000933,0.00008707171,0.00011559928,0.000022055,0.00005610065,0.0001405236,0.000019260264,0.0001259769,0.0022221166],"study_design_scores_gemma":[0.000014765874,0.00007274745,0.9989716,0.000014442157,0.00007200785,0.00036538552,0.000027824848,0.00015933068,0.0000330352,0.000041581334,0.00022521144,0.0000021321796],"about_ca_topic_score_codex":0.007966788,"about_ca_topic_score_gemma":0.00819815,"teacher_disagreement_score":0.007966788,"about_ca_system_score_codex":0.00017930215,"about_ca_system_score_gemma":0.00019060622,"threshold_uncertainty_score":0.015840828},"labels":[],"label_agreement":null},{"id":"W2982313632","doi":"10.1038/s41416-019-0610-7","title":"Phospholipase D2 in prostate cancer: protein expression changes with Gleason score","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Prostate Cancer UK; Cancer and Polio Research Fund; Daphne Jackson Trust; Barts Charity; Vanderbilt University","keywords":"PLD2; Prostate cancer; Cancer research; Biology; Stromal cell; Carcinogenesis; Viability assay; Phospholipase D; Cell growth; LNCaP; Cell; Cancer; Cell biology; Phosphatidic acid; Signal transduction; Biochemistry; Phospholipid","score_opus":0.0065937933782848025,"score_gpt":0.24096294008594965,"score_spread":0.23436914670766484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982313632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835746,0.011151589,0.0012947578,0.0002507933,0.000021930464,0.000021718522,0.0016882841,0.0001476347,0.0018487419],"genre_scores_gemma":[0.9952591,0.0018626541,0.00064388517,0.000039744293,0.000015138699,0.000018783438,0.00086306303,0.000010131069,0.0012874713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999946,0.00000970314,0.0000035649182,0.00001568066,0.000016117172,0.000008930337],"domain_scores_gemma":[0.99988484,0.00001616244,0.0000496575,0.000007199121,0.000012948029,0.000029038476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001329576,0.00021088246,0.00015452655,0.00073500455,0.000088865505,0.00034226017,0.00011558325,0.00025948707,0.0025315422],"category_scores_gemma":[0.00021063148,0.000095446405,0.00012447045,0.00092241657,0.00016512479,0.00016373224,0.00017711612,0.00033518104,0.00042351318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046762964,0.00014684416,0.21336223,0.0004988782,0.00019899929,0.000614852,0.00013334214,0.00062884064,0.73713154,0.00024463327,0.0013552053,0.04100824],"study_design_scores_gemma":[0.000044774257,0.00037615534,0.9437185,0.000014701389,0.00007875953,0.0022838812,0.000088637644,0.0007562963,0.04856902,0.0002083556,0.0038454095,0.000015508493],"about_ca_topic_score_codex":0.0006259421,"about_ca_topic_score_gemma":0.000484676,"teacher_disagreement_score":0.0025315422,"about_ca_system_score_codex":0.0002664248,"about_ca_system_score_gemma":0.000113088056,"threshold_uncertainty_score":0.008468807},"labels":[],"label_agreement":null},{"id":"W2988054158","doi":"10.1038/s41416-019-0665-5","title":"Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Oxford Cancer Imaging Centre; Medical Research Council; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Metformin; Transcriptome; Beta oxidation; Breast cancer; Gene expression profiling; Biology; Fatty acid; Medicine; AMPK; Cancer research; Cancer; Internal medicine; Bioinformatics; Pharmacology; Diabetes mellitus; Endocrinology; Gene expression; Gene; Biochemistry; Enzyme","score_opus":0.0066505518849471566,"score_gpt":0.2717331820543189,"score_spread":0.2650826301693717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988054158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861013,0.002375835,0.0014214651,0.00021244684,0.000032412492,0.00007065085,0.008722428,0.00004283859,0.0010206391],"genre_scores_gemma":[0.97321635,0.0024216513,0.0033173806,0.0002541762,0.000027120223,0.00016424409,0.018346189,0.000018456132,0.0022345325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986863,0.00001821125,0.000008751346,0.00003012773,0.000042124648,0.00003228247],"domain_scores_gemma":[0.99987817,0.000039536793,0.000025133464,0.000009627647,0.000033039832,0.000014514801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014024174,0.00014502007,0.00033901838,0.00047561873,0.0002460376,0.00027187943,0.000087031905,0.00021066118,0.0015984328],"category_scores_gemma":[0.00029136144,0.00008652951,0.0002960288,0.00081598153,0.00012714544,0.00007410832,0.0002038627,0.00022328392,0.0004321756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018236156,0.00006326398,0.028231127,0.00027481088,0.000054797838,0.00024886834,0.00011568575,0.00031030647,0.95676845,0.00006434413,0.0007145258,0.011330207],"study_design_scores_gemma":[0.00008681907,0.001195985,0.8069725,0.000059074617,0.00026025894,0.0015312594,0.0005688759,0.0026465019,0.17769888,0.0002842918,0.008671208,0.000024299401],"about_ca_topic_score_codex":0.0009778244,"about_ca_topic_score_gemma":0.0019006967,"teacher_disagreement_score":0.0015984328,"about_ca_system_score_codex":0.00022058302,"about_ca_system_score_gemma":0.0002692973,"threshold_uncertainty_score":0.0053473115},"labels":[],"label_agreement":null},{"id":"W2991054518","doi":"10.1038/s41416-019-0649-5","title":"FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Biotechnology and Biological Sciences Research Council; Almac Group; Almac Discovery; Medical Research Council; Department of Education and Learning, Northern Ireland","keywords":"Angiogenesis; Vasculogenic mimicry; Ovarian cancer; Cancer research; CD44; Cancer stem cell; Tissue microarray; Cancer; Immunohistochemistry; Medicine; Stem cell; Biology; Pathology; Cell; Internal medicine; Metastasis","score_opus":0.008069950884891174,"score_gpt":0.2466495777040419,"score_spread":0.2385796268191507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991054518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883354,0.008232664,0.0012200634,0.00026080964,0.000031000207,0.00006086413,0.00014283204,0.00006482828,0.0016515872],"genre_scores_gemma":[0.99659365,0.001672152,0.0008484142,0.00006325828,0.000018331302,0.000022029768,0.00014532066,0.0000043280056,0.0006324758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993515,0.000012997401,0.000005221651,0.000008937662,0.000017743328,0.00001995138],"domain_scores_gemma":[0.9999443,0.000011985005,0.000019092933,0.0000033772326,0.0000064443107,0.000014805223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014415536,0.00018560993,0.00015784647,0.00023940753,0.0001013892,0.00020787041,0.00011748965,0.00033464847,0.0009512134],"category_scores_gemma":[0.00010644673,0.000056852965,0.000092090966,0.00015970759,0.0002109064,0.000115821895,0.0001365924,0.00029893298,0.00025863224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071423483,0.00015114628,0.001514046,0.0003252987,0.000010473266,0.0002475974,0.000040119965,0.0005453753,0.9693625,0.0001635508,0.00034025562,0.026585378],"study_design_scores_gemma":[0.0005034395,0.009201061,0.02342702,0.000054870907,0.000081538135,0.0036665406,0.000095411335,0.0021555366,0.94304,0.00024694513,0.017511595,0.000016082906],"about_ca_topic_score_codex":0.00028079987,"about_ca_topic_score_gemma":0.00056687894,"teacher_disagreement_score":0.0009512134,"about_ca_system_score_codex":0.0002994647,"about_ca_system_score_gemma":0.00016607536,"threshold_uncertainty_score":0.0031821132},"labels":[],"label_agreement":null},{"id":"W2991497553","doi":"10.1038/s41416-019-0645-9","title":"Genotype–phenotype correlation in BRCA1/2 mutation-associated pancreatic cancer","year":2019,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Pancreatic cancer; Phenotype; Synthetic lethality; Genotype; Germline mutation; Biology; Mutation; Cancer research; Genetics; Germline; Homologous recombination; BRCA2 Protein; Population; PARP inhibitor; DNA repair; Cancer; Poly ADP ribose polymerase; Medicine; DNA; Gene; Polymerase","score_opus":0.017641569561614383,"score_gpt":0.30194003280151366,"score_spread":0.28429846323989927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991497553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8926807,0.005447623,0.0029153072,0.059056636,0.0024802678,0.000080526304,0.00069068687,0.0002210474,0.036427245],"genre_scores_gemma":[0.98423713,0.0016977601,0.00090108777,0.007214428,0.002329391,0.000020932144,0.00014893868,0.000038055157,0.003412269],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9996288,0.000107082,0.000049463924,0.000067347064,0.00008954565,0.000057809222],"domain_scores_gemma":[0.9988212,0.00066767423,0.00013856258,0.000099798875,0.00013435453,0.00013840014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041208588,0.00029133118,0.00052280904,0.00050421624,0.00037133426,0.00048053195,0.00025851539,0.0021098354,0.0027816484],"category_scores_gemma":[0.0031785606,0.00017837997,0.00015329993,0.0005694051,0.00042180062,0.0003680273,0.00024747837,0.00095901923,0.0010188387],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013448738,0.00019186175,0.28886372,0.00019161489,0.00005393182,0.61396676,0.00044857242,0.00073967286,0.011628859,0.0019337521,0.03033153,0.050304867],"study_design_scores_gemma":[0.00008483415,0.00037551968,0.18574817,0.000075908836,0.00004998446,0.78253657,0.00027314184,0.0030114662,0.0014752113,0.0035432042,0.022779083,0.00004690982],"about_ca_topic_score_codex":0.0005080398,"about_ca_topic_score_gemma":0.0006983212,"teacher_disagreement_score":0.0027816484,"about_ca_system_score_codex":0.00035415974,"about_ca_system_score_gemma":0.00014425327,"threshold_uncertainty_score":0.009305596},"labels":[],"label_agreement":null},{"id":"W2992176081","doi":"10.1038/s41416-019-0640-1","title":"Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the Jak1/STAT3/ERK1/2 and adenylate cyclase/PKA, respectively","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universidade Federal do Rio de Janeiro; Institut National Du Cancer; Ministério da Ciência, Tecnologia e Inovação; Johns Hopkins University; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Université Laval; American University of Beirut","keywords":"PKM2; Adenylyl cyclase; Biology; Glycolysis; Anaerobic glycolysis; Downregulation and upregulation; Pyruvate kinase; Cancer cell; Cell biology; Signal transduction; Endocrinology; Chemistry; Internal medicine; Biochemistry; Metabolism; Cancer; Medicine","score_opus":0.005777100606841385,"score_gpt":0.2506204117598505,"score_spread":0.2448433111530091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992176081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828452,0.01105726,0.0013355305,0.00032368422,0.000071360504,0.000032531836,0.0013851648,0.000061071405,0.0028881775],"genre_scores_gemma":[0.99450964,0.0023671342,0.00076469604,0.00007787205,0.00001161853,0.000025585923,0.00067574414,0.0000032066284,0.0015646054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999052,0.000017712535,0.000009720416,0.000013127162,0.000025419311,0.000028780954],"domain_scores_gemma":[0.99997663,0.00000428285,0.0000080396,0.0000023900977,0.0000037194152,0.0000050146036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068376496,0.00014911663,0.00015035995,0.0001230834,0.00013228231,0.00019411299,0.000066039865,0.00014428765,0.0015022677],"category_scores_gemma":[0.000058576738,0.000069762515,0.00020557671,0.00015191753,0.00007364435,0.00006594899,0.000092156326,0.00022019533,0.000305946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006518196,0.000050846804,0.0010656163,0.00021034652,0.000018862092,0.00013737594,0.000032171905,0.000114027986,0.9937774,0.00011257492,0.00024022968,0.0035888269],"study_design_scores_gemma":[0.00011541446,0.0009325497,0.075584844,0.000041821084,0.000099271616,0.0011078791,0.0001697394,0.0026643712,0.9118952,0.00014910083,0.0072247307,0.000015069855],"about_ca_topic_score_codex":0.0013437675,"about_ca_topic_score_gemma":0.0029234083,"teacher_disagreement_score":0.0015022677,"about_ca_system_score_codex":0.00023142634,"about_ca_system_score_gemma":0.00019921389,"threshold_uncertainty_score":0.005025625},"labels":[],"label_agreement":null},{"id":"W2999038208","doi":"10.1038/s41416-019-0702-4","title":"Dietary glycaemic index, glycaemic load and head and neck cancer risk: a pooled analysis in an international consortium","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Jonsson Comprehensive Cancer Center; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute on Drug Abuse; Associazione Italiana per la Ricerca sul Cancro; Oncosuisse; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Odds ratio; Quartile; Confidence interval; Internal medicine; Cancer; Head and neck cancer; Epidemiology; Case-control study; Logistic regression; Meta-analysis; Oncology; Gastroenterology","score_opus":0.02376437409114696,"score_gpt":0.3403638599250474,"score_spread":0.31659948583390046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999038208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6831,0.27213383,0.022276087,0.0006749931,0.00063665136,0.001522129,0.01637156,0.00031386802,0.0029708396],"genre_scores_gemma":[0.9759576,0.011967845,0.004922365,0.00034462544,0.00017842396,0.0010058046,0.0048238556,0.00006580818,0.0007336782],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9861688,0.008788515,0.0019102361,0.0018142154,0.0009036388,0.00041454996],"domain_scores_gemma":[0.98936886,0.0043811603,0.0022991546,0.002130664,0.0015591049,0.0002611419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01731889,0.0021902649,0.005839778,0.004021036,0.0004714895,0.0022490688,0.0009281523,0.0015906631,0.0023574436],"category_scores_gemma":[0.020506382,0.0013148353,0.017256107,0.005440516,0.0004912714,0.00062899257,0.0018491221,0.00065041846,0.0002867037],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0138015095,0.000097390046,0.12385792,0.007643409,0.84128445,0.00021165238,0.00015820996,0.0012584935,0.0015545968,0.00014025262,0.0013736837,0.008618395],"study_design_scores_gemma":[0.0025756247,0.0008482977,0.15005176,0.001085894,0.8407417,0.00022665538,0.00015307251,0.0011670109,0.00054819207,0.0002572573,0.0022673248,0.00007725378],"about_ca_topic_score_codex":0.010954322,"about_ca_topic_score_gemma":0.011526824,"teacher_disagreement_score":0.01731889,"about_ca_system_score_codex":0.00075773685,"about_ca_system_score_gemma":0.0009657504,"threshold_uncertainty_score":0.09159213},"labels":[],"label_agreement":null},{"id":"W2999383767","doi":"10.1038/s41416-019-0717-x","title":"Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Immune system; Cancer research; Phosphocholine; Biology; Tumor microenvironment; Pharmacology; Chemistry; Biochemistry; Immunology; Phospholipid","score_opus":0.0058796461725617085,"score_gpt":0.20129323455317685,"score_spread":0.19541358838061515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999383767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572396,0.0019749175,0.00076823577,0.00012671134,0.000033885033,0.000024464918,0.0002568761,0.000100474565,0.0009905907],"genre_scores_gemma":[0.9976629,0.00073914544,0.0005762784,0.00003172103,0.000010461833,0.000018377592,0.00026264615,0.000009584894,0.0006888401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998715,0.00001569231,0.000011031532,0.000019090121,0.00003689507,0.000045637],"domain_scores_gemma":[0.9999186,0.000012530781,0.000027637041,0.000008055573,0.000006033299,0.00002705686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011436914,0.00034358221,0.00031328594,0.00019074114,0.00013329984,0.00021359918,0.00026537778,0.00025445365,0.0016143135],"category_scores_gemma":[0.00011011162,0.000103617895,0.00016899193,0.00021651434,0.00027488414,0.00019865757,0.00014944203,0.0005437588,0.00028833057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004741217,0.00011097168,0.00020565507,0.00005614757,0.000009405779,0.00004098875,0.0000127231415,0.00014853095,0.9960407,0.00007407982,0.00009786775,0.0027288517],"study_design_scores_gemma":[0.00013498361,0.0033039306,0.0047695925,0.0000069309845,0.00002848905,0.0003325152,0.000026383666,0.00094556797,0.98788166,0.000054811637,0.0025085602,0.000006480906],"about_ca_topic_score_codex":0.0009638737,"about_ca_topic_score_gemma":0.002045059,"teacher_disagreement_score":0.0016143135,"about_ca_system_score_codex":0.00034828502,"about_ca_system_score_gemma":0.00025048797,"threshold_uncertainty_score":0.0054003596},"labels":[],"label_agreement":null},{"id":"W3003195528","doi":"10.1038/s41416-019-0705-1","title":"The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Government of Canada; California HIV/AIDS Research Program","keywords":"Stroma; Cancer; Disease; Medicine; Oncology; Pathology; Cancer research; Internal medicine; Biology; Immunohistochemistry","score_opus":0.03368502467627746,"score_gpt":0.3460510608635846,"score_spread":0.3123660361873072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003195528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011889424,0.99853635,0.000074481904,0.00023118076,0.00016419143,0.0000024788264,0.000011380852,0.0000032413905,0.00085788185],"genre_scores_gemma":[0.00063728273,0.9985575,0.00008857348,0.00009157825,0.00010116865,0.0000035354624,0.000016300752,7.823927e-7,0.0005031665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985886,0.000024044024,0.000017485345,0.000024802484,0.000057835157,0.000016971962],"domain_scores_gemma":[0.9997564,0.00012197535,0.000029096062,0.0000068483687,0.00006175553,0.000023927469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004053096,0.0004895777,0.0008414248,0.0016320297,0.000252938,0.00090898026,0.00046095572,0.0009016653,0.0027321503],"category_scores_gemma":[0.0005264954,0.00018814567,0.00027542008,0.0014955243,0.0004635608,0.00093523436,0.00049654447,0.0010941728,0.0015606744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006475707,0.000028003642,0.00016934596,0.012341219,0.000038219318,0.00019836822,0.00009887382,0.00024096682,0.0025320484,0.005154479,0.018647991,0.96048564],"study_design_scores_gemma":[0.0000066738453,0.00006680942,0.0008492744,0.002463479,0.00003688673,0.0010933422,0.00007289371,0.000042573625,0.00046807795,0.0013731322,0.9935154,0.000011548869],"about_ca_topic_score_codex":0.0012196352,"about_ca_topic_score_gemma":0.002203608,"teacher_disagreement_score":0.0027321503,"about_ca_system_score_codex":0.00058613566,"about_ca_system_score_gemma":0.0008935295,"threshold_uncertainty_score":0.009139955},"labels":[],"label_agreement":null},{"id":"W3006083633","doi":"10.1038/s41416-020-0749-2","title":"Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec-Société et Culture; Prostate Cancer Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Prostate cancer; Cancer research; Biochemical recurrence; Biology; Prostate; breakpoint cluster region; Androgen; Metastasis; Dihydrotestosterone; Internal medicine; Endocrinology; Cancer; Prostatectomy; Medicine; Gene; Hormone; Genetics","score_opus":0.01875105382115212,"score_gpt":0.34290333027836384,"score_spread":0.32415227645721173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006083633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051815,0.0040419796,0.0034859732,0.00006368303,0.000019530104,0.000018562676,0.001051593,0.0001385006,0.0006620305],"genre_scores_gemma":[0.9954918,0.0010167565,0.001312185,0.000024821089,0.000010864719,0.000021340218,0.0012727372,0.00004613335,0.00080331444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982196,0.000025901949,0.0000070286665,0.00005935227,0.00004991151,0.00003584331],"domain_scores_gemma":[0.99970067,0.000057064844,0.00010949823,0.000030083394,0.00004906207,0.000053650016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000211287,0.00024828335,0.00030105573,0.00031373787,0.00015603367,0.0006727621,0.00014433333,0.00015982214,0.0013407277],"category_scores_gemma":[0.00031210092,0.0001482289,0.00031709013,0.0003735847,0.00030222215,0.00018738121,0.00026941774,0.0002591973,0.00046227936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066701823,0.000024326822,0.02509575,0.00013418113,0.000043995853,0.00013128149,0.00013327031,0.00064450817,0.9665849,0.00034117198,0.00020055221,0.0059989435],"study_design_scores_gemma":[0.000054988916,0.00059943757,0.39350724,0.000053398475,0.00017236303,0.0012385214,0.0003625667,0.0065937946,0.5820253,0.00075064227,0.014596238,0.00004547668],"about_ca_topic_score_codex":0.0012506966,"about_ca_topic_score_gemma":0.0014113494,"teacher_disagreement_score":0.0013407277,"about_ca_system_score_codex":0.00043761195,"about_ca_system_score_gemma":0.00035753447,"threshold_uncertainty_score":0.0044851303},"labels":[],"label_agreement":null},{"id":"W3006091015","doi":"10.1038/s41416-019-0722-0","title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Context (archaeology); Cancer; Drug; Drug resistance; Pharmacology; Pharmacogenomics; Medicine; Cancer research; Biology; Internal medicine; Genetics","score_opus":0.09272287703452319,"score_gpt":0.4991450429838892,"score_spread":0.406422165949366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006091015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015572806,0.99852824,0.000111183595,0.00023100279,0.000087891334,0.0000024358792,0.000016629345,0.000007853499,0.0008590025],"genre_scores_gemma":[0.0008892071,0.9982668,0.00011129568,0.00011487042,0.00007051509,0.0000041011917,0.000027157741,0.0000012044989,0.00051491533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998536,0.00003253009,0.000018478222,0.000026227955,0.000049511156,0.000019639672],"domain_scores_gemma":[0.99980193,0.00008600913,0.00002976793,0.0000065835866,0.00005292071,0.000022805849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043615996,0.00063406833,0.0010478348,0.0017127449,0.00020651224,0.0009915167,0.00060723413,0.0009818336,0.0045196293],"category_scores_gemma":[0.0005262573,0.00021036956,0.00049776473,0.001980154,0.00038812237,0.0009486864,0.0006593909,0.0014498291,0.0019752532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094779,0.000055384473,0.00022964043,0.013538577,0.00008648536,0.0002488856,0.0000615648,0.00052156526,0.0019486375,0.0049811103,0.019908145,0.95832527],"study_design_scores_gemma":[0.000019629446,0.00010293906,0.0010901261,0.0022859287,0.00011052305,0.0012671313,0.00004644236,0.00013338223,0.00055616786,0.0027322024,0.9916393,0.000016179483],"about_ca_topic_score_codex":0.00102931,"about_ca_topic_score_gemma":0.0019301627,"teacher_disagreement_score":0.0045196293,"about_ca_system_score_codex":0.0006472348,"about_ca_system_score_gemma":0.00094329164,"threshold_uncertainty_score":0.015119731},"labels":[],"label_agreement":null},{"id":"W3007081246","doi":"10.1038/s41416-020-0861-3","title":"Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Distress; Ovarian cancer; Breast cancer; Cancer; BRCA mutation; Internal medicine; Gynecology; Obstetrics; Oncology; Demography; Clinical psychology","score_opus":0.009895654135100853,"score_gpt":0.292723191179369,"score_spread":0.28282753704426816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007081246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995597,0.00008660405,0.00002035997,0.000024158126,0.0000014970389,0.000005524165,0.00016916484,8.2897924e-7,0.00013199158],"genre_scores_gemma":[0.9995003,0.0000807617,0.000030115769,0.000009174356,0.0000035700098,0.000007118314,0.00029489922,7.4548893e-7,0.00007330974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997466,0.00007124208,0.000031954853,0.00005127114,0.000042706968,0.000056283705],"domain_scores_gemma":[0.9987866,0.00021788804,0.0005853425,0.000047303674,0.00008626145,0.0002766866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006733432,0.0002735062,0.00020811752,0.0009899654,0.0002880531,0.00040393355,0.0003204299,0.0003418998,0.0018146571],"category_scores_gemma":[0.0023218477,0.00022438641,0.00041854844,0.0008339524,0.0003119983,0.00039378312,0.0007816379,0.00033510695,0.00015824448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046349396,0.00001662961,0.999047,0.0000046653017,0.000017813712,0.000029803834,0.00009395878,0.000018033186,0.000043382686,0.0000043291166,0.000039692026,0.00063832494],"study_design_scores_gemma":[0.0000023552486,0.000036719448,0.9994956,0.0000032646324,0.000008861809,0.00007651544,0.0002563451,0.000061909166,0.000011021551,0.000003872959,0.000041928644,0.000001532642],"about_ca_topic_score_codex":0.005754487,"about_ca_topic_score_gemma":0.0044875112,"teacher_disagreement_score":0.005754487,"about_ca_system_score_codex":0.0002544704,"about_ca_system_score_gemma":0.0001624053,"threshold_uncertainty_score":0.011442006},"labels":[],"label_agreement":null},{"id":"W3010639071","doi":"10.1038/s41416-020-0764-3","title":"A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of General Medical Sciences; Wellcome Trust; National Cancer Institute; Ludwig Institute for Cancer Research","keywords":"Single-nucleotide polymorphism; Adrenocortical carcinoma; SNP; Allele; Minor allele frequency; Genotype; Genetics; Biology; Oncology; Retinoic acid; Genome-wide association study; Cancer research; Medicine; Bioinformatics; Internal medicine; Gene","score_opus":0.02752684396289872,"score_gpt":0.27927963588476507,"score_spread":0.25175279192186634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010639071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982152,0.0004452673,0.00038280204,0.000043978733,0.000008464063,0.0000037645661,0.0004927849,0.000013472394,0.0003943768],"genre_scores_gemma":[0.9993412,0.00009813456,0.00014180341,0.000013598381,0.000004812397,0.0000027628523,0.00020370483,0.0000058061432,0.00018822233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969673,0.00008932953,0.000027788727,0.00010845457,0.000043828888,0.000033904922],"domain_scores_gemma":[0.99894327,0.0003641014,0.0003862802,0.00012966621,0.000063522006,0.00011322207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037347293,0.00017624919,0.00026673867,0.00053804304,0.00016179707,0.00037773672,0.0002023759,0.0002748249,0.0025310416],"category_scores_gemma":[0.0011758388,0.0001135787,0.00032157355,0.00066132296,0.00019613009,0.00009468555,0.00016648522,0.00028913908,0.0002735774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072874007,0.000038426137,0.9712506,0.000031183255,0.000289739,0.00030015814,0.0001150385,0.00013562244,0.023331579,0.0000806606,0.00013322168,0.0035650097],"study_design_scores_gemma":[0.000008287595,0.00007896913,0.9972492,0.0000070388105,0.000110512425,0.0006992369,0.0000478374,0.00019190917,0.0012383782,0.000081673716,0.00028378057,0.000003260238],"about_ca_topic_score_codex":0.0018857617,"about_ca_topic_score_gemma":0.0017757204,"teacher_disagreement_score":0.0025310416,"about_ca_system_score_codex":0.0001314593,"about_ca_system_score_gemma":0.0001564929,"threshold_uncertainty_score":0.008467197},"labels":[],"label_agreement":null},{"id":"W3010696655","doi":"10.1038/s41416-020-0786-x","title":"Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Canadian Cancer Society Research Institute; European Society for Medical Oncology; GlaxoSmithKline","keywords":"Medicine; Lapatinib; Trastuzumab; Internal medicine; Cardiotoxicity; Breast cancer; Ejection fraction; Hazard ratio; Gastroenterology; Concomitant; Asymptomatic; Cancer; Surgery; Chemotherapy; Heart failure; Confidence interval","score_opus":0.014444381743291932,"score_gpt":0.27775303814313135,"score_spread":0.2633086563998394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010696655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960075,0.0024233407,0.00008571017,0.00020600665,0.000049875533,0.000069419744,0.00044757986,0.0000043679447,0.0007063838],"genre_scores_gemma":[0.99753726,0.00058388105,0.00006579612,0.00019558077,0.000096511234,0.00007845731,0.0010214831,0.0000014378937,0.0004194902],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995759,0.00023113692,0.000030042316,0.00006869282,0.00003082137,0.000063358035],"domain_scores_gemma":[0.99943215,0.00011248753,0.00017177017,0.000034138997,0.00003434224,0.00021505555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009861303,0.00033542764,0.0008144575,0.00012844164,0.00023424008,0.00076029234,0.00024446205,0.0006245638,0.0014320537],"category_scores_gemma":[0.00092995533,0.00012164148,0.0009862145,0.00024301591,0.00020817605,0.00039156573,0.0002614367,0.0009684371,0.00018620305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7036407,0.0061357175,0.21809919,0.00068051537,0.005144043,0.0002550979,0.00010736177,0.0024003286,0.0069866874,0.00026819526,0.003576718,0.0527055],"study_design_scores_gemma":[0.16709213,0.13774846,0.6740722,0.00025738028,0.0075041465,0.00054677087,0.000199332,0.0038409925,0.002329211,0.0009620493,0.0053657875,0.000081542355],"about_ca_topic_score_codex":0.000536054,"about_ca_topic_score_gemma":0.00097378035,"teacher_disagreement_score":0.0014320537,"about_ca_system_score_codex":0.00029741722,"about_ca_system_score_gemma":0.00030172756,"threshold_uncertainty_score":0.0052152276},"labels":[],"label_agreement":null},{"id":"W3012535443","doi":"10.1038/s41416-020-0774-1","title":"Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Chugai Pharmaceutical; Genentech; Ipsen; Astellas Pharma; Imperial Experimental Cancer Medicine Centre; Ono Pharmaceutical; Eisai; National Institute for Health and Care Research; Advanced Accelerator Applications; Daiichi Sankyo Europe; Bayer HealthCare; Sanofi; Exelixis; Astex Pharmaceuticals; Taiho Pharmaceutical; Boehringer Ingelheim; Yuhan; Gilead Sciences; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Internal medicine; Toxicity; Adverse effect; Dosing; Oncology; Insulin-like growth factor; Pharmacology; Growth factor; Gastroenterology; Receptor","score_opus":0.022605603460403474,"score_gpt":0.3198738740015921,"score_spread":0.29726827054118865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012535443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874608,0.004486187,0.0012958038,0.00038422577,0.00012743761,0.0029956498,0.0011967861,0.0000830266,0.0019699147],"genre_scores_gemma":[0.9828619,0.0032931194,0.0023165173,0.0007342094,0.0002674836,0.003493165,0.00311118,0.000048323436,0.0038741073],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991007,0.00048077828,0.000054658598,0.00015081766,0.00008124194,0.00013189184],"domain_scores_gemma":[0.99859387,0.0003137126,0.00033704206,0.00017559624,0.00011935746,0.00046041925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028077208,0.0016966292,0.0016927577,0.00039300832,0.00042223875,0.0008862718,0.0007710004,0.0012426019,0.00324191],"category_scores_gemma":[0.0015933046,0.00062331284,0.0013455598,0.00035489077,0.0010175742,0.0008708498,0.00046623257,0.0033760993,0.0007876753],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5122648,0.12642717,0.007841866,0.0024376598,0.0018399947,0.0006573085,0.0009823098,0.0023897248,0.18503761,0.00066178304,0.0068226373,0.15263715],"study_design_scores_gemma":[0.20930828,0.7528483,0.0094379885,0.00006792043,0.00057633955,0.0007423489,0.00006462768,0.0005293926,0.017085126,0.0002446842,0.009055057,0.000039900653],"about_ca_topic_score_codex":0.0006389713,"about_ca_topic_score_gemma":0.0014428721,"teacher_disagreement_score":0.00324191,"about_ca_system_score_codex":0.001267452,"about_ca_system_score_gemma":0.0012255481,"threshold_uncertainty_score":0.014848828},"labels":[],"label_agreement":null},{"id":"W3015521901","doi":"10.1038/s41416-020-0835-5","title":"Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Centers for Disease Control and Prevention; National Cancer Institute; National Institutes of Health; Cancer Research UK; Purdue University; National Institute of Environmental Health Sciences; Women's Health Initiative; American Cancer Society","keywords":"Hazard ratio; Medicine; Biobank; Proportional hazards model; Cohort; Gynecology; Women's Health Initiative; Intrahepatic Cholangiocarcinoma; Cohort study; Internal medicine; Oncology; Cancer; Physiology; Confidence interval; Observational study; Bioinformatics; Biology","score_opus":0.07769936904308894,"score_gpt":0.3348850047663597,"score_spread":0.25718563572327074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015521901","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90148747,0.073876515,0.001038816,0.0006092237,0.00007487796,0.00017396022,0.021930207,0.000028464981,0.00078038615],"genre_scores_gemma":[0.98500097,0.007035413,0.0006442222,0.00022469745,0.000042172156,0.00021986294,0.0065923794,0.000015686415,0.00022462395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930482,0.0032571442,0.0013484288,0.0011564298,0.00084824424,0.0003415024],"domain_scores_gemma":[0.9858623,0.0045771794,0.0062585985,0.0018705325,0.0010793221,0.0003520351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008921236,0.0006501569,0.0016565442,0.002630733,0.00034046813,0.0013867161,0.0007431627,0.0007303592,0.0015792429],"category_scores_gemma":[0.020688888,0.0005904467,0.004139942,0.0073038014,0.00044201218,0.000562049,0.0020111229,0.00047340489,0.00017382287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021435416,0.000017566847,0.96856904,0.0019740977,0.017252099,0.00022678805,0.00061320467,0.00022487364,0.00034249265,0.00008091352,0.0013054996,0.0072497157],"study_design_scores_gemma":[0.00016992792,0.00013902073,0.98541105,0.0004631979,0.010963884,0.0003155264,0.00021631178,0.000105306484,0.000085386,0.000057645055,0.0020511213,0.000021651516],"about_ca_topic_score_codex":0.022046782,"about_ca_topic_score_gemma":0.01895167,"teacher_disagreement_score":0.022046782,"about_ca_system_score_codex":0.0008178596,"about_ca_system_score_gemma":0.00078444876,"threshold_uncertainty_score":0.047180593},"labels":[],"label_agreement":null},{"id":"W3019565062","doi":"10.1038/s41416-020-0834-6","title":"Emerging role of PTEN loss in evasion of the immune response to tumours","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ministério da Ciência, Tecnologia e Inovação; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"PTEN; PI3K/AKT/mTOR pathway; Immune system; Immunotherapy; Biology; Cancer research; Carcinogenesis; Tumor microenvironment; Immune checkpoint; Cancer; Immunology; Signal transduction; Genetics","score_opus":0.018383244696894705,"score_gpt":0.3345164446963467,"score_spread":0.316133199999452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019565062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024774854,0.9985006,0.00008122404,0.00021958556,0.00012472094,0.0000027227711,0.000014130772,0.0000064137703,0.0008028641],"genre_scores_gemma":[0.0010714141,0.9981523,0.000097242606,0.00015667011,0.00008537363,0.0000040270934,0.000019750647,0.0000011888545,0.00041187857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998939,0.000019264367,0.000014389676,0.000016055077,0.000042189353,0.000014161182],"domain_scores_gemma":[0.9998641,0.00006956371,0.000018917013,0.0000035034063,0.00002998519,0.000013846981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041090787,0.0005128752,0.00096834725,0.0014008945,0.00013672649,0.0006666286,0.0005006689,0.0007305483,0.00227953],"category_scores_gemma":[0.00041563777,0.00016093205,0.0003754148,0.001093645,0.00034163232,0.0007038047,0.00048195993,0.0012713053,0.0010782024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001238404,0.0000468573,0.00016295131,0.013360879,0.00009701969,0.00031201597,0.000052595886,0.0003903906,0.0033460495,0.003649966,0.017782269,0.9606752],"study_design_scores_gemma":[0.00003830363,0.00018334738,0.0015225342,0.0030106066,0.0001381701,0.0021523798,0.00005206716,0.00010303351,0.0010693833,0.0021990996,0.98951346,0.00001769787],"about_ca_topic_score_codex":0.0005479625,"about_ca_topic_score_gemma":0.0011476442,"teacher_disagreement_score":0.00227953,"about_ca_system_score_codex":0.000423448,"about_ca_system_score_gemma":0.0005810795,"threshold_uncertainty_score":0.0076257586},"labels":[],"label_agreement":null},{"id":"W3019614276","doi":"10.1038/bjc.2013.782","title":"Erratum: DICER1 hotspot mutations in non-epithelial gonadal tumours","year":2013,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Vancouver General Hospital; McGill University; BC Cancer Agency; Jewish General Hospital","funders":"Medical Research Council","keywords":"Hotspot (geology); Biology; Pathology; Computational biology; Bioinformatics; Medicine; Cancer research","score_opus":0.011330797069957578,"score_gpt":0.2840847547807891,"score_spread":0.2727539577108315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019614276","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047971922,0.0025047886,0.00040670656,0.05997703,0.9319263,0.000022381035,0.0011519309,0.00020856553,0.0033225666],"genre_scores_gemma":[0.033676874,0.02586749,0.006456158,0.17688355,0.42236736,0.00020898102,0.0063064,0.0021141137,0.32611898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997512,0.00031218937,0.00069750176,0.00029537012,0.0009500572,0.00023284774],"domain_scores_gemma":[0.9857222,0.0038425806,0.0010980631,0.0005886832,0.008012217,0.00073626457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002164223,0.0016125577,0.0015635459,0.003075197,0.0018838205,0.0020709578,0.0018965283,0.0044352766,0.031508837],"category_scores_gemma":[0.032188945,0.0009816146,0.0013855716,0.002170593,0.0012651575,0.0015488244,0.00122524,0.006365624,0.018210908],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047456513,0.000007830717,0.00020248102,0.00011788041,0.000011461849,0.0012503228,0.000028798548,0.000042168464,0.00005387563,0.00026097376,0.9904041,0.0075726677],"study_design_scores_gemma":[0.00008191725,0.000038200164,0.0021198476,0.00086544926,0.00007273867,0.0065256245,0.00014780049,0.000194954,0.0004936644,0.00091472757,0.9884813,0.000063733],"about_ca_topic_score_codex":0.015287873,"about_ca_topic_score_gemma":0.016735835,"teacher_disagreement_score":0.031508837,"about_ca_system_score_codex":0.0026874626,"about_ca_system_score_gemma":0.0029895555,"threshold_uncertainty_score":0.105407536},"labels":[],"label_agreement":null},{"id":"W3021122327","doi":"10.1038/s41416-020-0860-4","title":"Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; China Scholarship Council; University of Aberdeen; Queen's University Belfast; Queen's University; Cancer Research UK","keywords":"Medicine; Odds ratio; Hazard ratio; Internal medicine; Cancer; Biobank; Confidence interval; Cohort study; Cohort; Population; Proportional hazards model; Bioinformatics; Environmental health","score_opus":0.030104596785992536,"score_gpt":0.33056230266264053,"score_spread":0.300457705876648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021122327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995529,0.002036681,0.0005202367,0.00017805095,0.00003839196,0.00008506443,0.0010047583,0.000011052878,0.0005966964],"genre_scores_gemma":[0.99815995,0.0003676897,0.00034302354,0.00010311684,0.000030957308,0.00008756239,0.0007882047,0.0000049642676,0.00011459237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918252,0.003704812,0.0010309588,0.0017941186,0.0011066532,0.0005380934],"domain_scores_gemma":[0.97957486,0.005724035,0.0071440185,0.0031159674,0.002647576,0.0017934617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00803408,0.0008696566,0.0008298782,0.0030719829,0.0011847364,0.0021129376,0.0013374456,0.001581762,0.0018646562],"category_scores_gemma":[0.019468596,0.0010538112,0.0028850976,0.0041637267,0.00084263994,0.00086155796,0.0019450568,0.0013278055,0.00020256064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004973494,0.00006960441,0.9967654,0.000056251858,0.0011499681,0.00018587356,0.00028171673,0.00003716645,0.00019477263,0.000041107352,0.00014184181,0.00057887123],"study_design_scores_gemma":[0.00010639479,0.00021654254,0.99741864,0.00003656561,0.0008464985,0.00049318356,0.000303912,0.00016819891,0.000059181995,0.000038992137,0.0002965601,0.000015373284],"about_ca_topic_score_codex":0.026669603,"about_ca_topic_score_gemma":0.020511989,"teacher_disagreement_score":0.026669603,"about_ca_system_score_codex":0.0009787985,"about_ca_system_score_gemma":0.001363406,"threshold_uncertainty_score":0.053028703},"labels":[],"label_agreement":null},{"id":"W3022795538","doi":"10.1038/s41416-020-0874-y","title":"Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"National Institute for Health and Care Research; Cancer Research UK; World Health Organization","keywords":"Downregulation and upregulation; Indoleamine 2,3-dioxygenase; Cancer research; Nicotinamide phosphoribosyltransferase; Biology; Kynurenine; Immune system; Immunology; NAD+ kinase; Enzyme; Biochemistry; Gene","score_opus":0.02757297852138995,"score_gpt":0.2764715563612481,"score_spread":0.24889857783985814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022795538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749049,0.018204886,0.0047578313,0.00036477708,0.000027278524,0.000032414133,0.0003475465,0.000088090164,0.0012723409],"genre_scores_gemma":[0.9953774,0.002499329,0.0014406221,0.000053754575,0.000016007865,0.000012042267,0.00019815347,0.0000061278365,0.00039658882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968934,0.000047313795,0.000030718664,0.00007604335,0.00011088093,0.000045717275],"domain_scores_gemma":[0.9995363,0.00005327606,0.00024147943,0.00003352832,0.00007529907,0.000060057984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004221377,0.00024503868,0.0005660499,0.00042027645,0.00018487075,0.0006526523,0.00029725762,0.0003529739,0.000957569],"category_scores_gemma":[0.00039192406,0.0000869633,0.00023310297,0.00039040804,0.00035846516,0.00038427577,0.00028173332,0.0004800201,0.00027888024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052366935,0.000050258088,0.038310025,0.00030571767,0.00009972554,0.00075757905,0.00009725944,0.0003165278,0.9403509,0.00040446813,0.00015436634,0.018629415],"study_design_scores_gemma":[0.00003661633,0.0009981816,0.50008905,0.00010980014,0.00020473338,0.009300935,0.00044416587,0.0022613388,0.47558114,0.0013066718,0.009627846,0.000039454455],"about_ca_topic_score_codex":0.00057392917,"about_ca_topic_score_gemma":0.00065889524,"teacher_disagreement_score":0.000957569,"about_ca_system_score_codex":0.00049083866,"about_ca_system_score_gemma":0.00036797803,"threshold_uncertainty_score":0.003561318},"labels":[],"label_agreement":null},{"id":"W3025515234","doi":"10.1038/s41416-020-0887-6","title":"UGT2B17 modifies drug response in chronic lymphocytic leukaemia","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; March of Dimes Canada; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Chronic lymphocytic leukemia; Drug; Medicine; Drug response; Immunology; Leukemia; Cancer research; Pharmacology","score_opus":0.02609349524528102,"score_gpt":0.3257147506949732,"score_spread":0.29962125544969215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025515234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974443,0.0014145093,0.00023192176,0.00004960427,0.000008412752,0.0000066345665,0.0005196885,0.000024474932,0.00030049824],"genre_scores_gemma":[0.9982023,0.00036388406,0.0001596419,0.000034993704,0.0000053879553,0.000011412939,0.0007126451,0.00000820591,0.00050160073],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998832,0.00002412622,0.0000066052025,0.00003074235,0.000027384254,0.000028003966],"domain_scores_gemma":[0.9998754,0.000013359299,0.000058501468,0.000010395991,0.000016498894,0.00002586981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016435132,0.00026523712,0.00023150623,0.0002950229,0.000114482275,0.0004281413,0.00008352638,0.00020161245,0.001644257],"category_scores_gemma":[0.0001767111,0.00008747764,0.00025231732,0.00033287168,0.00014629088,0.0000997889,0.00012269201,0.00022905461,0.00028107013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033301506,0.0001029678,0.10181657,0.00015486423,0.00013514806,0.00024678936,0.000083704406,0.000381871,0.8798456,0.000079340185,0.00036260675,0.013460358],"study_design_scores_gemma":[0.000116195886,0.0022778881,0.71027106,0.000033024808,0.0002605943,0.0016390098,0.0002463903,0.001587152,0.27505496,0.00026064113,0.008230339,0.000022764621],"about_ca_topic_score_codex":0.0007282999,"about_ca_topic_score_gemma":0.0008170284,"teacher_disagreement_score":0.001644257,"about_ca_system_score_codex":0.00039965558,"about_ca_system_score_gemma":0.00012648579,"threshold_uncertainty_score":0.005500555},"labels":[],"label_agreement":null},{"id":"W3027041709","doi":"10.1038/s41416-020-0868-9","title":"Rising to the challenge: designing, implementing and reporting exercise oncology trials in understudied populations","year":2020,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Rigour; Credibility; Medicine; Transparency (behavior); Oncology; Multiple myeloma; Quality of life (healthcare); Open data; Clinical trial; Internal medicine; Physical therapy; Computer science; World Wide Web; Nursing","score_opus":0.2392579811663438,"score_gpt":0.4402579144362099,"score_spread":0.20099993326986607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027041709","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042123033,0.0012909719,0.0006585378,0.99125755,0.0054544928,0.00004283326,0.000047900758,0.00003418273,0.0007924567],"genre_scores_gemma":[0.0052335425,0.0013185543,0.0039266604,0.96136934,0.02699475,0.00032204736,0.000053136624,0.000035736077,0.0007462806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8034867,0.13688862,0.027107926,0.00601046,0.023786403,0.0027198752],"domain_scores_gemma":[0.36691192,0.5302106,0.02277461,0.01661151,0.04786601,0.015625322],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15286465,0.000828903,0.0030405268,0.0018756301,0.003850199,0.008058057,0.004275526,0.053456496,0.00529054],"category_scores_gemma":[0.46656525,0.0013936589,0.00290228,0.0024508447,0.009138733,0.013211864,0.004077495,0.04431654,0.006857878],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005477088,0.00014830571,0.0058081653,0.001056112,0.00014987726,0.0020295314,0.0015329447,0.0003857308,0.0006964462,0.009285835,0.8800713,0.09828801],"study_design_scores_gemma":[0.0009137497,0.000723609,0.0072388505,0.0038077224,0.00020065947,0.0042580604,0.0023019032,0.0026182937,0.0008061052,0.09801926,0.8787509,0.00036095412],"about_ca_topic_score_codex":0.0053535854,"about_ca_topic_score_gemma":0.0064544505,"teacher_disagreement_score":0.84713537,"about_ca_system_score_codex":0.0066541703,"about_ca_system_score_gemma":0.018837707,"threshold_uncertainty_score":0.8084352},"labels":[],"label_agreement":null},{"id":"W3027443262","doi":"10.1038/s41416-020-0903-x","title":"Translating current basic research into future therapies for neurofibromatosis type 1","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Neurofibromatosis; Plexiform neurofibroma; Medicine; Neurofibroma; Cancer research; Janus kinase; Pathology; Biology; Bioinformatics; Immunology; Cytokine","score_opus":0.13250873565255855,"score_gpt":0.4413424741178399,"score_spread":0.30883373846528134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027443262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009064789,0.9983431,0.00008105904,0.00028026308,0.00024399422,0.0000055250343,0.000014154031,0.000006512664,0.000934741],"genre_scores_gemma":[0.00039374706,0.99870527,0.00016231947,0.00023464882,0.00010469055,0.0000071879404,0.000024221872,0.000001572654,0.00036634886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997731,0.000044518674,0.00004063147,0.000033678858,0.00008505597,0.000022980461],"domain_scores_gemma":[0.9996449,0.00021849891,0.00003520785,0.000010217488,0.000071288654,0.000020005406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006386945,0.00081406446,0.0014417316,0.0020529795,0.00028157572,0.0010285425,0.00090431405,0.0012636858,0.0055316854],"category_scores_gemma":[0.0009982155,0.0002933552,0.0006321444,0.0014534808,0.00040497514,0.0014562246,0.00068643305,0.0021623087,0.0023908222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009200651,0.00008273856,0.00007211164,0.03778545,0.000102003076,0.00030385857,0.00010387385,0.00034349677,0.0020166247,0.004658565,0.02336258,0.9310767],"study_design_scores_gemma":[0.00003356811,0.000100189965,0.00043293563,0.01161942,0.00012999668,0.00093723374,0.00008252877,0.00006879517,0.00036753234,0.00231656,0.983897,0.0000142443005],"about_ca_topic_score_codex":0.0009687232,"about_ca_topic_score_gemma":0.0019792987,"teacher_disagreement_score":0.0055316854,"about_ca_system_score_codex":0.0007112469,"about_ca_system_score_gemma":0.0011003839,"threshold_uncertainty_score":0.018505394},"labels":[],"label_agreement":null},{"id":"W3036702906","doi":"10.1038/s41416-020-0900-0","title":"Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Alberta Health Services; Royal Alexandra Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Vancouver General Hospital; University of Calgary; Vancouver Coastal Health","funders":"Medical Research and Materiel Command; National Cancer Institute; Cancer Council Tasmania; National Center for Advancing Translational Sciences; Medical Research Council; Peter MacCallum Foundation; National Center for Research Resources; Oak Foundation; BC Cancer Foundation; Canada Research Chairs; Conselho Nacional de Desenvolvimento Científico e Tecnológico; National Institutes of Health; Cancer Institute NSW; National Health and Medical Research Council; American Cancer Society; Academy of Medical Sciences; Calgary Laboratory Services; University of Cambridge; University College London; Cancer Research UK; Michael Smith Health Research BC; Deutsches Krebsforschungszentrum; Cancer Council Victoria; Cancer Australia; Kræftens Bekæmpelse; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Ovarian Cancer Australia","keywords":"Ovarian cancer; PTEN; Pathological; Oncology; Medicine; Pathology; Ovarian tissue; Ovary; Cancer; Internal medicine; Biology; Genetics; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.04998682333486856,"score_gpt":0.3713108150198223,"score_spread":0.32132399168495374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036702906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989925,0.0001073276,0.000097810174,0.000018333889,0.0000020906123,0.000024565272,0.00066994724,0.0000028839693,0.000084436164],"genre_scores_gemma":[0.99740344,0.000085207525,0.00016933231,0.000031618594,0.000008755499,0.000057302437,0.0021356437,0.000006207359,0.00010240673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763405,0.0008109248,0.00023071584,0.0006641946,0.00041274104,0.00024734897],"domain_scores_gemma":[0.9952304,0.00082810386,0.001762033,0.0008250941,0.0005899482,0.00076434435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027435839,0.000482297,0.0007302316,0.0013378602,0.00082550844,0.0009605684,0.00085048185,0.00057827553,0.00092805806],"category_scores_gemma":[0.0052446523,0.0005508636,0.00073801563,0.0023993258,0.0005341799,0.00045924415,0.002069297,0.00049545517,0.00029578447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003439307,0.000038681468,0.997783,0.000017613609,0.000105437335,0.00011611454,0.00019649093,0.000032358563,0.00057182775,0.000009780785,0.00015359178,0.00063122105],"study_design_scores_gemma":[0.000035559,0.00011209433,0.99883693,0.000004018082,0.0000597004,0.00039098656,0.00015865346,0.00008630422,0.00007541931,0.0000066914827,0.00022840347,0.0000053737117],"about_ca_topic_score_codex":0.013280285,"about_ca_topic_score_gemma":0.012238675,"teacher_disagreement_score":0.013280285,"about_ca_system_score_codex":0.0008106074,"about_ca_system_score_gemma":0.0007693047,"threshold_uncertainty_score":0.02640593},"labels":[],"label_agreement":null},{"id":"W3043725192","doi":"10.1038/s41416-020-0990-8","title":"Increasing operational and scientific efficiency in clinical trials","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Clinical trial; Drug development; Key (lock); Medicine; MEDLINE; Intensive care medicine; Medical physics; Computer science; Drug; Pathology; Pharmacology; Political science","score_opus":0.23072288466261529,"score_gpt":0.42167349427240414,"score_spread":0.19095060960978885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043725192","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05185205,0.043472495,0.5885885,0.1904778,0.0024508766,0.0043874406,0.0008874507,0.0013676172,0.11651575],"genre_scores_gemma":[0.7570533,0.011961597,0.19811592,0.017463423,0.004963669,0.0036942305,0.0005514793,0.0004850061,0.0057113934],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.4391985,0.47995988,0.024477996,0.010189654,0.03921317,0.006960923],"domain_scores_gemma":[0.15773769,0.6796284,0.051509164,0.06319155,0.038656656,0.009276593],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4683633,0.0022253564,0.004398843,0.007648903,0.0016279969,0.021552496,0.005696365,0.007073307,0.009864144],"category_scores_gemma":[0.72476196,0.001992193,0.0021539438,0.007485511,0.019098785,0.02540039,0.014829309,0.009455702,0.004089802],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025030863,0.00040405028,0.016727645,0.004353729,0.001408127,0.00032591927,0.0019395829,0.05509431,0.0015133847,0.5843933,0.021948814,0.309388],"study_design_scores_gemma":[0.0012631128,0.0012693729,0.011802651,0.003333861,0.00043584497,0.00048072744,0.00083032117,0.03704709,0.0012894819,0.89394677,0.048125707,0.00017503092],"about_ca_topic_score_codex":0.0019447957,"about_ca_topic_score_gemma":0.0013056527,"teacher_disagreement_score":0.5316367,"about_ca_system_score_codex":0.016106267,"about_ca_system_score_gemma":0.032319725,"threshold_uncertainty_score":0.6556027},"labels":[],"label_agreement":null},{"id":"W3045062385","doi":"10.1038/s41416-020-1006-4","title":"Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”","year":2020,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; March of Dimes Canada","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Drug; Medicine; Chronic lymphocytic leukemia; Leukemia; Immunology; Pharmacology","score_opus":0.028905233874551697,"score_gpt":0.3272973650289938,"score_spread":0.29839213115444213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045062385","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055150216,0.00063767267,0.00003497505,0.9830199,0.014456676,0.0000067055075,0.00014512178,0.00002218232,0.0011252967],"genre_scores_gemma":[0.0040340503,0.00048974465,0.0001081617,0.9685647,0.022598244,0.000038631468,0.00007503855,0.00002338786,0.004068019],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692506,0.0010354843,0.00048347207,0.00037219658,0.0006307345,0.0005531585],"domain_scores_gemma":[0.9911841,0.0055302493,0.0006560476,0.00026402093,0.0010841972,0.0012813747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040523247,0.0007372195,0.0016717416,0.0007178536,0.002689517,0.002192635,0.00173062,0.044445485,0.007640984],"category_scores_gemma":[0.024136705,0.0007640135,0.0011886933,0.0008893128,0.0022818705,0.0020504459,0.0013548738,0.025644816,0.007146723],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018571522,0.00002705827,0.0012819241,0.00006119568,0.00002683951,0.0013801304,0.0001350584,0.00005015557,0.00013965121,0.0009077347,0.9917745,0.0040300675],"study_design_scores_gemma":[0.00048149363,0.00028422324,0.0055472925,0.00040235708,0.00015167016,0.0028662938,0.0005516662,0.0005416697,0.00061614346,0.0056545516,0.9827854,0.00011712475],"about_ca_topic_score_codex":0.010875714,"about_ca_topic_score_gemma":0.011030484,"teacher_disagreement_score":0.044445485,"about_ca_system_score_codex":0.0049909665,"about_ca_system_score_gemma":0.003930569,"threshold_uncertainty_score":0.036212146},"labels":[],"label_agreement":null},{"id":"W3048232459","doi":"10.1038/s41416-020-1025-1","title":"Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Government of Canada; Egyptian Cultural and Educational Bureau","keywords":"Cancer research; Viability assay; Sulforaphane; SOX2; Cancer stem cell; Head and neck squamous-cell carcinoma; CD44; Cisplatin; In vivo; Stem cell; Cancer cell; Cytotoxicity; Cancer; Cell; Biology; Medicine; Head and neck cancer; Internal medicine; In vitro; Embryonic stem cell; Chemotherapy; Cell biology; Biochemistry","score_opus":0.012612729225990894,"score_gpt":0.24696906013518025,"score_spread":0.23435633090918936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048232459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455476,0.0033874486,0.00042002773,0.00007132484,0.000024372466,0.00004213213,0.00031056796,0.00006500478,0.0011243469],"genre_scores_gemma":[0.9949232,0.0015801147,0.00068954204,0.000053037158,0.000015075797,0.000039964358,0.00073514326,0.000015087074,0.0019488622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999923,0.000018699295,0.000009295463,0.000013656972,0.000018774774,0.000016567163],"domain_scores_gemma":[0.99989676,0.000029958217,0.000018898374,0.0000096994145,0.000021821521,0.000022810449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011462221,0.00027730083,0.00035713095,0.00042534556,0.00014053304,0.00018057453,0.00012717006,0.00023343255,0.0023663852],"category_scores_gemma":[0.0001171212,0.0000914006,0.00028241077,0.00018507428,0.00012624577,0.00017219187,0.00011835087,0.00045005273,0.0003146701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050305325,0.00012362334,0.00030689675,0.000089593996,0.000015053525,0.00003763674,0.000025874062,0.000035747948,0.9965088,0.000019553878,0.00006399667,0.0022701118],"study_design_scores_gemma":[0.000061513456,0.002939776,0.01152518,0.000020955662,0.000073211326,0.00020779987,0.000048166472,0.00031468872,0.9823208,0.0000249791,0.002456803,0.000006172032],"about_ca_topic_score_codex":0.00091746426,"about_ca_topic_score_gemma":0.0016346874,"teacher_disagreement_score":0.0023663852,"about_ca_system_score_codex":0.00017532079,"about_ca_system_score_gemma":0.00022240343,"threshold_uncertainty_score":0.007916391},"labels":[],"label_agreement":null},{"id":"W3084155739","doi":"10.1038/s41416-020-01041-x","title":"Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"National Cancer Institute; Takeda Oncology; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Tolerability; Endometrial cancer; Medicine; Pharmacodynamics; Renal cell carcinoma; Pharmacokinetics; Rash; Internal medicine; Bladder cancer; Urology; Dosing; Cancer; Carcinoma; Oncology; Gastroenterology; Adverse effect","score_opus":0.02676153683504138,"score_gpt":0.3543512937309712,"score_spread":0.3275897568959298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084155739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642134,0.00088706776,0.00035565218,0.00017196889,0.000032593605,0.0011163513,0.0003386892,0.00005791192,0.0006185038],"genre_scores_gemma":[0.9914937,0.0009879479,0.0020356693,0.00043848323,0.00007407129,0.0017059599,0.001816396,0.00003102036,0.0014167167],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999637,0.00014207391,0.000018934465,0.00006846614,0.000054074575,0.000079392055],"domain_scores_gemma":[0.9994012,0.00008201131,0.000119803975,0.00005420141,0.00004897983,0.0002937302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014615712,0.0013101539,0.0016096176,0.0003991115,0.00040328485,0.0005479625,0.00072794285,0.00073295727,0.0025444648],"category_scores_gemma":[0.00054447167,0.00050446886,0.00087735,0.00034288544,0.0006328437,0.0005508368,0.0003442273,0.0027520235,0.0005735201],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3307804,0.16792658,0.013279643,0.0015750494,0.0012381335,0.0009952805,0.0007573591,0.007220729,0.30545214,0.00037818926,0.0077884686,0.16260806],"study_design_scores_gemma":[0.26229328,0.6899213,0.017722165,0.000043633292,0.0004117475,0.00090766215,0.000065550135,0.0022250179,0.022846855,0.00017627687,0.0033480339,0.00003847761],"about_ca_topic_score_codex":0.0007658986,"about_ca_topic_score_gemma":0.00229741,"teacher_disagreement_score":0.0025444648,"about_ca_system_score_codex":0.0007641911,"about_ca_system_score_gemma":0.0016177994,"threshold_uncertainty_score":0.00851208},"labels":[],"label_agreement":null},{"id":"W3087415923","doi":"10.1038/s41416-020-01056-4","title":"Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Oestrogen receptor; Breast cancer; Oncology; Cancer; Internal medicine; Cancer research; Medicine; Mutation; BRCA2 Protein; Biology; Genetics; Germline mutation; Gene","score_opus":0.010174748481304088,"score_gpt":0.2650833726159853,"score_spread":0.25490862413468124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087415923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954826,0.00022494166,0.000014659116,0.000010911489,0.0000025409595,0.0000015011763,0.000090537134,8.7208315e-7,0.00010580756],"genre_scores_gemma":[0.9995171,0.00014456184,0.000030194844,0.0000064529318,0.000003891784,0.0000021943983,0.00021522609,0.000001068017,0.000079283636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998369,0.000039969924,0.000013935495,0.000049233473,0.000022072309,0.000037891656],"domain_scores_gemma":[0.99928457,0.00021818551,0.0002492603,0.00006627436,0.000078259734,0.00010351213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007082451,0.00027092436,0.00035318852,0.00073930837,0.00033637733,0.00046384567,0.00026325087,0.0004301846,0.00076905254],"category_scores_gemma":[0.0013375876,0.00019406469,0.00029152233,0.00046389695,0.00035815313,0.00017529221,0.00033377606,0.00032843393,0.00010992184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050187635,0.000021449689,0.99608743,0.000011309509,0.00006209503,0.00040318436,0.00013698146,0.00024991433,0.0004630246,0.000019716179,0.000121687066,0.0019212868],"study_design_scores_gemma":[0.000014260649,0.0001197084,0.99850583,0.000017610122,0.000055789955,0.0005625083,0.00017259376,0.0002533925,0.00007025793,0.00003349548,0.00018993864,0.0000045259067],"about_ca_topic_score_codex":0.019423943,"about_ca_topic_score_gemma":0.015666641,"teacher_disagreement_score":0.019423943,"about_ca_system_score_codex":0.00038087848,"about_ca_system_score_gemma":0.0004068769,"threshold_uncertainty_score":0.038621724},"labels":[],"label_agreement":null},{"id":"W3090245160","doi":"10.1038/s41416-020-01102-1","title":"Clinically and biologically relevant subgroups of Wilms tumour defined by genomic and epigenomic analyses","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Izaak Walton Killam Health Centre; Hospital for Sick Children; McMaster University; University of Toronto","funders":"National Cancer Institute; Sick Kids Foundation; Children’s Oncology Group","keywords":"DNA methylation; Epigenomics; Exome; Epigenetics; Biology; Methylation; Subgroup analysis; Oncology; Wilms' tumor; Genome instability; Bioinformatics; Internal medicine; Exome sequencing; Genetics; Medicine; DNA; Mutation; Gene; Confidence interval; Gene expression; DNA damage","score_opus":0.01815998166339994,"score_gpt":0.2883479635874976,"score_spread":0.27018798192409765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090245160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986934,0.00017341327,0.0005202703,0.000018282853,0.0000012753602,0.000009712237,0.00036067862,0.0000094273755,0.00021350913],"genre_scores_gemma":[0.9989349,0.00004051572,0.00037543758,0.000010441988,0.0000022838144,0.000010348197,0.0005598145,0.000004466965,0.000061765255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975604,0.00004491879,0.00002650388,0.000089581736,0.00004063535,0.000042357686],"domain_scores_gemma":[0.99953246,0.00011906472,0.00018917712,0.000055293935,0.00003453645,0.00006948455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040446452,0.00018588072,0.00028913605,0.0008510939,0.00021994015,0.00036788368,0.00017529656,0.00028390394,0.000885956],"category_scores_gemma":[0.0010181032,0.000080210746,0.00023654121,0.0005125685,0.00025808957,0.0001465858,0.00037440425,0.00018995417,0.00013076693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011378146,0.000034398498,0.86398035,0.000059776114,0.00015781172,0.00044560543,0.00027465902,0.00061538303,0.12421378,0.00030077432,0.00019616401,0.008583447],"study_design_scores_gemma":[0.000015064847,0.00016775857,0.98926723,0.000005258792,0.00007978193,0.0015762903,0.00015725831,0.001056098,0.006377705,0.00064277684,0.0006472029,0.000007672403],"about_ca_topic_score_codex":0.0007974861,"about_ca_topic_score_gemma":0.0011430042,"teacher_disagreement_score":0.000885956,"about_ca_system_score_codex":0.0002207587,"about_ca_system_score_gemma":0.0002474517,"threshold_uncertainty_score":0.002963841},"labels":[],"label_agreement":null},{"id":"W3090805719","doi":"10.1038/s41416-020-01077-z","title":"First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pharmacokinetics; Medicine; Nausea; Vomiting; Toxicity; Anorexia; Discontinuation; Pharmacology; Cmax; Internal medicine; Gastroenterology","score_opus":0.014423949262874767,"score_gpt":0.29599145480369526,"score_spread":0.2815675055408205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090805719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892218,0.0028623368,0.0006958686,0.00036673405,0.00010711899,0.003398913,0.0018413466,0.00009339227,0.0014125402],"genre_scores_gemma":[0.9801539,0.002950484,0.002286048,0.0010364484,0.00023852708,0.00474477,0.0040378114,0.00005322761,0.004498899],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968183,0.00012803022,0.000014678673,0.000050005558,0.00003947177,0.00008606181],"domain_scores_gemma":[0.999393,0.000108142194,0.0001314968,0.000044060365,0.000044299173,0.00027892244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012697,0.0013253809,0.0021797617,0.00029577545,0.00048405296,0.00086489454,0.00066446187,0.00093428453,0.004289348],"category_scores_gemma":[0.00068207376,0.0004992423,0.0008901822,0.00038516277,0.0008591486,0.0005842196,0.0003276705,0.0025585552,0.0009868856],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6345516,0.12307042,0.0097271595,0.0025411048,0.0013061913,0.00094108767,0.00057231274,0.0035733406,0.085374266,0.00036024948,0.009750369,0.1282319],"study_design_scores_gemma":[0.28244084,0.69082856,0.01233396,0.00006154161,0.00036060688,0.00073120143,0.000077308636,0.0009987231,0.006970403,0.00018492641,0.004975708,0.000036167334],"about_ca_topic_score_codex":0.0008113157,"about_ca_topic_score_gemma":0.0023816957,"teacher_disagreement_score":0.004289348,"about_ca_system_score_codex":0.0009814313,"about_ca_system_score_gemma":0.0018152611,"threshold_uncertainty_score":0.014349341},"labels":[],"label_agreement":null},{"id":"W3106721187","doi":"10.1038/s41416-020-01194-9","title":"Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity","year":2020,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Phosphatase; Gain of function; Mutant; Identification (biology); Phosphorylation; Function (biology); Enzyme; Biochemistry; Biology; Cancer; Computational biology; Cancer research; Chemistry; Cell biology; Genetics; Gene","score_opus":0.033658489468397584,"score_gpt":0.28386616807224735,"score_spread":0.25020767860384974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106721187","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016495152,0.031388767,0.0006649027,0.9488559,0.014659078,0.0000101046535,0.00004913724,0.0000495905,0.0026730762],"genre_scores_gemma":[0.031793423,0.05045539,0.001595205,0.7975685,0.10416252,0.00005761535,0.00006174131,0.00003002175,0.014275524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993017,0.00020019192,0.00008779633,0.00011538772,0.00020917502,0.000085711996],"domain_scores_gemma":[0.9982029,0.001091921,0.000166172,0.00010613416,0.00020911268,0.00022386384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020856715,0.0005700676,0.0008719603,0.0003351852,0.00064387213,0.0012071737,0.0010068077,0.01207036,0.0029845042],"category_scores_gemma":[0.0056565306,0.0003216815,0.00060632185,0.0002463357,0.0025471286,0.0047829696,0.0009314846,0.012334479,0.0025438014],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006833305,0.00018460352,0.0019142139,0.00079971,0.00007148868,0.01169523,0.00022495781,0.00048249567,0.0071074613,0.049185958,0.792705,0.13494545],"study_design_scores_gemma":[0.00020455632,0.00018010572,0.00090140756,0.00018802658,0.00004105752,0.01208734,0.0003521975,0.0010194244,0.0017603176,0.07490965,0.9083039,0.000051977804],"about_ca_topic_score_codex":0.00094351947,"about_ca_topic_score_gemma":0.0013230124,"teacher_disagreement_score":0.01207036,"about_ca_system_score_codex":0.0020447546,"about_ca_system_score_gemma":0.0009864589,"threshold_uncertainty_score":0.014835775},"labels":[],"label_agreement":null},{"id":"W3111987827","doi":"10.1038/s41416-020-01196-7","title":"Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Nova Scotia Health Authority; Canadian Partnership Against Cancer; Cancer Care Ontario; CancerCare Manitoba","funders":"Cancer Research UK; World Health Organization","keywords":"Cancer survival; Cancer registry; Cancer; Demography; Medicine; Population; Survival analysis; Statistics; Environmental health; Mathematics; Internal medicine","score_opus":0.40449665826576664,"score_gpt":0.4494096764824256,"score_spread":0.04491301821665894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111987827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829054,0.0003296868,0.0108158095,0.00056435284,0.000039545157,0.0002688386,0.0019188226,0.00007341666,0.003084136],"genre_scores_gemma":[0.9949373,0.0001051284,0.0033727293,0.000073112016,0.000009938555,0.00017094058,0.0008418241,0.000015568303,0.00047341787],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99263,0.0057754936,0.00023360096,0.0005123451,0.0002759312,0.00057264697],"domain_scores_gemma":[0.8827548,0.10407068,0.0053715133,0.0038986213,0.0027035472,0.0012008714],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018330032,0.000861105,0.0010949638,0.0015236079,0.00068105495,0.0014904306,0.001776986,0.0020645347,0.0046026767],"category_scores_gemma":[0.047947347,0.00055330945,0.0030422315,0.0021353308,0.0010521299,0.0014933825,0.0019111843,0.0020893298,0.00028933928],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010825596,0.00052781083,0.07049809,0.0001245899,0.0005838935,0.00021944045,0.00020650649,0.9187351,0.00019516656,0.0031540866,0.0009304072,0.0037423375],"study_design_scores_gemma":[0.00050598325,0.001128782,0.022807136,0.00009945145,0.0004198314,0.00024364852,0.00046692352,0.96953315,0.0005490212,0.0032049192,0.0009633119,0.000077921104],"about_ca_topic_score_codex":0.030784704,"about_ca_topic_score_gemma":0.0141763985,"teacher_disagreement_score":0.98166996,"about_ca_system_score_codex":0.0029280721,"about_ca_system_score_gemma":0.0020378064,"threshold_uncertainty_score":0.09693968},"labels":[],"label_agreement":null},{"id":"W3111996930","doi":"10.1038/s41416-020-01234-4","title":"Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"North Bristol NHS Trust; Newcastle upon Tyne Hospitals NHS Foundation Trust; University of Sussex; University of Oxford; Cancer Research UK; Queen's University Belfast; University College London; Imperial College London; Imperial College Healthcare NHS Trust; National Institute for Health and Care Research; Queen's University; Royal Marsden NHS Foundation Trust; Middlesex University","keywords":"Medicine; Pandemic; Breast cancer; Coronavirus disease 2019 (COVID-19); Cohort; Radiation therapy; Cancer; Internal medicine; Oncology; Disease; Infectious disease (medical specialty)","score_opus":0.1600086476791071,"score_gpt":0.4267537584642302,"score_spread":0.2667451107851231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111996930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947141,0.0006293288,0.00005199613,0.0005433603,0.000026814367,0.000077413824,0.003020627,0.000005151654,0.00093120505],"genre_scores_gemma":[0.99445456,0.00041099347,0.00007813107,0.00042979897,0.000033140466,0.0001225133,0.004163024,0.0000064014293,0.0003013507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997086,0.0010322309,0.00031149675,0.000330505,0.00047867282,0.00076105614],"domain_scores_gemma":[0.9906246,0.001362963,0.004085531,0.0006274989,0.0014938067,0.0018055819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002775473,0.0003192949,0.00050499424,0.00073152495,0.0008113768,0.0016719708,0.0006688636,0.0009382819,0.0026086944],"category_scores_gemma":[0.010738095,0.0003597951,0.0007801757,0.0021026954,0.00058530224,0.00097467605,0.0029294507,0.0015485383,0.0004392549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014152061,0.00015355641,0.98681086,0.00013218001,0.00014175072,0.00015520565,0.0009136866,0.00015516422,0.00008980884,0.00008629339,0.0034580026,0.0064882],"study_design_scores_gemma":[0.0000925278,0.0005886986,0.9953414,0.00015856164,0.000043225817,0.00016921219,0.0019001312,0.00014873924,0.000045785193,0.000041437503,0.0014467711,0.000023525194],"about_ca_topic_score_codex":0.07696214,"about_ca_topic_score_gemma":0.06353704,"teacher_disagreement_score":0.07696214,"about_ca_system_score_codex":0.0034122586,"about_ca_system_score_gemma":0.0032623159,"threshold_uncertainty_score":0.15302837},"labels":[],"label_agreement":null},{"id":"W3121425442","doi":"10.1038/s41416-020-01185-w","title":"CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval; Centre hospitalier universitaire de Québec; McGill University; University of Toronto; Royal Victoria Hospital; Queen's University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Medical Research and Materiel Command; Servicio Gallego de Salud; Robert Bosch Stiftung; Programme Grants for Applied Research; Instituto de Salud Carlos III; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; Cancer Council Tasmania; World Cancer Research Fund; Medical Research Council; European Commission; Canadian Institutes of Health Research; Ministry of Science and Higher Education of the Russian Federation; U.S. Army; Division of Cancer Prevention, National Cancer Institute; National Institutes of Health; Hellenic Health Foundation; Deutschen Konsortium für Translationale Krebsforschung; Universitätsklinikum Hamburg-Eppendorf; Xunta de Galicia; Rheinische Friedrich-Wilhelms-Universität Bonn; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; Ministero dello Sviluppo Economico; Deutsche Krebshilfe; National Health and Medical Research Council; Oulun Yliopisto; Cancer Institute NSW; Medizinischen Hochschule Hannover; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Centre International de Recherche sur le Cancer; Kreftforeningen; Cancer Council South Australia; Institut National Du Cancer; Leids Universitair Medisch Centrum; Karolinska Institutet; Associazione Italiana per la Ricerca sul Cancro; KWF Kankerbestrijding; Vetenskapsrådet; Norges Forskningsråd; Stockholms Läns Landsting; Ligue Contre le Cancer; Kuopion Yliopistollinen Sairaala; Fonds Wetenschappelijk Onderzoek; Cancer Australia; Russian Foundation for Basic Research; Freistaat Sachsen; University of Technology Sydney; University of Crete; Institut National de la Santé et de la Recherche Médicale; Wellcome Trust; Agence Nationale de la Recherche; University of Southern California; Cancerfonden; Ministerio de Sanidad, Servicios Sociales e Igualdad; European Regional Development Fund; National Cancer Institute; Cancer Council Western Australia; Academy of Finland; Gentofte Hospital; King's College London; Génome Québec; Fondation du cancer du sein du Québec; University of Cambridge; Government of Canada; Stavros Niarchos Foundation; Fondation de France; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Ministerio de Economía y Competitividad; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; National Breast Cancer Foundation; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; National Institute of Environmental Health Sciences; Swedish Cancer Foundation; Agency for Science, Technology and Research; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; University of California; McGill University Health Centre; David F. and Margaret T. Grohne Family Foundation; Genome Canada; Sundhed og Sygdom, Det Frie Forskningsråd; Deutsches Krebsforschungszentrum; Université Laval; Cancer Council Victoria; California Department of Public Health; Brigham and Women's Hospital; University of Sydney; Cancer Research UK; Deutsche Gesetzliche Unfallversicherung; Deutsche Forschungsgemeinschaft; Breast Cancer Research Foundation; McGill University; University of California, San Francisco; U.S. Department of Health and Human Services; Cancer Council NSW; Susan G. Komen for the Cure","keywords":"Oestrogen receptor; Internal medicine; Medicine; Breast cancer; Endocrinology; Allele; Progesterone receptor; Hormone; Hormone receptor; Mammary gland; Gynecology; Biology; Cancer; Estrogen receptor; Genetics; Gene","score_opus":0.004149702866736928,"score_gpt":0.22521270384589423,"score_spread":0.2210630009791573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121425442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978986,0.0006739509,0.00039868342,0.00013883466,0.000025464164,0.000007961051,0.00038869987,0.000016298201,0.0004515829],"genre_scores_gemma":[0.99928313,0.00009807628,0.00015402117,0.00003867967,0.00002472821,0.0000045251118,0.0001597116,0.0000065739855,0.00023044687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994124,0.00019766747,0.00004798498,0.00019783588,0.00007634224,0.00006766935],"domain_scores_gemma":[0.9984664,0.00049625064,0.00054300856,0.00014821674,0.00012431778,0.0002218985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055412593,0.0004727936,0.00042392133,0.0007650648,0.000325038,0.0005748492,0.00037778827,0.00073072826,0.0035729052],"category_scores_gemma":[0.0018747626,0.00023161377,0.00076758274,0.0009925095,0.00030385656,0.00012596355,0.00025161175,0.0005727098,0.00036829076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015619525,0.00006724136,0.98609924,0.000029608429,0.0005658415,0.00047193049,0.00006263593,0.0001322647,0.007237865,0.00008020186,0.00023737772,0.0034539257],"study_design_scores_gemma":[0.000044026343,0.0001136884,0.99709105,0.0000069424486,0.00033597497,0.00062671845,0.000033351982,0.00050192757,0.0007849469,0.0001379883,0.00031798793,0.000005374807],"about_ca_topic_score_codex":0.00454041,"about_ca_topic_score_gemma":0.002282839,"teacher_disagreement_score":0.00454041,"about_ca_system_score_codex":0.000170129,"about_ca_system_score_gemma":0.00022707021,"threshold_uncertainty_score":0.011952579},"labels":[],"label_agreement":null},{"id":"W3127009987","doi":"10.1038/s41416-020-01233-5","title":"Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment","year":2021,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Health Technology Assessment Programme; National Institute for Health and Care Research; UCL Hospitals Charitable Foundation","keywords":"Lumpectomy; Medicine; Radiation therapy; Breast cancer; Mastectomy; Intraoperative radiotherapy; Surgery; Cancer; Radiology; Internal medicine","score_opus":0.015612509006318885,"score_gpt":0.26802084697008755,"score_spread":0.25240833796376866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127009987","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02919226,0.010500384,0.00066423253,0.92957526,0.016806252,0.0002830755,0.00048141836,0.0000776732,0.012419484],"genre_scores_gemma":[0.09621655,0.009195927,0.00209211,0.8330992,0.042657804,0.00070615986,0.00042148738,0.00005396247,0.015556839],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867946,0.00069787604,0.00013657386,0.00010525304,0.000245186,0.00013565544],"domain_scores_gemma":[0.99633396,0.0024727238,0.00021908696,0.00010219795,0.00023165056,0.00064036384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00227898,0.00029156427,0.00079619186,0.00024387726,0.0005177517,0.00077488465,0.0007374852,0.010586824,0.0057073142],"category_scores_gemma":[0.0074705505,0.00023181149,0.0007582783,0.00038480898,0.00060310407,0.00068710954,0.00033205995,0.005782316,0.0023196342],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01767575,0.0020183804,0.012977592,0.0012418383,0.00028057452,0.010762791,0.00025638545,0.0011003789,0.0063048443,0.0048166555,0.63713336,0.30543137],"study_design_scores_gemma":[0.027178276,0.009632911,0.03735386,0.0010237109,0.0006498203,0.013883797,0.0004050228,0.003688102,0.0036766955,0.01195434,0.8903742,0.00017928336],"about_ca_topic_score_codex":0.0011671054,"about_ca_topic_score_gemma":0.0037225734,"teacher_disagreement_score":0.010586824,"about_ca_system_score_codex":0.0013796246,"about_ca_system_score_gemma":0.001395218,"threshold_uncertainty_score":0.019092917},"labels":[],"label_agreement":null},{"id":"W3130785111","doi":"10.1038/s41416-020-01247-z","title":"Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Cochrane; Impact; Health Sciences Centre; McMaster University Medical Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Guideline; Grading (engineering); Observational study; Cancer; Family medicine; Gynecology; Bioinformatics; Pathology; Biology","score_opus":0.047959592241852415,"score_gpt":0.32081713207558876,"score_spread":0.27285753983373634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130785111","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002227963,0.19264866,0.017772503,0.71041936,0.025049562,0.013854194,0.010591638,0.00076684094,0.026669307],"genre_scores_gemma":[0.026877087,0.13582972,0.26518708,0.5063233,0.0050444254,0.031010067,0.016166892,0.00042571474,0.013135673],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.8873639,0.055729076,0.031677168,0.003108432,0.018021086,0.004100232],"domain_scores_gemma":[0.7713444,0.08729395,0.030690772,0.0059199086,0.09724383,0.00750709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08525994,0.0026970957,0.005247636,0.0097151175,0.0022602936,0.00594788,0.012892601,0.02610102,0.0058981655],"category_scores_gemma":[0.22575383,0.0019138411,0.014692937,0.008477621,0.0024845505,0.0048434814,0.005951292,0.014497433,0.0041579395],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055326417,0.00023391453,0.0027618136,0.061795127,0.0022657346,0.00036776575,0.0009025682,0.0015518286,0.0008872356,0.010806206,0.7516523,0.16622227],"study_design_scores_gemma":[0.0019998208,0.0002510661,0.0050615133,0.25065187,0.006030309,0.00031289246,0.0006263097,0.0011872067,0.0008787345,0.014462552,0.7182198,0.00031788193],"about_ca_topic_score_codex":0.05236116,"about_ca_topic_score_gemma":0.04329932,"teacher_disagreement_score":0.08525994,"about_ca_system_score_codex":0.013403553,"about_ca_system_score_gemma":0.06288211,"threshold_uncertainty_score":0.45090306},"labels":[],"label_agreement":null},{"id":"W3131950767","doi":"10.1038/s41416-020-01164-1","title":"Survival from breast cancer in women with a BRCA2 mutation by treatment","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; Women's College Hospital","funders":"National Health and Medical Research Council; National Cancer Institute; Cancer Australia; Manchester Biomedical Research Centre; National Breast Cancer Foundation; Medical Research Council; National Institute for Health and Care Research","keywords":"Breast cancer; Medicine; Hazard ratio; Oophorectomy; Internal medicine; Oncology; Cancer; Ovarian cancer; Proportional hazards model; Gynecology; Retrospective cohort study; Prospective cohort study; Surgery; Hysterectomy; Confidence interval","score_opus":0.005801225448483067,"score_gpt":0.2584716869826394,"score_spread":0.25267046153415634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131950767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666864,0.0016157766,0.00010636682,0.00012607014,0.000007338421,0.0000059796166,0.0010699608,0.000004367294,0.00039535316],"genre_scores_gemma":[0.99838173,0.00034891683,0.000045946028,0.000028743243,0.000010432623,0.0000065619324,0.0011063172,0.0000016559707,0.000069637674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956197,0.00014109274,0.000029926428,0.0001148787,0.00007597813,0.00007615732],"domain_scores_gemma":[0.99843735,0.00058063306,0.000674992,0.00009626522,0.00008568721,0.0001250236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009208754,0.00015949072,0.00035675018,0.00052041805,0.00014243851,0.00033710044,0.00024782075,0.00035040002,0.0013025891],"category_scores_gemma":[0.0031098847,0.000110990906,0.00077147625,0.0006076918,0.00017263557,0.00029826455,0.0003273798,0.00028460394,0.00015477075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003891071,0.000010425167,0.9959409,0.00001516192,0.000108811386,0.000033769007,0.000019330608,0.00019518698,0.00009793431,0.000013016071,0.00014601859,0.003030278],"study_design_scores_gemma":[0.000014514026,0.00012909011,0.9987326,0.000014386774,0.000098474426,0.00027323738,0.00003846698,0.0003137786,0.000060181632,0.000061783256,0.00026036243,0.0000031207933],"about_ca_topic_score_codex":0.0019534105,"about_ca_topic_score_gemma":0.0025355949,"teacher_disagreement_score":0.0019534105,"about_ca_system_score_codex":0.00034019997,"about_ca_system_score_gemma":0.0002231145,"threshold_uncertainty_score":0.0048701167},"labels":[],"label_agreement":null},{"id":"W3133504058","doi":"10.1038/s41416-021-01311-2","title":"Correction: Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Phosphatase; Alkaline phosphatase; Pathology; Medicine; Biology; Bioinformatics; Computational biology; Biochemistry; Enzyme","score_opus":0.024376626158605905,"score_gpt":0.28852579073058204,"score_spread":0.2641491645719761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133504058","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003480138,0.0033041153,0.0017590179,0.062484283,0.9285057,0.00001376261,0.0008993752,0.00045468012,0.0022310754],"genre_scores_gemma":[0.051226027,0.032418597,0.011704445,0.13062969,0.4338715,0.0002155363,0.0042937403,0.0029815224,0.33265895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99622655,0.00041973146,0.0005903006,0.000761663,0.0015730364,0.00042865248],"domain_scores_gemma":[0.97869545,0.006154535,0.0014622562,0.0015727581,0.010462739,0.0016524006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030683225,0.0017172833,0.001444932,0.002138372,0.002244215,0.003789036,0.0029859303,0.0059965053,0.0392507],"category_scores_gemma":[0.042249974,0.00086804386,0.0013547397,0.0018109385,0.0030666003,0.0026093458,0.0017633053,0.012351738,0.020036906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006630845,0.000006936628,0.00010304685,0.00024184315,0.000024434004,0.0006287374,0.00005245185,0.00009351757,0.00034989498,0.0022994836,0.9847141,0.011419232],"study_design_scores_gemma":[0.00003433855,0.000020405503,0.000438206,0.00018054422,0.000028103068,0.0014139522,0.00006462173,0.00020445525,0.00095626956,0.0019180069,0.9947037,0.000037378373],"about_ca_topic_score_codex":0.0076681245,"about_ca_topic_score_gemma":0.008513065,"teacher_disagreement_score":0.0392507,"about_ca_system_score_codex":0.0033977765,"about_ca_system_score_gemma":0.004549213,"threshold_uncertainty_score":0.13130671},"labels":[],"label_agreement":null},{"id":"W3135466700","doi":"10.1038/s41416-020-01253-1","title":"Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; American Society of Clinical Oncology","keywords":"Microbiome; Fusobacterium nucleatum; Internal medicine; Metagenomics; Saliva; Head and neck squamous-cell carcinoma; Stage (stratigraphy); Medicine; Gut flora; Cohort; Chemoradiotherapy; Oncology; Gastroenterology; Biology; Cancer; Head and neck cancer; Immunology; Bioinformatics; Genetics","score_opus":0.008450015526898672,"score_gpt":0.27179689571798876,"score_spread":0.2633468801910901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135466700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879056,0.000292066,0.000053231848,0.000042107207,0.000005240154,0.000018244275,0.00048209255,0.0000035166238,0.00031304092],"genre_scores_gemma":[0.9985886,0.00013382433,0.00006550051,0.000042034422,0.000011026555,0.000023308692,0.0007419687,0.0000036177496,0.00039014654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964714,0.00008836361,0.000021794009,0.000111546855,0.00004728478,0.00008384198],"domain_scores_gemma":[0.99961805,0.000049569313,0.0001263686,0.000059082446,0.000051914074,0.00009496378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005430207,0.00021500025,0.0003929276,0.00022948766,0.00036669004,0.0008113783,0.0003055388,0.00043050208,0.0015213767],"category_scores_gemma":[0.0009630499,0.00021678122,0.0006641833,0.00029877684,0.00022660177,0.0002529385,0.0006932549,0.00048216974,0.00039953538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029554672,0.00028026628,0.9828006,0.00008559932,0.00023667054,0.00023289488,0.00045310683,0.000069057896,0.0034591705,0.000027251954,0.0005729058,0.008827058],"study_design_scores_gemma":[0.000035041,0.00055477535,0.9980836,0.000011994826,0.00008769165,0.00021417429,0.00018274662,0.000054381988,0.00020723254,0.000013618686,0.00055058434,0.0000041232765],"about_ca_topic_score_codex":0.005886201,"about_ca_topic_score_gemma":0.0053515877,"teacher_disagreement_score":0.005886201,"about_ca_system_score_codex":0.00046952782,"about_ca_system_score_gemma":0.0003918146,"threshold_uncertainty_score":0.011703849},"labels":[],"label_agreement":null},{"id":"W3136463040","doi":"10.1038/s41416-021-01317-w","title":"Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Strong; Government of Canada; CancerCare Manitoba Foundation; Canadian Institutes of Health Research; Cancer Research Society; University of Pennsylvania","keywords":"Cyclin E1; Cyclin D; Cancer research; Ubiquitin ligase; Cyclin B; Cyclin E; Cyclin A; Biology; Cell cycle; Skp1; Cyclin; Cyclin A2; Cell biology; Medicine; Cancer; Ubiquitin; Genetics; Gene","score_opus":0.01569016937950446,"score_gpt":0.28367592865697416,"score_spread":0.2679857592774697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136463040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960598,0.0015662328,0.0008435405,0.000086629654,0.000008471465,0.000021653304,0.0002371814,0.00004646947,0.0011299942],"genre_scores_gemma":[0.99819154,0.00054579106,0.00047014878,0.00002263078,0.0000017630443,0.000012951829,0.0001972632,0.000004938275,0.00055291556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999242,0.000009723455,0.000006451738,0.000014122943,0.00002785449,0.000017655784],"domain_scores_gemma":[0.9998803,0.00001811035,0.000041068706,0.00001083327,0.000013112796,0.00003648326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012621145,0.00012262043,0.00016821527,0.00023825622,0.00013605645,0.00032575495,0.00014147285,0.0002101861,0.0014331697],"category_scores_gemma":[0.0001739192,0.00011432432,0.0001066536,0.00014707148,0.00021412793,0.00013081258,0.00020323077,0.00037976902,0.00024404703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034172795,0.00005989761,0.007276422,0.00009114613,0.0000094730485,0.00031827358,0.00005569664,0.00014772583,0.98692816,0.00023345985,0.00017220028,0.004365618],"study_design_scores_gemma":[0.000052447358,0.0010183654,0.16980064,0.000022495844,0.000034470297,0.0035251058,0.00028451247,0.0020067785,0.81526214,0.00025682157,0.007724707,0.000011467202],"about_ca_topic_score_codex":0.001331606,"about_ca_topic_score_gemma":0.0017290835,"teacher_disagreement_score":0.0014331697,"about_ca_system_score_codex":0.00046359526,"about_ca_system_score_gemma":0.0003335884,"threshold_uncertainty_score":0.004794419},"labels":[],"label_agreement":null},{"id":"W3137052566","doi":"10.1038/s41416-021-01277-1","title":"Post-diagnostic coffee and tea consumption and breast cancer survival","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coffee research and impacts","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Prospective cohort study; Confidence interval; Cancer; Cohort study; Lower risk; Internal medicine; Proportional hazards model; Gynecology","score_opus":0.027862600210642057,"score_gpt":0.34653366667669677,"score_spread":0.3186710664660547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137052566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785559,0.015011857,0.00006649773,0.00083881104,0.00014361563,0.00000681366,0.0015775604,0.000019990815,0.0037788998],"genre_scores_gemma":[0.99511755,0.0016906745,0.000047127385,0.00010504221,0.000092662216,0.0000055382793,0.0007279625,0.000007125038,0.0022063542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962795,0.000098081495,0.000033597335,0.000068678324,0.000052565374,0.000119128345],"domain_scores_gemma":[0.9979984,0.00060257636,0.0006244298,0.00013942522,0.00016077141,0.00047436793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049642834,0.00025273772,0.0004403575,0.0006601457,0.00032370887,0.0008722562,0.00037939232,0.0010266502,0.00842953],"category_scores_gemma":[0.00416534,0.00036015132,0.0011618233,0.001045867,0.00020285693,0.0005588641,0.0005554889,0.0010933664,0.0008831548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058375755,0.00027434173,0.97676486,0.00016676857,0.0006683727,0.00025499793,0.00014673255,0.00017429974,0.00066104473,0.00009123709,0.00082249165,0.014137258],"study_design_scores_gemma":[0.000016087375,0.00015494268,0.9984296,0.000021265738,0.00016880622,0.0001189802,0.00009768022,0.00007762765,0.000044780674,0.000067964356,0.0007941607,0.000008049117],"about_ca_topic_score_codex":0.014609374,"about_ca_topic_score_gemma":0.016075473,"teacher_disagreement_score":0.014609374,"about_ca_system_score_codex":0.0005294863,"about_ca_system_score_gemma":0.0004016933,"threshold_uncertainty_score":0.029048681},"labels":[],"label_agreement":null},{"id":"W3138474425","doi":"10.1038/s41416-021-01321-0","title":"Achieving clinical success with BET inhibitors as anti-cancer agents","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":354,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Cancer; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.040768426589829036,"score_gpt":0.40492071774622207,"score_spread":0.364152291156393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138474425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035312196,0.9958763,0.00027330877,0.0007230033,0.0003966714,0.000010330453,0.000035213303,0.000019064066,0.0023129685],"genre_scores_gemma":[0.0023387398,0.9934708,0.00046258495,0.0008682464,0.00031974586,0.0000231849,0.00006902866,0.0000067968804,0.0024408733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997509,0.000047187514,0.00002893745,0.000041250652,0.00009783431,0.000033867625],"domain_scores_gemma":[0.9996495,0.00018301798,0.000037485526,0.000010285071,0.00007950169,0.00004013732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000859048,0.000901223,0.0013685947,0.0014196173,0.0002762872,0.0011804142,0.0009529005,0.00171027,0.0042124065],"category_scores_gemma":[0.0010244182,0.00034765506,0.00056739245,0.00096400967,0.0005560814,0.0012635762,0.0006509781,0.0037128595,0.0031582022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002735869,0.00014245561,0.0001208295,0.007652866,0.00010709424,0.00030306767,0.000060744667,0.0006286905,0.0033102455,0.009598777,0.04561863,0.932183],"study_design_scores_gemma":[0.00008162305,0.00020674702,0.00048238525,0.0013604413,0.000057443616,0.00079996133,0.000021778531,0.00012040498,0.0010400331,0.001923655,0.99389136,0.00001420826],"about_ca_topic_score_codex":0.0005741467,"about_ca_topic_score_gemma":0.0018107685,"teacher_disagreement_score":0.0042124065,"about_ca_system_score_codex":0.0008262497,"about_ca_system_score_gemma":0.00058200536,"threshold_uncertainty_score":0.014091909},"labels":[],"label_agreement":null},{"id":"W3139510287","doi":"10.1038/s41416-021-01297-x","title":"Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; Dan L. Duncan Cancer Center, Baylor College of Medicine; Cancer Prevention and Research Institute of Texas; U.S. Department of Health and Human Services","keywords":"Lactate dehydrogenase A; Glycolysis; Head and neck squamous-cell carcinoma; Cancer research; Warburg effect; Clonogenic assay; Lactate dehydrogenase; Small hairpin RNA; Cancer cell; Biology; Cancer; Head and neck cancer; Cell; Internal medicine; Medicine; Biochemistry; Metabolism; Enzyme; Gene knockdown; Apoptosis","score_opus":0.028225011515535015,"score_gpt":0.33133292809371484,"score_spread":0.3031079165781798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139510287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49745095,0.06564646,0.36802694,0.020531898,0.0017433722,0.0040533324,0.0017781513,0.0016974467,0.039071385],"genre_scores_gemma":[0.8755151,0.02095053,0.09526879,0.0022354978,0.00021475754,0.00086628465,0.0008703609,0.000117262585,0.0039612995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974245,0.00006938034,0.000017933282,0.000055434764,0.000052176507,0.00006269343],"domain_scores_gemma":[0.99984837,0.00004494852,0.000030156554,0.000018254628,0.00002945135,0.00002882332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078030647,0.00054865517,0.0007203769,0.00061112095,0.00036438956,0.0013631106,0.001023118,0.0006525347,0.0033644887],"category_scores_gemma":[0.00076639536,0.00029674993,0.00060456153,0.00034842483,0.00050990033,0.0007460297,0.00060963404,0.0023073128,0.0006329643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016664204,0.0020089003,0.0034096322,0.00071113475,0.00025803118,0.0006302084,0.00017435486,0.019436719,0.63240874,0.031285204,0.005274348,0.30273625],"study_design_scores_gemma":[0.0025041723,0.01750747,0.009793873,0.00059368997,0.0009894785,0.0038908413,0.000683698,0.054908853,0.6297507,0.03426599,0.24484625,0.00026491578],"about_ca_topic_score_codex":0.0011164991,"about_ca_topic_score_gemma":0.0028401387,"teacher_disagreement_score":0.0033644887,"about_ca_system_score_codex":0.00082532555,"about_ca_system_score_gemma":0.0017070385,"threshold_uncertainty_score":0.0112553835},"labels":[],"label_agreement":null},{"id":"W3141177924","doi":"10.1038/bjc.2012.530","title":"Comment on: ‘Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study’","year":2012,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Digit ratio; Medicine; Reliability (semiconductor); Cohort; Cancer; Numerical digit; Prospective cohort study; Cohort study; Oncology; Statistics; Internal medicine; Mathematics; Arithmetic","score_opus":0.008053885097827184,"score_gpt":0.2600191696000782,"score_spread":0.25196528450225103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141177924","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005498527,0.0013358387,0.000098862496,0.97307056,0.024044435,0.000010512527,0.00022028502,0.000057794812,0.00061185233],"genre_scores_gemma":[0.0029558372,0.0005955393,0.00016650712,0.9664305,0.027351694,0.000028306249,0.00006136376,0.00002441669,0.0023858265],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969331,0.0009990692,0.00049563416,0.0005515132,0.00072783016,0.00029291707],"domain_scores_gemma":[0.9899338,0.0061785826,0.00089253567,0.00034870577,0.0017833977,0.0008630148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045528947,0.0010874014,0.0019233815,0.00096037256,0.0025870393,0.0021750685,0.0023905684,0.033696435,0.0057612024],"category_scores_gemma":[0.025991198,0.00088882574,0.0013874493,0.0010227101,0.0018683813,0.0031609295,0.00102032,0.032202702,0.0074194404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013244073,0.000029711124,0.0014695876,0.00007164312,0.000030567116,0.000924159,0.00011594154,0.000037995742,0.00015972719,0.0004922903,0.9921435,0.004392442],"study_design_scores_gemma":[0.00041577208,0.00039128037,0.014608376,0.0009906741,0.00023768935,0.008918644,0.0011491369,0.001263212,0.0011470226,0.009096436,0.96139115,0.00039057987],"about_ca_topic_score_codex":0.0072313463,"about_ca_topic_score_gemma":0.010347432,"teacher_disagreement_score":0.033696435,"about_ca_system_score_codex":0.0023311046,"about_ca_system_score_gemma":0.001756656,"threshold_uncertainty_score":0.02407831},"labels":[],"label_agreement":null},{"id":"W3142622887","doi":"10.1038/s41416-021-01330-z","title":"Vascular normalisation as the stepping stone into tumour microenvironment transformation","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Norges Forskningsråd; Universitetet i Bergen; Queen's University; Rosetrees Trust; Prostate Cancer UK; University of Oxford","keywords":"Tumor microenvironment; Cancer; Cancer research; Vascular network; Metastasis; Medicine; Cancer cell; Biology; Pathology; Anatomy; Internal medicine","score_opus":0.016092786897582787,"score_gpt":0.2987482935599764,"score_spread":0.2826555066623936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142622887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000118329895,0.99746084,0.00023650196,0.00058587856,0.00036312654,0.00000309947,0.000008065993,0.000008641688,0.0012155295],"genre_scores_gemma":[0.00146037,0.99673164,0.00021320661,0.00029641797,0.00027790657,0.0000058015066,0.000014954786,0.0000029946245,0.0009966346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999752,0.00005275169,0.00002617317,0.000037148668,0.00010012192,0.0000317693],"domain_scores_gemma":[0.99970466,0.00014313839,0.000030583677,0.00001137852,0.00007238331,0.000037846563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070316147,0.00063665916,0.0012408237,0.0015966911,0.00033227215,0.0015632549,0.0007213033,0.0017206086,0.0027675328],"category_scores_gemma":[0.0006858253,0.00029549134,0.00032834566,0.0012989616,0.0013074029,0.0019754544,0.00084487296,0.0032985257,0.0021037122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011812923,0.00006867025,0.00014355865,0.011945688,0.00004394036,0.0004979786,0.00014018404,0.0006749606,0.004962222,0.03136274,0.03686846,0.9131735],"study_design_scores_gemma":[0.000010680682,0.00006331962,0.00036170485,0.0013234488,0.00001950706,0.0011965152,0.000050675306,0.00009861437,0.0009701126,0.005491224,0.99040014,0.000014094413],"about_ca_topic_score_codex":0.001124217,"about_ca_topic_score_gemma":0.001650392,"teacher_disagreement_score":0.0027675328,"about_ca_system_score_codex":0.0013315057,"about_ca_system_score_gemma":0.0010208207,"threshold_uncertainty_score":0.00966084},"labels":[],"label_agreement":null},{"id":"W3143375719","doi":"10.1038/s41416-021-01376-z","title":"Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre Hospitalier de l’Université de Montréal; McGill University; Université Laval; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"Urinary system; Prostate cancer; Medicine; Urine; Prospective cohort study; Internal medicine; Metastasis; Gynecology; Cancer; Cohort study; Oncology; Physiology; Endocrinology","score_opus":0.013711611370692328,"score_gpt":0.3457214588175842,"score_spread":0.3320098474468919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143375719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945807,0.0029908395,0.00016399266,0.000071407005,0.00001763819,0.000008381212,0.00055095565,0.000025346917,0.0015907187],"genre_scores_gemma":[0.99917245,0.00019521562,0.0000683925,0.000011438704,0.000011015884,0.0000025350334,0.00018658576,0.0000022574895,0.0003501347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995753,0.00017621058,0.000029802934,0.000059108548,0.0001044289,0.000055147375],"domain_scores_gemma":[0.99818844,0.0006012943,0.00067321793,0.000093589035,0.00013772279,0.00030568775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056206505,0.00027060788,0.00053066376,0.0009874527,0.00021118509,0.0007205389,0.00030511816,0.000625516,0.0028681594],"category_scores_gemma":[0.0026676368,0.00021519016,0.0005538833,0.0008752667,0.00028941984,0.0003233326,0.00056787557,0.000909257,0.0003199525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016165813,0.000055463355,0.99130577,0.00006914576,0.00019677667,0.00016801886,0.000081826205,0.00045723704,0.0010771947,0.000039692837,0.00011194454,0.0048205005],"study_design_scores_gemma":[0.0000071606405,0.00023727104,0.9982967,0.000012237701,0.000070866554,0.0004551949,0.00007262851,0.00044778833,0.00016608353,0.000034741224,0.0001911079,0.00000834881],"about_ca_topic_score_codex":0.003634006,"about_ca_topic_score_gemma":0.003588489,"teacher_disagreement_score":0.003634006,"about_ca_system_score_codex":0.0002825395,"about_ca_system_score_gemma":0.00025156882,"threshold_uncertainty_score":0.009594917},"labels":[],"label_agreement":null},{"id":"W3144193261","doi":"10.1038/s41416-018-0213-8","title":"Reply to ‘Comment on ‘Anthropometric measurements and survival after prostate cancer diagnosis”","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"South Health Campus; University of Calgary; University of Alberta; Alberta Health Services","funders":"","keywords":"Anthropometry; Prostate cancer; Medicine; Prostate; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.045299850297419,"score_gpt":0.3361512723776937,"score_spread":0.2908514220802747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144193261","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019084707,0.000745782,0.000030289984,0.9756157,0.022850307,0.0000052711903,0.000075559146,0.000012144203,0.00047412905],"genre_scores_gemma":[0.0015527841,0.0005424255,0.00005777386,0.95892483,0.036169913,0.000030391715,0.00003656973,0.000017436421,0.0026678706],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951633,0.0013161114,0.0008339458,0.0006813871,0.0010839073,0.0009211715],"domain_scores_gemma":[0.98205113,0.010268129,0.0021710203,0.0004152141,0.002862601,0.0022319413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005280214,0.0009813219,0.0018679065,0.0010009592,0.00409079,0.0033745624,0.0021171756,0.056165982,0.00845592],"category_scores_gemma":[0.048993837,0.0011488452,0.0013448917,0.0011734908,0.0031378518,0.0039033343,0.002730598,0.048574414,0.007110644],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005252616,0.000012810502,0.0005969719,0.0000588695,0.000011958398,0.00045091764,0.00016565196,0.000021982782,0.00005200375,0.0005972606,0.9955356,0.0024433876],"study_design_scores_gemma":[0.00018692204,0.0001054795,0.004550954,0.0007687388,0.00007490816,0.0017128689,0.0012783522,0.00029345474,0.00025465633,0.0037061374,0.98693776,0.00012967199],"about_ca_topic_score_codex":0.011928132,"about_ca_topic_score_gemma":0.013084874,"teacher_disagreement_score":0.056165982,"about_ca_system_score_codex":0.0053875227,"about_ca_system_score_gemma":0.0050698216,"threshold_uncertainty_score":0.03908944},"labels":[],"label_agreement":null},{"id":"W3160120934","doi":"10.1038/s41416-021-01420-y","title":"Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Health and Medical Research Council; Cancer Institute NSW; Cooperative Research Centres, Australian Government Department of Industry; NSW Health; Department of Education and Training; Australian Research Council","keywords":"Vinorelbine; Mitosis; Ovarian cancer; Cancer research; Biology; Paclitaxel; Microtubule; Cell biology; Cancer; Chemotherapy; Genetics","score_opus":0.006620576433483745,"score_gpt":0.24413412924272496,"score_spread":0.23751355280924122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160120934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897188,0.0054541156,0.0011532936,0.00024118643,0.00002340636,0.000025914163,0.00010709761,0.000045785666,0.0032303613],"genre_scores_gemma":[0.9967495,0.0016053347,0.0006573742,0.00003245243,0.0000068581894,0.0000144310325,0.000055776334,0.0000066348407,0.0008715228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991596,0.000017728578,0.000004840141,0.000009000031,0.000023364037,0.000028998422],"domain_scores_gemma":[0.999946,0.000015281117,0.000009722584,0.000005642233,0.0000074634904,0.000015761621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001595464,0.00017907628,0.00027888262,0.0002998421,0.00020709194,0.00030507596,0.00017541894,0.0002673492,0.0011766584],"category_scores_gemma":[0.000111524234,0.00017420267,0.00018310398,0.00020029992,0.00012422749,0.00018131953,0.00017368187,0.00034612013,0.0001661403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006817509,0.00007836188,0.0007294027,0.00013435722,0.000019409896,0.00011793627,0.00003406663,0.00069101644,0.9841015,0.00039979102,0.00017001313,0.012842532],"study_design_scores_gemma":[0.00009673232,0.0012264281,0.016373124,0.00002117925,0.000067631234,0.00056395953,0.00007946951,0.004671979,0.97011256,0.00017675865,0.0065998253,0.000010420612],"about_ca_topic_score_codex":0.0007913588,"about_ca_topic_score_gemma":0.0035071627,"teacher_disagreement_score":0.0011766584,"about_ca_system_score_codex":0.00031053944,"about_ca_system_score_gemma":0.00019773969,"threshold_uncertainty_score":0.0039362907},"labels":[],"label_agreement":null},{"id":"W3160472279","doi":"10.1038/s41416-021-01373-2","title":"Fruit and vegetable consumption and incident breast cancer: a systematic review and meta-analysis of prospective studies","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Relative risk; Prospective cohort study; Meta-analysis; Confidence interval; Lower risk; Cancer; Incidence (geometry); Gynecology; Internal medicine","score_opus":0.10831066124080356,"score_gpt":0.42856289284079085,"score_spread":0.3202522315999873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160472279","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004663679,0.9942742,0.00027850847,0.00008327284,0.0000725445,0.00011413004,0.00040188414,0.0000123790805,0.00009935403],"genre_scores_gemma":[0.1099694,0.88638896,0.0017127233,0.00053557224,0.000120640405,0.00033256813,0.0006598453,0.000022280186,0.000258046],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951696,0.0016725237,0.0016979859,0.0006992986,0.000540423,0.00022019037],"domain_scores_gemma":[0.99041545,0.006688384,0.0018253905,0.00035287463,0.0005595246,0.00015836212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071209334,0.002635301,0.015163927,0.0040322365,0.0006948966,0.002712113,0.00204905,0.00225178,0.003863868],"category_scores_gemma":[0.019472757,0.0019188,0.026556436,0.00662523,0.0007614219,0.0015968705,0.0020189513,0.0018440263,0.0003422812],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022433389,0.0000403894,0.006315387,0.42714122,0.5483768,0.00015282026,0.00013481121,0.00032962527,0.00034717654,0.00008747362,0.0006123903,0.01421847],"study_design_scores_gemma":[0.00053299556,0.00014950277,0.0065940763,0.020008534,0.970562,0.00012653261,0.000070801914,0.00007113761,0.00008626726,0.00011892637,0.0016502312,0.00002900292],"about_ca_topic_score_codex":0.009239527,"about_ca_topic_score_gemma":0.026948048,"teacher_disagreement_score":0.015163927,"about_ca_system_score_codex":0.0017681699,"about_ca_system_score_gemma":0.0033975295,"threshold_uncertainty_score":0.037659585},"labels":[],"label_agreement":null},{"id":"W3162357932","doi":"10.1038/s41416-021-01410-0","title":"PALB2 mutations and prostate cancer risk and survival","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Narodowe Centrum Nauki","keywords":"Prostate cancer; Hazard ratio; Medicine; Odds ratio; PALB2; Confidence interval; Internal medicine; Cancer; Oncology; Prostate; Gynecology; Mutation; Genetics; Biology; Germline mutation","score_opus":0.017558245570224507,"score_gpt":0.33631361155831363,"score_spread":0.3187553659880891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162357932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97354275,0.017705973,0.00020290524,0.0011426309,0.00010734367,0.0000059155063,0.0015017402,0.00004169108,0.005749031],"genre_scores_gemma":[0.9956981,0.0010515644,0.00007324682,0.00013795239,0.00006716456,0.000005218158,0.0007024794,0.000012790654,0.0022515976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971074,0.000076717304,0.00002072552,0.000070602,0.000052083036,0.000069058646],"domain_scores_gemma":[0.99905354,0.0002725204,0.00027564866,0.00006781648,0.000068464564,0.00026201483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035813285,0.00022772804,0.00035794917,0.0006584442,0.00026340576,0.00083446514,0.00032039295,0.0009397375,0.010653089],"category_scores_gemma":[0.0020386511,0.00034368297,0.000572852,0.0008893971,0.00028500636,0.00045959692,0.0004080684,0.0009980367,0.0009988486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029683984,0.000107204025,0.9725841,0.00012033437,0.0006991507,0.0006786108,0.000121982834,0.0006669772,0.0019593297,0.00037682662,0.0020018227,0.017715305],"study_design_scores_gemma":[0.000056733432,0.00013897114,0.99306947,0.000047622816,0.00017100133,0.0018598612,0.00013708344,0.00045100655,0.00024429563,0.0005311556,0.003273231,0.000019586982],"about_ca_topic_score_codex":0.0041005327,"about_ca_topic_score_gemma":0.0034700246,"teacher_disagreement_score":0.010653089,"about_ca_system_score_codex":0.00037395032,"about_ca_system_score_gemma":0.00024374755,"threshold_uncertainty_score":0.035638094},"labels":[],"label_agreement":null},{"id":"W3164536770","doi":"10.1038/s41416-021-01417-7","title":"The risk of contralateral breast cancer: a SEER-based analysis","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Cancer; Mastectomy; Ductal carcinoma; Gynecology; Internal medicine; Oncology; Obstetrics","score_opus":0.00375210834689115,"score_gpt":0.24932975891662035,"score_spread":0.2455776505697292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164536770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792636,0.011840701,0.000940313,0.00024338685,0.00004754831,0.000023547685,0.0042275926,0.000016195605,0.0033970454],"genre_scores_gemma":[0.99594635,0.001157582,0.00017476483,0.0000676342,0.000031264743,0.000016145486,0.0015859818,0.000014204194,0.0010061836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979011,0.0010938991,0.00018203646,0.00033108695,0.00031940744,0.00017256345],"domain_scores_gemma":[0.9977598,0.0008494053,0.00054038415,0.0003622785,0.00024174411,0.0002464305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001950563,0.00045744306,0.0010861104,0.0016351613,0.0003375962,0.0007663647,0.00059407525,0.0007349244,0.0051716496],"category_scores_gemma":[0.004101146,0.00039371915,0.0028105474,0.0024966258,0.00020355443,0.00044967924,0.0007596673,0.00084629474,0.0004009966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069427807,0.00006390197,0.97686756,0.00021680813,0.0051362813,0.00022122938,0.00009242745,0.00055143895,0.0013186515,0.0002523665,0.0007847255,0.0075516775],"study_design_scores_gemma":[0.00009551058,0.0003435511,0.9945387,0.00003700828,0.0023020736,0.00040653514,0.00013072626,0.0005504975,0.00019754819,0.00013619839,0.0012495616,0.000011976184],"about_ca_topic_score_codex":0.010520451,"about_ca_topic_score_gemma":0.012129702,"teacher_disagreement_score":0.010520451,"about_ca_system_score_codex":0.00036723056,"about_ca_system_score_gemma":0.00040184325,"threshold_uncertainty_score":0.020918429},"labels":[],"label_agreement":null},{"id":"W3164978296","doi":"10.1038/s41416-021-01440-8","title":"New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Bundesministerium für Gesundheit; Bundeszentrale für gesundheitliche Aufklärung; University of Oxford; Health Technology Assessment Programme; University College London; Menzies Centre for Australian Studies, King's College London, University of London; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Queen Mary University of London","keywords":"Medicine; Lumpectomy; Intraoperative radiotherapy; Breast cancer; External beam radiotherapy; Cancer; Radiation therapy; Radiology; Oncology; Surgery; Mastectomy; Internal medicine; Brachytherapy","score_opus":0.015317250788076003,"score_gpt":0.30903321430414055,"score_spread":0.29371596351606455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164978296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8591157,0.091006555,0.014594703,0.011932883,0.0021358766,0.0012428582,0.008591975,0.0002575046,0.011121929],"genre_scores_gemma":[0.9741735,0.007198671,0.004476851,0.003308527,0.0012040333,0.0007800383,0.005547952,0.00008521348,0.0032251454],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98568755,0.0125303725,0.00042723332,0.00055165775,0.00053669326,0.00026650185],"domain_scores_gemma":[0.9699966,0.024064388,0.0031320036,0.0017797061,0.0004417888,0.00058542413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02282141,0.0014586743,0.0019788917,0.00047525004,0.0001447159,0.0013202061,0.0009518081,0.0009559191,0.007991959],"category_scores_gemma":[0.030320114,0.00026262514,0.005075323,0.00071527844,0.00057813607,0.0011678415,0.000875127,0.0021590218,0.00053438154],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56881595,0.0025372512,0.08119746,0.010578599,0.04940761,0.00047086857,0.0005381474,0.019017702,0.0048742564,0.007376256,0.010903082,0.24428284],"study_design_scores_gemma":[0.31204408,0.09868468,0.29795358,0.0029353756,0.13967344,0.0010696084,0.0005130897,0.04259047,0.0026889285,0.037388828,0.064074196,0.00038373304],"about_ca_topic_score_codex":0.0007456928,"about_ca_topic_score_gemma":0.0012658023,"teacher_disagreement_score":0.02282141,"about_ca_system_score_codex":0.000404814,"about_ca_system_score_gemma":0.0008645377,"threshold_uncertainty_score":0.12069261},"labels":[],"label_agreement":null},{"id":"W3169994688","doi":"10.1038/sj.bjc.6601930","title":"Oral Presentations 4","year":2004,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine","score_opus":0.03377068451095193,"score_gpt":0.41469568713158056,"score_spread":0.3809250026206286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169994688","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012776376,0.0064130593,0.0025898193,0.013627471,0.033224236,0.00058335793,0.005907933,0.002696427,0.93368],"genre_scores_gemma":[0.0029514877,0.0028649978,0.0008052921,0.0042578443,0.004473043,0.00020256764,0.0026889355,0.0006245005,0.98113143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932253,0.00010167917,0.000040544433,0.00015251162,0.00027437226,0.00010846444],"domain_scores_gemma":[0.9984705,0.00016009009,0.00006186237,0.00015726294,0.00059295056,0.00055730896],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007974982,0.0009971705,0.0010078523,0.0010804536,0.0013744328,0.0043519316,0.0018889848,0.0036161884,0.85582525],"category_scores_gemma":[0.0037598764,0.00041011715,0.0013509825,0.0007541451,0.0004871559,0.0026555562,0.0036145225,0.0030863276,0.7000969],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006540074,0.00005549123,0.000117595104,0.00020515326,0.0000061382875,0.00017025524,0.000032340875,0.000049954706,0.0002504698,0.0019900594,0.9217102,0.075347014],"study_design_scores_gemma":[0.000015117975,0.000026039215,0.0001517527,0.00014035741,0.0000033685055,0.00021568182,0.0000414175,0.000025818843,0.00009085641,0.0006651411,0.9986186,0.0000056906965],"about_ca_topic_score_codex":0.0016244936,"about_ca_topic_score_gemma":0.002729649,"teacher_disagreement_score":0.14417475,"about_ca_system_score_codex":0.0013069771,"about_ca_system_score_gemma":0.0017880788,"threshold_uncertainty_score":0.20564783},"labels":[],"label_agreement":null},{"id":"W3170783756","doi":"10.1038/s41416-021-01455-1","title":"Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"King's College London; Medical Research Council; National Institute for Health and Care Research; King's Health Partners; Cancer Research UK","keywords":"Breast cancer; Oncology; Medicine; Internal medicine; Machine learning; Cancer; Stage (stratigraphy); Artificial intelligence; Bioinformatics; Computer science; Biology","score_opus":0.019309270440219187,"score_gpt":0.29338630509970814,"score_spread":0.27407703465948896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170783756","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40371168,0.0037602019,0.575716,0.0024921643,0.00028217156,0.00050069054,0.006553085,0.0031186314,0.0038654117],"genre_scores_gemma":[0.87398124,0.00054677133,0.119527966,0.00025333266,0.00013416189,0.00021339547,0.003477682,0.000102485275,0.0017630749],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999443,0.00020129087,0.000036245674,0.00012515084,0.00014806644,0.0000462521],"domain_scores_gemma":[0.9991442,0.0003984421,0.0001623922,0.000082552535,0.00016624117,0.000046188296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017532611,0.0008699031,0.000739808,0.001613221,0.0002678184,0.0009902569,0.00083292864,0.0005825079,0.00117459],"category_scores_gemma":[0.0041907043,0.0001670682,0.0011549635,0.0009785314,0.00022335075,0.00042643058,0.0005180338,0.0009040393,0.00051976315],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011837247,0.00046121597,0.2021898,0.00032596342,0.0007392317,0.0002795808,0.00011268492,0.28782654,0.00998302,0.0046682735,0.009825166,0.48240483],"study_design_scores_gemma":[0.00006584361,0.00041391607,0.02717034,0.000047696387,0.00026682435,0.00024027904,0.00002484572,0.9572803,0.0034368283,0.007798458,0.0032037678,0.000050902378],"about_ca_topic_score_codex":0.0052330378,"about_ca_topic_score_gemma":0.005500477,"teacher_disagreement_score":0.0052330378,"about_ca_system_score_codex":0.0009189331,"about_ca_system_score_gemma":0.0009813238,"threshold_uncertainty_score":0.010405183},"labels":[],"label_agreement":null},{"id":"W3174841530","doi":"10.1038/s41416-021-01415-9","title":"Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Breast cancer; Medicine; Oncology; Hormone receptor; Cancer; Internal medicine; Oestrogen receptor; Clinical trial; Hormone","score_opus":0.016977192218138756,"score_gpt":0.3431304860266393,"score_spread":0.32615329380850056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174841530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652604,0.02252426,0.0007657039,0.0020429238,0.0007761075,0.0007264238,0.0013282927,0.000101594815,0.006474304],"genre_scores_gemma":[0.99229515,0.002280418,0.00046607456,0.00086198555,0.00029478187,0.00048796885,0.00068640755,0.000038150865,0.0025890747],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99677235,0.0024025096,0.00015430742,0.00020970305,0.0001828724,0.00027819953],"domain_scores_gemma":[0.99702257,0.0017463786,0.0004768989,0.00029813146,0.00015515639,0.00030101783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039906423,0.00079116767,0.0025376254,0.00035538,0.00029275366,0.0010692318,0.000721678,0.0016542572,0.0077204257],"category_scores_gemma":[0.006796573,0.00041230457,0.0031770184,0.00036592528,0.0009231889,0.0011800516,0.0005082832,0.0037952831,0.0008678607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96025133,0.0009309807,0.0008466549,0.00064055674,0.0021947923,0.000034365472,0.000074986536,0.0009284051,0.0019448146,0.0003597333,0.0008862237,0.030907173],"study_design_scores_gemma":[0.8343752,0.13174807,0.018808188,0.00033400793,0.0038991154,0.00016123112,0.00012752242,0.0016266064,0.001529027,0.0021702123,0.005130408,0.000090479036],"about_ca_topic_score_codex":0.00075905834,"about_ca_topic_score_gemma":0.0019768886,"teacher_disagreement_score":0.0077204257,"about_ca_system_score_codex":0.00081520714,"about_ca_system_score_gemma":0.000578862,"threshold_uncertainty_score":0.025827467},"labels":[],"label_agreement":null},{"id":"W3187840688","doi":"10.1038/s41416-021-01432-8","title":"Mendelian randomisation study of smoking exposure in relation to breast cancer risk","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval; Centre hospitalier universitaire de Québec; McGill University; University of Toronto; Royal Victoria Hospital; Queen's University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Medical Research and Materiel Command; Servicio Gallego de Salud; Instituto de Salud Carlos III; Medical Research Council; European Commission; Canadian Institutes of Health Research; Division of Cancer Prevention, National Cancer Institute; National Institutes of Health; Hellenic Health Foundation; Freistaat Sachsen; Deutschen Konsortium für Translationale Krebsforschung; Universitätsklinikum Hamburg-Eppendorf; Xunta de Galicia; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; Ministero dello Sviluppo Economico; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Cancer Council South Australia; Memorial Sloan-Kettering Cancer Center; Centre International de Recherche sur le Cancer; Kreftforeningen; Institut National Du Cancer; Deutsche Krebshilfe; National Health and Medical Research Council; University of California, Irvine; Oulun Yliopisto; Cancer Institute NSW; Medizinischen Hochschule Hannover; Scottish Government; KWF Kankerbestrijding; Vetenskapsrådet; Norges Forskningsråd; Stockholms Läns Landsting; University of Westminster; Ligue Contre le Cancer; Kuopion Yliopistollinen Sairaala; University of Southern California; Cancerfonden; Cancer Council Tasmania; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; American Cancer Society; Cancer Australia; Russian Foundation for Basic Research; University of Crete; Institut National de la Santé et de la Recherche Médicale; Programme Grants for Applied Research; Robert Bosch Stiftung; Academy of Finland; Gentofte Hospital; King's College London; World Cancer Research Fund; Scottish Funding Council; University College London; Stavros Niarchos Foundation; Fondation de France; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Breast Cancer Campaign; National Cancer Institute; European Regional Development Fund; Ministerio de Sanidad, Servicios Sociales e Igualdad; University of Cambridge; Government of Canada; Fondation du cancer du sein du Québec; Génome Québec; National Breast Cancer Foundation; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; National Institute of Environmental Health Sciences; Swedish Cancer Foundation; Agency for Science, Technology and Research; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; McGill University Health Centre; David F. and Margaret T. Grohne Family Foundation; Centre Hospitalier Universitaire de Québec; Genome Canada; Sundhed og Sygdom, Det Frie Forskningsråd; Deutsches Krebsforschungszentrum; Deutsche Gesetzliche Unfallversicherung; Deutsche Forschungsgemeinschaft; Breast Cancer Research Foundation; McGill University; Associazione Italiana per la Ricerca sul Cancro; Karolinska Institutet; Harvard T.H. Chan School of Public Health; Ministry of Science and Higher Education of the Russian Federation; U.S. Army; Université Laval; Agence Nationale de la Recherche; Wellcome Trust; Cancer Council Victoria; California Department of Public Health; Brigham and Women's Hospital; Rheinische Friedrich-Wilhelms-Universität Bonn; Oak Foundation; Cancer Research UK; Beckman Research Institute, City of Hope; Cancer Council NSW; Susan G. Komen for the Cure; U.S. Department of Health and Human Services; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Ministerio de Economía y Competitividad; Bundesministerium für Bildung und Forschung; Ovarian Cancer Research Fund; Fonds Wetenschappelijk Onderzoek","keywords":"Breast cancer; Medicine; Oncology; Mendelian randomization; Cancer; Internal medicine; Genetics; Biology; Genotype; Gene; Genetic variants","score_opus":0.010123799043327197,"score_gpt":0.28303937869203893,"score_spread":0.2729155796487117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187840688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68261313,0.0062280367,0.293207,0.0011901702,0.0006308134,0.008998535,0.0023811623,0.0006198522,0.0041313237],"genre_scores_gemma":[0.93687665,0.00082332344,0.052154895,0.0004780793,0.00012759783,0.006071875,0.0009972266,0.00008991261,0.0023803986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9364694,0.053251594,0.0022499443,0.004369233,0.0028793681,0.000780442],"domain_scores_gemma":[0.95810896,0.026230386,0.004262231,0.00993245,0.0010924564,0.00037352194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04048593,0.0011398619,0.0018963387,0.0014138873,0.0007221127,0.00089151907,0.0016331917,0.0015039437,0.0042388127],"category_scores_gemma":[0.09390096,0.0007019225,0.0019189195,0.0020380644,0.0011972688,0.0006485664,0.0006936088,0.0012509205,0.00051282166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07315382,0.0012001991,0.6828197,0.0024831188,0.029632729,0.0054573994,0.0024248043,0.016009692,0.012485811,0.045982465,0.008143953,0.1202064],"study_design_scores_gemma":[0.041013286,0.030320136,0.5556501,0.0010015573,0.028189061,0.01797484,0.0007873536,0.16473222,0.009958168,0.11058953,0.039173827,0.00060993485],"about_ca_topic_score_codex":0.0033252998,"about_ca_topic_score_gemma":0.002023686,"teacher_disagreement_score":0.04048593,"about_ca_system_score_codex":0.00095315295,"about_ca_system_score_gemma":0.0011166108,"threshold_uncertainty_score":0.21411264},"labels":[],"label_agreement":null},{"id":"W3196604109","doi":"10.1038/s41416-021-01542-3","title":"The mental health impacts of receiving a breast cancer diagnosis: A meta-analysis","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Université de Montréal; Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Douglas Mental Health University Institute","funders":"","keywords":"Breast cancer; Medicine; Anxiety; Mental health; Depression (economics); Meta-analysis; Distress; Cancer; Psychiatry; Internal medicine; Clinical psychology","score_opus":0.0655620932208791,"score_gpt":0.4042981221627581,"score_spread":0.33873602894187904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196604109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011201658,0.98691064,0.00051451026,0.0002191608,0.00021898594,0.00007817572,0.000549801,0.000020974136,0.00028624057],"genre_scores_gemma":[0.33104682,0.6637329,0.0018440477,0.0010386771,0.00029831182,0.00029543394,0.0009996584,0.000045218978,0.0006989037],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99651307,0.0017406464,0.0007529746,0.00046951778,0.00032677827,0.00019689808],"domain_scores_gemma":[0.99132115,0.006624045,0.0010188825,0.00042817407,0.00043511306,0.00017260328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062269876,0.0021180694,0.008612132,0.0018980704,0.00042186957,0.0019006169,0.0014443933,0.0018906189,0.005417871],"category_scores_gemma":[0.017812554,0.0013618091,0.029589072,0.0031155148,0.00047502204,0.0011113744,0.0014689973,0.0025407895,0.00040495818],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041086986,0.000037714268,0.007050968,0.10843484,0.86471057,0.00013012323,0.00007131341,0.00047958674,0.00022959232,0.00012274504,0.00072063255,0.013903214],"study_design_scores_gemma":[0.0005848547,0.00016112988,0.006336062,0.005535534,0.9856355,0.00006963978,0.000038705482,0.000097358396,0.00005725856,0.00016361129,0.0013008092,0.000019450872],"about_ca_topic_score_codex":0.01141064,"about_ca_topic_score_gemma":0.02484513,"teacher_disagreement_score":0.01141064,"about_ca_system_score_codex":0.0015078549,"about_ca_system_score_gemma":0.0017876065,"threshold_uncertainty_score":0.032931864},"labels":[],"label_agreement":null},{"id":"W3198184344","doi":"10.1038/s41416-021-01533-4","title":"Timeliness of diagnosis and treatment: the challenge of childhood cancers","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McMaster University; McGill University","funders":"","keywords":"Pejorative; Medicine; Childhood cancer; Disease; Cancer; Intensive care medicine; Stage (stratigraphy); Cancer treatment; Pediatrics; Pathology; Internal medicine","score_opus":0.060591707003170056,"score_gpt":0.3747154553498467,"score_spread":0.3141237483466766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198184344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057182646,0.9988471,0.000013586747,0.0007419838,0.00013504026,7.395913e-7,0.0000085592765,7.809488e-7,0.00019496547],"genre_scores_gemma":[0.0012611281,0.99803954,0.000059185244,0.00029314685,0.00021744534,0.0000032320102,0.000016047508,9.259802e-7,0.00010931878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987288,0.00048842357,0.00017249571,0.000088313674,0.00042855376,0.00009331138],"domain_scores_gemma":[0.9956287,0.0029449956,0.00068149617,0.000044430803,0.0005275989,0.0001727967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002161498,0.0005840408,0.0023736795,0.0018323873,0.00036833197,0.001929649,0.0010758641,0.0015792367,0.00403695],"category_scores_gemma":[0.006765934,0.0002888173,0.000904243,0.0034109126,0.00093451503,0.0016989714,0.001045884,0.0026723272,0.00066062814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001311355,0.00004063117,0.0007234319,0.035315245,0.00039178366,0.000080909755,0.00021290593,0.00042479075,0.00016217926,0.007453931,0.04485457,0.9102085],"study_design_scores_gemma":[0.00006331205,0.00014727697,0.0092370715,0.07558569,0.0005542882,0.00069065514,0.00072833337,0.00016900997,0.00009577866,0.005268119,0.9074078,0.000052610467],"about_ca_topic_score_codex":0.011408209,"about_ca_topic_score_gemma":0.018872932,"teacher_disagreement_score":0.011408209,"about_ca_system_score_codex":0.0030407188,"about_ca_system_score_gemma":0.0037492514,"threshold_uncertainty_score":0.02268362},"labels":[],"label_agreement":null},{"id":"W3201227094","doi":"10.1038/s41416-021-01548-x","title":"Correction to: Timeliness of diagnosis and treatment: the challenge of childhood cancers","year":2021,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McMaster University; McGill University","funders":"","keywords":"Medicine; Childhood cancer; MEDLINE; Cancer; Internal medicine; Biology","score_opus":0.022725443292512897,"score_gpt":0.31330757920217567,"score_spread":0.29058213590966275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201227094","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034880184,0.0009392267,0.00008422048,0.08935333,0.9079768,0.000010315107,0.00031226315,0.00004646185,0.0012424905],"genre_scores_gemma":[0.0046569593,0.0100631965,0.0014203748,0.18975219,0.6702486,0.00019969471,0.0009476727,0.0005193199,0.12219195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931051,0.001259232,0.0013503057,0.000683769,0.00279623,0.00080537185],"domain_scores_gemma":[0.9457498,0.016381852,0.0021415884,0.002233134,0.029635081,0.0038585684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056588296,0.002673066,0.002536887,0.003854331,0.004182256,0.005848685,0.0047198567,0.013483148,0.039902277],"category_scores_gemma":[0.08500357,0.0013966857,0.0019926585,0.0031309847,0.0034356557,0.0028640467,0.0021452634,0.02596487,0.023867177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000970797,0.0000022050167,0.000022446984,0.00004932004,0.0000034700963,0.000065752116,0.000014734828,0.0000117211075,0.0000049809382,0.00024029803,0.9981831,0.0013921749],"study_design_scores_gemma":[0.00004520442,0.00001237005,0.0007035171,0.0005324676,0.000026649046,0.00034667613,0.00014455814,0.00009829742,0.00006979391,0.0007166549,0.9972683,0.000035569574],"about_ca_topic_score_codex":0.077238426,"about_ca_topic_score_gemma":0.092372626,"teacher_disagreement_score":0.077238426,"about_ca_system_score_codex":0.009135991,"about_ca_system_score_gemma":0.014069909,"threshold_uncertainty_score":0.15357774},"labels":[],"label_agreement":null},{"id":"W3202324966","doi":"10.1038/s41416-021-01525-4","title":"Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research","keywords":"Medicine; CHOP; Diffuse large B-cell lymphoma; Hazard ratio; Internal medicine; Population; Cancer; Lymphoma; Regimen; Proportional hazards model; Cancer registry; Pediatrics; Oncology; Confidence interval","score_opus":0.014400843372268678,"score_gpt":0.3071092908532081,"score_spread":0.29270844748093944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202324966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135816,0.0020888029,0.00011397485,0.00030559572,0.0000070399883,0.000029481418,0.005781465,0.000005646834,0.00030974756],"genre_scores_gemma":[0.99588853,0.0007923118,0.00013146315,0.00013780793,0.000009705839,0.000042597047,0.002883689,0.000003313656,0.00011066412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723595,0.0008101878,0.0008436205,0.00047191742,0.0003626614,0.0002756675],"domain_scores_gemma":[0.98622394,0.001894834,0.00940058,0.00058508577,0.0011329724,0.0007626247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001945441,0.000254177,0.00059984706,0.0017549018,0.00027792918,0.0012043432,0.00057146355,0.0005232889,0.0011636928],"category_scores_gemma":[0.008734895,0.00047482352,0.0007174952,0.004831031,0.00041159475,0.0013554469,0.0018113883,0.0005346852,0.00025825427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008843595,0.000011492536,0.99768424,0.00010423749,0.00007676336,0.00009691554,0.0004206163,0.0000696325,0.00004962136,0.000028984517,0.00024001309,0.0011290411],"study_design_scores_gemma":[0.00001112381,0.000038136655,0.99854666,0.000060925177,0.000021568325,0.00018236505,0.0005824039,0.0001226777,0.000017517958,0.00001590931,0.0003944408,0.0000060964608],"about_ca_topic_score_codex":0.065189324,"about_ca_topic_score_gemma":0.06519131,"teacher_disagreement_score":0.065189324,"about_ca_system_score_codex":0.0019394886,"about_ca_system_score_gemma":0.000968075,"threshold_uncertainty_score":0.12961978},"labels":[],"label_agreement":null},{"id":"W3207301911","doi":"10.1038/s41416-021-01560-1","title":"Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Cancer Research UK; Ottawa Hospital Research Institute; AstraZeneca","keywords":"Olaparib; PARP inhibitor; Oncology; Medicine; Internal medicine; Biomarker; Ovarian cancer; Cancer; Poly ADP ribose polymerase; Biology","score_opus":0.017735269981261938,"score_gpt":0.34137995415041744,"score_spread":0.3236446841691555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207301911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972363,0.00063172914,0.00037325965,0.000030472223,0.000009793043,0.000025074087,0.0011454257,0.0000046545283,0.0005433414],"genre_scores_gemma":[0.99850214,0.000094151714,0.00012329537,0.000020087276,0.000007185793,0.000016063861,0.0011073082,0.000003091824,0.0001265933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990834,0.00022200156,0.00015552604,0.00025455054,0.00016455202,0.00011990095],"domain_scores_gemma":[0.99677414,0.00073558895,0.0012576963,0.0005063753,0.00041820802,0.00030792644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011013718,0.00016640508,0.00028803467,0.0006513107,0.0002383312,0.00042337007,0.00022099752,0.00032142,0.0018727427],"category_scores_gemma":[0.0028969008,0.00015790081,0.0003284859,0.0007122176,0.00029531278,0.00025882342,0.0002927559,0.00033069358,0.00031367803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000775414,0.000016890095,0.99577063,0.000018321616,0.000058950878,0.00012402245,0.00003319255,0.00005700337,0.00064972683,0.000029008212,0.00018284725,0.002284023],"study_design_scores_gemma":[0.000023005836,0.00032893947,0.9966176,0.00001284047,0.000072484516,0.0010410773,0.00005748024,0.00025614092,0.0004864944,0.00004363747,0.001053693,0.0000065588893],"about_ca_topic_score_codex":0.001920384,"about_ca_topic_score_gemma":0.0017497678,"teacher_disagreement_score":0.001920384,"about_ca_system_score_codex":0.00033247174,"about_ca_system_score_gemma":0.00029761408,"threshold_uncertainty_score":0.0062649846},"labels":[],"label_agreement":null},{"id":"W3210328397","doi":"10.1038/s41416-021-01580-x","title":"A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Lustgarten Foundation; U.S. Department of Health and Human Services","keywords":"Ovarian cancer; Family history; Breast cancer; Pancreatic cancer; Medicine; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.010733809409504353,"score_gpt":0.25556795125196285,"score_spread":0.2448341418424585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210328397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8779913,0.0071870075,0.05624662,0.006728759,0.0009400668,0.000543356,0.025431376,0.004502329,0.020429209],"genre_scores_gemma":[0.9202053,0.001655582,0.052050643,0.00083610544,0.0006079647,0.00037089165,0.013287456,0.00021655251,0.010769636],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99966013,0.000072850016,0.000053251468,0.00007035526,0.00010518232,0.000038138427],"domain_scores_gemma":[0.9976053,0.0013352265,0.00037207903,0.00008404652,0.00033635442,0.00026692892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073033734,0.000851906,0.00069371617,0.0030459447,0.0003339126,0.0010390512,0.0005423992,0.00087649515,0.007873033],"category_scores_gemma":[0.005526638,0.0002891358,0.0005311131,0.0008745011,0.0000915255,0.0005179627,0.00076915405,0.0006824307,0.0019736663],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023713487,0.0003881873,0.69453114,0.00032240883,0.00037717787,0.0017197792,0.00016082458,0.0030378413,0.002833546,0.0009548987,0.037061017,0.25624192],"study_design_scores_gemma":[0.0007873641,0.0011011537,0.75536877,0.0007888762,0.0020516303,0.019101033,0.00057955796,0.1118274,0.010655825,0.0075893602,0.08988287,0.00026614915],"about_ca_topic_score_codex":0.0019326482,"about_ca_topic_score_gemma":0.00326023,"teacher_disagreement_score":0.007873033,"about_ca_system_score_codex":0.00019586696,"about_ca_system_score_gemma":0.00039423065,"threshold_uncertainty_score":0.026337922},"labels":[],"label_agreement":null},{"id":"W3211988828","doi":"10.1038/s41416-021-01616-2","title":"CSNK2 in cancer: pathophysiology and translational applications","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; American Society of Clinical Oncology","keywords":"Cancer; Cancer research; Metastasis; Protein kinase B; Kinase; PTEN; Biology; Medicine; Cancer cell; Translational research; Cell cycle; PI3K/AKT/mTOR pathway; Bioinformatics; Signal transduction; Pathology; Internal medicine; Cell biology","score_opus":0.028644542494351825,"score_gpt":0.3613751296212475,"score_spread":0.3327305871268957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211988828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000108053704,0.99839056,0.00007512372,0.00050052634,0.00026264953,0.000003790675,0.000017177901,0.000004389358,0.0006377598],"genre_scores_gemma":[0.00071537687,0.99836594,0.00011689389,0.000221039,0.00018650717,0.000004720029,0.000027968887,9.3554354e-7,0.00036059477],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998566,0.000030136734,0.000026196662,0.000022289118,0.000047371694,0.000017381642],"domain_scores_gemma":[0.99963224,0.00018737669,0.00004615369,0.00001110877,0.000092119495,0.000031010837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064067164,0.0005569994,0.0009544284,0.001869179,0.0002466932,0.0009503895,0.0005656718,0.00082290213,0.0036527677],"category_scores_gemma":[0.00085546164,0.00016680111,0.0005084559,0.0017122665,0.0004396036,0.0011149341,0.00062321307,0.0013941838,0.0011046965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012753862,0.00004396668,0.00021169355,0.030499851,0.00011950253,0.0001778495,0.00008279806,0.0003959523,0.001895151,0.0054565803,0.031408433,0.92958075],"study_design_scores_gemma":[0.00002323541,0.00011242069,0.0010173536,0.008065217,0.00015856232,0.0010724136,0.00007871669,0.00008970604,0.0004412152,0.0030182183,0.985905,0.000017957092],"about_ca_topic_score_codex":0.0009773839,"about_ca_topic_score_gemma":0.0023007963,"teacher_disagreement_score":0.0036527677,"about_ca_system_score_codex":0.0007262747,"about_ca_system_score_gemma":0.0017078967,"threshold_uncertainty_score":0.012219787},"labels":[],"label_agreement":null},{"id":"W3215143226","doi":"10.1038/s41416-021-01608-2","title":"Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Royal Victoria Hospital; Dalhousie University; University of Toronto; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Vancouver General Hospital; CancerCare Manitoba","funders":"Karyopharm Therapeutics; American Society of Clinical Oncology","keywords":"Carfilzomib; Medicine; Refractory (planetary science); Dexamethasone; Adverse effect; Internal medicine; Nausea; Multiple myeloma; Oncology; Gastroenterology; Lenalidomide","score_opus":0.016647814103603182,"score_gpt":0.30554761793782803,"score_spread":0.28889980383422487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215143226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968989,0.0022508993,0.000057110097,0.00014560728,0.000011340754,0.00003524113,0.00011046897,0.000007941252,0.00048260114],"genre_scores_gemma":[0.99897975,0.0004235791,0.00007255888,0.000099948746,0.000023471297,0.000019863282,0.00014253755,9.5141553e-7,0.00023728827],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998098,0.00006944102,0.000018667906,0.000036434896,0.00002885455,0.00003684666],"domain_scores_gemma":[0.99973255,0.0000636468,0.0000657208,0.000010015211,0.000011318532,0.00011676925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041983576,0.0002552307,0.00064087135,0.00019233384,0.00022376195,0.0003273745,0.00015883571,0.00026260663,0.0010276213],"category_scores_gemma":[0.00053153624,0.00011280716,0.00029823612,0.00020702225,0.00017729658,0.00021657895,0.0001420074,0.00043340132,0.00014382364],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.101759076,0.00395812,0.62353826,0.00058448396,0.0010821177,0.004886966,0.0006024733,0.0025140718,0.05251127,0.0002778692,0.0037845462,0.20450084],"study_design_scores_gemma":[0.010621754,0.073488176,0.89248943,0.000081023725,0.00066800293,0.0054897433,0.00028067315,0.0028617606,0.005973136,0.00027728526,0.0077374307,0.000031535765],"about_ca_topic_score_codex":0.00082108466,"about_ca_topic_score_gemma":0.002705676,"teacher_disagreement_score":0.0010276213,"about_ca_system_score_codex":0.0003721666,"about_ca_system_score_gemma":0.00034792995,"threshold_uncertainty_score":0.003437698},"labels":[],"label_agreement":null},{"id":"W3216876515","doi":"10.1038/s41416-021-01634-0","title":"Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Terumo BCT; Innovative Medicines Initiative; KWF Kankerbestrijding","keywords":"Circulating tumor cell; Medicine; Interquartile range; Lung cancer; Hazard ratio; Leukapheresis; Internal medicine; Oncology; Cancer; Confidence interval; Metastasis; Biology; Stem cell","score_opus":0.014093433957203234,"score_gpt":0.27833031426310023,"score_spread":0.264236880305897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216876515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950321,0.003236875,0.00021281689,0.0001190409,0.000057061454,0.000015398213,0.00021025768,0.000054477612,0.0010619424],"genre_scores_gemma":[0.99656373,0.00038414262,0.0002176508,0.00008957194,0.00004684414,0.000014820422,0.00047906997,0.000014915379,0.0021892348],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99971014,0.00007741591,0.000027574395,0.000039887633,0.00009534415,0.000049707854],"domain_scores_gemma":[0.9990701,0.0005090625,0.00012400988,0.00006484947,0.000070487615,0.00016157073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000303499,0.00020011686,0.0005272944,0.00029303206,0.00013027545,0.0005310448,0.00019427815,0.00043519828,0.0037258554],"category_scores_gemma":[0.001775193,0.00014194539,0.00016782852,0.00021825454,0.00015742605,0.00025697678,0.0002045502,0.00061800383,0.00064447534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04851081,0.0018762957,0.076480255,0.00032323223,0.0002991001,0.000719624,0.00029875254,0.0007901478,0.7871665,0.00021873573,0.0026968278,0.08061978],"study_design_scores_gemma":[0.0011686719,0.024957985,0.7292292,0.0000395704,0.00038288755,0.003453705,0.00023112478,0.003471656,0.22989096,0.00047468653,0.0066581806,0.000041369363],"about_ca_topic_score_codex":0.00059618725,"about_ca_topic_score_gemma":0.00093819783,"teacher_disagreement_score":0.0037258554,"about_ca_system_score_codex":0.00025983242,"about_ca_system_score_gemma":0.00018176975,"threshold_uncertainty_score":0.012464225},"labels":[],"label_agreement":null},{"id":"W322014996","doi":"10.1054/bjoc.2001.1870","title":"Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Kræftens Bekæmpelse","keywords":"Biology; Seminoma; Tumor suppressor gene; Germ cell; Cancer research; Gene expression; Pathology; Immunohistochemistry; Gene; Immunology; Carcinogenesis; Medicine; Genetics","score_opus":0.009509666767870082,"score_gpt":0.24579812205035867,"score_spread":0.2362884552824886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W322014996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980684,0.00047110303,0.00081066333,0.000012716949,0.0000059194267,0.000009546698,0.00012753755,0.00001892306,0.00047523758],"genre_scores_gemma":[0.9973066,0.00033520834,0.00096847396,0.000009398362,0.0000041888493,0.000008396796,0.00028681898,0.0000065969084,0.0010742146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999207,0.000011450339,0.0000050665894,0.000021259406,0.000022426075,0.000018991186],"domain_scores_gemma":[0.99985254,0.000035033576,0.000044597084,0.000010805926,0.000019683941,0.00003732272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008603297,0.0001486249,0.00018917822,0.00033320062,0.00011130218,0.00020652504,0.00010567485,0.00011728303,0.0011816302],"category_scores_gemma":[0.00020679637,0.00012057086,0.00008503674,0.00013502882,0.00027778323,0.00007585078,0.0000833565,0.00014472086,0.00017936372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001664343,0.000011392902,0.0038977661,0.00003922547,0.000005612033,0.00041281118,0.000041221083,0.00005780273,0.9934325,0.000083524246,0.000030198507,0.0018215203],"study_design_scores_gemma":[0.00003209459,0.0006110639,0.142994,0.000009069199,0.000051548664,0.0069397935,0.00015372748,0.0013095684,0.8439365,0.00010790652,0.0038465827,0.000008195191],"about_ca_topic_score_codex":0.00044338408,"about_ca_topic_score_gemma":0.00070828025,"teacher_disagreement_score":0.0011816302,"about_ca_system_score_codex":0.00021998546,"about_ca_system_score_gemma":0.00013480612,"threshold_uncertainty_score":0.00395298},"labels":[],"label_agreement":null},{"id":"W41764704","doi":"10.1054/bjoc.2001.1885","title":"Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Gene; RNA splicing; Cloning (programming); Cancer; Biology; Messenger RNA; Alternative splicing; Ovarian cancer; Genetics; Cancer research; Molecular biology; RNA","score_opus":0.02413331272117781,"score_gpt":0.3283993022758709,"score_spread":0.3042659895546931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W41764704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389595,0.0012640564,0.0033514085,0.00020753936,0.00004434857,0.000058045396,0.0006144627,0.00007739789,0.0004867849],"genre_scores_gemma":[0.9810067,0.0016561544,0.011438914,0.00008347565,0.00003585586,0.000076408294,0.002469937,0.000022527951,0.0032099665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999399,0.000006876382,0.0000061738683,0.0000171908,0.000017367714,0.000012464208],"domain_scores_gemma":[0.99988735,0.000030257666,0.000032058128,0.0000081628295,0.0000083856075,0.00003383786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010398175,0.00025862706,0.00022461994,0.000223944,0.00014581751,0.0001579939,0.00016875073,0.00025208457,0.0010512823],"category_scores_gemma":[0.00012582669,0.00017692184,0.0002319134,0.00018131571,0.00018456957,0.00010987793,0.00016641713,0.00037785905,0.00046549074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013512903,0.00003892551,0.0011713895,0.000062405226,0.0000069620814,0.00042475274,0.000030063304,0.000070914015,0.9943137,0.000113051065,0.000105751904,0.0035269433],"study_design_scores_gemma":[0.00027603438,0.0018319722,0.06629872,0.000032793665,0.00016339499,0.01209292,0.00013666204,0.004169862,0.88686925,0.00036901567,0.027733559,0.000025820711],"about_ca_topic_score_codex":0.0003064005,"about_ca_topic_score_gemma":0.00033576056,"teacher_disagreement_score":0.0010512823,"about_ca_system_score_codex":0.00017123831,"about_ca_system_score_gemma":0.00021053811,"threshold_uncertainty_score":0.0035168529},"labels":[],"label_agreement":null},{"id":"W4200219593","doi":"10.1038/s41416-021-01655-9","title":"Phenome-wide association study (PheWAS) of colorectal cancer risk SNP effects on health outcomes in UK Biobank","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Medical Research Council; Darwin Trust of Edinburgh; Cancer Research UK","keywords":"Biobank; Phenome; Colorectal cancer; Medicine; SNP; Epidemiology; Bioinformatics; Oncology; Internal medicine; Single-nucleotide polymorphism; Cancer; Biology; Genetics; Genotype; Genome","score_opus":0.009343082196304735,"score_gpt":0.3075991321943103,"score_spread":0.29825604999800553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200219593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97216237,0.00096226437,0.0043952735,0.0003068489,0.000027902946,0.00006469292,0.020714048,0.00003109636,0.0013354998],"genre_scores_gemma":[0.9873361,0.00036271158,0.0024112964,0.00010577486,0.000012690932,0.00013929339,0.009172534,0.000014041834,0.00044546663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699664,0.0015861517,0.00030287192,0.0006803138,0.00025646007,0.00017760809],"domain_scores_gemma":[0.9915776,0.0037622633,0.0023549492,0.0014522659,0.0005390861,0.0003136529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021710785,0.00025686508,0.00043865276,0.0011313823,0.00054592907,0.0007353808,0.00035854106,0.000555678,0.0035985368],"category_scores_gemma":[0.011451743,0.00023689556,0.00053394877,0.003917251,0.00030360202,0.00033683752,0.0011853358,0.0004145656,0.00030077976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004819545,0.000020931497,0.9860847,0.00023345015,0.0009788536,0.0003972579,0.0003742282,0.00078594685,0.001364303,0.00073321804,0.0023934986,0.006151693],"study_design_scores_gemma":[0.00005352964,0.00005891406,0.994076,0.00006777664,0.00033324515,0.00039584487,0.00010526442,0.00069065246,0.0002599118,0.0004352666,0.0035111492,0.000012470305],"about_ca_topic_score_codex":0.018782115,"about_ca_topic_score_gemma":0.021175178,"teacher_disagreement_score":0.018782115,"about_ca_system_score_codex":0.00046110363,"about_ca_system_score_gemma":0.00054994365,"threshold_uncertainty_score":0.03734559},"labels":[],"label_agreement":null},{"id":"W4200493934","doi":"10.1038/s41416-021-01650-0","title":"Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Manchester Biomedical Research Centre; Breast Cancer Research Trust; National Institute for Health and Care Research","keywords":"Breast cancer; Chemotherapy; Medicine; Oncology; Internal medicine; Randomized controlled trial; Cancer; Surgery","score_opus":0.008070169246526761,"score_gpt":0.2764005687684838,"score_spread":0.26833039952195703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200493934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96275795,0.013116496,0.0014216199,0.0015214457,0.00306725,0.012894738,0.0016834638,0.00022362724,0.003313355],"genre_scores_gemma":[0.9677115,0.0042460873,0.00304802,0.0020905803,0.0011184693,0.016595203,0.0009023154,0.000030543397,0.004257382],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979062,0.001317199,0.00019136466,0.00028051873,0.00012389637,0.00018087536],"domain_scores_gemma":[0.9971002,0.0012647101,0.00068179914,0.00023848053,0.00014278684,0.00057205773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028761947,0.0014316672,0.0045762598,0.0005166294,0.00052651495,0.0011380456,0.0011100385,0.002427759,0.012471281],"category_scores_gemma":[0.004770837,0.00071770145,0.0022194923,0.00061356137,0.0013985278,0.0009864053,0.0007010418,0.0037075398,0.0011048843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.994331,0.0012214142,0.0001126575,0.00038438707,0.0004918367,0.000008154308,0.00001414431,0.00006488468,0.00023362265,0.000028671757,0.000121581084,0.0029877415],"study_design_scores_gemma":[0.9754347,0.02323423,0.0005584122,0.000036742593,0.0002745551,0.00000861306,0.000007977767,0.00008660186,0.00005183978,0.0000658041,0.00023584106,0.000004629612],"about_ca_topic_score_codex":0.0017536876,"about_ca_topic_score_gemma":0.0029608896,"teacher_disagreement_score":0.012471281,"about_ca_system_score_codex":0.0008587435,"about_ca_system_score_gemma":0.0015290158,"threshold_uncertainty_score":0.04172063},"labels":[],"label_agreement":null},{"id":"W4200511560","doi":"10.1038/s41416-021-01676-4","title":"No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Trastuzumab; Oncology; Hazard ratio; Breast cancer; Taxane; Proportional hazards model; Radiation therapy; Lapatinib; Chemotherapy; Cancer; Surgery; Confidence interval","score_opus":0.07852426429881962,"score_gpt":0.4304724511525911,"score_spread":0.3519481868537715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200511560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931162,0.0033290817,0.00011571228,0.00017258518,0.000024582656,0.000014787842,0.00025968734,0.000008654115,0.0029586488],"genre_scores_gemma":[0.99882025,0.00021887715,0.000039778806,0.0000798369,0.000016222417,0.000006138754,0.00027260854,0.0000037056236,0.0005426339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994066,0.00024104891,0.00004985215,0.0000655316,0.00009796874,0.00013907615],"domain_scores_gemma":[0.99684876,0.0019227114,0.000459751,0.0001883605,0.00016738438,0.00041297384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019889902,0.0001185501,0.00062708405,0.0004571808,0.0002036348,0.00052921334,0.0002358487,0.0005792351,0.0030034976],"category_scores_gemma":[0.003001699,0.00007114439,0.00041980293,0.00026122047,0.00043760528,0.0005326348,0.00029174448,0.00060171087,0.0003522522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10459138,0.0006825905,0.74306697,0.00061636575,0.00059261126,0.0042273114,0.00077969674,0.0007973293,0.03748728,0.00039809872,0.0009971008,0.105763294],"study_design_scores_gemma":[0.00025916632,0.012469595,0.9753847,0.00006677247,0.00041419282,0.004713814,0.0006087558,0.00044738606,0.0022269303,0.0004541164,0.0029316563,0.00002301656],"about_ca_topic_score_codex":0.00069587975,"about_ca_topic_score_gemma":0.0014760013,"teacher_disagreement_score":0.0030034976,"about_ca_system_score_codex":0.0002922598,"about_ca_system_score_gemma":0.00018445766,"threshold_uncertainty_score":0.0105189085},"labels":[],"label_agreement":null},{"id":"W4205412845","doi":"10.1038/s41416-021-01691-5","title":"Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Ionizing radiation; Radiation therapy; Radiation sensitivity; Cell culture; Hypoxia (environmental); Cell survival; Cell; Cell growth","score_opus":0.005800646764930241,"score_gpt":0.2345790990590582,"score_spread":0.22877845229412794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205412845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932052,0.0033758618,0.0011239122,0.000082848106,0.00003382531,0.000016471638,0.0005445562,0.0000694131,0.0015478117],"genre_scores_gemma":[0.99416465,0.000751015,0.00073889573,0.000026956095,0.000012102188,0.000024401554,0.00088714436,0.00003681704,0.003358132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975365,0.00005868532,0.000021479253,0.000046296314,0.000049214963,0.00007065096],"domain_scores_gemma":[0.99976605,0.00010327677,0.000033517415,0.00003012665,0.000021607475,0.000045453802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023368422,0.0001665897,0.00045239518,0.00024300777,0.0002343833,0.00043456277,0.00020869038,0.00038290137,0.0025491598],"category_scores_gemma":[0.00019900354,0.00022642121,0.00023662872,0.00031001703,0.00024746094,0.00030906795,0.0001732586,0.00079180306,0.00044472574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090681296,0.000098699966,0.000423796,0.00003089352,0.000009879993,0.000059989714,0.000061757135,0.00016634708,0.9970318,0.00012987445,0.00008829277,0.0009917943],"study_design_scores_gemma":[0.000037291993,0.0012339669,0.0127338385,0.0000041753237,0.0000324548,0.00041858116,0.000097911114,0.0015831173,0.98142886,0.000065810935,0.002355483,0.000008650185],"about_ca_topic_score_codex":0.0029552504,"about_ca_topic_score_gemma":0.002210018,"teacher_disagreement_score":0.0029552504,"about_ca_system_score_codex":0.00031397995,"about_ca_system_score_gemma":0.0001957344,"threshold_uncertainty_score":0.008527815},"labels":[],"label_agreement":null},{"id":"W4206312263","doi":"10.1038/s41416-021-01692-4","title":"Immuno-genomic characterisation of high-grade serous ovarian cancer reveals immune evasion mechanisms and identifies an immunological subtype with a favourable prognosis and improved therapeutic efficacy","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Natural Science Foundation of Zhejiang Province","keywords":"Evasion (ethics); Ovarian cancer; Immune system; Serous ovarian cancer; Serous fluid; Immunotherapy; Selection (genetic algorithm); Cancer","score_opus":0.01715629107594695,"score_gpt":0.26333862470955716,"score_spread":0.2461823336336102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206312263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724364,0.000567989,0.0007620121,0.00007326284,0.0000076096376,0.0000117392365,0.00026475993,0.00002422941,0.0010446747],"genre_scores_gemma":[0.99876523,0.00016139455,0.00036622363,0.00003359226,0.000009310361,0.000005528984,0.0003657779,0.000007484354,0.00028551434],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999863,0.00002044666,0.000011061178,0.000025451618,0.000035763584,0.000044168617],"domain_scores_gemma":[0.99975365,0.000059399856,0.00007256456,0.00003826981,0.000036016496,0.00004004351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018861014,0.00011423321,0.00022775451,0.0007009148,0.000162383,0.0005275468,0.00014328692,0.0002760255,0.0020506156],"category_scores_gemma":[0.0005896321,0.0000876036,0.00014406988,0.00038363246,0.00023761691,0.00015962278,0.00023821602,0.00023770871,0.00035927942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001280167,0.00007545833,0.37309682,0.00018669777,0.00007336249,0.0013868074,0.00036950543,0.0005485783,0.5860661,0.0004965567,0.00053306855,0.035886817],"study_design_scores_gemma":[0.000032161544,0.00046980276,0.9509426,0.000017801514,0.00007442403,0.0063633034,0.00064607,0.0014348186,0.035244267,0.0005839854,0.0041825287,0.000008127223],"about_ca_topic_score_codex":0.00063605484,"about_ca_topic_score_gemma":0.0008631245,"teacher_disagreement_score":0.0020506156,"about_ca_system_score_codex":0.00012345424,"about_ca_system_score_gemma":0.00011560529,"threshold_uncertainty_score":0.006859958},"labels":[],"label_agreement":null},{"id":"W4206398506","doi":"10.1038/s41416-021-01667-5","title":"Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Université de Montréal; Institute of Cancer Research; International Hepato-Pancreato-Biliary Association","keywords":"Colorectal cancer; Immune system; Medicine; Tissue microarray; Internal medicine; Oncology; Acquired immune system; Phenotype; CD3; Pathology; Gastroenterology; Immunohistochemistry; CD8; Cancer; Immunology; Biology","score_opus":0.02002393869796565,"score_gpt":0.27344139741426166,"score_spread":0.253417458716296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206398506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987092,0.00027650397,0.000103780985,0.000024397,0.000004468034,0.0000031873549,0.000103221915,0.000007339203,0.0007677396],"genre_scores_gemma":[0.9994999,0.000051213978,0.00007329518,0.00000708649,0.000008345301,0.000002835119,0.000119514305,0.0000031247819,0.00023466695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997913,0.00006243527,0.000025452242,0.000029569472,0.00003015121,0.00006105937],"domain_scores_gemma":[0.9988109,0.00035365706,0.0003601556,0.00009562401,0.000106565865,0.00027308112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037162594,0.00023642168,0.00018714444,0.0009611955,0.0001711118,0.0005021878,0.00022959031,0.00039217615,0.0038254538],"category_scores_gemma":[0.0015448844,0.00014382406,0.00014749658,0.0003774873,0.00033027076,0.00032729306,0.00032636203,0.00034315768,0.0006379222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002747546,0.000041238294,0.95420164,0.000029292345,0.00003325379,0.0009886652,0.000072507966,0.00015960282,0.034907848,0.00010499059,0.00012942593,0.0065839523],"study_design_scores_gemma":[0.000017197453,0.00026408685,0.992653,0.00000859983,0.000027688011,0.0032331478,0.00014629576,0.00041347815,0.002605117,0.000114411414,0.0005102544,0.000006813264],"about_ca_topic_score_codex":0.00028678792,"about_ca_topic_score_gemma":0.00038488343,"teacher_disagreement_score":0.0038254538,"about_ca_system_score_codex":0.00013707856,"about_ca_system_score_gemma":0.00007988892,"threshold_uncertainty_score":0.012797415},"labels":[],"label_agreement":null},{"id":"W4213427343","doi":"10.1038/s41416-022-01750-5","title":"Allium vegetables intake and the risk of gastric cancer in the Stomach cancer Pooling (StoP) Project","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Garlic and Onion Studies","field":"Agricultural and Biological Sciences","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences","keywords":"Odds ratio; Medicine; Confidence interval; Allium; Stomach cancer; Confounding; Allium sativum; Epidemiology; Cancer; Internal medicine; Biology; Botany","score_opus":0.01782355509378698,"score_gpt":0.2579065310850546,"score_spread":0.24008297599126766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213427343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879695,0.000976345,0.0008277049,0.00039473208,0.000042277752,0.00009775118,0.007470239,0.000029477187,0.0013644509],"genre_scores_gemma":[0.99114674,0.00043114868,0.00059682224,0.00017092028,0.00006245726,0.00016659446,0.0052881874,0.000023090768,0.0021140496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973694,0.001908372,0.000108575245,0.00022172365,0.0001238237,0.00026810812],"domain_scores_gemma":[0.9973475,0.0004821679,0.0007034773,0.00057845993,0.0002713782,0.000616958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005026181,0.0008568697,0.0010148474,0.00048303732,0.0006561905,0.00087449234,0.00066853256,0.00078148,0.0027415806],"category_scores_gemma":[0.00478048,0.00057054893,0.0028972547,0.0010655295,0.00030533728,0.0003672463,0.002121832,0.00068511453,0.00038274884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056829367,0.0007086086,0.8704228,0.00094799604,0.028751329,0.0006111979,0.0015614826,0.001809585,0.0038751506,0.0010320435,0.008084318,0.025366092],"study_design_scores_gemma":[0.0020283717,0.0036320486,0.9620545,0.00012444411,0.02274413,0.00023808984,0.00074680103,0.00081162923,0.0006885745,0.00044690323,0.0064229625,0.00006153566],"about_ca_topic_score_codex":0.032883883,"about_ca_topic_score_gemma":0.024542948,"teacher_disagreement_score":0.032883883,"about_ca_system_score_codex":0.0006058525,"about_ca_system_score_gemma":0.001169494,"threshold_uncertainty_score":0.065384924},"labels":[],"label_agreement":null},{"id":"W4214892600","doi":"10.1038/s41416-022-01752-3","title":"Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia; University of Calgary; Cancer Care Ontario","funders":"Cancer Council Victoria; Partenariat Canadien Contre Le Cancer; Public Health Agency; Cancer Society of New Zealand; Cancer Institute NSW; Cancer Research UK; Public Health Wales; World Health Organization","keywords":"Pancreatic cancer; Stage (stratigraphy); Medicine; Cancer; Population; Cancer registry; Survival rate; Internal medicine; Environmental health; Biology","score_opus":0.023853098063496968,"score_gpt":0.3506016265377209,"score_spread":0.326748528474224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214892600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969258,0.00015312579,0.00007025903,0.000026154694,0.0000059899385,0.000012859674,0.0023639111,0.0000052037662,0.00043677114],"genre_scores_gemma":[0.99538404,0.00019379561,0.00009927994,0.000036984176,0.000011880275,0.0000397992,0.0038873677,0.000007985736,0.000338792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990715,0.00024023936,0.000109070796,0.00025350676,0.00011940976,0.0002062124],"domain_scores_gemma":[0.999062,0.00011600864,0.00028440054,0.00012186273,0.00015317113,0.0002626062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000802976,0.000797273,0.00093357125,0.0021068167,0.0009781739,0.0013316459,0.00063638226,0.0011369387,0.002097125],"category_scores_gemma":[0.0012492202,0.0010884715,0.0014524022,0.004420993,0.0006792438,0.0010896391,0.0016367385,0.0012171553,0.000815568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028146303,0.00004882677,0.997632,0.000020956779,0.00018104758,0.00019468837,0.0003287465,0.00007484383,0.0001702011,0.000017376877,0.00027621654,0.0007736337],"study_design_scores_gemma":[0.000018248304,0.00011024233,0.9985178,0.000009700515,0.00007359658,0.00020410457,0.00069590023,0.000052917905,0.00001707987,0.000009331787,0.0002827001,0.000008388831],"about_ca_topic_score_codex":0.029335922,"about_ca_topic_score_gemma":0.030230975,"teacher_disagreement_score":0.029335922,"about_ca_system_score_codex":0.0007588154,"about_ca_system_score_gemma":0.0005102389,"threshold_uncertainty_score":0.058330297},"labels":[],"label_agreement":null},{"id":"W4220831994","doi":"10.1038/s41416-022-01770-1","title":"The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"CHEK2; Medicine; Oophorectomy; Breast cancer; Internal medicine; Tamoxifen; Cancer; Gynecology; Oncology; Survival analysis; Surgery; Hysterectomy; Mutation; Germline mutation; Biology","score_opus":0.005139853108606226,"score_gpt":0.2682768304072974,"score_spread":0.2631369772986912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220831994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979752,0.013496061,0.00010467617,0.0021166857,0.00023858256,0.0000044240096,0.0006518931,0.0000091993825,0.003626365],"genre_scores_gemma":[0.9960758,0.0018007776,0.000047365622,0.00037026205,0.000209327,0.0000035816697,0.00067460194,0.000008563789,0.0008096462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999471,0.0001526858,0.000036528018,0.00007460532,0.00007947621,0.00018566175],"domain_scores_gemma":[0.9984187,0.0007752316,0.00019991874,0.0000649106,0.00009017766,0.00045095757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006450739,0.00025133244,0.00049543113,0.00027949858,0.0003037966,0.0006043913,0.00030789478,0.0009171737,0.0033784776],"category_scores_gemma":[0.0035768864,0.00016802242,0.0014473413,0.00041737323,0.00026119355,0.0005488919,0.00058325875,0.0012332035,0.0003586735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018766375,0.00035349609,0.89795953,0.000184963,0.001327253,0.001067713,0.0001931231,0.0019622694,0.001700186,0.00023207549,0.0026765147,0.07357637],"study_design_scores_gemma":[0.000119937264,0.00097289507,0.99522865,0.00005011358,0.00051781454,0.000623634,0.00014005743,0.0005035505,0.00010649297,0.00021138662,0.0015100237,0.000015396203],"about_ca_topic_score_codex":0.0055078478,"about_ca_topic_score_gemma":0.010737862,"teacher_disagreement_score":0.0055078478,"about_ca_system_score_codex":0.0006461128,"about_ca_system_score_gemma":0.00049393566,"threshold_uncertainty_score":0.011302173},"labels":[],"label_agreement":null},{"id":"W4220935466","doi":"10.1038/s41416-022-01776-9","title":"Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Liquid biopsy; Minimal residual disease; Cell-free fetal DNA; Circulating tumor DNA; Medicine; Precision medicine; Clinical Practice; Biomarker; Disease; Lung cancer; Molecular diagnostics; Pathology; Oncology; Computational biology; Bioinformatics; Internal medicine; Cancer; Biology; Genetics","score_opus":0.1290395294019193,"score_gpt":0.40521467459769245,"score_spread":0.27617514519577313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220935466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006207381,0.9966666,0.00036207365,0.0017571978,0.00042821575,0.0000030672884,0.0000116611645,0.000009942754,0.0006991333],"genre_scores_gemma":[0.0005108381,0.9971322,0.0005411408,0.000850447,0.0005842242,0.0000071277673,0.00002228376,0.000003987866,0.00034778228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990257,0.0002866642,0.00011849045,0.0001437686,0.0003594417,0.00006596062],"domain_scores_gemma":[0.9964552,0.0022266754,0.00019214794,0.000090238296,0.0008216906,0.0002141244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034257292,0.0008054859,0.0018316775,0.0019616382,0.00033662064,0.0022422397,0.0014695387,0.0029186376,0.0031917107],"category_scores_gemma":[0.00453729,0.0004037237,0.0006389987,0.0019280849,0.0014433387,0.0032211551,0.0014504167,0.0039736456,0.0029017697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056606143,0.00003662845,0.00018823333,0.008298993,0.000051735493,0.00018561697,0.000074544165,0.00033124108,0.0007599398,0.00529272,0.031309158,0.9534146],"study_design_scores_gemma":[0.000019004827,0.00008441634,0.0006110914,0.005971669,0.00006204747,0.0015350797,0.00013335278,0.00016926788,0.00031736,0.0056034187,0.98546,0.000033381435],"about_ca_topic_score_codex":0.0014804588,"about_ca_topic_score_gemma":0.0020742044,"teacher_disagreement_score":0.0034257292,"about_ca_system_score_codex":0.001291933,"about_ca_system_score_gemma":0.0024229046,"threshold_uncertainty_score":0.018117249},"labels":[],"label_agreement":null},{"id":"W4221040837","doi":"10.1038/s41416-022-01778-7","title":"VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft models","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Ottawa Hospital Foundation","keywords":"Invasive lobular carcinoma; Cancer research; Metastasis; In vitro; In vivo; Cell culture; Pathology; Cancer; Cancer cell; Cell growth; Breast cancer; Biology; Medicine; Internal medicine; Invasive ductal carcinoma","score_opus":0.014830665083671007,"score_gpt":0.24681060766266577,"score_spread":0.23197994257899476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221040837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98400176,0.0016904442,0.008512974,0.000343698,0.0000962888,0.00018239324,0.0023039356,0.00043666703,0.0024317545],"genre_scores_gemma":[0.97611976,0.001100314,0.011521491,0.0001023472,0.0000242666,0.00019984561,0.0051576975,0.0001707174,0.005603505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955624,0.000051384573,0.00004611191,0.000094221636,0.00016014132,0.00009182296],"domain_scores_gemma":[0.99963963,0.000071150615,0.00007885086,0.000068089044,0.000039436127,0.000102742684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005500939,0.0006976723,0.0005471402,0.0005073877,0.00026193622,0.0005488482,0.00047031077,0.00054710003,0.0018900811],"category_scores_gemma":[0.00020177032,0.00026791618,0.00048947835,0.00034279897,0.00028203486,0.00032879485,0.0002916341,0.0015591483,0.0006956351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008577321,0.00009055198,0.0003249174,0.000036022837,0.000008931476,0.00007594108,0.000040422223,0.00009252086,0.9980546,0.00016960647,0.00021015332,0.0008105656],"study_design_scores_gemma":[0.000083941006,0.0016304653,0.010691604,0.000017136746,0.00008126109,0.001553111,0.00009753638,0.0031790382,0.9723716,0.000077416626,0.010196489,0.000020489804],"about_ca_topic_score_codex":0.0019534968,"about_ca_topic_score_gemma":0.0022355332,"teacher_disagreement_score":0.0019534968,"about_ca_system_score_codex":0.0005608594,"about_ca_system_score_gemma":0.00028818107,"threshold_uncertainty_score":0.00632298},"labels":[],"label_agreement":null},{"id":"W4225262145","doi":"10.1038/s41416-022-01823-5","title":"BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Texas MD Anderson Cancer Center; Genentech; Conquer Cancer Foundation; Science Foundation Ireland; Irish Research eLibrary; Michael Smith Health Research BC; American Society of Clinical Oncology","keywords":"XIAP; Inhibitor of apoptosis; PARP inhibitor; Cancer research; Ovarian cancer; Apoptosis; Cell culture; Olaparib; Biology; In vivo; Poly ADP ribose polymerase; Cancer; Programmed cell death; Caspase; Enzyme; Genetics; Biochemistry","score_opus":0.0077800579727623715,"score_gpt":0.2541820066008831,"score_spread":0.2464019486281207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225262145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983259,0.00059565384,0.00023955326,0.00003993381,0.000007924835,0.000015155775,0.0001348634,0.000030346795,0.000610689],"genre_scores_gemma":[0.9985996,0.00028199083,0.00031873674,0.000029921119,0.0000040792593,0.000012749249,0.00017623075,0.0000060392167,0.000570661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992037,0.000016814602,0.000008812906,0.000014840505,0.000020040023,0.000019111203],"domain_scores_gemma":[0.9998611,0.000047015812,0.000042578544,0.000017976578,0.0000071576837,0.000024121111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001432637,0.00018503933,0.0002087101,0.00020691847,0.00010018344,0.00017718706,0.00012446131,0.0002666095,0.0022779915],"category_scores_gemma":[0.0002137905,0.0001152033,0.00015908989,0.00016059726,0.00016912009,0.000109017645,0.000124467,0.00030629884,0.0002245146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065101904,0.00016140792,0.0041892207,0.000058234826,0.000025736972,0.0005835035,0.000033336244,0.00030587337,0.99030954,0.00016187067,0.00018359991,0.0033366573],"study_design_scores_gemma":[0.00013221655,0.00245744,0.056512058,0.000010969319,0.000049662216,0.006168662,0.000055039676,0.0014619357,0.9283029,0.00016196712,0.0046790666,0.0000080321315],"about_ca_topic_score_codex":0.00038400732,"about_ca_topic_score_gemma":0.00040790488,"teacher_disagreement_score":0.0022779915,"about_ca_system_score_codex":0.0002256458,"about_ca_system_score_gemma":0.00011342187,"threshold_uncertainty_score":0.0076206923},"labels":[],"label_agreement":null},{"id":"W4226025919","doi":"10.1038/s41416-022-01797-4","title":"The STING pathway: Therapeutic vulnerabilities in ovarian cancer","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen's University","funders":"Canadian Institutes of Health Research; Queen's University; Government of Canada","keywords":"Immune system; Ovarian cancer; Cancer research; Tumor microenvironment; Biology; Immunology; Immunotherapy; Interferon; Cancer; Medicine; Genetics","score_opus":0.04738821610387843,"score_gpt":0.3369371907084461,"score_spread":0.28954897460456763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226025919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006487226,0.9983638,0.000063587795,0.00043278563,0.00043415435,0.0000022150061,0.000011632953,0.000005226453,0.0006217423],"genre_scores_gemma":[0.0006189657,0.9974062,0.000115610674,0.00041396482,0.00066838897,0.000005611219,0.000027495318,0.0000015584899,0.00074222387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981624,0.000037649323,0.000024177118,0.000030634557,0.00006404365,0.00002733762],"domain_scores_gemma":[0.99959606,0.00020768182,0.00004942449,0.000010556844,0.00008385896,0.00005237365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007254791,0.00090123806,0.0013748194,0.0013298215,0.00027388326,0.0011986501,0.00069896074,0.0016193975,0.004034949],"category_scores_gemma":[0.0009125241,0.00029579602,0.0003637133,0.0015437213,0.0006331152,0.0012377659,0.0008713773,0.0030340208,0.0022534432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019415906,0.000071148046,0.00013283941,0.0065893657,0.00005014347,0.00017242994,0.000036486555,0.00036473005,0.0014615146,0.0030896536,0.06484938,0.9229881],"study_design_scores_gemma":[0.000053291,0.00011808308,0.0006600101,0.002048881,0.000063055406,0.0007371302,0.000036235135,0.000099313,0.0002730122,0.0018424046,0.9940532,0.000015354412],"about_ca_topic_score_codex":0.000843563,"about_ca_topic_score_gemma":0.0024118333,"teacher_disagreement_score":0.004034949,"about_ca_system_score_codex":0.0008055162,"about_ca_system_score_gemma":0.0008871128,"threshold_uncertainty_score":0.013498187},"labels":[],"label_agreement":null},{"id":"W4230911957","doi":"10.1038/bjc.2015.81","title":"A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Kingston General Hospital; Centre Hospitalier de l’Université de Montréal; Queen's University","funders":"Fonds de Recherche du Québec - Santé; Queen's University; Ontario Institute for Cancer Research; Government of Ontario; Cancer Research Society","keywords":"Tumor microenvironment; Ovarian cancer; Immune system; Biology; Gene signature; Gene expression profiling; Cancer research; Tissue microarray; Chemotherapy; Serous fluid; Microarray analysis techniques; Cancer; Immunology; Gene expression; Medicine; Immunohistochemistry; Pathology; Internal medicine; Gene","score_opus":0.0198028542356665,"score_gpt":0.27721992786304395,"score_spread":0.2574170736273774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230911957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916315,0.00041204627,0.00014968718,0.000011737573,0.0000015425784,0.000005768443,0.00010536188,0.000006436206,0.00014430916],"genre_scores_gemma":[0.99942505,0.0001411971,0.00015635027,0.000011012136,0.0000038165163,0.000006418142,0.00018176775,0.0000017235376,0.00007263382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987984,0.000021937813,0.000014380337,0.000025634597,0.000036246376,0.000021962094],"domain_scores_gemma":[0.9996024,0.00008514264,0.00021172962,0.000022820397,0.00003617341,0.00004164733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020817766,0.00012145557,0.00021626179,0.0005895889,0.00016015225,0.0003275303,0.00008864638,0.00017651492,0.00091450557],"category_scores_gemma":[0.0004044726,0.00008854027,0.00016085965,0.00057787576,0.00025489292,0.00012638525,0.00019262655,0.0002046493,0.000101127625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009971358,0.000047865393,0.87419003,0.00013727359,0.000059187096,0.0003948255,0.0001517007,0.00020029135,0.116297826,0.000046315236,0.00010486758,0.007372669],"study_design_scores_gemma":[0.000004742715,0.00011564314,0.99407345,0.000004107004,0.000025089706,0.00059282087,0.0000804385,0.00020309983,0.0046464503,0.000029171344,0.00022273055,0.0000022133725],"about_ca_topic_score_codex":0.00028602334,"about_ca_topic_score_gemma":0.00062957645,"teacher_disagreement_score":0.00091450557,"about_ca_system_score_codex":0.00016660622,"about_ca_system_score_gemma":0.00015179865,"threshold_uncertainty_score":0.0030593276},"labels":[],"label_agreement":null},{"id":"W4231536325","doi":"10.1038/sj/bjc/6699167","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Medical Research Council; Medical Research Council","keywords":"Mifepristone; Progesterone receptor; Cell growth; Focal adhesion; MAPK/ERK pathway; Agonist; Transfection; Kinase; Chemistry; Cell biology; Endocrinology; Internal medicine; Receptor; Cell culture; Signal transduction; Biology; Medicine; Estrogen receptor; Cancer; Biochemistry; Breast cancer","score_opus":0.005171132987545773,"score_gpt":0.25775109446938793,"score_spread":0.25257996148184214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231536325","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003374764,0.0029452697,0.012540856,0.008772961,0.0065878835,0.00026664077,0.0057336744,0.0035195122,0.9562585],"genre_scores_gemma":[0.033831526,0.0028584593,0.010886681,0.0063066497,0.0015298516,0.00033550194,0.0076062563,0.00187472,0.9347704],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981654,0.0003181676,0.00012983069,0.00049230474,0.00061667693,0.00027759807],"domain_scores_gemma":[0.9982974,0.00025687966,0.00011850923,0.00038266488,0.00064640783,0.000298165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013603871,0.0009516512,0.00056790106,0.0014390245,0.0023823336,0.0054726265,0.0015335242,0.0021959257,0.5593696],"category_scores_gemma":[0.0047681755,0.0004344565,0.00062820147,0.0012617818,0.0010220108,0.004733962,0.004049554,0.0016389365,0.39701208],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025059583,0.00006135741,0.0016954505,0.0005761486,0.000026958913,0.000465844,0.00092190946,0.00014648482,0.0014296131,0.0861326,0.5784581,0.32983497],"study_design_scores_gemma":[0.000007594265,0.000011118585,0.00033224505,0.00008485134,0.0000045464085,0.00021893646,0.00016365292,0.000068392794,0.00023583983,0.0042582154,0.99460655,0.000008221497],"about_ca_topic_score_codex":0.002851341,"about_ca_topic_score_gemma":0.003269618,"teacher_disagreement_score":0.5593696,"about_ca_system_score_codex":0.0013234244,"about_ca_system_score_gemma":0.0020632353,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4232472258","doi":"10.1038/sj/bjc/6692125","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Ottawa; Statistics Canada","funders":"National Cancer Institute","keywords":"Tamoxifen; Medicine; Breast cancer; Gynecology; Endometrial cancer; Population; Cancer; Internal medicine; Demography; Obstetrics; Oncology; Environmental health","score_opus":0.01801247497500425,"score_gpt":0.3237475982634707,"score_spread":0.30573512328846647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232472258","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008199233,0.0017831721,0.030839643,0.009317297,0.0027476028,0.0004910631,0.020069635,0.00495102,0.92160136],"genre_scores_gemma":[0.1071362,0.0019926718,0.026800865,0.0063561434,0.00074111833,0.00063734275,0.030195193,0.0021432487,0.82399714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980659,0.00034890027,0.000095579664,0.00051458844,0.0006566692,0.0003184415],"domain_scores_gemma":[0.99801683,0.0003617444,0.00013794964,0.00044389511,0.0008512462,0.00018820284],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017914488,0.00069422374,0.00053349143,0.00092650054,0.0019990401,0.0035302022,0.001350614,0.0012359875,0.38985106],"category_scores_gemma":[0.007030246,0.00037766583,0.0007023799,0.0008618802,0.0007674024,0.0029778033,0.0025032952,0.0012502249,0.18129796],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048646677,0.000078489815,0.005464803,0.00042779936,0.00004733652,0.00027380293,0.00060057687,0.0005764729,0.0010417294,0.14119084,0.579248,0.2705637],"study_design_scores_gemma":[0.00005411356,0.000041428902,0.0018319357,0.00011081505,0.000020776703,0.0003250364,0.00024994623,0.00093576254,0.00054209813,0.02059909,0.9752647,0.000024228746],"about_ca_topic_score_codex":0.013541573,"about_ca_topic_score_gemma":0.0149451755,"teacher_disagreement_score":0.6101489,"about_ca_system_score_codex":0.0014119726,"about_ca_system_score_gemma":0.0025790355,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4232940111","doi":"10.1038/sj/bjc/6692165","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"National Institutes of Health","keywords":"P-glycoprotein; Chemosensitizer; Umbilical vein; Cytotoxicity; Pharmacology; Cancer cell; Cytotoxic T cell; Cell culture; Poloxamer; Chemistry; Multiple drug resistance; Biochemistry; Biology; Medicine; In vitro; Cancer; Internal medicine","score_opus":0.014471694898980102,"score_gpt":0.26917431887659626,"score_spread":0.25470262397761617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232940111","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024715643,0.0024778508,0.011959613,0.007349727,0.0073480136,0.00017919634,0.004847236,0.003386867,0.95997995],"genre_scores_gemma":[0.019402487,0.002200739,0.0075813313,0.0040070047,0.0010927219,0.000170584,0.006850599,0.0012762252,0.95741826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855655,0.00020778205,0.00009570703,0.00040996211,0.0005063143,0.00022373845],"domain_scores_gemma":[0.99878854,0.00016852457,0.00007482534,0.00030215096,0.0004592192,0.00020679808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010003877,0.0008219762,0.00054230745,0.0015197507,0.002371147,0.0051408913,0.0014648255,0.0020316995,0.5473918],"category_scores_gemma":[0.0035754084,0.00038618763,0.0005491609,0.0012292671,0.00084427505,0.004699204,0.0039525097,0.001581098,0.40760565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000177647,0.00004988031,0.0010760024,0.0003893337,0.000017730164,0.00029164462,0.0005731722,0.00014895301,0.0013313409,0.098605946,0.56373984,0.33359846],"study_design_scores_gemma":[0.0000041238463,0.000007674484,0.00021661457,0.00004855829,0.0000027771928,0.0001460983,0.00008515746,0.000053169457,0.00024557396,0.0032030982,0.9959811,0.0000062211293],"about_ca_topic_score_codex":0.0026656915,"about_ca_topic_score_gemma":0.0031440223,"teacher_disagreement_score":0.45260823,"about_ca_system_score_codex":0.0012083885,"about_ca_system_score_gemma":0.0015521529,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4233215484","doi":"10.1038/sj/bjc/6692090","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pregnancy; Medicine; Gestation; Malignancy; In utero; Fetus; Cancer; Obstetrics; Pediatrics; Pathology; Internal medicine","score_opus":0.01801247497500425,"score_gpt":0.3237475982634707,"score_spread":0.30573512328846647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233215484","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002603466,0.008223161,0.008330733,0.02192653,0.012126717,0.00028169874,0.007833992,0.0032364398,0.9354373],"genre_scores_gemma":[0.029353447,0.0077673118,0.0071764607,0.015374306,0.0032595913,0.00035890055,0.008217415,0.0018347881,0.92665774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997232,0.0005756915,0.00020529302,0.00060431403,0.0010505876,0.00033213524],"domain_scores_gemma":[0.9962902,0.00075141044,0.00029327028,0.00062790804,0.0015041156,0.0005331584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002057775,0.0007719808,0.0006317222,0.00158451,0.002152735,0.0063189226,0.0017453548,0.002418729,0.54181737],"category_scores_gemma":[0.010440233,0.00041380714,0.0007612456,0.0016457873,0.0010335806,0.0057237465,0.003699183,0.0020252638,0.39482394],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013389303,0.000034500066,0.0013231724,0.0005887424,0.000019513647,0.00035174127,0.0006152812,0.000055061904,0.00047917286,0.030942896,0.7351884,0.23026757],"study_design_scores_gemma":[0.0000058386345,0.000008187971,0.00029725992,0.00010392329,0.000004651291,0.0002925174,0.00015394503,0.000025537032,0.00011702118,0.0020869442,0.9968982,0.0000060709935],"about_ca_topic_score_codex":0.0031932055,"about_ca_topic_score_gemma":0.0038186095,"teacher_disagreement_score":0.45818263,"about_ca_system_score_codex":0.0017154801,"about_ca_system_score_gemma":0.002699887,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4235465754","doi":"10.1038/bjc.2013.828","title":"Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; York University; St. Michael's Hospital","funders":"Kidney Foundation of Canada; Prostate Cancer Canada; Canadian Institutes of Health Research; Government of Ontario; Cancer Research Society","keywords":"PI3K/AKT/mTOR pathway; Cancer research; Clear cell renal cell carcinoma; Protein kinase B; Biology; Renal cell carcinoma; Metastasis; Galectin-1; Galectin-3; Targeted therapy; Signal transduction; Cancer; Medicine; Pathology; Internal medicine; Immunology; Cell biology","score_opus":0.011038901967490721,"score_gpt":0.24253939947210065,"score_spread":0.23150049750460994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235465754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98036355,0.014201623,0.0018404169,0.0006157547,0.00005398335,0.000033243083,0.0011727294,0.00008353493,0.0016352624],"genre_scores_gemma":[0.99574775,0.001989075,0.0006368883,0.00006265014,0.00002531722,0.000015848324,0.0008577175,0.000007089391,0.0006577063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998647,0.000035770052,0.000008121274,0.000025189203,0.00004056913,0.000025640202],"domain_scores_gemma":[0.9997408,0.000032221535,0.00013236028,0.000009070855,0.000040636085,0.00004492517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022912408,0.00036514224,0.00025334905,0.00064717274,0.00019052591,0.0006565433,0.00018703115,0.00028599144,0.0021597513],"category_scores_gemma":[0.00037453452,0.00011993411,0.00028404663,0.0005901305,0.00024467518,0.00021096531,0.00024195886,0.0004988301,0.00032650985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035079992,0.00030395633,0.28506026,0.0008990135,0.0005003611,0.00072689756,0.00010881871,0.001058336,0.636852,0.000965195,0.0031875973,0.066829555],"study_design_scores_gemma":[0.00012866658,0.0009229848,0.7965089,0.00006569903,0.00044188727,0.0033471088,0.00012579262,0.0050732177,0.17933327,0.0009078689,0.0130980145,0.000046465262],"about_ca_topic_score_codex":0.0006137409,"about_ca_topic_score_gemma":0.00053794356,"teacher_disagreement_score":0.0021597513,"about_ca_system_score_codex":0.00046643062,"about_ca_system_score_gemma":0.00020330094,"threshold_uncertainty_score":0.0072250366},"labels":[],"label_agreement":null},{"id":"W4235802262","doi":"10.1038/sj/bjc/6692170","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Conjugate; Carcinoembryonic antigen; Molecular biology; Monoclonal antibody; Cell culture; Incubation; Antigen; Chemistry; Cytotoxicity; Antibody; Biology; Biochemistry; In vitro; Immunology; Cancer","score_opus":0.019332793656473023,"score_gpt":0.3553876841786613,"score_spread":0.3360548905221883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235802262","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005349679,0.0022815373,0.020822382,0.0062922733,0.0046086693,0.00029551328,0.005589732,0.004289869,0.95047027],"genre_scores_gemma":[0.052905466,0.0024149697,0.01750419,0.004919967,0.0010099816,0.0003815371,0.0096796695,0.0021414594,0.9090426],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982376,0.0002643186,0.00010003932,0.0005164689,0.0005827445,0.00029877987],"domain_scores_gemma":[0.9987551,0.00017479232,0.00008321354,0.0002971923,0.00049452344,0.00019512644],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012736899,0.0010061167,0.00052480516,0.0013302002,0.0022856416,0.005115896,0.0013796857,0.0017167241,0.4563999],"category_scores_gemma":[0.0037206442,0.00044619158,0.0006033801,0.00107318,0.0010664022,0.004520243,0.004096191,0.0015667365,0.28957936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003287265,0.000086527114,0.0023601004,0.0005692577,0.000037645015,0.00044954132,0.001177001,0.0002501385,0.0024545752,0.14338839,0.46472856,0.38416952],"study_design_scores_gemma":[0.00000948932,0.000016125672,0.0004914431,0.00008986925,0.0000062948097,0.00022788727,0.00021849989,0.00013062512,0.00047720576,0.007843916,0.9904777,0.0000110143765],"about_ca_topic_score_codex":0.0031090304,"about_ca_topic_score_gemma":0.003462357,"teacher_disagreement_score":0.5436001,"about_ca_system_score_codex":0.0012093685,"about_ca_system_score_gemma":0.0017246117,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4237285223","doi":"10.1038/s41416-018-0079-9","title":"Correction: Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study","year":2018,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Radiation therapy; Chemotherapy; Medicine; Multicenter study; Oncology; Medical physics; Radiology; Nuclear medicine; Surgery; Randomized controlled trial","score_opus":0.012780960527582512,"score_gpt":0.3004080317907772,"score_spread":0.2876270712631947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237285223","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004633048,0.0017304918,0.0009575194,0.06368025,0.9235194,0.00004942978,0.0072095124,0.0005301997,0.0018598897],"genre_scores_gemma":[0.07535058,0.018924002,0.014871701,0.18996832,0.4691568,0.0011974105,0.025545172,0.0077860644,0.19719993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99353445,0.0014682903,0.0016704637,0.0008395279,0.0020260583,0.00046124807],"domain_scores_gemma":[0.9229334,0.030224143,0.0057744863,0.0053149974,0.03371057,0.0020423406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009625626,0.0024899715,0.0023306734,0.0034054143,0.0017794821,0.0031696304,0.0042662267,0.004764911,0.07767556],"category_scores_gemma":[0.17972802,0.0012331383,0.0030532442,0.0045147105,0.0013324281,0.00215244,0.0015356642,0.006663718,0.024561785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086739834,0.000004501426,0.00023906963,0.0002487126,0.000037780053,0.00010169096,0.00002844202,0.000040646075,0.000020662985,0.00036234953,0.99434644,0.0044828807],"study_design_scores_gemma":[0.00047728178,0.00008316868,0.008113701,0.00305444,0.00048196322,0.0013874996,0.00020317986,0.0006443553,0.00060082,0.0025389881,0.9822703,0.00014429764],"about_ca_topic_score_codex":0.026883235,"about_ca_topic_score_gemma":0.022092361,"teacher_disagreement_score":0.07767556,"about_ca_system_score_codex":0.0038636702,"about_ca_system_score_gemma":0.005639868,"threshold_uncertainty_score":0.25985062},"labels":[],"label_agreement":null},{"id":"W4238063550","doi":"10.1038/sj/bjc/6692068","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"CDKN2A; Loss of heterozygosity; Biology; Cancer; Head and neck cancer; Genetic predisposition; Cancer research; Tumor suppressor gene; Epidermoid carcinoma; Genetics; Oncology; Gene; Pathology; Medicine; Allele; Carcinogenesis","score_opus":0.012580388318726245,"score_gpt":0.28550654181072066,"score_spread":0.2729261534919944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238063550","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003374933,0.0046393936,0.007740472,0.06104131,0.013464419,0.00016374791,0.0020901745,0.0013809329,0.90610456],"genre_scores_gemma":[0.03665916,0.0032074938,0.005691663,0.027742298,0.0027304105,0.00018107379,0.0022579455,0.0008437035,0.92068624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972351,0.0005064689,0.00013221905,0.00065658015,0.0010340426,0.00043566115],"domain_scores_gemma":[0.9964586,0.0005562905,0.00023725737,0.0006729312,0.001413284,0.00066168443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024032898,0.0006535414,0.0004795744,0.0010565973,0.0033550316,0.005600423,0.0013731531,0.0028060873,0.4098982],"category_scores_gemma":[0.010926506,0.00034900114,0.00064644753,0.0007453776,0.0020427278,0.0053989794,0.0038323596,0.0030470046,0.23278259],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013081143,0.000039750612,0.002235585,0.00024537882,0.000020449024,0.00045421414,0.0014320746,0.000062708845,0.0006391576,0.10553097,0.7310198,0.15818912],"study_design_scores_gemma":[0.000005960618,0.000008892397,0.00041441058,0.00007179844,0.0000044713524,0.00036052408,0.00031825757,0.000026442505,0.00012429128,0.0065645017,0.99209315,0.0000072554312],"about_ca_topic_score_codex":0.00443278,"about_ca_topic_score_gemma":0.0062838336,"teacher_disagreement_score":0.59010184,"about_ca_system_score_codex":0.0017670131,"about_ca_system_score_gemma":0.0028223833,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4239805948","doi":"10.1038/s41416-020-0841-7","title":"Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ataxia-telangiectasia; Poly ADP ribose polymerase; Polymerase; Cancer research; Medicine; License; Genetics; Biology; DNA; DNA damage; Computer science","score_opus":0.004985807314524316,"score_gpt":0.2337666823136347,"score_spread":0.2287808749991104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239805948","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011051652,0.0018090585,0.003045515,0.028900927,0.95955956,0.000026252865,0.0017298866,0.0010767555,0.0027469168],"genre_scores_gemma":[0.10403063,0.020758225,0.023224244,0.04928128,0.24149244,0.00030711625,0.010091056,0.0047596595,0.5460554],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975993,0.0002486032,0.00035453972,0.00037874578,0.0011547597,0.00026406997],"domain_scores_gemma":[0.98575926,0.0031060881,0.0009889592,0.0014319414,0.0076224394,0.0010913315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018892616,0.0016042152,0.001117675,0.0023454665,0.001643465,0.0022868707,0.0025996147,0.004932721,0.048106167],"category_scores_gemma":[0.024485355,0.0008935921,0.0012536824,0.0016600824,0.0017534096,0.0015174558,0.0012984792,0.0068396344,0.018530939],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012698246,0.00001650044,0.00015540182,0.00050724513,0.000051268325,0.001432104,0.00008243009,0.00021256172,0.002179913,0.0021871107,0.97807455,0.014973888],"study_design_scores_gemma":[0.00007643686,0.000044914043,0.0013734545,0.00022138543,0.00008710269,0.0037558454,0.000107055916,0.0006974275,0.006136125,0.0017600708,0.985672,0.00006810069],"about_ca_topic_score_codex":0.007105213,"about_ca_topic_score_gemma":0.0077101276,"teacher_disagreement_score":0.048106167,"about_ca_system_score_codex":0.0022451815,"about_ca_system_score_gemma":0.0030660057,"threshold_uncertainty_score":0.16093117},"labels":[],"label_agreement":null},{"id":"W4240087065","doi":"10.1038/s41416-019-0545-z","title":"Correction: Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"","keywords":"Cervical cancer; Medicine; Chemotherapy; Oncology; Cancer; Myeloid; CXCR4; Cancer research; Internal medicine; Medical physics; Computer science; Bioinformatics; Biology; Receptor","score_opus":0.009744363842875914,"score_gpt":0.2517582186876948,"score_spread":0.2420138548448189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240087065","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012637594,0.0034714416,0.0049487106,0.05925867,0.92451805,0.000054351258,0.0024052523,0.0013046461,0.0027751743],"genre_scores_gemma":[0.10894474,0.03767875,0.038905546,0.1184326,0.2632468,0.0006743583,0.010820779,0.006636052,0.4146604],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962788,0.0005305607,0.0005780121,0.0005644685,0.0016994756,0.00034865792],"domain_scores_gemma":[0.98446184,0.0045613456,0.0010053903,0.0012012841,0.007903306,0.0008668333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003066233,0.0015204512,0.001192304,0.0019585488,0.0015217062,0.0021813803,0.002406834,0.0054246043,0.035083923],"category_scores_gemma":[0.030486746,0.0008357984,0.0014082212,0.00132414,0.0017939319,0.001407339,0.0011922239,0.007274772,0.0158004],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020114295,0.000017608456,0.00018551621,0.0005806083,0.000040964165,0.0009070763,0.00008779,0.0001684468,0.002854316,0.002356199,0.9773037,0.015296642],"study_design_scores_gemma":[0.000089116365,0.00005644224,0.00093658455,0.00031470088,0.000094517105,0.002483108,0.000095502095,0.0005805423,0.008635877,0.0016859277,0.98496103,0.00006666879],"about_ca_topic_score_codex":0.008451963,"about_ca_topic_score_gemma":0.008398729,"teacher_disagreement_score":0.035083923,"about_ca_system_score_codex":0.0026209175,"about_ca_system_score_gemma":0.003671668,"threshold_uncertainty_score":0.11736739},"labels":[],"label_agreement":null},{"id":"W4243200943","doi":"10.1038/sj/bjc/6692061","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Thyroid cancer; Medicine; Incidence (geometry); Cohort; Cohort effect; Demography; Cohort study; Thyroid; Internal medicine","score_opus":0.05867303821499509,"score_gpt":0.3668876207907418,"score_spread":0.3082145825757467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243200943","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033670753,0.0029844434,0.017258327,0.0068436237,0.0016985396,0.00038569115,0.0571401,0.003916887,0.8761017],"genre_scores_gemma":[0.17584918,0.0022191098,0.012053125,0.003796404,0.0004260934,0.0003485296,0.057842955,0.0015600385,0.74590456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984176,0.0001238996,0.000057371373,0.0004774701,0.0005676431,0.0003560838],"domain_scores_gemma":[0.9980052,0.00023988204,0.00012787133,0.00033990256,0.0010609862,0.00022613906],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011548728,0.00055981125,0.000452018,0.0019329617,0.0022331518,0.0038752402,0.0012607877,0.0009152178,0.34683102],"category_scores_gemma":[0.005049576,0.0003305921,0.00064739486,0.0020682004,0.0005765164,0.0023815664,0.00182825,0.0008597046,0.14580122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049738196,0.00010798827,0.036283284,0.00038431896,0.00007285567,0.0005340388,0.0012198255,0.0006006422,0.0010059276,0.06842414,0.43806294,0.45280674],"study_design_scores_gemma":[0.00003138813,0.000031622545,0.018353332,0.00014126403,0.00003118565,0.00061629666,0.0008081575,0.0010191755,0.0005788032,0.0079713585,0.9703901,0.000027376427],"about_ca_topic_score_codex":0.1336314,"about_ca_topic_score_gemma":0.12495339,"teacher_disagreement_score":0.653169,"about_ca_system_score_codex":0.002897293,"about_ca_system_score_gemma":0.0040713423,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4249260600","doi":"10.1038/sj/bjc/6692196","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Malignancy; Cancer; Stage (stratigraphy); Epithelial ovarian cancer; Gynecology; Cytoreductive surgery; Multivariate analysis; Surgery; General surgery; Internal medicine","score_opus":0.016977546098720382,"score_gpt":0.3110622925530365,"score_spread":0.29408474645431615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249260600","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035406658,0.0023406425,0.008288297,0.009363413,0.0053249635,0.00023096992,0.007924584,0.0030556363,0.9599307],"genre_scores_gemma":[0.031483427,0.0019689254,0.006509446,0.004972074,0.0011713366,0.00025816905,0.0089740055,0.0014449276,0.94321775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977921,0.00041956917,0.0001629389,0.00056090293,0.0007197186,0.00034468708],"domain_scores_gemma":[0.9975399,0.00038980314,0.00019753962,0.00056873995,0.0009139223,0.00039022605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017428644,0.0007078474,0.00056719244,0.0014919136,0.0021225722,0.006115885,0.0014234192,0.0019485803,0.61692446],"category_scores_gemma":[0.0067968266,0.00045201826,0.0005783425,0.0013564503,0.0010037223,0.005043081,0.004058335,0.0014454426,0.44806537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020132407,0.00005227363,0.0023718392,0.00041463104,0.000020785199,0.00027573275,0.00091323326,0.00010038197,0.0006002917,0.067929536,0.6656685,0.26145148],"study_design_scores_gemma":[0.000010227021,0.0000127312915,0.0007003901,0.00008343379,0.000004121543,0.00020760957,0.00020489832,0.00006323533,0.00012727607,0.0040617445,0.9945148,0.000009427101],"about_ca_topic_score_codex":0.0046946746,"about_ca_topic_score_gemma":0.0053392053,"teacher_disagreement_score":0.38307554,"about_ca_system_score_codex":0.0012673989,"about_ca_system_score_gemma":0.0019333326,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4249395892","doi":"10.1038/sj/bjc/6692123","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Radiosensitivity; Perfusion; Hypoxia (environmental); Oxygenation; Biology; Cancer research; In vivo; Pathology; Cell; Medicine; Radiation therapy; Internal medicine; Chemistry; Oxygen; Biochemistry","score_opus":0.008798194602253308,"score_gpt":0.26561899820854096,"score_spread":0.2568208036062877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249395892","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008325481,0.0024692982,0.02171448,0.0064349766,0.0038987156,0.00028794026,0.006308422,0.0037749973,0.9467856],"genre_scores_gemma":[0.07716628,0.0020468896,0.016876321,0.004201233,0.000794115,0.00034767966,0.008652501,0.0017072525,0.8882077],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983392,0.00022074912,0.00009521095,0.0005330348,0.00051526394,0.00029651204],"domain_scores_gemma":[0.9988673,0.00015509223,0.00008846332,0.0002900128,0.00040852124,0.00019060503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011572972,0.000823474,0.0004848172,0.0011089172,0.002294115,0.0046441313,0.0012973294,0.0016230211,0.3620298],"category_scores_gemma":[0.0037710487,0.0004112445,0.0005522333,0.00091831037,0.0010491812,0.0042634564,0.0036080126,0.0013268137,0.21371283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046713435,0.00008985965,0.0034589975,0.00059924694,0.00003812183,0.0005375986,0.0019304564,0.0002538212,0.0045835595,0.19922245,0.43474606,0.3540727],"study_design_scores_gemma":[0.000010747673,0.000021390795,0.0006948381,0.00007188992,0.000006897731,0.00030151635,0.00028556742,0.0001413985,0.000838854,0.008550079,0.9890638,0.000013119762],"about_ca_topic_score_codex":0.0034388553,"about_ca_topic_score_gemma":0.0040661655,"teacher_disagreement_score":0.6379702,"about_ca_system_score_codex":0.0012299095,"about_ca_system_score_gemma":0.0015270988,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4250051927","doi":"10.1038/bjc.2011.413","title":"Reply: ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.07103125588195205,"score_gpt":0.35296899868407755,"score_spread":0.28193774280212547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250051927","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000783915,0.0051078717,0.00030810267,0.92157966,0.07151051,0.000018746929,0.00020584535,0.00007734647,0.0004079063],"genre_scores_gemma":[0.00663781,0.0034630897,0.0005723599,0.8848916,0.10147961,0.00006958342,0.00012920212,0.000054981163,0.002701764],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979442,0.0006146985,0.000433717,0.00037703555,0.00041175965,0.00021862387],"domain_scores_gemma":[0.98629606,0.0077226777,0.00092295825,0.00036653006,0.0038114043,0.0008802781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004427388,0.0011600698,0.0019046902,0.00090902566,0.001541421,0.002289491,0.0023200524,0.022114279,0.003422164],"category_scores_gemma":[0.028048653,0.0008010452,0.001154319,0.00066010637,0.0020448277,0.0038860452,0.0011515202,0.029268583,0.004303818],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025915177,0.000036825426,0.0013999006,0.0003008608,0.00005846508,0.0010658803,0.00016323857,0.00007946232,0.00054091867,0.0005911746,0.9848702,0.01063393],"study_design_scores_gemma":[0.000289997,0.00027478006,0.006900312,0.0005530161,0.00021024622,0.007116925,0.0007066768,0.00092423015,0.0014571339,0.004343359,0.9769986,0.0002246866],"about_ca_topic_score_codex":0.0017390638,"about_ca_topic_score_gemma":0.0020101585,"teacher_disagreement_score":0.022114279,"about_ca_system_score_codex":0.0015927341,"about_ca_system_score_gemma":0.001378541,"threshold_uncertainty_score":0.023414552},"labels":[],"label_agreement":null},{"id":"W4251412578","doi":"10.1038/s41416-019-0512-8","title":"Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy","year":2019,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; PD-L1; Internal medicine; Oncology; Immunotherapy; Pathology; Cancer","score_opus":0.006148988101065753,"score_gpt":0.26583518499217446,"score_spread":0.2596861968911087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251412578","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017816847,0.00075122766,0.00050220755,0.050759476,0.9458047,0.000019014082,0.000828873,0.00018847673,0.0009678487],"genre_scores_gemma":[0.023425845,0.00785721,0.005383188,0.11880476,0.7040768,0.00021474427,0.002638473,0.0014048296,0.13619415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614537,0.0006991603,0.0009032495,0.00055358163,0.0013389874,0.0003596236],"domain_scores_gemma":[0.96810067,0.009194288,0.0016523405,0.0018714385,0.017509159,0.0016720688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004439517,0.0020859505,0.0017785862,0.0032640705,0.002031163,0.0030555325,0.0032149542,0.0065789456,0.030832723],"category_scores_gemma":[0.083750464,0.0010656117,0.0017117955,0.0017204431,0.0021318072,0.001792824,0.0016569857,0.009856658,0.022628926],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005702295,0.0000060902016,0.00012392942,0.000122031925,0.000017556491,0.00043475925,0.000027956105,0.00003970962,0.00006121801,0.0003807767,0.9936837,0.0050453525],"study_design_scores_gemma":[0.00010620339,0.00004311264,0.0017198141,0.0006404144,0.000099213874,0.0026624217,0.000117379765,0.000501704,0.0006631802,0.0019566587,0.99141073,0.00007920505],"about_ca_topic_score_codex":0.012840898,"about_ca_topic_score_gemma":0.012068159,"teacher_disagreement_score":0.030832723,"about_ca_system_score_codex":0.0029683516,"about_ca_system_score_gemma":0.0039477893,"threshold_uncertainty_score":0.10314578},"labels":[],"label_agreement":null},{"id":"W4281391945","doi":"10.1038/s41416-022-01856-w","title":"Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Universidade do Porto; Fundação de Amparo à Pesquisa do Estado de São Paulo; Fundação para a Ciência e a Tecnologia; Associazione Italiana per la Ricerca sul Cancro; Kræftens Bekæmpelse","keywords":"Stomach cancer; Stomach; Pooling; Cancer; Medicine; Oncology; Internal medicine; Computer science","score_opus":0.01947061261795343,"score_gpt":0.3111726811699044,"score_spread":0.29170206855195097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281391945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8566552,0.06825236,0.008949391,0.001484144,0.0007256241,0.0010383757,0.05982866,0.00033625678,0.0027300073],"genre_scores_gemma":[0.9543033,0.00719383,0.0032677217,0.0008506309,0.00047048257,0.0014503623,0.03029825,0.00026405352,0.0019012942],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9863794,0.009369418,0.0012056252,0.0016508877,0.0007817653,0.0006130143],"domain_scores_gemma":[0.98822623,0.0039800014,0.0024659329,0.0034410898,0.0012830319,0.0006037751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0139068905,0.0022315471,0.005568087,0.0014889296,0.0007347115,0.0017984392,0.0012452103,0.0017771992,0.003949404],"category_scores_gemma":[0.024724903,0.0014557448,0.01641661,0.003341501,0.00055808056,0.00091564783,0.0036510623,0.001183777,0.0004512431],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10548393,0.00021597475,0.18886752,0.009689458,0.652151,0.00053282134,0.00066171575,0.0024092277,0.0024138216,0.0004387657,0.017776988,0.019358736],"study_design_scores_gemma":[0.015954766,0.0018789787,0.32939303,0.0011083928,0.64146364,0.00041532065,0.0004266671,0.00072072836,0.00048405182,0.00063124247,0.0073381825,0.00018495595],"about_ca_topic_score_codex":0.018886844,"about_ca_topic_score_gemma":0.024047945,"teacher_disagreement_score":0.018886844,"about_ca_system_score_codex":0.00090524676,"about_ca_system_score_gemma":0.0014092932,"threshold_uncertainty_score":0.0735476},"labels":[],"label_agreement":null},{"id":"W4281561154","doi":"10.1038/s41416-022-01844-0","title":"Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Ontario Institute for Cancer Research; Cancer Care Ontario","funders":"Medical Research Council; Cancer Research UK","keywords":"Medicine; Referral; Benchmarking; Cancer; General partnership; Family medicine; Ovarian cancer; Internal medicine","score_opus":0.0191230772184172,"score_gpt":0.3031562460684541,"score_spread":0.2840331688500369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281561154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133694,0.0016660378,0.00053996075,0.00054382713,0.00001971421,0.00004344402,0.0041532256,0.000016535487,0.0016803046],"genre_scores_gemma":[0.9973802,0.0002902598,0.00036391828,0.0000775977,0.0000043244086,0.000034259476,0.0017543194,0.0000075606335,0.00008752753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945294,0.0026007362,0.0006513893,0.00064292,0.0008142693,0.00076133705],"domain_scores_gemma":[0.98221785,0.004952364,0.007622942,0.0009268846,0.0029285147,0.0013513746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075885262,0.00020155209,0.0003749352,0.0020330825,0.00066911423,0.0011223027,0.0007053155,0.00039684994,0.0011174817],"category_scores_gemma":[0.021393696,0.00029764188,0.00048582847,0.0050374377,0.0006359169,0.0008253354,0.003251363,0.00065024674,0.00012671902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011959883,0.000035125657,0.9801925,0.00022875816,0.00009004388,0.000103133185,0.0045670005,0.00054585864,0.00011465074,0.0004493401,0.0017850373,0.011768889],"study_design_scores_gemma":[0.0000053509866,0.00004529094,0.9903441,0.0001302976,0.000041247746,0.00016513014,0.0065585305,0.00042516543,0.0000930989,0.00008845686,0.002090701,0.00001264373],"about_ca_topic_score_codex":0.107028164,"about_ca_topic_score_gemma":0.07064972,"teacher_disagreement_score":0.107028164,"about_ca_system_score_codex":0.0023803895,"about_ca_system_score_gemma":0.00271923,"threshold_uncertainty_score":0.21281034},"labels":[],"label_agreement":null},{"id":"W4281703599","doi":"10.1038/s41416-022-01859-7","title":"Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"National Cancer Institute; European Regional Development Fund; Engineering and Physical Sciences Research Council; Agència de Gestió d'Ajuts Universitaris i de Recerca; Canadian Institutes of Health Research; Fondation contre le Cancer; Stichting Tegen Kanker; Generalitat de Catalunya; Umeå Universitet; Koning Boudewijnstichting; Knut och Alice Wallenbergs Stiftelse; Cancerfonden; Vetenskapsrådet; Government of Canada; Cancer Research Foundation in Northern Sweden; Research Councils UK; McGill University","keywords":"Histopathology; Metastasis; Liver cancer; Biology; Cancer; Colorectal cancer; Pathology; Medicine; Bioinformatics; Internal medicine","score_opus":0.10417403090189503,"score_gpt":0.39629367409761557,"score_spread":0.29211964319572054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281703599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029498953,0.99396247,0.0014218565,0.0024936988,0.00049606466,0.000028684975,0.00028890237,0.000038195583,0.000975145],"genre_scores_gemma":[0.0041457266,0.9846618,0.0060891584,0.001928032,0.0008749301,0.00008380146,0.0010705483,0.000025275447,0.0011205954],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99823356,0.00041559595,0.00047365687,0.00023444541,0.0005459169,0.00009681634],"domain_scores_gemma":[0.9945226,0.0025956165,0.00062674796,0.00014587851,0.0019531224,0.00015613537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00580973,0.0010965179,0.0029368908,0.0051527284,0.00030777417,0.0023140968,0.002755195,0.0017984137,0.0022455542],"category_scores_gemma":[0.008695611,0.0004952524,0.0020646711,0.004175563,0.00094032136,0.0018352204,0.0012081681,0.002468564,0.0014873127],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018769076,0.0000432221,0.0019919944,0.01800153,0.00039657817,0.000183622,0.000080605016,0.00062019407,0.0006801662,0.0032259203,0.06806761,0.9065209],"study_design_scores_gemma":[0.00016222554,0.00020435697,0.013430628,0.036496364,0.0019074151,0.004318817,0.0002828133,0.001044264,0.000925445,0.008469088,0.93260175,0.00015693236],"about_ca_topic_score_codex":0.0074926526,"about_ca_topic_score_gemma":0.012438946,"teacher_disagreement_score":0.0074926526,"about_ca_system_score_codex":0.0018084594,"about_ca_system_score_gemma":0.0038344902,"threshold_uncertainty_score":0.030725121},"labels":[],"label_agreement":null},{"id":"W4283018691","doi":"10.1038/s41416-022-01840-4","title":"Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Partnership Against Cancer; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Ovarian cancer; Medicine; Germline mutation; Oncology; Serous fluid; Internal medicine; Cancer; Germline; BRCA mutation; Survival rate; Serous carcinoma; Stage (stratigraphy); Mutation; Gynecology; Biology; Genetics; Gene","score_opus":0.01579432277681403,"score_gpt":0.31718922269611755,"score_spread":0.3013948999193035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283018691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523723,0.0027755583,0.000033058266,0.00034097309,0.000054435037,0.0000013400796,0.00024111269,0.0000037629084,0.0013124826],"genre_scores_gemma":[0.99907386,0.00032531717,0.000014097818,0.000073637915,0.000031267118,0.0000010895461,0.00024453775,0.0000022232296,0.00023376076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962366,0.00009786534,0.000037262475,0.000056390352,0.00006126365,0.00012352841],"domain_scores_gemma":[0.99867576,0.00046045415,0.00036687072,0.00007004281,0.00012732172,0.0002994797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033797894,0.00014361808,0.00029126173,0.00029436295,0.0003360741,0.0006000532,0.0002041062,0.0005740523,0.0023466495],"category_scores_gemma":[0.0032215042,0.0001228381,0.0005304327,0.0004971379,0.0002456272,0.00044064745,0.00044556422,0.00074802083,0.00023751207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089645456,0.0000493608,0.98912877,0.000024481715,0.00019455997,0.00034708405,0.00005622512,0.00019884188,0.00042462608,0.000034039058,0.00027867942,0.008366875],"study_design_scores_gemma":[0.000014155117,0.00017300123,0.99843305,0.000015990974,0.000101654565,0.00053187454,0.00010691107,0.00012678544,0.000043853543,0.000072567535,0.00037441606,0.000005783914],"about_ca_topic_score_codex":0.0037891332,"about_ca_topic_score_gemma":0.005333804,"teacher_disagreement_score":0.0037891332,"about_ca_system_score_codex":0.000310742,"about_ca_system_score_gemma":0.0002577259,"threshold_uncertainty_score":0.007850289},"labels":[],"label_agreement":null},{"id":"W4285095591","doi":"10.1038/s41416-022-01904-5","title":"Multistate models for the natural history of cancer progression","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Inference; Markov model; Computer science; Markov chain; Markov process; Homogeneous; Process (computing); Statistics; Cancer; Econometrics; Statistical inference; Mathematics; Medicine; Artificial intelligence; Internal medicine","score_opus":0.06620877547627355,"score_gpt":0.3699848139367611,"score_spread":0.3037760384604875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285095591","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4213243,0.0066209584,0.5198174,0.013737421,0.00079883274,0.00045891,0.01533059,0.0019624017,0.01994909],"genre_scores_gemma":[0.90448314,0.0028409227,0.018731719,0.0006524881,0.00033450444,0.0007266751,0.004366703,0.00031101436,0.0675528],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99773645,0.0011512187,0.00007444205,0.00049666024,0.00012077861,0.00042049293],"domain_scores_gemma":[0.9805731,0.01602954,0.0011502296,0.0009316131,0.0006967761,0.00061869115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008259661,0.0014526393,0.0029370915,0.0026121668,0.0012148122,0.0033304922,0.0035086179,0.003992656,0.02022999],"category_scores_gemma":[0.02030578,0.0017317423,0.0032947704,0.0017543248,0.0019690187,0.003502748,0.0021829938,0.0051164813,0.0031316364],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007694121,0.0002004262,0.018981127,0.00022412489,0.00050215813,0.00029475248,0.00056251517,0.8216367,0.00055340934,0.13278648,0.0076509356,0.015837952],"study_design_scores_gemma":[0.00009793753,0.00008505724,0.0036250565,0.000071346745,0.00015968079,0.00014373224,0.00009050885,0.9286719,0.00011868448,0.06440147,0.002470477,0.00006417035],"about_ca_topic_score_codex":0.034636643,"about_ca_topic_score_gemma":0.027442591,"teacher_disagreement_score":0.034636643,"about_ca_system_score_codex":0.00226475,"about_ca_system_score_gemma":0.0021580493,"threshold_uncertainty_score":0.06887007},"labels":[],"label_agreement":null},{"id":"W4286111339","doi":"10.1038/s41416-022-01855-x","title":"Epitope detection in monocytes (EDIM) for liquid biopsy including identification of GD2 in childhood neuroblastoma—a pilot study","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Neuroblastoma; Epitope; Medicine; Flow cytometry; Biopsy; CD14; Liquid biopsy; Malignancy; Pathology; Immunology; Antibody; Internal medicine; Biology; Cell culture; Cancer","score_opus":0.03526806573449105,"score_gpt":0.3383743668063413,"score_spread":0.30310630107185027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286111339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990945,0.00026961762,0.00032480806,0.000009068337,0.000002565748,0.000059736758,0.000043461776,0.0000056824783,0.00019056496],"genre_scores_gemma":[0.998242,0.00022164374,0.0011321598,0.000028392726,0.00000808658,0.00005183969,0.00013231242,0.000004313764,0.00017918607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996567,0.00012840141,0.000020211446,0.000079674326,0.00004945271,0.00006549714],"domain_scores_gemma":[0.99954575,0.00016193032,0.00006206863,0.00003977954,0.00007113226,0.00011931922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055891555,0.0005756143,0.00033345103,0.00045197946,0.00032510125,0.00028120924,0.00022840581,0.0004077414,0.00084357226],"category_scores_gemma":[0.00070783426,0.00019649115,0.00020716661,0.00019718033,0.00037227533,0.00019990499,0.00038260108,0.0003143702,0.0002706298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008971998,0.002357714,0.58335686,0.00047443036,0.000082276674,0.017326295,0.0019603372,0.0003541946,0.35083193,0.00010716074,0.00019637353,0.033980396],"study_design_scores_gemma":[0.00050233025,0.037124723,0.83537096,0.00005911656,0.00017226172,0.037467692,0.0016527302,0.0018732853,0.082773425,0.00012257218,0.0028365143,0.000044367393],"about_ca_topic_score_codex":0.0018743282,"about_ca_topic_score_gemma":0.0015609716,"teacher_disagreement_score":0.0018743282,"about_ca_system_score_codex":0.00039036392,"about_ca_system_score_gemma":0.00031975488,"threshold_uncertainty_score":0.00372684},"labels":[],"label_agreement":null},{"id":"W4286561096","doi":"10.1038/s41416-022-01903-6","title":"Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"AstraZeneca","keywords":"Selumetinib; Gemcitabine; Medicine; Chemotherapy; MEK inhibitor; Cisplatin; Internal medicine; Toxicity; Oncology; Urology; Gastroenterology; Surgery; Cancer; MAPK/ERK pathway; Biology; Kinase; Colorectal cancer","score_opus":0.01100035852035191,"score_gpt":0.2962305676332977,"score_spread":0.2852302091129458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286561096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825783,0.0036717593,0.00087117706,0.0011793799,0.001160232,0.0049454886,0.0018845522,0.00012353732,0.0035855488],"genre_scores_gemma":[0.9770949,0.0034956804,0.0018719096,0.0019000382,0.00062264636,0.0053484878,0.002729446,0.0000607137,0.006876123],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99874324,0.00080538355,0.00006230472,0.00017102741,0.00006104728,0.00015702577],"domain_scores_gemma":[0.99829394,0.00044181076,0.0002942249,0.00019588225,0.000115407194,0.00065873004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024325855,0.002275628,0.0045290855,0.0005731393,0.0005664344,0.0017030402,0.001275189,0.0020357128,0.009806714],"category_scores_gemma":[0.0028989494,0.0016351779,0.0030061589,0.0007371679,0.001954702,0.0017532685,0.00085648155,0.0050004194,0.0017048068],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9840763,0.005532705,0.0004463315,0.00029248756,0.0009402289,0.000027689615,0.000053039963,0.00039538668,0.0019614068,0.00007626953,0.0005360562,0.0056621195],"study_design_scores_gemma":[0.94214845,0.055601202,0.000996932,0.000011995355,0.00030984113,0.000019209296,0.000024748822,0.00012044607,0.0001490501,0.00007477155,0.00053284277,0.000010548989],"about_ca_topic_score_codex":0.002870618,"about_ca_topic_score_gemma":0.0066445363,"teacher_disagreement_score":0.009806714,"about_ca_system_score_codex":0.0016345778,"about_ca_system_score_gemma":0.0020888916,"threshold_uncertainty_score":0.032806754},"labels":[],"label_agreement":null},{"id":"W4293222009","doi":"10.1038/s41416-022-01926-z","title":"Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Clinical trial; MEDLINE; Dermatology; Surgery; Internal medicine","score_opus":0.7884720102891636,"score_gpt":0.6858444371946468,"score_spread":0.10262757309451676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293222009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614993,0.0061609163,0.019954989,0.0010197068,0.00018319329,0.0010556044,0.0032862294,0.0001875281,0.0066526574],"genre_scores_gemma":[0.9945338,0.00034014098,0.0029382173,0.00014462101,0.000055712248,0.00040549794,0.0009867954,0.000022308597,0.00057302177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95621747,0.033514503,0.0036964477,0.0016538135,0.0043240483,0.000593685],"domain_scores_gemma":[0.7926978,0.16661948,0.028067928,0.0059366743,0.0045189173,0.0021591312],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05241296,0.0006439915,0.0018682051,0.0010178947,0.0002665887,0.0013909553,0.00060739735,0.000710054,0.0024260553],"category_scores_gemma":[0.11667508,0.00022110775,0.0027331116,0.0011252596,0.0006151742,0.001433963,0.0011194109,0.0019272795,0.00020873218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12243467,0.001591307,0.58926207,0.0042107515,0.01797976,0.00038192788,0.0013268298,0.03417825,0.004161103,0.0039586728,0.005551332,0.21496336],"study_design_scores_gemma":[0.004932384,0.090956606,0.786425,0.0004316603,0.008933655,0.0016915979,0.00088701205,0.08379325,0.00360767,0.0072848615,0.0108248675,0.00023150933],"about_ca_topic_score_codex":0.00021202299,"about_ca_topic_score_gemma":0.000568074,"teacher_disagreement_score":0.947587,"about_ca_system_score_codex":0.0006300936,"about_ca_system_score_gemma":0.00055781176,"threshold_uncertainty_score":0.27718955},"labels":[],"label_agreement":null},{"id":"W4294308288","doi":"10.1038/s41416-022-01963-8","title":"Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Internal medicine; Adjuvant chemotherapy; Adjuvant; Cancer; Adjuvant therapy; Trastuzumab","score_opus":0.005413167065929589,"score_gpt":0.22794554883141163,"score_spread":0.22253238176548204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294308288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972247,0.0015149849,0.000039754523,0.00006132727,0.000013548864,0.000010914304,0.00070659776,0.0000014789836,0.00042678817],"genre_scores_gemma":[0.9970126,0.00059948897,0.00003297369,0.000070561626,0.0000350227,0.0000216269,0.001852458,0.000003535656,0.00037168246],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991947,0.00030383535,0.00009468333,0.00013878541,0.00010013141,0.00016779285],"domain_scores_gemma":[0.998858,0.00025876547,0.00040167265,0.00009908852,0.0001352019,0.00024742723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007787814,0.00045772502,0.0012055115,0.00070168776,0.00041651516,0.00075461244,0.00043326043,0.00078477175,0.0013954785],"category_scores_gemma":[0.0018045452,0.00042965083,0.0016922728,0.0015777955,0.00033998146,0.00071050174,0.0008136523,0.000864019,0.00026811118],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012332487,0.0002977711,0.9787673,0.00014988171,0.0018598223,0.00033411448,0.00024806382,0.00028541026,0.00086613995,0.00006570085,0.0005379134,0.0042554727],"study_design_scores_gemma":[0.00037441286,0.0008230389,0.99696016,0.00002193088,0.0005999161,0.00026994554,0.00022896306,0.00009057466,0.00006532159,0.000036669146,0.00051384035,0.000015082234],"about_ca_topic_score_codex":0.009189994,"about_ca_topic_score_gemma":0.011920564,"teacher_disagreement_score":0.009189994,"about_ca_system_score_codex":0.00075218285,"about_ca_system_score_gemma":0.00038512863,"threshold_uncertainty_score":0.018272996},"labels":[],"label_agreement":null},{"id":"W4307977544","doi":"10.1038/s41416-022-02026-8","title":"Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; Simon Fraser University","funders":"National Health and Medical Research Council","keywords":"Medicine; Lung cancer screening; Lung cancer; National Lung Screening Trial; Cost effectiveness; Quality-adjusted life year; Cohort; Incremental cost-effectiveness ratio; Cost–benefit analysis; Internal medicine","score_opus":0.058508620106800656,"score_gpt":0.41979913207592556,"score_spread":0.36129051196912493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307977544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92287844,0.010004813,0.046153326,0.0017093802,0.00014967055,0.0021365583,0.006663936,0.0001770297,0.010126942],"genre_scores_gemma":[0.9879952,0.0010271515,0.0077703344,0.00022009174,0.000019601788,0.0005366907,0.001583609,0.000013714839,0.00083363947],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99616015,0.0028220078,0.00021496914,0.0002933548,0.00033799693,0.00017156085],"domain_scores_gemma":[0.9900478,0.0067140437,0.0012744236,0.00045405887,0.0012329511,0.00027671643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011869776,0.0010131656,0.0018038969,0.0013198421,0.0002350074,0.0011369967,0.0014550692,0.0008905869,0.003033656],"category_scores_gemma":[0.032902803,0.0006385457,0.004324719,0.000995792,0.00038255367,0.0015377648,0.0010467123,0.0015271098,0.00017120596],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005002153,0.0003634886,0.01654833,0.0019326516,0.004268109,0.00029056135,0.00014939408,0.9364881,0.00064537785,0.00383209,0.001261902,0.029217836],"study_design_scores_gemma":[0.0031729487,0.004594347,0.05895741,0.0011193079,0.009180921,0.00073738553,0.00011621105,0.9069415,0.0009726298,0.009501591,0.004564362,0.00014143875],"about_ca_topic_score_codex":0.047528863,"about_ca_topic_score_gemma":0.023173703,"teacher_disagreement_score":0.047528863,"about_ca_system_score_codex":0.006779508,"about_ca_system_score_gemma":0.0049223024,"threshold_uncertainty_score":0.094504416},"labels":[],"label_agreement":null},{"id":"W4308057531","doi":"10.1038/s41416-022-02014-y","title":"Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Canada's Michael Smith Genome Sciences Centre; Vancouver General Hospital; University of British Columbia; Foothills Medical Centre; University of Alberta; University of Calgary","funders":"Medical Research and Materiel Command; National Center for Advancing Translational Sciences; European Regional Development Fund; Instituto de Salud Carlos III; Cancer Council Tasmania; National Health and Medical Research Council; Horizon 2020 Framework Programme; National Institutes of Health; Translational Cancer Research Network; University College London; Cancer Institute NSW; National Cancer Institute; Peter MacCallum Foundation; NSW Ministry of Health; American Cancer Society; Cancer Council South Australia; Pomorski Uniwersytet Medyczny W Szczecinie; Ovarian Cancer Research Fund; Ministerio de Economía y Competitividad; Cancer Council Victoria; University of Pittsburgh; University of New South Wales; Cancer Council NSW; Universität Heidelberg; Canadian Institutes of Health Research; Medical Research Council; Department of Health and Social Care; National Institute for Health and Care Research; Michael Smith Health Research BC; Canada Research Chairs; NIHR Cambridge Biomedical Research Centre; University of Cambridge; Fred C. and Katherine B. Andersen Foundation; Cancer Australia; Ovarian Cancer Action; Calgary Laboratory Services; Mayo Foundation for Medical Education and Research; Deutsche Forschungsgemeinschaft; VGH and UBC Hospital Foundation; U.S. Department of Defense; Cancer Research UK; Minnesota Ovarian Cancer Alliance; National Center for Research Resources; BC Cancer Foundation; Oak Foundation; Ovarian Cancer Australia; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Cancer Research Society; European Commission","keywords":"Immunohistochemistry; Serous carcinoma; Serous fluid; Tissue microarray; Ovarian carcinoma; Ovarian cancer; Oncology; Univariate analysis; Survival analysis; Medicine; Pathology; Biology; Multivariate analysis; Internal medicine; Cancer","score_opus":0.009728865835018344,"score_gpt":0.2471646536283157,"score_spread":0.23743578779329735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308057531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995555,0.000094588984,0.000097021686,0.000013200719,0.0000013203331,0.0000048694483,0.00014309231,0.0000030822134,0.00008731532],"genre_scores_gemma":[0.9994968,0.000034976252,0.00007480117,0.0000076231954,0.0000034329285,0.0000047445847,0.0003193829,0.0000020028315,0.000056242276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962234,0.00011560034,0.000032377862,0.00009399343,0.00009508381,0.000040474522],"domain_scores_gemma":[0.99899286,0.00016137298,0.00034535606,0.0001529413,0.00013702904,0.00021043373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001063336,0.00022816313,0.00027138973,0.0007178471,0.0003050274,0.00041501637,0.00022827431,0.00018683974,0.0009133353],"category_scores_gemma":[0.0014455485,0.00014924708,0.00035869045,0.00064917083,0.00029668031,0.0001722073,0.00052504335,0.00020625307,0.00014042735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000458221,0.000023843619,0.99483263,0.000017598328,0.00016053476,0.0001327179,0.00008309624,0.000056361067,0.0026296158,0.000012514073,0.000111979876,0.0014807883],"study_design_scores_gemma":[0.000023567933,0.00008813444,0.99809057,0.000002630262,0.00008953892,0.0005180418,0.000085688895,0.00022287395,0.0006240299,0.000012828274,0.00023895952,0.0000032359073],"about_ca_topic_score_codex":0.0027187995,"about_ca_topic_score_gemma":0.0039564013,"teacher_disagreement_score":0.0027187995,"about_ca_system_score_codex":0.000323217,"about_ca_system_score_gemma":0.0003061126,"threshold_uncertainty_score":0.0056235194},"labels":[],"label_agreement":null},{"id":"W4308260067","doi":"10.1038/s41416-022-02025-9","title":"A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Tolerability; Medicine; Mucositis; Docetaxel; Internal medicine; Response Evaluation Criteria in Solid Tumors; Breast cancer; Triple-negative breast cancer; Oncology; Cancer; Phases of clinical research; Adverse effect; Gastroenterology; Chemotherapy; Surgery","score_opus":0.015299509663367824,"score_gpt":0.32773498653910155,"score_spread":0.3124354768757337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308260067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98203593,0.004018814,0.00102844,0.0014266825,0.00048596607,0.0029753041,0.003109646,0.00026565487,0.0046535544],"genre_scores_gemma":[0.9752609,0.0038232794,0.002626554,0.0018245986,0.00025684774,0.0030702008,0.004847293,0.00007344859,0.008216958],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997167,0.00010056672,0.000009524539,0.000057263325,0.000025293479,0.00009063827],"domain_scores_gemma":[0.9996189,0.000051919757,0.00005245673,0.000030674284,0.00002360994,0.00022249496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010776931,0.0017888322,0.00219851,0.00055013003,0.0004734963,0.0012253649,0.0008783441,0.0016702008,0.008293488],"category_scores_gemma":[0.00064751395,0.0009109661,0.00159928,0.00049275457,0.0011452024,0.0011192712,0.00036330943,0.0043651564,0.0019455493],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7340327,0.0859409,0.002618416,0.0013086337,0.0017210823,0.00032097875,0.00028714837,0.0043274174,0.045456134,0.0008504717,0.012684336,0.11045176],"study_design_scores_gemma":[0.66832876,0.31461486,0.005365787,0.00004648613,0.0003869397,0.0003747331,0.00007883176,0.0014808582,0.002603399,0.00039961404,0.0062687043,0.000050967556],"about_ca_topic_score_codex":0.0016222207,"about_ca_topic_score_gemma":0.0054711374,"teacher_disagreement_score":0.008293488,"about_ca_system_score_codex":0.0012492231,"about_ca_system_score_gemma":0.0015996782,"threshold_uncertainty_score":0.027744472},"labels":[],"label_agreement":null},{"id":"W4308524642","doi":"10.1038/s41416-022-02040-w","title":"Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier de l’Université de Montréal; Université Laval; Centre hospitalier de l'Université Laval; McGill University Health Centre; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec - Santé; Canada Research Chairs; Government of Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Prostate cancer; Biology; Gene; Metabolomics; Glycosyltransferase; Gene expression profiling; Metabolic pathway; Germline; Cancer research; Kynurenine; Cancer; Gene expression; Genetics; Bioinformatics","score_opus":0.014416089131540591,"score_gpt":0.31288699359598343,"score_spread":0.29847090446444285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308524642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946008,0.0013978577,0.0026265082,0.00007561335,0.000015799182,0.000019960764,0.0006946064,0.00011199382,0.00045694286],"genre_scores_gemma":[0.9964042,0.0009609484,0.0012580996,0.000039410475,0.0000042323286,0.000021151838,0.0007258951,0.00003832979,0.0005477139],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998253,0.000031034073,0.000012897741,0.00004698499,0.00005351882,0.000030382116],"domain_scores_gemma":[0.9998671,0.000021618029,0.00004947345,0.000020208221,0.000009281594,0.000032341188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014868003,0.00036534842,0.00028898753,0.00032235842,0.00013413743,0.00025631048,0.00015310709,0.00026719327,0.001365392],"category_scores_gemma":[0.0001629353,0.00014515787,0.0002850819,0.00033498427,0.00031871433,0.000119080236,0.00030235242,0.0004326158,0.00022115688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038043244,0.000028372164,0.0012637993,0.000058448994,0.000037406746,0.00020874158,0.000014103372,0.00023749763,0.99471104,0.0001075383,0.0000612944,0.0028913512],"study_design_scores_gemma":[0.000034967434,0.0013075221,0.031503417,0.0000147191495,0.00019191782,0.0041334303,0.00008040006,0.0013221451,0.9572307,0.00023759562,0.0039277826,0.000015403735],"about_ca_topic_score_codex":0.00064625376,"about_ca_topic_score_gemma":0.0008709183,"teacher_disagreement_score":0.001365392,"about_ca_system_score_codex":0.00023557834,"about_ca_system_score_gemma":0.00025047842,"threshold_uncertainty_score":0.0045676827},"labels":[],"label_agreement":null},{"id":"W4310962312","doi":"10.1038/s41416-022-02022-y","title":"Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency","funders":"EMD Serono; Genentech; Foundation Medicine; Sierra Oncology; PharmaMar; Newcastle University; MacroGenics; Relay Therapeutics; NGM Biopharmaceuticals; Loxo Oncology; Ribon Therapeutics; Mersana Therapeutics; Eisai; Adaptive Biotechnologies; Pharmacyclics; Agios Pharmaceuticals; Syndax Pharmaceuticals; BeiGene; Mirati Therapeutics; Clovis Oncology; Daiichi Sankyo Europe; Gilead Sciences; Calithera Biosciences; TG Therapeutics; Moderna; NuCana; Pfizer; HCA Healthcare; Incyte; Taiho Pharmaceutical; Merck KGaA; Array BioPharma; Revolution Medicines; Exelixis; GlaxoSmithKline; Verastem Oncology; Jounce Therapeutics; Celgene; AstraZeneca; Ignyta; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Ovarian cancer; BRCA mutation; Adverse effect; Oncology; Cancer; Progressive disease; Disease","score_opus":0.018940959345750533,"score_gpt":0.2929071395730326,"score_spread":0.2739661802272821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310962312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967665,0.0055587045,0.00023373278,0.00025975445,0.00006125522,0.00028959502,0.001805397,0.00004015691,0.0020747606],"genre_scores_gemma":[0.9929577,0.0018212271,0.00033056596,0.00032277912,0.00008461427,0.00018687881,0.0029331022,0.000024789397,0.0013382529],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999257,0.00040077986,0.00004550303,0.00009937819,0.00008781819,0.00010953087],"domain_scores_gemma":[0.9989428,0.00038663493,0.00022342682,0.00015931377,0.000087963715,0.00019987971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017703655,0.0006348372,0.0022005423,0.00029923924,0.00030423395,0.0008836489,0.00054689957,0.00087053084,0.0024183884],"category_scores_gemma":[0.0017071366,0.00034064427,0.0022518977,0.00044464777,0.0005131921,0.00051064644,0.0002362626,0.0021021303,0.0006615108],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77972466,0.009802197,0.04224553,0.0011023476,0.008748593,0.0003357741,0.00030702216,0.0020766258,0.018124882,0.00016387936,0.0030591257,0.13430929],"study_design_scores_gemma":[0.2920294,0.4577973,0.21935652,0.00019508338,0.009895752,0.0011009522,0.00020595659,0.0015605176,0.0068868464,0.00030619677,0.010555087,0.00011030761],"about_ca_topic_score_codex":0.0013955042,"about_ca_topic_score_gemma":0.0026849448,"teacher_disagreement_score":0.0024183884,"about_ca_system_score_codex":0.00072161196,"about_ca_system_score_gemma":0.0007201555,"threshold_uncertainty_score":0.009362698},"labels":[],"label_agreement":null},{"id":"W4312091642","doi":"10.1038/s41416-022-02123-8","title":"Synthetic miR-34a against solid tumours: a predictable failure","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Fondation ARC pour la Recherche sur le Cancer","keywords":"microRNA; Suppressor; Bioinformatics; Clinical trial; Medicine; Computational biology; Biology; Cancer research; Cancer; Internal medicine; Genetics; Gene","score_opus":0.015193418699762835,"score_gpt":0.29842661459529934,"score_spread":0.2832331958955365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312091642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012825778,0.99174434,0.001261482,0.0013892462,0.00082357926,0.000021147674,0.000082722385,0.00006461722,0.00333032],"genre_scores_gemma":[0.013931532,0.97745585,0.0014579194,0.0019133228,0.0005136896,0.0000756006,0.00016982305,0.000028596922,0.004453605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997534,0.00004849762,0.000031248277,0.00005575386,0.00007928764,0.000031909818],"domain_scores_gemma":[0.99958473,0.00023531145,0.00003713983,0.000020314803,0.00008695215,0.00003543637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012048732,0.0011287949,0.0018274827,0.0008136879,0.0002395763,0.001176055,0.0007271614,0.0014154615,0.0031621049],"category_scores_gemma":[0.0010049399,0.00044045842,0.00046110933,0.0007112727,0.00097315194,0.0010285161,0.00066820957,0.0034324834,0.0023427121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055046525,0.00013515445,0.0001678784,0.004550753,0.00015809567,0.00023326953,0.000060292536,0.0008017567,0.012783117,0.012059865,0.03309078,0.93540865],"study_design_scores_gemma":[0.00032752074,0.00060244504,0.0010820669,0.0011578074,0.00018738091,0.0011101216,0.000047308145,0.00037207865,0.010552,0.0063321153,0.97818303,0.000046234956],"about_ca_topic_score_codex":0.000738821,"about_ca_topic_score_gemma":0.0014684077,"teacher_disagreement_score":0.0031621049,"about_ca_system_score_codex":0.00079906295,"about_ca_system_score_gemma":0.00083970674,"threshold_uncertainty_score":0.010578334},"labels":[],"label_agreement":null},{"id":"W4312110018","doi":"10.1038/s41416-022-02109-6","title":"Cell proliferation, drug distribution and therapeutic effects in relation to the vascular system of solid tumours","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Cancer cell; Necrosis; Doxorubicin; Chemotherapy; Programmed cell death; Cell; Cell growth; Biology; Autophagy; Pathology; Cancer; Medicine; Apoptosis; Internal medicine; Biochemistry","score_opus":0.00855830196501309,"score_gpt":0.26733162080179573,"score_spread":0.2587733188367826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312110018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055112247,0.9994141,0.00004959073,0.0000958445,0.00009747163,0.0000013625161,0.000011662651,0.0000027598198,0.00027208682],"genre_scores_gemma":[0.00043306107,0.99887294,0.00008495135,0.0000708346,0.00014710116,0.0000034927912,0.000020387295,0.000001054551,0.00036616254],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99978167,0.000036551464,0.0000300813,0.000042875497,0.000084277526,0.000024646182],"domain_scores_gemma":[0.9996326,0.00018526829,0.000056358545,0.000011183799,0.00008381365,0.000030823412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007042365,0.0012317237,0.0027462414,0.0027097412,0.00031315786,0.0014626775,0.0010931288,0.0014339089,0.0034016215],"category_scores_gemma":[0.0007721937,0.00052572263,0.00046909833,0.0042309645,0.0009210795,0.0012773429,0.00072243734,0.0022148886,0.002052497],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024292762,0.000079717756,0.00020328241,0.016410828,0.00010169895,0.00022131641,0.000053067484,0.00067443994,0.0027918632,0.004167528,0.034039512,0.9410139],"study_design_scores_gemma":[0.00004259672,0.00016687615,0.0017295938,0.0022906873,0.00018807412,0.0013812353,0.000057840887,0.00016070806,0.00091364974,0.0029995271,0.9900344,0.00003475009],"about_ca_topic_score_codex":0.0022396648,"about_ca_topic_score_gemma":0.0043227524,"teacher_disagreement_score":0.0034016215,"about_ca_system_score_codex":0.0012294996,"about_ca_system_score_gemma":0.0009891909,"threshold_uncertainty_score":0.01137948},"labels":[],"label_agreement":null},{"id":"W4315798461","doi":"10.1038/s41416-022-02130-9","title":"Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment","year":2023,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; Women's College Hospital","funders":"","keywords":"Breast cancer; Oncology; Medicine; BRCA2 Protein; Mutation; Cancer; Internal medicine; Bioinformatics; Gynecology; Biology; Genetics; Germline mutation; Gene","score_opus":0.005261641868805272,"score_gpt":0.2533590535479434,"score_spread":0.24809741167913815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315798461","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011430538,0.0008087035,0.00017973725,0.042579517,0.9531048,0.000018367446,0.0015523686,0.0001012061,0.0015410109],"genre_scores_gemma":[0.014887556,0.0078912,0.0029994533,0.110187836,0.6463716,0.0003290009,0.004705656,0.0010580216,0.21156967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974667,0.00047803568,0.0004826233,0.00036331225,0.0008398882,0.00036953067],"domain_scores_gemma":[0.9815896,0.006462305,0.0008382191,0.000995088,0.00826664,0.0018482099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033406073,0.0025417893,0.002575733,0.002983216,0.0018703662,0.0030039772,0.0035493542,0.0073696575,0.060236555],"category_scores_gemma":[0.04023633,0.0011694083,0.0019777261,0.002054153,0.0014330066,0.001376724,0.0011099597,0.010957707,0.025337752],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005988834,0.0000045858137,0.00008659251,0.000104813626,0.000014629888,0.00018758124,0.000007933904,0.00003183265,0.000015079672,0.00018200533,0.9971474,0.0021577247],"study_design_scores_gemma":[0.00031228331,0.000045407345,0.0034873541,0.00082329416,0.00014331992,0.0014436075,0.000100845566,0.00044050513,0.00028432335,0.0015021625,0.99134713,0.00006991233],"about_ca_topic_score_codex":0.030866267,"about_ca_topic_score_gemma":0.03636872,"teacher_disagreement_score":0.060236555,"about_ca_system_score_codex":0.0038688895,"about_ca_system_score_gemma":0.0047714463,"threshold_uncertainty_score":0.20151138},"labels":[],"label_agreement":null},{"id":"W4316881885","doi":"10.1038/s41416-022-02116-7","title":"Thinking inside the box: intracellular roles for complement system proteins come into focus","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Academy of Medical Sciences; Cancer Research UK; Medical Research Council; Irish Cancer Society; Health Research Board","keywords":"Complement system; Anaphylatoxin; C3-convertase; Cell biology; Complement membrane attack complex; Intracellular; Extracellular; Biology; Mediator; Chemistry; Immunology; Alternative complement pathway; Antibody","score_opus":0.0184290485034194,"score_gpt":0.2804550445930981,"score_spread":0.2620259960896787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316881885","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001297265,0.30245194,0.002560315,0.6407357,0.04781786,0.000010710298,0.00013268262,0.000097484306,0.0048961],"genre_scores_gemma":[0.029417632,0.4760227,0.005559582,0.33766136,0.1378422,0.00003874394,0.0001626128,0.00016159558,0.013133601],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980387,0.0005558103,0.00010281967,0.0003689916,0.0007293044,0.00020435323],"domain_scores_gemma":[0.99356836,0.0029144208,0.00036983757,0.00026303204,0.0014643006,0.001420038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004629799,0.0007430193,0.0013859979,0.0009804076,0.0017225761,0.0042988085,0.0016981749,0.0088476855,0.0132072205],"category_scores_gemma":[0.005077647,0.00027656578,0.00078669307,0.0008055296,0.0072969003,0.0122663,0.002803228,0.017904343,0.003788156],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000402638,0.00009043688,0.0010421703,0.0018093536,0.00009252662,0.00061936805,0.0009010076,0.0002563482,0.0061674104,0.09045209,0.7226946,0.17547208],"study_design_scores_gemma":[0.000035791672,0.00011610998,0.0006244212,0.0009532043,0.00003686431,0.00074258575,0.0011960143,0.00014774271,0.0010328868,0.091199316,0.90387255,0.000042500702],"about_ca_topic_score_codex":0.00114893,"about_ca_topic_score_gemma":0.0020631107,"teacher_disagreement_score":0.0132072205,"about_ca_system_score_codex":0.0018084061,"about_ca_system_score_gemma":0.0028446245,"threshold_uncertainty_score":0.0441826},"labels":[],"label_agreement":null},{"id":"W4317718278","doi":"10.1038/s41416-023-02141-0","title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"Manchester Biomedical Research Centre; Leids Universitair Medisch Centrum; Universiteit Leiden; KWF Kankerbestrijding; National Institute for Health and Care Research","keywords":"Immunohistochemistry; Oestrogen receptor; Endometrial cancer; Medicine; Oncology; Internal medicine; Pathology; Biology; Breast cancer; Cancer","score_opus":0.023853030225662156,"score_gpt":0.31905856328287124,"score_spread":0.2952055330572091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317718278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667394,0.001893343,0.0007518945,0.00003013297,0.000006892872,0.00002196776,0.00026784657,0.000008185707,0.00034576035],"genre_scores_gemma":[0.9988525,0.00026971943,0.00043706055,0.0000075872194,0.000010649781,0.0000089496625,0.0003387967,0.0000026517998,0.00007214181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995314,0.00019669598,0.00006512254,0.000066391636,0.000100197634,0.000040109968],"domain_scores_gemma":[0.99843234,0.00070997584,0.00040039985,0.00019557936,0.00016442819,0.00009729438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002161854,0.00024132755,0.00033909566,0.00063505775,0.00012155324,0.00041488287,0.00025837345,0.00018243513,0.0011160611],"category_scores_gemma":[0.0034803303,0.000111137066,0.00035314474,0.0005510093,0.00017354579,0.000272124,0.00041294098,0.00023573,0.00018378929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094840134,0.000011315043,0.9810626,0.00006334589,0.00009817222,0.00013977072,0.000032339543,0.00022277817,0.0017619097,0.000018110519,0.00010158698,0.0155396],"study_design_scores_gemma":[0.0000318064,0.0001879215,0.9953746,0.000024690966,0.00018359456,0.0012207713,0.00004270059,0.001059511,0.0012514213,0.00009001124,0.00052841933,0.000004548947],"about_ca_topic_score_codex":0.00042413516,"about_ca_topic_score_gemma":0.00080793264,"teacher_disagreement_score":0.002161854,"about_ca_system_score_codex":0.00016293715,"about_ca_system_score_gemma":0.00017695525,"threshold_uncertainty_score":0.011433125},"labels":[],"label_agreement":null},{"id":"W4318041801","doi":"10.1038/s41416-023-02161-w","title":"Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer","year":2023,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine","score_opus":0.03128342957775556,"score_gpt":0.39316411581247945,"score_spread":0.3618806862347239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318041801","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009756519,0.0012068687,0.00046082708,0.055211492,0.939599,0.000046101173,0.0010806638,0.00024286858,0.0020546606],"genre_scores_gemma":[0.0068121445,0.009565402,0.0043266737,0.2058491,0.58962023,0.00034681504,0.0023340252,0.0012487074,0.17989689],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99556834,0.0008030361,0.00070266146,0.00047655107,0.0020458486,0.00040358232],"domain_scores_gemma":[0.9766337,0.007114321,0.0018562655,0.0009479674,0.011681391,0.0017663101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005140177,0.00221067,0.0027062497,0.0031357612,0.0022233191,0.0036345876,0.0035035317,0.00885258,0.05085322],"category_scores_gemma":[0.046278156,0.0014578459,0.0025541598,0.0016974484,0.002051373,0.0016834659,0.0013116035,0.013217859,0.03042385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006472442,0.0000066975913,0.000025561838,0.00010755975,0.00001316683,0.00013991799,0.0000066529465,0.000028046223,0.000030965744,0.000166059,0.9960259,0.0033846986],"study_design_scores_gemma":[0.0002576582,0.000047403904,0.00050972507,0.0003873825,0.00008150562,0.00055245974,0.000027377406,0.00029365777,0.00024887355,0.0008003755,0.9967602,0.000033468215],"about_ca_topic_score_codex":0.01733749,"about_ca_topic_score_gemma":0.02656156,"teacher_disagreement_score":0.05085322,"about_ca_system_score_codex":0.005196356,"about_ca_system_score_gemma":0.0061320825,"threshold_uncertainty_score":0.17012095},"labels":[],"label_agreement":null},{"id":"W4318253712","doi":"10.1038/s41416-023-02154-9","title":"Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Medical Research Council; Newcastle University; Cancer Research UK; Pathological Society of Great Britain and Ireland; JGW Patterson Foundation; National Health and Medical Research Council; Johns Hopkins University; George Washington University","keywords":"Biology; Cancer research; Gene knockdown; Hedgehog signaling pathway; Immunohistochemistry; Downregulation and upregulation; Hepatocellular carcinoma; In vivo; Signal transduction; Gene; Genetics; Immunology","score_opus":0.016043906315493135,"score_gpt":0.231639922575584,"score_spread":0.21559601626009087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318253712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663854,0.0015878282,0.00056065986,0.00006923621,0.000008648137,0.000009877283,0.00054721825,0.000045575325,0.0005323485],"genre_scores_gemma":[0.99852556,0.00037505332,0.0002500496,0.000026857215,0.0000031855504,0.000011769191,0.00047973712,0.000009265545,0.0003185818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979776,0.000034048175,0.000014108248,0.000054445733,0.000056392644,0.000043346285],"domain_scores_gemma":[0.99967,0.00009905707,0.00011758641,0.000030373747,0.000027680864,0.00005524198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002828265,0.00022619357,0.00022944501,0.00029662857,0.00014000712,0.0004352692,0.000118653144,0.00020638233,0.0016602396],"category_scores_gemma":[0.00034165056,0.000090189096,0.000205963,0.00023718935,0.00031787468,0.00018077006,0.00021145244,0.00034940962,0.00032955082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012603101,0.000043249343,0.013044135,0.0002026371,0.000033564782,0.00021684231,0.00004960184,0.00025553533,0.9780397,0.0000719579,0.00011959638,0.0066628475],"study_design_scores_gemma":[0.000045632583,0.0013905544,0.19004828,0.00003757706,0.00018775671,0.0019525314,0.0002361618,0.0021159155,0.79946065,0.00017470401,0.0043316036,0.00001863783],"about_ca_topic_score_codex":0.0003647533,"about_ca_topic_score_gemma":0.00044927088,"teacher_disagreement_score":0.0016602396,"about_ca_system_score_codex":0.00030214296,"about_ca_system_score_gemma":0.00016795403,"threshold_uncertainty_score":0.0055540204},"labels":[],"label_agreement":null},{"id":"W4319915926","doi":"10.1038/s41416-023-02174-5","title":"Tumour-educated platelets for breast cancer detection: biological and technical insights","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Center for Translational Molecular Medicine; KWF Kankerbestrijding; Centre for Transportation Engineering and Planning","keywords":"Breast cancer; Platelet; Medicine; Cancer; Oncology; Pathology; Biology; Cancer research; Internal medicine","score_opus":0.021379074131127104,"score_gpt":0.30838560488878836,"score_spread":0.28700653075766125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319915926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428286,0.009731607,0.043620482,0.0013609922,0.00012069198,0.00018854204,0.00038495965,0.00012735244,0.0016366505],"genre_scores_gemma":[0.9695441,0.0019640643,0.027177261,0.00019018645,0.00010222081,0.00009681986,0.00041946856,0.000019806053,0.00048611805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981844,0.0008518553,0.00015519564,0.00024138199,0.00047595412,0.000091196795],"domain_scores_gemma":[0.99598324,0.0021494224,0.000841455,0.00032104156,0.0006047038,0.00010014071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044920403,0.00036320466,0.00040055971,0.00075811206,0.00019660941,0.0014152392,0.00042443423,0.0006079299,0.0007607674],"category_scores_gemma":[0.009450634,0.00024875108,0.00025435397,0.00068820297,0.00047547728,0.0004365809,0.00038507592,0.0006902408,0.0003288334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002291606,0.00023319584,0.625465,0.0007741272,0.0002652863,0.00064833666,0.00038878448,0.005868038,0.11306914,0.000879194,0.0014141067,0.2487032],"study_design_scores_gemma":[0.00014487511,0.0038242033,0.6478321,0.00044233844,0.00080317596,0.00761349,0.0006312792,0.09741694,0.22374202,0.0048008906,0.012648681,0.00010009761],"about_ca_topic_score_codex":0.00042450224,"about_ca_topic_score_gemma":0.00050455035,"teacher_disagreement_score":0.0044920403,"about_ca_system_score_codex":0.0003250061,"about_ca_system_score_gemma":0.0003535707,"threshold_uncertainty_score":0.023756504},"labels":[],"label_agreement":null},{"id":"W4319930498","doi":"10.1038/s41416-023-02167-4","title":"Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges","year":2023,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Partenariat Canadien Contre Le Cancer; National Health and Medical Research Council; Servier; National Institutes of Health; Cancer Australia; Garnett Passe and Rodney Williams Memorial Foundation; Royal Brisbane and Women's Hospital Foundation; Medical Research Council; Cancer Research Institute","keywords":"Head and neck cancer; Cancer; Head and neck; Medicine; Disease; Precision medicine; In vivo; Tumour heterogeneity; Oncology; Bioinformatics; Pathology; Internal medicine; Biology; Surgery; Genetics","score_opus":0.17303086899871398,"score_gpt":0.38569863340021987,"score_spread":0.2126677644015059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319930498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017005646,0.99815863,0.0001494875,0.00025814594,0.00016106933,0.000008611456,0.00002967069,0.0000067369047,0.0010575956],"genre_scores_gemma":[0.00092118105,0.99776185,0.00020609709,0.00017091556,0.000066295914,0.000013406295,0.00006359141,0.0000025281206,0.000794146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996774,0.00007291488,0.00004145078,0.000046035326,0.00012955748,0.000032626875],"domain_scores_gemma":[0.999382,0.00030242995,0.000050466944,0.00002334288,0.00019318596,0.00004842032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012932929,0.00058902573,0.001591654,0.0015952111,0.0003015366,0.0014458384,0.0011084006,0.0012092988,0.0040097698],"category_scores_gemma":[0.0010629051,0.00037191992,0.0006026964,0.0014310279,0.0005465322,0.0014372373,0.00079655496,0.002083405,0.0027674893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010995601,0.000089759575,0.00015964548,0.020171596,0.000059835205,0.0002595024,0.000116977375,0.00040229136,0.003687179,0.005523608,0.027333988,0.94208556],"study_design_scores_gemma":[0.000014470033,0.000112102076,0.00040131173,0.0029221284,0.000052463573,0.0008194304,0.000087689106,0.000060483297,0.0011035262,0.001176933,0.99323297,0.000016578177],"about_ca_topic_score_codex":0.0015134261,"about_ca_topic_score_gemma":0.0030268277,"teacher_disagreement_score":0.0040097698,"about_ca_system_score_codex":0.0007268476,"about_ca_system_score_gemma":0.0011315084,"threshold_uncertainty_score":0.013414085},"labels":[],"label_agreement":null},{"id":"W4321766116","doi":"10.1038/s41416-023-02201-5","title":"Alternative methods to measure breast density in younger women","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Cancer Australia; National Breast Cancer Foundation; Australian Government","keywords":"Measure (data warehouse); Medicine; Breast cancer; Internal medicine; Computer science; Cancer; Data mining","score_opus":0.02053188281437466,"score_gpt":0.3424959251825704,"score_spread":0.3219640423681957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321766116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621156,0.0058944277,0.021260837,0.00051612,0.000100489575,0.00035093346,0.0019185101,0.0001261475,0.007716904],"genre_scores_gemma":[0.96719235,0.0021337343,0.027327422,0.0002725294,0.00008654919,0.0005121264,0.0007182837,0.000019051464,0.0017378605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99613994,0.00207401,0.0002985011,0.00028044207,0.0010957209,0.00011131548],"domain_scores_gemma":[0.9912704,0.0035723152,0.0029425807,0.0004878147,0.0015352216,0.00019152551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050877384,0.0005110954,0.00036930805,0.0016760844,0.00017038565,0.00050293654,0.0004834627,0.00058089726,0.0027130325],"category_scores_gemma":[0.010617305,0.00021948201,0.0005235663,0.00095813023,0.00027103134,0.0004458933,0.00084895396,0.00037405177,0.000590758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073423435,0.00015551562,0.8696633,0.0004704243,0.00023164625,0.00012882656,0.0015907199,0.00048931595,0.005436561,0.0003559557,0.0011014292,0.119642034],"study_design_scores_gemma":[0.00006871706,0.0014010429,0.9828493,0.00027714405,0.00013880037,0.0015576245,0.001562106,0.0021757123,0.0035602192,0.0006513199,0.0057038306,0.000054071832],"about_ca_topic_score_codex":0.0019305915,"about_ca_topic_score_gemma":0.0040340256,"teacher_disagreement_score":0.0050877384,"about_ca_system_score_codex":0.0002565195,"about_ca_system_score_gemma":0.00019150999,"threshold_uncertainty_score":0.026906848},"labels":[],"label_agreement":null},{"id":"W4322733329","doi":"10.1038/s41416-023-02166-5","title":"The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Thrombus; Nephrectomy; Systemic therapy; Urology; Internal medicine; Progression-free survival; Oncology; Surgery; Gastroenterology; Cancer; Overall survival; Kidney","score_opus":0.010381064924269066,"score_gpt":0.24133690922868262,"score_spread":0.23095584430441354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322733329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97676045,0.020673357,0.00041976554,0.0006957048,0.000030636445,0.000018397117,0.00011096807,0.0000116204565,0.001279176],"genre_scores_gemma":[0.9967744,0.0023711065,0.00040281113,0.000081431266,0.00008735566,0.000008414899,0.00018843108,0.0000024138676,0.000083681676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997551,0.00009305144,0.000025276871,0.000037070888,0.00006847247,0.000021026184],"domain_scores_gemma":[0.9985335,0.00074908073,0.00042861092,0.000032731827,0.00007826814,0.00017776046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009658631,0.0001224808,0.0003766361,0.00022875083,0.00014530729,0.00038032822,0.0001701029,0.00021759568,0.0006615663],"category_scores_gemma":[0.0028561673,0.00004463972,0.00024560027,0.00028023234,0.00020915791,0.00027607472,0.00018865224,0.00034977475,0.00008009114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024167623,0.00016756715,0.8118645,0.00024704714,0.00019471155,0.00052489113,0.00011661472,0.0012007585,0.002195424,0.00012287204,0.0008463843,0.18010251],"study_design_scores_gemma":[0.00029810634,0.0037757412,0.98069364,0.00015868843,0.00036410431,0.0055962224,0.00018092048,0.0033774797,0.0016249076,0.00032155885,0.003592863,0.000015869002],"about_ca_topic_score_codex":0.0006438445,"about_ca_topic_score_gemma":0.0015172131,"teacher_disagreement_score":0.0009658631,"about_ca_system_score_codex":0.0003813806,"about_ca_system_score_gemma":0.0004593059,"threshold_uncertainty_score":0.0051080585},"labels":[],"label_agreement":null},{"id":"W4327549845","doi":"10.1038/s41416-023-02214-0","title":"Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Health Sciences Centre; Ontario Institute for Cancer Research; Public Health Ontario; Western University; McGill University Health Centre; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Dalhousie University; University Health Network","funders":"Canadian Cancer Society Research Institute; Hebrew University of Jerusalem; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Medicine; Internal medicine; Adenocarcinoma; Oncology; Neutrophil to lymphocyte ratio; Pancreatic cancer; CD8; Gastroenterology; Immune system; Lymphocyte; Cancer; Immunology","score_opus":0.011382360203243397,"score_gpt":0.27653842993922073,"score_spread":0.26515606973597733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327549845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849945,0.009543643,0.00025512165,0.0005084128,0.000106628984,0.000010683973,0.0007359839,0.000014618644,0.0038304303],"genre_scores_gemma":[0.99667114,0.0014405794,0.00025815386,0.000059712977,0.00010391717,0.000009526981,0.0008017008,0.0000038704065,0.00065140467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967206,0.00009797999,0.000058345107,0.00003181081,0.00007337677,0.000066390414],"domain_scores_gemma":[0.9992299,0.00018608363,0.00022218343,0.000030797983,0.00015324554,0.00017769996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006257283,0.00027429016,0.0005459561,0.0010399806,0.0002746709,0.0007366848,0.00016050709,0.00037852276,0.0020318194],"category_scores_gemma":[0.0023880089,0.00015919188,0.0003410755,0.0018366185,0.00020224646,0.00042195705,0.0006386872,0.00061029824,0.00035957585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015032876,0.000036808113,0.9787764,0.0000791169,0.00008892323,0.00029025663,0.000058189562,0.00021625613,0.0004926618,0.00006118452,0.0007469579,0.01765001],"study_design_scores_gemma":[0.00004866777,0.00025181167,0.99505496,0.00006534677,0.0001342706,0.00089332426,0.0001778888,0.0006239368,0.00022621793,0.00024613048,0.0022642515,0.000013198542],"about_ca_topic_score_codex":0.0016661016,"about_ca_topic_score_gemma":0.0033492185,"teacher_disagreement_score":0.0020318194,"about_ca_system_score_codex":0.0003277689,"about_ca_system_score_gemma":0.00030889298,"threshold_uncertainty_score":0.006797135},"labels":[],"label_agreement":null},{"id":"W4328049371","doi":"10.1038/s41416-023-02226-w","title":"Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Pfizer Canada; Université de Montréal; Pfizer","keywords":"Carboplatin; Triple-negative breast cancer; Cancer research; Micrometastasis; Medicine; Metastasis; PARP inhibitor; Breast cancer; Oncology; Cancer; Internal medicine; Chemotherapy; Biology; Poly ADP ribose polymerase; Cisplatin","score_opus":0.015518409706924417,"score_gpt":0.29165390653839224,"score_spread":0.2761354968314678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328049371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958717,0.0021896088,0.00058980315,0.000047049354,0.000020242045,0.000042526186,0.00011430317,0.000048204343,0.0010764705],"genre_scores_gemma":[0.99741566,0.00082323636,0.00064577535,0.000021833715,0.0000066654898,0.000028227834,0.00019815724,0.0000068384234,0.00085360423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989724,0.000013428709,0.000008078434,0.000020321117,0.000029667546,0.00003124425],"domain_scores_gemma":[0.9999404,0.000008565704,0.000011053082,0.000006866241,0.0000071123195,0.000025885312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011329433,0.00028469568,0.0003982723,0.00021931906,0.00012083731,0.0002943405,0.00018716887,0.00015824613,0.0012955416],"category_scores_gemma":[0.000103841136,0.00013187237,0.00021710845,0.00015256148,0.000117462216,0.00012105989,0.00016293795,0.0004798291,0.00021727143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010688836,0.00044764124,0.0012483556,0.00010824517,0.000037959344,0.00009682919,0.000016502137,0.00041811093,0.9850894,0.000043304197,0.00023370412,0.011191127],"study_design_scores_gemma":[0.00030066443,0.010805514,0.02053922,0.000016237742,0.00012996249,0.0011462752,0.000044846936,0.002968769,0.9606469,0.000040670755,0.003352488,0.000008478644],"about_ca_topic_score_codex":0.0017672015,"about_ca_topic_score_gemma":0.0043998207,"teacher_disagreement_score":0.0017672015,"about_ca_system_score_codex":0.00036399203,"about_ca_system_score_gemma":0.00026457364,"threshold_uncertainty_score":0.004333973},"labels":[],"label_agreement":null},{"id":"W4360608486","doi":"10.1038/s41416-023-02222-0","title":"Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Daiichi Sankyo Europe; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Collier Charitable Fund","keywords":"Biology; Transcriptome; Cell cycle; Drug discovery; Cancer research; Computational biology; Genomics; Exome; DNA repair; Genetics; Exome sequencing; Cell; Gene; Bioinformatics; Mutation; Genome; Gene expression","score_opus":0.023454103193158313,"score_gpt":0.27874714000716455,"score_spread":0.2552930368140062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360608486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97503585,0.0070269885,0.005665981,0.001092198,0.000033105964,0.000020162584,0.0069743954,0.0000933441,0.0040578977],"genre_scores_gemma":[0.9872372,0.002157803,0.0022815787,0.0003570065,0.000019320305,0.000014976148,0.0053852373,0.000034878252,0.002512014],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988353,0.0000119192155,0.0000044899057,0.00003904763,0.000038138147,0.000022757282],"domain_scores_gemma":[0.9998851,0.000038135182,0.000022157335,0.00001069208,0.000030133571,0.000013702061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013209954,0.0001382554,0.00022319173,0.00035404883,0.0002157679,0.00042263255,0.00010762436,0.00027625982,0.001407516],"category_scores_gemma":[0.00027510227,0.00011520615,0.00023380834,0.00045345927,0.0001813095,0.00018716513,0.0001697764,0.0002982333,0.0003058069],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021693106,0.00001972453,0.011819019,0.00016439406,0.000042361935,0.00022951544,0.00013911432,0.0007438648,0.9724602,0.0010760662,0.00068276306,0.012406063],"study_design_scores_gemma":[0.000030171177,0.00026531258,0.70682365,0.000075601754,0.00016900167,0.0026961213,0.0006954231,0.0060970075,0.24270156,0.003932672,0.03646399,0.00004948094],"about_ca_topic_score_codex":0.0026684464,"about_ca_topic_score_gemma":0.0034208603,"teacher_disagreement_score":0.0026684464,"about_ca_system_score_codex":0.00031943803,"about_ca_system_score_gemma":0.00034704874,"threshold_uncertainty_score":0.0053058267},"labels":[],"label_agreement":null},{"id":"W4362735313","doi":"10.1038/s41416-023-02236-8","title":"A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Queen's University; McGill University Health Centre; Dartmouth General Hospital","funders":"Fonds de Recherche du Québec - Santé; Prostate Cancer Canada; McGill University Health Centre; Movember Foundation; McGill University","keywords":"Prostatectomy; Biochemical recurrence; Prostate cancer; Oncology; Medicine; Hazard ratio; Internal medicine; Multiplex ligation-dependent probe amplification; Proportional hazards model; Pathology; Cancer; Biology; Gene","score_opus":0.01697119278800655,"score_gpt":0.3237219752878316,"score_spread":0.306750782499825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362735313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990917,0.001614344,0.0020138773,0.0008569984,0.00017485191,0.000033357963,0.0020058826,0.00013667755,0.0022470509],"genre_scores_gemma":[0.9949032,0.000298698,0.0021349539,0.00009265082,0.00014321931,0.000015043697,0.0015151482,0.000014634485,0.0008823621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995173,0.00010351283,0.00005193419,0.00012106124,0.00013947503,0.00006659267],"domain_scores_gemma":[0.99775416,0.001186907,0.00037414007,0.00011241717,0.00032287976,0.00024936465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009579623,0.00039432463,0.0006539676,0.002151887,0.0003738621,0.0011709409,0.0004222508,0.00090994895,0.0035018492],"category_scores_gemma":[0.004995985,0.00021253689,0.0004376115,0.0010635691,0.00020184537,0.00066403614,0.00044625328,0.00072544004,0.0008824982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020189683,0.00017174179,0.92156583,0.00006173578,0.00020212078,0.00023607451,0.000056344063,0.0021765684,0.004106245,0.0001698815,0.00266866,0.066565834],"study_design_scores_gemma":[0.00014975863,0.001261262,0.906719,0.00009620011,0.0006236856,0.0028362474,0.00021630003,0.07559647,0.0054036756,0.0019861162,0.005043523,0.00006771337],"about_ca_topic_score_codex":0.0012941707,"about_ca_topic_score_gemma":0.0019293103,"teacher_disagreement_score":0.0035018492,"about_ca_system_score_codex":0.00028991696,"about_ca_system_score_gemma":0.00033008098,"threshold_uncertainty_score":0.011714876},"labels":[],"label_agreement":null},{"id":"W4366448631","doi":"10.1038/s41416-023-02263-5","title":"Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Centre hospitalier universitaire de Québec; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Juravinski Hospital; McMaster University; University of Toronto","funders":"Medical Research and Materiel Command; European Social Fund; National Center for Advancing Translational Sciences; European Regional Development Fund; Instituto de Salud Carlos III; Cancer Council Tasmania; Cancer Council NSW; Cancer Council Victoria; Medical Research Council; Canadian Institutes of Health Research; Cancer Center, University of Kansas; National Institutes of Health; Government of Canada; Centre Léon Bérard; NIH Office of the Director; Maastricht Universitair Medisch Centrum; Universiteit Leiden; Institut Claudius Regaud; Deutsches Krebsforschungszentrum; Unicancer; Freistaat Sachsen; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Hospices Civils de Lyon; Cancer Council South Australia; Institut Bergonié; Deutsche Krebshilfe; National Institute of General Medical Sciences; Leids Universitair Medisch Centrum; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Institut Gustave-Roussy; Erasmus Medisch Centrum; Radboud Universitair Medisch Centrum; Generalitat de Catalunya; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Universiteit Maastricht; Fundación Mutua Madrileña; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Radboud Universiteit; National Cancer Institute; Peter MacCallum Foundation; Institut National de la Santé et de la Recherche Médicale; Cancer Research UK; Fondation du cancer du sein du Québec; Gray Foundation; Royal Marsden NHS Foundation Trust; Centres de Recerca de Catalunya; Ovarian Cancer Australia; Associazione Italiana per la Ricerca sul Cancro; Genome Canada; Breast Cancer Research Foundation; Univerzita Karlova v Praze; National Institute for Health and Care Research; Kansas Bioscience Authority; Amsterdam University Medical Centers; Rijksuniversiteit Groningen; Cancer Australia; Ministerstvo Zdravotnictví Ceské Republiky; European Commission; Lietuvos Mokslo Taryba; National Health and Medical Research Council; Fundación Cellex; Universitair Medisch Centrum Groningen","keywords":"Cancer; Ovarian cancer; Pathogenicity; Pathology; Medicine; Biology; Oncology; Internal medicine","score_opus":0.008675891185583793,"score_gpt":0.2730566383193235,"score_spread":0.26438074713373966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366448631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981267,0.0006194073,0.00031602875,0.0000556087,0.000006083294,0.000009133394,0.00039969728,0.000005123033,0.0004622794],"genre_scores_gemma":[0.99936455,0.000064817694,0.00018026632,0.00000784819,0.000009489854,0.0000055855694,0.00031173765,0.0000027555914,0.000052915577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879706,0.00053190655,0.00014985968,0.00017643983,0.00024328177,0.00010139627],"domain_scores_gemma":[0.9824222,0.010937001,0.004590476,0.0007827141,0.0006582652,0.0006092724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003920469,0.00022292908,0.00029235397,0.0020392216,0.0002802243,0.00061321375,0.0003029067,0.0003453398,0.002783494],"category_scores_gemma":[0.017122168,0.000127254,0.00044422408,0.0015232487,0.00054089195,0.00035874295,0.00063854444,0.0004144629,0.00023740994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013600044,0.000004711356,0.9976954,0.00001455538,0.000047165417,0.000049760532,0.000033318807,0.000106514075,0.0001354166,0.000021963868,0.000044145043,0.0017109957],"study_design_scores_gemma":[0.000009895689,0.00007654359,0.9980179,0.000016237249,0.00007749004,0.00059869216,0.00008636629,0.00055259565,0.00015608534,0.00016947833,0.00023485726,0.0000038488],"about_ca_topic_score_codex":0.0014053027,"about_ca_topic_score_gemma":0.0015796963,"teacher_disagreement_score":0.003920469,"about_ca_system_score_codex":0.00020845236,"about_ca_system_score_gemma":0.0003472498,"threshold_uncertainty_score":0.020733654},"labels":[],"label_agreement":null},{"id":"W4366815856","doi":"10.1038/s41416-023-02272-4","title":"Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"CIHR Skin Research Training Centre; Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Breast cancer; Drug; Oncology; Cancer; Internal medicine; Pharmacology","score_opus":0.022176495954511766,"score_gpt":0.37173380882424717,"score_spread":0.3495573128697354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366815856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7521339,0.13822274,0.031440802,0.0037845534,0.0018466898,0.0004029575,0.0010801293,0.0010701197,0.07001818],"genre_scores_gemma":[0.92300844,0.036414683,0.007195687,0.0010354291,0.00019890601,0.00018983112,0.00054323045,0.00011050703,0.03130324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998723,0.000039390536,0.000005044932,0.00002076175,0.00002943734,0.00003305698],"domain_scores_gemma":[0.99995923,0.000008173318,0.000009466649,0.0000043677287,0.0000074367604,0.000011469108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002382251,0.0003551155,0.000291621,0.00032915082,0.00015450857,0.00046941437,0.00033772225,0.0004957263,0.0038643104],"category_scores_gemma":[0.00014700193,0.00015313528,0.00018056385,0.0002527623,0.00020028789,0.00037922256,0.0004123757,0.00064038043,0.0014880834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015199501,0.00034813612,0.00023565348,0.00065122196,0.00006995562,0.00037339545,0.00009117417,0.0026757987,0.8624045,0.0067771054,0.005559423,0.11929356],"study_design_scores_gemma":[0.00034292488,0.0030907895,0.0016925358,0.00007167157,0.00010679878,0.0012236936,0.000051772236,0.0036093437,0.8445436,0.0014473381,0.14377353,0.00004596417],"about_ca_topic_score_codex":0.00027947727,"about_ca_topic_score_gemma":0.00034273902,"teacher_disagreement_score":0.0038643104,"about_ca_system_score_codex":0.00042512832,"about_ca_system_score_gemma":0.00014357605,"threshold_uncertainty_score":0.012927413},"labels":[],"label_agreement":null},{"id":"W4367367470","doi":"10.1038/s41416-023-02289-9","title":"Precision medicine for prostate cancer—improved outcome prediction for low-intermediate risk disease using a six-gene copy number alteration classifier","year":2023,"lang":"en","type":"editorial","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prostate cancer; Classifier (UML); Medicine; Oncology; Cohort; Internal medicine; Pathology; Artificial intelligence; Computer science; Cancer","score_opus":0.03510274844559041,"score_gpt":0.39934056784165556,"score_spread":0.36423781939606514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367367470","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021729633,0.031114914,0.0012035113,0.05980159,0.90596086,0.00007109177,0.0002728911,0.00018838943,0.0011693613],"genre_scores_gemma":[0.0018214077,0.019746073,0.0008944927,0.032288663,0.9375157,0.00007740639,0.00017303645,0.0000929106,0.0073903725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943678,0.0015813237,0.0008970294,0.00071097567,0.0022616577,0.00018123197],"domain_scores_gemma":[0.95985746,0.022717057,0.0010433779,0.00066647766,0.013793489,0.0019220999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013209726,0.0027846352,0.003350575,0.0029695004,0.001360069,0.0049375026,0.0032493595,0.010322023,0.0063220165],"category_scores_gemma":[0.038247086,0.0014059258,0.0030860456,0.0011961516,0.0021984389,0.003304391,0.0010164654,0.018754637,0.0054357755],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038145462,0.000029636929,0.00012255709,0.00075187406,0.00020688442,0.00013465976,0.00002112996,0.00010784025,0.00020972133,0.0005507019,0.97151494,0.025968604],"study_design_scores_gemma":[0.001040112,0.00035656075,0.0018804148,0.002154965,0.0009139505,0.0010341665,0.00007272129,0.0022817622,0.0010765194,0.004646683,0.984426,0.00011601451],"about_ca_topic_score_codex":0.002898098,"about_ca_topic_score_gemma":0.0036717188,"teacher_disagreement_score":0.013209726,"about_ca_system_score_codex":0.002559875,"about_ca_system_score_gemma":0.002336766,"threshold_uncertainty_score":0.06986058},"labels":[],"label_agreement":null},{"id":"W4367395065","doi":"10.1038/s41416-023-02279-x","title":"A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Cancer Research UK; Incyte; NuCana; Astex Pharmaceuticals; Carrick Therapeutics; Sierra Oncology; National Institute for Health and Care Research; Verastem Oncology","keywords":"Medicine; Cancer; Oncology; Internal medicine","score_opus":0.009254080624268702,"score_gpt":0.2939590683124058,"score_spread":0.2847049876881371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367395065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912889,0.0017185725,0.00054886116,0.0004603974,0.00012797948,0.002982731,0.0010442398,0.00014593515,0.0016823943],"genre_scores_gemma":[0.98817134,0.0017191414,0.0018273542,0.0006611772,0.00018474746,0.002131973,0.0023397885,0.000036611847,0.0029278698],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971074,0.00013615059,0.000010847963,0.00004807279,0.000027671194,0.00006654956],"domain_scores_gemma":[0.99968326,0.00005481192,0.000048700083,0.000020433159,0.000028011615,0.00016477476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011226133,0.0013779124,0.0017020758,0.00040873064,0.00040710016,0.0007291527,0.0005283741,0.0008640177,0.004314356],"category_scores_gemma":[0.00048694885,0.00039920662,0.00079336646,0.0004259473,0.0007484732,0.00058108417,0.00024809735,0.0021951161,0.00076292036],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6000085,0.0693773,0.006417683,0.0014692729,0.0012066128,0.00069253094,0.00036369672,0.004597836,0.13361932,0.0005826803,0.010950427,0.17071421],"study_design_scores_gemma":[0.49939895,0.47909865,0.008059617,0.000040961208,0.00039663253,0.0003452885,0.000061613086,0.0022438578,0.0066142064,0.00024753765,0.0034589313,0.000033750883],"about_ca_topic_score_codex":0.0011411156,"about_ca_topic_score_gemma":0.003380426,"teacher_disagreement_score":0.004314356,"about_ca_system_score_codex":0.0008369875,"about_ca_system_score_gemma":0.0017896079,"threshold_uncertainty_score":0.014432967},"labels":[],"label_agreement":null},{"id":"W4376106635","doi":"10.1038/s41416-023-02281-3","title":"Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; McMaster Children's Hospital; London Health Sciences Centre; Princess Margaret Cancer Centre; Pediatric Oncology Group; Hamilton Health Sciences; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children; Public Health Ontario","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Pregnancy; Epidemiology; Medical history; Pediatrics; Logistic regression; Family history; Early childhood; Past medical history; Epilepsy; Case-control study; Psychiatry; Internal medicine; Psychology","score_opus":0.00597192283805433,"score_gpt":0.24261298985610405,"score_spread":0.2366410670180497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376106635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923443,0.0018865553,0.0001847238,0.00043495093,0.000038537164,0.000053228418,0.002642835,0.000010883557,0.0024039983],"genre_scores_gemma":[0.9959466,0.0010518503,0.00016682716,0.00013249337,0.0000137123425,0.000024430048,0.0007187273,0.000009072896,0.0019362444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846977,0.00017156026,0.00013356272,0.0002790669,0.00042910545,0.0005168955],"domain_scores_gemma":[0.9977527,0.0002369982,0.00044615337,0.00013137292,0.00086002663,0.0005727133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062395656,0.0005352234,0.00080794963,0.0013916376,0.0038422716,0.0017007622,0.001802564,0.0010462179,0.0032272357],"category_scores_gemma":[0.0019491322,0.0009996493,0.0011549586,0.0046847677,0.0012530474,0.0004452617,0.00087563624,0.00111987,0.00030258863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019595008,0.000061087245,0.994955,0.00004938972,0.00020164414,0.00040477503,0.0012990419,0.00008483235,0.0003144704,0.00016500792,0.00082616793,0.0014425447],"study_design_scores_gemma":[0.000029909916,0.000031635005,0.99776125,0.000038589395,0.000081491366,0.00012668227,0.0010032546,0.00013721242,0.000031268355,0.000026513226,0.00071884814,0.000013366201],"about_ca_topic_score_codex":0.9945095,"about_ca_topic_score_gemma":0.99525803,"teacher_disagreement_score":0.023264958,"about_ca_system_score_codex":0.023264958,"about_ca_system_score_gemma":0.021113655,"threshold_uncertainty_score":0.16879988},"labels":[],"label_agreement":null},{"id":"W4376598097","doi":"10.1038/s41416-023-02290-2","title":"Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Hazard ratio; Internal medicine; Colorectal cancer; Cancer; Confidence interval; FOLFOX; Proportional hazards model; Prospective cohort study; Oncology; Oxaliplatin","score_opus":0.013881931258799033,"score_gpt":0.2797538136270308,"score_spread":0.2658718823682317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376598097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594206,0.0014324934,0.000018761191,0.00020280045,0.000034756464,0.0000052422392,0.0015914856,0.000004153123,0.0007681113],"genre_scores_gemma":[0.996402,0.00044615724,0.000041063413,0.00012527368,0.000034986468,0.00001069882,0.0023845516,0.0000035287562,0.0005516633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998808,0.000029948938,0.000014311534,0.000017793658,0.000021558742,0.000035567755],"domain_scores_gemma":[0.9995734,0.000049747436,0.00014564898,0.000023031373,0.0000629086,0.00014527707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026829756,0.000200405,0.00026925956,0.0003553087,0.0002415808,0.00039930557,0.0002510065,0.0004051698,0.0017325965],"category_scores_gemma":[0.0008186221,0.00015359813,0.0005441456,0.00075647497,0.00012379764,0.00021225255,0.0004647242,0.0005086186,0.0002772004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010834984,0.00004609011,0.9944648,0.000040279254,0.00021556797,0.00009395391,0.00007587649,0.0000664718,0.00028857405,0.000007634207,0.00092897355,0.0026883457],"study_design_scores_gemma":[0.000019224382,0.00006673694,0.9992812,0.000009255735,0.00005852148,0.00007191883,0.00008431321,0.000029115368,0.000014938674,0.000004552686,0.00035742088,0.0000028257323],"about_ca_topic_score_codex":0.034920324,"about_ca_topic_score_gemma":0.058769315,"teacher_disagreement_score":0.034920324,"about_ca_system_score_codex":0.00042658445,"about_ca_system_score_gemma":0.00038503684,"threshold_uncertainty_score":0.069434166},"labels":[],"label_agreement":null},{"id":"W4376601978","doi":"10.1038/s41416-023-02299-7","title":"Neighbourhood social deprivation and risk of prostate cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Social deprivation; Demography; Medicine; Neighbourhood (mathematics); Odds ratio; Gerontology; Confounding; Logistic regression; Confidence interval; Incidence (geometry); Epidemiology; Androgen deprivation therapy; Psychological intervention; Cancer; Internal medicine; Psychiatry","score_opus":0.014302874808182564,"score_gpt":0.2988885482956417,"score_spread":0.28458567348745917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376601978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860713,0.0073570996,0.00007022952,0.00057964673,0.000080407895,0.0000046597333,0.0008111204,0.0000054441866,0.0050199926],"genre_scores_gemma":[0.99859697,0.0007203685,0.000019527155,0.000021720929,0.000034104876,0.0000013140634,0.00016802561,0.0000017943364,0.00043618827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962854,0.00012914531,0.000029910105,0.000039572187,0.00007237511,0.00010051509],"domain_scores_gemma":[0.99858785,0.00021798724,0.00042551564,0.00007225475,0.00012983485,0.0005665461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022895265,0.00013331356,0.0003576081,0.0007192118,0.0005086845,0.00067526696,0.00024249649,0.0004806455,0.0070126923],"category_scores_gemma":[0.0025829133,0.00028701356,0.000665078,0.0012236452,0.00025584345,0.00029970804,0.00075583655,0.0006900698,0.0003908631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048594398,0.00010819784,0.99247897,0.00008937391,0.0003363685,0.00014659046,0.00016536053,0.00027669867,0.00016725533,0.0001607643,0.0004887202,0.0050956807],"study_design_scores_gemma":[0.0000066913317,0.00006483628,0.9988707,0.00002719045,0.000040162697,0.00012622426,0.00019221388,0.00011594727,0.000009944559,0.00012562455,0.00041473896,0.000005817407],"about_ca_topic_score_codex":0.04246875,"about_ca_topic_score_gemma":0.04931695,"teacher_disagreement_score":0.04246875,"about_ca_system_score_codex":0.00044184853,"about_ca_system_score_gemma":0.0004152491,"threshold_uncertainty_score":0.08444309},"labels":[],"label_agreement":null},{"id":"W4378471674","doi":"10.1038/s41416-023-02276-0","title":"Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dosing; Medicine; Pharmacokinetics; Pharmacodynamics; Incidence (geometry); Limiting; Internal medicine; Pulmonary embolism; Maximum tolerated dose; Pharmacology","score_opus":0.005854355098554552,"score_gpt":0.2836575779162561,"score_spread":0.2778032228177016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378471674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883653,0.0027454586,0.0008409159,0.0007231692,0.00008108466,0.0029486949,0.001932815,0.00012353137,0.0022389868],"genre_scores_gemma":[0.9886912,0.0015634297,0.0020066604,0.0007279351,0.000093810064,0.0017080206,0.0027688108,0.000023680343,0.0024163567],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997458,0.00010358934,0.0000134542715,0.000047260954,0.000038232552,0.000051668198],"domain_scores_gemma":[0.999564,0.000065598266,0.00010947647,0.0000253553,0.000046813013,0.00018873726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010511411,0.0009309873,0.0009677606,0.00026327698,0.0003286062,0.00050767284,0.0003812601,0.0006932509,0.004636799],"category_scores_gemma":[0.0007278867,0.00034403816,0.0006740543,0.0002785319,0.00036911285,0.0004653286,0.00024156697,0.0022381565,0.0009012755],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41411597,0.08239907,0.03778641,0.0021887445,0.0016910944,0.0013003995,0.0008722088,0.0069798143,0.15081827,0.00072704034,0.022969794,0.27815118],"study_design_scores_gemma":[0.35142106,0.5871843,0.03661215,0.00008404321,0.0005436984,0.0014683043,0.00009713232,0.002337684,0.0101346,0.00041542167,0.009666422,0.000035216184],"about_ca_topic_score_codex":0.0006886757,"about_ca_topic_score_gemma":0.0029221547,"teacher_disagreement_score":0.004636799,"about_ca_system_score_codex":0.0006702528,"about_ca_system_score_gemma":0.001551118,"threshold_uncertainty_score":0.015511632},"labels":[],"label_agreement":null},{"id":"W4382046876","doi":"10.1038/s41416-023-02312-z","title":"Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Ontario Ministry of Research and Innovation; School of Public Health, Imperial College London; Agència de Gestió d'Ajuts Universitaris i de Recerca; Canadian Institutes of Health Research; Centers for Disease Control and Prevention; Instituto de Salud Carlos III; Xarxa de Bancs de Tumors de Catalunya; National Institutes of Health; Centre Hospitalier Universitaire de Nantes; Conseil Régional des Pays de la Loire; National Institute of Diabetes and Digestive and Kidney Diseases; Herzfelder'sche Familienstiftung; NIHR Imperial Biomedical Research Centre; Centre International de Recherche sur le Cancer; Grantová Agentura České Republiky; Medizinische Universität Graz; Imperial College London; Generalitat de Catalunya; Bundesministerium für Bildung und Forschung; National Institute on Aging; Harvard T.H. Chan School of Public Health; National Institute for Health and Care Research; Johns Hopkins University; Brigham and Women's Hospital; Emory University; Fred Hutchinson Cancer Research Center; Centres de Recerca de Catalunya; Ministerstvo Zdravotnictví Ceské Republiky; World Health Organization; Cancer Research UK; American Cancer Society; Office of Research Infrastructure Programs, National Institutes of Health; Junta de Castilla y León; Karl-Franzens-Universität Graz; U.S. Department of Health and Human Services","keywords":"Colorectal cancer; Diabetes mellitus; Medicine; Cancer; Internal medicine; Oncology; Bioinformatics; Cancer research; Computational biology; Biology; Endocrinology","score_opus":0.04011756778376931,"score_gpt":0.3241981905296975,"score_spread":0.2840806227459282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382046876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613137,0.003800352,0.028575001,0.0005791989,0.00012382619,0.00010242815,0.0037577678,0.00033857877,0.0014091455],"genre_scores_gemma":[0.9907052,0.00024699044,0.0074569834,0.00013013459,0.00005350113,0.00009405155,0.000924907,0.000044552566,0.0003436423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98367995,0.011749545,0.00057588285,0.0023709666,0.00087080867,0.00075284624],"domain_scores_gemma":[0.9788905,0.016086759,0.002197342,0.0016527489,0.0005211083,0.0006515311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067408765,0.0013382547,0.0013680846,0.0036000898,0.0008184251,0.001483115,0.0012143366,0.00082562916,0.004362351],"category_scores_gemma":[0.012494258,0.00055092375,0.0054991962,0.004400368,0.0007730644,0.00053711486,0.0017516027,0.00145982,0.0002740839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025703576,0.00014286465,0.95657665,0.00023287199,0.015914876,0.00077686796,0.00015751227,0.0019790542,0.008166651,0.00055714115,0.00067775627,0.012247361],"study_design_scores_gemma":[0.00019442846,0.0011371762,0.9717852,0.0000351309,0.008530896,0.0008447565,0.00020184937,0.011682213,0.0016388022,0.0020969366,0.001781368,0.00007132822],"about_ca_topic_score_codex":0.008121681,"about_ca_topic_score_gemma":0.008242051,"teacher_disagreement_score":0.008121681,"about_ca_system_score_codex":0.00052449707,"about_ca_system_score_gemma":0.0008907859,"threshold_uncertainty_score":0.035649598},"labels":[],"label_agreement":null},{"id":"W4382929676","doi":"10.1038/s41416-023-02346-3","title":"ACE inhibitors and the risk of lung cancer—is there causality?","year":2023,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of Toronto","funders":"","keywords":"Causality (physics); Lung cancer; Medicine; Cancer; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.01541183887034652,"score_gpt":0.31455842654885324,"score_spread":0.2991465876785067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382929676","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046012964,0.0043977834,0.00014136745,0.9860094,0.007567663,0.0000037980828,0.000076263546,0.000014294186,0.0013292877],"genre_scores_gemma":[0.02100173,0.016336445,0.0006704501,0.79828274,0.15751542,0.000048234397,0.00014364907,0.000045055203,0.0059563746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970079,0.0014264141,0.0003164872,0.00026396077,0.00077502034,0.00021024306],"domain_scores_gemma":[0.95997983,0.033898592,0.0010160337,0.0007520785,0.0023348173,0.0020187225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059928177,0.0005518534,0.0021257459,0.0008934193,0.0019822358,0.0031526005,0.0014645938,0.02324476,0.0071319966],"category_scores_gemma":[0.03656274,0.0005970923,0.0014466487,0.0010468639,0.002453651,0.0026832179,0.0009052796,0.0327212,0.004986808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077677134,0.00013089171,0.0054645706,0.00023663034,0.0002632396,0.0011326984,0.0001180757,0.0003582408,0.00027270813,0.014624229,0.9121592,0.064462736],"study_design_scores_gemma":[0.0013963106,0.00033385825,0.008032999,0.0009708627,0.0004665279,0.0025481374,0.00044835883,0.0058229626,0.00060946774,0.15115882,0.82804936,0.00016225362],"about_ca_topic_score_codex":0.009085969,"about_ca_topic_score_gemma":0.0133275995,"teacher_disagreement_score":0.02324476,"about_ca_system_score_codex":0.0028641992,"about_ca_system_score_gemma":0.0035129406,"threshold_uncertainty_score":0.0316934},"labels":[],"label_agreement":null},{"id":"W4383551038","doi":"10.1038/s41416-023-02307-w","title":"A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Tolerability; Clinical trial; Medicine; Adverse effect; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.42334773358831657,"score_gpt":0.5319927219761352,"score_spread":0.10864498838781866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383551038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.563974,0.0014379956,0.29941306,0.005278044,0.00065805856,0.0436619,0.058883857,0.003160123,0.02353293],"genre_scores_gemma":[0.65925115,0.0010654872,0.2569627,0.0024994574,0.0003244294,0.051592875,0.024944033,0.00029020937,0.003069626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9779302,0.015431632,0.003894757,0.0006929948,0.0016345874,0.00041585354],"domain_scores_gemma":[0.93039006,0.038564436,0.014555488,0.007283524,0.0071853767,0.002021106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025225641,0.0006137201,0.0007393034,0.0025212804,0.00033008537,0.0011245458,0.0004701721,0.00062523765,0.0047261976],"category_scores_gemma":[0.06630734,0.00023535361,0.0015201573,0.0025798378,0.00037232024,0.0010985631,0.0015632197,0.0010969365,0.0013940013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033113828,0.0015547145,0.3887317,0.002687656,0.0011938084,0.0001512762,0.0023431806,0.0060550487,0.0049218535,0.0031039582,0.044427354,0.54151815],"study_design_scores_gemma":[0.0013244854,0.0097968895,0.85812956,0.00078282034,0.00081152207,0.00064498786,0.0017919432,0.020989874,0.0072419248,0.008559382,0.089629196,0.0002973778],"about_ca_topic_score_codex":0.0005104218,"about_ca_topic_score_gemma":0.0015597421,"teacher_disagreement_score":0.025225641,"about_ca_system_score_codex":0.00059733307,"about_ca_system_score_gemma":0.0020394363,"threshold_uncertainty_score":0.13340753},"labels":[],"label_agreement":null},{"id":"W4383618206","doi":"10.1038/s41416-023-02353-4","title":"Fracture risk among patients with cancer compared to individuals without cancer: a population-based study","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; Women's College Hospital; University of Toronto","funders":"Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Cancer; Internal medicine; Breast cancer; Lung cancer; Prostate cancer; Population; Proportional hazards model; Relative risk; Osteoporosis; Oncology; Surgery; Confidence interval","score_opus":0.01498883161055673,"score_gpt":0.3314391492485287,"score_spread":0.31645031763797193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383618206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990396,0.00028309636,0.000057091325,0.00004625504,0.000012058411,0.000008741472,0.00022632229,0.000002601659,0.0003241846],"genre_scores_gemma":[0.9991032,0.00015528116,0.00004790056,0.000058581067,0.000020200832,0.000012752054,0.00031526096,0.000002504707,0.00028431436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999263,0.00015787015,0.00008600827,0.00024362958,0.00012654606,0.00012304934],"domain_scores_gemma":[0.9993642,0.00010065645,0.00018822038,0.00007050635,0.00009319762,0.00018321263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047681076,0.0005641946,0.0010690117,0.0012666858,0.0009215495,0.0011992852,0.0005096119,0.0019376719,0.00269662],"category_scores_gemma":[0.0017643321,0.0009905196,0.0017682768,0.0022035157,0.0005744663,0.0008959583,0.0007756345,0.0015818359,0.0004961258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018922804,0.00029128414,0.9948419,0.000029796305,0.00065590366,0.00025915678,0.00024620644,0.000039673338,0.0005314454,0.000018674702,0.00012475706,0.0010689758],"study_design_scores_gemma":[0.00009426314,0.00061465794,0.9979235,0.000008793209,0.00025222154,0.00041562694,0.00038598728,0.0000929663,0.000025772686,0.000031563686,0.00014163912,0.0000129200425],"about_ca_topic_score_codex":0.012590527,"about_ca_topic_score_gemma":0.011440191,"teacher_disagreement_score":0.012590527,"about_ca_system_score_codex":0.00043407897,"about_ca_system_score_gemma":0.00027030928,"threshold_uncertainty_score":0.025034487},"labels":[],"label_agreement":null},{"id":"W4384155464","doi":"10.1038/s41416-023-02344-5","title":"Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; Oncolytics Biotech; Merck","keywords":"Pembrolizumab; Medicine; Internal medicine; Chemotherapy; Oncology; CD8; Immunotherapy; Immune system; Gastroenterology; Regimen; Chemotherapy regimen; Immunology; Cancer","score_opus":0.012853819566891618,"score_gpt":0.2831648186824827,"score_spread":0.2703109991155911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384155464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964888,0.0021899242,0.00015705757,0.00010993346,0.00010230161,0.000030044908,0.000078186196,0.000029946963,0.0008137937],"genre_scores_gemma":[0.9980338,0.0007438861,0.00028304235,0.00007696636,0.00003776083,0.000031785585,0.0001303588,0.00000341887,0.0006590441],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998714,0.00002935551,0.000008376698,0.000017852384,0.000021596528,0.000051543324],"domain_scores_gemma":[0.99992406,0.000016798893,0.000008507056,0.000008782131,0.0000053866816,0.000036505735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019001286,0.00020399452,0.0005865758,0.0001503016,0.00013926867,0.00036830723,0.00014396716,0.0002547221,0.0017486322],"category_scores_gemma":[0.00020942112,0.00012766845,0.0003801336,0.00014150591,0.00015939023,0.00032265607,0.00017353636,0.0010661635,0.00036132146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0588643,0.009428312,0.009217581,0.00094114005,0.00039406112,0.0005794246,0.00017613993,0.0018145525,0.7218216,0.00026868904,0.0031899763,0.1933041],"study_design_scores_gemma":[0.012930782,0.31414035,0.22288045,0.00015333749,0.0019254588,0.0037256214,0.0007945768,0.0099791065,0.39963764,0.00063136703,0.033117317,0.000084064246],"about_ca_topic_score_codex":0.00029974547,"about_ca_topic_score_gemma":0.00073990034,"teacher_disagreement_score":0.0017486322,"about_ca_system_score_codex":0.0001726965,"about_ca_system_score_gemma":0.00024769673,"threshold_uncertainty_score":0.005849719},"labels":[],"label_agreement":null},{"id":"W4386047586","doi":"10.1038/s41416-023-02397-6","title":"Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer risk","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Natural Science Foundation of Zhejiang Province; Medical Research Council; Science Fund for Distinguished Young Scholars of Zhejiang Province; National Natural Science Foundation of China; Wellcome Trust; British Heart Foundation; Academy of Medical Sciences; Diabetes UK; Cancer Research UK","keywords":"DNA methylation; Colorectal cancer; Epigenetics; Methylation; Mendelian randomization; Oncology; Medicine; CpG site; MLH1; Cancer; Internal medicine; Genetics; Bioinformatics; Biology; Gene; Genotype; DNA mismatch repair; Gene expression; Genetic variants","score_opus":0.006909366524287928,"score_gpt":0.26966526445769423,"score_spread":0.2627558979334063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386047586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363,0.00059075194,0.005007284,0.00009772897,0.0000050569124,0.000014005617,0.00016997081,0.00003088348,0.0004543714],"genre_scores_gemma":[0.9984174,0.0000650875,0.0013663342,0.00002081113,0.0000030996387,0.000006948263,0.000044862492,0.000004717455,0.00007067459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992225,0.00041374058,0.000040719697,0.00014579501,0.00009916666,0.00007794519],"domain_scores_gemma":[0.9983535,0.0009423602,0.00033020476,0.00020360522,0.00007042678,0.00009984799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001630343,0.00026417992,0.00026624373,0.0004568299,0.00016349807,0.00033660894,0.00028025827,0.00029109878,0.0010965155],"category_scores_gemma":[0.003121247,0.00015324118,0.00044247994,0.00043227675,0.00033621173,0.00016241938,0.00036672116,0.00033211694,0.00009472683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014986643,0.00006548521,0.89887077,0.00012276371,0.0006571184,0.00027349047,0.00022101514,0.0008806031,0.076156825,0.0008647686,0.00011391368,0.02027463],"study_design_scores_gemma":[0.000026590933,0.00041872702,0.9859984,0.00000981092,0.00044903642,0.00040807674,0.00006669523,0.0029589552,0.008168294,0.0010036179,0.00048227145,0.000009593472],"about_ca_topic_score_codex":0.001682929,"about_ca_topic_score_gemma":0.0024231395,"teacher_disagreement_score":0.001682929,"about_ca_system_score_codex":0.00019152861,"about_ca_system_score_gemma":0.00046801302,"threshold_uncertainty_score":0.0086221695},"labels":[],"label_agreement":null},{"id":"W4386695399","doi":"10.1038/s41416-023-02415-7","title":"Correction: Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada","year":2023,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; McMaster Children's Hospital; London Health Sciences Centre; Princess Margaret Cancer Centre; Pediatric Oncology Group; Hamilton Health Sciences; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children; Public Health Ontario","funders":"","keywords":"Childhood cancer; Medicine; Case-control study; Pediatrics; Pathology; Cancer; Internal medicine","score_opus":0.008532451240408051,"score_gpt":0.25192345993760373,"score_spread":0.24339100869719568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386695399","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080879126,0.0022042277,0.0004367179,0.07737076,0.89854956,0.00009285023,0.01653827,0.00021914138,0.0037796353],"genre_scores_gemma":[0.0921872,0.018869972,0.008486928,0.16598724,0.25699884,0.0012813567,0.024994621,0.0025293252,0.4286645],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99287826,0.0008572954,0.0016686553,0.0007040432,0.0028911573,0.0010005365],"domain_scores_gemma":[0.9399348,0.009326253,0.0024960216,0.0029429344,0.042335268,0.0029647197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066807554,0.0021705786,0.0030373281,0.0045541287,0.0049626403,0.0035142275,0.0063283877,0.0065006404,0.049624033],"category_scores_gemma":[0.09848021,0.0016178972,0.0028837218,0.006633508,0.002426891,0.0014457887,0.0016567009,0.0072004865,0.010775023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041055497,0.0000033138656,0.0006035893,0.00014944428,0.000029777726,0.0002452505,0.000073927535,0.00003656155,0.00001175856,0.00027822773,0.9969969,0.0015301773],"study_design_scores_gemma":[0.00062637136,0.00004204779,0.025820505,0.003049712,0.00051400764,0.0018430667,0.0010406129,0.00067606213,0.00032814115,0.0013615951,0.9644813,0.00021650139],"about_ca_topic_score_codex":0.8747787,"about_ca_topic_score_gemma":0.8527787,"teacher_disagreement_score":0.12522131,"about_ca_system_score_codex":0.022692692,"about_ca_system_score_gemma":0.05482172,"threshold_uncertainty_score":0.25191748},"labels":[],"label_agreement":null},{"id":"W4386861913","doi":"10.1038/s41416-023-02429-1","title":"Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Nursing Research; National Human Genome Research Institute; Cancer Institute NSW; National Health and Medical Research Council; McGill University; Foundation for the National Institutes of Health","keywords":"Regret; Medicine; Clinical trial; Family medicine; Receipt; Precision medicine; Qualitative property; Qualitative research; Randomized controlled trial; Childhood cancer; Clinical psychology; Psychology; Cancer; Internal medicine; Pathology","score_opus":0.22070539878110393,"score_gpt":0.5879041545990111,"score_spread":0.3671987558179072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386861913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959,0.0014368219,0.00070424593,0.0008683299,0.000029147648,0.00021287538,0.00021243753,0.0000063130183,0.00062977447],"genre_scores_gemma":[0.9956513,0.0010459995,0.0012873475,0.00077232235,0.000029552104,0.0007477507,0.00013848554,0.000010755616,0.00031650448],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.97250867,0.02232402,0.0015370357,0.001053562,0.0015348158,0.0010418543],"domain_scores_gemma":[0.9408161,0.043233827,0.010026191,0.0015506182,0.0024464787,0.0019267421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03881555,0.00045720892,0.001052565,0.0012921694,0.0025185365,0.0037862328,0.0010843874,0.0011702508,0.0027328075],"category_scores_gemma":[0.06274755,0.0007610672,0.0013876198,0.001223429,0.0017902921,0.0034147305,0.0031634592,0.0022389616,0.00028139268],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012909285,0.0010115172,0.309567,0.0012991849,0.0004494048,0.0009517485,0.6428762,0.00014239656,0.00035439714,0.0010585623,0.0018054502,0.039193187],"study_design_scores_gemma":[0.00029967734,0.0033484807,0.18341361,0.0019140247,0.00037269882,0.002371481,0.79616654,0.0011559614,0.0006665256,0.0011499799,0.008933323,0.00020769765],"about_ca_topic_score_codex":0.0029897047,"about_ca_topic_score_gemma":0.004180483,"teacher_disagreement_score":0.03881555,"about_ca_system_score_codex":0.0030068236,"about_ca_system_score_gemma":0.0035135979,"threshold_uncertainty_score":0.2052787},"labels":[],"label_agreement":null},{"id":"W4387220566","doi":"10.1038/s41416-023-02443-3","title":"Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto","funders":"Movember Foundation","keywords":"Internal medicine; Seminoma; Stage (stratigraphy); Germ cell tumors; Oncology; Progression-free survival; Medicine; Cancer; Overall survival; Chemotherapy; Biology","score_opus":0.04783151474138426,"score_gpt":0.4064626711563925,"score_spread":0.35863115641500826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387220566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596263,0.0015964023,0.000082640254,0.00012685197,0.00000952511,0.00004393128,0.037802182,0.000015690106,0.0006964182],"genre_scores_gemma":[0.950955,0.00049220456,0.00011502011,0.00009919695,0.000012633543,0.000048075857,0.04815589,0.000011088937,0.000110918416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997693,0.0005840889,0.00040306148,0.0005379129,0.00051105814,0.0002708407],"domain_scores_gemma":[0.9935549,0.0013129908,0.0031402954,0.00048045054,0.000941363,0.00056987593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018204083,0.00028614636,0.0009082616,0.0024988782,0.00032251,0.0012663328,0.00080349,0.0006143539,0.0011548783],"category_scores_gemma":[0.007546198,0.00018236104,0.00060605316,0.0060796975,0.00028063662,0.0006500831,0.001025586,0.0003883677,0.00019628125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003569845,0.000013958298,0.99630225,0.00006262044,0.00022067783,0.000057017754,0.00006742442,0.00012495759,0.00004960393,0.0000245033,0.0012585793,0.0014614381],"study_design_scores_gemma":[0.000033056884,0.000048544855,0.9980919,0.000040995208,0.00013876874,0.00020585839,0.00015799553,0.0003899549,0.00003251963,0.000012599763,0.00084024546,0.000007594989],"about_ca_topic_score_codex":0.059642624,"about_ca_topic_score_gemma":0.06575001,"teacher_disagreement_score":0.059642624,"about_ca_system_score_codex":0.0015864137,"about_ca_system_score_gemma":0.0009885861,"threshold_uncertainty_score":0.11859089},"labels":[],"label_agreement":null},{"id":"W4387389324","doi":"10.1038/s41416-023-02405-9","title":"Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Occupational Cancer Research Centre","funders":"Canadian Institutes of Health Research; Vancouver Coastal Health Research Institute; Government of Canada","keywords":"Medicine; Basal cell; Oncology; Internal medicine; Carcinoma; microRNA; Pathology; Biology; Gene","score_opus":0.016418653455615294,"score_gpt":0.29690532326803254,"score_spread":0.28048666981241727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387389324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248946,0.00095477485,0.004340101,0.00009634437,0.000026800366,0.000044352295,0.0010962542,0.00012642302,0.0008253732],"genre_scores_gemma":[0.990538,0.00016594859,0.007528884,0.000086414046,0.00001666967,0.00004874238,0.0011764291,0.000017752422,0.00042114055],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99956805,0.00006187452,0.00004652724,0.00012729967,0.00015385306,0.000042465996],"domain_scores_gemma":[0.99925727,0.00023460729,0.00023238407,0.000048585873,0.00016271444,0.000064344225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006176476,0.00035434632,0.00055513694,0.0009107708,0.00019080788,0.0007980475,0.00018270653,0.000497077,0.00068295706],"category_scores_gemma":[0.0016763597,0.00017676788,0.00025282978,0.00051523006,0.0002647889,0.00018688285,0.00022779948,0.00040533475,0.00040731326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013427844,0.00019163091,0.33000088,0.00023240552,0.00011552663,0.0002842257,0.00018489998,0.00074227335,0.6327761,0.00014564225,0.00069119,0.033292446],"study_design_scores_gemma":[0.00008643465,0.0019943959,0.55334073,0.000054667344,0.00030616845,0.0053290455,0.00026228366,0.018597964,0.4154229,0.00037755683,0.0041692313,0.000058700807],"about_ca_topic_score_codex":0.00044258096,"about_ca_topic_score_gemma":0.00078623067,"teacher_disagreement_score":0.0009107708,"about_ca_system_score_codex":0.0003093424,"about_ca_system_score_gemma":0.00033619217,"threshold_uncertainty_score":0.0032665133},"labels":[],"label_agreement":null},{"id":"W4388600728","doi":"10.1038/s41416-023-02492-8","title":"Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Research and Development; European Society for Medical Oncology","keywords":"Medicine; Hazard ratio; Prostate cancer; Internal medicine; Enzalutamide; Proportional hazards model; Post-hoc analysis; Androgen deprivation therapy; Placebo; Antiandrogen; Oncology; Confidence interval; Cancer; Pathology; Androgen receptor","score_opus":0.027072574063498757,"score_gpt":0.39766135972430433,"score_spread":0.37058878566080555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388600728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943126,0.006398057,0.0004294672,0.00022891662,0.0000922779,0.0019450268,0.00060659036,0.000028083541,0.00084041664],"genre_scores_gemma":[0.99352455,0.002271429,0.0006760554,0.00035988507,0.00014861223,0.0017695255,0.0007825037,0.000008405096,0.0004590933],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99716634,0.0020971312,0.00022891586,0.00017449114,0.000189462,0.00014361355],"domain_scores_gemma":[0.9967475,0.0011390895,0.0011282461,0.00022841396,0.00023941848,0.00051741773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071829697,0.000785517,0.002035341,0.00043957026,0.0002581085,0.0006764354,0.0005572548,0.0007373773,0.0026671954],"category_scores_gemma":[0.004897612,0.000344268,0.0026529597,0.00056311203,0.0006902467,0.00058159366,0.0004920709,0.0012771562,0.00023175491],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95569927,0.003792895,0.0048393626,0.00091660395,0.004174724,0.000057933692,0.00013695868,0.0006142041,0.0037794346,0.000079470956,0.00048191112,0.025427343],"study_design_scores_gemma":[0.7410875,0.21665123,0.0354333,0.00007798949,0.0037243431,0.00012538565,0.000060908576,0.0005012268,0.0007018954,0.0002175057,0.0013831801,0.000035575395],"about_ca_topic_score_codex":0.0008849254,"about_ca_topic_score_gemma":0.0021471954,"teacher_disagreement_score":0.0071829697,"about_ca_system_score_codex":0.0006556645,"about_ca_system_score_gemma":0.0011731023,"threshold_uncertainty_score":0.03798765},"labels":[],"label_agreement":null},{"id":"W4388794355","doi":"10.1038/s41416-023-02487-5","title":"Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bristol-Myers Squibb Canada; Gateway for Cancer Research; National Cancer Institute; Celgene; Prostate Cancer Foundation","keywords":"Enzalutamide; Medicine; Prostate cancer; Internal medicine; Clinical endpoint; Rash; Adverse effect; PI3K/AKT/mTOR pathway; Oncology; Cancer; Urology; Pharmacology; Gastroenterology; Clinical trial; Androgen receptor","score_opus":0.034558653523682564,"score_gpt":0.36477653629771967,"score_spread":0.3302178827740371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388794355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854639,0.0041338834,0.0006758582,0.000830822,0.00027726716,0.002350475,0.0022421286,0.00024010948,0.0037855902],"genre_scores_gemma":[0.9799298,0.0035086824,0.0020526557,0.0011310757,0.00018557087,0.0021123758,0.003965469,0.00006995078,0.0070443293],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971217,0.00011965488,0.00001059036,0.000056315213,0.00002206137,0.000079235164],"domain_scores_gemma":[0.99951935,0.00006337535,0.000061114355,0.000029496516,0.000025923562,0.00030067717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009422289,0.0021980645,0.002277947,0.00056371104,0.00041876893,0.0010496221,0.0010091778,0.0015539437,0.0064476933],"category_scores_gemma":[0.00072015007,0.0008955615,0.001490375,0.00045970932,0.0010012172,0.00080732355,0.00032826833,0.0033968107,0.0014337498],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8496937,0.04570453,0.0017071605,0.0008375264,0.0011482919,0.00014917906,0.00022658061,0.0028223745,0.026432656,0.00033344474,0.0043960027,0.066548534],"study_design_scores_gemma":[0.6931053,0.29266003,0.007428863,0.000044973258,0.00039827655,0.00019813671,0.00006250633,0.0009967226,0.002124114,0.00022999874,0.0027092064,0.00004190422],"about_ca_topic_score_codex":0.0038428688,"about_ca_topic_score_gemma":0.010362958,"teacher_disagreement_score":0.0064476933,"about_ca_system_score_codex":0.0010722353,"about_ca_system_score_gemma":0.001637394,"threshold_uncertainty_score":0.021569729},"labels":[],"label_agreement":null},{"id":"W4389134878","doi":"10.1038/s41416-023-02503-8","title":"Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Saskatchewan; University of Toronto; Royal University Hospital; University Health Network; Health Sciences Centre; McGill University; North York General Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital","funders":"Canadian Institutes of Health Research; Women's College Hospital; Canada Research Chairs","keywords":"Breast cancer; Medicine; Hazard ratio; Mastectomy; Oncology; Cancer; Internal medicine; Prophylactic Mastectomy; Confidence interval; Gynecology","score_opus":0.010400639128705539,"score_gpt":0.29486935890653143,"score_spread":0.2844687197778259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389134878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95516914,0.037522398,0.0012907545,0.00061311893,0.00007639027,0.00019309964,0.001833655,0.000019622854,0.00328175],"genre_scores_gemma":[0.99192667,0.005461051,0.0006122054,0.00017871932,0.00006325998,0.00016376513,0.0010799825,0.00000975814,0.0005045409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667645,0.0022454846,0.00027969887,0.00039674222,0.00023911575,0.00016248808],"domain_scores_gemma":[0.995828,0.0016352372,0.0016204605,0.00040762094,0.00022673614,0.000281959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075158575,0.0006904273,0.0012164963,0.00094332214,0.00019660473,0.00067870674,0.0007025188,0.0007275798,0.004427274],"category_scores_gemma":[0.008917981,0.00034685142,0.0038218412,0.0016332344,0.00055842963,0.00036303434,0.00091022474,0.0006624281,0.00022388804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24972357,0.0008243077,0.61370295,0.0053520505,0.050465517,0.00046281778,0.0003563676,0.00419236,0.001545036,0.0013136719,0.002101367,0.06995999],"study_design_scores_gemma":[0.023161987,0.008787723,0.91923505,0.0008493814,0.038745448,0.0010405241,0.00028447484,0.0017475574,0.00058823655,0.00088870846,0.0046056984,0.000065179534],"about_ca_topic_score_codex":0.0019394598,"about_ca_topic_score_gemma":0.0014959666,"teacher_disagreement_score":0.0075158575,"about_ca_system_score_codex":0.00050187774,"about_ca_system_score_gemma":0.0003803781,"threshold_uncertainty_score":0.039748132},"labels":[],"label_agreement":null},{"id":"W4389297538","doi":"10.1038/s41416-023-02511-8","title":"Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Mutation; Medicine; Cancer research; Myeloid; Sorafenib; Transcriptome; Point mutation; Myeloid leukaemia; Oncology; Bioinformatics; Internal medicine; Biology; Genetics; Gene","score_opus":0.014348140268831489,"score_gpt":0.31258867330632395,"score_spread":0.2982405330374925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389297538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912389,0.0025510304,0.0014804923,0.00006783464,0.000007813063,0.000040592848,0.0038737343,0.000056376826,0.00068334636],"genre_scores_gemma":[0.9889792,0.0013747432,0.0031056947,0.00007666041,0.000018880937,0.000052021234,0.0059762835,0.000031982574,0.00038456856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99974674,0.000024060459,0.000022366816,0.00006841452,0.0000890555,0.000049324473],"domain_scores_gemma":[0.9997292,0.00007202942,0.00010884366,0.00001835413,0.000041716816,0.000029877192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023623962,0.00024467777,0.00033092164,0.0016155896,0.00016998842,0.0003446675,0.00017255741,0.0002677681,0.0012509103],"category_scores_gemma":[0.0005523652,0.000116687894,0.00022178402,0.001421887,0.0002273434,0.00012516123,0.00026435655,0.00023338606,0.000321481],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012711894,0.000045159046,0.2901182,0.0007184509,0.00013367824,0.0016841713,0.00047092678,0.0012127247,0.6606532,0.00018972675,0.00087504496,0.042627636],"study_design_scores_gemma":[0.0000469113,0.00025631554,0.91016996,0.000043147775,0.00016500735,0.009754538,0.0003579938,0.0011468339,0.06701306,0.0003687522,0.010659087,0.000018404608],"about_ca_topic_score_codex":0.0013501812,"about_ca_topic_score_gemma":0.0025859368,"teacher_disagreement_score":0.0016155896,"about_ca_system_score_codex":0.00034955138,"about_ca_system_score_gemma":0.00023074618,"threshold_uncertainty_score":0.0041847825},"labels":[],"label_agreement":null},{"id":"W4389382645","doi":"10.1038/s41416-023-02489-3","title":"Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"NIHR Cambridge Biomedical Research Centre; Medical Research Council; Cambridge University Hospitals; Research Councils UK; National Institute for Health and Care Research; Department of Health and Social Care; National Institutes of Health; University of Cambridge; Cancer Research UK; Economic and Social Research Council; World Health Organization","keywords":"Biobank; Cardiorespiratory fitness; Observational study; Medicine; Cancer; Gerontology; Environmental health; Demography; Internal medicine; Bioinformatics; Biology","score_opus":0.047476351132995614,"score_gpt":0.3413944226316898,"score_spread":0.2939180714986942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389382645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769909,0.0043376735,0.004997212,0.00080410024,0.0001629016,0.00087852887,0.009751477,0.000050774193,0.002026368],"genre_scores_gemma":[0.98927456,0.0005594426,0.0022664862,0.00035119947,0.000061593215,0.0017513062,0.0049354616,0.000024070703,0.0007760228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9693261,0.023009613,0.0024942602,0.0024633224,0.0019874137,0.0007193749],"domain_scores_gemma":[0.95027566,0.014431932,0.019637113,0.010106557,0.0041099023,0.0014388703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022320665,0.0005683667,0.000923401,0.00178873,0.0010393764,0.0013213897,0.0010873936,0.0014918802,0.0024678807],"category_scores_gemma":[0.056030616,0.00071133947,0.001173602,0.0048051192,0.0009852359,0.000769598,0.0023673917,0.0006820588,0.0004298257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018846119,0.00011003001,0.986587,0.0003886095,0.0016800631,0.00025637748,0.00123227,0.00026020332,0.00029535303,0.0004297476,0.003137716,0.0037380587],"study_design_scores_gemma":[0.00095146627,0.0004603165,0.99024266,0.00034755474,0.0014426216,0.00048960454,0.00048192195,0.0008807042,0.00023284585,0.0003304301,0.0040889774,0.000050981384],"about_ca_topic_score_codex":0.00995686,"about_ca_topic_score_gemma":0.007560568,"teacher_disagreement_score":0.022320665,"about_ca_system_score_codex":0.0009873967,"about_ca_system_score_gemma":0.0011230294,"threshold_uncertainty_score":0.118044436},"labels":[],"label_agreement":null},{"id":"W4389786703","doi":"10.1038/s41416-023-02518-1","title":"Factors associated with the melanoma diagnostic interval in Ontario, Canada: a population-based study","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Cancer Care South East; Health Sciences Centre; Cancer Care Ontario; Queen's University","funders":"Canadian Institutes of Health Research; Queen's University; Government of Canada","keywords":"Medicine; Interquartile range; Conventional PCI; Comorbidity; Confidence interval; Melanoma; Population; Cancer; Internal medicine; Environmental health","score_opus":0.023713238149567623,"score_gpt":0.25587841752159074,"score_spread":0.2321651793720231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389786703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943294,0.0008273545,0.00007633339,0.0003633146,0.000020335361,0.000036784113,0.0022165559,0.000008968767,0.0021208897],"genre_scores_gemma":[0.99781173,0.00041229874,0.000083753584,0.00011095653,0.000010974016,0.000016999224,0.0007212155,0.0000055184823,0.0008266963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988992,0.0000773816,0.000088542794,0.00019768452,0.00034335928,0.00039383347],"domain_scores_gemma":[0.997736,0.00013923444,0.0005801751,0.00009182671,0.0008073837,0.0006453669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039628195,0.00042689664,0.00056124467,0.0012105786,0.0027251046,0.0013911639,0.0015257595,0.0010801331,0.0027602147],"category_scores_gemma":[0.0021812704,0.0006862218,0.00081845245,0.004391198,0.00089632807,0.00050886057,0.00084003765,0.0011472583,0.0003121152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009000043,0.00004279795,0.9972389,0.00002107693,0.00005542249,0.00014606645,0.0006248707,0.00003858001,0.00015486951,0.000033707638,0.0005766348,0.0009771029],"study_design_scores_gemma":[0.000006483575,0.00002013849,0.99863535,0.000015145733,0.000022987802,0.0000713161,0.0008017027,0.000071012124,0.000011559114,0.000011152193,0.00032549645,0.000007647901],"about_ca_topic_score_codex":0.98693955,"about_ca_topic_score_gemma":0.98884517,"teacher_disagreement_score":0.017555652,"about_ca_system_score_codex":0.017555652,"about_ca_system_score_gemma":0.016964678,"threshold_uncertainty_score":0.12737578},"labels":[],"label_agreement":null},{"id":"W4390706040","doi":"10.1038/s41416-023-02560-z","title":"Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Minnesota Ovarian Cancer Alliance; Division of Cancer Prevention, National Cancer Institute; National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Autoantibody; Ovarian cancer; Medicine; Biomarker; Antigen; Stage (stratigraphy); Osteopontin; Oncology; Cancer; Immunology; Internal medicine; Antibody; Biology","score_opus":0.02331385625616697,"score_gpt":0.3370818268723073,"score_spread":0.31376797061614037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235266,0.005831648,0.0011574054,0.00012185603,0.000023414996,0.00004258435,0.00007202422,0.000026479858,0.00037194786],"genre_scores_gemma":[0.9968342,0.00040350223,0.0024799004,0.00004415189,0.000014312164,0.000013356189,0.00008551071,0.0000015306456,0.00012358777],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935013,0.0002638328,0.000048198737,0.000095410585,0.0001943017,0.000048118323],"domain_scores_gemma":[0.99888057,0.0005353869,0.00025461733,0.000044198958,0.00016016897,0.00012505251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019728004,0.0004178151,0.0003935452,0.0010451195,0.00013290271,0.0004113084,0.00023546224,0.00031958634,0.0005349462],"category_scores_gemma":[0.0028437385,0.00016846968,0.00025495415,0.000379356,0.00017481,0.00024505434,0.00024640874,0.00034149227,0.000075373595],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011239896,0.0005451473,0.70804924,0.0003393169,0.0007597747,0.00013290031,0.00007515697,0.001865515,0.10892543,0.00008022903,0.0005891553,0.16739823],"study_design_scores_gemma":[0.000766213,0.016877072,0.8711216,0.00013991045,0.00094021426,0.0017455957,0.000111098736,0.018795671,0.08641524,0.00043783046,0.0025961944,0.000053406915],"about_ca_topic_score_codex":0.00097087194,"about_ca_topic_score_gemma":0.0019302932,"teacher_disagreement_score":0.0019728004,"about_ca_system_score_codex":0.00039331004,"about_ca_system_score_gemma":0.00030511495,"threshold_uncertainty_score":0.010433257},"labels":[],"label_agreement":null},{"id":"W4391843582","doi":"10.1038/s41416-023-02550-1","title":"AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stiftung Charité; Deutsche Forschungsgemeinschaft; Deutschen Konsortium für Translationale Krebsforschung; European Commission; Berlin Institute of Health; Bundesministerium für Bildung und Forschung; Ministère de l'Économie, de la Science et de l'Innovation - Québec","keywords":"Serous fluid; In silico; Wnt signaling pathway; Biology; Oncology; Immunohistochemistry; Ovarian carcinoma; Cancer research; Pathology; Medicine; Cancer; Ovarian cancer; Gene; Immunology; Genetics","score_opus":0.018112362515437807,"score_gpt":0.2784674219992432,"score_spread":0.2603550594838054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391843582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982797,0.000991496,0.00023556521,0.000026034922,0.0000041277226,0.000004523902,0.00029711204,0.000008399219,0.00015302362],"genre_scores_gemma":[0.9991549,0.00017620149,0.00021509948,0.000011040492,0.00000585145,0.0000050676895,0.000324567,0.0000017841218,0.000105358406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998191,0.00002608437,0.000017895054,0.00004232975,0.00005518355,0.000039467028],"domain_scores_gemma":[0.9996482,0.000081113314,0.00016249224,0.00002496321,0.00003809522,0.00004499154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003601563,0.00017714179,0.0002663887,0.00057948823,0.00012872007,0.00040689993,0.00010488558,0.00022661255,0.001127175],"category_scores_gemma":[0.00062679214,0.00007705626,0.00028464518,0.0005607121,0.00024964396,0.00013298333,0.0002037259,0.0001790005,0.00022039338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015498935,0.00003359445,0.86228967,0.00021461614,0.00014970698,0.0007609693,0.00015803176,0.0004014325,0.11917866,0.00007283482,0.00017874569,0.015011951],"study_design_scores_gemma":[0.000017470613,0.00027592035,0.98471063,0.000013938753,0.00012161789,0.001996622,0.00018699677,0.00082754996,0.010757027,0.00010645157,0.0009793857,0.0000064474116],"about_ca_topic_score_codex":0.00041293824,"about_ca_topic_score_gemma":0.00058263977,"teacher_disagreement_score":0.001127175,"about_ca_system_score_codex":0.00017234118,"about_ca_system_score_gemma":0.00014527862,"threshold_uncertainty_score":0.0037708282},"labels":[],"label_agreement":null},{"id":"W4392139117","doi":"10.1038/s41416-024-02604-y","title":"Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"KRAS; Medicine; Oncology; Internal medicine; Cetuximab; Hazard ratio; Colorectal cancer; Panitumumab; Capecitabine; Confidence interval; Progression-free survival; Chemotherapy; Cancer","score_opus":0.03489373490124312,"score_gpt":0.3311728517719328,"score_spread":0.29627911687068964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392139117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6666474,0.32184783,0.0031433047,0.00047980162,0.00036080272,0.0009729933,0.0051864847,0.000078573765,0.0012829005],"genre_scores_gemma":[0.9836767,0.012442992,0.001134784,0.00023862034,0.00012337338,0.0006557871,0.001425926,0.000016209911,0.0002856568],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97824347,0.016548099,0.0026663898,0.0013370025,0.00088767963,0.0003173331],"domain_scores_gemma":[0.98261005,0.012370202,0.0036750205,0.00073816755,0.0003410425,0.00026547245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015800815,0.0012176788,0.008240691,0.0017744876,0.00020479101,0.0018615624,0.0008126407,0.0011274257,0.0019037847],"category_scores_gemma":[0.016799534,0.0005611104,0.017281387,0.0021281445,0.0005727914,0.0008803428,0.00082341244,0.0010999427,0.00012982938],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32204583,0.00017558246,0.036859695,0.026063055,0.587932,0.00014689504,0.00010024023,0.0033142047,0.0014123869,0.00023937217,0.00071853236,0.020992173],"study_design_scores_gemma":[0.12081571,0.01198848,0.099312834,0.002250826,0.7555562,0.00030952579,0.00014853943,0.0036421244,0.0011133733,0.0010675691,0.0036540367,0.00014080071],"about_ca_topic_score_codex":0.0010909291,"about_ca_topic_score_gemma":0.0022387689,"teacher_disagreement_score":0.015800815,"about_ca_system_score_codex":0.0007592482,"about_ca_system_score_gemma":0.00060461025,"threshold_uncertainty_score":0.083563745},"labels":[],"label_agreement":null},{"id":"W4392763594","doi":"10.1038/s41416-024-02643-5","title":"Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"China Scholarship Council; Darwin Trust of Edinburgh; Cancer Research UK","keywords":"Medicine; Hazard ratio; Internal medicine; Colorectal cancer; Proportional hazards model; Cancer; Population; Confidence interval; Prospective cohort study; Vitamin D and neurology; Oncology; Gastroenterology","score_opus":0.02017495063852357,"score_gpt":0.33765037535441805,"score_spread":0.31747542471589446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392763594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90630925,0.038497202,0.046429228,0.0014952475,0.00057271594,0.0008866262,0.0022985756,0.00023289632,0.003278289],"genre_scores_gemma":[0.9893121,0.0035091802,0.005408831,0.0003905043,0.00011180744,0.00031054305,0.0007014342,0.000041919033,0.00021370339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95014364,0.03858248,0.0030439536,0.0045130933,0.003212132,0.00050476077],"domain_scores_gemma":[0.87308794,0.08286718,0.019770712,0.02138684,0.002259288,0.0006279818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0581604,0.0007678615,0.0012780962,0.0010491497,0.00062564894,0.0017930107,0.0017315791,0.0015359882,0.0026224286],"category_scores_gemma":[0.13111569,0.0006740424,0.0033369355,0.0018587905,0.001731711,0.00074056984,0.0008701767,0.0009956326,0.00030622908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023588318,0.0003047275,0.866317,0.0025774997,0.039696634,0.00065809913,0.00080116244,0.003065117,0.00081726274,0.0045059416,0.001427033,0.05624117],"study_design_scores_gemma":[0.011359611,0.0069308616,0.85940224,0.0024936767,0.06178055,0.0045508784,0.00050020724,0.016166694,0.0018926274,0.020425275,0.014255322,0.00024201292],"about_ca_topic_score_codex":0.0030697845,"about_ca_topic_score_gemma":0.0016094407,"teacher_disagreement_score":0.0581604,"about_ca_system_score_codex":0.0005310263,"about_ca_system_score_gemma":0.0010017911,"threshold_uncertainty_score":0.30758524},"labels":[],"label_agreement":null},{"id":"W4392989411","doi":"10.1038/s41416-024-02660-4","title":"Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy","year":2024,"lang":"en","type":"retraction","venue":"British Journal of Cancer","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Docetaxel; Autophagy; Medicine; Pantoprazole; Cancer research; Pharmacology; Oncology; Internal medicine; Chemotherapy; Biology; Apoptosis; Biochemistry","score_opus":0.007665110844710987,"score_gpt":0.35716640631994345,"score_spread":0.34950129547523245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392989411","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042057704,0.0049792053,0.00022482948,0.07496657,0.9148878,0.000054395812,0.00032417165,0.00008825885,0.004054185],"genre_scores_gemma":[0.010138374,0.016192917,0.0015220366,0.064519905,0.63173914,0.0003289978,0.0011588953,0.00023533906,0.27416447],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972742,0.00029822832,0.000539946,0.00022955125,0.0012914833,0.00036660364],"domain_scores_gemma":[0.9907053,0.0030936368,0.0006229735,0.00042369025,0.004033567,0.0011208076],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031368362,0.0020531486,0.0020221649,0.0017779304,0.001868199,0.0022018221,0.0031723962,0.0113281375,0.014669085],"category_scores_gemma":[0.020291505,0.001053372,0.0016755523,0.0011665401,0.00161334,0.0014863315,0.0014646066,0.013240317,0.011944637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057092268,0.0000075646326,0.000024991481,0.00014289595,0.000011820414,0.00042741542,0.000021899095,0.000026006861,0.00031040306,0.0003688032,0.99219126,0.0064099045],"study_design_scores_gemma":[0.00004546233,0.000036353984,0.0007698939,0.00012687623,0.000037081747,0.0006367472,0.000032994903,0.00011964143,0.00054906646,0.000264948,0.9973621,0.000018870163],"about_ca_topic_score_codex":0.008330033,"about_ca_topic_score_gemma":0.010440262,"teacher_disagreement_score":0.98867184,"about_ca_system_score_codex":0.0049965964,"about_ca_system_score_gemma":0.0041656666,"threshold_uncertainty_score":0.04907298},"labels":[],"label_agreement":null},{"id":"W4393392723","doi":"10.1038/s41416-024-02638-2","title":"Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Faculty of Medicine and Health, University of Sydney; Wallenberg Centre for Molecular and Translational Medicine; School of Public Health, Imperial College London; National Health and Medical Research Council; Canadian Cancer Society Research Institute; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health; Deutschen Konsortium für Translationale Krebsforschung; Canadian Institutes of Health Research; Technion-Israel Institute of Technology; Universitat de Barcelona; Tokyo Medical and Dental University; Deutsches Krebsforschungszentrum; Clalit Health Services; Binus University; Massey University; Umeå Universitet; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Memorial University of Newfoundland; Imperial College London; University of Toronto; Ministerio de Economía y Competitividad; Vetenskapsrådet; National Natural Science Foundation of China; Monash University; Génome Québec; Medical Center, University of Pittsburgh; City of Hope; World Health Organization; Cedars-Sinai Medical Center; School of Public Health, University of Michigan; Swedish Cancer Foundation; American Cancer Society; University of Ioannina; Kaiser Permanente Washington Health Research Institute; Johns Hopkins University; Centre International de Recherche sur le Cancer; Capital Medical University; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Huntsman Cancer Institute; University of Leeds; McGill University; Division of Cancer Prevention, National Cancer Institute; University of Pittsburgh; University of Washington; Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill; University of Texas MD Anderson Cancer Center; Centers for Disease Control and Prevention; Cancer Council Victoria; University of Melbourne; University of North Carolina at Chapel Hill; Harvard University; Brigham and Women's Hospital; National Center for Advancing Translational Sciences; Kaiser Permanente; Broad Institute; Wageningen University and Research; Cancer Research UK; University of Southern California; Massachusetts General Hospital; U.S. Department of Health and Human Services","keywords":"Quartile; Medicine; Odds ratio; Internal medicine; Logistic regression; Colorectal cancer; Absolute risk reduction; Relative risk; Menopause; Oncology; Cancer; Gynecology; Demography; Confidence interval","score_opus":0.011795836408629563,"score_gpt":0.3085199928284912,"score_spread":0.2967241564198616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393392723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959902,0.0015907392,0.00071059505,0.0002786464,0.000023016186,0.000007886128,0.00036692788,0.000021637425,0.0010104529],"genre_scores_gemma":[0.99933785,0.00016284912,0.0002031646,0.000031343578,0.000013788801,0.000002209307,0.000067974106,0.0000043279697,0.0001764061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990544,0.0005061372,0.000056027056,0.00021077448,0.000088967776,0.00008382846],"domain_scores_gemma":[0.99807656,0.001037157,0.0004920314,0.00014917628,0.00007403406,0.00017110225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066222646,0.0003164849,0.0002715041,0.00052478263,0.00024703023,0.0006065628,0.00023502197,0.00042785285,0.0029784574],"category_scores_gemma":[0.0030618487,0.00018954258,0.00083444244,0.0006911653,0.0003457229,0.00018578343,0.0003330637,0.00038372262,0.0001840306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007495335,0.00005234773,0.9875377,0.000031042255,0.0008101889,0.00023212147,0.000065832945,0.00037844738,0.0049163033,0.00015644413,0.00014133846,0.0049288007],"study_design_scores_gemma":[0.000013111815,0.0001114245,0.9974475,0.0000074764753,0.00029552457,0.00029234609,0.000036354322,0.00090419175,0.00036313588,0.0002257163,0.000297741,0.0000054293478],"about_ca_topic_score_codex":0.0039781886,"about_ca_topic_score_gemma":0.0024746244,"teacher_disagreement_score":0.0039781886,"about_ca_system_score_codex":0.00016301098,"about_ca_system_score_gemma":0.00028584068,"threshold_uncertainty_score":0.00996387},"labels":[],"label_agreement":null},{"id":"W4394691025","doi":"10.1038/s41416-024-02679-7","title":"Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Human Genome Research Institute; BC Cancer Agency; Cancer Research UK; National Cancer Institute; Breast Cancer Now","keywords":"Breast cancer; Medicine; Oncology; Invasive lobular carcinoma; Metastasis; Cancer; Internal medicine; Disease; Bioinformatics; Biology","score_opus":0.006398528452897989,"score_gpt":0.2459426886190653,"score_spread":0.2395441601661673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394691025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933329,0.0007987272,0.003482612,0.00016683301,0.0000072062676,0.000016575339,0.0015897643,0.000060745242,0.000544634],"genre_scores_gemma":[0.99754614,0.00016098753,0.0012058312,0.000021996402,0.0000031162,0.000013815723,0.00091989344,0.0000065756394,0.000121624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998204,0.00004958209,0.000013916115,0.000045612604,0.00003947156,0.000030998188],"domain_scores_gemma":[0.99920183,0.00035409082,0.00027021675,0.000045980745,0.00006567745,0.00006217037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059194496,0.0002763931,0.00028722078,0.0005200766,0.00016488093,0.0005357573,0.00016874622,0.00021067525,0.0013808326],"category_scores_gemma":[0.0014250462,0.00009727,0.00031799136,0.0006086343,0.00019085556,0.00019423055,0.00035184107,0.0004674539,0.00021719956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016523143,0.00016748552,0.9097473,0.00021884264,0.00032973106,0.00023140812,0.00009075132,0.012110052,0.034450803,0.00037194203,0.0007730502,0.039856326],"study_design_scores_gemma":[0.000059199898,0.0005851224,0.90738016,0.000041829153,0.00048015828,0.0009512993,0.00017665654,0.06981049,0.015077675,0.0031742686,0.0022297546,0.000033432636],"about_ca_topic_score_codex":0.0006590465,"about_ca_topic_score_gemma":0.0011293015,"teacher_disagreement_score":0.0013808326,"about_ca_system_score_codex":0.0003567194,"about_ca_system_score_gemma":0.00051411643,"threshold_uncertainty_score":0.00461936},"labels":[],"label_agreement":null},{"id":"W4394813416","doi":"10.1038/s41416-024-02677-9","title":"Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; EMD Serono; Government of Canada; Merck KGaA","keywords":"Ovarian cancer; Immunotherapy; Cancer research; Cytotoxic T cell; Immune system; Medicine; CD8; Perforin; Immunology; Cancer; Transforming growth factor; Tumor microenvironment; Biology; Internal medicine","score_opus":0.02035811710824899,"score_gpt":0.32039403510583647,"score_spread":0.3000359179975875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394813416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622524,0.0010784625,0.0012903056,0.00010564232,0.00002484724,0.000044439876,0.00023042849,0.00010755296,0.000893176],"genre_scores_gemma":[0.9970611,0.00057389366,0.0010359144,0.000043829048,0.000009115174,0.000049355836,0.00029124843,0.000009827413,0.0009256673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990654,0.000010402791,0.000009218489,0.000013562105,0.000029159437,0.000031097778],"domain_scores_gemma":[0.99990344,0.000010208713,0.000033412038,0.000009263608,0.000008704538,0.000034954228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013846756,0.0003097606,0.00026194844,0.00024198493,0.00013084314,0.00021824478,0.00018222061,0.00015906684,0.0012557732],"category_scores_gemma":[0.00007792355,0.000085688844,0.00019056845,0.00014211399,0.00016656143,0.00019943285,0.00014651466,0.00080015714,0.00023268351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079382217,0.00031144134,0.00052380824,0.00007366588,0.000012937354,0.000033068023,0.000023764025,0.00024238009,0.99217856,0.00008051566,0.000120202974,0.0056057493],"study_design_scores_gemma":[0.00014486963,0.004843472,0.004066801,0.000008459963,0.00004082352,0.00022573084,0.000031746455,0.0009871853,0.9861546,0.000041874366,0.003449646,0.000004767828],"about_ca_topic_score_codex":0.0006233446,"about_ca_topic_score_gemma":0.001292594,"teacher_disagreement_score":0.0012557732,"about_ca_system_score_codex":0.0002602187,"about_ca_system_score_gemma":0.00028854868,"threshold_uncertainty_score":0.004200995},"labels":[],"label_agreement":null},{"id":"W4396688575","doi":"10.1038/s41416-024-02701-y","title":"Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Department of Medicine, University of Toronto; Instituto de Salud Carlos III; Conquer Cancer Foundation; Sociedad Española de Oncología Médica; American Society of Clinical Oncology; University of Toronto; Princess Margaret Cancer Foundation","keywords":"Microbiome; Medicine; Oncology; Carcinoma; Cancer; Basal cell; Cancer research; Internal medicine; Bioinformatics; Biology","score_opus":0.005781766799883451,"score_gpt":0.23897171963758207,"score_spread":0.2331899528376986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396688575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995523,0.00014034187,0.00005388894,0.000023106742,0.000007134431,0.000013180801,0.00008316948,0.0000022633028,0.0001246221],"genre_scores_gemma":[0.99882656,0.000104721126,0.00008505839,0.000051140145,0.000011358795,0.000029903784,0.00020463747,0.000004672099,0.0006820361],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997875,0.000065136366,0.000009429086,0.000052302716,0.000023025808,0.000062702886],"domain_scores_gemma":[0.99974376,0.000031860487,0.000060513597,0.00004223414,0.000027478663,0.00009406637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040070468,0.00041959208,0.00049819076,0.00012250473,0.0003866507,0.0005660941,0.0002497718,0.0005695859,0.0018711168],"category_scores_gemma":[0.0005549293,0.00033316982,0.00058716314,0.00023638517,0.0003053562,0.00028778546,0.00041355987,0.00072384626,0.0004343056],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14910899,0.011681901,0.6309401,0.0003246556,0.0016285337,0.0005566993,0.0008255463,0.00036180852,0.16236468,0.00023934893,0.0011093589,0.040858388],"study_design_scores_gemma":[0.0013851665,0.042907782,0.9413431,0.000029577173,0.0012334104,0.00043138184,0.00072328065,0.00059682806,0.008017359,0.00017748012,0.0031217756,0.000032856144],"about_ca_topic_score_codex":0.0012082643,"about_ca_topic_score_gemma":0.0014834936,"teacher_disagreement_score":0.0018711168,"about_ca_system_score_codex":0.00034260558,"about_ca_system_score_gemma":0.00035367048,"threshold_uncertainty_score":0.006259501},"labels":[],"label_agreement":null},{"id":"W4396920139","doi":"10.1038/s41416-024-02709-4","title":"Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer","year":2024,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"EMD Serono; Merck KGaA","keywords":"DNA sequencing; Workflow; Best practice; Computational biology; Medicine; Lung cancer; Bioinformatics; Computer science; Biology; Oncology; DNA; Genetics","score_opus":0.08287403178115656,"score_gpt":0.3611814531473736,"score_spread":0.27830742136621706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396920139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004823846,0.82835305,0.016066631,0.11341017,0.02046251,0.00087025197,0.0021818292,0.0009649657,0.017208226],"genre_scores_gemma":[0.0030273155,0.8540081,0.06961252,0.046622213,0.0041216877,0.0017720321,0.004804872,0.00030087246,0.015730418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9816279,0.006985155,0.0053953184,0.000853525,0.0045862133,0.00055196113],"domain_scores_gemma":[0.95363235,0.019667068,0.005256888,0.0016551694,0.018647315,0.0011412307],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022750853,0.0014646406,0.0027889514,0.006200343,0.0007353923,0.0034278051,0.0077851424,0.008314021,0.0075722476],"category_scores_gemma":[0.04876328,0.0011649289,0.0031860736,0.004855217,0.002516087,0.0052282237,0.0026776346,0.007780058,0.01358523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010789359,0.00006771837,0.00027350406,0.023402115,0.000115984534,0.0004833461,0.00031690436,0.000505792,0.0015190056,0.008321357,0.41343912,0.5514473],"study_design_scores_gemma":[0.000029305234,0.000034906094,0.00042530065,0.01673221,0.00010520251,0.00066846143,0.00010682395,0.00008326093,0.00040059883,0.003214129,0.97816885,0.000031006828],"about_ca_topic_score_codex":0.005560132,"about_ca_topic_score_gemma":0.005824685,"teacher_disagreement_score":0.97724915,"about_ca_system_score_codex":0.0028393257,"about_ca_system_score_gemma":0.007803744,"threshold_uncertainty_score":0.120319486},"labels":[],"label_agreement":null},{"id":"W4399071000","doi":"10.1038/s41416-024-02692-w","title":"The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Cohort; Oncology; Adjuvant chemotherapy; Cohort study; Pancreatic cancer; Adjuvant; Periampullary cancer; General surgery; Gastroenterology; Cancer","score_opus":0.03661280621149079,"score_gpt":0.4207692226584384,"score_spread":0.38415641644694765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399071000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475753,0.0009705686,0.00059167616,0.0006130425,0.000049062648,0.000022258293,0.0017747442,0.000009695334,0.0012113668],"genre_scores_gemma":[0.9971464,0.0003202245,0.0005506654,0.0002103204,0.000033456676,0.00003550887,0.0009940907,0.000017494744,0.0006919854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981731,0.0005146253,0.0001411074,0.0005618697,0.00018553084,0.00042376877],"domain_scores_gemma":[0.9966516,0.00040923696,0.0010742884,0.0011638226,0.0002841151,0.00041701505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021528117,0.00039636978,0.0005340905,0.0005921433,0.0011293418,0.0018192494,0.0009797955,0.0011396724,0.0024827821],"category_scores_gemma":[0.0059332964,0.00077647466,0.0012078115,0.0012400121,0.0003714113,0.0011254615,0.0023096423,0.0019677063,0.0003698055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000839003,0.00006330014,0.990871,0.000025941139,0.0006479378,0.00017309563,0.00048781183,0.00014208845,0.0004616191,0.00034741248,0.001054593,0.0048861783],"study_design_scores_gemma":[0.00006763801,0.00014633388,0.99491924,0.000051030434,0.00049663614,0.000500245,0.00068745785,0.00032160946,0.00011310557,0.00051092065,0.002155277,0.00003060972],"about_ca_topic_score_codex":0.016846327,"about_ca_topic_score_gemma":0.02683771,"teacher_disagreement_score":0.016846327,"about_ca_system_score_codex":0.0006904122,"about_ca_system_score_gemma":0.00084547256,"threshold_uncertainty_score":0.03349656},"labels":[],"label_agreement":null},{"id":"W4399322010","doi":"10.1038/s41416-024-02730-7","title":"Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Ono Pharmaceutical; Hirosaki University","keywords":"Nivolumab; Microsatellite instability; Medicine; Colorectal cancer; Internal medicine; Chemoradiotherapy; Gastroenterology; Oncology; Cancer; Surgery; Immunotherapy; Microsatellite","score_opus":0.009738101648636052,"score_gpt":0.2845658555059519,"score_spread":0.2748277538573159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399322010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667287,0.0022430664,0.00009921632,0.00009321409,0.000046469173,0.000007393202,0.00025310589,0.000008359606,0.0005764101],"genre_scores_gemma":[0.99877423,0.00027162288,0.00002959316,0.00006173711,0.000027315953,0.0000073964775,0.0005311716,0.0000030564406,0.00029389298],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995733,0.00008728614,0.00004935238,0.00006707821,0.00005956577,0.00016341978],"domain_scores_gemma":[0.99893576,0.00022581672,0.00031923133,0.00007610264,0.000089941976,0.00035316788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004888531,0.00024209062,0.0006920228,0.00025778316,0.00029915423,0.0007186082,0.00030258342,0.00055089797,0.0014703401],"category_scores_gemma":[0.0018273036,0.00014876599,0.0017113604,0.00036360705,0.00032409333,0.0005828461,0.00053418474,0.0010774831,0.00028565954],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08840072,0.0017088946,0.7680675,0.0005463666,0.0036977585,0.001479449,0.000703187,0.0058324337,0.0035590057,0.0002247493,0.0025195177,0.123260446],"study_design_scores_gemma":[0.00044508575,0.012360151,0.98000485,0.00009701052,0.0017203308,0.00075911975,0.00039990497,0.0015376324,0.00052585115,0.0002521546,0.0018253813,0.000072514085],"about_ca_topic_score_codex":0.0033927166,"about_ca_topic_score_gemma":0.0065442137,"teacher_disagreement_score":0.0033927166,"about_ca_system_score_codex":0.000823301,"about_ca_system_score_gemma":0.0003997849,"threshold_uncertainty_score":0.0067459345},"labels":[],"label_agreement":null},{"id":"W4399764893","doi":"10.1038/s41416-024-02755-y","title":"Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Government of Canada; Terry Fox Research Institute; Lung Cancer Research Foundation","keywords":"Biology; Adenocarcinoma; Lung cancer; Cancer research; DNA repair; Transcriptome; Gene; Genomics; Copy-number variation; Genetics; Cancer; Gene expression; Oncology; Medicine; Genome","score_opus":0.01157266906522251,"score_gpt":0.3248591430253017,"score_spread":0.3132864739600792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399764893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297804,0.0006847429,0.00467501,0.00007212668,0.0000072434973,0.000018932165,0.00090167805,0.000089443,0.00057285104],"genre_scores_gemma":[0.9952609,0.00033603507,0.0024495532,0.00004397169,0.000007976544,0.000009751644,0.0013971663,0.000016245154,0.0004784414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999175,0.0000082114375,0.0000046232926,0.000030005158,0.000027454178,0.00001217619],"domain_scores_gemma":[0.99989736,0.000028327688,0.000039303417,0.0000097556485,0.000008021197,0.00001720186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012855325,0.0002747125,0.00021592925,0.000484804,0.00012995633,0.00022046338,0.00019707,0.00025457548,0.0012916753],"category_scores_gemma":[0.00012913228,0.00011076,0.00033436497,0.00030410985,0.00018762758,0.000091245856,0.00027701387,0.0003253682,0.00024553938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015944902,0.000021247706,0.01199778,0.00007042756,0.000037804224,0.00044777646,0.000039358903,0.00031615017,0.9811116,0.00015203201,0.00006666866,0.00557976],"study_design_scores_gemma":[0.000054651675,0.00078137044,0.59044677,0.000031045733,0.0002952574,0.0072297067,0.00018952331,0.010846813,0.3832809,0.00065487355,0.0061656437,0.000023392906],"about_ca_topic_score_codex":0.00054144516,"about_ca_topic_score_gemma":0.0011347574,"teacher_disagreement_score":0.0012916753,"about_ca_system_score_codex":0.00017773818,"about_ca_system_score_gemma":0.00014794366,"threshold_uncertainty_score":0.0043210387},"labels":[],"label_agreement":null},{"id":"W4400099932","doi":"10.1038/s41416-024-02748-x","title":"The Physical Activity and Cancer Control (PACC) framework: update on the evidence, guidelines, and future research priorities","year":2024,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Cancer; Internal medicine","score_opus":0.15273906993052414,"score_gpt":0.48168691488541976,"score_spread":0.3289478449548956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400099932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001007122,0.9709463,0.0015728488,0.023091348,0.0021692782,0.0002661688,0.0003284048,0.000045920267,0.0014789841],"genre_scores_gemma":[0.0048557958,0.96736485,0.011259312,0.012011008,0.0015104879,0.0014795619,0.0009752479,0.00004250411,0.0005012186],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9627839,0.018510427,0.007497041,0.0019183704,0.007960445,0.0013297995],"domain_scores_gemma":[0.92170775,0.052462056,0.005841817,0.0014800566,0.016709989,0.0017983356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.062222976,0.0026411845,0.0077867853,0.0136233475,0.0015459144,0.005465409,0.0063631632,0.0071899407,0.0060919356],"category_scores_gemma":[0.075995184,0.0011596726,0.00649107,0.011268926,0.0034478516,0.0051937886,0.0049815723,0.009585385,0.0016086999],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018235524,0.00012202538,0.0009568461,0.14220355,0.0010575126,0.000094752744,0.00044037128,0.0010131713,0.00011815449,0.022800481,0.11645844,0.71455234],"study_design_scores_gemma":[0.00015662205,0.0001763147,0.00229341,0.43091697,0.0021696305,0.0002738253,0.00035780575,0.00052262895,0.00013157517,0.0122535955,0.55066156,0.00008593278],"about_ca_topic_score_codex":0.034387138,"about_ca_topic_score_gemma":0.03253599,"teacher_disagreement_score":0.062222976,"about_ca_system_score_codex":0.014157649,"about_ca_system_score_gemma":0.045354582,"threshold_uncertainty_score":0.32907045},"labels":[],"label_agreement":null},{"id":"W4400367857","doi":"10.1038/s41416-024-02782-9","title":"Cancer cell extravasation requires iplectin-mediated delivery of MT1-MMP at invadopodia","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Health Sciences Centre; University of Toronto; University of Windsor; Sunnybrook Health Science Centre","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Movember Foundation","keywords":"Invadopodia; Extravasation; Cancer; Matrix metalloproteinase; Medicine; Cancer research; Pathology; Cancer cell; Internal medicine","score_opus":0.00952251555105756,"score_gpt":0.2626276060215666,"score_spread":0.25310509047050905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400367857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864145,0.002309957,0.005047277,0.00038453453,0.00004154193,0.00004743568,0.0004654881,0.00013479342,0.005154585],"genre_scores_gemma":[0.9904411,0.00062426244,0.0029339036,0.00008212876,0.000008451873,0.000028750337,0.00044985727,0.00003185354,0.0053997133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998196,0.000018847493,0.0000113027,0.00003111317,0.000052407,0.0000666791],"domain_scores_gemma":[0.99989784,0.000026860085,0.00001963747,0.000013293715,0.000014769969,0.000027598358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010884064,0.0001714582,0.00022929891,0.000178255,0.00028065237,0.00055182975,0.00018597538,0.00048436705,0.0017875946],"category_scores_gemma":[0.00015452213,0.00018095286,0.00022509054,0.00018587646,0.00016738487,0.00035211636,0.00030924834,0.00084252516,0.0008484445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011376199,0.000027364316,0.00019556555,0.00005584903,0.000005372242,0.00010953882,0.000041683565,0.000120838624,0.99678063,0.00034648526,0.00014418998,0.0020588227],"study_design_scores_gemma":[0.0000248419,0.0001256408,0.006467617,0.000009586563,0.000009358936,0.00037809322,0.000049020626,0.0018779389,0.98466635,0.00006927284,0.0063159754,0.000006178839],"about_ca_topic_score_codex":0.0018617425,"about_ca_topic_score_gemma":0.002781159,"teacher_disagreement_score":0.0018617425,"about_ca_system_score_codex":0.0007163364,"about_ca_system_score_gemma":0.00028764937,"threshold_uncertainty_score":0.005980134},"labels":[],"label_agreement":null},{"id":"W4400781872","doi":"10.1038/s41416-024-02792-7","title":"Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: results from the Ovarian Cancer Association Consortium","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coffee research and impacts","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Medical Research and Materiel Command; Congressionally Directed Medical Research Programs; National Health and Medical Research Council; Medical Research Council; Peter MacCallum Foundation; National Cancer Institute; Ovarian Cancer Australia; Rutgers Cancer Institute of New Jersey; California Breast Cancer Research Program; Kræftens Bekæmpelse; U.S. Department of Health and Human Services; Ovarian Cancer Research Fund; National Institutes of Health; Cancer Council Victoria; Cancer Australia; U.S. Department of Defense","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Gynecology; Internal medicine; Traditional medicine","score_opus":0.024101199573402246,"score_gpt":0.32874444264456454,"score_spread":0.3046432430711623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400781872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7511693,0.17395666,0.001006599,0.004760468,0.00035928382,0.0003209526,0.05810443,0.000076181466,0.010246274],"genre_scores_gemma":[0.94718945,0.021403782,0.000485732,0.0006792443,0.00030996662,0.00031305352,0.028450694,0.000049543552,0.0011185003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930456,0.0029751062,0.001119805,0.00070748816,0.0017862183,0.00036582391],"domain_scores_gemma":[0.96871424,0.01300778,0.009294858,0.0020860306,0.0049115364,0.001985555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008710791,0.00032423425,0.0008987379,0.0035204682,0.0004103342,0.0011773787,0.00078497146,0.0006928431,0.003573104],"category_scores_gemma":[0.023008736,0.00028350443,0.0026281856,0.0064842594,0.00034836703,0.00038309963,0.0015222019,0.00063949946,0.00034369083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032757572,0.000043324773,0.9661799,0.0021138748,0.0068976567,0.00010202917,0.00017811146,0.00021339748,0.00021589707,0.000092294504,0.005199834,0.015487865],"study_design_scores_gemma":[0.00017744809,0.00010599781,0.9913231,0.00035653284,0.003085683,0.00013432479,0.00009071792,0.000047542377,0.00006154894,0.00004975893,0.0045476146,0.000019616225],"about_ca_topic_score_codex":0.019739743,"about_ca_topic_score_gemma":0.027576672,"teacher_disagreement_score":0.019739743,"about_ca_system_score_codex":0.000679428,"about_ca_system_score_gemma":0.0012054059,"threshold_uncertainty_score":0.046067595},"labels":[],"label_agreement":null},{"id":"W4400933413","doi":"10.1038/s41416-024-02796-3","title":"COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Bevacizumab; Medicine; Durvalumab; FOLFOX; Oxaliplatin; Colorectal cancer; Internal medicine; Confidence interval; Adverse effect; Oncology; Cancer; Surgery; Chemotherapy; Nivolumab; Immunotherapy","score_opus":0.0119592495075272,"score_gpt":0.2942578742307003,"score_spread":0.28229862472317313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400933413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069864,0.002418648,0.00022735108,0.00044690512,0.00034749488,0.0034797955,0.00059772097,0.00006784269,0.0017157017],"genre_scores_gemma":[0.9881088,0.0021191419,0.0010307027,0.0010053029,0.00036004835,0.0029713833,0.0011619771,0.000019738853,0.0032228986],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99919873,0.00044793784,0.000041542826,0.00012293998,0.00007711861,0.00011174986],"domain_scores_gemma":[0.99886286,0.00027153146,0.00019892889,0.00007295009,0.000075309574,0.000518495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016786635,0.0014488071,0.0023314597,0.00051461364,0.0004062591,0.0010976279,0.0012245114,0.0014962436,0.006951971],"category_scores_gemma":[0.0023338776,0.00082192494,0.001352546,0.00047970563,0.001152031,0.00086687016,0.0006080197,0.0025545936,0.00089205446],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9742536,0.008766989,0.0005321295,0.0005368668,0.0006280102,0.00004038324,0.000054908374,0.00024412367,0.0024068616,0.00006890068,0.00059427065,0.011873009],"study_design_scores_gemma":[0.927447,0.07038288,0.0011510856,0.000019286628,0.00022301082,0.000023149538,0.000015861842,0.00018344754,0.00012792018,0.00004253136,0.0003726643,0.0000111715935],"about_ca_topic_score_codex":0.0041669486,"about_ca_topic_score_gemma":0.012694319,"teacher_disagreement_score":0.006951971,"about_ca_system_score_codex":0.001794587,"about_ca_system_score_gemma":0.0025420575,"threshold_uncertainty_score":0.0232566},"labels":[],"label_agreement":null},{"id":"W4401118527","doi":"10.1038/s41416-024-02799-0","title":"Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG)","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent","keywords":"Wilms tumour; Medicine; Wilms' tumor; Urology; Internal medicine; Oncology","score_opus":0.010615376200675927,"score_gpt":0.2814045815394234,"score_spread":0.27078920533874745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401118527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981111,0.00023990979,0.000044748846,0.000032373275,0.000005168074,0.0000027368758,0.0010663003,0.000003275952,0.00049433875],"genre_scores_gemma":[0.99784064,0.00011354949,0.000017285482,0.000012287015,0.0000096239755,0.0000053200265,0.00176304,0.0000043603995,0.00023381467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960464,0.00008296992,0.000045183242,0.00011420349,0.000068210014,0.000084833875],"domain_scores_gemma":[0.9987208,0.00014817805,0.00055223616,0.00012634456,0.00009153734,0.0003608358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004801881,0.00026150877,0.00040619113,0.00073679,0.00028815086,0.0006791066,0.00039644574,0.0005613559,0.0017058613],"category_scores_gemma":[0.0014173627,0.00037493926,0.0005119511,0.0013383413,0.000257836,0.00062302983,0.0005719087,0.0005326061,0.00029439497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035406894,0.000017710428,0.997922,0.000008209945,0.000080783044,0.00026336432,0.00005226052,0.000082560065,0.00039598456,0.000018271554,0.00016128135,0.0006435484],"study_design_scores_gemma":[0.000010122096,0.000043916334,0.99928683,0.0000019984996,0.00002175275,0.00036184984,0.00006155352,0.0000509485,0.000027808954,0.000011573861,0.00011850887,0.0000031604986],"about_ca_topic_score_codex":0.0062768646,"about_ca_topic_score_gemma":0.0053795744,"teacher_disagreement_score":0.0062768646,"about_ca_system_score_codex":0.0003329393,"about_ca_system_score_gemma":0.00022354082,"threshold_uncertainty_score":0.012480676},"labels":[],"label_agreement":null},{"id":"W4401562362","doi":"10.1038/s41416-024-02819-z","title":"Cost-effectiveness of point of care smoking cessation interventions in oncology clinics","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Horizon Health Network; Government of New Brunswick; Ottawa Public Health; University of Ottawa","funders":"","keywords":"Medicine; Smoking cessation; Varenicline; Psychological intervention; Nicotine replacement therapy; Cost effectiveness; Bupropion; Psychiatry","score_opus":0.0796864497507714,"score_gpt":0.44783552567187856,"score_spread":0.3681490759211072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401562362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668952,0.007664578,0.009958889,0.0028111215,0.00013234126,0.001927449,0.0015761949,0.00009518139,0.0089390855],"genre_scores_gemma":[0.99647397,0.0007274142,0.0020133106,0.00017572434,0.000016476923,0.00024189906,0.0001519612,0.0000037702332,0.00019542933],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9930345,0.0052369423,0.00024139538,0.00034673774,0.00050484185,0.0006356144],"domain_scores_gemma":[0.9764836,0.019156927,0.0023335242,0.0002783637,0.00074621086,0.0010015017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058858376,0.0012078005,0.0012898558,0.0011775785,0.00040841108,0.0014272138,0.0016398022,0.0018836241,0.005899919],"category_scores_gemma":[0.032470126,0.0005960751,0.0026856498,0.0011092235,0.0007165205,0.0012044378,0.0010825003,0.001242044,0.00017951429],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009792167,0.0025863056,0.048439156,0.0019903395,0.0037961581,0.00027429525,0.00012951627,0.8517044,0.0004201601,0.0038914883,0.001361198,0.07561473],"study_design_scores_gemma":[0.008713226,0.020418683,0.05888878,0.0017072625,0.0061515425,0.00054452394,0.0005165769,0.8876514,0.00090916106,0.011510034,0.0028430407,0.00014576725],"about_ca_topic_score_codex":0.029527856,"about_ca_topic_score_gemma":0.017787628,"teacher_disagreement_score":0.029527856,"about_ca_system_score_codex":0.008149802,"about_ca_system_score_gemma":0.0061608027,"threshold_uncertainty_score":0.059131205},"labels":[],"label_agreement":null},{"id":"W4402635099","doi":"10.1038/s41416-024-02739-y","title":"Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multi-site study","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Medical Research Council; Maastricht Universitair Medisch Centrum","keywords":"Breast cancer; Multivariate statistics; Multivariate analysis; Medicine; Pathology; Computational biology; Cancer; Ex vivo; Oncology; Bioinformatics; Computer science; Biology; In vivo; Internal medicine; Machine learning; Genetics","score_opus":0.042403991679281154,"score_gpt":0.34582916297869204,"score_spread":0.3034251712994109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402635099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89492565,0.00049126544,0.10114402,0.00019730625,0.00007213402,0.0006130158,0.00069854176,0.00058548566,0.0012725468],"genre_scores_gemma":[0.89569294,0.00022247968,0.1019197,0.00014195597,0.000032145672,0.00037732936,0.00067928777,0.0001362056,0.0007979033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934702,0.0026983395,0.00030299657,0.001530571,0.0017092008,0.00028873805],"domain_scores_gemma":[0.9925299,0.0026585865,0.0010309279,0.0014776716,0.001923107,0.00037975522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013070915,0.0010605757,0.0006583325,0.0013115691,0.00057106634,0.0011121564,0.0012892005,0.0012508736,0.0015152654],"category_scores_gemma":[0.009192582,0.00041769946,0.00081808993,0.00068121887,0.0010138762,0.0006205755,0.0011814805,0.0006543716,0.00098112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002483151,0.0010802534,0.1340235,0.00038519458,0.0005979943,0.00032365456,0.0007253893,0.008173944,0.7916713,0.00032304783,0.0005361143,0.05967651],"study_design_scores_gemma":[0.00012895362,0.010289364,0.24624458,0.00007181068,0.0006425154,0.0023736474,0.0011339859,0.0748436,0.65978694,0.00078238384,0.003514121,0.0001881141],"about_ca_topic_score_codex":0.0016979027,"about_ca_topic_score_gemma":0.00240628,"teacher_disagreement_score":0.013070915,"about_ca_system_score_codex":0.0003357692,"about_ca_system_score_gemma":0.0005200746,"threshold_uncertainty_score":0.06912643},"labels":[],"label_agreement":null},{"id":"W4403074281","doi":"10.1038/s41416-024-02855-9","title":"Loss of EMI1 compromises chromosome stability and is associated with cellular transformation in colonic epithelial cell contexts","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada; CancerCare Manitoba Foundation; Cancer Research Society; Strong; Research Manitoba","keywords":"Biology; Gene silencing; Chromosome instability; Genome instability; CRISPR; Phenotype; Cell biology; Genetics; Cancer research; Gene; Chromosome; DNA damage; DNA","score_opus":0.006419839051853307,"score_gpt":0.2304855794365222,"score_spread":0.2240657403846689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403074281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988489,0.0022306582,0.0053149457,0.00016472794,0.000037215825,0.000029649149,0.0007536787,0.00019152525,0.002788586],"genre_scores_gemma":[0.9930836,0.00071004394,0.0021288362,0.00006355036,0.000002675126,0.000033189153,0.00081476686,0.000036094236,0.0031271162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975044,0.00002876791,0.000024463208,0.00006278524,0.0000822376,0.00005136036],"domain_scores_gemma":[0.99977595,0.000042962107,0.000068835776,0.00003340491,0.000027665084,0.000051114803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015771498,0.0003139533,0.00028177229,0.00033915625,0.00021739968,0.0003666677,0.00023351381,0.00040651613,0.0020343687],"category_scores_gemma":[0.00015914315,0.00016547754,0.0002865261,0.00021954041,0.00032085116,0.00019724462,0.00035159997,0.0007654112,0.00050574937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052622385,0.000015291995,0.0003151498,0.00003004304,0.0000040947098,0.000043105523,0.000009761037,0.00003831373,0.99883765,0.000041295985,0.000033591656,0.00057914364],"study_design_scores_gemma":[0.000003827418,0.00015713325,0.011432407,0.0000057972184,0.000010800223,0.00029815894,0.000044860724,0.0006732836,0.9857722,0.000025396615,0.0015717485,0.000004277504],"about_ca_topic_score_codex":0.0010179534,"about_ca_topic_score_gemma":0.0016934066,"teacher_disagreement_score":0.0020343687,"about_ca_system_score_codex":0.00046935127,"about_ca_system_score_gemma":0.00019788001,"threshold_uncertainty_score":0.0068056583},"labels":[],"label_agreement":null},{"id":"W4404575005","doi":"10.1038/s41416-024-02899-x","title":"Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research","year":2024,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Princess Margaret Cancer Centre; Takeda (Canada); University Health Network","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Observational study; Translational research; Stakeholder; Data science; Clinical study design; Management science; Precision medicine; Computer science; Clinical trial; Medicine; Medical physics; Pathology; Engineering; Political science; Public relations","score_opus":0.7331778549258957,"score_gpt":0.592358564171885,"score_spread":0.14081929075401067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404575005","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096490775,0.16605693,0.82230824,0.0071629724,0.0010840755,0.00038631586,0.00039606722,0.00041149685,0.001229077],"genre_scores_gemma":[0.042119272,0.140291,0.80626,0.004938394,0.0020000667,0.0028536727,0.00046554947,0.0002191332,0.000852913],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.94804156,0.043107886,0.0023189676,0.001987906,0.0042941654,0.00024959087],"domain_scores_gemma":[0.71511686,0.2685031,0.0034300473,0.0072531356,0.0048850398,0.00081190333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.108326405,0.0017503276,0.0058990885,0.0026276344,0.0005869603,0.002995898,0.005274157,0.0034975007,0.0019996264],"category_scores_gemma":[0.13691692,0.0013932965,0.0039577186,0.002596266,0.004645965,0.0022847196,0.003744741,0.009100345,0.0005331628],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000307447,0.00013231128,0.0035404116,0.013273879,0.003286119,0.00020570724,0.0004793499,0.026729682,0.0004377244,0.17443597,0.010702732,0.7664686],"study_design_scores_gemma":[0.00046818805,0.0005483588,0.005998834,0.008323654,0.0018211113,0.0006335696,0.0002135872,0.056985375,0.00076993793,0.8086427,0.11540522,0.00018949398],"about_ca_topic_score_codex":0.002737123,"about_ca_topic_score_gemma":0.0034578093,"teacher_disagreement_score":0.108326405,"about_ca_system_score_codex":0.002149574,"about_ca_system_score_gemma":0.005309601,"threshold_uncertainty_score":0.5728916},"labels":[],"label_agreement":null},{"id":"W4404642217","doi":"10.1038/s41416-024-02900-7","title":"Associations of blood lipids and LDL cholesterol lowering drug-targets with colorectal cancer risk: a Mendelian randomisation study","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Medical Research Council; World Cancer Research Fund; Wereld Kanker Onderzoek Fonds; National Cancer Institute; Cancer Research UK; World Cancer Research Fund International; World Health Organization","keywords":"Medicine; Blood lipids; Internal medicine; Diabetes mellitus; Colorectal cancer; Mendelian randomization; Cholesterol; Endocrinology; Cancer; Oncology; Bioinformatics; Biology; Genetics; Genotype; Genetic variants; Gene","score_opus":0.0057676751744467295,"score_gpt":0.25840113006603205,"score_spread":0.25263345489158534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404642217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90770763,0.003209265,0.08114692,0.00046365362,0.000203182,0.004030727,0.0014752838,0.0003384115,0.0014249056],"genre_scores_gemma":[0.98073673,0.00033075624,0.014275696,0.00028639886,0.000060391816,0.0027144237,0.0007285078,0.000045938585,0.0008210381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.975182,0.018968672,0.0013049729,0.0027260478,0.0013581443,0.0004601706],"domain_scores_gemma":[0.9839392,0.008002618,0.002403844,0.0047686114,0.0006100121,0.00027575126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022052577,0.0012137104,0.0015865767,0.000849873,0.00055135053,0.00072032644,0.0013057148,0.0011701705,0.0026447377],"category_scores_gemma":[0.043066368,0.0007938581,0.001979192,0.0010943584,0.00077255076,0.00052599655,0.00061963574,0.0008243309,0.00038498492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11029526,0.0019494481,0.7732143,0.0019980404,0.030868579,0.0033810327,0.001548112,0.0056753037,0.008839302,0.007280819,0.004539643,0.050410163],"study_design_scores_gemma":[0.056846566,0.043053597,0.7085923,0.0006797643,0.040453725,0.015831836,0.000583901,0.09284112,0.006761953,0.016122758,0.017669259,0.0005633123],"about_ca_topic_score_codex":0.0025619112,"about_ca_topic_score_gemma":0.0013690732,"teacher_disagreement_score":0.022052577,"about_ca_system_score_codex":0.0006216111,"about_ca_system_score_gemma":0.0007972106,"threshold_uncertainty_score":0.11662656},"labels":[],"label_agreement":null},{"id":"W4404974723","doi":"10.1038/s41416-024-02918-x","title":"Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Clusterin; Sorafenib; Renal cell carcinoma; Cancer research; Carcinoma; Medicine; Oncology; Internal medicine; Apoptosis; Biology; Hepatocellular carcinoma","score_opus":0.03053364576089337,"score_gpt":0.33815987954380083,"score_spread":0.3076262337829075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404974723","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006460522,0.00500362,0.00044166308,0.06320878,0.92849696,0.000038580132,0.00012929708,0.000115939736,0.0019191622],"genre_scores_gemma":[0.003895545,0.0038945214,0.00027961988,0.03880379,0.93771595,0.000040918756,0.000091058304,0.000036870613,0.0152417505],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853265,0.00022158904,0.00016399489,0.00024083653,0.00070948637,0.00013142785],"domain_scores_gemma":[0.9938187,0.0019900373,0.00054187607,0.00016405967,0.0024962244,0.0009890909],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0022783102,0.00152609,0.0013317049,0.00087327865,0.0011269168,0.0022333325,0.0016444371,0.0074190754,0.0057782107],"category_scores_gemma":[0.0062536392,0.0006660104,0.001396296,0.00042596803,0.0012424145,0.001195421,0.0005458957,0.009576159,0.0038741136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020288136,0.000027619015,0.00008927031,0.00026180313,0.000027638753,0.0003841453,0.000016299478,0.00003970563,0.0006647822,0.00030978816,0.98919314,0.008783],"study_design_scores_gemma":[0.00014583296,0.00016161523,0.00083061465,0.00015055132,0.00009767884,0.0009689481,0.000044418088,0.0003038736,0.0012842495,0.0006283427,0.9953571,0.000026827505],"about_ca_topic_score_codex":0.0007897489,"about_ca_topic_score_gemma":0.0013802141,"teacher_disagreement_score":0.99258095,"about_ca_system_score_codex":0.0015303501,"about_ca_system_score_gemma":0.0011463036,"threshold_uncertainty_score":0.019330084},"labels":[],"label_agreement":null},{"id":"W4406823484","doi":"10.1038/s41416-024-02915-0","title":"Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migration","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Technische Universität Dresden; Deutsche Forschungsgemeinschaft; Wilhelm Sander-Stiftung","keywords":"Pancreatic cancer; Cancer research; Tumor microenvironment; Cell migration; Metastasis; Downregulation and upregulation; Biology; Phenotype; Extracellular vesicles; Cancer cell; Extracellular vesicle; Cancer; Cell; Microvesicles; Medicine; Cell biology; Internal medicine; microRNA; Gene","score_opus":0.004792139690771729,"score_gpt":0.2305673150484834,"score_spread":0.2257751753577117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406823484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655163,0.0020879293,0.00055708154,0.000029125387,0.000009794815,0.000009482993,0.00014413019,0.00001580299,0.00059508625],"genre_scores_gemma":[0.9979341,0.0008463958,0.000361071,0.000015237346,0.0000065903973,0.000011443785,0.00029519934,0.000004178462,0.0005258077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999021,0.000018862644,0.0000102391705,0.000018479683,0.00002200422,0.000028274573],"domain_scores_gemma":[0.9999169,0.00001483833,0.000030222482,0.0000059929066,0.000011286469,0.000020635705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001316604,0.00018956228,0.00016534096,0.00025240058,0.00016946277,0.0004159858,0.000061954655,0.00018349128,0.0010277032],"category_scores_gemma":[0.00020218553,0.000060916012,0.00026133977,0.000197539,0.000108512766,0.00019136834,0.00038674913,0.00031743615,0.00022580397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010930636,0.00007317795,0.0213733,0.000292524,0.000058149744,0.0006828784,0.00014755,0.00028508,0.9607492,0.00015509895,0.00018945559,0.014900403],"study_design_scores_gemma":[0.000059172562,0.0019071088,0.2826244,0.00010402108,0.00018361118,0.008184596,0.0009812663,0.002082797,0.6895455,0.00033928992,0.013964034,0.000024205572],"about_ca_topic_score_codex":0.0002877583,"about_ca_topic_score_gemma":0.00030892153,"teacher_disagreement_score":0.0010277032,"about_ca_system_score_codex":0.00016515722,"about_ca_system_score_gemma":0.00017233312,"threshold_uncertainty_score":0.003437996},"labels":[],"label_agreement":null},{"id":"W4408253655","doi":"10.1038/s41416-025-02969-8","title":"The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics","year":2025,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Epigenetics; microRNA; Hepatocellular carcinoma; DNA methylation; Biology; Cancer research; Chromatin; Epigenetic therapy; Histone; Cancer; Bioinformatics; Genetics; Gene; Gene expression","score_opus":0.01711381264686379,"score_gpt":0.29949748922974884,"score_spread":0.28238367658288505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408253655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006261151,0.99843425,0.0001384999,0.00050028577,0.00022140118,0.000002096474,0.0000066570865,0.000005302873,0.00062880403],"genre_scores_gemma":[0.00067751436,0.99816847,0.00014011135,0.0002045163,0.00028182313,0.0000039080537,0.000016362248,0.000001304295,0.0005058678],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998511,0.000041485193,0.000018530322,0.000023108823,0.0000479709,0.000017884759],"domain_scores_gemma":[0.99971396,0.00013411,0.00002907239,0.00001327979,0.00007664881,0.000032945372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060442643,0.00076055137,0.001133087,0.0015766346,0.0002562719,0.00081934436,0.000923075,0.0012651206,0.003129397],"category_scores_gemma":[0.00065138,0.00022669467,0.0003551768,0.0015269723,0.00094715826,0.0014495392,0.00078917533,0.002009551,0.0018809332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097785225,0.00007250901,0.00021869174,0.008885638,0.00006223175,0.00033429073,0.00006659228,0.00062136666,0.0026561902,0.009583963,0.031208578,0.9461921],"study_design_scores_gemma":[0.00001757417,0.00009179202,0.0010269978,0.0025123684,0.000053645977,0.0019561942,0.00007502471,0.0001897822,0.0006850075,0.006851584,0.9865144,0.000025647194],"about_ca_topic_score_codex":0.0009778263,"about_ca_topic_score_gemma":0.0014544803,"teacher_disagreement_score":0.003129397,"about_ca_system_score_codex":0.00090644043,"about_ca_system_score_gemma":0.0011257066,"threshold_uncertainty_score":0.010468841},"labels":[],"label_agreement":null},{"id":"W4408519118","doi":"10.1038/s41416-025-02966-x","title":"Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck; AstraZeneca","keywords":"Olaparib; Medicine; BRCA mutation; Oncology; Ovarian cancer; Internal medicine; Germline mutation; Cohort; Cancer; Mutation; Biology; Genetics","score_opus":0.009865581849015198,"score_gpt":0.2956261631054802,"score_spread":0.285760581256465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408519118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430215,0.0045176176,0.00016316344,0.00010407472,0.000016561271,0.000050792594,0.0002967192,0.00001908632,0.000529778],"genre_scores_gemma":[0.9987104,0.0005497025,0.0000925347,0.00007086739,0.00002060888,0.000043731772,0.00040076315,0.0000019104712,0.00010956464],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997025,0.00011921679,0.000024659512,0.00006207044,0.000049298924,0.00004221601],"domain_scores_gemma":[0.999238,0.00023568433,0.0002903075,0.00006071768,0.000035969093,0.00013929758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010756702,0.0002614806,0.0005851218,0.00018995181,0.00009161798,0.0003818847,0.00029588796,0.0002804903,0.0013705831],"category_scores_gemma":[0.0010772132,0.00009149652,0.00064176373,0.00023211625,0.0001945974,0.0003261443,0.00024049148,0.0006217625,0.00010438719],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5000731,0.0025241547,0.13954023,0.0010476583,0.0024357869,0.0001989114,0.00012978936,0.0041555557,0.013220581,0.00016302211,0.002914328,0.33359694],"study_design_scores_gemma":[0.13565286,0.231381,0.60609674,0.0003138619,0.003997715,0.0021880472,0.00010559408,0.006334834,0.0063892934,0.00105461,0.0064238566,0.00006157211],"about_ca_topic_score_codex":0.00024871883,"about_ca_topic_score_gemma":0.0006108426,"teacher_disagreement_score":0.0013705831,"about_ca_system_score_codex":0.00045125748,"about_ca_system_score_gemma":0.00036183436,"threshold_uncertainty_score":0.005688727},"labels":[],"label_agreement":null},{"id":"W4410027641","doi":"10.1038/s41416-025-03029-x","title":"Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Saskatchewan; McGill University; Sunnybrook Health Science Centre; University of Manitoba; Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Public Health Ontario; University of British Columbia; McMaster University; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute; Canada Research Chairs; Kreftforeningen; Cleveland Clinic","keywords":"Breastfeeding; Breast cancer; Parity (physics); Medicine; Breast feeding; Oncology; Obstetrics; Gynecology; Cancer; Internal medicine; Pediatrics","score_opus":0.003493009805482302,"score_gpt":0.24228740530966075,"score_spread":0.23879439550417844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410027641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966627,0.001918372,0.00005704148,0.00021089446,0.00004466891,0.0000017342594,0.0002589555,0.0000059775284,0.0008396755],"genre_scores_gemma":[0.99874085,0.000378879,0.000057412555,0.000055562956,0.00002892272,0.0000031553786,0.00016256305,0.0000045017687,0.0005681348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999706,0.00009855038,0.00002567447,0.0000456573,0.000047123332,0.00007713349],"domain_scores_gemma":[0.99835867,0.0006072407,0.0004495654,0.00010623316,0.00007809846,0.00040026035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005730065,0.00026500988,0.0004502407,0.00053805456,0.00036038863,0.0005277834,0.00037675997,0.0010029816,0.0034860505],"category_scores_gemma":[0.0036685925,0.00044825065,0.00057306606,0.0006932004,0.00022801937,0.00034897815,0.00037410826,0.0010351475,0.00030626147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016373039,0.00007769138,0.99355924,0.000019714962,0.00013431294,0.0004533639,0.000114016446,0.00005774937,0.0007765042,0.000027183434,0.00016019263,0.0029825084],"study_design_scores_gemma":[0.000022966813,0.00018215062,0.99822885,0.000013250431,0.000088595334,0.000781085,0.00012274102,0.00023420741,0.000050034934,0.000055193967,0.00021276726,0.000008245979],"about_ca_topic_score_codex":0.0066506825,"about_ca_topic_score_gemma":0.005788127,"teacher_disagreement_score":0.0066506825,"about_ca_system_score_codex":0.0002139102,"about_ca_system_score_gemma":0.00024803446,"threshold_uncertainty_score":0.013223946},"labels":[],"label_agreement":null},{"id":"W4410111629","doi":"10.1038/s41416-025-03025-1","title":"Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"FOLFIRINOX; Gemcitabine; Paclitaxel; Medicine; Adenocarcinoma; Oncology; Neoadjuvant therapy; Internal medicine; Nab-paclitaxel; Induction chemotherapy; Chemotherapy; Oxaliplatin; Cancer","score_opus":0.01697114853347862,"score_gpt":0.33562212314476114,"score_spread":0.3186509746112825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410111629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835265,0.0011902034,0.000040478975,0.00005488303,0.000023986362,0.000017626706,0.000110413675,0.000003140166,0.00020661874],"genre_scores_gemma":[0.99867296,0.00040406425,0.00006057649,0.00012108177,0.000054782224,0.000038800394,0.0004006658,0.000004167598,0.00024299255],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989215,0.00046352018,0.0000824035,0.00025815383,0.00007574214,0.00019871985],"domain_scores_gemma":[0.9988533,0.00029713567,0.00030672565,0.00014458603,0.00004642636,0.00035182136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014431133,0.0008634445,0.0014741345,0.00037175382,0.0004267008,0.00088933867,0.0005220927,0.001121732,0.0013093993],"category_scores_gemma":[0.001808072,0.00047135202,0.0024427036,0.0006942939,0.0008083754,0.0010146807,0.0006141877,0.0015222069,0.00028882857],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6966614,0.004913648,0.2597143,0.0003657276,0.002937195,0.0006040182,0.0005523298,0.0018811263,0.006080272,0.00007038898,0.0006187574,0.025600843],"study_design_scores_gemma":[0.031015875,0.11357726,0.8465566,0.00011705665,0.0035505707,0.0008457329,0.0004263062,0.0010460971,0.0009847954,0.00020697924,0.0015695738,0.00010319066],"about_ca_topic_score_codex":0.0013076912,"about_ca_topic_score_gemma":0.0018049593,"teacher_disagreement_score":0.0014741345,"about_ca_system_score_codex":0.0011670365,"about_ca_system_score_gemma":0.0005998888,"threshold_uncertainty_score":0.008467436},"labels":[],"label_agreement":null},{"id":"W4411231153","doi":"10.1038/s41416-025-03064-8","title":"Association between methylation quantitative trait loci and colorectal cancer risk, survival and cancer recurrence","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Science Fund for Distinguished Young Scholars of Zhejiang Province; National Natural Science Foundation of China; Cancer Research UK","keywords":"Colorectal cancer; Oncology; Cancer; Methylation; DNA methylation; Quantitative trait locus; Biology; Internal medicine; Medicine; Genetics; Gene","score_opus":0.01592854420507332,"score_gpt":0.325806770660358,"score_spread":0.3098782264552847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411231153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974623,0.0004561319,0.0010291155,0.00007114006,0.0000052779474,0.000006702825,0.0006563168,0.000014408445,0.0002987187],"genre_scores_gemma":[0.99923587,0.00005510757,0.00031657793,0.000013874303,0.0000064196634,0.0000046797218,0.00024990388,0.00000263142,0.000114959454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942976,0.00014194522,0.00005177748,0.00018034928,0.0001299386,0.000066073],"domain_scores_gemma":[0.9978732,0.0008143439,0.00079418684,0.00018280814,0.00017034505,0.0001651071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010149741,0.00024878263,0.0002494962,0.0007371015,0.00025013357,0.00032116452,0.00031556172,0.00037110317,0.004329409],"category_scores_gemma":[0.0034844673,0.000117451695,0.00037039316,0.0008467299,0.00032136208,0.00013972877,0.00035892715,0.0004194471,0.00020649156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032331026,0.000024893521,0.98744863,0.000048213096,0.00021761346,0.000118450305,0.000079296435,0.00013951547,0.0063526295,0.00008151412,0.00010206314,0.0050639175],"study_design_scores_gemma":[0.000011093164,0.00009785095,0.9978072,0.000006574062,0.00009395366,0.00043855302,0.000021996306,0.00043191673,0.00070840254,0.00012682892,0.00025105686,0.0000044678277],"about_ca_topic_score_codex":0.0045092274,"about_ca_topic_score_gemma":0.004462879,"teacher_disagreement_score":0.0045092274,"about_ca_system_score_codex":0.00028396104,"about_ca_system_score_gemma":0.0002393991,"threshold_uncertainty_score":0.014483333},"labels":[],"label_agreement":null},{"id":"W4411687141","doi":"10.1038/s41416-025-03023-3","title":"Nutritional status, body composition and chemotherapy dosing in children and young people with cancer: a systematic review by the SIOP nutrition network","year":2025,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of British Columbia; McMaster University Medical Centre","funders":"Faculty of Medical and Health Sciences, University of Auckland","keywords":"Medicine; Dosing; Systematic review; MEDLINE; Cochrane Library; Pediatric cancer; Overweight; Meta-analysis; Malnutrition; Cancer; Obesity; Pediatrics; Internal medicine","score_opus":0.00975793712829588,"score_gpt":0.3129931161485618,"score_spread":0.3032351790202659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411687141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014853243,0.9955967,0.000111191446,0.00029908473,0.000096456955,0.000937453,0.0011616746,0.000008926286,0.00030318042],"genre_scores_gemma":[0.0119478945,0.984115,0.00077582296,0.00035515832,0.000074512216,0.0019158835,0.0005966058,0.000005008659,0.0002141598],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99493414,0.0014004963,0.002285965,0.00034523723,0.00084310723,0.00019097768],"domain_scores_gemma":[0.98638827,0.008051414,0.0037003406,0.00021289205,0.0014352511,0.00021183041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067059402,0.0013827342,0.008906925,0.012783379,0.0006505461,0.0019771482,0.0012289814,0.001706668,0.006206799],"category_scores_gemma":[0.023482086,0.0010202928,0.0074727754,0.0121843545,0.00067614566,0.001840667,0.0015852654,0.0010982283,0.00040422438],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024789246,0.000011510421,0.0006904616,0.9663753,0.005694283,0.00005822196,0.00010998776,0.00004940791,0.000101210644,0.00009024312,0.0012811318,0.025290342],"study_design_scores_gemma":[0.0005342617,0.00025859982,0.0082244,0.88733876,0.083909184,0.00037221258,0.00020149743,0.00007621491,0.00013480092,0.00019305844,0.018711148,0.000045685552],"about_ca_topic_score_codex":0.01300971,"about_ca_topic_score_gemma":0.03408791,"teacher_disagreement_score":0.01300971,"about_ca_system_score_codex":0.0040136427,"about_ca_system_score_gemma":0.015509938,"threshold_uncertainty_score":0.035464823},"labels":[],"label_agreement":null},{"id":"W4412020425","doi":"10.1038/s41416-025-03093-3","title":"AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research UK; National Cancer Institute; Medical Research Council; University of Edinburgh; Institute of Genetics; Chief Scientist Office","keywords":"Gefitinib; PI3K/AKT/mTOR pathway; Protein kinase B; Epidermal growth factor receptor; EGFR inhibitors; Cancer research; Medicine; Oncology; Cancer; Internal medicine; Biology; Signal transduction","score_opus":0.004327264510138713,"score_gpt":0.2609226785418296,"score_spread":0.2565954140316909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412020425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94543505,0.037508536,0.0030048292,0.0015107869,0.00020163986,0.0001794452,0.0026079956,0.0006174607,0.00893432],"genre_scores_gemma":[0.98387593,0.010018014,0.0018092318,0.0002647471,0.000035388428,0.00007859462,0.0022247725,0.00003962537,0.0016536022],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980694,0.000033879183,0.000013442551,0.000040019375,0.00006544541,0.000040310406],"domain_scores_gemma":[0.99990594,0.000012425783,0.000021058459,0.000009604465,0.000029242408,0.000021685237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006023556,0.000528785,0.0006406594,0.0006529239,0.000241841,0.0013066124,0.00036553686,0.0003727139,0.0024281312],"category_scores_gemma":[0.0002610676,0.0001664887,0.00059330114,0.0005047481,0.00024185322,0.0004466629,0.0004078825,0.0007926977,0.0006421984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004708458,0.00097064493,0.023795543,0.0033116592,0.0006662397,0.0006664798,0.00018346068,0.0102231745,0.6776606,0.0036083069,0.010474722,0.2637307],"study_design_scores_gemma":[0.0012780285,0.008288123,0.100499265,0.0006224581,0.0018065966,0.003938578,0.0005242378,0.026527451,0.72000647,0.00290711,0.1334828,0.00011894399],"about_ca_topic_score_codex":0.0007016624,"about_ca_topic_score_gemma":0.0017749742,"teacher_disagreement_score":0.0024281312,"about_ca_system_score_codex":0.001092855,"about_ca_system_score_gemma":0.0007331689,"threshold_uncertainty_score":0.008122981},"labels":[],"label_agreement":null},{"id":"W4412493537","doi":"10.1038/s41416-025-03117-y","title":"Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK population","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"NIHR Cambridge Biomedical Research Centre; European Commission; National Research Foundation Singapore; Fondation du cancer du sein du Québec; National Cancer Institute; National Medical Research Council; National Research Foundation; Canadian Institutes of Health Research; Gray Foundation; Cancer Research UK; Government of Canada; Wellcome Trust; National Institute for Health and Care Research; Genome Canada","keywords":"Ethnic group; Breast cancer; Demography; Population; Ovarian cancer; Risk assessment; Medicine; Gerontology; Cancer; Gynecology; Environmental health; Computer science; Internal medicine; Political science; Sociology","score_opus":0.01439992445351368,"score_gpt":0.2992882903027251,"score_spread":0.2848883658492114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412493537","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44414705,0.0041323574,0.5131965,0.0046967994,0.00095195434,0.0010473846,0.01747989,0.0017828237,0.0125651425],"genre_scores_gemma":[0.7993797,0.0014021115,0.17217399,0.00088079594,0.0002028568,0.0014363161,0.014505716,0.00038036614,0.00963812],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983865,0.00094216573,0.000109816,0.00027533437,0.00017171504,0.00011437193],"domain_scores_gemma":[0.99500847,0.0032098363,0.00023084872,0.00033485334,0.0010236076,0.00019239337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004896183,0.0008111143,0.0012929159,0.002016504,0.00059170835,0.0016416564,0.0018595409,0.00096674,0.0067401677],"category_scores_gemma":[0.023266843,0.0006173004,0.00218465,0.0013745865,0.00027533295,0.00067483017,0.0016581732,0.0016118529,0.0015354406],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001452026,0.00026520423,0.2628788,0.0003936462,0.002313577,0.00080947427,0.00070890755,0.49392176,0.0006324235,0.009438672,0.03811995,0.18906562],"study_design_scores_gemma":[0.00027756832,0.00018949017,0.033581227,0.00023489058,0.00040320496,0.00076380995,0.00027396722,0.9372201,0.00020576536,0.013029843,0.013735626,0.00008454425],"about_ca_topic_score_codex":0.1189054,"about_ca_topic_score_gemma":0.07514351,"teacher_disagreement_score":0.1189054,"about_ca_system_score_codex":0.0016649726,"about_ca_system_score_gemma":0.001724881,"threshold_uncertainty_score":0.23642659},"labels":[],"label_agreement":null},{"id":"W4412591591","doi":"10.1038/s41416-025-03123-0","title":"Postdiagnosis physical activity is associated with improved survival in prostate cancer patients treated with surgery but not with radiation therapy","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; Radiation therapy; Surgery; Prostate; Oncology; Urology; Cancer; Internal medicine","score_opus":0.010123719431410964,"score_gpt":0.26672569454115513,"score_spread":0.2566019751097442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412591591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962773,0.0016149766,0.000066454464,0.00034394808,0.00011411517,0.0000048230386,0.0002531372,0.00000771062,0.0013174897],"genre_scores_gemma":[0.9986652,0.0003089128,0.000036993166,0.00007684704,0.00006536937,0.000003438473,0.00028195046,0.000003690287,0.00055763597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994708,0.00017121779,0.000051015937,0.00009220841,0.0000700596,0.00014475021],"domain_scores_gemma":[0.99755657,0.00070405944,0.00088532973,0.00013866033,0.00014942027,0.00056597346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035663915,0.0003531673,0.0005767741,0.00063478365,0.00042127242,0.00091419806,0.00043787714,0.0012439336,0.004362674],"category_scores_gemma":[0.0043391795,0.00043243504,0.0009811139,0.0010719334,0.00039515572,0.00046090852,0.00068476493,0.0014115854,0.0004849637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008416202,0.00013337037,0.99436826,0.000037168193,0.0001923776,0.00014057099,0.00009571539,0.000080196376,0.00030815235,0.000014639371,0.00018796152,0.0035999084],"study_design_scores_gemma":[0.000011211895,0.00013215523,0.9994266,0.000007954178,0.000038844042,0.000107288666,0.000061098835,0.00006066824,0.000017622428,0.000021271753,0.00011140012,0.0000038960966],"about_ca_topic_score_codex":0.0070002973,"about_ca_topic_score_gemma":0.008816779,"teacher_disagreement_score":0.0070002973,"about_ca_system_score_codex":0.00028974397,"about_ca_system_score_gemma":0.00030680856,"threshold_uncertainty_score":0.0145946145},"labels":[],"label_agreement":null},{"id":"W4412655860","doi":"10.1038/s41416-025-03111-4","title":"Cumulative incidence and survival outcomes of brain metastases in sarcoma: a large single center retrospective analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Sarcoma; Incidence (geometry); Liposarcoma; Retrospective cohort study; Proportional hazards model; Cohort; Oncology; Soft tissue sarcoma; Internal medicine; Single Center; Surgery; Pathology","score_opus":0.01659102603506322,"score_gpt":0.3358464172746656,"score_spread":0.31925539123960234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412655860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986488,0.00032394778,0.00011494715,0.00001561604,0.0000021573237,0.0000069992275,0.00076446903,0.000004314682,0.00011882737],"genre_scores_gemma":[0.9987557,0.00015860969,0.000076241595,0.000008236449,0.0000053394283,0.000006813412,0.0009642903,0.0000018392484,0.000022928585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995022,0.000108310895,0.000084463536,0.00014761514,0.000096861375,0.000060585175],"domain_scores_gemma":[0.9977863,0.0004056295,0.0011694536,0.0001818649,0.00020538401,0.00025132613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008114618,0.00020513947,0.0003471763,0.0012677545,0.00024254044,0.00045589486,0.00033555785,0.00022682938,0.00070557604],"category_scores_gemma":[0.0020373634,0.0002651461,0.0003949676,0.0013628418,0.00022887868,0.0003699709,0.0004582834,0.0002953466,0.0001533625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039676972,0.0000055841683,0.99910814,0.00000690528,0.000038912258,0.000062296815,0.000014227453,0.000048413145,0.00005587687,0.00000544692,0.000057111356,0.0005573541],"study_design_scores_gemma":[0.000005283148,0.0000676094,0.9985355,0.0000069469384,0.00004405881,0.0006853735,0.000075105614,0.00034469925,0.000053744658,0.000017292108,0.00015981571,0.0000044508256],"about_ca_topic_score_codex":0.0040938533,"about_ca_topic_score_gemma":0.0050806804,"teacher_disagreement_score":0.0040938533,"about_ca_system_score_codex":0.0003756108,"about_ca_system_score_gemma":0.0004155447,"threshold_uncertainty_score":0.0081400275},"labels":[],"label_agreement":null},{"id":"W4414030845","doi":"10.1038/s41416-025-03158-3","title":"Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dalhousie University; Sunnybrook Health Science Centre; Kingston Health Sciences Centre; Public Health Ontario; Queen's University","funders":"","keywords":"Medicine; Cancer; Interval (graph theory); Oncology; Association (psychology); Internal medicine; Surgery; Psychology; Mathematics","score_opus":0.13350112965896796,"score_gpt":0.47431983917714954,"score_spread":0.3408187095181816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414030845","genre_codex":"commentary","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021559706,0.012082831,0.3092094,0.43486616,0.010624861,0.1814661,0.0022878253,0.0011216023,0.026781589],"genre_scores_gemma":[0.0436133,0.0052850842,0.7679588,0.026284525,0.00048543888,0.15307578,0.00070571725,0.00021987165,0.002371405],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.27531743,0.62419796,0.0625077,0.0061265565,0.02548434,0.00636598],"domain_scores_gemma":[0.26169306,0.54714876,0.026745135,0.024473727,0.12914693,0.010792379],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5632882,0.0046762154,0.0032563538,0.014598313,0.0099977385,0.012979131,0.009025946,0.014951522,0.01244633],"category_scores_gemma":[0.66854376,0.0038590406,0.010701943,0.0103554735,0.014072959,0.016889164,0.024374476,0.016763706,0.0049541523],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010051572,0.0008437194,0.004999485,0.046573166,0.0008590108,0.0011193077,0.23617391,0.0038971691,0.0039360747,0.067164436,0.19418737,0.4392412],"study_design_scores_gemma":[0.0018637398,0.0010122382,0.0068301167,0.17626087,0.00085905415,0.001151007,0.19232643,0.00957091,0.0029432413,0.20506467,0.40084967,0.001268104],"about_ca_topic_score_codex":0.009458003,"about_ca_topic_score_gemma":0.007909473,"teacher_disagreement_score":0.4367118,"about_ca_system_score_codex":0.020729132,"about_ca_system_score_gemma":0.062488485,"threshold_uncertainty_score":0.53854346},"labels":[],"label_agreement":null},{"id":"W4414042072","doi":"10.1038/s41416-025-03140-z","title":"Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Wellcome Trust; Wellcome; U.S. Department of Health and Human Services","keywords":"Albuminuria; Kidney disease; Cancer; Kidney cancer; Disease; Incidence (geometry); Risk factor; MEDLINE","score_opus":0.08808982380877839,"score_gpt":0.38158669503425685,"score_spread":0.29349687122547846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414042072","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1177332,0.8592635,0.011517728,0.0015292679,0.0010754602,0.00056647434,0.0067325276,0.0002875934,0.001294303],"genre_scores_gemma":[0.88301927,0.10105128,0.0088437,0.0012526908,0.00043425398,0.0011243826,0.0033479622,0.00013661763,0.00078993186],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9864804,0.009963915,0.0010449325,0.0013756903,0.0007594259,0.0003755654],"domain_scores_gemma":[0.9750656,0.019246109,0.0020732484,0.002074158,0.0012296881,0.00031133962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022014644,0.002297102,0.00984464,0.0030150684,0.0006176809,0.0027316723,0.0020573,0.001920587,0.0030134018],"category_scores_gemma":[0.034004185,0.0013246748,0.04577109,0.004541826,0.00050064933,0.0009654017,0.0013566667,0.0022109046,0.00029527253],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056218985,0.00003601729,0.021926677,0.016092114,0.9482021,0.00014681542,0.000041921197,0.0021004404,0.00032298948,0.0001177153,0.0009833723,0.0044079344],"study_design_scores_gemma":[0.001019997,0.00026306167,0.009724311,0.0011481211,0.98512864,0.00012470006,0.000019298632,0.00094533694,0.00013956918,0.00029403155,0.0011681895,0.000024638006],"about_ca_topic_score_codex":0.007961155,"about_ca_topic_score_gemma":0.009612252,"teacher_disagreement_score":0.022014644,"about_ca_system_score_codex":0.0012908113,"about_ca_system_score_gemma":0.0016917138,"threshold_uncertainty_score":0.11642599},"labels":[],"label_agreement":null},{"id":"W4414195648","doi":"10.1038/s41416-025-03181-4","title":"Single-cell multiomic modelling of early metastatic events promoted by the extracellular matrix","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"Ministry of Science and ICT, South Korea; Korea Advanced Institute of Science and Technology; Ministry of Science, ICT and Future Planning; National Research Foundation","keywords":"Extracellular matrix; Metastasis; Carcinogenesis; In vitro; Matrix (chemical analysis); Extracellular","score_opus":0.029136422061138565,"score_gpt":0.29651867957370276,"score_spread":0.26738225751256417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414195648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92274356,0.0002897371,0.07305215,0.00010997222,0.000027399663,0.00004684663,0.0011484958,0.00021354525,0.0023683053],"genre_scores_gemma":[0.97995687,0.0002636782,0.018172437,0.000022149376,0.0000048720026,0.00008629748,0.00052385667,0.000033373286,0.00093648455],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99994993,0.0000073041288,0.0000023885414,0.000015004261,0.000014528682,0.0000108717395],"domain_scores_gemma":[0.999894,0.000050202878,0.000016657237,0.000009147491,0.000016523574,0.000013348965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014502119,0.0003896187,0.0002911998,0.00027885073,0.0001839299,0.0004344263,0.0003869025,0.0006489794,0.0009653521],"category_scores_gemma":[0.0002307486,0.00017985694,0.00058264786,0.00031506392,0.00027718005,0.00024468498,0.0002571263,0.00033455275,0.00015354791],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009979558,0.00009387614,0.0039512496,0.0001298395,0.0000417711,0.00024334318,0.00007355763,0.8394205,0.15134938,0.00084531645,0.00020303194,0.003548411],"study_design_scores_gemma":[0.0000036935753,0.000047535734,0.0022415116,0.0000031175512,0.000009982673,0.000035482357,0.000028309241,0.9866454,0.010438124,0.00026774564,0.00026847664,0.000010642361],"about_ca_topic_score_codex":0.004145277,"about_ca_topic_score_gemma":0.003349274,"teacher_disagreement_score":0.004145277,"about_ca_system_score_codex":0.00038109388,"about_ca_system_score_gemma":0.0003592873,"threshold_uncertainty_score":0.0082422495},"labels":[],"label_agreement":null},{"id":"W4414788238","doi":"10.1038/s41416-025-03150-x","title":"Machine learning-based prediction of luminal breast cancer subtypes using polarised light microscopy","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Optical Polarization and Ellipsometry","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Universiteit Gent; Natural Sciences and Engineering Research Council of Canada; Government of Canada; Princess Margaret Hospital Foundation","keywords":"Breast cancer; Microscopy; Cancer; Human breast; Mammary gland","score_opus":0.005449196015842769,"score_gpt":0.24483597486627168,"score_spread":0.23938677885042892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414788238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582891,0.0010306664,0.038025107,0.00031662144,0.000023611163,0.000065307635,0.00057413365,0.00043120145,0.0012442732],"genre_scores_gemma":[0.98565316,0.00018283285,0.013186992,0.000032608074,0.000018015793,0.000027968143,0.000624187,0.000016725597,0.00025755598],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995708,0.00015219001,0.000034409823,0.00008728768,0.000104460596,0.000050758386],"domain_scores_gemma":[0.9968298,0.0018992368,0.0005368149,0.0001453052,0.00047806496,0.00011083086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002025101,0.000547681,0.00041978978,0.0018361169,0.00019128644,0.0008312711,0.000396551,0.00053289835,0.0009804938],"category_scores_gemma":[0.0045948494,0.00015004343,0.0004609274,0.000587955,0.00030372245,0.0004391307,0.00036090592,0.0005242509,0.00061245915],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001325595,0.00021835846,0.7833463,0.00012870782,0.00018066367,0.000112015,0.00009016585,0.058060378,0.00987039,0.0002944723,0.0016839512,0.14468889],"study_design_scores_gemma":[0.00005752457,0.00035965993,0.24309342,0.00007267627,0.00013323444,0.0006658654,0.00015586952,0.74242264,0.009615453,0.0022828511,0.0010937577,0.000047037665],"about_ca_topic_score_codex":0.0018376871,"about_ca_topic_score_gemma":0.0019327068,"teacher_disagreement_score":0.002025101,"about_ca_system_score_codex":0.00046260047,"about_ca_system_score_gemma":0.0003318745,"threshold_uncertainty_score":0.010709882},"labels":[],"label_agreement":null},{"id":"W4414861549","doi":"10.1038/s41416-025-03207-x","title":"Lung cancer burden attributable to ambient particulate matter: a nationally representative population-based case-control study","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; Office of the First Minister and Deputy First Minister; Queen's University; Health and Social Care Research and Development Division; Public Health Agency; Centre for Ageing Research and Development in Ireland; Queen's University Belfast; Wellcome Trust; United Kingdom Clinical Research Collaboration; Economic and Social Research Council; World Health Organization","keywords":"Lung cancer; Particulates; Cancer; Respiratory disease; Lung disease; Air pollution; Air pollutants; Air quality index","score_opus":0.019185132473935253,"score_gpt":0.3581152801409979,"score_spread":0.33893014766706264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414861549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510324,0.000539215,0.0005010045,0.00008081209,0.00002428785,0.000119682685,0.0028900688,0.00002161597,0.0007200958],"genre_scores_gemma":[0.99653107,0.0002221093,0.00043313403,0.00010231394,0.00003284136,0.00012916079,0.002291246,0.00000642887,0.00025180547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758613,0.0006535391,0.00025576146,0.0009845088,0.00034692485,0.00017307387],"domain_scores_gemma":[0.99797255,0.00026886625,0.0006609295,0.00039411444,0.0004896379,0.00021380701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015582688,0.0004168355,0.00076451886,0.0010582196,0.0006943141,0.0010679322,0.000940502,0.0009312441,0.0014547035],"category_scores_gemma":[0.0031523441,0.0008016526,0.0009567345,0.0020974183,0.00047482352,0.0005793154,0.00071442826,0.0008567505,0.00045764976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014099944,0.00012093399,0.9970708,0.000042929176,0.0004552117,0.0001507763,0.00009931075,0.000062150575,0.00029242664,0.000022342567,0.0005089761,0.0010331309],"study_design_scores_gemma":[0.00004564505,0.000101678765,0.998626,0.000015653748,0.00018718878,0.00029341478,0.00012147093,0.00019133656,0.000037327776,0.00001537143,0.0003569584,0.000008028075],"about_ca_topic_score_codex":0.027159372,"about_ca_topic_score_gemma":0.02849573,"teacher_disagreement_score":0.027159372,"about_ca_system_score_codex":0.0009472183,"about_ca_system_score_gemma":0.00063916703,"threshold_uncertainty_score":0.054002583},"labels":[],"label_agreement":null},{"id":"W4415067350","doi":"10.1038/s41416-025-03216-w","title":"Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Genome British Columbia; Genome Canada; Scheme for Promotion of Academic and Research Collaboration; AstraZeneca","keywords":"Acquired resistance; Drug resistance; Primary (astronomy); Cancer; Resistance (ecology)","score_opus":0.005566039474640553,"score_gpt":0.23504852688843866,"score_spread":0.22948248741379812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415067350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973562,0.00027795925,0.0015657197,0.000024572304,0.0000033964002,0.000011491737,0.0004484816,0.000031316707,0.0002808546],"genre_scores_gemma":[0.99646336,0.00039339424,0.001836059,0.000011181073,0.0000011082952,0.00001623964,0.00065800257,0.000010140425,0.0006105719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994564,0.000006837513,0.0000035253004,0.000016040636,0.000016480786,0.000011503973],"domain_scores_gemma":[0.9999647,0.000008383962,0.000009696218,0.0000044372628,0.000004782758,0.000008097755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007927074,0.00022917085,0.00026444023,0.00013399783,0.00008394776,0.00025315493,0.00016325114,0.00023232904,0.0007355613],"category_scores_gemma":[0.00007702166,0.00010223559,0.00026297744,0.0001600216,0.00009932013,0.00013650542,0.00010450979,0.0003708148,0.00019923042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020195066,0.000050360573,0.00279918,0.000027030135,0.000014063696,0.0000593332,0.000022298149,0.0064393175,0.98846215,0.000051721687,0.000056345576,0.0018162107],"study_design_scores_gemma":[0.000020073243,0.0016766795,0.022819035,0.000003825266,0.00003976466,0.0003466484,0.000084936924,0.04068347,0.9328889,0.00009384577,0.0013318873,0.000010765799],"about_ca_topic_score_codex":0.0020802042,"about_ca_topic_score_gemma":0.002218162,"teacher_disagreement_score":0.0020802042,"about_ca_system_score_codex":0.0003732065,"about_ca_system_score_gemma":0.00017538432,"threshold_uncertainty_score":0.0041362047},"labels":[],"label_agreement":null},{"id":"W4415242909","doi":"10.1038/s41416-025-03176-1","title":"Correction: Cumulative incidence and survival outcomes of brain metastases in sarcoma: a large single center retrospective analysis","year":2025,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Single Center; Retrospective cohort study; Incidence (geometry); Cumulative incidence; Survival analysis; Center (category theory)","score_opus":0.008666260954167565,"score_gpt":0.2912496759025512,"score_spread":0.2825834149483836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415242909","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046888646,0.0012665236,0.0014701664,0.04680277,0.9444393,0.000042795076,0.003695027,0.00039274173,0.0014217795],"genre_scores_gemma":[0.055224307,0.010539587,0.015452047,0.13230334,0.6226027,0.00073513016,0.014732092,0.0034874883,0.14492323],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9942935,0.001262271,0.0014663402,0.00088961096,0.0017544463,0.00033384582],"domain_scores_gemma":[0.95889676,0.014115656,0.0025503056,0.0028709096,0.019898714,0.0016675937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005697114,0.002625175,0.001905547,0.0039913603,0.0013968206,0.0027136882,0.003284842,0.003555628,0.031405963],"category_scores_gemma":[0.109718435,0.0011363394,0.0016664658,0.0034806775,0.0014353093,0.0018522171,0.0016610649,0.0073951064,0.015772669],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008047419,0.000005146692,0.00030071882,0.0002746979,0.000041532236,0.00025972677,0.000029932438,0.00007163039,0.000053816253,0.00036047836,0.99351716,0.005004651],"study_design_scores_gemma":[0.00023550034,0.000046198496,0.0058196527,0.0015061633,0.00025278708,0.002253638,0.00015958733,0.0009825358,0.00076990994,0.0029245333,0.9849141,0.00013536615],"about_ca_topic_score_codex":0.021149127,"about_ca_topic_score_gemma":0.016841866,"teacher_disagreement_score":0.031405963,"about_ca_system_score_codex":0.0031366183,"about_ca_system_score_gemma":0.0039877435,"threshold_uncertainty_score":0.10506338},"labels":[],"label_agreement":null},{"id":"W4416745819","doi":"10.1038/s41416-025-03291-z","title":"Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human Papillomavirus-positive oropharyngeal cancer","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Cardiff University; Cancer Research UK","keywords":"Pathological; Cancer; Correlation; Clinical trial; Radiation therapy; Randomized controlled trial","score_opus":0.017806048284632902,"score_gpt":0.3358578400001948,"score_spread":0.3180517917155619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416745819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98177254,0.0089699505,0.0005286104,0.0010197574,0.00081337587,0.005080178,0.0003077306,0.000047343838,0.0014604703],"genre_scores_gemma":[0.9917664,0.00129845,0.0011430917,0.0004729963,0.00033195037,0.004105747,0.0002898873,0.000007809383,0.0005837305],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.97987294,0.017259821,0.0009453205,0.0009135722,0.00049833284,0.00051001034],"domain_scores_gemma":[0.98214805,0.009653151,0.004864487,0.0011737985,0.00077279913,0.00138762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012738289,0.0009977277,0.0033086466,0.00053692335,0.0004964834,0.0015107135,0.000900463,0.0027590692,0.0030912696],"category_scores_gemma":[0.030075246,0.00074754807,0.0024864112,0.0006621845,0.0015256505,0.001447495,0.0010217845,0.002591682,0.00038553894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9830771,0.0011205099,0.0031460442,0.00090487977,0.0011642617,0.000042348114,0.00010298374,0.0003725634,0.0004003236,0.00009249281,0.00026420617,0.0093123],"study_design_scores_gemma":[0.9050666,0.07879875,0.012169422,0.00030262503,0.0014891892,0.00006328549,0.00006074451,0.0008218164,0.00021534383,0.0003478275,0.00063168094,0.000032604054],"about_ca_topic_score_codex":0.0012872227,"about_ca_topic_score_gemma":0.001761473,"teacher_disagreement_score":0.012738289,"about_ca_system_score_codex":0.0013963272,"about_ca_system_score_gemma":0.0020840762,"threshold_uncertainty_score":0.067367315},"labels":[],"label_agreement":null},{"id":"W4417156739","doi":"10.1038/s41416-025-03287-9","title":"Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Natural Science Foundation of Heilongjiang Province; National Natural Science Foundation of China; Harbin Medical University","keywords":"Breast cancer; Endocrine system; Mammary gland; Oestrogen receptor; Key (lock); Cancer","score_opus":0.013944085488671354,"score_gpt":0.3942441363294163,"score_spread":0.3803000508407449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417156739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971487,0.00046960785,0.0009011262,0.00002257732,0.0000028749153,0.000007281014,0.0009480795,0.000031396008,0.0004683033],"genre_scores_gemma":[0.99738103,0.00016727949,0.00070198235,0.000019815878,0.000002859688,0.0000139749045,0.0012157564,0.0000070750084,0.00049019075],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999249,0.000007804814,0.00000479253,0.000022515938,0.000019600508,0.000020472236],"domain_scores_gemma":[0.99993634,0.000007952924,0.000028540606,0.0000056083813,0.000011753279,0.000009785268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008491179,0.000121480705,0.00015493849,0.00030616077,0.00009478646,0.00023377869,0.0000923865,0.00015330286,0.0009392339],"category_scores_gemma":[0.00014074895,0.00008153783,0.00015278654,0.0003527808,0.00009695236,0.00011778299,0.00014398171,0.00016473055,0.00017447428],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011399629,0.00006400494,0.07401281,0.00012763766,0.00006086282,0.00014402403,0.00009159912,0.0011801835,0.90813357,0.000107225525,0.0002555458,0.014682496],"study_design_scores_gemma":[0.000013739572,0.00035833206,0.8620417,0.000008020743,0.00006544608,0.00078949897,0.00028762984,0.004281787,0.12970792,0.00018966732,0.002240634,0.00001566831],"about_ca_topic_score_codex":0.0005140873,"about_ca_topic_score_gemma":0.0009001451,"teacher_disagreement_score":0.0009392339,"about_ca_system_score_codex":0.00015531597,"about_ca_system_score_gemma":0.0000898921,"threshold_uncertainty_score":0.0031419992},"labels":[],"label_agreement":null},{"id":"W4417180871","doi":"10.1038/s41416-025-03283-z","title":"RNLS hypomethylation as a potential epigenetic marker of lung cancer metastasis: an epigenome-wide association study","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenetics; Lung cancer; DNA methylation; Biomarker; Methylation; Cancer; Epigenesis","score_opus":0.006221083234359233,"score_gpt":0.30815077420217146,"score_spread":0.30192969096781225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417180871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974498,0.0010749422,0.0006905798,0.00008714874,0.000011503584,0.000005846541,0.0002131404,0.000009729059,0.0004573504],"genre_scores_gemma":[0.99911934,0.00013635022,0.0001879015,0.000023528704,0.000009987129,0.0000033272604,0.00012568096,0.000005052082,0.0003887273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941444,0.00020060346,0.000044743996,0.0001876323,0.0000803677,0.00007216781],"domain_scores_gemma":[0.9994161,0.00020628843,0.00013122887,0.000073141426,0.000078308636,0.00009500672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000979998,0.00034312363,0.00046522258,0.0005325952,0.0004599252,0.00057029555,0.00041220788,0.0005188504,0.0022638913],"category_scores_gemma":[0.0012687976,0.0002770643,0.00066161674,0.000781588,0.00031212714,0.00023737937,0.00047448187,0.0006720501,0.00022595796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032515863,0.0001334174,0.93989044,0.00012711294,0.0020505649,0.00080498296,0.00043296057,0.00026858764,0.0401401,0.0002122787,0.0003881946,0.012299806],"study_design_scores_gemma":[0.000037105947,0.00023860618,0.9950269,0.000009410733,0.0008113368,0.00076562294,0.00013820243,0.0006900264,0.0012742386,0.00007249757,0.00092607085,0.000010044229],"about_ca_topic_score_codex":0.00520916,"about_ca_topic_score_gemma":0.00981313,"teacher_disagreement_score":0.00520916,"about_ca_system_score_codex":0.00022784443,"about_ca_system_score_gemma":0.00022746545,"threshold_uncertainty_score":0.010357678},"labels":[],"label_agreement":null},{"id":"W4417457436","doi":"10.1038/s41416-025-03296-8","title":"Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Hazard ratio; Hepatocellular carcinoma; Circulating tumor DNA; Meta-analysis; Confidence interval; Prospective cohort study; Minimal residual disease; Cochrane Library; Retrospective cohort study","score_opus":0.02065616346553874,"score_gpt":0.311864347715507,"score_spread":0.29120818424996825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417457436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014824341,0.983706,0.00047584556,0.00017229735,0.00016361663,0.00005504445,0.0004244625,0.000020957212,0.00015743203],"genre_scores_gemma":[0.5992974,0.39555985,0.0017459192,0.0013557423,0.00042429342,0.00022880422,0.00084323506,0.000046648354,0.00049814174],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99513704,0.0019501762,0.0012475165,0.0009852194,0.00044924434,0.00023079135],"domain_scores_gemma":[0.9893077,0.0075328504,0.0018223216,0.0005623929,0.0005558699,0.00021889525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006956894,0.0018498203,0.0125168525,0.0025479794,0.00043203225,0.0026072776,0.0017638843,0.002760589,0.0030816272],"category_scores_gemma":[0.015788147,0.00133982,0.03288853,0.0038035454,0.00076811435,0.0014903189,0.0015034563,0.0020653955,0.0003252981],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044589113,0.000036030244,0.017446099,0.11298501,0.8524152,0.00014021496,0.00009559468,0.0005978093,0.0004078938,0.000079455705,0.0005260419,0.010811785],"study_design_scores_gemma":[0.000715851,0.00022577718,0.011015061,0.004673911,0.9820264,0.00008860453,0.00005602112,0.00017982563,0.00007887582,0.00013195451,0.0007711519,0.00003652034],"about_ca_topic_score_codex":0.0061360677,"about_ca_topic_score_gemma":0.014748278,"teacher_disagreement_score":0.0125168525,"about_ca_system_score_codex":0.0012104005,"about_ca_system_score_gemma":0.0014884156,"threshold_uncertainty_score":0.03679198},"labels":[],"label_agreement":null},{"id":"W61689417","doi":"10.1054/bjoc.2001.2090","title":"Neurodevelopment of children exposed in utero to treatment of maternal malignancy","year":2001,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"In utero; Pregnancy; Medicine; Gestation; Malignancy; Fetus; Cancer; Obstetrics; Pediatrics; Pathology; Internal medicine","score_opus":0.04197365772468709,"score_gpt":0.3453487714311606,"score_spread":0.3033751137064735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W61689417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060867204,0.9985903,0.000024824156,0.000093743125,0.00003545612,0.0000030130057,0.000021235232,0.000001852372,0.0006209654],"genre_scores_gemma":[0.0026448623,0.99700385,0.00006795162,0.00004111338,0.000024013927,0.0000039762267,0.000020519701,3.897533e-7,0.00019339754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967647,0.00008547782,0.00006750576,0.000036780526,0.00011306964,0.000020795449],"domain_scores_gemma":[0.9994425,0.0003170371,0.00010968784,0.000011919778,0.00010120319,0.000017638144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056870974,0.00043681837,0.0012995327,0.0015341669,0.00017511747,0.0004357911,0.00041471346,0.00054388685,0.0018608281],"category_scores_gemma":[0.0017053727,0.00013110679,0.0005325563,0.0020337994,0.0002164394,0.00037609483,0.00023010641,0.00034906936,0.00046318912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014997598,0.000046316123,0.004641577,0.03222877,0.00028193803,0.0007548263,0.00013433519,0.00015447472,0.0006595728,0.00040538586,0.008786181,0.95175666],"study_design_scores_gemma":[0.00009044126,0.00089497666,0.094188295,0.05077906,0.0024201537,0.027439252,0.00076356914,0.00016794894,0.0031363664,0.0012201038,0.8188427,0.000057129924],"about_ca_topic_score_codex":0.0031323647,"about_ca_topic_score_gemma":0.005497236,"teacher_disagreement_score":0.0031323647,"about_ca_system_score_codex":0.0005205088,"about_ca_system_score_gemma":0.0008646507,"threshold_uncertainty_score":0.006228268},"labels":[],"label_agreement":null},{"id":"W7640235","doi":"10.1038/bjc.1995.358","title":"귀납적 방식과 연역적 방식의 기술자료가 중학생들의 생물 지식 구성에 미치는 영향","year":2008,"lang":"en","type":"dissertation","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mathematics","score_opus":0.014185161097180269,"score_gpt":0.32846176431068486,"score_spread":0.3142766032135046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7640235","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.281263,0.39022097,0.050037112,0.096293055,0.018227572,0.023374308,0.0044270144,0.00044997068,0.1357071],"genre_scores_gemma":[0.70860225,0.16722614,0.06832858,0.018870562,0.005413687,0.0069929617,0.0017999037,0.000083494684,0.022682415],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9930593,0.005094089,0.0006210338,0.00043189272,0.00067216076,0.00012153389],"domain_scores_gemma":[0.9618813,0.03220943,0.002314887,0.0012800166,0.0017226839,0.0005916793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023048537,0.00047432227,0.0014875117,0.00095010916,0.00038557,0.001221496,0.00058055134,0.0018927869,0.018057922],"category_scores_gemma":[0.058173716,0.00029687074,0.0016338152,0.00088226626,0.0013211387,0.00066158746,0.00044180048,0.0014496365,0.0023198095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06109013,0.0057590473,0.016513195,0.08442531,0.011847333,0.0002824273,0.00062845985,0.0024067238,0.007967322,0.03507166,0.030305441,0.7437029],"study_design_scores_gemma":[0.18265983,0.16381583,0.08284343,0.056848858,0.044737373,0.0012890818,0.001762349,0.0050252913,0.021848038,0.12585591,0.31285778,0.000456167],"about_ca_topic_score_codex":0.00092335563,"about_ca_topic_score_gemma":0.0012978709,"teacher_disagreement_score":0.023048537,"about_ca_system_score_codex":0.0007878525,"about_ca_system_score_gemma":0.003049464,"threshold_uncertainty_score":0.12189376},"labels":[],"label_agreement":null}]}